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SODIUM SELENATERETARDS EPILEPTOGENESIS
VIA ACTIVATING PROTEIN PHOSPHATASE 2A
P. Zheng*, S. Liu*, N. Jones*, S. Shultz*, G. Dezsi*, D. Wright†,
C. Hovens‡, T.J. O’Brien*,§
*The Royal Melbourne Hospital, Medicine, Melbourne,
Australia, †The Florey Institutes of Neuroscience and Mental
Health, Melbourne, Australia, ‡The Royal Melbourne Hospital,
Surgery, Melbourne, Australia, §Melbourne Brain Centre,
Neurology, Melbourne, Australia
Purpose: Epileptogenesis describes the neurobiological processes that
convert a healthy brain into an epileptic brain. There are no treatments
available to mitigate epileptogenesis in clinical practice. Down-regula-
tion of protein phosphatase 2A (PP2A) activity increases phosphorylated
tau (p-tau), which is implicated in acquired epilepsy. To investigate the
role of PP2A in epileptogenesis, and the effects of a specific PP2A activa-
tor – sodium selenate –we utilized three well-characterised rat models of
epilepsy: electrical amygdala kindling, post-kainic acid status epilepticus
(post-SE) and post-traumatic epilepsy (PTE).
Method: For amygdala kindling, rats were implanted with subcuta-
neous osmotic pumps that delivered selenate (1 mg/kg/day) or vehicle
continuously for 4 weeks. Rats received 30 electrical stimulations over
the final 3 weeks of treatment. For post-SE experiments, SE was
induced by kainic acid injections. Rats were then implanted with sub-
cutaneous osmotic pumps that continuously released selenate or vehicle
for 8 weeks. After 5 weeks of treatment, rats underwent MRI followed
by continuous video-EEG monitoring. Rats were then given a drug
washout period and then underwent additional video-EEG monitoring.
For PTE, rats randomly suffered sham surgery or lateral fluid percus-
sion injury and saline vehicle or selenate treatment. After 3-month
recovery, all rats underwent video-EEG monitoring during and after
the treatment.
Results: PP2A activity and expression of the PR55 regulatory subunit B
were significantly decreased, and phosphorylation of tau was increased,
in all three models. Selenate treatment slowed the progression of epilep-
togenesis in three models (delayed kindling and reduced spontaneous sei-
zures post-SE and PTE), reversed the biochemical abnormalities, and
reduced hippocampal atrophy in the post-SE model. In post-SE and PTE
model, this effect was sustained after drug washout, which indicated an
anti-epileptogenic effect.
Conclusion: Epileptogenesis is associated with down-regulation of
PP2A activity and an increase in phosphorylated tau, and enhancing
PP2A activity with selenate is a potential anti-epileptogenic therapy.
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MORPHOLOGICALCHANGES IN EEG, AQUAPORIN-
4, C-FOS ANDTHEHIPPOCAMPUSOFANIMAL
MODELSWITHTEMPORAL LOBE EPILEPSY
INDUCEDBYKAINIC ACID
E. Taskiran*, C. Yılmaz†, N. Orhan†, M. Bahceci†, M. Kaya‡,
B. Ahishali‡, M. Kucuk†, N. Arican‡, C. Gurses§
*Neurology Department, Istanbul Medipol University, Istanbul,
Turkey, †Istanbul University, Research Institute of Experimental
Medicine, Istanbul, Turkey, ‡Istanbul University Istanbul
Faculty of Medicine, Istanbul, Turkey, §Department of
Neurology and Clinical Neurophysiology, Istanbul University,
Istanbul Faculty of Medicine, Istanbul, Turkey
Purpose: Temporal lobe epilepsy (TLE) is the most frequent type of
localization-related focal epilepsy seen in humans. It has a frequency rate
of 30–35% among all epilepsies, and comprises 70% of intractable
epilepsies. With hippocampal sclerosis as the most often observed
histopathological finding, its epileptogenesis is still researched.
Method: We investigated alterations in EEG findings during epilepto-
genesis, and the immunohistochemical correlation of AQP4 and c-fos
levels to hippocampal morphology in TLE induced by kainic acid (KA)
models. Sixty four young adult (220–270 gr) Wistar albino rats were
divided into EEG and immunohistochemistry subgroups of sham, acute
and chronic KA groups. Following the implantation of depth electrodes,
rats were administered 5–15 mg/kg KA. In addition to observing AQP4
and c-fos proteins at the end of the first 24 hours and 60th day, continu-
ous video EEG monitoring (VEM) was carried out for 60 days. Seizure
patterns and interictal (II) epileptiform activities on VEM were investi-
gated.
Results: All rats in the acute KA group had status epilepticus (SE).
While no spontaneous convulsive seizures were observed in the chronic
KA group, electrophysiologically rhythmic slow waves were seen during
the clinical staring episodes. Interictally, spike/sharp waves were
observed. II activity tended to increase gradually during the 60 days. As
c-fos immune dying intensified in the hippocampal CA1 and amygdala,
an increased rate of AQP4 immune dying in the endotelial cells in the
brain capilleries (in the endotelial cells as well as the cytoplasma and feet
of the astrocytes) were observed. We determined a correlation between
the increased intensity of c-fos and AQP4 proteins in hippocampus and
amygdala with the electrophysiological finding of increased number of
spikes.
Conclusion: Based on our findings, it is possible to suggest that impaired
blood brain barrier (BBB) and increased AQP4 immunoreactivity
contibute to the development of epileptogenesis.
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SHARED PATHOPHYSIOLOGYOFTEMPORAL LOBE
EPILEPSYANDALZHEIMER’S DISEASE –A
DIFFERENTIAL PROTEOMICS APPROACH INA
POST-STATUS EPILEPTICUSMODEL
E.-L. von Rüden*, C. Zellinger*, A. Walker*, V. Russmann*,
K.J. Kleinwort†, C.M. Szober†, C. von Toerne‡, C.A. Deeg†,
S.M. Hauck‡, H. Potschka*
*Ludwig-Maximilians-University, Inst. of Pharmacology,
Toxicology, and Pharmacy, Munich, Germany, †Ludwig-
Maximilians-University, Inst. of Animal Physiology, Munich,
Germany, ‡Helmholtz Center Munich, Research Unit Protein
Science, Munich, Germany
Introduction: Clinical evidence points to a bidirectional link between
temporal lobe epilepsy (TLE) and Alzheimer’s disease (AD). However,
clear-cut conclusions about a functional link between the pathophysiolo-
gies are clinically difficult. Therefore, we performed a large-scale differ-
ential protome analysis in a rat TLE model of epileptogenesis and
compared these data sets with available information about differential
protein expression in ADmodels.
Materials and Methods: Following an electrically-induced status
epilepticus in female Sprague Dawley rats, hippocampal (HC) and
parahippocampal cortex (PHC) tissues were individually subjected to a
label-free liquid chromatography tandem mass spectrometry analysis at
three time points reflecting the early insult phase (2 days, n = 5), latency
phase (10 days, n = 5), and the chronic phase with spontaneous recurrent
seizures (8 weeks, n = 5). Control animals (n = 5 per timepoint) were
handled in parallel.
Results: We identified proteins associated with amyloid-beta process-
ing, deposition, plaque formation, and amyloid-beta-associated pathol-
ogy (ApoE and a-synuclein) being regulated in the time course of
epileptogenesis.
Moreover, the analysis pointed to an epileptogenesis-associated
down-regulation of the microtubule-associated protein Tau in the PHC,
whereas Tau exhibited an up-regulation in the HC in the latency phase.
Furthermore, our data sets reveal a prominent dysregulation of mito-
chondrial expression patterns, which is a typical feature of AD patho-
physiology, in the PHC and a less pronounced dysregulation in the HC
associated with epileptogenesis.
Conclusion: Altogether, our findings provide comprehensive informa-
tion about the time course of epileptogenesis-associated alterations in the
expression patterns of proteins functionally linked with AD pathophysi-
ology, pointing towards a shared pathophysiology of both diseases and
further providing information about potential biomarkers. These proteins
require immunohistological validation in future studies.
We are grateful to Marion Fisch, Sieglinde Fischlein, Fabian Gruhn,
Sandra Helm, Barbara Kohler, Regina Rentsch, Claudia Siegl, and
Angela Vicidomini for their excellent technical assistance.
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SYSTEMICDELIVERYOFANTAGOMIRS TARGETING
MICRORNA-134 AFTER STATUS EPILEPTICUS
REDUCE SPONTANEOUS RECURRENT SEIZURES IN
MICE
C. Ruedell Reschke, E.M. Jimenez-Mateos, A. Sanz-Rodriguez,
A. Batool, D.C. Henshall
Department of Physiology &Medical Physics, Royal College of
Surgeons in Ireland, Dublin, Ireland
Purpose: Acquired epilepsy is associated with large-scale changes in
gene expression which underlie the cell and network-level changes dur-
ing epileptogenesis. Despite various efforts we still have no treatments to
prevent the emergence of epilepsy following brain injury. Evidence has
emerged that microRNAs, a family of small non-coding RNAs, are
important regulators of gene expression in epilepsy. Recent work showed
that miRNA-134 is overexpressed in the temporal lobe of patients with
pharmacoresistant seizures and in experimental models of epilepsy.
Silencing miR-134 using intracerebroventricular injections of antago-
mirs (Ant) potently suppressed evoked and spontaneous seizures in mice.
Here we explored a more clinically relevant route of delivery of these
macromolecules, timing injection of antagomirs with blood-brain barrier
(BBB) opening after status epilepticus in mice.
Method: Status epilepticus (SE) was induced in C57BL/6 adult mice by
an intra-amygdala microinjection of kainic acid. Timing of BBB opening
was assessed by Evans blue and FITC-dextran injections, and confirmed
by extravasation of serum albumin and mouse IgG levels into the brain
parenchyma. Antagomirs were locked nucleic acid- and cholesterol-mod-
ified. Injections were then timed accordingly andmice subject to continu-
ous long-term video-telemetry EEG recording.
Results: BBB opening in this model was apparent 2 h after status epilep-
ticus. Systemic injection of Ant-134 at this time point did not alter the
duration or severity of status epilepticus in mice but significantly reduced
the number of spontaneous seizures recorded in mice compared with
scrambled-sequence and vehicle-injected status epilepticus controls.
These seizure-suppressive effects persisted at 1 and 2 months after the
SE.
Conclusion: The present study provides evidence that macromolecule
targeting of an epilepsy-associated microRNA is effective using a clini-
cally-relevant delivery route, supporting the potential translation of this
anti-epileptogenic treatment for epilepsy.
Platform Session: Drug Therapy
Sunday, 6th September 2015
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ASSESSINGBIOEQUIVALENCEOFGENERIC
MODIFIEDRELEASEANTIEPILEPSY DRUGS
E. Johnson*, Y.-T. Chang†, B. Davit‡, B. Gidal§, G.L. Krauss*
*Johns Hopkins School of Medicine, Neurology, Baltimore, MD,
USA, †Johns Hopkins University Bloomberg School of Public
Health, Biostatistics, Baltimore, MD, USA, ‡Merck
Pharmaceuticals, Rahway, NJ, USA, §University of Wisconsin
School of Pharmacy, Division of Pharmacy Practice, Madison,
WI, USA
Purpose: To determine how closely generic modified-release anti-epi-
leptic drugs (MR-AEDs) resemble brand formulations, we compared
bioequivalence (BE) data for United States Food and Drug Administra-
tion (FDA)-approved MR-AEDs. We compared peak concentrations
(Cmax), total absorption (AUC), time to Cmax (Tmax), intersubject vari-
ability, and food effects between generic/reference products.
Method: We collected Cmax and AUC data from the BE studies used to
support the approvals of 42 generic MR-AED formulations. We com-
pared the upper and lower limits of 90% confidence intervals (CI) of the
generic/brand AUC and Cmax geometric mean ratios (GMRs), and inter-
subject variability, Tmax, and fasting/fed differences for MR formula-
tions of: phenytoin (8 products), carbamazepine (5 products), divalproex
sodium (7 products), levetiracetam (15 products), and lamotrigine (7
products).
Results: Forty-two MR-AED formulations were studied with 3175 non-
epilepsy subjects in 97 fasting or fed BE studies. BE ratios for AUC and
Cmax were similar for most products: AUC ratios varied by >15% in
11.4% of BE studies; Cmax varied by >15% in 25.8% of studies. Tmax
was more variable, with >30% difference in 13 studies. Tmax was usually
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delayed in the fed BE studies compared to fasting studies. Generic and
brand products had similar intersubject variability, suggesting either
could be used for initial therapy. MR products did not generally reduce
intersubject variability in AUC and Cmax compared to immediate release
(IR) products; IR and MR lamotrigine provided variable concentrations
across subjects while the IR and MR carbamazepine products had less
variability.
Conclusion: Most generic and brand MR-AED formulations have simi-
lar AUC and Cmax values; a small number of products had 90% CI near
acceptance limits which could potentially be clinically significant. Food
effects are common with MR-AED products; most MR brand products
do not provide advantages with reduced variability across subjects com-
pared to generic products or when compared to IR products.
0007
DISEASE-MODIFICATION BYACOMBINATORIAL
TREATMENTOFANTI-INFLAMMATORYDRUGS IN
TWORODENTMODELSOF EPILEPSY
V. Iori, F. Frigerio, A. Pauletti, M. Rizzi, A. Torello, T. Ravizza,
A. Vezzani
Mario Negri Institute for Pharmacological Research,
Neuroscience, Milan, Italy
Purpose: Neuroinflammation is induced in epileptogenic foci after an
inciting event in epilepsy models; this phenomenon was validated in
brain specimens from pharmacoresistant patients. Specific anti-inflam-
matory treatments greatly reduce provoked or spontaneous seizures in
experimental models. We studied whether a combination of drugs target-
ing the ictogenic IL-1b/HMGB1 pro-inflammatory signaling affects the
disease onset or its progression in two rodent models of symptomatic epi-
lepsy.
Method: Status epilepticus (SE) was induced in adult male rodents by
electrical stimulation of the hippocampus (Sprague-Dawley rats) or by
intra-amygdala injection of kainate (C57BL6 mice). In rats, a combina-
tion of anakinra (IL-1 receptor antagonist), BoxA (HMGB1 antagonist)
and ifenprodil (NR2B antagonist) was given 1 h post-SE for 6 consecu-
tive days. In mice, a combination of VX-765 (IL-1 biosynthesis inhibi-
tor) and Cyanobacterial LPS (TLR4 antagonist) was given at the onset of
epilepsy for 7 days. Controls were vehicle-injected animals exposed to
SE. EEG recording (24/7) was done from SE induction until the onset of
spontaneous seizures, and for additional 2 weeks in the chronic epilepsy
phases. At the end of recording, the Morris Water Maze or the Novel
Object Recognition test was performed to assess cognitive performance,
then animals were fixative-perfused for brain histology.
Results: The combined treatments reduced by 2-fold the proportion of
animals with a progressive increase in seizure frequency: progression
occurred in 40% of treated animals vs 80% in the vehicle group. More-
over, the progression index was decreased by 2-fold in treated animals.
The treatment reduced by 3-fold seizure frequency in animals with a non-
progressive disease. Finally, treatment reduced neurodegeneration in
forebrain and improved non-spatial memory deficits in epileptic animals
while spatial memory was unaffected.
Conclusion: Pharmacological targeting of IL-1b/HMGB1 signaling
either before or after epilepsy onset, specifically interferes with disease
progression, suggesting that anti-inflammatory treatments modify the
disease course.
Supported by EPITARGET n°602102
0008
PHARMACOLOGICALOUTCOMES IN JUVENILE
MYOCLONIC EPILEPSYOVER 30 YEARS
A. Chowdhury, M.J. Brodie
Western Infirmary, Epilepsy Unit, Glasgow, UK
Purpose: To investigate the long-term outcomes in patients with Juve-
nile Myoclonic Epilepsy (JME) at a single centre over 30 years.
Method: A retrospective analysis was undertaken in 186 patients (male:
n = 78; female: n = 108) diagnosed with JME at the Epilepsy Unit in the
Western Infirmary, Glasgow, Scotland between July 1982 and 2012.
Results: Median age at treatment start was 16 years (range 12–44 years)
with a median duration of follow-up of 14 years (range 2–32 years).
Overall 171 patients (92%) achieved terminal remission on antiepileptic
drug (AED) therapy with a mean seizure-free period of 9.5 years (range
1–31 years). Fifteen patients (5 male, 10 female) continued to have sei-
zures despite taking up to 8 AED regimens, 7 of whom had psychiatric
comorbidities. Most commonly prescribed AEDs included sodium val-
proate (VPA; n = 142), lamotrigine (LTG; n = 66) and levetiracetam
(LEV; n = 22). Overall, VPA represented 44% of all AEDs prescribed to
male patients compared with 31% in females. Fewer males received LTG
(n = 17; 26% vs. n = 49; 74%) and LEV (n = 4; 18% vs. n = 18; 82%).
Terminal remission was achieved more often using monotherapy with
VPA (n = 74, 52%) and LEV (n = 12, 55%) than with LTG (n = 21;
32%). More males than females attained terminal remission on their first
or second AED (n = 69; 88% vs. n = 60; 56%). AED monotherapy
resulted in intolerable side-effects in 76 patients.
Conclusion: JME is a benign syndrome with high rates of seizure free-
dom. Female patients had a worse outcome than males, since they were
less likely to receive VPA because of concerns regarding teratogenicity.
Patients with psychiatric comorbidities were also less likely to achieve
optimal seizure control.
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EFFICACYAND SAFETYOFANTI-TUMORNECROSIS
FACTORALPHATHERAPY INRASMUSSEN’S
ENCEPHALITIS: ANOPEN STUDY
S. Lagarde*,†, N. Villeneuve‡,§, F. Bartolomei*,†, Adalimumab
Rasmussen Study Group
*Assistance Publique-Ho^pitaux de Marseille, Ho^pital de la
Timone, Service de Neurophysiologie Clinique, Marseille,
France, †Aix Marseille Université, Institut de Neurosciences des
Systemes, Marseille, France, ‡Ho^pital Henri Gastaut, Marseille,
France, §Assistance Publique-Ho^pitaux de Marseille, Ho^pital
de la Timone, Service de Neuropédiatrie, Marseille, France
Purpose: Rasmussen’s encephalitis (RE) is a severe chronic inflamma-
tory brain disorder affecting one cerebral hemisphere, leading to drug-
resistant epilepsy, progressive neurological deficit and unilateral brain
atrophy. Some immunomodulatory therapies have been tried with varied
efficacy, but there is no standardized treatment strategy. TNF a seems to
play an important role in RE pathophysiology including pro-inflamma-
tory, pro-epileptogenic and pro-excitotoxicity effects.
Method: We report an open study evaluating the effect of anti-TNF-a
therapy (Adalimumab) in 10 patients with RE. The main outcome crite-
rion was the decrease by 50% of monthly number of days with seizure.
Results: Adalimumab was started with a median delay of 4.8 years after
first seizures (range: 1 month-16 years) and followed-up a median per-
iod after initiation of 18.4 months (range: 12–36 months). Four patients
(40%) were found to be responders experiencing a rapid and prolonged
effect after Adalimumab initiation. Adalimumab was well tolerated with-
out remarkable clinical side effects.
Conclusion: Adalimumab showed safety of use and efficacy in a propor-
tion of patients with RE, in term of seizure control and neurological defi-
cit. The long-term effect of this treatment on larger series is needed to
confirm these preliminary promising results.
Epilepsia, 56(Suppl. 1):3–263, 2015
doi: 10.1111/epi.13241
5
Abstracts
0010
SPASMCONTROLAT 3, 6 AND 12MONTHS INWEST
SYNDROME: RANDOMISED, SINGLEBLIND
CLINICAL TRIALON INTRAMUSCULAR LONG
ACTINGACTHVERSUSORAL PREDNISOLONE
J. Wanigasinghe*, C. Arambepola*, S. Sri Ranganathan*,
S. Sumanasena†, E. Muhandirum*
*University of Colombo, Colombo, Sri Lanka, †University of
Kelaniya, Colombo, Sri Lanka
Purpose: Most literature on treatment for West syndrome, concentrate
on the immediate spasm control. What is important is to identify the long
term outcome in relation to spasm control and developmental outcome.
Hormonal therapy is currently established as its first line therapy.
However, which form of hormonal therapy i.e. intra-muscular long acting
tetracosactrine (ACTH) or oral prednisolone is more efficacious for long
term spasm control is not yet known.
Method: A prospective randomized, single blind clinical trial was con-
ducted in Sri Lanka. Ninety seven newly diagnosed, previously untreated
children with confirmed epileptic spasms, with hypsarrhythmia on EEG,
were randomized to receive oral prednisolone or ACTH for 14 days
according to the United Kingdom Infantile Spasm Study protocol. Spasm
control was evaluated at different time points (3, 6, and 12 months).
Spasm control was defined as absence of spasms for more than 1 week at
these reviews.
Results: Forty eight infants on prednisolone and 49 on ACTH completed
the treatment. Spasm cessation by 14th day occurred in 58.3% with pred-
nisolone in comparison to only 36.7% with ACTH (p = 0.03). The num-
ber of children completing follow up at 6 and 12 months were 29 and 29
for prednisolone and 23 and 25 for ACTH respectively. There were 3
deaths by 6 months and 6 deaths by 12 months. Absence of spasms at
3rd-month follow up was 66.7% with prednisolone and 38.2% with
ACTH (p = 0.006). Absence of spasms at 6 months with prednisolone
was 60.4% compared to 46.9% with ACTH (p = 0.18). Absence of
spasms at 12 months was 60.4% for prednisolone and 51% for ACTH
(p = 0.35).
Conclusion: This trial shows that the spasm control for first 3 months
was significantly better if treated with oral prednisolone. However, long-
term spasm control at 6 and 12 months was similar for oral prednisolone
and intramuscular ACTH.
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HIGH FREQUENCYOSCILLATIONS IN THE INTRA-
OPERATIVECORTICOGRAMBEFOREANDAFTER
SURGERY: BETTER PREDICTIONOFOUTCOME
M. van ‘t Klooster*, N. van Klink*, W. Zweiphenning*,
F. Leijten*, R. Zelmann†, C. Ferrier*, P. van Rijen*, K. Braun*,
G. Huiskamp*, M. Zijlmans*,‡
*Brain Center Rudolf Magnus, University Medical Center
Utrecht, Utrecht, Netherlands, †Montreal Neurological
Institute, McGill University, Montreal, Canada, ‡SEIN,
Stichting Epilepsie Instellingen Nederland, Heemstede,
Netherlands
Purpose: The aim of intra-operative electrocorticography (ECoG) is
delineation of epileptogenic tissue for complete resection. This tailoring
currently relies on interpretation of interictal spikes. High frequency
oscillations (HFOs, ripples 80–250 Hz, especially fast ripples (FRs, 250–
500 Hz), are considered a better biomarker for epileptogenic tissue than
spikes. We studied the predictive value of HFOs versus spikes in com-
bined pre- and post-resection ECoG for surgical outcome.
Method: We studied pre- and post-resection ECoG recorded at 2048 Hz
in patients with refractory focal epilepsy. We marked FRs, ripples and
spikes in 1 minute of each recording. We determined presence (+) or
absence (-) of these events pre- and post- resection and defined four
patient groups: pre+post- (+/-), pre+post+ (+/+), pre-post+ (-/+) and pre-
post- (-/-). We compared residual post-resection events to outcome, given
the presence or absence of pre-events (Fisher exact). Outcome was cate-
gorized into seizure freedom (Engel 1A) vs. seizure recurrence (Engel
1B-4).
Results: We included 54 patients (median age 15.5y, 33 TLE) with
25 months median follow-up. Twenty-four patients had recurrent sei-
zures. The number of patients with FRs[+/-,+/+,-/+,-/-] were
[28,10,2,14], with ripples [3,51,0,0] and with spikes [12,34,4,4]. Residual
FRs, given the presence of pre-resection FRs(+/-,+/+) were significantly
associated with outcome (p = 0.02): eighteen out of twenty-eight
patients with FRs before but not after resection were seizure-free and
eight out of ten patients with FRs before and after resection had seizure
recurrence. Presence or absence of residual FRs had no predictive value
in the absence of pre-resection FRs(-/+,-/-) (p = 1.0). There was no asso-
ciation with outcome for ripples (p(+/-,+/+)=0.25) and spikes (p(+/-
,+/+)=0.74, p(-/+,-/-)=1.0).
Conclusion: The presence or absence of FRs in post-ECoG, given FRs
in pre-ECoG is a prognostic marker for surgical outcome. The use of FRs
for tailoring with repeated ECoG recordings might influence the success
rate of epilepsy surgery in individual cases.
0012
LONGTERMOUTCOMEOF PATIENTSWITH
OCCURRENCEOF SEIZURES IN FIRST YEARAFTER
EPILEPSY SURGERY
M. Ryzí*, H. Oslejskova*, M. Brazdil†, Z. Novak‡,
J. Chrastina‡, I. Rektor†
*Brno University Hospital and Faculty of Medicine, Masaryk
University, Brno, Czech Republic, †Epilepsy Center Brno; First
Department of Neurology, St. Anne’s University Hospital and
Faculty of Medicine, Central European Institute of Technology
(CEITEC), Masaryk University, Brno, Czech Republic,
‡Epilepsy Center Brno; Department of Neurosurgery, St. Anne’s
University Hospital and Faculty of Medicine, Masaryk
University, Brno, Czech Republic
Purpose: The aim of the study was to evaluate the long term outcome of
patients with persisting seizures in first year after epilepsy surgery. The
secondary objectives were to analyse the conditions with impact on this
outcome.
Method: We retrospectively reviewed all patients who were surgically
treated between January 1995 and January 2010 at the Epilepsy Center
Brno. 96 patients (33.8% of all patients) with persisting seizures in first
year after surgery and minimal 5 years outcome were included in this
analysis. Outcome was assessed yearly by ILAE classification for first
5 years and variable last follow-up visit.
Results: At 5 year follow-up visit 27 out of 96 patients (28.1%) were
classified as ILAE class I, 16 (16.7%) as class 2, 8 (8.3%) as class 3, 23
(24.0%) as class 4, 19 (19.8%) as class 5 and 3 (3.1%) as class 6. At the
last follow-up visit (average of 10.0  3.73 years after surgery) were
seizure free 35 (36.5%) patients. This finding is explicable by statistically
significant difference between average time of onset add on AED therapy
in patient class 2 (median 5.5) and other groups (medians 1.0–2.4 years).
Outcome was dependent on localisation of epilepsy (at the last follow up
visit: 50.0% seizure free patients with other temporal, 33.3% with mesial
TLE associated with hippocampal sclerosis and 26.5% with extratempo-
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ral epilepsy) and initial outcome in first year (60.9% seizure free in ini-
tially class 3 patients and 25% in group initially class 5).
Conclusion: More than quarter of patients with seizures after surgery
have a chance to be seizure free and AED strategy after resective surgery
may be a potentially modifiable prognostic indicator influencing seizure
outcome in patients with intractable epilepsy.
0013
STEREOTACTIC ENCEPHALOGRAPHY (SEEG)
IMPLANTATIONOFTHE INSULA; TECHNIQUEAND
SAFETY IN PATIENTSWITHMEDICALLY
INTRACTABLE EPILEPSY
S.A. Alomar, S. Smithason, J. Mullin, J.A. Gonzalez-Martinez
Cleveland Clinic, Epilepsy Center, Cleveland, OH, USA
Purpose: We review our experience with SEEG recording in patients
with medically intractable epilepsy and suspected insular involvement in
the initiation and organization of the epileptic activity.
Method: 170 consecutive patients who underwent SEEG implantation
between June 2009 and July 2012 were analyzed. We identified patients
with suspected insular involvement based on seizure semiology, imaging
(MRI, PET and SPECT) or scalp EEG recording. Patients with at least
one insular electrode were included.
Results: A total of 1374 electrodes were implanted in 90 patients with
suspected insular involvement (9–17 electrode per patient). 187 elec-
trodes were implanted in the insula (1–4 electrodes per patient). 23
patients (25.6% of patients with insular implanation) were confirmed by
SEEG to have insular onset or early involvement of insula in epileptogen-
esis. The most common trajectory of implantation was orthogonal to the
insula. None of the patients experienced any medical or surgical compli-
cations related to the insular implantation.
Conclusion: Insular epilepsy is a rare entity. Stereotactic implantation of
depth electrodes in the insula is a safe technique for investigating sus-
pected insular involvement in cases of intractable epilepsy.
0014
ACOMPATIBILITY STUDYOFMRI AND FDG-PET
FINDINGSWITHHISTOPATHOLOGICALRESULTS IN
PATIENTSWITHFOCALCORTICALDYSPLASIA
G. Halac*, S. Delil†, D. Zafer†, C. Isler†, M. Uzan†, S.N. Yeni†,
M. Halac†, C. Ozkara†
*Bezmialem Vakif University, Istanbul, Turkey, †Istanbul
University Cerrahpasa Faculty of Medicine, Istanbul, Turkey
Purpose: Focal cortical dysplasia (FCD) is an abnormality of cortical
development that occurs during neuronal migration and often leads to
medically refractory seizures. The aim of this study was to examine the
compatibility of MRI, and PET findings in patients with epilepsy under-
went surgery for refractory seizures and diagnosed to have FCD after
pathological examination.
Method: Cranial MRI, FDG-PET and histopathological findings of
patients who underwent surgery were included in the study. All data were
reviewed retrospectively and analysed according to the different
histopathological subgroups of FCD.
Results: There were 71 patients (38 females, 33 males); mean age at the
seizure onset was 8.5 years (1 months- 30 years), at surgery was
21.6 years (4 months-46 years) and mean duration of disease was
21.8 years (3 months-38 years). According to the ILAE histopathologi-
cal classification, 21.2% (n = 20) patients were classified as type 1a;
19.7% (n = 14) as type 1b; 33.8% (n = 24) as type 2a and 18.3%
(n = 13) as type 2b. Localization of the lesions was as follows: temporal
35.2% (n = 25), frontal 46.4% (n = 33), parietal 16.9% (n = 12) and
occipital 1.4% (n = 1). FCD was visible in MRI of 76.05% (n = 54) of
patients, 29.6% (n = 16) of them had FCD type 1a; 14.8% (n = 8) type
1b; 33.3% (n = 18) type 2a and 22.2% type 2b. In 77.4% (n = 55)
patients there was FDG-PET hypometabolism where 24.4% (n = 14) of
them had temporal and FCD type 1a. In 59.1% (n = 42) patients both
MRI and PET was positive and 30.9% of them had type 1a and type 2a.
In. 14.08% (n = 10) of them PET positive MR negative and 40% (n = 4)
of them type 2a.The number of PET negative MRI positive was 11.2%
(n = 8).
Conclusion: EEG, MRI and 18F-PET have different importance and
should be evaluated in parallel before surgery.
0015
TAILORED FRONTALLOBECTOMYAFTER
POSTERIORQUADRANTECTOMYVERSUS
FUNCTIONALHEMISPHEROTOMYFOR
HEMISPHERIC PEDIATRIC EPILEPSY PATIENTS
D.-S. Kim*, H.-D. Kim†, J.-S. Lee†
*Yonsei University College of Medicine, Neurosurgery, Seoul,
Republic of Korea, †Yonsei University College of Medicine,
Pediatric Neurology, Seoul, Republic of Korea
Purpose: To study the outcome of Tailored Frontal lobectomy after pos-
terior quadrantectomy for hemispheric pediatric epilepsy patients, com-
pare to functional hemispherotomy.
Methods: A retrospective analysis of the Severance children’s hospi-
tal’s epilepsy surgery database was done in all children who underwent
a Functional hemispherotomy (FH) and Tailored frontal lobectomy
after posterior quadrantectomy (FLPQ) from February 2006 to Decem-
ber 2012. All patients underwent a delicated pre surgical evaluation.
Seizure outcome was used by the Engel’s classification. And complica-
tion related to surgery were compared with each group. FLPQ group
was underwent second staged operations. 1st surgery was performed
posterior quadrantectomy (behind motor cortex and temporo-occipital
lobe) and subdural grid insertion on the frontal area. After surgery,
patients underwent intracranial EEG monitoring using subdural grid
for a week. Based on that result, We decided the Frontal resection
margin. 2nd stage surgery was Frontal lobectomy along the determined
resection margin.
Results: There was 39 patients (50 operation cases including revision
of hemispherotomy) in FH group. Epilepsy etiology was due to Len-
nox-Gastaut syndrome, Rasmussen’s encephalitis (RE), Infantile hemi-
plegia seizure syndrome (IHSS), Hemimegalencephaly (HM), Sturge-
Weber syndrome (SWS) and due to post-encephalitis or post-traumatic
sequelae (PES or PTS). Seizure control rate of functional hemisphero-
tomy was 85.7% (42/49 cases, Engel classification I, II). 7 patients
were inserted shunt after hemispherotomy and 7 patients were in need
re-operation due to post- operative adhesion, incomplete disconnection.
Another 5 patients were underwent 2nd staged Tailored Frontal lobec-
tomy after Posterior quadrantectomy. 100% seizure control rate was
seen in this group. (Engel classification I, II). Just 1 case had post-
operative complication, hemiparesis. FLPQ group did not need to sac-
rify the unilateral motor function.
Conclusion: Tailored Frontal lobectomy after posterior quadrantec-
tomy was shown excellent seizure outcome. This new procedure
could be treat the hemispheric epilepsy patient without sacrifice of
motor function.
Epilepsia, 56(Suppl. 1):3–263, 2015
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0016
LONGTERMOUTLOOK INCHILDHOODABSCENSE
EPILEPSY (CAE) AND IN JUVENILE ABSCENSE
EPILEPSY (JAE)
L. Oller F. V*,A. Russi Tintore†, T. Tarancon Heras†,
H. Bhathal†
*Private Medical Consultation Neurology, Barcelona, Spain,
†Epilepsy Unit, Hospital Quiron-Teknon, Barcelona, Spain
Purpose: To evaluate the clinical and EEG characteristics in CAE and
JAE as predictors of outcome in a long term cohort.
Method: From our pool of approximately 7000 patients (from 1973 to
2013) we included, according to strict diagnostic criteria, the CAE and
JAE patients, with at least 1 year of follow-up. We studied the clinical
history, the neurophysiologic studies performed (EEG and VEEG), and
neuroimaging (CT and/or MRI). The main variables analyzed were sex,
age, family history of epilepsy, personal history of febrile seizures, sei-
zure types, EEG parameters and seizure outcome. Statistical procedure
was univariate analysis. Qualitative variables were studied by Chi-
square, and the quantitative variables by ANOVA tests and t-Student
analysis.
Results: We identified 168 CAE patients (43.5% male, 56.6% female)
and 50 JAE patients (54% male, 46% female), with a mean years of fol-
low-up of 29.4 and 25.4, respectively. Mean age of onset for CAE and
JAE was 6.5 and 14, respectively. Positive family history of epilepsy (1st
degree relative) in CAE group was 20.2%, and in JAE 20%. Previous his-
tory of febrile seizures was present in 3.6% of CAE group, and in 12% of
JAE group. Seizure rate of more than one per day was 86.3% in CAE and
72% in JAE. Total seizure remission rate was 82.2% for CAE and 8% for
JAE. Epileptogenic anomalies in EEG recordings were found in 88.1% of
CAE, and in 80% of JAE. Delta posterior rhythm was only found in CAE
patients.
Conclusion: Some authors consider CAE and JAE entities within the
same continuum. From our patient population we saw the following
differences which were statistically significant: seizure rate is higher in
CAE, generalized tonic-clonic seizures are more frequent in JAE, seizure
remission is higher in CAE.We thus conclude they are two different enti-
ties with a very different prognosis.
0017
SEIZURES AND PAROXYSMALNON-EPILEPTIC
EVENTS IN CHILDRENWITHANTI-NMDAR-
ENCEPHALITIS: A VIDEO-EEG STUDY
S. Matricardi*,†, E. Freri*, S. Binelli‡, F. Ragona*, F. Zibordi*,
M. Patrini*, F. Andreetta§, N. Nardocci*, T. Granata*
*”C. Besta” Neurological Institute, Department of Pediatric
Neuroscience, Milano, Italy, †University of Chieti, Department
of Pediatrics, Chieti, Italy, ‡”C. Besta” Neurological Institute,
Department of Neurophysiology, Milano, Italy, §”C. Besta”
Neurological Institute, Neuroimmunology Unit, Milano, Italy
Purpose: Anti-N-Methyl-D-aspartate-receptor (NMDAR) encephalitis
is a potentially treatable disease characterized by the abrupt onset of a
constellation of symptoms resulting from diffuse brain dysfunction. In
children, seizures and other paroxysmal events are frequently reported to
be the presenting or prominent symptoms.
We report our experience with 13 pediatric patients, focusing on the
electroclinical semiology of seizures, the co-occurrence of epilepsy and
movement disorders, and the differential diagnosis between seizures and
paroxysmal non-epileptic events.
Method: The series includes 13 patients (7 females and 6males) affected
by anti-NMDAR-encephalitis, observed at our Department between
2007 and 2014. All patients underwent clinical, and laboratory assess-
ment, including serial video-EEG-polygraphic recordings.
Results: The median age at disease onset was 10 years (3–17 years).
The median time from disease onset and the first observation at our
Department was 3 months (8 days–4 years). Median follow-up was
25 months (3–112 months). Seizures have been reported among the pre-
senting symptoms in 10 patients. In most cases, seizures recurred at high
frequency in the early stages, than frequency and severity decreased.
Mixed seizure types have been recorded in 6 patients, particularly focal
motor and dyscognitive. EEG is abnormal in almost all patients showing
focal and/or generalized slowing, and misdiagnosed as non-convulsive
status epilepticus in 3 cases. Paroxysmal non-epileptic events were
observed in all patients but one. They included a wide variety of move-
ment disorders (orofacial dyskinesia, choreoathetosis, catatonia, dysto-
nia, opistotonus, ballism, ataxia, and stereotyped and rhythmic
movements) often in combination in the same patient. Seizures did not
benefit from AEDs but disappeared after immunotherapy.
Conclusion: The differential diagnosis between epileptic and non-epi-
leptic paroxysmal events was particularly challenging in patients in
whom seizures and movement disorders were closely associated or inter-
mingled. The video-EEG-polygraphy allowed the correct diagnosis of
the different symptoms leading to the appropriate treatment.
0019
BURDEN, CAUSES, RISK FACTORSAND
BEHAVIOURALCONSEQUENCESOFACUTE
SEIZURES IN PRESCHOOLCHILDREN IN RURAL
KENYA: A POPULATION-BASED STUDY
S.M. Kariuki*, A. Abubakar*, A. Stein†, C.R. Newton†
*KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya,
†University of Oxford, Department of Psychiatry, Oxford, UK
Purpose: Acute seizures are common in children admitted to hospitals in
Africa, but there are no representative community based studies. Beha-
vioural/emotional problems may occur in children with acute seizures,
but the relationship between the two conditions is not understood. Com-
munity studies on the burden, risk factors and behavioural consequences
of acute seizures are required in Africa for planning interventions.
Method: We screened for acute seizures in 7,013 children aged 1–
6 years residing in a defined and regularly enumerated area in Kilifi,
Kenya. Prevalence of acute seizures was accounted for attrition between
first and second phases using multiple imputation. Disability-Adjusted
Life Years (DALYs) were computed as Years Lived with Disability since
mortality is relatively uncommon in acute seizures. Causes of acute sei-
zures were identified using aWHO algorithm for IntegratedManagement
of Childhood Illnesses. Risk factors for acute seizures were determined
with a multivariable logistic regression model. Behaviour was assessed
with preschool Child Behaviour Checklist.
Results: The adjusted prevalence of acute seizures was 4.0/100 popula-
tion (95% confidence interval (95%CI), 3.5–4.5). The DALYs lost to
acute seizures were 291/100,000 population (95%CI, 258–323). Com-
monest causes of acute seizures were malaria (51%), respiratory tract
infections (35%) and gastroenteritis (7%). Factors associated with acute
seizures were family history of seizures (odds ratio (OR)=4.53 (95% con-
fidence interval (95%CI), 2.22–9.27)), family history of febrile seizures
(OR=18.79 (95%CI, 9.73–36.31)), previous hospitalisation (OR=4.20
(95%CI, 2.05–8.60)), bed-net use (OR=1.90 (95%CI, 1.03–3.52)) and
head injury (OR=0.08 (95% (0.00–0.80)). Behavioural problems were
more common in those with acute seizures than those without (26% vs.
11%; p < 0.001).
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Conclusion: The burden of acute seizures in preschool children in Kenya
is high. Infections are common causes of acute seizures while family his-
tory of seizures is an important risk factor. Acute seizures are associated
with behavioural problems, but further studies are required.
0020
NEURONALNETWORKS IN EPILEPTIC
ENCEPHALOPATHIESWITHCSWC
N. Japaridze, M. Siniatchkin, U. Stephani, M. Muthuraman
UKSH, Kiel, Germany
Aim: Continues spikes and waves during slow sleep (CSWS) is an age
related epileptic encephalopathy characterized by occurrence of diffuse,
continues spike and wave discharges during NREM sleep, seizures and
psychomotor impairment. The aim of our study was to investigate the
neuronal networks underling background oscillations of CSWC using the
source analysis method Dynamic Imaging of Coherent Sources (DICS)
and renormalized partial directed coherence (RPDC).
Methods: In order to investigate underlying network and effective con-
nectivity within the detected network, a DICS analyses and renormalized
partial directed coherence (RPDC) methods were applied. The baseline
sleep EEG recordings and follow up sleep EEG recordings from 12
Patients with CSWSwere used for the analyses.
Results and Conclusions: The results revealed that independent of aeti-
ology and severely of the disease CSWS EEG pattern is associated with
the complex network of coherent sources in medial prefrontal cortex,
somatosensory association cortex/posterior cingulate cortex, medial pre-
frontal cortex, middle temporal gyrus/parahippocampal gyrus/insular
cortex, Thalamus and cerebellum. The described network underlying
CSWS was found on both group and individual levels and was no longer
observed in follow up EEGs of the patients with normalized sleep EEGs,
suggesting the specificity of the network for the CSWS pattern. Further
on, for the first time, using RPDC analyses we investigated the hierarchy
within the described network, which showed that Thalamus, together
with mesial temporal and parietal regions may be seen as a central hub of
the underlying network. The involvement of this thalamocortical net-
work, which was no longer observed in normalized EEGs, and a further
propagation towards the frontal region may interfere with restructuring
of cognitive networks in the sensitive phase of development.
Platform Session: Genetics 1
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EPILEPSYWITHAUDITORY FEATURES: A
HETEROGENEOUS CLINICO-MOLECULARDISEASE
F. Bisulli*, L. Licchetta*, S. Baldassari†, P. Flavia†,
V. Menghi*, D. Roberto‡, C. Leta*, C. Stipa*, G. Boero§,
G. d’Orsi¶, A. Magi**, I. Scheffer††, M. Seri‡‡,§§, P. Tinuper*,
T. Pippucci§§
*IRCCS Istituto delle Scienze Neurologiche of Bologna,
Bologna, Italy, †University of Bologna, Department of Medical
and Surgical Sciences, Bologna, Italy, ‡Laboratory of
Integrative Systems Medicine (LISM), Institute of Informatics
and Telematics and Institute of Clinical Physiology, National
Research Council, Pisa, Italy, §S.C. of Neurology, SS.
Annunziata Hospital, Taranto, Italy, ¶Epilepsy Centre, Clinic of
Nervous System Diseases, University of Foggia, Riuniti
Hospital, Foggia, Italy, **Department of Clinical and
Experimental Medicine, University of Florence, Florence, Italy,
††Florey Institute, University of Melbourne, Austin Health and
Royal Children’s Hospital, Melbourne, Australia, ‡‡Department
of Medical and Surgical Sciences, University of Bologna,
Bologna, Italy, §§U.O. Medical Genetics, Polyclinic
Sant’Orsola-Malpighi, Bologna, Italy
Purpose: Epilepsy with auditory features (EAF) is a rare focal epilepsy
phenotype. In the rare familial epilepsy syndrome of autosomal dominant
epilepsy with auditory features (AD-EAF), the majority of affected indi-
viduals usually have EAF and 50% of families have mutations in the
leucine-rich, glioma-inactivated 1 gene (LGI1). EAF also occurs in iso-
lated individuals, or in one or two members of families with marked phe-
notypic heterogeneity. Such families may not fulfill criteria for a specific
familial epilepsy syndrome nor show a clear-cut inheritance pattern; little
is known about their molecular basis. We sought to identify novel genes
for EAF.
Method: We identified 15 probands with EAF in whom a LGI1 mutation
had been excluded. We performed electroclinical phenotyping on all pro-
bands and available members affected with EAF or other epilepsy. We
used Whole Exome Sequencing (WES) in 20 individuals with EAF (in-
cluding 5 relatives) to identify single nucleotide, small insertions/dele-
tions and copy number variants.
Results: In 4 families, WES revealed pathogenic variants in genes which
had not been so far associated to EAF: a CNTNAP2 2-exon deletion, 2
truncating mutations of DEPDC5 and a missense SCN1A change. Addi-
tional candidate variants of unclear significance were observed in differ-
ent genes (CACNA1H, RELN) already associated or not with epilepsy.
Conclusion: Occurrence of EAF in families with DEPDC5 and SCN1A
mutations widens the phenotypic spectrum of the epilepsy phenotypes
related to these genes. CNTNAP2 encodes CASPR2, a member of the
VGKC-complex in which LGI1 plays a role. The finding of a CNTNAP2
deletion emphasizes the importance of this complex in EAF and shows
biological convergence.
0022
CLINICALWHOLE-EXOME SEQUENCING IN FOCAL
EPILEPSIES OF SUSPECTEDGENETIC ETIOLOGY
P. Perucca*,†, I.E. Scheffer†,‡,§, T.J. O’Brien*,†, S. Harvey§,
P.A. James*, S. Lunke†,¶, N. Thorne**, C. Gaff**, P. Kwan*,†,
Melbourne Genomics Health Alliance
*Royal Melbourne Hospital, Melbourne, Australia, †University
of Melbourne, Melbourne, Australia, ‡Florey Institute, Austin
Health, Melbourne, Australia, §Royal Children’s Hospital,
Melbourne, Australia, ¶Centre for Translational Pathology,
Melbourne, Australia, **Melbourne Genomics Health Alliance,
Melbourne, Australia
Purpose: Mutations in a growing number of genes have been implicated
in the pathogenesis of different focal epilepsies, but how this information
assists in routine clinical care has not been explored. We investigated the
diagnostic yield of whole-exome sequencing (WES) in the management
of patients with focal epilepsies in whom genetic factors were suspected
to play a role.
Method: This was a prospective study of patients routinely assessed as
either outpatients or inpatients who met predefined criteria: age
>4 weeks; diagnosis of focal epilepsy; noMRI epileptogenic lesion; fam-
ily history of epilepsy or febrile convulsions in first- or second-degree
relatives. Previous genetic testing, severe intellectual disability and
benign epilepsy with centro-temporal spikes were exclusion criteria.
Patients underwent WES, and identified variants in 59 epilepsy genes
were classified by pathogenicity. The “presumptive diagnostic rate” was
the proportion of patients with pathogenic or likely/potentially patho-
genic variants.
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Results: Thirty-six patients were recruited (9 children, 27 adults).
Twenty-seven patients had a single first- or second-degree relative with
epilepsy or febrile convulsions, 6 had two affected relatives, and 3 had
three. The presumptive diagnostic rate for the cohort was 22% (8/36
patients). Pathogenic and likely or potentially pathogenic variants were
found in different genes, including SCN1A, PCDH19, KCNT1, KCNQ2,
GABRG2, POLG, SPTAN1, and PRRT2. The presumptive diagnostic rate
was 22% in both children and adults, 26% in patients with one-first- or
second-degree affected relative and 11% in those with multiple affected
relatives.
Conclusion: WES identifies pathogenic or likely/potentially pathogenic
mutations in more than one in five patients with common focal epilepsies
of suspected genetic etiology, supporting its use in the routine clinical care.
0024
QUANTITATIVE FEATURESOF SCN1AASSOCIATED
EPILEPSIES: RELATIONSHIPS AMONGGENOTYPE,
FUNCTIONALALTERATION, AND PHENOTYPE
W. Liao*, H. Meng*,†, H. Xu*, L. Yu*, N. He*, Y. Shi*,
J. Wang*, Y. Yi*
*Institute of Neuroscience and The Second Affiliated Hospital of
Guangzhou Medical University, Guangzhou, China,
†Department of Neurology, The First Affiliated Hospital of
Jinan University, Guangzhou, China
Purpose: Mutations in SCN1A gene have been identified in epilepsies
with widely variable severity, ranging from the extremely severe form of
severe myoclonic epilepsy of infancy to the mild form of generalized epi-
lepsy with FS plus, or pure FS. It is suspected whether there is a quantita-
tive correlation between phenotype severity and mutation impairment.
Method: We systematically reviewed all SCN1A mutations and estab-
lished a database (http://www.gzneurosci.com/scn1adatabase/). Further
analysis was performed to explore the quantitative relationships among
genotype, functional alteration, and phenotype.
Results: In total, 1,248 SCN1A mutations were identified in patients with
epilepsy. There was a negative correlation between phenotype severity and
frequency ofmissensemutation, which does not result in gross proteinmal-
formation. Missense mutations in the pore region were characterized by
complete loss of function (LOF), similar to haploinsufficiency. Mutations
with severe phenotypes were more frequently located in the pore region,
with a quantitative correlation between the frequency of LOF mutants and
the phenotype severity. To date, 30 mosaic SCN1A mutations have been
reported. Mosaic mutation loads of <12.5% (a quarter of a heterozygous
mutation) were not associated with any symptom; whereas mutation loads
of >25% were associated with FS or mild epilepsy, and mutations with a
load of 12.5–25.0%were potentially pathogenic with low penetrance.
Conclusion: The data frommosaic mutations showed that a 25% impair-
ment of SCN1A function was pathogenic, suggesting that the normal
excitability of the brain is highly dependent on the fully functioning of
SCN1A gene. The phenotype severity of SCN1A mutation is quantita-
tively correlated with mutation impairment.
0025
GENEHUNTING INDRAVETANDMYOCLONIC
ATONIC EPILEPSY SYNDROME
S. Weckhuysen*,†, S. von Spiczak‡, R.S. Møller§, M. Zemel¶,
C. Meyers**, H. Mefford††, EuroEPINOMICS-RES Dravet,
MAE working group
*Institut du Cerveau et de la Moelle Epiniere - ICM - CNRS
UMR 7225 - INSERMU 1127 - UPMC-P6 UMR S 1127, Team
‘Genetics and Physiopathology of Familial Epilepsies’, Paris,
France, †VIB DMG, Antwerp, Belgium, ‡Universitaet Kiel,
Universit€atsklinikum Schleswig-Holstein, Klinik für
Neurop€adiatrie, Kiel, Germany, §Danish Epilepsy Centre,
Dianalund, Denmark, ¶University of Washington, Seattle, WA,
USA, **University of Washington, Dept of Pediatrics, Seattle,
WA, USA, ††University of Washington, Division of Genetic
Medicine, Seattle, WA, USA
Purpose: Dravet syndrome (DS) and Myoclonic Atonic Epilepsy
(MAE) are two infantile-childhood onset epilepsy syndromes showing
some overlap in clinical features (e.g, myoclonic seizures), and genetic
causes (e.g. mutations in SCN1A, CHD2). We aimed to find additional
genes underlying these two related syndromes.
Method: Trio whole exome sequencing was performed on 31 DS
patients and 40 MAE patients. Forty brain-expressed candidate genes
with only a single de novo hit were selected for follow up screening of a
larger cohort of 122 DS(-like) and 86 MAE patients, using a gene panel
using Molecular Inversion Probe Sequencing (MIPS) technique. Eleven
known genes linked to DS andMAE syndrome were added to the panel.
Results: A total of 95 novel variants were identified in the whole cohort.
At the moment of abstract submission, segregation analysis of 60 novel
variants was performed, and 16 variants occurred de novo, 44 variants
were inherited. Eleven patients carried a de novo mutation in a known
gene: Six DS patients in SCN1A, 1 DS patient in HCN1, and 2 DS-like
patients in SCN8A and PCDH19 respectively. TwoMAE patients carried
a de novomutation in SYNGAP1. We further identified a second de novo
mutation in 5 different candidate genes. Functional validation of these
genes is ongoing.
Conclusion: Whole exome sequencing followed by targeted gene panel
analysis is a powerful technique for novel gene identification, especially
when performed in clinically well-defined patient cohorts. Collaborative
networks are extremely valuable for the collection of large, well pheno-
typed cohorts. Ongoing functional studies will provide further evidence
for the role of the five candidate genes in myoclonic epilepsies.
Platform Session: Status Epilepticus
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CEREBROSPINAL FLUID TOTALTAU PROTEIN ASA
BIOMARKER IN STATUS EPILEPTICUS: A
RETROSPECTIVE STUDY
G. Monti*,†, A. Chiari†, G. Giovannini*,†, R. Bedin†,
M. Tondelli*,†, P. Nichelli*,†, T. Trenti‡, S. Meletti*,†
*University of Modena and Reggio Emilia, Department of
Biomedical, Metabolic and Neural Science, Modena, Italy,
†Neurology Unit, Nuovo Ospedale Civile S. Agostino-Estense,
AUSLModena, Modena, Italy, ‡Clinical Pathology-Toxicology,
Nuovo Ospedale Civile S. Agostino-Estense, AUSLModena,
Modena, Italy
Purpose and background: Predicting status epilepticus (SE) outcomes
is difficult and primarily based on clinical and EEG parameters. To date,
no reliable biomarkers exist to predict SE outcome. Tau protein is a phos-
phorilated microtubule-associated protein, principally localized at neu-
ronal and axonal level in central nervous system (CNS). High total tau (t-
tau) levels in CSF are related to neuronal and axonal damage. No study
has specifically evaluated the prognostic value of CSF t-tau level in SE.
Methods: We retrospectively identified 28 patients with SE in an 8-
years-long period. Exclusion criteria were acute structural brain damage
as causative event of SE. All patients underwent lumbar puncture at SE
onset to exclude CNS infection. CSF t-tau level was measured in each
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patient and correlations with SE electro-clinical variables, response to
treatment, neurological and epilepsy outcomes were analyzed.
Results: t-tau level was extremely high (>50.000 pg/ml) in 6 patients,
moderately high (between normal values and 50.000 pg/mL) in 7 and
normal in 15 patients. A positive correlation between SE duration and t-
tau levels was present. Out of 17 cases that resolved with anti-epileptic
drugs, none had extremely high t-tau levels. Out of 11 cases that pre-
sented refractory or super-refractory SE, 7 had pathological t-tau levels
(extremely high in 6 patients). Univariate logistic regressions performed
with disability outcome as dependent variable showed that high CSF t-
tau levels were significant predictors of disability development or wors-
ening (OR=38.8, p = 0.004). 30-day mortality was 3 in 13 cases with ele-
vated t-tau levels.
Conclusions: CSF t-tau seems to be a good candidate biomarker for SE
severity. In fact CSF t-tau reliably and independently predicted disability
outcome after SE.
0027
EEG STAGE PREDICTS IMPAIRMENTOF SPATIAL
MEMORYANDLEARNING IN THELITHIUM/
PILOCARPINE ANDTHEKAINIC ACIDMODELSOF
EXPERIMENTAL STATUS EPILEPTICUS IN THERAT
D.M. Treiman, S.T. Marsh
Barrow Neurological Institute, Neurology, Phoenix, AZ, USA
Purpose: Status epilepticus (SE) is a dynamic state with progressive
changes in behavior, response to treatment, extent of neuronal damage,
and EEG patterns during prolonged episodes. SE also causes deficits in
learning and memory, but no studies have correlated progressive impair-
ment with increasing severity of SE. We tested the hypothesis that the
EEG stage during SE, rather than the duration, predicts the extent of sub-
sequent cognitive impairment.
Method: Sixty 250–280 gm male Sprague-Dawley rats were
implanted with 4 stainless steel epidural electrodes for EEG record-
ing. SE was induced by either LiCl, 3 mmol/kg IP, followed 24 hrs
later by pilocarpine, 30 mg/kg, or kainic acid, 15 mg/kg IP. SE was
stopped with IP diazepam, 10 mg/kg, plus phenobarbital, 25 mg/kg,
at EEG stage I (discrete electrographic seizures), III (continuous ictal
activity), or V (periodic epileptiform discharges). Spatial learning and
memory were assessed 1 week before and 1 week after SE induction,
using a modification of the Morris Water Maze (MWM). Effect of
the SE EEG stage on the mean escape time to a submerged platform
was compared.
Results: Initial MWM performance did not differ among all rats. How-
ever, for both models after SE the mean escape time for the first 6 trials
on test day one (memory) and for all 24 trials (learning), was significantly
worse (p < 0.001) in Stage V rats, compared with Stage I and III rats.
The mean time to Stage V for KA rats (354.1  10.7 min) was signifi-
cantly (p < 0.0001) longer than for Li/pilocarpine rats
(187.9  17.4 min.) but the mean escape time at Stage Vwas not signifi-
cantly different.
Conclusion: Prolonged SE results in a marked progressive impairment
of visual-spatial memory and learning. These data provide further evi-
dence that the EEG stage during prolonged SE is a better marker of its
severity than is duration alone.
0029
PREDICT FUNCTIONALOUTCOMEOF STATUS
EPILEPTICUS
B.S. Kang*, D. Kim†, K.K. Kim‡, Y.-S. Kim§, H.J. Moon¶,
Y.W. Cho¶, K.-Y. Jung**, S.K. Lee**
*Korean University Anam Hospital, Department of Neurology,
Seoul, Republic of Korea, †Konkuk University College of
Medicine, Department of Neurology, Seoul, Republic of Korea,
‡Dongguk University Ilsan Hospital, Department of Neurology,
Goyang, Republic of Korea, §Samsung Changwon Hospital,
Department of Neurology, Changwon, Republic of Korea,
¶DongsanMedical Center, Keimyung University, Department of
Neurology, Daegu, Republic of Korea, **Seoul National
University Hospital, Department of Neurology, Seoul, Republic
of Korea
Purpose: Status epilepticus (SE) is a frequent neurologic emergency
with high mortality and morbidity. However, two available clinical scor-
ing system for patients with SE, status epilepticus severity score (STESS)
and epidemiology-based mortality score in SE (EMSE), are limited to
predict individual in hospital mortality, not to functional outcomes. The
aim of this study was to validate the prognostic utility of STESS and
EMSE for prediction function for functional outcome in adult patients
with SE.
Method: This study was performed in epilepsy center of ten academic
tertiary medical centers in South Korea. The clinical and electroen-
cephalographic (EEG) data for all adult patients with SE from January
2013 to December 2014 were derived from a prospective SE database, in
order to calculate the STESS and EMSE. The primary outcome variable
was defined as poor outcome that is score ranged 1–3 of Glascow
Outcome Scale (GOS) at discharge.
Results: Of total 73 with SE, excluding those who had anoxic etiology,
37 patients (50.1%) had poor outcome. The receiver operating curve
(ROC) for prediction of poor outcome by the EMSE using a combination
of etiology, age and EEG had an area under the curve of 0.712
(p = 0.0004) with optimal cut-off point > 54 (sensitivity= 67.57%, speci-
ficity=67.12, NPV= 67.57%, PPV = 66.67%, corrected classified
67.12%) and by those using a combination of etiology, age, comorbidity
and EEG had an AUROC of 0.727 (p = 0.0001) with cut-off point >64
(sensitivity= 67.57%, specificity=67.12, NPV= 67.57%, PPV = 66.67%,
corrected classified 67.12). STESS could not predict poor outcome
(AUROC 0.581, p = 0.2292).
Conclusion: Although EMSE was the clinical scoring system focused
on individual mortality, EMSE can explaine the individual functional
outcome using various combination.
0030
STATUS EPILEPTICUS, AN EASY SCORE
ASSESSMENTTO PREDICTMORTALITYOF SE
G.M. Gonzalez-Cuevas*, E. Santamarina†, M. Toledo†,
M. Quintana†, M. Sueiras†, L. Guzman†, J. Salas-Puig†
*Vall d’Hebron University Hospital. Universitat Autonoma de
Barcelona, Neurology, Barcelona, Spain, †Vall d’Hebron
University Hospital. Universitat Autonoma de Barcelona,
Barcelona, Spain
Purpose: Status epilepticus (SE) has an important clinical impact, with a
high short-term mortality. We aimed to find an easy score assessment to
predict outcome in the initial evaluation of SE.
Methods: We reviewed consecutive patients with SE >16 years old at
our Center between March 2011 and March 2014. We recorded demo-
graphic and clinical data. We estimated the modified Rankin scale (mRS)
at admission. Patients with post-anoxic SE were excluded.We performed
ROC curves to determine the best cut-off points of numeric variables to
predict mortality. A logistic regression model was performed to assess
the independent prognostic factors and estimate the scores of a new scale
proposal.
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Results: We included 136 patients. Mean age: 62.01  17.62[19–95].
54.4% male. Level of consciousness, (OR=7.989 IC [2.934–21.745],
p < 0.001), the modified-Rankin scale (OR=3.344[1.037–10.790],
p = 0.043) and age >70 years (OR=3.035 [1.116–8.313], p = 0.030)
were the only independent risk factors for mortality.
The coefficients of the logistic regression model and results of ROC
curves allowed us to classify the variables as follows: Level of conscious-
ness (0 = Alert/Confusion; 1 = Stuporous/Comatose), mRS
(0 = mRS:0; 1 = mRS:1-3; 2 = mRS:>3) and Age (0 = ≤70; 1 = >70).
The results varied between 0 and 5 points for the score.
The capability of this score to predict mortality was 82.8% (IC:
74.7%-90.9%). By means of ROC curves, we divided the risk of short-
term mortality as follows: Low (3.4%) scores 0–1, Medium (25%) scores
2–3 and High (66.7%) scores 4–5. Scores ≥4 established an overall accu-
racy of 83.3% to predict mortality.
Conclusion: We proposed a novel and easy score to assess the risk of
mortality at admission in patients with SE, which includes a combined
evaluation of the level of consciousness, age (70 years) and mRS.
Platform Session: Clinical Trials 1
Monday, 7th September 2015
0031
MULTICENTER, DOUBLE-BLIND, RANDOMIZED,
PLACEBO-CONTROLLED TRIALOF SUSTAINED-
RELEASEVINPOCETINE AS ADJUNCTIVE
TREATMENTOF FOCAL-ONSET SEIZURES
S.J. Garza-Morales*, M. Pizarro-Castellanos†, M. Sitges-
Berrondo‡, E. Briceno-Gonzalez§, H. Ceja-Moreno¶,
I. Rodríguez-Leyva**, C. Alonso-Rivera††, F. Gongora-
Rivera‡‡, L. Ruiz-Sandoval§§, Mexican Colaborative Group for
study of vinpocetine
*Instituto Nacional de Perinatologia, NEUROCIENCIAS,
Mexico, Mexico, †Hospital Infantil de México‘Federico
Gomez’, Neurodesarrollo, Mexico City, Mexico, ‡Instituto de
Investigaciones Biomédicas, UNAM, Neuroquimica, Mexico
City, Mexico, §Instituto Nacional de Neurología y Neurocirugía,
Consulta Externa, México City, Mexico, ¶Hospital Civil de
Guadalajara, Neuropediatría, Mexico City, Mexico, **Hospital
Central ‘Ignacio Morones Prieto’, Neurología, San Luis Potosi,
Mexico, ††Hospital Central ‘Ignacio Morones Prieto’,
Neuropediatría, San Luis Potosi, Mexico, ‡‡Hospital
Universitario “Dr José Eleuterio Gonzalez de Monterrey”,
Neurología, Monterrey, Mexico, §§Hospital Civil de
Guadalajara, Neurología, Guadalajara, Mexico
Purpose: Evaluating the efficacy and tolerability of vinpocetine as
adjunctive therapy in children and adults with focal onset epilepsy.
Method: Patients between 6 and 65 years old with a diagnosis of focal
epilepsy with at least 4 confirmed seizures per month, refractory to base-
line antiepileptic theraphy (1-3 AED) were invited. Patients were ran-
domized asigned to receive vinpocetine or placebo in a clinical, double-
blind and parallel-group trial (4-weeks baseline phase, 4-weeks titration
phase and a 8 weeks follow-up maintenance phase).
Results: 87 patients (56 adults and 31 children) were recruited (41
patients were assigned to vinpocetine and 46 to placebo). The final dose
of vinpocetine was 2 mg/kg/day. Vinpocetine was more effective than
placebo in the reduction of frecuency of seizures (50% with vinpocetine
vs. 0% with placebo, p < 0.0001). 69% of patients with vinpocetine
experienced a reduction > 50% compared to 13% in the placebo group.
The adverse events associated with the use of vinpocetine were headache
(7.9%) and diplopia (5.2%).
Conclusion: Vinpocetine as adjunctive therapy is more effective in
reducing the frequency of seizures compare to placebo, besides being
well tolerated. Vinpocetine shows a wide safety profile, all adverse
events were known, of short duration and without sequelae.
0032
MODIFIED ATKINS DIET INADULT PATIENTSWITH
REFRACTORYEPILEPSY: A CONTROLLED
RANDOMIZEDCLINICAL TRIAL
M. Zare*, A.A. Okhovat*, A. Esmaillzadeh*, J. Mahvary*,
M.R. Najafi*, M. Saadatnia†
*Isfahan Medical Science University, Isfahan, Iran, Islamic
Republic of, †Isfahan Neurosciences Research Center, Isfahan
University of Medical Sciences, Isfahan, Iran, Islamic Republic
of
Introduction: The usefulness of the modified Atkins Diet (mAD) in
refractory epilepsy in adults has been rarely investigated. We aimed to
evaluate the efficacy of mAD in adult with refractory epilepsy.
Method: In a controlled randomized clinical trial, we enrolled 66 refrac-
tory adult epileptic cases from February 2010 to December 2012. The
Patients were divided into two groups randomly, case groups (22
patients) used antiepileptic drugs and mAD and control group (32
patients) only use antiepileptic drugs. The primary outcome was at least
50% decrease in seizure frequency after 2 months of therapy.
Results: Our data showed no significant difference between groups
regarding baseline characteristic. The differences of mean seizure attacks
after 2 months (p ≤ 0.001) and fifty percent reduction in seizure fre-
quency between the two groups showed significant differences
[p ≤ 0.001, Odd ratio= 2.19, 95% confidence interval (1,39, 3.47)].
There was a positive correlation between the mean urinary Ketone level
and >50% seizure reduction in case group (p = 0.04). In repeated mea-
sures analysis and based on the per-protocol principle, there was a signifi-
cant difference between Modified Atkins Diet and control groups
regarding mean number of seizure attacks (F = 14.6, p < 0.001). Such
differences were also significant in the intention- to- treat analysis
(F = 6.14, p = 0.01, Fig 2).
Conclusion: The mAD may be effective as a co-therapy treatment for
adults with refractory epilepsy and can decrease 3.66 times seizure fre-
quency in comparison with control groups. Trials with more tolerant diet-
ary regime, with larger sample size and longer duration, should be
performed in future.
0033
HOWMUCHVARIABILITY IS THERE IN EPILEPSY
DIAGNOSES? THEEPINETVALIDATION STUDY
P.S. Bergin*,†, E. Beghi‡, W. D’Souza§, M. Tripathi¶,
L. Sadleir**, M. Richardson††, E. Bianchi‡, EpiNet
Study Group
*Auckland City Hospital, Neurology Department, Auckland,
New Zealand, †University of Auckland, Centre for Brain
Research, Auckland, New Zealand, ‡IRCCS - Mario Negri
Institute Pharmacology Research, Milan, Italy, §St Vincent’s
Hospital, University of Melbourne, Department of Medicine,
Melbourne, Australia, ¶All India Institute of Medical Sciences,
Neurosciences Centre, New Delhi, India, **Univeristy of Otago,
School of Medicine and Health Sciences, Wellington, New
Zealand, ††King’s College, Institute of Psychiatry, Department
of Clinical Neuroscience, London, UK
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Purpose: 1) To determine variation in epilepsy diagnosis when neurolo-
gists are presented with identical case scenarios;
2) To accredit investigators for the EpiNet-First trials.
Method: Epileptologists, neurologists and pediatricians with an interest
in epilepsy were invited to assess 32 scenarios describing patients (6 chil-
dren, 26 adults) with various events (21 epilepsy, 11 other paroxysmal
events). Cases were presented on-line via the EpiNet database. For each
patient, participants had to:
 determine how likely it was the patient had epilepsy;
 classify the patients’ seizures (ILAE 2010 classification);
 determine the aetiology (structural/metabolic; genetic; or unknown),
and epilepsy syndromewhen appropriate.
In 24 cases, information was presented in 2 steps; clinical information
was presented in Step 1. After completion of this step, neuroimaging and
EEG studies were provided (Step 2).
18 cases were used to accredit investigators for EpiNet studies.
Acceptable responses were determined by consensus amongst the EpiNet
steering committee. 12 cases were initially assessed. If all responses were
not satisfactory, a further 6 cases were checked.
Results: 201 participants from 35 countries completed the 32 cases. Full
data was available for 189 participants, of whom 105 were accredited for
the trials. Kappa values for step 1 for all 32 cases were: diagnosis of epi-
lepsy; accredited, k = 0.70 (entire group, k = 0.60); seizure type(s),
k = 0.47 (0.39); etiology, k = 0.45 (0.38).
Kappa values increased at Step 2 for all participants: diagnosis of epi-
lepsy; accredited k = 0.77 (entire group, k = 0.68); seizure type,
k = 0.59 (0.48); and etiology, k = 0.51 (0.44).
Conclusion: Agreement for the diagnosis of epilepsy between neurolo-
gists assessing identical scenarios was moderate when based on clinical
findings alone. Agreement for seizure type and etiology was less good,
but improved when investigations were included. Agreement was higher
in all categories for investigators accredited for the EpiNet-First trials.
0034
FACTORSDETERMINING PLACEBORESPONSE IN
DRUG-RESISTANT FOCALEPILEPSY
E. Bagiella*, M. Suprun*, P. Kwan†, E. Somerville‡,
D. Schmidt§, J. French¶
*Icahn School of Medicine at Mount Sinai, New York, NY, USA,
†The University of Melbourne, Parkville, Australia, ‡University
of New South Wales, Sydney, Australia, §Epilepsy Research
Group, Berlin, Germany, ¶NYU Comprehensive Epilepsy
Center, New York, NY, USA
Purpose: To determine factors associated with response in patients ran-
domized to placebo in adjunctive-therapy randomized clinical trials of
AEDs of patients with focal epilepsy.
Methods: Data on adult patients treated in the placebo arm in 16 partial-
onset seizure randomized controlled trials conducted between 1990 and
2010 by 6 pharmaceutical companies were used in this analysis. All trials
included a baseline period of at least 4 weeks, and titration and/or main-
tenance periods up to 20 weeks. Responder rate was calculated as the
proportion of patients with 50% or greater reduction in seizure frequency
during the treatment period compared to their baseline frequency.
Patients’ and protocol specific characteristics were collected for all trials.
Multivariate logistic models were used to determine factors indepen-
dently associated with the response to placebo with generalized estimat-
ing equations to account for clustering by study.
Results: The sample comprises 1719 adults aged 16–82 y.o. (mean
age=37.7), of which 881 (51%) are women. Responder rates vary from
5.6% to 38.5% across the 16 trials. In univariate analysis Asia and East
Europe showed higher responder rates (27.3% and 27.4%, respectively)
than West Europe (13.4%) and the US (15.5%). In multivariate models
controlling for age, gender and race, Asia was associated with increased
odds of response (OR=1.8; p = 0.008) while West-Europe was associ-
ated with decreased odds of response (OR=0.54; p = 0.04) compared to
the US. The odds of response also decreased with increased number of
concomitant AEDs (OR=1.11; p = 0.02) and the occurrence of AEs
(OR=0.71; p = 0.04).
Conclusions: Preliminary analysis of a large dataset of individuals ran-
domized to the placebo arm of adjunctive-therapy AED trials suggest that
response to placebo are influenced by both patients’ and protocol related
factors. Further analyses are needed to confirm these results.
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SECONDARY SCREENINGOF PATIENTS IN
RANDOMIZED PERAMPANEL PGTCS STUDY
EXCLUDES 29.9%OF ELIGIBLE PATIENTS DUE TO
INACCURATECLASSIFICATION
J.A. French*, B. Diventura†, E. Trinka‡, F. Bibbiani§, H. Yang§
*NYU Comprehensive Epilepsy Center, New York, NY, USA,
†Epilepsy Study Consortium, Herndon, VA, USA, ‡Paracelsus
Medical University, Salzburg, Austria, §Eisai Inc, Woodcliffe
Lake, NJ, USA
Purpose: Patients enrolled in clinical trials should be accurately classi-
fied to meet inclusion criteria. We assessed how many patients screened
for enrollment in a randomized placebo-controlled study of drug-resistant
primary generalized tonic-clonic (PGTC) seizures in idiopathic general-
ized epilepsy (IGE), using the noncompetitive AMPA receptor antagonist
perampanel, were rejected due to inaccurate classification when
reviewed independently by The Epilepsy Study Consortium (TESC).
Method: Patients were reviewed by TESC to ensure a clear IGE diagno-
sis. Sites submitted all information used to determine each diagnosis.
Patients were excluded if submitted information could not confirm an
IGE diagnosis (e.g. only GTC seizures and a normal EEG with no family
history or supporting seizure types) or showed an incorrect IGE diagnosis
(e.g. slow spike-wave, developmental delay, age of onset ≤1 year, or
symptomatic cause). Patients considered ineligible were sent to a second,
independent TESC reviewer. If both reviewers agreed, the patient was
screen failed. If they disagreed, a third reviewer made the final decision.
Results: Of 307 patients screened, 143 patients failed (not meeting inclu-
sion criteria; n = 117). Of these, 70/117 patients failed only after TESC
review (IGE misdiagnosis [n = 35]; insufficient information to confirm
diagnosis [n = 35]). A third reviewer made the final decision twice. Ulti-
mately 164 patients received perampanel or placebo (1:1) highlighting
that TESC review eliminated 70/234 (29.9%) patients initially consid-
ered eligible. The trial demonstrated a median percent change in PGTC
seizure frequency per 28 days during Titration/Maintenance Periods ver-
sus Baseline of -76.5% perampanel versus -38.4% placebo; p < 0.0001.
Conclusion: TESC review eliminated 29.9% inappropriate patients from
inclusion. This was the first PGTCS study that used external review to
ensure appropriate classification of trial participants. Without such a
review, the interpretability of results may be compromised.
Platform Session: Epidemiology
Monday, 7th September 2015
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SPECIFIC PATTERNSOFMONOAMINERGIC
DYSFUNCTIONAS BIOMARKERSOFEPILEPSY-
ASSOCIATEDDEPRESSIONANDATTENTION
DEFICIT/HYPERACTIVITY DISORDER (ADHD)
A. Mazarati, R. Sankar, J.D. Jentsch
Epilepsia, 56(Suppl. 1):3–263, 2015
doi: 10.1111/epi.13241
13
Abstracts
D. Geffen School of Medicine, University of California, Los
Angeles, CA, USA
Purpose: Depression and ADHD are common comorbidities of epilepsy.
Furthermore, high degree of comorbidity exists between depression and
ADHD. Disentangling mechanisms of depression and ADHD is con-
founded by their overlapping monoamine transmitter substrates. We
examined patterns of monoaminergic dysfunction and their correlation
with depressive and ADHD behavioral impairments in animals with
chronic epilepsy.
Method: Studies were done in maleWistar rats 4–8 weeks after the pilo-
carpine status epilepticus and the establishment of spontaneous recurrent
seizures. Serotonergic tone in the raphe nucleus-prefrontal cortex path-
way and noradrenergic tone in the locus coeruleus-prefrontal cortex path-
way were measured by fast scan cyclic voltammetry. The function of 5-
HT1A autoreceptors in raphe nuclei, and of a2A adreno-autoreceptors in
locus coeruleus was examined by autoradiography. Profiles of serotoner-
gic and noradrenergic transmission were correlated with behavioral per-
turbations reflecting depressive disorder in the forced swimming test,
and those reflecting ADHD in the lateralized reaction time task.
Results: Around 2/3 of epileptic rats presented with depressive, and
around 1/3- with ADHD behavioral impairments. Five-fifteen percent of
animals exhibited both depressive and ADHD abnormalities. All
depressed animals showed diminished serotonergic tone and the up-regu-
lation of 5-HT1A autoreceptors. None of depressed-only animals had
noradrenergic dysfunction. All ADHD rats showed diminished noradren-
ergic tone and the up-regulation of a2A-adrenoreceptors. None ADHD-
only animals had perturbations in serotonergic transmission. Epileptic
animals with depression and ADHD had both serotonergic and noradren-
ergic deficits. Within each comorbidity, the extent of respective
monoaminergic perturbations strongly correlated with degrees of depres-
sive and ADHD-like behaviors.
Conclusion: Epilepsy-associated depression and ADHD each has speci-
fic monoaminergic correlate evident as the respectively diminished trans-
mitter tone and the up-regulation of a respective receptor. Such specific
profiles of transmitter dysfunction should help with diagnosis and with
devising effective therapies of these two comorbidities.
Supported by the NIH grant R01NS065783.
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DIFFERENCE BETWEENELDERLY EPILEPTIC
PATIENTS ANDELDERLYEPILEPSY
A. Suller Marti, E. Bellosta-Diago, J.L. Camacho-Velasquez,
A. Sanabria-Sanchineli, A. Velazquez-Benito, C. García-A
rguedas, S. Santos-Lasaosa, J.A. Mauri Llerda
Universitary Hospital Lozano Blesa, Neurology, Zaragoza,
Spain
Purpose: Epilepsy is more often in infants and old people. Nowadays,
the population is getting older and the epilepsy prevalence is increasing.
The type of epilepsy changes with the age.
Method: We present a prospective observational study to compare
epileptic patients diagnosed before 65 and after 65, that now are
≥65 years old. We study the epilepsy features, comorbility, dependency
status and the antiepileptic drugs that they used (time, dosage and side
effects).
Results: The sample was 123 patients, 62 who were diagnosed with
≥65 years old (group A), and 61 with < 65 (group B). Both groups have
similar percentage of gender, male 62.9% (N = 39) in A and 60.7%
(N = 37) in B. The average age was 77.29  6’73 in group A and
69.97  5’6 in B. The most common type of seizure was parcial com-
plex, in both groups, in 53’2% (N = 33) in A and 41% (N = 25) in B.
16.1% (N = 10) had Status Epilepticus in group A and only 1.6%
(N = 1) in B. The most frequent result in the EEGwas normal in group A
(40.3%, N = 25) and focal in B(26.2%, N = 16). The etiologymost com-
mon was vascular in group A(74.2%, N = 46) and cryptogenic in B
(44.3%, N = 27). The Stroke incidence was 51.6% (N = 32) in A and
19.7% (N = 12) in B. The doses in almost all de the antiepileptic drugs
that have been registred were lower in the group A. If we compare both
groups, we saw stadistic significance in the hypertension (p = 0.00), dia-
betes mellitus (p = 0.00), stroke incidence (p = 0.00), ischaemic car-
diopathy (p = 0.003), status epilepticus (p = 0.00), dependence grade
(p = 0.00).
Conclusion: The epilepsy that starts after 65 years old, is related with
cardiovascular risk factors that we should prevent. This epilepsy
responds better with lower doses of treatment, however in some cases
starts with a Status Epilepticus. Although both kinds are the same disease,
the risk factors and the management are different.
0038
SUDEP IS NOTALWAYS SUDEP!REPORTOF 70
DEATHS THROUGHA 20 YEARS PERIOD FROMA
TERTIARYEPILEPSY CENTRE IN NORWAY
T.R. Olsen*, K.O. Nakken†, M.I. Lossius†
*Oslo University Hospital, National Centre for Rare Epilepsy-
Related Disorders, Oslo, Norway, †Oslo University Hospital,
National Centre for Epilepsy, Oslo, Norway
Purpose: Patients with refractory epilepsy are referred to our national
epilepsy centre from all over Norway. From the centre, SUDEP cases in
the period 1967–1996 has previously been examined and published.
The aim of this study was to examine “new” SUDEP cases reported at
our center in the period 1996–2015. Here we focus on the correctness of
the SUDEP diagnosis and give some background characteristics from the
cohort.
Method: We have examined the medical record from patients treated at
the centre who were reported of having suffered SUDEP in the period
1996–2014. The study was approved by the local medical ethical com-
mittee.
Results: 70 SUDEP cases were reported. At closer examination, only 57
(81.4%) fulfilled the SUDEP criteria. Other causes of death were: sui-
cides: 3, cancer related: 2, status epilepticus: 2, infection: 1, respiratory
failure (Rett syndrome): 1, AVM (bleeding): 1, neurodegerative disorder:
1, ceroid lipofucinose: 1, unknown cause, but not epilepsy related: 1. In 4
cases the death might have been seizure-related (accidents and drown-
ing).
35 (63%) were male, mean age at death was 28.8 years. 9 (13%) had
undergone epilepsy surgery. Additional 15 (26%) had gone through epi-
lepsy surgery work-up. 12 (21%) had implanted Vagus Nerve Stimuta-
tion (VNS).
11 (16%) had seizure remission for more than 1 year prior to SUDEP.
Two of these patients had reported seizure freedom in 10 and 15 years
prior to SUDEP, respectively. Only 17 (24%) had co-morbid conditions.
In those not seizure free, the frequency of generalized tonic-clonic sei-
zures (GTCS) showed large variations from daily seizures to 3-4/year.
Conclusion: Not all those reported to have suffered SUDEP turn out to
have had SUDEP after a more thorough investigation. In order to identify
predictors for SUDEP, we are preparing a case-control study.
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LARGE-SCALE, OBSERVATIONAL STUDYOFALL-
CAUSEMORTALITYAND SUDEP IN PATIENTSWITH
DRUGRESISTANTEPILEPSY TREATEDWITHVNS
THERAPY
P. Ryvlin*, D. Hesdorffer†, M. Sperling‡, E. So§, O. Devinsky¶,
M. Bunker**, C. Gordon††, B. Olin‡‡
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*Universitary Hospital of Lyon, Département des Neurosciences
Cliniques, Lausanne, France, †Columbia University,
Department of Neurology, New York, NY, USA, ‡Thomas
Jefferson University, Clinical Neurophysiology Laboratory,
Philadelphia, PA, USA, §Mayo Clinic, Neurology Department,
Rochester, MN, USA, ¶NYU Langone Medical Center,
Neurology Department, New York, NY, USA, **Cyberonics, Inc.,
Global Medical Affairs, Houston, TX, USA, ††Cyberonics, Inc.,
Quality Systems, Houston, TX, USA, ‡‡Cyberonics, Inc.,
Clinical, Quality and Regulatory, Houston, TX, USA
Purpose: Annegers et al. (2000) reported that the rate of sudden unex-
pected death in epilepsy (SUDEP) in patients undergoing VNS Therapy
decreased from 5.5 per 1000 patient-years (PY) over the first 2 years to
1.7 per 1000 PY thereafter. Since that report, over 80,000 patients with
drug-resistant epilepsy have been implanted worldwide, providing the
opportunity to revisit the impact of VNS on SUDEP.
Methods: This retrospective study included all US patients with drug-
resistant epilepsy who were implanted with VNS from 1988-2012 with
known social security numbers. Exposure to VNS was calculated from
date of implant until death, device explant, known date at which the
device was disabled or the last follow-up date of December 31, 2012.
Occurrence, date and cause of death were obtained from the Social Secu-
rity Death Index Master File and the National Death Index, which pro-
vides ICD-9 or ICD-10 codes. A group of cause-of-death codes was
selected as reflecting potential SUDEP and a sample categorized accord-
ing to Annegers’ SUDEP classification.
Results: A total of 40,443 patients (mean age at implant: 30.8 years)
with a median follow-up of 7.6 years, representing 277,661 PY, were
included. A total of 3,689 deaths were recorded, translating into a 13.3/
1000 PY all-cause mortality rate (SMR=4.58). 953(26%) corresponded
to cause-of-death codes that potentially include SUDEP, with a decreas-
ing trend as duration of VNS increased. A preliminary review of a ran-
dom sample of 200 of these cases adjudicated 109 (54.5%) as possible/
probable/definite SUDEP (1.9/1000 PY).
Conclusion: This large mortality study of patients with VNS therapy
offers an 80 fold increase in available PY of follow-up as compared to
published data. Preliminary findings show crude all-cause mortality rates
consistent with those observed in drug-resistant epilepsy. Ongoing analy-
ses will provide specific information regarding SUDEP risk and the
impact of VNS therapy.
0040
PSYCHIATRIC COMORBIDITY INCHILDRENAND
YOUTHTREATEDATTHENATIONALCENTRE FOR
EPILEPSYNORWAY
M.I. Lossius*, B. van Roy†, B.H. Hansen‡, L. Gjerstad§,
K.A. Alfstad¶
*National Centre for Epilepsy, Division for Clinical
Neuroscience, Oslo University Hospital, Children and Youth,
Sandvika, Norway, †Child and Adolescent Mental Health,
Akershus University Hospital, Oslo, Norway, ‡Division of
Mental Health, Akershus University Hospital, Norway,
Lørenskog, Norway, §Department of Neurology, Division for
Clinical Neuroscience, Oslo University Hospital, Oslo, Norway,
¶National Centre for Epilepsy, Division for Clinical
Neuroscience, Oslo University Hospital, Sandvika, Norway
Purpose: We have previously found a high frequency of psychiatric
symptoms (31%) among children and youth with epilepsy (CYWE) in a
population based questionnaire study without confirmed psychiatric
diagnoses. The aims of this study were to asses the frequency of psychi-
atric symptoms and further classify psychiatric disorders among CYWE
at a tertiary epilepsy centre.
Method: A prospective study of consecutive children and youth aged
10–19 years. referred to the National Centre for Epilepsy from January
2012 to June 2014. All participants and parents filled in the Strengths and
Difficulties Questionnaire (SDQ). Those who scored in the borderline or
pathological range were examined by a child psychiatrist using the Kid-
die-SADS-PL.
Results: One hundred and nineteen children and youth with epilepsy
were included. Mean age was 14.yrs (10–19) and there was a slight over-
weight of girls, 55%. Psychiatric symptoms were reported in sixty-five
participants (55%). They underwent child psychiatric interview where a
diagnosis was confirmed in 53 participants (82%). The most common
diagnoses found were ADHD and anxiety. More boys than girls received
a psychiatric diagnoses (58.5% vs. 41.5%, p = 0.03).There was no differ-
ence in psychopathology between focal and generalized epilepsy.
Conclusion: We found psychiatric symptoms in 55% of children and
youth referred to the National Centre for Epilepsy. Eighty two % of these
had a clinically confirmed psychiatric diagnosis. Compared to the popu-
lation based material the frequency of psychiatric symptoms is even
higher in a tertiary care setting. The aetiology is complex, probably due
to a combination of biological and psychosocial factors.
Platform Session: Epilepsy Surgery 2
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WHATDETERMINES LONG-TERMEPILEPSY
OUTCOMEAFTERMULTILOBARRESECTION?
E.Y. Joo*, E.B. Cho*, S. Choi*, D.W. Seo*, S.-C. Hong†,
S.B. Hong*
*Samsung Medical Center, Sungkyunkwan University School of
Medicine, Neurology, Seoul, Republic of Korea, †Samsung
Medical Center, Sungkyunkwan University School of Medicine,
Neurosurgery, Seoul, Republic of Korea
Purpose: There is no doubt that surgical treatment for medically intract-
able epilepsy can be a best option in seizure control and improvement of
quality of life. However, scarce literatures demonstrated the long-term
results following multilobar epileptic surgery. We aim to evaluate the
surgical outcome of multilobar epilepsy and to explore prognostic factors
of good outcome.
Method: We retrospectively reviewed the records of patients who had
underwent multilobar surgery between 1995 and 2010 (more than
12 months of follow-up). Multilobar epilepsy syndrome was defined as
having independent epileptic foci in more than two lobes. Engel class Ia
and Ib were considered as seizure free.
Results: 73 patients were enrolled (mean follow-up 10.2 years, range
2.7–18.8). Mean age of seizure onset was 12.4 years and at surgery was
25.6 years. Fifteen (20.5%) had underwent surgery on more than three-
lobes and the others had a surgery on two-lobes; 22 (30.1%) in fronto-
temporal, 17 (23.3%) in temporo-occipital, 12 (16.4%) in parieto-tem-
poral, and 7 (9.6%) in fronto-parietal resection. At postsurgical one-year,
55.4% of patients were seizure free (95% confidence interval, CI, 43–
66), 43.2% at 5-years (CI 31–54), and 44.6% remained free at the last fol-
low-up (CI 19–41). Reoperation was performed in one patient who was
seizure free after second surgery. Significant risk factors in seizure recur-
rence were preoperative, contralateral interictal spikes (p = 0.03) and the
abnormal MRI findings contralateral to resection (p = 0.01) in univariate
analysis. The risk of abnormal MRI lesion was high as 3.0 (CI 1.10–
8.17). Abnormal MRI findings significantly affected on the seizure out-
come in multivariate analysis (p = 0.03).
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Conclusion: Long-term surgical outcome of multilobar resection was
favorable. Nearly half of patients remained seizure free at the last follow-
up. Preoperative MRI and PET and postoperative EEG findings are
important for surgical prognosis.
0042
MRI-BASEDHIPPOCAMPAL SUBFIELDANALYSIS
ACCURATELY PREDICTS SURGICALOUTCOME
B.C. Bernhardt, J. Kulaga-Yoskovitz, B. Caldairou, S.-J. Hong,
M. Liu, N. Bernasconi, A. Bernasconi
McGill University, Montreal Neurological Institute,
Neuroimaging of Epilepsy Laboratory, Montreal, Canada
Purpose: Temporal lobe epilepsy (TLE) is the most common drug-resis-
tant epilepsy in adults. Its hallmark lesion is hippocampal sclerosis,
apparent on MRI as atrophy, T2 signal changes, and diffusion alterations.
Surgery renders the most patients seizure-free; yet, individualized out-
come predictors remain unknown. Subfield-level descriptors promise to
provide novel markers of hippocampal pathology, with potential benefits
for outcome prediction.
Method: We studied 39 drug-resistant TLE patients and 25 age- and sex-
matched controls. MRI data were acquired on a 3T Siemens TimTrio,
including submillimetric T1- and T2-weighted images, and diffusion-
weighted MRI. One rater manually segmented the hippocampal subfields
cornu Ammonis (CA) 1-3, CA4-dentate gyrus (DG), and subiculum. We
automatically extracted medial sheets of a given subfield, on which we
sampled surface-wise T2 intensity, mean diffusivity, and fractional aniso-
tropy, and calculated local columnar volume. Surface-based comparisons
assessed anomalies in patients relative to controls and the relationship to
post-surgical outcome in operated patients (16 seizure-free out of 21 oper-
ated; 48  18 months follow-up). Findings were corrected for multiple
comparisons at FWE< 0.05. A support vector machine with leave-one-
out-cross-validation was employed to predict outcome in single patients.
Results: Compared to controls, patients showed T2-increases across all
subfields bilaterally, with most marked effects in ipsilateral CA1-3 and
CA4-DG; the latter subfields also showing increased mean diffusivity
and decreased anisotropy. Columnar volume was decreased in ipsilateral
CA1-3 and subiculum. Compared to those achieving seizure freedom,
non-seizure free patients displayed bilateral mean diffusivity increases
and contralateral columnar volume decreases. A classifier combining
volume and mean diffusivity changes accurately predicted outcome in
20/21 (96%).
Conclusion: Surface-based analysis of morphology, signal and diffusion
provides invivo phenotyping of hippocampal subfield pathology in TLE,
and accurately predicts post-surgical outcome.
0043
EPILEPSYANDLOW-GRADEGLIOMAS: A UK
SINGLECENTRERETROSPECTIVEANALYSIS
L.F. Steele*, O. Riley†, J.R. Goodden*, M. Maguire‡
*Leeds Centre for Neurosciences, Neurosurgery, Leeds, UK,
†University of Leeds, Leeds, UK, ‡Leeds Centre for
Neurosciences, Neurology, Leeds, UK
Purpose: Epilepsy is a common presentation of low-grade gliomas
(LGG). Gross total resection (GTR) is the strongest predictor of seizure
freedom, but with limited evidence regarding efficacy and tolerability of
newer antiepileptic drugs (AEDs) in managing LGG epilepsy, we investi-
gated factors affecting seizure control with AEDs and/or surgery to pro-
vide evidence-based guidelines for practice.
Method: Retrospective analysis of 238 suspected/confirmed LGG
cases in a single neurosciences centre. Variables recorded: patient
demographics, tumour features (size/location/histology/molecular mark-
ers), seizure characteristics pre-/post- AED and post-surgery (type/
duration/frequency), operative intervention (time from diagnosis/propor-
tion resected), and use of adjuvant therapy. Long-term patient outcomes
focused on seizure control.
Results: 33 patients excluded (found to be high grade within
12 months). 205 analysed: average age at diagnosis 36 (ranging 1–77),
2:3 female:male. 77% initially presented with seizure. LGG location pre-
disposes to epilepsy, most common in frontal (45%) and temporal (33%)
lobes, with seizure types most varied in the latter. No seizures occurred
with non-cortical LGGs. All DNETs and 83% astocytomas and oligoden-
drogliomas presented with seizures. Presence of IDH-1 mutation, 1p19q
codeletion and MGMT methylation was increased in seizure patients.
Overall post-AED seizure reduction at 12 months was 65% (69% in
astrocytomas; 57% oligodendrogliomas; 50% oligoastrocytomas, and
71% in temporal; 65% frontal; 50% parietal lobe tumours). Monothera-
peutic AED reduced seizures in 31%, with levetiracetam the most effec-
tive. 155/205 (76%) underwent surgery (resective in 53%), ranging from
same day to 15 years post-diagnosis. Post-resective seizure reduction
was 76%, with 59% seizure-free. This improved to 74% seizure-freedom
with GTR.
Conclusions: Tumour location, histology, and cytogenetics affect sei-
zure frequency and response to treatment. Significant seizure reduction
with AEDs is achieved. Pharmacological conclusions are complicated by
polytherapy and biased selection of AEDs. Ongoing analysis will evalu-
ate AED properties and impact on seizure control and tumour progres-
sion. GTR remains the strongest predictor of seizure freedom.
0044
PROLONGED POST-ICTALCEREBRAL
HYPOPERFUSIONDETECTED BYARTERIAL SPIN
LABELLING (ASL)MRI - A POSSIBLEREPLACEMENT
FOR ICTAL SPECT?
S. Singh*, I. Gaxiola-Valdez†, S. Sandy*, P. Federico‡
*University of Calgary, Clinical Neurosciences, Calgary,
Canada, †Hotchkiss Brain Institute, University of Calgary,
Radiology, Calgary, Canada, ‡Hotchkiss Brain Institute,
University of Calgary, Neurosciences, Radiology, Calgary,
Canada
Purpose: Seizures can be followed by transient neurological impair-
ments (e.g., Todd’s paresis). Several case reports of post-ictal hypoperfu-
sion exist in literature. More recently, prolonged post-ictal
hypoperfusion and hypoxemia (lasting up to 1 hour) has been demon-
strated at the seizure focus in rats (Teskey GC, unpublished observa-
tions). Thus, our objective was to determine whether post-ictal vascular
changes can be demonstrated in humans using Arterial Spin Labelling
(ASL) MRI and whether they could assist in localizing the seizure onset
zone.
Method: 3 Tesla ASL MR images were obtained in a group of 15
patients with refractory focal epilepsy undergoing scalp VEM within
90 minutes of seizure termination. Interictal baseline ASL scans were
also obtained to generate cerebral blood flow (CBF) subtraction maps
(baseline vs. postictal) to identify areas of postictal hypoperfusion. These
results were compared to information obtained from routine investiga-
tions (video-EEG, PET, SPECT,MRI).
Results: Routine clinical investigations identified seizure foci in the
patients as follows: 5 unilateral temporal lobe, 2 independent bitemporal,
3 frontal, 1 central, 2 broad left hemispheric with unclear localization, 2
non-lateralized. Five patients had unremarkable MR scans. ASL scans
were obtained 45–83 minutes following seizure termination and focal
post-ictal hypoperfusion was seen in 13/15 subjects as 2 patients could
not be analyzed due to technical issues. The ASL was concordant to the
‘presumed’ seizure focus in 9 patients, providing localizing information
in 3 and lateralizing information in 6 patients.
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Conclusion: Prolonged focal post-ictal hypoperfusion can be seen using
ASLMR imaging in the majority of patients, concordant with the seizure
focus. Post-ictal vascular imaging may be a potentially useful tool to
assist in localizing or lateralizing the seizure onset zone. It may therefore
serve as a potential replacement for ictal SPECT, which is a labour and
cost intensive investigation.
0045
CONTINUING SEIZURES AFTERTEMPORAL
LESIONECTOMY - IS IT IN THEHIPPOCAMPUS?
K. Gau*, N. Foit*, C. Kaller†, J. Zentner*, I. Mader‡,
A. Schulze-Bonhage§, K. Wagner§
*University Hospital Freiburg, Neurosurgery, Freiburg,
Germany, †University Hospital Freiburg, Neurology, Freiburg,
Germany, ‡University Hospital Freiburg, Neuroradiology,
Freiburg, Germany, §University Hospital Freiburg,
Comprehensive Epilepsy Center, Freiburg, Germany
Purpose: Non-mesiotemporal lobe epilepsy (TLE) may arise from vari-
ous extrahippocampal (eHC) lesions (Dhiman et al. 2013). Although sur-
gical resection usually leads to freedom from seizures, we have recently
demonstrated that eHC lesionectomy bears a risk of longterm memory
decline (Wagner et al. 2013) and may lead to ipsilateral hippocampal
atrophy.We therefore sought to determine factors associated with contin-
uing seizures after eHC lesionectomy.
Methods: All patients who underwent lesionectomy for unilateral, drug-
refractory eHC TLE between January 2000 and December 2014 were
screened for eligibility (singular pathology, availability of pre- and post-
operative volumetric MRI). Fifty-two patients (29 left TLE; 28 male,
mean age 31.1  12.8 years; mean duration of epilepsy 9.4 years) were
enrolled. We employed voxel-based morphometry as integrated in
SPM12 to extract hippocampal volumes by atlas-derived (SPMAnatomy
Toolbox) masks. Volumes of the surgical lesion were semi-autmatically
calculated (Yushkevich u. a. 2006). To identify predictors, a binary logis-
tic regression analysis including loss of hippocampal volume, mean dura-
tion of epilepsy and size of resection was performed.
Results: More than 2/3 of all patients were seizure-free (Engel I) at fol-
low-up (72.9%, 3–6 months). A significant volume-loss in the ipsilateral
hippocampus was observed at follow-up MRI (pre-op: 2.65 ml0.46 ml
vs. post-op: 1.69  0.52 ml; mean loss -.96  0.55 ml, p < 0.001). A
longer duration of epilepsy (p < 0.05) and smaller resection volumes
(p < 0.05) explained 85.4% of all unfavorable outcomes within the logis-
tic regression model (p < 0.05).
Conclusion: This study provides evidence that longer duration of epilepsy
and smaller resection size, which is maybe incomplete, may lower the
chance of seizure freedom. The role of hippocampal atrophy needs further
investigation (Fernandes u. a. 2014). It is conceivable that atrophy leads to
sclerosis and, potentially, secondary epileptogenesis within the hippocam-
pus (Bonilha u. a. 2006). Prospective evaluation of patients with continu-
ing seizures after lesionectomywill aid in clarifying this hypothesis.
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0046
PAROXYSMALEVENTS IN CHILDRENANDYOUNG
ADULTSWITHACQUIREDNON-PROGRESSIVE
BRAIN INJURY: REVISITINGDIAGNOSIS
FOLLOWINGVIDEO-EEG
P. Dragoumi, M. Brady, F. Chivers, K.B. Das
Young Epilepsy, Lingfield, UK
Objectives: Acquired brain injury (ABI) is a well-known risk factor for
epilepsy in children and young adults. However various paroxysmal phe-
nomena can mimic epileptic seizures causing diagnostic confusion. This
study was undertaken to estimate the occurrence of non-epileptic events
identified by video-EEG in this specific population.
Methods: We carried out a retrospective review of EEG studies per-
formed in children and young adults with ABI and paroxysmal events at
a specialist epilepsy centre. Data was analyzed to identify and character-
ize these events, estimate their occurrence and establish the frequency of
misdiagnosis.
Results: 70 children and young adults (M:F 46/24, mean age 11 years
old, age range 1–26 years) with ABI underwent video-EEG at Young
Epilepsy between January 2002 and January 2015. Events in question
were captured in 50 cases (71.4%). Of these, 32% (16/50) of patients only
had epileptic seizures, 32% (16/50) had only non-epileptic events and the
remaining 36% (18/50) had both. At the time of referral non-epileptic
events were suspected in only 44% of patients. In 34 patients a total of 48
non-epileptic events were recorded and the main types were: motor phe-
nomena 16/48 (33%), staring events 11/48 (23%), behavioural episodes
8/48 (17%) and sleep related phenomena 5/48 (10%). In the remaining 8/
48 (17%) a mixture of other events, i.e. abnormal eye movements,
automatisms, autonomic changes were documented. Video-telemetry
was successful in capturing and clarifying these events in 64% of the
cases, whereas routine EEGs were useful in only 20%. Video-EEG find-
ings resulted in revising the original diagnosis in 4/13 (30.8%) of patients
who were taking AEDs unnecessarily.
Conclusion: The frequency of non-epileptic paroxysmal events is signif-
icant in children and young adults with ABI, often leading to misdiagno-
sis and inappropriate treatments. Video-EEG, and especially long term
video-telemetry, is an invaluable tool in establishing the correct diagnosis
and aiding management.
0047
PREDICTORS FOREPILEPSYAFTERNEONATAL
SEIZURES
G. G€okdogan, Z.Öztürk, T. Hirfanoglu, İ.M. Hirfanoglu,
S. €Unal, E.Önal, C. Türkyılmaz, E. Koc, E. Ergenekon, Y. Atalay
Gazi University, Ankara, Turkey
Purpose: Neonatal seizures have a high risk of mortality and adverse
neurological outcomes such as cerebral palsy, developmental delay and
epilepsy. In previous studies a scoring system has been attempted for
early prognostic information. Few clinical studies explored the early pre-
dictive factors for epilepsy. The aim of the study is to identify clinical risk
factors for epilepsy after neonatal seizures, and to compare with previous
studies.
Method: A retrospective study of 92 newborns (55.4% boys, 44.6%
girls, 63% term, 37% preterm) (born January 2007–December 2012) who
admitted to the Gazi University faculty of medicine, department of
neonatology and experienced neonatal seizures were performed. Clinical
variables such as the delivery of birth, gestational age at birth, 1-minute
and 5-minute apgar scores, birth weight, the need for resuscitation at
birth, seizure onset age, etiology, cerebral ultrasonography, response to
anticonvulsant therapy, EEG findings, seizure duration were docu-
manted. Chi-square test and bivariate analysis were performed to deter-
mine the prediction of those parameters for epilepsy.
Results: Epilepsy rate 1 and 6 years follow up was 57.6%. Birth weight,
gestational age at birth, the need for resuscitation at birth, cerebral ultra-
sonography, etiology were the most powerful risk factors for epilepsy.
We found no association between delivery of birth, 1-minute and 5-min-
ute apgar scores, seizure onset age, response to anticonvulsant therapy,
EEG findings with epilepsy. Any patient had status epilepticus.
Conclusion: Term and preterm infants with neonatal seizures had poorer
outcome for epilepsy development if low (<2500 g) birth weight,
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<37 week gestational age at birth, need for resuscitation at birth, abnor-
mal cerebral ultrasonography, hypoxic ischemic encephalopathy and
intracerebral hemorrhage in etiology exist.
0048
EPILEPTIC NEGATIVEMYOCLONUS: CLINICALAND
EEG-POLYGRAPHIC STUDY INCHILDRENWITH
FOCALONSET EPILEPSY
D. Caputo, G. Cantalupo, F. Darra, S. De Simone, S. Pellegrin,
A. Mingarelli, E. Fiorini, R. Mandarano, E. Fontana, B. Dalla
Bernardina
Verona University-Hospital, Child Neuropsychiatry, Verona,
Italy
Purpose: To describe clinical presentation, evolution, and polygraphic
features of inhibitory seizures with Epileptic Negative Myoclonus
(ENM) in children with focal-onset epilepsy of different etiology: symp-
tomatic, idiopathic, cryptogenic.
Method: We retrospectively analyzed clinical charts and neurophysio-
logical data of 91 children with partial onset epilepsy and anamnestic
findings of presumed inhibitory phenomena. We included only patients
with clear documentation of ENM and tailored polygraphic recording.
Furthermore we analyzed clinical presentation of ENM as reported by
patients or caregivers, EEG-polygraphic findings and outcome of ENM.
We excluded cases with progressive diseases.
Results: 49 children were included (symptomatic = 47%, idio-
pathic = 29%; cryptogenic = 24%, M:F = 2:3) with the following
features: mean age at epilepsy-onset = 2.9 year (0–8.0), at ENM-
onset = 4.2 year (1.4–9.1), mean ENM latency from epilepsy-
onset = 1.4 year (0–7.0), mean follow-up = 7.3 year (0–29.3). In the
symptomatic group most frequent etiologies were anoxic-ischemic peri-
natal injury and malformation of cortical development; neurological
examination was pathological in 61%. ENMwas the first epileptic symp-
tom in 31% overall, in 50% of idiopathic. In three cases ENM was CBZ-
induced. The most common ENM-related clinical presentation was
inability to maintain postural control with drops of head, trunk or limbs,
fallings or gait instability, often accompanied with atypical absences; tre-
mors/jerks (27%), underuse of one limb (16%) were also possible. EEG
correlate of ENM was in most patients represented from peri-central
spike/spike-wave, either focal unilateral (45%), bilateral asynchronous
(8%) or diffuse (57%). Response to treatment is variable, however 93%
of the 28 patients with ≥5 years follow-up underwent complete remission
of ENM from at least 3 years.
Conclusion: ENM is often difficult to recognize only with clinical
examination and its incidence in childhood epilepsy is probably underes-
timated due the great variability of clinical presentation, particularly in
symptomatic forms with pre-existing neurological deficits. Accurate
EEG-polygraphic recording is mandatory to prompt diagnosis and treat-
ment.
0050
ACCURACYOFBEDSIDE AEEGMONITORING
VERSUS CEEGFOR SEIZUREDETECTION IN ATRISK
FULL TERMNEONATES
I. Schmidt*, K. Acevedo†, T. Mesa†, P. Toso‡, A. Toso‡,
M. Ocampo§, S. Saavedra§
*Catholic University, Pediatric Neurology, Santiago, Chile,
†Catholic University, Pediatric Neurology/EEG Laboratory,
Santiago, Chile, ‡Catholic University, Department of
Neonatology, Santiago, Chile, §Catholic University, EEG
Laboratory, Santiago, Chile
To compare the sensibility for seizure detection in full term neonates
between 2-channel amplitude integrated electroencephalography (aEEG)
and simultaneous continuous conventional electroencephalography
(cEEG).
From August 2013 until November of 2014, full term neonates during
their first week of life, were admitted to the neonatal intensive care unit
(NICU) of Catholic University of Chile Hospital, with risk factors for sei-
zures, were prospectively enrolled in this blinded observational cohort.
Approval of the Ethics Committee and informed consent from parents
were obtained. Both aEEG and cEEG were simultaneously installed and
recorded for at least 24 hours. Biodemographical data were collected.
The readings were blindly analyzed by skilled neurophysiologists
(stEEG) and neonatologists (aEEG).
25 babies were monitored for a total of 615 hours. 12 patients were
male. The most common diagnosis were hypoxic-ischemic encephalopa-
thy (8 babies) and congenital diaphragmatic hernia (7 babies). The stEEG
detected 327 seizures and 4 status epilepticus in 10 patients. The aEEG
identified 96 seizures and 2 status epilepticus in 4 patients. Additionally,
aEEG showed 81 seizures and 1 status epilepticus that corresponded to
false positive events. As compared with stEEG, the aEEG seizure detec-
tion sensitivity (S) was 31%, specificity (Sp) 74%, positive predictive
value (PPV) 54% and negative predictive value (NPV) 52%. S for alter-
ations of the baseline activity with aEEG was 88%, Sp 96%, PPV 96%
and NPV 89%.
Seizure recognition in neonates is a challenging clinical problem.
EEG is essential for the diagnosis. aEEG has low sensitivity for seizure
detection in full term babies. Even though its widespread use in NICU,
our results support the use stEEG at least for 24 hours in babies at high
risk for seizures, to contribute in decision making in order to improve
accurate seizure detection, management and early treatment.
Platform Session: Genetics 2
Monday, 7th September 2015
0051
MUTATIONS IN THEGABATRANSPORTER SLC6A1
CAUSE EPILEPSYWITHMYOCLONIC ATONIC
SEIZURES
G.L. Carvill*, J.M. McMahon†, A. Schneider†, M. Zemel*,
C.T. Myers*, J. Saykally*, J. Nguyen*, A. Robbiano‡, F. Zara‡,
N. Specchio§, O. Mecarelli¶, R.L. Smith**, R.J. Leventer†,
R.S. Møller††, M. Nikanorova††, P. Dimova‡‡, A. Jordanova§§,
S. Petrou†, I. Helbig¶¶, P. Striano***, S. Weckhuysen†††,
S.F. Berkovic†, I. Scheffer†, H.C. Mefford*, Euroepinomics RES
MAE/Dravet working group
*University of Washington, Pediatrics, Seattle, WA, USA,
†University of Melbourne, Melbourne, Australia, ‡Istituto
Giannina Gaslini, Genoa, Italy, §Bambino Gesu Children’s
Hospital, Rome, Italy, ¶University of Rome, Rome, Italy, **John
Hunter Children’s Hospital, Newcastle, Australia, ††Danish
Epilepsy Centre, Dianalund, Denmark, ‡‡St. Ivan Rilski
University Hospital, Sofia, Bulgaria, §§University of Antwerp,
Antwerpen, Belgium, ¶¶The Children’s Hospital of Philadelphia,
Philadelphia, PA, USA, ***University of Genoa, Genoa, Italy,
†††INSERM, Paris, France
Purpose: GAT-1, encoded by SLC6A1, is one of the major GABA trans-
porters in the brain responsible for re-uptake of GABA from the synapse.
Overlapping 3p25.3 microdeletions encompassing SLC6A1 have been
reported in individuals with a wide spectrum of neurodevelopmental dis-
orders. Moreover, two single de novomutations in SLC6A1were reported
in two individuals with intellectual disability and autism who were part
of large whole exome sequencing studies. These molecular genetics stud-
ies as well as the function of GAT-1 at the synapse, suggest SLC6A1 is an
excellent candidate gene for epileptogenesis.
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Method: To investigate the role of SLC6A1 in the etiology of the sev-
ere infantile and childhood epilepsies, we performed targeted resequenc-
ing in 644 individuals with a range of epileptic encephalopathies.
Results: We identified six mutations in SLC6A1 in seven individuals.
All presented with the syndrome of epilepsy with myoclonic-atonic sei-
zures (MAE). We describe two truncations and four missense alterations,
all likely lead to loss-of-function of GAT-1 and thus reduced GABA re-
uptake from the synapse. These individuals share many of the electro-
physiological properties of Gat1-deficient mice, including spontaneous
spike-wave discharges.
Conclusion: Overall, pathogenic mutations occurred in 6/160 indi-
viduals with MAE, accounting for ~4% of unsolved MAE. Mutations
in SLC6A1 seem to occur specifically in individuals presenting with
MAE. Collectively this suggests that SLC6A1 mutations may cause a
specific epilepsy syndrome, MAE that occurs in the context of abnor-
mal early development, and this may be reflected in the specific func-
tion of GAT-1 and GABA transport in the human brain. While certain
antiepileptic drugs are known to work on the GABA system, enhance-
ment of GAT-1 provides a novel target for the development of preci-
sion medicines.
0052
THE PHENOTYPIC SPECTRUMASSOCIATEDWITH
GABRB3MUTATIONS: FROMFEBRILE SEIZURES TO
SEVEREEPILEPTIC ENCEPHALOPATHIES
R.S. Møller*,†, M. Nikanorova*,†, E.H. Brilstra‡, U. Vaher§,
I. Talvik§,¶, T. Talvik§,¶, G. Kluger**, J.R. Lemke††,
C. Myers‡‡, L.H.G. Larsen§§, M. Pendziwiat¶¶, Y. Mang***,
K.L. van Gassen‡, H.A. Dahl§§, G. Rubboli*, N. Tommerup***,
I. Helbig¶¶,†††, H.C. Mefford‡‡, H. Muhle¶¶
*Danish Epilepsy Centre, Dianalund, Denmark, †Institute for
Regional Health Services, University of Southern Denmark,
Odense, Denmark, ‡Department of Medical Genetics, University
Medical Center Utrecht, Utrecht, Netherlands, §Department of
Neurology and Neurorehabilitation, Children’s Clinic of Tartu
University Hospital, Tartu, Estonia, ¶Department of Pediatrics,
University of Tartu, Tartu, Estonia, **Clinic for Neuropediatrics
and Neurorehabilitation, Epilepsy Center for Children and
Adolescents, Sch€on Klinik Vogtareuth, Vogtareuth, Germany,
††Department of Diagnostics, Institute of Human Genetics,
University of Leipzig, Leipzig, Germany, ‡‡Department of
Pediatrics, Division of Genetic Medicine, University of
Washington, Seattle, WA, USA, §§Amplexa Genetics, Odense,
Denmark, ¶¶Department of Neuropediatrics, University Medical
Center Schleswig-Holstein, Kiel, Germany, ***Wilhelm
Johannsen Centre for Functional Genome Research, University
of Copenhagen, Copenhagen, Denmark, †††Division of
Neurology, The Children’s Hospital of Philadelphia,
Philadelphia, PA, USA
Purpose: Mutations in GABRB3 encoding the b3 subunit of the GABAA
receptor have recently been reported in patients with epileptic encephalo-
pathies. We aimed to delineate the clinical spectrum associated with
GABRB3mutations.
Method: We used high-throughput sequence analysis of the GABRB3
gene in 130 patients with a range of epileptic encephalopathies (EE) and
childhood epilepsies. In addition, we ascertained cases with GABRB3
mutations from other centers. A detailed clinical history was obtained
together with a review of EEGs.
Results: Eleven patients/families with heterozygous mutations of
GABRB3 were studied. The phenotypic spectrum of the 11 probands var-
ied from Febrile Seizures Plus (FS+) (2) and MAE (2) to Dravet syn-
drome (1), West syndrome (1) and unclassified EEs (5). Segregation
analysis was performed in eight cases; six occurred de novo (2 MAE, 1
West syndrome, 3 EE), whereas one FS+ associated mutation and the
Dravet associated mutation were found to segregate with a GEFS+ phe-
notype in the affected families. In total, we studied 17 individuals with
febrile seizures or epilepsy due to aGABRB3mutation. Seizure onset ran-
ged from day one to 3 years, however the majority of the probands had
seizure onset around 6–9 months of age. Eleven of the individuals had
febrile seizures, and two of them never developed afebrile seizures. The
majority of the patients with epilepsy had multiple seizure types includ-
ing GTCS, myoclonic seizures, absences, atonic seizures, focal seizures
and epileptic spasms; seizures were refractory to antiepileptic therapy in
approximately half of them. Ten had intellectual disability, ranging from
mild to severe and 6 had neurodevelopmental disorders or behavioral
problems including ASD, ADHD or aggressiveness.
Conclusion: The present study shows that GABRB3 mutations are asso-
ciated with a phenotypic spectrum ranging from febrile seizures, FS+ to
severe epileptic encephalopathies, defining a novel genetic disease
within the GEFS+ spectrum.
0053
TESTINGEPILEPTIC ENCEPHALOPATHY
CANDIDATEGENES IN ADDITIONAL SAMPLES:
PRIORITISINGTOOLS
C.G.F. de Kovel*, E.H. Brilstra*, R. van ‘t Slot*, R.S. Møller†,
A. Suls‡, S. Weckhuysen§, I. Helbig¶, B.P.C. Koeleman*,
EUROEPINOMICS-RES
*UMCUtrecht, Utrecht, Netherlands, †Danish Epilepsy Centre,
Dianalund, Denmark, ‡Universiteit Antwerpen, Antwerpen,
Belgium, §Ho^pital Pitié Salpe^triere, Paris, France,
¶Universitaet Kiel, Kiel, Germany
Purpose: In recent studies of mutations underlying epileptic encephalopa-
thies, numerous genes have been identified with unsufficient statistical
support. We seek to increase support for at least some of those genes.
Methods: samples from 362 patients with epileptic encephalopathy
were tested on a panel of 370 known and candidate genes. The genes had
been collected from literature and earlier experiments in our labs. Eigh-
teen genes had OMIM-annotations for epileptic encephalopathy; 66
genes were expected to be recessive, 288 dominant, 13 X-linked, the
remainder unknown. In the first screen, no parents were included. We
looked for novel coding variants. We are using various databases such as
RVIS, CADD and the Broad-Exac database, as well as the number of hits
to prioritise genes for follow-up.
Results: Thirty-eight patients had probably pathogenic variants in
OMIM-annotated genes. Over 600 other coding variants novel to EVS
and dbSNP were found. OMIM genes and dominant candidate genes had
significantly more hits per gene than X-linked or recessive genes. CADD
scores were significantly higher for OMIM-genes than for dominant
genes, with X-linked in-between.
Conclusions: Despite previous screening in part of the samples, possi-
bly pathogenic variants in OMIM-genes were common. CADD-scores
and number of hits per gene seem good filters to prioritise genes for fur-
ther follow-up, i.e. testing parents to check de novo status. A shortlist of
genes which combine high CADD-scores, low RVIS-scores and excess
unique hits relative to Exac-database will be presented.
0055
APPROXIMATELY 10%OF “DENOVO”
SCN1AMUTATIONS CAUSINGDRAVET SYNDROME
ARE INHERITED FROMUNDETECTED PARENTAL
MOSAICISM
Y.-H. Zhang*, X. Xu*, X. Yang†, Q. Wu†, X. Wu*, L. Wei†
*Peking University First Hospital, Pediatrics, Beijing, China,
†Center for Bioinformatics, School of Life Sciences, Peking
University, Beijing, China
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Purpose: Mutations in the gene SCN1A were identified in approxi-
mately 70% of Dravet syndrome (DS) patients and most mutations are
identified as de novo using Sanger sequecing. Parental mosaicism has
been detected in few DS families by Sanger sequencing. Sanger sequenc-
ing cannot detect mutant alleles with low allelic fraction. It is reasonable
to suspect that parental mosaicism may be under-detected, especially
when the allelic fraction is low. We investigated how many of the “de
novo”mutations as determined by Sanger sequencing might in fact be
undetected parental mosaicism in a cohort of 363 DS families in China.
Method: For mutations determined by Sanger sequencing to be “de
novo”, we subjected the parents’DNA to a new protocol we developed to
detect and quantify mosaicism using amplicon re-sequencing by Ion tor-
rent Personal GenomeMachine (PGM) followed by a Bayesian model.
Results: We discovered that a surprising 17 (9.8%) of the “de novo”
mutations in DS were in fact inherited from parental mosaicism that was
undetectable by Sanger sequencing. These mosaicisms were validated by
pyrosequencing and RainDrop digital PCR. Eleven (64.7%) mutations
originated from paternal mosaicism and only six (35.3%) from maternal
mosaicism. Twelve (70.6%) of the mosaic parents did not have any
epileptic symptoms, and their mutant allelic fractions were significantly
lower than those in mosaic parents with epileptic symptoms (p = 0.01).
We identified mosaicism with varied allelic fractions in blood, saliva,
urea, hair follicle, oral epithelium, and semen, demonstrating that postzy-
gotic mutations could affect multiple somatic cells as well as germ cells.
Together with five other cases of parental mosaicism detectable by San-
ger sequencing, we identified a total of 22 (12.3%) cases of parental
mosaicism.
Conclusion: Parental mosaicism in DS family is likely to be more com-
mon than previously thought by current Sanger-based technologies.
Genetic counseling in DS family should be cautious.
Platform Session: Neuropsychology
Monday, 7th September 2015
0056
ASSESSINGACCELERATED LONG-TERM
FORGETTING INNEWLYDIAGNOSED FOCAL
EPILEPSY
S.M. Makin*, C.F. Jackson†, C. Shippen‡, A.G. Marson†,§,
D. Smith¶, R. Mohanraj**, G.A. Baker*,§
*The Walton Centre NHS Foundation Trust, Neuropsychology,
Liverpool, UK, †The Walton Centre NHS Foundation Trust,
Liverpool, UK, ‡Merseycare NHS Trust, Neuropsychology,
Liverpool, UK, §University of Liverpool, Department of
Molecular and Clinical Pharmacology, Liverpool, UK,
¶WrexhamMaelor Hospital, Neurology, Wrexham, UK,
**Salford Royal NHS Foundation Trust, Neurology,
Manchester, UK
Purpose: Many people with epilepsy report an increased rate of forget-
ting for verbal or episodic memory (accelerated long-term forgetting;
ALF). To date, there has been no research that assesses neuropsychologi-
cal functioning, including ALF, of people with newly diagnosed focal
epilepsy compared with healthy controls.
Method: Twenty-two people with newly diagnosed epilepsy (PWE) and
25 controls were included in the study. All participants completed neu-
ropsychological assessments of executive functioning, memory and a
novel episodic memory test.
Results: PWE generated significantly fewer words than control partici-
pants on a letter fluency task (t(45) = 2.775, p = 0.008), category flu-
ency task (t(45) = 2.947, p = 0.005) and category switching task (t(45)
=-3.179, p = .003). PWE had significantly higher rates of ALF after a
4 week delay than controls for story recall (t(45) = 3.383, p = 0.001).
Within the PWE group, a significant negative relationship was found
between recall of verbal information after a 4 week delay and number of
words generated in the letter fluency task (r = 0.544, p = 0.009). Assess-
ment of caseness within the PWE group identified three participants with
impaired letter fluency, three participants with impaired story recall at
4 weeks and no participants displayed impairment across both tasks. No
control participant fell into the impaired range on either task. There was a
trend towards higher rates of forgetting for PWE on the episodic memory
task after a 4 week delay but this did not reach significance
(t(45) = 1.883, p = 0.069). There was significant positive correlation
between rates of forgetting in story recall at 4 weeks and episodic mem-
ory at 4 weeks (r = 0.394, p = .006).
Conclusion: These findings suggest the ALF phenomenon cannot solely
be a product of chronicity as it is present in those with newly diagnosed
epilepsy. Conventional verbal memory tests were found to be a practical
way of assessing ALF and they were also a more sensitive measure than
problematic episodic memory assessments.
0057
TO EVALUATEQUALITY-OF-LIFE (QOL), BEFORE
ANDAFTERADMINISTRATIONOFCOGNITIVE
BEHAVIOURAL THERAPY (CBT) AS A TREATMENT
IN PATIENTS DIAGNOSEDWITHPSYCHOGENIC
NON-EPILEPTIC SEIZURES (PNES) ANDASSESS THE
SAMEONWHOQOL-BREF (FIELD TRIALVERSION)
ANDM.I.N.I SCALE
D. Masiwal, M. Tripathi, R. Sagar
AIIMS, Neurology, New Delhi, India
Despite the high prevalence and disabling nature of psychogenic non-
epileptic seizures(PNES), treatment is unknown. We evaluated the
effect of Cognitive Behavioral Therapy(CBT) on reduction of PNES.
Psychogenic non-epileptic seizures, also known as Non epileptic attack
disorder, are events superficially resembling an epileptic seizure, with-
out the characteristic electrical discharges associated with epilepsy.
Cognitive Behavioral Therapy has emerged as a “treatment of choice”,
since it is used when patients are reluctant to make behavioural
change. This abstract proposes many future directions to address these
limitations in the efficacy and clinical effectiveness of CBT for
patients with PNES.
Methodology: All PNES patient’s male/females and children above the
age of 10 years were enrolled. To see the effect of minimum five CBT
sessions of 30–60 minutes duration for patient and their family over the
period of 1 year. The sample size was 50. Paired t test was applied to
compute the differences between pre and post intervention.
Result: After administration of Cognitive Behavioral Therapy, we
checked the significance of its effect on four domains of QOL scale. The
average Social Relationship, Physical Health, Psychological and Envi-
ronment score increased by 19.45%, 20.33%, 22.38% and 24.04%
respectively. Pre and Post intervention statistical values were highly sig-
nificant at p < 0.01. Likewise, the effect of CBT on Major Depressive
Disorder, Anxiety, Dysthymia, Anorexia Nervosa and Panic disorder
decreased the average score by 25%, 31.25%, 30%, 33.33% and 37.5%
respectively.
Conclusion: This study supports the use of CBT for PNES patients in a
population that is largely poor, illiterate and culturally biased. It is a suc-
cessful cure for mental health and Quality of life of PNES patients.This
study gives both therapist and patient an opportunity to understand not
only the psychological distress but limit overprotection and misunder-
stood preconceived notions. Further therapeutic interventions are
required to understand the dissociative psychological disorders in order
to reduce disability and burden in PNES patients.
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0058
DECISIONMAKINGAND SKINRESISTANCEAS A
SOMATICMARKER INMESIAL TEMPORAL LOBE
EPILEPSY
S. Delil*, S. Icellioglu†, S. Yagci Kurtish*, B. Korkmaz*,
S.N. Yeni*
*Istanbul University Cerrahpasa Faculty of Medicine,
Neurology, Istanbul, Turkey, †Istanbul Kültür University,
Psychology, Istanbul, Turkey
Purpose: Iowa Gambling Test (IGT) showed that patients with frontal
lobe lesions performed well on standard neuropsychological tests, how-
ever showed lower net scores on IGT. IGT is used to assess decision
making(DM). Somatic marker hypothesis(SMH) proposes that emo-
tional processes can be guided by a variety of somatic signals such as
skin conductance,especially in decision making behavior. The purpose
of this study is to test the SMH and to assess DM performances of
patients with mesial temporal sclerosis (MTS) by using IGT with a con-
trol group.
Method: 22 patients (MSS = 32.7  10.998 for age) and 24 healthy
paticipants with similar sociodemographic characteristic (MSS =
31  9.8 for age) were included. The computerized version of IGT had
been used to assess DM as published elsewhere. Skin resistance was mea-
sured as an indicator of somatic marker during IGT. Skin resistance val-
ues are recorded just before -2 ms. the participant makes his choice and
this measure is evaluated as an anticipatory response. These anticipatory
responses then compared (AB and CD) to see if the groups generated
somatic markers before making disadvantegous decks. The effect of deck
on anticipatory responses had been analysed by using Univariate
ANOVA statistics. Independent samples T-test had been used to compare
IGT total net scores between control and epilepsy group.
Results: In control group, analysis of variance showed a main effect of
deck (AB/CD) on anticipatory responses for AB decks (F(1,184) = 4.33;
p < 0.05). No main effect had been found in epilepsy group. Results indi-
cated that the scores were significantly higher for control group
(M = 11.6, SD = 14.5) than for epileptic group (M = 2.55,
SD = 17.96), (t(44) = 2.95; p < 0.05).
Conclusion: The control group makes more adventogeous choices than
the patient group in IGT. MTS patients showed different SM responses
with controls. This result may be comparable with patients having ven-
tromedial frontal lobe lesions.
0059
CURRENT STANDARDSOFNEUROPSYCHOLOGICAL
ASSESSMENT IN PATIENTSWITHEPILEPSY:
RESULTS FROMASURVEY IN 24 EUROPEAN
EPILEPSYCENTERS
V.L. Vogt, J.-A. Witt, C.E. Elger, C. Helmstaedter, E-
PILEPSY consortium
University of Bonn, Department of Epileptology, Bonn, Germany
Purpose: To assess the current practice of neuropsychological assessment
in patients with refractory epilepsy in european epilepsy centers.
Method: In context of a european project on the harmonization of
presurgical diagnostics in patients with refractory epilepsy (E-PILEPSY;
a European pilot network of reference centers in refractory epilepsy and
epilepsy surgery) funded by the European Agency for Health and Con-
sumers, a survey was conducted on the status quo of neuropsychological
testing.
Results: Responses of 24 participating centers revealed that neu-
ropsychological assessment is considered to be an essential part of
presurgical work-up. A mean number of 180 patients are tested per
year. The most frequent indications comprise localization of dysfunc-
tions, pre- and postsurgical testing and monitoring of pharmacological
effects. Most frequently assessed domains are verbal and nonverbal
memory, attention and executive functions, language, visuo-spatial
functions and IQ. There is a large variety of tests applied for each of
these domains with little overlap between the centers. Even greater
variability can be found in regard to the assessment of hemispheric lan-
guage dominance, including different indications, methods and para-
digms. The most frequent method is fMRI in addition to lateralizing
neuropsychological tests and hand dominance. In general, the Wada test
is very rarely performed (on average 7 patients per year) and cannot be
regarded as a standard procedure.
Conclusion: While there is a huge variety in regard to specific tests in
use, very high agreement can be found concerning the principles of neu-
ropsychological testing. Differences in regard to the assessment of lan-
guage dominance are more fundamental. Future efforts will aim for
establishing a minimal consensus on standardized neuropsychological
tests across the centers focusing on proven criterion and ecological valid-
ity of the measures in the field of epilepsy. This core test battery will then
be sought to be normalized in context of the project.
0060
INSOMNIA IN PEOPLEWITHEPILEPSY:
PREVALENCE, PREDICTORS AND IMPLICATIONS
Z.C. Thayer*,†, H. Johnson‡, S. King‡, A. Ridalgh‡,
A. Mohamed§,¶, J. Boserio§, L. Miller*,†, K. Nicholson-Perry‡
*Royal Prince Alfred Hospital, Institute of Clinical
Neurosciences, Neuropsychology, Sydney, Australia,
†University of Sydney, ARC Centre of Excellence in Cognition
and its Disorders, Sydney, Australia, ‡Australian College of
Applied Psychology, Sydney, Australia, §Royal Prince Alfred
Hospital, Institute of Clinical Neurosciences, Sydney, Australia,
¶University of Sydney, Faculty of Medicine, Sydney, Australia
Purpose: There is a well recognised, albeit poorly understood, complex,
reciprocal relationship between sleep and epilepsy. Despite evidence
showing insomnia is common in people with epilepsy (PWE) (Vendrame
et al., 2013), there is a lack of research into its predictors and ramifica-
tions. This study aimed to determine the prevalence of self-reported
insomnia symptoms in PWE referred to a hospital outpatient clinic. We
examined the influence that epilepsy variables, mood, sleep hygiene, pre-
sleep worry and dysfunctional beliefs about sleep had on insomnia sever-
ity. In addition we investigated relationships between insomnia and self-
reported memory function and quality of life.
Method: A prospective sample of 90 English-speaking PWE, aged 18–
65 completed the Pittsburgh Sleep Quality Inventory (PSQI), Sleep
Hygiene Index (SHI), Generalised Anxiety Disorder-7 (GAD-7), Neuro-
logical Disorders Depression Inventory in Epilepsy (NDDI-E), Everyday
Memory Questionnaire (EMQ) and Quality of Life Inventory in Epilepsy
(QOLIE-31).
Results: 56% of the sample scored in the insomnia range on the self-
report PSQI, a figure nearly three times higher than the reported base-rate
for the general population of 19% (Bazil, 2003). Neither type of epilepsy,
duration of disease, nor number of AEDs correlated with severity of
insomnia symptoms. However, higher symptoms of depression and anxi-
ety as well as poor sleep hygiene practices were related to insomnia
severity. Insomnia severity was correlated with number of self-reported
memory failures and lower quality of life.
Conclusion: A high proportion of PWE experience insomnia, but we
found no specific disease-related factors to be associated with severity of
self-reported insomnia symptoms. Instead insomnia severity was associ-
ated with poor sleep hygiene, anxiety and depression. Ramifications of
insomnia included memory problems and lower quality of life. Given
these findings, behavioural and psychological interventions tailored for
PWE experiencing insomnia have the potential to be effective and have
an important functional impact.
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0061
PREHOSPITAL EPILEPSY EMERGENCY SCORE
(PEES) FOR PRECLINICAL DIFFERENTIATION
BETWEEN SYNKOPEANDEPILEPTIC SEIZURE IN
EMERGENCYCASE
T.M. Kniess*, H. Stefan†, H. Hamer†, E. Pauli†, K. Mai†
*Clinic of Neurology, Bad Neustadt, Germany, †Clinic of
Neurology University Hospital Erlangen, Epileptology,
Erlangen, Germany
Purpose: In preclinical emergency case of sudden loss of consciousness
it is difficult to distinguish between syncope or an epileptic seizure.With-
out documentation essential information`s are often lost. We aim to
develop an easy to handle score for a preclinical setting, which may pro-
vide recognition of essential clinical signs for the differential diagnosis.
Method: 124 subjects were shown 4 videos with one syncope and three
seizures, respectively according to ILAE IA, IB, IC. The Researcher asks
the subject, after watching the video, to assess their clinical observations
judged by what they have seen. SPSS 22.0 (Generalized estimating equa-
tion) was used for Data Analysis. The category “known epileptic” listed
in the PEES (tabl.1) was not included in the statistical analysis, because
this cannot be recognized by subject from the video information. The cut-
off point is a score equal or greater to 5 as sign for an epileptic seizure.
Results: N = 124
Syncope: mean 2.6 (SD 1.0) Min: 0; Max: 6
Seizure IA: mean 6.8 (SD 1.7) Min: 3; Max: 10
Seizure IB: mean 5.3 (SD 0.9) Min: 3; Max: 8
Seizure IC: mean 8.5 (SD 1.3) Min: 4; Max: 10
The total-sum-score demonstrates sensitivity (0.97) and specifity
(0.97).
Conclusion: The PEES records the basic clinical signs for syncope and
epileptic seizures. The score system showed a high sensitivity across all
averages. The cut-off point for seizure, which was defined as 5 or greater
based on the results of the initial studies (1.2) should be now, with regard
to the new results, >5 points. Based on these findings, the score should be
tested in a field test project in prehospital emergency situations. The find-
ings should be transmitted digitally to the receiving hospital and the
results of PEES will be compared with the final diagnosis in a following
study.
0062
EXPLORING THEROLEOFANXIETYAND
DEPRESSION IN THELIVESOFAUSTRALIAN
ADULTSWITHEPILEPSY; RESULTS FROMTHE 2010
AUSTRALIAN EPILEPSY LONGITUDINAL SURVEY
C.F. Walker*, C.L. Peterson†, G. Shears‡
*Chronic Illness Alliance, Surrey Hills, Australia, †La Trobe
University, Sociology, Melbourne, Australia, ‡Epilepsy
Foundation, Executive Officer, Melbourne, Australia
Purpose: Psychological distress is higher among people living with epi-
lepsy than many other disease groups. Our purpose is to examine key
determinants of anxiety and depression in a community sample of people
with epilepsy.
Method: Data come from the 2010 Australian Epilepsy Longitudinal
Survey, which explores the social impact of living with epilepsy in Aus-
tralia. The HADS scale was analysed and Pearson correlations and block
recursive regression were undertaken to identify key associations
between anxiety, depression and a range of variables to identify key
determinants of anxiety and depression.
Results: Key factors to influence anxiety were social aspects of stigma,
effectiveness of seizure control, employment status and the number of
different epilepsy drugs a person was prescribed.
Determinants for depression were social effects of stigma, whether in
employment and the effectiveness of seizure control. Stigma was also
found to be an important mediating variable for employment, control and
number of drugs.
Conclusion: These results indicate that psycho-social issues such as
employment status and experience of stigma interact with epilepsy and
its treatments to account for high rates of anxiety and depression in this
community sample of epilepsy. The results reinforce the need for com-
munity-based measures to ameliorate the negative effects of unemploy-
ment and stigma in order to reduce anxiety and depression associated
with epilepsy. Further research into the relationships between anxiety
and depression and lived experience of epilepsy would assist in develop-
ing targeted strategies to alleviate the effects of anxiety and depression
for people with epilepsy.
0063
ACOMPARATIVE STUDY INTOTHE IMPACTOF THE
EPILEPSY SPECIALIST NURSEON PATIENTS’
KNOWLEDGE, CARE PROCESS, SATISFACTION
WITHCAREANDQUALITYOFLIFE
A. Higgins*, J. Varley*, C. Begley*, M. White†, C. Doherty‡,
C. Normand§, N. Elliott*, SENSE HRB/Epilepsy Ireland
study group
*Trinity College Dublin, School of Nursing and Midwifery,
Dublin, Ireland, †Beaumont Hospital, Department of Nursing,
Dublin, Ireland, ‡St James’Hospital, Department of Neurology,
Dublin, Ireland, §Trinity College Dublin, Department of Health
Policy and Management, Dublin, Ireland
Purpose: To determine if there is a difference in patients’ knowledge of
epilepsy, experience of care, satisfaction with care, and quality of life
(QoL) for those receiving care from services with an Epilepsy Specialist
Nurse, compared to those receiving care from services without an Epi-
lepsy Specialist Nurse (ESN).
Method: Following ethical approval, outcomes for patients receiving
care for more than a year within a service with an ESN (n = 255), were
compared to outcomes from a cohort of patients receiving care within a
service without an ESN (n = 271), using a validated survey. Both groups
were comparable for all the demographic, psychosocial and epilepsy
variables measured.
Results: Statistically significant differences were found in overall
knowledge, with patients in the ESN sites having higher mean scores for
knowledge (M = 4, SD=0.710) compared to the Non ESN sites
(M = 3.67, SD=0.758) [t(493) = 4.914, p < 0.000]. There was a statis-
tically significant difference in involvement in care with respondents
from the ESN sites having higher mean scores (M = 4.23, SD=0.720)
compared to the Non ESN sites (M = 3.94, SD=0.824) [t(491) =4.254,
p < 0.000]. Respondents from ESN sites also reported higher satisfaction
with emotional support (M = 7.38, SD = 2.408) compared to respon-
dents from Non ESN sites (M = 6.61, SD = 2.755) [t (475) = 3.185,
p < 0.002] and higher satisfaction with practical support (M = 8.04;
SD = 2.11) compared to respondents from Non ESN sites (M = 7.38;
SD = 2.408) [t (480) = 3.231 p < 0.001). The average QOLIE 10P
score was similar for both Non ESN sites (M = 38.32, SD = 28.65) and
ESN sites (M = 37.45, SD= 26.77) with no statistical difference
observed [t (477) =.346, p = .729].
Conclusion: Although no differences were reported in QoL, patients
receiving care within a service with an ESN report greater knowledge of
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epilepsy, involvement in own care and satisfaction with support offered
compared to those being cared for in a service without an ESN.
0064
COMPARISONOFEPILEPSYANDASTHMA
PERCEPTIONAMONGPRESCHOOLTEACHER IN
TAIWAN - PAST ANDPRESENT
L.P. Hsieh*, H.H. Chiou†
*Cheng-Ching Hospital, Neurology, Taichung, Taiwan,
Republic of China, †Hung Kuang University, Child Care &
Education, Taichung, Taiwan, Republic of China
Purpose: Epilepsy and asthma are two common chronic illnesses of
childhood.We had performed the study to investigate preschool teachers’
perceptions to children with epilepsy and asthma in 2001; the results
revealed that perceptions of these two chronic illnesses were different
significantly. The purpose of this survey was to assess the changes in the
attitudes and perceptions toward these diseases during a twelve years per-
iod by testing of preschool teachers in Taiwan.
Methods: Two hundred seventy-four preschool teachers were investi-
gated with a questionnaire regarding their knowledge, attitude and prac-
tice. There were 22 paired questions (half for epilepsy and the others for
asthma) in this questionnaire. Differences between teachers’ perception
of children with epilepsy and asthma were analyzed. We also compared
the present results with past data performed on 2001.
Results: In recent survey, more teachers thought epilepsy was a heredi-
tary disease and associated with insanity than asthma (p < 0.05). Accep-
tance of a child with epilepsy was less than a child with asthma with
significant difference. Teachers seem to have more understanding for
asthma than epilepsy and this difference was also significant. Regarding
to relations of illness with insanity, there are no significant differences
between present and past 12 years results. More teachers are willing to
accept a child with both epilepsy and asthma in the class than 12 years
before. Teachers’ worry of objection by other kids’ parents to the child
with epilepsy also declines significantly in two surveys. The participants
felt that they have more resources for understanding knowledge of both
for epilepsy and asthma with significant difference.
Conclusions: Perceptions of epilepsy and asthma among preschool
teachers were different significantly in recent study. Even though they
had more resources for understanding knowledge of epilepsy and more
confidence to communicate with epilepsy children’ parents compared
with 12 years ago.
0065
STIGMAAND ITS UNDERLYINGCONTRIBUTORS IN
CHINESE EPILEPSY PATIENTS
J. Ding*, K. Wang†, L. Mao*, Q. Zhang*, X. Wang*
*Zhongshan Hospital, Fudan University, Neurology, Shanghai,
China, †Shanghai World Foreign Language Middle School,
Shanghai, China
Purpose: Epilepsy is a chronic disorder of the brain that affects people
of all ages. Stigma and exclusion which affected quality of life are com-
mon features of epilepsy patients. Our study was aimed to study the
stigma in epilepsy in Chinese patients and to investigate the underlying
contributors.
Method: A total of 301 individuals with epilepsy were enrolled. A clini-
cal questionnaire including clinical and demographic details was applied.
Patient-perceived stigma was collected by using self-completed ques-
tionnaire (The Stigma Scale). The relationship between clinical variables
and stigma scale was confirmed by Logistic regression analysis.
Results: The patients’ scores of stigma ranged from 0 to 4. The percent-
age of patients with stigma score greater than or equal to 1 was 42.2%.
Among them, 55 patients had stigma score 1(18.3%), 47 patients had
stigma score 2(15.6%), 25 patients had score 3(8.3%). Patients with
stigma score greater than or equal to 1 had lower age of onset and educa-
tion year compared to patients with stigma score 0. There was no differ-
ence between two groups in age, sex, income, economic status, disease
duration, seizure type, epilepsy etiology and taking antiepileptic drugs.
Logistic regression analysis revealed that age of onset, education year
and seizure frequency were independent risk factors of stigma in epilepsy
patients.
Conclusion: Our study revealed high percentage of stigma in Chinese
epilepsy patients. Age of onset, education year and seizure frequency are
significant contributors on scores on the stigma scale. Further research
should be done to seek for the way to reduce the percentage of stigma in
patients with epilepsy.
Platform Session: Clinical Trials 2
Tuesday, 8th September 2015
0066
DIFFERENTIAL NEUROPSYCHOLOGICAL ANDEEG
EFFECTSOF LACOSAMIDEVERSUS
CARBAMAZEPINE IMMEDIATE-RELEASE IN
HEALTHY SUBJECTS: A FOCUSONEEGEFFECTS
K.J. Meador*, D.W. Loring†, A. Boyd‡, W. Byrnes§, D. Dilley§,
S. Borghs¶, M. De Backer**, T. Story††, P. Dedeken**,
E. Webster§
*Stanford University, Stanford, CA, USA, †Emory University,
Atlanta, GA, USA, ‡CNS Vitals, Morrisville, NC, USA, §UCB
Pharma, Raleigh, NC, USA, ¶UCB Pharma, Slough, UK, **UCB
Pharma, Brussels, Belgium, ††UCB Pharma, Atlanta, GA, USA
Purpose: Antiepileptic drug (AED) tolerability is determined largely by
adverse cerebral effects. This study evaluated the neuropsychological
and EEG effects of lacosamide (LCM) versus carbamazepine immediate-
release (CBZ-IR).
Methods: Neuropsychological and EEG effects of LCM (300 mg/day)
and CBZ-IR (600 mg/day) were compared in healthy adults using a ran-
domized, double-blind, double-dummy, two-period crossover design
with assessments at screening, pre-drug baseline, end of each treatment
period (3-week Titration; 3-week Maintenance Period), and end of each
washout period (4 wks) after drug treatment. The primary outcome-vari-
able was an overall neuropsychological composite Z-score derived from
computerized and traditional neuropsychological measures, which
assessed attention, processing speed, executive functions, and memory.
EEG measures included relative delta power, relative theta power, alpha
peak, and event-related potential latency.
Results: 60 adults (57% female, mean age 34y [SD 10.5]) were random-
ized; 44 completed both treatments. The primary analysis included 41
per-protocol subjects. The overall composite neuropsychological Z-
scores differed in favor of LCM (0.33 [SD 1.36], p = 0.01). Absolute Z-
score differences compared with the average of non-drug conditions were
-0.26 for CBZ-IR and +0.08 for LCM. In secondary analyses of individ-
ual neuropsychological variables, CBZ-IR was statistically worse than
LCM on 25% (4/16); none favored CBZ-IR. The overall composite EEG
Z-scores for the AEDs differed in favor of LCM (0.74 [SD 1.42],
p = 0.0014). Z-scores were significantly different (p < 0.05) in favor of
LCM for 75% (3/4) of the individual EEG measures. Drug-related
adverse events (AEs) were reported in 22% of subjects on LCM and 49%
on CBZ-IR. Discontinuations due to AEs occurred in 2 (4%) subjects
during LCM and 8 (14%) during CBZ-IR treatment.
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Conclusion: LCM 300 mg/day monotherapy showed statistically signif-
icantly fewer untoward neuropsychological and EEG effects than CBZ-
IR 600 mg/day in healthy subjects. Overall, fewer AEs and AEs leading
to discontinuation were observed during LCM than during CBZ-IR treat-
ment.
0067
STRESSMANAGEMENT INTERVENTION FORLIVING
WITHEPILEPSY:RESULTSOFARCT
M. Privitera*, E. Polak†, A. Fleck*, S. Haut†
*University of Cincinnati, Neurology, Cincinnati, OH, USA,
†Montefiore Medical Center, Neurology, Bronx, NY, USA
Purpose: Stress is the most common self-reported seizure precipitant
in multiple surveys and many people with epilepsy believe stress
reduction improves seizure control. We performed a prospective, ran-
domized, controlled trial (RCT) of stress reduction with smartphone
monitoring of stress and mood variables in people with medication
resistant epilepsy.
Method: Three epilepsy centers recruited subjects with at least 2 focal
onset seizures per month despite optimal medical treatment. Subjects
identified stress or other factors as seizure precipitants. For 3 month
treatment phase, subjects were randomized to active treatment with 2–3
times daily progressive muscle relaxation versus sham treatment with
extremity movements and writing a journal of daily activities. Subjects
recorded seizures and answered questions about stress and mood twice
daily into a study smartphone. Each day subjects reported how likely they
thought a seizure was in next 24 hours. In addition to diary counts of sei-
zure frequency, subjects completed a treatment credibility scale that
asked if the treatment reduced stress or seizures.
Results: 67 subjects were randomized; 64 completed the entire 5 month
study. 94% of days all the diary entries were completed. Mean seizure
frequency during baseline was 12 per month; range 2–99. Interim analy-
sis (53 subjects) showed 81% of all participants reported stress was
reduced during the study. In active treatment arm, 85% reported stress
reduced; 77% reported seizures reduced. In the sham arm 78% reported
stress reduced; 58% reported seizures reduced. Final results will be
presented.
Conclusion: A RCT of stress reduction treatment for medication resis-
tant seizures is feasible and subjects are highly compliant with treatment
and daily diary entries. Subjects believed that both the active and sham
arms reduced stress and seizures, but more seizure reduction was reported
in the active treatment arm. Final results will be presented.
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LONGTERMPATIENTOUTCOMESUSINGCARDIAC-
BASED SEIZUREDETECTION
P. Boon*, K. van Rijckevorsel†, R. El Tahry†, C.E. Elger‡,
N. Mullatti§, A. Schulze-Bonhage¶, K. Vonck*, G.L. Wagner**,
W. Van Grunderbeek††, R.M. McGuire‡‡
*Universitair Ziekenhuis Gent, Ghent, Belgium, †Cliniques
Universitaires Saint-Luc, Brussels, Belgium,
‡Universit€atsklinikum Bonn, Bonn, Germany, §King’s College
Hospital, London, UK, ¶Albert-Ludwigs-Universit€at, Freiburg,
Germany, **Kempenhaeghe, Heeze, Netherlands,
††Cyberonics, Inc., Diegem, Belgium, ‡‡Cyberonics, Inc.,
Houston, TX, USA
Purpose: A novel vagus nerve stimulation (VNS) pulse generator, model
106, was developed with a cardiac-based seizure detection algorithm
(CBSDA) to automatically trigger VNS (AutoStim Mode) in response to
seizure activity associated with an increased heart rate. Patient follow-up
in the E-36 clinical trial is planned for a 2 year period to analyze the
safety and clinical benefit of the new device.
Method: The E-36 study (NCT01325623) enrolled 31 patients with drug
resistant epilepsy who were admitted to an Epilepsy Monitoring Unit
(EMU) for up to 5 days of continuous video electroencephalography.
Clinical benefit was assessed based on the proportion of seizures which
ended during automatic stimulation, seizure severity scoring by patients
(Seizure Severity Questionnaire, SSQ) and physicians (National Hospital
Seizure Severity Scale, NHS3), and patient-rated quality of life.
(QOLIE-31-P).
Results: Safety profiles were comparable to prior VNS Therapy trials.
Within the EMU, 55% (6 of 11) of debilitating focal seizures ended dur-
ing automatic stimulation. NHS3 scores for debilitating focal seizures
showed significant improvement (p < 0.05) at EMU discharge, and at 6
and 12 month follow-up compared to baseline. During 3, 6, and
12 month follow-up, patients reported significant improvement in key
components of seizure severity compared to baseline, including: move-
ments that could result in harm, overall recovery, and physical/cognitive
aspects of post-ictal recovery. Nearly all categories within the patient-
rated quality of life scale (QOLIE-31-P) showed significant improvement
at the 12 month follow-up. Results from extended follow-up periods will
be available at the meeting.
Conclusion: AutoStim delivered near seizure onset appears to have sim-
ilar clinical benefit to magnet-activated (on-demand) stimulation. This
convenience feature extends the benefits of acute stimulation to patients
who cannot use the magnet to manually activate treatment. The NHS3,
SSQ, and QOLIE showed sustained improvement over time using com-
bined AutoStim and standard VNSmodes.
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ARANDOMIZEDCONTROLLEDCLINICAL TRIALOF
CATHODALTRANSCRANEALDIRECTCURRENT
STIMULATION IN PATIENTSWITHTEMPORAL LOBE
EPILEPSYWITHHIPPOCAMPAL SCLEROSIS
REFRACTORYTO PHARMACOLOGICAL
TREATMENT
D.A. Espinoza Lopez*, D. San Juan Orta*, L. Morales
Quezada†, A. Orozco Gardu~no‡, M.A. Alonso Vanegas§,
M. Fernandez*, R. Vazquez Gregorio‡, D. Anschel¶,
F. Fregni**
*National Institute of Neurology and Neurosurgery “Manuel
Velasco Suarez”, Neurophysiology, Distrito Federal, Mexico,
†Laboratory of Neuromodulation, Spaulding Rehabilitation
Hospital and Massachusetts General Hospital, Harvard Medical
School, Laboratory of Neuromodulation, Department of
Physical Medicine & Rehabilitation, Spaulding Rehabilitation
Hospital and Massachusetts General Hospital, Harvard Medical
School, Massachusets, MA, USA, ‡National Institute of
Neurology and Neurosurgery “Manuel Velasco Suarez”,
Distrito Federal, Mexico, §National Institute of Neurology and
Neurosurgery “Manuel Velasco Suarez”, Neurosurgery,
Distrito Federal, Mexico, ¶Comprehensive Epilepsy Center of
Long Island, Neurophysiology, Long Island, NY, USA,
**Hospital and Massachusetts General Hospital, Harvard
Medical School, Department of Physical Medicine &
Rehabilitation, Massachusets, MA, USA
Introduction: Transcranial direct current stimulation (tDCS) is an
emerging non-invasive neuromodulation therapy have demonstrated pre-
liminary safety and efficacy in animals and patients with epilepsy. tDCS
induce widespread changes of cortical excitability through a weak con-
stant electric current depending of the polarity. Hyperpolarization using
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cathodal tDCS suppress epileptiform interictal discharges (EIDs) and
clinical seizures (Sz).
Purpose: Evaluate safety and efficacy of different cathodal tDCS proto-
cols in the frequency of clinical Sz and EIDs in adult patients with tempo-
ral lobe epilepsy (TLE) with hippocampal sclerosis (HS).
Method: Clinical trial phase II, randomized, double blind, prospective
with three arms (2 active [3 days and 5 days 9 30 min, 2 mA] and pla-
cebo) that consisted of 3 phases:
1) pre-treatment,
2) intervention active (with tDCS stimulation device (Hong Kong) or
placebo and
3) post-treatment with follow-up at 30 and 60 days (Jan 2012–May
2014).
The frequency of Sz, EIDs and side effects were record in each phase.
The EEGs recordings were performed at pre-treatment, immediately
post-treatment, 30 and 60 days. We used descriptive statistics and
ANOVA for analysis.
Results: We included 28 patients, 16/28 (57%) men, age 37.8 ∓
10.9 years-old (3 day n = 12, 5 day n = 8, placebo n = 8). We found a
significant reduction of the number of Sz at 2 months between the two
actives groups (48%) versus placebo (-36%) (F = 6.824, df = 2,
p < 0.008) and using Bonferroni test 3 days versus placebo (43% vs. -
36%, p < 0.015) and 5 days versus placebo (-55% vs.36%, p < 0.027)
were significance. We didn0t found any reduction in EIDs at the follow-
up or sz at 1 month. Cathodal tDCS was well tolerated in the active
groups.
Conclusion: Cathodal tDCS sessions of 3 days and 5 days (2 mA,
30 min) decreased the frequency of Sz at 2 months in adult patients with
TLE with HS compared with placebo.
Platform Session: Epilepsy and Seizures:
Causes and Precipitants
Tuesday, 8th September 2015
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GREAT SPHENOIDWINGDEFECTS IN REFRACTORY
CRYPTOGENIC TEMPORAL LOBEEPILEPSY: A
CONTROLLED STUDY
G. Pustorino*, E. Ferlazzo*,†, S. Calabro*, S. Gasparini*,†,
A. Gambardella†, A. Labate†, V. Cianci*, A. Gangemi‡,
P. Versace‡, E. Africa‡, A. Porcelli‡, M. Campello§,
U. Aguglia*,†
*Regional Epilepsy Centre, Azienda Bianchi-Melacrino-Morelli
Hospital, Reggio Calabria, Italy, †Magna Græcia University,
Department of Medical and Surgical Sciences, Catanzaro, Italy,
‡Neuroradiology Unit, Azienda Bianchi-Melacrino-Morelli
Hospital, Reggio Calabria, Italy, §Neurosurgery Unit, Azienda
Bianchi-Melacrino-Morelli Hospital, Reggio Calabria, Italy
Introduction: Bone defects of the skull may occur in middle cranial
fossa and may lead to menino-encephalocele, whose association with
seizures is well established. Aims of this study are to investigate the
prevalence of great sphenoid wing defects in refractory “cryptogenic”
temporal lobe epilepsy (rcTLE) and in non-epileptic patients.
Methods: We included thirty consecutive patients (12 M;mean age
43 years;range 19–81) with rcTLE. Forty-four consecutive seizure-free
subjects (24 M;mean age 72 years;range 33–91), admitted to our stroke
unit for acute middle cerebral artery occlusion, were included. Both
groups underwent a thin layer (0.6 mm thickness) cranial CT scan. CT
images were off-line reconstructed on three orthogonal axes to detect the
bone defects. Subjects with CT evidence of bone leaks of the middle
cranial fossa performed a supplementary ad hoc 1.5T brain MRI, using
volumetric T1-weighted and FIESTA sequences.
Results: CT scan showed a significant (p = 0.0238) difference between
patients (4/30;13.3%) and controls (0/44) as regards the presence of great
sphenoid wing defects. No bilateral bone defect was found. The side of
the bone defect was always ispilateral to the side of the rcTLE. Targeted
brain MRI confirmed the presence of encephalocele in 2/4 patients, while
meningocele was found in the two remaining subjects. One of the two
patients with encephalocele underwent lesionectomy and he remained
seizure-free during the 30-month follow-up.
Discussion: We firstly showed that great sphenoid wing defect was signif-
icantly associated with rcTLE as compared to controls, thus confirming its
strict association with epilepsy. Middle cranial fossa bone defects should
systematically be investigated in patients with rcTLE, since these anatomic
lesions predispose to epilepsy probably by leading to temporal encephalo-
cele. The latter is a treatable condition and lesionectomy may lead to sei-
zure freedom. Relationship between temporal meningocele and refractory
epilepsy remains unknown and should be investigated in future studies.
0072
MORPHOLOGICALCHANGESOF
PEDUNCULOPONTINE NUCLEUS IN PATIENTSWITH
SLEEP-RELATED SEIZURES IN CRYPTOGENIC
EPILEPSY
K.H. Cho*, Y.-J. Cho†, K. Heo†, H.I. Kim†, B.I. Lee†
*Department of Neurology, Severance Hospital, Yonsei
University College of Medicine, Department of Neurology,
Seoul, Republic of Korea, †Department of Neurology, Severance
Hospital, Yonsei University College of Medicine, Seoul,
Republic of Korea
Purpose: Sleep, especially with Non-Rapid eye movement (NREM)
increases the interictal epileptiform discharges and the frequency of sei-
zure, whereas REM sleep suppresses them, in various epilepsy syn-
dromes. Therefore, it could be speculated that brain structures regulating
REM sleep have a control over epileptogenicity in relation to human
wake-sleep cycle. Among REM-activating brain structures, the coordi-
nate of pedunculopontine tegmental nucleus (PPN) is investigated in a
MRI-based stereotactic localization study. We questioned if measured
volume of PPN differs between sleep-related epilepsy patients and not
sleep-related epilepsy, using a non-biased automated analysis of MRI.
Method: Subjects were were diagnosed with epilepsy of unknown
causes based on clinical and electroencephalography findings, and whose
conventionalMRI were negative for focal structural lesion.
Based on clinical data, two groups were compared for our hypothesis;
(1) 33 subjects with more than 80% of seizures occurred during sleep, (2)
45 subjects who had no seizures during sleep. 3D T1 MR scans were
acquired and analyzed with Voxel based morphometry-based, automated
region of interest generation method.
Results: The two group did not differed in clinical localization, mean
age at registration, proportion of male gender, age of disease onset, total
count of seizures and total intracranial volume.
PPN volume was statistically smaller in sleep-related epilepsy patients
than non-sleep related epilepsy (student’s t test, p = 0.012).
Multivariate analysis revealed a significant of PPN volume difference
between the two group after controlling for age, sex and intracranial vol-
ume (ANCOVA, F (1,74) = 6.63, p = 0.012).
Conclusion: This the first study which discovered structural change of
PPN associated with predominant timing of seizure across the wake-sleep
cycle.
Supported by investigation of PPN in animals, the structure is consid-
ered to be a modulator of both REM sleep and epilepsy. Our finding
might help understand a intervenient pathomechanism that lies between
sleep cycle and epilepsy.
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THEROLEOFAUTOIMMUNEANTIBODIES IN
CRYPTOGENIC EPILEPSY
G. Gozubatik-Celik*, C. Ozkara*, C. Ulusoy†, S. Delil*,
A. Gunduz*, N. Yeni*, E. Tuzun†
*Istanbul University Cerrahpasa Medical Faculty, Department
of Neurology, Istanbul, Turkey, †Institute for Experimental
Medical Research, University of Istanbul, Department of
Neuroscience, Istanbul, Turkey
Purpose: Autoimmunity is an emerging point of research in the etiology
of different neurological disorders including epilepsy. We aimed to
search for autoantibodies against VGKC, GAD, LGI1, CASPR2, NMDA,
AMPA and GABA receptors and investigate the clinical presentation as
well as the risk factors which can be correlated with autoimmune etiol-
ogy.
Method: Patients with cryptogenic epilepsy with focal seizures were
included in this study. Patient demographics, age at seizure onset, seizure
frequency, risk factors, seizure precipitants, type of seizures were noted.
Plasma obtained from patients was frozen at -80 °C and analyzed for
autoantibodies against VGKC, LGI1, CASPR2, NMDA, AMPA, GABA
receptors and GAD with immunocytochemistry techniques, ELISA
method or radioimmunoassay technique as required. Positive samples
were confirmed by immunohistochemistry and western blotting.
Results: There were 94 patients (55 male), with mean age 37.5,15 yrs
(18–84). Thirteen patients had autoimmune antibodies, GAD (4 pt),
VGKC (5 pt), NMDA (1 pt), AMPA (1 pt), both GAD and VGKC 2 pt).
Higher incidence of autoimmune disease or serious infection in personal
history was observed in seropositive group. Nine of 13 patients were sei-
zure free during the last year on one or two antiepileptic drugs where the
rest 3 had drug resistant seizures. Corticosteroids helped to control sei-
zures in two patients. Statistical analyses did not reveal any significance
for all parameters evaluated.
Conclusion: Autoimmune antibodies may be detected in a subgroup of
cryptogenic epilepsy. Some of them may have drug resistant seizures
with immune system related events in the patient’s history where
immunomodulator therapy may be considered in selected cases. These
findings indicate the role of immunity in a subgroup of patients with
epileptic seizures of unknown etiology and some specific features.
0074
DOTHE PROVOCATIVE FACTORSCHANGEWITH
TIME IN JUVENILEMYOCLONIC EPILEPSY?
K. Mulhan, B. Tekin Güveli, D. Ataklı, S. Akbulut, H. Sarı,
M. Dedei Daryan
Bakirkoy Research and Training Hospital for Psychiatry,
Neurology, Neurosurgery, Department of Neurology, Istanbul,
Turkey
Purpose: In juvenile myoclonic epilepsy (JME), occurrence of seizures
and epileptiform EEG discharges are influenced by some factors.
Approximately two-thirds of the patients with JME, seizures are pro-
voked by a variety of general factors like stress, fatigue, fever, and sleep
and more specific precipitants like flashing sunlight, music, reading,
thinking, and excess alcohol intake. The objective of this study was to
assess the prevalence and long-term outcome of seizure provocative fac-
tors in JME.
Method: Data from 200 patients (85 men, 115 women) with JME who
had presented our epilepsy outpatient clinic, were reviewed. All of them
had a follow-up of at mean 7.6  4.9 years, and their medical records
were reevaluated. All patients completed a standardized questionnaire to
assess for the presence of precipitant factors for their seizures in a face-
to-face interview.
Results: The mean age of patients was 26.7  8.46 (12–55). The mean
duration of epilepsy was 10.7  7.28 years (1–35). The most frequently
used drugs were valproat (147), levetirasetam (12) and lamotrigine (19).
Almost all of the participants could identify at least one provocative fac-
tor, including in order of frequency: stress (33.8%), sleep deprivation
(36.3%), fatigue (27.9%), starvation (12.5%), specific thoughts/concen-
tration (12.3%), flashing lights and playing games (15%), alcohol intake
(0.5%), reading (3.4%), calculating (1%),writing (4.9%), listening to
music (2%), menstrual cycle (9.4%) talking on the mobile phone (3.9%).
The results show that some provocative factors were more frequent in
certain age ranges and changed with time.
Conclusion: There are many things that can provoke the seizures in
JME. Some provocative factors may change in time. Therefore, we
shouldn’t forget to ask about provocative factors, every visit.
0075
CONVULSIVEANDNONCONVULSIVE SEIZURES
AFTERCARDIAC SURGERY
T. Kishmaraia*, I. Rukhadze*, K. Zaza†, V. Kaloiani‡
*Central University Clinic, Neurology and Clinical
Neurophysiology, Tbilisi, Georgia, †Central University Clinic,
Cardiology, Tbilisi, Georgia, ‡Central University Clinic,
Critical Care, Tbilisi, Georgia
Purpose: Neurological complication are the most frequent factors of
mortality and morbidity after cardiac surgery under cardiopulmonary
bypass (CPB).Convulsive and non- convulsive seizures are mostly pre-
dictor acute cerebral injury or persistent coma. Especially, non-convul-
sive status (NCSE) is not life threatening or brain damaging but should
be recognized and treated.
Method: Under our observation there were 640 patients who needed car-
diac surgery.91 patients of them different type of neurological complica-
tions. The patients underwent through the following types of cardiac
surgery: coronary artery bypass graft surgery(CABG) in 69 patients,
valve surgery in 19 cases, surgery of ascending aorta and aorta arch 4
patients. All cases we used EEG study and CT scan. There been used car-
diopulmonary bypass during cardiac surgery in all cases.
Results: In 19 cases we discovered different types of convulsive and
non- convulsive seizures, there was shown focal and generalized epilep-
tic activities on the EEG, in 12 cases of them we founded acute ischemic
stroke on CT scan without clinical neurological changes. We divided all
patient in two clinical groups:
I group: patient with convulsive seizures and: II group: patient with
NCSE.
Conclusion: Cardiac surgery might cause some neurological complica-
tion among them are convulsive and non convulsive epileptic seizures,
that are predictors of stroke. Early diagnosis and treatment is very impo-
tent to outlet of neurological complications after cardiac surgery.
Platform Session: Imaging
Tuesday, 8th September 2015
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ASSESSINGTHE IMPACTOF INTERICTAL
DISCHARGESONRESTING STATENETWORK
CONNECTIVITY IN FOCALEPILEPSY USINGEEG
FMRI ANDANATURAL STIMULUS TASK
E.A. Shamshiri*, M. Centeno*, T.M. Tierney*, K. St Pier†,
R. Pressler†, S. Perani*,‡, J.H. Cross†,§, D.W. Carmichael*
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*UCL Institute of Child Health, Developmental Imaging and
Biophysics Section, London, UK, †Great Ormond Street
Hospital for Children NHS Trust, London, Epilepsy Unit,
London, UK, ‡Institute of Psychiatry, Psychology, and
Neuroscience, King’s College London, Department of Basic and
Clinical Neurosciences, London, UK, §UCL Institute of Child
Health, Clinical Neurosciences, London, UK
Purpose: Patients with focal epilepsy have been widely studied using
resting state fMRI where abnormalities have been frequently reported in
the so-called ‘default mode network’ (DMN). However, the role of ongo-
ing interictal epileptiform discharges (IEDs) and the relevance to these
DMN abnormalities are unclear. We therefore decided to study alter-
ations in network properties due to IEDs both during ‘rest’ and during a
‘natural stimulus’ video task requiring low level attention that was
expected to produce more controlled changes in the DMN and salience
networks.
Method: We collected simultaneous EEG-fMRI data at 1.5T using an
MRI compatible EEG system. Subjects included 13 pre-surgical drug-
resistant patients with mixed localisation and 11 age-matched controls,
all between the ages of 9–18. The task consisted of a video condition
watching a cartoon and an attending condition where a screen with the
words ‘please wait’was presented.
Results: We found a significant group level increase in activity in the
‘please wait’ condition that was greater in the controls relative to patients
in the dorsal anterior cingulate, frontal poles, posterior cingulate, and pre-
cuneus regions, which are usually associated with the salience and
default mode networks (DMN) respectively. We then explored the net-
work integrity using functional connectivity within the salience and
DMN networks based on the GLM derived seeds in precuneus and
DACC. We found that there was stronger intra-network connectivity in
controls compared to patients. These differences were significantly
reduced when controlling for IEDs.
Conclusion: This result shows that brain networks that should be con-
nected during a task block are perturbed by IEDs but their overall
response to the task is not. Accounting for IEDs is important to interpret
functional connectivity results in epilepsy.
0078
ENHANCEDDYSFUNCTIONALWIRINGBETWEEN
THEHIPPOCAMPUSANDTHETHALAMUS IN
MEDIAL TEMPORALLOBE EPILEPSY
V. Dinkelacker*,†, R. Valabregue†, L. Thivard*,†, S. Lehéricy†,
M. Baulac*, S. Samson‡, S. Dupont†,§
*Hopital Pitié-Salpe^triere, Epilepsy Unit, Paris, France, †ICM,
Paris, France, ‡University of Lille, Laboratoire de
Neurosciences Fonctionnelles et Pathologies, Lille, France,
§Hopital Pitié-Salpe^triere, Paris, France
Purpose: Medial temporal lobe epilepsy with hippocampal sclerosis is
often accompanied by widespread changes in ipsi and contralateral white
matter connectivity. Recent studies proposed that patients may show
pathologically enhanced wiring of the limbic circuits. To better address
this issue, we specifically probed connection patterns between hippocam-
pus and thalamus and examined their impact on cognitive function.
Method: A group of 44 epileptic patients (22 with right and 22 with left
hippocampal sclerosis) and 24 healthy control participants were exam-
ined with high-resolution T1 imaging, memory fMRI and probabilistic
diffusion tractography. Thirty six patients had further extensive neu-
ropsychological testing. After whole brain segmentation with FreeSurfer,
tractography streamline samples were drawn with hippocampus as the
seed and thalamus as the target region. Two tractography strategies were
applied: The first targeted the anatomical thalamic volume segmented in
FreeSurfer and the second a functional region of interest in the medio-
dorsal thalamus derived from the activation during delayed recognition
memory.
Results: We found a pronounced enhancement of connectivity between
the sclerotic hippocampus and the ipsilateral thalamus both in right and
left TLE as compared to healthy control participants. This finding held
for both the anatomically and the functionally defined thalamic target. In
terms of cognitive function, the number of hippocampal-thalamic con-
nections was correlated with poorer performance in a variety of executive
tasks, notably in the Trail Making Test, thus suggesting that the patholog-
ical wiring did not compensate cognitive curtailing.
Conclusion: We suggest that TLE is accompanied by an abnormal and
dysfunctional enhancement of connectivity between the hippocampus
and the thalamus, which is maximal on the side of the sclerosis. This
pathological pattern of limbic wiring might reflect structural remodeling
along common pathways of seizure propagation.
0079
INCREASEDRELAXATION TIMECORRELATES
WITHASTROGLIOSIS AND INCREASED
CHONDROITIN SULFATE IN TLE PATIENTS
J.E. Peixoto-Santos*, T.R. Velasco*, L. Kandratavicius*,
J.A. Assirati†, C.G. Carlotti†, C.E.G. Salmon‡,
R.C. Scandiuzzi*, A.C. Santos§, J.P. Leite*
*University of Sao Paulo, Ribeirao Preto School of Medicine,
Neuroscience and Behavior, Ribeirao Preto, Brazil, †University
of Sao Paulo, Ribeirao Preto School of Medicine, Surgery,
Ribeirao Preto, Brazil, ‡University of Sao Paulo, Faculty of
Philosophy, Science and Languages of Ribeirao Preto, Physics,
Ribeirao Preto, Brazil, §University of Sao Paulo, Ribeirao Preto
School of Medicine, Internal Medicine, Ribeirao Preto, Brazil
Purpose: Patients with drug resistant temporal lobe epilepsy present
increased hippocampal T2 relaxation time in pre-surgical examination.
Although astrogliosis is believed to be responsible for this increase, it is
possible that extracellular matrix molecules, which influence tissue water
content, are also important factors. Our aim was to evaluate the correla-
tions between relaxation time and tissue gliosis and extracellular matrix.
Method: Patients with TLE (n = 43) were scanned prior to surgical
resection of the hippocampus in a 3 Tesla MRI scanner. For T2 relaxome-
try, spin echo images with multiples echoes (TE = 20, 40, 60, 80 and
100 ms; TR= 3 s) were acquired and post-processed. Age-matched con-
trols were obtained from voluntaries (radiological control, RC, n = 20)
for the MRmeasurements, and from autopsy tissues (histological control,
HC, n = 14) for the pathological measurements. Immunohisto-
chemistries for GFAP.
(a marker of reactive astrogliosis) and CS-56 (a marker for the extra-
cellular matrix molecule chondroitin sulfate) were performed in formalin
fixed, paraffin embedded tissues, and were evaluated as immunopositive
area fraction. Results were considered significant at p < 0.05.
Results: TLE patients presented increased T2 values when compared to
RC (p < 0.001). Increased immunopositive GFAP area was observed in
the hippocampus of TLE patients, when compared to HC,
in the molecular layers, granule cell layer, hilus, CA4, CA3, CA2,
CA1 prosubiculum, and subiculum
(p < 0.05). Increased immunopositive CS-56 area was observed in the
molecular layers, subgranule zone, hilus, CA4, CA3, CA2, CA1 pro-
subiculum, and subiculum (p ≤ 0.002) of TLE patients, compares to HC.
Relaxation time correlated with GFAP area fraction in the subiculum
(r = 0.541; p = 0.0296) and with the CS-56 area fraction in the hilus
(r = 0.473; p = 0.0303) in TLE patients.
Conclusion: Our data indicate that astrogliosis and increased extracellu-
lar matrix molecules are associated with the increased hippocampal T2
relaxation observed in TLE patients.
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THE IMPACTOF EEG-FMRIONTHEEPILEPSY
PRESURGICALCLINICALDECISIONMAKING
PROCESS: A PROSPECTIVE STUDY
S. Markoula*,†,‡, U.J. Chaudhary*,†, S. Perani*,
A.D. Ciantis*,†, B. Diehl*, J.S. Duncan†, L. Lemieux*,†
*Department of Clinical and Experimental Epilepsy, UCL
Institute of Neurology, University College London, London, UK,
†MRI Unit, Epilepsy Society, Chalfont St. Peter,
Buckinghamshire, UK, ‡Department of Neurology, University
Hospital of Ioannina, Ioannina, Greece
Purpose: To establish the utility for a test conducted in clinical practice,
its effect on the decision making process should be evaluated. We report
results of an ongoing, long-term clinical study in epilepsy, where EEG-
fMRI was evaluated through its impact on the presurgical clinical deci-
sion-making process.
Method: Adults with refractory extratemporal focal epilepsy, referred
for presurgical evaluation, underwent EEG-fMRI. The EEG-fMRI based
localization of epileptic focus was presented during a multi-disciplinary
meeting after the team had defined the presumed epileptogenic zone,
based on clinical, electrographic and imaging findings and were blinded
to the EEG-fMRI findings. The impact of EEG-fMRI findings on the epi-
lepsy surgery decision making process, in terms of changes in the place-
ment of invasive electrodes or surgical candidacy was documented.
Results: Fourteen consecutive patients (six women) with a median age
of 27 years were recruited. EEG-fMRI results were available in 11
patients, including 8 in whom IEDwere recorded; seizures were recorded
in two patients; in one patient, no epileptic activity was captured during
EEG-fMRI acquisition and IED topographic map correlation (between
EEG recorded inside the scanner and long term video EEG monitoring)
was used.
A change in the surgical decision, following presentation of the EEG-
fMRI results, was recorded in eight (57%) patients; In two patients the
EEG-fMRI results had an impact on the decision leading to additional
non-invasive tests and in six patients the impact was on the placement of
invasive electrodes.
Conclusion: Our study is specifically designed to assess the impact of
EEG-fMRI on the clinical decision making process, indicating a signifi-
cant role in epilepsy surgery planning.. Decision in presurgical work up
should synthesize the information and the impact of various diagnostic
strategies, optimal for every surgery candidate, to help the decision mak-
ing by clinicians.
Platform Session: Paediatric Epileptology 3
Tuesday, 8th September 2015
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PEDIATRIC PSYCHOGENIC NONEPILEPTIC EVENTS:
NEWER PERSPECTIVE
P. Madaan*, S. Gulati†, S. Sapra*, R. Sagar‡, B. Chakrabarty†,
A. Mohamed†, M. Tripathi§, M. Kabra*, R.M. Pandey¶
*All India Institute of Medical Sciences, Department of
Pediatrics, New Delhi, India, †All India Institute of Medical
Sciences, Child Neurology Division, Department of Pediatrics,
New Delhi, India, ‡All India Institute of Medical Sciences,
Department of Psychiatry, New Delhi, India, §All India Institute
of Medical Sciences, Department of Neurology, New Delhi,
India, ¶All India Institute of Medical Sciences, Department of
Biostatistics, New Delhi, India
Purpose: To analyze clinical spectrum of Psychogenic nonepileptic
events (PNEE) in children.
Method: This prospective study (AIIMS, New Delhi; September, 2012-
April, 2014) included children (6–16 years) with clinically suspected
PNEE, subsequently confirmed by short duration VEEG which was ana-
lyzed for semiological characteristics. Events were classified as per
Seneviratne classification.
Stressors, associated co morbidities, Verbal IQ and behavioral abnor-
malities were assessed using questionnaires/tests - HTP test, DSM IV TR
criteria, MISIC and CBCL.
Results: Children with clinically suspected PNEE (94), 5 had epilepsy
so VEEG was done for 89. Events observed- spontaneously: 4, induced
with simple methods: 76 (failed induction: 9). Eighty children {45 boys;
mean age: 10.5 (1.6) years} diagnosed as PNEE were enrolled. Median
delay in diagnosis was 5 months (IQR- 0.5 to 48 months) and 45%
patients were already on AEDs. Family history of seizures (6/80) and
psychiatric disorders (6/80) was observed in 12/80 patients.
Semiological characteristics: Dialeptic PNEE (42.5%), mixed PNEE
(28.8%), Nonepileptic aura (13.8%) and Motor PNEE (15%). Most
events were abrupt in onset, median duration: 180sec (IQR:11 to
1500sec). Ictal eye closure and unresponsiveness were observed in 67%
patients. Pelvic thrusting and back arching were seen in 4/80 & 7/80
patients respectively.
Stressors in family and school were identified in 39/80 and 17/80
patients respectively. Psychiatric co morbidities were seen in 11/80
patients (commonest: adjustment disorder).
Mean Verbal IQ of PNEE patients was 100.7 (range 85.2–127.6) signi-
fying no intellectual deficit. About 50% children had associated somatic
complaints.
Conclusion: More than 90% of PNEE are inducible with simple meth-
ods. Unlike adults, Dialeptic PNEE were frequent in children. Motor
PNEE were observed more commonly in boys than girls. We suggest use
of induction protocols and a high index of suspicion to pick these events
early. We also suggest a comprehensive assessment protocol for pediatric
PNEE.
0083
DRAVET SYNDROME: A “NOCTURNAL” PATTERNOF
SEIZURES
E. Losito*,†, N. Chemaly‡,§, A. Kaminska¶, R. Nabbout†,§
*Inserm U1129 University Paris Descartes, PRES Sorbonne,
Paris, France, †Centre de Reference Epilepsies Rares et
Sclérose Tubéreuse de Bourneville Department of Pediatric
Neurology Necker Enfants Malades Hospital, APHP, Paris,
France, ‡Centre de Référence Epilepsies Rares, Department of
Pediatricneurology, Necker Enfants Malades Hospital, Paris,
France, §INSERMU1129 ‘Infantile Epilepsies and Brain
Plasticity’, Paris, France, ¶Neurophysiology Departement,
Department of Pediatric Neurology Necker Enfants Malades
Hospital, APHP, Paris, France
Purpose: Dravet Syndrome (DS) is a rare epileptic encephalopathy with
poor cognitive outcome. Seizures are refractory to AEDs, but they tend to
decrease with age. A trend toward a switch from “awake” to “sleep/noc-
turnal” seizures is reported during the clinical course of DS but literature
lacks details about the incidence of nocturnal seizures, the age onset and
the proposed change in therapies.
Method: In a longitudinal cohort of 73 patients with DS followed at our
centre, we report 20 patients who developed a pattern of almost exclusive
nocturnal seizures. We have retrospectively analyzed the genotype
(SCN1A mutation) and the epilpetic phenotype at the onset and the last
follow-up (seizure types, treatments, cognitive and behavioural out-
come). As for the EEG, we detailed those realised during the phase of
“sleep/nocturnal” seizures.
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Results: This population presented a strong prevalence of males
(14 M and 6 F). All had mutations in SCN1A and with a higher inci-
dence of splicing mutations (35%). Median age of “noctunal seizures”
onset was of 6 y6 m(4y-11y). Last follow-up ranged between 5y11 m
and 24y6 m (mean 14y4 m), and 19 over 20 patients still presented
“nocturnal/sleep” seizures predominantly. All had the tritherapy
(VPA, STP, CLB) before the nocturnal seizures onset. Seizures were
difficult to control despite AEDs adjustment and many trials. On
EEG, 8 showed paroxysmal anomalies, predominant in the frontal
region. All had at last follow-up cognitive disability and behavioural
disorders.
Conclusion: Despite the limits of our observation related to the retro-
spective data and the small sample, we could identify a sub-populations
of patients with DS. A better and more systematic prospective collabora-
tive data could help to better understand this group and to guide our treat-
ments choices.
(This research has received funding from the European Union Seventh
Framework Programme FP7/2007-2013 under the project DESIRE (grant
agreement n°602531).
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CLINICALCHARACTERISTICS AND SEIZURE
SPREAD PATTERNSOFOCCIPITAL LOBE EPILEPSY
INCHILDREN - AN SEEG STUDY
L. Craciun*, D. Taussig†, G. Dorfmuller†,‡, S. Ferrand-
Sorbets†, A. Biraben§, N. Dorison†, O. Delalande†,
C. Bulteau†,‡, A. Lebas†, M. Fohlen†, M. Chipaux†
*Emergency University Hospital of Bucharest, Neurology,
Bucharest, Romania, †Fondation Ophtalmologique Adolphe de
Rothschild, Pediatric Neurosurgery Department, Paris, France,
‡Inserm U 1129, University Paris Descartes, PRES Sorbonne
Paris Cité, Paris, France, §Centre Hospitalier Universitaire de
Rennes, Neurology, Rennes, France
Purpose: Occipital lobe epilepsy (OLE) is the least common among sur-
gical series. We tried to determine the clinical characteristics and seizure
spread patterns of OLE in a pediatric population.
Method: We included 20 children whose seizure onset zone (SOZ) was
in the Occipital lobe, as defined by SEEG recordings. We divided the
patients in two groups: an infra-calcarine (IC) group, whose SOZ was in
the infracalcarine and basal part of the Occipital lobe, and supra-calcarine
(SC) group.
Results: We observed four dominant seizure-patterns: Occipital (40%),
presenting mainly with oculomotor symptoms and head turning, Tempo-
ral (30%), with the occurrence of hypomotor behavior and automatisms,
Frontal (20%), with prominent tonic and/or clonic movements of the
upper and/or lower limbs and asymmetrical spasms (10%). The patients
from the SC group had seizures that spread predominantly to the internal
part of the Parietal lobe, while the patients in the IC group showed a pref-
erential seizure spread to the mesial and basal temporal structures, but
also to the external part of the Temporal and Parietal lobe, insula and con-
tralateral Occipital lobe.
From the patients in the SC group 5 exhibited an Occipital pattern, 2 a
Frontal pattern and one patient had spasms.
From the IC group, 6 patients showed a Temporal pattern, 3 an Occipi-
tal pattern, 2 a Frontal pattern and one had spasms. Automatisms were
only observed in the IC group (p = 0.001) and there was a correlation
between their occurrence and the involvement of the external part of the
Temporal lobes (p = 0.007).
The patients from the SC group had a better surgical outcome (87.5%
Engel I) compared to the patients in the IC group (25% Engel I).
Conclusion: There are multiple seizure spread patterns in OLE, with
different clinical expressions, but most of the patients showed an Occipi-
tal seizure pattern.
0085
LONGTERMEVOLUTIONOFAGROUPOF PATIENTS
WITH FEBRILE INFECTION-RELATED SYNDROME
(FIRES): OUR EXPERIENCE
M.L. Fernandez*, M. Vaccarezza†, M. Toma†, W. Silva†,
C. Puga†, G. Agosta†
*Hospital Italiano de Buenos Aires, Child Neurology, Buenos
Aires, Argentina, †Hospital Italiano de Buenos Aires, Buenos
Aires, Argentina
Purpose: To analyse the long-term follow-up of patients with febrile
infection-related epilepsy syndrome (FIRES).
Febrile infection-related epilepsy syndrome is a catastrophic epileptic
encephalopathy in previously well children in a setting of a febrile illness.
It usually rapidly evolves into refractory status epilepticus and in the long
term, into a chronic refractory epilepsy with significant cognitive and
behavioural impairment.
Method: Seven patients with FIRES were studied, four males and three
females, with an age at presentation between 3 and 12 years. Clinical,
electroencephalography (EEG), neuroimaging, and intellectual findings
during the chronic phases were reviewed.
Results: During the chronic epilepsy phase, seizure characteristics were
focal in all patients. The EEGs showed focal spikes predominantly in
temporal and frontotemporal lobes.
Seizures were refractory to multiple antiepileptic medications in five
patients.
Neuropsychologic testing revealed a borderline intellectual impair-
ments in five patients and moderate to severe intellectual deficit in two.
Behavioral difficulties, including aggression and impulsivity, were pre-
sent in three male patients. These problems were severe and required
involvement of personal carers, and antidepressant or antipsychotic med-
ication.
Conclusion: Febrile infection-related epilepsy syndrome is a rare dis-
ease recently described. There are few works that communicate their
long-term evolution. The outcome of our series of patients was generally
severe, with seizures refractory to different therapeutic options and cog-
nitive impairment in later evolution, with behavioral disorders in almost
half of the cases.
Platform Session: Neurophysiology
Tuesday, 8th September 2015
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HIGH-FREQUENCYOSCILLATIONS AND SEIZURE
ACTIVITYAND IN THEHUMANANTERIORNUCLEUS
OFTHETHALAMUS
I. Rektor*, I. Dolezalova†, J. Chrastina†, P. Jurak‡,
J. Halamek‡, M. Brzadil*
*Masaryk University, Brno Epilepsy Center and CEITEC, Brno,
Czech Republic, †Brno Epilepsy Centre, Brno, Czech Republic,
‡ISS ASCR, Brno, Czech Republic
Purpose: Deep brain stimulation of the anterior nucleus of the thalamus
(ANT-DBS) has recently been introduced into therapy for refractory epi-
lepsy. The role played by the ANT in human epileptic seizures and the
mechanisms leading to the anti-seizure effects of ANT-DBS have not yet
been fully elucidated. This is the first report of recording interictal and
ictal activity in the human ANT.
Methods: DBS electrodes were implanted in the ANT of six pharma-
coresistent patients with temporal and extratemporal epilepsies who had
not responded to vagus nerve stimulation. Interictal and ictal video-EEG
was recorded via the DBS electrodes before the electrodes were internal-
ized and a neurostimulation device was implanted.
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Results: Interictal high frequency oscillations (HFO) of 80 to 240 Hz, in
one case of 500 Hz, were recorded in four patients. Eight clinical seizures
in four patients were recorded; a robust broad-band increase of power
occurred in the early phases of all seizures. In two patients, the ictal
changes preceded the clinical symptoms. No interictal epileptiform dis-
charges were recorded; early epileptiform pattern preceding the clinical
onset was recorded in one seizure.
Conclusion: Based on our recordings of HFO, of early ictal EEGmodifi-
cations, and of occurrences of ictal epileptiform pattern, we suggest that
the ANT may participate actively in the network elaborating seizures in
human epilepsies.
0087
CORTICALCORTICAL EVOKED POTENTIAL
RECORDINGS FROMSTEREOEEG IN EVALUATING
HUMANPRECUNEUS CONNECTIVITY
I. Noviawaty, B. Krishnan, J. Mosher, D. Nair
Cleveland Clinic, Adult Epilepsy (Neurology), Cleveland, OH,
USA
Purpose: Precuneus is a major association area that is implicated in high
level of cognitive processing and aspects of consciousness. The purpose
of this study is to evaluate functional and pathological cortical connectiv-
ity in human precuneus using the method of cortical cortical evoked
potential (CCEP).
Method: We conducted a retrospective review and prospective recruit-
ment of medically intractable epilepsy patients who underwent stereo
EEG (SEEG) in Cleveland Clinic Foundation between the years of 2010
to now. We identified 19 patients, ten male and nine female. Age ranges
from nine to sixty year old.
The SEEG implantation targets were determined by clinically gener-
ated hypothesis for the localization of epileptogenic zone.
Extra operative CEEP with stimulation to the precuneus, was per-
formed through two adjacent contacts in a bipolar manner. Electrical
stimulus consisted of a constant current square wave pulse of 0.3 msec
duration and pulse frequency of 1 Hz with alternating polarity. Current
intensity started at 2 mA, increasing by 2 mA in stepwise increments to
8 mA. Forty to sixty stimuli were delivered. Matlab 2014a was utilized
to calculate root mean square (RMS) value of these averaged CCEP data.
Results: We identified four patients with anterior, five patients with pos-
terior, three patients with ventral, four patients with central, two patients
with anterior and posterior and one patient with posterior and central pre-
cuneus electrodes.
This study shows electrophysiological connectivity of the precuneus
to of the other part, including contralateral precuneus, angular gyrus, pos-
terior cingulate, post central gyrus, superior and inferior parietal lobule.
Lesser degree of connection was seen in insula, lateral temporal, precen-
tral gyrus, amygdala and hippocampus.
Conclusion: This study shows functional electrophysiological connec-
tivity between different region of precuneus and various components of
the brain. This information is useful in aiding the invasive EEG implanta-
tion planning and in further understanding seizure propagation network.
0088
MULTIMODALRESPONSES INDUCED BYCORTICAL
STIMULATIONOF THE PARIETAL LOBE: A STEREO-
ELECTROENCEPHALOGRAPHY STUDY
S. Balestrini*, S. Francione†, R. Mai†, L. Castana†,
G. Casaceli†, D. Marino‡, L. Provinciali*, F. Cardinale†,
L. Tassi†
*Marche Polytechnic University, Neurological Clinic,
Department of Experimental and Clinical Medicine, Ancona,
Italy, †Niguarda Hospital, ‘Claudio Munari’ Epilepsy Surgery
Centre, Milan, Italy, ‡University of Siena, Department of
Neurological and Sensorial Sciences, Siena, Italy
Purpose: The main purpose of the current study was to explore the func-
tional organisation of the dominant and non-dominant parietal cortices
using electrical stimulations (ES), with a specific emphasis on hemi-
spheric lateralisation.
Method: We retrospectively analysed all the clinical manifestations
induced by intracerebral bipolar electrical stimulation in 172 patients suf-
fering from drug resistant focal epilepsy (mean age 25.6, standard devia-
tion 11.6; 44% females and 56% males) with at least one electrode
stereotactically implanted in the parietal cortex.
Results: A total of 1186 electrical stimulations were included in the anal-
ysis. In the dominant parietal lobe, clinical responses were observed for
56 (25%) of the low-frequency stimulations and for 76 (50%) of the high-
frequency stimulations. In the non-dominant parietal lobe, 111 (27%)
low-frequency and 176 (55%) high-frequency stimulations were associ-
ated with a clinical response. Body scheme alteration was the only clini-
cal effect showing a lateralisation, as they were evoked only in the non-
dominant hemisphere. The occurrence of somatosensory sensations,
motor symptoms, dysarthria andmultimodal responses were significantly
associated with stimulation of the post-central gyrus (OR 5.83,
p < 0.001; OR 8.77, p < 0.001; OR 5.44, p = 0.011; OR 8.33,
p = 0.006; respectively). Stimulation of the intraparietal sulcus was asso-
ciated with the occurrence of sensory illusions or hallucinations (OR
8.68, p < 0.001) and eyeball/eyelid movements or sensations (OR 4.35,
p = 0.047).
Conclusion: To our knowledge, this is the only currently available com-
plete revision of electrical stimulation of the entire parietal cortex with
the aim to evaluate the neurophysiology of this relevant brain region. Our
analysis offers a general overview of the polyhedral function of the pari-
etal cortex and supports its crucial role in different networks involved in
complex integrative functions.
0089
DYSREGULATIONOFHYPERPOLARIZATION-
ACTIVATED INWARDCATIONCURRENT (IH)
AFFECTS THETHALAMOCORTICAL
OSCILLATIONS: THEROLEOFAUXILIARY SUBUNIT
TRIP8BONHCNCHANNEL FUNCTION IN THALAMIC
ANDCORTICALNEURONS
M. Zobeiri*, A. Lütjohann*, P. Mueth†, H.C. Pape*,
D.M. Chetkovich‡, T. Budde*
*Institute für Physiologie I, Westf€alische Wilhelms-Universit€at,
Münster, Germany, †Universit€atklinikumMünster, Department
of Neurology, Münster, Germany, ‡Northwestern University,
Davee Department of Neurology and Clinical Neurosciences
and Department of Physiology, Chicago, IL, USA
Purpose: The hyperpolarization-activated cyclic nucleotide-gated
cation (HCN) channels have a major role in controlling neuronal
excitability and rhythmic oscillatory activity in individual neurons and
neuronal networks and abnormal regulation of HCN channels has been
implicated in different types of epilepsy including absence epilepsy. The
aim of the present study was to determine how dysregulation of HCN
channels due to the lack of expression of auxiliary subunit TRIP8b, alters
the basic properties of hyperpolarization-activated current (Ih) in thala-
mic and cortical neurons and consequently affects the thalamocortical
oscillations.
Method: Ih was measured in whole-cell patch-clamp recordings from
thalamocortical (TC) neurons of different thalamic nuclei, as well as
pyramidal neurons in layer V and VI of the somatosensory cortex of
TRIP8b-deficient (TRIP8b-/-) and control (C57Bl/6J) mice (p15 - p30).
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Effects of Ih dysregulation on thalamocortical oscillations was monitored
by local field potential (LFP) recordings from ventro-posterior thalamic
nucleus (VPM), somatosensory cortex and motor cortex (p 90 - p120)
in vivo.
Results: In all investigated brain regions, Ih amplitude was significantly
lower in TRIP8b/ as compared with control mice. Analysis of the half-
maximal activation (Vh) of Ih revealed that steady states activation curves
were significantly shifted towards more hyperpolarized values in
TRIP8b/ mice. Analysis of cAMP dose-response curves showed a sig-
nificant increase in the sensitivity of TC neurons for cAMP in TRIP8b/
mice in comparison to control group. This higher sensitivity was shown
by a stronger maximal shift of Vh induced by cAMP in TRIP8b
/.
Reduction of Ih also increased the probability of burst activity in TC neu-
rons with lower depolarizing current injection and altered the cortical
neuronal oscillations towards more slow activities.
Conclusion: The results of this study show that alterations in Ih proper-
ties due to the lack of TRIP8b auxiliary subunit may contribute to the
generation of abnormal thalamocortical oscillations.
Platform Session:Women’s Issues
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FAMILYHISTORYOFCONGENITAL
MALFORMATIONS DOES NOT INCREASE THERISK
OF FETALMALFORMATIONS INWOMENWITH
EPILEPSY
M. Jose*, S.V. Thomas†
*Sree Chitra Tirunal Institute for Medical Sciences and
Technology, Thiruvananthapuram, India, †Sree Chitra Tirunal
Institute for Medical Sciences and Technology, Trivandrum, India
Purpose: Ascertain the association between family history of congenital
malformations (CM) and risk of fetal malformation for women with epi-
lepsy (WWE).
Method: WWE are enrolled in the preconception period or first trimester
of pregnancy. Three generation pedigree for CM was prepared for WWE
and their spouses at registration. WWE with consanguineous partners
were excluded. Family history is positive when one or more first or sec-
ond relatives are reported to have CM.Malformation status is ascertained
in pregnancy (ultrasonography) and after birth (clinical examination,
echocardiography, abdomen ultrasonography at 3 months of age). All
offspring with malformations formed the case group. Two offsprings
without malformations (the enrolments just preceding and following each
case) constituted the control group.
Results: 1351 WWE (Localization related epilepsy 49.2%, IGE 39.5%,
unclassified epilepsy syndromes 11.3%) with pedigree chart had com-
pleted pregnancy (mean age 25.9  3.7). There were 122 (9.03%) off-
spring with CM. Pedigree analysis showed that there were 3614 family
members (887 first degree, 2727 second degree) for the cases (n = 122)
and 7344 family members(1773 first degree, 5571 second degree) for the
controls (n = 244). Family history was positive for seven cases; positive
among first degree relatives for 4 cases and positive among the second
degree relatives for two cases and positive among first and second degree
relatives for one case. For the controls, family history was positive for 38
of them, positive among first degree relatives for 22, among second
degree relatives for 14 and among first and second degree relatives for 2).
There was no significant difference (p = 0.64; in the positive family his-
tory for cases (5.7%, 95% CI 0.03–0.11) when compared to controls
(15.6%, 95%CI 0.12–0.21).
Conclusion: Family history of CM does not increase the risk of fetal
malformation forWWE.
0091
HYPERTENSIVEOBSTETRICCOMPLICATIONS IN
WOMENWITHEPILEPSYANDANTIEPILEPTIC
DRUGEXPOSURE IN PREGNANCY: A POPULATION-
BASEDCOHORT STUDY
K. Danielsson*,†, N.-H. Morken*,‡, I. Borthen*, N.E. Gilhus†,§
*Haukeland University Hosptital, Department of Obstetrics and
Gynecology, Bergen, Norway, †University of Bergen/Haukeland
University Hospital, Department of Clinical Medicine, Bergen,
Norway, ‡University of Bergen, Department of Global Health
and Primary Health Care, Bergen, Norway, §Haukeland
University Hosptital, Department of Neurology, Bergen, Norway
Purpose: The aim of this study was to assess the risk of hypertensive
obstetric complications in women with epilepsy (WWE) and to investigate
the impact of treatment with the most common antiepileptic drugs (AED).
Method: Population based study including all deliveries recorded in
Medical Birth Registry of Norway (MBRN) during 1999–2013. Only
nullipara pregnancies were analysed. WWE and the three most common
AED used as monotherapy were identified. Pregnancies of WWE were
compared to women without epilepsy (WWOE) and pregnancies of
WWE unexposed to AED also served as controls.
Main outcome variables were: gestational hypertension, mild and sev-
ere preeclampsia (PE), early preeclampsia, HELLP and eclampsia. Odds
Ratios (OR) and corresponding confidence intervals (CI) were analyzed
using logistic regression and adjusted for maternal age, maternal educa-
tion and chronic diseases other than epilepsy.
Results: In all 893 330 deliveries, leaving 370 669 first pregnancies for
analyses. 2886 (0.78%) pregnancies in WWE of whom 1071 were
exposed to AED and 906 with monotherapy: Lamotrigine (N = 372),
Carbamazepine (N = 245) and Valproate (N = 124). WWE had an sig-
nificant increased risk of mild PE (4.8% vs. 3.3%), OR 1.5 CI: (1.3–1.8),
compared to WWOE. WWE not exposed to AED had similarly an
increased risk for mild PE (4.5%) OR 1.5 CI: (1.1–1.7).
WWE exposed to Carbamazepine had an significant increased risk for
mild PE (10.2%) OR 3.1 CI: (1.8–5.0) compared to WWOE and com-
pared toWWEwithout AED, OR 2.2 CI: (1.3–3.8).
Lamotrigine was not associated with increased complications.
Valproat was nonsignificantly associated with an increase in mild PE
(6.5%).
There were no significant differences in the risk for other hypertensive
complications.
Conclusion: WWE have a significant increase in mild preeclampsia
independent of AED exposure. Carbamazepine was associated with a sig-
nificant risk for mild preeclampsia in pregnancy.
0092
SEXUALABUSE INWOMENWITHEPILEPSY
M.H. Bjørk*,†, G. Veiby†, N.E. Gilhus*,†
*University of Bergen, Department of Clinical Medicine,
Bergen, Norway, †Haukeland University Hosptital, Department
of Neurology, Bergen, Norway
Purpose: To estimate the frequency of previous and recent sexual abuse
in pregnant women with epilepsy compared to women without epilepsy
and women with other chronic diseases.
Method: Pregnant women with epilepsy (WWE, n = 706) were com-
pared to all women without epilepsy (WwoE, n = 106 511) and to
women with other chronic diseases (WCD, n = 8372) included in the
population based Norwegian Mother and Child Cohort Study. Mothers
reported on sexual abuse as a child and during the last year using items
from the validated Abuse Assessment Screen. Additional information on
maternal health and medication was obtained from the Medical Birth
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Registry of Norway. Risk of sexual abuse was estimated as odds ratios
(ORs) with confidence intervals (CI) using logistic regression with
adjustment for age and adverse socioeconomic factors (low income, low
education and being single).
Results: Sexual abuse during childhood was reported by 13.7% of
WWE, 10.1% of WCD and 7.2% of WwoE (p < 0.001 and 0.006 respec-
tively). The last year, 5.5% of WWE, 3.5% of WCD and 2.3% of WwoE
reported sexual abuse (p < 0.001 and 0.015 respectively). Patients that
needed more than one antiepileptic drug frequently reported abuse
(15.4% during childhood and 13.7% during the last year, p = 0.02 and
<0.001 respectively). The odds of having experienced childhood and
recent sexual abuse were also increased after adjustment (OR 1.9, CI
1.5–2.4 and 2.3 CI 1.6–3-4 respectively). Abuse history was not related
to epilepsy aetiology or seizure characteristics.
Conclusion: Sexual abuse is frequent in the female epilepsy population.
Possibly, sexual abuse is related to a less controllable epilepsy regardless
of disease cause or type of seizures.
0093
PREGNANTWOMENWITHEPILEPSY: OVERWEIGHT
INCREASES COMPLICATIONS
E. Kolstad*, N.E. Gilhus*, M. Lossius†, G. Veiby*, M. Bjørk*
*University of Bergen/Haukeland University Hospital, Bergen,
Norway, †Oslo University Hospital, Oslo, Norway
Purpose: To investigate whether overweight in epilepsy is associated
with complications during pregnancy and delivery.
Method: This study is based on The NorwegianMother and Child Cohort
Study (MoBa) linked to the Medical Birth Registry of Norway. A pre-
pregnancy diagnosis of epilepsy was reported in 706 pregnancies. The
remaining cohort (n = 106, 511) served as the reference group. Over-
weight was defined as BMI>25. The risks of pregnancy complications
were calculated as odds ratios (ORs) with 95% confidence intervals (CIs)
adjusted for maternal age, smoking, parity and socioeconomic factors.
Results: Women with epilepsy were more overweight than women with-
out epilepsy (38.4% vs. 31.3%, p < 0.001). Women with epilepsy and
overweight had a significantly increased risk of caesarean section (OR
1.6, CI 1.1–2.3, p < 0.05), gestational hypertension (OR 2.0, CI 1.1–3.5
p < 0.05), preeclampsia (OR 2.3, CI 1.2–4.5, p < 0.05), gestational dia-
betes (OR 10.5, CI 1.3–88.3, p < 0.05) and neonatal transfers (OR 2.2,
CI 1.3–3.6, p < 0.01) compared to normal-weight women with epilepsy.
Compared to overweight women without epilepsy there was an increased
risk of caesarean section (OR 1.5, CI 1.04–2.3, p < 0.05) and anxiety
and/or depressive symptoms peripartum (OR 2.3, CI 1.4–3.7, p < 0.001).
Overweight women using lamotrigine had more caesarean sections (OR
3.2, CI 1.7–6.1 p < 0.001), gestational diabetes (OR 4.0, CI 1.2–13.2,
p < 0.05), anxiety and depression symptoms peripartum (OR 2.6, CI
1.1–6.3, p < 0.05), small for gestational age (SGA< 2.5 percentile)
infants (OR 4.3, CI 1.03–6.3 p < 0.05) and neonatal transfers (OR 2.7, CI
1.3–5.7, p < 0.01) than overweight women without epilepsy.
Conclusion: Overweight in combination with epilepsy may produce a
synergistic negative effect on risk of complications during pregnancy and
delivery. Women with epilepsy at risk of overweight should be referred
to a nutritionist when an antiepileptic drug is started, as well as when a
pregnancy is planned.
0094
EPILEPTICWOMEN IN REPRODUCTIVEAGE
A. Erdal*, F. Genc*, E. Uygur*, Y. Biçer Gömceli*, G. Kutlu†
*Antalya Research and Training Hospital, Neurology, Antalya,
Turkey, †Mugla SK University School of Medicine, Neurology,
Mugla, Turkey
Introduction: Epilepsy is a frequently encountered neurological disease
and affects 1% of general population. A significant part of epileptic
patients are women in the reproductive age. These patients are a signifi-
cant group in terms of pregnancy and contraceptive methods.
Method: 1140 patients who were followed in epilepsy department of
neurology clinic in Antalya Training and Research Hospital between July
2011 and January 2015 were examined retrospectively. All patients with
reproductive age were recruited into the study.
Results: Total 368 patients were examined; The age average was
28.94  7.66; the youngest one of patient was 15 years old and the eld-
est one was 45 years old. Average epilepsy terms were
14.01  9.27 years. There were 74 (%20.1) patients having catamenial
epilepsy. While 210 (57.1%) of patients were not married, and 151 (41%)
patients are married, information could not be obtained regarding marital
status of 7 (1.9%) patients. While 229 patients (62.2%) have not a job, 71
(19.3%) patients were employed, information could not be obtained
regarding employment status of 6 (1.6%) patients. While 330 (89.7%)
patients did not become pregnant in our follow-up, 38 (10.3%) patients
become pregnant. 206 (56%) patients were in partial onset epilepsy
group, 100 (27.2%) patients in primary generalized epilepsy group, 56
(15.2%) patients were in the unclassified group. 6 (1.6%) patients were in
the syndromic group. While 211 (57.3%) patients were receiving
monotherapy, 153 (41.6%) patients were receiving polytherapy. 4 (1.1%)
patients did not receive treatment. Among the patients who received
monotherapy, there were 64 patients (17.4%) using valproic acid, 38
patients (10.3%) using lamotrigine, 53 patients (14.4%) using carba-
mazepine, 13 patients (3.5%) using oxcarbamazepine, 33 patients (% 9)
using levetiracetam, 3 (0.8%) patients using topiramate.
Conclusion: In reproductive age female patients, many factors such as
pregnancy, contraception should be taken into account while planning
epilepsy treatment.
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PRE-ICTALYAWNINGANDTEMPORAL LOBE
EPILEPSY
W. Abdellaoui*, S. Bahbouh*, S. Chenini†, E. Attal*, M. Ait-
Kaci-Ahmed*
*Ait Idir Hospital, EEG Laboratory, Department of Neurology,
Algiers, Algeria, †Hopital Gui de Chauliac, Centre de Reference
Narcolepsie Hypersomnie Idiopathique, Montpellier, France
Purpose: Yawning has been described in various medical condi-
tions.The occurrence of yawning as a part of peri-ictal semiology in focal
epilepsy has been described,mostly in case reports.In our case report we
study pre-ictal yawning and temporal lobe epilepsy.
Method: Clinical case report.
Results: A 48-year old women,left handed with no neurological antece-
dents.Began haven epileptic attacks at age 20.The seizure semiology
comprized psychic aura (anxiety) and generalized tonic-clonic seizures
GTCS. Since the age of 20 years Phenobarbital PB at 100 mg/day was
used in monotherapy. Brain CT and MR imaging were normal.Video-
EEG recording showed yawning in the pre-ictal period followed by slow
waves over left temporal regions. He had repetitive,irresistible and force-
ful yawning starting from one to 12 secondes. Yawning started with a
deep inspiration through her wide-open mouth. She received carba-
mazepine CBZ 600 mg/day (start dose of 100 mg).We noted decrease in
the frequency of yawning.
Conclusion: Video-EEG recording is useful in diagnosis of temporal
epilepsy in patients with repetitive, irresistible and forceful yawning.
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PERIORALMYOCLONIAWITHABSENCES: TWO
CASES
K. Agan*, I. Midi*, M. Ates*, B. Aktekin†, C. Aykut-Bing€ol†
*Marmara University School of Medicine, Neurology, Istanbul,
Turkey, †Yeditepe University School of Medicine, Neurology,
Istanbul, Turkey
Purpose: The classification of idiopathic generalized epilepsies (IGEs)
is still debatable. Perioral myoclonia with absences is one of the absence
syndromes in this controversial group. Our aim is to demonstrate differ-
ent presentations of absences with perioral myoclonia.
Method and results:: First case: 20 years-old female. Her seizures
began at the age of 8 with absences. At the beginning seizures were well
controlled with Na valproate. At the age of 12, generalized tonic clonic
seizures (GTCS) commenced. Patient came our control 1 year ago with
complain of absences with head drop, which were new onset. After
6 months she developed Status Epilepticus with perioral myoclonia with
absences.
Second case: 31 years old male. His seizures began at the age of 4, in
front of TV and in the form of GTCS. In the adolescent period he devel-
oped myoclonic jerks predominantly occurred just after he woke up early
in the morning and followed with the diagnosis of juvenile myoclonic
epilepsy. He was diagnosed as IGE. On the short-term video EEG; he had
multiple generalized spike/multispike and slow waves and besides in one
of these discharges predominantly left sided very brief perioral myoclo-
nic jerks. We could not able to detect his consciousness level just because
the event is too short.
Conclusion: We want to share two important points in the light of these
patients. First, our observation showed that absences have distinct sub-
groups. POMA is one of them. We observed two patients nearly with the
same ictal phenomenology and EEG findings with different response to
AED treatment. Second, the Absence status epilepticus is frequently seen
in POMA patients and resistant to routine regimens. Here we have a
splendid response to oral lacosamide loading.
p0098
LEVETIRACETAM IN THETREATMENTOF
EPILEPSYAS ADDONORMONOTHERAPY
S.J. Al-Bajalan*, M.W. Kamil†
*Sulaimani University/School of Medicine, Medicine,
Sulaimani, Iraq, †DOH/Kanakin General Hospital, Medicine,
Kanakin/Dyiala, Iraq
Purpose: To define the efficacy and safety of Levetiracetam (LEV) in
the treatment of epilepsy as add on or monotherapy.
Method: A random sample of 52 patients with epilepsy, evaluated in a
descriptive cross-sectional study for the efficacy and safety of LEV in
epilepsy, they were collected among epileptic patients attending the Neu-
rology consultation Clinic in Sulaimani city in the Iraqi Kurdistan Region
from May 2012 to May 2013. All the patients were interviewed by using
questionnaire forms with comprehensive history, clinical examination,
radiological, EEG and laboratory studies done for all patients.
Results: The sample involved female patients 2 folds more than males.
Mean patients age was 24.54 years. Mean duration of treatment;
2.7 years. Mean LEV dosage: 1475.9 mg/day. Seventeen patients
received monotherapy and 35 patients received add on therapy. Mean
Seizure frequency was 44 attacks/month before treatment and 4 after
treatment. Mean percent of seizure reduction was 95.1% in mono therapy
and 91.46% in add on therapy.
Conclusion: LEV is a safe, effective, broad spectrum antiepileptic drug
that could be used as monotherapy or add on therapy in the treatment of
generalized and focal epilepsy.
p0099
THEHAZYTEMPORALNEOCORTEX SIGNON
MAGNETIC RESONANCE IMAGING: CLINICAL
SIGNIFICANCE IN TEMPORAL LOBE EPILEPSY
F. Al-Otaibi*, M. Alkhateeb*, S. Alharbi*, S. Baz*,
T. Abalkhail*, H. Aldhalaan*, I. Thubaiti*, A. Alattas*,
H. Alhindi†, A. Alsemari*
*King Faisal Specialist Hospital and Research Center,
Neuroscience Department, Riyadh, Saudi Arabia, †King Faisal
Specialist Hospital and Research Center, Pathology
Department, Riyadh, Saudi Arabia
Purpose: To investigate the clinical and metabolic significance of the
hazy temporal neocortex sign onMagnetic Resonance Imaging (MRI).
Method: A retrospective analysis was conducted for 124 consecutive
patients who underwent temporal lobectomy for epilepsy. Grading of the
hazy temporal neocortex (HTN) sign was done based on the density of
temporal white matter on MRI. Correlation betweenMRI findings, surgi-
cal outcome, electroencephalographic (EEG) findings, Positron Emission
Tomography (PET) scan, and histopathology was done. Comparison was
done using chi-squared and Fisher’s exact tests.
Results: Significant positive correlation was found between HTN high
density on MRI and clinical-radiological variables such as duration of
epilepsy, PET scan hypometabolism, EEG localization, and degree of
heterotopia in neocortex histology. HTN was evident on MRI even in the
absence of heterotopia in neocortex histology (6 cases) and histological
hippocampal sclerosis (4 cases). High density HTNwas found in all cases
with radiological hippocampal sclerosis and neocortical atrophy.
Conclusion: Hazy temporal neocortex on MRI correlates well with the
lateralization of temporal epilepsy and can be used as a radiological
localizing and lateralizing sign even in the absence of hippocampal scle-
rosis features.
p0100
CIRCADIANDISTRIBUTIONOF EPILEPTIC SEIZURES
S. İlhan Alp*, R. Alp†, B. Baklan‡
*Namik Kemal University, Tekirdag, Turkey, †Namik Kemal
University, Neurology, Tekirdag, Turkey, ‡Dokuz Eylül
University, Neurology, Izmir, Turkey
Purpose: We investigate the temporal distribution of the seizures of
epileptic patients during the day and the relationship with sleep.
Method: This study was conducted as a retrospective, non-interven-
tional and descriptive research. 113 patients identified to have seizures
and included in the study were investigated at Epilepsy and Sleep Center
Laboratories from 2005 to 2011. Age and sex of the patients, types of the
seizures they experienced, EEG pathologies, the times at which these sei-
zures happened and the numbers of seizures were evaluated. EEG
pathologies were classified according to ictal and interictal periods.
Results: There were 60 female (53%) and 53 male (47%) patients. Mean
age of the patients was 28.56  11.7 years, total number of observed sei-
zures was 497, mean duration of a seizure was calculated as 84.6 (2–560)
seconds. Distribution of the types of seizures; 19.5% were primer gener-
alized, 45.1%were partial, 32.7%were secondary generalized.
In 5 day video recordings were obtained, first seizure was experi-
enced: 41.6% of the seizures were on day 1, 29.2% were on day 2, 22.1%
were on day 3, 7.1% were on day 4. No seizure recordings were obtained
on day 5. Partial and secondary generalized seizures happen more fre-
quently during sleep (p < 0.05).
Temporal distribution of the seizures based on ictal EEG pathology,
the frontal and temporal seizures showed an increase from 00.00 to 05.59
am.
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Conclusion: Our study demonstrates that follow-up of 3 days with video
imaging could be sufficient for diagnosis purposes and some seizures
types had a distribution in relation with sleep.
p0101
ASSESSMENTOFNEURONALAUTOANTIBODIES IN
EPILEPSY PATIENTSWITHPERI-ICTAL
AUTONOMIC FINDINGS
L. Baysal Kırac*, E. Tüzün†, C. Ulusoy†, E.N. Vanlı Yavuz‡,
E. Ekizoglu Turgut*, N. Bebek*, C. Gürses*, A. G€okyigit*,
B. Baykan*
*Istanbul University, Istanbul Faculty of Medicine, Department
of Neurology and Clinical Neurophysiology, Istanbul, Turkey,
†Istanbul University, Research Institute of Experimental
Medicine, Department of Neuroscience, Istanbul, Turkey, ‡Koc
University Hospital, Department of Neurology, Istanbul, Turkey
Purpose: The aim of this study was to investigate frequency of neuronal
autoantibodies that associate epilepsy patients with peri-ictal autonomic
symptoms.
Method: Sera of consecutive patients with documented peri-ictal auto-
nomic symptoms were investigated by RIA, ELISA and cell based assays
for various neuronal auto-antibodies. The clinical and laboratory features
of seropositive and seronegative patients were compared.
Results: A total of 62 consecutive patients (37 F, 25 M, mean age
31.6  9.4 years, mean duration of epilepsy 16.2  9.2 years) were
included in the study. The investigated neuronal autoantibodies were pre-
sent in the sera of 9 patients (14.5%) (3 F, 6 M, mean age
31.8  11 years). Antibodies were detected against N-methyl-D-aspar-
tate receptor (NMDAR) in 3 (5%), voltage-gated potassium channel
(VGKC)-complex in 3 (5%), glutamic acid decarboxylase (GAD) in 2
(3%) and glycine receptor (GLYR) in one
(2%) of the patients. In the seropositive group 6 patients (67%) had
nausea and epigastric aura,: 5 patients (55%) had tachycardia, 2
patients (22%) had abdominal pain and 2 patients (22%) had peri-ictal
fever. Epilepsy etiology was hippocampal sclerosis in 4 (44%), crypto-
genic in 4 (44%) and birth trauma in one (11%) patient. The number of
male patients, history of psychosis, peri-ictal nausea, epigastric aura, and
fever were significantly more frequent in the seropositive group
(p < 0.05). There was no correlation between duration of epilepsy, epi-
lepsy etiology, antiepileptic drug resistance and seropositivity.
Conclusion: The relation between neuronal autoantibodies and epilepsy
patients with peri-ictal autonomic findings are found at similar rates like
other epilepsy patients and this group does not have higher risk for autoim-
munity. Psychosis, epigastric aura, and peri-ictal fever were more frequent
in seropositive group. Relevant autoantibodies should be screened for
immunotherapy options in patients with antiepileptic drug resistance.
p0102
FREQUENCYANDLATERALIZINGVALUEOF PERI-
ICTALAUTONOMIC SYMPTOMS IN EPILEPSY
L. Baysal Kırac*, E.N. Vanlı Yavuz†, H. Yener*, N. Bebek*,
C. Gürses*, A. G€okyigit*, B. Baykan*
*Istanbul University, Istanbul Faculty of Medicine, Department
of Neurology and Clinical Neurophysiology, Istanbul, Turkey,
†Koc University Hospital, Department of Neurology, Istanbul,
Turkey
Purpose: Autonomic changes during seizures are often overshadowed
by other dramatic motor symptoms. The aim of this study was to investi-
gate the frequency and lateralizing value of peri-ictal autonomic signs.
Method: Consecutive patients with documented peri-ictal autonomic
symptoms who were followed up in our epilepsy center were included in
the study. Localization and lateralization characteristics were supported
by at least two diagnostic methods that were consistent with each other
without any other evidence suggesting otherwise. In patients with non-
specific/normal MRI and functional imaging findings lateralization of
epileptogenic zone was decided only by the EEG and the seizure semiol-
ogy.
Results: Peri-ictal autonomic symptoms were recorded in 35 out of 230
patients (15%) (21 F, 14 M, mean age 30.2  8.8 years) during video
EEG monitoring. We observed the following peri-ictal autonomic find-
ings: Epigastric aura, nausea and retching in 9 (26%), genital automa-
tisms in 6 (17%), hypersalivation in 5 (14%), peri-ictal water drinking in
5 (14%), pilomotor aura in 4 (11%), cough in 4 (11%), spitting in 3 (8%),
fever in 2 (6%) and urinary urge in one (3%) of the patients. Peri-ictal
autonomic findings were most commonly observed in patients with tem-
poral lobe epilepsy (TLE) (83%). Isolated autonomic seizures were
observed in 4 patients (11%). Peri-ictal nausea and retching, hypersaliva-
tion, spitting and drinking were observed mostly in right; piloerection,
cough, and genital automatisms were observed mostly in left hemisphere
onset seizures. But the findings were not statistically significant. Four-
teen patients were operated,13 of themwere classified as Engel 1.
Conclusion: The etiopathogenesis and lateralizing/localizing value of
rare peri-ictal autonomic findings were investigated in a limited number
of studies with contradictory results. Further investigation of these
intriguing seizures may provide important clues for central nervous sys-
tem networks and electrophysiological propagation patterns of temporal
lobe structures.
p0103
BENIGNTEMPORAL LOBEEPILEPSY INMALAYSIA
S.A. Bazir-Ahmad, K.S. Lim, C.T. Tan
University of Malaya, Division of Neurology, Kuala Lumpur,
Malaysia
Purpose: Benign temporal lobe epilepsy (bTLE) remains as a common
but poorly recognise clinical entity. We aimed to characterise bTLE in
Malaysia.
Method: Patients were diagnosed as having temporal lobe epilepsy
(TLE) if they fulfil at least one of the following criteria:
(i) semiology suggestive of TLE, or:
(ii) EEG showing temporal lobe discharges or slowing or: (iii) MRI
brain showing temporal lobe abnormalities.
bTLE is defined as TLE with remission for ≥1 year; refractoriness is
defined based on ILAE criteria.
Results: 586 (30.8%) out of 1903 epilepsy patients had TLE. 160
patients (27.3%) were classified as having bTLE, 32.4% refractory, and
40.2% unclassfied. Of those with bTLE, mean age was 43.9 years old
(SD 16.5), with mean age of onset of 26 years old (SD 17.7). Average
disease duration was 17.7 years (SD 12.3). 21 patients (13.1%) fulfil all 3
criteria for TLE. 23 patients (14.4%) had viscerosensory and experiential
auras, and 40% had secondarily generalisation. Only 7.5% had underly-
ing cognitive impairment. Majority of our bTLE aetiologies were crypto-
genic (63.1%), followed by structural (30%). Twelve (7.5%) had mesial
temporal sclerosis (MTS). Majority of patients did not have family his-
tory of epilepsy, history of febrile seizures nor status epilepticus. Major-
ity were on monotherapy (66.9%) and remission achieved with only one
AED in 59.5%. 70.6% had been on remission for ≥ 2 years. As compared
with those with refractory TLE, the age of onset was older (25.95 vs
18.07 years-old, p < 0.001), duration of illness was shorter (17.69 vs.
21.75 years, p < 0.001), and less with MTS (21.1% vs 7.5%, p < 0.001).
Conclusion: Our bTLE cohort had older age of onset, shorter duration of
illness and less MTS as compared to those with refractory TLE.
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HEALTH-RELATEDQUALITYOFLIFE (HRQOL) IN
PATIENTSWITHEPILEPSY SWITCHING FROM
LEVETIRACETAM (LEV) TOBRIVARACETAM (BRV):
ANOPEN-LABEL PROSPECTIVE STUDY
S. Borghs*, S. Yates†, T. Fakhoury‡, W. Liang†, K. Eckhardt§,
J. D’Souza¶
*UCB Pharma, Slough, UK, †UCB Pharma, Raleigh, NC, USA,
‡Kentucky One Health, Lexington, KY, USA, §UCB Pharma,
Monheim, Germany, ¶UCB Pharma, Smyrna, GA, USA
Purpose: Non-psychotic behavioural adverse events (BAEs) have been
reported in patients receiving LEV. A study of patients experiencing
BAEs who switched from LEV to BRV found that patients may benefit
from a switch to BRV (Yates et al., AES 2014, abstract 3.300). HRQoL
results from this study are reported here.
Method: Patients ≥16 years, on 2–3 AEDs including LEV 1–3 g/day
and experiencing BAEs within 16 weeks of LEV treatment initiation,
enrolled in a prospective, open-label, Phase IIIb study (NCT01653262)
comprising ≤1-week screening, switch of LEV to BRV 200 mg/day
(without titration; other AEDs unchanged), and 12-week treatment per-
iod. HRQoL endpoints were change in Patient-Weighted Quality of Life
in Epilepsy Inventory-Form 31 (QOLIE-31-P) from baseline to Week 12,
Investigator Global Evaluation Scale (I-GES) and Patient Global Evalua-
tion Scale (P-GES) at Week 12.
Results: Of 29 patients enrolled, 26 (89.7%) completed the study. Mean
(SD) change from baseline to Week 12 in QOLIE-31-P Total Score was
12.1 (11.4), indicating improved HRQoL. There was a consistent mean
(SD) increase in all QOLIE-31-P subscale scores: Cognitive Functioning
10.4 (19.0); Emotional Well-being 14.0 (17.4); Energy/Fatigue 10.6
(13.7); Medication Effects 27.6 (25.5); Overall Quality of Life 13.8
(13.3); SeizureWorry 12.1 (26.0); Social Functioning 10.3 (23.3); Health
Status 6.5 (16.5). Improvements in P-GES and I-GES were recorded for
most patients: P-GES: any improvement 20/26, 76.9%; no change 5/26,
19.2%; any worsening 1/26, 3.8%; I-GES: any improvement 24/26,
92.3%; no change 1/26, 3.8%; any worsening 1/26, 3.8%.
Conclusion: Switching from LEV to BRV due to BAEs was associated
with improvements in HRQoL across all subscales in this study. The lar-
gest improvement was in QOLIE-31-P Medication Effects subscale,
which may relate to a reduction in BAE incidence. However, these results
should be interpreted with caution owing to small sample size and open-
label nature of the study.
UCB supported
p0105
ETIOLOGY IN PERIODIC LATERALIZED
EPILEPTIFORMDISCHARGES
K. Aslan, D. Işcan, H. Bozdemir
Cukurova Univercity Faculty of Medicine, Neurology, Adana,
Turkey
Purpose: Periodic lateralized epileptiform discharge (PLEDs); consist
of spike or sharp wave occur over variable extents of one hemisphere
and occasionaly appear over both hemispheres independently. PLEDs
are found in patients with a variety of hemispheric lesions including
acute infarction, hemorrhage, head injury, tumors, and infections espe-
cially when associated with metabolic abnormalities and chronic sei-
zure disorder. In this study, we identified etiologic factors of patients
with PLEDs.
Method: Ninety five with PLEDs between the years of 2004–2014 were
examined and included in this study.
Results: The mean age of the patients (48 F, 47 M) were 46.9  19.01
(15–83) years old. The etiology of these patients were; 40% with epi-
lepsy, 23.2% with stroke, 11.6% with acute metabolic dysorder, %2.1
with intracranial tumor, 6.3% with stroke and epilepsy, 6.3% with
encephalitis (one of them with Jacops-Creutfeild disease), 2.1% with
head injury, 1.1% with vasculer abnormalites, 3.2% with vasculitis of
central nervous system and 4.2% with unknow etiology. Radiologic find-
ings were related with their disease but only in 20% of the patiens mag-
netic resonans imaging (MRI) were normal.
Conclusion: Classical knowledge is that acut destructive lesions can
result in PLEDs. However these result show that PLEDs can result not
only with acut disease but also with chronic disease.
Adult Epileptology 2
Sunday, 6th September 2015
p0107
CYSTICERCOSIS AS ACAUSEOFMEDICALLY-
INTRACTABLE EPILEPSY: A SYSTEMATIC REVIEW
J.G. Burneo*,†, E. Boyce‡, M. Villafuerte§, A.L. Escalaya¶
*Western University, London, Canada, †London Health
Sciences Center, Clinical Neurological Sciences, London,
Canada, ‡London Health Sciences Center, London, Canada,
§Hospital Nacional Edgardo Rebagliati Martins, Lima, Peru,
¶Universidad Peruana Cayetano Heredia, Medicine, Division of
Neurology, Lima, Peru
Purpose: To determine the role of Neurocysticercosis (NCC) in medi-
cally-intractable epilepsy (MIE).
Method: MEDLINE, EMBASE, Scopus and LILACS were interro-
gated, since their inception until Jan of 2015, searching for clinical stud-
ies, including case reports and case series of patients with NCC and MIE.
We investigated all cases where the ictal-onset zone was determined with
standard pre-surgical evaluation in an epilepsy center. Only cases in
which there was concordance between the anatomical location of NCC
and the ictal-onset zone were included. Abstracted data included semiol-
ogy of seizures, presence of other lesions in imaging, type of pre-surgical
investigations, surgical treatment, seizure outcomes and histological
reports.
Results: A total of 4427 references were identified using terms related to
cysticercosis and epilepsy. After the first screening, 57 documents were
read and critically reviewed. 5 final articles were selected. They included
13 patients. Nine (69.2%) of the patients had NCC in the temporal lobe.
Mesial temporal sclerosis (MTS) was detected using MRI imaging in
four (30.8%) patients (three had a NCC in the temporal lobe and one in
the parietal lobe). One patient with frontal NCC had recurrent perile-
sional edema. Four patients (30.8%) required extensive pre-surgical
investigation (one with invasive recording and three with PET scan). Ele-
ven patients had epilepsy surgery, and 10 of them became seizure free at
least 13 months. Details about histological description were available
only in two patients, both demonstrated perilesional gliosis.
Conclusion: NCC rarely represents the ictal-onset zone in patients with
DRE. There is a need of prospective studies to clarify the association
between NCC and MTS and the role of NCC in DRE. Most importantly,
the role of perilesional gliosis in NCC-related MIE.
p0108
CONSCIOUSNESS IN EPILEPSY: OBJECTIVEAND
SUBJECTIVE COMPONENTS
N. Campora, H. Paz, S. Kochen
Hospital Ramos Mejia, Buenos Aires, Argentina
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Purpose: The alteration of consciousness (AOC) during seizures is one
of the most striking features in patients with epilepsy and them evaluation
remains a challenge to the present. It is important to include in its assess-
ment of both the appreciation of the observer and the subjective evalua-
tion of the patient.
We investigated the AOC implementing an objective and subjective
assessment during seizures.
Method: It was included 35 patients (104 seizures) with resistant epi-
lepsy (19 temporal and 16 extratemporal), 50% temporal. Everyone had
VideoEEG and IRM. The conciousness seizure scale (CSS) and Ictal
Consciousness Inventory (ICI) were applied, and a scale designed by our
group, Subjective Evaluation of Consciousness during Seizures (SECS).
We asked patients self-reported duration and their memories during sei-
zures before viewing video-EEG. Then we review the video with patients
and ask them to check from when they stop to remember the beginning
and when they recover the memory at the end of seizures.
Results: 62 seizures had profund, 38 moderate and 4 without AOC using
CSS. Temporal groups had more seizures with profound AOC than
extratemporal (p < 0.05). We did not find differences in level and con-
tent of conciousness using ICI between temporal and extratemporal
groups.
We found an adequately correlated (p = 0.006, rho = 0.274) between
the subjective perception of the duration of the seizure with the objective
duration of it, being better in profound AOC(rho = 0.381,p = 0.002).
The recovery of memory at the end of seizure took longer the higher
the AOC (p = 0.019) and when they had less content (p = 0.0001). In
addition, we found that memory recovery was delayed when seizures
lasted longer (p = 0.002).
Conclusion: The objective evaluation of AOC through the VideoEEG
together with subjective evaluation by the patient, are a valuable tool for
diagnostic accuracy. They are a contribution to the research of conscious-
ness both behavioral and neurophysiological level.
p0109
NOVELAMBULATORY EMG-BASEDGTC SEIZURE
DETECTIONDEVICE FORHOMEANDHOSPITALUSE
J.E. Cavazos, M. Girouard, L. Whitmire, Brain Sentinel Seizure
Detection Device Investigators
Brain Sentinel, San Antonio, TX, USA
Purpose: In the USA, there are no FDA-cleared devices outside of an
epilepsy monitoring unit (EMU) that can reliably alert for generalized
tonic-clonic (GTC) seizures and provide accurate semiological details to
physicians. This study was a pivotal trial designed to validate the effec-
tiveness of a novel EMG-based, real-time, GTC seizure detection system
that can be discreetly worn in the biceps without interfering with activi-
ties of daily living.
Methods: This is a phase III double-blind controlled device trial at 11
EMUs of NAEC level IV Epilepsy Centers in the USA in over 150 sub-
jects with history of GTC seizures. The sensitivity and specificity of the
Brain Sentinel GTC seizure detection system was compared to video-
EEG semiology to determine the effectiveness of the Brain Sentinel
device to detect classic GTC seizures when it is placed accurately over
the belly of the biceps muscle in children or adult patients with a history
of GTC seizures.
Results: To date, 8217 hours of EMG and video-EEG data have been
collected from 157 subjects with history of GTC seizures admitted to the
participating EMU sites. Provisional analysis reveals a sensitivity for
detection of GTC seizures comparable to current FDA-cleared automated
EEG seizure detection algorithms while maintaining a high level of
specificity and low number of false positive alerts. Recorded EMG data
preserves clinically relevant semiology of events such as temporal com-
ponents of motor recruitment during GTC seizures and EMG activity fol-
lowing convulsive events.
Conclusions: Brain Sentinel’s system has promise to provide people
with epilepsy greater independence and peace of mind in a home or clini-
cal setting while providing physicians with useful data for seizure man-
agement.
p0113
THERELATIONSHIP BETWEENTHETEMPORAL
POLE SIGNALABNORMALITY ANDABNORMALITY
OFEXTRA-TEMPORAL POLEONMRI IN
POSTOPERATIVE PATIENTS FOR INTRACTABLE
EPILEPSY
S. Chen, J. Wang
Beijing Sanbo Brain Hospital, Beijing, China
Purpose: To study the relationship between the characteristics of the
temporal pole (TP) signals and the signals of the extra-TP on magnetic
resonance imaging (MRI) in postoperative patients for intractable epi-
lepsy.
Method: 339 postoperative patients(male: female = 224:115), aged
23.16  8.00 years, with intractable localization-related epilepsy were
included. All patients were examined by long-term scalp and/or intracra-
nial video EEG monitoring before operation. The signal characteristics
of the TP and extra-TP on brain MRI were analyzed. The temporal pole
MRI abnormalities are defined as a white matter increased T2 and/or T2
fluid-attenuated inversion-recovery (FLAIR) signal, resulting in a loss of
gray-white matter demarcation, with or without associated atrophy.
According to whether the temporal region was involved or not the
patients were divided into the group with temporal involved or non-tem-
poral involved. According to whether the mesial temporal structures were
involved or not the patients were divided into the group with normal or
abnormal mesial temporal structures. The data were statistically analyzed
by chi - square test.
Results: Among the 339 postoperative patients for intractable localiza-
tion-related epilepsy. The TP signal abnormality was correlated with the
extra-TP abnormality on MRI(x2=8.897, p = 0.0029). Almost all
patients with the TP signal abnormality showed structural abnormality in
extra-TP regions (97.33% (82/187). The TP signal abnormality on MRI
was more common in the temporal involved group than that in normal
MRI and non-temporal involved group (72.17% vs. 23.81%,27.36%
respectively; x2=66.270, P < 0.0001). The TP signal abnormality was
also more common in the group with abnormal mesial temporal struc-
tures than that in the group with normal ones (77.24% vs. 38.66% respec-
tively; x2=49.940, p < 0.0001)
Conclusion: This study suggests the TP signal abnormality probably is
useful for determination of the localization, especially the lateralization
of the epileptic lesion.
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A LONGTERMFOLLOWUP STUDYOF POST STROKE
SEIZURES
R.K. Dhamija
Lady Hardinge Medical College and Associated Hospitals New
Delhi, Medicine, New Delhi, India
Purpose: Stroke is the most common cause of seizures in the elderly
population. The epidemiological data for Post Stroke Seizures and their
natural history is lacking in developing countries where there are no
stroke registries.The present study was carried out to ascertain occur-
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rence, associated risk factors and long term follow up of Post Stroke Sei-
zures.
Methods: A consecutive 181 Stroke Patients were evaluated and fol-
lowed up for 12 months. The occurrence of Seizures was studied during
hospital stay and follow up visits in next 12 months. The patients were
studied for predictive factors and type of seizures following Stroke.
Results: Mean age of the patients was 53.91 years. 127 patients had
Ischemic Stroke, 49 patients had Intra Cerebral Haemorrhage and 19
patients had Sub Arachnoid Haemorrhage 19 (9.5%) patients had Sei-
zures. 37% of these patients with seizures developed early onset seizures
while 63% of these patients developed late onset seizures. The occur-
rence of the seizures was seen more in Ischemic Strokes and majority of
these were cortical lesions. 26% of these patients developed generalized
tonic clonic seizures(GTCS), 42% developed focal seizures and 32% of
these patients had focal onset generalized seizures. 16% of these patients
had puerperium related Strokes. Risk factors for recurrent seizures were
large cortical Strokes, severe Strokes, Recurrent Strokes and puerperium
related Strokes.
Conclusion: Post Stroke Seizures are not uncommon and are mostly
focal or focal onset generalized seizures. Puerperium related Strokes,
large cortical Strokes and recurrent Stroke patients are at a more risk to
develop seizures.
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SIMULTANEOUSOCCURRENCEOFNON-EPILEPTIC
ANDEPILEPTIC SEIZURES: ANUNDERREPORTED
ENTITYWHICHMAYREQUIRE LONGER PERIODS
OFCVEEGMONITORING
H. El-Naggar*, P. Moloney†, N. McNicholas†, R. Kilbride†,
N. Delanty‡, G. Mullins†
*Royal College of Surgeons, Beaumont Hospital, Dublin,
Ireland, †Beaumont Hospital, Dublin, Ireland, ‡Royal College
of Surgeons, Dublin, Ireland
Purpose: Psychogenic non-epileptic seizures (PNES) pose a diagnostic
challenge to neurologists, particularly in patients with PNES and epilep-
tic seizures (ES). There is limited data characterising this subgroup in the
literature to-date. Accurate diagnosis of PNES requires continuous video
electroencephalogram (cvEEG)monitoring, with a sensitivity of approxi-
mately 90%. Delay to diagnosis is common and estimated to be 7 years
in those with PNES alone.
In the Epilepsy Monitoring Unit at our institution, we sought to
explore the co-existence of both ES and PNES during a single cvEEG
monitoring admission. We aimed to identify prevalence, establish any
distinguishing patient characteristics and compare outcomes following
diagnosis to those with PNES alone.
Method: This was a retrospective study of all patients diagnosed with
PNES by cvEEG between June 2013 and February 2015 at the National
Epilepsy Centre.
Results: Of 260 patients monitored, 58 were diagnosed with PNES. 17
patients had a diagnosis of epilepsy and PNES. This is higher than other
published work. ES and PNES were recorded during the same admission
in 13 patients. The majority of events recorded were non-epileptic. Non-
epileptic events occurred earlier in admission, with epileptic events
occurring later.We observed a female predominance, polypharmacy with
anti-epileptic drugs and a greater delay to diagnosis in patients with ES
and PNES. Longer periods of monitoring were required to record both ES
and PNES to ensure accurate diagnosis.
A favourable prognosis was seen in patients with PNES following psy-
chological intervention.
Conclusion: Patients with PNES and epilepsy are a unique cohort, with
some distinguishing features compared to PNES alone. Longer periods of
cvEEG monitoring are required to ensure maximal diagnostic accuracy
particularly where there are historical indicators of epilepsy. Shorter peri-
ods of monitoring may lead to misdiagnosis which may have devastating
consequences.
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CLINICALANDETIOLOGICAL PROFILESOF
PATIENTSWITH SYMPTOMATIC EPILEPSY
H. Ertaşoğlu Toydemir, D. Bozkurt, F. Azman, H.Örnek,
B. Yurtsever, V.A. Yayla
Bakırk€oy Dr.Sadi Konuk Training and Research Hospital,
Department of Neurology, Istanbul, Turkey
Purpose: The purpose of the study was to evaluate the etiological factors
and clinical features of our patients with symptomatic epilepsy.
Method: A retrospective analysis was performed to143 patients with
symptomatic epilepsy attending our epilepsy department between 2011
and 2014.
Results: Mean age of 60F:83M patients was 32.2  14.2 (12–81) years.
Age at seizure onset was between the first year of life and 80 years. Neu-
rological examination was unremarkable in 82 (57%) patients, 17
(11.9%) patients had motor-mental retardation, 13 (9.1%) had mental
retardation, 13 (9.1%) had hemiparesis and the rest (12.9%) had other
neurological deficits. The most common identified etiological factors
were trauma (41%), perinatal incidents (21.7%), mesial temporal sclero-
sis (30%), central nervous system infections (11.9%), brain operations
(8.4%), congenital malformations (7%), stroke (5%), aneurysms/AVM
(4.2%) and brain tumors (3.5%). Status epilepticus was detected in 9
patients (6.3%). The seizure types were mostly generalized tonic clonic
seizures (52.4%), complex partial seizures (47.6%), secondarily general-
ized seizures (26.6%) and simple partial seizures (23.8%). EEG revealed
pathological patterns in 88 (61.5%) patients. Polytherapy was applied to
73 (51%) patients, 67 (46.9%) patients were treated with monotherapy
and the remainder discontinued medication.
Conclusion: The distinction between idiopathic, symptomatic and pro-
voked seizures may sometimes be difficult due to multifactorial nature of
epilepsy. At first glance, symptomatic epilepsies may be underestimated
in terms of determining the underlying cause, classifying the seizures and
in diagnosis but it could be more complex than it seems. We want to doc-
ument our data and to draw attention to this nature of symptomatic
epilepsies.
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SEIZURE-PRECIPITATING FACTORS IN EPILEPTIC
PATIENTS
H. Ertaşoglu Toydemir, D. Bozkurt, B. Yurtsever, H.Örnek,
F. Azman, V.A. Yayla
Bakırk€oy Dr.Sadi Konuk Training and Research Hospital,
Department of Neurology, Istanbul, Turkey
Purpose: The purpose of the study was to determine the most frequently
reported seizure precipitants and to identify the frequencies of these pre-
cipitating factors. Moreover, we aimed to find out whether there exists
any relationship between the seizure precipitants and the types of epi-
lepsy.
Method: nWe analyzed patients who were followed up in our epilepsy
department between 2011 and 2014, retrospectively. Information about
precipitating factors was obtained during the interview or from the medi-
cal reports and telephone inquiries.
Results: Mean age of total 363 patients was 30.9  13.9 (10–83) years
and 182 (50.1%) of them were female, 181 (49.9%) were male. Age at
seizure onset was between the first year of life and 80 years. Patients
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were divided into 3 groups regarding the classification of epilepsy syn-
dromes; idiopathic (38.3%), symptomatic (39.4%) and cryptogenic
(22.3%). The precipitating factors were emotional stress (31.4%), sleep
deprivation (23.7%), fatigue (16.3%), television/computer (8%), missing
meals (6.3%), missing medication (5.5%), menstruation (4.1%), fever
(3%), flickering lights (2.2%) and alcohol (0.3%). Only one precipitating
factor was reported by 19% of the patients whereas 8.4% reported two or
more precipitating factors. The analysis of the relationship between the
precipitating factors and the types of epilepsy syndromes showed signifi-
cance only in stress factor (p < 0.05). Patients with idiopathic epilepsy
seemed to be less sensitive to stress than those with symptomatic and
cryptogenic epilepsies (p = 0.01 and p = 0.025).
Conclusion: Seizures were triggered by one or more precipitating fac-
tors in our patients as emphasized in recent studies. Patient’s awareness
about triggering factors and modification of life styles may significantly
reduce the seizure frequency.
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SYMPTOMATIC VERSUS IDIOPATHIC TEMPORAL
LOBEEPILEPSIES: FINDINGS FROMACOHORTOF
75 PATIENTS
A. Gargouri-Berrechid, F. Laatar, I. Abdelkefi, Y. Sidhom,
M. Ben Djebara, I. Kacem, Y. Hizem, R. Gouider
Razi Hospital, Neurology Department/Research Unit
12SP21Razi, Tunis, Tunisia
Purpose: To determine clinical, electrical and radiological differences
between mesial and neocortical variants of temporal lobe epilepsies in
idiopathic versus symptomatic groups.
Methods: Retrospective study of clinical, electrical and radiological fea-
tures in four groups: mesial symptomatic (MSTLE), neocortical symp-
tomatic (NSTLE), mesial idiopathic (MITLE) and neocortical idiopathic
(NITLE). This study was established in neurological department of Razi
hospital between 2004 and 2012
Results: Total of 75 patients: 24 MSTLE, 33 NSTLE, 14 MITLE and 4
NITLE. The mean age of onset was respectively: 11.54, 22.63, 9.78 and
15.7 years. history of febrile seizures is found in 66% in MSTLE. The
main types of seizures are automatisms and visceral sensory auras in
MTLE symptomatic (75% and 58% respectively) and idiopathic (43%
and 71% respectively). Psychic auras are the most frequent type in
NSTLE (42%) and language alterations in NITLE (100%). spike-waves
are common in mesial group. Pharmaco-resistance is more frequent in
MSTLE (54%) and NITLE (50%). In the symptomatic group, brain MRI
shows association of other temporal lobe abnormalities to mesial sclero-
sis in 46%.
Conclusion: Our study shows earlier age of onset with a higher fre-
quency of febrile seizures and pharmcoresistance in MSTLE group. The
Symptomatic group of TLE is characterized by older age and higher fre-
quency of background EEG abnormalities. Some features are shared
between the symptomatic or idiopathic variants and others depend on the
mesial or neocortical localization.
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DEMOGRAPHICANDCLINICAL PROFILEOF
EPILEPSY IN TURKISH POPULATION
İ. Ilgezdi, I.F. Uludag, Y. Zorlu
Izmir Tepecik Educational Research Hospital, Neurology, Izmir,
Turkey
Purpose: We aimed to address the commonest types of seizures, their
etiologies, electro-encephalography and neuroimaging results and anti-
epileptic drugs most commonly used in epileptic patients.
Method: Observational, descriptive, cross-sectional analysis of the
recorded data from all patients diagnosed with epilepsy who attended to
our Epilepsy Outpatient Unit in the last 20 years was performed.
Results: The sample included 1502 patients (749 men; 49.9%) with epi-
lepsy. Mean age was 36.7  14.5. Most frequent type of epilepsy was
idiopathic generalized epilepsy (n = 853; 56.8%). The main etiologic
factors in symptomatic epilepsies were, intra perinatal pathology and
cerebral vascular diseases. Most common focal epilepsy was temporal
lobe epilepsy.
Only 7.2% of patients had no seizures over 1 year of pharmacological
therapy and in 70.5% the frequency of seizures was 1–12 per year.
Valproate was most prescribed antiepileptic drug (in 52.5% of cases).
Conclusion: We found similar demographic, clinical and treatment
response features with previous studies.
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EPILEPSY INADULTWITH SUPRATENTORIAL
GLIOBLASTOMA: INCIDENCEAND INFLUENCE
FACTORS
S. Liang*, X. Fu†, X. Yu†
*First Affiliated Hospital of PLA General Hospital, Neursurgery
Department, Beijing, China, †First Affiliated Hospital of PLA
General Hospital, Beijing, China
Purpose: To discuss incidence of epilepsy in adult patients with supra-
tentorial glioblastoma and its influence factors.
Methods: To retrospectively analyze clinical data of 184 adults who
were not <18 years old and suffered supratentorial glioblastomas. All of
the patients underwent comprehensive therapies in our hospital and died
in 2003–2013. To count patients’ incidence of epilepsy before and after
first resective operation (FRO) every 2 month, and analyze the effect of
epilepsy prophylaxes with anti-epilepsy drugs (AEDs) in patients who
absented preoperative epilepsy.
Results: There were 43 (23.37%) patients with epilepsy before FRO,
and 126 patients (68.48%) presented epilepsies in the whole history of
glioblastoma. The active epilepsy reached over 80% in patients with sur-
vival time over 13 month of FRO. Patients with glioblastomas at frontal
lobes and temporal lobes presented high incidence of epilepsy. Among
the 33 adults with epilepsy before FRO, patients with total removement
of glioblastoma presented significant less postoperative seizure than
those without total removement. The patients with glioblastomas pre-
formed epilepsy prophylaxes with AEDs for not <6 month had signifi-
cant less postoperative epilepsy and high Karnofsky score than those
without AEDs or with AEDs for 1 month.
Conclusion: The incidence of epilepsy in adult patients with glioblas-
tomas was high, and those epilepsy presented poor response to AEDs
treatment in were poor. AEDs prophylaxes for epilepsy should be not
<6 month.
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THE SUDEP SAFETYCHECKLIST LIST PROJECT:
STEPS TOWARDS SELF-MANAGEMENTOF SUDEP
RISK FOR PATIENTSWITHEPILEPSY (PWE)
R. Shankar*, J. Hanna†, B. McLean‡, D. Cox*, C. Jory*,
C. Newman§, T. Anderson¶, M. Walker**
*Cornwall Partnership NHS Foundation Trust, Truro, UK,
†SUDEP Action, Oxford, UK, ‡Royal Cornwall Hospital, Truro,
UK, §Plymouth University, Plymouth, UK, ¶Newquay Health
Centre, Newquay, UK, **UCL Institute of Neurology, London,
UK
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Purpose: To assess the usefulness and acceptability of the introduction
of the SUDEP Safety Checklist to clinicians, PWE and their carers to rou-
tine clinical use across different settings.
Method: The Checklist is an easy reference, practical, evidence based
tool that is quickly completed in clinic to support prioritisation of clinical
activity, give a baseline to compare change of risk factors and have mean-
ingful communication.
A comprehensive literature review developed the checklist (Shankar
R et al. Seizure 12/2013). Further evidence was gained from a 9 year
SUDEP population study (Shankar R Seizure 4/2014). Previously
unrecognised findings included only 20% PWE had contact with special-
ist services in the previous year prior demise and in most deaths there was
a noted clinical worsening of seizures in the previous 3–6 months. The
Checklist was introduced in routine practice 2013 in local epilepsy clinics
in Cornwall UK with feedback from 200 PWE/carers. A telehealth pro-
ject used the Checklist on a quarterly basis to monitor 15 high risk but
stable PWE of 90 PWE registered in a community-based general practice
(catchment 16,000).
Results: 80% PWE accessing Cornwall epilepsy services had their
SUDEP risk assessed and recorded compared to 4% nationally (Waddell
B et al. Seizure 01/2013), following a NICE guideline (2004 &
2012).98% PWE/carers responded positively to the use of the Checklist,
whilst 2% were neutral. 17% PWEmonitored using the telehealth Check-
list received a step-up of care with interventions that would not have hap-
pened otherwise.
Conclusion: The SUDEP Safety Checklist is useful to both doctors
and PWE leading to a step-up of care and better awareness of safety.
Clinicians reported that the checklist raised awareness of manage-
ment of patients at risk of SUDEP. The Checklist is now being
developed as a digital Application to support PWE with self-monitor-
ing of risk.
p0127
HAND POSTUREAS LOCALIZING SIGN IN ADULT
PARTIAL EPILEPTIC SEIZURES
I. Ferando*, J.R. Soss*,†, G. Lo Russo‡, L. Tassi‡,
J. EngelJr*,†, C.A. Tassinari§,¶
*Department of Neurology, the David Geffen School of Medicine
at UCLA, Los Angeles, CA, USA, †The UCLA Seizure Disorder
Center, UCLA, Los Angeles, CA, USA, ‡Centro Specialistico
Chirurgia dell’Epilessia “C. Munari”, Ospedale Niguarda,
Milano, Italy, §Dipartimento di Neurologia, Ospedale Bellaria,
Bologna, Italy, ¶AlmaMater Studiorum, Universita di Bologna,
Facolta di Medicina e Chirurgia, Bologna, Italy
Purpose: One of the most challenging aspects for the medical treatment
of adult epilepsies is their tendency to become resistant to antiepileptic
drugs. It is estimated that 40% of chronic epilepsies fail to respond to
medical treatment. While much interest is rising in the development of
disease-modifying drugs, to this day the most effective intervention in
controlling medically resistant epileptic seizures is the surgical removal
of the epileptogenic zone. The clinical semiology of the epileptic seizures
contains lateralizing and localizing information, but unlike lateralizing
signs, distinct recognized localizing signs are few, rare and not easily
detected on video. With this study we aim to identify specific localizing
signs that could help the pre surgical evaluation, through the analysis of
ictal hand postures.
Method: We evaluated ictal hand postures in videos of patients who
underwent epilepsy monitoring and surgery between 1999 and 2005 at
the Seizure Disorder Center of UCLA (62 patients) or at the Centro
Specialistico Chirurgia dell’Epilessia “C. Munari” of the Ospedale
Niguarda in Milan (53 patients). As we were aiming to investigate
the presence of distinct hand postures that correlated with specific
localizations, inclusion criteria were 1 year of seizure freedom after
surgery and a sustained hand posture in at least one of the recorded
seizures.
Results: Sustained hand postures were present in 83% of frontal lobe
patients (where they were mostly bilateral) and 59% of temporal lobe
patients (where they were mostly contralateral). We divided hand pos-
tures into 7 classes depending on the reciprocal position of the fingers
(extended hand, gun, thumb-up, fist, cup, pincer, thumb-on-top). We
found a striking correlation between frontal localization and the “fist”
and the “gun” posture, and between temporal localization and the
“pincer” posture.
Conclusion: These results are meant to be used as a new complimetary
tool, during phase 1 surgical evaluation.
Basic Science 1
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EFFECTSOF PROBIOTICCONSUMPTIONON
ABSENCE SEIZURES
S. Akkol*, M.C. Dogan†, D. Esenkar†, H. Dogan†,
T. Karamahmutoglu‡, F. Onat‡
*Istanbul University, Cerrahpasa Medical Faculty, Istanbul,
Turkey, †Besiktas Kabatas High School, Istanbul, Turkey,
‡Marmara University School of Medicine, Department of
Pharmacology and Clinical Pharmacology, Istanbul, Turkey
Purpose: Probiotics are living microorganisms in intestinal microflora
which are beneficial for human health. Childhood Absence Epilepsy is a
common epileptic disorder of childhood. It is characterized by typical
absence episodes with electroencephalography (EEG) pattern of bilat-
eral, synchronous and symmetric 3 Hz spike-and-wave discharges. There
are two validated similar rat models of absence epilepsy, Genetic
Absence Epilepsy Rats from Strasbourg (GAERS) and Wistar Albino
Glaxo from Rijswijk (WAG/Rij). To this date, there are nor clinical nei-
ther experimental studies about effects of probiotics on absence epilepsy.
In this study, we investigated the effects of probiotics on absence seizures
in GAERS.
Method: GAERS were used to examine the effects of probiotics. Nine
male rats were divided into two groups (Group1, n = 5; Group 2,
n = 4). The animal in both groups were fed with free access to food
and water. Commercially available probiotic product was given in the
water to one group of animals. This period was 1 month. Then surface
electrodes were implanted for EEG recordings. Analysis of EEG
recordings was considered in cumulative total duration and total num-
ber of absence seizures which are characterized by spike-and-wave
discharges.
Results: Analysis of spike-and-wave discharges between probiotic
group and standard group showed no significant difference in both
aspects of cumulative total duration and total number (p > 0.05). On the
other hand, probiotic group consumed more than the other group
(p < 0.05).
Conclusion: The results of our study showed that probiotic consumption
has no effect on total duration and number of spike-and-wave discharges
of GAERS in 1 month feeding period. The consumption of water is
increased in probiotic group because of the ingredients of the commer-
cially available product. We hope that this study may shed light on inter-
action between absence epilepsy and probiotics. Further studies are
needed.
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ACEA, A SELECTIVECANNABINOID CB1 RECEPTOR
AGONIST COMBINEDWITHLEVETIRACETAM
STIMULATES NEUROGENESIS IN ADOLESCENT
MOUSE BRAIN
M. Andres-Mach*, A. Haratym-Maj†, M. Zagaja*, R. Rola‡,
M. Maj§, J. Luszczki*,¶
*Institute of Rural Health, Isobolographic Analysis Laboratory,
Lublin, Poland, †Institute of Rural Health, Department of
Physiopathology, Lublin, Poland, ‡Medical University of
Lublin, Department of Neurological Surgery, Lublin, Poland,
§Medical University of Lublin, Department of Clinical
Immunology, Lublin, Poland, ¶Medical University of Lublin,
Department of Pathophysiology, Lublin, Poland
Purpose: Hippocampal neurogenesis is very important for proper learn-
ing and memory functions. Seizure attacks, by alterations of neurogene-
sis, may contribute to progressive memory dysfunction. The aim of the
study was in vivo evaluation of the impact of arachidonyl-20-chloroethy-
lamide (ACEA), a highly selective cannabinoid CB1 receptor agonist
combined with levetiracetam (LEV) on proliferating neural precursor
cells in mouse brain. Additionally, we established the relationship
between treatment with ACEA in combination with LEV and hippocam-
pal neurogenesis in mouse brain.
Method: All experiments were performed on adolescent male CB57/BL
mice. The following drugs were used: levetiracetam (LEV), arachidonyl-
20-chloroethylamide (ACEA), phenylmethylsulfonyl fluoride (PMSF).
PMSF was used to limit the degradation of ACEA by inhibiting the fatty
acid amide hydrolase. Experiments were conducted in two time points:
Time point 1- acute response of proliferating neural precursor cells to
ACEA and LEV administration (Ki-67 staining) Time point 2 - long term
response to ACEA and LEV administration (BrDU, Neun, GFAP stain-
ing). Confocal microscopy and cell counting was done using Zeiss micro-
scope and ImageJ software.
Results: ACEA in combination with PMSF significantly increased the
total number of Ki-67 positive cells comparing to the control group. Sim-
ilarly, ACEA combined with LEV increased the number of Ki-67 posi-
tive cells, whereas PMSF, administered alone had no significant impact
on proliferating cells. Moreover, ACEA with PMSF administered alone
and in combination with LEV had a significant impact on neurogenesis
increasing the total number of BrDU, particularly neurons comparing to
the control group, whereas LEV administered alone significantly reduces
the total number of NeUN/BrDU-positive cells compare to the control
group.
Conclusion: ACEA combined with LEV stimulates the process of pro-
liferation, migration and differentiation of newborn cells, while chronic
administration of LEV itself decreases neurogenesis. Obtained results
make possible in vivo determination of the neurogenesis after drugs
administration.
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ADIRECTMECHANISMFORTHEMCTKETOGENIC
DIET IN SEIZURECONTROL
K. Augustin*, P.E. Chen*, M. Walker†, S. Heales‡,
R.S. Williams*
*Royal Holloway University of London, Egham, UK,
†University College London, Institute of Neurology, London,
UK, ‡University College London, Institute of Child Health,
London, UK
Purpose: Ketogenic diets are low-carbohydrate, high-fat diets that are
used to treat children and adolescents with refractory epilepsy. In the
medium-chain triglyceride (MCT) ketogenic diet a large proportion of
fats is provided through the medium chain fatty acids decanoic acid and
octanoic acid. Whilst ketogenic diets have been used successfully for
decades in seizure control, their mechanism of action is not yet under-
stood.
Method: We are using the Xenopus laevis oocyte expression system to
investigate a potential role of medium chain fatty acids in reducing
excitatory signal transduction mediated by AMPA receptors. AMPA
receptors have been demonstrated to mediate neuronal hyperexcitabil-
ity and seizure generation and are a target for epilepsy drug develop-
ment. We employed the two-electrode voltage clamp (TEVC) method
to study the effects of decanoic acid and octanoic acid on receptor acti-
vation in the presence of glutamate and the desensitization inhibitor
cyclothiazide.
Results: Here we show that decanoic acid, but not octanoic acid, inhibits
AMPA receptor mediated currents (IC50 0.52 mM at GluA2/3) in a non-
competitive, subunit dependent and use-dependent manner. Using
mutant constructs that are resistant to the well-characterized non-compe-
titive AMPA receptor antagonist GYKI 53655, we also demonstrate that
decanoic acid interacts with the receptor at a site distinct from the pro-
posed GYKI binding site. To further investigate the mechanism by which
decanoic acid reduced AMPA receptor activation we have assessed inhi-
bition in the presence of cyclothiazide and show that the inhibitory effect
of decanoic acid is influenced by AMPA receptor desensitization.
Conclusion: Our results suggest that the fatty acid decanoic acid con-
tributes to seizure control by directly reducing AMPA receptor mediated
currents through a novel mechanism that stabilizes the receptor confor-
mation in the desensitized state.
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ANTIEPILEPTOGENIC ACTIVITYOF SALVIANOLIC
ACID B INKAINATE-INDUCEDMODELOF
TEMPORAL LOBEEPILEPSY IN THERAT
T. Baluchnejadmojarad*, N. Jamali-Raeufy†, F. Nikbakht†,
S. Ramazi‡, M. Roghani§
*Department of Physiology, School of Medicine, Iran University
of Medical Sciences, Tehran, Iran, Islamic Republic of, †Iran
University of Medical Sciences, Tehran, Iran, Islamic Republic
of, ‡Tehran University of Medical Sciences, Tehran, Iran,
Islamic Republic of, §Neurophysiology Research Center, Shahed
University, Tehran, Iran, Islamic Republic of
Purpose: Temporal lobe epilepsy (TLE) is a chronic neurological disor-
der that is characterized by spontaneous recurrent seizures. Among
involved pathological mechanisms, the role of oxidative stress in the
development of TLE has been documented. While salvianolic acid B (Sal
B) is an efficient antioxidant with neuroprotective property, but its action
has not been investigated in kainate-induced model of TLE. In the present
study, the effect of Sal B was evaluated in this respect.
Method: Male Wistar rats (n = 40) were randomly allocated into four
groups: sham-operated, Sal B-pretreated-sham-operated (intraperitoneal
administration of Sal B at a dose of 10 mg/kg for 1 week), kainate (in-
trahippocampal injection of kainic acid at a dose of 0.8 lg), and Sal B-
pretreated-kainate.
Results: In kainate group, seizure activity was high and recurrent,
intense mossy fiber sprouting was observed, averaged iEEG amplitude
was higher, a severe neuronal loss was observed in CA3 region of the hip-
pocampus in Nissl staining and some markers of oxidative stress were
greater in hippocampal homogenate versus sham group. In contrast,
administration of Sal B significantly decreased these changes.
Conclusion: This study indicates that Sal B could attenuate some kai-
nate-induced impairments in the rat through attenuation of oxidative
stress and prevention of the development of epileptogenic circuits.
Epilepsia, 56(Suppl. 1):3–263, 2015
doi: 10.1111/epi.13241
40
Abstracts
p0134
ENDOGENOUSACTIVITYOFNMDARECEPTORS
CONTRIBUTES TOTHEENHANCED
GLUTAMATERGIC TONEANDHYPEREXCITABILITY
INRESECTED BRAIN SAMPLESOBTAINED FOR
PATIENTSWITHMESIAL TEMPORAL LOBE
EPILEPSY
J. Banerjee*, A. Dixit*, M. Tripathi†, P.S. Chandra‡
*National Brain Research Center (NBRC), Center of Excellence
for Epilepsy, Gurgaon, India, †All India Institute of Medical
Sciences, Neurology, New Delhi, India, ‡All India Institute of
Medical Sciences, Neurosurgery, New Delhi, India
Purpose: Altered synaptic transmission is one of the primary causes of
seizure generation in patients with mesial temporal lobe epilepsy
(MTLE). Enhanced excitatory drive-mediated by glutamate receptors is
responsible for hyperexcitability in these patients. The present study is
designed to delineate the contribution of NMDA receptors to the gluta-
matergic tone in patients with MTLE.
Method: Resected brain samples were obtained from patients with
MTLE and for non-epileptic control experiments tumour margin
obtained during tumour surgeries were used. Using whole cell patch
clamp technique spontaneous excitatory postsynaptic currents (EPSCs),
sensitive to NMDA receptor antagonist APV (50 lM) and AMPA recep-
tor antagonist CNQX (10 lM) were recorded from pyramidal neurons at
-70 mV in slice preparations obtained from patients with MTLE.We also
examined the effects of selective receptor antagonists on spontaneous
fast current transients (CTs), which represent action potentials, recorded
from these pyramidal neurons under cell-attached configuration.
Results: We observed that frequency of EPSCs were higher in slices
obtained from patients with MTLE compared to that in case of non-epi-
leptic controls. Both APV and CNQX reduced the frequency of EPSCs
but the magnitude of reduction of EPSC frequency by APV is higher
compared to that by CNQX in case of MTLE. We found that the fre-
quency of CTs in pyramidal neurons is higher in case of MTLE samples
compared to non-epileptic controls. The frequency of CTs increased in
the absence of extracellular Mg2+ in both MTLE and control samples. In
Mg2+ -free condition APV completely blocked the CTs frequency in case
of MTLE specimens.
Conclusion: This study suggests that there is increase in the basal synap-
tic glutamate activity in slice preparations obtained from patients with
MTLE. Endogenous activity of NMDA receptors significantly con-
tributes to the enhanced glutamatergic synaptic transmission and neu-
ronal firing on to the pyramidal neurons in MTLE.
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EFFECTSOFCONTINUOUS LOW-DOSEMERCURY
CHLORIDE (HGCL2) EXPOSURE INGESTATIONAL
ANDLACTATION PERIODSON SWDACTIVITYAND
SUBCONVULSIVE-DOSE PTZ-INDUCED SEIZURE IN
GENETICALLYABSENCE EPILEPTICWAG/RIJ RATS
S. Beyaz*, D. Sahin†, S.M. Karadenizli†, G. Bayrak*,
C.O. Erdolu*, B. Demir*, N. Ates†
*Kocaeli University/Medical Faculty, Kocaeli, Turkey, †Kocaeli
University/Medical Faculty, Physiology, Kocaeli, Turkey
Purpose: Mercury is a ubiquitous environmental toxin that causes a wide
range of adverse health effects in humans, especially in the fetus0 and
infants’ early neurodevelopmental period. Effects of chronic low-dose
maternal exposure to mercury on features of absence epilepsy, epilepto-
genesis and subconvulsive dose of PTZ-induced seizure were investi-
gated in 5-month-old offspringWAG/Rij rats.
Method: WAG/Rij pregnant rats were exposured low-dose HgCl2 (im.
injection) or saline chronically during gestational/lactation periods. Off-
spring rats were divided into four groups; HgCl2-exposed groups (which
were subdivided; SWD activity and PTZ-induced seizure group) and con-
trol groups (which were subdivided; SWD activity and PTZ-induced sei-
zure group) consisting of 32 rats. After 5 months, HgCl2-exposed and
control rats were placed singly into plexiglas cage, connected to EEG
leads, habituated to the experimental conditions. Then, the EEGwas con-
tinuously recorded in freely moving rats for 1 h. Numbers and mean-
durations of the SWDs were calculated off-line analysis. Next to the
EEG, behavior changes during the subconvulsive-dose PTZ-induced
seizure were observed and scored.
Results: All WAG/Rij rats exhibited spontaneously occurring SWDs
(hallmarks of absence epilepsy) on EEG and behavioural symptoms of
absence epilepsy. According to EEG findings, HgCl2-exposed group
showed a significant decrease in number of SWDs compared to the con-
trol. Our results also suggest that a subconvulsive-dose of PTZ induced
generalized tonic-clonic seizures and increased the seizure intensity in
HgCl2-exposed group (p < 0.05).
Conclusion: Mercury exposure was found to be associated with epilep-
togenesis at early period of brain development. While inorganic mer-
cury-exposure in WAG/Rij rats lead to very rapid progression in PTZ-
induced seizure steps, and increases seizure intensity, it suppressed
absence epileptic SWD activity. We can explain these results with the
degeneration of GABAergic inhibitor interneuron in cortical region after
mercury exposure (O’Kusky et al., 1989, Inad et al., 2011).
p0137
NOEVIDENCE FORHUMANPAPILLOMAVIRUS
INFECTION IN FOCALCORTICALDYSPLASIA IIB
I. Blumcke*, K. Korn*, C. Bien†, R. Coras*
*University Hospital Erlangen, Erlangen, Germany, †Hospital
Mara, Epilepsy Center, Bielefeld, Germany
Purpose: The aetiology of Focal Cortical Dysplasia Type IIb (FCDIIb)
remains enigmatic in patients suffering from drug-resistant epilepsy, and
an aberrant activation of the mammalian target of rapamycin complex 1
signalling pathway (mTORC1) was detectedin this developmental brain
malformation. Recently, the human papillomavirus (HPV) oncoprotein
E6 has been identified as a potent activator of mTORC1, and HPV16 E6
described to persist in balloon cells obtained from surgical FCDIIb speci-
mens. Although this observation was replicated by an independent sec-
ond report, it contradicts current knowledge of HPV biology. HPV
infects the squamous or mucocutaneous epithelium; haematogenic
spread into other tissues has not been observed. In addition, brain car-
cinogenesis has never been reported in FCDIIb patients. Herein, we have
tried to confirm two previous reports of HPV16 E6 infection using an
independent series of 14 surgical specimens with histopathologically
confirmed FCDIIb.
Method: Snap-frozen FCDIIb specimens were tested for HPV DNA
using the primer set for amplification of the complete E6 reading frame
of HPV16 and three other sets of primers (two consensus primer sets
detecting multiple HPV genotypes, and another primer set specifically
used for HPV16). Furthermore, formalin-fixed and paraffin-embedded
(FFPE) histopathological preparations were immunohistochemically
analysed using previously described antibodies directed against the HPV
E6 oncoprotein.
Results: All 14 FCDIIb specimens were negative for HPV DNA with all
four primer sets. Antibodies directed against the HPV E6 epitope showed
weak labelling of cytoplasm in balloon cells, as previously described in
FCDIIb, but also in other cell populations.
Conclusion: Our data did not confirm previously reported evidence for
HPV16 detection in FCDIIb.
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CHARACTERIZATIONOF THECORTICAL
INITIATION SITE INMOUSEMODELSOFABSENCE
EPILEPSY
N. Carcak*, M. Lorincz†, C. Mccafferty‡, M. Venzi‡, F. Onat§,
V. Crunelli‡, F. David‡
*Istanbul University Faculty of Pharmacy, Department of
Pharmacology, Istanbul, Turkey, †MTA-SZTE Research Group,
Department of Physiology, Anatomy and Neuroscience, Szeged,
Hungary, ‡Cardiff University School of Biosciences,
Neuroscience Division, Cardiff, UK, §Marmara University,
Faculty of Medicine, Department of Pharmacology and Clinical
Pharmacology, Istanbul, Turkey
Purpose: The EEG hallmark of absence seizures, spike-and-wave dis-
charges (SWDs), are not generalized from their very start despite their
classical characterization as generalized events. Experimental work has
shown that in genetic rat models of absence epilepsy (WAG/Rij and
GAERS), SWDs can be detected in a localized cortical area (i.e. the
perioral region of the somatosensory cortex) before they spread to
other cortical areas and to thalamic territories. A similar observation
has been made in children with absence epilepsy, where the existence
of a putative cortical initiation site was found mostly in fronto-parietal
areas. In particular, it will be interesting to know why human sufferers
and rat models have different initiation sites, and whether all well-
established animal models have a similar initiation site in somatosen-
sory cortex. Thus, we investigated the presence of a putative initiation
site by recording multisite local field potentials (LFPs) in different cor-
tical areas of genetic mouse models (Stargazer and GAT-1 knock-out)
and in the pharmacological c-hydroxybutyrate (GHB) model of
absence epilepsy.
Method: Animals were stereotaxically implanted with recording elec-
trodes over the frontal, motor, anterior and posterior somatosensory, and
visual cortices and allowed 3 days of recovery before the 2 h recording
session start. The delays of propagation between each pair of recording
sites were analysed.
Results: LFP recordings in freely moving Stargazer mice (n = 6)
revealed that typical SWDs at 4-7 Hz concomitant with behavioural
arrest were observed in the primary motor cortex 84.59  10.39 msec
before other cortical sites. In GAT-1 knock-out (n = 6) and GHB (n = 5)
models, SWDs started in posterior somatosensory cortex 120.6  10.72
and 67.54  17.3 msec, respectively, before other cortical areas.
Conclusion: These results suggest that the cortical initiation site can
vary across species and models of absence epilepsy. In stargazer mice the
initiation site is in the motor cortex and different from the other mice
models.
Basic Science 2
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ELECTROENCEPHALOGRAPHIC
CHARACTERIZATIONOFAMURINEMODELOF
SEPTIC ENCEPHALOPATHY
N. Chemaly*, A. Mazeraud†, T. Sharshar†, F. Chretien†,
R. Nabbout*
*UMR INSERM 1129 - Necker Enfants Malades Hospital, Paris,
France, †Institut Pasteur, Human Histopathology and Animal
Models, Paris, France
Purpose: Sepsis and septic shock is a major cause of admission and
death in intensive care units. In 60% of cases, septic associated
encephalopathy complicates severe infections resulting in mortality or at
least persistent cognitive dysfunction. The mechanisms underlying this
septic encephalopathy are complex and involve ischemic and neuro
inflammatory processes. Electroencephalographic studies (EEG) in
humans show early signs that can be predictive of this encephalopathy.
Method: To better understand the pathophysiological mechanisms
underlying the EEG modifications present in this septic encephalopathy,
we used a murine model. Sepsis is induced by caecal ligation and punc-
ture (CLP) in adultWT c57bl6 mice previously implanted with a telemet-
ric device for prolonged EEG recording.
Results: 31 mice were implanted with a telemetric device at least 1 week
before inducing sepsis. Animals were monitored until full recovery and
recording of a normal EEG. Sepsis was induced by CLP in 16 animals,
and by intraperitoneal injection of LPS (lipoplysaccharid) in 10 animals.
5 animals were implanted and used as controls. 50% of the CLP induced
sepsis mice died within 3 days. EEG recordings showed findings similar
to humans, i.e slowing of the background activity, disappearance of cir-
cadian rhythms, slow waves, and a microvolted activity preceding death
with a concomitant hypothermia.
Conclusion: The telemetric study of a murine model of septic
encephalopathy successfully replicated the EEG findings of human septic
encephalopathy. Therapeutic tests can therefore be performed in this
model to improve the global and cognitive outcome of this severe condi-
tion.
p0141
INCREASED SUPEROXIDEDISMUTASE 1 BY
LAMOTRIGINE AMELIORATES SUPEROXIDEANION-
RELATEDCELLDEATHAFTER PILOCARPINE-
INDUCED STATUS EPILEPTICUS INMICE
I.J. Cho*,†, Y.J. Cho*, H.W. Kim*, W.J. Kim*, K. Heo*,
B.I. Lee*,†
*Department of Neurology, Severance Hospital, Yonsei
University College of Medicine, Seoul, Republic of Korea,
†Brain Korea 21 Plus Project for Medical Science, Yonsei
University, Seoul, Republic of Korea
Purpose: Various reactive oxygen species (ROS) afterepileptic seizure
has been related to neuronal death and subsequent epileptogenesis. How-
ever, the role of superoxide anion, one of the powerful ROS, in the sei-
zure-induced cell death has been remained unclear. We investigated the
role of superoxide anion in seizure-induced cell death and the possible
mechanism of neuronal protection underlying lamotrigine treatment in
regard to superoxide dismutase (SOD)1, one of superoxide dismutases
responsible for destroying free radicals.
Method: Adult male C57BL/6J mice were given injections of pilo-
carpine 30 min after scopolamine treatment. Seizures were terminated
by diazepam injection after status epilepticus (SE) at various time points.
Hippocampal cell death was assessed by cresyl-violet and TUNEL stain-
ing. The hippocampal superoxide anion was assessed using in situ detec-
tion of oxidized hydroethidine (HEt); administered intravenously after
SE. SOD1 level was analyzed by bothWestern blot and semi-quantitative
immunofluorescent staining in subfields of hippocampus. Various doses
of lamotrigine (30, 60 mg/kg, i.p.) were administrated.
Results: Superoxide anion significantly increased after pilocarpine-
induced SE, compared to normal control, which were in concordance
with increased cell death by TUNEL and cresyl-violet staining. The pro-
duction of superoxide anion in response to SE was least in dentate gyrus,
which was reversely in agreement with maximal SOD1 increase in the
same subfield. Treatment of lamotrigine significantly decreased the pro-
duction of superoxide anion after SE, compared to vehicle treatment. In
addition, hippocampal neuronal death was significantly attenuated by
lamotrigine treatment in dose dependent manner. SOD1 also increased
by lamotrigine treatment after SE, and the effect was the greatest in CA3
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subfield, in which SOD1was significantly decreased without lamotrigine
treatment.
Conclusion: Increased production of superoxide anion after SE may
contribute hippocampal neuronal death after seizure. The lamotrigine
may inhibit superoxide anion-related neuronal cell death through
increase of SOD1 in the hippocampus after SE.
p0142
ANTIEPILEPTIC EFFECTSOFAXITINIB ON
PENTYLENETETRAZOL-INDUCEDKINDLING IN
RATS
V. Chubach*, T. Muratova*, S. Myronenko†, L. Godlevsky*
*Odessa National Medical University, Odessa, Ukraine, †Lviv
National Medical University after Danilo Galytsky, Lviv,
Ukraine
Last time tyrosine kinase B receptor is supposed as a target for epilepsy
development. Hence, the aim of the investigation was to identify pecu-
liarities of pentylenetetrazol (PTZ) induced kindling development under
conditions of axitinib administrations, which is able to inhibit intracellu-
lar tyrosine kinase signaling pathways. Experiments were performed on
Wistar male rats, which have been kindled daily with PTZ (30.0 mg/kg,
i.p.). Daily p.o. administrations of axitinib have been performed in
60 min before PTZ in a dosage of 5.0 mg/kg. The latency of kindled sei-
zures was prolonged by axitinib and the difference with the control group
(kindling + saline solution, p.o.) became significant started from 5th PTZ
injection. The development of generalized seizures have been substan-
tially postponed and the precipitation of generalized seizures was
observed starting from 12th PTZ administration while in control group
generalized fits have been observed after 7th injection of epileptogen.
Significant differences when compared with the control group main-
tained up to the final 21-d PTZ injection. Electrographic manifestations
were characterized by more than two-fold times decrease of amplitude
and frequency of spike discharges along with shortening periods of gen-
eralized spike-wave activity in ventral hippocampus. Two weeks free
from PTZ administration with the consequent injection of PTZ (30.0 mg/
kg, i.p.) resulted in clonic type of seizures in rats treated with axitinib
while in control kindled rats repeated generalized seizures have been reg-
istered. Axitinib (10.0 mg/kg, p.o.) did not modify acute generalized sei-
zures induced with PTZ (60.0 mg/kg, i.p.), while in early period of
kindling (24 h from the last administration of PTZ) prevented the devel-
opment of generalized seizure fits. The pronouncement of antiepileptic
action of axitinib was comparable with such one registered after diaze-
pam administration in a dosage of 0.5 mg/kg, i.p. Hence, gained data
showed antiseizure activity of axitinib on the model of PTZ-induced
kindling.
p0143
ELECTRONMICROSCOPIC INVESTIGATIONOF
NEUROGENESIS ANDGABA IMMUNOREACTIVITY IN
GENETIC ABSENCE EPILEPTIC RATS
O.T. Cilingir*, D. Gursoy*, C. Moore†,‡, C.K. Meshul†,‡,
F. Onat§, S. Sirvancı*
*Marmara University School of Medicine, Histology and
Embryology, Istanbul, Turkey, †Veterans Hospital, Portland,
OR, USA, ‡Oregon Health and Science University, Behavioral
Neuroscience and Pathology, Portland, OR, USA, §Marmara
University School of Medicine, Pharmacology and Clinical
Pharmacology, Istanbul, Turkey
Purpose: Hippocampal neurogenesis is an issue which has not been
investigated in genetic absence epilepsy rats from Strasbourg (GAERS).
In the present study, we investigated neurogenesis in adult and 3-week-
old GAERS to determine if newly formed neurons form synapses with
GABAergic terminals.
Method: Brain tissues were obtained by perfusion fixation and pro-
cessed for electron microscopic assessments. Thin sections from hip-
pocampal dentate gyrus were double-labeled for anti-GABA and anti-
DCX (doublecortin) antibodies using a postembed immunogold
method. Sections were photographed on the transmission electron
microscope.
Results: DCX immunoreactivity was demonstrated in axons, dendrites
and cell bodies in all groups.We observed that DCX(+) structures formed
synapses and synapse-like contacts with GABAergic structures. There
were more DCX(+) dendrites in all groups compared to DCX(+) axons.
Also, the percentage of asymmetrical synapses formed by DCX(+) pro-
files was higher than that of symmetrical synapses in all groups. 21-day-
old animals were qualitatively observed to have more GABA labeling in
DCX(+) mossy terminals (MTs), compared to 3-month-old groups. DCX
(+) profiles including GABA showed a tendency to increase in 21-day-
old groups compared to 3-month-old groups; and there was a trend for an
increase in GABA and DCX densities in GAERS, although the differ-
ences were not statistically significant.
Conclusion: Our data demonstrated that newly born DCX-ir neurons
join the local hippocampal network. In 21-day-old animals, DCX(+) pro-
files had an increased tendency to be GABAergic; this may result from
the trophic effects of GABA in immature animals. Our findings showing
more GABA labeling in MTs of immature animals may suggest accumu-
lation of GABA inside the terminal. Further studies are needed to mea-
sure extracellular levels of GABA. In our study, DCX and GABA
densities had a tendency to increase in GAERS groups; suggesting that
the alterations in the hippocampus may also have effect on the mecha-
nisms of absence epilepsy.
p0144
PERAMPANEL EFFECTS IN THEWAG/RIJ RAT
MODELOFEPILEPTOGENESISWITHCOMORBID
DEPRESSIVE-LIKE BEHAVIOR
R. Citraro*, V. Franco*, E. Russo†
*University of Catanzaro, Science of Health, Catanzaro, Italy,
†Faculty of Medicine, University of Catanzaro, Health Science,
Catanzaro, Italy
Purpose: Perampanel (PER), a selective non-competitive AMPA-recep-
tor antagonist has demonstrated efficacy and tolerability in patients with
partial seizures[1]. PER is approved for adjunctive treatment of partial
seizures with or without secondarily generalized seizures in patients with
epilepsy[1]. PER exhibited broad-spectrum efficacy in several animal
models of acute seizures[2]. Prevention of epileptogenesis is a priority
research field in epilepsy. Therefore, we determined whether an early
long-term treatment with PER might alter both absence seizure develop-
ment and onset of depressive-like behavior in the WAG/Rij rat model of
absence epilepsy, epileptogenesis and comorbid depressive-like behav-
ior.
Method: Rats were early long-term treated with PER (1 and 3 mg/Kg;
o.s.), as previously described[3]. Briefly, drug treatment lasted 17 weeks
and was started at P30. Age-matched control rats were kept under the
same housing conditions over the same period of time with vehicle. At
the age of ~6 and ~10 months, all WAG/Rij rats underwent three EEG
recordings of 3 h each on 3 consecutive days and determination of immo-
bility time in the forced swimming test (FST)[3]. Plasma PER levels were
determined by HPLC-UV.
Results: PER (only at 3 mg/kg/day) significantly reduced (about 45%)
the development of absence seizures in WAG/Rij rats both at 6 (1 month
after treatment withdrawal) and 10 months of age (5 months after treat-
ment withdrawal). In FST, PER at both doses tested reduced immobility
time displaying antidepressant-like properties at 6 and 10 months of age.
Mean plasma levels (ng/mL) throughout treatment were PER 1 mg/kg =
13.99 (SD 2.73) and PER 3 mg/kg = 33.13 (SD 9.83), which remained
stable every month.
Epilepsia, 56(Suppl. 1):3–263, 2015
doi: 10.1111/epi.13241
43
Abstracts
Conclusion: These findings suggest that PER might have antiepilepto-
genic properties and positive effects on animal behavior, displaying,
therefore, possible disease-modifying properties.
[1] Franco et al. Expert Opin Pharmacother 2014;15:637–44.
[2] Russo et al. Expert Opin Investig Drugs 2012;21:1371–89.
[3] Citraro et al. Epilepsia 2014;55:1284–91.
p0145
ZEBRAFISH-BASED IDENTIFICATIONOF
APICULARENAASANANTICONVULSANT
COMPOUND FROMMYXOBACTERIA
D. Copmans*, J. Herrmann†, A. Ny*, Y. Zhang*,
G. Adriaenssens*, R. Müller†, P.A.M. de Witte*,
A.D. Crawford*
*KU Leuven, Laboratory for Molecular Biodiscovery, Dept. of
Pharmaceutical and Pharmacological Sciences, Leuven,
Belgium, †Helmholtz Institute for Pharmaceutical Research
Saarland, Saarbrücken, Germany
Purpose: Given the need for new and improved anti-epileptic drugs, this
study focused on the identification of new anticonvulsant compounds
from myxobacterial origin, using zebrafish larvae as the primary screen-
ing model.
Method: A library of 242 myxobacterial compounds from the Helm-
holtz Centre for Infection Research was screened for neuroactivity by
the zebrafish photomotor response (PMR) assay. Next, neuroactive hits
were screened for anticonvulsant activity by the zebrafish pentylenete-
trazole (PTZ) seizure assay. Anticonvulsant activity was further inves-
tigated by local field potential (LFP) recordings of the zebrafish
midbrain to evaluate the effect of a compound on PTZ-induced epilep-
tiform discharges. Finally, anticonvulsant activity was investigated in
the mouse timed i.v. PTZ assay to investigate activity in the mouse
model.
Results: 56 myxobacterial compounds were identified as neuroactive by
the PMR assay. 24 selected neuroactive hits were screened for anticon-
vulsant activity by the zebrafish PTZ assay. 8 compounds were identified
as anticonvulsant hits and confirmed for their activity. Among them,
apicularen A significantly reduced PTZ-induced seizure behavior with
high efficacy in a concentration-dependent manner and significantly
reduced PTZ-induced epileptiform discharges. Moreover, apicularen A
significantly increased the PTZ dose needed to trigger forelimb clonus in
the mouse timed i.v. PTZ assay.
Conclusion: Myxobacteria are increasingly recognized as producers of
bioactive secondary metabolites and can be considered as a rich source
for drug discovery. In this study, we identified for the first time anticon-
vulsant myxobacterial compounds using a zebrafish-based screening
approach. The anticonvulsant activity of apicularen A was verified by
LFP recordings of the zebrafish midbrain and confirmed in the mouse
timed i.v. PTZ model. Our results not only support the potential of
myxobacterial compounds, but expand their utility as an interesting
source for anti-epileptic drug discovery.
p0146
EVALUATIONOFBLOOD-BRAIN BARRIERDAMAGE
USINGGADOLINIUM-ENHANCEDMAGNETIC
RESONANCE IMAGING INGENERALIZED SEIZURE
MODELMICE
S. Danjo*,†, J. Danjo*, I. Ishikawa*, S. Fukumoto*, T. Mori*,
Y. Nakamura*
*Kagawa University, School of Medicine, Kagawa, Japan,
†Mihune Hospital, Kagawa, Japan
Purpose: Our aim was to non-invasively and sequentially evaluate
blood-brain barrier (BBB) damage in generalized seizure model (GSM)
mice, using gadolinium (Gd)-enhanced magnetic resonance imaging
(MRI). In addition, we assessed whether valproate (VPA) could prevent
BBB damage.
Methods: GSMmice were kindled with daily intraperitoneal administra-
tion of 40 mg/kg pentylenetetrazol (PTZ). After each PTZ injection, con-
vulsive behaviors were observed, and seizures were classified and scored
as follows: 0 = normal; 1 = immobilization, sniffing; 2 = short myo-
clonic jerk; 3 = continuous myoclonic jerk; 4 = generalized limbic sei-
zures or violent convulsions; 5 = continuous generalized seizures. Five
consecutive scores of 4 or 5 were required to ensure kindling. We evalu-
ated changes in BBB permeability using the signal intensity (SI) ratio of
Gd-enhanced MRI. Because the contrast material does not enter the brain
parenchyma through the BBB in naive mice, an increase in SI was indica-
tive of BBB damage. SI was sequentially measured at baseline, score 1,
score 3, PTZ-kindled, and post-kindled 1 week after PTZ withdrawal.
Moreover, SI was measured in the mice pretreated with VPA (400 mg/
kg, p. o.) before PTZ injection.
Results: SI values (mean  SE) at score 1, score 3, PTZ-kindled, and
post-kindled increased to 0.7  0.2, 7.2  1.9, 7.4  1.6, 6.8  1.3%,
respectively. All values (except at score 1) were significantly higher than
those at baseline (p < 0.05). We did not observe significant differences
at score 3 or post-kindled, compared to PTZ-kindled. In VPA-pretreated
mice, SI significantly increased to 8.8  1.6% compared to baseline,
although convulsions were fully controlled.
Conclusions: Our data suggest that BBB damage started before PTZ-
induced kindling was acquired. BBB damage was irreversible after
PTZ-induced kindling. In addition, VPA prevented epileptic convul-
sive seizures, but could not suppress BBB damage in PTZ-kindled
mice.
p0148
RNA-SEQANALYSIS OFHIPPOCAMPAL TISSUES
REVEALS NOVELCANDIDATEGENES FORDRUG
REFRACTORYEPILEPSY IN PATIENTSWITHMTLE-
HS
A. Dixit*, J. Banerjee*, A. Srivastava†, M. Tripathi†,
C. Sarkar†, A. Kakkar†, P.S. Chandra†
*National Brain Research Center, New Delhi, India, †AIIMS,
New Delhi, India
Purpose: Array-based profiling studies shows aberrant gene expression
patterns during Epileptogenesis. We have performed transcriptomic anal-
ysis of the hippocampal tissue resected from the patients with MTLE-HS
undergoing surgery by RNAseq to investigate the molecular basis of
epileptogenicity, the anti-epileptogenic mechanisms and pharmacoresis-
tance in MTLE.
Method: Resected brain samples were obtained from patients with
MTLE and for non-epileptic control experiments tumour margin
obtained during tumour surgeries were used. RNA sequencing was per-
formed using standard protocols on Illumina HiSeq 2000 platform.
Reannotation, mapping and bioinformatic data analysis was performed
using the Bowtie/TopHat/Cufflinks/Cuffmerge/SAMtools and SIFT/
PolyPhen/SpliceSeq algorithms. Differential gene expression data was
validated through quantitative real-time polymerase chain reaction
(qPCR).
Results: At a fold change of ≥ 2, deregulation of more than 1000 genes
was observed. Significantly at p < 0.005, 33 genes were up-regulated
and 25 were down-regulated. SNP analysis revealed 7000 novel SNPs
and 1517 novel Indels, 29 possible damaging mutations. Using SpliceSeq
algorithm software we identified 58 novel differential splicing isoforms
(>= 10FPKM). Correlation analysis of gene expression, SNP and splicing
data revealed 9 DEGs showing SNPs and 11 DEGs showing differential
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splicing patterns. Only in one of the DEG SCNM1 both SNPs as well as
differential isoforms were observed.
Conclusion: Using RNAseq approach we could identify a set of dif-
ferentially expressed genes, novel transcripts, pseudogenes, LncRNAs,
genefusions, SNPs and splicing isoforms of various genes associated
with MTLE. The Gene Ontology and pathway analysis revealed
important hubs of molecules involved in neuroinflammation, modula-
tion of synaptic transmission, and the restructuring of neuronal net-
works supporting the intrinsic severity hypothesis of
pharmacoresistance. This study identified few important molecules
like SCNM1, CSNKIIB, CABP1, KIF5A and ASB4 which needs fur-
ther evaluation for their potential as diagnostic/prognostic biomarkers
in intractable MTLE.
p0149
COMPARISONOF SPIKE-WAVEDISCHARGES IN
NORMALANIMALS TO SPONTANEOUS RECURRENT
SEIZURES ACROSS SEVERALANIMALMODELSOF
ACQUIRED EPILEPSY
F.E. Dudek*, K.M. Rodgers†, W.A. Pouliot*, S. Kadam‡,
E.H. Bertram§, D.S. Barth†
*University of Utah School of Medicine, Dept. Neurosurgery,
Salt Lake City, UT, USA, †University of Colorado Boulder,
Dept. Psychology, Boulder, CO, USA, ‡Johns Hopkins School of
Medicine, Dept. Neurology, Baltimore, MD, USA, §University of
Virginia School of Medicine, Dept. Neurology, Charlottesville,
VA, USA
Purpose: Several publications have reported spontaneous recurrent
seizures in animal models of acquired epilepsy based on brain insults
proposed to be more realistic than previous models. These studies
have reported periods of oscillatory, spike-and-wave discharges
(SWDs) with blank-stare behaviors, which have been considered to
represent the non-convulsive seizures of acquired epilepsy. However,
similar events are also seen in normal animals (i.e., non-injured con-
trols). The present studies compare SWDs with non-convulsive and
convulsive seizures recorded in diverse animal models of acquired
epilepsy.
Methods: In addition to pilocarpine- and kainate-induced status epilepti-
cus, animal models (rats) included unilateral carotid occlusion with
hypoxia at postnatal day 7, controlled cortical impact in adults, and a
model of penetrating brain injury in adults.
Results: SWD-like events in normal rats were much shorter in dura-
tion than the non-convulsive and convulsive seizures in the models of
acquired epilepsy (see above). Normal SWD events were typically
<5–10 second, but could be longer. The convulsive/non-convulsive
seizures in the models of acquired epilepsy were routinely 20–40 sec-
ond, but could also be longer (e.g., 2–3 min). The SWD-like events
started abruptly; non-convulsive/convulsive seizures began with a pro-
gressive increase in amplitude and/or frequency. Inter-spike intervals
were relatively homogeneous during normal SWD, while frequency of
EEG spikes in non-convulsive and convulsive seizures was more vari-
able with distinct shifts in pattern. The non-convulsive/convulsive sei-
zures often had post-ictal depression, which was not seen with SWDs
in normal rats.
Conclusions: Electrographic properties of SWD in normal rats (and after
postnatal hypoxia or fluid percussion injury) could be readily distin-
guished from seizures characteristic of acquired epilepsy. Non-convul-
sive and convulsive seizures in these diverse models of brain injury were
much more similar to each other than they were to the SWDs.
Research support: NIH: Conflict of Interest: FED - grants, consulting
fees and equity in Epitel, Inc.
Clinical Neurophysiology 1
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CHANGES IN CARDIACAUTONOMICCONTROL
DURING SEIZURES
F. Abreu*, R. Luz*, T. Neves*, L. Nashef†, R. Elwes*,
R. Delamont*
*King’s College Hospital, Clinical Neurophysiology, London,
UK, †King’s College Hospital, Neurology, London, UK
Purpose: The spread of ictal activity to autonomic centres in the central
nervous system might lead to cardio-vascular changes observed in sei-
zures. This might contribute to an increased risk of sudden unexpected
death in epilepsy (SUDEP). Simultaneous monitoring of cardio-vascular
variables during seizures could provide a better understanding of the
mechanisms involved in SUDEP. Our aim is to identify autonomic pat-
terns and correlate them with ictal electroencephalographic changes and
different seizure types.
Method: We are undertaking a continuous and non-invasive study of
autonomic parameters including heart rate (HR), blood pressure (BP),
cardiac vagal tone (CVT) and cardio-sensitivity to baroreflex (CSB) dur-
ing seizures in subjects undergoing pre-surgical evaluation in the teleme-
try unit at King’s College Hospital.
Results: Of fifteen subjects recruited, only three had seizures during
the study. We have analysed five simple partial seizures from subject
one; one subclinical seizure and two complex partial seizures (CPS)
from subject two and three CPS of which two became secondarily
generalized from subject three. A consistent pattern in CSB is
observed with a mean reduction in amplitude from baseline of 72% in
CPS and 90% in secondary generalised. CVT showed no consistent
pattern in the seizures. BP showed a tendency to increase during CPS
and secondarily generalised seizures. Heart rate changes varied
between patients in CPS but showed a trend in secondarily gener-
alised: HR decreased during CPS phase (x̅=26% from baseline) and
subsequently increased after secondary generalisation (x̅=41% from
baseline).
Conclusion: Ictal events may affect neurological centres involved in
the control of cardio-sensitivity to baroreflex, yet little has been pub-
lished on this. A change in CSB might compromise haemodynamic
stability and cardio-protection mechanisms making it a potential
SUDEP risk factor. Inter-individual variability was seen in HR changes
and CVT changes but not CSB. Further seizures will be recorded to
confirm these findings.
p0152
A FAMILYWITH JUVENILEMYOCLONIC EPILEPSY
COMPLAININGOFTREMOR: ANALYSISWITH
ACCELEROMETERAND SOMATOSENSORY EVOKED
POTENTIALS
Z. Aydin-Özemir*,†, Z. Matur*,‡, B. Baykan*, A.E.Öge*
*Istanbul University, Istanbul Faculty of Medicine, Department
of Neurology, Clinical Neurophysiology Unit, Istanbul, Turkey,
†Memorial Atasehir Hospital, Department of Neurology, Turk,
Department of Neurology, Istanbul, Turkey, ‡Istanbul Bilim
University, Faculty of Medicine, Department of Neurology,
Istanbul, Turkey
Purpose: There are some juvenile myoclonic epilepsy (JME) patients
complaining of tremor. The etiology and generators of this tremor are not
clear and speculated as being a valproate (VPA) enhanced essential tre-
mor (ET). On the other hand, some families from different countries with
cortical myoclonic tremor and epilepsy have been reported. Unfamiliar-
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ity with this syndrome often leads to an initial misdiagnosis of essential
tremor or progressive myoclonus epilepsy. We aimed to report three sib-
lings who had been initially evaluated as JME since their common com-
plaints of tremor were under-recognized.
Method: We assessed three siblings (2 females) diagnosed with JME
complaining of hand tremor by their median somatosensory evoked
potentials (SEP) and accelerometric recordings, after their consent. In all
of them, tremor had started before VPA treatment. We compared their
results with JME patients without tremor (14 patients) and 14 patients
with essential tremor (ET).
Results: These patients have characteristic clinical and EEG pictures of
JME with photosensitivity. The N20-P25 and P25-N35 amplitudes of
SEP were significantly higher in three siblings with tremor and epilepsy
compared to both JME group without tremor and ET group. Typical
“giant SEPs” were observed in all of the siblings. Tremor frequencies
were similar with ET group whereas they had mild interrupting non-
rhythmic myoclonus and lower amplitude of tremor, suggesting a differ-
ent and cortical origin.
Conclusion: Our findings might be interpreted as tremor characteristics
are different in JME patients in comparison to ET patients regarding to
intervening myoclonus in distal part of the fingers and lower tremor
amplitudes. JME patients complaining of tremor should be investigated
with caution for other familial syndromes and possibility of cortical
tremor.
p0153
DYNAMICSOFCONVULSIVE SEIZUREGENERATION,
TERMINATIONANDRECOVERY
P.R. Bauer*,†, R.D. Thijs*,‡, R.J. Lamberts*, D.N. Velis*,
G.H. Visser*, E.A. Tolner‡, J.W. Sander*,†,§, F. Lopes da
Silva¶, S.N. Kalitzin*,**
*Stichting Epilepsie Instellingen Nederland, Hoofddorp,
Netherlands, †NIHR University College London Hospitals
Biomedical Research Centre, UCL Institute of Neurology,
London, UK, ‡Leiden University Medical Centre, Neurology,
Leiden, Netherlands, §Epilepsy Society, Chalfont St Peter, UK,
¶University of Amsterdam, Center of Neurosciences,
Swammerdam Institute of Life Sciences, Amsterdam,
Netherlands, **Utrecht University, Image Sciences Institute,
Utrecht, Netherlands
Purpose: To elucidate the nature of mechanisms underlying seizure
onset, termination and postictal generalized EEG suppression (PGES) in
convulsive seizures (CSs).
Methods: We validate predictions from a multi-unit neural mass compu-
tational model with EEG recordings from 48 CSs from 48 people with
refractory, localisation-related epilepsy.
Results: We confirm a previous finding that both simulated and real
ictal periods show a probability distribution suggestive of an underly-
ing deterministic process and show that this is also the case for postic-
tal periods. Plasticity towards the end of a seizure may be reflected by
the exponential increase of interclonic intervals (ICIs). In the model,
the plasticity feedback parameter determines the time needed for the
system to recover to the normal state. In the human data, the ICI at the
end of a seizure is associated with the occurrence and duration of
PGES.
Conclusion: Our findings point towards an autonomous inhibitory neu-
ronal process underlying seizure termination and PGES, relevant for
understanding epileptic transitions and sudden unexpected death in epi-
lepsy (SUDEP).
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COMPUTERASSISTEDANALYSIS OFRESPONSE TO
HIGHFREQUENCY (50HZ) STIMULATIONDURING
INTRACRANIAL PRESURGICAL STEREOEEG
MONITORING
E. Bellistri*, V. Gnatkovsky*, I. Sartori†, V. Pelliccia†,
F. Gozzo†, S. Francione†, F. Cardinale†, M. de Curtis*
*Fondazione I.R.C.C.S. - Istituto Neurologico ‘Carlo Besta’,
Unit of Epileptology and Experimental Neurophysiology,
Milano, Italy, †Ospedale Niguarda Ca’Granda, Claudio
Munari Epilepsy Surgery Center, Milano, Italy
Purpose: Patients suffering from pharmacoresistant focal epilepsies can-
didate to epilepsy surgery are monitored using intracerebral stereo-EEG
to identify the epileptogenic zone (EZ). In recent years an increasing
number of computer assisted analysis of intracerebral human signals have
been developed to define biomarkers of the EZ and to improve the defini-
tion of the boundaries of the area of resection during epilepsy surgery.
We propose a method to automatically define a subset of EZ contacts,
focusing on response to high frequency (HF, 50 Hz) stimulation per-
formed for diagnostic purposes during invasive stereo-EEG studies with
intracranial electrodes. Our study presents a new algorithm to evaluate
signal parameters that
1) are characterized by a rapid response and
2) are masked by the HF stimulation artifacts,
3) cannot be visually identified by clinical neurophysiologist.
Method: We use time/frequency analysis, graph theory and clustering
methods to extract parameters and to test their specificity to the EZ.
The analysis was focused on 60–80 Hz activity that represents the lar-
gest frequency component evoked by HFS. The distribution of HFS-
evoked fast activity across all recording contacts (up to 162) allowed
to define different clusters of contacts. Retrospective correlation to the
EZ identified by the clinicians on the basis of traditional visual stereo-
EEG analysis allows to quantify and validate the algorithm perfor-
mance.
Results: On a group of 13 retrospectively analyzed patients we found an
average specificity = 84.8% and sensitivity = 81%, showing a good
matching between the algorithm selection and the clinical identification.
Conclusion: HFS-evoked activities not only contributes to the definition
of the epileptogenic network, but also represent a tool for biomarkers def-
inition. Epileptogenic regions show different response patterns to HF
stimulation, suggesting the opportunity to identify specific parameters
automatically extracted by computer assisted analysis.
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MODULATIONOFCORTICO-CORTICAL
FUNCTIONALCONNECTIVITYWITH
INTRACEREBRAL PAIRED-PULSES ELECTRICAL
STIMULATIONS
S. Boulogne*,†, N. Andre-Obadia*, P. Ryvlin†,‡, S. Rheims*,†
*Hopital Neurologique - Lyon, Epileptology and Clinical
Neurophysiology, Bron, France, †INSERMU 1028 / CNRS UMR
5292, Translational & Integrative Group in Epilepsy Research,
Lyon, France, ‡Centre Hospitalier Universitaire Vaudois
(CHUV), Cognitive Sciences, Lausanne, Switzerland
Purpose: Widely used with transcranial magnetic stimulation (TMS),
paired pulses (PP) paradigm has scarcely been studied with intracranial
stimulation, and never on distant cortico-cortical connections.
Method: We performed intracerebral PP electrical stimulation in three
patients with refractory focal epilepsy investigated with depth electrodes
located within the primary motor cortex:
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(i) Functional connectivity between the primary motor cortex and the
other brain regions was first explored using cortico-cortical evoked
potentials (CCEPs). Electrical stimulation consisted in series of 10 pulses
of 1 ms duration at 0.2 Hz frequency and 3 mA intensity.
(ii) We then studied the impact of PP stimulations, using 5, 15, 50, 100
and 200 ms interstimulus intervals (ISIs).
Given the variable morphology and duration of CCEP, theoretical PP
curves were built to analyze ISI-inducedmodulation – inhibition, facilita-
tion or unchanged –. To assess the paradigm validity, concomitant motor
evoked potentials (MEPs) were recorded on the contralateral psoas. After
electrodes withdrawal, these MEPs were compared to those obtained
with MRI-guided TMS of the same area, with 120% resting motor thresh-
old intensity and conditions identical to intracranial stimulations.
Results: Intracranial PP stimulation of the primary motor cortex could
induce ISI-dependent modulation of both MEPs and CCEPs. The pattern
of MEPs modulation observed with intracerebral stimulation was similar
with that observed with TMS. Modulations of CCEPs after PP stimula-
tions were more heterogeneous across cortico-cortical connections and
could be different from those observed in concomitant MEPs.
Conclusion: Intracranial PP electrical stimulation can modulate MEPs
as well as CCEPs, which provide interesting perspectives for future corti-
cal excitability studies.
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DIRECT ELECTRICAL CORTICAL STIMULATION TO
RECONSTRUCT EPILEPTIFORMAFTERDISCHARGE
NETWORKS
L. Caciagli*, C. Scott†, T. Wehner*,†, A. McEvoy*,‡,
L. Lemieux*, B. Diehl*,†, G. Baier§
*UCL Institute of Neurology, Department of Clinical and
Experimental Epilepsy, London, UK, †National Hospital for
Neurology and Neurosurgery, Department of Clinical
Neurophysiology, London, UK, ‡National Hospital for
Neurology and Neurosurgery, Department of Neurosurgery,
London, UK, §University College London, Department of Cell
and Developmental Biology, London, UK
Purpose: Extra-operative direct electrical cortical stimulation (DCS)
is widely employed to map eloquent cortex in patients with intracra-
nial electrodes undergoing pre-surgical assessment for refractory epi-
lepsy. Some DCS trials can evoke local paroxysms of epileptiform
activity, known as afterdischarges (ADs). Currently, there is limited
understanding of the neurophysiological underpinnings of ADs, and
more generally of the effects of DCS on local neural dynamics. In
this study, we compared intracranial electro-encephalogram (iEEG)
traces containing post-stimulation ADs against baseline activity, using
power-spectral and covariance analyses, to identify the AD-underlying
networks.
Method: We collected iEEG data recorded from subdural grid electrodes
of three patients with pharmacoresistant frontal lobe epilepsy secondary
to focal cortical dysplasia. For each subject, we extracted a 32s interictal
baseline trace, corresponding to a state of active wakefulness, and post-
stimulation segments containing ADs. Power spectra for delta, theta,
alpha, beta, low gamma and high gamma bands were obtained for all the
extracted traces. Across each frequency band, we calculated the number
of iEEG channels in the AD-containing epochs with power values signifi-
cantly different from baseline levels (which we refer to as “nodes”), and
quantified their discordance. Further, considering all frequency bands,
we identified abnormal networks of nodes by comparing their covariance
matrices with Fourier-adjusted surrogate data.
Results: Delta band power and, to a lesser extent, theta band power were
increased in AD-containing post-stimulation traces compared to baseline.
Conversely, alpha, beta, low gamma and high gamma band powers were
in line with baseline levels. Covariance matrices for the AD-containing
traces showed striking reconfigurations of neural interactions compared
to baseline.
Conclusion: After discharges evoked by DCS are associated with an
increased proportion of slow components in the EEG power spectrum.
Our analysis also allows us to define the network of nodes that participate
in the after discharge.
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SEIZURES DUETO FAMILIAL PAROXYSMAL
KINESIGENIC DYSKINESIA LEADINGTO
MISDIAGNOSIS AS EPILEPSY
T. Chen, H.J. Li, D. Yang, J.P. Song, Y.F. Zhu
The First Affiliated Hospital, Kunming Medical University,
Neurology Department, Kunming, China
Paroxysmal dyskinesias are movement disorders characterized by sudden
episodes of involuntary movements, of which Paroxyal kinesigenic dysk-
inesia (PKD) is the most common form, characterized by recurrent brief
involuntary hyperkinesias triggered by sudden movements. Because of
the similarity in clinical manifestation, and the fact that most patients
respond well to antiepileptic drugs, PKD is easily misdiagnosed as epi-
lepsy. We report a family with PKD in which the presenting patient, a
22 year old man, was misdiagnosed as Epilepsy for 12 years. He suffered
intermittent paroxysmal episodic involuntary movements, including stiff
rigidity in trunk and limbs only during physical exercise or when startled,
which spontaneously ceased seconds later. In the family history, his
father and younger brother also had similar symptoms. Second genera-
tion exon gene sequencing technology was used to determine PRRT2
gene and 73 genes associated with epilepsy; results showed that the
PRRT2 gene exon 2 was found in abnormal sequence: c. 649 dupc, frame-
shift mutations,which was characterized finally as PKD. Subsequent
treatment with Carbamazepine was successful. This case illustrates the
difficulty in diagnosis, and differences in the pattern of intermittent
paroxysmal episodic involuntary movements other than epilepsy.
Comorbidities 1
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EVALUATIONOF SEXHORMONES IN EPILEPSY
PATIENTS
B. Kurt*, A. Mutlu*, B. Bastan*, B. Petek Balci*, F. Ozer†,
O. Cokar*
*Haseki Research and Training Hospital, Neurology, Istanbul,
Turkey, †Medipol University, Faculty of Medicine, Neurology,
Istanbul, Turkey
Purpose: The main focus of epilepsy treatment is seizure control with
the minimum side effects of the antiepileptic drugs. These side effects
are mostly on hematologic, dermatologic or liver and renal functions.
However, in recent years, studies investigating the relation of antiepilep-
tic drugs and sex hormones or sexual functions have increased.
Method: This study includes the epilepsy patients (18–45 years old)
followed up in outpatient clinics of Haseki Research and Training
Hospital, in the period of April to November 2014. Forty-five out of
the 83 patients were treated with monotherapy (carbamazepine, val-
proic acid, lamotrigine or levetiracetam) and 38 with polytherapy. The
patients and healthy controls (n = 40) were assessed by blood tests.
These blood tests include sex hormones-dehydroepiandroterone-sul-
phate (DHEA-S), sex hormone binding globuline (SHBG), follicular
stimulating hormone (FSH), luteinizing hormone (LH), testesterone
(TT), prolactin, estradiol (E2). In addition; valproic acid or carba-
mazepine serum levels were tested in the corresponding patients. Free
androgen index (FAI) was calculated.
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Results: We found that FAI was lower and SHBG was higher compared
to control group (p = 0.002, for both). Serum carbamazepine levels of
men were positively correlated with FSH and PRL, and negatively corre-
lated with FAI (p = 0.046 p = 0.035 p = 0.032; respectively). Women
on carbamazepine treatment had a positive correlation between serum
carbamazepine levels and PRL levels (p = 0.036). Polyterapy did not
show a statistical significant difference in sex hormone levels. The time
length of lamotrigine use was positively correlated with E2 levels
(p = 0.003).
Conclusion: In conclusion, this study shows that levatiracetam had no
effect on sex hormones, and lamotrigine had nearly none. However, car-
bamazepine and valproic acid had affected sex hormones of epilepsy
patients.
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QUALITYOFLIFEMEASURES EVALUTIONOFTHE
PATIENT’S RELATIVESHAVINGTEMPORALAND
EXTRATEMPORAL LOBEEPILEPSYANDWHOM
EPILEPSY SURGERYAPPLIEDORNOTAPPLIED
İ. Bora, G. Atasayar, A. Bican Demir
Uludag University, Bursa, Turkey
Purpose: In patients with epilepsy the life quality is depends mainly on
the clinical properties of seizures, the type of seizures, the duration of epi-
lepsy, the frequency and the seriousness of seizures as well as use of
antiepileptic drugs, surgical processes, being inany psychiatric comorbid
situations like depression or anxiety.
Method: In this practice we studied 203 patients followed in our neuro-
logical department, The University of Uludag, Medical Faculty.For each
patient and the relatives Epilepsy Evaluating Form, socio-demographic
informing form, The Scale of Life-Quality in Epilepsy, the short form
life-quality scale, the short form life-quality scale of world health organi-
zation and the scale of social performance which evaluate the patients
basic abilities and social attitudes in terms of their quantities were applie-
d.Also to evaluate the depression and the anxiety in patients and the rela-
tives, we applied other scales: Hamilton Anxiety Grading Scale and
Hamilton Depression Grading Scale .
Results: Between the groups we found statistically remarkable differ-
ences in life-qualities, social performances, depression and anxiety levels
of both patients and the relatives. It was observed that the lowest scores
was accompanied with the resistant TLE patients with regard to the sub
scales of life quality and the social performance. The highest anxiety and
depression scores were detected in those as well. It was thought that these
results could be related to any damage in the limbic system components.
Conclusion: We found a negative correlation between the depression
and anxiety levels and the life-qualities in both the patients and the rela-
tives.As a conclusion, in plans that aims to increase the life qualities of
patients, it is needed to take precautions in order to enhance the social
performance, to investigate the patients and the relatives in context with
psychiatric comorbid situations such as anxiety and depression and to
inform the patients to consult psychiatric specialists.
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HEADACHE IN PATIENTSWITH JUVENILE
MYOCLONIC EPILEPSY
M. Dedei Daryan, B. Tekin Güveli, D. Ataklı, S. Akbulut, H. Sarı,
K. Mulhan
Bakirkoy Research and Training Hospital for Psychiatry,
Neurology, Neurosurgery, Department of Neurology, Istanbul,
Turkey
Purpose: Headache and epilepsy are often comorbid disorders in the
general population. The objective of this study was to assess the preva-
lence of headache in juvenile myoclonic epilepsy (JME).
Method: In this work, we studied in 200 patients with JME had pre-
sented our epilepsy outpatient clinic. Headache was classified in patients
using a questionnaire, is validated according to ICHD-III beta. We inves-
tigated the correlations between the characteristics of the headache and
the clinical manifestations of JME.
Results: One hundred-fifteen (57.5%) of patients conducted survey were
women and 85 (42.5%) of them were men. The mean age of patients was
26.7  8.46 (12–55). The mean duration of epilepsy after seizures onset
was 10.7  7.28 years (1–35). Headache was presented in 111 (55, 5%)
patients. 47 had migraine [30 migraine without aura, 17 migraine with
aura]. Four patients with migraine had tension-type headache in addition.
Fifty-two patients had only tension-type headache. Headache of 81(40,
5%) patients were not related with seizures. Headache was specified pos-
tictal in 18 patients (9%), preictal in 10(5%), ictal in 2(2%).
Conclusion: In this study, it is demonstrated that both migraine and ten-
sion-type headache in patients with JME is higher than expected from
studies on the general population. Furthermore, migraine with aura, the
subtype of migraine, was also found higher in patients with JME in com-
parison with general population. Because of their comorbidity and shared
same risk factors, it gives strongly rise to thought that migraine and epi-
lepsy have some common pathophysiological pathway.
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INFREQUENTATRAUMATIC PAINFUL
COMPLICATIONOF SINGLE SEIZURE
H.E. Elhasin*, R. Radhakrishnan*, A.R. Dehashtian†,
D. Somarajan*, N.A. Moussa*, M.A. Arif*, D. Gokhale†,
A.R. Dehdashtian†, K.A. Siddiqui*
*Al Ain Hospital, Neurology, Al Ain, United Arab Emirates, †Al
Ain Hospital, Radiology, Al Ain, United Arab Emirates
Purpose: Bilateral or unilateral fracture/dislocation of the shoulders is
exceedingly rare. Typical position of the shoulder during a convulsion is
adduction, internal rotation and flexion, with the spasm the humeral head
is forced superiorly and posteriorly over the glenoid cavity, resulting in
fracture/dislocation.
Methods: We describe three cases that presented to us with unprovoked
seizures and were discovered to have fractures/dislocation.
Results: Case Series. Case 1: 51-years-old-male presented with a single
unprovoked generalized tonic clonic seizure (GTCSz), developed post
seizure, bilateral shoulder pain, history of seizure seven years ago, he
was not on AEDs. X-ray Shoulder showed bilateral Comminuted hum-
eral head fracture, which CT confirmed, started on AEDs. Neuroimag-
ing & EEG were normal. Transferred to Orthopedics for further
management. Case 2: 68-year-old-male presented with single GTCSz,
right-sided shoulder pain post seizure, he had history of epilepsy and
was seizure free and was taken off AEDs, prior history of head trauma.
His X-ray Shoulder showed right sided fracture head of humerus and
dislocation. He was restarted on AEDs, his neuroimaging and EEG were
normal. Transferred to Orthopedics. Case 3: 65-year-old-male pre-
sented with first seizure of life time, GTCSz, developed post seizure
bilateral shoulder pain. X-ray Shoulder showed bilateral humeral head
fracture, confirmed by CT shoulders, his EEG and MRI brain-negative,
started on AEDs, in view of severity of single seizure, transferred to
Orthopedics.
Conclusions: We present three cases with fracture/dislocation, which
were sequelae to a single unprovoked GTCSz and none of the patient
were on any AEDs. Compliance and adherence to AEDs is the key for
preventing these complications, in non-drug na€ıve patients.
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FROMDUSK, TILL DAWN; PATIENTSWITHBOTH
EPILEPSYANDOBSTRUCTIVE SLEEP APNEA
SYNDROME (OSAS)
A.D. Elmali, G. Benbir Senel, D. Karadeniz
Istanbul University, Medical Faculty of Cerrahpasa,
Department of Neurology, Sleep Disorders Unit, Istanbul, Turkey
Purpose: With this study, we aimed to document the demographic data,
polysomnographic (PSG) findings and analyze effects of PAP treatment
on seizure control in OSAS patients with epilepsy.
Method: All 7092 PSGs performed between the years of 2006–2015
were reviewed retrospectively. All of the data is gathered from the patient
files and via phone visits.
Results: In our sleep disorders unit, 456 PSGs were performed in
patients diagnosed with epilepsy, 24 of them were diagnosed with OSAS
and undergone PAP titration. The mean age was 43.83; male to female
ratio was 19:5. Fourteen patients had comorbid diseases other than epi-
lepsy. Four patients had NREM parasomnias, two had restless leg syn-
drome and two had REM sleep behavior disorder (RBD) clinically.
Seventeen patients were diagnosed as severe OSA, ten patients had wors-
ening of the OSA and/or desaturations in supine position and eleven
patients during REM sleep. Ten patients had focal pathological activity
during sleep EEG. Four patients had epileptic seizures during the PSG.
Two patients had REM without atonia, one of them also had RBD. All
patients were using at least one antiepileptic drug and 9 of them were
using multiple antiepileptics. Three patients stopped using one or more
antiepileptics and dosage was decreased in one patient during follow up.
Two patients needed additional antiepileptic drugs, after PAP titration;
both of themwere not consistent with the PAP usage and follow up.
Conclusion: We aim to present the contribution of the PAP treatment on
seizure control and antiepileptic drug necessity.
Comorbidities 2
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MIGRAINEANDEPILEPSY:METABOLIC
ABNORMALITIES
K. Sadokha, V. Evstigneev, V. Kistsen
Belarusian Medical Academy of Postgraduate Education,
Neurology and Neurosurgery, Minsk, Belarus
Purpose: Migraine and epilepsy are comorbid neurological diseases pos-
sessing a number of clinical and pathophysiological manifestations
including a positive effect of taking anticonvulsants.
Method: 22 migraine and 28 epilepsy patients underwent 1H-MRS (Pro-
ton magnetic resonance spectroscopy). Migraine and epilepsy were diag-
nosed according to International Recommendations. In brain, the peaks
of N-acetylaspartate (NAA), choline (Cho), creatine (Cr) are the most
evident ones. The statistical analysis was performed using the program
STATISTICA 6.0.
Results: The results of 1H-MRS revealed the reduction in the most
important correlation of NAA/(Cho+Cr) less 0.71 in hippocampus on the
side of epileptic focus in the half of patients and in the other half - on both
sides. Significant changes in the NAA/ (Cho+Cr) correlation in hip-
pocampus were recorded in all patients, mainly on the side of a hemicra-
nias localization, with being more marked in a comorbid aura seizure that
ranged from 0.29 to 0.64 (normal - more 0.71). As for changes in the cor-
relation of neurometabolites in thalamus, there was a downward tendency
for all indices only in migraine with aura. Migraine without aura was
characterized by Cho/Cr decreasing without changing other metabolite
concentration. The change in the correlations of neurometabolites in a
frontal lobe in migraine without aura and significant Cho/Cr changes in
migraine with aura attract our attention. Studying the investigated occipi-
tal lobe indices revealed their decrease in patients with aura on a hemicra-
nias side which was similar to changes in the hippocampal complex
(p < 0.05).
Conclusion: Thus, hippocampus is one of the main structures in disinte-
grating neuronal combinatorics and forms peculiarities of clinical mani-
festations of paroxysmal states, involving these or those brain areas at
these two diseases.
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THE PROGRAMFORACTIVECONSUMER
ENGAGEMENT IN SELF-MANAGEMENT (PACES) IN
EPILEPSY
R.T. Fraser*, E.K. Johnson†, S. Lashley‡, J. Barber§,
N. Chaytor*, J. Miller¶, P. Ciechanowski**, N. Temkin§,††,
L. Caylor‡‡
*University of Washington, Rehabilitation Medicine, Seattle,
WA, USA, †University of Washington, Health Promotion
Research Center, Seattle, WA, USA, ‡University of Washington,
Neurology Vocational Services Unit, Seattle, WA, USA,
§University of Washington, Neurological Surgery, Seattle, WA,
USA, ¶University of Washington, Neurology, Seattle, WA, USA,
**University of Washington, Psychiatry and Behavioral
Sciences, Seattle, WA, USA, ††University of Washington,
Biostatistics, Seattle, WA, USA, ‡‡Swedish Medical Center,
Neuroscience Institute, Seattle, WA, USA
Purpose: Self-management interventions provide patient education to
improve medical, role, and emotional management. Previous interven-
tions were developed primarily on expert opinion; reported issues with
participant engagement/retention with limited follow-up evaluation.
PACES used direct patient needs assessment to derive program content
and design for a randomized controlled trial (RCT).
Method: Study 1: Sampled two populations: patients age 18 + with
chronic epilepsy (n = 165) and epilepsy center health providers
(n = 20). All completed surveys about patient psychosocial problems
and self-management program design. Study 2: Participants age 18 +
with chronic epilepsy, randomized to intervention (n = 41) or control
condition (n = 42). The 8-week intervention involved weekly group ses-
sions of 6–8 members co-lead by a psychologist and trained peer. Topics
addressed psychosocial concerns from Study 1. Study 3: Telephone-
based replication of Study 2 (n = 11); added booster component during
follow-up. Study 4: Replication of Study 1 with diverse sample.
Results: Studies 1 and 4: Identified two patient subgroups: “epilepsy-
only” and “epilepsy-plus,” marked by probable depression and/or cogni-
tive problems. Subgroups differed by psychosocial problem severity.
Providers rated patient problemsmore severe in all domains (Work, Inde-
pendent Living, Socializing, Life with Epilepsy, Mood, Cognition, Gen-
eral Health and Well-Being, and Medical Care) relative to the “epilepsy-
only” subgroup (all p < 0.001). Study 2 and 3: At 8 weeks, PACES par-
ticipants improved relative to controls on the ESMS (p < 0.0001) and
subscales (all p < 0.023); ESES (p < 0.0001); and QOLIE-31
(p = 0.002). At 6 months, PACES participants remained improved on
ESMS (p = 0.009) and subscales [Information (p = 0.005); Medication
(p = 0.084)]; ESES (p = 0.040) and QOLIE-31 Energy/Fatigue
(p = 0.027) and Medication Effects (p = 0.003). Attrition was low (8%);
program satisfaction exceeded 4.0 out of 5.0.
Conclusion: Findings demonstrate dissonance between patient and clini-
cian perceptions of self-management problems. This has implications for
engaging patients in therapeutic programs. A consumer generated epi-
lepsy self-management program appears to be a promising intervention.
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LONG-TERMPSYCHOSOCIAL FOLLOW-UPOF
EPILEPSY SURGERY IN TEMPORAL LOBEEPILEPSY
WITHHIPPOCAMPAL SCLEROSIS IN ADEVELOPING
COUNTRY:WHAT IS IMPORTANT TOEMPHASIZE?
N.B. Alonso*, L. Mazetto*, G.M. de Araujo Filho*,
L.M.F. Guilhoto*,†, M.B. Guaranha*, M.V. Dourado*,
E.M.T. Yacubian*, R.S. Centeno‡
*Universidade Federal de Sao Paulo-Unifesp, UNIPETE, Sao
Paulo, Brazil, †Universidade de Sao Paulo, Hospital
Universitario, Sao Paulo, Brazil, ‡Universidade Federal de Sao
Paulo-Unifesp, Neurosurgery, Sao Paulo, Brazil
Purpose: To investigate patients0 long-term follow-up of postoperative
quality of life (QoL) with preoperative indicators of maladjustment status.
Methods: We analyzed a consecutive homogeneous series of 120
patients who underwent corticoamygdalohippocampectomy due to drug
resisant mesial temporal lobe epilepsy with hippocampal sclerosis in Epi-
lepsy Surgery Program at Universidade Federal de S~ao Paulo between
July 2002 and July 2014. Subjects had a follow-up period ranging from
five to 10 years. Presurgical assessment of QoL included a semi-struc-
tured interview, Beck Depression Inventory (BDI), and Epilepsy Surgery
Inventory (ESI-55). The following seven variables were selected to indi-
cate adjustment degree, considered as possible predictors of unfavorable
psychosocial outcomes:
1- unemployment in a period of 5 years;
2- no stable romantic partnership in a period of 5 years;
3- dropout from school and/or cognitive daily impairment;
4- lack of family support;
5- lack of significant friendly relationships in the community,
6- psychiatric diagnostic categories (DSM IV);
7- BDI scores more than 17 points.
We postulated that the presence of 50% of these variables might be
indicative of poor psychosocial functioning. A multivariate analysis was
done with a logistic regression model to identify possible clinical and
socio-demographic predictors of post-surgical unfavorable adjustment
outcome evaluated by clinical and psychosocial interviews.
Results: Thirty patients (25%) had four or more factors indicative of
poor psychosocial functioning prior to surgery. Preoperative psychoso-
cial maladjustment was related in a long-term follow-up to: dependence
perception (p = 0.018), worsening family relationship (p = 0.005),
worsening social status (p = 0.012), unemployment (p = 0.035), percep-
tion of cognitive impairment to remember names (p = 0.007), antiepilep-
tic drugs continuation (p = 0.003), presence of psychiatric disorder
(p < 0.001), worsening in scores of Social Adjustment Scale (p = 0.008)
and QoL domains (p < 0.001).
Conclusion: Psychosocial functioning before surgery is the most impor-
tant predictor of psychosocial adjustment and QoL in a long-term follow-
up surgical treatment.
Support: FAPESP, CAPES, CNPq. (Brazil)
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ICTALANALGESIA IN TEMPORAL LOBEEPILEPSY -
THEMECHANISMOF SEIZURE-RELATED BURNS
A. Horvath, A. Sakovics, A. Szucs
National Institute of Clinical Neurosciences, Budapest, Hungary
Objective: Seizure-related injuries have substantial role in the higher
mortality risk of patients suffering from epilepsy. Besides cognitive alter-
ations during seizures, ictal and postictal analgesia may have an impact
on seizure-related injuries. We aimed to identify seizure-types increasing
the risk of burns by the lack of nociception.
Methods: Our patients filled our self-designed burn and pain question-
naire and detailed epileptology data were collected.
Results: 51% of the patients reported of subjectively decreased nocicep-
tion in the ictal or postictal phase and 18% of those answering sustained a
burn-accident. Half of them suffered a seizure-related burn incidentally
falling to a hot surface. Half of them grasped a hot object or boiling fluid
while in complex partial seizure; without defending or removing the limb
being burnt and without experiencing pain during or within some minutes
after the seizures. All these patients had temporal lobe epilepsy.
Significance: The experimentally shown pain-modulator function of the
dorsal hippocampus as well as the connections of the temporal lobe to the
central pain modulator system could explain the analgesia related to tem-
poral lobe seizures. We wanted to call attention to the existence of ictal
analgesia as a risk factor for injuries and to the importance of advising
increased burn- prevention for patients with temporal lobe epilepsy.
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EVALUATIONOFZEBRAFISHAS A POTENTIAL
MODEL FORCOGNITIVE IMPAIRMENTASSOCIATED
WITHDRAVET SYNDROME
M. Jacmin*,†, A.D. Crawford*,†
*Theracule S.a.r.l., Esch-sur-Alzette, Luxembourg, †University
of Luxembourg, Luxembourg Centre for Systems Biomedicine,
Esch-sur-Alzette, Luxembourg
Purpose: Dravet syndrome (DS) is one of the most frequent genetic
epilepsies, with an incidence of 1/30,000. The large majority of DS
patients are pharmacoresistant, and do not respond adequately to any of
the more than 20 currently available anti-epileptic drugs (AED). Many
DS patients suffer from cognitive impairment that can also be aggravated
by the seizure medications prescribed. DS mouse models exhibit cogni-
tive deficits similar to those of DS patients, but are only suitable for the
evaluation of small number of compounds, thereby limiting their utility
for drug discovery. An animal model with higher screening throughput
would therefore be of value for drug discovery efforts focused on DS.
Methods: Recent studies on zebrafish have demonstrated its ability to be
a promising in vivo model for DS. Two different zebrafish DS models -
one based on a loss-of-function mutation in the zebrafish ortholog of
SCN1A, the other based on an antisense knockdown of this gene - show
seizure-like behavior (as determined by automated video tracking analy-
sis of locomotor activity) and epileptiform discharges (as determined by
local field potential recordings). Both phenotypes are exacerbated by
hyperthermia, as is the case for human DS patients andmouse DSmodels.
Results: We are investigating the cognitive functions of these zebrafish
DS models in order to determine possible similarities with cognitive
impairment in human DS patients and mouse DS models. Initial data
obtained in a light/dark transition assay indicates these DS zebrafish
models to exhibit memory impairment. These findings provide an initial
insight into the resemblance between human patients and zebrafish in
terms of cognitive deficit.
Conclusions: Subsequent to an in-depth evaluation of the cognitive
functions of these zebrafish DS models, we will use them to evaluate
AEDs currently under investigation as potential DS therapeutics as to
their possible procognitive activity.
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PRECEDINGANXIETYANDDEPRESSION IN FIRST
SEIZURE PRESENTATIONS? - A SYSTEMATIC
PROSPECTIVE APPROACH
C. Lane*, C. Crocker*,†, K. Legg*, M. Borden*, B. Pohlmann-
Eden*,†
*Epilepsy Program, Division of Neurology, Queen Elizabeth
Health Science Center, Dalhousie University, Halifax, Canada,
†Brain Repair Center, Dalhousie University, Halifax, Canada
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Purpose: There is increasing evidence that psychiatric comorbidities
(PC) such as anxiety and depression may precede first seizure presenta-
tions. This suggests an abnormal biochemical brain environment in
which the first seizure presents the “loudest noise” alerting the health care
system. Systematic longitudinal data are entirely missing to explore this
potential linkage.
Method: The Halifax First Seizure Clinic (HFSC) uses a strictly
prospective cohort approach with multimodal data (clinical, social,
genetics, structural [3T MRI], and functional [routine and sleep deprived
EEG]) with follow-up visits at months 6, 12, 24 and 60. Screening for PC
also occurred at the time of initial assessment. 63 patients screened for
PC were identified with either a first unprovoked seizure (FS) only,
n = 12; new-onset epilepsy (NOE= seizures occur within 12 months),
n = 14; newly diagnosed epilepsy (NDE= seizures occur longer than
12 months), n = 14; first provoked seizure (FPS), n = 9; psychogenic
non-epileptic seizure (PNES), n = 4; others (syncope, migraine etc),
n = 10. All study patients completed 3 questionnaires: validated NDDI-
E (depression), validated GAD7 (anxiety) and the newly developed Hali-
fax Anxiety Screening Test (HAST). Scoring results were compared to
22 healthy controls. All assessments were performed prior to initial clini-
cal assessment and diagnosis.
Results: There was no significant difference in scoring results for any of
the identified subcategories compared to the control group except for the
FPS that had significantly higher scores on the NDDI-E. A significant
trend was observed with increasing scores for depression dependent on
the stage/duration of diagnosis as identified by FS < NOE < NDE for the
NDDI-E, but no significance for the anxiety tests.
Conclusion: Our pilot study confirms the feasibility of PC testing in first
seizure assessments. Subcategory analysis suggests shared disturbed neu-
ronal networks in some individuals with PCs manifesting prior to occur-
rence of an epileptic seizure and more significant PC the longer seizures
existed.
Drug Therapy 1
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ANTICONVULSANTACTIVITYANDMECHANISMS
OFACTIONOFGINGER (ZINGIBEROFFICINALE
ROSCOE) RHIZOMES
E.M. Awad*, E.M.M. Ahmed*, T.M.H. El-Hadiyah†
*University of Gezira / Faculty of Pharmacy, WadMedani,
Sudan, †Ahfad University for Women, Khartoum, Sudan
Purpose: Ginger (Zingiber officinale Roscoe.) is used commonly in
treatment of many ailments. Ginger contains many biologically active
chemical compounds that are known to be important compounds for acti-
vation of vanilloid receptors (Vadim N et al. Br J Pharmacol 2002; 137:
793–798). These recently cloned vanilloid receptors and their agonists
were reported to be involved in several pathological conditions (Awad E
et al. Sudan JMS 2013; 8(4): 175–180; Calixto J et al. Pharmacology and
therapeutics 2005;106:179–208). The present study aimed to investigate
the potential anticonvulsant activity of ginger extract. Involvement of
gamma aminobutaric acid (GABA) and vanilloid receptors in ginger
mechanism of action as anticonvulsant were also investigated.
Method: Experimental animal models as maximum electroshock (MES)
and pentylenetetrazole (PTZ) induced seizures were used to determine
the anticonvulsant activity of ginger. Picrotoxin (noncompetitive GABA
antagonist) and capsazepine (vanilloid receptor antagonist) were used to
determine the possible mediation of GABA and vanilloid receptors
respectively in the mechanism of action of ginger as anticonvulsant.
Results: Ginger extract (400 mg/kg) produced 100% seizure protection
in MES and PTZ induced seizure animal models. The ED100 of ginger in
the previous two models produced 20% seizure protection in picrotoxin
induced seizure animal model indicating possible partial involvement of
GABA receptors. Capsazepine produced 80% and 60% block to the anti-
convulsant activity of ginger on the MES and PTZ seizure animal models
respectively, indicating possible involvement of vanilloid receptors.
Conclusion: Ginger represents a potential source for anticonvulsant
agents. GABA and vanilloid receptors have a role in the mechanism of
action of ginger as anticonvulsant. Vanilloid receptors mediation seems
to be a possible new mechanism of anti-epileptic drugs. Crude ginger
could be used as potential anticonvulsant agent and/or as co-drug in com-
bination with antiepileptic drugs, especially if further investigations are
conducted clinically to explore its possible safety and efficacious use.
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USEOFLACOSAMIDEAS ADD-ONTHERAPY IN
CHILDRENANDYOUNGADULTSWITH
SYMPTOMATIC EPILEPSYCAUSED BY
MALFORMATIONSOFCORTICALDEVELOPMENT
D. Battaglia, V. De Clemente, C. Brogna, G. Olivieri,
M. Quintiliani, D. Ranalli, R. Scalise, M. Perulli, I. Contaldo
Catholic University, Child Neurology, Rome, Italy
Use of lacosamide as add-on therapy in children and young adults with
symptomatic epilepsy caused by malformations of cortical development.
Malformations of cortical development (MCD) are recognized causes of
neurodevelopmental disorders and drug resistant epilepsy; epilepsy type
and outcome are variable. Lacosamide (LCM) is a new antiepileptic
drugs mostly used in treatment of refractory epilepsy, approved for adults
over 16 years but still off-label in children.
Purpose: The aim of the study is to evaluate efficacy of LCM as add-on
therapy in children and young adults with refractory symptomatic epi-
lepsy due toMCD.
Method: Prospective, uncontrolled, observational, open label therapeu-
tic trial. Population: 22 patients (14 M). Age: range 4–27 y (median
14 y). Type of MCD: 10 patients with focal cortical dysplasia (FCD); 12
patients multilobar or hemispheric malformations. Type of epilepsy: 17
focal epilepsy; 5 epileptic encephalopathy. Follow-up 12 months. LCM
was started at 1 mg/kg and increased weekly. Dose: 4-10 mg/kg/die in
children and 200–400 mg/die in young adults.
Results: At the end of follow 54% of our patients were responders (13%
seizure-free). Three patients of four younger than 6 years with FCD were
responders without side effects. Better response was observed in patients
with focal epilepsy (64%). Discontinuation rates: 18% for inefficacy. Side
effects (dizziness, headache, somnolence, irritability) were observed in 4
patients during titration, disappeared with reduction of add-on therapy.
Conclusion: Despite limits of our study (small sample and uncontrolled
trial) LCM seems efficacy and safety as add-on therapy in childre and
young adults with symptomatic refractory epilepsy due to MCD. We
observed better results in younger patients with focal epilepsy.
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SEIZURECONTROLWITHLACOSAMIDE (≤400MG/
DAY) FOLLOWINGCROSS-TITRATION FROMA
SODIUMCHANNELBLOCKER IN PATIENTSWITH
PARTIAL-ONSET SEIZURESRECEIVING STABLE
DOSESOF LEVETIRACETAM
M. Baulac*, W. Byrnes†, P. Williams†, E. Webster†, M. De
Backer‡, P. Dedeken‡
*Ho^pital la Pitié-Salpe^triere, Department of Neurology, Paris,
France, †UCB Pharma, Raleigh, NC, USA, ‡UCB Pharma,
Brussels, Belgium
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Purpose: This subgroup analysis investigates the effect of in-label
dosages (≤400 mg/day) of adjunctive lacosamide (LCM) on seizure con-
trol following cross-titration from a sodium channel-blocking antiepilep-
tic drug (SCB) in patients with partial-onset seizures not adequately
controlled on levetiracetam and SCB dual therapy.
Methods: In this prospective, Phase 4, open-label study (SP0980;
NCT01484977), LCM was titrated to 200-600 mg/day per investigator’s
judgment. SCB reduction started when LCM dosage reached 200 mg/
day. A 12-week Baseline Period (8 weeks retrospective; 4 weeks
prospective) was followed by a 21-week Treatment Period (9-week
Cross-titration; 12-week LCMMaintenance).
Results: Of 120 patients who started on LCM titration, 118 had an effi-
cacy assessment, 51 of whom received lacosamide ≤400 mg/day at any
time during Treatment (mean age, 41.4  12.1 years; mean epilepsy
duration, 20.1  16.18 years; median seizure frequency/28 days, 5.67;
complex POS, 36/51 of patients; secondarily generalized seizures, 43/
51). The most common concomitant SCBs were lamotrigine (21/51), car-
bamazepine (17/51) and oxcarbazepine (11/51). The median LCM dose
was 398 mg/day (199–400 mg/day) during Maintenance (n = 39) and
285 mg/day (67–375 mg/day) during Treatment (n = 51). 33/51
(64.7%) patients completely withdrew their SCB. Of 37/51 patients who
completed Maintenance, 7/37 (18.9%) were seizure-free. Seizure free-
dom was highest for patients who withdrew from carbamazepine (4/8,
50%). During the full Treatment Period, 16/51 patients (31.4%) experi-
enced ≥75% reduction and 26/51 (51.0%) experienced ≥50% reduction
in seizure frequency. The most frequently reported adverse events were
dizziness (8/51 [15.7%]), headache (6/51 [11.8%]), fatigue (4/51
[7.8%]), and nausea, urinary tract infection, fall, and depression (3/51
[5.9%] each); 3/51 (5.9%) patients discontinued due to an adverse event.
Conclusion: In a relatively difficult-to-treat population, flexible titration
of LCM to ≤400 mg/day with cross-titration of SCB, when added to a
stable dose of levetiracetam, provided additional seizure control and was
generally well tolerated.
Disclosure:UCB Pharma-funded:
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ANALYSIS OF ADJUNCTIVE BRIVARACETAM IN
ADULTSWITHPARTIAL-ONSET (FOCAL) SEIZURES
ACCORDING TOPATHOLOGICAL SUBSTRATE:
METHODOLOGY FROMAPHASE III STUDY
A. Beydoun*, F. Semah†, V. Villanueva‡, B. O’Boyle§,
S. Elmoufti§, J. D’Souza¶
*American University of Beirut Medical Center, Beirut,
Lebanon, †University Hospital, Lille, France, ‡Hospital
Universitario y Politécnico La Fe, Valencia, Spain, §UCB
Pharma, Raleigh, NC, USA, ¶UCB Pharma, Smyrna, GA, USA
Purpose: Several studies in patients with newly-diagnosed and medi-
cally refractory epilepsy have shown that antiepileptic drug (AED) effi-
cacy varies greatly according to patient pathological substrate (aetiology)
identified by neuroimaging. However, clinical trials conducted to date to
evaluate AED safety and efficacy have not stratified patients according
to presence/type of epileptogenic lesion identified by neuroimaging.
Here, we report on a post-hoc methodology to evaluate the feasibility of
stratifying patients according to the pathological substrate.
Method: Subject Eligibility Criteria forms were routinely completed at
screening. This analysis was conducted on data from a Phase III trial
(N01358; NCT01261325) in adults with partial-onset (focal) seizures
(POS) receiving add-on placebo, BRV 100 mg/day or 200 mg/day. To
ensure that the correct aetiologies were identified, clinical semiology,
neuroimaging and electroencephalogram data were independently
reviewed by three expert consultants blinded to efficacy and tolerability
results. Lesions shown by neuroimaging were classified as epileptogenic/
non-epileptogenic, and sorted into one of nine categories (vascular,
mesial temporal sclerosis [MTS], tumoural, disorders of cortical malfor-
mations [DCM], neurocutaneous syndromes, traumatic, infectious,
immunological, others). Kappa coefficient analysis was performed to
measure agreement between the results of each reviewer. In cases of dis-
agreement, the experts discussed the findings to reach agreement.
Results: Of 714 patients analysed, 39.4% lesions were considered
epileptogenic; kappa ranged between 0.672–0.746, indicating substantial
agreement between reviewers. Epileptogenic lesions were MTS (33.8%),
DCM (21.0%), vascular (16.4%), traumatic (9.6%), infectious (6.4%),
tumoural (5.0%), neurocutaneous syndromes (0.7%), immunological
(0.0%) and other lesion types (7.1%). Kappa based on category ranged
between 0.534–0.707, indicating substantial agreement.
Conclusion: In this subgroup analysis, epileptogenic lesions in adult
patients with POS were most commonly classified as MTS, DCM and
vascular lesions, with agreement between the three blinded reviewers.
This analysis demonstrates the feasibility of stratifying POS patients par-
ticipating in clinical trials according to pathological substrate.
UCB supported.
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PRELIMINARYDATAONTHEEFFICACYAND
TOLERABILITYOF ESLICARBAZEPINE AS
ADJUNCTIVE THERAPY IN PATIENTSWITH
REFRACTORY PARTIAL EPILEPSY
G. Boero*, T. Francavilla†, S. Interno*, G. Clemente‡,
C. Luisi†, G. Pontrelli†, M. Pappata†, A. La Neve†
*Complex Structure of Neurology - ‘SS. Annunziata’Hospital,
Taranto, Italy, †Centre for Epilepsy, Department of
Neurological and Psychiatric Sciences, University of Bari, Bari,
Italy, ‡University of Magna Grecia, Catanzaro, Italy
Purpose: To assess and tolerability of eslicarbazepine, a new antiepilep-
tic drug recently marked in Italy, as add-on treatment in patients with
refractory partial epilepsy.
Method: A prospective, open label, longitudinal study conducted in 24
patients with refractory partial epilepsy. The study included 3 periods:
Baseline (3 months), drug titration (2 weeks), Observation, during which
ESL could be increased until the maximum tolerated dose. Inclusion cri-
teria comprised: age over 16 years, diagnosis of focal epilepsy, resistance
to at least 2 previous antiepileptic drugs, stable concomitant antiepileptic
therapy within 3 months. Exclusion criteria were: progressive neurologi-
cal disease, poor compliance, history of pseudo-seizures, pregnancy.
Efficacy has been evaluated by comparing the mean monthly seizures
frequency of the last quarter observation period with baseline seizures
frequency using T-test for dependent sample.
Results: The mean number of antiepileptic drugs tried before ESL was
6.5  3.8 (2–15). ESL was administrated at a daily mean dose of
914 mg (400–1600). The mean duration of observation was 3.1 months:
8 patients didn’t reach three months and were excluded from efficacy
analysis which, therefore, included 16 patients. A statistically significant
reduction of the mean monthly seizures rate was observed
(25.22  26.47 vs. 18.04  19.7, p = 0.03). 1 patient withdrew ESL for
seizure worsening. 2 patients (8%) complained side effects (somnolence)
that did not lead to discontinuation.
Conclusions: Our data, even if preliminary, suggest good efficacy and
and excellent tolerability of ESL ad add-on therapy in partial epileptic
patients, especially considering the severe refractoriness of patients and
the drug administration in polytherapy.
Epilepsia, 56(Suppl. 1):3–263, 2015
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ANTICONVULSANT EFFECTSOF BRIVARACETAM IN
THE 6HZ FULLY-KINDLEDMICE
K. Leclercq, R. Kaminski
UCB Pharma, Braine-l’Alleud, Belgium
Purpose: Brivaracetam is a selective, high affinity ligand for the synap-
tic vesicle protein 2A (SV2A), which recently demonstrated positive
phase III results as adjunctive treatment of focal-onset seizures in adults
with epilepsy. Previous preclinical studies with brivaracetam revealed
broad spectrum anticonvulsant properties in diverse models of seizures
and epilepsy (Matagne et al., BJP 2008). We wanted to evaluate the
potency and efficacy of brivaracetam in the newly developed 6 Hz cor-
neal kindling model in mice, comparing its effects against both partial
and generalised seizures.
Method: Chronic electrical stimulations at 6 Hz were carried out twice
daily according to a previously described protocol (Leclercq et al.,
Epilepsy Res 2014). During the course of kindling stimulations, initial
partial seizures evolved to secondarily generalised seizures. Fully-
kindled mice displayed at least ten consecutive secondarily generalised
seizures and were selected for testing after brivaracetam administration
(ip, 30 min).
Results: Brivaracetam afforded protection against secondarily gener-
alised seizures with an ED50 value of 3.5 mg/kg. It was also able to
reduce significantly the median seizure severity score from 5 to 2 from
the dose of 3 mg/kg. Protection against partial seizures (scores 1-2) was
also observed, with an ED50 of 51.5 mg/kg.
Conclusion: These experiments confirm the high potency and efficacy
of brivaracetam against both partial and generalised seizures in the newly
developed 6 Hz kindling model.
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INTAKEOFANTIEPILEPTIC DRUGS BY PATIENTS
WITHEPILEPSY: A SURVEY IN PHARMACIES AND
PATIENTS TREATEDBY SPECIALIZED
NEUROLOGISTS
T.W. May*, R. Berkenfeld†, D. Dennig‡, B. Scheid§,
H. Hausfeld¶, T. Surowy**, S. Walther††, U. Specht¶
*Society for Epilepsy Research, Bielefeld, Germany,
†Schwerpunktpraxis Epilepsie, Neukirchen-Vluyn, Germany,
‡Schwerpunktpraxis Epilepsie, Stuttgart, Germany,
§Schwerpunktpraxis Epilepsie, Leipzig, Germany, ¶Clinic Mara,
Epilepsy Center Bethel, Bielefeld, Germany,
**Landesapothekerkammer, Rheinland-Pfalz, Mainz, Germany,
††Desitin Arzneimittel, Hamburg, Germany
Purpose: Poor adherence to antiepileptic drugs (AED) is considered as a
main cause of breakthrough seizures. We assessed how patients handle
drug intake, e.g. we asked the patients what they do if they recognize that
they had missed a dose and for barriers to adherence.
Method: The study was performed in cooperation with the Regional
Chamber of Pharmacists of Rhineland-Palatinate and 3 neurologists in
private practice specialized in epileptology. In total, 108 patients sur-
veyed in 43 pharmacies (Group-P) and 119 patients treated by neurolo-
gists (Group-N) completed anonymously a questionnaire on drug intake
of AED.
Results: The efficacy of AED was rated higher by Group-P compared to
Group-N (p < 0.01) and more patients were seizure-free in Group-P
(72.9% vs. 53.0%, p < 0.01). The vast majority of patients rated the tol-
erability of AED as very good (42.5%) or good (36.2%). Most patients
took their AEDs at a fixed time of the day (64.6%) or related to specific
activities, e.g. teeth brushing, (45.6%). Group-N more often used adher-
ence aids, e.g. pill boxes, compared to Group-P (68.6% vs. 46.3%,
p < 0.01). If patients recognized that they had missed a dose, 45.3%
skipped the missed dose (Group-P: 48.1%, Group-N: 43.0%, n.s.); this
was especially the case (70.6%) in older patients (≥ 60 years). Different
types of tablets (20.9%), unpleasant intake (14.5%), division of tablets
(12.3%), and fear of side-effects (10.9%) were the most frequently men-
tioned barriers to adherence.
Conclusions: Gaps in knowledge and shortcomings of AED regimes
may affect adherence. Counseling of patients may improve reliability of
drug intake and thus reduce the risk of breakthrough seizures. For exam-
ple, patients should be informed about strategies to improve adherence,
e.g. the use of pill boxes, and how to handle the situation when they miss
a dose.
Sponsored by Desitin Arzneimittel GmbH.
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EXPOSURETOLACOSAMIDE IN BLOODPLASMA
DURINGADJUNCTIVE THERAPYAND
MONOTHERAPY: PHARMACOKINETIC ANALYSIS
OFDATA FROMACONVERSIONTOLACOSAMIDE
MONOTHERAPY STUDY
W. Cawello
UCB Pharma, Monheim am Rhein, Germany
Purpose: To compare the exposure of lacosamide in blood plasma dur-
ing adjunctive and monotherapy phases of a conversion to lacosamide
monotherapy study in patients with partial-onset seizures.
Methods: The lacosamide conversion to monotherapy study (SP902,
NCT00520741) comprised an 8-week Baseline, 3-week Titration, 6-
week background AEDWithdrawal and 10-week lacosamide Monother-
apy Phase. Patients (16–70 years) on 1–2 AEDs were randomized to
lacosamide 400:300 mg/day (3:1). Blood plasma samples for lacosamide
concentration were taken during adjunctive lacosamide (Titration Phase;
end of Weeks 1 and 2) and during monotherapy (Monotherapy Phase;
end of Weeks 11 and 15, corresponding to 2 and 6 weeks after back-
ground AED Withdrawal). Patients providing plasma samples taken
between 1.5 and 12 h after the actual dose during the Titration and
Monotherapy Phase were included in the analysis. These single samples
were used to approximate PK parameters peak and trough lacosamide
concentration in plasma under steady state condition [Cpeak,ss, Ctrough,ss],
area under the concentration-time curve at steady state [AUCtau,ss], and
total body clearance [CL/F] [Cawello et al. Epilepsy Res. 2014]. Log-
transformed dose-normalized concentrations and PK parameters (except
CL/F without dose-normalization) were used to conduct paired t-tests for
all comparisons between monotherapy and adjunctive therapy. After
back-transformation of the differences between means, geometric mean
ratios (90%–confidence intervals [CI]) between monotherapy and
adjunctive therapy were derived.
Results: Mean ratios (90%–CI; n = 138–173) for the dose-normalized
PK parameters ranged from 1.039 (0.993, 1.086) to 1.071 (1.026, 1.118).
Because of linear relationship, the results of ratios and CIs were identical
for PK parameters Cpeak,ss, Ctrough,ss, as well as AUCtau,ss. The mean
ratios for the concentrations were about the same ranging from 1.040
(0.993, 1.093) to 1.068 (1.021, 1.116). Ratios of CL/F resulted in ranges
from 0.934 (0.895, 0.975) to 0.963 (0.921, 1.007).
Conclusion: Results of this post-hoc analysis suggest similar lacosamide
exposure and CL/F during adjunctive and monotherapy.
UCB Pharma-Funded
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LONG-TERMOUTCOMEOF 1,805 PEOPLEWITH
NEWLYDIAGNOSED EPILEPSY
Z. Chen*, M.J. Brodie†, D. Liew*,‡, P. Kwan*,§
*The University of Melbourne, Department of Medicine,
Melbourne, Australia, †Western Infirmary, Epilepsy Unit,
Glasgow, UK, ‡Royal Melbourne Hospital, EpiCentre,
Melbourne, Australia, §Royal Melbourne Hospital, Department
of Neurology, Melbourne, Australia
Purpose: Our previously study demonstrated about two-thirds of the epi-
lepsy patients could remain seizure-free during antiepileptic drug (AED)
treatment and those who have an inadequate response to the first AED
are likely to have refractory epilepsy. We expanded our study cohort and
assessed the long-term response to AED therapy in patients with newly
diagnosed epilepsy.
Method: We studied 1,805 newly diagnosed and treated epilepsy
patients who were prospectively followed up for a minimum of two years
(median 11, interquartile range [IQR] 7–16) between 1982 and October
2014. Epilepsy was classified as generalised or focal. Patients were con-
sidered to be seizure-free if they had not had any seizures for at least one
year. Logistic regression was performed to assess the effect of number of
AED used on the treatment outcome.
Results: Among the 1,805 patients (46% female, median age at diagno-
sis 33 years [IQR 21–50]), 1,143 (63%) were seizure-free at the end of
study period. The seizure-free rate was not statistically different between
patients with generalised and focal epilepsy (67% vs. 62%, P = 0.07).
811 (45%) patients became seizure-free on the first AED schedule, 213
(12%) on the second schedule, 4.4% on the third schedule, 1.8% on the
fourth to seventh schedules, but none beyond. Among the patients who
became seizure-free, 97% did so within the first three schedules; 88%
were taking monotherapy and 12% polytherapy. Patients who did not
become seizure-free on the first AED had 1.77 times odds of uncontrolled
epilepsy for each additional AED tried (95% confidence interval 1.60–
1.96) after adjusting for epilepsy classification, age and gender.
Conclusion: The probability of achieving seizure-free diminishes for
each unsuccessful AED schedule. Despite the available of new AEDs
over the last decade, the long-term outcome of epilepsy has not improved
substantially.
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STEVENS-JOHNSON SYNDROME (SJS) INDUCEDBY
OXCARBAZEPINE (OXC) TREATMENT IN CHINESE
PATIENTSWITHEPILEPSY
Q. Dai
Sun Yat-sen University, Guangzhou, China
Purpose: Investigate the incidence of SJS after treatment with OXCin
Chinese epileptic patients.
Method: Observation of clinical individual cases .case 1, 17 year-old,
male, had a 7 years epileptic history, attack form were SPC, CPC and
SGTCS, with febrile convulsion history when he was 1 year old. The
patient was treated with VPA 0.5gbid, poor control, on Nov 27,
2014added OXC began from 150 mg bid for 1 week,then 300 mg bid for
1 week, and finally increased to 450 mg bid 3 days after the treatment
with 450 mg bid, the rash occurred, and was diagnosed as SJS.HLA-B *
1502 allele: positive, Cyp2c19 genetic testing: negative, the rash faded
10 days later after corresponding therapy, finally the AED was changed
to LEV.Case 2.5 year-old, male, epileptic history for half a year, with 3
febrile convulsions history at 3–4 year-old, took VPA, seizurefree, but
EEG still showed epileptic form charge of frontal lobe, so on Nov,
2014VPA was decreased gradually, and OXC was added from 3 ml bid
to 5 ml bid weekly, also the rash occurred 3 days later, confirmed
SJS.HLA-B * 1502allele: negative, Cyp2c19 genetic testing: positive,
the rash also faded 10 days later after corresponding therapy, again the
AEDwas changed to LEV.
Results: The SJS induced by OXC may be related with aromatic mole-
cule structure and Asian population. Asian patients with positive HLA-B
* 1502,would have more serious rash if they take carbamazepine(CBZ),
OXC has similar molecule structure with CBZ, positive HLA-B *
1502allelein our cases is 50%.
Conclusion: SJS induced by OXC has certain incidence in Asian popula-
tion, needs pay more attention to.
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ESLICARBAZEPINE ACETATEAS ADD-ONTO
ANTIEPILEPTICMONOTHERAPY INADULTSWITH
PARTIAL-ONSET SEIZURES (EPOS STUDY):
ANALYSIS BY BASELINE ANTIEPILEPTIC DRUG
P. Derambure*, R. McMurray†, R. Sousa‡, M. Holtkamp§
*University Hospital Roger Salengro, Lille, France, †Eisai
Europe Ltd, Hatfield, UK, ‡Bial - Portela & Cª, S.A., S~ao
Mamede do Coronado, Portugal, §Charité - Universit€atsmedizin
Berlin, Berlin, Germany
Purpose: Eslicarbazepine acetate (ESL) is approved as adjunctive ther-
apy for adults with partial-onset seizures, with or without secondary gen-
eralisation. The Eslicarbazepine acetate in Partial-Onset Seizures
(EPOS) study investigated the effectiveness and safety/tolerability of
ESL as add-on to antiepileptic monotherapy in everyday clinical practice
across eight European countries. It is important to obtain additional infor-
mation on how effective an antiepileptic drug (AED) is in combination
with different types of other AEDs. Here we present an analysis from the
EPOS study of ESL’s effectiveness by baseline AED.
Method: Adult patients with uncontrolled partial-onset seizures under
antiepileptic monotherapy, whose clinician had previously and indepen-
dently decided to initiate ESL add-on therapy, were included if they pro-
vided informed consent. Retention rate, responder rate (≥50% seizure
frequency reduction from baseline) and change from baseline in Quality
of Life in Epilepsy Inventory-10 (QOLIE-10) scores were assessed after
6 months according to the most frequent baseline monotherapies (>5%
of patients).
Results: Of 219 patients included in the study, 85, 57, 31 and 14
received baseline monotherapy with levetiracetam (LEV), lamotrigine
(LTG), valproate (VAL) and carbamazepine (CBZ), respectively.
Retention rates (95% confidence intervals) at 6 months were 100%
(76.8–100.0%) for CBZ, 85.5% (76.1–92.3%) for LEV, 80.0% (61.4–
92.3%) for VAL and 75.9% (62.4–86.5%) for LTG. Responder rates at
6 months were 92.9% (CBZ), 88.5% (VAL), 81.9% (LEV) and 69.8%
(LTG). Mean changes in QOLIE-10 scores at 6 months were -20.1%
(LEV), 16.7% (LTG) and 13.1% (VAL); not calculated for CBZ due
to low numbers.
Conclusion: The retention, efficacy and impact on quality of life of ESL
as add-on to antiepileptic monotherapy were favourable regardless of the
type of monotherapy to which ESL was added. These findings must be
interpreted with caution due to low subgroup patient numbers.
Study supported by Eisai
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EFFECTOFTREATMENTWITHLEVETIRACETAM
ONCOGNITIVE EVOKED POTENTIALS AND
COGNITIVEABILITIES OF PATIENTSWITH
EPILEPSY
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*EEG Laboratory, Neurological Clinic, Kluczbork, Poland,
†Public Higher Medical Professional School, Opole, Poland
Purpose: To investigate the effect of levetiracetam on cognitive evoked
potentials and cognitive functions in patients treated for epilepsy. Leve-
tiracetam is a recognized and widely used antiepileptic drug especially in
epilepsy with partial seizures and secondary generalized partial seizures,
but also in idiopathic generalized epilepsies and juvenile myoclonic epi-
lepsy (as additional therapy). Cognitive evoked potentials (e.g., P300
wave) are the evoked potentials recorded in response to cognitive pro-
cesses occurring in the brain during decision making (Duncan C et al.
Clinical Neurophysiology 2009; 120:1883–1908).
Method: Levetiracetam-treated patients with epilepsy diagnosis in addi-
tion to the standard elektroneurophysiological examinations (EEG) and
neuroimaging were performed several times in the course of therapy
study of cognitive evoked potentials, especially with the assessment of
P300 wave. They had also carried out a simple psychological tests for
assessing cognitive function. We have examined 20 patients treated with
levetiracetam and the results were compared with 20 patients treated for
epilepsy, but with other drugs than levetiracetam. P300 wave was
obtained as a result of visual stimulation using a proprietary protocol cov-
ering a variety of geometric patterns appearing in the field of view of the
subject (DerkowskiW, Epilepsia 53, 195,Suppl. 5).
Results: There are the differences in cognitive processes in patients
receiving levetiracetam with epilepsy compared to the control group con-
sisting of patients treated with other antiepileptic agents. There is a corre-
lation between the efficiency of cognitive processing and cognitive
parameters of evoked potentials, especially the P300 wave.
Conclusion: Cognitive evoked potentials, especially the P300 wave
allow objectively monitor the efficiency of cognitive deficits in patients
with epilepsy. In our study we have confirmed the beneficial properties
of levetiracetam in terms of its impact on cognitive processes in patients.
It was found usefulness of our own proprietary protocol of visual stimula-
tion for obtaining cognitive evoked potentials- especially P300 wave.
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ASSESSMENTOF THE IMPACTOFLACOSAMIDEON
COGNITIVEABILITIES OF PATIENTS TREATED FOR
EPILEPSY
W. Derkowski
EEG Laboratory, Neurological Clinic, Kluczbork, Poland
Purpose: The aim of this study was to estimate the effect of lacosamid
treatment on cognitive evoked potentials and cognitive functions in
patients with epilepsy.
Method: Patients with epilepsy treated with lacosamid were performed
during the therapy study of cognitive evoked potentials, especially with
the assessment of P300 wave. They had also carried out psychological
tests for assessing cognitive function- EpiTrack (Lutz MT, Helmstaedter
C. EpiTrack: Tracking cognitive side e ects of medication on attention
and executive functions in patients with epilepsy. Epilepsy Behav. 2005
Dec;7(4):708-14). We have examined 20 patients treated with lacosamid
and the results were compared with 20 patients treated for epilepsy, but
treated without it. P300 wave was obtained as a result of visual stimula-
tion using a proprietary protocol covering a variety of geometric patterns
appearing in the field of view of the subject (Event-related potentials in
patients with epilepsy treated with levetiracetamWDerkowski Epilepsia
53, 195, Suppl. 5).
Results: The results show the differences in cognitive processes in
patients treated with lacosamid compared to the control group treated
with other antiepileptic drugs.
Conclusion: We have found beneficial effects of lacosamid on cognitive
processes. Examination of cognitive evoked potentials is the useful
method of objectification of the results.
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PERAMPANEL IN THETREATMENTOF EPILEPSY
E. Theochari*, R. Elwes*, W. Louden*, C. Queally*,
M. Tristram†, N. Moran‡, L. Nashef*, M.P. Richardson*,
S. Slaght§, A. Sen†, J. Adcock†, J. Aram¶, N. Rayner¶
*King’s College Hospital, London, UK, †John Radcliffe
Hospital, Oxford Epilepsy Research Group, NIHR Biomedical
Research Centre, Oxford, UK, ‡Kent and Canterbury Hospital,
Canterbury, UK, §University Hospital Southampton,
Southampton, UK, ¶Brighton and Sussex University Hospitals,
Brighton, UK
Purpose: Perampanel is a non-competitive a-amino-3-hydroxy-5-
methyl-4-isoxazolepropionic acid receptor(AMPA) receptor antagonist
recently licensed for add on therapy in partial epilepsy. In randomised
double blind studies of short duration about one third of cases achieve
improvements in seizures control. The purpose of this study is to assess
the longer term efficacy and tolerability of the drug.
Method: A multicentre prospective audit has been initiated in adult
patients. Data relating to monthly seizure counts, global assessments and
adverse events have been recorded in all people who took the drug. The
primary outcomemeasure is actuarial retention time on perampanel.
Results: Eighty-two cases, mean age of 41, 72 with partial epilepsy, have
been identified. Thirty-six had learning difficulties. Mean duration of
epilepsy was 23 years. An average of six previous and three current
antiepileptic drugs were used. Mean follow-up was 9 months. Twenty-
one were followed for 12 months or more. The actuarial percentage
retention on perampanel was 83% at 6 months (.95 CI, 72–90) and 70%
at 12 months (.95 CI, 58–79). Five percent were seizure free, and 25%
reported a 50%+ reduction in seizures. The commonest side-effects were
aggression (36%), sedation(15%) and weight gain(15%). Perampanel
was withdrawn in 38%, two-fifths due to side-effects, one-fifth lack of
efficacy and two-fifths both.
Conclusion: This study confirms the results of short term randomised
trials. Around one third of cases have a significant and sustained period
of improvement and retention time is high. The commonest side effects
are irritability, drowsiness and weight gain.
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FYDATA STUDY: RETROSPECTIVEANALYSIS OF
PERAMPANEL INAREAL-LIFE SETTING (6-MONTH
INTERIMANALYSIS)
V. Villanueva*, M. Garcés*, F.J. Lopez Gonzalez†,
X. Rodriguez-Osorio†, M. Toledo‡, J. Salas-Puig‡,
M. Gonzalez-Cuevas§, J.A. Mauri¶, J. Montoya**,
D. Campos††, J. Rodríguez Uranga‡‡, J.J. Poza§§,
A. Castillo¶¶, J. Lopez-Trigo¶¶, P. Giner***, A. Molins†††,
R. Saiz-Diaz‡‡‡, J. Gonzalez de la Aleja§§§, J. Flores¶¶¶,
P. Esteve****, J.J. Baiges****
*Hospital Universitario y Politécnico La Fe, Valencia, Spain,
†Hospital Clínico Universitario Santiago, Santiago de
Compostela, Spain, ‡Hospital Universitario Vall d0Hebron,
Barcelona, Spain, §Hospital Universitari Vall d’Hebron,
Barcelona, Spain, ¶Hospital Clinico Universitario Lozano
Blesa, Zaragoza, Spain, **Hospital Lluis Alcanyis, Xativa,
Spain, ††Hospital Clínico Universitario Valladolid, Valladolid,
Spain, ‡‡Clínica Sagrado Corazon-Quiron, Sevilla, Spain,
§§Hospital Universitario Donosti, San Sebastian, Spain,
¶¶Hospital General Universitario Valencia, Valencia, Spain,
***Hospital Universitario Dr. Peset, Valencia, Spain,
†††Hospital Universitario Josep Trueta, Girona, Spain,
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‡‡‡Hospital Universitario 12 de Octubre, Valencia, Spain,
§§§Hospital Universitario 12 de Octubre, Madrid, Spain,
¶¶¶Hospital Universitario Candelaria, Santa Cruz de Tenerife,
Spain, ****Hospital de Tortosa Verge de la Cinta, Tortosa, Spain
Purpose: Real-life experience with perampanel (PER) in a large series
of patients with partial epilepsy.
Method: Multicenter, retrospective, 1-year, observational study. Inclu-
sion criteria:
1) patients older than 12 years;
2) partial-onset seizures;
3) Add-on treatment with PER according to clinical practice;
4) At least 1 partial seizure in the year prior to starting PER.
The source of data was patient clinical records. Time-points for revi-
sion were considered at 3, 6 and 12 months.
Results: An interim analysis was performed at 6 months in 315 patients.
The mean number of seizures per month at onset was 19.6 and the mean
number of prior antiepileptic drugs (AED) was 8.5. A total of 89.8% and
79.4% of the patients remained on PER at 3 and 6 months respectively.
The mean dose after 6 months was 6.4 mg (range: 2–12 mg). At
6 months, 8.6% of the patients were seizure-free and 32.9%were respon-
der. Additional efficacy was observed in patients with secondary general-
ized seizures -the number of patients was reduced from 27.2% to 17.6%-,
patients ≥65 years (responder rate (RR) 68.8%) -p = 0.002-, and patients
that had tried ≤5 AEDs (RR 42.3%)-p = 0.029-.A tendency to a higher
RR was observed if concomitant enzyme inducer were not used (38.3 vs.
23.2%). AE were reported by 55.9% of the patients, being most of them
mild or moderate. The most frequent were dizziness (20.3%), somno-
lence (15.9%) and irritability (14.6%). 7.9% of patients discontinued
because of AE. Psychiatric AE were statistically more frequent if patients
had a prior psychiatric condition (p < 0.001), but no differences were
observed if they were on levetiracetam.
Conclusion: Preliminary results at 6 months in a refractory population
with PER showed a promising response and retention rate. Main adverse
events were psychiatric or central nervous system-related. Prior psychi-
atric condition should be considered to improve tolerability.
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ANTIEPILEPTIC DRUGCHANGE PATTERNSAND
QUALITYOFLIFE IN ACOMMUNITY-BASED
EPILEPSYCOHORT
M.Wassenaar*,†, F.S. Leijten†, J.W. Sander*,‡,§, S.G. Uijl¶,
T.C.G. Egberts**,††
*SEIN; Stichting Epilepsie Instellingen Nederland, Heemstede,
Netherlands, †Brain Center Rudolf Magnus, University Medical
Center Utrecht, Department of Neurology and Neurosurgery,
Utrecht, Netherlands, ‡NIHRUniversity College London
Hospitals, Biomedical Research Centre, UCL Institute of
Neurology, London, UK, §Epilepsy Society, Chalfont St Peter,
UK, ¶Julius Center for Health Sciences and Primary Care,
University Medical Center Utrecht, Utrecht, Netherlands,
**University Medical Center Utrecht, Department of Clinical
Pharmacy, Utrecht, Netherlands, ††Utrecht Institute for
Pharmaceutical Sciences, Utrecht University, Department of
Pharmacoepidemiology and Clinical Pharmacology, Utrecht,
Netherlands
Purpose: Antiepileptic drug (AED) changes are commonly regarded as
an indicator of adverse treatment outcomes and reduced quality of life
(QoL). This inference underlies epilepsy management and research, yet
current studies often do not account for quality of life. Moreover, previ-
ous AED attempts (changes) are rarely included in the assessment of
treatment results. We assessed AED change patterns and their association
with QoL in a community-based setting.
Method: We performed a retrospective cohort study involving 248 peo-
ple with epilepsy identified from public pharmacy records from whom
we retrieved AED dispensing history. We assessed AED changes during
the 2 years prior to the index date and current QoL using the validated
Dutch QOLIE-31 questionnaire.
Results: Thirty-one percent had at least one AED treatment change during
the study period. People who changed showed a significantly lower QoL
(QOLIE score 68), than those without AED changes (score 74), with the
lowest QoL for those who intensified their treatment (score 65). Each addi-
tional change was associatedwith a further reduction of-4.9 in QoL-score.
Conclusion: Changes in AED treatment are common practice and occur
frequently even in people with longstanding epilepsy. Frequent changes
are found associated with a lower QoL and thus seem to be an indicator of
suboptimal treatment outcome. QoL should be acknowledged as the most
important treatment outcome in epilepsy. However can be subjective and
frequency of drug changes could be used as surrogate marker for QoL in
daily clinical practice. This can be seen as a red flag requiring changes in
epilepsy management such as earlier referral or more thorough evaluation
in people with epilepsy, with the aim of optimizing epilepsy care. AED
changes should also be acknowledged in treatment outcome research for a
better translation and applicability of results to general practice.
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PHARMACOEPIDEMIOLOGICALASSESSMENTOF
THEMEDICINES FOR JUVENILE IDIOPATHIC
GENERALIZED EPILEPSIES
R.M. Shaimardanova*,†, R.G. Gamirova*,†,‡, F.M. Zaikova†,‡
*Kazan Federal University, Department of Basic and Clinical
Pharmacology, Kazan, Russian Federation, †Kazan Municipal
Children’s Hospital N 8, Kazan, Russian Federation, ‡Kazan
State Medical Academy, Department of Pediatric Neurology,
Kazan, Russian Federation
Purpose: To evaluate the long-term therapeutic outcomes of the juvenile
idiopathic generalized epilepsies.
Method: We conducted a retrospective comparative analysis of the ther-
apy of 93 patients (33 males and 60 females) with the juvenile idiopathic
generalized epilepsies (JIGE): juvenile absence epilepsy (JAE) - 22
patients (24%), juvenile myoclonic epilepsy (JME) - 32 patients (34%)
and epilepsy with generalized tonic-clonic seizures only (EGTCS) - 39
patients (42%).We calculated Risk Ratio (RR with ReviewManager 5.2)
of favorable therapeutic outcomes of different JIGE forms after 1 year
from the start of treatment and after the 3-years follow-up. Favorable out-
come: clinical remission (the number of patients without seizures).
Results: Monotherapy was used in 97% of all cases of JIGE: valproic
acid 90.7%, topiramate 3.4%, lamotrigine 1.7%, levetiracetam 0.8%, suc-
cinamide 1.7%, carbamazepine 1.7% (solely for EGTCS). Polytherapy
(valproates + succinamide) was used only for treatment of JAE. Mean
prescribed daily doses of valproates used in monotherapy of JAE were
1276.9 mg; JME - 1128, 1 mg; EGTCS - 1096, 4 mg. RR calculations
revealed comparable efficacy of valproate monotherapy of JAE versus
JME (RR=1.04; 95% CI[0.80, 1.34]), JAE vs EGTCS (RR=0.95 95% CI
[0.76, 1.20]), JME vs EGTCS (RR=0.92; 95% CI[0.75, 1.13]) after
1 year from the start of treatment. We found similar outcomes valproate
monotherapy after 3 years of follow-up: JAE vs JME (RR = 1.10; 95%
CI[0.80, 1.51]), JAE vs EGTCS (RR=0.99 95% CI[0.75, 1.13]), JME vs
EGTCS (RR=0.99; 95%CI[0.75, 1.33]).
Conclusion: Valproates were the most commonly prescribed antiepilep-
tics for all forms of the juvenile idiopathic generalized epilepsies. Juve-
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nile absence epilepsy required the prescribing of higher doses of val-
proate monotherapy and, probably, polytherapy for achieving of clinical
remission versus JME and EGTCS.We found no statistical differences in
short-term and long-term outcomes valproate monotherapy between dif-
ferent forms of JIGE.
Conflicts of interest - None.
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ONE-YEARCLINICAL EXPERIENCEWITH
PERAMPANEL IN SPAIN: STUDYOF THEEFFICACY
ANDTOLERABILITY
I. Garamendi Ruiz*, V. Bertol Alegre†, J.A. Mauri Llerda‡,
I. García Morales§, V. Garayoa Irigoyen‡, M. Agundez
Sarasola¶, M.E.G. García§, M.J. García Gomara**, C. Arcos
Sanchez††, E. Mu~noz Fargas‡‡, S. Santos-Lasaosa‡, J.A. Olivan
Usieto‡‡, L. Díaz de Cerio Julian§§, J.C. Gomez Esteban*,
A. Marinas Alejo¶
*Cruces University Hospital, Neurology, Baracaldo, Spain,
†Miguel Servet University Hospital, Neurology, Zaragoza,
Spain, ‡Lozano Blesa Clinical University Hospital, Neurology,
Zaragoza, Spain, §San Carlos Clinical Hospital, Epilepsy Unit.
Neurology, Madrid, Spain, ¶Cruces University Hospital,
Epilepsy Unit. Neurology, Baracaldo, Spain, **Royo Villanova
Hospital, Zaragoza, Spain, ††Defense General Hospital,
Zaragoza, Spain, ‡‡Alca~niz Hospital, Neurology, Alca~niz,
Spain, §§Barbastro Hospital, Neurology, Barbastro, Spain
Purpose: To analyze the efficacy and tolerability of perampanel (PER)
at 6 and 12 months in daily clinical practice conditions.
Method: Patients which started on PER in eight different Spanish hospi-
tals were included. Data were collected at 6 and 12 months. The follow-
ing data were collected: age, gender, age at onset of epilepsy, seizure and
epilepsy types, aetiology, monthly seizure frequency, adverse events and
number of previous anti-epileptic drugs (AEDs). Response was analysed
in 6 and 12 month completers and defined as a > 50% reduction in
monthly seizure frequency compared with the baseline.
Results: Two-hundred and eight patients were included in the study.
After 6 months 175 patients (84%) continued on PER and 69/102
(67.6%) at 12 months. Mean number of AEDs used in the past was 6.99
and mean number of concomitant AEDs was 2.56. Mean PER dose was
7.09 mg and 7.74 mg at months 6 and 12, respectively. The responder
rate was 45.4% and 44.9% at both follow up points. Seizure freedom at
month 12 was achieved in 2/68 (3%). Adverse events were experienced
in 64/208 (30.8%) and resulted in withdrawal in 36 (17.4%). The most
common adverse events were somnolence, dizziness and irritability.
Retention rate was 60.7% after 12 months. We found no significant dif-
ferences between concomitant use of inducer and non-inducer AEDs,
regarding dose and efficacy, but with more adverse effects with the lat-
ters.
Conclusion: In this long term study, PER showed efficacy in 45.4% of
patients in daily clinical practice conditions. Tolerability was good in this
drug-resistant population. The concomitant use of inducer AEDs did not
modify the efficacy of PER.
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TRENDS INCHOOSINGCONVENTIONALVERSUS
NEWANTIEPILEPTIC DRUGS IN EPILEPSY
TREATMENT
G. Genc*, O. Arslan†, H. Akgun‡, S. Bek§, Z. Gokcil‡,
Z. Odabasi‡
*Gumussuyu Military Hospital, Department of Neurology,
Istanbul, Turkey, †Diyarbakir Military Hospital, Department of
Neurology, Diyarbakir, Turkey, ‡Gulhane Military Medical
Academy, Department of Neurology, Ankara, Turkey, §Baskent
University, Department of Neurology, Adana, Turkey
Purpose: Recent studies reveal that conventional antiepileptic drugs
(AEDs) used without alternative in the treatment of epilepsy for years,
seem to leave their place to new AEDs during last two decades. We
aimed to assess whether the results of those studies hold any truth in
Turkish clinical practice. The study was carried out in two different hos-
pitals from distinct places of Turkey.
Method: Medical records of patients that present to our clinic with the
diagnosis of epilepsy 2007–2012 were investigated retrospectively.
Results: Data on 1126 patients were evaluated. Among them, 624 (55%)
patients had monotherapy and 449 (40%) patients had polytherapy
whereas 53 (5%) patients had no therapy.While 916 (%81) of the patients
were on conventional AEDs, 447 (%40) of the patients were on AEDs.
887 (79%) of the patients were using either valproate or carbamazepine.
523 (84%) of 624 patients on monotherapy were on conventional AEDs
whereas 101 (16%) patients were on newAEDs.
Conclusion: In our previous study, we found the percentage of choosing
new AEDs as 1% before 1994, 10% in 1995–2000, 14% in 2000–2007,
respectively. Although there was an increase (40%) in the use of new
AEDs in 2007–2012 in our current study, it seems that conventional
AEDs still keep their place as a first-line treatment choice, at least in the
Turkish clinical practice. It is obvious that new AEDs are candidates for
the throne as much more experience gained by both the epileptologists
and the patients.
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IS ADJUNCTIVE PERAMPANELANOPTION FOR
INTRACTABLE SEIZURES IN LAFORADISEASE?
P. Genton*, N.J. Jovic†, G. Lesca‡, M. Kecmanovic§
*Centre Saint Paul-Henri Gastaut, Marseille, France, †Clinic of
Neurology and Psychiatry for Children and Youth, Neurology,
Belgrade, Serbia, ‡Service for Clinical Molecular Genetics,
Lyon, France, §Center for HumanMolecular Genetics,
Belgrade, Serbia
Purpose: Perampanel (PER), non-competitive AMPA receptor antago-
nist, with specific action on glutamate-mediated neurotransmission, was
approved for partial seizures in patients ≥12 years. Lafora disease (LD)
is progressive myoclonus epilepsy with onset in late childhood/adoles-
cence. It is characterized by intractable myoclonus and seizures, inex-
orable neurological deterioration, cognitive decline and poor prognosis.
PERwas reported as highly effective in LD case (Schorlemmer 2013).
Method: Eight LD patients, 5 females, 3 males, aged 16–31.5 (mean
21.6) were collected from Marseilles and Belgrade. All patients and/or
their parents gave informed consent. Mutation of either EPM2A (3) or
NHLRC1 gene (5) was identified. Three patients are bedbound. All had
failed ≥3 antiepileptics in stable doses for mean 8.8  4.3 years (range
3–14) and continued to suffer from daily myoclonus and frequent gener-
alized tonic-clonic seizures (GTCS). Once-daily PER dosed 6–8 mg,
was gradually used in co-medication with valproate (7), clonazepame (4)
and levetiracetame (4). Patients experiencing adverse events (AEs)
deferred up-titration or have their dose reduced.
Results: Compared with baseline, sustained remission of myoclonus and
GTCS was achieved in 6 of 8 patients for a follow-up of 2–3 months.
Reduction of myoclonus in 4 and its disappearance in two was noted.
Five patients were GTCS-free and two had GTCS reduced for
>50%.Two patients had discontinued PER, due to a lack of efficacy. In
two patients co-medicated with valproate and levetiracetame, aggression
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and irritability appeared with PER doses of 8 and 6 mg daily. Up-titration
was deferred in one, while the dose was reduced to 6 mg in remaining
patient. Frequently reported AEs (dizziness, somnolence, and headache)
were rated mild-moderate.
Conclusion: Perampanel started in patients with advanced LD led to sus-
tained remission in myoclonus and GTCS. Psychiatric side effects
appeared at higher PER dose. In LD population, PER seems to be promis-
ing drug which requires further study.
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PERAMPANEL IN 28 ADULTSWITHLENNOX-
GASTAUT SYNDROMEANDRELATED
ENCEPHALOPATHIES
P. Genton*, N.P.L. Tang†, P. Gélisse†, P. Coubes†, A. Crespel†
*Centre Saint Paul-Henri Gastaut, Marseille, France, †Ho^pital
Gui de Chauliac, Epilepsy Unit, Montpellier Cedex, France
Purpose: The Lennox-Gastaut syndrome (LGS) is a severe epileptic
encephalopathy, in which bilateral synchrony plays a major role. Peram-
panel (PER), an add-on in focal epilepsy, has a new mechanism of action
and may be relevant. All LGS patients newly treated with PER have been
prospectively added to a database in two tertiary epilepsy clinics.
Method: Patients were reviewed at 3 month intervals and frequent carer
contacts were encouraged. We recorded all epilepsy parameters and
actively looked for side-effects. There was no videoEEG quantification
of discharges or seizures. We asked carers to quantify visible seizures.
Results: As of February 15, 2015, we have treated 17 patients with LGS
and 11 with related epileptic encephalopathies (17 M, 11 F, mean age
40 years, range 18–68). All patients had a history of mixed seizures,
mental handicap, and drug resistance. 12 were cryptogenic, 4 had had
infantile spasms, 2 herpes encephalitis, 2 perinatal damage, 2 pachygyria,
6 other causes. They were receiving an average of 4.5 anticonvulsants
(range: 3–7), 8 had VNS, all had daily seizures (including uncounted
tonic seizures during sleep). All had tried recommended treatments,
including valproate + lamotrigine cotherapy. Side effects included: beha-
vioural disturbances, who stopped but retried PER later with slower titra-
tion, 1; seizure aggravation at 10 mg/d, with marked benefit at 6 mg/d, 1;
improved alertness, mood and behaviour, 5. Among 14 patients with
≥3 months follow-up, 1 patient has seizure freedom, 6 a 50% to 90% sei-
zure reduction, 4 are still uptitrating PER at 4 mg/d and above without
clear improvement.
Conclusion: Although the follow-up is still short at this time, the use
of PER in a cohort of LGS and LGS-like patients has allowed us to
observe marked improvement in a majority of cases, without severe
side-effects.
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PRELIMINARY EXPERIENCE FROMTHETURKEY
EPILEPSY PREGNANCYREGISTRY
B. Tekin Güveli*, A. Bican†, S. Keskin Güler‡, İ. Bora†,
C. Gürses§, Turkey Epilepsy Pregnancy Registry
*Bakirkoy Research and Training Hospital for Psychiatry,
Neurology, Neurosurgery, Department of Neurology, Istanbul,
Turkey, Istanbul, Turkey, †Uludag University, Bursa, Turkey,
‡Ankara Training and Research Hospital, Ankara, Turkey,
§Istanbul University, Istanbul Faculty of Medicine, Department
of Neurology and Clinical Neurophysiology, Istanbul, Turkey
Purpose: Use of antiepileptic drugs (AED) in pregnancy is associated
with congenital malformations. The aim of our study is to examine the
congenital malformations in children of mothers with epilepsy on AED
or mothers who discontinued AEDs during pregnancy to reveal any cor-
relation between these anomalies and AEDs.
Method: The Turkey Epilepsy and Pregnancy Register is a prospective,
observational registration and follow-up study set up to determine the
effects of AED in pregnancy. Patients who were followed up by the 12
epilepsy outpatient clinics and got pregnant between the years of 2013–
2015 were included in this study.
Results: In this study, 83 mothers with epilepsy were included. The
mean age of the patients was 29.4  4.9 (20–39) years. Of all the moth-
ers, 72 were on AEDs, whereas 11 discontinued AED during pregnancy.
A patient had voluntarily curettage, one died, 7 had abortions. In the
AED group, 59 (71.1%) of the pregnancies were completed under
monotherapy, and the most frequently used drugs were carbamazepin
(16), valproat (13), levetirasetam(12) and lamotrigine (12). Sixty-six
(79.5%) patients used folic acid. In a patient who discontinued AED, had
to have curettage because of her baby had a major cardiac anomaly. All
of children with major malformation(7) were in the AED group (mono-
threapyh=3 and polyteraphy =4). There are no correlations between the
congenital malformations and folic acid usage.
Conclusion: Using safe AEDs in pregnancy is important not only to ren-
der the mother seizure free but also to prevent teratogenic side effects in
the baby. Our study may suggest that taking folic acid with AEDs does
not eliminate teratogenic consequences.
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ADJUVANT LACOSAMIDE TREATMENT: EARLY
EXPERIENCE IN PATIENTSWITHREFRACTORY
PARTIALONSET SEIZURES
F. Eren, A. Ceyhan Dirican, G. Gül, B. Tekin Güveli, D. Ataklı,
S. Baybaş
Bakirkoy Research and Training Hospital for Psychiatry,
Neurology, Neurosurgery, Department of Neurology, Istanbul,
Turkey
Purpose: Lacosamide, is a new anti-epileptic drug (AED), which modu-
lates slow inactivation of sodium dependent voltage channels. It is an
effective treatment in patients over the age of 16 with refractory partial
onset seizures with or without secondary generalizations. This study aims
to report our short term experience with adjuvant lacosamide therapy in
patients with uncontrolled seizures under other antiepileptic drugs.
Methods: Twelve female and 36 male patients with an average age of
31.7 (15–56) were included in the study. Demographic and clinical fea-
tures of patients with refractory partial onset seizures with or without sec-
ondary generalizations were assessed.
Results: Etiologies of the patients included, mesial temporal sclerosis,
focal cortical dysplasia, cerebral palsy, hydrocephaly, meningitis
sequela, intracranial mass, WEST syndrome, poststroke and crypto-
genic etiology. All patients were on polytherapy which consisted of
different AED combinations. Lacosamide was included in the treat-
ment regimen as the 2nd drug in 1 patient, 3rd in 24 patients, 4th in 21
patients and 5th in 2 patients. Preferred dose varied from 100 to
400 mg/day. Average treatment period was 3.6  1.67 months. There
was no difference in seizure frequency in 6 patients. Nine were seizure
free in their last month. Eight discontinued treatment due to side
effects following an average period of 1.91  1.69 months. There was
statistically significant improvement in seizure frequency in patients
who were medicated at least 1 month (p = 0.0001). Two reported
increased seizure frequency after lacosamide. Encountered side effects
were nausea in 2 patients, dizziness in 3 patients, anxiety/irritability in
Epilepsia, 56(Suppl. 1):3–263, 2015
doi: 10.1111/epi.13241
58
Abstracts
2 patients, headache in 1 patient, diplopia in 1 patients and gastroin-
testinal discomfort in 1 patient.
Conclusion: Our early experience suggests that 100 to 400 mg/day
lacosamide improve seizure frequency significantly. Lacosamide may
be an effective adjuvant therapy in patients with refractory partial
onset seizures, however side effects is a remarkable reason for non-
compliance.
p0210
POTENTIALDRUG INTERACTIONSWITH
ANTIEPILEPTICS IN THE INTENSIVE CAREUNIT
PATIENTSOFAUNIVERSITYHOSPITAL
M.I. Gulcebi, N.C. Duman, R. Gulhan, A. Karaalp, Z. Goren,
F. Onat
Marmara University, School of Medicine, Department of
Medical Pharmacology, Istanbul, Turkey
Purpose: Use of antiepileptic drugs which plays an important role in the
occurrence of drug-drug interactions (DDIs) can be critical for intensive
care unit (ICU) patients with many medications, co-morbid diseases and
altered organ functions. Particularly phentytoin and levetiracetam are the
well-known drugs used for seizure prophylaxis following traumatic brain
injury in the ICU patients. This study aimed to determine the prevalence
and clinical severity of potential DDIs with antiepileptics in surgical ICU
patients of a university hospital.
Method: The Medical Pharmacology Department organized consulta-
tion reports for ICU patients in Marmara University Hospital for
6 months (from July-2014 to December-2014) to detect DDIs. DDIs
were identified by databases; Micromedex, Rx Media 2014, Lexi-Inter-
actTM Online “interactions checker” and Pubmed. Only clinically impor-
tant 0C, D or X0 risk rating category DDIs of Lexi-InteractTM Online
database were analyzed.
Results: Of 177 ICU patients, 53 (30%) were on therapy with
antiepileptics [levetiracetam (n = 28), phenytoin (n = 11), midazolam
(n = 4), carbamazepine (n = 1) and polytherapy with antiepileptics
(n = 9)]. Of 117 patients with DDIs, 27% were with antiepileptics.
Potential C (n = 33.6%), D (n = 9.2%) or X (n = 1.2%) risk rating cat-
egory DDIs with antiepileptics were detected. DDIs which can result
with therapeutic failure or adverse and toxic reactions of antiepileptics
were found between valproic acid and meropenem, phenytoin and
nimodipine, cefazolin or cyprofloxacin, clonazepam and voriconazole
and midazolam and dexamethasone or propofol. The most frequent
DDI with antiepileptics was between levetiracetam and remifentanil
(9%) which both have depressive effects on central nervous system.
The only contraindicated X risk rating category interaction was
between phenytoin and nifedipine which can cause therapeutic failure
of nifedipine.
Conclusion: In conclusion DDI mechanisms which can lead to changes
in serum levels or degree of binding to plasma proteins of antiepileptics
are noteworthy for effective seizure prophylaxis in the ICU patients.
p0211
WHENUNCONTROLLED EPILEPSY BECOMES
CONTROLLED: A PROSPECTIVE STUDY INRURAL
WESTOFCHINA
X. Hao*, B. Yan†, P. Kwan‡,§, D. Zhou*
*West China Hospital, Sichuan University, Neurology
Department, Chengdu, China, †West China Hospital, Sichuan
University, Chengdu, China, ‡The University of Melbourne,
Departments of Medicine and Neurology, North Melbourne,
Australia, §Chinese University of Hong Kong, Prince of Wales
Hospital, Department of Medicine and Therapeutics, Hong
Kong, China
Purpose: In rural areas of China, about 41% of patients have never
received appropriate treatment. To assess the clinical benefits of ade-
quate AED therapy in rural west of China, prospectively follow up the
outcomes of patients with uncontrolled epilepsy after further drug manip-
ulation.
Method: Epilepsy patients were enrolled between 3 Dec 2010 and 18
Aug 2011. According to ILAE consensus definition, outcomes were cate-
gorized to: seizure-free; drug-resistant, undefended. At baseline, patients
with “undefined” receiving at least one AED at <50% WHO defined
daily dose (WHO DDD) will included and followed up for until 28th Jan
2014. Patients with current AEDs less than 50% DDD will principal
increase dosage or substitute/ add other AEDs according to the doctors.
Final outcomes, reasons for “undefined” and risk factors of drug resistant
will analyzed at last follow-up.
Results: 197 patients included in this study. At the last follow up, 33
(16.75%) patients became to “seizure-free”, while 54 patients became
“drug resistant” and 110 patients were still “undefined”. Most common
reason for undetermined AEDs was inadequate dose both at baseline
(93.29%) and last follow-up (51.56%). 17 of 93 patients became seizure-
free after the dosage of their AED(s) was increased, while 16 of 104 did
so after substitution or addition of AED(s).3 patients with history of treat-
ment failure became seizure-free, while 35 patients were drug-resistant
(p < 0.001). There were similar probability of seizure freedom in
patients received 1compared with 2 to 4 regiment (p = 0.745). At last fol-
low-up, there0re 31 AEDs stopped for AEs, compared 8 AEDs at base-
line.
Conclusion: Patients with inadequate-dose AEDs can get seizure free
with further drug manipulation. History of treatment failure is a risk fac-
tor to drug-resistant, while history of AEDs with inadequate dosage
won’t affect further outcome. Inadequate dosage is the urgent problem in
rural China which needs epilepsy education.
p0212
REAL-WORLDDATAONESLICARBAZEPINE
ACETATEAS ADD-ONTREATMENT TO
ANTIEPILEPTICMONOTHERAPY INADULTSWITH
PARTIAL-ONSET SEIZURES: THE EPOS STUDY
M. Holtkamp*, R. McMurray†, R. Sousa‡, E. Kockelmann§
*Charité –Universit€atsmedizin Berlin, Berlin, Germany, †Eisai
Europe Ltd, Hatfield, UK, ‡Bial – Portela & Cª, S.A., S~ao
Mamede do Coronado, Portugal, §Eisai GmbH, Frankfurt,
Germany
Purpose: Eslicarbazepine acetate (ESL) is approved as adjunctive ther-
apy for adults with partial-onset seizures, with or without secondary gen-
eralisation. Patients encountered in everyday clinical practice are more
diverse in terms of clinical characteristics than those included in clinical
trials and require individually tailored treatment to encourage long-term
compliance and improve overall outcomes. ‘Real-world’ studies are
therefore needed to complement evidence from clinical trials. The aim of
the prospective, non-interventional Eslicarbazepine acetate in Partial-
Onset Seizures (EPOS) study was to assess retention rate, seizure control
and safety/tolerability of ESL as add-on to antiepileptic monotherapy in
everyday clinical practice across eight European countries.
Method: Adult patients with uncontrolled partial-onset seizures under
antiepileptic monotherapy, whose clinician had previously and indepen-
dently decided to initiate ESL add-on therapy, were offered participation
in the study if they provided informed consent. Primary endpoint
was retention rate after 6 months. Other assessments included responder
rate after 6 months (response defined as ≥50% seizure frequency reduc-
tion from baseline), seizure freedom rate after 6 months, and safety/
tolerability.
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Results: Overall, 219 patients were included (mean age 45.9 years;
57.5% male). Mean time since epilepsy diagnosis was 12.3 years. Mean
ESL dose after titration was 944.8 mg/day (range 428.6–2800.0 mg/
day). After 6 months, retention, responder and seizure freedom rates
were 82.2% (95% confidence interval [CI] 76.5–87.0%), 81.8% (95% CI
75.5–87.1%) and 39.2% (95% CI 32.2–46.5%), respectively. Adverse
events (AEs) were reported for 57 (26.0%) patients; eight (3.7%) patients
experienced serious AEs. No AE was reported in >5% of patients. The
most frequently reported AEs were dizziness (4.6%), headache (3.2%),
convulsion (3.2%) and fatigue (2.7%).
Conclusion: ESL as add-on to antiepileptic monotherapy demonstrated
a favourable rate of retention and seizure control, and was well tolerated
by the majority of adult patients in a real-life setting.
Study supported by Eisai
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PREDICTORS FORADVERSE EVENTSOF
PHARMACOTHERAPY IN EPILEPSY
M. Holtkamp, F. Weissinger, V. Gaus, P. Fidzinski, F. Losch,
A. Kowski
Charité - Universit€atsmedizin Berlin, Epilepsy-Center Berlin-
Brandenburg, Department of Neurology, Berlin, Germany
Objective: In patients taking antiepileptic drugs (AED) for epilepsy,
adverse events (AE) are a common cause of impaired adherence or dis-
continuation of pharmacological treatment. This study aimed to identify
independent predictors for abundant AE and to assess the role of specific
AED in patients treated with monotherapy.
Methods: All outpatients 16 years and older with epilepsy lasting
12 months or more were routinely asked to complete the Liverpool
Adverse Event Profile (LAEP; 19 items; score 19–76). Demographics,
epilepsy and treatment variables were derived from our comprehen-
sive outpatient database. Logistic regression analyses were used to
identify independent predictors for high LAEP score (≥45) and for
distinct AE.
Results: A total of 841 patients (53.6% female; mean age
45.9  16.7 years) were analyzed. Independent predictors for a high
LAEP score were female sex (OR 1.823), lack of 12-month terminal sei-
zure remission (OR 2.097), pharmacoresistance (OR 1.464), and partial
epilepsy (OR 1.791). In the subgroup of patients with AED monotherapy
(n = 507), the most common substances were levetiracetam (n = 151),
lamotrigine (n = 167), valproic acid (n = 73) and carbamazepine deri-
vates (n = 75). None of these substances was associated with a high
LAEP score. Distinct AE were mainly predicted by lack of 12-month sei-
zure freedom (10/19 AE) and female sex (7/19 AE). Furthermore, AE
were associated with intake of specific AED, namely shaky hands with
valproic acid (OR 2.983), depression and sleep disturbance with leve-
tiracetam (OR 3.001 and OR 2.355), memory problems with carba-
mazepine derivates (OR 2.518), and concentration difficulties with
lamotrigine (OR 2.594).
Conclusions: Predominant AE were predicted by female sex and clinical
features of difficult-to-treat epilepsies, but interestingly not by AED
polytherapy. The monotherapy setting allowed assessing the capability
of individual substances to predict specific AE. Our findings may help to
further identify patients with epilepsy at high risk for general and specific
AE and to reduce non-adherence.
p0215
EFFICACYANDTOLERABILITYOF STIRIPENTOL TO
3 PATIENTSWITHDIFFERENT SCN1AMUTATIONS
N. Ishihara*,†, C. Ogawa†, T. Takeuchi†, S. Hirose‡,
H. Kurahashi§, J. Natsume†
*Fujita Health University School of Medicine, Pediatrics,
Toyoake, Japan, †Nagoya University Graduate School of
Medicine, Pediatrics, Nagoya, Japan, ‡Fukuoka University
School of Medicine, Pediatrics, Fukuoka, Japan, §Fujita Health
University, Institute for Comprehensive Medical Science,
Molecular Genetics, Toyoake, Japan
Purpose: Stiripentol (STP) is a new drug limited to Dravet syndrome
which has efficacy when combined with valproate (VPA) and clobazam
(CLB). SCN1Amutation is found in more than 70% of patients with Dra-
vet syndrome, while severity of the clinical feature is heterogeneous.
Here we present three patients with different mutations of SCN1A, and
compared efficacy and tolerability of STP.
Subjects: Patient 1 is a 14 year-old girl, who had myoclonic seizures
and febrile induced seizures since 5 months of age. Seizures were not
well controlled with antiepileptic medications (VPA, CLB). Patient 2 is a
one year-old boy who had status epilepticus with fever at 5 months of
age. Even after starting antiepileptic medications (VPA, CLB, PB), sei-
zures were easily induced with fever. Patient 3 is a 3 year-old boy who
had extremely severe hypotonia and multiple anomaly. He started to have
myoclonic seizures and partial seizures since 12 months of age, and
received antiepileptic medications (VPA, CLB, PB). Although frequency
of the seizure was decreased, the seizures were easily clustered with fever
and intensive cares were required.
Results: Genetic analysis was performed in three patients. De novo
mutation of c.2819C>T (p.Ser940Phe) was found in patient 1,
c.4554_4555insA (p.Pro1519Thr fsX18) in patient 2, 11 Mb deletion
including SCN1A in chromosome 2q24.2-31.1 was found in patient 3.
STP treatment had started with three patients. Patient 1 discontinued STP
because of insufficient efficacy. Patient 2 needed additional medication
(TPM) to control seizures. Patient 3 became seizure free for 3 months
after initiation of STP, dose up was difficult because of anorexia problem
and needed additional therapy.
Conclusion: Although efficacy of STP to 3 patients was limited, con-
junction therapy would be a key of the treatment.
Epidemiology 1
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UTILIZATIONOFANTIEPILEPTIC DRUGS IN
EPILEPSYAND INNON-EPILEPSY DISORDERS IN
NORWAY
A. Baftiu*, A. Gottas†, S.I. Johannessen†, P.G. Larsson‡,
C.J. Landmark*
*Oslo and Akershus University College of Applied Sciences,
Department of Life Sciences and Health, Oslo, Norway, †Oslo
University Hospital, National Center for Epilepsy, Department
of Pharmacology, Sandvika, Norway, ‡Oslo University Hospital,
Department of Neurosurgery, Oslo, Norway
Purpose: Antiepileptic drugs (AEDs), and especially the newer drugs
are increasingly used in non-epilepsy disorders, as psychiatric disorders,
neuropathic pain and migraine. Recently, several other new AEDs have
become available as add-on in epilepsy as the orphan drugs (rufinamide,
stiripentol). The aim of this study was to investigate changes in utilization
of the newest and unlicensed AEDs in epilepsy and in non-epilepsy disor-
ders in Norway to improve patient safety aspects by close drug surveil-
lance.
Methods: Data consisted of all prescriptions of AEDs from the Norwe-
gian Prescription Database (NorPD) from 2004 to 2013. Variables
included anonymous data regarding age, gender, reimbursement codes
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for specific diagnoses and utilization of AEDs until 2012 and data until
2013 regarding the newest AEDs.
Results: From 2004 to 2012, the utilization in non-epilepsy disorders
accounted for 0.85 to 7.0 DDDs/1000 inhabitants/day (51% of the
total use in 2012). Predominant AEDs in non-epilepsy disorders are
lamotrigine in psychiatry, pregabalin and gabapentin in neuropathic
pain and topiramate in migraine. The use of unlicensed (clobazam,
ethosuximide, sultiame) and the newest AEDs (eslicarbazepine acet-
ate, lacosamide, rufinamide, stiripentol, perampanel) has increased by
120% from 1003 patients in 2009 to 2230 patients in 2013 (0.14
DDDs/1000 to 0.31 DDDs/1000 inhabitants/day). A clear reduction in
the use of retigabine was seen from 2012 to 2013 due to restrictions
because of serious adverse effects reports. An increase in use of these
drugs elucidates a need for establishing an extended analytical reper-
toire.
Conclusions: NorPD as a source to follow the utilization of these drugs
is useful to offer an improved individualized treatment by establishing
new analytical methods for drug monitoring, as a new orphan drug pack-
age. Awareness of the increased exposure of AEDs to new groups of
patients followed by careful clinical considerations regarding safety
aspects is of great importance and contributes to improved pharmacovigi-
lance.
p0219
LONGTERMPROGNOSIS OF EPILEPSY (PRO-LONG).
MULTICENTRIC RETROSPECTIVE STUDYOF
PROGNOSTIC PATTERNS IN NEWLYDIAGNOSED
PATIENTS
S. Beretta*,†, E. Beghi‡, E. Bianchi‡, C. Zanchi*, D. Carone*,
M. Pirovano*, C. Trentini*, G. Padovano*, M. Colombo*,
G. Bogliun*, C. Ferrarese*,†, per il gruppo di studio PRO-
LONG
*University of Milano Bicocca, Epilepsy Center, San Gerardo
Hospital, Monza, Italy, †Milan Center for Neuroscience
(NeuroMi), Milano, Italy, ‡IRCCS Istituto di Ricerche
Farmacologiche Mario Negri, Milano, Italy
Purpose: The aim of the PRO-LONG study is to assess the long term
prognosis of epilepsy according to pre-defined prognostic patterns in
newly diagnosed patients.
Methods: This is a multicentric retrospective study recruiting 1000 uns-
elected patients, newly diagnosed with epilepsy in secondary or tertiary
epilepsy centers, with a minimum follow-up of 10 years. The interim
analysis of the first 504 recruited patients, with a mean follow-up of
15 years from diagnosis, is presented. Clinical, EEG and neuroimaging
data were collected, as well as remission periods (defined as seizure-free
periods longer than 12 months). Patients were classified in four prognos-
tic patterns: 1. Early remission: 1 + year remission from treatment onset
to last observation; 2. Late remission: 1 + year remission to last obseva-
tion after 1 + treatment changes; 3. Relapsing-remitting course: 1 +
remission periods and not in remission; 4. No remission: no 1 + year
remission period during follow-up.
Results: 29.2% of patients achieved remission (early or late), 61.9% dis-
played a relapsing-remitting pattern with at least 1 year of remission and
8.9% never achieved remission. Multivariate analysis showed that the
probability of achieving remission (early or late) was inversely associ-
ated with age at disease onset (0–14 vs. >14; p = 0.0334), duration of dis-
ease before diagnosis (p = 0.0277) and number of antiepileptic drugs
used (p < 0.0001). Epileptic syndromes and etiology did not show a con-
sistent effect on prognosis.
Conclusions: Long-term remission of epilepsy is achieved by about one
third of newly diagnosed patients and could be anticipated based on
demographic and clinical characteristics of the subject.
p0220
EARLY SEIZURES IN ACUTE STROKE
M. Chraa, N. Kissani
Mohammed VI University Hospital, Neurology, Marrakech,
Morocco
Purpose: The aim of this study was to assess the frequency and the pre-
dictive factors for early seizures as well the clinical outcome in patients
with first-ever stroke.
Method: A total of 352 consecutive patients with first-ever stroke,
admitted to our department, were included in this retrospective study.
Early seizures were defined as seizures occurring within 7 days from
acute stroke. Patients with history of epilepsy were excluded.
Results: About 47 patients (13%) had early seizure, and 8 had a status
epilepticus. We had 28 women and 19 men. The mean age was
71.6  14.6. They were significantly more common in patients with cor-
tical involvement, severe and large stroke, and in patient with cortical
associated hemorrhage. ES were associated with an increase in adverse
outcome (mortality and disability).
Conclusion: Early seizures occurred in about 13% of patients with acute
stroke. In these patients hemorrhagic transformation is a predictive factor
for ES. ES seem to be associated with a worse outcome after acute stroke
episode.
p0221
PARENTAL INFLUENCEONEPILEPSYRISK IN
SIBLINGS
J. Christensen*, M. Overgaard†, E.T. Parner‡,
M. Vestergaard§, D. Schendel¶
*Aarhus Universitetshospital, Neurology, Aarhus, Denmark,
†Aarhus University, Aarhus, Denmark, ‡Aahrus University,
Department of Biostatistics, Aarhus, Denmark, §Aarhus
University, Research Unit and Section for General Practice,
Department of Public Health, Aarhus, Denmark, ¶Aarhus
University, Department of Economics and Business, National
Centre for Register-based Research, Aarhus, Denmark
Purpose: The recurrence risk of epilepsy in full siblings is increased.
However, it is not known to what extent the recurrence is influenced by
parental factors. We studied the recurrence risk of epilepsy in full and
half siblings.
Method: This was a population-based cohort study in Denmark of all
children born in Denmark between 1980 and 2006. Children were identi-
fied and followed up to December 31. 2012. Children having an older sib-
ling with epilepsy were compared with children not having an older
sibling with epilepsy.We identified a maternal sibling sub-cohort derived
from mothers with at least two children and a paternal sibling sub-cohort
derived from fathers with at least two children.
Results: We followed 1,663,302 children born in Denmark. The overall
adjusted relative recurrence risk of epilepsy in siblings was 3.49 (95%
CI: 3.15–3.87). In the maternal cohort the overall recurrence risk was
3.68 (95% CI: 3.25–4.16) - in full siblings it was 3.78 (95% CI: 3.30–
4.33) whereas in half siblings it was 2.97 (95% CI: 2.20–4.02). In the
paternal cohort the overall recurrence risk was 3.37 (95% CI: 2.96–3.85)
- in full siblings it was 3.70 (95% CI: 3.23–4.25) whereas in half siblings
it was only 1.57 (95%CI: 1.00–2.44).
Conclusion: The risk of epilepsy in children having an older sibling with
epilepsy was 3–4 times increased compared with children not having an
older sibling with epilepsy. In the maternal cohort the risk was similar in
full and half siblings whereas in the paternal cohort the risk was lower in
half siblings. The difference in the recurrence risk between full- and half-
siblings in the paternal cohort supports the role of genetics in epilepsy,
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while the significant recurrence risk in maternal half-siblings may sup-
port the role of factors associated with pregnancy and the maternal
intrauterine environment in epilepsy.
p0222
HAEMORRHAGERELATEDTORENAL
ANGIOMYOLIPOMA IN PATIENTSWITHTUBEROUS
SCLEROSIS COMPLEX. A FRENCHANDNORWEGIAN
QUESTIONNAIRE STUDY
I. Cockerell*, M. Guenin†, Y. Kamaleri‡, K. Heimdal§,
M. Bjørnvold¶, K.K. Selmer*,**, O. Rouviere†
*Oslo University Hospital, National Center for Rare Epilepsy
Related Disorders, Oslo, Norway, †Ho^pital Edouard Herriot,
Department of Urinary and Vascular Imaging, Lyon, France,
‡Oslo University Hospital, Department of Reseach Adm. and
Biobank, Oslo, Norway, §Oslo University Hospital, Department
of Medical Genetics, Oslo, Norway, ¶Oslo University Hospital,
National Centre for Epilepsy, Division for Clinical
Neuroscience, Oslo, Norway, **Oslo University Hospital and
University of Oslo, Oslo, Norway
Introduction: Tuberous Sclerosis complex is a rare genetic disorder
which is characterized by benign tumours occurring in multiple organs.
The brain, kidneys, lungs and skin are most frequently affected. Common
symptoms are epilepsy, neurocognitive impairments, autism, and dys-
function in the renal and pulmonary organ systems. Angiomyolipomas
(AML) occur in 60–80% of the patients, and they tend to increase in size
with age. There is a risk of haemorrhage related to AMLs and the risk is
associated with the size of the lesion. Screening and monitoring of renal
lesions is indicated in all patients with TSC.
Purpose: To identify age of increased risk of renal bleeding in TSC
patients.
Method: A cross-sectional study on renal manifestations in TSC patients
was performed in France and Norway using a French questionnaire trans-
lated to local language. Three hundred and fifty seven patients were
recruited, 257 in France and 100 in Norway.
Results: Fifty four percent (n = 189) of those who answered (n = 350)
reported occurrence of AMLs (France, 143/254, 56%; Norway, 46/96,
48%).
Haemorrhage related to renal AML was reported in 11% of those who
answered (26/248; France, 19/172/11%; Norway, 7/ 76/ 9%).
We found indications of an increased risk of first incidence of bleeding
between 20–30 years, however the increase was small and may not be
clinically significant.
Conclusion: Our results show that occurrence of first incidence of bleed-
ing seems to be age-related.
p0223
DEVELOPMENTOFA PROGNOSTIC SCOREOFLATE-
ONSET SEIZURES AFTER ISCHEMIC STROKE
M. Galovic*,†, N. D€ohler†, M. Koepp*, M. Arnold‡, G. K€agi†,
B. Tettenborn†
*UCL Institute of Neurology, Department of Clinical and
Experimental Epilepsy, London, UK, †Kantonsspital St. Gallen,
Department of Neurology, St. Gallen, Switzerland, ‡University
Hospital Inselspital Bern, Department of Neurology, Bern,
Switzerland
Purpose: Seizures after stroke have a negative impact on clinical out-
come, however the prediction of the risk of post stroke seizures proved to
be difficult yet. We aimed to develop a prognostic score of late-onset
(>7 days) seizures after ischemic stroke.
Method: Between 2002 and 2008 we included 1200 consecutive acute
ischemic stroke patients in the prospective Stroke and Epilepsy Registry
of Eastern Switzerland (SERES) who received telephonic or clinical
follow up after 36  19 months. A prognostic score was developed
using multivariate logistic regression modeling and internally validated
with bootstrapping techniques.
Results: Late-onset seizures within 3 years of stroke onset occurred in
69 (6%) patients. Predictors were early onset seizures (5 points), corti-
cal involvement (4 points), neglect at initial evaluation (2 points),
involvement of the medial cerebral artery territory (2 points) and NIH
Stroke Scale at admission (NIHSS 4–10: 1 point; NIHSS >10: 2
points). Internal validation corrected for overoptimism found the
obtained 5 item score (range 0–15 points) to be a significant predictor
of late-onset seizures (p = 0.001). Model discrimination assessed with
the area under the receiver operating characteristics curve was
0.80  0.03 (p < 0.001) and the score was well calibrated (p = 0.18).
A score value of ≥ 10 points was 95% specific for late-onset seizures,
whereas a score value of ≤5 points hat a 99% negative predictive value
for late-onset seizures.
Conclusion: This easily applicable prognostic score was a good predic-
tor of the risk of late-onset seizures after stroke and might help guide
diagnostic and therapeutic decisions in these patients.
p0224
DEVELOPMENTOFA POST-STROKEEPILEPSYRISK
SCOREUSINGANADMINISTRATIVE CLAIMS
DATABASE
Y.-H. Huang*, L.-N. Chien†, N.-F. Chi*, Y.-C. Kuan*, H.-
Y. Chiou‡
*Taipei Medical University - Shuang Ho Hospital, Department
of Neurology, New Taipei City, Taiwan, Republic of China,
†School of Health Care and Administration, College of Public
Health and Nutrition, Taipei, Taiwan, Republic of China,
‡School of Public Health, College of Public Health and
Nutrition, Taipei, Taiwan, Republic of China
Purpose: To develop a scoring system to predict one-year risk of post-
stroke epilepsy.
Methods: We included 59,975 stroke patients in the derivate cohort
and 25,703 stroke patients in the validation cohort from the National
Health Insurance Research Database of Taiwan. The risk score for
post-stroke epilepsy was constructed with Cox regression analysis with
the time from stroke to epilepsy as the response and age, sex, the
stroke type, length of hospital stay and comorbidities as covariates.
The one-year risk of post-stroke epilepsy was calculated by summing
up the number of independent predictors weighted by their correspond-
ing beta-coefficients.
Results: In the derivate cohort, 3.0% of patients had post-stroke epilepsy
(N = 1776) within a year of follow-up. A four-point score was derived
based on multivariate Cox regression (subarachnoid hemorrhage or
intracerebral hemorrhage = 1, length of hospital stay >10 days = 1, his-
tory of atrial fibrillation = 1, and pneumonia within 14 days after
stroke = 1). The incidence of post-stroke epilepsy was 1.1 (95% CI: 1.0–
1.23) at low risk (score = 0), 3.3 (95% CI: 3.0–3.6) at medium risk
(score=1), 10.1(95% CI: 9.4–10.8) at high risk (score =2) and 17.5(95%
CI: 14.8–20.7) at very high risk (score ≧3) per 100 person-year.
Conclusion: The risk of post-stroke epilepsy can be stratified based on
the current scoring system. It might suggest that using the risk score
instrument in creating individualized patient management algorithms
and improving clinical practice aimed at preventing the occurrence of
post-stroke epilepsy.
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SYSTEMATIC REVIEWANDMETAANALYSIS OF
EPIDEMIOLOGYOFEPILEPSY IN LATIN AMERICA
S. Kapoor*,†, A. Kapoor*, C. Hun†,‡, V. Chan†,‡,
K. Srivastava§, A. Abdelrahman¶, M. Cruz**, B. Giagante††,
S. Chan†,‡, P. Nubukpo‡‡, D. Bhalla†,§§
*All India Institute of Medical Sciences, New Delhi, India,
†Cambodian Society of Neurology, Phnom Penh, Cambodia,
‡Calmette Hospital, Phnom Penh, Cambodia, §Bharati
Vidyapeeth University, Neurology, Pune, India, ¶University of
Khartoum, Khartoum, Sudan, **Ecuadorean Academy of
Neurosciences, Quito, Ecuador, ††El Cruce Hospital,
Department of Neurosciences, Buenos Aires, Argentina,
‡‡Centre Hospitalier Esquirol, Département de Psychiatrie,
Unité d’Addictologie, Limoges, France, §§Institute of
Neurological Epidemiology and Tropical Neurology, Limoges,
France
Purpose: Epilepsy is a worldwide neurological disorder and has two
broad aspects-lifetime and active epilepsy. We conducted a system-
atic review and meta-analysis of epilepsy in Latin America (LA), in
order to better present the needs related to epilepsy in this region,
with particular, but differentiating emphasis, on lifetime and active
epilepsy.
Method: Literature search was performed on Pubmed, LILACS, BV
Salud, and Google, using different keywords and their combinations (epi-
lepsy, epilepsia, prevalence, prevalencia, incidence, incidencia), except
on Google where free text search was conducted for each individual
country. Results are presented in counts, proportions, and medians along-
with 95% confidence intervals (CI). Unpaired t-test with unequal vari-
ance was conducted and so were the regressions by taking four variables
(study year, population size, age-group and population type), altogether
and individually, and seperately for lifetime and active prevalence as well
as incidence.
Results: In total, 42 prevalence (56 after including children-exclusive
studies, N = 751609) and seven incidence estimates (N = 487997) were
identified from 14 out of 26 countries between 1970 and 2009. Most
prevalence studies were from Columbia (n = 15) and Brazil (n = 10).
Active prevalence was reported by 14 studies while lifetime prevalence
was reported by 40 studies. Excluding children studies, median lifetime
prevalence was 17.0 (95% CI 13.0–19.7, range 1.0–43.2) and active
prevalence was 10.9 (95% CI 5.7–16.6, range 3.8–17.9). In LA, only,
64% of the total case-load requires active intervention for their epilepsy.
Incidence (/100,000) varied from 7.0 in Brazil to 190 in Ecuador and
median incidence was 92.7 (95% CI 16.0–181.2). Various methodologi-
cal issues were identified.
Conclusion: Lifetime prevalence of epilepsy is high but methodological
issues remain. Only, 64% of total case-load requires an active interven-
tion for their epilepsy. Because of more focus on lifetime epilepsy, treat-
ment gap is possibly over-estimated; yet >6.5 million need intervention
for their active epilepsy in LA.
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EPIDERMIOLOGYOF THEACCIDENTALDEATH IN
SEIZURE PATIENTS
Y. Lee*, J.P. Hong†, J.K. Kang*
*University of Ulsan College of Medicine/ AsanMedical Center,
Department of Neurology, Seoul, Republic of Korea,
†Sungkyunkwan University School of Medicine/Samsung
Medical Center, Seoul, Republic of Korea
Purpose: To evaluate the demographical profile of the seizure patients
who died by accident.
Methods: We retrospectively identified 115 patients who were treated
because of seizure in Asan medical center in Korea and died on account
of accident from January 1989 to December 2010. We excluded patients
who killed themselves and died by accident instantly. Finally total 71
patients were included. We confirmed whether the patients die or not
until December 2010 and cause of death through data of the National Sta-
tistical Office of Korea.
Results: Mean age when the patients visited our hospital for the first time
is 32.25 year-old ( 20.37 year) and mean age when the patients start to
seizure is 24.05 year-old ( 20.99 year). Among 71 patients, 55 patients
were man and 16 patients were female. Frequency of seizure: 0–2 times
per year is 28 cases (39.4%), 3–12 times per year is 20 cases (28.2%), 13–
49 times per year is 15 cases (21.1%), over 50 times per year is 8 cases
(11.3%). Etiology of death is traffic accident (29 cases), falling (17
cases), drowning (23 cases) and other (2 cases). Mean number of
antiepileptic drug is 1.71( 1.14 SD). Almost all patients have no men-
tal retardation (95.77%), familial history (91.55%) and psychiatric
history (92.96%). We classified epilepsy in 4 categories as generalized
seizure (1 case, 1.4%), partial symptomatic seizure (27 cases, 38%), par-
tial cryptogenic seizure (9 cases, 12.7%) and undetermined (34 cases,
47.9%). Electroencephalography shows normal finding (45.1%) or
abnormal findings including spike and sharp (43.7%) or slowing (9.9%).
Over half of patients (56.3%) have brain lesion in magnetic resonance
imaging which is congruent with seizure.
Conclusions: The results suggested that epileptic patients who died by
accident had taken more than 1 AED and usually had symptomatic partial
seizures with no mental retardation or psychiatric history.
p0227
NOCTURNAL FRONTALLOBEEPILEPSY (NFLE):
LONG-TERMOUTCOME INALARGECOHORT
L. Licchetta*,†, F. Bisulli*,†, L. Vignatelli‡, C. Rinaldi†,
I. Trippi†, L. Di Vito†, B. Mostacci*, I. Naldi*, G. Bernabé†,
G. Plazzi*,†, F. Provini*,†, P. Tinuper*,†
*IRCCS Instituto delle Scienze Neurologiche of Bologna,
Bologna, Italy, †University of Bologna, Department of
Biomedical and Neuromotor Sciences, Bologna, Italy, ‡Local
Health Trust of Bologna and Health and Social Regional
Agency, Emilia-Romagna Region, Bologna, Italy
Purpose: To evaluate the prognosis of NFLE in a large, representative
cohort with long follow-up.
Methods: We included consecutive patients attending our Institute,
diagnosed with NFLE on clinical and video-polisomnographic (VPSG)
criteria and a follow-up period ≥5 years. Terminal remission (TR) was
defined as seizure-free period of five or more consecutive years at the last
follow-up. Potential prognostic factors examined included “any underly-
ing brain disorder”, defined as at least one of the following: ID, patholog-
ical NE, brain abnormalities. To evaluate cumulative time-dependent
probability of achieving TR from onset, survival curves were generated
(Kaplan-Meier method). Univariate analysis (logrank test) and multivari-
ate analysis (Cox0s regression model) were performed to identify prog-
nostic predictors.
Results: The final cohort included 139 patients (M/F:92/47) with a med-
ian follow-up of 27 years (range: 5–65). Mean age at onset was
13.4  10.2 years (range 1–56). About 86% of patients are sporadic
cases, 14% had a positive history for epilepsy (5% ADSHE; 9.4% other
focal epilepsy). Twenty-two (15.8%) were lesional cases.
Thirty-three patients (23.7%) achieved TR, with a cumulative proba-
bility of 9%, 17%, 24% and 32% by 10, 20, 30 and 40 years from disease
onset, respectively.
At log-rank test, age at onset >11 years (median) and the absence of
“any underlying brain disorder” condition were significantly associated
with TR (p:0.048 and p:0.003). Cox model confirmed that the absence of
“any underlying brain disorder” correlates independently with TR (HR:
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3.47, CI 95% 1.04–11.58, p: 0.043). “Time to diagnosis” is inversely
associated with TR
(HR 0.93, CI 95% 0.89–0.97, p < 0.001).
Conclusions: Only about 25% of NFLE patients achieved TR after
30 years of disease. Absence of ID, structural brain abnormalities and
pathological NE is associated with a three-fold higher probability of TR.
The risk of not attaining TR increase by 7% per each year of delay in the
diagnosis.
p0228
CAUSE-SPECIFICMORTALITY IN EPILEPSY. A
SYSTEMATIC REVIEW
M.M. Watila*, S.A. Balarabe†
*University of Maiduguri Teaching Hospital, Department of
Medicine, Maiduguri, Nigeria, †Usman Danfodio University
Sokoto, Department of Medicine, Sokoto, Nigeria
Purpose: Epilepsy is associated with premature mortality, having a two
to three folds increased risk of early death when compared to the general
population. A systematic review was conducted to investigate the causes
and determinants of premature mortality.
Method: A standardised search of online databases was made and
selected suitable articles published between 1980 and 2014. The study
extracted and reported the overall and cause-specific standardized mor-
tality (SMR) and proportional mortality ratios (PMR).
Results: Twenty articles from eighteen cohorts met the inclusion criteria
and were retrieved for qualitative synthesis. There were twelve popula-
tion-based studies from nine cohorts and eight hospital-based studies
from nine cohorts. The main findings revealed that people with epilepsy
(PWE) have an overall increased risk of mortality, with an SMR range of
1.6–6.5 for population-based study and 1.4–3.6 for hospital-based study
compared to the general population. They are at higher risk of dying from
various medical conditions directly or indirectly related to occurrence of
seizure. PWE were at increased risk of dying from cancer, stroke, cardio-
vascular disease, drowning, status epilepticus, SUDEP, suicide and road
accidents. Deaths from low- and middle-income countries were higher
for epilepsy-related deaths, whilst in high-income countries mortality
was higher for causes indirectly-related to epilepsy. Mortality was ele-
vated in the young compared to the elderly. There is an increase in the
risk of death in all aetiological causes of epilepsy, especially in those with
symptomatic epilepsy and congenital deficits.
Conclusion: Despite the heterogeneity and wide variation in the
reported data, the finding in this study supports the evidence that PWE
are associated with increased mortality. More research is needed to bet-
ter understand the mechanisms, and to determine biomarkers for pre-
dicting mortality, with more efforts put in order to prevent this excess
mortality.
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EPILEPSYANDELDERLY
S. Akbulut*, M. Dedei Daryan*, B. Tekin Güveli*, D. Ataklı*,
S. Şenadım†, C. Dayan*, M. Yatmazoglu*
*Bakirkoy Research and Training Hospital for Psychiatry,
Neurology, Neurosurgery, Department of Neurology, Istanbul,
Turkey, †Bakırk€oy Education and Research Hospital for
Psychiatric and Neurological Diseases, Department of
Neurology, Istanbul, Turkey
Purpose: Epilepsy in the elderly is an important and increasingly com-
mon clinical problem. The prevalence and incidence of epilepsy are high-
est in later life with around 25% of new cases occurring in elderly people.
The main reason for such a high incidence of epileptic seizures in elderly
patients is the number of acute symptomatic (or situation-related) sei-
zures. Major known causes include cerebrovascular disease, brain tumor,
degenerative disorders such as Alzheimer disease, metabolic distur-
bances, traumatic brain injury, tumor, or drug therapy. The purpose of
this study is to illuminate most common etiological factors and prognosis
of epilepsy in elderly.
Method: In this study, 49 patients, with represented seizures over age
65 years, were analyzed retrospectively. We examined patients accord-
ing to demographic and clinical properties, seizure etiology, the elec-
troencephalogram, neuroimaging and other additional neurological and
systemic disorders.
Results: 23 of the patients (46.9%) were men and 26 of them (53.1%)
were women. The mean age of patients was 75  8. In order of the most
common causes were post-stroke seizure (36.7%), acute stroke present-
ing with seizure (14.3%), tumor (10.2%) and metabolic (10.2%). Infec-
tion, drug interruption and metabolic factors were found the most
common causes of seizure in 23 of patients with previously known epi-
lepsy. In EEG, epileptiform activity was showed only in 12 of patients.
Four patients were died and their etiological factors were stroke present-
ing with seizure (1), dementia (1), brain tumor (2). Others patients were
discharged with partial recovery.
Conclusion: The etiologic factors of epilepsy are different in elderly
people than young people. Because of many comorbid diseases, manage-
ment of the older patients with epilepsy is more difficult. So we must be
aware of epilepsy in elderly.
p0230
ACUTE SYMPTOMATIC SEIZURESANDEPILEPSY IN
ELDERLY
A. Ali
Labaid Specialized Hospital, Neurology, Dhaka, Bangladesh
Purpose: Though epilepsy is thought to be a disease of early age, it is
even most common among persons aged 65 and older. When an elderly
patient presents with acute confusion, neuroimaging is normal and no
metabolic disturbances, an epileptic seizure or nonconvulsive status
epilepticus must be considered. We have got 60 hospital admission
patients diagnosed as acute symptomatic seizures during last 6 months.
Hyponatremia was the leading cause. After that acute stroke and nonke-
totic hyperglycemia were common causes. Epilepsy patients in old age
admitted into hospital following a old stroke which was confirmed by
neuroimaging was a leading cause of epilepsy. Neurodegenerative disor-
der with cognitive impaitment was a frequent etiology of epilepsy. Sleep
related seizures were also found. In intensive care units, during last six
months 20 patients present with acute confusional state. Neuroimaging
was normal and no metabolic abnormalities were found. EEG shows
epileptiform activities and patients improved with antiepileptic drugs. So
acute stroke and remote stroke both are causes of seizures in elderly
patients. Neurodegenerative brain disorders are also causes of epilepsy in
elderly patients. Any acute confusional state patients should be evaluated
for nonconvulsive status epilepticus.
p0231
CLINCAL FEATUREANDCAUSEONEPILEPSY IN
THEELDERLYOFWESTERNCHINA
L. Chen*, P. Feng†, Y. Li*, Y. Huang*, D. Zhou*
*West China Hospital in Sichuan University, Neurology,
Chengdu, China, †Chengdu University of Traditional Chinese
Medicine Hospital, Chengdu, China
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Purpose: To investigate the common causes, clinical characteristics and
prognosis of epilepsy in Chinese old populations in recent decade.
Method: 340 epilepsy elders over 65 years old in western China were
continuously registered during 2003 to 2013, and their epileptic causes,
clinical characteristics, outcomes were prospectively recorded.
Results: The onset age of 96.47% patients was after 65 years old. The
most common causes of epilepsy were cerebral infarction (38.24%),
brain surgery (9.71%), cerebral hemorrhage (7.65%). 54.73% patients
had generalized tonic-clonic seizure and 37.57% had focal epilepsy,
7.10% have generalized tonic clonic seizure secondary to focal epilepsy.
80.59% patients were controlled by anti-epilepsy drugs (AEDs), andmost
of them take only one kind of AEDs. A total of 172 cases underwent EEG
examinations, and 73.26% of them have abnormal discharge. All patients
were followed up to date at least 12 months, and there were 139 patients
(40.88%) alive, 81 patients (23.82%) dead, 120 patients (35.29%) loss. In
those patients alive, 88 patients had no epilepsy recurrence. The progno-
sis in those patients with onset age after 65 years old was better than
those ones whose onset before 65 years old (v2=6.82, p = 0.03).
Conclusion: Most patients here had first epilepsy after 65 years old. The
major cause of epilepsy is cerebral infarction, and generalized tonic-clo-
nic seizure is the main epilepsy type. Epilepsy could be under control in
most patients taking one kind of AEDs. There is correlation between the
epilepsy prognosis and onset age, with statistical significance. However,
the lost of follow up rate of our study is higher, which may be related to
the common phenomenon “Empty nest elders” in China, and many
patients could not attend to hospital for follow-up. As a result, the estab-
lishment of a complete health care guarantee system is urgent to assist the
follow-up elder patients.
p0232
EPILEPSY IN ELDERLY PATIENTS ANDAFFECTIVE
DISORDERS
A.K. Druzhinin*, V.A. Mikhailov†
*Psychoneurological Research Institute, Psychosomatyc
Neurorehabilitation, Sankt-Peterburg, Russian Federation, †St.
Petersburg V.M. Bekhterev Psychoneurological Research
Institute, Sankt-Petersburg, Russian Federation
Introduction: This makes the issues of epilepsy in elderly patients and
of emotional and affective disorders more and more topical.
Study objectives: To study the structure of non-psychotic psychiatric
disorders (NPD) in post-stroke elderly patients and in patients with symp-
tomatic post-stroke epilepsy.
Materials and methods: Two groups of 105 patients were studied. In
Group 1 (65 patients: 31 men and 34 women), the stroke was complicated
by the development of symptomatic post-stroke localization-related epi-
lepsy. In Group 2 (40 patients: 28 men and 12 women), no paroxysmal
states of the epileptic nature were found. The average age of Group 1
patients was 63.00 years, of Group 2 patients, 62.5 years.
Results: In Group 1, affective depression-spectrum disorders were found
more frequently than in Group 2 (Group 1 - 78.9%; Group 2 - 33.3%),
whereas in Group 2, affective anxiety-spectrum disorders were found
more frequently than in Group 1 (Group 1 - 21.1%; Group 2 - 66.7%).
The average depression score in Group 1 and Group 2 was 34.81  2.73
and 28.57  3.07 on the BDI scale and 21.84  1.50 and 13.79  1.36
(p ≤ 0.01) on the HRDS scale, respectively.
In Group 1, a considerable correlation dependence between the index
of the impact of depression and anxiety on the manifestation of other psy-
chopathological factors (up to .819**) and the General Severity Index
(GSI) was found. In Group 2, a weak correlation dependence between
anxiety and the GSI (up to .828*).
Conclusion: The study results have shown a high severity of depression
in elderly patients with symptomatic post-stroke epilepsy.
p0233
ANTIEPILEPTIC DRUGUSEANDEPILEPTIC
SEIZURES IN ELDERLYNURSINGHOMERESIDENTS
IN THE PROVINCEOF PAVIA, NORTHERN ITALY: A
REAPPRAISAL 12 YEARSAFTERA FIRST SURVEY
C.A. Galimberti*, E. Tartara*, S. Dispenza*, E. Bonizzoni*,†,
E. Perucca*,†
*IRCCS - C. Mondino National Neurological Institute, Epilepsy
Centre, Pavia, Italy, †University of Pavia, Department of
Internal Medicine and Therapeutics, Pavia, Italy
Purpose: To assess the prevalence of antiepileptic drug (AED) use and
epileptic seizures among nursing home residents and to compare findings
with a previous survey conducted in 2000.
Method: We collected data on demographics, age at institutionalization,
functional and cognitive status (Barthel’s Index and MMSE), chronic
drug use and diagnoses of all subjects aged ≥60 in 21 nursing homes.
Data from residents with a diagnosis of epileptic seizures and AED users
were compared with non-seizure, non-AED subjects. Results were com-
pared with the previous study.
Results: Among the 2,163 subjects surveyed (79% females, age at obser-
vation 84.9  7.8 years, mean  SD), 278 (12.8%, vs. 4.3% in the pre-
vious survey) received chronic treatment with AEDs, in 174 cases
without a diagnosis of seizures. The 116 residents with a diagnosis of sei-
zures (5.4%, vs. 2.9% in the previous study) were mostly on AED treat-
ment and had a significantly lower age (both at observation and
institutionalization), lower cognitive abilities, and a significantly higher
number of comorbidities and co-medications compared with non-AED-
users and the whole sample. The most common AEDs in seizure subjects
were phenobarbital (43.3%, vs. 70% in the previous survey) and leve-
tiracetam
(27.9%, not available at the time of the previous survey). At multivari-
ate analysis, a diagnosis of seizures was significantly associated with a
younger age at observation, a history of neurological (cerebrovascular
events, meningiomas) and non-neurological conditions (psoriasis and
chronic bronchitis), and a lower MMSE score.
Conclusion: The prevalence of AED use and seizures was higher than in
our previous study and more aligned with data from other countries. Sei-
zures, AED use and co-morbidities were associated with earlier institu-
tionalization. Utilization of newer and possibly more appropriate AEDs
was > 12 years ago, although treatments appeared to be suboptimal in
many cases.
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EPILEPSY IN ELDERLY PATIENTS
G. Halac*, H.R. Bilgen†, G. Kocaman†, E. Niftaliyev†,
C. Deniz†, T. Asil†
*Bezmialem Vakif University, Department of Neurology,
Istanbul, Turkey, †Bezmialem Vakif University, Istanbul, Turkey
Purpose: The incidence of new-onset epilepsy is higher among the
elderly. In this study, we present the demographic characteristics, etio-
logical factors, seizure types and response rates to treatment in the
patients with delayed-onset epilepsy whose age was 65 or older.
Method: A total of 43 patients with delayed-onset epilepsy diagnosis
aged 65 or older who were admitted to epilepsy clinics of Neurology
Department of Medical Faculty of Bezmialem University were included
in this study. Medical records of patients were evaluated retrospectively.
Results: Of the patients, 24 were male, 19 were female and the mean age
was 74.9 (66–92). Underlying diseases were found to be cerebrovascular
disease in 16 patients, brain tumor in 8, neurodegenerative diseases in 4,
and trauma in 2 patients. In 2 patients, serebrovascular disease and neu-
rodegenerative disease were both present. In the rest 11 patients, any etio-
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logical cause couldn’t be found. Based on seizure types, 20 patients had
secondarily generalized tonic clonic seizure, 13 had generalized tonic
clonic seizure, 6 had simple partial seizure and 1 had generalized tonic
seizure. EEG findings were neither lateralized nor localized in 16
patients, both lateralized and localized in 11 and only lateralized in 2
patients. In 14 patients, EEG examination was normal. Based on treat-
ment protocols, 40 patients were taking monotherapy and 3 patients had
combination of two antiepileptic drugs. When assessing the side effects
of drugs, there was no complaint in 38 patients. In the last 3 months, 2
patients experienced 1 seizure and other patients were seizure free.
Conclusion: The most common etiological factor of new-onset epilepsy
was found as cerebrovascular disease among elderly patients. Secondar-
ily generalized tonic clonic seizure was the most common seizure type.
In most of the patients, EEG findings were neither lateralized nor local-
ized. All patients responds well to monotherapy and have a good progno-
sis.
p0238
CLINICAL EXPERIENCEWITHESLICARBAZEPINE
ACETATEWITH FOCUSONELDERLY
M.K. Nielsen, V. Petrenaite, N. Andersen Becser
University Hospital of Copenhagen, Rigshospitalet and Glostrup
Hospital, Epilepsy Clinic, Department of Neurology, Glostrup,
Denmark
Background: Eslicarbazepine acetate (ESL) is with its favorable safety
profile a widely used newer antiepileptic drug (AED) in adults with focal
epilepsy. Age is a major factor influencing the pharmacokinetic profile
of AEDs. Tolerability of ESL and whether there is need for dose-adjust-
ments in elderly have not yet been reported.
The main aim of this study was to evaluate the effect and side effects
of ESL in our patients at age 60 years or older.
Method: The retrospective analysis of 74 patients with focal epilepsy
treated with ESL was carried out at the Epilepsy Clinic, Glostrup Hospi-
tal, Denmark. The subgroup of 13 patients aged 60 years or older was
selected. Data were collected by reviewing the patients’ clinical and labo-
ratory files. The course of ESL treatment, doses, concomitant AEDs, sei-
zure frequency and adverse effects to ESL has been analysed.
Results: The sex distribution was 54% men and 46% women with a
mean age of 69.5 years (60–82). Epilepsy was caused by a structural
brain lesion in 11 cases. In seven patients ESL was initiated due to lack of
seizure control and in six due to adverse effects to previous AEDs. Five
patients shifted to ESL from OXC and needed 12–65% lower dose to
achieve seizure control, while two shifted from CBZ.
All the patients with uncontrolled epilepsy achieved better seizure
control on ESL add-on. However, seizure reduction was not significant
(p = 0.07) after at least six months of treatment.
Good tolerability was seen in 10 patients. The most common adverse-
effect was somnolence. ESL was withdrawn because of side-effects (in
three cases) and lack of seizure control (one case).
Conclusion: Although our study group is small, the results indicate that
ESL has an advantageous profile according to seizure control and well-
tolerated also in elderly. Further prospective studies are needed to con-
firm these data.
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POST-STROKEEPILEPSY IN ELDERLY PATIENTS
A.A. Sadykova*, R.V. Magzhanov*, S.R. Nurmukhametova*,
A.V. Lebedeva†
*Bashkir State Medical University, Ufa, Russian Federation,
†N.I. Pirogov Russian National Research Medical University,
Moscow, Russian Federation
Purpose: To estimate disease progression peculiarities, cognitive
impairments, life quality in patients with post-stroke epilepsy.
Method: 21 patient with post-stroke epilepsy (1st group) and 12 patients
with a stroke without epilepsy (2nd group) were examined according to
the following parameters: clinic and anamnesis, MOCA test, HADS
scale, SF-36 scale.
Results: A stroke with its focus located in the right hemisphere was
exposed in 67% of patients in the 1st group and in 83% of patients in the
2nd group. Post-stroke seizures developed in 196.72  36.45 days. Sec-
ondary generalized seizures were observed in 35% of patients, while
65% of patients had simple motor seizures. MOCA test results in the 1st
group were 22  1, 11 points, in the 2nd group 25.2  1.98 points.
Pursuant to life quality assessment SF-36, physical functioning index
(PF) was equal to 48.5  7.22 points in the 1st group and 34.3  6.5
points in the 2nd; role-physical index evaluating physical problems
impact to disability (RP) amounted to 11.25  4.61 points in the 1st
group and 0 points in the 2nd; social functioning index (SF) was equal to
57.1  6.95 points in the 1st group and 60.67  7.33 points in the 2nd;
role-emotional index evaluating emotional problems impact to disability
(RE) was 25.0  7.81 points in the 1st group and 5.5  3.7 points in the
2nd; mental health index amounted to 50.15  5.5 points in the 1st group
and 46.67  5.5 points in the 2nd; physical health index (PH) in the 1st
group was 35.4  2.12 points, mental health index (MH) was
34.0  2.91 points in the 1st group, 32.0  1.89 and 32.17  2.07
points in the 2nd group correspondingly.
Conclusion: Terms of post-stroke epileptic seizures manifestation were
196.72  36.45 days, dextrocerebral stroke, simple motor seizures pre-
vailed. Depression was more typical in patients who suffered a stroke
without epilepsy, while cognitive impairments severity was higher
among patients with post-stroke epilepsy.
p0240
ELDERLY SUBJECTSWITHNEWLY-DIAGNOSED
FOCALEPILEPSYOFUNKNOWNCAUSE
E. Tartara, C.A. Galimberti
IRCCS C. Mondino National Neurological Institute, Epilepsy
Centre, Pavia, Italy
Purpose: To report clinical, EEG and neuroimaging characteristics of
elderly subjects with new-onset unprovoked epileptic seizures of
unknown cause.
Method: Medical records of subjects consecutively referred to our out-
patient practice since 2005, with a diagnosis of unprovoked focal epilep-
tic seizures of unknown cause with age at onset ≥60 performed by one of
us (CG) and maintained after a one-to-20-year follow-up, were reviewed
to collect demographics, clinical, EEG, neuroimaging data and treatment
outcomes. CT/MRI signs of leukoaraiosis and/or non-focal cortical atro-
phy were not considered as aetiological factors. Subjects with psy-
chogenic seizures and major psychiatric and cognitive disorders were
excluded.
Results: Eighty patients (40 females) aged (mean  SD)
70.5  6.6 years at seizure onset and 77.7  6.4 years at the last obser-
vation, with a single (six subjects) or recurrent unprovoked seizures (74
subjects) were identified. Fifty-two (65%) patients had seizures with
impairment of consciousness whose semiology suggested a temporal
lobe origin, 24 (30%) convulsive attacks during wakefulness, 26 (32.5%)
sleep-related convulsive seizures. At seizure onset: standard EEG (S-
EEG) detected interictal epileptiform abnormalities (IEAs) in nine
patients (11.2%); 24-hour home-recorded ambulatory EEG performed in
70 subjects, detected IEAs in 52 (mainly or exclusively during 3–4
NREM sleep in 27), involving temporal lobe derivations in all cases. All
patients underwent brain neuroimaging (MRI in 57 cases), with normal
findings in 38 patients, leukoaraiosis in 41 and/or non-focal cortical atro-
phia in three. Forty-one patients (51.2%) became seizure-free for at least
one year taking the first AED (at the lowest target dose in 38 of them).
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Conclusion: In our series, late-onset focal epilepsies of unknown cause
seem to be mainly of temporal lobe origin, and show a favourable
response to AED treatment. First S-EEG showed a poor sensitivity in
these patients; however, spontaneous sleep EEG recordings revealed a
remarkable propensity to express IEAs predominantly during 3–4 NREM
sleep stages.
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EPILEPSY SURGERY INCHILDRENAND
ADOLESCENTS: OUTCOME IN RELATIONTO
ETIOLOGY, LOCATIONANDEPILEPSYDURATION
M. Aberastury, B. Comas, G. Besocke, C. Ciraolo, G. Agosta,
W. Silva
Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
Purpose: Epilepsy surgery reportedly produces remarkable results in
terms of seizure outcome and quality of life for medically intractable
focal epilepsy in children. We reviewed the epilepsy characteristics and
duration, neuroradiologic findings, pathologic findings, surgical
approaches, complications and clinical outcomes in pediatric patients fol-
lowing an epilepsy surgery.
Method: Prospective observational study that included 43 consecutive
patients (20 males) with drug-resistant focal epilepsies between 2005 and
2014.
Results: The median age at epilepsy onset was 4.0 years (range, 0–
14 years) and the median age at surgery was 10 years (range 1–
21 years), with a median epilepsy duration of 6 years, longer in children
with an epilepsy onset between 7–9 years (p > 0.05). The epilepsy syn-
dromes identified were: focal symptomatic epilepsy (n = 38), West syn-
drome (n = 1), and Rasmussen0s syndrome (n = 4). Histopathology
revealed: malformation of cortical development (n = 19), gliosis
(n = 10), tumor (n = 6), Rasmussen0s encephalitis (n = 4), hippocampal
sclerosis (n = 3) and dysembryoplastic neuroepithelial tumor (n = 1).
After a median follow up of 5.4 years, 27 patients (68.8%) had an
Engel 1, (9/11 hemipherotomies, 2/3 posterior epilepsies, 9/13 temporal
epilepsies, and 7/16 of the frontal epilepsies), with a median epilepsy
duration of 6 years. (engel 2-3-4, median duration of 5 years, p = 0.7).
Resective surgery was performed in all patients, with chronic invasive
neurophysiology in 31 (72.1%) Functional hemispherotomy was per-
formed in 11 patients, with a median epilepsy duration of 3 years. 9/11
were seizure free (p = 0.13).
Conclusion: In out study population we observed that patients who
underwent functional hemispherotomy had a shorter epilepsy duration
and better outcome, however it was not statistically significant.
p0244
PERCEPTUALDISTURBANCES AFTEREPILEPSY
SURGERY
P. Braga, A. Bogacz, A. Scaramelli
Epilepsy Section, Institute of Neurology, Facultad de Medicina,
Universidad de la Republica, Montevideo, Uruguay
Purpose: To present and discuss data on unexpected perceptual changes
found in patients after epilepsy surgery.
Method: As part of routine follow-up after epilepsy surgery, patients
were asked to refer post-surgical modifications in mood, perception and
behavior. All adult patients operated on since April 2010, able to provide
reliable data, were included.
Results: 5 out of 15 patients reported changes in perception, experienced
as enhanced perception of specific sensory modalities in all cases, and
transient in time in 4: 2 olfactory, 2 visual, 1 auditory. They lasted from 3
to 9 months, and were usually associated to changes in mood and/or
libido. All cases were resective surgeries: 3 mesial temporal sclerosis, 1
perventricular nodular heterotopia, 1 tumor.
Conclusion: Perceptual, as well as behavioral, sexual and mood
changes, should be addressed in patients after epilepsy surgery. The iden-
tification of these phenomena could help to understand ictogenesis and
compensatory mechanisms involving changes of excitability in func-
tional networks somehow connected to epileptic foci.
p0246
CASE REPORT - TEMPORALOR FRONTALEPILEPSY
T. Chepreganova-Changovska*, E. Cvetkovska†,
B. Boshkovski‡
*Hospital Clinic Sistina, Dept.of Neurology, Skopje, Macedonia,
the Former Yugoslav Republic of, †University Clinic of
Neurology, Department of Epilepsy, Skopje, Macedonia, the
Former Yugoslav Republic of, ‡University Clinic of Neurology,
Skopje, Macedonia, the Former Yugoslav Republic of
Purpose: Patient DL 18 year old right handed forwarded from Pediatric
Clinic with frequent complex partial seizure. MRI read with normal
range. Seizures duration was 30 sec., patient stare, left arm hanging with
hand making discrete pendulous movements (flapping), tap with his left
leg sometimes with urination but without generalized seizure. The sei-
zure started from unexpected and noisy sound (ring bell, screaming).
Method: Controlled MRI was made (dual pathology- right frontal Tay-
lor displasia and right temporal hippocampal sclerosis), EEG with foto-
stimulation, Video EEG(sharp and slow waves complexes localized over
the right frontal- temporal region with contra lateral transmission).
Results: For the last 6 months the seizure has lasted longer from few
minutes to several hours. It has been started like before with difficulty in
breathing and gazing, with flapping on the left arm and leg which produce
automatisms (opening and closing the watch, or replacing something in
the room etc) .
Conclusion: It is needed to think in different direction about aetiology of
the seizures, possible temporal or frontal epilepsy.
p0247
MORBIDITY ANDMORTALITY ASSOCIATEDTO
DEEP ELECTRODES IMPLANTATION (SEEG) IN
REFRACTORY EPILEPSY
C. Ciraolo, G.L. Garategui, J.A. Rasmussen, S. Beltrame,
M. Toscano, B. Comas, M.D.C. Garcia, W. Silva
Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
Purpose: To determine the complications rate related to deep electrodes
implantation (stereoelectroencephalography-SEEG) for pre-resective
topographic diagnosis of the epileptogenic zone.
Method: Retrospective analysis involving patients implanted with deep
electrodes carried out by the Department of Neurosurgery, Hospital Ital-
iano de Buenos Aires, since November 2009 to December 2014. The
implantations were performed under stereotactic guidance and were
planned through merger of Angiography and Magnetic Resonance Imag-
ing. Were excluded those patients who were simultaneously implanted
with subdural grids. For complications analysis was used Wellmer0s.
Both relevant data patients and surgical management were collected.
Results: A total of 287 depth electrodes were placed in 22 implantation
procedures. The average age was 32.5 (21–58) years. From the total 9
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cases were men and 12 cases were women. On average, 13.0 (6–20) elec-
trodes were placed per procedure, bilaterally in 12 (54.5%) of them. The
average time of VEEG monitoring was 6.6 (2–19) days. There were 2
(9.1%) patients presenting postoperative complications due to develop-
ment of intracerebral hematoma, requiring surgical evacuation. Tomo-
graphic anomalies were detected in control scans without clinical impact
in three patients (lineal subarachnoid hemorrhage, intracerebral hema-
toma, laminar subdural hematoma; respectively).
The overall incidence of complications was 1.7% per electrode, while
clinically relevant complications were 0.7% per electrode. There were no
deaths.
Conclusion: The SEEG is useful for a correct identification of epilepto-
genic zone. This allows a good delination of brain electrophysiology, and
can study in a 3D fashion the epileptogenic networks. the use of elec-
trodes is a safe process when associated with a proper execution of the
preoperative preparation, planning implantation and surgical technique.
p0248
WEST SYNDROMEASSOCIATEDTOUNILATERAL
MESIAL TEMPORAL SCLEROSIS
C. Cukiert*,†,‡, A. Cukiert*,‡, J. Burattini*, P. Mariani*,
R. Guimaraes‡
*Clinica de Epilepsia de Sao Paulo, Department of Neurology,
Sao Paulo, Brazil, †Santa Casa de Sao Paulo, Sao Paulo, Brazil,
‡Faculdade de Medicina do ABC, Sao Paulo, Brazil
Purpose: Children with West syndrome often present with refractory
and life-threatening seizures. Primary treatment is medical, but surgical
options have been considered in very refractory patients. Resective pro-
cedures, mostly involving the posterior quadrant were performed in
selected cases; neuromodulation has been sparsely employed. MRI is
rarely positive. We describe a kid with West syndrome associated to a
focal, usually epileptogenic lesion (mesial temporal sclerosis).
Method: This 1.5 year-old boy started having spasms by the age of
9 months. By that time, spasms were symmetric. Ictal and interictal EEG
showed diffuse bilateral spike and wave discharges and an hysparhytmic
background. MRI showed left hippocampal edema by the time of seizure
initiation. He was treated with high dose AEDs, ACTH, ketogenic diet
and cannabidiol. At presentation, spasms were slightly asymetric (right
side predominance). EEG showed diffuse spike-and-wave-discharges
and multifocal activity prevailing over the left posterior quadrant. MRI
showed left mesial temporal sclerosis. PET showed marked temporal
lobe hipometabolism. Development was retarded; at presentation he was
sedated and was not able to sit.
Results: He was submitted to a temporo-parieto-occipital resection.
There was a 90% reduction in spasms’ frequency, which from then on
concentrated on night-time. At one month postoperatively he was much
more alert and able to sit with help. Pathological examination of the tem-
poral lobe specimen showed mesial temporal sclerosis; the parietal-occi-
pital cortex was normal.
Conclusion: This kid greatly benefited from surgery, suggesting that the
removed cortex was indeed involved in his epileptogenesis. Mesial tem-
poral sclerosis is rarely seen in kids with West syndrome. It is likely that
mesial temporal sclerosis represented an epiphenomenum of a prevailing
left hemisphere epileptogenesis and not the etiology of this kid’s epileptic
syndrome.
p0249
REFLEX SEIZURES INDUCEDBY SENSORY STIMULI:
A SEEG STUDY
L. De Palma*, A. De Benedictis†, S. Cappelletti‡, F. Vigevano*,
C.E. Marras†, N. Specchio*
*Division of Neurology, Department of Neuroscience, Bambino
Gesu Children’s Hospital IRCCS, Rome, Italy, †Neurosurgery
Unit, Department of Neuroscience and Neurorehabilitation,
IRCCS Bambino Gesu Children’s Hospital, Rome, Italy, ‡Unit of
Clinical Psychology, Department of Neuroscience, Bambino
Gesu Children’s Hospital, IRCCS, Rome, Italy
Seizure precipitation by sensory stimuli is a well-known condition in
which a specific stimulus can induce a specific type of seizure. Photo-
sensitive epilepsy is the best characterized syndrome. In the 2011–
2015 period we studied 22 patients (M/F: 9/13) affected by focal epi-
lepsy with SEEG. Among them two male patients presented focal sei-
zures following somato-sensory stimuli. The first patient is a 28 year-
old man with seizures characterised by a focal paresthesia in the left
hand followed, after 30’’, by an impairment of consciousness, some
oral and bilateral gestural automatism. Secondary generalization were
quite frequent (1–2 every month). The seizures were caused by sudden
stimuli in the left arm or emotion. The interictal and ictal EEG showed
a fronto temporal involvement. He was then studied with a right
perisilvian SEEG exploration who evidenced a primary posterior insula
involvement with diffusion in the SII region and opercular region. The
second patient is a 5 year old boy with seizures characterized by left
clonic buccal jerking. Jerks were mostly related to stimuli in the left
inferior dental arch mainly induced by tooth brushing or by speaking.
Like the previous patient sudden emotions can induce seizure. The
SEEG, mainly centered in the central operculum, evidenced a quite
extended ictal origin encompassing the central insulo-opercular region
with a fast diffusion over the inferior part of the rolandic sulcus. Till
nowadays some SEEG data come from seizures induced by eating and
startle in which the insula and the SMA region, respectively, are the
most involved regions. Here we report the first two patients with reflex
seizures caused by somatosensory stimuli showing a clear cut epilepto-
genic zone in the central and post-central insulo opercular region high-
lighting the importance of the insula and SII region in the genesis of
the reflex seizure.
p0250
ICTAL SEMIOLOGYCANDISCRIMINATE TEMPORAL
FROMEXTRATEMPORALLOBE SEIZURES: THE
ETESSMODEL
F. Deleo*, V. Pelliccia†, L. Tassi†, F. Villani*, V. Chiesa‡,
G. Didato*, R. Mai†, S. Francione†, M.P. Canevini‡,
R. Spreafico*
*IRCCS Foundation, Neurological Institute ‘C. Besta’,
Clinical Epileptology and Experimental Neurophysiology Unit,
Milan, Italy, †Niguarda Hospital, ‘Claudio Munari’ Epilepsy
Surgery Centre, Milan, Italy, ‡University of Milan, Department
of Health Sciences, EpilepsyCenter, San Paolo Hospital, Milan,
Italy
Purpose: The aim of the present study is to develop and validate a com-
putational model (ETESS: extratemporal and temporal epilepsy seizure
semiology scale) to differentiate temporal from extratemporal lobe sei-
zures, based on ictal semiology.
Method: We retrospectively analyzed 128 consecutive seizures recorded
during pre-surgical monitoring at the three participating centers. Only
patients with at least 1 year of follow-up after surgery and with a favor-
able outcome (Engel’s class Ia) were admitted to this study. Video-EEG
recordings of each seizure were independently and blindly analyzed by
three experts. Fourteen symptoms and 15 signs, as well seizure duration,
were analyzed for each seizure, and included in the computational model.
In order to create and test the model all seizures were randomly divided
in two groups: the “training group”
(103 seizures) and the “testing group” (25 seizures). ETESS was built
on the training group calculating the odd ratio for each sign and symptom
using multiple logistic regression analysis.
Epilepsia, 56(Suppl. 1):3–263, 2015
doi: 10.1111/epi.13241
68
Abstracts
Results: In the testing group ETESS model recognized 19/25 sei-
zures and the accuracy is 76%. The positive predictive value in rec-
ognizing a temporal lobe seizure is 73% whereas the negative
predictive value is 80%. There is a significant association between
the ETESS prediction and the lobe of seizure onset (Fisher exact
test p = 0.015).
Conclusion: ETESS can be a useful tool in distinguishing temporal from
extratemporal lobe seizures, particularly when planning epilepsy sur-
gery.
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RETROSPECTIVEANALYSIS OF EPILEPSY SURGERY
PATIENTS: A SINGLECENTER EXPERIENCE
K. Deniz*, S. Akkol*, M. Uzan†, Ş. Delil‡, C. Yalcınkaya‡,
A. Dervent†, C .Özkara‡
*Istanbul University Cerrahpasa Faculty of Medicine, Istanbul,
Turkey, †Istanbul University Cerrahpasa Faculty of Medicine,
Neurosurgery, Istanbul, Turkey, ‡Istanbul University
Cerrahpasa Medical Faculty, Department of Neurology,
Istanbul, Turkey
Purpose: Surgery is a widely approved approach to long-standing epi-
lepsy patients for whom the pharmacological option is both an eco-
nomical burden for the patients and a futile way to compensate the
disease.
Method: Epilepsy surgery started in our department 20 years ago. We
performed a retrospective study on total 449 surgery patients starting
from 1995 to 2015. Patients’ operation dates, the age at operation, socioe-
conomic status, localization of the lesion, the pathologies and the opera-
tion type were collected and analyzed.
Results: Of the patientes analyzed 50% (225) were women and 50%
(224) were men. 15% (69) of patients were under the age of 12, 13%
(60) were between 13–18, 66% (297) were between 19–45 and 3%
(13) were over 45. There were 7 patients younger than 2 years.
According to years: 15% (67) were operated before 2000, 25%(111)
between 2000–2004, 30%(135) between 2005–2009, 28%(126)
between 2010–2014, unknown %2(10). 39.9%(179) of patients pre-
sented with mesial temporal sclerosis (MTS), 19.2%(86) with cortical
dysplasia (CD), 18.7%(84) with tumoral lesions, 6.7% (30) with dual
pathology, 1.1% (5) with developmental anomalies, 3.3%(15) with vas-
cular lesions, 7.1%(32) others. %4(18) patients underwent corpus cal-
losectomy, functional hemispherectomy and partial hemispherectomy.
Ten patients were lost to follow-up. Througout years the incidence of
mesial temporal sclerosis and cortical dysplasia have changed recipro-
cally. MTS before 1999-%18(32), 2000–2004:%41(73), 2005–2009:%
20(36), 2010–2014:%21(38). CD before 1999- %6(5), 2000–2004:%6
(5), 2005–2009:%44(38), 2010–2014:%44(38). Surgery techniques dif-
fered according to the time and type of the operation such as:14%(63)
amigdalohippocampectomy,34.3%(154) temporal lobectomy, 43%
(193) non-specific excision,0.7%(3) corpus callosectomy 4.2%(19)
Hemispherectomy, 0.4%(2) lobectomy(frontal and occipital). It is note-
worthy to state that the trend in amigdalohippocampectomy declined
and replaced with anterior temporal lobectomy.
Conclusion: Epilepsy surgery is an effective treatment in well selected
cases. The pathology and surgical procedures are changing during the
years. Moreover number of children is increasing including the very
young ages.
p0252
SAFETY PROFILEOF STEREOTACTIC DEPTH
ELECTRODERECORDINGS INDRUGRESISTANT
EPILEPSY
B. Mathon*,†, V. Dinkelacker†,‡, H. Belaid*, C. Adam‡,
D. Hasboun§, V.-H. Nguyen-Michel‡, L. Bédos-Ulvin†,
M. Baulac†,‡, S. Dupont†,‡, V. Navarro†,‡, P. Cornu*,
S. Clémenceau*
*Hopital Pitié-Salpe^triere, Neurosurgery, Paris, France, †ICM,
Paris, France, ‡Hopital Pitié-Salpe^triere, Epilepsy Unit, Paris,
France, §Hopital Pitié-Salpe^triere, Neuroradiology, Paris,
France
Purpose: Invasive stereo-electroencephalography (SEEG) with depth
electrodes is a common approach to identify the epileptogenic focus
in intractable partial epilepsy. The purpose of this study was to ana-
lyze the safety profile of depth electrode implantation in an experi-
enced tertiary center and to identify possible risk factors for
complications.
Method: We retrospectively examined the adverse events in the course
of 163 procedures of depth electrode implantation performed in our insti-
tution between 1991 and 2014 in patients aged 15 to 60 years (mean
32.4 years). Implantation schemes comprised mostly oblique SEEG
(n = 128) but also occipito-hippocampal Spencer electrodes in combina-
tion with strip electrodes (n = 35). A majority of patients (58.9%) had
MRI negative non-lesional epilepsy. Complications were scaled in 5
grades of severity and classified as major (requiring treatment or leading
to neurological impairment) or minor.
Results: The rate of overall complications was 4.9%, and complications
classified as major occurred in 3.1% of procedures, but none were asso-
ciated with permanent morbidity or mortality. Clinically relevant infec-
tion occurred in 1.2% and hemorrhage in 3.7% of patients, respectively.
One case of epidural hematoma requiring emergency evacuation is
reported. Collapsed over all patients, the risk of hemorrhage per elec-
trode was 4.4&. We identified only one significant risk factor for
adverse events: MRI negative cryptogenic epilepsy, which was associ-
ated with a higher risk of overall (p = 0.04) and hemorrhagic (p = 0.04)
complications. This might well be related to a higher number of
implanted electrodes in non lesional versus lesional epilepsy. There was
no correlation between the implantation technique and the overall com-
plication rate.
Conclusion: Depth electrode implantations have a favorable safety pro-
file. However, despite a well-standardized surgical technique, invasive
workup can in rare cases lead to serious complications. Thus, the proce-
dure requires a careful assessment of risks and benefits.
p0254
THE EVOLVINGROLEOFMRI GUIDEDLASER
ABLATION IN RESECTIVE EPILEPSY SURGERY
D. Eliashiv*, S. Dewar†, J. Stern†, I. Fried†
*UCLA School of Medicine, Neurology, Los Angeles, CA, USA,
†UCLA School of Medicine, Los Angeles, CA, USA
Purpose: Recognition of indications,outcome and management of
patients undergoing MRI Laser Ablation as an alternative to open cran-
iotomy resective epilepsy surgery.
Method: Review of last 5 cases treated with MRI Guided Laser Abla-
tion.
Results: One patient with occipital periventricular heterotopia and four
patients with hypothalamic hamartomas(HH) were treated with MRI
Guided Laser Ablation. All patients with HH showed significant
improvement in seizure control even if non gelastic seizures occured.
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One patient developed transient global amnesia and a second had signifi-
cant cerebral edema. The patient with heterotopia showed significant
reduction in seizures.
Conclusion: MRI Guided Laser Ablation provides a minimally invasive
alternative to open resective epilepsy with good seizure outcome but
awareness of potential complications should be noted.
p0255
COGNITIVEOUTCOMESANDCORTICAL
METABOLIC ACTIVATIONCHANGESOFDIFFERENT
SURGICALAPPROACHES INMESIAL TEMPORAL
LOBEEPILEPSY
C.A. Bing€ol*, B. Aktekin*, O. Eranıl Terim*, N. Selcuk†,
E.Özdeniz Varan‡, B. Ormeci*, C. Sayman*, U. Ture§
*Yeditepe, Neurology, Istanbul, Turkey, †Yeditepe, Nuclear
Medicine, Istanbul, Turkey, ‡Yeditepe, Neurophysicology,
Istanbul, Turkey, §Yeditepe, Neurosurgery, Istanbul, Turkey
Purpose: Epilepsy surgery is a succesful treatment option for drug
resistant focal epilepsies. However, cognitive impairment is very com-
mon in epilepsy patients and could be negativetly or positively affected
by surgery. Long-standing debate of whether different surgical
approach for mesial temporal lobe epilepsies may be superior with
regards to seizure control as well as cognitive outcome. We aimed to
investigate seizure control, cognitive outcome and cortical metabolic
activation changes between two different selective amygdalohippocam-
pectomy (SA) techniques in patients with unilateral mesiotemporal lobe
epilepsy (MTLE).
Method: In this study, thirty-three patients with unilateral MTLE (17
females, mean age: 31.6 years, 12 right side) were enrolled. All of them
were evaluated by routine pre-op test for MTLE (including neuropsycho-
logical tests, 18-flurodeoxyglucose positron emission tomography
(PET), magnetic resonans imaging (MRI), video-EEG). As for the surgi-
cal approach, five patient had standart AH+ anterior temporal lobectomy,
11 patient had transsylvian hippocampal transection and 17 patient had
paramedian supracerebellar-transtentorial PSTA. Post operative seizure
outcome, neuropsychological test results and PET scan were evaluated.
Results: Thirty-two patients had complete follow-up. Twenty-seven
patient were class I and thee patient were class II seizure freedom was
achieved. There were differences in memory outcome between the sides
of operation, and between the operation types. On the left side, neuropsy-
chological test results were significantly improved in PSTA group
(p < 0.05) Additionally, cortical metabolic activation changes before
and after operation and between the surgery types were different. The
PSTA group showed significant improvement on statistical parametric
mapping of cortical metabolic activation values (p < 0.05).
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HFODETECTION IN INTRA-OPERATIVE ECOG
RECORDINGS: VALIDATIONOFATIME-
FREQUENCYBASEDAUTOMATIC DETECTOR
T. Fedele*, S. Burnos*,†, M. van ‘t Klooster‡, N. van Klink‡,
W. Zweiphenning‡, M. Zijlmans‡,§, J. Sarnthein*
*University Hospital Zurich, University of Zurich,
Neurosurgery, Zürich, Switzerland, †Institute of
Neuroinformatics, ETH Zurich, Zürich, Switzerland, ‡Brain
Center Rudolf Magnus, Department of Neurology and
Neurosurgery, University Medical Center Utrecht, Utrecht, the
Netherlands, §SEIN-Stichting Epilepsie Instellingen Nederland,
Heemstede, the Netherlands
Purpose: High frequency oscillations (HFOs) in the electrocorticogram
(ECoG) have recently been shown by several centers to be a specific bio-
marker for epileptogenic tissue. Time consuming and subjective visual
inspection prevents to benefit from the HFO information in intraopera-
tive sessions. While several automatic HFO detectors have been pro-
posed, we validate here our time-frequency based HFO detection
algorithm (Burnos et al., 2014).
Methods: Pre-resection intra-operative ECoG (N = 7 patients, 2xN
recordings of 1 minute) was recorded at 2048 Hz in the UMC Utrecht
and HFO events were marked visually. For each patient, we optimized
the detector’s parameters defining baseline and threshold on a first data-
set (training), and validated it on a second dataset (test). The performance
was quantified in terms of ROC (Receiving Operator Curve). Automatic
detection of a visually marked event was considered as a True Positive
(TP). A correctly undetected baseline interval was a True Negative (TN).
False Positives (FP) were events detected but not marked visually, and
False Negatives (FN) were undetected but visually marked events.
Results: In the ECoGwith visually marked HFOs, we achieved high sen-
sitivity and specificity (across patients TP rate>0.95, FP rate <0.01). The
detector robustly identified baseline intervals (low FP rate). Optimal tun-
ing of baseline and threshold parameters over 1 minute data emulated
visual detection for each single patient (high TP rate). Interestingly, in
the ECoGwithout visually marked HFOs, in test sessions the method pro-
vides very low FP rate (<0.01), corresponding to a very high specificity.
Conclusion: Our semi-supervised HFO detector rapidly and accurately
emulates experienced visual HFOmarking, which is currently considered
the gold standard. It thereby holds promise for future clinical application.
p0257
COMPARISONOFAUTOMATICALLYDETECTED
PREOPERATIVEHIGHFREQUENCYOSCILLATIONS
(HFOS)WITHCLINICALOUTCOME
T. Fedele*, O. Schmid*, S. Burnos*,†, N. Krayenbühl*,
P. Hilfiker‡, K. K€onig‡, T. Grunwald‡, J. Sarnthein*
*University Hospital Zurich, University of Zurich, Zurich,
Switzerland, †Institute of Neuroinformatics, ETH Zurich,
Zurich, Switzerland, ‡Swiss Epilepsy Center, Zurich,
Switzerland
Purpose: In recent years, invasively detected interictal HFOs - Ripples
(R, 80–250 Hz) and Fast Ripples (FR, 250–500 Hz) - have been sug-
gested as a reliable biomarker for epileptogenic tissue identification.
Nevertheless, the functional significance of R and FR still remain to be
clarified. A crucial aspect regarding the characterization of HFOs is their
detection, which is mainly performed by visual marking, a highly time
consuming process affected by subjective criteria. Here we present an
innovative automatic detector, in order to describe the role of HFOs in
comparison to the clinical outcome.
Method: Preoperative invasive data from five epileptic patients, three
with good and two with poor clinical outcome, has been analyzed with a
two stage automatic detector, based on instantaneous spectral estimation.
This detector has been previously validated on a visually marked dataset.
The analysis has been conducted separately for R (80–250 Hz) and FR
(250–500 Hz) events. Areas with high HFO occurrence were compared
with the clinically identified Seizure Onset Zone (SOZ) and the area of
surgical resection.
Results: In patients with temporomesial electrodes, we observed both R
and FR, while FR were more rarely detected in cortical signals. In
patients with good outcome, we observed a high specificity of FR, while
in 1/3 cases we observed the detection of possibly physiological R con-
tralateral to the SOZ. In patients with poor clinical outcome, R and FR
occurred in a subset of contacts showing epileptiform potentials and were
present also outside resected areas.
Conclusion: The time-frequency based automatic HFO detection pro-
vides a rapid assessment of their potential contribution. The simultaneous
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presence of R and FR shows a high specificity for the epileptogenic zone.
The mismatch between the HFO area and the SOZ in patients with poor
outcome needs further HFO investigation, now supported by an automa-
tized tool.
p0258
ELECTROCORTICOGRAPHIC LANGUAGEMAPPING
WITHALISTENINGTASKCONSISTINGOF
ALTERNATING SPEECHANDMUSIC PHRASES
A.H. Mooij*,†, G.J.M. Huiskamp*, P.H. Gosselaar*,
C.H. Ferrier*
*University Medical Center Utrecht, Brain Center Rudolf
Magnus, Department of Neurology and Neurosurgery, Utrecht,
the Netherlands, †Montreal Neurological Institute, McGill
University, Montreal, Canada
Purpose: Electrocortical stimulation mapping (ESM), the gold standard
in pre-surgical language mapping of epilepsy patients, is time consum-
ing, requires good patient cooperation and carries the risk of inducing
afterdischarges and seizures. Electrocorticographic (ECoG) mapping of
high gamma activity induced by language tasks has been proposed as an
alternative, but it often reveals more areas involved in language process-
ing than those considered critical with ESM. We investigated if critical
language areas can be localized with a listening task consisting of speech
and music phrases.
Method: Nine patients with implanted subdural grid electrodes listened
to a short audio fragment in which music and speech alternated four
times. We analysed ECoG power in the 65–95 Hz band and used princi-
pal component analysis to obtain task-related activity patterns in elec-
trodes over language areas. We used t-tests to determine if discrimination
between listening to speech and music was significant. The spatial distri-
bution of discriminating sites was compared to ESM results using sensi-
tivity and specificity calculations.
Results: Electrodes with significantly more high gamma activity dur-
ing listening to speech compared to music or vice versa (‘speech’ and
‘music’ electrodes) were identified on the superior temporal gyrus and
inferior frontal gyrus. Compared to ESM, our test of alternating speech
and music phrases had a low sensitivity (0.32) but a high specificity
(0.95).
Conclusion: Our test cannot replace ESM, but this short and simple task
can give a reliable indication where to find critical language areas, better
than ECoG language mapping using language tasks alone.
p0259
COMPARISONOFNON-HARMONICITY ANDHIGH-
FREQUENCYOSCILLATIONS IN INTRA-OPERATIVE
ELECTROCORTICOGRAPHYDATA
E.E. Geertsema*, M. van ‘t Klooster†, G.H. Visser*,
S.N. Kalitzin*, M. Zijlmans*,†
*Stichting Epilepsie Instellingen Nederland (SEIN), Heemstede,
the Netherlands, †University Medical Center Utrecht, Rudolph
Magnus Institute for Neuroscience, Utrecht, the Netherlands
Purpose: During epilepsy surgery, biomarkers in intra-operative electro-
corticography (ECoG) can be of great value in guiding the neurosurgeon
by effective delineation of the epileptogenic zone (EZ). We investigate
the ability of a fast and automated algorithm, the AutoRegressive model
Residual variation (ARR), to identify electrode positions delineating
epileptogenic tissue. This was done by determining the correspondence
between ARR and the amount of high-frequency oscillations (HFOs; 80–
500 Hz).
Method: We analysed pre-resection intra-operative ECoG recordings
of three patients with refractory focal epilepsy (2 temporal, 1 fron-
tal). Per patient one-minute epochs in one or two grid orientations
were selected, resulting in a total of five epochs. In each epoch we
visually marked HFOs, resulting in a ripple (80–250 Hz) and fast rip-
ple (FR; 250–500 Hz) rate per channel. ARR measures high residual
variation after autoregressive model fit to quantify the presence of
non-harmonicity in the signal. ARR values were calculated per chan-
nel for the same epochs and for five-second artefact-free sub-selec-
tions (ARR5). We analysed the association between ARR or ARR5
results and the ripple and FR findings, using Pearson’s correlation
coefficient, q.
Results: 93 channels were analysed in total; 79 showed ripples and 20
showed FR. Combining results from the total dataset, correlation analysis
between ripples and ARR showed q = 0.73, and q = 0.72 for ARR5.
Comparison with FR results showed even stronger correspondence:
q = 0.89 for ARR and q = 0.82 for ARR5. All findings were significant
with p < 0.0001.
Conclusion: These preliminary results suggest correspondence between
brain areas producing HFOs and areas producing high ARR values, espe-
cially for more pathological FRs. Moreover, results indicate only a short
five-second epoch is sufficient to obtain reliable ARR results. This
method could be a valid tool for online intra-operative delineation of the
EZ, as it is quick and easy to compute and requires only a very short mea-
surement.
p0260
FORAMENOVALEELECTRODES: “ANOLDNEW
FRIEND”. OBSERVATIONAL STUDY
D. Gomez Meza*, H. Carmona Villada†
*Universidad CES - Neurocentro, Neurology, Medellin,
Colombia, †UAM - Neurocentro, Medellin, Colombia
Purpose: Describe our experience with Foramen Ovale Electrodes and
to determine the abillity of foramen ovale electrodes to localize and later-
alize epileptogenic foci in patients referred to the VideoEEGMonitoring
department in a center in colombia.
Method: We identified patients who had undergone to Foramen Ovale
Investigation for to localize and lateralize epileptogenic foci in the Video
Monitoring department of our center Neurocentro in Colombia by three
years, between July of 2011 to July 2014 and analyzed retrospectively
the surgical outcomes after the procedure, the indication for to underwent
to videoEEG + FOE, average of time of register and take conclusions, the
final result of VideoEEG + FOE study. all patients were followed up and
were grouped on into three categories:
(1) patients who underwent to surgery epilepsy. and freedom of sei-
zures after the follow up.
(2) patients who underwent to medical treatment,
(3) patients who the study was no conclusive.
Results: Sixteen patients underwent VideoEEG + FOE investigation,
all of them were conclusive. The first indication to indicate VideoEEG
+ FOE was lateralize epileptogenic foci 16 (100%), the average of
time register was 72 hours (+/- 12 hours), Adverse Events was
reported in 1(6%) a cerebral abscess 1 week after the FOE implanta-
tion, It was solved with antibiotic treatment, without sequelae. 7 (43%)
were determinated to be appropriate candidates for resective surgery. 9
(56%) were to medical treatment, for consider them at high risk for
verbal memory déficit after surgery or poor candidates for surgical
treatment.
Conclusion: We have evidence, that the Foramen ovale Electrodes
implantation after 24 hours of initial register, is a safety procedure and a
conclusive method when it is add to VideoEEG, that we can use for later-
alize the inicial ictal foci, in a Latinoamerican country where advance
techniques of images are not broadly available.
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IDENTIFYING PATIENTSWITH
PHARMACORESISTANT EPILEPSYUSINGA PLASMA-
BASED TEST
S. Avansini*, B. Lima*, R. Secolin*, M. Santos*, A.C. Coan†,
A. Vieira*, B. Carvalho*, M. Alvim†, F. Torres*, L. Silva†,
F. Rogerio‡, F. Cendes†, I. Lopes-Cendes†
*University of Campinas, Medical Genetics, Campinas, Brazil,
†University of Campinas, Neurology, Campinas, Brazil,
‡University of Campinas, Anatomical Pathology, Campinas,
Brazil
Purpose: Refractory epilepsy occurs in ~30% of all patients and major
causes are focal cortical dysplasia (FCD) and mesial temporal epilepsy
(MTLE). Epilepsy surgery can be performed in order to achieve seizure
control; nevertheless, this indication may be may delayed due to a long
clinical investigation. Therefore, the identification of biomarkers for phar-
macoresistant epilepsy could improve diagnosis and decrease of this time.
Circulating microRNAs (miRNAs) are potential candidates to be used as
biomarkers. These small noncoding RNA have been associated with dif-
ferent disease states. In this context, the objectives of this study are
i) to determine if changes in expression of three candidate miRNAs,
previously associated with mechanisms underlying MTLE and FCDs:
hsa-miR-23a, hsa-miR-31 and hsa-miR-134 are present in plasma of
patients with pharmacoresistant seizure and
ii) to verify if plasma levels of these miRNAs can distinguish between
patients who respond to antiepileptic drug (AED) treatment and those
who are resistant to drug treatment.
Methods: We determined plasma levels of these miRNAs by qPCR.
This study is divided into two stages: an initial discovery phase and a val-
idation study. In the first trial, miRNAs were quantified in 18 patients
with FCD, 14 patients with MTLE, both with refractory epilepsy and 16
controls. To further verify the discriminating power of these miRNAs we
accessed an additional cohort of patients with MTLE, divided into
patients who are responsive to AED therapy (n = 38) and unresponsive
(n = 40), as well as control subjects (n = 80). We used ROC curve and
Wilcoxon test, corrected by Bonferroni.
Results: Our preliminary results indicate that hsa-miR-31 is up-regu-
lated in patients with FCD and MTLE when compared to controls; more-
over, hsa-miR-31 was able to distinguish patients with and without
epilepsy, with AUC of 0.785.
Conclusions: Elevated hsa-miR-31 is a potential non-invasive biomarker
for pharmacoresistant epilepsy. Further validation studies are under way.
p0262
BROAD-SPECTRUMANALYSIS OF POLYMORPHISMS
INVOLVED IN PHARMACOGENOMICSOFDRUG-
RESISTANT EPILEPSY. PRELIMINARYRESULTSOF
ANONGOING STUDY
D. Chatzistefanidis*, L. Lazaros†, E. Siarava*, K. Giaka†,
A.P. Kyritsis*, I. Georgiou†, S. Markoula*
*University Hospital of Ioannina, Neurology Department,
Ioannina, Greece, †University Hospital of Ioannina, Medical
Genetics and Assisted Reproduction of Obstetrics-Gynaecolog,
Ioannina, Greece
Purpose: To investigate the combined role of a broad spectrum of poly-
morphisms involved in pharmacogemics of drug-resistant epilepsy
patients accounting of almost 30% of total patients despite the recent
advances in therapeutics.
Method: Two hundred consecutive patients were recruited in the study.
All their electroclinical and imaging data were recorded and patients
were classified according to their pharmacoresistance. Patients were
genotyped for polymorphisms of proteins implicated in three steps of
pharmacokinetics and pharmacodynamics: a) drug absorbance and trans-
portation (ABCB1 and ABCC2), b) drug metabolism (UGT1A6,
UGT2B7, CYP2C9, CYP2C19 and EPHX1) and c) target-proteins
(SCN2A). In total, patients were genotyped for 17 polymorphisms,
which, according to literature, are mostly implicated in drug-resistance.
This study has been co-financed by the European Union (European
Regional Development Fund) and Greek national funds through the
Operational Program “THESSALY- MAINLAND GREECE AND
EPIRUS-2007-2013” of the National Strategic Reference Framework
(NSRF 2007–2013).
Results: Genotyping has been completed in 69 patients (38 males). Sub-
jects’ median age was 37 years. Median age of epilepsy onset was
18 years. Twenty five patients (36%) have pharmacoresistant epilepsy.
There was no statistically different distribution of genotypes and alleles
tested with the exception of G2677A/T of ABCB1 protein (p = 0.049)
and a trend for G1249A of ABCC2 protein (p = 0.090). This may suggest
a possibly significant role of transport proteins in absorbance and distri-
bution of antiepileptic drugs in drug-resistant patients.
Conclusion: The small number of genotyped patients does not allow any
final conclusions. Of interest is the approach of investigation of possible
interactions across different steps of pharmacokinetics and pharmacody-
namics in drug-resistant epilepsy. Literature lacks such broad approaches
which are necessary to understand the complexity of pharmacoresistance.
As soon as our study is complete, the aforementioned approach
could be assayed and decided if it is worthy to be tested in larger popula-
tions.
p0263
TARGETEDNEXTGENERATION SEQUENCINGAS A
DIAGNOSTIC TOOL IN 163 PATIENTSWITH
EPILEPTIC ENCEPHALOPATHIES
H.A. Dahl*, L.H.G. Larsen*, K. Olofsson†, M. Miranda‡,
J.E.K. Nielsen§, L. Lavard¶, K. Linnet**, P. Uldall†,††,
T. Talvik‡‡, I. Talvik‡‡, M. Frangu§§, P. Born¶¶, P. Gellert†,
M. Nikanorova†,***, B. Jepsen†, D. Marjanovic†, B. Kragh-
Olsen†††, M.-B. Mosbech*, Q. Hao*, K. Brusgaard*,
H. Hjalgrim†,***, R.S. Møller†,***
*Amplexa Genetics, Odense, Denmark, †Danish Epilepsy
Centre, Dianalund, Denmark, ‡Herlev University Hospital,
Department of Pediatrics, Herlev, Denmark, §Roskilde Hospital,
Department of Clinical Medicine, Section of Gynaecology,
Obstetrics and Paediatrics, Roskilde, Denmark, ¶Hvidovre
Hospital, Børneafdelingen, Hvidovre, Denmark, **Aarhus
Universitetshospital, Børneafdelingen, Aarhus, Denmark,
††Copenhagen University Hospital, Pediatric Clinic,
Copenhagen, Denmark, ‡‡Tartu University Hospital, Childrens
Clinic, Tartu, Estonia, §§Holbæk Hospital, Department of
Pediatrics, Holbæk, Denmark, ¶¶Copenhagen University
Hospital, Department of Pediatrics, Copenhagen, Denmark,
***University of Southern Denmark, Institute for Regional
Health Services, Odense, Denmark, †††Aarhus
Universitetshospital, Department of Pediatrics, Aarhus,
Denmark
Purpose: Epilepsy is one of the most common neurological disorders,
and is known to have a very heterogeneous background with a strong
genetic contribution. In recent years several genes have been associated
with epilepsy. However, making a genetic diagnosis in a patient can still
be challenging as there is both genetic heterogeneity for a given epilepsy
syndrome and phenotypic heterogeneity for a specific gene. The aim of
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this study was to develop a diagnostic screening method to analyze the
genetic basis of childhood epilepsies.
Method: A gene panel targeting 45 known epilepsy genes was devel-
oped for next generation sequencing. Potentially causative variants were
evaluated by literature and database searches and submitted to bioinfor-
matic prediction algorithms. Variants were verified by Sanger sequenc-
ing and parents were included for segregation analysis. We used this
panel on an unselected cohort of 163 patients, sequentially referred for
panel testing. The majority of the patients had a range of epileptic ence-
phalopathies or childhood epilepsies.
Results: We identified a presumed disease-causing mutation in 40 of
163 patients. The aberrations encompassed known and unknown point
mutations in several different genes e.g. SCN1A, STXBP1, CDKL5,
SCN2A, SCN8A, CHD2, GNAO1, GABRA1, GABRB3, KCNA2, STX1B.
All mutations were confirmed by conventional Sanger sequencing and,
when possible, validated by parental testing and segregation analysis.
A clinical follow-up showed that the genetic diagnosis had lead to
changes in medication in at least 10 of the patients.
Conclusion: We have developed a rapid and cost-efficient screening
panel for the analysis of the genetic basis of childhood epilepsies. With
this panel we were able to find a disease-causing genetic variation in 25%
of the analyzed patients. Furthermore, this study demonstrates the poten-
tial for a genetic diagnosis to guide antiepileptic treatment.
p0264
EPILEPSY PHENOTYPE IN PATIENTSWITHDOUBLE
CORTEX: ANARGENTINE SERIES
R.A. Diaz, B. Comas, W. Silva, M. Abetastury
Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
Purpose: To analyze the clinical and neuroradiological features of
patients whit double cortex.
Method: A retrospective descriptive study was performed of 10 patients
whit diagnosis of HSB from January 2000 until June 2013.
Results: The mean age was 22 years, the average age of onset, 3.5 years,
60% were women. 40% had focal seizures, 20% generalized seizures and
40% both. Most patients had symptomatic focal epilepsy related to local-
ization 50%, followed by 30% unclassifiable and 20% Lennox Gastaut
syndrome. All had refractory epilepsy and developmental delay. Eight
patients with moderate developmental delay and 2 severe. In the elec-
troencephalogram, 50% had focal discharges, 40% both and 10% not pre-
sent. The MRI showed diffuse involvement, 3 with anterior
predominance and 2 with back predominance. The average number of
drugs used was 6. Valproic acid was the most AED indicated (9p), fol-
lowed by lamotrigine and carbamazepine (8p). The semiology was
related to the focal dominance of the double cortex. (p 0.0039)
Conclusion: We found an association between the seizure semiology
and focal predominance double cortex. No significant difference was
found in other clinical variables and neuroradiological subclassification.
p0265
NOVELHCN IONCHANNELSMUTATIONS IN
IDIOPATHICGENERALIZED EPILEPSY
J.C. Di Francesco*,†, B. Castellotti*, R. Milanesi‡, I. Riva†,
M. Bonzanni‡, A. Barbuti‡, A. Castucci*, S. Magri*,
C. Gellera*, T. Granata*, E. Freri*, F. Ragona*,
L. Canafoglia*, M. Casazza*, S. Binelli*, S. Franceschetti*
*Foundation Carlo Besta Neurological Institute, Milano, Italy,
†San Gerardo Hospital, University of Milano-Bicocca, Monza,
Italy, ‡University of Milano, Milano, Italy
Purpose: The Ih current, generated by the hyperpolarization-activated,
cyclic nucleotide-gated (HCN) channels, controls intrinsic excitability in
neurons. Because of their role, defective HCN channels are natural candi-
dates in the search for the causes of epilepsy. We previously identified
the firstHCN2 recessive mutation (E515K) in generalized epilepsy (IGE)
(DiFrancesco et al., 2011). Recently,HCN1 de novomutations have been
identified in early infantile epileptic encephalopathy (EIEE) (Nava et al.,
2014). So far, there are no reports of HCN4mutations linked to epilepsy,
even if this channel is highly expressed in the CNS.
Methods: For this study, we recruited 226 IGE patients (children and
adult subjects, both sporadic and familiar cases), characterized by clini-
cal, pharmacological, neuroradiological and electrophysiological data.
Patients were screened to search for mutations inHCN channels (isoform
1, 2, 4), using Next Generation Sequencing (NGS) TruSeq Custom
Amplicon (Illumina).
Results: We report the identification of the first mutation on HCN4
(R550C) in two male brothers, both affected by juvenile myoclonic epi-
lepsy. Interestingly, this mutation affect the Arg550 residue of hHCN4
that is strategic for the correct channel’s activity.
In one drug-resistant IGE case, we identified the L157V de novomuta-
tion on HCN1, located on the S1 domain of the channel. Notably, the two
sisters of the proband, both affected by absence epilepsy responsive to
drug treatment, resulted negative for this mutation.
Conclusion: We report the first evidence in humans of a mutation on
HCN4, presumably responsible for epilepsy. This result, together with
the identification of a novel HCN1 mutation, support an important role
played by HCN channels in the pathogenesis of generalized epilepsies.
Further studies are needed to better understand the pathogenetic mecha-
nisms linking epilepsy to the dysfunction of HCN activity, potentially
proposing these channels as possible therapeutic targets for the treatment
of the disease.
p0267
FAMILIAL TREMOR, EPILEPSY ANDMENTAL
RETARDATION
S. El Tawil, A. Gaber, A. Fouad, N. El Nahhas, M. Hemeda,
M.A. El Etribi
Ain Shams University, Cairo, Egypt
Purpose: Familial cortical tremor, myoclonus, and epilepsy is a well
described epilepsy syndrome that was first reported in Japanese families
and later in European families. We describe an Egyptian family with tre-
mor, epilepsy, and mental retardation with an autosomal dominant pat-
tern of inheritance.
Method: Patients were recruited from outpatient clinics of Ain Shams
University hospitals. Affected family members were invited for clinical
examination. EEG and imaging studies were reviewed.
Results: The family included a father and two of his children. The father
was 55 years old at the time of assessment. He had mild action tremors of
the upper limbs that appeared in early adolescence and reached a peak in
his early thirties then became less disruptive as he grew older. His son
was 21 years old at the time of assessment. He had an IQ of 52. At the
age of 10 he developed coarse action tremors involving both hands that
increased in severity with time and interfered with daily activity such as
dressing and feeding. At the age of 20 the patient started to experience
generalized tonic clonic seizures. Neurological examination confirmed
coarse postural and action tremors of both upper limbs and neck. EEG
showed diffuse background slowing but no focal activity. MRI of the
brain is unremarkable. The daughter was 23 at the time of presentation.
She had an IQ of 54. She developed frequent GTC seizures from the age
of 13, and CPS, likely of temporal origin from the age of 21. Seizures
were well controlled on a combination of carbamazepine and valproate.
Neurological examination revealed fine postural and action tremors of
the upper limbs but is otherwise unremarkable. Inter-ictal EEG and MRI
showed no abnormality.
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Conclusion: The clinical features in this family make autosomal domi-
nant cortical myoclonus with epilepsy the most likely diagnosis.
p0268
FAMILIAL FOCALEPILEPSY: DOES LOCALIZATION
MATTER?
S. El Tawil, A. Gaber, A. Fouad, N. El Nahhas, M. Hemeda,
M.A. El Etribi
Ain Shams University, Cairo, Egypt
Purpose: Studies in epilepsy genetics have often followed the traditional
classification dividing epilepsies into generalized and focal, and then fur-
ther classifying focal epilepsy based on seizure localization. This
approach led to the identification of genetic focal epilepsy syndromes
ADNFLE, ADLTE and ADFEVF. The classification of familial focal
epilepsy based on localization of seizures may not be justified. To test
this, we compared clinical features in a group of patients with familial
temporal and frontal lobe seizures.
Method: Patients were recruited from the outpatient clinics of Ain
Shams university hospital based on clinical features of partial epilepsy
and positive family history of epilepsy or febrile convulsions. Patients
with history or investigations evidence of an underlying lesion were
excluded. Patient’s evaluation included detailed clinical and family his-
tory, neurological examination, EEG and brain MRI. Patients were fur-
ther classified according to presumed lobe of origin.
Results: The study involved 23 patients (10 males), with a mean age of
21.87 + /-10.6 years. Diagnosis was temporal lobe epilepsy in 15
patients and frontal lobe epilepsy in 8 patients. There were no significant
differences in the frequency and type of epilepsy in families of patients
with temporal or frontal lobe epilepsy. The two groups should no signifi-
cant differences regarding age at onset, seizure types (simple partial,
complex partial, secondary generalized) or seizure frequency.
Conclusion: In the absence of clinical features characteristic of well-
defined familial focal epilepsy syndromes such as ADNFLE and
ADLTE, localization of seizure onset has limited value in classification
of familial epilepsy.
p0269
FAMILIAL FOCALEPILEPSYWITHVARIABLE FOCI
IN ANARGENTINIAN FAMILY: CLINICAL
CHARACTERISTICS ANDDEPDC5MUTATION
DIAGNOSED THROUGHEXOME SEQUENCING
P.R. Fernandez*, M. Cordoba†, B. Comas*, M. Peralta*,
M. Kauffman†, W. Silva*
*Hospital Italiano, Neurologia Infantil, Buenos Aires,
Argentina, †Hospital Ramos Mejias, Buenos Aires, Argentina
Introduction: Familial focal epilepsy with variable foci (FFEVF) is an
autosomal dominant partial epilepsy syndrome. FFEVF is a relatively
rare syndrome and the exact incidence remains unclear. Different family
member share a unifocal epilepsy, with different cortical locations that
include temporal, frontal, centroparietal, or occipital lobe regions.
Purpose: To describe a two generation agentinian family with a domi-
nant focal epilepsy and a mutation in DEPDC5 gene.
Methods: Clinical characteristics, EEG and MRI findings were ana-
lyzed. Exome sequencing was performed followed by a pipeline analysis
with bioinformatic tools. The findings were confirmed through Sanger
sequencing.
Results: The mutation was found in three members of two generations
without consanguinity history. Median age of onset was 9 years old. The
father had occipital lobe semiology and the two sibling frontal lobe epi-
lepsy semiology. Physical, neurological examinations andMRI were nor-
mal. The three are seizure free, two with carbamazepine and one with
valproate acid. The boy0s VideoEEG showed a frontotemporal ictal
onset. Exome sequencing revealed a new missense mutation in DEPDC5
gene, c.4657T>C p.Leu1553Pro.
Conclusions: The clinical characteristics of this family fulfilled criteria
for FFEVF and exome sequencing proved useful as a diagnostic tool. As
described in other reports, we observed an excellent responds with carba-
mazepine.
p0270
HICCUP-LIKE SEIZURES ANDANOVEL STOPCODON
MUTATION INANEWBORNWITHNON-KETOTIC
HYPERGLYCINEMIA
P. Gencpinar*, N. Olgac Dundar†, D. Cavusoglu†,
O. Ozbeyler‡, F. Baydan*
*Tepecik Training and Research Hospital, Pediatric Neurology,
Izmir, Turkey, †Katip Celebi University, Pediatric Neurology,
Izmir, Turkey, ‡Tepecik Training and Research Hospital,
Pediatrics, Izmir, Turkey
Purpose: Non-ketotic hyperglycinemia (NKH) is an autosomal reces-
sive inborn error of glycine metabolism, resulting in the accumulation of
large amounts of glycine in body fluids and severe neurologic distur-
bances immediately after birth. This metabolic disorder is due to a defect
in the liver enzyme complex, termed the glycine cleavage system. More
than 80% of patients with NKH have a defect in P protein. Mutations in
the GLDC gene are responsible for 70% of non-ketotic hyperglycinemia
cases, whereas mutations in the AMT and GCSH genes account for 20%
and <1% of non-ketotic hyperglycinemia cases, respectively. Here we
report a novel stop codon mutation of AMT gene in NKH.
Method: Case Report.
Results: A four-month male infant was hospitalized in pediatric neurol-
ogy department for hiccups, hypotonia and lethargy. Electroencephalog-
raphy (EEG) indicated spike-wave activity in bilateral centro-temporal
areas. Magnetic resonance imaging (MRI) demonstrates subdural hemor-
rhage in frontal area. The culturing and viral examination of cere-
brospinal fluid produced negative results. Cerebrospinal fluid/plasma
glycine ratio was 0.17 (normal <0.08). The child was homozygous for a
sequence modification: the substitution of a cytosine by thymine at posi-
tion 565 (c.565C>T, p.Q189*) in the AMT gene. A diagnosis of NKH
was made secondary to elevated plasma and cerebrospinal fluid glycine
concentrations and sequence analyze of the AMT gene.
Conclusion: Non-ketotic hyperglycinemia should be included as a dif-
ferential diagnosis in an unwell neonate presenting with hiccup, seizures
and hypotonia. Metabolic studies of suspected patients with molecular
analysis can confirm a diagnosis of NKH, support genetic counseling,
and prenatal diagnosis. We would like to emphasize a novel stop codon
mutation in NKH in this case report.
Genetics 2
Sunday, 6th September 2015
p0271
PHARMACOGENOMIC EXPLORATIONOF
LACOSAMIDERESPONSE
S. Heavin*, M. McCormack*, L. Slattery*, N. Walley†,
A. Avbersek‡, J. Novy‡, S. Sinha†, N. Alarts§, B. Legros§,
R. Radtke†, S. Sisodiya‡, C. Depondt§, D. Goldstein¶,
N. Delanty*,**, G.L. Cavalleri*
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*Royal College of Surgeons in Ireland, Molecular and Cellular
Therapeutics, Dublin, Ireland, †Duke University, Centre for
Human Genome Variation, Durham, NC, USA, ‡University
College London, Clinical and Experimental Epilepsy, London,
UK, §ULB-Hopital Erasme, Neurology, Brussels, Belgium,
¶Institute for Genomic Medicine, Columbia University, New
York, NY, USA, **Beaumont Hospital, Neurology, Dublin,
Ireland
Purpose: Approximately 65 million people in the world have epilepsy.
Seizures are effectively controlled by anti-epileptic drugs (AEDs) in up
to 70% of patients. Lacosamide (LCM) is an AED that was first approved
in 2008 for the treatment of focal-onset seizures. We aimed to determine
the clinical relevance of genetic variation in predicting LCM response
and predicting adverse drug reactions to LCM.
Method: Patients were recruited from four tertiary epilepsy referral cen-
tres: Dublin, Ireland; London, UK; Brussels, Belgium; North Carolina,
USA. Response to LCM was determined into four categories; (a) seizure
freedom, (b) ≥75% reduction in seizure frequency, (c) no response and
(d) seizures worsening. Statistical analysis using Stata was carried out
to determine the clinical predictors of LCM response. Genomewide asso-
ciation studies (GWAS) and whole exome sequencing (WES) was used
to investigate the potential importance of genetic variation in predicting
LCM response.
Results: Overall, 13% of patients showed a positive response (seizure
freedom or ≥75% reduction in seizure frequency) to LCM treatment,
while 8% experienced an increase in seizures while on LCM. Response
varied depending on epilepsy diagnosis, with idiopathic generalised
epilepsy (also known as genetic generalised epilepsy) emerging as a
potential target group for LCM treatment. Up to 40% of patients reported
an adverse drug reaction (ADR), with variability across the four sites.
Investigation into the contribution of common and rare variants in LCM
response is ongoing.
Conclusion: 13% of patients showed a positive response to treatment
with LCM. Response varied depending on epilepsy diagnosis - LCM
could have potential benefits for patients with generalised epilepsy.
Acknowledgement: This project has been funded by an investigator-
initiated grant fromUCB Pharma.
p0272
THE PHENOTYPIC SPECTRUMOFGABRA1
MUTATIONS: FROMGGEANDGEFS+TO SEVERE
EPILEPTIC ENCEPHALOPATHIES
H. Hjalgrim*,†, R. Steensbjerre Møller*,†, C. Marini‡,
M. Nikanorova*,†, L. Larsen§, H.-A. Dahl§, R. Guerinni‡,
O. Maier¶, D. Mei**, S. Biskup††, S. Pfeffer‡‡, S. Maljevic‡‡,
H. Lerche‡‡, J.R. Lemke§§
*Danish Epilepsy Centre, Dianalund, Denmark, †University of
Southern Denmark, Odense, Denmark, ‡A. Meyer Children’s
Hospital University of Florence, Pediatric Neurology and
Neurogenetics Unit and Lab, Florence, Italy, §Amplexa
Genetics, Odense, Denmark, ¶Children’s Hospital, St. Gallen,
Switzerland, **Catholic University, Department of
Neuroscience, Rome, Italy, ††CeGaT GmbH, Tübingen,
Germany, ‡‡Hertie-Institute for Clinical Brain Research,
University of Tuebingen, Department of Neurology and
Epileptology, Tübingen, Germany, §§Institute of Human
Genetics, University Hospital Leipzig, Leipzig, Germany
Purpose: Mutations in GABRA1, encoding the alpha subunit of the
GABAA receptor, have been associated with mild genetic generalized
epilepsies and febrile seizures and recently been reported in severe
epileptic encephalopathies such as Dravet syndrome. We aimed to delin-
eate the clinical spectrum associated with GABRA1mutations.
Method: Using high-throughput sequence analysis of the GABRA1
gene in 130 patients with a wide range of epileptic encephalopathies and
childhood epilepsies. Cases with GABRA1 mutations were ascertained
from other centers along with clinical data.
Results: Seven patients with heterozygous mutations of GABRA1 were
found. The phenotypic spectrum varied from Genetic Generalised Epi-
lepsy (1) to Generalised Epilepsy with Febrile Seizures Plus (1), Dravet
Syndrome (1) and Epileptic Encephalopathies (4). Four de novo muta-
tions (3 of the EE and the DS), while the remaining 3 probands had a epi-
lepsy positive family history, not available for testing. Seizure onset
between 5 and 17 months (mean 10 months) with a single outlier with
seizure debut 13 years. Three had febrile seizures at onset, one experi-
enced febrile seizures at a later point. Three never developed afebrile sei-
zures. 6/7 patients had GTCS, and the majority had multiple seizure
types including myoclonic seizures, atypical absence, atonic seizures and
focal seizures with/without dyscognitive features. In 2 patients seizures
were refractory to antiepileptic therapy; 3 patients became seizure free.
Cognitive development normal in 3 patients, affected in 3 patients. Func-
tional studies were made on two of the patients with de novo mutations
and EE and one with familiar GGE - all showed reduced GABA-induced
currents.
Conclusion: The present study shows that GABRA1 mutations are asso-
ciated with a phenotypic epilepsy spectrum ranging from GE FS+ to sev-
ere epileptic encephalopathies, and a cognitive development ranging
from normal to severe intellectual disability. This variety in outcome
highlights the necessity for thorough knowledge when counseling fami-
lies.
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SPECTRUMOFHLA-B ALLELES IN PERSONSWITH
EPILEPSYWITHCUTANEOUSADVERSE DRUG
REACTIONS TOANTI-EPILEPTICS IN NORTH INDIAN
POPULATION
K. Ihtisham*, N. Khanna†, S. Raghavan‡, V. Ramesh§, S. Jain*,
G. Kaur¶, S. Srivastava*, N.K. Mehra¶, B. Ramanujam*,
M. Tripathi*
*All India Institute of Medical Sciences (AIIMS), Neurology,
New Delhi, India, †All India Institute of Medical Sciences
(AIIMS), Dermatology, New Delhi, India, ‡Safdarjung Hospital,
Neurology, New Delhi, India, §Safdarjung Hospital,
Dermatology, New Delhi, India, ¶All India Institute of Medical
Sciences (AIIMS), Transplant Immunology and Immunogenetics,
New Delhi, India
Purpose: To assess HLA-B alleles present in persons with epilepsy
(PWE) having cutaneous adverse drug reactions (cADRs) to antiepileptic
drugs (AEDs) in north Indian population.
Method: This is a case-control study with 70 PWE having cADRs to any
of AEDs CBZ, VPA, PHT, PB, CZP, OXC, LTG, GBP, TPM, LEV and
50 controls with no cADRs. Inclusion criterion was any PWE having
cADRs after 2 or more months of AED consumption. DNA samples were
genotyped for HLA-B alleles by PCR using sequence specific primers
(PCR-SSP). Samples positive for HLA-B*15 were further subjected to
high resolution typing (SSO-One Lambda).
Results: In 68 PWE with cADRs,56 had Maculopapular rash (MPE),
Steven Johnsons Syndrome (SJS)-3, Toxic Epidermal Necrolysis
(TEN)-2, Drug Reaction with Eosinophilia and Systemic Symptoms
(DRESS)-3, Drug hypersensitivity Syndrome (DHS)-1, SJS/TEN over-
lap-2 and 1 had fixed drug eruption. 32 were males (47.05%) and 36
females (52.94%). Age ranged between 6 and 72 years. HLA-B*15
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was present in 8 cases (11.76%) (CBZ-2, PHT-3,LTG-1, multiple
AEDs-2) and 10 controls (20%). Amongst cases HLA-B*15:02 was
present in 5(4 heterozygous and 1 homozygous); and 1 was HLA-
B*15:08. Amongst the 50 controls 24 were males (48%) and 26 were
females (52%). Age range was 8–70 years. HLA-B*15:02 was found in
only 1 control (2%).
Other HLA-B alleles present in patients with cADRs wereB*40 in
16cases (23.52%) (PHT-5, CBZ-4, LTG-3, LEV-1, VPA-1, PB-1multi-
ple AEDs-1), B*35 in 16cases (23.52%)(PHT-6, CBZ-6, LTG-2,
LEV-1,multipleAEDs-1) and 12 controls each (24%), B*51 in 14
cases (20.58%)(PHT-4,CBZ-4, VPA-2, LTG-1, OXC-1, multiple
AEDs-2) and 08 controls (16%), B*07in 08 cases (11.76%) (CBZ-4,
PHT-3, multiple AEDs-1) and 04 controls (8%), B*44 in 08 cases
(11.76%)(CBZ-3, PHT-2, LTG-1, multiple AEDs-2) and11 controls
(22%), B*13in4cases (5.88%)(CBZ-2,LTG-1, multiple AEDs-1) and 1
control (2%), B*27 in 2 cases (2.94%)(PHT-1, multiple AEDs-1) and2
controls (4%).
Conclusion: Most rashes were due to CBZ(24)(35.29%) and least due to
PB(1) and OXC(1)(1.47%). B*40 and B*35 mostly associated with LTG.
There is no statistically significant difference in the prevalence of various
HLA-B alleles studied, between PWE with and without cADRs. How-
ever, prevalence of B*15:02, B*40, B*35, B*51, B*07, B*13 was higher
among cases. A larger sample size would be required to find any definite
association of other HLA alleles with AED-induced cADRs in this
population.
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GENOMEWIDEANALYSIS OFNOVELCOPY
NUMBERVARIATIONS DUPLICATIONS/DELETIONS
OFDIFFERENT EPILEPTIC PATIENTS IN SAUDI
ARABIA
M.I. Naseer*, M. Faheem†, A.G. Chaudhary*,
T.A. Kumosani†,‡, M.M. Al-Quaiti*, M.M. Jan§, M.H. Al-
Qahtani*
*King Abdulaziz University, Center of Excellence in Genomic
Medicine Research, Jeddah, Saudi Arabia, †King Abdulaziz
University, Department of Biochemistry, Faculty of Science,
Jeddah, Saudi Arabia, ‡King Abdulaziz University, King Fahd
Medical Research Center, Jeddah, Saudi Arabia, §King
Abdulaziz University, Department of Pediatrics, Faculty of
Medicine, Jeddah, Saudi Arabia
Purpose: Epilepsy is genetically complex neurological disorder affect-
ing millions of people of different age groups varying in its type and
severity. Copy number variants (CNVs) are key players in the genetic eti-
ology of numerous neurodevelopmental disorders and prior findings also
revealed that chromosomal aberrations are more susceptible against the
pathogenesis of epilepsy. Novel technologies, such as array comparative
genomic hybridization (array-CGH), may help to uncover the pathogenic
CNVs in patients with epilepsy.
Methods: This study was carried out by high density whole genome
array-CGH analysis with blood DNA samples from a cohort of 22 epi-
lepsy patients to search for CNVs associated with epilepsy.
Results: Pathogenic rearrangements which include 6p12.1 microdupli-
cations in 5 patients covering a total region of 99.9 kb and 7q32.3
microdeletions in three patients covering a total region of 63.9 kb were
detected. Two genes BMP5 and PODXL were located in the predicted
duplicated and deleted regions respectively. Furthermore, these CNV
findings were confirmed by qPCR.
Conclusion: We have described, for the first time, several novel CNVs/
genes implicated in epilepsy in the Saudi population. These findings
enable us to better describe the genetic variations in epilepsy, and could
provide a foundation for understanding the critical regions of the genome
which might be involved in the development of epilepsy.
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GENETIC TESTING INADULTSWITH
INTELLECTUALDISABILITYANDEPILEPSY
L.H.G. Larsen*, E. Riesch†,‡, D. Marjanovic§, S. Biskup†,
L.L. Klitten§, T. Dorn‡, K. Brusgaard*, H. Hjalgrim§,¶,
R.S. Møller§,¶, J. Lemke**
*Amplexa Genetics, Odense, Denmark, †CeGaT GmbH,
Tübingen, Germany, ‡Swiss Epilepsy Center, Zürich,
Switzerland, §Danish Epilepsy Centre, Dianalund, Denmark,
¶University of Southern Denmark, Institute for Regional Health
Services, Odense, Denmark, **University Hospital Leipzig,
Institute of Human Genetics, Leipzig, Germany
Purpose: The genetic contribution to the development of epilepsies
has in recent years been shown to be significant with new genes being
linked to the disease frequently. However due to the heterogeneity of
even a single epilepsy syndrome as well as the phenotypic spectrum of
variations in a specific gene, it can be difficult to determine the causa-
tive genetic defect. Here we searched for point mutations and copy
number variations (CNV) in adult patients with intellectual disabilities
(ID) and epilepsy.
Method: A cohort of 67 well characterized adult patients with ID and
epilepsy, with or without structural brain malformations, was analyzed
using a Next Generation Sequencing (NGS) gene panel targeting 280
genes and by array CGH. Genetic variations were evaluated with data-
base searches such as dbSNP, 1000Genomes, HGMD professional as
well as an in-house database and prediction softwares MutationTaster
and PolyPhen2. Segregation analysis was performed with Sanger
sequencing to test inheritance when possible.
Results: Of the 67 patients we were able to identify damaging genetic
variations in 16 cases – 11 from the gene panel (e.g. SIX3, KCNQ2,
GRIN1, GABRB3, KCNA2 etc.) and 5 using array CGH (e.g. 20p13,
5q33q35, dup17q12q21 etc.) In additional 9 patients we found potentially
damaging variations but segregation analysis was not possible. An
unsolved patient with progressive myoclonic epilepsy has since been
tested positive for a mutation in KCNC1, a gene not on the panel.
Conclusion: We were able to detect point mutations and CNVs in 24%
of adult patients with ID and various forms of epilepsy. In addition in
12% of the cohort we found potentially damaging variations. This study
demonstrates the potential for clarifying genetic causes in adult patients
with clear as well as unspecific epilepsy phenotypes and ID, using gene
panels and array CGH.
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GENETIC VARIATION IN TNFAANDCLINICAL
CHARACTERISTICSOFMESIAL TEMPORAL LOBE
EPILEPSYWITHHIPPOCAMPAL SCLEROSIS
B. Leal*, D. Boleixa*, J. Chaves†, C. Carvalho*,
A. Bettencourt*, J. Freitas†, J. Lopes†, J. Ramalheira†,
P.P. Costa*,‡, A. Martins da Silva†, B. Martins da Silva*
*UMIB - ICBAS-UP, Porto, Portugal, †Hospital Santo Antonio -
Centro Hospitalar do Porto, Porto, Portugal, ‡Instituto
Nacional de Saude Dr. Ricardo Jorge, Porto, Portugal
Background: Epileptic seizures are associated with a profound change
in gene expression. The immune response is among the most affected.
Several studies have demonstrated high cytokines levels, such as IL-1b
and TNF-a, in plasma and/or CNS in Mesial Temporal Lobe Epilepsy
(MTLE) patients, that may contribute to the expression of the disease.
Production of TNF-amay be influenced by the rs1800629 polymorphism
(-308 G>A) in the promoter region of its gene. Our aim was to analyse
the association of rs1800629 with MTLE-HS susceptibility and clinical
characteristics in a Portuguese population.
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Methods: A cohort of 162 MTLE patients all with Hippocampal Sclero-
sis (87F, 75M, mean age= 44  11 years, age of onset= 13  9 years,
82 with Febrile Seizures (FS) antecedents) was compared with a cohort
of 206 healthy individuals (HI) in a case-control genetic association
study. Genotyping used a PCR- Restriction Fragment Length Polymor-
phism (RFLP) assay.
Results: Genotypic and allelic frequencies were similar between patients
and controls. Accordingly to FS antecedents, two subgroups of patients
were considered. The frequency of the rs1800629 AA genotype was sig-
nificantly lower in FS positive than in FS negative patients (0% vs. 5.4%,
p = 0.047 OR=0.945 [0.894 - 0.999]).
Conclusion: Our results do not support a role for rs1800629 in MTLE-
HS susceptibility, at least in the studied population. The rs1800629 AA
genotype has been associated with higher TNF-a expression which may
interfere not only with immune response but also with neurotransmission.
It has been argued that a different genetic background underlies MTLE-
HS development in individuals with and without FS antecedents. Our
results show that rs1800629 could be a factor contributing to that genetic
difference.
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DENOVOLOSS- ORGAIN-OF-FUNCTION
MUTATIONS INKCNA2CAUSE EPILEPTIC
ENCEPHALOPATHY
S. Syrbe*, U. Hedrich†, E. Riesch‡, T. Djémié§, S. Müller†,
R.S. Møller¶, B. Maher**, L. Hernandez-Hernandez**,
M. Synofzik†, H. Caglayan††, M. Arslan‡‡, J. Serratosa§§,
M. Nothnagel¶¶, P. May***, R. Krause***, H. L€offler†,
K. Detert†, T. Dorn†††, H. Vogt†††, G. Kr€amer†††, L. Sch€ols†,
P. Mullis‡‡‡, T. Linnankivi§§§, A.-E. Lehesjoki§§§,
K. Sterbova¶¶¶, D. Craiu****, D. Hoffman-Zacharska††††,
C. Korff‡‡‡‡, Y. Weber†, M. Steinlin‡‡‡, S. Gallati‡‡‡,
A. Bertsche*, M. Bernhard*, A. Merkenschlager*, W. Kiess*,
M. Gonzalez§§§§, S. Züchner§§§§, A. Palotie§§§, A. Suls§,
P. De Jonghe§, I. Helbig¶¶¶¶, S. Biskup‡, M. Wolff†,
S. Maljevic†, R. Schüle†, S. Sisodiya**, S. Weckhuysen§,
H. Lerche†, J. Lemke*, EuroEPINOMICS RES Consortium
*University of Leipzig, Leipzig, Germany, †University of
Tübingen, Tübingen, Germany, ‡CeGaT GmbH, Tübingen,
Germany, §University of Antwerp, Antwerp, Belgium, ¶Danish
Epilepsy Centre, Dianalund, Denmark, **University College
London, London, UK, ††Bogazici University, Istanbul, Turkey,
‡‡Gulhane Military Medical School, Ankara, Turkey,
§§University of Madrid, Madrid, Spain, ¶¶University of
Cologne, Cologne, Germany, ***University of Luxembourg,
Esch-sur-Alzette, Luxembourg, †††Swiss Epilepsy Center,
Zurich, Switzerland, ‡‡‡University of Bern, Bern, Switzerland,
§§§University of Helsinki, Helsinki, Finland, ¶¶¶Charles
University, Motol University Hospital, Czech Republic of Prague,
****University of Bucharest, Bucharest, Romania, †University
of Warsaw, Warsaw, Poland, ‡University of Geneva, Gen-
eva, Switzerland, §§§§University of Miami, Miami, FL, USA,
¶¶¶¶Children’s Hospital of Philadelphia, Philadelphia,
PA, USA
Epileptic encephalopathies are a phenotypically and genetically hetero-
geneous group of severe epilepsies accompanied by intellectual disability
and other neurodevelopmental features. Using next-generation sequenc-
ing, we identified four different de novo mutations in KCNA2, encoding
the potassium channel KV1.2, in six isolated patients with epileptic
encephalopathy (one mutation recurred three times independently). Four
individuals presented with febrile and multiple afebrile, often focal
seizure types, multifocal epileptiform discharges strongly activated by
sleep, mild to moderate intellectual disability, delayed speech develop-
ment and sometimes ataxia. Functional studies of the two mutations asso-
ciated with this phenotype showed almost complete loss of function with
a dominant-negative effect. Two further individuals presented with a dif-
ferent and more severe epileptic encephalopathy phenotype. They carried
mutations inducing a drastic gain-of-function effect leading to perma-
nently open channels. These results establish KCNA2 as a new gene
involved in human neurodevelopmental disorders through two different
mechanisms, predicting either hyperexcitability or electrical silencing of
KV1.2-expressing neurons.
Neuroimaging 1
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GENERALIZED EPILEPSY SYNDROMES AND
CALLOSAL THICKNESS: DIFFERENTIAL EFFECTS
BETWEEN PATIENTSWITH JUVENILEMYOCLONIC
EPILEPSYANDTHOSEWITHGENERALIZED TONIC-
CLONIC SEIZURESONLY
S. Anastasopoulou*, F. Kurth†, E. Luders†, I. Savic‡
*Karolinska University Hospital, Neuropediatrics, Stockholm,
Sweden, †UCLA School of Medicine, Department of Neurology,
Los Angeles, CA, USA, ‡Karolinska Institute and Karolinska
Hospital and Neurology Clinic, Karolinska University Hospital,
Stockholm, Sweden
Purpose: Although the definition of two well studied genetic general-
ized epilepsy syndromes (GGE), juvenile myoclonic epilepsy (JME) and
epilepsy with generalized tonic-clonic seizures alone (GTCS), suggests
the absence of structural cerebral abnormalities, such have been reported
in both, particularly in JME. Their localization in the thalamus andmesial
prefrontal regions raises the question whether JME is linked to midline
structure abnormalities, possibly also involving the corpus callosum
(CC), and suggesting a different pathophysiology fromGTCS.
Method: We studied the CC in 22 JME patients, 15 GTCS patients, and
42 controls. The two epilepsy groups were matched for age, medication,
and life time total GTCS. All three groups were statistically compared
with respect to the local thickness of the CC.
Results: In both patient populations the CC was significantly thinner
compared to controls. However, disease-related aberrations were more
extensive in JME patients than in GTCS patients. Specifically, effects
were evident within the callosal genu (JME< controls), isthmus (JME<
controls, JME<GTCS), and posterior midbody (GTCS< controls).
Conclusion: Altogether, these data support the notion that callosal
abnormalities exist in GGE, and are more pronounced in JME than in
GTCS patients. The specific locations of the callosal aberrations suggest
an impairment of interhemisperic communication between prefrontal,
parietal and temporal cortices in JME, and between frontal and parietal
cortices in GTCS alone. Together, this argues that the two types of GGE
have their own anatomical signatures on which further research seems
indicated.
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LATERALITYANDMEDICATIONEFFECTS IN THE
FUNCTIONALCONNECTIVITYOFMESIAL
TEMPORAL LOBEEPILEPSY
F.F. Bellentani, E.K. Fujisao, A.S. Braga, S. Yamashita,
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Purpose: Functional connectivity is abnormal in mesial temporal lobe
epilepsy (MTLE). Left MTLE is probably associated with a more pro-
nounced abnormality. The objective of this study was to investigate later-
ality and medication effect in the functional connectivity of MTLE.
Method: Thirty patients with MTLE (15 right and 15 left) and 37 con-
trols were investigated. Images were acquired with a 3T scanner. 3D vol-
umetric T1 sequences and functional BOLD data images were acquired.
fMRI data was processed and analyzed by using Analysis of Functional
NeuroImages (AFNI). Basically, EPI images were submitted to slice tim-
ing and motion correction, temporal filtering, registration, blurring and
masking. Finally images were processed with regression analysis gener-
ating residual error time series. Regions of interest (ROIs) were bilater-
ally created for the hippocampus, amygdala and parahippocampal gyrus.
Correlation maps were generated and submitted to a Z-score transforma-
tion. Whole brain voxel wise statistical analysis was performed using
unpolled T test with a p < 0.05. Comparisons were performed between
controls and patients with right or left MTLE. A subsequent comparison
was conducted according to the dose of antiepileptic drug (AED).
Results: Total number of voxels with abnormal functional connectivity
was 579 for right MTLE and 3400 for left. Major clusters were localized
in the insula and superior frontal gyrus for patients with right MTLE
(Z = 3.5, 4.1 and 3.5) and in the superior, middle and medial frontal
gyrus for left MTLE (Z = 3.8, 3.9 and 4.3). Analysis according to the
AEDs showed 670 abnormal voxels for high dose (599 left, 71 right) and
1094 for low dose (868 left, 246 right). Major clusters where localized in
the anterior cingulate, middle and superior frontal gyrus.
Conclusion: Areas of abnormal functional connectivity were disclosed
in patients with MTLE. Left MTLE presented a more diffuse pattern.
Doses of medications may influence these observations.
Neuropsychology 1
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INFLUENCEOFTOPIRAMATEONCOGNITIVE
FUNCTIONING IN PATIENTSWITHMIGRAINE
B. Abou-Khalil*, R. Abou-Khalil†, M. de Riesthal†, P. Lavin*
*Vanderbilt University, Neurology, Nashville, TN, USA,
†Vanderbilt University, Hearing and Speech Sciences,
Nashville, TN, USA
Purpose: To evaluate effect of incremental small doses of topiramate on
language and cognitive function in patients with migraine.
Method: Participants were recruited from a headache clinic after topira-
mate was prescribed for migraine prophylaxis. Cognitive and language
assessments were performed prior to administration of the first dose and
1 week after titration to 50 mg, 100 mg, 150 mg, and 200 mg. The final
maintenance dose varied between patients. Final re-evaluation occurred
4 weeks after reaching the maintenance dose. Cognitive/language mea-
sures included Trail Making Test (A&B), Controlled Oral Word Associa-
tion Test (COWAT), Revised Token Test (RTT), Story retell subtest
from the Rivermead Behavioral Memory Test (RBMT), Boston Naming
Test (BNT), and Aphasia Depression Rating Scale (ADRS).
Results: Fifteen participants were enrolled; nine participants completed
the study. Premature termination was due to significant adverse effects
on memory and mood requiring medication withdrawal (2 patients) and
loss to follow up (4 patients), There were statistically significant changes
in performance on the RTT from baseline to maximal dose (p < 0.03)
and from baseline to final assessment (p < 0.01). Changes on story retell,
COWAT (FAS), and Trail Making Test-A approached significance.
There was no significant change on the BNT and ADRS.
Conclusion: The results indicate a negative effect of topiramate on fron-
tal lobe functioning, as well as auditory comprehension and processing.
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UTILITYOFRBANS IN FOCAL INTRACTABLE
EPILEPSY PATIENTS IN ANARABCOHORT
S.A. AL Jarrah, K.A. Siddiqui
Al Ain Hospital, Neurology, Al Ain, United Arab Emirates
Purpose: The RBANS (Repeatable Battery for the Assessment of Neu-
ropsychological Status) is a widely used screening battery in patients
with neurological cerebral dysfunction. However, there is little published
research in patients who have epilepsy. We present its utility in patients
in an Arab cohort, who have focal intractable epilepsy.
Method: In this observational study, we selected patients with focal
intractable epilepsy who were referred from an Epilepsy clinic for neu-
ropsychological evaluation in a tertiary care hospital, in Al Ain, UAE.
The RBANS was administered to patients and their standard scores were
calculated for each of the five Indexes of the battery (Immediate Mem-
ory, Visuospatial/Constructional, Language, Attention and Delayed
Memory) and compared to matched healthy controls. We collected
demographics and underlying lesional etiology for epilepsy.
Results: Each group (n = 14) was comprised of 1male and 6 females,
age in years  SD (26.71  4.6) in the focal intractable epilepsy group
and (28.29  3.7) in the healthy matched controls. Four patients had
temporal lobe epilepsy and three, extra-temporal lobe epilepsy. The Chi-
Square test was performed to examine the relation between groups and
Index scores that indicated potential impairment (<75). The relation
between these scores was significant, X2 (2, N = 14) = 14 (p < 0.01).
Epilepsy patients showed impairments across RBANS Index and Total
scores compared to healthy controls.
Conclusion: We conclude that RBANS is a quick and convenient tool
for detecting cognitive impairment in a cohort of Arab patients with focal
intractable epilepsy and can be used to identify impaired cognitive
domains for further selective neuropsychological evaluation. The utility
of the RBANS in a larger cohort of epileptic patients should be further
investigated.
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FACIAL EMOTIONRECOGNITIONAFTEREPILEPSY
SURGERY IN CHILDREN
O. Braams*,†,‡,§, J. Meekes*,†,‡, O.V. Nieuwenhuizen†,¶,
R. Schappin§, P.V. Rijen†,**, W. Veenstra††, K. Braun†,¶,
A. Jennekens-Schinkel*,‡
*Wilhelmina Children’s Hospital, University Medical Center
Utrecht, Sector of Neuropsychology for Children and
Adolescents, Utrecht, Netherlands, †Brain Center Rudolf
Magnus, University Medical Center Utrecht, Utrecht,
Netherlands, ‡Bio Research Center for Children, Arnhem,
Netherlands, §Wilhelmina Children’s Hospital, University
Medical Center Utrecht, Pediatric Psychology and Social Work,
Utrecht, Netherlands, ¶Wilhelmina Children’s Hospital,
University Medical Center Utrecht, Child Neurology, Utrecht,
Netherlands, **University Medical Center Utrecht,
Neurosurgery, Utrecht, Netherlands, ††University Medical
Center Groningen, Child Clinical Neuropsychology,
Department of Neurology, Groningen, Netherlands
Purpose: To know whether epilepsy surgery in children has impact on
their recognition of emotions expressed by faces and whether the latter is
associated with demographic variables [age, sex and verbal intelligence
(VIQ)] and illness variables (epilepsy duration, side of the surgery,
surgery area, resection of the amygdala, etiology, anti-epileptic drug use
and seizure freedom).
Method: Two years after epilepsy surgery, we administered the Facial
Expression of Emotion: Stimuli and Tests (FEEST) to 41 patients (mean
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age 13.5 years, mean VIQ = 84; 24 girls) and 82 age- and sex-matched
controls (mean VIQ = 112). FEEST data obtained in a smaller group (11
patients and 22 matched controls) were explored longitudinally from
shortly before surgery to 2 years thereafter. Scored and analyzed (MAN-
OVA) were proportions of correct responses, controlling for VIQ.
Results: In the cross-sectional study, the mean proportion of correct
responses differed significantly between patients and controls, to the dis-
advantage of the patients. Relationships between FEEST scores and ill-
ness-related variables were non-significant. Only age at assessment was
associated with FEEST scores, in both patients and controls.The explora-
tory longitudinal data showed a ‘dip’ at the first postsurgical assessment;
the six younger patients (age <13 years) were the only ones to dip. Over
the 2 years after surgery, their scores recovered slightly but did not
exceed the pre-surgical level. Five of the six younger children, all girls,
had a left-hemisphere resection. The five older patients (two with a left
sided resection) showed a continuous increase of scores, on a lower level
than but similar to that in control children.
Conclusion: Two years after epilepsy surgery, recognition of emotions
expressed by faces is deficient. The aberrant course of FEEST scores in
the younger patients emphasizes the necessity of disentangling develop-
mental, demographic and epilepsy influences.
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WHAT’S THE IMPACTOFANTERIOR TEMPORAL
LOBEEPILEPSY IN FACES PERCEPTION?
H. Brissart*,†, J. Jonas*,†,‡, L. Maillard*,†, T. Busigny‡,§
*CHUNancy, Neurology, Nancy, France, †University of
Lorraine, UMR 7039, CNRS, Nancy, France, ‡University of
Louvain-la-Neuve, Louvain-la-Neuve, Belgium, §CHU
Toulouse, Neurology, Toulouse, France
Estimates of the risk of decline in specific neuropsychological domains
after epilepsy surgery assist surgical decision making in clinical practice.
Face perception is a critical brain function, essential to social interac-
tions. Neuropsychological and neuroimaging studies have recently
pointed out the critical role of the anterior temporal lobe in face percep-
tion. Nevertheless, no studies have examined in details the impact of
anterior temporal lobe epilepsy (ATLE) and its surgical therapy (anterior
temporal lobectomy) on face perception. The aim of this study was to
assess face perception performances in patients with left and right ATLE.
We included 26 patients with refractory ATLE (15 right, 11 left) as
well as 26 matched controls. Patients and controls subjects performed
tests on face detection, individual face discrimination and famous face
recognition.
Overall, left ATLE patients showed normal performances on face per-
ception. In the right ATLE group, one half showed normal performances
and the other half was severely impaired. In this group, an effect of
epilepsy duration is observed. At me moment, 10 ATLE (8 right, 2 left)
were also tested after surgery and we did not find any significant decline.
Our results show that right ATLE impairs face perception perfor-
mances and that this impairment increases with epilepsy duration. These
results argue for an early surgical therapy in right ATLE and also for a
systematic neuropsychological evaluation of face perception perfor-
mances in these patients.
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BETTER POST-OPERATIVE VERBAL LEARNING
CAPACITY IN PATIENTSWITHEARLIERONSETOF
EPILEPSY
S.M. Buck*, E. Isaacs†, T. Baldeweg*, C.E. Polkey‡,
M. Mishkin§, F. Vargha-Khadem*
*Institute of Child Health, University College London, Cognitive
Neuroscience & Neuropsychiatry, London, UK, †Institute of
Child Health, University College London, MRC Childhood
Nutrition Research Centre, London, UK, ‡Institute of
Psychiatry, King’s College London, Department of Clinical
Neurosciences, London, UK, §Laboratory of Neuropsychology,
NIH/NIMH, Bethesda, MD, USA
Purpose: We investigated postsurgical verbal and nonverbal learning
ability in a group of patients who underwent surgery for temporal lobe
epilepsy. The aims were to examine whether there was.
(i) a material-specific effect of the side of resection, and
(ii) an effect of age of epilepsy onset and/or of age at surgery.
Method: We analysed postsurgical data from 75 participants (43 with
surgery on the left and 32, on the right). The data covered a wide range of
age of epilepsy onset (from age 4 months to 25 years) and of age at sur-
gery (from age 6 to 46 years). The age at testing varied from 8 to 49 years.
Verbal and nonverbal paired associate learning tasks were used, with
recall tested over three learning trials. Analyses of covariance andmultiple
regression analyses were performed to assess the effect of side of resec-
tion, with age at onset of epilepsy and age at surgery as covariates.
Results: There was a significant interaction between side of resection
and type of material (p < 0.001), with poorer verbal learning after left
than after right resections, and poorer visual learning after right than after
left resections. In addition, there were effects on verbal learning of age at
epilepsy onset (p = 0.033) and of age at surgery (p = 0.034), with linear
declines in learning with increasing age. However, only age at epilepsy
onset remained significant after controlling for age at test (p = 0.030)
and postoperative seizure outcome (p = 0.009). Nonverbal learning
remained constant along the age spectrum.
Conclusion: Patients with earlier onset of epilepsy have better postoper-
ative verbal learning ability than patients with later onset, due perhaps to
more effective cerebral reorganization after early onset.
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COGNITIVE FUNCTIONS ANDDRUG
RESPONSIBILITY INMESIAL TEMPORAL LOBE
EPILEPSY
S.Çeliker Uslu, B. Tekin Güveli, D. Ataklı, S. Sezikli, H. Sarı,
C. Keskinkılıc
Bakirkoy Research and Training Hospital for Psychiatry,
Neurology, Neurosurgery, Department of Neurology, Istanbul,
Turkey
Purpose: Mesial temporal lobe epilepsy (MTLE) is the most prevalent
form of complex partial seizures with temporal lobe origin and affects
several domains of cognitive functioning. In this study, we aimed to com-
pare memory, verbal attention, executive function of drug responsive and
pharmacoresistant MTLE patients.
Method: We included 79 patients of MTLE and 30 healthy controls. The
patients were divided in to two groups according to seizure frequency
indicating the response to antiepileptic drugs. Then we evaluated mem-
ory, verbal attention, executive functions.
Results: Of the 79 patients with MTLE, mean age was 33.5  9.6 years,
49 (62%) were female. The mean age of 30 participants from control
group was 35.9  7.9 and 14 of them (46.7%) were female. The drug
responsive and pharmacoresistant groups had poorer memory than the
controls in all memory tests. However, the comparison of drug responsive
group with pharmacoresistant group revealed that verbal attention test was
significantly worse in pharmacoresistant group. The analysis of verbal
memory functions revealed that the poor verbal function in left MTLE.
Conclusion: In our study, verbal attention were similar between the
patients with drug responsive group and control group, pharmacoresistant
patients were significantly worse and this result reveal that seizure fre-
quency is the probable reason of verbal attention deficit. However, mem-
ory impairment in both of groups shows that memory dysfunction is the
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result of underlying hippocampal pathology. Executive functions were
worse in all patients compared to control group, this may be related to
intense network between frontal and temporal lobe. Presence of nonver-
bal memory deficit in left MTLE and verbal memory deficit in right
MTLE show that material specific memory dysfunction requires over-
view and more specific neuropsychological tests should be improved.
p0297
MEMORY&LEARNINGAFTERTEMPORALLOBE
SURGERY: EFFECTSOFHEMISPHERIC SIDEAND
EXTENTOF SURGICALREMOVAL
A. Dehghani*, E. Isaacs†, A.I. Della Rocchetta‡, G. Pitts§,
C.E. Polkey¶, M. Mishkin**, F. Vargha-Khadem§
*Baha’i Institute for Higher Education (BIHE), Biology, Tehran,
Islamic Republic of Iran, †University College London/Institute
of Child Health, MRC Childhood Nutrition Research Centre,
London, UK, ‡The Wellington Hospital North Tower,
Neuropsychology, London, UK, §University College London,
Section on Cognitive Neuroscience & Neuropsychiatry, Institute
of Child Health and Great Ormond Street Hospital for Children,
London, UK, ¶King’s College London, University of London and
Maudsley Hospital, London, UK, **Laboratory of
Neuropsychology, NIH/NIMH, Bethesda, MD, USA
Purpose: To examine
(a) long term learning and memory outcome in relation to hemispheric
side and extent of temporal lobe excisions in patients with temporal lobe
epilepsy,
(b) to determine whether or not there is a double dissociation in verbal
and nonverbal learning of paired associates in relation to side of temporal
lobe removal.
Methods: 48 adults with left (n = 28) or right (n = 20) temporal lobec-
tomy (TL; n = 22) or amygdalohippocampectomy (AH; n = 26) and 11
normal controls (NC) participated in the study. Intelligence (Verbal,
Nonverbal, Full Scale IQs), and Immediate and Delayed Verbal and
Visual Memory and Learning were examined in all groups using the
Wechsler Scales. In addition, an experimental nonverbal paired-associate
recall task was administered together with, and as an analogue for, a ver-
bal paired-associate task.
Results: There were no significant differences between the groups in IQ
and MQ. Nevertheless, MQ was selectively lower than IQ in both left TL
and left AH groups relative to the NC group. The same selective lowering
of MQ relative to IQ was also seen in the left AH group compared to the
RT group. Analyses of variance with repeated measures across the learn-
ing trials indicated that both the left AH and left TL groups were signifi-
cantly poorer on the verbal than on the nonverbal paired associates, and
that the reverse pattern was shown by the right AH and right TL groups
on the learning and recall of nonverbal paired associates. Impairments in
verbal or nonverbal paired associate learning were unrelated to extent of
temporal lobe removals.
Conclusion: Both patient groups with left-sided excisions showed a selec-
tive lowering of memory in relation to intelligence. In addition, verbal
paired-associate learning was more severely impaired after left-sided sur-
gery than after right, whereas the reverse occurred after right-sided
removals.
p0298
PREVALENCEANDPROFILEOFAMUSIA IN
PATIENTSWITHTEMPORAL LOBEEPILEPSY
V.H. Gomez Arias
National Medical Center ‘November 20’, Neurology, Mexico
DF, Mexico
Purpose: To determine the prevalence and profile of amusia in patients
with temporal lobe epilepsy of the National Medical Center “20 de
Noviembre” at Mexico City.
Method: Adult patients with temporal lobe epilepsy (TLE) were
included. We excluded patients with a history of neurosurgical proce-
dures, structural epilepsy, psychiatric disorders and deafness. The Mon-
treal Battery of Evaluation of Amusia (MBEA) was used (sensitivity
89%, specificity 78%). It contains tests that explore perception of melo-
dic dimension (intervale, scale and contour), of temporal dimension
(rhythm and mether), and of musical memory. Amusia in general popula-
tion has a prevalence of 4%, that was compared with the results obtained
in our patients and between right and left focus.
Results: We studied 44 patients aged 19–61 years, 18 men, 26 women,
12 with right focus, 16 left and 16 bitemporal or indeterminate. 16
(36%) met criteria for amusia. We found 9 patients (25%) with amusia
of the melodic dimension, 2 (4.5%) with amusia of temporal dimension.
2 (4.5%) with alteration in both. 10 with alteration in the musical mem-
ory, (7 with simultaneous alteration of melodic perception, 2 with
simultaneous alteration of temporal perception. only 1 with isolated
amnesic amusia). amusia of the temporal dimension was greater in left
epileptic focus (p < 0.0.1). There were no significant differences in the
other results.
Conclusion: Prevalence of amusia in patients with TLE is 36%, 9 times
higher than in the general population. It is primarily amusia of melodic
dimension and musical memory. Amusia of the temporal dimension is
preferably associated with left focus. Further studies are needed to deter-
mine whether the MBEA could be used as an aid in the location of the
epileptic focus.
p0299
VALIDATIONOFTHEDUTCHVERSIONOFTHE
WECHSLERMEMORY SCALE - FOURTHEDITION IN
PATIENTSWITHTEMPORAL LOBEEPILEPSY
M.P.H. Hendriks*,†, Z. Bouman*,†, D. Elhorst*,
R.P.C. Kessels†,‡, A.P. Aldenkamp§,¶,**
*Academic Center of Epileptology, Kempenhaeghe, Heeze,
Netherlands, †Radboud University Nijmegen, Donders Institute
for Brain, Cognition and Behaviour, Nijmegen, Netherlands,
‡Radboud University Medical Center, Department of Medical
Psychology, Nijmegen, Netherlands, §Academic Center of
Epileptology, Kempenhaeghe &Maastricht UMC+, Heeze,
Netherlands, ¶University Hospital Gent, Department of
Neurology, Gent, Belgium, **Technical University Eindhoven,
Faculty of Electrical Engineering, Signal Processing System
Group, Eindhoven, Netherlands
Purpose: TheWechsler Memory Scale (WMS) is one of the most widely
used test batteries to assess different memory functions in impaired
patients with brain dysfunctions of different etiologies. This study inves-
tigates the clinical validation of the Dutch version of the Wechsler Mem-
ory Scale - Fourth Edition (WMS-IV-NL) in patients with Temporal
Lobe Epilepsy (TLE).
Method: A group of 139 patients with TLE (mostly surgical candidates)
enrolled the study. Besides neuropsychological assessment including the
WMS-IV-NL, patients underwent a thorough interview and extensive
medical investigations. Patients with a clearly identified and localized
epileptic focus based on video EEG monitoring and MRI were divided
into two groups according to the lateralization of the abnormalities (84
left TLE and 53 right TLE). 230 matched healthy controls were also
examined with theWMS-IV-NL.
Results: Results showed significantly poorer memory performance of
patients compared to controls (p < 0.05). Moreover, patients with left or
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right temporal focus performed equally on the auditory memory index
and the visual memory index (p > 0.05).
Conclusion: The WMS-IV-NL is capable of detecting memory prob-
lems in patients with TLE, indicating sufficient validity of this memory
battery. Moreover, the findings support previous research, showing that
the WMS-IV-NL has limited value in identifying material specific mem-
ory deficits for either left or right TLE patients.
p0300
INTELLIGENCEQUOTIENT (IQ) OF CHILDRENWITH
INTRAUTERINE ANTIEPILEPTIC DRUGEXPOSURE
PRELIMINARYDATA
N. Gogatishvili*, T. Ediberidze*, S. Mamukadze*, G. Lomidze*,
N. Tatishvili†, S. Kasradze*
*Institute of Neurology and Neuropsychology, Tbilisi, Georgia,
†M. Iashvili Children Central Hospital, Tbilisi, Georgia
Purpose: According to clinical studies fetal exposure to antiepileptic
drugs increase the risk of neurodevelopmental impairment. Aim of the
study was to assess long-term cognitive outcome of children prenatally
exposed to AEDs.
Method: In this retrospective cohort study the children aged 3–6 years
with fetal exposure of AED therapy were recruited. The control group
was created by 3–6 years old children from mothers without epilepsy
randomly selected from the database of primary health care unit. In all
of them were performed neuropsychological assessment with Wechsler
Preschool and Primary Scale of Intelligence (WPPSI - IV). Statistical
analysis was performed using SPSS version 20 (SPSS Inc, Chicago,
Illinois).
Results: In total 48 children (32– exposed and 16 controls) were
assessed: 16 (50%) were exposed to intra-uterine VPA, 6(19%) to CBZ,
1(3%) to LTG, 2(6%) to PB, 7(22%) to polytherapy and 16 were unex-
posed.
Our primary outcome was intelligence quotient (IQ). From exposed
group average IQ (91–110) was detected in 12 children (37%), low aver-
age IQ (81–90) in 9 (28%), borderline IQ (71–80) in 5(16%) and extre-
mely low IQ (<70) in 6 (19%).
From unexposed group average IQ (91–110) was detected in 10
(63%), superior IQ (121–130) in 3(19%),very superior IQ (>131) in 1
(6%), borderline IQ (71–80) in 2 (12%).
Conclusion: Children with fetal AED exposure have reduction of cogni-
tive abilities. The effects of VPA and polytherapy appear to carry more
risks compared with AED-monotherapy.further research is needed.
Acknowledgements: The study was performed within the scientific
grant from the Shota Rustaveli National Scientific Foundation (project
FR/373/8-313/13).
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LONG-TERMPRODUCTRELIABILITYOF
IMPLANTABLEGENERATORS FORVAGUSNERVE
STIMULATIONTHERAPY (VNS THERAPY)
T. Bunker, C.M. Gordon
Cyberonics, Inc., Houston, TX,USA
Purpose: VNS Therapy plays an expanding role in treating patients
with drug-resistant epilepsy. In addition to device labeling and diagnos-
tics, tracking device reliability informs physicians when to increase
patient follow-up for generator battery replacement. Reliability and bat-
tery longevity of the implantable pulse generator are important to
patients, physicians and payers.
Method: Cyberonics has registered 80,000 generators for patients
implanted with VNS Therapy having a known Social Security Number.
All device-related complaints are investigated as potential failures, and
all returned explanted products are analyzed for specific component fail-
ures. Survival curves for generator performance were calculated using
the actuarial method from the date of implant to the date of the first occur-
rence of normal battery depletion, any device failure, or a censored event
such as a patient’s death or the cut-off date of the analysis. Battery long-
evity estimates incorporate the known under-reporting rate based on
long-term follow-up as it is known that all batteries will eventually
deplete.
Results: In the US, all VNS Therapy generators have accumulated over
450,000 patient years of experience. We report a median longevity of
7.9 years for Model 101 including normal battery depletion. Device fail-
ures are rare, as demonstrated by a reliability rating of 99.6% at 5 years
post-implant for PulseTM Model 102/102R generators. Data through July
2015 will be available at the time of presentation.
Conclusion: Improvements in technology in subsequent device models
reflect design changes based on feedback from patients and physicians.
These reliability data and battery longevity analyses summarize the
expected performance of VNS Therapy to assist physicians in determin-
ing the optimal device for their patients and the frequency of patient fol-
low up evaluations. We report the reliability of implantable generators
for the VNS Therapy Systemwith a 5-year defect free rate of 99.6%.
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LONG-TERMPRODUCTRELIABILITYOF
IMPLANTABLE LEADS FORVAGUSNERVE
STIMULATIONTHERAPY (VNS THERAPY)
M.T. Bunker, C.M. Gordon
Cyberonics, Inc., Houston, TX,USA
Purpose: The VNS Therapy System has two implantable components:
the pulse generator and the lead relaying the electrical signal from the
generator to the vagus nerve. Tracking lead reliability helps interpret the
expected failure rate at different time points following implant.
Method: Cyberonics has registered 50,000 unique patients implanted
with VNS Therapy having a known Social Security Number. All device-
related complaints were investigated as potential failures, and all
returned explanted leads were analyzed for specific failures. Survival
curves for lead performance were calculated using the actuarial method
starting on the implant date and ending on the first occurrence of a device
failure or a censored event such as a patient’s death or the cut-off date of
the analysis.
Results: In the US, all implanted leads accumulated over 450,000
patient-years of experience. Over sixteen years of follow-up data are
available on the earliest lead Model 300, with a cumulative survival of
86.7% at 10 years. Design improvements in the currently distributed
models have reduced the average annual failure rate by 61% (Perre-
niaFLEX 304) and 67% (PerreniaDURA 303) compared to Model
302. Data through July 2015 will be available at the time of presentation.
Conclusion: Improvements in lead models over time reflect design
changes from internally identified improvements to fatigue resistance,
validated through extensive testing. The newest PerreniaFLEX 304 has
a lower failure rate compared to the Model 302 yet maintains the han-
dling characteristics during implantation of less fatigue-resistant models.
High reliability of implantable leads minimizes loss of therapy delivery
and need for additional surgical procedures. VNS Therapy System
implantable leads have an average failure rate of approximately 1% per
year across all lead models. Newer lead models reduced the lead failure
rate by nearly two-thirds over previous models.
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HIPPOCAMPALDEEP BRAIN STIMULATION (HIP-
DBS) IN PATIENTSWITHTEMPORAL LOBE
EPILEPSY (TLE) ANDNORMALMRI FINDINGSOR
MESIAL TEMPORAL SCLEROSIS (MTS)
A. Cukiert*,†, C. Cukiert*,†,‡, J. Burattini*, A. Lima§
*Clinica de Epilepsia de Sao Paulo, Department of Neurology,
Sao Paulo, Brazil, †Faculdade de Medicina do ABC, Sao Paulo,
Brazil, ‡Santa Casa de Sao Paulo, Sao Paulo, Brazil, §Hospital
Brigadeiro, Sao Paulo, Brazil
Purpose: We present our experience with Hip-DBS, a non-resective
technique, in patients with temporal lobe epilepsy.
Method: Fourteen patients with temporal lobe epilepsy were studied.
Four had normal MRI, 4 had bilateral MTS and 6 had unilateral MTS.
Ten patients were implanted bilaterally in the hippocampus, and 4 unilat-
erally, using a Kinetra device. The electrodes were inserted along the axis
of the hippocampus through a posterior approach; the most anterior con-
tact was positioned in the head of the hippocampus. Pre-, intra- and post-
stimulation scalp EEG recordings were obtained in all patients intra-
operatively. Continuous stimulation was carried out using 300usec,
130 Hz,1-2,5V pulses.
Results: In 9 patients, an increase in temporal lobe spiking was
noticed unilaterally at the time of electrode insertion. In all patients an
ipsolateral temporal lobe recruiting response was noted during low fre-
quency acute stimulation. In 8 patients, high frequency intraoperative
hippocampal stimulation reduced or abolished interictal spiking. Ele-
ven patients received unilateral and 4 bilateral stimulation (3 with nor-
mal MRI and 1 with bilateral MTS) so far. Five patients with
unilateral stimulation are seizure free and the other seven had at least
90% reduction in seizure frequency. Two patients with bilateral hip-
pocampal stimulation were non-responders and the other two had 50%
seizure frequency reduction. There was no memory decline in patients
submitted to bilateral hippocampal stimulation. Mean follow-up time
was 26 months.
Conclusion: Hippocampal stimulation seems to be an effective and safe
non-resective technique in this patient population. Memory decline did
not occur with bilateral hippocampal stimulation suggesting that Hip-
DBS did not lead to complete inactivation of the hippocampus.
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EFFICACY, SIDE EFFECTS ANDOUTCOMEOFVAGUS
NERVE STIMULATION IN PATIENTSWITHDRUG
RESISTANTEPILEPSY
H.O. Dede, C. Gurses, N. Bebek, B. Baykan, A. Gokyigit
Istanbul University Istanbul Faculty Of Medicine, Neurology,
Istanbul, Turkey
Background: Vagus nerve stimulation (VNS) is an adjunctive therapy
for patients with drug-resistant epilepsy (DRE) who are excluded from
ablative surgery or who have had such surgery with no optimal outcome.
In this study, we provide an analysis of seizure outcomes after VNS
implantation for patients with DRE.
Method: We retrospectively examined 14 adult cases (M/F: 9/5) of DRE
that received VNS treatment in our center from 2004 to May 2014 and
analyzed the parameters: age of patient with VNS, seizure frequency
before and after VNS as well as treatment duration and etiological param-
eters of seizures. Patient outcomes were evaluated using the McHugh
VNS-specific outcome scale.
Results: The overall response rate was 57.1% (8/14). The mean age of
initial seizure was 13.7, the mean duration of VNS treatment was
4.5 years, seizure frequency before and after VNS were 32.5/19.4 per
month. Epilepsy was caused by a structural or metabolic disorder of the
brain: neoplasm, infarct, trauma, mesial temporal sclerosis and
encephalitis, in eight patients (57.1%). Positive response rate was 75% in
this group. The well response rate was %33.3 in the genetic or unknown
etiology group. The mean age of initial seizure (p = 0.26) and VNS treat-
ment duration (p = 0.24) were not associated with better response to
VNS. The most frequent side effect was hoarseness (35.7%) and 42.9%
of the patients complained of no side effects.
Conclusions: VNS is a safe and effective treatment for DRE. Etiology of
seizure may be a crucial factor on prognosis.
p0305
RESINTANT SEIZURECONTROLAFFECTQUALITY
OFLIFE AFTERVAGALNERVE STIMULATION:
CLINICAL SERIES
H. Ekmekci*, H. Kaptan†
*Selcuk University Faculty of Medicine, Department of
Neurology, Konya, Turkey, †Selcuk University Faculty of
Medicine, Department of Neurosurgery, Konya, Turkey
Purpose: Vagus Nerve Stimulation (VNS) has shown to be an effica-
cious and safe treatment for patients with refractory epilepsy.
Method: In last 2 years four patients were referred for having the VNS
implantation in our clinic. All patients had medically refractory epilepsy
after a period of medical treatment for 21.83  8.22 years, and were on
average four medications at the time of referral.
Results:: Patient 1 (40.M) subcortical epileptic seizures plus frequent
myoclonic and tonic-clinic attacks and twice suffered status epilepticus.
He in general tolerated the calibration sessions quite well and by 18-
months post VNS, his convulsions had decreased to maximum two sei-
zures per month.
Patient 2 (35.F). She experienced a general epileptic attack at the age
of 20 and has experienced myoclonic seizures accompanied by sudden,
high-pitched cries. 12 months post-VNS, the second patient showed a
70.56% reduction in the maximum number of spikes and 92.97% reduc-
tion in the number of seizures on EEG.
Patient 3 (27.F) She, too, was diagnosed with secondary generalized,
complex partial seizures and tonic-clonic attacks. In second 6 month of
period, the effect of seizure showed obviously decrement response for
life quality.
Patient 4 (20.M). He suffered Complex Partial epileptic activity from
the age of 6. For the last 1.5 year, daily seizure numbers reached up to
40–50. After VNS, the response was dramatically from the beginning
such as seizure free days has been reached a week.
Conclusion: VNS is an effective therapy for medically refractory par-
tial-onset seizures, with an approximate long-term decrease in mean sei-
zure frequency of 40–50% and a short-term decrease in mean seizure
frequency of 20–30%. In our presentation, the early findings of VNS
achievement goes up seizure control up to 70% and also acceptable
improvement in daily life quality is achieved in these patients.
p0306
VNS THERAPYAUTOMATICMAGNETMODE
OUTCOMES STUDY IN EPILEPSY PATIENTS
EXHIBITING ICTAL TACHYCARDIA
R. Fisher*, P. Afra†, B. Najimipour‡
*Stanford University Medical Center, Stanford, CA, USA,
†University of Utah, Salt Lake City, UT, USA, ‡Cyberonics, Inc.,
Houston, TX, USA
Purpose: The Automatic Magnet Mode (AMM) feature of the Aspire
SR VNS Therapy System stimulates upon detecting a heart rate
increase associated with seizure onset. This study evaluates performance,
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safety and clinical outcomes of the AMM feature during a 5-day Epilepsy
Monitoring Unit (EMU) stay and follow-up visits for up to 2 years.
Method: The E-37 protocol (NCT01846741) is a prospective,
unblinded, US multi-site study of the AspireSR in subjects with refrac-
tory partial onset seizures and history of ictal tachycardia. AMM perfor-
mance was evaluated in the EMU, and standard cycling VNS was added
to AMM functionality at EMU discharge. Subjects were seen at 3, 6 and
12 months, while completing questionnaires (SSQ; Seizure Severity
Questionnaire; QOLIE-31-P: Quality of Life In Epilepsy). Adverse
events were monitored.
Results: Twenty subjects (ages 21–69) were implanted, and experienced
84 seizures in the EMU. 83.3% of simple partial and 38.5% of complex
partial or secondarily generalized seizures stopped during 60 seconds of
stimulation, on average 37.9 seconds after stimulation onset. QOLIE and
SSQ scores exceeded twice the Minimal Important Changes (MIC) crite-
ria at 3 and 6 months. QOLIE sub-domain of cognitive functioning and
SSQ sub-domains of activity during seizures, postictal emotional and
physical recovery exceeded three times the MIC. Twelve month data
analysis will be updated.
Conclusion: This study shows that the AspireSR performed as intended
in the study population. Seizure duration during EMU stay with only
AMM stimulation was relatively short, but there was no controlled com-
parator. The SSQ and QOLIE questionnaires showed sustained improve-
ment in seizure severity, post-ictal recovery and quality of life with
combined AMM and standard VNS compared to baseline. These results
suggest significant clinical benefit when the AMM feature is added to
standard VNS therapy. Which factors are responsible for improvement
remain to be determined.
p0307
THE EFFECTOFVAGALNERVE STIMULATIONON
QUALITYOFLIFE IN PEDIATRIC CASES
H. Gazeteci Tekin*, G. Serdaroglu*, S. G€okben*, S. K€ose†,
T. Turhan‡, S. Yılmaz*, S. Erermiş†
*Ege University Medical Faculty, Pediatrics, Division of Child
Neurology, Izmir, Turkey, †Ege University Medical Faculty,
Child and Adolescent Psychiatry, Izmir, Turkey, ‡Ege University
Medical Faculty, Neurosurgery, Izmir, Turkey
Purpose: To evaluate the value of vagal nerve stimulation (VNS) in
improving quality of life, and mood in children with pharmacoresistant
epilepsy.
Method: Eleven pharmacoresistant epileptic children implanted with
the VNS Therapy device between 2010 and 2014 were included in this
prospective longtidunal study. Clinical assessment for DSM-IV psychi-
atric disorders, schedule for affective disorders and schizophrenia for
school children were applied. Childhood Depression Inventory (CDI),
Beck Depression Inventory (BI) were filled. Child Behavior Checklist
and The Pediatric Quality of Life Inventory (PedsQL) were filled by par-
ents before the implantation. All of these tests were repeated at the first
and the second year of implantation.
Results: Mean age at first VNS therapy device implantation was 11.5
(2.5 and 16). Mean duration of epilepsy prior to VNS implantation was
30.4 months (10–96). ILAE classification of predominant seizure type
was partial in 7 and generalized in 4 patients. Decrease in number of sei-
zures was 42% and 43% in the first and the second year respectively.
While four of 11 patients had no psychopathology, different problems
were determined in seven patients. There was no statistically significant
difference between the scores of CDI/Beck DI at the beginning and the
first year. Also the scores of CBCL and the Pediatric Quality of Life
Inventory (PedsQL) prior to implantation and 1 year and 2 years after
implantation didn0t differ.
Conclusion: VNS is partially effective for controlling drug-resistant
epilepsy. Although a positive effect on depression and quality of life
is reported in literature, the results of this study were not statisti-
cally significant. We think that the scores of depression inventory
should gradually decrease in years as it is reported for seizure fre-
quency.
p0308
THE EFFICACYOFHIGHDUTYCYCLEVAGUS
NERVE STIMULATION INCHILDRENWITH
CATASTROPHIC EPILEPSIES - OUTCOMEON
SEIZURE FREQUENCY
G. Hmaimess*, W. Tohme*, S. El Sayad†, A. Nachanakian*
*Saint Georges Hospital University Medical Center, Beirut,
Lebanon, †Cyberonics, Inc., Brussels, Belgium
Purpose: Vagus Nerve Stimulation therapy (VNS Therapy) is a well-
established treatment for patients with drug resistant epilepsy (DRE).
This study reports the outcome of using high duty cycle VNS Therapy
(ON time divided by OFF time represented as a percentage) in children
with catastrophic epilepsies; mainly Lennox Gastaut, Dravet, West and
Ohtahara syndromes.
Method: Children with catastrophic epilepsy implanted with VNS
were retrospectively evaluated. For those patients who did not respond
to the standard 10–16% duty cycle, a duty cycle of 29% or higher
was applied. Seizure frequency reduction was assessed at the last fol-
low-up which was at least 3 months post programing of the high duty
cycle.
Results: 26 children (9F/17M, median age 5 (6 months -18 years)) were
included. Median VNS duty cycle was 44% (range 29% - 44%); with
73% (19/26) of patients on 44% duty cycle. The current was between
1.75 mA and 3 mA and was kept constant once the duty cycle was
ramped up beyond 16%. Median follow up time was 2 years (range 1–
5 years). 15 (57%) patients were responders (≥50% seizure reduction),
with 14 (54%) patients having a seizure reduction of ≥75%, 7 (27%) hav-
ing a seizure reduction of ≥90% and 3 (11%) patients becoming seizure-
free. 7 (27%) patients had some reduction in seizure frequency but did
not reach response (≤50%) and 4 (15%) patients had no change in their
seizures. 12 patients had amelioration in the severity of the remaining sei-
zures, 6 patients had shorter seizure duration and 7 patients had shorter
post-ictal state.
Conclusion: Using higher than standard duty cycles with VNS Therapy
shows a reduction in seizure frequency in patients with catastrophic
epilepsies. It is therefore crucial to assay all programing options includ-
ing the higher duty cycles, even starting with high duty cycles, to increase
the chance of response in difficult epilepsies.
p0309
NEURONALBEHAVIOURDURINGDELAYED
RESPONSES TO SINGLE PULSE ELECTRICAL
STIMULATION (SPES) IN SUBJECTSWITHEPILEPSY
D. Jiménez-Jiménez*,†,‡, D. Martín-Lopez*,†,§, R.P. Selway¶,
J. Martinez**, M.J. Ison**,††, H.G. Rey**,††, R. Quian
Quiroga**,‡‡, A. Valentín*,†, G. Alarcon*,†,§§
*King’s College London, Department of Basic and Clinical
Neuroscience, Institute of Psychiatry, Psychology and
Neuroscience, London, UK, †King’s College Hospital,
Department of Clinical Neurophysiology, London, UK,
‡Universidad San Francisco de Quito, School of Medicine,
Quito, Ecuador, §St Peter’s Hospital, West Surrey Clinical
Neurophysiology, Chertsey, UK, ¶King’s College Hospital,
Department of Neurosurgery, London, UK, **University of
Leicester, Department of Engineering, Leicester, UK,
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††University of Leicester, Centre for Systems Neuroscience,
Leicester, UK, ‡‡University of Magdeburg, Leibniz Institute for
Neurobiology, Magdeburg, Germany, §§Universidad
Complutense, Departamento de Fisiología, Facultad de
Medicina, Madrid, Spain
Purpose: To describe neuronal firing patterns associated with presence
and absence of delayed responses to SPES in humans.
Method: Behnke-Fried microelectrodes were inserted in 35 consecutive
patients assessed with depth electrodes for presurgical assessment of epi-
lepsy. SPES (1 ms, 4–6 mA) was delivered at least 20 times at each
implanted region. At each area with microelectrodes showing delayed
responses to SPES, the proportion of neurones showing burst, suppres-
sion, burst-suppression or no change immediately after the stimulus was
compared between those stimuli showing delayed responses and those
not showing delayed responses.
Results: Among the 35 patients assessed with depth electrodes and
microelectrodes, 4 showed delayed responses in areas with microelec-
trodes. Forty-one neurons were recorded in the regions showing delayed
responses. After the stimuli that did not induce delayed responses, 24.3%
of neurons showed burst, 19.5% suppression, 7.3% burst-suppression and
48.7% no change. After the stimuli that induced delayed responses,
39.0% of neurons showed burst, 21.9% suppression, 4.8% burst suppres-
sion and 34.1% no change. There was no significant difference in the pro-
portions of each neuronal type between the stimuli showing and not
showing delayed response (Chi2 = 5.43; 3 df; p = 0.14).
Conclusion: There is no difference in the proportion of each neuronal
type between the stimuli that induced delayed responses and those do
not.
Significance:Mechanisms other than the proportion of each cell type
may be responsible for delayed responses, such as the amount of inhibi-
tion or bursting.
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CHANGES IN SEIZURE FREQUENCYWITHVNS
THERAPY IN JAPANESE PATIENTSWITHDRUG-
RESISTANT EPILEPSY: 2 YEARRESULTS FROMA 3-
YEAR PROSPECTIVE REGISTRY
K. Kawai*, T. Tanaka†, H. Baba‡, M. Bunker§, Y. Inoue¶,
S. Kameyama**, S. Kaneko††, A. Kato‡‡, T. Nozawa§§,
E. Maruoka¶¶, M. Osawa***, T. Otsuki†††, S. Tsuji‡‡‡,
E. Watanabe§§§
*NTTMedical Center Tokyo, Epilepsy Center, Tokyo, Japan,
†Yamabiko Medical Welfare Center, Kagoshima, Japan,
‡National Hospital Organization Nagasaki Medical Center,
Nagasaki, Japan, §Cyberonics, Huston, TX, USA, ¶National
Epilepsy Center Shizuoka Institute of Epilepsy and Neurological
Disorders, Shizuoka, Japan, **Nishi-Niigata Chuo National
Hospital, Niigata, Japan, ††Minato Hospital, Hachinohe,
Japan, ‡‡Kinki University Hospital, Faculty of Medicine,
Osaka, Japan, §§Toranomon Hospital, Tokyo, Japan, ¶¶Nihon
Koden Corporation, Clinical Development Group, Tokyo,
Japan, ***Tokyo Women’s Medical University, Tokyo, Japan,
†††National Center of Neurology and Psychiatry, Tokyo, Japan,
‡‡‡International University of Health and Welfare, Fukuoka,
Japan, §§§Jichi Medical University Hospital, Tochigi, Japan
Purpose: The efficacy and safety of vagus nerve stimulation (VNS)
Therapy has been established in the treatment of drug resistant epilepsy
patients in the U.S and Europe. However, there are no published large
scale prospective studies in Japan.
Method: VNS Therapy was approved for use in Japan in 2010. As a con-
dition for approval a registry, to follow the natural course of patients trea-
ted with VNS was required. We conducted a multi-center, open–label,
long–term, prospective registry of all patients with VNS Therapy in
Japan to follow their clinical course and outcome. Patients who were
expected to benefit from neurosurgical intervention were excluded. The
final decision to include patients into the registry and to perform the
implantation surgery was done by board-certified epilepsy surgeons. The
primary objective was to assess responder-rate based on >50% reduction
in baseline seizure frequency. Baseline data were collected prior to
implantation and at 3, 6, 12, 24, and 36 months after the start of VNS
Therapy. Two years of data has been collected.
Results: The registry included 385 patients aged 12 months to 72 years
at time of device implantation (mean: 24.0 years), including 19% (72/
385) who were <12 years of age at implant. Approximately half of
patients had prior epilepsy surgery. Responder rates at 6, 12 and
24 months of VNS Therapy were 46.6%, 56.0% and 58.6% for all seizure
types. Response for partial seizure was 49.8%, 55.6% and 59.3%.
Response for generalized seizures, including secondarily generalized,
was 55.0%, 63.7% and 68.2%, respectively. No new safety signal was
identified.
Conclusion: Similar to the published literature from the US and Eur-
ope, the results from the preliminary analysis of the first, long-term,
prospective registry in Japan support the safe and effective use of VNS
Therapy in this population of Japanese patients with drug–resistant
epilepsy.
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OCT PARAMETERS IN PATIENTSWITH
PHOTOSENSITIVE JUVENILEMYOCLONIC
EPILEPSY
Y. Bicer Gomceli*, B. Dogan†, F. Genc*, E. Uygur*, D. Turgut
Coban†, A. Erdal*, M.K. Erol†
*Antalya Research and Training Hospital, Neurology, Antalya,
Turkey, †Antalya Research and Training Hospital,
Ophthalmology, Antalya, Turkey
Purpose: In this study, we aim to explore the relationship between the
PPR and Optical Coherence Tomography (OCT) parameters in order to
determine whether optic nerve layer or other structural differences have a
causative role of photosensitivity in patients with JME.
Method: We studied 53 consecutive patients with Juvenile myoclonic
epilepsy (JME) at our outpatient department. The interictal EEG findings
for each patient were analyzed for the presence of any photoparoxysmal
features. The peripapillary Retina Nerve Fibre Layer (RNFL) thickness,
macula thickness and ganglion cell thickness were analyzed using OCT.
Results: We classified the 53 patients in our study into two groups as
those with PPR (Group 1; 43.4%) and those without PPR (Group 2;
56.6%). There were statistically significant differences in the average
RNFL thickness values of left eye between the two groups (p < 0.001).
Although the RNFL thickness of the right eye was higher in Group 1, no
statistically significant differences were observed in this respect between
the two groups. The RFNL thickness of the superior quadrants both in the
right and the left eyes was significantly higher in Group 1 patients
(p < 0.001). Macular thickness of the right and left eyes were signifi-
cantly thinner in Group 1 patients (p < 0.001). Choroid thickness of the
left eye was significantly higher in Group 1 than in Group 2 patients
(p < 0.001). Although choroid thickness of the right eye higher in Group
1 patients, no statistically significant differences was observed between
the two groups.
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Conclusion: We have found out that the RFNL thickness especially of
the superior quadrants both in the right and left eyes, and choroid thick-
ness were higher while macular thickness was significantly thinner in
photosensitive patients with JME. In this study, we concluded that these
structural features may be related to photosensitivity in patients with
JME.
p0318
THE SKINOF FEAR EPILEPSY IN THENOVELOF
JAVIERVASCONEZ
J. Carrizosa
University of Antioquia, Pediatrics, Medellín, Colombia
Purpose: Javier Vasconez-an Ecuadorian writer- uses epilepsy as one
guiding principle in his novel “The Skin of Fear”. Fear and epilepsy
steep the development of the protagonist and of his environment. The
objectives are to characterize the literary references concerning epi-
lepsy in the novel, and to classify and anayze the literary description
of epilepsy.
Method: Reading, identification, classification and analysis of the tex-
tual references pertaining epilepsy and its influence in the novel0s envi-
ronment. Literary concepualization of epilepsy.
Results: Fear appears as a clínical manifestation of seizures, but also as
an emotional condition of the protagonist. Fear is also present in the pro-
taginists0relatives and friends, and even in the environment of the city,
Quito. Other literary references regarding epilepsy describe postictal
state, shame, self-compassion, secret, sorrow, excuse, stigma, supranatu-
ral power, insecurity, emptiness, alienation, identity or contrition.
Conclusion: Javier Vasconez presents epilepsy as a disease that goes
beyond the biological and clinical aspects, having a great impact in the
psychological and social fields, and even charging the urban environment
with a perception of fear. It seems that these descriptions were derived
from the epilepsy suffered by himself.
p0319
POETRYOFCLEMENCIA TARIFFA: LIGHT INA
NEGLECTEDEPILEPSY
J. Carrizosa
University of Antioquia, Medellín, Colombia
Poverty and epilepsy were lifelong mates of poetess Clemencia Tariffa.
Beside these adverse situations she reached an autodidactic approach
to literature and poetry. The splendor of her work was intense but
passed frequently unrecognized. The macabre comfabulation of a
neglected disease with social missery destroyed her mental and physi-
cal state leading finally to death. The case demonstrates how uncon-
trolled epilepsy associated to adverse social conditions harm human
dignity and liberty.
Stranger
Another woman lives in me
a stranger an intruder
I cannot understand
Friendship
If our friendship
wouldn0t be so pure
like love
we do in secrecy
or so clear
as your smal chestnut colored eyes
or so firm
as the moon of ivory
fluttering through my country
seriously I woudn0t write this night.
I, only want your friendship.
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TILT-INDUCEDVASOVAGAL SYNCOPEAND
PSYCHOGENIC PSEUDOSYNCOPE: OVERLAPPING
CLINICAL ENTITIES
H. Blad*, R.J. Lamberts*, G. van Dijk†, R. Thijs*,†
*Stichting Epilepsie Instellingen Nederland (SEIN), Heemstede,
Netherlands, †Leiden University Medical Centre, Leiden,
Netherlands
Purpose: Vasovagal syncope (VVS) and psychogenic pseudosyncope
(PPS)may both occur in the same person during a tilt table test: combined
vasovagal syncope/psychogenic pseudosyncope (VVS/PPS). We
described this combination to aid its clinical recognition.
Method: We identified tilt-induced VVS/PPS cases from two tertiary
syncope referral centres. For each case three controls with tilt-induced
VVS were selected at random from the same centre. Clinical characteris-
tics were compared between both groups adjusting for multiple compar-
isons.
Results: Of 1164 tilt-table tests, 23 (2%) resulted in VVS/PPS; these 23
cases were compared with 69 VVS controls. VVS and PPS coincided
more often than chance would predict: 2% vs 0.6%, (p < 0.001). Typical
VVS prodromes and triggers were reported in all VVS/PPS cases and
VVS controls. Attack frequency was significantly higher in the VVS/PPS
(2 per month, range 0.1–60) than in the VVS group (0.25 per month,
range 0.02–4; p < 0.001). Delayed recovery of consciousness was more
frequently reported in the VVS/PPS group (83% vs. 10%, p < 0.001), as
were episodes without prodromes (57% vs. 10%, p < 0.001), atypical
triggers (43% vs. 9%, p < 0.001), eye closure (43% vs. 12%, p = 0.002),
and duration of unconsciousness over 1 minute (91% vs. 32%,
p < 0.001).
Conclusion: VVS/PPS presents with a complex phenotype. High attack
frequency, delayed recovery of consciousness, prolonged loss of con-
sciousness, ictal eye closure, atypical triggers and the absence of pro-
dromes may serve as indicators that PPS coincides with VVS.
p0322
EFFECTSOFANTIEPILEPTICS ONMITOTIC
PROLIFERATIONAT IN VITROCELLCULTURESOF
GLIOBLASTOMAANDNEUROBLASTOMA
Ş.Çevik*, Z. Vargün†, A. Altun‡, G. Uzun Soykok§, E. Bolayır†,
A.S. Topaktaş†
*Necip Fazıl City Hospital, Neurology, Kahramanmaraş, Turkey,
†Cumhuriyet Unıversıty, Neurology, Sıvas, Turkey, ‡Cumhuriyet
Unıversıty, Pharmacology, Sıvas, Turkey, §Sıvas Numune
Hospıtal, Neurology, Sıvas, Turkey
Purpose: The aim of the study was to identify the priority of antiepilep-
tic agents on mitotic proliferation in glioblastoma and neuroblastoma cell
cultures in vitro.
Method: The in vitro anti-tumoral activities of antiepileptic agents
including gabapentin, pregabalin, valproic acid, levetiracetam, zon-
isamide, phenytoin and carbamazepine were assessed by a real-time cell
analysis system by using E-plate 16. After inoculation of cancer cell lin-
eages into wells, plate was placed into incubator and cell proliferation
was monitored at every 1 hour. Tumor cells adhered to the bottom of
wells and proliferated in appropriate nutrient and O2/CO2 conditions.
Following cells entered to rapid proliferation phase (log phase), agents to
be evaluated for anti-tumoral activity was added to the wells predefined
as experiment group in different concentration with a volume of 10 lL.
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The plates were again placed into incubator. Measurements were main-
tained at every hour after adding agents. Monitorization was maintained
for 24–48 hours. The differences were evaluated by using analysis of
variance (ANOVA) followed by post hoc Tukey test.
Results: The present study showed that xCELLigence is a convenient
and rapid method to determine effects of antiepileptic agents on mitotic
proliferation.Antiepileptic agents have diverse cytotoxic activities on
tumor cells.
Conclusion: Within studied seven antiepileptic drugs while valproic
acid and pregabalin had more cytotoxic effects on C6 glioma cells. Cyto-
toxic effects of gabapentin were not observed.
It was also found that, only valproic acid and zonisamide cause cyto-
toxic effects On NA/AN1 neuroblastom cells. The other antiepileptic
drugs showed no cytotoxic effects.
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TWO SIBLINGSWITHHOTWATEREPILEPSY: CASE
REPORT
A.E. Çilliler, H. Güven, S.S. Comoglu
Dışkapı Yıldırım Beyazıt Training and Research Hospital,
Neurology, Ankara, Turkey
Reflexs epilepsies are seizures triggered by specific stimulants and
account for 6% of all epilepsies. Hot water epilepsy is a rare form of
reflex epilepsies which occurs while bathing. Pathophysiology of this
clinical entity is complex and unknown. It is supposed that a defect in the
thermoregulatory system leads to the seizures due to rapid rise of body
temperature. Both partial and generalized seizures may occur. The diag-
nosis of the disorder is usually based on clinical history. Interictal EEG
and neuroimaging studies are usually normal. Although the pathogenesis
is not clear, familial clustering suggests that genetic factors may play a
role in the development of the disease. In this report, two siblings, one of
whom is 35 year old male and the other 39 year old female, who have
complex partial seizures that are triggered by contact with hot water dur-
ing bathing are presented. The aim was to review the relevant literature in
view of these two cases diagnosed with hot water epilepsy.
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ANAUDITOF ELECTRO-CLINICAL, EEG, ETIOLOGY
AND PROGNOSTICOUTCOMEOF PATIENTSWITH
SPINDLECOMA (SC)
G.K. Dash*, B.N. Chauhan†
*Institute of Neurosciences, Narayana Hrudayalaya
Multispeciality Hospital, Neurology, Bangalore, India,
†Institute of Neurosciences, Narayana Hrudayalaya
Multispeciality Hospital, Bangalore, India
Purpose: To audit the electro-clinical, etiology and prognostic variables
in patients with spindle coma.
Method: We analyzed 12 patients with spindle coma and audited their
clinical, EEG, etiological and prognostic variables. Clinical out come at
discharge were defined by modified rankin score (mRS). mRS >4 was
considered to have poor outcome.
Results: The etiology of SC were hepatic encephalopathy (3, 25%), drug
intoxication (3, 25%) infections (2, 16.7%), thrombotic thrombocy-
topenic purpura (1, 8.3%), trauma (1, 8.3%), cerebral bleed (1, 8.3%) and
multifactoral encephalopathy in 1 (8.3%) case. Five (41.7%) patients had
a Glasgow coma scale (GCS) of more than 9 and 7(59.1%) patients had a
GCS <8. Two (16.7%) patients had poor outcome and 10(83.3%) had
favorable outcome at discharge. EEGwas reactive in all patients.
Conclusion: Majority (83.3%) of patients with SC had good outcome in
our study. Contrast to some previous reports, EEG reactivity did not
influence the clinical out come nor the level of GCS. The underlying eti-
ology of SC determined the clinical outcome. The two patients who had
poor out come had multiorgan dysfunction syndrome and cortical venous
sinus thrombosis with infarctions.
p0325
ICTALMUSICALHALLUCINATIONS - A CASE
REPORT
V. Espírito Santo, R. Almendra, A.G. Velon, M.R. Silva,
P. Guimar~aes
Centro Hospitalar de Tras-os-Montes e Alto Douro, Vila Real,
Portugal
Introduction: Auditory hallucinations are an unusual manifestation of
seizures. In this work we report the case of a patient with musical aura.
Clinical case: A 76 years-old woman, with history of arterial hyperten-
sion and breast tumor submitted to surgery and chemotherapy with no
signs of recurrence after 5-year of follow-up, followed in our hospital by
a tonic-clonic seizure in the context of hyponatremia 2 years ago. During
one appointment, she revealed experiencing several musical hallucina-
tions in the past 6 months. Her hallucinations developed suddenly, with-
out any identifiable case, and consist in different types of melodies, that
the patient recognizes already heard them in youth or more recently. She
denied any other symptom during the episodes and she didn’t have any
auditory complains. Her neurological exam was unremarkable. Complete
blood count, complete metabolic panel, sedimentation rate, homocys-
teine, iron, folic acid and vitamin B12 were normal. Anti-neuronal, anti-
NMDA and anti-potassium channels antibodies were also normal. HIV,
Hepatitis B and C, Herpes simplex and CMV serologies were negative.
She has negative tumor markers and no signs of tumor recurrence in tho-
raco-abdominal tomography. Electroencephalography showed mild
fronto-temporal bilateral paroxysmal activity. MRI revealed moderate
cortical-subcortical atrophy and signs of ischemic leukoencephalopathy
with periventricular predominance associated with multiple small hyper-
intense fronto-parietal bilateral subcortical foci related to gliotic
ischemic foci. She started treatment with oxcarbamazepine with amazing
improvement of her symptoms and a completely normal electroen-
cephalography after 1 year of follow-up.
Conclusion: With this case report we intended to draw attention to this
unusual form of epilepsy, not even fully yet understood, especially in
what concerns the association between the auditory cortex, memories
and how they are evoked.
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RAPID IDENTIFICATIONOF ICTALEVENTS IN
LONG-TERMEEGRECORDINGS FROMEPILEPSY
MONITORING
M. Hartmann*, F. Fürbass*, G. Gritsch*, A. Skupch*,
J. Koren†, J. Herta‡, C. Baumgartner†, T. Kluge*
*AIT Austrian Institute of Technology GmbH, Vienna, Austria,
†General Hospital Hietzing with Neurological Center
Rosenhügel, Vienna, Austria, ‡Medical University Vienna,
Vienna, Austria
Purpose: A quantitative EEG trending tool called NeuroTrend was used
for rapid review of EEG recordings from an EMU in order to identify
ictal events. NeuroTrend automatically identifies periodic discharges and
rhythmic EEG activity and shows trends of their localization, frequency
and amplitude. It furthermore shows trends of aEEG and background
EEG frequency and allows viewing the corresponding EEG.
Method: Two reviewers used the NeuroTrend software to review long-
term EEG recordings from 14 randomly selected patients from an EMU.
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Only patients who had electrographic seizures during EEG monitoring
were included. Patients with ictal EEGs characterized solely by paroxys-
mal fast activity were excluded. Mean recording duration per patient was
3 days and 20 hours. The reviewers were asked to compile lists of time
instances with suspicious patterns that potentially correspond to seizures.
They were not asked for a detailed assessment of the patterns. The lists of
events were compared with the ictal events from the clinical reports from
standard clinical review procedures. Sensitivity and specificity were
assessed.
Results: The mean review time spent by the two reviewers was 3 min-
utes per 24 hours of EEG data. The two reviewers found 100% of the sei-
zures in the EEGs of 8 out 14 patients (57%) and more than 2/3 of the
seizures in 11 out of 14 patients (79%). In 3 patients they found less than
2/3 but at least one of the seizures.
Conclusion: We could demonstrate the suitability of NeuroTrend for
rapid review of long-term EEG recordings from EMUs. In our study it
allowed identifying ictal events with a high mean sensitivity of 81% and
a high mean specificity of 63%, while spending only 3 minutes for
reviewing 24 hours of EEG recordings on average.
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THECLASSICAL PHENOTYPEOFGLUCOSE
TRANSPORTER-1 DEFICIENCY SYNDROME (GLUT-1
DS): DIFFERENTCLINICAL EXPRESSIONAND
KETOGENIC DIETRESULTSOF PEDIATRIC
PATIENTS
A. Kacar Bayram*, H. Per†, F. Kardas‡, M. Canpolat§,
A.O. Caglayan¶, S. Kumandas§, M. Kendirci‡, H. Gumus§
*Erciyes University Medical School, Department of Pediatrics,
Division of Pediatric Neurology, Kayseri, Turkey, †Erciyes
University, Faculty of Medicine, Department of Pediatrics,
Division of Pediatric Neurology, Kayseri, Turkey, ‡Erciyes
University Faculty of Medicine, Department of Pediatrics,
Division of Pediatric Nutrition and Metabolism, Kayseri,
Turkey, §Erciyes University Faculty of Medicine, Department of
Pediatrics, Division of Pediatric Neurology, Kayseri, Turkey,
¶Yale University, School of Medicine, Departments of
Neurosurgery, Neurobiology and Genetics, New Haven, CT,
USA
Purpose: The purpose of this study was to characterize patients who
diagnosed with glucose transporter protein-1 deficiency syndrome
(GLUT-1 DS), and also assess the efficacy of ketogenic diet (KD) ther-
apy on seizure control, cognitive functions and other neurological disor-
ders.
Method: We studied 6 unrelated Turkish patients with the classical phe-
notype of GLUT-1 DS, focusing on clinical and laboratory features, the
KD therapy and outcome over the 25-month follow-up period.
Results: Five patients became seizure-free with the onset of ketosis,
and anticonvulsants were discontinued. Other neurological features
such as ataxia, spasticity, and dystonia improved less striking than the
seizure control. There was no significant change in the IQ level and
microcephaly after treatment of KD. In all patients, alertness, concen-
tration, motivation, and activity resulted moderately improved with
variable degree based on parents0 reports and clinical presentations. On
the KD epileptiform discharges had completely normalized in 5
patients. Slowing of background activity was still present in 1 patient.
During follow-up, early-onset adverse effects of the KD as nausea,
vomiting, constipation, and fatigue were observed in 5 patients but
late-onset complications were not detected in any patients. The KD
regimen was failed in 1 patient, therefore his diet was changed with
alternative KD.
Conclusion: Treatment with a KD results in marked improvement of sei-
zures and cognitive functions, and appeared less striking on other neuro-
logical disorders of patients. When the classic KD was not tolerate,
another alternative ketogenic diet may be helpful.
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LATE-ONSET SSPECASE SHOWINGTEMPORARY
AMELIORATIONWITHCARBAMAZEPINE THERAPY
N. Gurgor Kanat, I. Tatlidil, Y. Beckman, H.S. Ture, S. Arici
Izmir Katip Celebi University Ataturk Research and Training
Hospital, Izmir, Turkey
Introduction: Subacute Sclerosing Panencephalitis (SSPE) is a rare pro-
gressive, fatal neurodegenerative disease caused by a persistent defective
measles virus. Clinically, it is characterized by insidious onset of behav-
ioral changes and deterioration in cognitive functions followed by myo-
clonus and result in vegetative state, coma and death. No curative
treatment has been reported. We present a case diagnosed as SSPE and
giving temporary response to carbamazepine therapy.
Case: 17 year old male patient presented with behavioral change, cog-
nitive decline, urine incontinence, retropulsive posture, followed by pro-
gressive myoclonus. Upon admission routine laboratory test results were
normal. First Cranial Magnetic resonance imaging (MRI) revealed small
size nospesific hyperintense lesion in medial frontal region in T2
weighted image. Later Cranial MRI views showed bilateral diffuse corti-
cal hyperintensity which is prominent in parieto-occipital region. EEG
revealed generalized periodic spike and waves.
Results: Diagnosis of SSPE in stage 2 was suspected, CSF sample con-
firmed the diagnosis of SSPE with highly elevated titers. During follow-
up his myoclonus frequency was increased and cognitive functions were
deteriorated and he became mute and bounded to bed. There was no
response to Vaproic acit therapy which was firstly started. After initiation
of carbamazepine therapy his cognitive functions dramatically amelio-
rated, he was able to ambulate with support and had a speech with several
basic words. The frequency of myoclonus was reduced. A month after
treatment his progression was continued and progressed in to stage 3.
Conclusion: According to our classical knowledge, carbamazepine is an
antiepileptic drug exacerbating myoclonic seizures and causing no
improvements in cognitive functions. As it is shown in the literature as
well as in our case temporary carbamazepine response in SSPE is one of
controversy of classical carbamazepine treatment and underlying mecha-
nism of this response is still unknown.
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TEMPORAL LOBEEPILEPSY PRESENTEDWITH
ATYPICALLY PROLONGED POSTICTAL PSYCHOSIS:
A PEDIATRIC CASEREPORT
E.-J. Ahn*, E.-H. Kim*, M.-S. Yum*, Y.-J. Lee*, H.-W. Kim†, T.-
S. Ko*
*Asan Medical Center Children’s Hospital, Department of
Pediatrics, Seoul, Republic of Korea, †Division of Pediatric
Psychiatry, Department of Neuropsychiatry, AsanMedical
Center, University of Ulsan College of Medicine, Seoul,
Republic of Korea
Background: Postictal psychosis (PIP) is a common complication, pre-
dominantly occurring in patients with temporal lobe epilepsy (TLE). PIP
usually runs a benign and brief course although its psychopathology is
often polymorphic, with abnormal mood, paranoid delusions, and impair-
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ment of consciousness and orientation. We describe a girl with TLE who
developed a prolonged episode of PIP lasting 3 months.
Case: A14 year-old girl was transferred due to uncontrolled recur-
rent seizures and psychotic symptoms. Her neurodevelopment was nor-
mal without a history of febrile seizures. About a month ago, she
presented with dozens of dazzling and left side twinges and weakness,
sometimes evolving left side clonic seizures with partly impaired con-
sciousness. EEG and brain MRI revealed normal. After the first cluster
of seizures, she had complained of severe continuous headache and she
experienced another generalized tonic-clonic seizures (GTCS) followed
by disorientation, anxiety and restless and aggressive behaviors
2 weeks after the first seizure. The psychotic symptoms did not
respond to neuroleptic medications and GTCS recurred after introduc-
tion of antiepileptic drugs. Even after the discontinuation of all antipsy-
chotic medications to exclude the deliriant side effects, her psychosis
continued. Laboratory test to identify other medical causes was unre-
markable. Repeated EEG recording revealed focal epileptiform dis-
charges from right temporal area and definite postictal diffuse
background slowings. Although recurrent GTCS were controlled by
administration of phenytoin, her psychotic symptoms persisted despite
multiple neuroleptic medications and multiple AEDs. However, her
psychosis gradually disappeared from 2 months after the diagnosis.
She completely recovered from the psychotic symptoms 3 months of
treatment and now has been seizure-free without psychotic symptoms
for 3 months.
Conclusion: We describe a rare case with TLE who developed the pro-
longed PIP following poorly controlled seizure. PIP can be another dif-
ferential diagnosis of abnormal behavior or psychosis in children with
epilepsy.
p0332
NEURODEVELOPMENTALOUTCOMEOFCHILDREN
WITHWEST SYNDROME INATERTIARYCARE
CENTRE
S. Akhter*, K. Fatema*, M. Mannan†, M.M. Rahman*
*Bangabandhu Sheikh Mujib Medical University, Peadiatric
Neurology, Dhaka, Bangladesh, †Bangabandhu Sheikh Mujib
Medical University, Neurology, Dhaka, Bangladesh
West syndrome represents a seizure disorder with unique clinical and
electroencephalographic features. It is a catastrophic type of epilepsy
where the outcome is guarded. The study was done to follow up the
outcome of infants who were diagnosed as a case of West syndrome. It
was a cross sectional study done in Child Neurology Unit, BSMMU.
Forty seven diagnosed cases of West syndrome were followed up for a
period of average 4.31 year (highest 10 year and lowest 2 years). Mean
age of the patients were 14.6 months. In 12.8% patients age of onset of
spasm was <3 months, 51% 3–6 months, 27.7% 6–9 months. Regard-
ing developmental status, 57% of the patients were diagnosed as cere-
bral palsy while 23% had global developmental delay. Only 2 patients
had normal development. Most of the patients had perinatal asphyxia
16 (34%) as risk factors. In EEG 29 patients had hypsarrythmia (17
classical and 12 modified) while other had multifocal spikes etc.
Regarding neuroimaging, 81% had abnormal finding. Patients were
treated with multiple antiepileptic drugs. ACTH was given in 8
patients, vigabatrin in 14, prednisolone 13 and valproate in 10 patients.
In follow up we found, 36% patients had cerebral palsy, 27.6% patients
has epilepsy, 12.7% patients died, 2 patients had autism while 5
patients had other complications. Only 11% patient had normal neu-
rodevelopmental outcome. Regarding cognition, 37 patients had psy-
chological assessment, out of them 81% had moderate to severe mental
retardation. Causes of death of the patients were epilepsy (16%), dis-
continuation of antiepileptic drug (16%), pneumonia (16%) and
unknown (50%). There are very limited studies involving the outcome
of West syndrome, particularly in developing countries. This study
highlights the clinical pattern and outcome of this disorder in a low
resource country like Bangladesh.
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EFFICACYOFLEVETIRACETAMMONOTHERAPY IN
CHILDHOODEPILEPSY
M. Arslan*, S. Güng€or†, B. Lılıc†
*In€onü University Faculty of Medicine, Child Neurology,
Malatya, Turkey, †In€onü University Faculty of Medicine,
Malatya, Turkey
Purpose: Levetiracetam is a new antiepileptic drug especially approved
for treatment of focal seizures in adults and children. The aim of this
study was to investigate efficacy and tolerability of levetiracetam
monotherapy in pediatric patients.
Method: In the study 225 children (aged 1 month-18 years) receiving
levetiracetam and had being followed for at least 1 year were evaluated.
The dagnosis of epilepsy was made by history of two or more unpro-
voked seizures. Dermographic characteristics, reason for antiepleptic
treatment, the dose of levetiracetam, duriation of the treatment,
antiepileptic drugs used previously, seizure type, seizure duriation, cra-
nial MRI and EEG, seizure etiology and side effects of the drug were
documented.
Results: A total of 225 patients, 95 girls and 130 boys, were enrolled in
the study. 125 (55.6%) patients had generalized, 90 (%40) had focal sei-
zures and 10 (4.4%) had epileptic syndromes of childhood. Overall, 186
(82.7%) patients remained seizure-free. According to the seizure type;
80.8% (101/225) of generalized and 87.8% (79/225) of focal seizures
ended. When evaluated according to the EEG; 82.8% of generalized and
82.9% of focal seizures were terminated. There was no difference in the
effectiveness of levetiracetam in partial and generalized epilepsy. Over-
all, 8 (18%) patients had advers events. The most common side effects
were evaluated as irritability and nervousness. There was no relationship
between drug dose and side effects.
Conclusion: Levetiracetam monotherapy is effective in childhood
epilepsies with focal and generalized seizures. It is well tolerated inspite
of mild and transient side effects which not require drug discontinuation.
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INSULIN-LIKEGROWTHFACTOR-1 IS ASSOCIATED
WITHCOGNITIVEOUTCOME IN INFANTILE SPASMS
R. Riikonen
Kuopio University Hospital, Kuopio, Finland
Purpose: The molecular mechanisms that lead to long-term conse-
quences of infantile spasms (IS) are poorly understood. Insulin-like
growth factor-1 (IGF-1) is regulated by insults that might be stressful to
the brain, and is crucial for early brain development. The aim of the pre-
sent study was to correlate cerebrospinal fluid (CSF) levels of IGF-1 with
antecedent insults and cognitive outcome.
Methods: We studied CSF IGF-1 and the adrenocorticotropic hormone
(ACTH) concentrations in infants with idiopathic IS (IIS), symptomatic
IS (SIS), and controls.
Results and conclusions: Infants with IIS had CSF IGF-1 concentra-
tions similar to those of the control children, but children with SIS had
markedly low CSF IGF-1 concentrations. In addition, CSF ACTH con-
centrations were significantly lower in the children with SIS than in those
with IIS. High CSF IGF-1 concentrations were associated with an idio-
pathic etiology, absence of early (pre- or perinatal) insults or stress, nor-
mal brain imaging studies, good response to ACTH therapy, and
favorable cognitive outcome. Low CSF IGF-1 concentrations were asso-
ciated with low CSF ACTH concentrations, a history of early insults or
stress, cerebral atrophy, poor response to therapy, and poor cognitive out-
come. In children with IS, insults or stress in early life may affect the syn-
thesis of IGF-1, which might play a role in the reduction of certain
cognitive functions.
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SEIZUREDURATIONWITHANDWITHOUTRESCUE
MEDICATION IN AEUROPEAN SURVEYOF
CHILDRENWHOEXPERIENCE PROLONGEDACUTE
CONVULSIVE SEIZURES
F. Vigevano*, F.J. Kirkham†,‡, B. Wilken§, M. Raspall-
Chaure¶, R. Grebla**, N. Roskell††, T. Kiechle‡‡, L. Lagae§§
*Bambino Gesu Children’s Hospital, Department of
Neuroscience, Rome, Italy, †University Hospital Southampton
NHS Trust, Department of Child Health, Southampton, UK,
‡Institute of Child Health, University College London, London,
UK, §Klinikum Kassel, Department of Paediatric Neurology,
Kassel, Germany, ¶Vall d’Hebron University Hospital,
Department of Paediatric Neurology, Barcelona, Spain,
**Shire, Global Health Economics and Outcomes Research,
Wayne, PA, USA, ††BresMed Health Solutions, Sheffield, UK,
‡‡Shire, Global Medical Affairs, Zug, Switzerland, §§University
Hospitals, Katholieke Universiteit Leuven, Pediatric Neurology,
Leuven, Belgium
Purpose: To investigate the effect of rescue medication on seizure dura-
tion in children with epilepsy who have prolonged acute convulsive sei-
zures (PACS).
Method: Practices in Emergency and Rescue medication For Epilepsy
managed with Community-administered Therapy 3 (PERFECT-3) was a
cross-sectional study in Germany, Italy, Spain and the UK. Eligible
patients were non-institutionalized children aged 3–16 years who had
been diagnosed with epilepsy ≥ 12 months previously, had experienced ≥
1 PACS within the last 12 months and had currently prescribed rescue
medication(s) for PACS. Investigators provided clinical assessments and
parents/guardians completed web-based questionnaires. Assessments of
average seizure length were based on parental recollections, not on mea-
surements; seizure start- and end-points were not defined. Statistical tests
were post hoc; p values are descriptive, non-inferential and uncorrected
for multiple comparisons.
Results: At baseline, most of the 286 enrolled patients had prescriptions
for diazepam (69.2%) or midazolam (55.9%), and some had two (26.6%)
or three (2.4%) prescribed rescue medications. According to parents
(n = 258), the average length of children’s prolonged seizures without
rescue medication was 0 to <5 minutes in 35.7% of patients, 5 to <
0 minutes in 42.6% and ≥ 20 minutes in 21.7%.When rescue medication
was given, seizures reportedly lasted 0 to <5 minutes in 69.4% of
patients, 5 to <20 minutes in 25.6% and ≥ 20 minutes in 5.0%. Rescue
medication was statistically significantly associated with shorter seizures
lasting <5 minutes, compared with seizures lasting ≥ 5 minutes (Χ² =
58.8; p < 0.0001).
Conclusion: In this parent-reported survey of children with epilepsy
who had ≥ 1 PACS in the previous year, significantly more children’s sei-
zures lasted <5 minutes with rescue medication than without, and fewer
children’s lasted ≥ 20 minutes.
Study funded by ViroPharma (part of the Shire Group of Companies).
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RISK FACTORS FOREPILEPSY INCHILDREN IN THE
REPUBLICOFMOLDOVA
C. Calcii, S. Hadjiu, I. Iliciuc, N. Revenco
Hospital of Mother and Child Health Care, Chisinau, Republic
of Moldova
Purpose: The goal of this study was to identify the major risk factors for
epilepsy in children with epilepsy in the Republic of Moldova.
Method: A total of 108 cases, in children aged 1–36 months were fol-
lowed for epilepsy at the Pediatric Neurology Department during 2009–
2012 and a control group of 108 children were included in the study. The
most important examined risk factors examined were perinatal
encephalopathy, febrile seizures, family history of epilepsy, arterial
hypertension during pregnancy, head trauma, central nervous system
infections. Data were obtained through a questionnaire, via personal
interviews and the medical records and were assessed using univariate
and multivariate analysis.
Results: We observed an increased risk for epilepsy in children with sev-
ere neonatal encephalopathy (OR 28.95, 95% CI 3.8319–218.7607),
CNS infection (OR 22.84, 95% CI 2.9986–174.0101), severe head injury
(OR 20.36, 95% CI 2.1254–163.0101), presence of maternal hyperten-
sion during pregnancy (OR 13.56, 95%CI 3.1011–9.2773), with a history
of atypical febrile seizure (OR 11.31, 95% CI 2.5652–49.9060), history
of epilepsy in first, second or third-degree relatives (OR 6.54, 95% CI
1.9930–265436).
Conclusion: The most important risk factors for epilepsy identified in
this study were perinatal encephalopathy, history of atypical febrile sei-
zures, severe head injury, CNS infection. Other identified important risk
factors were a history of epilepsy in the family and maternal hypertension
during pregnancy.
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BRAINMR IMAGINGANDMR SPECTROSCOPY
FINDINGS IN CHILDRENWITHBREATHHOLDING
SPELLS
D.S. Dokumaci*, M. Calik†, H. Kandemir‡, S. Sarikaya§,
N.E. Boyaci*, E.S. Kucuk¶, C. Kaya¶, T.K. Yoldas**
*Harran University School of Medicine, Department of
Radiology, Sanliurfa, Turkey, †Harran University School of
Medicine, Department of Pediatric Neurology, Sanliurfa,
Turkey, ‡Harran University School of Medicine, Department of
Child and Adolescent Psychiatry, Sanliurfa, Turkey, §Harran
University School of Medicine, Department of Neurology,
Sanliurfa, Turkey, ¶Harran University School of Medicine,
Department of Pediatrics, Sanliurfa, Turkey, **Yildirim Beyazit
University School of Medicine, Department of Neurology,
Sanliurfa, Turkey
Purpose: Breath-holding spells are relatively common and generally
benign paroxysmal attacks in infancy. However, it has been suggested
that the neurological impairment secondary to cerebral hypoxemia occa-
sionally accompanied in the children with breath-holding spells. Our aim
in this study was to analyze the findings of brain magnetic resonance
imaging and magnetic resonance spectroscopy of children with breath
holding spells.
Method: This case-controlled cross-sectional study was performed at
the Department of Pediatric Neurology, Harran University School of
Medicine, Sanliurfa, in Turkey. Brain magnetic resonance imaging and
magnetic resonance spectroscopy were performed in 18 (5 females, 13
males) children with breath-holding spells and in 13 (9 females, 4 males)
controls.
Results: The radiological abnormalities such as delayed myelination in
brain magnetic resonance imaging were not found in the all cases. More-
over, there was an insignificant difference in N-acetyl aspartate/creatine,
choline/creatine, and myo-inositol/creatine ratios between the patients
and controls in the brain magnetic resonance spectroscopy (all
p > 0.05). Also, lactate peak was not found in any of the cases. On the
other hand, a statistically significant difference was determined in respect
of glutamate levels between the patients and the controls (p = 0.034).
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Conclusion: These new findings suggest that the permanent neuronal
damage was not found in the patients with breath holding spells. Addi-
tionally, our results were demonstrated that increased glutamate levels
certainly may play a role in the risk for developing neuronal hyperex-
citability in these children.
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CLINICAL PARAMETERS INCHILDRENWITH
CEREBRAL PALSYANDEPILEPSY
N.M. Cerovac, P.M. Ignjatovic
School of Medicine, University of Belgrade, Serbia, Department
for Neurology and Psychiatry for Children and Youth, Belgrade,
Serbia
Purpose: Cerebral palsy (CP) is characterised by chronic nonprogressive
neurological disorders of motor function, posture and movement. The
purpose of this study was to determine the clinical parameters in children
with CP and epilepsy.
Method: This retrospective study included 31 children with CP who
were treated at the Clinic for Neurology and Psychiatry for Children and
Youth. In all children were analysed the clinical form of CP, type of
epileptic seizures, Apgar score, the presence of neonatal epileptic sei-
zures, ultrasound (US) of the brain and electroencephalographic (EEG)
results in the first year of life and positive family history for epilepsy.
Results: Epilepsy developed in 10 children with CP, and 7 children had
partial seizures with or without secondary generalisation, and 3 had
infantile spasms. In the group with epilepsy, 9 children had hemiparetic
and quadriparetic form of the disease, and 1 child had diplegic form.
Neonatal seizures and abnormal EEG showed statisticaly significant
association with occurence of epielpsy in children with CP (x = 5.9,
DF=1, p < 0.05; x = 5, DF=1, p < 0.05), while US of the brain (x = 2.8,
DF=1, p > 0.05), low Apgar score (t = 0.183, p > 0.05) and positive
family history for epilepsy (x = 3.1, DF=1, p > 0.05) did not showed
such significant association.
Conclusion: Neonatal seizures and early EEG are good predictors for
later occurence of epilepsy in children with CP, while US of the brain,
Apgar score and positive family history for epilepsy are not such a good
predictor. The most common type of CP associated with epilepsy were
hemiparetic and quadriparetic type.
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PAEDIATRICOFF-LABELUSEOFANTIEPILEPTIC
TREATMENT IN INTRACTABLECHILDHOOD
EPILEPSY: A SURVEY INA LARGECOHORTOF
PATIENTSWITHDRAVET SYNDROME
N. Coqué*,†,‡, N. Chemaly§,¶, R. Nabbout§,¶
*Alliance Syndrome de Dravet, Brest, France, †AgroParisTech,
UMRMIA, Paris, France, ‡INRA, UMR 518MIA, Paris,
France, §Necker-Enfants Malades Hospital, AP-HP, National
Referral Center for Rare Epilepsies, Department of Pediatric
Neurology, Paris, France, ¶University Paris V - Paris
Descartes, INSERMU 663, Paris, France
Purpose: The aim of this study is to explore the extent of off-label use of
antiepileptic drugs (AEDs) in a cohort of patients with Dravet Syndrome
(DS), a pharmacoresistant epilepsy.
Method: We proposed auto-administered semi-close on-line survey to
families of pediatric patients with DS in December 2013 on the website
of DS alliance, France. Questions addressed different aspects of patients0
medications in particular the off-label including all aspects of drug pre-
scription not included in the SPC: therapeutic indication, posology, phar-
maceutical form and route of administration.
Results: 89 families answered the questionnaire. Patients were aged
from 0.84 years to 17.60 years (mean 8.06).
The most used AEDs were the following:
• clobazam (92%, CLB)
• valproate (90%, VPA)
• stiripentol (81%, STP)
• topiramate (46%, TPM)
We reported the major category of off-label use for these four drugs:
• 28% of patients use CLB out of the age-subsets,
• All patients with TPM are not in therapeutic indication for DS,
• 35% takes STP in a mixture non indicated with this treatment,
• The usual posology is not appropriate for TPM, VPA, CLB and STP
respectively in 93%, 66%, 52% and 21% of patients,
• The dosage for age is not appropriate for CLB, STP, VPA and TPM
respectively in 57%, 26%, 11% and 10% of patients,
• Care givers should manipulate CLB, STP, VPA and TPM in respec-
tively 63%, 31%, 13% and 12% of patients.
Conclusion: This study raises the difficulties in families with children
with DS using often off-label AEDs polytherapy. These results empha-
size the need for further development and studies of paediatric formula of
drugs currently used in Dravet Syndrome.
Acknowledgement: Funds were provided by Ansm, France.
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NATIONALREGISTRYOFDRAVET’S SYNDROME
ANDOTHER SYNDROMESCORRELATEDWITH
GENES SCN1AANDPCDH19
B. Dalla Bernardina, Dravet Italia Onlus
University of Verona, Science of Life and Reproduction, Verona,
Italy
Purpose: Patient registers have been recognized by the European Com-
munity as one of the priorities of strategic intervention in the Rare Ill-
nesses sector and as an essential instrument for improving understanding
of the illness through the systematic and continual registration of data for
basic, clinical and epidemiological researches. The objective of Dravet
Italy registry is to collect the cases of Dravet S. and other syndromes
related with SCN1A and PCDH19mutations.
Method: The working group, after having identified the main aims of
the registry, elaborated its structure, establishing 9 headings: Anagraphic
Data; Genetic Investigations; Familial and Personal History; Semeiol-
ogy, Frequency and Evolution of different Seizures; EEG and Neuroradi-
ological features; Neuropsychological Outcome, Treatments and
Adverse Events. The data are longitudinally collected.
Results: Preliminary dates: They have been thin to now inserted 102
patients of which 86 with mutation of the gene SCN1A (46 F and 40 M)
and 16 PCDH19 (F); of these 10 between 1 and 3 years old, 13 among 3
and 5, 20 among 5 and 10, 24 between 10 and 15 and 35 older than
15 years. The analysis of genetic mutations, seizures semeiology at onset
and during evolution neuropsychological picture at the used AED will be
presented and discussed.
Conclusion: The collected data confirm that the Registry could represent
an important instrument for the systematization of data regarding DS and
other syndromes related with SCN1A and PCDH19mutations.
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EFFICACYOFRUFINAMIDE THERAPY INCHILDREN
WITHREFRACTORYEPILEPSY
B. Konuskan, M. Gungor, G. Haliloglu, D. Yalnizoglu, M. Topcu
Hacettepe University, Medical Faculty, Pediatric Neurology,
Ankara, Turkey
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Purpose: Rufinamide is a new antiepileptic drug (AED) approved for
adjunctive treatment of partial-onset seizures with and without sec-
ondary generalization in patients ≥12 years, and adjunctive treatment of
seizures associated with Lennox-Gastaut syndrome in children
≥4 years. We studied the efficasy of Rufinamide in children with refrac-
tory epilepsy.
Method: We studied patients treated with Rufinamide for refractory epi-
lepsy at Hacettepe University Children’s Hospital Department of Pedi-
atric Neurology between January 2012–2015. We reviewed the medical
charts and documented demographic and clinical data, seizure outcome
and side effects. Missing information was completed by telephone inter-
views with parents.
Results: Thirty patients (14 boys and 16 girls) were studied. The mean
age when rufinamide was started ranged between 2 years and 19 years,
the mean age at seizure onset was 2.7 years (1 month-10 years). The
most common underlying etiologies were cortical dysplasia (9/30), fol-
lowed by the perinatal hypoxia and infections of the central nervous sys-
tems. The patients were on 1–5 AEDs, 2 patients underwent epilepsy
surgery, 3 had vagus nerve stimulation, and 3 previously tried ketogenic
diet. Nineteen patients (%63) had tonic-clonic seizures, 7 had (%23)
focal seizures, 6 (%20) had epileptic spasms, 10 had (%33) drop attacks,
5 (%17) myoclonic seizures. Average follow up duration on rufinamide
treatment was 13 months (1–27 months). Thirteen patients (43%)
achieved 50% or more seizure reduction, 6 patients (20%) had 25–50%
reduction, and remaining 10 patients (33%) had no change, one patient
experienced increased frequency and severity of the seizures. Patients
with drop attacks responded best to treatment. There was no difference in
seizure frequency with respect to underlying etiology.
Conclusion: Rufinamide was well tolerated and showed efficasy in chil-
dren with refractory epilepsy as add on therapy, particularly in the man-
agement of drop attacks.
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EVALUATING THEASSOCIATION BETWEEN
DRONABINOLUSEANDOCCURRENCEOF SEIZURES
A.D. Malphrus*, M. Messinger†
*Baylor College of Medicine, Houston, TX, USA, †Texas
Children’s Hospital, Neurology, Houston, TX, USA
Purpose: Cannabis has received much attention for its potential
antiepileptic properties and novel mechanism of action. The main com-
ponents of cannabis are tetrahydrocannabinol (THC) and cannabidiol
(CBD). THC has been shown to be anticonvulsant but also induce epilep-
tiform activity. Dronabinol (Marinol) is synthetic delta-9-tetrahydrocan-
nabinol, not extracted from the cannabis plant. It was first FDA approved
in 1985 for nausea and vomiting in patients undergoing cancer
chemotherapy. The objective of this study was to evaluate whether dron-
abinol use was associated with subsequent seizures and/or epilepsy.
Method: A retrospective cohort study was performed in patients who
received dronabinol at Texas Children’s Hospital from October 1, 2010
until January 15, 2015 using the electronic medical record. Patients were
excluded if administration and/or dose of dronabinol was undetermined.
The following data was collected for each patient: baseline demograph-
ics, date of administration and dose of dronabinol, diagnosis of seizure
and/or epilepsy based on ICD-9 diagnostic code(s), and antiepileptic drug
utilization.
Results: Two hundred and thirty patients received dronabinol over the
4 year study period, 34 patients were excluded, for a total of 196 patients
meeting study criteria. The majority of patients were male (61%) with a
median age of 15 years (range 3–31 years). Median dose of dronabinol
was 10 mg/day (range 2.5–60 mg/day). Thirteen patients were identified
with a diagnosis of seizure and/or epilepsy. Only 4 (2% of included
patients) had received dronabinol prior to the diagnosis. Of the 4 patients
with clinical seizures following dronabinol use, one had EEG confirmed
epileptiform activity and was treated with clonazepam.
Conclusion: Of the 196 patients included in this study, 1 patient (0.5%)
had subsequent EEG correlated epileptiform abnormalities, and 4
patients (2%) had a diagnosis of epilepsy following dronabinol adminis-
traion. Therefore, it appears that using dronabinol is not associated with a
significant risk of subsequent seizures.
p0349
TUBEROUS SCLEROSIS COMPLEX (TSC): A
NORWEGIAN INTERDISCIPLINARYGUIDE
M. Tuft, T. Rath Olsen
Oslo University Hospital, Oslo, Norway
Purpose: Making an interdisciplinary TSC guide to reach a broad range
of people.
Method: The guide was authored by a a multidisciplinary team consist-
ing of a pediatrician, a specialist in genetics, a neuropsychologist, a spe-
cial education teacher, two nurses and an information consultant.
Methods for diagnostics, treatment and long term follow-up was adjusted
to the Norwegian health care system, using the international guidelines
for TSC. Because TSC is a multiorgan disease with several medical, psy-
chiatric and neurocognitive difficulties, we established a reference group
consisting of
• Medical specialists in neurosurgery, genetics, psychiatry, neurology,
pediatrics, skin and internal medicine.
• The Norwegian TSCAllience
• Special nurse working with rehabilitation
• Specialist in clinical neuropsychology
• Dentist with specific knowledge about TSC School nurse with special
education in the field of sexology
The reference group contributed with second opinions and securing
the quality of the contents.
Results: All questions about the disease are registered at the National
Centre for Rare Epilepsy-Related disorders.
• Medical specialists
• GPs
• The Norwegian Tuberous Sclerosis Alliance
• Rehabilitation
• Language- and speech therapists
• School
• Nurses in the school system
• Kindergarten
• Institutions and private caretaking homes
• Parents
• People with TSC
have contacted us, asking questions about treatment.
Conclusion:
• Patients and caregivers report that they bring the guide to their local
doctor, and the doctor further uses the internet based TSC guide in refer-
ring to specialists.
• The cooperation between an interdisciplinary team and the Norwegian
Tuberous Sclerosis Alliance has been a success. There is now a network
of people with good knowledge about TSC throughout the counties, as
well as in the TSC Allience.
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ACOMPARISON BETWEENCLINICAL FEATURESOF
CHILDRENWITHFEBRILE SEIZURES FOLLOWED
BYBENIGNEPILEPSIES ANDOFCHILDRENWITH
FEBRILE SEIZURES PLUS
D. Turkdogan, O. Unver, B. Kutlubay
Marmara University, Faculty of Medicine, Department of
Pediatric Neurology, Istanbul, Turkey
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Purpose: Febrile seizures (FS) are the most common cause of seizure
activity in early childhood. The relationship between FS and childhood
epilepsies has been a topic of major clinical interest. The aim of this retro-
spective study is to delineate clinical features in patients with FS fol-
lowed by idiopathic epilepsy and to compare that with patients with FS
extending beyond 6 years (FS).
Methods: The study group consisted of 74 patients (37 females) with FS
evolving to idiopathic epilepsy (group 1) and 22 patients (8 females) with
FS (group 2). Because group 1 consisted of patients with FS naturally
evolving to epilepsy, the patients with hippocampal sclerosis or any other
MR abnormality which may be causally related to a prolonged FS epi-
sode were excluded.
Results: The age onset of seizures was 23.5 months in group 1 and
22.6 months in group 2. Total number of FS were significantly increased
in group 2 (5.0) compared to group 1 (3.1) (p < 0.05). The family history
for FS or epilepsy did not demonstrate any significant difference between
2 groups. The occurrence of febrile status did not show any significant
difference between 2 groups (15% of patients in group 1 and 22% in
group 2). There was no significant difference between 2 groups regarding
the recurrence rate of FS in the first 24 hours or in the first week. Epilep-
tic syndromes were classified as focal in 36 (49%), generalized in 32
(43%) and unclassified in 6 children.
Conclusions: This study showed that two subphenotypes of FS syndrome
(the evoluton of febrile seizures to a benign epilepsy or extending beyond
early childhoodwithout associatedwith afebrile seizures) share the similar
clinical features and seem to be participitated in the same spectrum.
Paediatric Epileptology 3
Sunday, 6th September 2015
p0351
EFFICACYOFBIOFEEDBACK IN TEENEGERSWITH
PNES ANDEPILEPSY
M. De Rinaldis, L. Russo, L.A. Gennaro, L. Losito, A. Trabacca
Scientific Institute I.R.C.C.S. ‘Eugenio Medea’, ‘La Nostra
Famiglia’ Brindisi Research Centre, Unit for Severe Disabilities
of Developmental Age and Young Adults (Developmental,
Neurology,and,Neurorehabilitation), Brindisi, Italy
Psychogenic nonepileptic seizures (PNES) can be defined as paroxysmal
events that resemble or can be mistaken for epilepsy without being asso-
ciated with abnormal electrical activity in the brain (Brown RJ et al
2011). Psychogenic nonepileptic seizures represent a puzzling clinical
condition for which etiology, evidence-based treatments and outcomes
are not yet defined. Epilepsy is considered a risk factors for PNES with
prevalence up of 58% (Reuber M et al 2003).We report data from three
adolescent patients (mean age 17 years) with PNES and Epilepsy for
which we have used biofeedback for psychological assessment and treat-
ment of PNES. All patients achieved a good control of epilepsy (1–3 sei-
zures /year) but developed PNES (1–3 PNES/month). The semiology of
the PNES resembled for two patients the semiology of epileptic seizures
and was different for one patient. We have differentiate between PNES
and epileptic seizures with video-long-term monitoring EEG. Assess-
ment of psychological profiles was made with CBCL 6–18 and MMPI
and neuropsychological profiles with WISC-IV/WAIS IV.All patients
showed a normal cognitive functioning but low QI (between 75 and 85);
psychological findings didn’t show criteria for depression, conversion
disorders or personality disorders.In all patients electrodermal biofeed-
back pointed out an increase in skin conductance (measured in microsie-
mens) related to an increase of arousal level in emotional task (as waiting
physical discomfort). We have proposed a biofeedback training (for a
total of 8 sessions); during session training the patient actively covert
physiological activity and learn self-directed strategies to obtain and con-
trol a physiological response. The training also explicitly emphasized the
goal of transfer of the skills learned during the session into everyday life
and the patient was encouraged to practice at home self-regulation skills
in PNES-prone situations. All the patients showed a marked reduction in
PNES frequency (60–70%) during months of biofeedback treatment.
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CLINICAL, EEGANDCYTOGENETIC FEATURESOF 4
CASESWITHRINGCHROMOSOME 20 SYNDROME
P. Dimova*, I. Boneva†, V. Tomov‡, D. Deneva‡, A. Todorova†
*St. Ivan Rilski University Hospital, Epilepsy Center, Clinic of
Neurosurgery, Sofia, Bulgaria, †“Genica”Genetic Medical
Diagnostic Laboratory, Sofia, Bulgaria, ‡St. Naum University
Hospital, Clinic of Child Neurology, Sofia, Bulgaria
Purpose: Ring chromosome 20 syndrome (R20) has an almost constant
association with refractory epilepsy and intellectual and behavioral dis-
abilities. Early diagnosis is usually difficult, yet particular electroclinical
patterns have been found to be very helpful. Here, we present the clinical,
EEG and cytogenetic correlations in four R20 patients.
Method: Four patients, aged 17, 13, 4 and 7 years, respectively, were
studied by video-EEG monitoring (VEEG) for drug-resistant seizures.
Brain MRI was normal; standard EEGs showed anterior epileptiform
activity with one-sided predominance, correlating to some ictal clinical
features; intellectual and behavioral problems increased with age and dis-
ease course. VEEG was considered as a part of presurgical evaluation for
refractory epilepsy.
Results: All three patients presented an electroclinical pattern consistent
with frontal lobe epilepsy. They also had subclinical or subtle clinical
episodes, both awake and in sleep, corresponding to non-convulsive sta-
tus epilepticus (NCSE). The epilepsy started at age 1½ year in the 7-year
old patient with the most severe epilepsy resembling Dravet syndrome,
and at 3 years in the youngest patient presenting with focal status epilep-
ticus. The seizures started later (age 7 and 9 years, respectively) and were
rarer in the first two patients, who showed mild cognitive and behavioral
disability. Due to the particular electroclinical picture R20 was suspected
and cytogenetic analysis was performed. It revealed R20 mosaic kary-
otype, at 10%, 25%, 45% and 40%, respectively.
Conclusion: The presented cases show again that the R20 syndrome
diagnosis is usually delayed and is based on the very characteristic for the
syndrome electroclinical NCSE pattern and the “frontal lobe” seizure
appearance. Our cases add further evidence for the genotype-phenotype
correlation in the syndrome, since the degree of mosaicism reflects the
age of epilepsy onset, the severity and refractoriness of the seizures, and
the severity of the associated intellectual and behavioral disabilities.
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EPILEPSY12 - UKCOLLABORATIVE CLINICAL
AUDITOFHEALTHCARE FORCHILDRENAND
YOUNGPEOPLEWITH SUSPECTED EPILEPTIC
SEIZURES
C. Dunkley*, C. Down†, B. Waldron‡, R. Maini§,
F.L. Williams§, A. Brown¶, L. Notghi**, K. Martin¶,
R. Chin††, H. Basu‡‡, M. Kirkpatrick§§, C. Ferrie¶¶,
W.P. Whitehouse¶,***
*Sherwood Forest Hospitals, Paediatrics, Sutton in Ashfield,
UK, †Royal College of Paediatrics and Child Health, London,
UK, ‡University Hospitals of Leicester, Leicester, UK, §Dundee
University, Dundee, UK, ¶Nottingham Children’s Hospital,
Nottingham, UK, **Birmingham Children’s Hospital,
Birmingham, UK, ††University of Edinburgh, Muir Maxwell
Epilepsy Centre, Edinburgh, UK, ‡‡Lancashire Teaching
Hospitals NHS Foundation Trust, Preston, UK, §§Tayside
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Children’s Hospital, Dundee, UK, ¶¶Leeds Teaching Hospitals
NHS Trust, Leeds, UK, ***University of Nottingham,
Nottingham, UK
Purpose: To assess changes in the quality of care for UK children and
young people with seizures and epilepsies.
Method: Epilepsy12, a UK wide audit, commenced in 2009 with the
aim of evaluating epilepsy care against national guidelines. All hospital
and community paediatric services managing children with epilepsy
were invited to participate. A second round was undertaken between
2013 and 2014 to assess changes since Round 1 and results are reported
here. Children referred for first EEG were used ascertain a second
cohort of eligible children aged 1 month to 16 years receiving a first
paediatric assessment between January and April 2013 for afebrile
paroxysmal episodes. Retrospective case-note analysis was undertaken
using a web-based platform and audit pack. Service descriptor data were
collected on census day, 1 January 2014. Patient reported experience
measures (PREM) were collected from sequential attendees at clinics,
February-March 2014.
Results: 192/196 paediatric services enrolled. 186 units provided ser-
vice descriptor data, 174 clinical audit data and 145 PREM data. The
clinical cohort consisted of 3449 patients; median age 5.2 years; male:
female 55:45%. PREM data were received from 2335 parents, carers,
children and young people. 45% of first assessments occurred within
an acute presentation. 35% of children had epilepsy diagnosed by
12 months. 22.6% of children had a documented neurodisability. 68%
of paediatric services now have an Epilepsy Specialist Nurse (ESN).
There has been a significant increase in percentage of children having
ESN input; access to a paediatrician with expertise in epilepsies; appro-
priate assessment, classification and investigations in 2014 compared
to 2012. PREM data showed 88% (1897/2148) overall satisfaction with
services.
Conclusion: There is evidence of significant improvements in the provi-
sion of medical and nursing epilepsy care. Systematic audit, alongside
other quality improvement initiatives, can demonstrate improvements in
care.
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SUCCESSFULVNS TREATMENTOFEPILEPSYWITH
MYOCLONIC ABSENCES: THEREPORTOF 2CASES
K. Ehrenreich, M. Nikanorova
Danish Epilepsy Centre, Dianalund, Denmark
Purpose: To evaluate VNS therapy efficacy in epilepsy with myoclonic
absences
Methods: Two boys (aged 11 and 5 years) with epilepsy with mycolonic
absences were followed prospectively for the period 1–3 years since
VNS-therapy initiation. Both patients have been treated with 5 AEDs in
different combinations prior to VNS-therapy. One child had also tried
ketogenic diet without sufficient effect. The clinical efficacy and tolera-
bility of VNS treatment have been assessed during the entire treatment
period and at the end of follow-up.
Results: Both patients achieved the complete seizure control after 13–
16 months since VNS therapy initiation. One child has been seizure-
free 2 years 4 months on VPA monotherapy and VNS. In the other
patient the number of concomitant AEDs was reduced from 3 to 2 after
reaching the complete seizure control on VNS therapy. Of interest, the
complete seizure control in both children has been observed on the
same VNS settings. No adverse events have occurred during the entire
study period.
Conclusion: VNS therapy might be considered the first choice
therapeutic option for treating this drug-resistant epileptic syndrome.
More studies are needed to provide further evidence in favor of that
conclusion.
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IDIOPATHIC EPILEPSIES CHILD: STUDYOFA
RETROSPECTIVECOHORTOF 186 CHILDREN
FOLLOWEDDURING 3YEARS AT FANNTEACHING
HOSPITAL (DAKAR - SENEGAL)
M. Fall, M.E.Y. Ndong, M. Ndiaye
University Cheikh Anta Diop, Neurology, Dakar, Senegal
Purpose: Epilepsy is a public health problem in Senegal with a preva-
lence of 8–14%. It was to study the therapeutic and evolutionary epidemi-
ology, clinics, idiopathic epilepsies and assess the impact on them
education.
Method: Retrospective, descriptive and analytical study from July 2003
to July 2011, of 186 children with idiopathic epilepsy aged from 1 month
to 19 years followed for at least 3 years.
Results: Male predominated with a sex ratio of 1.3. A family history of
epilepsy and parental consanguinity, respectively, were found in 34%
and 24% of cases. Eighty-nine patients had an idiopathic generalized epi-
lepsy and 90 others idiopathic partial epilepsy. Seven children had
repeated febrile seizures. The median time to treatment was 7.1 years
and the extreme 1 month and 14 years. In idiopathic partial epilepsy, epi-
lepsy with rolandic paroxysms were more frequent with 46% followed by
5% occipital idiopathic epilepsies. In idiopathic generalized epilepsy,
epilepsy with generalized tonic-clonic seizures (81%) were at the fore-
front, followed by epilepsy absences (18%). Of the 184 patients, 89%
were on monotherapy and 11% in the combination therapy. Two patients
had no treatment. The most commonly used molecules were valproic acid
(48%), Phenobarbital (43%) and carbamazepine (8%). PHB-CBZ was
the most frequent combination. Monotherapy remission was noted in
93% of cases. Adverse effects (17%) were noted primarily with VPA and
PHB to type hyperactivity, weight gain, memory impairment, drowsi-
ness, learning difficulties, lethargy, hypotonia, allergy and trophic disor-
ders. One hundred twenty five patients were of school age. Among them,
107 children (86%) were enrolled, 11 others (9%) were dropouts and 7
(5%) were unschooled.
Conclusion: Idiopathic epilepsy is a good prognosis but still there are
many problems supported in underdeveloped countries.
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LEFT INTERMITTENTVAGALNERVE STIMULATION
INCHILDRENWITHREFRACTORYEPILEPSY
R. Galimova*, S. Ivanov*, A. Timershin†
*Republic Children Hospital, Neurosurgery, Ufa, Russian
Federation, †Republic Children Hospital, Ufa, Russian
Federation
Purpose: To observe the tolerance and efficacy of periodic left vagal
nerve stimulation (VNS) in a group of children with medically intractable
epilepsies.
Method: A vagal nerve stimulator (Cyberonics Inc,) was implanted in
32 children with medically and surgically refractory epilepsies. Two of
them were after neurosurgical operations conducted to cure epilepsy.
These children were followed up for 2 months to 4 years. Mean (SD) age
of the patients was 10.8 years (range 2 to 18). They underwent complete
presurgical evaluation including detailed clinical history, magnetic reso-
nance imaging, and long term video-EEGwith ictal and interictal record-
ings.
Results: 18 (56%) of the 32 patients had a > 70% reduction in the num-
ber of monthly seizures. Five patients (15%) became seizure-free after
the VNS implantation. Global evaluation scores indicated that there were
no deteriorations from baseline and that there was a considerable number
with improved status. Four patients were able to reduce the number of
antiepileptic drugs used. No significant adversities were noted.
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Conclusion: Stimulation of the left vagal nerve appears to be a safe,
adjunctive therapy for the treatment of children with epilepsy intractable
to available antiepileptic drugs. The reduction in seizure frequency in
children was similar to that reported in adults. The specific epilepsies or
seizures were not detected that were sensitive to this intervention.
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ICTALANDPERIICTALHEADACHE IN CHILDREN
WITHEPILEPSY - CORRELATIONWITHTYPEOF
SEIZURES ANDEEG-CHANGES
M. Zawadzka, M. Mazurkiewicz-Beldzinska, M. Szmuda
Medical University of Gdansk, Developmental Neurology,
Gdansk, Poland
Purpose: Data from the literature show that 34–47% patients with epi-
lepsy suffer from periictal, mainly postictal headache. There are poor
information about correlations between type of headache with children’s
age and sex, type of seizures, type of eeg changes, localization of head-
aches and differentiation if the headache is preictal, ictal or postictal in
children.The aim of the study was to evaluate the frequency of the preic-
tal, ictal and postictal headaches in children with epilepsy and correlation
between these symptoms with types of seizures and changes in eeg.
Methods: The prospective study conducted in the Department of Devel-
opmental Neurology in Medical University of Gdansk, include 30
patients, 6–17 years old, with diagnose of epilepsy and periictal head-
aches. The study group was divided into three subgroups according to the
headache: preictal, ictal or postictal.
Results: In 76% children focal seizures, in 40% secondary generalized
and in 16% primary generalized seizures were observed. 73% patients
suffered from postictal headache, ictal headache occurred very rarely
(7%). The mean intensity of the pain measured with the VAS scale was
6.5. We found the correlation between lateralization of headache and
interictal changes in eeg in patients with focal seizures.
Conclusion: The frequency of periictal headaches correlates with type
of seizures and type of changes in eeg.
Paediatric Epileptology 4
Sunday, 6th September 2015
p0362
PREVENTABLECAUSESOF EPILEPSY INMEXICAN
CHILDREN. COMPARATIVE STUDYOFTWO
POPULATIONS
S.J. Garza-Morales*, G. Garza-Mayén†, A. Camiro-Zu~niga†,
B. Haro-Trueba†, M. Careaga-Sotomayor†, L. Zarate-Flores†,
S. Bermudez-Richard‡
*Instituto Nacional de Perinatologia, Neurociencias, Mexico,
Mexico, †Universidad Anahuac, Facultad de Medicina, Mexico,
Mexico, ‡Hospital Infantil de México‘Federico Gomez’,
Neurología, Mexico, Mexico
Purpose: The objective of this investigation is to identify and measure
the preventable causes in mexican children and compare the frequency of
said causes amongst two different populations with different socioeco-
nomic status.
Method: We analyzed the medical records from a 10 year period (2004–
2014) of patients that had been diagnosed with epilepsy (ILA-IBE, 2005)
from a public (Hospital Infantil de Mexico) and private institution
(Hospital Espa~nol) to find attributed causes of epilepsy and then classi-
fied into preventable and non-preventable causes.
Results: We identified 334 patients, (139 public institution and 188 pri-
vate institution). 149 (45.5%) were classafied to have a preventable
cause, 109 (32.6%) from the public institution and 40 (12%) from the pri-
vate institution. Preventable causes that occurred during the prenatal per-
iod were 4 times as common in the people attending the public institution
(68.8% vs 17.5%). The most common preventable cause was inadequate
prenatal care (21.5% p < 0.005). Other important preventable causes
were: perinatal hypoxia (16.1%), prenatal asphyxia (14.1%), and mater-
nal infections during pregnancy (9.4%). Patients with preventable causes
tended to have drug resistant epilepsy (24.16% vs 19.66%).
Conclusion: Epilepsy in mexican children had a preventable cause in
almost half of the instances, suggesting that improving seems to be the
most effective way of having a positive impact in the prevention of epi-
lepsy. We proposed that future efforts in developing countries should be
focused in more cost effective strategies like improving prenatal care,
instead in spending resources in newer and expensive antiepileptic
drugs.
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WEST SYNDROME: ABOUT 26 CASES IN DAKAR
(SENEGAL)
N.M. Gaye, M. Ndiaye, S.M.L. Dadah, A.D. Sow, O. Cissé,
A.M. Diop, M.S. Diop, N.S. Diagne, L.B. Seck, K. Touré,
A.G. Diop, M.M. Ndiaye
Cheikh Anta Diop, Neurological Clinic’s Fann Hospital, Dakar,
Senegal
Purpose: Determine epidemiology, etiology, treatment and outcome of
West syndrome.
Method: This was a retrospective study in which we reviewed the charts
of patients treated in the pediatric neurology consultation Fann and
Albert Royer Hospital from July 2003 to December 2011, with a follow-
up of at least 2 years.
Results: Twenty-six cases of patients have been recorded. The average
age was 12 months. The youngest are aged 3 months and the oldest
6 years. The sex ratio (M/F) was 3.3. The average of the disease onset
was 4 and a half months; 42.3% had the onset of disease between 1 and
6 months. In about 69.5% of cases, the initial psychomotor development
was abnormal. Perinatal asphyxia was found in 46.3% children. All
patients had spasms in flexion and 34.6% had more than three crisis. The
most frequent types of crisis in 30% of patients were myoclonic seizures
and partial motor seizures. In 3.85% of children, these 2 types of seizures
were associated. The main clinical findings at examination were axial
hypotonia (49.9%) and language delay (19.2%). Fifty percent of children
had a poor social contact. A cerebral scan was normal in 15.4% of cases.
34.62% of scanners showed cortical and / or subcortical atrophy and
11.4% had porencephaly. 57.7% of patients were followed for 3 to
4 years. 38.5% of them required antiepileptic treatment. The most fre-
quent drugs used were sodium valproate (61.54%), clonazepam
(30.77%) and carbamazepine (23%). In 53.8% of cases, the progression
of the disease was favorable with stopping of the seizures however the
cognitive dysfunctions persisted. 19.2% of patients were not in school.
Conclusion: West syndrome is a pharmaco-resistant epilepsy, character-
ized by multiple risk factors. It combines various neurological deficit
which affect the quality of life and makes it harder to treat.
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LOWFREQUENCY PREICTAL EEGWAVES
PRECEDING EPILEPTIC SEIZURESORIGINATING
FROMRIGHT FRONTALLOBE
G. Giannakakis*, P. Vorgia†, S. Voutoufianakis†,
M. Pediaditis*, D. Champsas†, H. Dimitriou†, M. Tsiknakis*,‡
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*Institute of Computer Science, Foundation for Research and
Technology Hellas (FORTH), Iraklio, Greece, †Faculty of
Medicine, University of Crete, Department of Mother and Child
Health, Iraklio, Greece, ‡Technological Educational Institute of
Crete, Iraklio, Greece
Purpose: Seizure prediction despite the fact that there is not yet a consis-
tent and general methodology, could provide an alternative solution for
persistent and sudden epileptic seizures. Patient oriented predictive fea-
tures can probably derive from scalp EEG signals. This work describes
one case of probable predictive evidence.
Method: The study till this time consists of 15 drug resistant pediatric
epileptic patients recorded with long term video EEG using the 10–20
system, at the University General Hospital of Iraklio, Crete. Only 6 of
them (3 males/3 females, aged 8–16 years old) presented seizures during
monitoring. The dataset contains a total of 27 seizures.
Results: An 8 year old female patient suffering from focal epilepsy orig-
inating from the right frontal lobe presented a specific EEG pattern with
increased activity of rhythmic delta EEGwaves (0.5–4 Hz) a short period
(6–17 second) before seizure onset. Although this phenomenon appears
only on this patient, it still occurs repetitively in her vast majority of sei-
zures (7 out of 8 seizures observed) in at least 6 bipolar pairs of right fron-
tal and central electrodes. All seizures occurred during sleep. Spectral
power of delta band were significantly greater (p < 0.01) between preic-
tal period (15 sec before seizure onset) and normal EEG periods. In this
preictal period and the selected bipolar pairs, delta band power presented
high concentration of 93.01%  1.74% of total power.
Conclusion: A case of distinctive repetitive EEG pattern with increased
rhythmic preictal delta waves of right frontal focal epilepsy is presented.
Since this is the case for only one specific subject, it enforces the fact that
a computational predictor could yield findings if it is personalized to each
patient. This evidence could be a valuable feature towards prediction of
the same seizure type.
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EFFICACYOFNEWANTIEPILEPTIC DRUGS (AEDS)
IN CHILDRENWITHPARTIALONSET SEIZURES
A. Gniatkowska-Nowakowska, I. Gniatkowska
Outpatient Clinic of Child Neurology, Kielce, Poland
Purpose: To evaluate influence, clinical usefulness and safety of three
new AEDs (levetiracetam, lacosamide and oxcarbazepine) in monother-
apy and add-on therapy in children.
Methods: We compared efficacy and tolerability of three AEDs in a
group of 101 children of age between 6 and 18 years which were on
monotherapy or add-on therapy with either of three drugs (LEV,LCM,
OXC). There were 47 children treated with only one AED and 54 chil-
dren on 2 or more AEDs.
Results: During our period of observation we noted a slightly higher effi-
cacy of treatment with either LCM or LEV than with OXC while all the
patients were on full therapeutic doses of the drugs.
Conclusions: There was no statistical significance in the efficiency of
treatment of partial onset seizures with either of three studied AEDs.
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EPILEPTIC SPASMS IN CONGENITALDISORDERSOF
GLYCOSYLATION - ELECTRO-CLINICAL
CHARACTERIZATIONOF FIVE PATIENTS
A. Gomes Pereira*, C. Barnerias†, R. Nabbout†,‡,
A. Kaminska§,¶, N. Bahi-Buisson†,¶, M. Eisermann§,¶
*Hospital Dona Estefa^nia, Pediatric Neurology Department,
Lisbon, Portugal, †Necker-Enfants Malades Hospital, Pediatric
Neurology Department, Paris, France, ‡Necker-Enfants
Malades Hospital, Reference Center for Rare Epilepsies and
Tuberous Sclerosis Complex, Paris, France, §Necker-Enfants
Malades Hospital, Clinical Neurophysiology Department, Paris,
France, ¶University Paris V - Paris Descartes, Paris, France
Purpose: Congenital Disorders of Glycosylation (CDG) are a group of
rare metabolic diseases, characterized by impaired glycosylation of pro-
teins and lipids. Multisystemic involvement is common and neurological
impairment is severe and disabling, concerning central and peripheral
nervous system. Epilepsy is frequent, but detailed electro-clinical
description is rare. West syndrome has been described in only two
patients with CDG syndrome with -Im subtype. However, epileptic
spasms without hypsarrhythmia have not yet been reported in CDG
patients.
Method: We describe retrospectively the electro-clinical features in five
children with CDG syndrome, Ik, Ic and Ip subtypes, and epileptic
spasms.
Results: Spasms occurred at an early age, before 6 months in all
cases, except one who started at 18 months. In this patient, spasms had
an unusual aspect, they did not occur in clusters and were immediately
preceded by a myoclonus. All but one children presented also rare
myoclonias. On EEG, background activity was poorly organized with
abundant posterior spike and fast rhythm activity but without hypsar-
rhythmia. At last evaluation (age ranged between 6 and 12 years), two
patients still presented epileptic spasms and subcortical myoclonias,
one showed rare generalized tonic-clonic seizures and two were sei-
zure free.
Conclusion: In CDG disorders associated with epileptic spasms, particu-
lar features were noted, such as posterior EEG anomalies, absent hypsar-
rhythmic pattern and unusual combination of epileptic spasms with
myoclonus. These features, associated to preexisting developmental
delay and subcortical myoclonias, may contribute to the diagnosis of
CDG syndrome.
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PROFILE NON-EPILEPTIC EVENTS IN CHILDREN
S. Hadjiu*, C. Calcii*,†, N. Revenco*,†, I. Iliciuc*
*Medical University ‘Nicolae Testemitanu’, Chisinau, Republic
of Moldova, †Hospital of Mother and Child Health Care,
Chisinau, Republic of Moldova
Purpose: Paroxysmal manifestations occupy an important place
between the children diseases. Differential diagnosis of non-epileptic
paroxysmal events with epilepsy is a major problem in Neuropediatrics.
Method: Appreciation of clinical peculiarities in children with critical
manifestations toward the differentiation of the non-epileptic paroxysmal
clinical events from the epileptic ones.The study included 387 patients
with clinically suspected diagnosis of “epilepsy”, aged between 0–
18 years who were investigated by complex neurological examination
and laboratory tests: electroencephalography (EEG), echocardiography
(ECG), computed tomography brain (CT) and magnetic resonance brain
imaging (MRI) (if necessary).
Results: Abnormal paroxysmal motor events that might be not discov-
ered as epileptic because of their unusual characteristics were diagnosed
in 130 children (33.6%) exposed to the research, that constituted: anoxic/
hypoxic convulsions - 67.7%, toxic agents-determined paroxysmal
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strokes - 1.54%, pseudoepileptic convulsions and other psychiatric
manifestations - 3.08%, hyperventilation syndrome - 6.15%, movement’s
paroxysmal disturbances - 0.77%, other disturbances of movement -
1.54%, episodes characterized by the damaging of response to stimuli -
2.31%, migraines and periodical syndromes - 10.76%, paroxysmal disor-
ders during the sleep - 6.15%.
Conclusion: Approximately 33.6% of patients with suspected diagnosis
of “Epilepsy” actually suffered from paroxysmal non-epileptic states.
The most of diagnostic errors of paroxysmal manifestations may be
avoided by a meticulous anamnesis, which remains the major step in
diagnostic establishment. The second step of the diagnostic is the objec-
tive examination, to which we add laboratory examinations, adjusted to
each case, which constitutes the third step of diagnostic and leads to the
differentiation of the epilepsy from other non-epileptic paroxysms. The
misinterpretation of EEG or its interpretation without taking into consid-
eration the case history represents a source of error to epilepsy diagnostic.
The differential diagnosis between the paroxysmal states and the epilepsy
is possible only by creating offices and special centers equipped with
video-EEGmonitoring.
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LYSINE-RESTRICTEDDIET IN PYRIDOXINE-
DEPENDENT EPILEPSY
H. Hartmann*, J. Prüfe*, U. Meyer*, A.M. Das*, C. van
Karnebeek†
*Hannover Medical School, Pediatrics, Hannover, Germany,
†University of British Columbia, Department of Pediatrics,
Vancouver, Canada
Purpose: Pyridoxine-dependent epilepsy (PDE) is an autosomal reces-
sive epileptic encephalopathy caused by deficiency of antiquitin (ATQ),
an enzyme that facilitates cerebral lysine catabolism (MIM# 266100).
While seizures usually are controlled by pyridoxine treatment, 75–80%
of patients develop mental retardation regardless of therapy. Add-on
treatment with lysine-restricted diet has been shown to improve biomark-
ers of lysine degradation (1). We aimed to assess whether add-on treat-
ment with lysine-restricted diet will result in improvement of
development.
Method: In 6 patients (5f, 1 m) with genetically confirmed ATQ defi-
ciency, lysine-restricted diet was initiated at a median age of 4.41 y
(0.39–11.75). All patients received a lysine-free aminoacid supplement
fortified with micronutrients (Lys-2 prima, Nutricia metabolics, Ger-
many). One patient discontinued the diet after 6 m, the others continue
for a median duration of 2.7 y (2.13–6.39).
Results: The diet was well tolerated. Physical examination and bio-
chemical safety panels showed no evidence of malnutrition. Break-
through seizures during infections occurred in 2/6. Interictal EEG
showed epileptiform discharge in 5/6. Developmental test yielded nor-
mal results in 2/6 and abnormal results in 4/6. Follow-up tests avail-
able in 3/6 showed improvement in 2 and no change in 1.
Additionally, parents initially reported features suggestive of autistic
spectrum disorders in 3/6 which improved following initiation of the
diet. In 3 of 4 patients with a squint, deficits of visual perception were
identified.
Conclusion: In PDE, add-on treatment with lysine-restricted diet is safe.
Whilst in our cohort, a positive effect on the developmental prognosis of
the children could not be established by standard neurocognitive tests,
parents frequently describe improved behaviour. In order to assess the
natural course of the disease and treatment effects, an international Red-
Cap database is been suggested (1). (1) van Karnebeek et al (2014).
Lysine-Restricted Diet as Adjunct Therapy for Pyridoxine-Dependent
Epilepsy: The PDE Consortium Consensus Recommendations (2014).
JIMDRep.
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EFFICACYOFADDONCORTICOSTEROIDS IN THE
MANAGEMENTOF PHARMACORESISTANT
EPILEPSY IN LENNOXGASTAUT SYNDROME (LGS),
MULTI CENTER PILOT STUDY
N.N. Hewage*, M.S.S. Fernando*, R. Gamage†
*Teaching Hospital Anuradhapura, Department of Paediatric
Neurology, Anuradhapura, Sri Lanka, †National Hospital of Sri
Lanka, Colombo, Sri Lanka
Purpose: Lennox-Gastaut syndrome (LGS) is a childhood epileptic
encephalopathy, which is notoriously difficult to treat. Children often
end up on poly-pharmacy with numerous anticonvulsants, causing haz-
ardous adversities. The aim was to investigate efficacy of corticosteroids
in the management of pharmaco-resistant epilepsy in LGS.
Method: Single armed, open-labeled, efficacy trial with add on corticos-
teroids was performed over 24-weeks. Primary outcome parameter was
seizure freedom, secondary outcome parameters were safety, improve-
ment in behaviour and quality of life. Intravenous Methyl-Prednisolone
was given 30 mg/kg over 5 days, followed by oral Prednisolone 2 mg/kg
for 9 days. Steroid was weaned gradually over 6 weeks. Twice weekly
pulses of Prednisolone (2 mg/kg) were commenced thereafter, 30 mg/kg
intravenous Methyl-Prednisolone once in 6-weeks. Patients were moni-
tored closely at regular intervals.
Results: Twenty one children, mean age 5.7 years (2.3–16.3 years),
males-11, fulfilled the inclusion criteria. All had daily seizures; axial/
axio-rhizomelic tonic seizures (21), myoclonic (16), drop attacks (11),
atypical- absences (05). Average numbers of seizures were 6/day (2–12/
day). Four dropped out on days 05,08,12 and 13 due to hospital-acquired-
infection, maternal concerns, uncontrollable hypertension and severe uri-
nary tract infection respectively. All who completed up to day-14 had
>50% seizure reduction (Seizure freedom in 12). Two relapsed between
18–24 weeks. Three had positive urine sugar, all had significant rise in
BMI. Height-velocity and electrolytes remained unchanged. The quality
of life and childhood behavior scores improved significantly (p < 0.05)
by 24 weeks.
Conclusion: Majority achieved significant seizure control through ster-
oids, with minimum adverse effects. The quality of life and behavior
scores improved significantly. Suggest randomized-blinded-placebo-
controlled study to confirm the findings.
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EEG SENSITIVITY IN SUBTLE CORTICALDYSPLASIA
ONMRI
T. Hirfanoglu*, A. Seradroglu*, M. Ucar†, K. Aydin*,
I. Capraz‡, E. Bilir‡, G. Kurt§, O. Akdemir¶, O. Kapucu¶,
E. Arhan*
*Gazi University School of Medicine, Department of Pediatric
Neurology, Ankara, Turkey, †Gazi University School of
Medicine, Department of Radiology, Ankara, Turkey, ‡Gazi
University School of Medicine, Department of Neurology,
Ankara, Turkey, §Gazi University School of Medicine,
Department of Neurosurgery, Ankara, Turkey, ¶Gazi University
School of Medicine, Department of Nuclear Medicine, Ankara,
Turkey
Purpose: Malformations of cortical development (MCD) is a wide range
of lesions varying from congenital lesions and represent a major cause of
developmental disabilities and severe epilepsy. MRI is important to
detection such lesions. Sometimes it is difficult to detect on MRI due to
type of subgroups or small for detection. We presented two cases that
were followed previously as intractable seizures and non lesional
epilepsy, and then detected cortical dysplasia on MRI depends on EEG
findings for suspiciousMCD.
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Method: Two patients aged 13 and 17 year old and diagnosed with
intractable epilepsy were submitted to Video EEG Monitoring Unit at
Gazi University School of Medicine. Their EEG findings and final diag-
nosis were discussed.
Results: When evaluated of EEG records, interictal EEG shows repete-
tive fast spikes and intermittent slow on left parasagittal region in
patient one while paraoxysmal fast activity and persistent spikes on pos-
terior head regions in patient two. Depends on these EEG findings,
MRI’s are repeated and obtained as 3T thin sliced epilepsy protocol,
especially targeted the regions of suspected areas on EEG. Their final
diagnosis was focal cortical dysplasia in left anterior cingulate gyrus in
patient one and double cortex-pachygyria in posterior head region in
second patient.
Conclusion: There are highly epileptogenic electrographic patterns due
to extreme hyperexcitability in MCDs. Scalp EEG or invasive records
can show continuous, rhythmic or semirhythmic spikes; paroxysmal
bursts of high frequency spikes; recurrent electrographic seizures. In par-
ticular, the continuous rhythmic spiking suggests that an intradysplastic,
self-sustained, hyperexcitable areas in the brain. As supported by our
findings, if the patients have such EEG findings, they need to careful and
appropriate examination on MRI even if normal MRI findings previ-
ously.
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EEGUTILITY INNEWBORNS
Y. Akbaş, T. Hirfanoglu, Z.Öztürk, C. Havalı, E. Arhan,
K. Aydın, A. Serdaroglu
Gazi University, Pediatric Neurology, Ankara, Turkey
Purpose: Electroencephalogram (EEG) is most important tool for differ-
entiate epileptic or non epileptic events. Newborns are unique age group
for clinical presentation of many disorders and needs to appropriate diag-
nosis to prevent subsequent neurologic co-morbidities. Neonatal seizures
are one of an acute manifestation of central nervous system disorder. We
aimed to evaluate EEG utility and benefits in neonatal age group in terms
of differential diagnosis of epileptic-non epileptic events and correlation
of neurological status.
Method: This study was conducted from January 2014 to January 2015
at Gazi University School of Medicine Department of Pediatric Neurol-
ogy & Routine EEG Unit. Neonatal EEG’s was re-evaluated in terms of
contribution of the differential diagnosis. For this purpose, postconcep-
tional age (Limited to neonatal age, sex, age, EEG trace, and cranial mag-
netic resonance imaging (MRI) was analyzed and compared to reason of
EEG request and final diagnosis.
Results: We analyzed 1246 EEG trace and 268 of them were recorded
from term or preterm newborns. Seventy-one patients were re-evaluated
for EEG, MRI and neurological conditions and final diagnosis. The most
common indication was the suspected seizures. Thirty nine patient were
term newborn and 39.9 of those patients had abnormal EEG .
Conclusion: The recent technological advances in neonatal care have
changed aetiological profile of neonatal seizures. Eighty percent of
neonatal seizures occur in the first week of life, constituting the most
common and distinctive sign of neurological dysfunction. We found
EEG features of term and preterm newborns is valuable for predict subse-
quent neurologic status and diagnosis.
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BRAINMRI ABNORMALITIES DIFFERBETWEEN
TSC1 ANDTSC2 PATIENTS - A PILOT STUDY
H.M. Hulshof, E. Brakema, K.P.J. Braun, F.E. Jansen
University Medical Center Utrecht, Rudolph Magnus Institute
for Neuroscience, Pediatric Neurology, Utrecht, Netherlands
Purpose: TSC1 or TSC2 mutations are found in 80% of patients with
Tuberous Sclerosis Complex (TSC). The expression of neurological fea-
tures varies between patients and the exact relation between genotype
and brain MRI abnormalities has to be further explored. This pilot is the
first study to compare TSC1 to TSC2 mutations on a large range of TSC-
relatedMRI characteristics.
Method: In this retrospective explorative study we included patients
with a DNA confirmed diagnosis of TSC, refractory epilepsy, and MRI
of sufficient quality, who were referred to our center for presurgical eval-
uation. We evaluated the most recent MRI (either 1.5T or 3T), with at
least T1, T2, and FLAIR sequences. We compared the following MRI
characteristics between patients with TSC1 and TSC2 mutations: tubers
according to the tuber classification of Gallagher et al. (i.e. type A, B, C
tubers), subependymal nodules (SEN), subependymal giant cell astrocy-
toma, focal cortical dysplasia (FCD)-like features, white matter lesions,
radial migration lines, cysts, calcifications and hydrocephalus.
Results: 30 patients, 8 with TSC1 and 22 with TSC2 mutations, were
included. Epilepsy characteristics and level of development were compa-
rable between groups. Type C tubers were more frequent amongst
patients with TSC2 mutations (0% of patients with TSC1, versus 45.5%
of those with TSC2 mutations) and FCD-like features were more com-
mon amongst patients with TSC2 mutations (90.9% vs. 50% in TSC1).
The other MRI characteristics did not differ between TSC1 and TSC2.
Conclusion: The findings of this pilot-study add to previous research
that found evidence for a more severe phenotype in patients with TSC2
mutations, as FCD-like features and type C tubers were more common
amongst patients with TSC2. We are currently extending the MRI analy-
sis to the entire population with genetically determined TSC in our
center.
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ANEWCASEOFALPERS SYNDROMEWITHRAPID
ONSETOF PARTIAL STATUS EPILEPTICUS:
NEURORADIOLOGICALAND
ELECTROPHYSIOLOGICAL EVOLUTION
A. Iodice*, S. Ferrari†, C. Spagnoli*, L. Pinelli‡, C. Vezzoli§,
G. Cantalupo¶, B. Dalla Bernardina¶, P. Accorsi**,
L. Giordano**
*IRCCS - Arcispedale Santa Maria Nuova, Unit of Pediatric
Neurology, Reggio Emilia, Italy, †S. Orsola-Malpighi University
Hospital, Medical Genetis Unit, Bologna, Italy, ‡Spedali Civili,
Department of Neuroradiology, Brescia, Italy, §Spedali Civili,
Unit of Pediatric Anaesthesiology and Intensive Care,
Department of Clinical and Experimental Sciences, Brescia,
Italy, ¶University of Verona, Department of Life and
Reproduction Sciences, Verona, Italy, **Spedali Civili, Unit of
Child Neurology and Psychiatry, Department of Clinical and
Experimental Sciences, Brescia, Italy
Background: Alpers-Huttenlocher syndrome (AHS) is at the severe end
of a broad clinical spectrum of disorders due to mutations of POLG1
gene. EEG and MRI features can be pathognomonic in some cases. It is
unclear whether different MRI and EEG patterns reflect the timing of
electroencephalograms in relation to the stage of cerebral degeneration
or if they identify different patients’ populations.
Case presentation: We report on a 6 years old girl who rapidly devel-
oped myoclonic status epilepticus. Initially EEG and polygraphic
recordings documented rhythmic high-amplitude delta with superim-
posed (poly)spikes associated with myoclonic jerks, followed after
1 month by epilepsia partialis continua, characterised by continuous
multifocal asynchronous myoclonus without any clear correlation
between muscle activation on EMG and EEG discharges. Epilepsy,
which was initially drug resistant, eventually ceased spontaneously
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after 11 months. Brain MRI at the onset showed symmetric hyperinten-
sities of the hippocampi mimicking limbic encephalitis; after 3 months
she presented abnormal cortical and thalamic signal at Diffusion
Weighted Imaging and a marked increase in lactate associated with N-
acetilaspartate reduction at Spectroscopy. POLG1 gene sequencing in
exon 21 documented a de novo heterozygous mutation, consisting in a
T to G substitution of the nucleotide 3294 of the cDNA of the gene
(NM_002693: c.T3294G). This substitution has never been described
before, but we reasonably consider it to be pathogenic because it is pre-
dicted to be damaging with high score and based on its evolutionary
conservation. Three years later our patient is still alive with a need of
close medical support.
Conclusion: Our case provides detailed information on neuroradiologi-
cal and electrophysiological temporal evolution of AHS. Peculiar MRI
and EEG findings became evident at different stages of the disease
course, preventing early diagnosis of AHS.
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SHORT FORMSOF THEWECHSLER INTELLIGENCE
SCALES FORCHILDREN (WISC-III) IN PAEDIATRIC
EPILEPSY: ARERESULTS RELIABLE?
L. van Iterson*, Y. Huber-Mollema†, R. Rodenburg†,‡,
P.B. Augustijn†
*SEIN / DeWaterlelie, Cruquius, Netherlands, †SEIN –
Stichting Epilepsie Instellingen Nederland, Heemstede,
Netherlands, ‡UvA, Amsterdam, Netherlands
Purpose: Time constraints may press psychologists to use short forms of
the WISC. In satisfactory short forms, 81% of the IQs fall within the 90%
CI of the full-length form. Two short forms of the Dutch WISC-III -
short-form4 (Information, Vocabulary, Picture Arrangement, Block
Design) and short-form6 (Information, Similarities, Comprehension, Pic-
ture Completion, Block Design, Puzzles) - were tested on children most
liable to show elevated subtest scatter: children with lateralized epilepsy
with/out MRI lesions.
We studied
(1) the utility of each short form, and
(2) the contribution of laterality and MRI-status to measurement
errors.
All children had originally taken the full-length form.
Methods: Participants were 83 children (54% boys) with partial epilepsy
(48 LH/35 RH), 29 with MRI+ (17LH /12RH) having short-form4 FS-
IQs between 65 and 125. Mean age at epilepsy onset: 5.7 years ( 3.4).
At testing, age in years= 10.1( 3.1), median number of AEDs= 1 (range
0–3). FS-IQ on the full-lengthWISC-III: 87.47 ( 11.7).
Analyses: (1) Overall rates of children falling within the 90% CI of full-
length form.
(2) MANCOVA for contribution of seizure lateralization andMRI sta-
tus (with duration of epilepsy as covariate) on absolute differences
between short and full-length IQs (=short-form deviations).
Results: (1) Rates within 90% CI, short-form4/short-form6: VIQ 80.7%/
85.5%, PIQ 84.3%/79.5% and FS-IQ 85.5%/86.7%.
(2) Short-form4/short-form6: No significant contribution of seizure
onset side or MRI status was seen on the short-form deviations on any
scale. Short-form4: A side*MRI-status interaction on the verbal scale
indicated that RHMRI+ increased the short-form deviations.
Conclusion: Both short forms proved satisfactory for paediatric epi-
lepsy. However, increased measurement errors appeared in MRI+ (short-
form4). Short forms should be tested for utility.
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ICTAL POUTING “CHAPEAUDEGENDARMA”
Z.S. Karal€ok*, T. Hırfanoglu†, A. Serdaroglu†, E. Bilir‡,
İ. Capraz‡, M. Ucar§,Ö. Akdemir¶,Ö. Kapucu¶, K. Aydın†,
E. Arhan†, E. Demir†, K. Gücüyener†
*Ankara Children’s Hematology and Oncology Training and
Research Hospital, Department of Pediatric Neurology, Ankara,
Turkey, †Gazi University School of Medicine, Department of
Pediatric Neurology, Ankara, Turkey, ‡Gazi University School
of Medicine, Department of Neurology, Ankara, Turkey, §Gazi
University School of Medicine, Department of Radiology,
Ankara, Turkey, ¶Gazi University School of Medicine,
Department of Nuclear Medicine, Ankara, Turkey
Purpose: Clinical semiology and EEG findings of frontal lobe seizures
are complex and difficult to understand because of its anatomic position
and richness of neuronal network. Recently, a new type of facial expres-
sion is called ictal pouting which is also named ‘‘chapeau de gendarme’’,
turned-downmouth looks like the hats of gendarme’s at the time of Napo-
leon. A patient had frontal lobe seizures and sign of ictal pouting was pre-
sented.
Method: A Nine-year-old male patient was referred to Gazi University
School of Medicine, Pediatric Video EEG Monitoring Unit center due to
his intractable seizures.
Results: The seizures of the patient were characterized by forced expir-
ium, eye blinking, tonic contraction of the face, turned-down mouth (ic-
tal pouting) “chapeau de gendarma” and followed by hypermotor
seizure lasted for 15–20 seconds. Both ictal and interictal activity was
pointed to bilateral frontal and parasagittal region. 3T MRI showed that
suspicious of left inferior frontal gyrus focal cortical dysplasia (FCD).
Positron emission tomography (PET) confirmed hypometabolism in left
inferior frontal gyrus. The lesion was found overlapped with Broca’s
region at functional MRI. Therefore, he was planned to continue medi-
cal treatment and VNS (vagal nerve stimulation) therapy if necessary in
the future.
Conclusion: Ictal pouting, ‘Chapeau de Gendarme’was defined by sym-
metrical turned-down mouth (>5 s), and contraction of the chin. An
SEEG study showed anterior cingulate cortex (ACC), less orbitofrontal
cortex, inferior frontal gyrus and insula are responsible for ictal pouting.
The lesion of our patient was in left inferior frontal gyrus resulted from
cortical dysplasia as supported of the limited literature. Ictal pouting is a
rare semiology, for the patients who cannot be localized or lateralized by
radiological or electrophyslogical, must be keep in mind for the epilepto-
genic zone of frontal lobe and insula.
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CLINICAL PREDICTORSOF INTRACTABLE
EPILEPSY INCHILDHOOD
P. Karaoğlu*, U. Yiş†, A.I. Polat†, M. Ayanoglu†, S. Hiz†
*Van Ipekyolu Children’s Hospital, Pediatric Neurology, Van,
Turkey, †Dokuz Eylül University, Pediatric Neurology, Izmir,
Turkey
Purpose: Despite the use of antiepileptic drugs either individually or in
combination, up to 20% of epileptic patients will continue to have sei-
zures. These individuals are regarded as having intractable epilepsy.
Intractable epilepsy often has deleterious effects such as intellectual dis-
ability, psychiatric comorbidity, physical injury, sudden unexpected
death, and poor quality of life. Early identification of these patients is
important in considering the use of alternative treatments. In this retro-
spective study, we aimed to determine the clinical, electroencephalo-
graphic, and radiological factors associated with medically intractable
seizures in children.
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Method: Records of the patients with intractable epilepsy and well con-
trolled epilepsy were reviewed to identify the variables that may be asso-
ciated with seizure intractability. Intractable epilepsy is defined as at
least 1 seizure in a month in the past 6 months despite treatment with at
least 2 antiepileptic drugs and at least 1 year-long seizure-free time is
defined as seizures under control.
Results: There were 458 epileptic children (210 female and 248 male)
with a mean age of 7.73  4.72 years. 177 of them had intractable epi-
lepsy and 281 had well controlled epilepsy. Univariate analysis showed
that age at seizure onset, having mixed seizure types, history of status
epilepticus, history of neonatal seizures, having daily seizures at onset,
abnormality on first electroencephalogram, abnormal neurodevelopmen-
tal status, abnormal neuroimaging, having a symptomatic etiology were
significant risk factors for the development of intractable epilepsy
(p < 0.05). Side effects of antiepileptic drugs were significantly higher
in intractable epilepsy group.
Conclusion: There are a number of clinical features that can be identi-
fied in the course of childhood epilepsy that may predict the outcome.
Early identification of patients at high risk of developing intractable epi-
lepsy will guide appropriate therapy. These findings have to be verified
by further prospective studies.
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SEIZURE PRECIPITANTS IN DRAVET SYNDROME
N. Verbeek*, M. Wassenaar†, J. van Campen†, A. Sonsma‡,
B. Gunning§, N. Knoers‡, D. Lindhout‡, F. Jansen†, F. Leijten†,
E. Brilstra‡, D. Kasteleijn-Nolst Trenité‡
*University Utrecht, Utrecht, Netherlands, †University Utrecht,
Brain Center Rudolf Magnus, Utrecht, Netherlands, ‡University
Utrecht, Medical Genetics, Utrecht, Netherlands, §Stichting
Epilepsie Instellingen Nederland, Zwolle, Netherlands
Purpose: To determine seizure precipitants in Dravet syndrome (DS)
compared to other people with epilepsy.
Method: Seizure precipitants as reported in a Dutch cohort of DS chil-
dren with pathogenic SCN1A-mutations (n = 71), were compared with
those of a childhood epilepsy cohort (n = 149) and a community-based
epilepsy cohort (n = 248); all three Dutch cohorts used the same type of
questionnaire. Seizure precipitants were categorized as ‘fever’, ‘visual
stimuli’, ‘sleep deprivation’, ‘stress, including physical exercise’, ‘audi-
tory stimuli’ and ‘other’.
Results: For 70 of 71 (99%) DS children at least one seizure precipitant
was recalled by parents. Seizure precipitants that were reported in more
than half of the DS cohort were: fever (97%), a cold (68%), a bath (61%),
acute stress (58%) and physical exercise (56%). Seizure precipitants
freely recalled by parents were often related to ambient warmth or cold-
warmth shifts (41%) and to various visual stimuli (18%).DS children had
more positive seizure precipitant categories (median 4) compared to the
childhood (median 2) and community-based epilepsy cohort (median 0)
(p < 0.001) and showed the highest percentage in each category (all
p < 0.001). Within the category ‘stress, including physical exercise’,
physical exercise was more often reported to provoke a seizure in stress-
sensitive children within the DS than in the childhood epilepsy cohort
(78% vs. 35%, p < 0.001).Within the childhood epilepsy cohort physical
exercise was more often reported in fever-sensitive than in other children
(25% vs. 12%, p = 0.042).
Conclusion: Our study shows a high prevalence of a range of sei-
zure precipitants in DS, compared to patients with other epilepsies.
Our results underscore elevated body temperature as an important
seizure precipitant, whether caused by fever, warm bath, ambient
warmth or physical exercise. Knowledge of these seizure precipitants
may improve preventive strategies in the otherwise difficult treat-
ment of DS.
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STRETCH SYNCOPE: ARARECASEMIMICKING
SEZIURE
G.D. KayaÖzçora, M. Canpolat, S. Kumandaş, H. Per, A. Kacar
Bayram, H. Gümüş
Erciyes University Faculty of Medicine, Kayseri, Turkey
Introduction: Syncope is characterized by a temporary loss of con-
sciousness and postural tone secondary to a lack of adequate cerebral
blood perfusion.The peak incidence is around the age of 15 years, more
frequent in girls than boys. The most common cause of syncope in young
subjects is a reflex syncopal event and in particular a vasovagal faint.Pro-
longed standing especially in combination with warm temperature,
crowded or confined environments, standing quickly, pain, emotional
circumstances,early after intense exercise,lack of sleep, menstruation,
fatigue, illness with fever,micturition, hyperventilation, stretching,-
coughing and rapid weight loss may be trigger a reflex syncope. We
report this rarely seen 7 years old stretch syncope who was admitted with
complaint with seziure.
Case: A 7 years girl admitted to emergency department with complaint
fainting while her mother browsing her hair.There was no history with
syncope or seziure. Her physical and neurological examination was nor-
mal. After a detailed history was learned that fainting was occurred after
hyperextension of the neck while browsing. Routine laboratory tests,
electroencephalogram and cardiac evaluation were normal and she was
diagnosed as stretch syncope.
Conclusion: Stretch syncope is a rare condition associated with
decreased systemic blood pressure and decreased cerebral blood flow
due to mechanical compression of the vertebral arteries.Mechanical com-
pression may occur during stretching the neck hyperextended while
standing or browsing hair. Seziure,syncope and psychogenic fainting
may be considered when a patient presented with loss of consciousness.
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EPILEPSY INANGELMANANDPRADER-WILLY
SYNDROMES
A. Kholin*,†, E. Il`ina†, L. Kolpakchi†, I. Fedonyuk†,
M. Ostrovskaya†, N. Zavadenko*
*Russian National Research Medical University, Department of
Neurology, Neurosurgery and Medical Genetics, Moscow,
Russian Federation, †Russian Children Clinical Hospital,
Department of Psychoneurology N2, Moscow, Russian
Federation
Purpose: To examine the age of epilepsy onset, seizures characteristics
and the effectiveness of antiepileptic therapy of epilepsy in children with
Angelman (AS) and Prader-Willy syndromes (PWS).
Method: At the period of 2005–2014 were studied 7 children with genet-
ically identified AS and 14 children with PWS. For all the children were
provided dynamic video-EEGmonitoring.
Results: AS manifested with epilepsy in all cases. Only one girl has a 1
type of seizures, in 1 case - 2, in 3 cases - 3 and one - 4 types. The most
frequent seizure types were: atypical absences- 4 (57.1%), myoclonic- 3
(42.9%), GTCS- 3 (42.9%), tonic versive- 3 (42.9%), rarely- serial infan-
tile spasms, axorhyzomelic tonic, myoclonic-astatic, atonic-astatic, phar-
yngo-oral and hemiconvulsive types- in one case each (14.3%). Clinical
remission was achieved in 3 children (42.9%) and 4 children (57.1%)
showed significant decrease of seizures with persistence of high index
epileptiform discharges. The most effective drugs were valproates with
ethosuximide. In PWS the most frequent seizure types were: tonic
spasms- 3 (50%), myoclonic- 2 (33.3%), autonomic (33.3%), rarely-
atypical absences, GTCS, focal versive and atypical febrile- in one case
each (16.7%). Electro-clinical remission was achieved in 3 children
(50%) and 3 children (50%) showed a significant decrease of seizures
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and index of epileptiform discharges on the EEG. The most effective
drugs were valproates in monotherapy and in combinations with topira-
mate, carbamazepine and ethosyximide.
Conclusion: Epilepsy is an obligate symptom of AS and characterized
by early onset and polymorphic seizure types. In PWS 42.9% patients
suffered from epilepsy. In AS positive prognosis for epileptic seizures is
combined with a poor prognosis for the persistence of epileptiform dis-
charges on EEG, severe cognitive deficits and manifestations of atypical
autism. Children with PWS had better prognosis for clinical and EEG
signs of epilepsy.
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FORCEDNORMALIZATION FOLLOWINGUSEOF
LACOSAMIDE
K.J. Abou Khaled*, J. Khoury†, G. Macaron*, S. Richa†
*Saint Joseph University, Neurology, Beirut, Lebanon, †Saint
Joseph University, Psychiatry, Beirut, Lebanon
Purpose: In this report we present a case of forced normalization and
review its clinical characteristics and the potential pathogenic mecha-
nisms. Forced normalization is a phenomenon that has been reported sec-
ondary to several anti-epileptic drugs use. In this report we describe its
occurrence after use of lacosamide in a 21 years old man with refractory
complex partial seizures and known bitemporal epileptogenic zones. The
patient had failed numerous anti-epileptic drug trials, had some improve-
ment following VNS implantation but kept on having disabling seizures
and multiple hospital admissions per year for status epilepticus. Follow-
ing introduction of lacosamide, seizures resolved but he had psychotic
symptoms associated with this remission and disappearance of the epilep-
tiform activity or subclinical seizures on video-EEGmonitoring.
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PSYCHIATRIC FEATURESOFEPILEPSY INACCRA,
GHANA
P. Adjei*,†, K. Nkromah†, R. Laryea*, S. Nartey‡, F. Osei-
Poku†, A. Akpalu†
*University of Ghana, School of Medicine and Dentistry,
College of Health Sciences, Department of Medicine and
Therapeutics, Accra, Ghana, †Korle Bu Teaching Hospital,
Medicine and Therapeutics, Accra, Ghana, ‡University of
Ghana, School of Medicine and Dentistry, College of Health
Sciences, Department of Psychiatry, Accra, Ghana
Purpose: Epilepsy has for many years been considered a psychiatric
disorder. In recent times, the physical basis of epilepsy has been
emphasised and the psychiatric feature regarded more as comorbidity.
To what extent this is true is arguable but this may underlie the reason
for considering epilepsy as a psychiatric disorder in most low and mid-
dle income countries. In Ghana, epilepsy remains a strong preserve of
psychiatry and the prevalence of typical psychiatry presentations in
epilepsy has not been studied. The management of the psychiatric
symptoms in epilepsy forms a very significant part for the control of
seizures in epilepsy. In this study we evaluated the prevalence and pat-
terns of affective and anxiety disorders in patients with epilepsy in
Accra Ghana.
Method: Over 500 patients with chronic epilepsy were identified from
the only dedicated epilepsy clinic at the Korle Bu Teaching hospital,
Accra Ghana. All patients who consented and agreed to be a part of the
study were evaluated using the 53 item Brief Symptom Inventory.
Preliminary results: Suggests a high incidence of depression and other
affective disorders with a high incidence in the older age group and the
patients with lower socioeconomic back ground.
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PSYCHIATRIC EVALUATIONOFEPILEPSY
PATIENTSWITHPERI-ICTALWATERDRINKING
E. Altindag*, E. Ertekin†, A. Gokyigit‡, B. Aslantas-Ertekin†,
E.N. Vanli Yavuz§, S. Ozel-Yildiz¶, N. Bebek‡, C. Gurses‡,
I. Baral-Kulaksizoglu†, B. Baykan‡
*Istanbul Florence Nightingale Hospital, Department of
Neurology, Istanbul, Turkey, †Istanbul University, Istanbul
Faculty of Medicine, Department of Psychiatry, Istanbul,
Turkey, ‡Istanbul University, Istanbul Faculty of Medicine,
Department of Neurology, Istanbul, Turkey, §Koc University,
Faculty of Medicine, Department of Neurology, Istanbul,
Turkey, ¶Istanbul University, Istanbul Faculty of Medicine,
Department of Biostatistics, Istanbul, Turkey
Purpose: Peri-ictal water drinking (PIWD) is a rare vegetative symptom
which has been reported in temporal lobe epilepsy (TLE). Underlying
reasons and related psychological factors of this behavior are not appro-
priately known. Our aim was to investigate the psychiatric comorbidities
of the patients who report PIWD in their seizures.
Method: Patients reporting “water drinking” behavior, without asking,
more than two times in their visits, as a consistent peri-ictal phe-
nomenon were included and systematically questioned for the character-
istics of PIWD. The demographic and clinical information consisting of
age, sex, age at onset of epilepsy, seizure types and semiological find-
ings of their seizures, syndromic diagnoses, EEG findings, MRI find-
ings, and neuropsychological evaluations were recorded from patients’
medical files. Epileptic patients having same epileptic syndromes with-
out PIWD (Group II) and age and sex matched normal subjects (Group
III) were included the study as two control groups for psychiatric evalu-
ations.
Results: Yale Brown Obsessive Symptoms, Dissociative Experiences
Scale, Hamilton Anxiety Rating Scale and Depression Rating Scale
scores were significantly high in the main study group (Group I) com-
pared to normal controls (Group III) but these scores were not different
compared to Group II. Although there was not any difference between
the Group I and Group II according to comorbid psychiatric diagnoses,
compulsive symptom category of “washing” was detected significantly
more frequent in the group with PIWD (p:0.007).
Conclusion: Although the presence of PIWD does not seem to have a
specific association with substantial psychiatric comorbidity in patients
with TLE, our study is providing preliminary evidence for the first time,
the presence of PIWD might be associated with only a specific type of
compulsions, namely washing compulsions.
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FREQUENCYOF SEIZUREDISORDER IN PATIENTS
UNDERGOINGALCOHOLDETOXIFICATONWITH
FRONT-LOADINGDIAZEPAM - FINDINGSOFAN
AUDIT
S. Arshad*, L. Nashef†
*King’s College Hospital, Psychiatry, London, UK, †King’s
College Hospital, Neurology, London, UK
Purpose: The abrupt cessation of heavy alcohol consumption results in
alcohol withdrawal symptoms and seizures are a recognized complica-
tion. A fixed dose treatment with long acting Benzodiazepines is
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routinely offered to individuals presenting in a state of alcohol with-
drawal. An alternate is to offer front-loading dose of Diazepam. The pur-
pose of this audit is to establish seizure related safety of the alternate
treatment regime.
Method: Patients who attended Emergency Department with alcohol
withdrawal symptoms were assessed for suitability of front-loading
regime. Any serious underlying physical illness like head trauma, sepsis
were ruled out. A front-loading regime with diazepam 20 mg was initi-
ated in eligible patients and their symptoms were recorded periodically.
The patients then received additional 20 mg of Diazepam two hourly if
indicated until a light sedation was achieved. A three days treatment plan
was carried out followed by transfer to community based services.
Results: Out of the 79 patients, majority (75.9%) were men. Average
reported weekly consumption of alcohol was 37.5 units. Physical co-mor-
bidities were common (74.6%). A witnessed seizure was recorded in
30.3% while 11.3% were found collapsed with a suspected seizure. Only
1 patient undergoing front loading regime sustained a seizure and
required transfer to medical unit. 9 patients discharged themselves
against medical advice while the remaining completed treatment and
were successfully discharged.
Conclusion: Some previous studies have highlighted the benefit of
front-loading regime against conventional fixed dose titration but report
a higher incidence of seizures during front loading regime. This audit
establishes the benefit of front-loading regime and highlights its safety.
No serious or life threatening complications were reported. The length
of stay in hospital was significantly reduced. The overall dose of Benzo-
diazepine used was significantly lower than that used in fixed dose
regime.
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MONITORING INTERACTION BETWEEN
ANTIEPILEPTIC AND PSYCHOTROPIC DRUGS IN
PEOPLEWITH INTELLECTUAL DISABILITIES
S. Arshad, B. Fitzgerald
Central & North West London NHS FT, Intellectual Disabilities,
London,UK
Purpose: The prevalence of epilepsy in people with Intellectual Dis-
abilities (ID) is significantly higher than that in general population and
varies in direct proportion to severity of ID. According to an estimate,
the prevalence of epilepsy in people with moderate ID ranges between 1
in 4 and 1 in 5 such patients. The cumulative risk for developing epi-
lepsy is estimated as high as 38% at the age of 22 years. People with ID
and epilepsy very commonly present to psychiatric clinics with chal-
lenging behaviour or co-morbid psychopathology. It is common practice
for them to receive treatment through psychotropic drugs. Most psy-
chotropic drugs interact with Anti Epileptic Drugs (AEDs) and some
even potentiate the effect. The purpose of current audit is to monitor
how these interactions are recorded in psychiatric clinics and whether
introduction of a simplified drug interaction algorithm improves the
overall quality of care.
Method: We propose to review medical records of all people with ID
and Epilepsy attending community psychiatric clinic who receive treat-
ment with AEDs and psychotropic drugs. We aim to monitor if interac-
tions are recorded, explained and communicated before and then after
introduction of drug interaction algorithm. We also aim to assess if and
what impact the intervention has on overall delivery of care.
Results: The project is at data collection stage and we aim to complete it
by June 2015.
Conclusion: The provision of a simplified algorithm will improve the
overall quality of care and influence the outcomes positively like fewer
attendances to emergency department or improved compliance with
medication.
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PSYCHIATRIC ASPECTS IN FAMILIESWITH
AUTOSOMALDOMINANTCORTICAL TREMOR,
MYOCLONUS ANDEPILEPSY
A. Coppola*, C. Caccavale†, L. Santulli†, S. Balestrini‡,
C. Cagnetti§, L. Licchetta¶, F. Bisulli¶, P. Tinuper¶,
P. Striano**, S. Striano†
*Federico II Naples, Department of Neurology,
Odontostomatology and Reproductive Sciences, Naples, Italy,
†Federico II Naples, Naples, Italy, ‡UCL Institute of Neurology,
London, UK, §Ancona University, Ancona, Italy, ¶University of
Bologna, Bologna, Italy, **Giannina Gaslini Institute, Genova,
Italy
Purpose: To assess the psychiatric comorbidity in Autosomal Dominant
Cortical Myoclonus and Epilepsy (ADCME) patients by using reliable
and valid pshycodiagnostic scales.
Method: Patients with a clinical and electrophysiologic diagnosis of
ADCME from two Italian centers. Two control groups: healthy subjects
and patients with Juvenile Myoclonic Epilepsy (JME). A myoclonus
score was assigned to each ADCME patient by using the Unified Myo-
clonus Rating Scale. Psychiatric evaluation battery included: BDI (Beck
Depression Inventory), STAI-Y (State-Trait Anxiety Inventory Y; 1 and
2) MMPI-2 (Minnesota Multiphasic Personality Inventory-2) and
QoLIE-31 (Quality-of-Life in Epilepsy Inventory). Kruskal-Wallis rank
test, Wilcoxon rank-sum test or one-way analysis of variance (ANOVA),
according to the normality of the distribution, and Pearson c2 test, were
used. Spearman correlation analysis was used to identify relationships
between the neuropsychological scores and the myoclonus score, after
Bonferroni correction for age.
Results: The STAI-S score was higher in ADCME than JME patients
and controls (p = 0.035, p = 0.019) The STAI-T score in ADCME group
was not different from JME (p = 0.087), but higher than healthy controls
(p = 0.017). The BDI score was increased in ADCME patients compared
with JME patients and controls (p = 0.040 and p = 0.017). The overall
QoLie-31 score was lower in ADCME than JME (p = 0.006), but there
was no difference in the single subscales score. A higher prevalence of
elevated score in at least oneMMPI-2 subscale was found in the ADCME
group (p = 0.012). ADCME patients showed a higher prevalence of ele-
vated scores in hypochondriasis, depression and schizophrenia subscales,
than JME and healthy controls.
Conclusion: This study firstly reports a high prevalence of mood disor-
ders, particularly depression and anxiety, in ADCME patients, often
associated to pathological traits of personality. A statistically significant
correlation is present between anxiety and myoclonus severity. Moreover
these patients show a worse quality of life compared to other patients pre-
senting only with seizures.
p0397
SYMPTOMSOFANXIETY IN PERSONSWITH
EPILEPSY
K.M. Fiest*, S. Wiebe†, S.B. Patten‡, A.G.M. Bulloch*, N. Jette†
*University of Calgary, Department of Community Health
Sciences, Calgary, Canada, †University of Calgary, Department
of Clinical Neurosciences & Community Health Sciences,
Calgary, Canada, ‡University of Calgary, Community Health
Sciences & Psychiatry, Calgary, Canada
Purpose: Though anxiety is common in persons with epilepsy, it often
understudied relative to other psychiatric comorbidities. The current
study aims to estimate the prevalence of anxiety, examine associations
and correlates, and characterize common symptoms of anxiety in persons
with epilepsy.
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Method: Consecutive persons with epilepsy (n = 225) from the epilepsy
program clinic in a city of 1.2 million people completed questionnaires,
including the Hospital Anxiety and Depression Scale (HADS) to assess
anxiety symptoms, and the Short Form 12 (SF-12) to measure physical
and mental quality of life.
Results: According to the HADS, the prevalence of anxiety was 26.7%
(95% Confidence Interval (CI): 20.8–32.5), and depression was 15.5%
(95% CI: 10.7–20.2). The most common symptoms of anxiety were wor-
rying thoughts (33.8%; 95% CI: 27.9–40.2), the feeling that something
awful will happen (27.9%; 95% CI: 22.5–34.2), and feeling tense or
wound up (27.4%; 95% CI: 22.0–33.6). Anxiety was significantly corre-
lated with physical (r = -0.18; p = 0.02) and mental quality of life
(r = 0.54; p < 0.0001). Persons were more likely to have anxiety if
they: were smokers (Odds Ratio (OR): 2.37; 95% CI: 1.20–4.69),
reported antiseizure medication side-effects (OR: 2.01; 95% CI: 1.10–
3.69), reported more severe epilepsy (OR: 3.17; 95% CI: 1.61–6.24), and
very disabling seizures (OR: 2.07; 95% CI: 1.08–3.98).
Conclusion: In our sample of persons with epilepsy, anxiety was more
common than depression. Some symptoms of anxiety are more often
reported than others in epilepsy. By identifying factors associated with
anxiety in epilepsy, interventions to improve disease management and
quality of life can be appropriately targeted.
p0398
PATIENTSWITHEPILEPSYAND PSYCHOGENIC
NON-EPILEPTIC SEIZURES
S. Bek*, G. Koc†, G. Genc‡, Z. Gokcil§
*Baskent University, Medical Faculty, Adana Research and
Teaching Center, Neurology, Adana, Turkey, †Turkish Armed
Forces Rehabilitation Center, Neurology, Ankara, Turkey,
‡Gumussuyu Military Hospital, Neurology, Istanbul, Turkey,
§Gulhane Medical Faculty (Retired), Neurology, Ankara,
Turkey
Purpose: Psychogenic non-epilepticseizures (PNES) can be defined as
paroxysmal involuntary behavioural patterns that mimic epileptic events
without organic cause. The incidence of PNES is between 2-33/100.000
in general population. The purpose of our study is to evaluate patients
with PNES and epilepsy associated with PNES.
Method: We evaluated data of 2086 patients retrostpectively. PNES
was diagnosed with video - EEG monitorization and/or observation of
PNES.
Results: Fifty patients had PNES and 37 patients had epilepsy associated
with PNES. 66 patients are women (75.9%) 21 are men (24.1%). The
diagnoses had been made with video - EEG monitorization in 24 patients
(27.6%) and with observation in 63 patients (72.4%). Half of the patients
(50%) who had PNES had been on AEDs and 48 (96%) of them were on
psychiatric treatment but 34 patients came to follow up visit sand just 5
of them had benefits from psychiatric support. Five patients had an
epileptic family member. The mean diagnose duration was
5.9  6.5 years. Thirty two epileptic patients associated with PNES and
86.5% of them took psychiatric treatment and 29 patients came to follow
up visits and 4 of them had benefits from psychiatric support.
Conclusion: The prognosis of PNES in adults is not favorable. The
rate of false diagnosis in PNES is very high and the diagnose dura-
tion calculates with years. Also PNES and epileptic seizures can be
together in a same patient. Multi discipliner treatment strategy needs
to treat PNES and epilepsy associated with PNES. In our study the
response to psychiatric treatment is low this result consistent with
literature.
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INFORMATION SEEKINGBEHAVIOR FOREPILEPSY:
AN INFODEMIOLOGICAL STUDYOFWIKIPEDIA
ARTICLE SEARCHES
F. Brigo*,†, S.C. Igwe‡, F. Tezzon†, E. Trinka§, W.M. Otte¶,**
*University of Verona, Department of Neurological Sciences,
Verona, Italy, †Division of Neurology, Franz Tappeiner
Hospital, Merano, Italy, ‡Federal Teaching Hospital,
Department of Neuro-Psychiatry, Abakaliki-Ebonyi, Nigeria,
§Paracelsus Medical University, Department of Neurology,
Christian Doppler Klinik, Salzburg, Austria, ¶Brain Center
Rudolf Magnus, University Medical Center Utrecht, Department
of Pediatric Neurology, Utrecht, Netherlands, **Biomedical MR
Imaging and Spectroscopy Group, Image Sciences Institute,
University Medical Center Utrecht, Utrecht, Netherlands
Purpose: Millions of people worldwide use the Internet daily as a source
of health information. Wikipedia is a popular free online encyclopedia
used by patients and physicians to search for health-related information.
Our aim was to evaluate information seeking behavior of English-speak-
ing Internet users searching Wikipedia for articles related to epilepsy and
epileptic seizures.
Method: Using Wiki Trends, which provides quantitative information
on daily article views; data on global search queries for Wikipedia arti-
cles related to epilepsy and seizure were analyzed. The daily Wikipedia
article views on syncope, psychogenic non-epileptic seizures, migraine,
and multiple sclerosis served as comparative data. The period of analysis
covered from January 2008 to December 2014.
Results: Overall, the Wikipedia article “epilepsy and driving” was
found to be more frequently searched than that on “epilepsy and employ-
ment” and “epilepsy in children”. Since January 2008, Wikipedia article
“multiple sclerosis” was more often searched than that on “epilepsy”,
“syncope”, “psychogenic non-epileptic seizures” and “migraine”. The
article “epilepsy” ranked 3,779 and was less searched than that on “mul-
tiple sclerosis” (rank 571) in traffic on Wikipedia. The highest peak in
search volume for the article “epilepsy” corresponded to news of a celeb-
rity having seizures.
Conclusion: Fears and worries about epileptic seizures, their impact on
driving and employment, and news about celebrities with epilepsy might
be major determinants in searchingWikipedia for information.
p0400
SOCIALAND FAMILIAL PROBLEMS BETWEEN
PATIENTS ANDTHEIR FAMILIES REFER TO
EPILEPSYASSOCIATION, TEHRAN, IRAN
R. Esmaieli, M. Esmaieli
Shahid Beheshti University of Medical Sciences, Tehran, Iran,
Islamic Republic of
Purpose: High rate of epilepsy in the society and negligence of social-
familial problems is one of factors in reduction of life quality of the epi-
lepsy patients, which deprives the patients from a normal life. This study
is an attempt to determine social and familial problems of the patients
from the patients and their families0 viewpoint.
Method: The present study was conducted as a descriptive study
on120 patients and120 of their family members. Sampling method
was convenience sampling and two researcher designed questionnaires
were used for data gathering. The patients0 questionnaire included
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three sections of demographic information, disease information, and
social/familial information. The families0 questionnaire was comprised
of two sections of demographic information and social/familial prob-
lems from the families0 viewpoint. Based on literature review results
and using Peirce and Harris questionnaires, the measure of family sol-
idarity and compatibility was build. Validity of data gathering tools
was ascertained using face and content validity and for reliability,
internal consistency method with correlation coefficient of 83% was
used.
Results: The results showed that social problems from the patients0
viewpoint were severe and moderate in 65.52% and 34.48% of the cases
respectively and from the families0 viewpoint were 88.24% moderate,
9.5% no problem, and%1.96 severe. Familial problems from the patients0
viewpoint were moderate and severe in 56.32% and 37.93% of the cases
respectively. From the families0 viewpoint, familiar problems were
74.76%moderate and 25.24% no problem.
Conclusion: The differences between viewpoints of families and the
patients regarding social and familial problems showed lack of enough
information among the family members regarding the patients. The
results herald the necessity to implement training courses to increase
mutual understanding between the family members and the patients;
while there is a need to pay more attention to the problems of social and
familial nature.
p0401
TYPEOF SIZURE INFLUENCEDEPRESSIONAMONG
APILEPSY PATIENT
K.M. Farhana*, Y. Yudiyanta†
*Central Aceh District Hospital, Neurology, Takengon,
Indonesia, †Gadjah Mada University, Neurology, Yogyakarta,
Indonesia
Purpose: Depression is a common mental disorder in epilepsy patient
but often undertreated or even underdiagnosed. This study is an attempt
to estimate the prevalence of depression among patients with epilepsy.
Methods: A cross sectional study was conducted to 30 epilepsy outpa-
tients in neurology clinic Sarjito Hospital. Epilepsy patients with
intracranial lesion and comorbid of psychotyc and skyzophrenia were
excluded. Neurological Depression Disorder in Epilepsy (NDDIE) was
performed to all patients to asses depression, NDDIE score above 16 is
confirmed diagnosis of depression.
Result: The subject of study were 30 patients with epilepsy, 14 are
female (46.67%) and 16 are male (53.3%). Subject ≤21 years were 5
patients (16.6%) and ≥21 years are 25 patients (83.33%). Of 30
patients with epilepsy, 56.67% patients were having depression accord-
ing to their NDDIE score. general tonic clonic seizure occurred in 11
patients (36.6%) and 6 of them (54.4%) experience symptoms of
depression. While subject with partial simple seizure are 8 patients
(26.6%) and only 1of them (12.5%). Four patients (57.1%) of 7 who
experienced absance seizure, and 1 of 4 (25%) patients with partial
compleks seizure were having depression at the time of the interview.
Chi square test showed that general tonic clonic seizure has greatest
prevalence ratio (8.45) but it0s not statistically significant (p 0.061).
We also evaluate the use of single and multiantiepileptic drugs among
the patients, but no significant correlation between antiepileptic drugs
and depression.
Conclusion: Depression was found to be highly prevalent psychiatric
co- morbidity among the patients with epilepsy. The study demon-
strated a relationship between partial simpleks seizure and depression
among epilepsy patient. The study emphasized need for proper
psychiatric evaluation for overall management of patients with
epilepsy.
p0402
EPILEPSYKNOWLEDGE IS THEKEYTOWARDS
SOCIALACCEPTANCEAMONGUNIVERSITY
STUDENTS IN JAPAN
M. Fujikawa*, N. Kaneko†, Y. Kakisaka*, T. Ueno‡,
N. Nakasato*
*Tohoku University Graduate School of Medicine, Department
of Epileptology, Sendai, Japan, †Tohoku University School of
Education, Department of Educational Psychology, Sendai,
Japan, ‡Tohoku University Graduate School of Education,
Department of Clinical Psychology, Sendai, Japan
Purpose: Stigma and discrimination associated with epilepsy have been
persistent worldwide. In Japan, many children with epilepsy experience
interpersonal issues (i.e., bullying, isolation), while adults with epilepsy
often face reduced employment and social opportunities. Much of these
is caused by the society’s long-standing myths and misunderstanding
about epilepsy. This study investigated the knowledge and attitudes
towards people with epilepsy among university students in Japan.
Method: A modified version of a pre-tested questionnaire was used to
make inferences regarding the participants’ experience and knowledge
about epilepsy. A semantic differential (SD) rating scale was used to
derive attitudes towards epilepsy. Two hundred seventy-one university
students were recruited from 9 academic departments at a Tohoku regio-
nal university. Data were analyzed statistically.
Results: Among 271 participants, 8% personally knew someone with
epilepsy, and 16% had witnessed an epileptic seizure. 51% perceived
themselves as having some knowledge about epilepsy. While only 10%
objected to females with epilepsy getting married in general, 36%
objected to their own children marring to one (v2 = 116.32, df = 3,
p < 0.001). Exploratory factor analysis and cluster analysis yielded 3
attitude groups towards epilepsy:
(a) empathy group,
(b) negative feeling group, and
(c) indifferent group. Furthermore, analysis of variance (ANOVA)
revealed the empathy group showed significantly higher knowledge
about epilepsy than the other two groups (F(2,268) = 9.66, p < 0.001).
On the contrary, no significant group difference was observed based
on personal interaction with individuals with epilepsy.
Conclusion: The present findings demonstrated that epilepsy knowledge
may be associated with empathetic attitudes towards people with epilepsy.
This provides a strong future implication for public education and out-
reach activities towards gaining social acceptance of epilepsy in Japan.
p0403
KNOWLEDGE, ATTITUDES AND PRACTICES
REGARDINGEPILEPSYAMONGCHRISTIANS
CLERICS COMPAREDTOTHEIR CONGREGATION IN
SOUTHWESTERNNIGERIA
M.A. Komolafe*, A.R. Adekunle†, M.A. Ojo†
*Obafemi Awolowo University, Neurology, Ile-Ife, Nigeria,
†Obafemi AwolowoUniversity, Religious Studies, Ile-Ife, Nigeria
Purpose: Epilepsy is a common chronic brain disorder, in Sub-Saharan
Africa. The traditional and religious beliefs concerning epilepsy con-
tribute to the stigma, exclusion of Persons with Epilepsy (PWE) and late
presentation to hospital.
Method: The study is a cross-sectional study carried out from June to
August 2012 among urban and rural churches. A structured questionnaire
was used to obtain information on the socio-demographic profile, knowl-
edge and attitudes of the participants regarding epilepsy.
Results: One hundred and fifty congregation members (male: female
ratio 2:1) and 12 clerics (all male) responded to the questionnaires (re-
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sponse rate of 83.3%), mean age was 37  1. Majority of the clerics
(58%) believed that epilepsy was due to possession by a spirit compared
to 22% of the congregation. A quarter of both groups believed that epi-
lepsy was contagious. The knowledge of the features of generalized sei-
zures was similar for both groups, while none of the clerics were aware of
staring as a feature of epilepsy. Although two thirds of both clerics and
congregation recommend medical consultation, half of the clerics and
95% of the congregation would recommend a healing or deliverance ses-
sion. Members of the congregation were more tolerant toward epilepsy
compared to the clerics.
Conclusion: Clerics do not have adequate knowledge of epilepsy and
were less tolerant towards PWE compared to their congregation. Both
clerics and congregation recommend church/spiritual/divine healing and/
or deliverance session in addition to medical consultation. Epilepsy
awareness educational programmes are needed in churches in South
Western Nigeria to improve the knowledge of epilepsy among clerics
which would improve the quality of advice they give their congregation.
p0404
FIGHTING STIGMAOFEPILEPSY THROUGHMUSIC
K. Lin*, J.G.B. Rios*, L. Sukys-Claudino*, P. Wolf*,†
*Servico de Neurologia, Departamento de Clínica Médica,
Hospital Universitario, Universidade Federal de Santa Catarina
(UFSC), Florianopolis, Brazil, †Danish Epilepsy Centre,
Dianalund, Denmark
Purpose: Epilepsy is a common neurological condition frequently asso-
ciated with psychosocial difficulties. Prejudice and discrimination
(stigma) are often worse than the seizures themselves in terms of impact
on daily life of people with epilepsy (PWE). We produced a song and a
movie clip regarding epilepsy and evaluated the impact of this song in
general population.
Method: A song and a related brief movie clip with 4 minutes duration
were developed addressing the most common stigma issues on epilepsy
and attitudes and perceptions towards someone having a seizure. Before
and after listening to the song and watching to the movie healthy individ-
uals were evaluated using the Stigma Scale of Epilepsy (SSE), which is a
previously validated instrument in Brazil that allows quantification of
stigma in epilepsy expressed as a scale. Also, individuals answered to a
semi-structured interview addressing their knowledge about epilepsy.
Results: There were 128 interviewed individuals, who scored
(mean  standard deviation) 38.15  14.08 (minimum and maximum =
13–76) before and after 24.20  14.74 (1–71) listening to the music
(p < 0.0001). Their age was an average of 25.98  10.04 (11–62), 71%
were female and 83% have completed high-school. Among diverse ques-
tions addressing their knowledge about correct attitudes and perceptions
towards someone having a seizure, we highlight that 43 individuals
answered they would hold the tongue of a person having a seizure before
listening to the music, while 13 answered the same after listening to the
song (p < 0.0001).
Conclusion: There is an urgent need to improve the level of education in
relation to epilepsy and knowledge, attitudes and perception about epi-
lepsy can be easily improved through simple actions such as listening to a
brief song.
p0405
PARENTING STRESS IN PEDIATRIC EPILEPSY: A
CASE-BASED TIME-SERIES STUDYOFTHEEFFECTS
OF THERELAXED PARENTING PROGRAM
R. Rodenburg, L. van Iterson, A.M. Meijer
University of Amsterdam, Behavioral Sciences, Amsterdam,
Netherlands
Purpose: To evaluate a newly developed parenting stress reduction pro-
gram for parents of children with epilepsy (Relaxed Parenting Program;
RPP) on parenting stress, parenting behavior, and child behavior by
means of a Single Case Experimental Design (SCED). Aim of the study
is to examine whether the treatment generates daily improvement in
maternal and child outcome and how this improvement unfolds over
time: the process of change.
Methods and results: This study is part of a greater study into the effects
of RPP. For the purpose of this study online daily diaries and pre- and
posttreatment questionnaires of N = 9 mothers will be examined. Daily
improvement: effect sizes for treatment effects will be calculated with
simulation modeling analysis (SMA). The daily process of change: this
will be examined with SMA via cross-correlational analysis. Pre- and
posttreatment questionnaires will be evaluated with the Reliable Change
Index (RCI).
Conclusion and discussion: RPP will be discussed as a possibly effica-
cious treatment with regard to parenting stress, parenting, and the reduc-
tion of child behavioral problems. If former inadequate parenting
strategies will successfully be changed, with positive consequences child
behavior, RPP may be a promising treatment for parents of children with
epilepsy.
p0406
RESTRICTIONS IMPOSEDONCHILDRENWITH
EPILEPSYAND ITS ASSOCIATIONWITH
CHARACTERISTICSOF EPILEPSY IN THEAGE
GROUPOF 6 TO 12 YEARS
T.V. Soundaram*, S. Giri*, A.D.A.W. Sooriyaarachchi*,
J. Wanigasinghe†, D. Jeyakumaran*
*University of Colombo, Faculty of Medicine, Colombo, Sri
Lanka, †University of Colombo, Faculty of Medicine,
Department of Paediatrics, Colombo, Sri Lanka
Purpose: Epilepsy is the most common neurological disease in chil-
dren and adolescents. The fear of injury and impact on social stigma
results in parental restrictions on many of the activities children love
to do.
This descriptive cross sectional study was performed to evaluate the
restrictions imposed on children with epilepsy, and the association of
these restrictions with epilepsy characteristics such as seizure type, fre-
quency, seizures with loss of consciousness, age at first seizure, history
of status epilepticus and family history of epilepsy.
Method: Children aged 6–12 years with epilepsy for at least 6 months,
were identified from a tertiary care neurology clinic at the premier chil-
dren’s hospital in the country, with bed strength of 900. Children with
problems in ambulation, permanent disability, impairment/loss of vision
and hearing were excluded. Interviewer administered questionnaire mod-
ified from Hague Restrictions in Childhood Epilepsy Scale
(HARCES) was used to collect data on activity restrictions. Seven
important determinants of daily childhood activities were tested.
Results: Primary care givers of 150 children (mean age of 8.54 years)
were interviewed. Participation in indoor (94.6%) and outdoor sports
(85.9%) was allowed by parents adequately. General daily play outside
the house (97.3%) and pursuing hobbies (100%) were also allowed fre-
quently. A large majority of children (77.9%) were not allowed to swim.
This was significantly association with occurrence of seizures with loss
of consciousness (p = 0.01) and poor seizure control (p = 0.04). More
than one third (37.6%), were not allowed to go on trips, but no signifi-
cantly associated cause was identified.
Conclusion: Significant restriction was imposed on swimming and
going on trips among Sri Lankan children with epilepsy. Awareness on
appropriateness of these activity restrictions needs to be improved among
primary care-givers.
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PERCEIVED STIGMAAND ITS ASSOCIATES IN
ADULTEPILEPSY PATIENTS FROM ISTANBUL
K. Yeni*, Z. Tulek*, N. Bebek†
*Istanbul University, Florence Nightingale School of Nursing,
Istanbul, Turkey, †Istanbul University Istanbul Faculty of
Medicine, Department of Neurology, Istanbul, Turkey
Purpose: Epilepsy is one of the most stigmatizing medical conditions.
The purpose of this study was to examine the perception of stigma and
factors associated with stigma.
Method: This descriptive cross-sectional study has been carried out
among patients attending to an epilepsy outpatient clinic of a university
hospital between February-October 2014. One hundred-ninety-four
patients with age above 18, able to communicate and having diagnosis of
definite epilepsy constituted the study sample. Patients seizure-free for
2 years were excluded from the group. Three-item Jacoby’s Stigma Scale
was used to determine level of stigma and also Social Support Scale,
Generalized Self-efficacy Scale, Epilepsy Knowledge and Attitude
Scales were used to examine factors associated with stigma.
Results: In total, 66 out of 194 subjects (%34) reported feeling stigma-
tized, with almost half of them (n = 31) feeling highly stigmatized.
Education, income, age of onset, seizure frequency in previous year,
social support and knowledge and attitutudes toward epilepsy were sig-
nificant factors determining scores on stigma scale. It was also deter-
mined that stigma was associated with injuries, seeking help from
mystics, disclosure of the diagnosis, impact of epilepsy on private life
and self-efficacy.
Conclusion: This study confirms the findings of previous studies that
have identified the importance of both clinical and nonclinical factors in
understanding the stigma of epilepsy. Findings support the need for social
support, knowledge and awareness to decrease the stigma associated with
epilepsy.
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EFFICACYOFCARBAMAZEPINE IN TEMPORAL
COMPLEX PARTIAL STATUS EPILEPTICUS
W. Abdellaoui, S. Bahbouh, R. Benalia, M.R. Belabed, E. Attal,
M. Ait-Kaci-Ahmed
Ait Idir Hospital, EEG Laboratory, Department of Neurology,
Algiers, Algeria
Purpose: Temporal complex partial status epilepticus TCPSE is a condi-
tion usually manifest as variable periods of confusion with a prolonged
epileptic episode in which fluctuating or frequently recurring focal elec-
trographic epileptic discharges, arising in temporal regiones. In our case
report on two patients with TCPSE we study the response to carba-
mazepine after failure of first and second line therapy.
Method: Clinical case report.
Results: A 39-year old women had a history of cryptogenic epilepsy,
was treated since the age of 20 years with phenobarbital PB 100 mg/
day.She was admited for prolonged disturbed consciousness over 3 dayS,
after abrut withdrawal of PB.She had complex partial seizures character-
ized by motor automatisms, and appeared to be experiencing visual and
auditory hallucinations.EEG showed continuous left temporal spike/
wave and slow waves discharges. Normal brain MRI.A diagnosis of
TCPSE was made.No response to intravenous Diazepam 0.15 mg/kg and
PB 15 mg/kg after 4 days. Phenytoin PHT was not available in our hos-
pital. Clinical improvement and ictal EEG pattern resolved after oral Car-
bamazepine CBZ treatment 600 mg/day (initial dose of 100 mg/day).
Case 2: A 61-year old women with symptomatic complex partial seizure
disorder,secondary to CNS lymphoma resected 18 years earlier.Was
treated with Phenobarbital PB 100 mg/day and Carbamazepine CBZ
600 mg/day. Her established complex partial seizures were manifest by
confusion with agitation and experiencing visuel hallucinations, after
abrut withdrawal of CBZ.EEG revealed continuous temporal slow
waves.CT scaning was unchanged from imaging studies 6 month earlier.
No respnse to intravenous Diazepam 0.1 mg/kg and PB 15 mg/day after
3 days.Improvement in her clinical delirium and EEG pattern after oral
CBZ treatment 600 mg/day (start dose of 100 mg/day).
Conclusion: Carbamazepine CBZ was effective and safe in controlling
TCPSE in our patients. Oral administration of CBZ is an effective alter-
native.
p0409
RISK FACTORS FOR STATUS EPILEPTICUS IN
PAEDIATRIC PATIENTS
M.A. Ahmed, J.R. Pitts, Z. Aldahash, A. Haque
Queen’s Hospital, Romford, Paediatrics, London, UK
Purpose: The study aimed to identify risk factors for patients presenting
with a single episode of status epilepticus (SE) in paediatric patients with
an aim to identify methods that could reduce its occurrence.
Method: Notes for children presenting with seizures between August
2009 and August 2014 were collected by audit department. Patients were
excluded if they went on to have further SE episodes.
Case notes were manually reviewed and included in the study if
there was evidence of prolonged seizure (>20 minutes) or multiple
seizures without a documented complete recovery back to baseline
behaviour.
Results: Of the notes retrieved 36 (53% male, 47% female) met inclu-
sion criteria. The mean age of cases was 4.8 years with the majority pre-
school children (53% under 3 years old). 11% had metabolic or neurode-
velopmental syndromes 44% had no previous history of epilepsy (or had
suffered from simple febrile convulsions only). 56% had a history of pre-
vious seizures (excluding febrile convulsions); 25% of these had poor
control requiring increase in anti-epileptic treatment prior to the SE
event. In 17% the SE event was associated with multiple seizures without
documented full recovery inbetween seizures. These cases tended to be
longer than SE with a single convulsive period and associated with signif-
icant delay in administration of rescue medication. Only 25% of cases
was treatment beyond benzodiazepines required to terminate the SE
event. Causes of SE event are febrile illness (44%) or non-febrile infec-
tion in child with epilepsy (8%), poor adherence (8%), suboptimal pro-
phylactic treatment and delayed benzodiazepine treatment were also
common.
Conclusion: Excellent parental education is vital in particular in the fol-
lowing areas: need to always take rescue medication with them, ensuring
understanding on indications for use; prompt treatment of fever with
antipyretics in at risk children and seeking medical attention when suffer-
ing febrile illnesses.
p0410
NONCONVULSIVE STATUS EPILEPTICUS: A 7 YEARS
REVIEW
R. Almendra, V. Espírito Santo, A. Veiga, A. Matas, A.G. Velon,
R. Chor~ao, P. Guimar~aes
Centro Hospitalar de Tras-os-Montes e Alto Douro, Vila Real,
Portugal
Purpose: Nonconvulsive status epilepticus (NCSE) is an under diag-
nosed condition. A high index of clinical suspicion is required to its
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recognition and to perform an electroencephalographic study to establish
a correct diagnosis.
Method: Retrospective study, from 2008 to 2014, of a group of patients
categorized as a nonconvulsive status epilepticus electroclinical diagno-
sis. Medical records were reviewed to analyse age, history of epilepsy,
aetiology, clinical presentation, neurophysiological findings, treatment
and outcome.
Results: 33 patients were identified in a total of 34 episodes of NCSE,
with a mean age of 72.7 years [45–94] and a slight predominance of
females (53%, n = 18). There was a previous history of epilepsy in 30%
(n = 10). The most frequent type of NCSE was the complex partial type
(56%, n = 19) and disturbance of language was the most common neuro-
logical sign. The electroencephalogram showed a predominant hemi-
spheric epileptiform activity in 82% (n = 28) of patients. The most
frequent aetiology was structural vascular lesions (48%, n = 16) fol-
lowed by post-traumatic structural lesions (15%, n = 5). Regarding the
antiepileptic treatment, polytherapy was used in 76% (n = 26) of patients
and at least three antiepileptic drugs was the regimen of 44% (n = 15).
The hospital mortality rate was 35% (n = 12).
Conclusion: This analysis highlights the advanced age of the popu-
lation studied and concordant vascular aetiology. It is also important
to emphasize the use of polytherapy in a high proportion of
patients, and the high mortality. Despite the limitations of this retro-
spective study, the present data are in agreement with published lit-
erature.
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NEUROPROTECTIVE ROLEOFARGANOILAGAINST
THEDEVELOPMENTOF STATUS EPILEPTICUS IN
LITHIUM-PILOCARPINEMODELOFTEMPORAL
LOBEEPILEPSY IN THEWISTARRAT
Y. Bahbiti, H. Ammouri, A. Ouichou, A. El Hessni, I. Berkiks,
L. Bekjdaouene, O. Akhouayri, A. Mesfioui
Ibn Tofail University. Laboratory of Genetics,
Neuroendocrinology and Biotechnology. Unit of Nervous and
Endocrine Physiology. Faculty of Sciences, Biology, Kenitra,
Morocco
Purpose: Temporal lobe epilepsy (TLE) is the most common form of
human epilepsy. Patients with TLE often have a clinical history
including an initial precipitating injury, such as status epilepticus
(SE). In this regard, neuroprotective treatments are considered a
promising therapy for preventing and treating TLE. Thus, being well
known for its physical and chemical composition, particularly vitamin
E, and unsaturated essential fatty acids, we are interested in Argan oil
pretreatment in order to examine the neuroprotective effects on the
development and severity of SE in lithium-Pilocarpine (Li-PC) model
of TLE.
Method: Wistar rats (21 days of age) were gavaged daily with Argan oil
or with NaCl (1 ml/100 g) during 3 months. SE was induced in adult rats
by lithium (3 mEq/kg) followed 18 h later by Pilocarpine (30 mg/kg),
yet it is interrupted by diazepam in all rats. SE severity and Racine stages
are assessed by video-recording.
Results: Pilocarpine injection induces a high mortality rate (40%) and
high frequency of tonic-clonic seizures (stage 5 of Racine) in the control
rats, while pretreatment rats with Argan oil significantly decreased the
index. Indeed, 50% of rats pretreated with Argan oil have shown resis-
tance to develop SE; whereas, all control rats have developed the affec-
tion.
Conclusion: The current study suggests that Argan oil pretreatment is
capable of attenuating seizure severity of Li-PC induced SE. This indi-
cates that Argan oil provides a neuroprotection against the TLE.
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A SERIES OF 30 PATIENTSWITHEPILEPSIA
PARTIALIS CONTINUA
A. Suzen Ekinci, S. Ciftci, A. Guler, A. Yıldız Tabakoglu,
I. Aydogdu, N. Arac, F. Bademkıran, B. Uludag
Ege University Medical Faculty, Izmir, Turkey
Purpose: Epilepsia partialis continua (EPC) is a rare type of localiza-
tion-related motor epilepsy. It is characterised by simple partial motor
seizures, restricted to one part of the body with repetitive regular or irreg-
ular clonic jerks without loss of consciousness. In this study, we want to
discuss etiology,clinical and electroencephalographic characteristics of
EPCwith our patients findings.
Method: Patients diagnosed as EPC were ascertained from medical
records of the hospital for the period 2008–2015. Demographic
datas, affected body parts from seziure,electroencephalographic
(EEG) findings during seizure, pathology on cranial imaging were
analyzed.
Results: We identified 30 patients (16 female,14 male) with EPC. Their
ages ranged between 16 to 82 years. Majority of them had the diagnosis
of malignancy and epilepsia before. Facial and distal limb muscles were
preferentially involved and with other parts, motor seizure on tongue
(n = 5), abdominal muscles (n = 3) and scrotum (n = 1) were also seen.
Focal EEG abnormalities commonly consisted of discrete spikes,sharp
waves or slow-wave activity but there was no ictal activity on EEG in 12
patients. Primary brain tumours and metastasis were main pathologic
findings in our patients but ischemia, gliosis and encephalitis were also
seen on neuromaging.
Conclusion: Although rare, EPC can be seen with a varied causes, and
structural brain abnormality most commonly seen. Generally, localiza-
tion of ictal and interictal activity correlate with body parts where seizure
seen. Sometimes there was no any activity on scalp EEG so clinician
should be alert.
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RISK FACTORS FORRECURRENT STATUS
EPILEPTICUS
A. Coulden*, M. Ahmed†
*Barts and the London, London, UK, †Queen’s University
Hospital, Paediatrics, London, UK
Purpose: The aim of this study was to identify risk factors for multiple
episodes of status epilepticus (SE) among children with either epilepsy,
either pre or post-diagnosed.
Method: Patients attended the emergency department because of SE
were identified by combining ‘seizure’, with ‘Resus’ between the dates
of August 2010– August 2014. Case notes of all eligible patients were
manually analysed. Data included patient’s details, seizure semiology,
epilepsy diagnosis, medications, and causes of SE, fever/infection, and
characteristics of each episode of SE.
Results: 16 patients (9 males; average age = 6.1 years) had recurrent
SE with an overall total of 69 episodes. 7 patients were of ethnic origin
and 6 were known to social services. Of the 16 patients, 12 had febrile
convulsion, 10 had positive FH of epilepsy, 15 had global developmen-
tal delay, 5 had cerebral palsy, 8 had visual difficulties, 2 had hearing
impairment and 1 was within the autistic spectrum. Seizures were gen-
eralised (n = 4), focal (n = 12). Epilepsy diagnoses included symp-
tomatic (n = 11) and idiopathic (n = 5). 15 patients were on
prophylactic AEDs and 14 on rescue AED. Poor compliance was
reported among 3 patients. Average age of 1st SE was 2.6 years and
duration ranged from 30 minutes to 9 hrs. Causes of SE were identified
in 65/69 episodes, including CNS infection (1.5%), metabolic disorders
(5%), recent AED change/ withdrawal (29%) and febrile illnesses
(46%).
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Conclusion: The main risk factors that we have highlighted span from
socioeconomic to therapeutic with specific eminence placed upon ethnic-
ity, febrile illness, neurological abnormality, epilepsy diagnosis, early
age of onset of both seizure and SE and poor seizure control and late initi-
ation of AED treatment being related to higher rates of recurrent SE.
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STATNET EEG, A FASTANDRELIABLEOPTION TO
DIAGNOSENCSE IN EMERGENCY SETTING
L.D. Ladino*, J.F. Tellez-Zenteno†, L. Hernandez-Ronquillo†,
F. Moien-Afshari†
*Hospital Pablo Tobon Uribe, Medellin, Colombia, †University
of Saskatchewan, Saskatoon, Canada
Purpose: The conventional method of EEG lead application could be
time consuming and can only be performed by specially trained person-
nel that are not always available. The StatNet electrode set is a system
that can be applied by non-EEG technologist after minimal training. The
primary objectives of this study are to assess the quality of the recordings
and the ability to detect abnormal findings. Secondary objectives are to
compare the setup duration and time delay from EEG request to start of
acquisition between the StatNet and conventional EEG (cEEG) test.
Method: Over 10 months, 19 patients with suspected NCSE were
included from Saskatoon Royal University Hospital ED, ICU, and hospi-
tal wards. Each patient received a StatNet EEG by minimally trained epi-
lepsy fellow and a cEEG by trained technologists. We compared the two
studies, in a blinded fashion, for the time from EEG order to acquisition,
the setup time, duration of artifact, and detection of abnormal findings.
The nonparametric Mann-Whitney two-sample T-test was used for com-
parisons. The kappa score was used to assess congruence between readers.
Results: Mean age of patients was 61  16(25–93) years (63%
females). The inter-observer agreement for detection of abnormal find-
ings was 0.83 for StatNet EEG and 0.75 for cEEG. NCSE was detected in
10% (2/19) in both studies. The delay from the time of EEG requisition to
acquisition was significantly shorter in the StatNet (22.4  2.5 minutes)
than the cEEG (217.7  44.6 minutes) p < 0.0001. The setup time was
also significantly shorter in the StatNet (9.9  0.8 minutes) compared to
the cEEG (17.8  0.8 minutes) p = 0.0001. Finally, there was no differ-
ence in the percentage of artifact duration between StatNet and cEEG
(42% vs. 39%, p = 0.89).
Conclusion: This study demonstrates that StatNet EEG is a practical and
reliable tool, which reduces the delay of testing compared to cEEG, with-
out significant compromise of study quality.
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WOMENWITHEPILEPSY INMOHAMMEDVI
UNIVERSITYHOSPITALOFMARRAKESH,
MOROCCO
N. Adali, N. Louhab, I. Hajjaj, N. Kissani
Medicine and Pharmacy Faculty, Cadi Ayyad University,
Neurology Department, Mohammed VI University Hospital
Marrakesh, Marrakesh, Morocco
Purpose: The incidence of epilepsy is the same in men and women, but
social and medical issues seem to be different according to gender espe-
cially in developing countries. Few studies were conducted in Arab world
to objective the impact of epilepsy on women. We aimed to describe
social and medical aspects of a series of women with epilepsy (WWE).
Method: Descriptive study among WWE who consulted neurology
outpatient of Marrakesh university hospital in Morocco among
1 year.
Results: Among 161 epileptic patients, 77 were female. Mean age of
WWE was 36.29 years (ranging between 14 and 78 years). 36/77
patients were single whereas 28 were married with mean number of chil-
dren of 4.22 (ranging between 1 and 10). 61.03% of patients were unem-
ployed and 39.2% of them were illiterate. 10% of patients were born
from consanguineous marriage, 15.7% had familial history of epilepsy
and 11.4% febrile seizures. 54.5% had partial epilepsy with predomi-
nance of frontal and temporal lobe epilepsy. Majority of patients had
monotherapy with problems of AED0s compliance due to financial prob-
lems. 4 patients were pregnant under prohibited AEDs. Majority of
patients had depression.
Conclusion: Although there was a great focus on women0s issues in epi-
lepsy in recent time, studies on WWE in Arab and African countries are
still lacking. In this study, we objective social burden of epilepsy on
women with Low household income, high unemployment rate, and low
educational attainment. Serious Health problems in pregnancy and
depressive comorbidity were seen in our patients.
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HORMONAL PATHOLOGY INWOMENOF
CHILDBEARINGAGEWITH JUVENILEMYOCLONIC
EPILEPSY
D. Anisimova*, R. Magzhanov*, P. Vlasov†, V. Petrukhin‡,
S. Vitushko‡, S. Nurmukhametova*, F. Garifullina*
*Bashkir State Medical University, Ufa, Russian Federation,
†Moscow State University of Medicine and Dentistry, Moscow,
Russian Federation, ‡Moscow Regional Research Institute of
Obstetrics and Gynecology, Moscow, Russian Federation
Purpose: To identify the nature of hormonal abnormalities in women of
reproductive age with juvenile myoclonic epilepsy taking anti-epileptic
drugs as mono and polytherapy for over a year and to assess the role of
epilepsy and anti-epileptic drugs in the genesis of hormonal abnormali-
ties.
Method: The study involved 48 women with juvenile myoclonic epi-
lepsy aged 17–35 years and 15 women in the control group, identical in
age and lack of gynecological pathology. Levels of gonadotropins and
sex steroids were defined in the blood serum in the first phase of the
cycle. Progesterone levels were determined in the second phase with a
cycle of 28 days (n = 6). During the study the patients received drugs of
valproic acid 63%, levetiracetam -10.9%, Topamax-8.7%, lamotrigine-
2.2%, and valproate combination with levetiracetam-8.7%, and lamotrig-
ine -6, 5%.
Results: while evaluation of hormonal status in patients a significant
increase in LH levels by 53.2% and testosterone by 61.25% was estab-
lished compared with the control group. In general, patients had an
increase tendency in LH levels with increasing duration of the disease, in
absence of clinical remission by 29%, with irregular cycle by 29%. There
was a tendency of increase in estradiol levels with increasing age of onset
of the disease – by 18.2% and 38.8%, increase in testosterone levels by
54.3%, with irregular cycle, decrease in progesterone level by 4 times
with irregular cycle, and by 67% at polytherapy. In general, the ovaries
dysfunctions were found in 58.7% (n = 27), most often when taking val-
proate -69%.
(n = 20).
Conclusion: endocrine profile in patients with juvenile myoclonic epi-
lepsy statistically is significantly different from healthy women. It
depends on the disease duration, onset of the disease. Influence of anti-
epileptic drugs on the nature and abnormalities frequency was doubtful,
but more often occurred while taking valproate.
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EPILEPSYOF PREGNANTWOMENASAN
INDICATION FORDELIVERYBYOBSTETRICAL
SURGERY
P.S. Bozhinov
Medical University of Pleven, Neurology and Neurosurgery,
Pleven, Bulgaria
Despite the great progress in diagnosis and treatment of epilepsy, the
questions about the way of delivery in pregnant women with epilepsy are
still discountable.
Purpose: To determine the frequency and the main indications for Sectio
Caesarea (SC) in pregnant women with epilepsy (PWWE).
Method: The survey is prospective and covers a period of 16 years
(1997–2012), 283 PWWE are tracked over time during this period.195 of
them got delivery in Risk Pregnancy Clinic of the University Hospital-
Pleven, 77 in other hospitals and for the rest 11 PWWE the pregnancy
finished with abortion. In all the PWWE the etiology and the prescription
of epilepsy, the type and frequency of the seizures were clinically deter-
mined. EEG records, ultrasound of fetus and cardiotocograph monitoring
were made.
Results: The frequency of SC for the whole group is 33.83%. Partus
Normalis (PN) is assessed in 65.07% and vacuumextractio and forceps
(VE/F) - in 1.10%. In PWWE who got delivery in Pleven the frequency
of SC is 38.46%, PN - 60.00% and VE/F - 1.54%. In 76 cases with deliv-
ery by SC for 56 the indications were obstetrical and in 19 (25.33%) the
major indication was epilepsy. It was the main indication for SC for preg-
nant women with frequent and pharmacoresistant epileptic seizures.The
higher frequency of SC in PWWE who got delivery in the University
Clinic is explained by the fact that the most complicated cases are con-
centrated there.
Conclusion: The good collaboration between the neurologist - epilep-
tologist and the obstetrician, planning and supervising the delivery of
PWWE, may contribute to the selection of the most appropriate way
of delivery, leading to a favorable outcome for the mother and the
newborn.
Keywords: Epilepsy, pregnancy, delivery, Sectio Caesarea, Partus
Normalis
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HYPERTENSIVE DISORDERS IN PREGNANTWOMAN
WITHEPILEPSY
P.S. Bozhinov
Medical University of Pleven, Neurology and Neurosurgery,
Pleven, Bulgaria
Purpose: To determine the frequency and the course of hypertensive dis-
orders in pregnant women with epilepsy (PWWE).
Method: The survey is prospective and covers 206 PWWE during the
period 1997–2012 year, monitored and treated in Risk Pregnancy Clinic
of University Hospital - Pleven. All the patients (PWWE) are with clini-
cally established etiology and prescription of epilepsy, type of seizures
and their frequency. EEG records, ultrasound of fetus and car-
diotocograph monitoring were conducted. Eleven of PWWE were with
Praeeclampsia - Eclampsia (PE-Ecl).
Results: The frequency of PE-Ecl is 5.33%. Praeeclampsia and Eclamp-
sia were found (monitored) during two consecutive pregnancies in one of
the PWWE. Six patients were with severe Praeeclampsia and one of them
was with data of HELLP syndrome. There were three cases with Eclamp-
sia. Delivery by surgery was made in 8 cases, (7 patients, but for one of
them twice). The other 4 pregnant women with moderate Praeeclampsia
got delivery per vias naturales. Epileptic seizures during pregnancy were
recorded for 5 of PWWE. One patient was with generalized clonic-tonic
seizures and 4 other were with partial seizures. During the period
24 hours after delivery seizures were noted for 4 patients. Six PWWE
were without therapy with antiepileptic drugs (AED). Three of them
started monotherapy with AED during pregnancy. One other patient with
pharmacoresistant symptomatic epilepsy (meningiomas of the brain with
two neurosurgical operations) was on polytherapy with 3 AED during the
whole pregnancy. The EEG study showed focal activity predominantly
occipital, occipito-temporal and parieto-occpital.
Conclusion: The detection of arterial hypertension and proteinuria in
PWWE should focus attention on PE-Ecl. The united active clinical mon-
itoring and treatment by a neurologist-epileptologist and obstetrician is
the most accurate clinical behavior.
Keywords: Epilepsy, pregnancy, preeclampsia-eclampsia, AED
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EPILEPSYANDREPRODUCTIVEHEALTH: AFRICAN
COHORT
S.M.L. Dadah*, M. Ndiaye†, M.S. Diop†, L.B. Seck†,
A.G. Diop†, M.M. Ndiaye†
*University of Nouakchott, Nouakchott, Mauritania, †University
Cheikh Anta Diop, Clinique Neurologique de FANN, Dakar,
Senegal
Purpose: Epilepsy is a public health problem in Senegal and Africa
because of its severity and its social importance. It occurs at any age spar-
ing no sex. It can influence the sexual life and vice versa. The objective
of this work is to study the effects of antiepileptic drugs on the sex lives
of women with epilepsy, the influence of these drugs on pregnancy and
when breastfeeding.
Method: This prospective study was conducted in the month of
March in the month of August 2011 in the neurological clinic teach-
ing hospital Fann Dakar Senegal and is directed only at women with
epilepsy.
Results: We collected, 120 patients aged 16–64 years with a mean age
of 30.58 years, 45%married, 44.16%were uneducated preponderant. All
patients were taking antiepileptic drugs, 89 16% was alone. 55% of our
patients had epilepsy for at least 6 years. 45.83% had generalized epi-
lepsy, 44.17% of partial seizures. In our cohort, 64.16% were under phe-
nobarbital, 69.16% had good adherence. As side effects of drugs 90%
had sexual problems. 75% enjoyed an active sex life, was noted a
decrease in the number of sex per week for the disease [31/
55 = 56.66%]. In addition, 51.17% were using contraception, including
38.7% of oral kind. 64.86% had noticed an increase in seizure frequency
during their pregnancies. Of the 74 women who had contracted a preg-
nancy, 41.89% had premature infants, 16.21% have made abortions.
61.17% had psychosocial life affected.
Conclusion: People with epilepsy often experience sexual problems that
may be caused by epilepsy, antiepileptic and / or reactions of the partner
and the other facing the diagnosis of epilepsy.
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EVALUATINGHYPOTALAMO-HYPOPHYSEAL
FUNCTIONUNDERTREATMENTVALPROATAND
CARBAMAZEPINE THERAPY INWOMENEPILEPTIC
PATIENTS
F.F. Erdogan*, H. Sacmacı*, H.K. S€onmez*, K. €Unlühızarcı†,
F. Keleştemur†
*Erciyes University, Neurology, Kayseri, Turkey, †Erciyes
University, Endocrinology, Kayseri, Turkey
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Purpose: To determine the association of long-term valproate and carba-
mazepin therapy with reproductive endocrine disorders in women with
generalized or parsiyel epilepsy.
Method: Clinical parameters, ovarian morphology, and serum reproduc-
tive hormone concentrations were evaluated in 25 clinically normal and
52 reproductive age women with epilepsy who were newly initiated on
valproate or carbamazepine therapy. Longitudinal evaluations were done
in these women after 1 year of therapy.
Results: Of the 43 women who completed 1 year follow-up, we
observed clinically relevant weight gain in 40%, hirsutism in 20%, men-
strual abnormalities in 30%, polycystic ovaries (PCO) in 20%, polycys-
tic ovarian syndrome (PCOS) in 20%, and a significant increase in
mean serum testosterone (p = 0.046). A significant positive correlation
existed between weight gain and the development of menstrual abnor-
malities (r = 0.66, p < 0.0001), hirsutism (r = 0.53, p = 0.006) and
PCO (r = 0.51, p = 0.012). Yearly follow-up for next 1 year in some of
these women revealed persistence of menstrual abnormalities, hirsutism
and PCO, a significant linear increase in mean body weight, body mass
index, and serum testosterone concentrations, and an increase in serum
LH levels. This study will complete after 5 patients utilized test of mes-
truel hormones and this results will be able to change at the end of
study.
Conclusion: Long-term valproate and carbamazepine therapy in women
with epilepsy is associated with development of hirsutism, significant
weight gain, stable or progressive alterations in reproductive hormonal
function, and ultimately a higher occurrence of PCOS. Researchers
should collaborate to develop interventions treatments that incorporate
reproductive considerations.
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CATAMENIAL EPILEPSY
F. Genc*, A. Erdal*, E. Uygur*, Y. Bicer G€omceli*, G. Kutlu†
*Antalya Research and Training Hospital, Neurology, Antalya,
Turkey, †Mugla SK University School of Medicine, Neurology,
Mugla, Turkey
Purpose: Catamenial epilepsy is characterized by an increase in seizures
during particular phases of the menstrual cycle. Reproduction hormones
decrease the seizure threshold in women with epilepsy. It was reported
that seizures get worse with puberty and menarche in about 1/3 of women
with epilepsy.
Method: In this study; 1140 patients who were followed in Epilepsy
Department of Antalya Training and Research Hospital were examined
retrospectively. Increases which epileptic female patients aged between
15–45 in fertility period experienced in menstrual period, in seizure fre-
quency were examined.
Results: Total 368 female patients were in reproductive age. Informa-
tion of 1 patient was not obtained. 74 (20.1%) of these patients were
catamenial epilepsy patients. Age average of patients was 29.04 
0.8, average epilepsy duration was 17.38  1.008. Of the patients, 49
(66.2%) patients were partial-onset epilepsy patients, 14 (18.9%)
patients were generalized epilepsy, 9 (12.2%) patients were unclassi-
fied and 2 (2.7%) patients were syndromic patients. While 31 of
patients (41.9%) were taking monotherapy, 43 patients (58.1%) were
taking polytherapy. 43 patients (58.1%) were married, 31 of which
(41.9%) were not married. There was no statistically significant dif-
ference between catamenial epilepsy patients and other female
patients in reproductive age in terms of the age and marital status dis-
tribution.
Conclusion: It is reported that catamenial seizures are seen in about 12%
of female with epilepsy. It was shown that there is a relation between
ovary hormones and neuronal hyperexcitability. It was reported that
estrogens decrease epilepsy threshold, progestin shows protective impact
on seizures.
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TWORARECASESOFMAJORCONGENITAL
MALFORMATIONSWITHLEVETIRACETAMUSE IN
PREGNANCY
A. Haldar*, S. Saha†, G. Guha‡
*Fortis Hospital, Neurology, Kolkata, India, †Fortis Hospital,
Pediatrics, Kolkata, India, ‡NRSMedical College, Neurology,
Kolkata, India
Purpose: Levetiracetam is considered to be one of the safest antiepilep-
tics in pregnancy .Based on the available pregnancy registry data, the risk
of a major congenital malformation(mcm) with Levetiracetammonother-
apy is 0.7%.(Confidence Interval 0.19%-2.51%).We attempted to look at
the mcm rate with Levetiracetammonotherapy at our centre.
Method: This was a retrospective study and included women with
monotherapy of Levetiracetam during pregnancy. Patients on Levetirac-
etam polytherapy were not included.Patients with other co-morbid ill-
nesses or addictions which could lead to malformations were also
excluded.
Results: Out of 60 pregnancies with Levetiracetam,there were two cases
of mcm.One baby was born with anencephaly. The diagnosis in this case
was made antenatally in the 3rd trimester by ultrasound examination.
The parents decided to continue with the pregnancy and the baby died
shortly after birth. The second baby was born with duodenal atresia .The
diagnosis in this case was made with both clinical and ultrasound exami-
nation after birth. The baby underwent surgery in the neonatal period and
survived.There were ten cases of low birth weight.No major cardiac mal-
formation or skeletal malformation were reported.
Conclusion: Major congenital malformations with Levetiracetam are
exceedingly rare.Animal experiments suggested that they may be skele-
tal,while pregnancy registry reported it to be mainly cardiac. These were
one of the first cases to show neural and gastrointestinal tract malforma-
tions with Levetiracetam. Based on these findings, we suggest that more
studies are needed before recommending Levetiracetam as a safe anti
epileptic in pregnancy.
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DELIVERYOUTCOMES INWOMENWITHEPILEPSY
IN BRITISHCOLUMBIA
K. McIntosh, P. Janssen
University of British Columbia, School of Population and Public
Health, Vancouver, Canada
Purpose: The objective of this study is to compare rates of cesarean sec-
tion delivery and induction of labour among women with and without
epilepsy in British Columbia.
Design/methods: 545 women identified in the British Columbia Perina-
tal Data Registry as having epilepsy or convulsions at labour admission
were compared to 545 women identified as not having epilepsy at labour
admission who gave birth between 1/1/2000 - 31/12/2010.
Results: Women with epilepsy were significantly more likely to require
a cesarean delivery compared to women without epilepsy (30.8% vs.
19.3%; OR, 1.87; 95% CI, 1.41–2.47). In women with epilepsy who had
cesarean deliveries, the most prevalent indication for delivery was
“Other” (31.6% vs. 7.6%). Induction of labour was more likely to occur
in women with epilepsy compared to women without epilepsy (31.3% vs.
21.8%; OR, 1.63; 95% CI, 1.19–2.24) with the most common indication
listed as “Maternal condition” (36% vs. 19.8%). Compared to women
without epilepsy, women with epilepsy were more likely to receive
epidural anesthesia when delivering vaginally (36.9% vs. 23.6%; OR,
1.89; 95% CI, 1.41–2.47), more likely to have assisted vaginal delivery
(21.5% vs. 11.1%; OR, 1.83; 95% CI, 1.23–2.74) and more likely to
receive general anesthetic during cesarean delivery (12.5% vs. 3.8%;
OR, 3.61; 95%CI, 1.20–10.82).
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Conclusion: The most frequently given indication for delivery was
“Other” In women with epilepsy who had cesarean deliveries. The most
frequently listed indication in women with epilepsy for induction of
labour was “Maternal condition”. Epilepsy is not an indication for
induction or for cesarean delivery, however, seizures are. Still, a review
of the literature suggests that <2% of women with epilepsy experience
a seizure during labour. Health care providers and patients need to be
counselled surrounding this issue and encouraged to pursue normal
birth.
Adult Epileptology 4
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CLINICALANDEEGFINDINGSOFROTATORY
EPILEPSY
A.D. Yalcin, U.A. Kelleci, Y. Diler, T. Dogan
Umraniye Education and Research Hospital, Umraniye, Turkey
Purpose: In this report two patients with rotatory epilepsy were evalu-
ated retrospectively in terms of their clinical, EEG findings, aetological
features and response to treatment.
Case: The first patient is 26 years old female suffering from rotatory
seizures for 10 years. When she was admitted to our epilepsy-outpati-
ent department she had totally eight seizures characterized by deviation
of the head and eyes to the right side followed by one complete clock-
wise turn without loss conscious but evolved to be generalized tonic-
clonic seizure every time. Her video-EEG monitoring showed general-
ized spike and wave discharges lasting one-two seconds and none of
them was associated with absences. She was followed for 10 years
under lamotrigine treatment and remained seizure free. The second
patient is thirty 2 years old male with rotatory seizures for 2 years.
His seizures started with forced deviation of head and eyes to the right
side followed by complete turns without disturbing of conscious and
ended with generalized tonic-clonic seizure. He had only three seizures
before treatment. His video-EEG monitoring revealed generalized
spike and wave discharges. After 1 year levetiracetam treatment, his
seizures ended like the first patient. The cranial MRIs of both patients
are normal.
Result: Both patients were seizure free when treated with adequate anti-
convulsive medications.
Conclusion: Although rotatory seizures are uncommon and occur
mainly secondary to a focal intracranial pathologies, this type of seizure
is also described in patients with primary generalized epilepsies like our
patients.
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ANTI-GADMEDIATEDDRUGRESISTANTEPILEPSY:
A CASEREPORT
A. Kiryttopoulos*, G. Karafylles*, M. Spilioti*, V. Kimiskidis†,
I. Kalevrosoglou‡, D. Panou†, H. Alexopoulos§, S. Akrivou§
*Aristotle University of Thessaloniki, 1st Department of
Neurology, AHEPA Hospital, Thessaloniki, Greece, †Aristotle
University of Thessaloniki, Laboratory of Clinical
Neurophysiology, AHEPA Hospital, Thessaloniki, Greece,
‡Aristotle University of Thessaloniki, 1st Propaedeutic
Department of Internal Medicine, AHEPA Hospital,
Thessaloniki, Greece, §University of Athens, Medical School,
Neuroimmunology Unit, Department of Pathophysiology,
Athens, Greece
Purpose: We present the case of a patient with immune-mediated
drug resistant epilepsy and very high titers of antibodies against gluta-
mate decarboxylase (GAD-Abs) and we discuss the therapeutic man-
agement and outcome. Antibodies against glutamate decarboxylase
are associated with neurological disorders such as stiff-person syn-
drome, refractory epilepsy, cerebellar ataxia and most recently with
limbic encephalitis characterized by temporal lobe epilepsy, neuropsy-
chological deficits and neuroimaging findings in the medial temporal
lobes.
Method: We describe the case of a 44 year old female patient who
developed refractory temporal lobe epilepsy, impairment of recent mem-
ory, Hashimoto’s thyroiditis and vitiligo. Brain MRI showed abnormal
T2 signal in the mesial temporal lobes bilaterally. The EEG showed
bitemporal focal slowing and epileptiform discharges. Thorough radio-
logical investigations, tumor blood markers and paraneoplastic antibod-
ies (anti-Hu, Yo, Ri, Ma2/Ta, CV2, amphiphysin) were all negative. The
immunological screening (NMDAR, LGI1, CASPR2, GABAb1R,
AMPA1R, AMPA2R, GAD) revealed extremely high GAD-Abs titers in
serum and CSF (4.161.678 U/ml and 591.108 U/ml respectively) with
the presence of oligoclonal bands in CSF.
Results: Due to the high titer of GAD-Abs, the patient underwent 10 ses-
sions of plasma exchange followed by an oral treatment with prednisone
that led to neuropsychological and EEG improvement, reduction of sei-
zures and a significant decline in GAD-Abs titers.
Conclusion: The patient belongs to the subgroup of patients with anti-
GAD limbic encephalitis and associated epilepsy with a good response to
plasma exchange. The administration of steroids, IVIg and plasma
exchange have shown varied efficacy while monoclonal antibodies may
be a future therapeutic approach. However there are no established thera-
peutic guidelines. In our case, the reduction of seizures and the improved
neuropsychological deficits were related to the decrease of the GAD-Abs
titer.
p0434
PREGNANCYOUTCOME INGENETICGENERALIZED
EPILEPSIES ONVALPROATE TREATMENT
G.A. Kiteva-Trenchevska
University Clinic of Neurology, Clinical Neurophysiology,
Skopje, the Former Yugoslav Republic of Macedonia
Purpose: The aim is to evaluate the pregnancy outcome in genetic gener-
alized epilepsies (GGE) treated with VPA during pregnancy.
Methods: 41 pregnant women with GGE on age 17–35 years gave birth
to 57 newborns.
Results: Out of these 57 newborns there was one female newborn
with meningomyelocela in lumbal spinal region. This was the second
pregnancy of the mother who gave birth to 3 single newborns while
taking VPA 900 mg per day during her first pregnancy with 5 mg
folan supplementation, and 600 mg per day during her second and
third pregnancy with 0.4 mg folan supplementation. There were 3
spontaneous abortions, one in second pregnancy of a woman who
gave birth to healthy newborn, at her age of 17, but after her divorce
became noncompliant to VPA with uncontrolled seizures. Her second
pregnancy ended with spontaneous abortion in the second month of
pregnancy. The other 2 abortions happened subsequently in the same
woman while she was on combination of VPA and TPM, but with
VPA monotherapy she gave birth to two single healthy newborns in
the following years. Her EEG helped for correct diagnosis of GGE
instead of focal epilepsy of unknown cause. As to the development of
children in the following years after birth there is one child with
ADHD of a mother taking VPA and TPM during pregnancy who gave
birth to 2 healthy newborns. There is a finding of major malformation
in newborn while his pregnant mother was on phenobarbiton, and a
healthy newborn and child from her second pregnancy while on VPA
and 5 mg folan supplementation.
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Conclusion: Despite a small number of findings that suggest that other
factors except pharmacotherapy are involved in pregnancy outcome,
there is a need for more detailed and individual approach in evaluating
women with epilepsy and pregnancy outcome.
p0435
PREDICTORSOFRESPONSE IN PATIENTSWITH
EPILEPSY INADOUBLE-BLIND, PLACEBO-
CONTROLLED STUDYOF BRIVARACETAM
P. Klein*, P. Doty†, S. Elmoufti†, J. Whitesides†, M. Gold†
*Mid-Atlantic Epilepsy and Sleep Center, Bethesda, MD, USA,
†UCB Pharma, Raleigh, NC, USA
Purpose: A study of patients with inadequately controlled partial-onset
(focal) seizures found that 100 and 200 mg/day brivaracetam was well
tolerated and led to statistically significant reductions in seizure fre-
quency (Klein et al. AES 2014, abstract 2.417). This post-hoc analysis
was intended to identify factors that may predict response to brivarac-
etam. Predictors identified for response to brivaracetam were also evalu-
ated for placebo to determine if there were common predictors.
Method: Patients taking 1–2 antiepileptic drugs (AEDs) enrolled in a
prospective, double-blind, placebo-controlled Phase III study
(NCT01261325) comprising 8-week screening and 12-week treatment
period, were categorised by response (100%, 90%, 80%, 75%, 60%, 50%
reduction in seizure frequency from baseline). Relationship between
response and various predictor variables (brivaracetam dose, epilepsy
duration, age, gender, classification of epileptic syndrome, aetiology, sei-
zure profile, historical seizure frequency, baseline seizure frequency,
prior AED count, inducer status, prior levetiracetam use at entry, con-
comitant AEDs and region) was examined using a logistic regression
model.
Results: Among brivaracetam responders, statistically significant pre-
dictors were: lower historical seizure frequency for 100%, 90% and 80%
responders; lower prior AED count for 90%, 80%, 75%, 60% and 50%
responders; and lower baseline seizure frequency for 75%, 60% and 50%
responders. Among placebo-treated patients, due to low sample size or
the potential of extreme splits on frequency distribution of either depen-
dent or independent variables, the model fit was questionable for 100%,
90% and 80% responder rates. Both lower prior AED count and negative
inducer status were found to be statistically significant predictors for the
75% and 60% responder rates.
Conclusion: Historical seizure frequency and prior AED count were sig-
nificant positive predictors of response in patients receiving brivarac-
etam, which is not unique among AEDs. Prior AED count was also
predictive of placebo response, the only predictor common to both bri-
varacetam and placebo responders.
UCB supported.
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STRESS-SENSITIVITYOF SEIZURES INFLUENCES
THERELATIONSHIP BETWEENCORTISOL
FLUCTUATIONS AND INTERICTALEPILEPTIFORM
DISCHARGES IN PEOPLEWITHEPILEPSY
E.L. Hompe*,†, J. van Campen†,‡, D. Velis§, W. Otte‡, F.
van der Berg§, F. Jansen‡, K. Braun‡, G. Visser§, J. Sander§,
M. Joels‡, M. Zijlmans‡
*SEIN – Stichting Epilepsie Instellingen Nederland, Heemstede,
Netherlands, †Equal Contributions, Heemstede, Netherlands,
‡University Medical Center Utrecht, Utrecht, Netherlands,
§SEIN – Stichting Epilepsie Instellingen Nederland, Heemstede,
Netherlands
Purpose: People with epilepsy often report seizures precipitated by
stress, which possibly results from effects of stress hormones on neuronal
excitability and seizure threshold. Stress hormones are released in a cir-
cadian rhythm with additional hourly pulses. The effect of these ultradian
hormone level peaks on epileptic activity is unknown.We expected that
(1) stress hormone levels correlate with the incidence of epileptiform
abnormalities in the electroencephalogram (EEG), and
(2) this relationship is stronger in people with stress-precipitated sei-
zures.
Method: We included people with pharmaco-resistant localization-
related epilepsy who were admitted for long-term video-EEG monitor-
ing. Cortisol levels were measured in saliva samples obtained every
15 minutes for five hours, starting directly after awakening, on one or
2 days. The incidence of interictal epileptiform discharges (IEDs) was
determined for the same periods. We compared cortisol levels to the inci-
dence of IEDs per patient and on group-level. We analyzed the effect of
individual, epilepsy and recording characteristics, including self-reported
stress sensitivity of seizures, on the strength and direction of this relation.
Results: Twenty-nine recordings were performed in twenty-one people.
Overall, cortisol levels showed a significant positive relationship with
the incidence of IEDs (b = 0.11, p = 0.046). On an individual basis both
positive and negative correlations occurred. In multivariable analysis, the
relationship between cortisol and IEDs was positively associated with the
self-reported stress sensitivity of seizures (b = 0.32, p = 0.005), and not
with other individual, epilepsy or recording characteristics.
Conclusion: The relationship between cortisol levels and the incidence
of IEDs suggests that stress hormones may influence the occurrence of
IEDs as biomarkers of epilepsy, also under basal conditions. Self-
reported stress sensitivity of seizures partly explains individual differ-
ences in this relationship, which provides indirect proof for the existence
of a pathophysiological basis for this subjective phenomenon.
p0444
THE EFFICACYOFADD-ON THERAPYANDTHE
COGNITIVE FUNCTIONOF PATIENTSWITHDRUG-
RESISTANT PARTIAL EPILEPSY TREATEDWITH
TIAGABINE - OBSERVATIONAL STUDY
I. Halczuk*, A. Lipa†, K. Szewczyk-Mitosek*, P. Sobolewski‡,
Z. Stelmasiak*, J. Kaczynski†
*Medical University of Lublin, Neurology, Lublin, Poland,
†Teva Poland, Warsaw, Poland, ‡Hospital in Sandomierz,
Neurology, Sandomierz, Poland
Purpose: The purpose of the study was to assess the efficacy of tiagabine
as add-on therapy in patients with drug-resistant, partial epilepsy, and to
assess the patient’s cognitive functions, when used in everyday clinical
practice.
Method: Multicenter, open-label, single arm, observational study per-
formed in Q1 2013-Q2 2014 in Poland (3 visits: V0 - upon enrolment of
the tiagabine-treated patients into the study, V1 -4 weeks after reaching
the initial dose of tiagabine, V2 -4 weeks after reaching the target dose of
tiagabine). Patients (n = 437) with drug-resistant partial epilepsy, treated
with tiagabine as add-on therapy at a dose of 15–50 mg per day were
observed. The type and number of seizures, antiepileptic therapy used,
auxiliary therapy and adverse effects were analysed. The McNemar’s,
Wilcoxon’s and Fisher’s tests were used. The patients’ cognitive func-
tions were assessed using theMMSE scale.
Results: The mean observation time was 90 days. About 80% of the
patients took valproic acid and carbamazepine before adding tiagabine.
The percentage of patients experiencing epileptic seizures was reduced
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from 72.2%: between V0-V1 to 58.7% between V1-V2, (p < 0.001). A
reduction was observed in the average number of seizures (V1-V2: by an
average of 2.9 in the 18-39 years age group, by 1.6 in the 40-59 age group
and by 2.1 for patients above 60 years for age, p < 0.001). The propor-
tion of patients without seizures increased from 9.6% (V0) to 41.5%
(V2), p < 0.001. Adverse events occurred in 4 (0.9%) patients. The Mini
Mental State Examination (MMSE) was performed in 25% of patients.
Cognitive functions did not deteriorate (an average 22.6 points (V0) and
23.6 (V2), p = 0.19). The average MMSE score corresponded to a mild
level of cognitive impairment.
Conclusion: Tiagabine is a well-tolerated drug, effective in controlling
partial seizures, showing no unfavourable effect on cognitive functions.
p0446
MALFORMATIONSOFCORTICALDEVELOPMENT
ANDEPILEPSY: A COHORTOF 150 PATIENTS IN
WESTERNCHINA
W. Liu
West China Hospital in Sichuan University, Chengdu, China
Purpose: Malformations of cortical development (MCDs) are increas-
ingly identified as important etiology for refractory epilepsy. Little is
known about the spectrum, distribution and clinical features of MCDs,
especially in a resource-limited region. This study investigates the distri-
bution of MCDs and compares the clinical features and long-term prog-
nosis among three subtypes and between simple and multiple forms in a
cohort of Chinese patients.
Method: Consecutive 150 epilepsy patients with radiologically con-
firmed MCD were included from a tertiary epilepsy center in western
China. Patients were divided into three subtypes according to the
scheme of Barkovich. Distribution of MCDs was presented and com-
parison of the clinical features and long-term prognosis were made
among three subtypes and between simple and multiple forms in Chi-
nese patients.
Results: The mean age was 23, female 47%. The most common type of
MCD is focal cortical dysplasia, followed by heterotopias, polymicrogyr-
ia, schizencephaly and pachygyria. Comparing the three groups, we
found pre-perinatal insults more common in Group3 patients. Further-
more, we identified multiple malformations in 36/150 patients. Patients
in the multiple group had higher rates of delayed milestones, cognitive
impairment and neurological deficits. Extra-temporal epilepsy was more
commonly seen. They were younger at the seizure onset and at assess-
ment, also had worse outcomes comparing to the simple group. Patients
with heterotopias were more commonly associated with other abnormali-
ties.
Conclusion: Malformations of cortical development are important
causes for drug-resistant epilepsy, also a big challenge for resource-lim-
ited countries. Imaging techniques are crucial in diagnosing and classify-
ing cortical deformities. Multiple malformations (combined with other
cortical or cerebral malformations) lead to more severe clinical features
and poorer prognosis.
p0447
BURDENS INWORKINGFOREPILEPSY PATIENTS IN
JAPAN
T. Mitsueda-Ono, T. Ishimoto, S. Minamiyama, M. Tojima,
G. Murakami, M. Matsui
Otsu Red Cross Hospital, Neurology, Otsu, Japan
Purpose: For epilepsy patients of the adulthood, working is one of the
important elements in point of getting worth doing and means to become
independent socially. We examined problems bearing upon working epi-
lepsy people.
Method: Subjects were patients who visited to our department from
April 2013 to March 2014. We investigated the epilepsy patients who
were working, about clinical information and working situation.
Results: 170 people (male: 97, female: 73) corresponded to working-age
population (15~64 year) among 260 epilepsy patients who visited our
department during this period (male: 146, female: 114). 105 patients were
employees (61.4%), 43 patients were non-employee (25.0%), and 23
(13.0%) patients were unclear. In terms of the occupational category, 11
patients (10.5%) were working in service or production process, 13
(12.4%) in businesslike occupations, and 17 (16.2%) in specialized tech-
nical occupations, respectively. In aspects of seizure control, 74 (43.5%)
patients obtained seizure free more than 2 years. 48 (28.2%) patients had
yearly seizure, and 25 (14.7%), 9 (5.3%), 8 (4.7%) patients had monthly,
weekly, and daily seizure, respectively. However, the employment rate
(66.7~84.0%) did not relate with the seizure frequency. In the patients
who developed their epilepsy after starting the work, five patients (4.7%)
were drivers, four patients (3.8%) were engaged in the shift work includ-
ing the night duty, and three patients (2.9%) were on the dangerous duties
in high places. After the onset of epilepsy, five patients could continue to
work by changing the position, but five patients resigned because of epi-
lepsy.
Conclusion: Epilepsy patients could find work regardless of their seizure
control; however sometimes need to work under appropriate considera-
tion. The transfer in the workplace might be difficult and result in quitting
a job. We should be conscious of the necessity for living guidance and
planning prescription along the working situation of each patient.
p0448
PERINCAT: EXPERIENCEWITH PERAMPANEL IN
CATALONIA
M. Gonzalez Cuevas*, J. Miro†, P. Esteve‡, D. Muriana§,
M. Jiménez¶, M. Toledo*, X. Salas-Puig**, M. Falip†,
J.L. Becerra††, J.J. Baiges‡, P. Fossas§, P. Millet‡‡,
A. Quílez§§, T. Casadevall¶¶, A. Molins***
*Hospital Vall d’Hebron, Neurology, Barcelona, Spain,
†Hospital de Bellvitge, Neurology, Barcelona, Spain, ‡Hospital
Verge de la Cinta, Neurology, Tortosa, Spain, §Hospital de
Mataro, Neurology, Mataro, Spain, ¶Hospital de Granollers,
Nurology, Granollers, Spain, **Hospital Vall d’Hebron,
Neurology, Barcelona, Spain, ††Hospital Germans Trias i Pujol,
Neurology, Badalona, Spain, ‡‡Consorci Sanitat Integral,
Neurology, Hospitalet del Llobregat, Spain, §§Hospital Arnau
de Vilanova, Neurology, Lleida, Spain, ¶¶Corporacion de Salut
del Maresme i la Selva, Neurology, Calella, Spain, ***Hospital
Dr. Josep Trueta, Neurology, Girona, Spain
Purpose: To describe clinical experience with perampanel (PER) as
regards efficacy and tolerability in a series of patients with refractory par-
tial-onset epilepsy.
Method: Multicenter, retrospective, observational study developed in
several centres in Catalonia. Patients received PER because of parcial
onset pharmacoresistant epilepsy or side effects in previous antiepileptic
treatment according to clinical practice. Results at 6 months are
presented.
Results: PER was administered to 128 patients. Only 78 of the were suit-
able to 6 month analisis. The main reason to add PER was lack of control
of seizures in 97.4%. The mean seizure count in the previous year was
12.1 (1–40) per month and the previous num¡ver of antiepileptic drugs
used was 6.3 (2–15). The mean dose of PER used was 6.3 mg (2–12).
Retention rate was 82.1 and 70.5% at 3 and 6 months. The seizure-free
patients were 6.5% and 29.9%were responders.
Seizure reduction was significant at 3 months in complex partial
seizures (p < 0.001) but not between 3 and 6 months, and secondary
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generalized seizures (p = 0.006). Concomitant use of non inducers dis-
closed an improvement in efficacy. Adverse events (AE) were reported
in 69.2% of patients, leading to PER withdrawal in 19.2%. The main AE
were dizziness (35.9%), somnolence (24.4%) fatigue (12.8%) and irri-
tability (10.3%).
Conclusion: PER in clinical practice, at 6 months and in a highly resis-
tant population shows an efficacy similar to that disclosed in clinical tri-
als and a high retention rate. Efficacy seems to be shown already at
3 months.
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FOCALEPILEPSIESWITHVISUAL SYMTOMS
N. Okujava*, A. Tsereteli†
*Tbilisi State Medical University, Neuromedicine, Tbilisi,
Georgia, †S.Khechonashvili University Hospital, SEIN - SKUH
Epilepsy Centre, Tbilisi, Georgia
Purpose: Visual symptoms as ictal manifestation are often neglected by
patients, or misdiagnosed by physicians. Aim of this study was to analyze
etiology, semiology and diagnostic pitfalls in patients with focal epilepsy
with visual signs.
Method: Retrospective review of patients referred to our centre in years
2013–2014 was carried out. Inclusion criteria: verified diagnosis of focal
epilepsy with visual signs. Clinical, EEG and MRI data, along with time
span from first clinical manifestation to correct diagnosis were taken into
consideration.
Results: 22 patients, 10 males and 12 females were included into the
study. Age range: 11 - 74 years. Seizures were presented with elementary
visual hallucinations (EVH) in 14 patients and with complex visual hallu-
cinations (CVH) in 8 patients. Distribution of interictal spikes and/or
slowing on standard EEGwas: 8- occipital, 9-mixed occipital and tempo-
ral, 4 -mixed occipital and parietal, 1 -mixed occipital and frontal.Com-
plex visual hallucinations correlated with mixed focal distribution of
interictal spikes and slowing on EEG, as well as with false psychiatric
diagnosis. Structural changes on MRI were established in 8 cases, in 14
patients MRI remained normal. Diagnosis by the time of reference was:
12 cases - secondarily or primary generalized tonic-clonic seizures, psy-
chiatric disorder - 4 patients, migraine - 2 cases and 4 patients remained
without diagnosis. Time span to correct diagnosis varied between
3 months and >30 years (mean 6.75 years). Only 2 patients received
antiepileptic treatment, 12 received other medication but anticonvulsants
and 8 stayed without any treatment.
Conclusion: Neglecting importance of visual symptoms for diagnosis of
focal epilepsy may lead to long lasting diagnostic and treatment failure
with serious medical and social cosequences.
p0452
EVALUATIONOFBALANCEANDGAIT
ABNORMALITIES IN REFRACTORYEPILEPSY:
COMPARISONWITHREMISSION EPILEPSY
Ö.Önder*, R.R. Bilgin*, B. D€onmez Balcı†, N. Kahyaoglu*
*Izmir Bozyaka Educational Research Hospital, Neurology,
Izmir, Turkey, †Dokuz Eylül University, School of Physiotherapy
and Rehabilitation, Izmir, Turkey
Purpose: Falls due to seizures and related complications are well known.
Problems of balance and gait unrelated to seizures constitute a distinct
area of interest. The aim of this study is to evaluate abnormalities of bal-
ance and gait and to estimate the risk of falling in epileptics.
Method: One hundred and four patients are classified in two groups:
Treatment-resistant epilepsy(TRE) and remission epilepsy(RE). All
patients were applied Tinetti Balance and Gait Scale(TBGS) and Falls
Efficacy Scale(FES). Afterwards, they completed Modified Clinical Test
of Sensory Interaction on Balance, Walk Across, Tandem Walk, Step/
Quick Turn, Limits of Stability tests in BalanceMaster systems.
Results: There were 54 patients in TRE, 50 in RE group. Groups were
compatible for age, sex, body mass indexes. The scores of standing eyes
open and on a foam surface eyes open, speed of tandem walk, degree of
swing to the right, reaction time, movement velocity, endpoint and maxi-
mum excursion, directional control tests were markedly abnormal in
TRE group by comparison to RE group(p < 0.05). Negative correlations
were found between TBGS and seizure types, duration and number of
antiepileptic medications. Correlations between diversity of seizure types
and FES score; age at onset of disease and eyes open balance were posi-
tive. Accordingly, the correlation between Short Test of Mental Status
(STMS) and reaction time towards a target was negative.
Conclusion: Our results point that the abnormalities of balance and gait
are related not only to the frequency and total number of the seizures, but
also to diversity of the seizure types, duration of the treatment, number of
antiepileptic drugs, age at onset of the disease and existence of some cog-
nitive dysfunction. As we found remarkable abnormal findings in RE
group, we conclude that factors other than frequency and total number of
seizures must be operative in balance and gait abnormalities.
p0453
DURATIONANDAMPLITUDEOF
INTRACEREBRALLYRECORDEDHIGHFREQUENCY
OSCILLATIONS ANDEPILEPTOGENIC NETWORKS
M. Pail*, P. Rehulka*, J. Cimbalnik†, I. Dolezalova*,
J. Chrastina‡, M. Brazdil*
*St. Anne’s University Hospital and Faculty of Medicine,
Masaryk University, Department of Neurology, Brno, Czech
Republic, †International Clinical Research Center, St. Anne’s
University Hospital, Brno, Czech Republic, ‡St. Anne’s
University Hospital and Faculty of Medicine, Masaryk
University, Department of Neurosurgery, Brno, Czech Republic
Purpose: Interictal high-frequency oscillations (HFO) in frequencies
over 80 Hz (ripples and fast ripples) have been repeatedly identified in
recordings from invasive EEG monitoring in epileptic patients. These
phenomena may serve as biomarkers for epileptic brain. Conversely, the
studies describing the presence of interictal HFO of nonepileptic nature
are on the increase. The purpose of present study is to identify if there are
frequency-independent HFO parameters (amplitude and duration) which
potentially differ in epileptic and non-epileptic region.
Method: We studied 31 consecutive patients with medically intractable
focal (temporal and extratemporal) epilepsies. Automated detection was
used to detect HFO. All of the contacts of electrodes in each patient were
categorized by independent visual identification in standard SEEG into
three groups - the seizure onset zone (SOZ), the irritative zone (IZ) and
areas outside the irritative zone/seizure onset zone (nonSOZ/nonIZ). The
characteristics (amplitude and duration) of HFO within these three
groups were statistically compared.
Results: The rate of fast ripples (FR) in SOZ was significantly higher
than in nonSOZ/nonIZ region, for IZ the result was not significant. In
ripple range (R) the differences among groups of contacts were not sig-
nificant. The relative amplitude of HFO (both ripples and fast ripples)
was higher in SOZ in comparison with IZ and nonIZ/nonSOZ region.
Statistical analysis showed significantly shorter duration of ripples in
SOZ in comparison with duration of HFO in either nonSOZ/nonIZ or
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IZ (in FR range the result was significant only between SOZ and non-
SOZ/nonIZ).
Conclusion: In SOZ fast ripples are significantly more frequent and
shorter with higher relative amplitude than in nonSOZ/nonIZ region.
SOZ can be differentiate from IZ through the duration of R.
p0454
EPILEPSY; IMPROVINGTHE PATIENT JOURNEY.
SEVEN SHORT FILMSANDACCOMPANYING
BOOKLETS
S. Pashley*, L. Flinton*, M.F. O’Donoghue†
*Nottinghamshire Healthcare NHS Trust, Nottingham, UK,
†Nottingham University Hospitals NHS Trust, Neurology,
Nottingham, UK
Purpose: Epilepsy is a common co-morbidity in people with a learning
disability. It has a negative impact on quality of life and life expectancy.
Access to healthcare and up take in clinical investigations is more diffi-
cult in this population. Our aim was to produce accessible resources to
help adults with epilepsy and a learning disability understand more about
their condition and how to live well with epilepsy.
Method: People with a learning disability who had previously under-
gone hospital tests shared their experiences of anxiety not knowing what
to expect. This helped in the planning and development of a series of
short films and booklets. People with a learning disability and epilepsy
took the lead parts in the films.A patient focus group reviewed draft ver-
sions of the films and booklets and provided constructive criticism to help
produce the final products in an accessible format.
The films portray patient journeys. In the Transition film, the patient
and parent were filmed before, during, and after transition to the adult
epilepsy service to obtain their views and perspectives about the process.
Results: Seven short films and accompanying booklets have been pro-
duced and are available in hard copies and on the internet via our service
webpage at Nottinghamshire Healthcare NHS Trust and Nottingham
University NHS Trust websites www.nottinghamshirehealthcare.nhs.uk/
epilepsy.www.nuh.nhs.uk/our-services/services/neurology/epilepsy-
and-seizure-disorders/
Conclusion: The resources will promote better access to specialist inves-
tigations and treatment of epilepsy, raise awareness of the services avail-
able for people with epilepsy and a learning disability, encourage and
enable patients to be more involved in the management of their condition,
enhance the experience of young people and their families in the transi-
tion from paediatric to adult epilepsy care, and encourage people with
epilepsy and a learning disability to live a full and active life.
p0457
UNDERSTANDINGCLINICAL EPILEPTOGENESIS -
NEWHYPOTHESES DRIVENBYA FIRST SEIZURE
CLINIC APPROACH (THEHALIFAX EXPERIENCE)
B. Pohlmann-Eden*,†, K. Legg*, M.H. Schmidt†,‡,
C. Crocker*,†
*Queen Elizabeth II Health Science Centre, Dalhousie
University, Division of Neurology, Epilepsy Program, Halifax,
Canada, †Brain Repair Center, Dalhousie University, Halifax,
Canada, ‡Queen Elizabeth II Health Science Centre, Dalhousie
University, Department of Radiology, Halifax, Canada
Purpose: To arrive at a deeper understanding and new perspective on
the evolution and mechanisms of epileptogenesis by collecting multi-
modal longitudinal data on any patient diagnosed with a first seizure
(FS).
Method: As of 2/2015, the Halifax First Seizure Clinic has assessed 630
patients with either strictly FS, n = 196, new-onset epilepsy (NOE = > 1
seizure < 12 months), n = 152, or 3) newly-diagnosed epilepsy (NDE =
seizures > > 12 months), n = 53. 229 patients were excluded (no seizure,
n = 193 or not confirmed seizure, n = 36). All patients were assessed in
detail with regards to clinical information (including psychiatric comor-
bidities), epilepsy protocol MRI, routine and sleep-deprived EEG, social
parameters, and life style. Follow-up visits occurred at 6, 12 and
24 months.
Results: Interim analysis of the current data suggests the following
hypotheses
A) Preceding anxiety and depression are common suggesting subtle
changes in brain biochemistry before seizure occurrence,
B) Marijuana use is over presented, compared to the general population;
it either reflects coping strategy for A or is ictogen itself,
C) Prognostication of pharmacoresistance (PR) in the early course of
epilepsy is almost impossible as of a highly diverse temporal pattern with
long phases of seizure freedom,
D) MRI findings usually associated with poor treatment prognosis may
actually have a good prognosis in early stages (example: focal cortical
dysplasia),
E) Combining volumetric findings of the amygdala and preexisting psy-
chiatric symptoms may serve as early predictors for seizure recurrence,
F) The frequent MRI findings in late-onset epilepsy are not well under-
stood with regards of epileptogenesis and need further sophistication and
exploration.
Conclusion: Our preliminary data provide exciting new hypotheses for
clinical epileptogenesis which challenges knowledge originating from
retrospective studies in advanced stages of epilepsy. A well organized
longitudinal prospective cohort approach needs to be a critical compo-
nent in an academic comprehensive epilepsy program.
p0458
DELAYED ICTALATONIA IN TEMPORAL LOBE
SEIZURES ASA SIGNOF SEVERE ICTALCARDIAC
BRADYARRHYTMIA
B.I. Rosso*, W. Silva†, G. Fernandez‡, G. Maid‡, A. Rodriguez
Alfici§, A.P. Cortes*, A.G. Besocke*, E. Cristiano*,
M.D.C. Garcia*
*Hospital Italiano de Buenos Aires, Neurology, Caba,
Argentina, †Hospital Italiano de Buenos Aires, Pediatric
Neurology, Caba, Argentina, ‡Hospital Italiano de Buenos
Aires, Cardiology, Caba, Argentina, §Hospital Privado de
Mendoza, Mendoza, Argentina
Introduction: Ictal bradycardia and asystole (IB and IA) are rare auto-
nomic manifestations in focal seizures, with a prevalence of 0.4%, asso-
ciated with injuries from falls and/or sudden unexplained death
(SUDEP).
Objectives: Generate alert between the association of seizures with falls
because of delayed ictal atonia (DIA) and IB/IA in patients without pre-
existing cardiac disorders, highlighting the usefulness of videoelectroen-
cephalogram with simultaneous electrocardiogram (VEEG-EKG) to rec-
ognize symptoms and perform appropriate and precocious treatment.
Material andmethods: Description of two cases with DIA
Results: Case 1: 45 year-old woman with refractory epilepsy since age
18, presenting focal dyscognitive seizures. Recently she refers sudden
falls, having had head trauma in an opportunity. She is on Oxcarbacepine
1200 mg/day. Brain MRI is normal; EEG showed left temporal sharp
waves. The VEEG-EKG captured 5 seizures with left temporal electro-
clinical semiology; in one of the events, 30 second-long asystole was
observed after 49 seconds of ictal onset with DIA and myoclonus. The
patient was treated with cardiac pacemaker with no additional falls. Case
2: 32 year-old young man with epilepsy since age 15, presenting focal
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dyscognitive seizures with aura of Deja-vu and/or throat paresthesia,
occasionally followed by falls with atonia. He is on Oxcarbacepine
1800 mg/day and Clobazam 15 mg/day. Brain MRI shows right hip-
pocampal sclerosis. VEEG-EKG registered three electroclinical seizures
with right temporal semiology. In two events DIA was observed in asso-
ciation with 10-second long asystole occurring 44 seconds after seizure
onset. The patient underwent right anterior lobectomy 6 months ago, sei-
zure free since then.
Conclusions: Atypical clinical presentation of focal seizures with tem-
poral lobe semiology and delayed ictal atonia with or without myoclonus
should generate suspicion of severe ictal cardiac bradyarrhythmia. Diag-
nosis by VEEG-EKG is critical for an earlier and more aggressive treat-
ment, including surgery and / or pacemaker, in order to reduce morbi-
mortality.
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EARLY ICTAL SIGNS INMESIAL TEMPORAL LOBE
EPILEPSYWITH ISOLATEDHIPPOCAMPAL
PATHOLOGYANDEXCELLENT EPILEPSY SURGERY
OUTCOME
A. Rysz*, A. Nowak†, E. Maj‡, E. Matyja§
*Medical University of Warsaw, Dept. of Neurosurgery,
Warszawa, Poland, †Medical University of Warsaw, Warszawa,
Poland, ‡Medical University of Warsaw, II Dept. of Radiology,
Warszawa, Poland, §Medical Research Center, Polish Academy
of Science, Warszawa, Poland
Purpose: Identification patients with mesial temporal epilepsy (MTLE)
is crucial, because such intractable epilepsy is associated with encourag-
ing surgical outcome.
The aim of the study was assessment of early ictal signs in cases with
isolated medial temporal pathology.
Method: We studied video-EEG recorded seizures in 14 (9 F, 5 M)
patients who underwent anterior tailored temporal resections with refrac-
tory MTLE, and had isolated hippocampal pathology: 9 pure hippocam-
pal sclerosis, 3 gliomas (gangioglioma, 1 astrocytoma), 1 cavernoma and
1 focal cortical dysplasia type IIB. All patients were with excellent out-
come (seizures free of disabling seizures; Engel class 1A or 1 B) for at
least five years. The ictal signs for the period of first 30 seconds were
assessed.
Results: Early ipsilateral upper-limb elementary automatisms occurred
in all seizures. Head and eyes deviations (13/14 subjects), oroalimen-
tary automatisms (12/14 subjects) contralateral upper-limb dystonic
posturing (11/14 subjects), contralateral lower limb tonic posturing
(10/14 subjects), and vocalizations (8/14 subjects) were frequent early
ictal signs. Verbal automatisms was observed during 2 seizures begin-
ning in nondominant temporal lobe. Initial loss of contact was never
observed.
Conclusion: Our findings may be useful in differentiation of MTLE
semiology with pure hippocampal pathology from other forms of tempo-
ral lobe epilepsy.
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TEMPORAL ENCEPHALOCEL: ARARECAUSEOF
INTRACTABLE SEIZURES
O. Tosun Meric*, S. Saygi*, F.İ. Tezer*, K. Karli Oguz†,
F. Soylemezoglu‡, B. Bilginer§
*Hacettepe University, Neurology, Ankara, Turkey, †Hacettepe
University, Radiology, Ankara, Turkey, ‡Hacettepe University,
Pathology, Ankara, Turkey, §Hacettepe University,
Neurosurgery, Ankara, Turkey
Encephaloceles are defects of the skull and meninges, which are usually
congenital. Temporal lobe encephaloceles are rarely recognized and may
cause epileptic seizures. Here we present a case of drug resistant temporal
lobe epilepsy due to temporal lobe encephalocel which is a rare cause of
seizures. Twenty years old man has sufferred from intractable partial sei-
zures since he was sixteen years old. Seizures usually started with bad
odour and then followed by oral automatism with loss of consciousness.
Secondarily generalized seizures were rare and postictal aphasia was also
reported. Seizures were not controlled despite the combined theraphy
carbamazepin and levetiracetam. There was head trauma history when he
was fourteen years old. In the family, his nephew suffered from epileptic
seizures since childhood due to hippocampal sclerosis. His physical and
neurologic examination were normal. During long term video EEGMon-
itoring, ictal and interictal EEG showed epileptiform activity in the left
temporal lobe. Brain MRI initially was reported as normal but then
reviewed again, and left temporal lobe encephalocel and probable corti-
cal dysplasia in adjacent cortex could be identified. He underwent epi-
lepsy surgery including left temporal lobectomy without
hippocampectomy but with lesionectomy. Although pathology showed
non specific changes such as Chasline degeneration, he is seizure free
over 1 year since surgery. Middle fossa encephaloceles should be recog-
nized as a potential epileptogenic lesion in patients with partial seizures.
Temporal lobe encephaloceles can easiliy be missed when brain MRI is
reported and patients can be defined as having nonlesionel temporal lobe
epilepsy. As reported few patients’ data with intractable seizures and
temporal lobe encephalocel who underwent surgery, our patient’s data
and follow up also suggest that hippocampus may not be included the
resection and sparing of mesial temporal lobe structures allows individu-
als to continue to have normal verbal memory postoperatively.
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CEREBELLARNUCLEI STIMULATION STOPS
EPILEPTIC ABSENCE SEIZURES IN
CACNA1ATOTTERINGMOUSEMUTANTS BY
OVERRULINGOSCILLATORYACTIVITY IN
THALAMICNUCLEI
O.H.J. Eelkman Rooda*, L. Kros*, C.I. De Zeeuw*,†,
F.E. Hoebeek*
*Erasmus Medical Center, Department of Neuroscience,
Rotterdam, Netherlands, †Netherlands Institute for
Neuroscience, Royal Dutch Academy for Arts and Sciences,
Amsterdam, Netherlands
Absence seizures appear as generalized spike-wave discharges
(GSWDs) in electrocorticographical recordings (ECoG) and most stud-
ies on generalized forms of epilepsy have focused on disturbances of
activity in thalamocortical networks. Given the dense input of cerebel-
lar nuclei (CN) afferents on the thalamus, we recently explored the
impact of CN stimulation on GSWDs in two unrelated mouse models
of absence seizures. Increasing the frequency and regularity of CN
activity by pharmacological or optogenetic manipulations decimated
seizure occurrence, whereas blocking their activity dramatically
increased the occurrence of seizures (Kros et al., 2015, Ann Neurol, in
press). Here, we explored the underlying mechanisms of these effects
by extracellular recordings in thalamic nuclei and ECoG in awake,
head-restrained homozygous tottering (tg) mice during pharmacologi-
cal or optogenetic manipulation of CN neurons. During absence sei-
zures, we found that in a subset of recordings the action potential firing
pattern of neurons in thalamic nuclei were significantly modulated at
6–9 Hz, i.e., the representative frequency for SWDs in tg mutants. We
found that the firing patterns of the thalamic neurons that were phase-
locked to GSWDs changed drastically upon successful optogenetic
manipulation of CN neurons. More specifically, the rhythmic, phase-
locked and low-frequency activity of these neurons switched into an
irregular but tonic, high-frequency activity when the seizures were
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stopped using optogenetic stimulation of CN. These data indicate that
increased CN output can stop absence seizures by potently driving tha-
lamic action potential firing and altering the regularity, which together
overrule thalamocortical oscillations.
p0462
PLASMAMICRORNA PROFILING IDENTIFIES
POTENTIAL BIOMARKERSOFHUMANTEMPORAL
LOBEEPILEPSY
H. El-Naggar*, R. Raoof†, C.M. Mooney†, P. Moloney‡,
A. Sanz-Rodriguez†, E. Jimenez-Mateos†, S. Bauer§,
K.M. Klein§, F. Rosenow¶, N. Delanty†, D. Henshall*
*Royal College of Surgeons in Ireland, Molecular Physiology
and Neuroscience, Dublin, Ireland, †Royal College of Surgeons
in Ireland, Dublin, Ireland, ‡Beaumont Hospital, Dublin,
Ireland, §Philipps-University Marburg, Epilepsy Center Hessen,
Marburg, Germany, ¶Goethe-University, Epilepsy Centre
Frankfurt Rhine-Main, Frankfurt, Germany
Purpose: There is an important and unmet need for biomarkers of epi-
lepsy to identify patients at risk of epilepsy development, progression
or remission. Epilepsy biomarkers could also support decisions on
when and how to treat and differential diagnosis. Imaging and EEG
biomarkers are either time-consuming or expensive. A molecular bio-
marker in biofluids such as blood would help solve this problem.
Although several studies have attempted to identify blood biomarkers
of epilepsy, focusing on protein-coding transcripts and protein markers,
no sensitive and specific biomarker has yet been proven. MicroRNAs
are a class of small non-coding RNA that regulate gene expression at a
post-transcriptional level. MicroRNAs are important contributors to
brain function and emerging animal and human data suggest micro-
RNAs control multiple pathways in epilepsy. MicroRNAs are also
detectable in various body fluids and their stability as well as link to
disease mechanism makes them potentially ideal molecular biomarkers
of epilepsy.
Method: To determine whether there are microRNA biomarkers of
human epilepsy we collected blood samples from 20 temporal lobe epi-
lepsy patients during in-patient video-EEG monitoring, along with blood
from 20 age and gender-matched healthy volunteers. We profiled levels
of over 800 microRNAs in each sample using the OpenArray miRNA
analysis platform run on a 12K Flex QuantStudio PCR.
Results: Over 200 microRNAs were consistently called present in con-
trol plasma, confirming high specificity of the profiling platform. There
were expected high levels of known plasma microRNAs including miR-
16, miR-24, miR-150 and miR-484 and low or undetectable levels of
brain-expressed microRNAs.
Conclusion: A number of significantly differentially expressed micro-
RNAs were identified between control and epilepsy samples including
known brain-expressed microRNAs implicated in epilepsy. These results
support the existence of a set of microRNAs implicated in disease patho-
genesis that may be biomarkers of human epilepsy.
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BYPRODUCTSOF PROTEINOXIDATIVE DAMAGE
ANDANTIOXIDANTENZYMEACTIVITIES IN
PROGRESSIVEMYOCLONUS EPILEPSY
M. Ercegovac*, N. Jovic†, D. Sokic*, D. Nikolic‡, A. Savic-
Radojevic§, V. Coric§, T. Radic¶, M. Matic§, T. Simic§,
M. Pljesa-Ercegovac§
*Faculty of Medicine, University in Belgrade, Clinic of
Neurology, Clinical Center of Serbia, Belgrade, Serbia,
†Faculty of Medicine, University in Belgrade, Clinic of
Neurology and Psychiatry for Children and Youth, Clinical
Centre of Serbia, Belgrade, Serbia, ‡Faculty of Medicine,
University in Belgrade, University Children’s Hospital,
Belgrade, Serbia, §Faculty of Medicine, University in Belgrade,
Institute of Medical and Clinical Biochemistry, Belgrade,
Serbia, ¶Institute of Medical and Clinical Biochemistry,
Belgrade, Serbia
Purpose: It has been shown that oxidative stress may contribute to
neuronal hyperexcitability, while antioxidants may alleviate the pro-
gression of progressive myoclonus epilepsy (PME). However, the
molecular mechanisms underlying oxidative stress and its role in PME
remain elusive. Since oxidative damage to proteins is one of the major
mechanisms underlying neuronal cell damage, we evaluated byprod-
ucts of oxidative damage to proteins (protein thiol groups and nitrotir-
osine), as well as, activities of mayor antioxidant enzymes, superoxide
dismutase (SOD) and glutathione peroxidase (GPX) in patients with
PME.
Method: 26 patients with PME (5 had Unverricht-Lundborg disease, 14
Lafora body disease, 5 myoclonic epilepsy with ragged red fibers and 2
had late infantile neuronal ceroid lipofuscinosis) and 66 healthy, non-epi-
leptic subjects, without any drug treatment, matched for sex, age, ethnic-
ity and geographic origin were included in the study. The amount of
protein thiol groups (P-SH) in plasma, as well as, SOD and GPX activi-
ties were determined spectrophotometrically, while nitrotyrosine content
was measured by enzyme immunoassay.
Results: Although the content of P-SH, important chain breaking antiox-
idant in plasma, was lower and nitrotyrosine, a reliable marker of nitrosa-
tive damage to proteins, was found to be higher in patients with PME in
comparison to healthy controls, this change in byproducts of protein dam-
age did not reach statistical significance (p ˃ 0.05). However, the activi-
ties of antioxidant enzymes, SOD and GPX, were found to be statistically
significantly higher in PME patients when compared to controls
(p = 0.003 and 0.005, respectively).
Conclusion: Due to increased antioxidant enzyme activities, it may be
concluded that oxidative stress is associated with pathogenesis of pro-
gressive myoclonus epilepsy.
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THEASSESSMENTOF LEARNING,MEMORY,
BEHAVIORANDNEURONALDAMAGE, AMOUNTOF
GABA-A ALPHA 1 RECEPTORAFTER
PENTYLENETETRAZOLE-INDUCED STATUS
EPILEPTICUS IN IMATUREANDMATURERATS
A. S€onmez*, F.F. Erdogan†, N. Liman‡, A. S€onmez§
*Erciyes University Faculty of Medicine, Neurology, Kayseri,
Turkey, †Erciyes University Medical Faculty, Neurology
Department, Kayseri, Turkey, ‡Erciyes University Faculty of
Veterinary, Histology Embriology, Kayseri, Turkey, §Erciyes
University Faculty of Medicine, Physiology, Kayseri, Turkey
Purpose: We aimed to evaluate age-dependent cognitive and behavioral
changes, neuronal damage, the amount of GABA-A Alpha 1 receptor in
mature and immature rats after status epilepticus (SE).
Method: Following PTZ-induced SE, open field and Morris water maze
test were applied in pups (17 days), adolescent (45 days) and adult
(150 days) rats. All rats were underwent histological investigation to
assess neuronal cell damage (caspase and calpain activity) and amount of
GABAA alpha 1 receptor, and compared with control groups.
Results: No statistically significant differences were seen between
control and experimental groups according to behavioral tests in early
stage after SE. The calpain mediated neuronal damage with necrotic
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morphology was seen in adult rats, but in adolescant and pups rats
were not observed. The caspase mediated neuronal damage with apop-
totic morphology was seen in pups, after SE. The amount of GABA A
Alpha 1 receptor decreased in the three experimental groups compared
with control groups. The amount of GABA A alpha 1 receptor is seen
the least in adult experimental group. The decrease of amount of
GABA A alpha 1 receptor is more prominent in hippocampus than it is
in cortex.
Conclusion: Our data show that PTZ-induıced SE did not effect learning
and behavior in early stage after SE, histological data proved that it lead
to calpain and caspase mediated neuronal damage with necrosis. Cal-
pain-mediated cell necrosis was seen particularly in the adult group and
caspase-dependent apoptotic morphology was observed in immature rats.
The decreased of GABA A alpha 1 receptor is the highest in the adults.
Our study has supported that SE induced cell damage getting higher with
increasing age and the calpain-mediated cell damage was observed in the
adult group, too. We need to long-term follow-up studies to understand-
ing the long term effect of SE-depending neuronal damage on cognition
and behavior.
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EFFECTSOF LOWDOSEMERCURYCHLORIDE
(HGCL2) EXPOSURE INGESTATIONALAND
LACTATIONAL PERIODS TOONBEHAVIOR,
LEARNINGANDHEARINGLOSS INWAG/RIJ RATS
D. Sahin*, C.O. Erdolu†, G. Bayrak†, S. Beyaz†,
S. Karadenizli†, A. Kara†, B. Demir†, N. Ateş†
*Kocaeli University/Medical Faculty, Physiology, Kocaeli,
Turkey, †Kocaeli University/Medical Faculty, Kocaeli, Turkey
Purpose: Our aim was to investigate the effects of inorganic mercury
exposure in gestational/lactational periods on litters’ behavior, learn-
ing and hearing function in 5-week-old and 5-month-old WAG/Rij
rats.
Method: Chronic exposure was begun with IM injections of low-dose
HgCl2 or saline to pregnant rats. Injections were applied to mothers dur-
ing gestation/lactation periods. 5-week-old and 5-months-old rats were
divided in four different groups and tested to locomotor activity, morris
water-maze, passive avoidance for learning and memory performance
and distortion product otoacustic emission responses (DPOAE) tests for
observing age-dependency.
Results: There was no significant difference between 5-week-old rat
groups in locomotor activity. Significant difference was detected in
mercury-treated group in passive avoidance and morris water-maze and
DPOAE tests compared to the control group. There was no significant
difference between the groups of 5-month-old rats in locomotor activ-
ity, morris water-maze and passive avoidance tests except DPOAE tests
which became worse in mid and high frequency hearing. Mercury-trea-
ted 5-week-old group exhibited worse emotional memory performance
in passive avoidance test, worse spatial learning and memory perfor-
mances in morris water-maze tests. Mercury-treated 5-month-old group
were not differed from control group in same tests. Hearing loss seen
in 5-week-old rats became worse in 5-month-old rats that caused poor
hearing.
Conclusion: According to our results, mercury exposure during gesta-
tion/lactation periods may deteriorate learning and memory perfor-
mances, hearing at high frequencies in young rats. There was no
difference in behavior-learning tests in adult rats, but DPOAE test was
found to be deteriorated. These results clearly indicate that DPOAE test
is very sensitive in determining age-dependent mercury ototoxicity.
Early detection of effects of mercury exposure provides the medical team
an opportunity to determination treatment regimens and to mitigate hear-
ing changes. For this purpose, DPOAE tests can be used in clinical and
experimental research investigating heavy metal ototoxicity and hearing
loss.
p0466
THECORRELATIONOFGABAANDADENOSINE
CONCENTRATIONSWITHCHANGES IN
HIPPOCAMPALEXCITABILITY AFTER STATUS
EPILEPTICUS IN IMMATURERATS
P. Fabera, H. Kubova, P. Mares
Institute of Physiology of the Czech Academy of Sciences,
Department of Developmental Epileptology, Prague, Czech
Republic
Purpose: Status epilepticus (SE) induced in immature rats may result
in development of spontaneous seizures. Majority of spontaneous sei-
zures is generated in hippocampus therefore we started to study hip-
pocampal excitability after SE. The functional changes were correlated
with concentration of neurotransmitters (GABA, adenosine) in this
structure.
Method: LiCl-pilocarpine SE was elicited in P12 rats and hippocampal
epileptic afterdischarges (ADs) were studied in P15, P18, P25, P32 rats
with electrodes implanted into dorsal hippocampus. Control animals
received saline instead of pilocarpine. All age groups consisted of 10–14
animals. Rats were stimulated with suprathreshold intensities (2-s series
of 60 Hz pulses of 1-ms duration) at 20-min intervals six times. Thresh-
olds and duration of ADs were evaluated. The hippocampal homogenate
of P15 and P32 rats (both controls and SE) was analyzed for concentra-
tion of GABA and adenosine by HPL chromatography.
Results: Threshold for hippocampal ADs was significantly higher in
P15 SE rats in comparison with controls. The P18 and P25 groups did not
exhibit a difference between SE and controls but 32-day-old group
revealed significantly lower threshold for SE rats than for controls. Cor-
responding changes were found in AD duration - shorter ADs were
recorded in P15 SE rats whereas ADs in P32 SE rats were significantly
longer in comparison with appropriate controls. These findings corre-
lated with concentration of inhibitory neurotransmitters - increased
GABA in P15 SE rats and decreased adenosine in P32 SE rats in contrast
with their age-matched controls.
Conclusion: Our data demonstrated that during 20 days after SE com-
plex changes of hippocampal excitability took place. P32 rats revealed
higher excitability of dorsal hippocampus than age-matched controls.
The changes in hippocampal excitability after SE correlated with changes
in GABA and adenosine in this structure.
Supported by grants of the Grant Agency of the Czech Republic
No.15-16605S and P304/12/G069.
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AUTONOMOUS ICTALACTIVITY IN THEDENTATE
GYRUS IN THE STATUS EPILEPTICUS RATMODEL
OFEPILEPSY
P. Fidzinski, F. Weissinger, M. Holtkamp
Charité-Universit€atsmedizin Berlin, Neurology, Berlin, Germany
The dentate gyrus (DG) plays an important role in the pathophysiology of
epilepsy. The DG is believed to serve as a gatekeeper against uncon-
trolled propagation of neuronal activity into downstream structures by
means of massive intrinsic inhibitory activity. During epileptogenesis,
the DG looses its gate function and therefore enables propagation of ictal
activity into the hippocampal loop. The epileptic DG in principle should
be able to generate ictal activity in an autonomous and input-independent
manner. However, apart from a single report of ictal activity in the iso-
lated DG in hippocampal slice cultures (Gutiérrez et al. 1999), there is
currently little evidence for this hypothesis as in various rodent models of
epilepsy, ictal activity originated in other regions such as the CA3 and
CA1, but not in the DG. In the current study, we used intrinsic optical
imaging in combination with electrophysiological recordings in the low-
Mg++ in vitro model inducing ictal epileptiform acitivity. In brain slice
preparations from epileptic animals exposed to lowMg2 + , we observed
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spontaneous and autonomous epileptiform activity in the DG. Impor-
tantly, this activity was completely independent from epileptiform activ-
ity generated in adjacent neocortical structures. Thus, in an in vivo model
of TLE, the DG can serve as an independent generator of epileptic activ-
ity contributing to general hyperexcitability and increasing the seizure
load in the temporal lobe.
p0469
RESVERATROLATTENUATESOXIDATIVE STRESS
ASSOCIATEDWITH STATUS EPILEPTICUS IN
IMMATURERATS
J. Folbergrova, P. Jesina, H. Kubova, J. Otahal
Institute of Physiology of the Czech Academy of Sciences,
Prague, Czech Republic
Purpose: We have demonstrated recently that status epilepticus (SE)
induced in immature rats leads to oxidative stress and mitochondrial dys-
function. The aim of the present study was to investigate potential protec-
tive effect of a natural polyphenol Resveratrol.
Methods: Seizures (having a character of SE) were induced in immature
12-day-old male Wistar rats by substances with a different mechanism of
action, namely by DL-homocysteic acid (bilateral i.c.v., 600 nmol/side),
4-aminopyridine (bilateral i.c.v.,100 nmol/side), Li-pilocarpine (i.p.,
LiCl 127 mg/kg and the next day pilocarpine 35 mg/kg) and kainic acid
(i.p., 6 mg/kg). Dihydroethidium (Het) method was employed for detec-
tion of superoxide production in brain in situ. The determination of the
oxidized products of Het (reflecting superoxide production) was assessed
microscopically by fluorescence (>600 nm). Mitochondrial function was
evaluated by measuring respiratory chain complex I activity in isolated
mitochondria. Resveratrol was given i.p. in two or three doses (25 mg/kg
each), 30 min before, 30 min or 30 min and 90 min after induction of
SE.
Results: The treatment with resveratrol provided a clear protective effect
in all the studied models of SE. It prevented or significantly reduced the
increase of superoxide formation and it substantially attenuated the inhi-
bition of complex I activity associated with SE.
Conclusions: The present findings suggest that substances with antioxi-
dant properties combined with conventional therapies might provide a
beneficial effect in treatment epilepsy.
Supported by the Czech Science Foundation (grant No. 15-08565S).
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ACRITICAL PERIODTO SUPPRESS
EPILEPTOGENESIS
C.N.G. Giachello, R.A. Baines
University of Manchester, Faculty of Life Sciences, Manchester,
UK
Purpose: Using the fruit fly Drosophila melanogaster as an experimen-
tal model, we investigated whether epileptogenesis can be prevented by
early intervention during embryogenesis.
Method: Seizure behaviour, in defined genetic seizure mutants, was
tested in the larval stage using an electroshock assay. Electroshocked
larvae exhibit a temporary paralysis, corresponding to a period of sei-
zure-like activity, until resumption of normal motile behaviour. Manip-
ulation of neural activity during embryogenesis, using both
optogenetic and pharmacological tools, prevents epileptogenesis from
proceeding in these mutants. Optogenetic manipulation defines a criti-
cal period for this effect. Targeted optogenetic expression, in a cell-
specific manner, allowed the contribution of different neuron types to
be evaluated. Finally, electrophysiological recordings quantify the
levels of synaptic excitation of larval motoneurons following optoge-
netic manipulation.
Results: We report that preventing hyper-excitability in bang-sensitive
mutants, a genetic seizure model, is sufficient to dramatically reduce
postembryonic seizure-behaviour. Moreover, we have identified a criti-
cal period during embryogenesis, corresponding to onset of action poten-
tial firing in developing locomotor networks, in which disturbance of
neuronal activity results in altered seizure susceptibility at postembry-
onic stages. This effect can be blocked by prior treatment of gravid
females with the same antiepileptic drugs currently used to treat human
epilepsy. Whole-cell recordings revealed an increased synaptic excita-
tion of larval motoneurons consequent to embryonic manipulation.
Again, these changes can be reverted by early drug intervention.
Conclusion: Preventing abnormal neuronal activity during a critical per-
iod of embryogenesis is sufficient to prevent epileptogenesis in defined
Drosophila genetic seizure models. These results provide persuasive evi-
dence that early drug intervention during development can suppress sei-
zure occurrence in later life, offering a new perspective for the treatment
of human idiopathic epilepsy.
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ANTICONVULSIVE EFFECTSOF SELECTEDNEW
GENERATIONANTIEPILEPTIC DRUGS IN THE 4-
AMINOPYRIDINE IN VITRORATMODELOF
EPILEPSY
H. Heuzeroth, F. Weissinger, R. Dag, M. Holtkamp, P. Fidzinski
Charité-Universit€atsmedizin Berlin, Neurology, Berlin, Germany
During the last years, several new generation antiepileptic drugs (AEDs)
have been introduced on the market and their clinical use keeps to
increase due to good efficacy and tolerability. However, little is known
on the efficacy of these compounds in acute epilepsy models. Due to its
good reproducibility, the 4-aminopyridine (4-AP) acute in vitro rat model
of epilepsy is a widely used approach to study ictal activity in brain slices.
Here, we used extracellular recordings in combination with intrinsic opti-
cal imaging to test the anticonvulsive efficacy of three new antiepileptic
drugs with putatively distinct mechanisms of action: levetiracetam, laco-
samide and zonisamide. Horizontal entorhinal-hippocampal slices were
prepared from male, adult Wistar-Han rats. After 60 min of exposure to
4-AP (100 lM) and full appearance of seizure like events (SLEs), tested
drugs were applied in varying concentrations for the duration of 60 min
and followed by a wash phase of another 60 min. Levetiracetam (33 lM-
100 lM-300 lM) reduced the incidence of SLEs in a concentration-
dependent manner but had no effect on the duration or the amplitude of
SLEs. Similarly, application of lacosamide (10 lM-33 lM-100 lM) or
zonisamide (33 lM-100 lM-300 lM) resulted in a concentration-
dependent reduction of SLE incidence whereas no change of SLE dura-
tion or amplitude were observed. In addition, a reduction of the tonic
component of SLEs was observed upon application of lacosamide, In
contrast to levetiracetam and zonisamide which reduced but did not abol-
ish SLEs, lacosamide completely blocked SLE incidence when used at
higher concentrations (100 lM). Moreover, at higher concentrations all
three compounds reduced the extent of seizure propagation as observed
by intrinsic optical imaging. All reported effects were reversible during
the wash-out phase. We conclude that the clinical efficacy of the new
generation antiepileptic drugs levetiracetam, lacosamide and zonisamide
is adequately reflected in the 4-AP acute in vitro model of epilepsy.
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Purpose: Disruption in thalamocortical circuits is responsible for gener-
alized absence epilepsy. However, the role of thalamic relay neuron
activity in absence epilepsy is controversial. Human studies report blood
flow increases in thalamus during electroencephalographic (EEG) spike
wave discharge (SWD) of absence seizures. Yet animal studies report
that at the single neuron level, thalamic relay neurons only participate in
a sparse manner, suggesting that large-scale synchrony of thalamic neu-
rons is not required to support the seizures. This raises the question of
whether or not active participation of thalamic relay neurons is required
at all, and has implications regarding seizure therapies that might target
thalamus versus cortex. We tested for necessity of thalamic neuron firing
using optogenetic inactivation of relay neurons in two rodent genetic
absence models, stargazer mice andWAG/rij rats.
Method: An enhanced version of the inhibitory opsin (eNpHR 3.0) was
expressed in thalamic ventrobasal neurons through viral transduction dri-
ven by CamKII promoter, which targets excitatory relay neurons. Ani-
mals were instrumented with optrodes which allowed targeted delivery
of light to thalamus, as well as depth electrode thalamic recordings and
surface corticography (to provide an analog of EEG).
Results: Yellow, but not blue light was able to interrupt absence seizures
and the assocated SWD in both stg andWAG/Rij animals. This was asso-
ciated with a blockade of neural firing, as obtained with depth electrodes.
Conclusion: These data show that continuous activity is indeed required
in thalamic neurons to sustain the large scale synchrony during general-
ized absence epilepsy.
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ANTIEPILEPTOGENIC EFFECTOF INTERMITTENT
FEEDINGDIET INMOUSE PTZ-INDUCEDKINDLING
MODEL
M. Iqbal*, Z. Karimi†, M. Raza‡
*Faculty of Medicine, Baqiyatallah University of Medical
Sciences, Tehran, Iran, Islamic Republic of, †Department of
Toxicology, Faculty of Medical Sciences, Tarbiat Modares
University, Tehran, Iran, Islamic Republic of, ‡Section of
Neuroscience, Department of Neurology, Baqiyatallah
University of Medical Sciences, Tehran, Iran, Islamic Republic
of
Purpose: Epilepsy is one of the common neurological disorders with
over 50 million patients worldwide. Over 30% of patients have pharma-
coresistant seizures. Additionally, current anticonvulsant drug therapy
only suppresses seizure and doesn’t cure underlying epileptogenic lesion.
Intermittent feeding (IF) has been shown to be neuroprotective and
reduce seizures in animal models. In this study we investigated the effect
of IF regimen on pentylenetetrazole (PTZ)-kindling model of epileptoge-
nesis in mice.
Method: Animals (all male mice, 20 g) were divided into 2 groups.
Group I (AL, ad libitum, n = 5) received food every day while group II
(IF) received food on alternate days for five 5 weeks. The IF group was
divided into 2 sub-groups (IF-1, PTZ given on IF feeding days, and IF-2,
PTZ given on AL feeding days, n = 7 each group). Epileptogenesis was
induced by PTZ (35 mg/kg. s.c) on alternate days and animals were
observed for 30 minutes for seizure severity by the Becker’s five point
scale. Seizure severity and kindling process were compared between the
groups.
Results: Seizure stages according to Becker’s five point scale were sig-
nificantly delayed in IF-1 group compared to the AL and IF-2 groups. AL
group achieved stage 5 after 23 sessions (p < 0.05); however, IF-1 group
didn’t achieve full stage after 23 sessions. There was no significant dif-
ference between AL and IF-2 group (p > 0.05).
Conclusion: Results show that IF regimen significantly delays PTZ-
kindling induced epileptogenesis attributable to its acute on chronic
effect. In order to elaborate mechanism of anti-epileptogenic effect of IF
diet, further studies are suggested.
Keywords: PTZ-kindling, intermittent feeding, anti-epileptogenesis,
mice
Acknowledgements: Thanks to the organizing committee of the third
student and research festival BUMS for financial support.
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MICRORNA PROFILEOF THETUBEROUS SCLEROSIS
COMPLEXCORTICAL TUBERSUSINGNEXT
GENERATION SEQUENCING
A.M. Iyer*, J. van Scheppingen*, A. Muehlebner-
Fahrngruber*,†, B. Scicluna‡, J.J. Anink*, B. Janssen§,
W.G. Spliet¶, F.E. Jansen**, J. Zamecnik††, P. Krsek‡‡,
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*Academic Medical Center, Neuropathology, Amsterdam,
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Austria, ‡Academic Medical Center, Center for Experimental
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B.V., Leiden, Netherlands, ¶University Medical Center Utrecht,
Pathology, Utrecht, Netherlands, **University Medical Center
Utrecht, Pediatric Neurology, Utrecht, Netherlands,
††University Hospital Motol, Pathology and Molecular
Medicine, Prague, Czech Republic, ‡‡University Hospital
Motol, Pediatric Neurology, Prague, Czech Republic,
§§Erasmus Medical Center, Clinical Genetics, Rotterdam,
Netherlands, ¶¶Harvard Medical School, Medicine, Boston, MA,
USA, ***Stichting Epilepsie Instellingen Nederland, Heemstede,
Netherlands, †††Swammerdam Institute for Life Sciences,
Center for Neuroscience, Amsterdam, Netherlands
Purpose: Tuberous sclerosis complex (TSC) is a rare genetic disease,
frequently associated with severe epilepsy which is often unresponsive to
anti-epileptic drugs. Recent studies have implicated microRNAs (miR-
NAs) as crucial regulators of various processes involved in epilepsy
pathogenesis. MicroRNAs interact with protein-encoding mRNAs usu-
ally leading to translational repression. Deregulation of miRNA expres-
sion has been reported previously in human epileptic brain samples. The
aim of the present study was to characterize the miRNA profile in TSC
cortical tubers and corresponding perituberal tissue using Next Genera-
tion Sequencing and identify candidate miRNAs associated with these
cortical malformations that may contribute to their epileptogenicity.
Method: Total RNA, including miRNA, was isolated from cortical
tubers (n = 16) and matched perituberal cortex (n = 4) from TSC cases
and age matched control cortex (n = 13). The samples were processed
using the Illumina TruSeq Small RNA-Seq Sample Prep Kit and
sequenced on the Illumina HiSEq 2500 Sequencer. The sequences were
aligned to the Homo sapiens GRCh37 genome build and further aligned
over known miRNAs, quantified by read count quantification and nor-
malized by matched distribution using the Seqmonk platform.
Results: A total of 12 miRNAs were differentially expressed between
TSC tubers and age-matched control samples. Eight of the 12 miRNAs,
including miR34b, recently shown to be expressed at increased levels in
TSC tubers associated with epilepsy, showed increased reads whereas 4
showed decreased reads in tubers compared to control tissue. Unsuper-
vised cluster analysis showed 3 main groups, with a majority of tubers
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doi: 10.1111/epi.13241
119
Abstracts
(14/16) clustering together. A large proportion (7/14) of TSC tubers in
the major cluster showed a mutation in TSC2. Validation of the differen-
tially expressed miRNAs by qPCR is in progress.
Conclusion: The study demonstrated differential expression of miRNAs
in cortical tubers, whichmight help identify important pathways involved
in the epileptogenecity of these lesions and new candidates for targeted
interventions.
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THE LINKBETWEENCHOLESTEROLAND
HEDGEHOG SIGNALLING IN EPILEPSYANDAUTISM
SPECTRUMDISORDER: ACELLULARMODELOF
SMITH-LEMLI-OPITZ SYNDROME
J. Jacob*,†,‡, R. Blassberg§
*Oxford University, Nuffield Dept of Clinical Neuroscience,
Oxford, UK, †John Radcliffe Hospital, Dept. of Neurology,
Oxford, UK, ‡Milton Keynes NHS Foundation Trust, Dept. of
Neurology, Milton Keynes, UK, §MRCNational Institute for
Medical Research, Division of Developmental Biology, London,
UK
Purpose: Disorders of cholesterol metabolism cause epilepsy, autism
spectrum disorder, and uniquely amongst the inborn errors of metabo-
lism, congenital malformations. The commonest disorder, Smith-Lemli-
Opitz syndrome (SLOS) results from mutations in the enzyme, DHCR7
leading to a cholesterol deficit and an accumulation of its precursor,
7DHC in fetal tissues. Congenital malformations in SLOS bear a striking
resemblance to those seen in sonic hedgehog (SHH) deficient states, and
SLOS pathogenesis is thought to be mediated by aberrant SHH sig-
nalling. SHH signalling critically depends on signal transduction through
the transmembrane protein, Smoothened (SMO), which is susceptible to
potent positive and negative regulation by sterols. SMO dysregulation is
thought to occur in SLOS as a result of an altered sterol environment, but
whether the accumulation of 7DHC or a deficit of a cholesterol-derived
sterol is responsible is unclear.
Aims: 1. To establish a cellular model of SLOS.
2. To determine how cholesterol metabolism affects SHH signalling.
3. To propose a mechanistic model for how deficient SHH signalling
in SLOS could result in epilepsy and ASD.
Method: 1. Development of a cell culture model system to test the effect
of cholesterol deficiency on SHH signalling.
2. We assess the effect of DHCR7 disruption on the SHH signalling
pathway in two ways. First, SHH signalling output is assayed by qPCR
for targets of SHH signalling, and using a luciferase reporter assay. Sec-
ond, we use quantitative cell biological techniques that probe critical
molecular-subcellular systems that mediate SHH signalling.
Results: 1. A cholesterol deficit, independently of known sterol regula-
tors of SMO, impairs SMO activation in SLOS.
2. 7DHC does not block SHH pathway activity.
3. Cholesterol deficit impairs SHH signaling by reducing SMO
translocation to the appropriate sub-cellular compartment.
Conclusion: Epilepsy and ASD in SLOS could arise through a SHH-
dependent mechanism rather than through 7DHC toxicity.
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DETECTIONOFHHV-6B IN ADULTMESIAL
TEMPORAL LOBEEPILEPSY: ASSOCIATIONOF
VIRAL INFECTIOUS STATEWITH INFLAMMATORY
CYKELETON IN BRAIN TISSUEANDCSF
L. Jin-Mei*, H. Yang*, X. Shao†, C. Huang*, W. Liu*, D. Zhou*
*West China Hospital, Sichuan University, Department of
Neurology, Chengdu, China, †National Chengdu Center for
Safety Evaluation of Drugs, State Key Lab of Biotherapy,
Chengdu, China
Purpose: HHV-6B has been confirmed as an important etiologic factor
of mesial temporal lobe epilepsy. Here, we aimed to analyze the different
courste of HHV-6B infection and the association with inflammatory fac-
tors in MTLE brain tissue and cerebral spinal fluid (CSF).
Method: Nested polymerase chain reaction (nPCR) was performed to
dectect HHV-6B DNA, and immunohistochemistry (ICH) HHV-6B pro-
tein. Real-time PCR, immunofluorence and suspension bead array were
performed for cytokines in brain tissues and CSF.
Results: HHV-6B DNA was detected in 18 of 49 MTLE patients
(36.73%) and 1 of 19 controls (5.26%) in brain tissue, but not in CSF.
ICH showed different course of HHV-6B protein of latency stage(U94)
in 8 patients (16.32%), early state (P41) in 3 patients (6.12%), late state
(gp116/54/64 or P98) in 5 patients (10.20%),and multiple stages (two or
more different stage specific proteins) in 9 patients (18.36%). None of
these HHV-6 related proteins were found positive in control brain tissue.
PCR revealed up-regulation of IL-1b and IL-7 in tissue with complex
virus state, but not in lesion with simple virus state. Suspension bead
array in csf confirmed up-regulation of IL-1 and IL-7. The logistic analy-
sis revealed the association with seizure frequency and complex virus
state.
Conclusion: The data showed HHV-6B may be in different infection
courses. The virus replicates and reactivates periodically. In MTLE
patients with HHV-6B protein positivity, different course of HHV-6
infection may be associated with seizure frequency. It may also play an
important role in up-regulation of inflammatory factors.
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MORPHOLOGICALALTERATIONS IN THEMODEL
OFNON-LESIONAL TEMPORAL LOBEEPILEPSY
P. Jiruska*, L. Demeterova*, J. Kudlacek*,†, P. Vlk*,†,
A. Posusta*, J. Otahal*
*Institute of Physiology of the Czech Academy of Sciences,
Department of Developmental Epileptology, Prague, Czech
Republic, †Faculty of Electrical Engineering, Czech Technical
University, Department of Circuit Theory, Prague, Czech
Republic
Purpose: Temporal lobe epilepsy (TLE) is the most common form of
epilepsy and hippocampal sclerosis represents the main underlying struc-
tural abnormity. Approximately 20% of TLE cases are non-lesional due
to absence of any obvious epileptogenic lesion and tetanus toxin model is
traditionally considered as a model of non-lesional TLE. In this study we
utilized direct markers of cell degeneration to evaluate the cell damage in
this model.
Method: Epilepsy was induced in nine Wistar rats by injection of 10 ng
of tetanus toxin to the right dorsal hippocampus. Control animals were
injected with 50 mM PBA 2% BSA solution. After the injection, animals
were placed on video monitoring to verify the development of sponta-
neous seizures. On day 16 animals were perfused and brains extracted.
Postfixed brains were sectioned to 50 lm slices and labeled using Nissl
and FluoroJade B staining (FJB).
Results: All animals developed spontaneous seizures. In 3/9 animals
areas of decreased Nissl staining were observed in contralateral hip-
pocampus. FJB revealed presence of degenerating neurons in the areas
corresponding to decreased Nissl labeling. In rostro-caudal direction, the
areas containing degenerating neurons extended over 3.0  1.2 mm. In
1/9 animals hippocampal sclerosis was present. No structural abnormali-
ties and presence of FJB positive neurons were observed outside the hip-
pocampus.
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Conclusion: This study demonstrates that from the perspective of
classical neuropathology the tetanus toxin model can be still classified
as a non-lesional. However, microscopic cell loss is present and must
be always considered when this model is used for experimental
purposes.
Supported by grants from the Ministry of Health of the Czech Republic
(IGA MZCR NT/13357-4), Czech Science Foundation (14-02634S, 15-
08565S) and by Neuron Fund for Support of Science (NFKJ 001/2012).
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ASSESSMENTOF THEANTI-CONVULSANT EFFECTS
OFCANNABIDIOLWHENCO-ADMINISTEREDWITH
ANTI-EPILEPTIC DRUGS INACUTEMODELSOF
SEIZUREANDTHEIR INDIVIDUALTOLERABILITY
PROFILES
N. Jones*, T. Hill*, C. Stott*, G. Stephens†, C. Williams†,
B. Whalley†
*GWResearch Ltd, Cambridge, UK, †University of Reading,
Reading, UK
Purpose: Plant-derived cannabidiol (CBD) has previously demonstrated
anti-convulsant properties in chemically-induced, in vivo models of sei-
zure. Here, the effects of CBD in combination with commonly used
antiepileptic drugs (AEDs) on generalised and temporal lobe seizures
were investigated to:
(1) ascertain whether CBD retains its anti-convulsant effects when co-
administered with AEDs,
(2) whether CBD is well-tolerated when co-administered with AEDs
and
(3) reveal any beneficial drug-drug interactions. Moreover, the tolera-
bility profiles of CBD and these AEDs is described.
Method: CBD effects were investigated in the pentylenetetrazole and
pilocarpine models of seizure by using a known, effective anti-convul-
sant dose of CBD (100 mg/kg) co-administered with effective anti-con-
vulsant doses (ED25, ED50 and ED75) of AEDs, sodium valproate,
phenobarbital and ethosuximide. The tolerability profile of CBD and the
AEDs (ED25, ED50 and ED75 anti-convulsant doses in the pentylenetetra-
zole model of generalized seizure) in rats was investigated using the sta-
tic beam test.
Results: CBD retained its anti-convulsant effects when co-administered
with the AEDs in the pentylenetetrazole- and pilocarpine-inducedmodels
of seizure, and was well-tolerated and devoid of any negative drug-drug
interactions. Moreover, a beneficial drug-drug interaction in the
pentylenetetrazole model was revealed when CBD was co-administered
with sodium valproate. In comparison to these AEDs, CBD did not pro-
duce any motor deficits or neurotoxicity in the tolerability assay.
Conclusion: These results demonstrate promising anti-convulsant
effects of CBD in combination with AEDs in two chemically-induced
acute in vivo models of seizure and tolerability test. This suggests that
CBD may be a novel therapeutic candidate for a range of human epilep-
sies, with a potentially favourable tolerability profile, supporting further
clinical investigation.
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ENHANCINGKCC2 BYACUTETRKB INHIBITION
RESCUES PHENOBARBITAL-RESISTANT SEIZURES
IN AMODELOFNEONATAL ISCHEMIA
S.K. Kang*, M.V. Johnston†, S.D. Kadam‡
*KKI, Baltimore, MD, USA, †KKI and Johns Hopkins University
School of Medicine, Baltimore, MD, USA, ‡KKI and Johns
Hopkins University School of Medicine, Neurology, Baltimore,
MD, USA
Purpose: Hypoxic-ischemic encephalopathy (HIE) accounts for 50–
60% of the reported cases for neonatal seizures, and results in adverse
neurodevelopmental morbidity and lethality depending on the severity of
the underlying brain injury. HIE-associated neonatal seizures are difficult
to treat because of their well-known resistance to 1st-line anti-seizure
drugs such as phenobarbital (PB) and benzodiazepines. In this study,
using a previously established ischemic mouse model, we investigated a
novel therapeutic strategy of enhancing KCC2 to rescue the occurrence
of PB-resistant neonatal seizures.
Method: The ischemic seizure model in CD1 mice develops acute
PB-resistant seizures at postnatal day 7 (P7) that are PB-responsive at
P10. Using this model, this study addressed the question of whether the
PB-resistance can be reversed by the presence of a KCC2 modulator,
ANA-12. The therapeutic potential of an acute dosing with ANA-12 (IP;
2.5 mg/kg), a small molecule selective TrkB receptor antagonist was
investigated at P7 and was compared to P10. The main evaluation criteria
for ANA-12’s therapeutic benefit included: 1) quantitative electroen-
cephalographic (EEG) seizure burden and 2) KCC2 and NKCC1 protein
expression levels with and without its treatment after an acute ischemic-
insult.
Results: ANA-12 treatment significantly rescued PB-resistant seizures
at P7. Additionally, ANA-12 enhanced the PB efficacy at P10. Wes-
tern blot results showed that ANA-12 + PB treatment significantly
prevented the acute post-ischemic KCC2 downregulation documented
in the model. NKCC1 expression was not affected either by ischemia
or ANA-12 treatment. At both ages investigated, bumetanide a NKCC1
antogonist, not only failed to act as an efficacious adjunct therapy, but
resulted in a significant aggravation of the effectively subdued post-PB
seizures.
Conclusion: This study shows that KCC2 modulation helps reverse the
occurrence of PB-resistant seizures recorded in P7 mice that may be a
potent strategy in treating this fragile patient population.
Basic Science 5
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MULTIMODALMETHODANDANALYSIS OF THE IN
VITROHUMANCORTICAL SPONTANEOUS
SYNCHRONOUS POPULATIONACTIVITY
B.P. Kerekes*,†, K. Toth*, A. Bago‡, B. Chiovini†,§,
Z. Szadai†,§, D. Palfi†,§, B. Rozsa†,§, I. Ulbert*,†, L. Wittner*,‡
*Hungarian Academy of Sciences, Research Centre for Natural
Siences Institute of Cognitive Neuroscience and Psychology,
Budapest, Hungary, †Pazmany Péter Catholic University,
Faculty of Information Technology and Bionics, Budapest,
Hungary, ‡National Institute of Clinical Neurosciences,
Budapest, Hungary, §Hungarian Academy of Sciences, Institute
of Experimental Medicine, Two-Photon Imaging Center,
Budapest, Hungary
Purpose: From the cortical slices of epileptic and non-epileptic tumor
patients maintained in physiological medium in vitro spontaneous syn-
chronous population activity (SPA) emerges. SPA was recorded until
now by our group using sharp intracellular and laminar extracellular
methods to analyze the neural mechanisms giving rise to population
synaptic/trans-membrane and spiking activity. We introduced the two-
photon line scan Ca-imaging technique on human in vitro slice prepara-
tions to gain additional information about the network mechanisms
involved in the SPA generation. The excellent spatial coverage and reso-
lution of this technique supplements the laminar extracellular, sharp
intracellular and whole cell patch techniques.
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Method: Human slices were maintained in a dual superfusion cham-
ber of high flow rate physiological incubation medium and otherwise
conventional submerged technique to elicit SPA in a two-photon
microscope. The population activity was recorded by laminar extra-
cellular and extracellular patch electrodes. Bulk loading of OGB-1-
AM and SR101 was applied on the tissue. This way we were able to
image the SPA related Ca-transients in pyramidal or interneuron cells
with two-photon technique, simultaneously with extracellular and
whole cell patch measurements. The patched cells were loaded with
biocitin as well for later anatomical analysis. The filled cells were 3D
reconstructed, and observed with light microscope, and transmission
electron microscope.
Conclusion: Combining high spatial resolution two-photon Ca-imaging
technique and high temporal resolution extra- and intracellular electro-
physiology techniques may permit a deeper understanding about the net-
work properties of SPA in the human cortex.
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SPATIO-TEMPORAL PROFILEOF SEIZURE
INITIATION IN TEMPORAL LOBEEPILEPSYOF
HIPPOCAMPALORIGIN
J. Kudlacek*,†, P. Vlk*,†, L. Demeterova*, A. Posusta*,
J. Otahal*, P. Jiruska*
*Institute of Physiology of the Czech Academy of Sciences,
Department of Developmental Epileptology, Prague, Czech
Republic, †Faculty of Electrical Engineering, Czech Technical
University, Department of Circuit Theory, Prague, Czech
Republic
Purpose: Despite decades of study of the pathophysiology of TLE, the
role of the individual limbic structures in seizure genesis is still not well
understood. Traditional models of TLE (kainate, pilocarpine) do not
allow for determination of the causal role of each limbic structure in icto-
genesis due to widespread damage across the limbic system induced by
the initial status epilepticus. The goal of this study was to elucidate the
spatio-temporal profile of seizure initiation in TLE induced in the dorsal
hippocampus.
Method: TLE was induced in seven adult rats by injection of 10 ng of
tetanus toxin into the right dorsal hippocampus. Following the injection,
animals were implanted with bipolar recording electrodes in the follow-
ing structures of both hemispheres: amygdala, dorsal hippocampus, ven-
tral hippocampus and piriform, perirhinal and entorhinal cortices. The
animals were video-EEGmonitored for 4 weeks.
Results: In total 140 seizures (20 seizures per animal) were analyzed.
The average duration of each seizure was 53.2  3.9 s. Seizure onsets
were classified as hypersynchronous with high-amplitude spikes initi-
ated simultaneously across several sampled structures. Analysis of sei-
zure onset revealed that the majority initiated in the ipsilateral (41%)
and contralateral (21%) ventral hippocampi. These structures had a sig-
nificantly higher probability of seizure initiation than other studied
structures. The involvement of other limbic structures varied between
individual animals. Only 7% of seizures initiated in the injected dorsal
hippocampus.
Conclusion: This study demonstrates the involvement of multiple limbic
structures in seizure initiation in TLE induced in the dorsal hippocampus.
Furthermore, it confirms the significance of the epileptogenic network
concept to understand TLE ictogenesis, in which the ventral hippocampi
play the dominant role.
Supported by grants from the Ministry of Health of the Czech Republic
(IGA MZCR NT/13357-4), Czech Science Foundation (14-02634S) and
by Neuron Fund for Support of Science (NFKJ 001/2012).
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ASSESSMENTOFANXIETYANDCOGNITIVE
PERFORMANCE IN POST-STATUS EPILEPTICUS
RATS TREATEDWITHCURCUMINAND
LEVETIRACETAM
M.Makmor Bakry, H.Y. Yow
Universiti Kebangsaan Malaysia, Faculty of Pharmacy, Kuala
Lumpur, Malaysia
Purpose: Patients with epilepsy have been associated with anxiety and
cognitive dysfunction. This study investigated the effects of levetirac-
etam and curcumin on anxiety and cognitive performance of post-status
epilepticus (SE) rats.
Method: Kainate induced SE in Wistar rats were used in the experi-
ments. Pre and post performance tests were conducted prior to kainic acid
administration and after 7 days treated with either levetiracetam or cur-
cumin, respectively. The anxiety assessment was conducted by using the
Open Field Test and Light/Dark Box Test, and the cognitive performance
assessement was conducted by using the Novel Object Recognition Task
and Object Location Recognition Task. Overall anxiety evaluation was
based on locomotor activity, exploratory activity and anxiety-like beha-
viour.
Results: Kainate-induced status epilepticus not only caused an increase
in anxiety-like behaviours, but also impaired both spatial and non-spatial
recognition memory in rats (all p < 0.05). Levetiracetam-treated epilep-
tic rats exhibited anxiolytic behaviours (p < 0.05), however, levetirac-
etam treatment showed no effect in ameliorating cognitive impairments
caused by kainic acid, either in spatial or non-spatial recognition mem-
ory. Curcumin showed the ability to ameliorate anxiety and non-spatial
recognition impairment due to kainic acid (p < 0.05), but yet no effect on
spatial recognition impairment.
Conclusion: Both levetiracetam and curcumin may be useful in improv-
ing anxiety condition, however, only curcumin has the potential to
improve cognitive function in post-kainate induced SE rats.
Clinical Neurophysiology 2
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ROLEOFROUTINE BENZODIAZEPIN IN ELICITING
CLASSICAL EEGRESPONSE IN SUSPECTED SUB-
ACUTE SCLEROSING PANENCEPHALITIS (SSPE)
CASES
Y.S. Chowdhury, N.C. Saha
National Institute of Neurosciences, Pediatric Neurology,
Dhaka, Bangladesh
Purpose: This ongoing study was undertaken with a view to improving
classical EEG sensitivity after routine IV Benzodiazepine during EEG
recording in a resource poor country like Bangladesh. The purpose of the
study is therefore to find out necessity of administration of Benzodi-
azepine during EEG recording of SSPE cases and to compare the efficacy
of Diazepam andMidazolam in eliciting EEG pattern.
Method: It is a clinical trial done on consecutive suspected cases of
SSPE based on clinical and positive measles antibody in serum/CSF. Dia-
zepam and Midazolam were given IV during EEG recording on alternate
cases.
Results: In Diazepam group, 3 (50 suggestive %) had typical periodic
slow wave complexes (PSWC) from beginning of EEG recording
which increased in amplitude and more regular after Diazepam. 2
(33.3%)of them had normal EEG even after Diazepam. Interestingly
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1 (16.7%) had normal EEG initially which showed typical PSWC
after Diazepam. In Midazolam group, 3 (60%) had typical PSWC
from the beginning of EEG and the changes after Midazolam was
similar to Diazepam in positive PSWC patients. 1 (20%) developed
PSWC after Diazepam which had normal EEG initially. There was
also 1 (20%) with normal EEG which did not change even after
Midazolam.
Conclusion: At this stage of evaluation of study it is apparent that
Benzodiazepin has a positive impact in eliciting classical EEG finding.
p0495
CLINICALVALUEOF SOURCELOCALIZATIONS
WITHGAMMABANDOSCILLATIONDURING ICTAL
STATE: ANMEG STUDY
W. Jeong*,†, J.S. Kim‡, C.K. Chung*,†,‡
*Seoul National University Hospital, Neurosurgery, Seoul,
Korea, Republic of, †Seoul National University College of
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Purpose: We evaluated the diagnostic value of MEG source localization
for power spectral activity during preictal period in relation with surgical
outcome, and compared the results with manually selected time and
frequency analysis at ictal onset.
Method: Data for 13 epilepsy patients who showed an ictal event during
MEG were analyzed. Several seconds of preictal data were localized in
the theta, alpha, beta, and gamma bands by using wavelet transformation
and the sLORETA algorithm. The same analysis was performedwith nar-
row time and frequency band. Localization concordances to the surgi-
cally resected area were compared.
Results: Source localization in the gamma band for a 10 s window
before ictal onset showed best concordance to the resection cavity. Eight
of 13 patients showed sub-lobar concordance in the 10 s gamma band
localization, whereas 3 showed concordance in the narrow time and fre-
quency analysis. In terms of surgical outcome and pathology, 4 of 7
patients with focal cortical dysplasia pathology achieved seizure free out-
come and all of 4 patients showed sub-lobar concordance, whereas none
of remaining 3 showed the concordance. Moreover, 2 of 4 showed no
abnormal findings onMRI.
Conclusion: A 10 s time window gamma source localization method can
be used to delineate the epileptogenic zone. The use of a long period dur-
ing preictal gamma source localization has the potential to become a
localizing biomarker of the epileptogenic zone in candidates for surgical
intervention, especially in MRI-suspected FCD or even non-leisonal
cases.
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INITIAL EEG PATTERNSASANADJUNCTIVE
PROGNOSTIC INDICATOR INCARDIACARREST
PATIENTS UNDERGOINGTHERAPEUTIC
HYPOTHERMIA
J.M. Chung*, D. Maher†, H. Tran‡, M. Nuno*, W.Q. Yu§,
A. Moheet*
*Cedars-Sinai Medical Center, Neurology, Los Angeles, CA,
USA, †Cedars-Sinai Medical Center, Anesthesiology, Los
Angeles, CA, USA, ‡University of NewMexico, Neurology,
Albuquerque, NM, USA, §University of California, Irvine,
Neurology, Orange, CA, USA
Purpose: Continuous EEG (cEEG) is used frequently to provide real-
time neurological information in post cardiac arrest (CA) patients under-
going therapeutic hypothermia (TH) and medically induced coma. We
set to investigate if specific EEG pattern correlates with outcome.
Method: We retrospectively identified 83 consecutive post CA patients
who have undergone TH and cEEG. cEEG was started within 6 hours of
initiating TH and continued past 24 hours after the patient had achieved
normal body temperature. The findings were categorized into the follow-
ing groups: diffuse slowing, epileptiform abnormality/seizure, burst sup-
pression, background attenuation, and isoelectric background.
Neurologic outcomes were measured at discharge according to Glasgow-
Pittsburg Cerebral Performance Category (CPC) 5-point scale.
Results: Of the 83 post CA patients included in this study, 29 had ini-
tial cEEG pattern of diffuse slowing, 24 burst suppression, 23 back-
ground attenuation, 3 epileptiform abnormality/seizures, and 4
isoelectric background. Seven of 29 (24.1%) patients with initial cEEG
showing diffuse slowing did not survive. In comparison, the mortality
rate of patients with initial cEEG patterns of isoelectric background,
epileptiform abnormality/seizure, burst suppression, and background
attenuation were 100% (4/4), 66.7% (2/3), 66.7% (16/24), and 87% (20/
23), respectively. Among those who survived, 12 of 22 (54.5%) patients
with initial cEEG pattern of diffuse slowing had good neurological out-
come (CPC scores 1-2) whereas the ratios for those with isoelectric
background, burst suppression, and background attenuation were 0%,
25%, 33.3%, respectively.
Conclusion: Similar to previous studies, the survival in our patients was
poor. However, 54.5% of those who had initial cEEG patterns of diffuse
slowing had good neurological outcome. Thus, the finding of diffuse
slowing as an initial cEEG pattern may be an adjunctive indicator for
prognosis at the onset of TH for post CA patients in whom the neurologi-
cal examination findings are of limited reliability.
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CORRELATION BETWEENHIPPOCAMPAL
CONNECTIVITYANDMEMORYPERFORMANCE IN
MESIAL TEMPORAL LOBEEPILEPSY
S.-H. Jin*, C.K. Chung*,†,‡
*Seoul National University Hospital, Department of
Neurosurgery, Seoul, Korea, Republic of, †Seoul National
University College of Medicine, Department of Neurosurgery,
Seoul, Korea, Republic of, ‡Seoul National University College of
Natural Sciences, Department of Brain and Cognitive Sciences,
Seoul, Korea, Republic of
Purpose: Left mesial temporal lobe epilepsy (mTLE) patients generally
show greater impairment in memory than right mTLE patients. Since
memory function is associated with the function of the hippocampus in
the brain, we hypothesized that hippocampal connectivity would be dif-
ferent between right and left mTLE patients and might be correlated with
memory performance.
Method: We investigated the resting state functional connectivity with
mutual information at the source level with magnetoencephalography in
41 mTLE (left mTLE: 22, right mTLE: 19) patients who had hippocam-
pal sclerosis that was surgically removed and who were postoperatively
seizure free (>2 years of follow-up) in the theta, alpha, beta, and gamma
frequency bands. Network-based statistics (Zalesky et al., 2010) was per-
formed to identify which functional connectivity would be statistically
different between groups (t-value threshold = 3.8, and 10,000 permuta-
tions with a p-value <0.01 as significant).
Results: Left mTLE patients showed more impaired verbal delayed
memory function than right mTLE patients. We found that functional
connectivity between the right hippocampus (HIP_R) and the left mid-
dle frontal gyrus (F2_L) in the theta frequency band was stronger in
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right mTLE patients than left mTLE patients. More interestingly, func-
tional connectivity between HIP_R and F2_L in the theta frequency
band was positively correlated with verbal delayed memory perfor-
mance.
Conclusion: Our results suggest that more impaired verbal delayed
memory function in left mTLE patients than right mTLE patients might
be attributed to the decreased hippocampal connectivity in the theta
frequency band.
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FRONTAL INTERMITTANTRHYTHMICDELTA
ACTIVITY (FIRDA): CLINICALANDLABORATORY
CORRELATES IN 20 PATIENTS
S. Ciftci, A. Ekinci, A. Tabakoglu, A. Guler, I. Aydogdu,
F. Bademkıran, B. Uludag, N. Arac
Ege University Medical Faculty, Izmir, Turkey
Purpose: Frontal intermittent rhythmic delta activity (FIRDA) is a fre-
quent transient electroencephalographic finding in adults. Its pathophysi-
ologic significance is unknown. So far clinical, laboratory and
neuroimage findings related to FIRDA have been reported in the litera-
ture. In the light of these findings, we want to evaluate our patients and
share the results.
Method: All electroencephalograms (EEGs) with FIRDA between Jan-
uary 2009 - December 2014 at our institution were identified. Demo-
graphic data, clinical history, laboratory results and neuroimaging
studies were recorded.
Results: We identified 20 patients with this electrographic pattern.
FIRDA was detected on EEGs recorded at the time of hospital admission
or during clinical follow up. Age of patients ranged from 23 to 74 years.
11 of them were female and 9 were male. Chronic illness was present in 8
patients. 3 patients were epileptic before and 2 were pregnant. EEGs were
performed because of history of seizures in 7 patients, altered state of
consciousness in 10 patients, forgetfulness in 1 patient, speech distur-
bance in 1 patient. In 1 patient there was no any complaint. Normal back-
ground activity was observed in 3 cases. Epileptic discharges
accompanying FIRDA were seen in 3 patients. Amongst the 20 patients
with FIRDA, 5 had asymmetric pattern on EEG. Renal function impair-
ment was present in 1 patient and 1 patient had elevated serum ammonia
level. Cranial magnetic resonance imaging was abnormal in 9 of 19.
Intrahemispheric lesions, hemorrhage, encephalomalacia, tumor, were
present in 5, and basal ganglia hemorrhage in 1. In 1 patient, hydro-
cephalus was detected.
Conclusion: FIRDA can be seen with a variety of conditions and is not a
specific marker of brain tumor, hydrocephalus or encephalopathy.
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THE EPILEPTIC BRAIN: A STRESSFULNETWORK
J.M. den Heijer*, J.S. van Campen*, W.M. Otte*, L. Hompe†,
W. Zweiphenning*, J.W. Sander†,‡, K.P. Braun*, E. van
Diessen*, M. Zijlmans*,†
*University Medical Center Utrecht, Utrecht, Netherlands,
†SEIN – Stichting Epilepsie Instellingen Nederland, Heemstede,
Netherlands, ‡University College London, London, UK
Purpose: People with epilepsy show EEG functional network alter-
ations, most prominently in the theta frequency band. Stress is one of the
main seizure-precipitating factors in epilepsy. Cortisol, one of the main
stress hormones, has not yet been investigated in relation to functional
network changes. We attempted to study the effect of the natural circa-
dian rhythm of cortisol on global network characteristics in patients with
epilepsy.
Method: Long term EEG recordings and cortisol samples were available
of 17 subjects diagnosed with focal epilepsy. Saliva samples were
acquired to measure cortisol concentration every 15 minutes over a per-
iod of 5 hours following awakening. For every saliva sample taken, we
selected up to four EEG epochs of 4 seconds each. The phase lag index
(PLI) was used to compute an undirected weighted network and a mini-
mum spanning tree (MST). Then we calculated the normalized shortest
path (lambda) and the MST diameter, both measurements of global inte-
gration, lower in a more random network as opposed to an ordered net-
work. We compared lambda and MST diameter (theta band) to cortisol
levels using a linear mixed model.
Results: We found lambda to decrease slightly when cortisol increased
(estimate: 0.00042, p-value: 0.02). We found no time lag between
cortisol and lambda. MST diameter did not decrease (estimate:
0.00088, p-value: 0.65). We did not yet study the influence of potential
confounders.
Conclusion: These preliminary findings suggest a tendency towards a
more random global network as cortisol increases. Further analyses are
needed to interpret the data correctly to understand how this might influ-
ence seizure susceptibility. This study invites to evaluate the effect of
stress and cortisol in epilepsy from a graph analytical perspective.
p0500
COMPARISONOFAUTOMATICANDVISUALHIGH
FREQUENCYOSCILLATIONS DETECTION
I. Doležalová*, J. Cimbalník†, M. Brazdil*
*Masaryk University, Brno Epilepsy Center and CEITEC, Brno,
Czech Republic, †Internation Center for Clinical Research
(ICRC), Brno, Czech Republic
Purpose: To compare automatic and visual high frequency oscillation
(HFO) detection.
Methods: We compared automatic and visual high frequency oscilla-
tions (HFO) detections in 5 patients. HFO were automatically detected
by a custom made matlab detection algorithm. First, the signal in the
statistical window (10 s) was filtered in a series of overlapping fre-
quency bands. Power envelopes and the frequency stability between
narrow band signal and broad band signal were computed. HFO detec-
tions were obtained by thresholding the normalized dot product of the
power envelopes and frequency stability. To increase algorithm speci-
ficity amplitude, frequency stability and duration thresholds, previously
obtained from HFOs marked by expert reviewer, were applied on puta-
tive HFO. This automatic detection was compared with visual HFO
analysis.
Results: We reached excellent congruence between manual and auto-
matic HFO detection measured by Cohen0s kappa (Ƙ = 0.8).
Conclusion: We manged to prove excellent concordance between auto-
matic and visual HFO detection.
p0501
A FUNCTIONALCONNECTOMEOFTHEHUMAN
BRAIN, BASEDON INTRACRANIAL ELECTRICAL
STIMULATION
C. Donos*, M. Maliia†, I. Mindruta†,‡, J. Ciurea§,
A. Barborica*,¶
*University of Bucharest, Bucharest, Romania, †University
Emergency Hospital Bucharest, Bucharest, Romania, ‡Carol
Davila University of Medicine and Pharmacy, Bucharest,
Romania, §Bagdasar-Arseni Hospital Bucharest, Bucharest,
Romania, ¶FHC Inc., Bowdoin, ME, USA
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Purpose: Several MRI and DTI methods already delivered a whole brain
connectome, however none of them are able to probe the brain connectiv-
ity using native signaling: electrical pulses. The study of cortico-cortical
evoked potentials using high-density stereoelectroencephalographic
(SEEG) recordings represents perhaps the most direct way of exploring
brain connectivity. However, SEEG investigations are limited to the
patients with drug-resistant epilepsy, which may present disrupted con-
nectivity patterns. In order to dissociate pathological from physiological
connectivity, we propose a method that combines individual patient’s
connectivity with saliency maps and epileptogenicity of the cortical areas
calculated retrospectively on a larger patient dataset.
Method: 16 patients with refractory epilepsy were implanted with depth
electrodes for presurgical evaluation. Single pulse electrical stimulation,
using biphasic pulses with 3 ms pulse duration and current intensity in
the 0.25–5 mA range was applied to each pair of adjacent contacts and
responses evoked by stimulation were recorded from other contacts
located in remote brain areas. We calculated the RMS value over the 10–
110 ms interval after each stimulation pulse. We considered that a con-
tact is activated by stimulation if the responses are correlated with the
stimulation current (Spearman’s r > 0.5, p < 0.05) and the mean RMS
value across all stimulation pulses in a trial is higher than the 3rd quartile
value (Q3) of all the responses recorded within a patient. Responses from
the activated contacts were weighted by the epileptogencity of each area
and averaged for each patient. Further weighting was performed by cal-
culating the saliency of each non-pathological connection in the patient
database. The directionality of the connections was assessed by pairwise
analysis of stimulated structures.
Results: We obtained the physiological functional connectivity between
68 brain structures from both hemispheres.
Conclusion: Through direct electrical stimulation, we deliver a physio-
logical functional connectome covering a large number of brain struc-
tures, including the directionality of connections.
Clinical Neurophysiology 3
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ENLARGINGTHE SPECTRUMOF SCN8A-RELATED
EPILEPTIC SYNDROMES
E. Gardella*,†, G. Rubboli*,‡, J. Larsen*,‡, F. Becker§,
J. Schubert§, J. Lemke¶, G. Kluger**, S. Syrbe¶, B. Jepsen*,
P. Gellert*, M. Nikanorova*,†, H. Hjalgrim*,†, S. Beniczky*,††,
H. Lerche§, Y.G. Weber§, R.S. Møller*,†
*Danish Epilepsy Centre, Dianalund, Denmark, †University of
Southern Denmark, Odense, Denmark, ‡University of
Copenhagen, Copenhagen, Denmark, §University of Tübingen,
Tübingen, Germany, ¶University of Leipzig, Leipzig, Germany,
**Sch€on Klinik Vogtareuth, Vogtareuth, Germany, ††Aahrus
University, Aarhus, Denmark
Purpose: Mutations in SCN8A-gene, encoding a voltage-gated sodium
channel, have been recently associated with more or less severe mental
retardation, epilepsy and neurological deficits (Larsen et al, 2014). We
aim to further describe the heterogeneous phenotypic pictures of SCN8A-
related epilepsy.
Method: We compared the clinico-neurophysiologic data of patients
with SCN8A-mutation.
Results: We identified three different clinico-neurophysiologic sub-
types: 1) Sporadic patients with de novo heterozygous mutations of
SCN8A, presenting with early onset severe drug resistant epilepsy, cogni-
tive deterioration, pyramidal/extra-pyramidal signs and SUDEP (ca.12%
of this cases). Patients had both generalized and focal prolonged seizures,
with prominent hypomotor and vegetative symptoms, evolving to sec-
ondary generalization. EEG showed progressive background deteriora-
tion with epileptic abnormalities predominant in the posterior regions.
2) Sporadic patients with de novo heterozygous mutations of SCN8A,
presenting with mild to moderate intellectual disability, mild or none
neurological signs and drug resistant epilepsy with extended seizure-free
periods. EEG showedmultifocal epileptiform abnormalities.
3) Interestingly, three unrelated families with the same SCN8A mis-
sense mutation presented with a very mild form of epilepsy, remitting
before puberty, and not associated with any cognitive or neurological
deficit. Interictal EEG was either normal or showed non specific diffuse
abnormalities in all adult affected members.
Conclusions: We provide new data that further enlarge the phenotypic
spectrum of SCN8A-related epilepsy including familial and sporadic
cases, ranging from severe early onset encephalopathy with epilepsy,
milder form of drug resistant epilepsy to familial cases with a very mild
form of epilepsy.
p0505
UTILITYOFELECTROENCEPHALOGRAPHYATAUS
TERTIARYCAREMEDICAL CENTER
K. Gururangan*, B. Razavi†, J. Parvizi†
*Stanford University School of Medicine, Stanford, CA, USA,
†Stanford University, Laboratory of Behavioral and Cognitive
Neurology, Stanford, CA, USA
Purpose: Electroencephalography (EEG) is a common but resource-
intensive diagnostic test for real-time assessment of brain function. We
aimed to assess the utility of EEG at a top tertiary care center in the US to
determine its diagnostic yield and accessibility.
Method: Our retrospective chart review sampled continuous EEGs
(cEEGs) from ICU (n = 100) or inpatient wards (n = 100) and spot
EEGs (sEEGs) in the ED (n = 100). Diagnostic yield was assessed as the
percentage of EEGs found to be abnormal. Accessibility (time to EEG, in
hours) was calculated as the time from study request to the study’s start.
Access predictors (ward, priority, time, and day of week) were coded as
dichotomous independent variables. EEG result was coded according to
Crepeau et al.’s (2013) guidelines. Differences in time to EEG associated
with categorical predictors were evaluated with Kruskal-Wallis one-way
ANOVA.
Results: While the indication for EEG was to rule out seizures (90%
ICU, 100% inpatient/ED), only 8.5% of cEEGs (ICU 9%, inpatient 8%)
and 1% of sEEGs revealed seizure activity. Epileptic discharges were
reported in 24% ICU, 21% non-ICU and 8% ED cases. The median (and
maximum) time to EEG was 2.4 (20) for ICU, 2.8 (26) for inpatient, and
1.5 (23) for ED, and by result was 1.9 (26) for normal, 1.9 (17) for mildly
abnormal, 2.6 (21) for moderately abnormal, and 2.2 (24) hours for
severely abnormal (p = 0.183). Median time to EEG was lower by 0.1
for stat requests (p = 0.32), 0.8 for studies during work-hours (p = 0.01)
and 0.9 for studies on weekdays (p = 0.05).
Conclusion: Our study demonstrates reduced yield and imperfect acces-
sibility of EEG, which together underscore the importance of not only
optimizing current hospital routines to greatly improve the utility of the
EEG in guiding appropriate therapy, but also devising novel EEG devices
that provide faster, point-of-care information about brain function.
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RELATIONSHIP BETWEEN ICTALEEGAND
NEUROIMAGING FINDINGS IN PATIENTSWITH
TEMPORAL LOBEEPILEPSY
I. Itabashi*, K. Jin*, S. Sato†, M. Iwasaki‡, Y. Kitazawa*,
K. Kato*,§, Y. Kakisaka*, M. Fujikawa*, N. Nakasato*
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*Tohoku University Graduate School of Medicine, Department
of Epileptology, Sendai, Japan, †Tohoku University Graduate
School of Medicine, Department of Diagnostic Radiology,
Sendai, Japan, ‡Tohoku University Graduate School of
Medicine, Department of Neurosurgery, Sendai, Japan, §Tohoku
University Graduate School of Medicine, Department of
Neurology, Sendai, Japan
Purpose: Classifications of ictal EEG findings in patients with temporal
lobe epilepsy (TLE) have been proposed. Recently, neuroimaging studies
including 3-tesla MRI and FDG-PET have been widely used for presurgi-
cal evaluation. However, the relationship between ictal EEG and neu-
roimaging findings has not been clarified. This study compared the ictal
EEG findings with the suspected etiology/neuropathology based on neu-
roimaging findings in patients with TLE.
Method: This study included 21 patients who had complex partial sei-
zures with electro-clinical diagnosis of TLE (8 men, 12–54 years). All
patients underwent long-term video EEG monitoring, 3-tesla MRI, and
FDG-PET for presurgical evaluation. The patients were classified into
the following 3 groups based on MRI and FDG-PET findings: Group A,
hippocampal atrophy (HA) on MRI and temporal hypometabolism (TH)
on FDG-PET; Group B, no HA but TH; and Group C, neither HA nor TH.
A total of 62 seizures from these patients were retrospectively reviewed
and ictal EEG findings assessed during the initial 10 seconds and 10 to
30 seconds after onset.
Results: Five of 7 patients in Group A showed temporal rhythmic delta
activity during the initial 10 seconds followed by temporal rhythmic
theta activity during the 10 to 30 seconds after onset. Five of 7 patients in
Group B showed temporal rhythmic alpha-theta activity during the initial
10 seconds evolving to theta-delta activity. Seven patients in Group C
presented with various ictal EEG patterns including initial attenuation of
background activities.
Conclusion: The present study identified characteristic ictal EEG find-
ings corresponding to HA and TH. Rhythmic delta followed by theta
activity indicated seizures arising from the hippocampus, especially hip-
pocampal sclerosis. Rhythmic alpha-theta followed by delta activity indi-
cated seizures arising from the neocortex of the temporal lobe, especially
focal cortical dysplasia.
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RELATIONSHIP BETWEENCARDIACAUTONOMIC
DYSREGULATIONAND SEIZURELATERALIZATION
IN PATIENTSWITHFOCAL EPILEPSY
K. Jin*, N. Suzuki*, K. Kato*,†, Y. Kitazawa*, Y. Kakisaka*,
M. Iwasaki‡, M. Fujikawa*, N. Nakasato*
*Tohoku University Graduate School of Medicine, Department
of Epileptology, Sendai, Japan, †Tohoku University Graduate
School of Medicine, Department of Neurology, Sendai, Japan,
‡Tohoku University Graduate School of Medicine, Department
of Neurosurgery, Sendai, Japan
Purpose: Heart rate variability (HRV) is an established parameter for
the assessment of cardiac autonomic regulation, a balanced parasympa-
thetic-sympathetic autonomic activity. Patients with epilepsy show
abnormal HRV during interictal periods, which may correlate with sud-
den unexpected death in epilepsy (SUDEP). However, the clinical factors
associated with abnormal HRV remain unclear, and the relationship
between abnormal HRV and seizure lateralization is controversial. This
study investigated the effect of seizure lateralization on HRV in patients
with focal epilepsy.
Method: The present study included 15 patients with focal epilepsy (4
men, aged 16–51 years; 8 left and 7 right) and 11 with non-epileptic sei-
zures (4 men, aged 15–39 years). EKG for HRV analysis, polysomno-
graphic data for sleep stage, and video EEG monitoring for epilepsy
diagnosis were retrospectively reviewed. HRV spectra consist of high
frequency (HF; 0.15–0.4 Hz) and low frequency (LF; 0.04–0.15 Hz)
regions. Analyses were performed for 3 hours of each wakefulness and
non-rapid eye movement (NREM) sleep recording.
Results: Patients with right hemispheric focal epilepsy showed signifi-
cantly lower HF power during NREM sleep than non-epileptic patients
and patients with left hemispheric focal epilepsy. Patients with left hemi-
spheric focal epilepsy showed significantly higher LF power during
NREM sleep than non-epileptic patients.
Conclusion: Right hemispheric cerebral infarction showed higher corre-
lation with lower abnormal LF and HF than left hemispheric cerebral
infarction. Lower abnormal HF in right hemispheric epilepsy is similar to
stroke, but higher abnormal LF in left hemispheric epilepsy is different
from stroke. The findings were more complex for focal epilepsy com-
pared to stroke, possible because of the irritative effect of the epilepto-
genic focus. Notably, these abnormalities only occurred during NREM
sleep, which may indicate a relationship with SUDEP, which usually
occurs during sleep.
p0508
CLINICAL PRESENTATIONONEPILEPSYVISAVISE
BEHAVIORCHANGE, BY JOANKAGEMA
REGISTEREDNURSEKENYATTANATIONAL
HOSPITAL, NAIROBI, KENYA
J.N. Kagema
Kenyatta National Hospital, Nairobi, Kenya
Introduction: Epilepsy is one of the commonest neurological problems
in the world, and one of the oldest conditions known to mankind. The
belief held in many countries is that a person with Epilepsy is being pos-
sessed by supernatural forces of powers. This has been largely responsi-
ble for stigma against persons living with epilepsy. This has widely held
belief is incorrect as there is now evidence that seizures are as a result of
ABNORMAL ELECTRICAL DISCHARGES in a group of BRAIN
CELLS. This is a clinical presentation and scenario whereby EPILEPSY
can manifest in an ABNORMAL BEHAVIOR resulting to patients being
incaserated in a psychiatric unit. Most of this abnormal behavior is a
symptom or sign of either a seizure will occur. This can be Pre-ictal or
Post-ictal phase. Many patients ‘will present differently before actual sei-
zures occur.
Objectives:  To distinguish behavior change that occurs on, before, and
after a seizure or a convulsion in epilepsy.
 To distinguish the pre-ectal and post-ectal behavior, in patients with
mental disorder due to epilepsy.
 To analyze the trends and issues of behavior change in epilepsy.
Conclusion: What is this syndrome?
New Psychiatric problem?
Is it a new type of seizures?
Could it be side effects of drugs?
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EFFECTSOFHIGHPLASMAESTRADIOL LEVELSON
EEG
K. Sofuoglu*, S. Bodur†, M.T. Kendirli‡, İ. Gün†
*Zeynep Kamil Research and Training Hospital, Obstetrics &
Gynecology, Istanbul, Turkey, †GATA Haydarpasa Training
Hospital, Obstetrics & Gynecology, Istanbul, Turkey, ‡GATA
Haydarpasa Training Hospital, Neurology, Istanbul, Turkey
Purpose: Reproductive hormones in womenmay increase the risk of sei-
zures by lowering the seizure threshold which is especially noteworthy in
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the case of catamenial epilepsy. Although it is widely accepted that estro-
gens have proconvulsant effect, in some studies anticonvulsant activities
were also showed. In this study, we aimed to show the effects of estradiol
(E2) on electroencephalography (EEG) of the women who receiving IVF
(in vitro fertilization) treatment.
Method: Two EEG analyses were performed before and at the peak-E2
levels state in a patient group who will receive IVF treatment. Routine
EEG recordings according to international 10–20 system were obtained
from each patient for about 30 minutes duration. Low and high fre-
quency filters were kept as 0.5 and 70, respectively. Intermittent photic
stimulation was carried out at 1-2-8-10-15-18-20-25-40-50-60 flash fre-
quencies. EEG findings were analyzed by a neurologist. First and sec-
ond EEG results were compared statistically by using Kruskal-Wallis
test.
Results: Thirteen women between the ages from 25 to 37 (mean 30.7)
were enrolled in this study. Basal and peak serum levels of E2 were
measured 53.3  26.7 pg/mL and 2243.2  1255.9 pg/mL, respec-
tively. Abnormal EEG findings were reported % 46.2 of the women
when the first EEG recorded but this percentage was raised to % 61.6 at
the time of the peak-E2 measurement. Slow baseline EEG rhythm and
generalized slow wave discharges were the main abnormalities which
were observed.
First and second EEG results were compared statistically by using
Kruskal-Wallis test.
Conclusion: High dose E2 treatment causes slow baseline EEG activi-
ties and increases generalized slow wave discharges. Tthese findings
might support the hypothesis about estrogens proconvulsant effects.
p0511
SEEG PROPAGATION PATTERNS INDRUG-
RESISTANT TEMPORAL LOBE/TEMPORAL PLUS
EPILEPSYAND ITS CORRELATIONWITHTHE
OCCURRENCEOFORALAUTOMATISMS
M. Ley Nácher, A. Principe, R. Rodrigo Alberto
Hospital del Mar, Epilepsy Monitoring Unit, Barcelona, Spain
Purpose: The oral automatisms are a common finding in clinical symp-
tomatology of patients with TLE. In the current literature the anatomical
correlate resulting in the appearance of the oral automatisms during tem-
poral lobe seizures is not described with invasive studies. We describe
the pattern of ictal propagation and the electrodes involved in the appear-
ance of oral automatisms in a survey of patients with temporal lobe/tem-
poral plus epilepsy studied by SEEG in our center.
Method: A retrospective study of 19 patients implanted between
2011 and 2014. We removed from the analysis extratemporal patients
or those who were implanted with the sole purpose of lateralization
of epilepsy because of the insufficient number of electrodes. The pat-
tern of spread was studied with coherence analysis, and a novel set of
nonlinear analysis tools including techniques that measure permuta-
tion entropy. We analysed whole seizures and seizures up to the event
of interest (oral automatisms). We provide network maps of these
analyses.
Results: Records of 10 patients were analyzed. 9 had oral automatisms.
In 8/9 patients these were produced simultaneously to the involvement of
the entorhinal cortex in the low region of the frequency domain. The most
interesting results come from the analysis of patients who presented sei-
zures with or without oral automatisms. The maps of activation signifi-
cantly differed between the two types of seizures.
Conclusion: Oral automatisms have no lateralization value in temporal
lobe epilepsy but imply participation of the mesial region. The involve-
ment of the entorhinal cortex seems to be a relay access point to the sub-
cortical and cortical structures related with the control of alimentary
primitive reflexes.
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MEGBEAMFORMER FOR ICTAL FAST ACTIVITY
MAPPING: AMPLITUDEVERSUSKURTOSIS
M.Medvedovsky*,†, D. Ekstein‡, D. Inbar‡, T. Gazit*,
I. Klovach*, F. Fahoum*, A. Nissenkorn§,¶, B. Ben-Zeev§,¶,
M.Y. Neufeld*,¶, S. Kipervasser*,¶, U. Kramer*,¶, I. Fried*,¶,
**, Y. Harpaz††
*Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel,
†University of Alabama at BirminghamHelsinki, Helsinki,
Finland, ‡Hadasa Medical Center, Jerusalem, Israel, §Shiba
Medical Center, Ramat-Gan, Israel, ¶Tel-Aviv University, Tel-
Aviv, Israel, **UCLA, Los Angeles, CA, USA, ††Bar Ilan
University, Ramat-Gan, Israel
Purpose: Fast ictal oscillations in EEG and MEG are an important mar-
ker of ictal onset zone (IOZ). The MEG source localization of this activ-
ity, however, is challenging. Synthetic aperture magnetometry (SAM)
beamformer has been demonstrated as a promising tool for ictal and
interictal MEG source localization.
Method: We retrospectively compared the source solutions of two SAM
beamformer approaches: absolute amplitude based SAM (SAM (ampli-
tude)) and excess kurtosis based SAM (SAM (g2)), using the fast (filtered
by 40 and130 Hz) ictal MEG signal of two patients with epilepsy. Patient
1 relapsed after previous surgery, but resection specimen contained par-
tially removed focal cortical dysplasia. Therefore, surgical cavity mar-
gins were used as an epileptogenic zone marker. In Patient 2 the MEG
sources were compared to ictal subdural grid recordings.
Results: In patient 1 SAM (g2) demonstrated both preictal and ictal acti-
vations at resection cavity margin with incremental time-course (mostly
preictal). SAM (amplitude) demonstrated ictal (but not preictal) activa-
tion on the same area. The absolute amplitude rose mostly during the ictal
stage, simultaneously with excess kurtosis drop. In patient 2 SAM (am-
plitude) localized preictal and ictal activation maxima contralaterally to
the invasively proven IOZ. SAM (g2) localized the preictal maximum
anterior to proven IOZ and ictal maximum - to invasively proven IOZ.
Conclusion: SAM (amplitude) and SAM (g2) beamformers provide
non-redundant information complimenting each other in ictal MEG
source localization.
Comorbidities 3
Monday, 7th September 2015
p0514
FRONTALLOBE EPILEPSYANDANXIETY:
BIDIRECTIONALRELATIONS / ANADOLESCENT
CASEREPORT
S. Ayta*, O.T. Poyraz Fındık†, D. Murat†, A. Rodopman Arman†
*Maltepe University, Faculty of Medicine, Neurology, Istanbul,
Turkey, †Marmara University, Faculty of Medicine, Child and
Adolescent Psychiatry, Istanbul, Turkey
Introduction: Frontal Lobe Epilepsy is the second most frequent type of
partial epilepsy and is the disorder that begins in childhood. The relation-
ship between epilepsy and psychiatric disorders, as well as their recipro-
cal interaction, has been confirmed in many studies. Patients with focal
epilepsies have higher incidence of depression, anxiety or psychosis.
Here, we report a case of asymmetric motor seizures after anxiety attacks
in terms of difficulties to diagnose during follow up.
Case: 12 year old boy was admitted with the complaints of 6 years
history of episodes that include locking, contraction with anxiety and
fear, and there was no response to verbal stimuli during attacks. In the
video taken by family, the upward extension of the arms, then flexion of
the right arm, lastly, occuring clonic jerks on head and arms was observed
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during sleep. Neurological examination and cranial MRI were normal.
Synchronous epileptic activity in the midline and right frontosentral
regions, and asymmetric generalized discharges were identified on EEG.
Carbamazepine treatment, been started at another center, was continued.
His mother described that his seizures have decreased but still have
tended to occur after intense fear and anxiety. The diagnosis of General-
ized Anxiety Disorder, Obsessive Compulsive Disorder, Social Phobia
was made following consultation with child psychiatry, and he was
referred for cognitive behavioral psychotherapy. Later, his treatment was
added antidepressant drug. Fear of contraction started to decline, severity
and number of attacks reduced during follow up.
Conclusion: The greater prevalence of mood disorders in persons with
epilepsy is most probable a reflection of a bidirectional relation between
the two issues. The educational and social development of a child with
epilepsy depends not only on seizure control but also on cognitive and
behavioral factors. Cooperation between disciplines offers the best hope
for early diagnosis and treatment of these conditions.
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BRAIN TUBERCULOMASREVEALED BYEPILEPTIC
GENERALIZED SEIZURES AFTER
TUBERCULOSTATIC TREATMENT: ACASEREPORT
D.I. Cuciureanu*,†, I. Moisei Constantinescu*,†, F. Danciu†,
T. Cuciureanu‡
*Gr. T. Popa University of Medicine and Pharmacy, Neurology,
Iasi, Romania, †Emergency Hospital ‘Prof. Dr. N. Oblu’,
Neurology, Iasi, Romania, ‡Gr. T. Popa University of Medicine
and Pharmacy, Iasi, Romania
Purpose: Central nervous system is a rare localization for tuberculosis
(TB) compared to other systems, affecting predominanly children and
immunosuppressed adults. A paradoxical reaction occurring after com-
pletion of appropiate antituberculous therapy, consisting in developp-
ment of intracranial tuberculomas, is rare and may represent a clinical
and radiological challenge.
Method: We present the case of a 25 year old man, imunocompetent,
previously diagnosed with pulmonary tuberculosis and tuberculous
meningitis that successfully underwent antituberculous treatment for
1 year.
Results: The brain imagery performed at the time of the diagnosis
revealed no intraparenchymal TB lesions. Six months after the tuberculo-
static treatment was stopped, the patient presents generalized tonic-clonic
seizures. The neurologic examination shows no focal abnormality. The
initial cerebral CT scanning without contrast was normal and only after
contrast enhancement reveals multiple tuberculomas located both infra
and supra-tentorially. The tuberculostatic therapy is reinitiated, con-
jointly with antiepileptic treatment (levetiracetam), with favorable clini-
cal and radiological outcome at 6 months follow-up interval. We present
the EEG record and CT images.
Conclusion: Seizures are commonly associated with CNS tuberculomas
and most often resolve after successful medical treatment of the underly-
ing CNS tuberculosis. However, these patients should be kept under
observation even after completion of anti-tuberculous treatment.
Keywords: CNS tuberculomas, epilepsy, tuberculostatic therapy
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EFFECTOFVALPROATEONTHE SLEEP
MICROSTRUCTUREOF PATIENTSWITH JUVENILE
MYOCLONIC EPILEPSY
C.S. Nayak*, S. Sinha†, M. Nagappa†, K. Thennarasu‡,
A.B. Taly†
*National Institute of Mental Health and Neurosciences
(NIMHANS), Neurology; Clinical Neurosciences, Bengaluru,
India, †National Institute of Mental Health and Neurosciences
(NIMHANS), Neurology, Bengaluru, India, ‡National Institute
of Mental Health and Neurosciences (NIMHANS), Biostatistics,
Bengaluru, India
Introduction: Studies looking at the effect of epilepsy and/or anti-epi-
leptic medications on the sleep microstructure are sparse. The aim of this
study was to compare the sleep microstructural characteristics of drug
na€ıve patients with juvenile myoclonic epilepsy (JME) and those on val-
proate monotherapy.
Methods: This prospective study included subjects who underwent over-
night polysomnography (3 subgroups- 20 each): group 1- drug na€ıve
JME (mean age: 21.2  4.06 years; women = 9), group 2 - JME on val-
proate (mean age: 21.85  4.28 years. women = 11); group 3-controls
(mean age: 21.85  4.28 years; women = 9). Scoring and analysis of
arousals [ASDA (2002)] and cyclic alternating pattern (CAP) [Terzano
et al (2002)] parameters was performed. Kruskal-Wallis test followed by
pairwise comparisons [Tukey and Kramer (Nemenyi) test] between 3
groups (p ≤ 0.05) was done.
Results: The arousal indices were comparable among the 3 groups, both
during NREM (p = 0.607) and REM (p = 0.123) sleep. The overall CAP
rate was higher in group 1 (p < 0.001) and 2 (p < 0.001) compared to
controls. The CAP cycle and sequence indices were higher in group 2
compared to controls (p = 0.012) and group 1 (p < 0.001). The duration
of CAP cycles/sequences, phase A1 (p = 0.042) and A2 (p = 0.01)
indices were lower in group 1 compared to controls, and similarly, they
were also lower in group 1 compared to group 2 (p < 0.001). Finally, the
phase A1 percentage (p = 0.003) was lower and A3 percentage
(p = 0.045) was higher in group 1 compared to controls.
Conclusions: We found significant alterations in several CAP parame-
ters in patients of JME (with and without valproate) compared to con-
trols. Valproate significantly increased the CAP cycling and reduced the
duration of CAP cycles and some of the phase A indices suggesting dif-
ferential influence of valproate on arousal mechanisms of patients with
JME, thereby altering the sleep integrity and microstructure.
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ADHD-LIKE BEHAVIOURAL PROFILE INDOGSWITH
IDIOPATHIC EPILEPSY
R.M. Packer*, E. Davies*, Y. Pan†, B. Zanghi†, T.H. Law*,‡,
H.A. Volk*
*Royal Veterinary College, Clinical Science and Services,
Hertfordshire, UK, †Nestle Purina Research, St Louis, MO,
USA, ‡Imperial College London, Department of Surgery and
Cancer, London, UK
Purpose: Psychiatric disorders are common comorbidities in human
patients with epilepsy, with attention-deficit/hyperactivity disorder
(ADHD) one of the most common co-occurring disorders alongside
depression and anxiety. ADHD-like behaviours have also been observed
in laboratory rat models of epilepsy. Naturally occurring epilepsy in the
domestic dog could mirror human epilepsy; however, the behavioural
profiles of these dogs have been little studied thus far. The purpose of the
study was to examine the behavioural profile of dogs with epilepsy to see
if they exhibit ADHD-like symptoms similar to rodent models and
humans with epilepsy.
Method: Twenty-one dogs diagnosed with epilepsy were fed the same
diet consistently for 3 months (as previous studies have shown dietary
effects upon ADHD symptoms). Owners completed a validated beha-
vioural questionnaire to measure 11 defined behavioural domains at the
end of the study to report their dogs’ behaviours in this time period. All
dogs were suspected to have idiopathic epilepsy based on an unremark-
able MRI scan and CSF analysis; no clinically significant findings on
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haematology and biochemistry or dynamic bile acid results; and unre-
markable interictal neurological examination. All dogs were receiving
anti-epileptic drugs.
Results: The three most prominent behavioural factors of the 11 mea-
sured were excitability (meanSD: 1.92  0.57), chasability
(1.84  0.97) and attachment/attention seeking (1.30  0.62), mirror-
ing behavioural traits of humans with epilepsy and ADHD. In contrast,
the ‘trainability’ behavioural domain was relatively low (0.41  0.57),
with two thirds of owners reporting that their dog is ‘always’ easily dis-
tracted by interesting sights, sounds and smells.
Conclusion: Our data suggests that dogs with actively treated idiopathic
epilepsy may exhibit behaviours that mirror ADHD found in children
with epilepsy, and rat models of epilepsy, adding further evidence to the
notion that there may be common neurobiological mechanisms present in
epilepsy and ADHD.
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KNOWLEDGEOFEPILEPSY BYCAREGIVERS
WORKING INAN INSTITUTION FOR PEOPLEWITH
AN INTELLECTUALDISABILITY
H.P.J.A. Peeters*, G.A. Graveland*, R. Soekhoe*,
T.H.J. Meijs†, J.H.J. Schelhaas‡
*Kempenhaeghe, Oosterhout, Netherlands, †HANUniversity of
Applied Sciences, Nijmegen, Netherlands, ‡Kempenhaeghe,
Heeze, Netherlands
Purpose: To acquire information regarding the required knowledge with
respect to epilepsy according to the guidelines of The Dutch Association
of Doctors for Intellectual Disabled (NVAVG) for caregivers, working in
an organization for patients with intellectual disability (ID).
Method: The guideline of the NVAVG specifically indicates the
required information with respect to epilepsy for caregivers working in
an organization for patients with ID. To asses whether the knowledge of
the caregivers is in line with this guideline, an epilepsy questionnaire was
taken among 135 caregivers, working within a care facility in the south-
west of the Netherlands. The questionnaire contained 30 “true”, “false”
or “don’t know” questions about epilepsy.
Results: According to the test the knowledge was adequate in 44 (34%)
caregivers. In 53 (40%) caregivers the knowledge was just reasonable
and in 34 (26%) caregivers the knowledge was insufficient. Scores were
divided in items as described by the NVAVG guidelines. The scores on
general items like: “forms of epilepsy”, “anti- epileptic drugs” and were
relatively adequate. In contrast, knowledge for example with respect to
“seizure types”, “risk factors of epilepsy and precepts” was relatively
poor. Caregivers with a nursing background, those working fulltime as
well as those who had followed an learning module on epilepsy per-
formed significantly better.
Conclusion: We conclude that the knowledge of epilepsy is, according
to the guidelines of the NVAVG not sufficient in caregivers working with
patients with both ID and epilepsy. Our results suggests that investment
in the nursing staff and training of staff might improve the quality of care.
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THEANTI-DEPRESSION EFFECTOFXYLARIA
NIGRIPES IN PATIENTSWITHEPILEPSY: A
MULTICENTERRANDOMIZEDDOUBLE-BLIND
STUDY
W. Peng*, X. Wang*, Z. Hong†, G. Zhu†, B. Li‡, Z. Li§,
M. Ding¶, Z. Geng**, Z. Jin††, L. Miao‡‡, L. Wu§§, S. Zhan¶¶
*Zhongshan Hospital, Fudan University, Shanghai, China,
†Huashan Hospital, Fudan University, Shanghai, China,
‡Epilepsy Center of the Second Affiliated Hospital of
Guangzhou Medical University, Guangzhou, China, §The First
Municipal Hospital of Guangzhou, Guangzhou, China, ¶The
Second Affiliated Hospital of Zhejiang University School of
Medicine, Hangzhou, China, **The Sixth People’s Hospital of
Shanghai Jiaotong University, Shanghai, China, ††The Fifth
People’s Hospital, Fudan University, Shanghai, China, ‡‡Renji
Hospital, Shanghai Jiaotong University, Shanghai, China,
§§Peking Union Medical College Hospital, Shanghai, China,
¶¶Shanghai Medical College, Fudan University, Shanghai,
China
Purpose: The comorbidity of depression in patients with epilepsy is
common and treatment is still controversial. This pilot study was aimed
at evaluating the efficacy and safety of Xylaria nigripes for treating
depressive symptoms in patients with epilepsy during 12 weeks of treat-
ment.
Method: A multicenter, double-blind, placebo-controlled, randomized
superiority study was performed. A total of 104 patients with epilepsy
who fulfilled the study criteria were randomized 1:1 to receive Xylaria
nigripes (the Wu Ling group) or placebo (the placebo group) treatment in
the 12-week period of study. The participants were visited on weeks 0, 2,
4, 8, and 12 of the treatment course.
Results: Eighty-one patients finished all of the visits. The primary effi-
cacy endpoint in this study was the total effective rate for depression,
which was significantly greater in the Wu Ling group (51.3%, n = 39)
than in the placebo group (35.7%, n = 42, 0.51 and 0.36 = 0.15, 95%CI -
0.06~0.37, U = 2.83, P = 0.002) after 12 weeks of treatment. No differ-
ences in seizure frequency or changes in severity were found between the
Wu Ling and the placebo groups. In addition, the quality of life and sei-
zure worry subscale scores in patients with epilepsy were also improved
more notably in the Wu Ling group than in the placebo group (p < 0.05).
Most of the adverse effects (AEs) in this study were mild and there were
no differences between the Wu Ling and the placebo groups. The reasons
for dropout were mostly due to withdrawal of consent or AEs.
Conclusion: Xylaria Nigripes can alleviate depressive symptoms with
12 weeks treatment and is well tolerated in patients with epilepsy.
p0521
UPREGULATEDEXPRESSIONOFN-METHYL-D-
ASPARTATERECEPTORNR2B SUBUNIT AND
EPILEPSY-ASSOCIATEDDEPRESSIVE BEHAVIOURS
IN LITHIUMCHLORIDE-PILOCARPINE RAT
EPILEPSYMODEL
W. Peng, X. Wang, J. Ding, X. Li, F. Fan, Q. Zhang
Zhongshan Hospital, Fudan University, Shanghai, China
Purpose: Depression is a common comorbidity in patients with epilepsy
with unclear mechanisms. This study is to explore the role of glutamate
N-methyl-D-aspartate (NMDA) receptor NR1, NR2A and NR2B sub-
units in the comorbidity of epilepsy and depression.
Method: Lithium chloride (Licl)-pilocarpine chronic rat epilepsy model
was established, and rats were divided into epilepsy with depression
(EWD) and epilepsy without depression (EWND) subgroups based on
forced swim test. Control Rats were also administered Licl but used sal-
ine instead of pilocarpine. Expression of NMDA receptor NR1, NR2A
and NR2B subunits was studied by western blot and immunofluorescence
methods.
Results: No differences of spontaneous recurrent seizure (SRS) counts
and latency were found between EWD and EWND groups. Immobility
time (IMT) was significantly greater in EWD group than in EWND
group. The number of NeuN positive cells was significantly less in Licl-
Pilocarpine model group than Control group, but had no difference
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between EWD and EWND groups. The ratios of p-NR1/NR1 and p-
NR2B/NR2B were significantly greater in the hippocampus in EWD
group than in EWND group. Selective blockage of NR2B subunit with
ifenprodil could alleviate depressive behaviour of Licl-pilocarpine rat
epilepsy model.
Conclusion: In conclusion, NR2B subunit of glutamate NMDA receptor
was involved in the pathogenesis of comorbidity of epilepsy and depres-
sion, and might be a target for treating epilepsy-associated depression.
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PROFILING SOCIALCOGNITION IN PEOPLEWITH
EPILEPSY: EVIDENCE FOR SHAREDMECHANISMS
BETWEENEPILEPSY ANDAUTISM SPECTRUM
DISORDER
A.E. Richard*, I.E. Scheffer†,‡,§, S.J. Wilson*,†,‡
*The University of Melbourne, The Melbourne School of
Psychological Sciences, Melbourne, Australia, †Comprehensive
Epilepsy Program, Austin Health, Melbourne, Australia,
‡Florey Institute of Neuroscience and Mental Health,
Melbourne, Australia, §The University of Melbourne,
Departments of Medicine and Paediatrics, Melbourne, Australia
Purpose: We conducted meta-analyses to determine if features of autism
spectrum disorder (ASD) are found in people with epilepsy (PWE) with-
out intellectual disability. We also investigated how demographic (age,
IQ, sex) and epilepsy-related factors (seizure onset age, frequency, dura-
tion, laterality and focus) relate to the expression of ASD features. We
hypothesized that phenotypic traits of ASD, such as poor facial emotion
recognition (FER) and theory of mind (ToM), would be more common in
PWE than healthy controls. We also compared our findings in PWE with
findings of relatives of individuals with ASD (ASD-relatives) compared
to controls.
Method: A systematic search of studies examining FER and ToM in
PWE versus controls, and in ASD-relatives versus controls, was con-
ducted across three databases: PubMed, PsycINFO, and Current Contents
Connect. Four meta-analyses were conducted to examine objective mea-
sures of FER and ToM in PWE and ASD-relatives. Further meta-ana-
lyses, ANOVA, and meta-regressions examined the relationship of
demographic and epilepsy-related factors to social cognition.
Results: Thirty studies of PWE (N = 1434: 77% TLE, 10% extra-TLE,
5% GGE) and 21 of ASD-relatives (N = 1284) were ascertained. FER
and ToM were reduced in PWE compared to controls (p < 0.001)
whereas only ToM was reduced in ASD-relatives compared to controls
(p < 0.001). Effect sizes indicated that ToM was poorer in PWE than
ASD-relatives. There were no significant associations between FER and
ToM and the demographic or epilepsy-related factors.
Conclusion: Overall, social cognition was poorer in PWE and ASD-rela-
tives compared to controls with a more pronounced ToM deficit in PWE
than in ASD-relatives. These findings suggest shared mechanisms
between epilepsy and ASD, independent of intellectual disability, that
provide intriguing insights into the neurobiology of these disorders.
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DUPUYTREN’S CONTRACTUREANDPROLONGED
TREATMENTWITHPHENOBARBITAL
W. Abdellaoui, S. Bahbouh, R. Benalia, M.R. Belabed, E. Attal,
M. Ait-Kaci-Ahmed
Ait Idir Hospital, EEG Laboratory, Department of Neurology,
Algiers, Algeria
Purpose: Dupuytren’s contracture is a progressive fibrotic condition
affecting the palmar and digital fascia, leading to a progressive and irre-
versible flexion of the fingers. Antiepilepsy drug like Phenobarbital PB
have been implicated in the development of Dupuytren’s contracture.
In our case report on two patients we study the association between
prolonged treatement with PB and Dupuytren’s contracture.
Method: Clinical case report.
Results: Case 1: A 45-year old male had a history of cryptogenic epi-
lepsy with generalized seizure. Since the age of 20 years PB at 100 mg/
day was used in monotherapy. No others significant risk factors for
Dupuytren’s contracture. The patient presented palmar fibromatosis of
the right hand IV and the left one III, severe extension deficit without
pain. PB was substituted by Lamotrigine LTG 50 mg/day. Subsequently
a partial aponeurectomy of the hand was performed. Case 2: A 29-year
old male had a history of symptomatic epilepsy with focal seizures due to
meningitis, was treated since the age of 5 years with PB monotherapy.
The palmar fibromatosis occurred after 24 years of drug therapy at
dosage 200 mg/day. No history of the risk factors for palmar fibromato-
sis. Flexion contracture without pain of the right little finger. PB was sub-
stituted by Levetiracetam LEV 1500 mg/day. Surgical treatment was
performed by partial aponeurectomy.
Conclusion: Phenobarbital PB is implicated in palmar fibrosis. Develop-
ment of Dupuytren’s contractures may take longer after intiation of
Phenobarbital.
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LACOSAMIDE TREATMENT FOR PATIENTSWITH
DRUG-RESISTANCE EPILEPSY
O.O. Erdinc*, D. Ilhan Algın†, G. Akdag*, K.B. Carman‡,
M.F. Yimenicıoglu†
*Eskisehir Osmangazi University Medical Faculty, Department
of Neurology, Eskisehir, Turkey, †Eskisehir Y.E. Hospital,
Department of Neurology, Eskisehir, Turkey, ‡Eskisehir
Osmangazi University Medical Faculty, Pediatric Neurology,
Eskisehir, Turkey
Purpose: Lacosamide (LCM) is a novel anti-epileptic drug (AED) that
enhances the slow inactivation of voltage-gated sodium channels. The
aim of this study was to report the first experiences of using LCM in
patients with drug-resistance epilepsy in Eskisehir, Turkey. To evaluate
the efficacy and safety of lacosamide in 50 patients with uncontrolled sei-
zures.
Methods: Thirty of the patients were male and twenty were female. Fifty
epileptic patients with different etiologies (patients with Lenox-Gastaut
Syndrome, Myoclonic Epilepsy with Ragged Red Fibers, Dandy -Walker
Syndrome, Rett Syndrome, sequelae of cerebral palsy, idiophatic gener-
alized epilepsy, operated medullablastoma, encephalomalacic area in the
left temporal region, cerebral infarction in the left occipital region, liver
embryonal sarcoma operation, gliosis in the left temporal lobe, an autism
spectrum disorder, frontal cortical-subcortical hyperintense lesions, fron-
tal cortical dysplasia, a right frontal cortical-subcortical hyperintense
lesion, post-traumatic epilepsy, post stroke epilepsy) were included in
this report. The seizure types of the patients were generalized tonic-clo-
nic, complex partial, secondary generalised partial seizures and complex
partial seizures in accordance with myoclonias in one. Twelve of the
patients received 4 AEDs, 18 received 3 AEDs, 12 received 2 AEDs, 8
received 1 AEDs.
Results: The mean age of the patients were 29.46 (19–47). The mean
duration time for taking LCM was 8.2 months. LCM therapy was
started between January 2013–March 2015 in these patients. The sei-
zure frequency and severity were reduced < 50% in 8, >50% in 11 and
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50% in 5 patient. Sixteen patients reported complete seizure freedom.
No changes were reported in 5 of the patients yet. In four patients,
instability, difficulty walking, and blurred vision or dizziness were
reported.
Conclusions: The results of this study provide preliminary evidence for
the efficacy of lacosamide in patients with refractory epilepsy.
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THE EFFECTOFTOPIRAMATEONCEREBRAL
GLUCOSEMETABOLISM IN PATIENTSWITH
IDIOPATHICGENERALIZED EPILEPSY
B.E. Joo*, E.Y. Joo†
*Sungkyunkwan University School of Medicine/Samsung
Medical Center, Neurology, Seoul, Republic of Korea,
†Sungkyunkwan University School of Medicine/Samsung
Medical Center, Department of Neurology, Seoul, Republic of
Korea
Purpose: The effect of anti-epileptic drugs (AEDs) on global cerebral-
glucose metabolism or cerebral blood flow may be associated with their
mechanism of action and impact on cognitive performance. Topiramte is
well-known AED to deteriorate cognitive and language function in epi-
lepsy patients, but its detail mechanism and related brain metabolism are
not clear. To investigate the effects of topiramate on cerebral metabo-
lism, we performed 18F-fluorodeoxy glucose positron emission tomogra-
phy (FDG-PET) in patients with drug-na€ıve idiopathic generalized
epilepsy.
Method: FDG-PET was performed twice in 23 patients before and
after topiramate treatment (M/F = 13/10, 23.2  3.5 years) who had
been seizure free for at least 16 weeks. For SPM analysis, paired pre-
and linearly transformed post-topiramate FDG-PETs were spatially
normalized into a standard PET template, provided in SPM-99, using
a 12-parameter affine and a non-linear transformation. Spatially nor-
malized images were then smoothed by convolution by using an iso-
topic Gaussian kernel with a 14 mm full width at half maximum. The
paired t-test was used to compare the pre- and post-topiramate PET
images.
Results: Mean dose of topiramate at the time of post-topiramate FDG-
PET scanning was 244.7  44.7 mg/day. SPM analysis showed the sig-
nificant hypometabolism in the bilateral caudate nuclei, bilateral anterior
cingulate gyri, bilateral anterior thalami, corpus callosun, and white mat-
ters of both fronto-parietal lobes at a level of false discovery rate
p < 0.05 after topiramate administration. No brain region showed post-
topiramate hypermetabolism.
Conclusion: This study is the first to reveal that topiramate treatment
reduces glucose metabolism more in subcortical gray and white matters
such as corpus callosum, which may be related to unavoidable side
effects such as cognitive decline and naming difficulty observed in
patients who have taken topiramate for a long time.
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CLINICAL EXPERIENCEWITHADJUNCTIVE
PERAMPANEL INADULT PATIENTSWITH
UNCONTROLLEDEPILEPSY: A UKAND IRELAND
MULTICENTRE STUDY
S. Kemp*, M. Reuber†, P. Goulding‡, C. Flynn§, N. Delanty§,
E. Shah*
*Leeds Teaching Hospitals NHS Trust, Dept of Clinical and
Health Psychology, Leeds, UK, †Sheffield Teaching Hospitals,
Dept of Neurology, Sheffield, UK, ‡Leeds Teaching Hospitals
NHS Trust, Dept of Neurology, Leeds, UK, §Beaumont Hospital,
Dublin, Dept of Neurology, Dublin, Ireland
Purpose: To derive clinically useful information about the efficacy and
tolerability of adjunctive treatment with perampanel for refractory
epilepsy in an outpatient setting.
Method: We pooled retrospective data from the case notes of adult
patients with refractory epilepsy that had been prescribed perampanel
from 15 hospitals throughout the UK and Ireland.
Results: Three hundred and ten patients were included (mean age 40.9,
50% women, 27.7% with learning disability). The mean duration of epi-
lepsy for these patients was 26.7 years (range 2–67 years) and 91.9%
were taking two or more anti-epileptic drugs at the time of perampanel
initiation. Mean retention time was 6.9 months (range 1 day-
22.3 months). The retention rates were 86% at 3 months, 71% at
6 months, 47.6% at 12 months and 27% at 18 months. At the final fol-
low-up a > 50% reduction in seizure frequency was reached in 39.7% of
those with tonic-clonic seizures, 52.2% of those with complex partial sei-
zures and 45.8% of those with simple partial seizures. 11 patients (3.5%)
became seizure free. Two hundred and nine patients (67.4%) experiences
adverse effects and of these 59.3% withdrew treatment due to their
effects. The most common were sedation, behaviour/mood disturbance,
dizziness, and unsteadiness.
Conclusion: Although few patients in this highly refractory population
described achieved complete seizure control, perampanel was found to
be a safe and effective treatment when used as adjunctive therapy in
patients with uncontrolled partial epilepsy.
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EVALUATIONOFRETINALNERVE FIBER LAYER
WITHOPTICCOHERENCE TOPOGRAPHY IN
PATIENTS USINGVIGABATRIN
B. Tugcu*, D. Ataklı†, S. Kaya‡, B. Tekin Güveli†, M. K€oseoglu†
*Bezmialem Vakif University, Istanbul, Turkey, †Bakirkoy
Research and Training Hospital for Psychiatry, Neurology,
Neurosurgery, Department of Neurology, Istanbul, Turkey,
‡Bakirkoy Sadi Konuk Research and Training Hospital,
Department of Radiology, Istanbul, Turkey
Purpose: To evaluate the thickness of retinal nerve fiber layer (RNFL)
in patients using vigabatrin and to compare the results with healthy con-
trol group.
Method: The patients who have received vigabatrin for the treatment
of epilepsy were included. Inclusion criteria was the absence of eye
pathology and the diseases affecting retina. Healthy control group with
similar age and sex was constituted. The thickness of RNFL was
measured with spectralis optic coherence tomography in all the
participants.
Results: Mean age was 32.96  12.95 years ranging between 6 and 60.
Mean age was 32.64  13.69 in patient group and 33.33  12.62 in con-
trol group. There were 13 (50%) males and 13 (50%) females. No signifi-
cant difference was found in the thickness of temporal and inferior
quadrants between two grous(p > 0.05) However, significant retinal
thinning were observed in nasal and superior quadrants of patientt group
compared to control group (p < 0.01).
Conclusion: Optic coherence tomography is a practical noninvasive
method without need of patient compatibility and it is useful in
the assessment of retina morphologically for the patients using
vigabatin.
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RELATIONSHIP BETWEEN PERAMPANEL
EXPOSURE, SEIZUREOUTCOMESANDTREATMENT-
EMERGENTADVERSE EVENTS (TEAES) IN PATIENTS
WITH PRIMARYGENERALIZED TONIC-CLONIC
(PGTC) SEIZURES IN IDIOPATHICGENERALIZED
EPILEPSY (IGE): A RANDOMIZED, DOUBLE-BLIND
PHASE III STUDY
G. Krauss*, R.T. Wechsler†, F. Bibbiani‡, A. Patten§,
B. Williams‡, H. Yang‡, B. Gidal¶, Z. Hussein§
*Johns Hopkins School of Medicine, Baltimore, MD, USA,
†Idaho Comprehensive Epilepsy Center, Boise, ID, USA, ‡Eisai
Inc, Woodcliff Lake, NJ, USA, §Eisai Ltd, Hatfield, UK,
¶University of Wisconsin, Madison, WI, USA
Purpose: Characterize relationships between perampanel exposure,
PGTC seizure outcomes, and TEAEs in patients with IGE.
Method: Patients aged ≥12 years with IGE and uncontrolled PGTC sei-
zures received placebo or adjunctive perampanel (Study 332;
NCT01393743). Following a 4–8-week Baseline Period, perampanel was
up-titrated over 4 weeks (2-mg/week; target dose 8 mg/day, Mainte-
nance 13 weeks). Primary endpoints were percent change in PGTC sei-
zure frequency per 28 days and 50% responder rate. Pharmacokinetic/
pharmacodynamic models were used to describe relationships between
perampanel exposure and seizure outcomes, and neuropsychiatric
TEAEs of special interest (e.g. hostility/aggression-related TEAEs using
Standardized MedDRAQueries), in an actual dataset of patients with sei-
zures and pharmacokinetic data.
Results: Perampanel reduced PGTC seizure frequency in a log-linear
exposure relationship with no time effect (perampanel, n = 72; placebo,
n = 77) versus placebo. During Maintenance, the model predicted PGTC
seizure frequency reductions of perampanel 62.3% versus placebo 31.7%
for a typical male without concomitant enzyme-inducing AEDs
(EIAEDs). Concomitant EIAED treatment reduced probability of
responding due to lower perampanel exposure (perampanel 8 mg/day: no
EIAEDs 0.85, concomitant carbamazepine 0.80; placebo: 0.39). In the
dataset of exposure-safety assessments (perampanel, n = 73; placebo,
n = 78), median perampanel exposure was higher in patients experienc-
ing hostility/aggression-related TEAEs (n = 12) than in those without,
although concentrations overlapped substantially. High variability in
event probability and low patient numbers prevented formal modeling of
the exposure-AE incidence relationship.
Conclusion: Higher perampanel exposure was associated with greater
reduction in average PGTC seizure frequency and probability of respond-
ing. Median perampanel exposure was higher in patients experiencing
hostility/aggression-related TEAEs versus those without, although con-
centrations overlapped substantially.
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CURCUMINRESIST THEEFFECTOF POST
TRAUMATIC EPILEPSYONMIR-3120 EXPRESSION
P. Kumar, D. Sharma
School of Life Science, Jawaharlal Nehru University, New Delhi,
India
Purpose: Epilepsy is a chronic disorder which is characterized by gen-
eration of seizure which occur due to abnormal excessive or syn-
chronous activity of neurons. In post traumatic epilepsy (PTE) seizures
are developed because of traumatic head injury. MicroRNAs (miRNA)
are evolutionary conserved class of small non-coding RNA which
function as post-transcriptional regulators of gene expression by target-
ing protein-coding mRNAs. So miRNAs can coordinate the expression
genes in response to neuronal activity. miR-3120 is a novel brain
specific mirror-miRNA of class miR-214 already shown much relation
in cell apoptosis. In this study attempts have been made to find relation
of miRNA-3120 with Post traumatic epilepsy. Curcumin is an antioxi-
dant and it have already shown anti-epileptic effects so in this study
we will try to observe the effect of diatery curcumin on miR-3120
expression.
Method: Intracortical injection of FeCl3 dissolved in normal saline (5ul,
100 mM/5 min) was injected to the somatosensory region of rat brain.
Electrophysiological recordings were done to verify the PTE model. Rats
were sacrificed, brain was isolated, microdisected then RNAwas isolated
from cortex and hippocampus. miRNA expression was quantified by RT-
pcr. Bioinformatical Target identification and Comparison of miR-3120
were done. To see the effect of curcumin on this micro-RNA, rats were
fed with normal feed mixed with curcumin at a concentration of
1000 ppm.
Results: Our EEG recording data confirms our PTE model as the
increased burst and Multi unit activity spike count in EEG recording pat-
tern indicates the generation of seizures. Gel pictures shows increase in
expression of miR-3120 with progression of epilepsy.
Conclusion: RT-pcr data shows that there is a relationship of the micro-
RNAwith epilepsy as expression of miR-3120 is increasing with progres-
sion of epilepsy. Decrease in miR-3120 along with simultanious decline
in epileptic bursts is an indicative of beneficial effect of Curcumin on
post-traumatic epileptic seizure.
p0531
GENERALIZED ELECTROENCEPHALOGRAPHIC
FEATURES ANDDRUGRESISTANCE IN JUVENILE
MYOCLONIC EPILEPSY
S. Sezikli*, B. Tekin Güveli*, D. Ataklı*, S. Celiker Uslu*,
H. Sarı*, Z. Kurtpınar†
*Bakirkoy Research and Training Hospital for Psychiatry,
Neurology, Neurosurgery, Department of Neurology, Istanbul,
Turkey, †Bakırk€oy Education and Research Hospital for
Psychiatric and Neurological Diseases, Department of
Neurology, Istanbul, Turkey
Purpose: Juvenile myoclonic epilepsy (JME) is an idiopathic general-
ized epilepsy syndrome characterised by myoclonia, absance and gener-
alised tonic-clonic seizures. Ictal and interictal electro-encephalography
(EEG) demonstrates fast, generalised, usually irregular wave and spike
and polyspike and wave discharge activities. Under appropriate
antiepileptic drugs up to 85% of patients become seizure-free. We aimed
to search the correlations between EEG asymmetry and treatment
response.
Method: Thirty patients with JME who had EEG with asymmetrical
generalized discharge and 15 patients with JME who had EEG with sym-
metrical generalized discharge and 15 healthy controls were included.
Patients were under the valproate treatment. The demographic and clini-
cal features of patients were noted. The patients were divided into two
groups according to their response to antiepileptic drugs.
Results: Of the 45 patients with JME, mean age was 22.89  6.77 years,
34 (75.6%) were female. The mean age of 15 participants from control
group was 23.20  4.72 and 11 of them (73.3%) were female. Mean
VPA dose was 783.33  379.14 mg/day with a range of 250–1500 mg/
day. 30 respondents had asymmetric EEG, while 15 respondents had
symmetric EEG. Thirteen patients were in pharmacoresistant group. The
patients who had asymmetric EEG were more drug resistant and it was
statistically significant.
Conclusion: There is a subgroup of patients with JME who are drug
resistant and the asymmetric EEG features may be associated with drug
resistance.
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PHENOTYPEOPTIMISATION IN EPILEPSYUSINGAN
ELECTRONIC PATIENT RECORD
M.White*, M. Fitzsimons†, L.M. Slattery‡, G.L. Cavalleri‡,
N. Delanty*,‡
*Beaumont Hospital, Division of Neurology, Dublin, Ireland,
†Beaumont Hospital, Department of Medical Physics and
Clinical Engineering, Dublin, Ireland, ‡RCSI, MCT, Dublin,
Ireland
Purpose: Anti-epileptic drug (AED) side-effects are an important phe-
notype in gene discovery research. The fidelity of this phenotype is
highly dependent on the standards used by individual clinicians when
describing a side-effect during clinical documentation at the point of
patient care. Electronic patient records (EPR) can play a key role in opti-
mising phenotypes.
Aim: To illustrate the role of an epilepsy EPR in optimizing the AED
side-effect phenotype.
Method: A centrally hosted, secure web-based epilepsy EPR used in epi-
lepsy centres across Ireland was interrogated to anonymously analyse
data for 4846 individual patients and 9190 AEDs (i.e. average of 1.8
AEDs per patient). When recording the occurrence of side-effects in
association with particular AEDs, EPR users can select from a drop-down
list of 15 items, select “other” and enter a free text comment, select
“none”, or leave the field blank.
Results: Taken as a whole, the side-effect field was left blank for 49% of
AEDs; “none” was selected for 17%; “other” 9%; Cognitive/behavior
7%; fatigue 6%; 2% each for rash, weight gain; 1% each for weight loss,
hyponatraemia, headache, visual symptoms, ataxia, tremor; 0.5% each
for insomnia, visual field constriction, hepatotoxicity; Thrombocytopae-
nia and bone marrow suppression were each selected in <0.5%. Examina-
tion of the “other “ free-text comments showed side-effects such as hair
loss, sleep disturbance etc. It was also possible to demonstrate the profile
of side effects for each of 34 different AEDs.
Conclusion: EPRs facilitate both improved clinical care and the efficient
collection and standardization of phenotypes. Opportunities for enhanc-
ing the side-effect drop-down categories (e.g. commonly used “other”
comments) and for clinician training (e.g. leaving the field blank when
“none” intended) were identified. Using the EPR, interrogation of the
data was conducted in 30 minutes. The traditional paper-based medical
chart could not enable an examination of such a volume of data.
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IMPACTONQUALITYOFLIFE ANDCLINICIAN-
RATEDGLOBAL IMPROVEMENTWITH
ESLICARBAZEPINE ACETATEAS ADD-ON
TREATMENT TOANTIEPILEPTICMONOTHERAPY
INADULTSWITH PARTIAL-ONSET SEIZURES
M. Kerr*, R. McMurray†, R. Sousa‡, M. Holtkamp§
*Cardiff University, Cardiff, Wales, UK, †Eisai Europe Ltd,
Hatfield, UK, ‡Bial - Portela & Cª, S.A., S~ao Mamede do
Coronado, Portugal, §Charité - Universit€atsmedizin Berlin,
Berlin, Germany
Purpose: It is important to assess how an antiepileptic drug affects qual-
ity of life (QOL), particularly since this may influence treatment compli-
ance. Here we present an analysis from the EPOS (Eslicarbazepine
acetate in Partial-Onset Seizures) study of the impact of eslicarbazepine
acetate (ESL) on patient-rated QOL and clinician-rated global improve-
ment. ESL is approved as adjunctive therapy for adults with partial-onset
seizures, with or without secondary generalisation. The prospective, non-
interventional EPOS study investigated the effectiveness and safety/tol-
erability of ESL as add-on to antiepileptic monotherapy in clinical prac-
tice across eight European countries.
Method: EPOS included adults with uncontrolled partial-onset seizures
receiving antiepileptic monotherapy, whose clinician had previously and
independently decided to initiate ESL add-on therapy. QOL was assessed
(at baseline and after 3 and 6 months) using the QOL in Epilepsy Inven-
tory-10 (QOLIE-10) at sites where the QOLIE-10 was used in routine
clinical practice and in countries where it was available and validated in
the local language. Global improvement was assessed (after 3 and
6 months) using the Clinical Global Impression-Global Improvement
scale (CGI-GI).
Results: Overall, 219 patients were included in the study (mean age
45.9 years; 57.5% male). Median number of seizures during 3 months
prior to baseline was 9.0. Complete QOLIE-10 data were available for
109 patients. Mean QOLIE-10 score decreased from 2.9 (n = 128) at
baseline to 2.4 (-14.6%; n = 114) after 3 months and 2.1 (-20.8%;
n = 109) after 6 months. The majority of patients were shown to have
‘much improved’ or ‘very much improved’ on the CGI-GI after 3 months
(‘much improved’, 49.8%; ‘very much improved’, 14.9%; n = 211) and
6 months (‘much improved’, 41.7%; ‘very much improved’, 33.9%’;
n = 192).
Conclusion: In this open-label, prospective study, ESL as add-on to
antiepileptic monotherapy provided beneficial effects on patient-rated
QOL and clinician-rated global improvement.
Supported by Eisai
p0535
USEOFLACOSAMIDE LOADING-DOSE IN THE
TREATMENTOF SEIZURECLUSTERING
A. La Neve*, G. Pontrelli*, C. Luisi*, T. Francavilla*,
G. Clemente†, G. Boero‡
*Amaducci Neurology Unit, University of Bari, Policlinico di
Bari, Bari, Italy, †Universita della Magna Grecia, Catanzaro,
Italy, ‡S.C. Neurologia, ‘SS. Annunziata’Hospital, Taranto,
Italy
Purpose: In an epileptic patient, seizure clustering is defined by the
occurrence of three or more seizures in a day as a changing of the typical
seizure pattern; it is a condition where it would be useful an intravenous
antiepileptic drug which, moreover, should be continued by oral adminis-
tration. The aim of this study is to evaluate efficacy and tolerability of
lacosamide (LCM) administrated with an intravenous loading dose fol-
lowed by oral intake, in refractory focal epileptic patients with seizure
clustering.
Method: Prospective open-label study. Inclusion criteria: age 16–
65 years; refractory focal epilepsy; seizure clustering. Esclusion criteria:
generalized epilepsy; status epilepticus, pregnancy, pseudoseizures.
LCM was administered with a first intravenous dose of 200 mg over
15 minutes followed after 12 hours by intravenous dose of 100 mg over
15 minutes. After 24 hours from the first intravenous dose, oral LCM
treatment was began at the dose of 100 mg twice daily. Concomitant
antiepileptic drugs were manteined unchanged. ECG and EEG record-
ings were performed before and 24 hours after intravenous LCM dose.
Efficacy was evaluated comparing daily seizure frequency 7 days after
and before LCM. Tolerability was evaluated reporting adverse effects
and changing in P-R interval in ECG recordings.
Results: Five patients were included in the study. They were affected by
refractory focal epilepsy, two cryptogenic and three symptomatic (one by
oligoastrocytoma, two by focal cortical dysplasia). Seizure daily frequen-
cies before and after intravenous lacosamide were respectively: patient1:
7–8 and 7–8; patient2: 4 and 0; patient3: 4-6 and 4-6; patient4: 3 and 1;
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patient5: 3-4 and 0-1. No patients complained adverse effects. No varia-
tions in P-R interval were observed comparing ECG recordings. All
patients continued LCM oral intake.
Conclusion: Our preliminary results suggest LCM loading dose as use-
ful and safe option in the treatment of refractory focal epilepsy with clus-
tering seizures.
p0536
ESLICARBAZEPINE ACETATE INREFRACTORY
EPILEPSY: EXTENSIVEUSEOFVARIOUS
POLYTHERAPIES ANDCLINICAL EVALUATIONOF
THE SUGGESTEDREFERENCERANGE
C.J. Landmark*, T. Svendsen†, E. Brodtkorb‡, A. Reimers‡,
E. Sætre†, S. Johannessen§
*Oslo and Akershus Unviersity College of Applied Sciences,
National Center for Epilepsy, Dept of Pharmacy and Biomedical
Science, Dept of Pharmacology, Oslo, Norway, †National
Center for Epilepsy, Sandvika, Norway, ‡St Olav’s Hospital, and
Norwegian University of Science and Technology, Trondheim,
Norway, §National Center for Epilepsy, Dept of Pharmacology,
Sandvika, Norway
Purpose: Eslicarbazepine acetate (ESL) is used as add-on treatment in
patients with focal seizures. Patients with refractory epilepsy often use
antiepileptic drugs (AEDs) in polytherapy. Therapeutic drug monitoring
(TDM) is useful to optimize clinical efficacy and tolerability, and forms
the basis to evaluate the suggested reference range (50–140 mmol/L).
Methods: Retrospective data from main laboratories providing TDM of
ESL in Norway during 2012–2013 were included. Drug fasting samples
at steady state were used. A clinical evaluation of efficacy and tolerabil-
ity was performed by the treating clinicians and handled anonymously.
The study was approved by the Regional Ethics Committee.
Results: TDM-data and clinical evaluation were available for 108
patients with refractory epilepsy. The pharmacokinetic variability as
measured by concentration/dose-ratios was 10-fold. 44% of the patients
had concentrations below the suggested reference range. There were no
significant differences between the patients having no effect, some effect,
good effect or CNS-related adverse effects with mean concentrations of
46–59  21 lmol/L. This could be due to small subgroups or that clini-
cal efficacy was evaluated at an early, suboptimal stage. 30 patients had
tapered ESL; 15 of them due to adverse effects. In 10 of these patients,
serum concentrations were available with a mean of 80  45 lmol/L.
Seven patients used ESL in monotherapy. 101 patients who used ESL in
polytherapy (2–4 AEDs) used 31 different combinations. The most com-
monly used co-medications were valproate (n = 21), lamotrigine
(n = 18), levetiracetam (n = 15) and lacosamide (n = 12).
Conclusions: The extensive use of various polytherapies in patients with
refractory epilepsy makes it difficult to evaluate the efficacy and tolera-
bility of ESL. Our data indicate however, that many patients respond well
to ESL. The suggested reference range for ESL appears to be too high in
clinical practice. TDM may be useful to optimize ESL treatment in the
individual patient.
p0537
DRUG-TARGETINGOFVOLTAGE-GATED SODIUM
CHANNEL SPLICING PROVIDES EFFECTIVE
SEIZURECONTROL
W.-H. Lin, M. He, R.A. Baines
University of Manchester, Faculty of Life Sciences, Manchester,
UK
Purpose: Seizure often results from increased neuronal voltage-gated
persistent sodium current (INaP) expression. Whilst many clinically-
approved antiepileptic drugs (AEDs) target INaP, none exclusively
repress this current without also adversely affecting the transient voltage-
gated sodium current (INaT). The fruitfly, Drosophila, has one voltage-
gated sodium channel gene (DmNav) that is highly homologous to its
mammalian counterparts. In DmNav, the magnitude of INaP is regulated
by alternative splicing of a pair of mutually-exclusive spliced exons, ter-
med K and L. Inclusion of exon L results in a channel with a large INaP,
but no change in INaT, compared to when exon K is present. Moreover,
expression of exon L is increased in genetic seizure mutants. Conversely,
conditions that favour inclusion of exon K effectively ameliorate seizure
severity. Manipulation of splicing of mammalian voltage-gated sodium
channels may, therefore, represent an attractive route for achieving sei-
zure control.
Method: Two luciferase-based mini-genes to report splicing at exon K/L
ofDmNavwere used to screen aDrosophila genome-wide dsRNA library
in S2R+ cells. Splicing regulators identified from the screen were beha-
viourally tested by expressing RNAi constructs in two different genetic
seizure mutants, bang-sensitive1 and bang-senseless1.
Results: We identify 291 splicing regulators that, on knockdown, favour
exon K inclusion. A behavioural screen shows knockdown of 95 of these
genes significantly reduce seizure duration. Importantly, inhibition of the
protein products of many of these genes is anti-convulsive inDrosophila.
Many suppress seizure-activity in both genetic seizure mutants, indica-
tive that they are part of well-conserved pathways and may, therefore, be
optimal candidates to take forward to mammalian seizure studies.
Conclusion: We have developed a new screen to identify compounds
with anti-convulsive properties. Based on the similarity between flies
and mammals, there is every reason to predict that these compounds will
have anti-epileptic properties and may catalyse the development of novel
AEDs.
p0539
MONOAND POLYTHERAPY IN EVERYDAY
PRACTICE - OUREXPERIENCE
I. Markovic*,†, D. Sporis*,†, I. Susak*, S. Basic*,†
*University Hospital Dubrava, Department of Neurology,
Zagreb, Croatia, †School of Medicine, Josip Juraj Strossmayer
University of Osijek, Osijek, Croatia
Purpose: To evaluate factors which could have an influence on the num-
ber of antiepileptic drugs (AEDs) in epilepsy treatment and to correlate
the number of AEDs in therapy with disease control.
Method: 248 patients with epilepsy were included in the analysis. Inclu-
sion criteria were the diagnosis of epilepsy, good compliance and avail-
able brainMRI finding.
Results: There is statistically significant difference in the number of
AEDs in therapy between patients with good seizure control and non-
responders to the AED therapy (p < 0.001). Twenty-nine different com-
binations were used in patients on two AEDs, twenty-seven in patients
with three AEDs and fourteen in patients on four AEDs. Patients on four
andmore AEDs in therapy are all non-responders. In the group of patients
with good seizure control the number of AEDs in therapy has no influ-
ence on the length of the seizure free period (p = 0.11). There is no statis-
tically significant difference between patients with generalised and those
with partial seizures as first presentation of the disease and the number of
AEDs in the further therapy (p = 0.08). Patients experiencing more than
one seizure type in their history take more AEDs than those with only one
seizure type (p < 0.001); they also have shorter seizure free period than
those with only one seizure type (p = 0.007). Epilepsy etiology has no
influence on the number of AEDs in therapy (p = 0.94).
Conclusion: Initial presentation of the disease and the ethiology have no
influence on the number of AEDs in therapy while more different seizure
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types in patient0s hystory increases the possibility of higher number of
AEDs in the further therapy. and lower seizure control.
p0540
MONOTHERAPY EXPERIENCEWITH
ESLICARBAZEPINE ACETATE
L. Mauri Fábrega, C. Del Río Oliva, F. Delgado Lopez, H. Pérez
Díaz, R. Vallejo Exposito, J. Rodríguez Uranga
Instituto de Especialidades Neurologicas (IEN), Seville, Spain
Purpose: Our purpose was to assess the monotherapy experience with
Eslicarbazepine acetate (ESL) in our centre, in terms of safety and effi-
cacy profile.
Method: This is a retrospective single-centre 4-year series of cases. All
the patients who initiated single treatment with ESL within this period
were consecutively included. Follow-up was considered until November
‘14. Data was collected on demographics, clinical features, adverse
events and treatment response, using a standardized data form.
Results: We included 77 patients between 11–85 years old, 51%
female. Minimum follow-up was 3 months and for a mean period of
17 months. 90% suffered some kind of comorbidity and all of them
coursed with partial seizures: at some point of their disease 40% had
presented simple partial seizures, 66% complex partial seizures, 46%
secondary generalized seizures and 9% partial status. 43% had an active
epilepsy being 10% considered drug-resistant. 84% of all patients had
tried other AEDs previous to single treatment with ESL. Six-month
retention rate was 91%, 87% for 1 year. Around 13% of the whole dis-
continued monotherapy with ESL: 2% presented some adverse effect,
7% required to add up or change to other AED and 4% did not need
AEDs any longer. All the rest (87%) were good responders and keep on
being well controlled on ESL monotherapy to present, 84% of which
are seizure free.
Conclusion: According to our experience, monotherapy with ESL seems
to be a good alternative for the treatment of partial epilepsy. However,
further studies must be carried out to confirm it.
p0542
PRELIMINARYDATAONPERAMPANEL
ESTABLISHINGTHEUTILITYOF THECORNWALL
UK INTELLECTUALDISABILITY (ID) ANTI-
EPILEPTIC DRUG (AED) REGISTERUSED FOR
COLLECTINGANDMEASURINGOUTCOMESOF
LICENSEDAEDS IN PATIENTSWITHEPILEPSY (PWE)
AND ID
R. Shankar*, Z. Doran*, B. McLean†, D. Cox*, R. Hillier*,
M. Parratt†, C. Jory*, M. Mohan‡, M. Sadler§
*Cornwall Partnership NHS Foundation Trust, Truro, UK,
†Royal Corwall Hospital Trust, Truro, UK, ‡North Bristol NHS
Trust, Bristol, UK, §Plymouth Hospitals NHS Trust, Plymouth,
UK
Purpose: To ascertain utility of Cornwall UK ID AED Register focusing
on safety of Perampanel in PWE and ID.
Method: The Register was set up in 2015 to ascertain safety of licensed
AEDs post 2000 in PWE and ID. Ethical approval was received from the
National Research Ethics Service UK to collect data for 10 years. Partici-
pants are assessed for nature of ID based on GP register and categorised
as non-ID, mild, medium or severe. Assessments occur every 3 months
on dropout rates, safety profile and AED efficacy outcomes. Data of 21
PWE (ID =15, general = 6) collected in the last 3 months in Cornwall
were compared.
Results: Non-parametric data testing was conducted using a three way
log linear analysis and one-way ANOVA. No significant relationship
(p < 0.05) emerged between severity of ID/non-ID, side effect profile
and discontinuation of Perampanel. However there was a notable lack of
numbers for conclusive opinion.
Conclusion: 25% of PWE have ID and are at higher risk of various co-
morbidities. They can respond differently to medications compared with
the general population. This has been poorly studied scientifically till
date. In the current sample there is no statistical evidence to suggest that
Perampanel is more likely to influence side effect severity in PWE with
ID than non-ID. Our preliminary data do not raise any concerns of tolera-
bility and efficacy of Perampanel in the population studied. These are
early trends and possibly non-conclusive due to lack of numbers but high-
light the potential usefulness of the Register long term when larger sam-
ples are looked to identify relevant clinical associations in a poorly
studied population esp. given the swiftness of recruitment, longitudinal,
practical nature of study and availability of national ethics to recruit UK
wide. The collection is on-going and the updated results on Perampanel
would be presented.
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PROMETEO: INTERIM PRELIMINARYANALYSIS OF
A PROSPECTIVEOBSERVATIONAL STUDYTO
ASSESS THETREATMENTEFFECTAFTER
INTRODUCTIONOFADIFFERENTAED IN PATIENTS
WITH PARTIAL EPILEPSY FULFILLING THE 2010
ILAECRITERIAOFDRUG-RESISTANT EPILEPSY
R. Michelucci*, B. Ferro†, E. Perucca‡, on behalf of SP0992
Study Group
*IRCCS-Istituto delle Scienze Neurologiche di Bologna, Unit of
Neurology, Bellaria Hospital, Bologna, Italy, †UCB Pharma,
Milan, Italy, ‡Clinical Pharmacology Unit, Department of
Internal Medicine and Therapeutics, University of Pavia, Pavia,
Italy
Purpose: The recent publication of the ILAE consensus definition of
drug-resistant epilepsy (Epilepsia 2010;51:1069–77) emphasized the
need for prospective, long-term studies to obtain further evidence on the
probability of achieving sustained seizure control after failure of succes-
sive informative trials of AEDs. This prospective, observational study
was designed to assess treatment outcomes in adults with focal epilepsy
meeting ILAE criteria of drug-resistance.
Methods: Consecutive patients with focal seizures considered drug
resistant by the enrolling physician were followed for 18 months to
assess treatment outcome after introduction of one or more additional
AEDs. Seizure-free patients, who at the 18-month visit required further
follow-up to determine outcome, remain in the study for up to an addi-
tional 16 months. Appropriate application of ILAE drug-resistance/out-
come criteria is being determined by an external Expert Panel. This
interim preliminary analysis using the Full Analysis Set (FAS; treatment
outcome with the first additional drug introduced) is based on the initial,
non-validated classification of pharmacoresistance/outcomes made by
the enrolling physician.
Results: 1063 patients received an additional AED and were enrolled
at 45 sites in Italy from 2011 to 2012. Mean age was 44.4 (SD 14.25)
years, mean epilepsy duration was 23.1 (SD 15.2) years, median base-
line monthly seizure frequency was 5.0 (range 0–220.0) and median
number of previously tried AEDs was 5 (range 0–33). 874 (82.2%)
patients completed 18-month follow-up. Of the 1043 patients included
in the FAS and evaluated using ILAE outcome criteria, 91 (8.7%) were
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seizure-free, 639 (61.3%) had treatment failure, and 313 (30.0%) were
undetermined.
Conclusion: This preliminary analysis confirms that most patients con-
sidered to be pharmacoresistant by the enrolling physician remain resis-
tant after introducing another AED. However, almost one out of ten
patients achieved seizure freedom. Further follow-up after validation of
the classified outcomes is needed to better characterize the prognostic
features of this population.
UCB Pharma-funded.
p0545
ANTIEPILEPTIC DRUGSANDWEIGHTCHANGES
H.C. Mısırlı*, N. Erdogan†, T. Tanyel*, E. Gülsunar†,
S. G€okceer†
*Haydarpaşa Numune Research and Educational Hospital,
Neurology, Istanbul, Turkey, †Haydarpaşa Numune Research
and Educational Hospital, Istanbul, Turkey
Purpose: Weight gain or loss can be a serious side effect of antiepileptic
drugs in epileptic patients. In this study, we investigated the weight
changes of the body associated with drug treatment.
Method: We included patients aged 18 years and over with a diagnosis
of epilepsy. We measured their body weights before drug using and
12 months after starting antiepileptic drugs. We calculated the weight
difference.
Results: Hundred and fifty-three patients were identified in total. Weight
gain was seen in 60% of patients on valproat, 32% on carbamazepine,
24% on levetirasetame, 18% on pregabaline. Weight loss was encoun-
tered on topiramate and zonisamide treatment, 58% and 41%, respec-
tively.
Conclusion: Valproat, carbamazepine, levetirasetame and pregabaline
were associated with weight gain, and topiramate and zonisamide with
weight loss. Lamotrigine and oxcarbazepine were not associated with
any weight change.
p0547
PERAMPANELADMINISTRATION EXPERIENCE IN
TREATMENTOF PATIENTSWITHREFRACTORY
FOCALEPILEPSY
S. Nurmukhametova, R. Magzhanov
Bashkir State Medical University, Ufa, Russian Federation
Purpose: To evaluate efficacy and safety of perampanel as adjunctive
therapy in combination with other antiepileptic drugs in patients with
uncontrolled focal seizures.
Method: 11 patients were observed: 4 men and 7 women. Their average
age was 33.45  6.6 years. The average duration of the disease -
19.55  8.5 years.
Results: Changes in morphological structure of the brain were detected
by MRI in 6 (54.55%) patients in the form of mesial sclerosis, and in 1
(9.09%) patient as a cerebrospinal fluid cyst of parietal region, no pathol-
ogy was identified in 4 (36.36%) patients. Simple partial seizures in com-
bination with complex ones were observed in 2 (18.18%) patients,
complex partial seizures in combination with secondary generalized ton-
icoclonic seizures - in 4 (36.36%) patients, secondary generalized tonico-
clonic seizures in combination with simple partial seizures and complex
partial seizures - in 5 (45.45%) patients. All patients had a high incidence
of seizures: daily - in 3 (27.27%) patients, 1-6 times a week - in 6
(54.54%) patients, 2–4 times a month - in 2 (18.18%) patients. Alongside
with perampanel 1 (9.09%) patient received 1 antiepileptic drug; 10
(90.90%) - 2. The combination of perampanel with two antiepileptic
drugs was as follows: oxcarbazepin + levetiracetam - 4 (36.36%), carba-
mazepine + levetiracetam - 6 (54.55%). The daily dose of perampanel
was 4–8 mg/day. Reduction of seizure frequency by more than 50% was
achieved in 3 (27.27%) and by <50% in 4 patients (36.36%) and therapy
was ineffective in 4 (36.36%) patients. Side effects such as dizziness,
drowsiness occurred in 7 (63.64%) patients, but were transient and disap-
peared after the dose stabilization.
Conclusion: As a result of this study high efficacy and safety of peram-
panel in treatment of drug-resistant epilepsy was established. It is
planned to include more patients in the further study.
p0548
ADESCRIPTIVE STUDYOF THEEXPERIENCESOF
RELATIVES/CARERSWITHTHEUSEOFBUCCAL
MIDAZOLAM IN THECOMMUNITY SETTING
Y. Owen*, C. Clune Mulvaney†, N. Delanty*
*Beaumont Hospital, Dublin, Ireland, Neurology Department,
Dublin, Ireland, †Royal College of Surgeons in Ireland, Faculty
of Nursing and Midwifery, Dublin, Ireland
Purpose: Prolonged seizures can increase the risk of status epilepticus
which is potentially harmful and life threatening. Buccal midazolam
(BM) is recognized as an effective, safe and acceptable form of first-line
treatment for prolonged seizures in the pre-hospital setting. The person
most commonly responsible for administration of BM is the relative or
carer of the person with epilepsy. However there are a limited number of
studies in the literature examining the use of BM from the relative/carers
perspectives. The purpose of this study is to explore and describe the
experiences of relatives/carers with the use of buccal midazolam in the
community setting.
Method: A qualitative descriptive design was employed. Semi-struc-
tured telephone interviews were used for data collection and a total of 16
interviews were undertaken. Data analysis was performed using
Colazzi0s Data Analysis Framework (1978).
Results: Participants reported anxiety and distress when faced with sei-
zures in the community. Many of participants found BM easy to use and
effective in stopping seizures. Many reported that BM made them feel
safe and reassured and reduced emergency department attendances.
However there was a significant lack of awareness of time in relation to
the duration of seizures and at what stage BM should be administered.
Despite having been informed about BM by clinicians there was a knowl-
edge deficit amongst participants in regards to BM administration, its
actions, potential side effects, dosing and seizure response.
Conclusion: Dealing with seizures can be a stressful experience with
associated negative emotions for the relative/carer. They require compre-
hensive education on recognition of seizures, appropriate response to sei-
zures and BM administration so that they can manage these situations
more effectively. A variety of training methods should be considered to
cater for the varying educational needs of relatives/carers as well as sup-
portive documentation such as individualized seizure care plans.
p0550
DERMATOLOGIC ADVERSE EFFECTSOF
ANTIEPILEPTIC DRUGS
S. Ozyurt, Y. Cetinkaya, K. Tutkavul, M.F. Yilmaz, M. Gencer,
H. Tireli
Haydarpasa Numune Educational and Research Hospital,
Neurology, Istanbul, Turkey
Purpose: In patients under antiepileptic medication it is very essential to
receive the drug regularly. Common adverse effects may impair patient
compliance and require alternative therapies. We investigated the derma-
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tologic issues and their frequency in most preferred drugs in our depart-
ment.
Method: We detected 361 epileptic patients’ records for skin rash and
hair loss complaints in this retrospective analisis. The patients were
examined by dermatologists to differ the drug side affects from other eti-
ologies. The most prescribed 4 antiepileptic drugs were in corporated in
the study. Patients receiving combined therapy also are taken into
account by the state.
Results: In our 361 patients including series; usage of valproic acid was
present in 221 patients, carbamazepine in 152, levetiracetam in 125 and
lamotrigine in 47. Hair loss was determined in 19 (8.59%) patients while
skin rash in 1 of 221 patients receiving valproic acid. In carbamazepine
group skin rash was present in 6 (3.94%) of 152 patients and no hair loss
was observed. 2 (1.6%) of 125 patients using levetiracetam had skin rash
and one of them had hairloss. In 4 (8.5%) of 47 patients using lamotrigine
skin rash was recorded while only one of them complained about hair
loss.
Conclusion: Antiepileptic drugs may create skin healt or cosmetic prob-
lems. Possible dermatological problems in the follow-up of epileptic
patients should be kept in mind.
p0551
FIRSTGENERATIONANTIEPILEPTIC DRUGS:
EFFECTONCARDIOVASCULARRISKMARKERS
M.P. Pereira, L.P. de Andrade Valenca
Universidade Federal de Pernambuco - UFPE,
Neuropsiquiatria, Recife, Brazil
Purpose: We aimed to determine whether antiepileptic drugs (AEDs)
induce modifications on cardiovascular risk markers.
Method: 138 patients receiving first generation AEDs monotherapy
(carbamazepine, valproate, phenobarbital) or politerapy (n = 36) for at
least 1 year and 63 matched controls had serum lipid profile, erythrocyte
sedimentation rate (ERS), uric acid and carotid intima media thickness
(C-IMT) measured.
Results: Compared to controls, patients on phenobarbital (n = 25) had
total cholesterol significantly higher (p = 0.007, t test), VPA group
(n = 22) had significantly lower HDL-c (p = 0.004, t test) and increased
uric acid (p = 0.004, t test) and ESR (p = 0.026, t test), polytherapy
group had higher ESR (p = 0.01, t-test). No significant diference in lipid
profile was observed in carbamazepine (CBZ) e and polytherapy group.
FB group also had total cholesterol (p = 0.006, chi-square), LDL-choles-
terol (p = 0.004, chi-square) and triglycerides (p = 0.055, chi-square)
rates above the reference ranges, compared to controls. None of the
groups had increased carotid intima-media thickness (C-IMT) compared
to controls. Age and duration of therapy had positive correlations to lipid
profile and C-IMT.
Conclusion: First generation AEDs had different effects on cardiovascu-
lar risk markers, even among inducers of P450 system. Our results suggest
a need for monitoring serum TC, HDL-cholesterl, LDL-cholesterol and
triglycerides specially in aged and in individuals high cardiovascular risk.
p0552
OLIGOHYDROSIS: ADVERSE EFFECTOF
ZONISAMIDE
J. Son
Bongseng Memorial Hospital, Neurology, Busan, Republic of
Korea
Purpose: Zonisamide is classified as a sulfonamide and is characterized
having multiple antiepileptic action-mechanisms including inhibiting
carbonic anhydrase, which may lead to the oligohydrosis. The purpose of
this study is including the followings:
(1) to determine the incidence and: (2) to reveal the risk factor of oligo-
hydrosis-related symptoms in epileptic patients treated with zonisamide.
Methods: I prospectively studied 153 patients under 20 ages who was
newly diagnosed with epilepsy or referred from other hospitals for con-
trolling a seizure. The patients were treated with zonisamide as a
monotherapy or adjuvant therapy. The data was collected by direct inter-
view at least 3 months after taking zonisamide. Facial flushing, lethargy,
itching sensation, irritability with hyperthermia, heat sensation and heat
intolerance were considered as a oligohydrosis-related symptom.
Results: 24.8% of patients were treated by zonisamide as a monother-
apy, and the other patients were treated by zonisamide as an adjuvant
therapy. The oligohydrosis-related symptoms were observed in 11.1% of
patients, and 2% of the patients have stopped taking zonisamide due to
the symptoms. The oligohydrosis-related symptoms were observed more
frequently in the patients between 15 and 20 years old than younger ages,
and more frequently in the patients who had taken topiramate.
Conclusion: The frequency was significantly higher than the results
from previous studies. Clinicians should monitor the patients who are
taking zonisamide regarding the oligohydrosis-related symptoms. Espe-
cially, the patients between 15 and 20 years old ages and the patients
who have a drug history of topiramate should be observed carefully.
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MORTALITY IN PEOPLEWITHCONVULSIVE
EPILEPSY: 12 YEARSOF FOLLOWUP INARURAL
COMMUNITY IN EAST CHINA
D. Ding, Y. Ge, Z. Hong
Institute of Neurology, Fudan University, Shanghai, China
Purpose: Data of long-term mortality risk of epilepsy are rare from
resource-poor settings. We conducted a 12 years follow up study to
explore the causes of death, mortality risk and related impact factors
among people with convulsive epilepsy in a rural community in east
China.
Method: In 2014, we traced 60 people who had previously diagnosed
with convulsive epilepsy in a community-based epidemiological survey
in 2002. Putative causes of death for those who died were obtained by
verbal autopsy, and recorded according to the International Classification
of Diseases. We calculated the proportional mortality ratios (PMRs) and
standardized mortality ratios (SMRs) for each age-group and cause. Sur-
vival analysis was used to determin risk factors associated with increased
mortality.
Results: We successfully followed 55 (92%) people with convulsive epi-
lepsy, and obtained 11 death cases, indicating 20% of the case fatality
rate. The highest PMRs were for cancer (27%), cerebrovascular disease
(18%), diabetes (18%) and chronic obstructive pulmonary disease (18%).
The risk of premature death was 2.8 times greater in people with epilepsy
than in the general population. Older (50–65 years) people with epilepsy
had a high relative mortality risk with SMR 1.7–3.8. A much higher risk
(SMR=18) was found in middle aged (40–45 years) people with epi-
lepsy. Age and partial seizure were risk factors for premature death.
Conclusion: Our results indicated that among people with chronic
epilepsy, the most common causes of death were cancer and geriatric
diseases. High mortality risk found in middle aged and older people
suggested efficient interventions to protect those people with very long
duration of epilepsy.
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ETIOLOGIC FEATURES ANDUTILIZATIONOF
ANTIEPILEPTIC DRUGS IN PEOPLEWITHCHRONIC
EPILEPSY INCHINA: REPORT FROMTHEEPILEPSY
COHORTOFHUASHANHOSPITAL (ECOH)
D. Ding, P. Yu, Y. Ge, Z. Hong
Institute of Neurology, Fudan University, Shanghai, China
Purpose: Chronic epilepsy is estimated to affect more than 2 million
people in China. However, data of its clinical characteristics is still lack-
ing in China. In the present study, we summarized the etiologic features
and utilization patterns of antiepileptic drugs (AEDs) in people with
chronic epilepsy in a tertiary medical center in China.
Method: We recruited people with chronic epilepsy treated at the Epi-
lepsy Outpatient Clinic of Huashan Hospital during October 2009 to
August 2013. Demographic data, clinical characteristics, AED treatment,
epilepsy-associated risk factors and medical history, and results of sup-
plementary examinations of each participant were collected via an inter-
viewer-administered questionnaire and confirmed by the medical
records.
Results: Among 554 people with chronic epilepsy, 58.0% of them were
male, 66.8% had focal seizure, and 29.2% had symptomatic cause.
Developmental anomalies of cerebral structure (16.7%) and cerebral
trauma (16.7%) shared the leading cause of symptomatic epilepsy among
children with epilepsy.While cerebral trauma (29.1%) and cerebrovascu-
lar disorder (36.4%) were the most common causes in groups of adults
and elderly. Fifty percent of participants were taking AED monotherapy.
Proportions of people with idiopathic, cryptogenic and symptomatic epi-
lepsy treated by multitherapy were 35%, 46% and 45.6%, respectively.
Valproic acid (VPA) was the most frequently utilized AED as monother-
apy (32.7%) and within multitherapy (62.5%).
Conclusion: This hospital-based study reported that etiologic features
were diverse in different age groups of people with chronic epilepsy.
VPAwas widely utilized to treat chronic epilepsy in mainland China.
p0556
MARIJUANAUSE BY PATIENTS ADMITTEDTOA
CANADIAN EPILEPSYMONITORINGUNIT
A. Massot*, E. Martinez*, R. McLachlan†
*Western University, Neurology, London, Canada, †Western
University, London, Canada
Purpose: In Canada, medical marijuana is legal for epilepsy. We aim to
determine the prevalence of marijuana use and assess the perceived
effects in intractable epilepsy patients compared to those found not to
have epilepsy.
Method: Information was collected over 14 months from consecutive
adult patients admitted to our Epilepsy Monitoring Unit using a 27 item
self-administered questionnaire. Only patients able to give consent for
participation were recruited. Readmissions were excluded. Subjects were
divided into 2 groups, those with proven epilepsy and those without.
Results: 310 patients median age 36 (range 28–49) years, 57% female
were studied. Median duration of spells was 9 (range 3–21) years occur-
ring daily or weekly in 49%. Epilepsy was documented in 215, non-epi-
leptic attacks in 76 and unknown in 19. Overall, 56% had tried
marijuana. Use over the past year was 38% in epilepsy and 36% in non-
epilepsy. Only 6% was government approved. Utilization was daily in
56% of epilepsy users and 32% in non-epilepsy. Estimated mean dose
was 1 gm/day. Overall cigarette use was 31%, alcohol 43% and street
drugs 3%. In current users, perceived improvement in seizures/spells was
84% in epilepsy and 79% in non-epilepsy. In the 2 groups stress was
decreased in 85% and 89%, sleep improved in 79% and 89%, memory/
concentration better in 37% and 32% and drug side effects less in 75%
and 67%. Perceived effect on seizures/spells correlated with the effect on
stress (r = 0.4, p < 0.001) Adverse effects of marijuana included
impaired memory/concentration 17% and worsening of seizures 3%.
Conclusion: Patients investigated for intractable epilepsy use marijuana
more than the general population and perceive improved seizure control,
lower stress, better sleep and reduced drug side effects. Those with non-
epileptic events describe the same effects. Stress reduction contributes to
the impact of marijuana on seizures and non-epileptic events in adults.
p0557
THE PREVALENCEOF SYMPTOMATIC EPILEPSIES
AMONGCHILDREN IN TWOLARGE PEDIATRIC
NEUROLOGYCENTERS IN POLAND - 2 YEAR
PROSPECTIVE STUDY
M.Mazurkiewicz-Beldzinska*, B. Steinborn†, M. Szmuda‡,
M. Zawadzka‡, A. Winczewska-Wiktor†
*Medical University of Gdansk, Developmental Neurology,
Gdansk, Poland, †Medical University of Poznan, Poznan,
Poland, ‡Medical University of Gdansk, Gdansk, Poland
Purpose: To evaluate the prevalence of symptomatic epilepsies among
children and adolescents with epilepsy.
Method: All epilepsy patients who entered the Developmental Neurol-
ogy Departments (In and Outpatients Clinics) in 2 years period between
were included in the study and followed prospectively. 1553 children and
adolescents with diagnosed and treated epilepsy entered the study. The
symptomatic epilepsy group consisted of 703 patients - they presented
clear documented etiology. The comparison of type of seizures and treat-
ment effects was performed.
Results: The most common type of seizures among symptomatic
patients were complex partial seizures and generalized seizures (mainly
tonic, myoclonic and atypical absences). There were 64% of patients
from symptomatic group who were drug resistant according to proposed
definition (Kwan et al. 2010). The comparisons between symptomatic
and non-symptomatic group was done. There were significant differences
in types of seizures, seizure freedom and number of drugs in therapy.
Conclusion: This large population based study shows the differences
between the treatment strategies among symptomatic and non-sympto-
matic groups, in our opinion not always justified and presents the surpris-
ingly high incidence of drug-resistant epilepsies among children and
adolescents with symptomatic epilepsies.
p0562
DETERMININGCHARACTERISTICSOFACUTE
STROKERELATEDWITHEARLYANDLATEONSET
SEIZURES
A. Ozdemir, H.S. Ture, T. Kurt Incesu, N. Gurgor Kanat,
I. Tatlidil, S. Arici, G. Akhan
Izmir Katip Celebi University Ataturk Research and Training
Hospital, Izmir, Turkey
Purpose: According to International League against Epilepsy, seizures
occurring in 2 weeks after stroke are defined as early-onset-post-stroke-
seizures (EOPSS). Late-onset-post-stroke-seizures (LOPSS) are the sei-
zures occurring 2 weeks after acute stroke. The aim of the study is to
determine characteristics of Acute Stroke related with EOPSS and
LOPSS.
Method: 150 patient (67 female and 83 male) experiencing post stroke
seizures and admitted our clinic between 2006 and 2014 were included in
this retrospective study. Patients having intracranial malignancy, sub-
arachnoid hemorrhage, cerebral sinus thrombosis and former epilepsy
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were excluded. Patients were grouped in two according to having EOPSS
and LEOPSS. Characteristics of Acute Stroke according to stroke type,
ischemic stroke (136 patient) or hemorrhagic stroke (14 patient), local-
ization of infarction and etiology of acute stroke were determined. EEG
findings and other demographic findings were also compared between
two groups. Chi-square test and Mann-Whitney-u test were used statisti-
cally.
Results: Early onset seizures were highly seen with hemorrhagic strokes
while late onset seizures highly seen with ischemic stroke (p = 0.005).
Seizures related to cardio embolic stroke or large artery atherosclerosis
related stroke showed significant association with late onset post epilep-
tic seizures (p = 0.006). There were no statistically significant differ-
ences among gender, EEG findings, hemispheric localization and
cortical involvement.
Conclusion: Since different pathophysiological mechanism work in
EOPSS and LOPSS, both type requires different clinical approach. While
EOPSS are related with high risk of mortality, LOPSS are related with high
recurrence of the seizures. Determining Characteristics of EOPSS and
LOPSS could be helpful to improve right approach to post stroke seizures.
p0563
RISKOFMORTALITY AMONGPEOPLEWITH
EPILEPSY IN TAIWAN
Y. Tseng*, H. Lin*,†
*Sijhih Cathay General Hospital, Neurology, New Taipei,
Taiwan, Republic of China, †Taipei Medical University,
Graduate Institute of Biomedical Informatics, Taipei, Taiwan,
Republic of China
Purpose: The aim of this study is to estimate the risk of mortality among
patients with epilepsy (PWE) in Taiwan and clarify the causes of death in
different age groups of PWE, using a nationwide population-base data
set.
Method: All patients who were newly diagnosed as epilepsy (ICD-9-
CM code 345.x) between January 1, 2002 and December 31, 2006
(n = 6,005) were selected. Another 6,005 control subjects were ran-
domly selected with adjustment of age, gender and enrolled year. The
endpoint of observation is either death of subject or 3 years after the
enrolled date. Information on date and cause of death were retrieved from
the Taiwan Death Registry. We divide the PWE group into 2 parts by the
age of 30 to differentiate the five leading causes of death.
Results: There are 1,156 (19.3%) deaths noted in the PWE group and
388 (6.5%) in the controlled group (hazard ratio 3.48, 95% confidence
interval 3.10–3.90). In the observation period of 3 years, the median age
of death is 73 in PWE group and 77 in control group. The leading causes
of death in PWEwith age > 30 years are trauma, cerebrovascular disease,
diabetes mellitus, pneumonia and liver cirrhosis. The leading causes of
death are trauma, malignant brain tumors, epilepsy, sepsis and liver cir-
rhosis in PWEwith age <30 years.
Conclusion: In our study, we concluded that patients with newly diag-
nosed epilepsy had 3.48 times risk of death than patients without epi-
lepsy. The average age of decease in PWE is 4 years younger. As trauma
is the leading cause of death in PWE, the importance of prevention of
trauma is indisputable. As for younger PWE, aggressive treatment of epi-
lepsy to reduce seizure attack may improve the survival.
p0564
PREVALENCEOFCHILDHOODEPILEPSY IN SRI
LANKA
J. Wanigasinghe*, C. Arambepola*, R. Murugupillai†,
T. Chang*
*University of Colombo, Colombo, Sri Lanka, †Eastern
University Sri Lanka, Batticaloe, Sri Lanka
Purpose: The prevalence of epilepsy in children from the developed
countries range between 3.4- 4.0 per 1000. The estimated prevalence of
epilepsy in developing countries is much higher. The prevalence of child-
hood epilepsy in Sri Lankan children is still not known.
Method: A two phase survey was performed in a district which has a
population of 650,000 and has the most balanced representation of all
ethnic groups in the country. A house to house survey was performed
for 0–5 year age group and a school-based cross sectional survey was
performed for 6–16 age group. Screening was performed using direct
interview for household survey and pretested questionnaire for the
school survey. Those screened were subsequently evaluated in detail
by a paediatric neurologist for classification of broad epilepsy syn-
dromes according to 1989 ILAE classification. Detailed history, review
of clinic records, EEGs and neuro-imaging were used to classify the
epilepsies.
Results: Total of 5090 children (1090 from the community and 4000
from school survey) were screened. Response rates were 100% in the
house to house survey, while was only 81% for the school survey. Total
number of children screened as having epilepsy was 39 out of which epi-
lepsy was confirmed only in 25 children. Three of the 25 epileptics did
not present for detailed evaluation of epilepsy syndrome. Prevalence of
epilepsy in the 0–5 year age group was 6.4:1000 while prevalence in 6–
16 age group was 5.5:1000. Commonest broad epilepsy syndrome was
symptomatic focal epilepsy. Idiopathic generalized epilepsy occurred in
4%, idiopathic focal epilepsy in 8% and symptomatic generalized epi-
lepsy in 8%, transition from one to another in 4%.
Conclusion: Overall epilepsy prevalence among Sri Lankan children is
5.8:1000 and was higher in the 0–5 group. Prevalence of epilepsy in Sri
Lankan children is higher than that described for children in developed
countries.
Epilepsy in Severely Resource-restricted
Settings
Monday, 7th September 2015
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HIPPOCAMPAL SUBFIELDVOLUMES IN
PHYSIOLOGICALDÉJAVERSUSMESIAL TEMPORAL
LOBEEPILEPSY AND SCHIZOPHRENIA
M. Brazdil, E. Peslova, R. Marecek, T. Kasparek
Fakultní Nemocnice u sv.Anny, Brno, Czech Republic
Using Source-Based Morphometry a significantly less gray matter was
recently revealed within a set of cortical (predominantly both-sided hipo-
campi) and subcortical regions in healthy subjects experiencing déja vu
(DV) when compared to déja vu non-declarers (Brazdil et al, 2012).
Importantly in these regions gray matter (GM) volume was inversely cor-
related with the frequency of déja vu. Despite observed GM volume dif-
ferences mirrored the distribution of GM volume reduction in subjects
suffering frommesial temporal lobe epilepsy (MTLE), the pattern of GM
differences within hippocampi were distinctive between MTLE and DV
(Brazdil et al, 2013). Schizophrenia (SCH) represents another condition
in which hippocampal GM volume was found to be significantly
decreased (Haukvik et al, 2014). In this study we compared differences in
GM volume within distinctive hippocampal subfields (CA1; CA2 + 3;
CA4 + DG; Subiculum; Presubiculum) among healthy DV non-
declarers (N = 26) and healthy DV declarers (N = 85), MTLE (N = 47)
and schizophrenia (N = 46) patients alternatively. The images were auto-
matically segmented and registered using SPM8 and its toolbox DAR-
TEL. Local GM volume was corrected with respect to age, gender and
total intracranial volume. The decrease of local GM volume across vox-
els (relatively to the nonDV group) was correlated between DV and
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MTLE and between DV and SCH. The results revealed significant corre-
lations between GM volume reduction in DV and SCH as well as DV ver-
sus MTLE in the majority of analyzed hippocampal subfields.
Importantly GM volume correlations were significantly higher for SCH
(thanMTLE) within left CA4 + DG, left and right CA2 + 3, and left pre-
subiculum. The only significantly higher correlation for MTLE was
observed within right subiculum. Our findings reveal common structural
features of hippocampal involvement in physiological déja and both
investigated SCH andMTLE.
p0568
INJURIES IN UNTREATED EPILEPSY INRURAL
INDIA: A CROSS-SECTIONAL PARALLELGROUP
STUDY
A. Kapoor*, S. Kapoor*, C. Stredny†, L. Taudorf‡, M.B. Singh§
*All India Institute of Medical Sciences, New Delhi, India,
†Boston Children’s Hospital, Boston, MA, USA, ‡Kobenhavns
Universitet, Copenhagen, Denmark, §All India Institute of
Medical Sciences, Neurology, New Delhi, India
Purpose: With a treatment gap of up to 90% in some parts of rural India,
many patients have frequent generalized seizures. Untreated or inade-
quately treated epilepsy (UE) patients are at a greater risk of physical
injury compared to adequately treated epilepsy (TE) patients. Our study
compared injuries in UE and AE patients.
Method: In this cross-sectional parallel group observational study UE
patients were recruited from the epilepsy clinic on the Lifeline Express, a
mobile train hospital serving rural communities while TE patients were
recruited from the Neurology Outpatient Department of All India Insti-
tute of Medical Sciences, New Delhi. A questionnaire was used to collect
information on each patient’s seizure frequency, medication and history
of injury.
Results: We had 106 UE and 149 TE patients. There was no signifi-
cant difference between the two groups with respect to age at onset,
gender and family history of epilepsy. Daily, weekly and monthly sei-
zures were present in 13%, 20% and 35% of the UE patients compared
to 6%, 5% and 13% in the TE. Only 6% of UE patients had <1 seizure
per year compared to 44% in the TE group. Of the TE patients, 97%
were on AEDs where as only 54% of the UE patients reported ongoing
AEDs. Injuries were reported by 41 (39%) of the UE and 12 (8%) of
the TE patients. Most injuries in both groups were facial injuries and
also soft tissue injuries. There was one burn injury in the TE and six
in the UE group.
Conclusions: UE has multiple implications including the potential to
cause serious injuries. The scars and mutilation associated with injuries
including burns adds further to the stigma associated with epilepsy.
Acknowledgement: Impact India Foundation and Lifeline Express are
acknowledged for the opportunity to work for rural Indian epilepsy
patients.
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TRADITIONALMEANINGSOF EPILEPSY
TREATMENTANDTHEIR SOCIO-CULTURAL
INTERPLAYS INAYETE, SOUTHWESTNIGERIA: AN
INTERPRETIVIST-APPROACH
O. Omotoso
University of Ibadan, Archaeology and Anthropology, Ibadan,
Nigeria
Purpose: Cultures throughout the world give different meanings to ill-
ness. These meanings which determine the culturally-driven healing pro-
cesses are embedded in symbols and require interpretations. This work
uses an interpretivist-approach to explain the traditional meanings of
epilepsy treatment and their sociocultural interplays in Ayete, southwest
Nigeria.
Method: The study was a mini-ethnographic research in Ayete com-
munity, southwest Nigeria. An interpretivist-approach that looked at
the way cultures use symbolic meanings to describe and understand
health and disease was used. The research design was based on multi-
ple ethnographic case studies explaining each stage of the healing pro-
cesses within its context. Multiple data collection methods like life
history, interview, observation and content analysis provided informa-
tion on social meanings, symbols, and experiences of participants. The
relationship of cultural beliefs and practices in connection with the
health and healing processes of people living with epilepsy was
described.
Results: The study is significant in different respects. First, it narrated
the life histories of epileptic patients from childhood to adulthood and the
events that changed their life-courses. Secondly, it uses ethnographic
techniques to discuss the cultural-dimension of traditional healing from
the healers and patients’ perspectives, explaining the healing processes
which fall outside the current biomedical understanding. Finally, it pro-
vides new culturally-driven healing processes on epilepsy for similar
sociocultural-settings.
Conclusion: Since traditional cultural beliefs regarding causes of illness
—spirit aggression, witchcraft, and god’s punishments—have effects on
psycho physiological processes, including inducing both healing and
stress responses cultural explanation of the healing processes that fall
outside the current biomedical understanding is needed.
p0571
KNOWLEDGE, ATTITUDE ANDREACTIONS
TOWARDS EPILEPSYAMONG STUDENTSOF
ECONOMICS INHERAT, AFGHANISTAN
S. Daber-Taleh, R. Benecke, J. Rösche
Universit€atsmedizin Rostock, Klinik für Neurologie und
Poliklinik, Rostock, Germany
Purpose: We conducted this explorative study on knowledge, attitude
and reactions towards epilepsy in Afghanistan, where Islam has to come
to terms with shamanistic elements derived from earlier beliefs and prac-
tices and the concepts of modern medicine.
Method: In order to determine the knowledge of, attitude and reactions
towards epilepsy by students at the Faculty of Economics, University of
Herat, Afghanistan, we designed a self-administered 23-item question-
naire mainly based on questions used in previous similar studies. We
obtained the official permission from the Dean of the Faculty of Eco-
nomics for our study. Questionaires in which gender and number of
semesters studied so far were not revealed were excluded from the analy-
sis. Also questionaires in which the item “not familiar with epilepsy”was
marked were not included in the analysis. Finally all questionaires in
which the observation of seizure symptoms was stated without having
witnessed a seizure were excluded from the analysis.
Results: 515 of 520 questionaires were returned. After excluding ques-
tionaires according to the criteria given above 276 questionaires (filled
out by 208 male and 68 female students) were available for analysis. 9
students (= 3.26%) revealed to have epilepsy themselves. About 50% of
the students stated that they had witnessed a seizure. 33.33% thought that
a seizure is caused by an abnormal psychic reaction. 15.42% supposed a
seizure to be result of jinn possession and another 5.43% considered
witchcraft as a possible cause for a seizure. For a relative with epilepsy
only 48.9% would recommend to see a doctor. 28.3% would recommend
to see an Imam and 9.42%would recommend to see a magician.
Conclusion: There are tremendous deficits concerning knowledge, atti-
tude and reactions towards epilepsy in resource poor countries like
Afghanistan even in the higher educated population.
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STARTLE EPILEPSY
M. Sezgin*, N. Bebek†, C. Gürses‡, B. Baykan‡, A. G€okyigit†
*Istanbul University Istanbul Faculty of Medicine, Neurology,
Istanbul, Turkey, †Istanbul University, Istanbul Faculty of
Medicine, Istanbul, Turkey, ‡Istanbul University Istanbul
Faculty of Medicine, Istanbul, Turkey
Purpose: Startle epilepsy is characterized with seizures precipitated with
sudden, unexpected noise or somatosensory stimulus. This study aimed
to describe patients suffering from startle epilepsy.
Method: Medical records of 38 patients suffering from startle epilepsy
were investigated retrospectively. Clinical and laboratory features of the
patients were evaluated.
Results: Onset of seizures of 19 males and 19 females patients varied
from birth to 28 years. Touching or striking to any part of the body in
patients (specially to head in) was the main trigering stimulus. Sudden
noise in 6, touching and noise in 13, and drop in 1 patient were the other
stimulus. One patient described self induction property. The seizure
pattern was different: Secondarily Generalized tonic clonic in 16 patients,
simple or complex partial in 9, myoclonus in 3. 76.3% of the patients had
also spontaneous seizures. Head trauma in 6 patients, birth injury in 8
patients and febrile or nonfebrile convulsion in 8, and a patient had a sub-
dural hematoma surgery at the first month of his life were present in their
medical history. Epilepsy history in family was repoted in 6 of patients.
Neurologic examination revealed mental retardation in 11 and hemipare-
sis in 7 patients. Neuroimaging (CT and/or MRI) showed generally pari-
etal lesions in 14 patients and was normal in 6. EEG showed pathologic
activity in 21 patients, and normal in 9. The response of antiepileptic
treatment was followed in 16 patients. In 7 patients seizure frequency
was decreased.
Conclusion: Startle epilepsy is frequent, symptomatic type of epilepsy.
Sensorimotor stimulus is most prominent triggering factor. Seizure
paterns shows a wide variety. Neuroimaging and neurological examina-
tion reveal pathological finding in majortiy of patients. Insufficient con-
trol of frequent and unexpected seizures is the main reason of poor
quality of life.
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REASONS FORREFERRALDELAYAMONGST
EPILEPSY SURGERYCANDIDATES IN INDIA - A
QUESTIONNAIRE BASED STUDY
M.B. Singh*, N. Rai†, R. Bhatia†, D. Vibha†, K. Prasad†
*All India Institute of Medical Sciences, Neurology, New Delhi,
India, †All India Institute of Medical Sciences, New Delhi, India
Purpose: India has 500,000 potential epilepsy surgery candidates but
< 200 surgeries happen annually. Referral delay contributes to surgi-
cal treatment gap and our aim was to identify factors contributing to
this.
Method: Doctors attending a Neurology conference answered a ques-
tionnaire. Questions included respondents’ perception of drug resistant
epilepsy (DRE) and factors that led to surgical referral of DRE.
Results: Responses of neurologists 100/114 were analyzed; 57% were
young (practicing for < 10 years) and 78% treated >20 epilepsy
patients/month. Epilepsy surgery was available >100 kilometers from
the practice of 47% respondents. ‘Failed monotherapy’ meant patients
failing two AED monotherapy trials for 43% respondents and three tri-
als for 57%. For diagnosing DRE, patients should have failed AED
combination trials, 87% respondents needing at least 2 and 36% need-
ing 3 failed trials. Knowledge of epileptogenic foci (93%), seizure fre-
quency (89%), patient’s willingness for surgery (81%), seizure type
(82%), epilepsy duration (80%) and patient’s age (67%) were factors
considered before referral. In TLE, 82% respondents referred for sur-
gery only if MRI showed HS and 17% even if MRI was normal. In
ETLE, 52% referred if MRI was abnormal and 14% if MRI was nor-
mal. Seizure frequency of at least 1 per month had to be present for
88% respondents to consider referral. 85% thought epilepsy surgery
was under recommended; 25% had never referred any patient. Factors
considered important by neurologists who had referred patients for sur-
gery included serious surgical complications (81%, 30 of 37), seizure
freedom (80%, 44 of 56), getting feedback from referral centre (80%,
29 of 37), and opportunity to follow-up patients after surgery (70%, 29
of 41).
Conclusion: Educating neurologists about benefits of epilepsy surgery
may reduce referral delays. Indications for surgery, criteria for diagnos-
ing DRE and prognostic indicators of good surgical outcomes have to be
reiterated.
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HEALTHCAREUTILIZATIONANDOUT-OF-POCKET
COSTSOF PEOPLEWITHEPILEPSY INRURAL
SOUTHAFRICA: ACROSS-SECTIONAL SURVEY
R.G. Wagner*,†, M. Bertram‡, F.X. Gomez-Olivé*, S. Tollman*,
L. Lindholm†, C. Newton§, K. Hofman*
*University of the Witwatersrand, MRC/Wits Rural Public
Health & Health Transitions Research Unit (Agincourt),
Johannesburg, South Africa, †Umea University, Umea, Sweden,
‡World Health Organization, Geneva, Switzerland, §Oxford
University, Oxford, UK
Purpose: Epilepsy is a common neurologic disorder, with 80% of cases
found in low- and middle- income countries (LMICs). Studies from high-
income countries have found significant economic burden associated
with epilepsy, yet few studies from LMICs, where out-of-pocket costs for
healthcare are substantial, have explored these costs for outpatient epi-
lepsy care.
Methods: Two hundred-fifty people, previously diagnosed with active
convulsive epilepsy within an established health and demographic
surveillance system in rural South Africa, were administered a question-
naire to assess self-reported health care utilization. We determined
patient’s out-of-pocket, medical and non-medical costs resulting from
epilepsy outpatient consultation and treatment.
Results: In the 12-months prior to the study, 132 people with epilepsy
(53%) reported consulting for epilepsy at a clinic, 162 (65%) at a hos-
pital and 34 (14%) with traditional healers. Of those with epilepsy,
168 (67%) have consulted both biomedical and traditional caregivers
at some time. Direct outpatient, median costs per visit varied signifi-
cantly (p < 0.001) between hospital consultations (2010 International
dollar (I$) 32.82; IQR: I$22.93-I$39.56) and clinic consultations (I
$12.17; IQR: I$7.38-I$20.40). Traditional healer consultations were
found to cost I$52.36 (I$34.90-87.26) per visit. Annual outpatient,
clinic and hospital out-of-pocket costs totaled I$158.31 (IQR: I$77.46-
$276.86) or nearly 2% GDP per capita, with 73% of this cost due to
time spent traveling to and waiting to be seen by the healthcare
worker.
Conclusions: South Africans with epilepsy in this rural area practice
dual health-seeking behavior, consulting both biomedical and tradi-
tional caregivers. Local primary care clinics, which should form the
foundation of the South African health care system, are used less often
than hospitals for epilepsy consultation. Given efforts to revitalize pri-
mary health care in South Africa, interventions aimed at strengthening
epilepsy care at primary care clinics by reducing transportation costs
and waiting time could substantially reduce the out-of-pocket cost of
outpatient epilepsy care.
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CREUTZFELDT-JAKOBDISEASE: A CASEREPORT
WITHTYPICAL EEGANDMRI FINDINGS
M.F. Yetkin, F.F. Erdogan, S. Ismailogullari, M. Mirza
Erciyes University Faculty of Medicine, Neurology Department,
Kayseri, Turkey
Purpose: Sporadic Creutzfeldt-Jakob (sCJD) disease is a rare neurode-
generative disorder of unknown etiology that causes rapidly progressive
dementia with myoclonus, visual disturbances, and cerebellar, pyramidal
and extrapyramidal signs. The aim of this study is to report a case of
Creutzfeldt - Jakob disease to express clinical presentation and typical
EEG andMRİ findings.
Method: Case report and review of the literature.
Results: The patient was a 66-year-old woman who was referred for
further investigation for rapidly progressive dementia and ataxia. Three
months before admission forgetfulness was started, after a month patient
was unable to walk because of lower extremity weakness and cerebellar
ataxia. Subsequently generalized asynchronous multifocal myoclonic
jerks occurred and finally patient was unable to talk and was unable to
recognize her close relatives. Her past medical history was non-contrib-
utory. She had not had any previous surgeries, and her family history
was not significant. Neurological examination revealed; akinetic mut-
ism, seriously impaired cerebellar tests and weakness in both lower
extremities. Her first EEG exhibited just slowing background activity.
Diffusion-weighted brain magnetic resonance imaging showed diffuse
hyperintensity in bilateral cerebral cortices. With these findings EEG
examination was repeated 1 week later on suspicion of sCJD. EEG
demonstrated periodic synchronous discharges (PSD). Later on, the pro-
tein 14-3-3 in the cerebrospinal fluid came back positive, which sup-
ported the diagnosis of CJD. On the basis of history, clinical and
laboratory findings, typical brain MRI and EEG changes, diagnosis of
sporadic CJD was made.
Conclusion: Clinical signs combined with MRI, EEG, and 14-3-3 and/or
tau protein determination might be sufficient to diagnose or exclude
sCJD but our findings suggest that EEG findings may be subtle or equivo-
cal to diagnose CJD, EEG examination should be repeated on the suspi-
cion of CJD.
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PEDIATRIC EPILEPSY SURGERY: A STUDYOF 201
PATIENTS ACROSS 20 YEARS
C. Gunbey*, B. Bilginer†, K.K. Oguz‡, E.L. Ergun§,
F. Soylemezoglu¶, N. Akalan†, M. Topcu*, G. Turanli*,
D. Yalnizoglu*
*Hacettepe University, Pediatric Neurology, Ankara, Turkey,
†Hacettepe University, Neurosurgery, Ankara, Turkey,
‡Hacettepe University, Radiology, Ankara, Turkey, §Hacettepe
University, Nucleer Medicine, Ankara, Turkey, ¶Hacettepe
University, Pathology, Ankara, Turkey
Purpose: Epilepsy surgery has proved efficasy both for children and
adults with medically intractable epilepsy.We analysed pediatric patients
who underwent epilepsy surgery in order to analyse the changing patient
profile over time.
Method: A total of 236 children underwent epilepsy surgery at Hacet-
tepe University Children0s Hospital between June 1994–January 2015.
We excluded 35 patients who had corpus callosotomy and retrospectively
studied the remaining 201 patients.
Results: The median age at seizure onset was 36 months (first day of
life-14 years), the age at surgery ranged between 2 months-19.8 years,
time to surgery after seizure onset ranged between 1 month-15 years.
Among 201 patients, 110 (54.7%) patients had temporal lobe resection,
62 (30.8%) had extra-temporal resection and 29 (14.4%) had hemi-
spherectomy/hemispherotomy. Temporal resections showed better sei-
zure outcome than the other surgical techniques. The majority of
underlying etiologies were central nervous system (CNS) tumor (23.3%),
and developmental abnormalities of the CNS (%22.6). Seventy three
patiens underwent surgery between 1994 and 2004, and 128 patients
between 2005–2015. The patient profile of two decades revealed that age
at the time of surgery was significiantly younger in the second group, yet
age at seizure onset showed no difference. Etiological profile showed that
CNS tumors were the leading cause in both groups, however in the sec-
ond group patients with malformations of cortical development increased
significantly.
Conclusion: Children with intractable epilepsy who underwent epi-
lepsy surgery at our center increased over time with younger age at the
time of surgery. Etiological profile of patients showed that patients
with malformations of cortical development increased which might be
due to improvement in presurgical evaluation protocols and surgical
technique.
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EPILEPSY SURGERY INCHILDRENWITHEPILEPSY:
A TERTIARYCENTER EXPERIENCE
T. Hirfanoglu*, A. Seradroglu*, I. Capraz†, E. Bilir†, G. Kurt‡,
A. Erdem§, M. Ucar¶, A.Y. Oner¶, O. Akdemir**, O. Kapucu**,
K. Aydin*, E. Arhan*
*Gazi University School of Medicine, Department of Pediatric
Neurology, Ankara, Turkey, †Gazi University School of
Medicine, Department of Neurology, Ankara, Turkey, ‡Gazi
University School of Medicine, Department of Neurosurgery,
Ankara, Turkey, §Ankara University Faculty of Medicine,
Department of Neurosurgery, Ankara, Turkey, ¶Gazi University
School of Medicine, Department of Radiology, Ankara, Turkey,
**Gazi University School of Medicine, Department of Nuclear
Medicine, Ankara, Turkey
Purpose: Epilepsy is one of the most common chronic neurological dis-
orders. Despite many effective AEDs therapies, about 20–30% of
patients are not successfully treated and still having harmful seizures
especially in terms of quality of life and cognitive functions. As advanced
surgical techniques were developed with time, successful and satisfying
results are obtained from the epilepsy surgery. The purpose of this study
was to evaluate the efficacy of resective surgery in children with focal
epilepsy.
Method: This study was designed as retrospectively among 48 children
aged between 2–18 year old who were evaluated for presurgical work up
in Gazi University Department of Pediatric Neurology Pediatric Video
EEG Monitorization Unit and then underwent epilepsy surgery. Detailed
history, Video EEG, neuroimaging, and postoperative seizure freedom
was evaluated.
Results: Twenty six (54.1%) patients were girl, 22 (45.8%) patients
were boys. While 37 (77%) patient were diagnosed as TLE, 11 (23%)
of those were extra TLE depends on electrographic records Twenty
patient had hypometabolism in different lobe but predominantly in
temporal lobe at PET CT. fMRI was performed to 9 (18.75%) patient.
As to pathology, 22 (45.8%) patient had hippocampal sclerosis and
second frequent was gliosis (33.3%). 85.4% of patient was seizure free
after resective surgery.
Conclusion: Resective surgery is one of the effective treatment methods
in children with pharmacoresistant epilepsy. Seizure reduction depends
of the localization and nature of the lesions. Temporal lobe localization
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and hippocampal sclerosis is the best results in terms of seizure freedom.
In early life period, resective surgery for appropriate patients reduces the
morbidity and increase quality of life. As develop supportive and
advanced techniques, deciding the margin of the surgery is easier and
confident for physician.
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INTERICTAL EPILEPTIFORMACTIVITYALTERS
PERFORMANCE INMEMORYTASKS
B.C. Jobst*, A.A. Robbins†, P.C. Horak*, M.E. Testorf‡,
A.C. Connolly*
*Dartmouth-Hitchcock Medical Center, Neurology, Lebanon,
NH, USA, †Dartmouth College, Hanover, NH, USA, ‡Dartmouth
College, Neurology, Hanover, NH, USA
Purpose: We have previously reported that interictal epileptiform activ-
ity (IEA) during a memory task causes deficits in performance. The defi-
cits that we have shown were dependent on the location of the IEA in the
brain, i.e. whether it occurred bilaterally or ipsilateral/contralateral to the
seizure focuses. In addition, the IEA only produced a performance deficit
when it occurred during the recognition phase of the experiment. In order
to determine whether IEA alters performance in other types memory
tasks we have analyzed data collection from free recall and virtual navi-
gation experiments.
Method: 78 patients were monitored with intracranial EEG and had
depth electrodes implanted either bilaterally or unilaterally in the hip-
pocampus. We analyzed hippocampal EEG that was collected from sub-
jects while they performed free recall or spatial navigation tasks. The
EEG was analyzed, and IEA was marked using a custom spike detection
algorithm. Each trial for either task was separated into an encoding and
retrieval condition to determine the timing specificity of the task.
Results: In the free recall task we determined that there was an effect of
IEA during word encoding but not during recall. We tested whether the
occurrence of IEA during word presentation reduced the likelihood that
the word would later be recalled, and compared that probability against a
bootleg dataset of shuffled spike times and found a significant effect
(n = 78, p < 0.05). In the virtual navigation task we did not see an effect
in performance as measured by percent distance error from the target
with IEA in either encoding or retrieval (n = 6).
Conclusion: We found alterations to task performance in the free recall
task when the activity occurred during the encoding phase of the task.
Spatial navigation may be less affected by IED, but a greater sample size
is needed.
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SYSTEMATIC REVIEWANDMETA-ANALYSIS OF
MEDICALVERSUS INVASIVE EPILEPSY THERAPY
FOR PATIENTSWITHARTERIOVENOUS
MALFORMATIONSOF THEBRAIN
C.B. Josephson, K. Sauro, F. Clement, S. Wiebe, N. Jette
University of Calgary, Calgary, Canada
Purpose: Routine intervention to prevent future hemorrhage for patients
with unruptured arteriovenous malformations (AVMs) has been associ-
ated with increased short-term risk of stroke and death. We performed a
systematic review and meta-analysis to determine if invasive AVM ther-
apy targeted specifically for epilepsy is superior to conservative anti-sei-
zure drug (ASD) only management.
Method: We searched Medline, Embase, and Cochrane Central using
Medical Subject headings and keywords related to epilepsy and
AVMs. We included original research involving observational cohort
studies (OCS) or randomized controlled trials (RCTs) comparing
seizure outcomes in those undergoing invasive AVM therapy to those
managed only with ASDs. We also compared case series of invasive
AVM therapy containing ≥20 patients (all lacking a conservatively
managed ASD only arm) to those derived from controlled OCS and
RCTs. Study quality was evaluated and a random-effects model was
used to derive a pooled risk ratio (RR) for Engel class I seizure free-
dom for OCS and RCTs.
Results: Of 1865 identified abstracts, 155 were reviewed in full-text.
Two OCS (n = 106 patients) met all eligibility criteria. Both were similar
with respect to demographics and AVM-related variables, but varied by
study quality. The pooled RR of 0.99 (95%CI 0.69–1.43) did not indicate
superiority to either approach. Twenty-five case series met eligibility cri-
teria but a meta analysis was not performed due to statistical heterogene-
ity (I2 = 93.6%; p < 0.001). Seizure freedom in case series ranged from
19% (95% CI 11–30%; stereotactic radiosurgery) to 93% (95% CI 87 to
96%; microsurgery) at last follow-up. These outcomes are comparable to
the ASD arms of the two OCS (57% [95% CI 35 to 79%] and 46% [95%
CI 26 to 65%]).
Conclusion: There is insufficient evidence available to recommend uni-
versal invasive AVM management for seizure control. A randomised-
controlled trial of interventional versus medical management using stan-
dardized epilepsy-specific pre-surgical protocols is warranted.
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LONG-TERMTREATMENTOUTCOMEOFCORPUS
CALLOSOTOMY IN LENNOX-GASTAUT SYNDROME
J.W. Kang*, T. Khusainov†, S. Park‡, H.-C. Kang‡, J.S. Lee‡,
Y.-M. Lee§, D.S. Kim¶, H.D. Kim‡
*Chungnam National University Hospital, Chungnam National
University College of Medicine, Pediatrics, Daejeon, Republic
of Korea, †Republic Children’s Hospital of Tashkent Pediatric
Medical Institute, Pediatric Neurology, Tashkent, Uzbekistan,
‡Pediatric Epilepsy Clinics, Severance Children’s Hospital,
Epilepsy Research Institute, Yonsei University College of
Medicine, Pediatric Neurology, Seoul, Republic of Korea,
§Gangnam Severance Hospital, Yonsei University College of
Medicine, Pediatrics, Seoul, Republic of Korea, ¶Division of
Pediatric Neurosurgery, Severance Hospital, Yonsei University
College of Medicine, Pediatric Neurosurgery, Seoul, Republic of
Korea
Purpose: Lennox-Gastaut syndrome (LGS) is a severe childhood-onset
epileptic encephalopathy that causes significant cognitive decline and
behavioral problems. The aim of this study is to evaluate the long-term
treatment outcome of corpus callosotomy in LGS patients in a single cen-
ter.
Method: We reviewed 78 cases of corpus callosotomy of LGS patients
treated at Severance Children’s Hospital between 2003 and 2012, with a
minimum follow-up of 3 years. All patients failed multiple trials of
antiepileptic medication, and had no data clearly indicating the hemi-
sphere of seizure onset.
Results: The age of patients at the time of surgery was between 2.9 and
20.7 years (8.9  4.4 years). Time from seizure onset to surgery ranged
from 0.9 to 17.5 years (6.3  3.8 years). At an average postoperative
follow-up of 6.2  2.5 years, 14 patients (17.9%) had no seizures. More
than 50% seizure reduction including seizure free were noted in 61
patients (78.2%), who were 23 of 31 (74.2%) patients with atonic seizure,
21 of 25 (84.0%) with tonic seizures and 7 of 9 (77.6%) patients with
epileptic spasms. On high-resolution MRI, 49 patients (62.8%) showed
normal or mild cerebral atrophy, and others had structural or destructive
lesions. Thirteen patients (16.5%) experienced mild postoperative com-
plications that were all transient, and there was no mortality. Seventeen
patients showed lateralized epileptiform discharges on long-term moni-
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toring electroencephalogram after corpus callosotomy. Among them, 10
patients were performed resective surgery, and 5 patients achieved sei-
zure free via resective surgery.
Conclusion: Corpus callosotomy is a safe treatment option for LGS with
high expectation of seizure reduction.
p0581
CHANGES IN CENTRALAUDITORY PROCESSING IN
PATIENTSWITHMESIAL TEMPORAL LOBE
EPILEPSYAFTERANTERIOR TEMPORAL
LOBECTOMYWITH
AMYGDALOHIPPOCAMPECTOMY
J.K. Kang*, S.-H. Han*, J.W. Chung†
*University of Ulsan College of Medicine/ AsanMedical Center,
Neurology, Seoul, Republic of Korea, †University of Ulsan
College of Medicine/ Asan Medical Center, Otolaryngology,
Seoul, Republic of Korea
Purpose: The aim of this study was to investigate the effect of anterior
temporal lobectomy with amygdalohippocampectomy (ATL-AH) on
central auditory processing (CAP) in patients with mesial temporal lobe
epilepsy with hippocampal sclerosis (mTLE-HS), and identify the factors
that may contribute to postoperative worsening of CAP.
Method: We performed frequency pattern, duration pattern, and dichotic
tests before and after epilepsy surgery in 22 patients with normal hearing
on pure tone audiometry.
Results: While there was no significant difference in CAP scores
between preoperative and postoperative tests, there was a strong associa-
tion between postoperative worsening in right-side dichotic test results
and surgery of the language-dominant hemisphere (p < 0.05). The proba-
bility of decreased performance on the right-side dichotic test after sur-
gery was 7.5 times higher in patients who underwent surgery on the
dominant hemisphere than in those who underwent surgery on the non-
dominant hemisphere. The association of postoperative worsening in
CAP with verbal I.Q., non-verbal I.Q., or side of lobectomy was not sig-
nificant.
Conclusion: Our results suggest that dominant temporal lobectomy in
patients with mTLE-HS may worsen postoperative right-side dichotic
function on CAP test.
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AMULTIMODALAPPROACHTOACHIEVE
SUPERIOROUTCOMES IN THE SURGICAL
MANAGEMENTOFEXTRATEMPORAL LOBE
EPILEPSY (ETLE)
N.K. Kumar
Amrita Institute of Medical Sciences, Neurosurgery, Cochin,
India
Purpose and objective: To analyse seizure outcomes in ETLE surgery
following a multimodal presurgical and surgical approach beyond the tra-
ditional semiology, scalp EEG andMRI.
Methods: A prospective study of all patients undergoing surgery for
ETLE at Amrita Advanced Epilepsy Centre over a 4 year period (2010–
2014) was performed. Patients with medically refractory epilepsy (ILAE
criteria of 2 drug failure) were included.
Results: Among 90 patients undergoing epilepsy surgery, 21 lesional
and 11 nonlesional (20 adults and 12 paediatric) ETLE cases were
included. The mean duration of epilepsy was 14.5 years  4.5. Addi-
tional modalities used presurgically were interictal FDG-PET (20),
Ictal SPECT (6), 3T MRI (21) and WADA (1). Intracranial EEG
(ICEEG) monitoring was performed using subdural and conventional
depth electrodes in 14 and Stereo-EEG in 4. Extraoperative electrocor-
tical stimulation mapping of language, sensorimotor, visual and sup-
plementary motor cortex was performed in nine patients.
Intraoperative transcranial-MEP and ECOG were used in 11 patients.
Surgical procedures were image-guided (3T MRI/PET) resection (15),
ICEEG-guided resection (13), hemispherotomy (3), posterior quadran-
tic disconnections (3), and multiple subpial transection (1). The mean
follow up period was 18.5 months  1.5. One year seizure-free out-
come (Engel 1a) was achieved for 87% (13/15) of phase 1 discordant
and 94% (15/16) of phase 1 concordant patients. Postoperative compli-
cations included grade 4 limb paresis in 2 non-hemispherotomy
patients (6.7%) and no mortality.
Conclusion: Excellent seizure freedom rates with good functional out-
come is possible for patients with both lesional and nonlesional focal
ETLEwhen using a multi-modal approach.
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TWOCASESOF EPILEPSY SURGERYVIA
SUPRACEREBELLAR TRANSTENTORIAL APPROACH
N. Kunii*, K. Kawai†, N. Saito*
*University of Tokyo Hospital, Tokyo, Japan, †NTTMedical
Center Tokyo, Tokyo, Japan
Purpose: Lesions in the posterior medial temporal area (PMTA) could
be causes of complex partial seizures, due to its proximity to the mesial
temporal lobe. It seems difficult to resect epileptogenic area completely
since the posterior limit of an operative field secured by anterior
approach is around the lateral geniculate ganglion. On the other hand,
supracerebellar transtentorial approach (SCTA) is reported to be useful
for lesions in more posterior parts. We experienced two cases of epilepsy
surgery using SCTA approach, which seems to be unfamiliar to most neu-
rosurgeons. We will present our operative videos and discuss tips, useful-
ness, and limitations of SCTA. Case 1: 53 y.o. female. The onset was a
generalized tonic clonic seizure at age 21. MRI showed a gadolinium-
enhanced brain tumor in the right PMTA, which increased in size during
a short period. The tumor was resected via SCTA with the operator posi-
tioned at the patient’s right side. Bridging veins existed in the medial and
lateral side, which narrowed the operative field, resulting in a residual
lesion. Pathological diagnosis was ganglioglioma. Case 2: 66 y.o female.
Her seizure was characterized as visual hallucination followed by deteri-
oration of consciousness. Weekly seizures continued more than 20 years.
MRI showed a cavernous malformation in the right PMTA.Whereas ictal
EEG pattern was typical of mesial temporal lobe epilepsy, a limited corti-
cal area including the lesion was considered the epileptic focus based on
the seizure semiology. The lesion was completely removed via SCTA
with the operator positioned at the patient’s left side, which allowed us an
enough operative field.
Conclusion: Slight modifications in the surgical setup produced a signif-
icant difference of the operative field. With careful consideration and
appropriate management of the venous sinus, bridging veins and the ten-
torium, SCTA will provide an optimal operative filed for surgery in
PMTA.
p0584
RESECTIVEOPEATIONCOMBINEDCORPUS
CALLOSOTOMY IN PATIENTSWITHLENNOX-
GASTATU SYNDROME
S. Liang*, X. Hu†, S. Zhang*
*First Affiliated Hospital of PLA General Hospital, Neursurgery
Department, Beijing, China, †First Affiliated Hospital of PLA
General Hospital, Paediatric, Beijing, China
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Purpose: Lennox-Gastaut syndrome (LGS) in typical medicine intact-
able epilepsy. esective opation can render seizure free in half patients
with lesional LGS, but cognitive stagnation and behavioral problem are
still seen in most patients. We designed this prospective randomized con-
trolled trial to study the safety and validity for resective operation com-
bined corpus callosotomy for patients with LGS.
Method: 198 patients with LGS were enrolled, and 87 of them finished
preoperative evaluation. thirty four cases underwent resective operation,
including 11 operationes in 18 months after evalustions (late resection
group), 9 in 2 months after evalustions (ealy resection group), and 12
early operations combined with aCCT (combined group). Also, 21
patients without FEZ underwent aCCT as exclusive opeation (CCT
group). The patients0 clincal characteristics and surgical outcomes were
compared among groups.
Results: The patients with FEZ presented higher score of QOL and
full-IQ, and age at first seizure than those without FEZ. The scores of
QOL and full-IQ in later operation group decreased 5.02 and 4.51 from
preoperative evaluation to operation period respectivly, and improved
6.38 and 4.04 from operative period to 2 years follow-up after surgery.
Percentages of postoperative seizures free were 50% in resection
group, 58.3% in combined group, and 14.3% in CCT group at 2 years
follow-up. No significant differences were found in seizure control or
complication between resective group and combined group, and
between early and later resective group. However, patients in com-
bined group showed more improvement of QOL and full-IQ than those
in resective groups.
Conclusion: Resective operation combined corpus callosotomy is safe
and can render improvement of QOL and full-IQ in patients with Len-
nox-Gastaut syndrome epilepsy and FEZ.
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EPILEPSY SURGERY IN SLOVENIA: FOLLOWUP
RESULTS AFTERA 10 YEAREXPERIENCE FROMA
CROSS-BORDERCOLLABORATION
A. Cus*, E. Pauli†, D. Gosar‡, H. Hamer†, B. Kasper†,
K. R€ossler§, G. Granda*, H. Stefan†, M. Buchfelder§,
D.B. Vodusek*, B. Lorber*
*University Hospitals Ljubljana, Department of Neurology,
Ljubljana, Slovenia, †Epilepsy Center, University Hospital
Erlangen, Department of Neurology, Erlangen, Germany,
‡University Hospitals Ljubljana, Department of Pediatric
Neurology, Ljubljana, Slovenia, §Epilepsy Center, University
Hospital Erlangen, Department of Neurosurgery, Erlangen,
Germany
Purpose: In small countries cross-border collaboration might be an
effective way of performing epilepsy sugery. An ongoing collaboration
exists between the Department of Neurology at the University Medical
Centre in Ljubljana, Slovenia, and the Epilepsy Centre and the Neurosur-
gical Department at University Hospital in Erlangen, Germany. In order
to evaluate the effectiveness of this collaboration we retrospectively
reviewed the results.
Method: Data were obtained from medical records and from additional
follow-up assessment in all patients. We evaluated seizure and medica-
tion outcome, psychiatric comorbidity, psychosocial outcome and patient
satisfaction. We also conducted postoperative neuropsychological
assessment.
Results: Between 2001 and 2012 a total of 53 Slovenian adult patients,
age 18 to 58 years (mean 34.3 years), with medically intractable epilepsy
underwent surgical treatment in Erlangen. Nearly 90% suffered from
temporal lobe epilepsy (47% left and 43% right), in 10% extra- temporal
lobe epilepsy was diagnosed. We found that 42 (89.4%) patients were
free of disabling seizures (Engel Class 1). Complete seizure freedom
(1A) was achieved in 29 (61.2%) patients. Four of the remaining patients
still experience occasional auras (1B). An additional two patients were
classified as having an Engel 1C outcome. Clinically important level of
Cognitive decline after surgery was recorded in 2 (4%) patients, and de
novo mood disturbances were mostly of a transient nature in 9 (17%)
patients. Surgical treatment did not impact employment status. The
majority of patients (89%) felt that the surgical treatment largely fulfilled
their expectations.
Conclusion: This study demonstrates that despite additional challenges
of cross-border collaboration, distant epilepsy surgery can be a very
effective way to start epilepsy surgery program. The promising results
may be attributed to the careful selection of patient and the high level of
professional colaboration between the two centers.
Epilepsy Surgery 4
Monday, 7th September 2015
p0586
EPILEPSY SURGERYTRENDS IN SWEDEN 1990 - 2013
K. Malmgren*, B. Rydenhag*, I. Olsson†, E. Kumlien‡,
P. Mattsson‡, R. Flink§
*Sahlgrenska Academy at Gothenburg University, Institute of
Neuroscience and Physiology, Dept of Clinical Neuroscience
and Rehabilitation, G€oteborg, Sweden, †Sahlgrenska Academy
at Gothenburg University, Institute of Clinical Sciences, Dept
of Paediatrics, G€oteborg, Sweden, ‡Uppsala University
Hospital, Dept of Neurology, Uppsala, Sweden, §Uppsala
University Hospital, Dept of Clinical Neurophysiology,
Uppsala, Sweden
Purpose: To improve the understanding of the reasons for the underutili-
sation of epilepsy surgery in patients with drug-resistant focal epilepsy,
studies of temporal trends and referral patterns are needed. The aim of
this study was to analyse temporal trends in Sweden for all kinds of epi-
lepsy surgery procedures both at national and regional level during the
time period 1990–2013.
Method: In this study, we analysed data from the prospective and pop-
ulation based Swedish National Epilepsy Surgery Register (SNESUR)
focusing on temporal trends for all epilepsy surgery procedures (resec-
tive and non-resective) in adults and children annually and in 4-year
periods. Among the variables studied are: time from epilepsy diagnosis
to presurgical investigation; referring region; MRI pathology; scalp or
invasive seizure monitoring; surgical procedure; main histopathological
findings.
Results: 1495 epilepsy surgery procedures were performed during the
time period, 1317 resective and 178 non-resective. The number of surg-
eries has decreased from up to 90/year the first 4-year period to 50-60/
year the last 4-year period. There was a non-significant trend over the
years towards slightly shorter epilepsy duration at surgery. During the
first three 4-year periods temporal lobe resection (TLR) was by far the
most common resection type and hippocampal sclerosis (HS) the most
common histopathology. During the last three 4-year periods extratem-
poral resections have increased in frequency and malformations of corti-
cal development (MCD) have become as common as HS. There are
clear-cut differences in the number of operated patients from different
regions in Sweden, and these differences remain fairly constant over the
years.
Conclusion: In Sweden as in other countries fewer patients undergo
TLR for HS while extratemporal resections and histopathological diag-
noses of MCD have increased. Fewer patients are operated today com-
pared to 20 years ago. There is an important variation in the number of
operated patients from different regions in Sweden.
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CHANGING SPECTRUMOFPAEDIATRIC EPILEPSY
SURGERY INMALAYSIA
A.R. Mohamed*, T.B. Khoo*, H.I. Muhammad Ismail*,
V. Ganesan†, S. Ali‡, N.A. Yahya§, S.W. Wong¶, A. Alias**,
B. Selladurai††
*Kuala Lumpur Hospital, Paediatric, Kuala Lumpur, Malaysia,
†Penang Hospital, Paediatric, Georgetown, Malaysia, ‡Subang
Jaya Medical Centre, Paediatric, Petaling Jaya, Malaysia,
§Kota Bharu Hospital, Paediatric, Kota Bharu, Malaysia,
¶Universiti Kebangsaan Malaysia Medical Centre, Paediatric,
Kuala Lumpur, Malaysia, **Kuala Lumpur Hospital,
Neurosurgery, Kuala Lumpur, Malaysia, ††Ara Damansara
Medical Centre, Neurosurgery, Petaling Jaya, Malaysia
Purpose: To describe the spectrum of surgery performed in children
with refractory epilepsy following expansion of the paediatric epilepsy
surgery programme inMalaysia in 2012.
Method: Review of presurgical and outcome data of 45 children (age
range 1.8–18.2, median 11.1 years) who underwent epilepsy surgery fol-
lowing evaluation at the Paediatric Institute, Hospital Kuala Lumpur,
Malaysia between June 2012 until February 2015.
Results: Presurgical evaluation included brain MRI and video EEG
monitoring in all and FDG-PET in 12. EEG was well lateralised in 35
children and showed bilateral abnormalities in 10. MRI showed clear
lesions in all except four children. When performed, FDG-PET added
localising/ lateralising information in children with no clear lesions
(n = 4), bilateral EEG changes (n = 5) or multiple lesions (n = 2). The
most common procedure was temporal lobectomy (n = 21), followed by
functional disconnection (hemispherotomy in12 and temporo-parieto-
occipital disconnection in 1) and focal resection (n = 11). Intra-operative
electrocorticography was performed in six children. Cortical malforma-
tions were the most prevalent epileptogenic substrate (n = 22), followed
by tumours (n = 11), atrophy/gliosis (n = 7), hippocampal sclerosis
(n = 4) and Rasmussen encephalitis (n = 1). One child developed mild
post-operative hemiparesis following resection of an adherent uncal
tumour. Of those with at least 6 months follow up, 85% are seizure free.
Conclusion: Earlier paediatric epilepsy surgery series in Malaysia con-
centrated on children with clear lesions and concordant EEG findings.
Expansion of the epilepsy surgery programme through training and col-
loboration with established epilepsy surgery centres have allowed more
complicated cases to be evaluated and operated.
p0589
POSTOPERATIVEOUTCOMEAFTEREPILEPSY
SURGERY IN RESPECTOFKEEPINGOR STOPPING
OFANTIEPILEPTICMEDICATION
E. Pataraia*, K. Trimmel*, C. Dorfer†, S. Aull-Watschinger*,
H. Stefanits†, R. Jung*, T. Czech†
*Medical University of Vienna, Neurology, Vienna, Austria,
†Medical University of Vienna, Neurosurgery, Vienna, Austria
Purpose: The postoperative antiepileptic drug (AED) withdrawal
remains problematic. The aim of the study is to assess the relation
between the keeping or stopping of AEDs after epilepsy surgery and
long-term seizure outcome.
Methods: A total of 582 adult patients, who underwent presurgical eval-
uation and epilepsy surgery at the Epilepsy Center, Medical University of
Vienna, from 1994 until 2013 were analyzed. We collected data on clini-
cal, imaging and electrophysiological patient characteristics. Only
patients with at least 1 year of postoperative follow-up, were included in
final analyses.
Results:: 215 patients did not fulfill inclusion criteria, thus the data of
367 patients were analyzed. 308 patients (83.9%) underwent resection
on temporal lobe: 137 patients (37.3%) had selective amygdalohip-
pocampectomy, 119 patients (32.3%) had anteromesial resection and
52 patients (14.1%) underwent resection of epileptogenic tumors
localized in temporal lobe. 59 patients (16.1%) had epilepsy surgery
due to extratemporal lesional and nonlesional causes. Mean postopera-
tive follow-up time was 110 month (range 12–210 month). Overall
290 patients (79%) achieved an excellent postoperative outcome with
Class 1a, 1 and 2 according to ILAE Classificaion (Wieser et al.). 45
patients had outcome Class 3, 21 patients Class 4 and 11 patients
class 5. 68 patients (45%) out of 154 patients who were absolutely
seizure free after operation (Class 1a) were off medication, whereas
only 28 patients (24%) of 117 with Class 1 and none of 19 patients
with Class 2 (only auras). 39 patients (14.3%) out of 271 patients who
were on AEDs at the last follow-up visit, had at least once tried to
stop the medication, however had to start the treatment after seizure
recurrence.
Conclusion: AED withdrawal increases the risk of breakthrough sei-
zures after epilepsy surgery, but the seizures are usually well controlled
after readministration of medication. Large randomized studies are nec-
essary for validation of the data.
p0591
POSTERIORQUADRANTIC SCAREPILEPSY:
EXCELLENT SEIZUREANDCOGNITIVEOUTCOMES
WITHREGIONALDISCONNECTIVE SURGERY - A
CASE SERIES
A. Pillai*, S. Gopinath†, K.P. Vinayan‡
*Amrita Advanced Center for Epilepsy, Amrita Institute of
Medical Science, Neurosurgery, Kochi, India, †Amrita
Advanced Center for Epilepsy, Amrita Institute of Medical
Science, Neurology, Kochi, India, ‡Amrita Advanced Center for
Epilepsy, Amrita Institute of Medical Science, Pediatric
Neurology, Kochi, India
Purpose: Posterior quadrantic gliotic scars commonly result from
neonatal cerebral injury and can be associated with a progressively
refractory focal epilepsy. The electroclinical and imaging features are
reviewed and correlated with surgical outcomes.
Method: Patients with medically refractory posterior quadrantic epi-
lepsy and MRI evidence of unilateral or bilateral peri-calcarine gliosis
undergoing posterior quadrantic disconnective surgery were retrospec-
tively analysed over a 3 year period.
Results: Six patients (age 10–31) finally underwent posterior quad-
rantic disconnective surgery after completion of a phase 1 noninva-
sive (2) or followed by phase 2 invasive evaluation (4). Two were
left-handed, one ambidextrous. The average age of onset of seizures
was 2 years (range 3 months to 6 years). A visual aura was present
in two (33%), four (67%) had lateralizing features in the motor com-
ponent of the seizures, and four patients (67%) had preoperative
homonymous hemianopia which lateralized concordantly with the
electroclinical and imaging features. Interictal epileptiform discharges
correctly lateralized in five (83%) and scalp EEG Ictal rhythms later-
alized in 5 (83%). MRI revealed peri-calcarine cortical volume reduc-
tion and gliosis - bilateral in 3 (50%) and unilateral in the remaining.
Following posterior quadrantic disconnection, all patients had Engel
1a seizure freedom on follow-up ranging from 3 to 19 months. Com-
plete neuropsychological evaluation showed preoperative performance
IQ 50–72, and postoperative assessment at 6–12 months showed
improved scores in all patients. Transient neurological deficits were
noted in language function (1 - ambidextrous) and motor weakness
(1), but no long term deficits. One patient with bilateral imaging find-
ings and visual field defects preoperatively, suffered from visual
agnosia.
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Conclusion: Parieto-occipital gliotic scar epilepsy represents an impor-
tant clinical syndrome frequently refractory to medications. Posterior
quadrantic disconnective surgery results in excellent seizure and cogni-
tive outcomes. Further standardization of the electroclinical and imag-
ing-based selection of patients for surgical intervention is warranted.
p0594
MESIAL TEMPORAL LOBEEPILEPSY SYNDROME:
CANAND SHOULDWEDISTINGHUISH IT BECAUSE
OF SURGICALOUTCOME?
M.Wassenaar*,†, F.S. Leijten†, G.J. de Haan*, S.G. Uijl‡,
J.W. Sander*,§,¶
*SEIN, Stichting Epilepsie Instellingen Nederland, Heemstede,
Netherlands, †Brain Center Rudolf Magnus, University Medical
Center Utrecht, Department of Neurology and Neurosurgery,
Utrecht, Netherlands, ‡Julius Center for Health Sciences and
Primary Care, University Medical Center Utrecht, Utrecht,
Netherlands, §NIHR University College London Hospitals,
Biomedical Research Centre, UCL Institute of Neurology,
London, UK, ¶Epilepsy Society, Chalfont St Peter, UK
Purpose: Mesial temporal lobe epilepsy syndrome (MTLE) with speci-
fic electroclinical characteristics and hippocampal sclerosis (HS) onMRI
is considered the prototype of syndromes with good surgical prognosis.
Recent studies, however, question its status as a sharply delineated syn-
drome suited for surgery. Ictal onset zones have been found outside the
hippocampus. Temporal lobe (“plus”) epilepsies (TLEs), due to a lesion
or dual pathology, may imitate MTLE electroclinically and may also be
associated with a similar surgical prognosis. We compared MTLE with
HS with these lesional TLEs and assessed if the MTLE characteristics
influenced surgical outcome.
Method: We performed a retrospective cohort study including 389 per-
sons with temporal MRI abnormalities who underwent temporal lobe
resection, and divided them into “HS only” or “lesional” TLE. We
assessed surgical outcome and fulfillment of the MTLE criteria in both
groups.We definedMTLE according to 9 electroclinical criteria, adapted
from Engel.
Results: 57% patients had ‘HS only’. Five electroclinical signs (age at
onset, febrile seizures, memory dysfunction, auras and contralateral dys-
tonic posturing) distinguished ‘HS only’ from ‘lesional’ TLE. Freedom
of disabling seizures (Engel class 1) rates after surgery were similar; 66%
in ‘HS only’ and 67% in ‘lesional’ TLE. Neither presence of HS, nor elec-
troclinical criteria were associated with surgical outcome.
Conclusion: Our findings support the idea that MTLE is not a sharply
delineated syndrome but more likely to be part of a larger spectrum of
temporal lobe or temporal ‘plus’ epilepsies with similar characteristics
and outcomes. MTLE with ‘HS only’ does not stand out from ‘lesional’
TLEs with respect to surgical outcome, questioning the prognostic rele-
vance of discerning this syndrome.
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A PROPOSEDNEWPROTOCOLOFCOMPLICATIONS
IN EPILEPSY SURGERYAND INVASIVE DIAGNOSTIC
PROCEDURES
B. Rydenhag*,†, J. Bjellvi†,‡, K. Malmgren†,‡
*Neurosurgery, G€oteborg, Sweden, †Sahlgrenska Academy at
the University of Gothenburg, Department of Clinical
Neuroscience and Rehabilitation, Institute of Neuroscience and
Physiology, Gothenburg, Sweden, ‡Neurology, Sahlgrenska
University Hospital, Gothenburg, Sweden
Purpose: Much work is presently being done to increase safety and
promote good outcome of epilepsy surgery worldwide. Both epilepsy
surgery and invasive diagnostic procedures (including Wada test) carry
a risk for serious complications, including permanent neurological
morbidity or even death. A number of studies and reviews deal with
this subject. However, definitions and classifications of complications
vary markedly between studies. Furthermore, since many complica-
tions are rare, multi-center studies are needed to collect the number of
patients necessary for analyzing risk factors. The aim of this study is
to propose a uniform and evidence-based protocol for prospective
reporting of complications in epilepsy surgery and in invasive diagnos-
tic procedures.
Method: Based on the literature, a first version of the protocol was
developed by the present authors. The feasibility of web-based systems
to increase the speed and ease of entering data has been of fundamental
importance in the design of the protocol. The protocol was then discussed
within the E-pilepsy consortium (an EU-funded project with the title: A
European pilot network of reference centres in refractory epilepsy and
epilepsy surgery) and within the ILAE Commission on Surgical Thera-
pies, and thereafter revised and endorsed.
Results: Separate protocols are proposed for invasive diagnostic proce-
dures and for epilepsy surgery. For both invasive diagnostic procedures
and epilepsy surgery, technical details of the procedure are specified.
All complications are registered in a multiple-choice fashion. Further-
more, it is specified whether a complication has any patient-related
impact (e g unplanned surgery, or prolongation of hospital stay), if it
results in permanent morbidity, and, if so, whether activities of daily
life are affected.
Conclusion: A protocol for multi-axial reporting of complications has
been developed and has been endorsed by the E-pilepsy consortium and
by the ILAE Commission on Surgical Therapies. The structure of the
final protocol will be presented.
p0596
EFFICACYOF INTRA-OPERATIVE
ELECTROCORTICOGRAPHY IN TERMSOF SEIZURE
OUTCOMES IN FOCALEPILEPSY
B. Aktekin*, C.A. Bing€ol*, U. Ture†, B. Ormeci*, C. Sayman*,
O. Eranıl Terim*
*Yeditepe, Neurology, Istanbul, Turkey, †Yeditepe,
Neurosurgery, Istanbul, Turkey
Introduction: Intra-operative electrocorticography (ECoG) is a useful
tool to guide surgical resection of both the lesion and epileptogenic zone
(EZ). The outcome of epilepsy surgery becomes clear only after serial
follow up, incomplete removal of EZ as a main cause for early relapses.
In this study, we evaluated the efficacy of ECoG on post-operative sei-
zure outcome in patients with focal epilepsy.
Methods: The present study reviewed 68 patient (33 females, mean age:
26.01 years) ECoG recordings data from April 2009 till January 2015
performed at our center. The study included 63 focal epilepsy patients,
who had been surgically treated. Inclusion criteria for this series included
only those cases with concordance seen on video-EEG, MRI, PET and
neuropsychological test results. The ECoG recordings were performed
32-channel machine. Recording from neocortical surfaces were usually
performed by using a different size grids and/or strips electrodes. Record-
ing from deep structures like hippocampus were usually performed by
using a depth and/or strip electrodes.
Results: Intraoperative ECoG recording before resection demonstrated
frequent epileptiform discharges in all patients. If significant abnormal
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activity was still recorded from the margins, further resection was per-
formed. In terms of functional cortical areas some resections were not
completed even if the existence of residual spiking. 11 patient have Class
II or III seizure freedom and the remaining all patients have Class I sei-
zure freedom.
Discussion: In this observational study, we found the main determinant
of seizure freedom is underlying etiology. Although the numbers are
small in respect to meaningful comparison between the groups, the sei-
zure recurrence mainly occurred in grade-II or higher-grade glial tumor
patients. Especially in the mesial temporal sclerosis, cavernoma and cor-
tical dysplasia group we had very high seizure free rates. Our results
show that sequential ECoG recordings guided surgical resections has an
additional beneficial effect on good seizure outcomes.
p0599
THE SPATIALRELATIONBETWEENEARLYAND
DELAYEDRESPONSES EVOKEDBY SINGLE PULSE
ELECTRICAL STIMULATION IN PRE-SURGICAL
EVALUATIONOFEPILEPSY PATIENTS
D. van Blooijs*,†, G. Huiskamp*, J. Hebbink*,†, M. van ‘t
Klooster*, H. Meijer†, S. van Gils†, P. Gosselaar*, F. Leijten*
*Brain Center Rudolf Magnus, Department of Neurology and
Neurosurgery, University Medical Center Utrecht, Utrecht,
Netherlands, †MIRA Institute for Biomedical Technology and
Technical Medicine, Enschede, Netherlands
Purpose: Single pulse electrical stimulation (SPES) assists delineating
epileptogenic tissue during long-term intracranial monitoring for pre-sur-
gical evaluation. The SPES protocol consists of systematic stimulation of
neighboring electrode pairs and analysis of responses in all other elec-
trodes. SPES evokes early (ER) and delayed (DR) responses. DRs occur
in epileptogenic tissue, but are stochastic: 10 stimuli are needed to reli-
ably establish a response. ERs occur in healthy and diseased tissue and
require only a single stimulus. We studied the spatial relation between
ERs and DRs. If it is possible to predict DRs from ERs, this might
improve the efficiency of SPES.
Method: Data of one patient with TLE recorded in 84 grid electrodes
were used. We counted per electrode the number of stimulus pairs that
evoked ERs (eER) and per stimulus pair the number of ERs that were
evoked (sER). Similarly, for DRs, eDR and sDR were determined. Also,
per electrode we counted the number of stimulus pairs that evoked both
ERs and DRs, eERDR and vice versa for sERDR. We selected electrodes
with eER or sER >median as eER50 or sER50. We tested whether values
for eDR and sDR were significantly more in the eER50 and sER50
groups. Finally we tested whether the ratios eERDR/eDR and sERDR/
sDR differed significantly from 0.5.
Results: eER values ranged from 0 to 41, median=8; sER:3-27, med-
ian=17; eDR:0-28, median=17 and sDR:0-26,median=9. eDR and sDR
values were higher in eER50 (p < 0.001) and sER50 (p = 0.1) elec-
trodes. The ratios of eERDR/eDR and sERDR/sDR ranged from 0 to 1,
median=0.24 and 0–0.64, median=0.25 respectively, with the average
significantly lower than 0.5 (p < 0.001).
Conclusion: The correlation between eER50 electrodes and high values
of eDR indicates that ERs and DRs seem to occur within the same net-
work. The low ratio eERDR/eDR suggests that ERs and DRs are not
directly related.We will analyze more patients to confirm these findings.
p0600
LONG-TERMOUTCOMEAFTER
HEMISPHERECTOMY INCHILDHOOD
M. van Schooneveld*, K. Braun†, O. van Nieuwenhuizen†,
A. Jennekens-Schinkel‡
*University Medical Center Utrecht / Wilhemina Children’s
Hospital, Utrecht, Netherlands, †University Medical Center
Utrecht, Brain Center Rudolf Magnus, Utrecht, Netherlands,
‡University Medical Center Utrecht, Sector Neuropsychology,
Brain Center Rudolf Magnus, Utrecht, Netherlands
Purpose: To assess cognitive, behavioural and psychosocial outcome as
well as health-related quality of life (HrQoL) at least 5 years after hemi-
spherectomy in childhood.
Method: We performed a countrywide cohort study of 31 patients
who underwent hemispherectomy between 1994 and 2009, in whom
we had a semi-structured interview with parents, assessed cognitive
outcome (using intelligence or developmental scales), screened for
behavioural and psychosocial problems [parents rated the Strength
and Difficulties Questionnaire (SDQ)], and addressed HrQoL [Euro-
qol-5D, a questionnaire that inventories overall and specific HrQoL
(mobility, self-care, usual activities, pain/discomfort and anxiety/de-
pression)].
Results: Exploration of the data compelled the formation of three
groups: a) 9 children [median age 9.7 years (0.25 at epilepsy onset, 1.4
at hemispherectomy)] who could not be assessed with age-appropriate
instruments, b) 14 school-age children [all younger than 18 years (me-
dian age 0.3 at epilepsy onset and 2.6 at hemispherectomy); median IQ
62], and c) 8 young adults [18 years or older (median age at epilepsy
onset 1.2 and at hemispherectomy 9.9); median IQ 63]. All children in
group a) were severely mentally retarded and almost totally dependent
on others in activities of daily living. This group had the highest pro-
portions of preoperative contralateral MRI-abnormalities, postoperative
seizure recurrence and behavioural and psychosocial problems, com-
pared to both other groups. Most parents rated overall HrQoL posi-
tively. In group a), overall HrQoL was better in seizure-free
participants than in those with seizure recurrence. As for specific
HrQoL, parents perceived most problems with respect to self-care,
daily activities and mobility. Most important perceived changes after
the hemispherectomy were according to parents’ seizure freedom and/
or restart of development.
Conclusion: Functional long-term outcome of childhood hemispherec-
tomy is best described in terms of a broad spectrum, varying from almost
total dependence to more or less unproblematic cognitive, behavioural
and psychosocial functioning.
p0602
COULDHISTOPATHOLOGICAL FINDINGS IN
SURGICALLYTREATEDMESIAL TEMPORAL LOBE
EPILEPSY INFLUENCE THE SEIZUREOUTCOME?
L. Volpi*, R. Michelucci*, P. Riguzzi*, F. Santoro*,
G. Rubboli*, P. Tinuper*, F. Bisulli*, F. Marliani†,
M. Giulioni‡, M. Martinoni‡, G.L. Marucci§
*Bellaria Hospital, Neurology Department, Bologna, Italy,
†Bellaria Hospital, Neuroradiology Service, Bologna, Italy,
‡Bellaria Hospital, Anatomo-Pathology Service, Bologna, Italy,
§Bellaria Hospital, Institute of Neurological Sciences, Bologna,
Italy
Purpose: Surgery represents the treatment of choice for mesio-tem-
poral lobe (MTLE) drug resistant epilepsy. Patients undergo extensive
pre-surgical evaluation for surgical planning and outcome prevision.
Evidence of mesial temporal sclerosis (MTS) is considered a prognos-
tic indicator of good surgical outcome. Several studies identified other
pre-surgical favorable prognostic factors that will be discussed. Despite
of ectroclinical, neuroradiological and neuropsychological concordance
and positive prognostic factors, post-surgical seizures recurrences may
occur. We suggest that recent neuropathological classification accord-
ing to Blumke et Al of MTS (type 1 and type 2) and granule cell
pathology (GCP, 3 different patterns) could represent another predict-
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ing factor explaining unexpected seizure recurrences and neuropsycho-
logical outcome.
Method: We describe 34 consecutive patients (19 females and 15 males)
presenting with MTLE and magnetic resonance concordant MTS finding.
After non invasive extensive pre-surgical evaluation, they underwent tai-
lored antero-mesial temporal lobe resection between 2001 and 2012.
MTS was always pathologically confirmed. Mean follow-up after sur-
gery is 7.9 years. Seizure outcome was separately correlated either with
pathological findings according to Blumke classification or with the pre-
dicting pre-surgical factors.
Results: 29 patients (82.85%) are on Engel class I (15 pts=Ia; 2 pts=Ib; 5
pts=Ic; 7 pts=Id); 5 pts on class II. 27 pts are still on simplified anti
epileptic drugs treatment. Best results were achieved in patients with
MTS type 1 associated with GDC type 1 or 2. Lack of GDC seems related
to seizures recurrence after drugs withdrawal. Recurrence of seizures
mainly occurred in patients with MTS 2 and lack of GDC, despite of a
number of positive pre-surgical prognostic factors and concordance in
pre-surgical data.
Conclusion: Pathological substrate seems to be taken in account as an
important element for seizures recurrence and consequent decision about
drug withdrawal following surgery for intractable TLE. Neuropsycholog-
ical outcome according to neuropathological findings is still on evalua-
tion.
p0603
SURGICALOUTCOME IN TEMPORAL LOBE
EPILEPSY: COMPARISONOF SELECTIVE
AMYGDALA-HIPPOCAMPECTOMYVS. ANTERIOR
TEMPORAL LOBERESECTION
G. Walser*, L. L€oberbauer*, M. Bergmann*, M. Prieschl*,
E. Trinka†, C. Unterhofer‡, M. Ortler‡, I. Unterberger*
*Medical University Innsbruck, Neurology, Innsbruck, Austria,
†Paracelsus Medical University Salzburg, Neurology, Salzburg,
Austria, ‡Medical University Innsbruck, Neurosurgery,
Innsbruck, Austria
Purpose: Epilepsy surgery is a favorable option for patients with medi-
cally refractory temporal lobe epilepsy (TLE). There is still controversy
about advantages of selective amygdala-hippocampectomy (SAHE) over
standard 2/3 resection of the temporal lobe. Therefore we evaluated the
postoperative outcome in TLE patients at the Medical University Inns-
bruck.
Method: We retrospectively analyzed data of patients operated in our
epilepsy center between 1999 and 2014. Outcome and morbidity after
SAHE and standard resection respectively was compared.
Results: 210 patients (101 male; 100 right) had surgery in the temporal
lobe, 89 (42%) SAHE (group I), 62 (30%) standard 2/3 resection (group
II), 59 (28%) other. Outcome Engel IA in group I was 52% after 5 years
(n = 65), 47% after 10 years (n = 43); in group II 44% after 5 years
(n = 43), 30% after 10 years (n = 10). Four patients not seizure free after
SAHE had then standard resection. Histology showed mesial temporal
sclerosis in 67/89 pt. in group I and 32/63 pt. in group II. For those pts.
outcome (5 ys FU) was Engel IA in 53% of group I and 61% of group II.
Complications were rare in both groups.
Conclusion: Both, SAHE and standard temporal lobe resection lead to a
comparable favorable postoperative outcome. Patients should be selected
for one procedure according to all findings of an extensive preoperative
workup.
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FOCALEPILEPSYWITHAUDITORY FEATURES: A
NOVELGEFS+ PHENOTYPE
C. Leta*,†, L. Licchetta*,†, S. Baldassari‡, V. Menghi*,†,
F. Pittau*,§, C. Stipa*,†, G. Cantalupo¶, F. Darra¶,
R. Guerrini**, E. Fontana¶, M. Seri‡, C. Marini**,
P. Tinuper*,†, T. Pippucci‡, F. Bisulli*,†
*IRCCS Istituto delle Scienze Neurologiche di Bologna,
Bologna, Italy, †University of Bologna, Department of
Biomedical and Neuromotor Sciences, Bologna, Italy, ‡Medical
Genetics Unit, Polyclinic Sant’Orsola-Malpighi, DIMEC,
Bologna, Italy, §Unité d’EEG et d’Exploration de
l’Epilepsie, Service de Neurologie / Ho^pitaux Universitaires de
Geneve, Geneve, Switzerland, ¶Child Neuropsychiatry Unit,
University Hospital Verona, Verona, Italy, **Pediatric
Neurology Unit and Laboratories, A. Meyer Children’s Hospital
–University of Florence, Florence, Italy
Purpose: To identify the mutation underlying ADEAF in a family nega-
tive for LGI1mutations.
Method: All ten affected family members underwent clinical investiga-
tion, including comprehensive neurophysiological assessment in three.
Whole exome sequencing (WES) analysis was performed on the proband
and her affected daughter.
Results: Of the ten patients (M/F:3/7; mean age at onset: 4.5 years),
seven had epilepsy whilst three had isolated febrile seizures (FS). The pro-
band and her daughter had focal epilepsy with auditory features (EAF).
Among the other patients, one had another type of focal epilepsy, three
generalized seizures in childhood and one infantile epileptic encephalopa-
thy. Intellectual disability (ID) and/or psychiatric disorders were reported
in five family members. Three of the family members with epilepsy had a
history of prolonged FS. Interictal EEG in four subjects showed general-
ized spike-wave discharges, which coexisted with clear-cut focal epilepti-
form abnormalities in the proband. Neuroradiological findings were
unremarkable. WES disclosed a p. M956T mutation inSCN1A,encoding
the voltage-gated sodium channel 1 (Nav1.1). Screening of 15 familial
and sporadic EAF patients revealed a different p.Tyr790Phe mutation in a
sporadic case with typical phenotype and no antecedent FS. Supporting
the causality of both mutations, the wild-type residues are evolutionarily
conserved, the changes are predicted as pathogenic and the mutations
have previously been implicated in different epilepsy phenotypes.
Conclusion: We describe missense pathogenic mutations in SCN1A in
association with EAF. These findings show that SCN1A should be con-
sidered in the screening of LGI1-negative EAF patients and that muta-
tions in major genes other than LGI1 can be associated with familial and
sporadic EAF characterized by both atypical and typical phenotypes.
p0605
CLINICALANDGENETICAL FEATURESOF
DYSSYNERGIA CEREBELLARISMYOCLONICA
L.C. Sun*, J.G. Wu†, Z. Wang*, D.W. Wang*, W.H. Lin*
*First Hospital of Jilin University, Changchun, China,
†Hospital of Balinzuoqi, Chifeng, China
Purpose: To investigate the clinical and genetical features of two Chi-
nese families with Dyssynergia Cerebellaris Myoclonica.
Method: All the clinical information was collected based on the
members of the families, patients’ onset age, symptoms, signs and
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auxiliary examinations. Pedigree charts of the two families were fin-
ished.
Results: The proband of family catagory I was female aged 9. When she
was 4 years old,she was unable to walk steadily as ordinary people.She
signaled unusual actions like swing of her upper limbs.Gradually, kinetic
tremulous movements of her hands happened and the burst-like speech
emerged. Intelligence was normal. Cerebellar language, cerebellar ataxia
and horizontal nystagmus of both eye balls were positive. Muscle
strength and muscle tension were normal.There was no sensory impair-
ment. Limb tendons exhibited hyperreflexia and pathological signs were
negative. Brain MR scan of showed nothing abnormal except slightly
widened cerebral sulcus. Evoked potentials and bilateral TSEP were nor-
mal.EEG demonstrated atypical multiple spike and slow wave bursts.
Dyssynergia Cerebellaris Myoclonica was diagnosed. The results of
treatment was poor. The proband of family catagory II was male agae
54.Since his age at 20, he complained of hand tremor when reaching the
goal subjects with the jerk of the limbs.He developed the burst-like
speech at the age of 45.The examinations and the diagnosis were alike as
the proband of family catagory I. The pedigree of family catagory I and
catagory II included 16 patients (M/F: 9/7) and 5 patients (M/F: 2/3)
respectively. All members are non-consanguineous marriage. All the
patients are ataxia and myoclonus onset without tonic clonic seizure or
cognitive impairment.
Conclusions: DCM is transmitted as an autosomal dominant trait. The
main clinical feathers of DCM are ataxia and myoclonus without tonic
clonic seizure or cognitive impairment. The pathogenic gene identifi-
cation will be tested by the Second Generation Sequencing
approaches.
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ADVANTAGESOFWHOLEEXOME SEQUENCING
FOR PATIENTSWITHEPILEPSY
A.D. Malphrus
Baylor College of Medicine, Child Neurology, Houston, TX,
USA
Purpose: Approximately one third of patients with epilepsy do not have
a known etiology, despite extensive evaluations. Some patients have syn-
dromes unique to the patient or the family. Whole exome sequencing
(WES) analyzes the exons or coding regions of thousands of genes simul-
taneously using next-generation sequencing techniques. There are
approximately 180,000 exons in the human genome, which represents
about 3% of the genome. These 180,000 exons are arranged in about
22,000 genes. WES includes a mitochondrial genome sequencing. It has
been commercially available since 2011 and provides a diagnosis in
about 30% of previously undiagnosed cases. It identifies those variants
found in the coding region of genes which affect protein function. It
allows identification of novel gene mutations that could be causative for
the patient’s epilepsy.
Method: Patients with unique or rare syndromes diagnosed via whole
exome sequencing were identified through a single center comprehensive
epilepsy program.
Results: Five patients were identified with rare or novel genetic causes
for epilepsy including: a novel homozygous mutation in MTFMT, a
female with a KIAA 2022 mutation, a patient with an SLC35A2 muta-
tion, a PCDH19 mosaicism mutation in a male, and two half-brothers
with a UPF3B mutation. An epilepsy panel (Athena) sequences 141
genes. Whole exome sequencing covers approximately 22,000 genes.
Conclusion: Whole exome sequencing is a useful tool in identifying rare
and novel mutations that would otherwise not be identified through single
gene or gene panel testing. It is a potentially cost effective measure that
should be considered early when there is a question of a genetic etiology
for patients with epilepsy or when the etiology of the epilepsy is
unknown.
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PROTEOMICANALYSIS OFDORSALANDVENTRAL
DENTATEGYRUS FROMEPILEPTIC RATS INDUCED
BY PERFORANT PATHWAY STIMULATION
A. Morato do Canto*, A. Hilario Berenguer Matos*,
A. Schwambach Vieira*, R. Glioli†, I. Lopes-Cendes*
*Brazilian Institute of Neuroscience and Neurotechnology
(BRAINN), University of Campinas - UNICAMP, Campinas,
Brazil, †Multidisciplinary Center for Biological Investigation of
Laboratory Animals (CEMIB), University of Campinas,
Campinas, Brazil
Purpose: Proteomic analysis is a promising tool for the identification of
key biological processes leading to epilepsy. However, the power of such
“omic” approach is dependent on the preparation of homogeneous cell
populations. In this context, laser-capture microdissection presents the
ability to select specific cell populations that would give the most infor-
mative data in proteomic studies. The aim of this study is to identify dif-
ferentially expressed proteins in the dorsal and ventral Dentate Gyrus
(dDG and vDG) from epileptic rats. Epilepsy was induced by a perforant
pathway stimulation protocol which leads to classical hippocampal scle-
rosis.
Methods: Rats were induced as described by Norwood et al., 2010. Fro-
zen sections were prepared and the dDG and vDG were laser microdis-
sected (Zeiss PALM). Total proteins were obtained from using 8M urea
and analyzed by LC-MS/MS using an LQT-Orbitrap (Waters).
Results: We identified a total of 1271 proteins in samples of dDG and
vDG combined. Of these, 42 proteins were found to be differently
expressed in dDG and 50 in vDG. Although there was some overlap
between proteins that were differently expressed in dDG and vDG, we
found that 76% of proteins differentially expressed in dDG and 80% in
vDGwere unique to these sub-fields. Most of the differentially expressed
proteins are involved in neuronal pathways such as GABA-receptor recy-
cling and cytoskeleton remodeling, as indicated by gene ontology analy-
sis employing the Metacore software (Thomson Reuters).
Conclusion: The identified proteins can indicate new pathways involved
in epileptogenesis. Furthermore, we found that additional information
molecular complexities could be observed as hippocampal subfields were
analyzed separately. We believe that the further integration of the pro-
teomic data with other “omics” approaches could generate even more
informative data about those neuronal processes.
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GENEDISCOVERYANDHIGH-THROUGHPUT
RESEQUENCINGOFCANDIDATEGENES IN
EPILEPTIC ENCEPHALOPATHIES
C.T. Myers*, J.M. Mcmahon†, A. Schneider†, R.S. Møller‡,§,
G.L. Carvill*, I.E. Scheffer†, H.C. Mefford*, Epi4K Consortium
*University of Washington, Seattle, WA, USA, †University of
Melbourne, Florey Institute of Neurosciences and Mental
Health, Melbourne, Australia, ‡University of Southern
Denmark, Odense, Denmark, §Danish Epilepsy Centre,
Dianalund, Denmark
Purpose: Whole exome studies in patients with epileptic encephalopa-
thies (EE) have demonstrated the breadth of genetic heterogeneity in
these severe childhood epilepsy syndromes. Our previous study identi-
fied 329 de novo mutations in 305 genes when 264 trios (affected child
and unaffected parents) were sequenced. We aimed to identify additional
patients with de novomutations in 27 of these candidate genes to confirm
the role of each gene and the phenotypic spectrum in the genetic etiology
of EE.
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Method: We performed targeted capture and high-throughput rese-
quencing of 27 genes in which a de novo mutation was identified in one
or more proband with Infantile Spasms (IS) or Lennox-Gastaut syndrome
(LGS) in our prior study. More than 600 patients with diverse EE pheno-
types were screened.
Results: We have identified at least 16 patients with de novo mutations
in 7 genes. Among these are recurrent mutations in CACNA1A,GABRB3,
GNAO1, and ALG13 highlighting the importance of these genes in EE.
Segregation studies are pending for additional probands but it is likely
that genes involved in glutamate transport, endocytic trafficking, and
transcriptional regulation are important for healthy neural circuitry, and
mutations in these pathways cause EE. We will report the frequency of
de novomutations for each gene screened in our cohort as well as investi-
gate genotype-phenotype correlations for genes in which multiple
patients harbor mutations.
Conclusion: We have confirmed the role of at least 7 additional genes in
the genetic etiology of EE and expanded the phenotypic spectrum associ-
ated with these genes beyond IS and LGS in which they were first discov-
ered.
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EXPANDINGCLINICAL SPECTRUMOFGRIN2A
MUTATIONS TOATYPICALRETT SYNDROME
K. Nakamura*, M. Kato*,†, M. Ito‡, M. Kawasaki*,§,
T. Shinozaki§, M. Nakashima¶, N. Matsumoto¶, H. Saitsu¶
*Yamagata University Faculty of Medicine, Pediatrics,
Yamagata, Japan, †Showa University School of Medicine,
Pediatrics, Tokyo, Japan, ‡Tokyo Metropolitan Bokuto Hospital,
Pediatrics, Tokyo, Japan, §Nihonkai General Hospital,
Pediatrics, Sakata, Japan, ¶Yokohama City University Graduate
School of Medicine, Human Genetics, Yokohama, Japan
Purpose: GRIN2A encodes a subunit of N-methyl-D-aspartate (NMDA)
receptor.GRIN2Amutations have been reported to be mainly responsible
for focal epilepsy, such as epilepsy-aphasia spectrum disorders (benign
epilepsy with centrotemporal spikes [BECTS], Landau-Kleffner syn-
drome, and epileptic encephalopathy with continuous spike and wave
during sleep), idiopathic focal epilepsy, and intellectual disability. We
examined possible involvement of GRIN2A mutations in patients with
infantile epilepsy.
Method: Blood samples and clinical information were collected from
the patients and their parents. Written informed consent was obtained
from their guardians. Patients were analyzed by GRIN2A-focused WES
analysis, and candidate GRIN2A mutations were validated by Sanger
sequencing.
Results: We detected one novel missense mutations in GRIN2A and one
splicing mutation in two families. Individual 1 with a de novo
c.1643C>G mutation in GRIN2A showed febrile seizures, stereotypical
hand movements, respiratory abnormality, severe intellectual disability,
and epilepsy. She was diagnosed as atypical Rett syndrome. Individual 2
with unclassified epileptic encephalopathy and autism carrying a splicing
mutation (c.1007 + 1G>A) developed febrile seizures at 1 year of age,
followed by focal clonic seizures and developmental deterioration. Elec-
troencephalography showed multifocal sharp waves on left hemisphere.
The mutation was found in her mother and grandmother, who also
showed epilepsy during childhood without autistic features. All the muta-
tions were not found in our 575 control exomes, and were predicted to be
damaging byWeb-based prediction tools.
Conclusion: Our study suggests that GRIN2A mutations can be associ-
ated with atypical Rett syndrome. A variety of severity is to be noted in
patients withGRIN2Amutations.
p0612
VARIANTS INMICRORNAGENES: CANTHEYCAUSE
EPILEPTIC ENCEPHALOPATHIES?
J. Roovers*,†, S. Cammaerts*,†, M. Strazisar*,†, J. Lemke‡,§,
S. Weckhuysen*,¶, P. De Rijk*,†, P. De Jonghe*,†,**, J. Del-
Favero*,†,††, A. Suls*,†, RES-EuroEPINOMICS
*VIB DMG, Antwerp, Belgium, †University of Antwerp,
Antwerp, Belgium, ‡University of Leipzig, Leipzig, Germany,
§University Children’s Hospital Inselspital, Bern, Switzerland,
¶Inserm U 1127, CNRS UMR 7225, Sorbonne Universités,
UPMCUniv Paris 06 UMR S 1127, Institut du Cerveau et de la
Moelle épiniere, ICM, AP-HP, Ho^pital de la Pitié Salpe^triere,
Service de Neurologie, Paris, France, **Antwerp University
Hospital, Antwerp, Belgium, ††Multiplicom NV, Niel, Belgium
Purpose: The role of miRNAs in the pathomechanism of epilepsy is
increasingly researched. Variants in miRNA genes can have a drastic
effect on their processing and functioning. However, a mutation analysis
of these genes has never been performed for the epileptic encephalopa-
thies (EE). We anticipate that variants in brain-expressed miRNAs can
alter the expression of their target genes, leading to the severe phenotype
of EE.
Method: We screened miRNA genes in EE patients and their healthy
parents using ‘Multiplex Amplification of Specific Targets for Rese-
quencing’ (MASTR) assays (Multiplicom NV). The first assay amplifies
289 human brain-expressed miRNAs and was used to screen 119 trios, 13
duos, 2 quartets and 54 probands with EE. Furthermore, we created and
optimized a second MASTR assay containing 183 additional miRNA
genes and the coding region of six genes involved in miRNA biogenesis
(AGO2, DICER1, DGCR8, DROSHA, TARBP2, XPO5). The second
assay was used to screen 45 trios, 4 duos, 2 quartets and 38 probands with
EE. Further screening in currently ongoing. Prioritization of variants was
done using different inheritance models, the position and predicted
impact on the structure of the miRNA and their frequency in controls.
Results: So far, we identified one de novo variant, which is present in the
mature miRNA and predicted to severely disrupt the secondary structure
of the miRNA. Functional follow up is now started to evaluate the impact
of the variant on the miRNA biogenesis and function.
Conclusion: Identification of miRNAs linked to EE will lead to novel
insight into the underlying pathomechanisms of epilepsy.
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TWOCASESWITHEPILEPSYANDDYSMORPHIC
FEATURES ASSOCIATEDWITH 17Q21.31
MICRODELETION SYNDROME
E. Uctepe*, D. Aktas†, M.A. Kasifoglu†, E. Gunduz‡,
F.M. Sonmez§
*Turgut Ozal University, Faculty of Medicine, Medical Biology,
Ankara, Turkey, †Hacettepe University, Pediatric Genetics,
Ankara, Turkey, ‡Turgut Ozal University, Faculty of Medicine,
Medical Genetics, Ankara, Turkey, §Turgut Ozal University,
Faculty of Medicine, Pediatric Neurology, Ankara, Turkey
Purpose: The 17q21.31 microdeletion syndrome is characterized by
intellectual disability, epilepsy, distinctive facial dysmorphism, hypoto-
nia and friendly behavior. Here we report on two Turkish patients with
the 17q21.31 microdeletion syndrome.
Method: Both of the cases have clinical features which mostly overlap
with reported 17q21.31 microdeletion syndrome cases. Additionally, we
determined syringomyelia in our first case which expanding the pheno-
typic spectrum. Array CGH analyses identified a 740 kb deletion on
chromosome 17q21.31.
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Results: Array CGH analyses identified a 740 kb deletion on chromo-
some 17q21.31 (chr17: 43513428-44254354 bp) in case 1. The deleted
region in case 1 contains the following genes: MAPT, CRHR1,
KANSL1, SPPL2C, PLEKHM1 and STH. In second case, array-CGH
analyses identified a 1.3 Mb deletion on chromosome 17q21.31 (chr17:
42579621-43846470 bp) in case 2. The deleted region in case 2 contains
the following genes: CRHR1, EFTUD2, PLEKHM1, GFAP, DBF 4B,
FMNL1, DCAKD, PLCD3, GJC3, ADAM11, C17 ORF 104, ACBD4,
HEXIM2, MAP3K14, and ARHGAP24. But the microdeletion region in
case 2 does not include KANSL1 gene which also confirmed by Real-
time PCR.
Conclusion: To the best of our knowledge this is the first report of a
patient with the 17q21.31 microdeletion which does not encompass
KANSL1 gene. As this patient presents the classical phenotype of
17q21.31 syndrome, these data make it possible to find another gene or
genes causing similar phenotype in this region. Further investigations
and new cases will help to clarify this challenging question.
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DIFFERENTIAL DISTRIBUTIONOFCORTICAL
THINNINGAND SUBCORTICALWHITEMATTER
DIFFUSIONANOMALIES IN TEMPORAL LOBE
EPILEPSY
M. Liu, B.C. Bernhardt, S.-J. Hong, B. Caldairou,
N. Bernasconi, A. Bernasconi
McGill University, Neuroimaging of Epilepsy Laboratory,
McConnell Brain Imaging Center, Montreal Neurological
Institute and Hospital, Montreal, Canada
Purpose: Quantitative MRI studies have consistently demonstrated that
drug-resistant temporal lobe epilepsy (TLE) is associated with multilobar
cortical thinning. Diffusion MRI studies have also reported widespread
white matter (WM) changes, but mainly along deep fibre tracts, thus,
with an unclear spatial relationship to cortical pathology. Here, we anal-
ysed conjointly diffusion properties of the immediate subcortical WM
with cortical thickness measures in a unified surface-based framework.
Method: We studied 61 drug-resistant TLE patients (31/30 left/right)
and 42 healthy controls. Based on T1-weighted 3T MRI, we generated
cortical surface models and measured cortical thickness across thousands
of surface-spanning vertices. We computed a Laplacian potential field
between cortex and ventricles, which guided the placement of subcortical
surfaces at 1, 2, and 3 mm depth below the GM-WM boundary, with ver-
tex-correspondence to the cortex. Based on co-registered diffusion MRI,
we sampled mean diffusivity (MD) and fractional anisotropy (FA) on
subcortical WM surfaces. Hemisphere-specific measurements of left and
right TLE patients were normalized with respect to controls, and sorted
into ipsilateral/contralateral. We performed vertex-wise t-tests to detect
thickness and WM diffusion differences between patients and controls
across all surfaces. Findings were corrected for multiple comparisons at
FWE< 0.05.
Results: Patients showed bilateral cortical thinning in anterior temporal,
frontal, and centro-parietal regions; conversely, subcortical WM diffu-
sion changes (MD increase and FA decrease) were largely limited to ipsi-
lateral parahippocampus, anterior cingulate, lateral temporal, and
orbitofrontal regions. Diffusion anomalies overlapped with cortical thin-
ning only in temporo-limbic regions including parahippocampal, lateral
temporal and prefrontal regions.
Conclusion: Our study compared for the first time point-wise patterns of
cortical morphology and diffusion-derived parameters of subcortical
microstructure and architecture in TLE, revealing a differential distribu-
tion of anomalies. Ipsilateral limbic diffusion alterations may reflect glio-
sis and demyelination due to mesiotemporal deafferentation; bilateral
mainly fronto-central GM atrophy is likely secondary to excitotoxic sei-
zure spread.
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CONTRIBUTIONOFEEG-FMRI IN THE PRE-
SURGICAL EVALUATIONOF PEDIATRIC PATIENTS
WITHEPILEPSY
M. Centeno*,†, S. Perani*, S. Vulliemoz‡, T. Tierney*,
E. Samshiri*, K. St Pier†, R. Pressler†, J. Clayden*, C. Clark*,
H. Cross†, D. Carmichael*
*UCL Institute of Child Health, Imaging and Biophysics Unit,
London, UK, †Great Ormond Street Hospital for Children NHS
Trust, London, Epilepsy Unit, Londond, UK, ‡Ho^pitaux
Universitaires de Geneve, Unité d’EEG et Exploration de
l’Epilepsie, Geneva, Switzerland
Purpose: EEG-fMRI can contribute to more accurate localization of the
epileptic focus in focal epilepsy. Furthermore, EEG-fMRI activations
have good correlation with intracranial EEG. Studies targeting large sam-
ple of patients and focusing in challenging groups of patients such as
MRI negative and large lesions aiming for partial resections are needed
to evaluate its contribution in the clinical setting. In this study we use
EEG-fMRI to localize the epileptic focus in a large population of children
with drug resistant epilepsy and analyse the contribution of this technique
in the presurgical evaluation.
Method: 48 children with drug resistant epilepsy recruited from the
pre-surgical epilepsy program underwent simultaneous EEG-fMRI
scan. Patient’s fMRI time series were analysed using a general linear
model to determine the presence of regional interictal epileptiform dis-
charges (IED)-related BOLD changes in SPM8. EEG-fMRI maps were
classified as concordant or discordant with the presumed epileptogenic
region.
Results: 81% of patients had IED during EEG-fMRI sessions, from
these, 84% had significant BOLD signal changes related to IED. Sensi-
tivity of EEG-fMRI was 81% for the detection of focal activations in the
presumed epileptogenic region. 15 out of 22 patients with normal MRI
had IED during EEG-fMRI. Focal activations on the presumed epilepto-
genic region were observed on 66% of them. In 9 out of 26 patients with
structural lesions, the clinical evaluation aimed of the detection of 9 of
them had large lesions and the aim was to attempt a partial resection. In
66% of these, a focal region within the lesion was shown by EEG-fMRi.
Validation for 30% of these patients has been obtained so far.
Conclusion: EEG-fMRI can contribute to localize more accuratly the
epileptogenic region in 45% of patients with normal MRI and 66% of
patients with large lesions. This information may be relevant in planning
the implantation in these patients.
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CEREBRALHYPERPERFUSIONMRFINDINGS
FOLLOWING SEIZURE PRESENTINGWITHTODD’S
PARALYSIS
H. Chang, J. Cheong, Y. Hwang
Wonkwang University School of Medicine and Hospital, Iksan,
Republic of Korea
Purpose: Patient who have focal or transient neurological deficit, it is
not easy to distinguish post ictal neurological deficits after seizure from
those because of cerebral ischemia. In that situation, cerebral perfusion
study can help to identify postictal state with helping to exclude large
vessel territory stroke. Cerebral perfusion can be rapidly decreased or
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increased following seizure termination. We called it as postictal switch.
We reported the MR findings following seizure presenting with todd’s
paralysis. Case report: A 67-years-old female was awakened from sleep
and founded with left side hemiparesis by her son. No one knew the exact
time of onset and circumstance when her symptoms occurred. On admis-
sion, she had moderate degree of dysarthria, both eye ball deviation to
right side and Left hemiparesis (MRC grade 5/1, 5/3). It suggested that
right MCA territory infarction. We perfomed brain MR with perfusion
study. In brain MR with perfusion study, mild diffuse cortical edematous
swelling at right entire cerebral hemisphere and increased regional CBF
&CBV and rapid TTP in right cerebral hemisphere with normal diffusion
weighted image were observed. Also, in brain MRA, more increasing
vascularity of right cerebral hemisphere compared to contralateral side
was observed. These MR findings are indicated the hyperperfusion status
of right cerebral hemisphere. And electroencephalography revealed dif-
fuse slow wave in right hemisphere without ictal findings. The next day
after almost 24 hours of onset of symptoms, the symptoms of patients
was fully recovered and we performed brain MR with perfusion study
again. Compared to previous study, brain MR with perfusion study
showed normal findings and electroencephalo-graphy had no abnormal
waves.
Conclusion: Todd’s paralysis can be misdiagnosed as acute cerebral
infarction. In this situation, cerebral perfusion study such as brain MR
with perfusion study can be helpful diagnostic method for distinguishing
between seizure and cerebral infarction.
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EEGRESTING-STATEDIRECTEDCONNECTIVITY IN
TEMPORAL LOBEEPILEPSYVSHEALTHY
CONTROLS
A. Coito*, G. Plomp*, E. Abela†, G.R. Iannotti*,
A. Thomschewski‡, Y. H€oller‡, E. Trinka‡, R. Wiest†, M. Seeck§,
C. Michel*, S. Vulliemoz§
*Functional Brain Mapping Lab, University of Geneva, Geneva,
Switzerland, †Institute for Diagnostic and Interventional
Neuroradiology, University of Bern, Bern, Switzerland,
‡Paracelsus Medical University, Department of Neurology,
Salzburg, Austria, §Epilepsy Unit, University Hospital of
Geneva, Geneva, Switzerland
Purpose: The characterisation of pathological networks in the absence
of interictal epileptiform discharges (IED) could have an important diag-
nostic/prognostic value. Using high-density EEG, we investigated rest-
ing-state directed brain connectivity independent from IED in left and
right temporal lobe epilepsy (LTLE and RTLE) compared to healthy con-
trols.
Method: Twenty LTLE, 20 RTLE patients and 20 healthy controls
underwent a resting-state high-density EEG. Source activity free of IED
was obtained for 82 regions of interest (ROI) using an individual head
model and a distributed linear inverse solution. Granger-causal modeling
was applied to the source signal of all ROIs in theta, alpha and beta fre-
quency bands to estimate the summed outflow (SO) from each ROI (to
all others) and pair-wise connectivity between ROIs with high SO. Corre-
lations with the duration of the disease were computed.
Results: In all regions and groups, SO peaked in the alpha band. Consis-
tent across frequency bands and groups, the highest SO occurred in the
hippocampus, amygdala, parahippocampus, posterior cingulate cortex
(PCC) and anterior cingulate cortex (ACC), concordant with the Default
Mode Network (DMN). In LTLE, SO of the ipsilateral amygdala, PCC,
olfactory and contralateral ACC was significantly lower than in controls.
SO of the contralateral hippocampus, amygdala and ACC and ipsilateral
ACC was significantly decreased in RTLE. In the alpha-band, the stron-
gest connections in controls were from the PCC, while in both patient
groups these were from the ipsilateral hippocampus. In RTLE, disease
duration was negatively correlated to SO in bilateral amygdala and
contralateral hippocampus, olfactory and rectus. No correlation was
found in LTLE.
Conclusion: In TLE, we identified connectivity impairments in
regions of the DMN and known to play a major role in TLE. RTLE
was more contralaterally affected than LTLE. These network abnor-
malities could help identify patients when interictal abnormalities can-
not be detected.
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PLASTICITYOF LANGUAGE FUNCTIONAFTER
SURGERY FOR FOCAL EPILEPSY INCHILDREN
R. Coleman*, L. Croft*, C. Skirrow*, S. Harrison†,
J.H. Cross*,†, P. Rankin*,†, P. Sanfilippo†, F. Liegeois*,†,
W. Harkness†, J. Clayden*, C. Clark*, F. Vargha-Khadem*,†,
T. Baldeweg*,†
*UCL Institute of Child Health, London, UK, †Great Ormond
Street Hospital for Children NHS Trust, London, UK
Purpose: Surgery for medication-resistant epilepsy often involves resec-
tion of tissue in close proximity to eloquent cortex. The long-term effects
of surgical resections on language ability are poorly understood, espe-
cially in children.
Method: We present preliminary findings from a follow-up study of 38
children who underwent assessments for epilepsy surgery and 13 healthy
sibling controls. Twenty-nine children went on to have surgery (5 hemi-
spheric, 14 temporal lobe, 4 parietal lobe, 3 frontal lobe and 3 multi-lobar
surgeries). The remaining 9 children were deemed not suitable candidates
for surgery. Mean elapsed time from baseline to follow-up was 6 years
for the surgical group and 5 years for the non-surgical group. All patients
with epilepsy underwent neuropsychological assessments and language
fMRI at baseline and follow-up. Language fMRI using verb generation
was used to determine language lateralisation in Broca’s and Wernicke’s
areas.
Results: At follow-up, 69% of the surgical group was seizure-free com-
pared to 0% in the non-surgical group. In the surgical group, 90% showed
stable or increased verbal IQ (VIQ) compared to 44% in the non-surgical
group (of whom none improved and 66% deteriorated). Pre- to post-
operative change in VIQ was not related to age at surgery, pre-operative
VIQ, resection lobe or resected hemisphere. Seizure-freedom and being
free from medication was associated with significant gains in verbal and
performance IQ, and in processing speed. Lateralisation of language
function to the left temporal lobes evidenced by fMRI at follow-up, as
well as a leftward change in lateralisation from pre-op to follow-up, was
associated with gains in VIQ.
Conclusion: Our findings suggest better verbal intellectual outcome in
those who had surgery and became seizure-free, regardless of the extent
or location of the resection. Additionally, our findings suggest that a more
typical temporal lobe language lateralisation is associated with better
long-term verbal outcome.
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EPILEPTOGENICMRI LESIONDETECTIONUSING
TIME-EFFICIENT EPILEPSY-DEDICATED FIRST FIT
MRI PROTOCOL
M. Farag*, P. Rich†, D.-R. Anwar*, H.R. Cock*,‡, D. Lozsadi‡,
T.J. von Oertzen*,‡,§
*St George’s, University of London, London, UK, †St George’s
Healthcare NHS Trust, Department of Neuroradiology, London,
UK, ‡St George’s Healthcare NHS Trust, Department of
Neurology, London, UK, §Wagner-Jauregg Neuroscience
Centre, Department of Neurology, Linz, Austria
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Purpose: To ascertain the diagnostic yield and frequency of detecting
epileptogenic lesions in MRI scans using a time-efficient epilepsy-dedi-
cated first fit MRI protocol.
Method: All consecutive patients attending the first fit clinic at St
George’s Hospital over the course of 1 year were included. Patients
were referred from the emergency department or via primary care fol-
lowing a suspected first seizure. All patients were assessed by an
Epileptologist and referred for MRI if an epileptic seizure diagnosis
was suspected. A ‘first fit MRI protocol’ was used, comprising axial
FLAIR and DWI (5 mm slice thickness), coronal T2-weighted turbo
spin echo angled perpendicular to the temporal lobes (3 mm slices)
and sagittal T1-weighted scans (5 mm slices) through the whole brain
in 15-minute scan time. All scans were acquired on a 1.5T machine
and interpreted by Consultant Neuroradiologists during routine report-
ing sessions. MRI reports were then reviewed retrospectively with
findings classified as epileptogenic lesions, non-epileptic abnormalities
or normal.
Results: 121 patients were screened and first fit MRI protocol scans were
acquired in 67 patients. Potentially epileptogenic lesions were detected in
15 patients (22.3%), consisting of vascular anomalies [n = 3], malforma-
tions of cortical development [n = 3], other epileptogenic (scarring)
[n = 4], tumour [n = 1] and probable lesions warranting further imagin-
ing [n = 4]. Non-epileptogenic abnormalities were detected in 12
patients (17.9%). Normal scans were reported in 39 patients (58.2%).
One patient did not tolerate theMRI and the scan was abandoned.
Conclusion: Our reported pick-up rate of epileptogenic lesions follow-
ing a 15-minute shortened first fit MRI protocol is equivalent to detection
rates reported using a longer MRI protocol, for example the 23% lesion
detection rate reported by Hakami et al. (2013).We conclude that a short-
ened MRI protocol is sufficient for detecting epileptogenic lesions in
patients presenting with a new-onset seizure disorder whilst enabling
more efficient use ofMRI scanner time.
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TYPE II FOCALCORTICALDYSPLASIA: EX VIVO
HIGHRESOLUTION 7TMR IMAGINGWITH
HISTOPATHOLOGICALCOMPARISON
R. Garbelli*, G. Milesi*, V. Medici*, L. Tassi†, G. Didato*,
F. Deleo*, L. D’Incerti‡, N. Colombo§, V. Fugnanesi¶,
M. Morbin¶, M. Figini**, R. Spreafico*, I. Zucca**
*Fondazione I.R.C.C.S. Istituto Neurologico ‘C. Besta’,
Department of Clinical Epileptology and Experimental
Neurophysiology, Milano, Italy, †Niguarda General Hospital,
Epilepsy Surgery Center ‘C. Munari’, Milano, Italy,
‡Fondazione I.R.C.C.S. Istituto Neurologico ‘C. Besta’,
Neuroradiology, Milano, Italy, §Niguarda General Hospital,
Neuroradiology, Milano, Italy, ¶Fondazione I.R.C.C.S. Istituto
Neurologico ‘C. Besta’, Neuropathology, Milano, Italy,
**Fondazione I.R.C.C.S. Istituto Neurologico ‘C. Besta’,
Scientific Direction, Milano, Italy
Purpose: Focal cortical dysplasias (FCD) type II are highly epilepto-
genic lesions frequently reported in surgical series of patients operated
on drug-resistant focal epilepsy. The success of epilepsy surgery largely
depend on the precise localization and complete excision of the epilepto-
genic zone that often coincide with the site of the lesion. MRI allows
many cases of FCDII to be visualized, however, in some pathology-pro-
ven cases, MRI changes are subtle or overlooked. Aim of the present
work is to investigate the histopathological correlates of the MRI abnor-
malities in order to determine the efficacy of high-resolution imaging in
lesion detection.
Method: Cortical specimens obtained either from patients with a clinical
MRI diagnosis of FCD or MRI-negative were used: These specimens,
after fixation, were admitted to imaging protocol on a 7T scanner. Subse-
quent histological and ultrastructural analysis were performed to
define the neuropathology (FCDIIb=10 and FCDIIa=4) and confirmMRI
findings.
Results: In 7T T2wi we observe:
1) inhomogeneous signal intensity in the grey matter that clearly
defined the boundary between the lesion and adjacent perilesional area.
This altered signal match with the presence of abnormal cells (DNs and
BCs, when present) and fibers disorganization.
2) A different extent of white matter hyperintensity in FCDIIb only,
that corresponds to axonal degeneration, dramatic reduction in the num-
ber of myelinated fibres, vacuolization and presence of numerous abnor-
mal cells.
3) No evident T2 signal alteration in MRI-negative patients that corre-
sponds to white matter integrity and poor cortical alterations.
Conclusion: The present imaging-histopathological study suggest that
high resolution 7T MRI is able to identify the boundaries between the
lesion and adjacent perilesional area but highlight the need of a quantita-
tive approach in MRI-negative cases.
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MULTICONTRASTMRI PROFILINGOF FOCAL
CORTICALDYSPLASIA TYPE-II
S.-J. Hong, B. Bernhardt, D. Schrader, N. Bernasconi,
A. Bernasconi
Neuroimaging of Epilepsy Laboratory, Montreal Neurological
Institute and Hospital, McGill University, Neurology and
Neurosurgery, Montreal, Canada
Purpose: Focal cortical dysplasia (FCD) Type-II is a common cause
of drug-resistant extra-temporal epilepsy. This lesion is histologically
characterized by cortical dyslamination and dysmorphic neurons, either
in isolation (Type-IIA) or with balloon cells (Type-IIB). FCD compu-
tational models of cortical thickening, blurring of the grey and white
matter transition and intensity on T1-weighted MRI have increased
detection rates relative to standard evaluation. Here, we propose a new
approach to describe the lesional spectrum through multicontrast MRI
data.
Method: Multicontrast lesion profiling was performed in patients with
histologically-verified FCD (9 Type-IIA, 24 IIB) using T1-weighted,
FLAIR, and diffusion-weighted MRI acquired on 3T MRI. Two experts
manually segmented lesions. Using multiple surfaces running through
cortex and underlying white matter, we quantitatively assessed multi-
parametric features (morphology, intra-/sub-cortical tissue intensity,
fractional anisotropy and mean diffusivity) vertically across cortical
depths. We also analyzed adjacent cortex in the horizontal direction
along the cortical mantle as a function of geodesic distance from the
lesion. Supervised machine-learning validated our approach to automati-
cally predict FCD subtypes.
Results: Compared to 41 controls, Type-IIB was characterized by
marked alterations in morphology, tissue intensity and diffusion prop-
erties, while abnormalities in IIA were subtle and restricted to FLAIR
intensity (qFDR < 0.05). Anomalies in IIB were seen across all intra-
and sub-cortical levels whereas those in IIA clustered around the corti-
cal interface (qFDR < 0.05). Peri-lesional analysis demonstrated atypi-
cal features in up to 6 mm in both subtypes, but again more severely
in IIB. Our machine-learning classifier predicted the histological grad-
ing with 93% accuracy, supporting a subtype divergence at individual
level.
Conclusion: In agreement with histopathology, FCD Type-II present
with distinct MRI patterns. Given that imaging features extend beyond
the visible FCD into the adjacent normal-looking cortex, quantitative
modeling may assist accurate definition of the surgical target.
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MEMORYENCODING IN PATIENTSWITH JUVENILE
MYOCLONIC EPILEPSYANDTHEIR UNAFFECTED
SIBLINGS: AN FMRI STUDY
L. Caciagli*, B. Wandschneider*, L.A. Van Graan*,
C. Vollmar*,†, M. Centeno*,‡, P. Thompson*,
J. O’Muircheartaigh§, M. Richardson§, J. Duncan*, M. Koepp*
*UCL Institute of Neurology, Department of Clinical and
Experimental Epilepsy, London, UK, †Ludwig-Maximilians-
Universit€at, Department of Neurology, Munich, Germany, ‡UCL
Institute of Child Health, Imaging and Biophysics Department,
London, UK, §King’s College London, Institute of Psychiatry,
London, UK
Purpose: Impaired frontal lobe functions are reported for patients with
Juvenile Myoclonic Epilepsy (JME) and their unaffected siblings. In both
groups, previous functional magnetic resonance imaging (fMRI) studies
revealed co-activation of the motor cortex and supplementary motor area
during a working memory task. The extent to which temporal lobe func-
tions are also affected in this syndrome remains controversial. We aimed
to characterize memory encoding networks and recognition performance
in JME and their unaffected siblings.
Method: We studied 31 JME patients, 12 siblings and 20 healthy con-
trols using an fMRI memory encoding paradigm: 210 items were pre-
sented inside a 3T MRI scanner, grouped in 30s blocks of 10 pictures
(black and white nameable line-drawn objects), 10 words (single con-
crete nouns) and 10 faces (photographs unfamiliar to the subjects), sepa-
rated by 15 s cross-hair fixation. Participants were instructed to actively
memorize the items for subsequent out-of-scanner recall, in which the
210 presented items were randomly intermixed with an additional 105
novel items.
Results: Recognition performances did not differ across the three
groups. Compared with controls, JME patients exhibited greater activa-
tions in the left sensory-motor cortex, bilateral supplementary motor
areas, superior temporal gyri and rolandic opercula across different stim-
ulus types. Siblings showed greater activations than controls in the left
motor cortex, right temporal gyrus and rolandic operculum.
Conclusion: Both JME patients and their siblings showed a hyperactiva-
tion of the motor system during a memory encoding task, which further
emphasizes the hyperexcitability of the motor cortex during cognitive
tasks as an imaging endophenotype of JME. In the absence of between-
group performance discrepancies, we interpret increased activations in
the superior temporal gyri and rolandic opercula as a compensatory
mechanism for known frontal lobe disturbances in JME and their sib-
lings.
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SPECIFICITYOFEPILEPTIC NETWORKS
ESTIMATED IN THEABSENCEOF SCALP EPILEPTIC
SPIKES
G.R. Iannotti*, F. Pittau†, F. Grouiller‡, A.L. Coito*,
M. Centeno§, D. Carmichael§, M. Seeck†, C.M. Michel*,
S. Vulliemoz†
*Functional Brain Mapping Lab, Faculty of Medicine,
University of Geneva, Geneva, Switzerland, †Service de
Neurologie, Ho^pitaux Universitaires de Geneve, Geneva,
Switzerland, ‡Dpt de Radiologie, Ho^pitaux Universitaires de
Geneve, Geneva, Switzerland, §Imaging and Biophysics Unit,
Institute of Child Health, University College London; Epilepsy
Unit, Great Ormond Street Hospital, London, UK
Purpose: Epileptic activity arises from dysfunction of pathological neu-
ronal networks (epileptic networks) exhibiting coherent fluctuations
independently from the occurrence of IEDs on scalp EEG. This suggests
that epileptic network could represent a new/modified resting state physi-
ological network in drug-resistant epilepsy. The aim of this study was to
assess the specificity of such epileptic networks.
Method: From EEG-fMRI database we select the resting state record-
ings of 10 drug-resistant patients with focal epilepsy, having multifocal
BOLD response and maximal t-value in the spike field. For each patient
we performed a seed-based Functional Connectivity (FC), considering as
seed a 10 mm-diameter sphere drawn around the BOLD map maximum.
For the same seed we obtained the FC maps in a cohort of 20 healthy sub-
jects, matched for age to the individual patients. We calculated the Z-
scored FC map of each patient. In order to quantify the specificity of the
FC network in individual patients we considered thresholds of Z > 2 and
Z < -2.
Results: In each patients, FC maps were significantly different from the
group FC maps. Particularly, patients FC maps had increased FC in
regions ipsilateral to the epileptic focus, (Z > 2), whereas the FC of con-
tralateral hemisphere diminished (Z < -2).
Conclusion: Epilepsy involves a reorganisation of brain FC patterns that
is specific for each patient and can be detected in the absence of scalp
spikes. The interaction between the epileptic and physiological resting
networks remains to be elucidated.
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STUDYTHEBRAINMETABOLITES BY 1HMRS
METHOD IN PATIENTSWITHEPILEPSYAND
DEPRESSION
T. Kapustina, L. Lipatova, B. Butoma
St. Petersburg V.M. Bekhterev Psychoneurological Research
Institute, St. Petersburg, Russian Federation
Functional neuroimaging is used for localizing the brain dysfunction, pri-
marily through the breach in the metabolism of the brain.
Purpose: Study the brain metabolites by 1H MRS method in patients
with epilepsy and depression.
Method: MRI of brain and proton magnetic resonance spectroscopy (1H
MRS) was performed 32 patients with epilepsy (PE), 28 patients with epi-
lepsy and depression (PED), 20 patients with depression only (D) and 40
healthy volunteers (HV). Method 1HMRS was used to analyze the meta-
bolism of N-acetyl aspartate (NAA), choline (Cho) and creatine (Cr) by
calculating its concentration peaks, and to determine the ratio of these
metabolites.
Results: In the group of PE all investigated parameters were signifi-
cantly reduced relative to the norm, and the ratio of these metabolites
were as follows: NAA / Cho = 1.58  0.22 and 1.78  0.22; Cho / Cr =
1.00  0.14 and 1.00  0.14; NAA / Cho = 1.50  0.22 and
1.50  0.22 ppm, respectively. In D group, the ratio of NAA / Cho was
equal to 1.58  0.22, Cho / Cr = 0.96  0.14; NAA / Cho =
1.50  0.22 ppm, and in PED noted marked reduction all investigated
parameters: NAA / Cho = 1.38  0.22, Cho / Cr = 0.90  0.14; NAA /
Cho = 1.40  0.22 ppm.
Conclusion: We obtained data decrease of three main brain metabolites
in PED: Cho, marker of neuron0s membranes, component of phospho-
lipid metabolism; Cr, marker of aerobic brain processes and NAA- mar-
ker of neurodegeneration, using method 1H MPC that allows non-
invasive biochemical study of brain metabolism, indicating a common
pathogenetic mechanisms of epilepsy and depression and increasedmeta-
bolic abnormalities in combination. These finding are particularly impor-
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tant in diagnosis, choice of treatment strategy and prognosis of the dis-
ease.
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THECLINICAL SIGNIFICANCEOFMRI SIGNAL
CHANGES IN PATIENTSWITH FIRST SEIZURES
S.E. Kim, K.M. Park, S.E. Kim
Haeundae Paik Hospital, Inje University College of Medicine,
Busan, Republic of Korea
Purpose: There has been few information about the clinical signifi-
cance of MRI signal changes, especially in patients with first seizures.
The aims of this study were to determine the clinical significance of
MRI signal changes in patients with first seizures visiting to emer-
gency room.
Method: We conducted a retrospective study subjecting patients with
their first seizures visiting to emergency room from March, 2010 to
August, 2014. The inclusion criteria for this study were patients with
1) first seizures regardless of acute symptomatic seizures or not, and
2) MRI performed within 24 hours of the first seizures.
The definition of MRI signal changes was any signal changes on MRI
including possibly periictal signal changes. The clinical variables were
analyzed with multivariate logistic regression with or withoutMRI signal
changes as a dependent variable.
Results: Of 427 patients with seizures visited to emergency room from
March, 2010 to August, 2014, 74 patients met inclusion criteria. Twenty
one patients (28.3%) hadMRI signal changes; 11 with acute symptomatic
seizures, 4 with first unproved seizures, 6 with remote symptomatic sei-
zures. Of 21 patients with MRI signal changes, 6 patients showed possi-
bly periictal signal changes as a consequence of their seizures.
Multivariable analysis revealed that acute symptomatic seizures (odds
ratio 7.3, 95% confidence interval 1.9–28.4, p = 0.0039) and age (odds
ratio 0.96, 95% confidence interval 0.94–0.98, p = 0.0004) were inde-
pendently significant variables predicting the presence of MRI signal
changes in patients with their first seizures.
Conclusion: The MRI signal changes in patients with first seizures were
associated with acute symptomatic seizures. In addition, the younger age
may more frequently develop theMR signal changes.
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MRI PROSPECTIVE EVALUATIONOF PATIENTS
WITHDRUG-RESISTANT FOCALEPILEPSY: 3T VS.
1.5T
L.D. Ladino*,†, P. Balaguera‡, J.F. Tellez-Zenteno†,
L. Hernandez-Ronquillo†, J.A. Delgado§
*Hospital Pablo Tobon Uribe, Medellín, Colombia, †University
of Saskatchewan, Saskatoon, Canada, ‡Clínica Medellín,
Medellín, Colombia, §Instituto de Alta Tecnología Médica
IATM, Medellin, Colombia
Purpose: Magnetic resonance imaging (MRI) is an essential tool in the
presurgical evaluation of patients with epilepsy. Our aim was to evaluate
the value of re-imaging patients with drug-resistant focal epilepsy who
were initially scanned with 1.5T, using 3TMRI.
Method: Thirty patients with drug-resistant focal epilepsy and nega-
tive or non-consistent 1.5T-MRI were re-scanned with 1.5T and 3T.
The epilepsy protocol was the following: T1-weighted 3D, FLAIR-
3D, T2-weighted 3D, T2 coronal, T1 inversion recovery coronal and
DWI-ADC axial. Two neuro-radiologists, blinded for prior imaging
results and patient information randomly reviewed the MRIs. Kappa
score was used to assess the inter-observer and intra-observer relia-
bility. The findings identified from radiologists of non-specialized
centers were compared with reports from neuro-radiologists of our
center.
Results: Mean age of patients was 30  11, 87% had onset seizures in
the frontal or the temporal region. The intra-observer agreement for the
first radiologist was 0.74 for 1.5T and 0.71 for 3T. In the second radiolo-
gist was 0.82 and 0.66 respectively. The inter-observer agreement was
0.76 for 1.5T and 0.77 for 3T. Three non-consistent lesions (10%) were
identified by general radiologists in non-specialized centers using a 1.5T
standard protocol. In our center a consensus between two neuro-radiolo-
gists using epilepsy protocol identified seven lesions (23%) using 1.5T
and ten lesions (33%) using 3T-MRI (p < 0.02). In two of seven patients
(28%) this additional information resulted in a change in clinical man-
agement.
Conclusion: Use of 3T-MRI, epilepsy protocols and interpretation by
experienced neuroradiologists can improve the diagnostic yield in focal
epilepsy. This is extremely relevant for patients who are assessed for sur-
gical work-up, especially in developing countries where MRI and other
imaging tools are not always available.
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LANGUAGE FMRI TASK IS FUNCTIONALLY
CONNECTEDWITHEXECUTIVE FUNCTIONAREAS
INMESIAL TEMPORAL LOBE EPILEPSY
T.M. Lopes*, B.M. Campos*, T.A. Zan~ao*, A.C. Coan*,
M.L. Balthazar*, J.R. Binder†, F. Cendes*
*State University of Campinas, Neurology, Campinas, Brazil,
†Medical College of Wisconsin, Neurology, Milwaukee, WI,
USA
Purpose: Functional magnetic resonance imaging (fMRI) based on task
is a noninvasively method useful to determine language dominance in
mesial temporal lobe epilepsy (MTLE). We studied a well-established
fMRI language method, tone decision-semantic decision-Brazilian-ver-
sion (TD-SD-bv) (Binder, 1995) in MTLE and correlated with 12 known
functional networks. Our aim was to investigate the differences in the
functional connectivity (FC) betweenMTLE0s groups and the correlation
between networks and TD-SD-bv.
Method: We scanned 96 subjects on a 3T-MR to obtain functional imag-
ing during a language task, including 27 healthy volunteers and 69
patients with frequent (FS) and infrequent seizure (nFS); with right (R),
left (L) or non hipocampal atrophy (nl): 11 nFS-L; 11 nFS-nl; 14 FS-R;
18 FS-L and 15 FS-nl. We performed the functional connectivity (FC)
preprocessing using UF²C toolbox (www.lni.hc.unicamp.br/app/uf2c)
and added 84 ROIs in 12 functional networks to extract BOLD time series
and performed a full cross-correlation analysis (between all ROIs time
series). We used the SPSS21 to carry out the GLM analysis with
Tukey’s-post-hoc test to compare the average inter-connectivity between
groups and to test the correlation between the TD-SD-bv and the net-
works.
Results: There were no differences between groups related to age
(F = 0.664; p = 0.652) and educational level (F = 0.795; p = 0.556).
We found no difference related to FC between groups in the 12 networks
(p > 0.05). The higher correlation occurred between TD-SD-bv and
executive control network (r = 0.6) and the lower correlation with the
salience and basal ganglia networks (r = 0.3).
Conclusion: We concluded that all groups connected equally within the
networks to perform language task, suggesting that the FC between net-
works is not associated with side of hippocampal atrophy or seizure fre-
quency in the MTLE. In addition, language task strongly activates
network areas related with goal-directed behavior and cognitive control,
whereas network areas related with behavioral changes and action selec-
tion are less activated.
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NEURALCORRELATESOFRHYTHMIC THETA/
DELTAACTIVITY PRECEDING SPIKEANDWAVE
GENERATION INHUMANABSENCE EPILEPSY
L. Mirandola*,†, A.E. Vaudano*, P. Avanzini‡, A. Ruggieri*,
F. Benuzzi*, S. Meletti*,†
*University of Modena e Reggio Emilia, Department of
Biomedical, Metabolic, and Neural Sciences, Modena, Italy,
†NOCSAE Hospital, ASLModena, Neurology Unit, Modena,
Italy, ‡University of Parma, Department of Neuroscience,
Parma, Italy
Purpose: Studies on animal models of absence epilepsy (AE) enhanced
the presence of oscillatory slow (“theta”) activity preceding the onset of
generalized spike and wave discharge (GSWD) recorded from both corti-
cal and thalamic neurons. In human absence epilepsies these rhythmical
EEG oscillations preceding GSWD have not been clearly identified. The
aim of this study is to assess GWSD in human AE by means of multi-
modal EEG and fMRI techniques to reveal and characterize in terms of
neural generators rhythmical theta activities preceding the onset of spike
and wave complexes.
Method: 35 patients with AE underwent video-EEG-fMRI at 3 Tesla.
For each patient a two-step analysis was conducted:
(1) presence and topography of theta/delta rhythms preceding GSWD
was evaluated by means of EEG Independent Component Analysis
(ICA), FFT and CSDmaps;
(2) EEG periods with theta activity and GSWD were used to inform
fMRI signal analysis to reveal related BOLD changes.
Finally, second level group fMRI analysis was obtained for “theta”
and GSWD (P < 0.001 uncorrected).
Results: absence seizures (n = 182) were recorded in 18 patients. In all
patients a rhythmic theta/delta activity (mean FFT peak 3 Hz) preceded
the appearance of GSWD on EEG by a mean of 9.8 sec. fMRI analysis
related to GSWD and theta/delta activity showed BOLD signal changes
in the same cortical subcortical network involving default mode network
(DMN) areas and thalamus. Contrasting theta-related versus GSWD-
related BOLD changes showed areas of increased BOLD signal in DMN.
Conclusion: A rhythmic theta/delta activity anticipating GSWD by a
few seconds was reliably observed in each AE patients. This activity may
contribute to the initiation of 3 Hz GSWD, as observed in animal models
of absence epilepsy. The theta/delta activity correlated to a BOLD incre-
ment in DMN areas that may be crucial for the generation of absence
seizure.
Neuropsychology 2
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ACOMPARISONOFALTERNATIVE NON-INVASIVE
TESTSOF LANGUAGELATERALIZATION TOTHE
WADA-TEST: A SYSTEMATIC REVIEWANDMETA-
ANALYSIS
N.E. Kadish*,†, T. Loddenkemper‡, A. Jansen§
*University Medical Center Schleswig-Holstein, Christian-
Albrechts-University, Department of Neuropediatrics, Kiel,
Germany, †University Medical Center Schleswig-Holstein,
Christian-Albrechts-University, Department of Medical
Psychology and Medical Sociology, Kiel, Germany, ‡Boston
Children’s Hospital, Neurology, Boston, MA, USA, §Philipps-
University Marburg, Department of Psychiatry and
Psychotherapy, Marburg, Germany
Purpose: Functional magnetic resonance imaging (fMRI) is increas-
ingly used as a non-invasive alternative to the intracarotid amobarbital
test (IAT or Wada-test) to evaluate language dominance prior to epi-
lepsy surgery. However, fMRI is restricted by patient cooperation, age
and availability. We aim to provide a systematic review of the most
common other non-invasive alternatives to the IAT according to the
Preferred Reporting Items for Systematic Reviews and Meta-Analysis
(PRISMA) guidelines.
Method: A structured electronic literature search was conducted in
March 2015 for studies comparing the eight most common alternative
non-invasive methods to the gold-standard, the IAT. The literature
search yielded 476 results, of which 53 studies were included in the
final analysis. Sensitivity and specificity were analyzed and studies
were assessed with the Quality Assessment of Diagnostic Accuracy
tool (QUADAS-2).
Results: The following techniques were included in the analysis:
dichotic listening (n = 7 studies), diffusion tensor imaging (n = 4),
functional transcranial Doppler sonography (n = 3), magnetoen-
cephalography (MEG; n = 20), near-infrared spectroscopy (n = 5),
positron emission tomography (n = 5), structural magnetic resonance
imaging (n = 4) and transcranial magnetic stimulation (n = 5). Sensi-
tivity and specificity showed a wide range and might be misleading
as the base rate of atypical language dominance is often low. Many
studies had pilot character introducing new measurements, paradigms
and analyses. On a descriptive level, the classification of bilateral lan-
guage dominance was often more difficult than determining unilateral
language dominance.
Conclusion: While MEG is best studied, more validation studies using
consistent paradigms including multi-method comparisons are still
needed. Variability in paradigms may confound comparisons between
studies. There continues to be a need for exploring new methods or para-
digms in search of a valid assessment tool that will determine both unilat-
eral and bilateral language dominance.
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TALKINGABOUTTHERIGHTHEMISPHERE: STUDY
ONCOMMUNICATIONABILITIES IN TEMPORAL
LOBEEPILEPSY PATIENTS
C. Lomlomdjian*,†, C. Munera*,†, D. Low*, V. Terpiluk*,†,
B. Gori†, P. Solis*,†,‡, S. Kochen*,†,‡
*Epilepsy Center, Ramos Mejía Hospital, Buenos Aires,
Argentina, †Center for Clinical and Experimental Neuroscience:
Epilepsy, Cognition and Behavior. Cell Biology and
Neuroscience Institute (IBCN), School of Medicine, UBA -
CONICET, Buenos Aires, Argentina, ‡National Neuroscience
and Neurosurgery Center, El Cruce Hospital, Florencio Varela,
Buenos Aires, Argentina
Purpose: Language research in epilepsy has previously been focused on
dominant hemisphere processing and mainly at single word level. Com-
munication skills like discourse abilites, that enable social functioning
and in which the right hemisphere has a central role, have remained unex-
plored. The purpose of this study was to investigate narrative and conver-
sational discourse abilities in patients with right lateralized medial
temporal lobe epilepsy (TLE).
Method: Sixty patients with TLE and hippocampal sclerosis that
were candidates for surgical treatment were evaluated: 28 with a
right epileptic zone (EZ) (RTLE) and 32 with a left EZ (LTLE).
Subjects underwent a battery of tests that measure abilities on: sen-
tence to text comprehension; conversational and narrative discourse;
prosody; social inference, indirect speech and idiom expressions’
comprehension; verbal fluency; naming and logic-temporal sequenc-
ing. Disease related variables and general neuropsychological data
were evaluated.
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Results: RTLE compared to LTLE patients, showed interictal conversa-
tional and narrative discourse impairments, a tendency to tangential and
disintegrated speech, lack of hierarchical and categorized codification,
and misinterpretation of social intention. RTLE showed lower perfor-
mance in conversational discourse, narrative comprehension retelling
and production, idiom expressions’ and indirect speech’s comprehension,
social meaning inference, emotional prosody, strategies for lexical and
categorization. Otherwise, LTLE group showed lower performance in
logical temporal sequencing.
Conclusion: RTLE patients showed deficits which are similar to what
has been described in right hemisphere damaged patients. It is therefore
important to evaluate these skills in RTLE patients to detect potential
impairments. Medial and anterior temporal lobe structures seem to have
a key role in discourse processing as a link between semantic, world
knowledge, and social cognition associated areas to construct a contextu-
ally related coherent meaning.
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DURATIONOFEPILEPTIFORMDISCHARGES
NEGATIVELY PREDICTSMEMORYANDGENERAL
COGNITIVEABILITY INGENETICGENERALISED
EPILEPSY (GGE)
A. Loughman*, U. Seneviratne†,‡, W.J. D’Souza†,
S.C. Bowden*,§
*University of Melbourne, Melbourne School of Psychological
Sciences, Parkville, Australia, †St Vincent’s Hospital, University
of Melbourne, Department of Medicine, Melbourne, Australia,
‡Monash Medical Centre, Department of Neuroscience,
Melbourne, Australia, §St Vincent’s Hospital, Clinical
Neurosciences, Melbourne, Australia
Purpose: The current study investigates the relationship between the
total duration of epileptiform discharges and cognition in GGE, con-
trolling for variables known to compromise cognitive function in epi-
lepsy.
Method: As part of a larger prospective cohort study, 63 patients with
EEG-confirmed GGE aged 11-58 (mean age: 28 years) underwent
detailed neuropsychological assessment using the Woodcock Johnson III
Tests of Cognitive Abilities during a period of 24-hour ambulatory EEG
monitoring.
Results: Standard multiple linear regression analyses revealed that
the total duration of epileptiform discharges during the 24-hour EEG
monitoring period explained 39% of the variance of general cognitive
ability (standardised beta coefficient = 0.39, p < 0.001). None of
the included covariates were significant predictors: AED treatment;
epilepsy duration; history of absence seizures (standardised beta coef-
ficients = 0.25; 0.06; 0.02, all ns). The overall adjusted model fit was
R2 = 0.10, F (4, 58) = 2.80, p < 0.05. Total duration of epileptiform
discharges explained 46% of the variance of memory function (stan-
dardised beta coefficient = 0.46, p < 0.001). None of the included
covariates were significant predictors: AED treatment; epilepsy dura-
tion; history of absence seizures (standardised beta coefficients =
0.10; 0.13; 0.09, all ns). The overall adjusted model fit was R2 =
0.19, F (4, 58) = 4.67, p < 0.01. All assumptions of linear regression
were met.
Conclusion: These results suggest that the total duration of epileptiform
discharges negatively predicts general cognitive ability and memory
function specifically, when controlling for AED use, epilepsy duration
and history of absence seizures. To our knowledge this is the first time
such a relationship has been demonstrated in GGE, measuring general
and specific cognitive functioning (i.e. beyond reaction time and atten-
tion) or with 24-hour EEG recording. Further research is required to elu-
cidate the extent of epileptiform discharges impacts on specific GGE
syndromes and causal mechanisms.
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IN-DEPTHNEUROPSYCHOLOGICAL ASSESSMENT IN
PATIENTSWITHNOCTURNAL FRONTALLOBE
EPILEPSY (NFLE)
V. Menghi*,†, N. Pilolli*,†, L. Licchetta*,†, R. Poda*,†,
B. Mostacci*, C. Leta*,†, C. Stipa*,†, F. Provini*,†,
G. Plazzi*,†, F. Bisulli*,†, P. Tinuper*,†
*IRCCS Istituto delle Scienze Neurologiche di Bologna,
Bologna, Italy, †University of Bologna, Department of
Biomedical and Neuromotor Sciences, Bologna, Italy
Purpose: To study systematically the neuropsychological profile of a
cohort of patients with Nocturnal Frontal Lobe Epilepsy (NFLE), focus-
ing particularly on frontal lobe functions.
Method: All NFLE patients referred to our Institute from July 2013 to
December 2014 were invited to participate. All consenting patients
underwent a neuropsychological assessment including evaluation of gen-
eral intelligence (Wechsler Intelligence Scale for Adults and Raven’s
Progressive Matrices). A subgroup of selected patients (normal intelli-
gence, aged >16 years) underwent an extensive standard neuropsycho-
logical battery focused on executive functions: language, verbal and non-
verbal memory, working memory, visuospatial abilities, attention, men-
tal flexibility. All results were calculated after adjustment for age and
education level and collected in an ad hoc database.
Results: We recruited 33 cases (M:F = 14:19; mean age 40.3 years,
range 17–69; handedness: right 100%) for the neuropsychological study.
Three patients showed cognitive impairment and did not undergo the fur-
ther specific battery. In 27 patients (M:F = 11:16; mean age 40.1 years)
the evaluation of general intelligence showed a worse score in verbal IQ
(mean total IQ 97.7; verbal IQ 92.7, performance IQ 104.3). Patients with
at least one impaired neuropsychological test of the extensive battery
were 63%. Phonemic fluency and selective visual attention tests were
impaired in 34.5% and 31% of patients respectively. Working memory
was impaired in 10.4% of patients, whereas 34.4% showed deficits in ver-
bal and non verbal memory. Performance on the mental flexibility and
shifting tests were normal in all tested patients. Among five patients with
multiple impaired tests, two had drug-resistant epilepsy with weekly/
daily seizures.
Conclusion: These preliminary data suggest that performance IQ is bet-
ter than verbal IQ in NFLE patients. Verbal fluency, memory tasks and
selective visual attention are the cognitive patterns most often impaired,
whereas performance on the mental flexibility is preserved.
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ARE PATIENTSWITHNONDOMINANTMESIAL
TEMPORAL SCLEROSISMORE PRONETO
NONCONVULSIVE STATUS EPILEPTICUS DURING
VIDEOEEGMONITORING?
S.F. Menku, Y. Abanoz, Y. Abanoz, A. Gunduz, S.N. Yeni
Istanbul University Cerrahpasa Faculty of Medicine, Neurology,
Istanbul, Turkey
Purpose: Epilepsy is a disturbance of neuronal networks with altered
connectivity. Seizures of each temporal lobe (TL) may have different
aspects as a result of so-called connectivity differences. We speculate
that epileptic seizures of unilateral hippocampal sclerosis may vary
between each TL in terms of seizure duration during video EEGmonitor-
ing and nonconvulsive status epilepticus may be more prevalent in non-
dominant TL epilepsy.
Method: All right handed patients with intractable TL epilepsy who had
unilateral hippocampal sclerosis on cranial MR, unilateral concordant
neuropsychological test were included. During video EEG monitoring,
the dose of each drug was decreased approximately by 25% every con-
Epilepsia, 56(Suppl. 1):3–263, 2015
doi: 10.1111/epi.13241
158
Abstracts
secutive day. All complex partial seizures (CPS) were evaluated in terms
of seizure duration. If there was secondary generalisation, it was noted. A
nonconvulsive status epilepticus (NCSE) is defined when CPS lasts more
than 5 minutes.
Results: We evaluated 78 epileptic seizures of 40 patients (25 female).
Twenty one patients had right MTLE-HS. The mean age was 26.9  9.0
in right, 32.7  9.7 in left sided patients (p = 0.060). Patients with left
and right MTLE-HS were compared in terms of age at seizure onset,
duration of epilepsy, history of febrile seizures, history of secondarily
generalized seizures, number of antiepileptic drugs without any signifi-
cant difference. Duration of seizures between left and right sided MTLE-
HS were not different statistically (R:160.8  158.5 sec vs.
L:133.6  157.7 sec, p = 0.358). Number of seizures which evolved
into NCSEwere 9 (20.9%) on right and 2 (5.7%) on left sidedMTLE-HS.
This ratio reached statistical significance (p = 0.053).
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JUVENILEMYOCLONIC EPILEPSY ANDDEPRESSION
D. Yalcın, D. Polisci, E. Oguz Akarsu, R. Sürmeli
Umraniye Education and Research Hospital, Istanbul, Turkey
Purpose: Depression is common but underdiagnosed in people with epi-
lepsy. The purpose of this study is to determine the rate and severity of
depression in patients diagnosed juvenile myoclonic epilepsy (JME).
Method: Nineteen patients (17 women, 2 men)suffering from JME and
regularly followed by our Epilepsy Outpatient Departmant were screened
for depression using Beck Depression Inventery (BDI). None of the
patients had generalised tonic-clonic seizure in the last 1 year and all
patients were under monotherapy with valproic acid, lamotrigine or leve-
tiracetam.
Results: According to the scores of BDI 8 patients did not any sign of
depression. Six patients had mild, two moderate and three severe depres-
sion. JME accounts for 25–30 percent of idiopathic generalised epilepsies
and upto 10 percent of all cases of epilepsy.
Conclusion: There is growing evidence that patients with JME are at
increased risk for comorbid psychiatric illness and personality disorder.
our prelimanry data support these findings.
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LIFE AFTERBEINGDIAGNOSEDWITH
PSYCHOGENIC NON-EPILEPTIC SEIZURES (PNES): A
SOUTHAFRICAN PERSPECTIVE
C. Pretorius, M. Sparrow
Stellenbosch University, Psychology, Stellenbosch, South Africa
Purpose: The purpose of the study was to explore the life experiences of
South Africans who have been diagnosed as having psychogenic non-epi-
leptic seizures (PNES), with a focus on the aspects of the challenges
which these individuals face, as well as the resources and coping strate-
gies which are either made available to them or used by them in order to
cope with PNES.
Method: Ten qualitative, semi-structured interviews were analysed by
means of thematic analysis in order to explore themes around challenges
and resources for those diagnosed with PNES.
Results: Although many challenges were encountered by those who are
diagnosed with PNES, substantial resources on which these individuals
lean on in order to live fulfilling and satisfactory lives were identified.
Some of the challenges included unexpected seizures, medical profes-
sionals, belief systems as well as family. However, resources to counter-
act these challenges were social support, medical professional as well as
religion and spirituality.
Conclusion: Exploring the lives of those diagnosed with PNES in South
Africa is a new chapter in helping to discover methods to make the lives
of people with PNES easier, and ensuring that knowledge is spread in
order that those who have the symptomology can be readily and accu-
rately diagnosed, and given adequate information about the condition. By
uncovering life experiences, those who are diagnosed with PNES can
know that they are not alone. As more information and research is assem-
bled, more resources may become available to benefit these individuals
and allow them to recover from PNES.
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EXPLORING THEEXPERIENCESOF INDIVIDUALS
DURINGTHEDIAGNOSTIC PROCESSOF
PSYCHOGENIC NON-EPILEPTIC SEIZURES (PNES)
C. Pretorius, L. Farrow
Stellenbosch University, Psychology, Stellenbosch, South Africa
Purpose: Psychogenic non-epileptic seizures (PNES) are often misdiag-
nosed as epilepsy. It may take many years for someone to receive the cor-
rect diagnosis of PNES. The purpose of this study was therefore to
explore the experiences of individuals during the diagnostic process of
PNES. The focus was on the challenges that individuals face during the
diagnostic process, as well as the resources that help these individuals to
cope during the process of getting to a diagnosis of PNES.
Method: Thematic analysis was used to explore the qualitative, semi-
structured interviews that were conducted with ten individuals with
PNES.
Results: Data analysis revealed several themes relating to challenges
and resources. The first major challenge that emerged was healthcare
providers; especially with regards to misdiagnosis, medication and the
negative side effects, and uninformed healthcare providers. The second
major challenge to emerge was medical aid. The third was loss of inde-
pendence with regards to driving, socialisation and employment. The last
challenge was comorbid disorders; with the main comorbid disorder
being depression. The major resources were social support, medical aid,
healthcare providers and religion.
Conclusion: This study suggests that patients with PNES face many
challenges during the diagnostic process of PNES, but are also able to
make use of several resources. The role of healthcare providers during
the diagnostic process was highlighted as tremendously important. This
study will hopefully contribute to the improvement of the services pro-
vided by healthcare providers in particular to facilitate the experiences of
these individuals in a positive way.
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LONG-TERMEVOLUTIONOFDRAVET SYNDROME:
COGNITIVE IMPAIRMENT, BEHAVIORAL
PHENOTYPEANDADAPTIVE FUNCTIONING
F. Ragona*, C. Bersani*, M. Patrini*, S. Franceschetti†,
L. Canafoglia†, P. Veggiotti‡, E. Piazza*, T. Granata*
*National Neurological Institute C.Besta, Pediatric
Neuroscience, Milan, Italy, †National Neurological Institute
C.Besta, Neurophisiology and Epileptology, Milan, Italy,
‡National Neurological Institute C.Mondino, Department of
Child Neurology and Psychiatry, Pavia, Italy
Purpose: To report on clinical picture of adult patients with Dravet syn-
drome, with particular attention to the cognitive and behavioral pheno-
types, and to the adaptive functioning.
Method: Thirteen adult patients (mean age: 28.3 years, range 19–
48 years) and their caregivers underwent a comprehensive standardized
evaluation of:
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1) cognitive functioning: Mini Mental State Examination (MMSE),
Severe Impairment Battery (SIB), Raven test;
2) neuropsychiatric symptoms: UCLANeuropsychiatric Inventory;
3) adaptive functioning: modified Barthel Index, Vineland Adaptive
Behavior Scale;
4) family problems: Multidimensional Scale of Perceived Social Sup-
port (MSPSS), structured interview.
Results: All patients but one still experience seizures. The clinical neu-
rological picture is dominated by extrapyramidal symptoms (bradykine-
sia, hypomimia, rigidity, dystonia) and by orthopedic problems
(scoliosis, kyphosis, valgism, pes planus). Mental deficits are present in
all cases. The severity of clinical picture precluded a standardized evalua-
tion in 5/13 patients. Language, attention and memory are the most
impaired areas (SIB battery administered to 8 patients). Only 4 patients
were able to sustain Raven test, and performed below 25th centile.
Behavior disorders, reported in all cases but two, are mostly character-
ized by aggressiveness, agitation, and irritability. Eleven patients still
live with their own families, two patients in supervised community. The
mental age, according to the Vineland Scale is lower than 3 years in 7
patients, and between 5 and 12 years in 6. Accordingly, all the patients
but one are dependent from caregivers, albeit a certain degree of self care
is preserved in 5 patients (Barthel index). MSPSS and interviews high-
light difficulties in finding respite care outside family, and the heavy
impact of the disease on the caregivers’ lives.
Conclusion: Our data confirm that the disability of DS patients and the
quality of life of their families is mainly related to the severity of mental
deficits and the level of dependency from caregivers.
Neurostimulation 2
Monday, 7th September 2015
p0645
LONG-TERMOUTCOMEOFVAGUSNERVE
STIMULATION IN CHILDHOODONSET
REFRACTORYEPILEPSY
B. Konuskan*, D. Ardicli*, B. Bilginer†, K.K. Oguz‡,
N. Akalan†, G. Turanli*, M. Topcu*, D. Yalnizoglu*
*Hacettepe University, Pediatric Neurology, Ankara, Turkey,
†Hacettepe University, Neurosurgery, Ankara, Turkey,
‡Hacettepe University, Radiology, Ankara, Turkey
Purpose: Vagus nerve stimulation (VNS) has been used as an adjunctive
therapy for children and adults with medically intractable epilepsy for the
last three decades. We report our experience and long-term follow-up in
patients with medically intractable who underwent VNS implantation.
Method: We reviewed clinical data and long-term outcome of 53 chil-
dren (39 boys, 14 girls) with VNS followed between 1998 and 2014 at
Hacettepe University Children’s Hospital.
Results: Age at seizure onset ranged between 1 month and 14 years,
median duration of epilepsy was 9.6 years. The mean age at VNS
implantation was 12.5 years (4.6–18 years), the minumum follow-up
duration was 3 months. The most common underlying etiologies were
perinatal insult (32.5%), malformations of cortical development (22.4%),
meningoencephalitis (8.2%), Rett syndrome (6%), and 16% had negative
MRI. Seven patients had undergone epilepsy surgery before implantation
(3 patients with corpus callosotomy, 4 with resective surgery). The
majority of patients had cognitive and/or behavioral problems. Overall
40 patients had adequate follow-up data. Three patients (7.5%) were sei-
zure free including one with resolution of electrographical status epilepti-
cus in sleep; underlying etiologies were cortical dysplasia,
meningoencephalitis, and perinatal insult, each in one patient. 12.5% of
the patients had ≥90% decrease in seizure frequency, 22.5% had 50–90%
seizure reduction, 20% had <50% seizure reduction, whereas 37.5% had
no significant change in seizure frequency. Two patients underwent cor-
pus callosotomy, one resective surgery after VNS. Vocal disturbances
and paresthesias were the most common side effects, in two patients
VNSwas removed due to local reaction.
Conclusion: Our long-term follow-up results showed that VNS is an
effective and well-tolerated therapy for intractable childhood epilepsy.
Almost half of our patients had more than 50% seizure reduction follow-
ing VNS implantation. Our patients had a diverse etiological profile, and
seizure outcome was not related to the underlying etiology.
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VAGUSNERVE STIMULATION INCHILDRENWITH
DRUG-RESISTANT EPILEPSY: A LONGTERM
FOLLOW-UPDATA IN A SINGLECENTER
Y.-J. Lee*, M.-S. Yum*, E.-H. Kim*, S.H. Hong†, J.-K. Lee†,
T.-S. Ko*
*Asan Medical Center Children’s Hospital, Department of
Pediatrics, Seoul, Republic of Korea, †Asan Medical Center,
University of Ulsan College of Medicine, Department of
Neurosurgery, Seoul, Republic of Korea
Purpose: To evaluate long-term efficacy and safety of vagus nerve
stimulation (VNS) in children and adolescent with drug-resistant
epilepsy.
Method: The medical records of pediatric patients who underwent VNS
implantation in a single Korean tertiary center were reviewed. At
6 months, 1 year, 3 years, and 5 years after VNS implantation, the major
seizure frequency reduction from the baseline was assessed. The respon-
ders were defined as the ≥50% reduction in baseline seizure frequency at
1 year follow-up and the patient characteristics were compared between
responder and non-responder group.
Results: Thirty-five patients were identified. The mean age at implanta-
tion is 10.9 years (range, 4.2–19.9 years) and mean follow-up period
after VNS implantation is 6.9 years (range, 0.4–13.2 years). At
6 months, 1 year, 3 years, and 5 years after implantation, 33.3%, 45.1%,
51.8%, and 58.3% of patients showed ≥50% seizure frequency reduction.
Patients with generalized seizures were more likely to be responders than
those with focal seizures at 1 year after VNS implantation (p = 0.020).
The discontinuation rate was 11.4% (4/35), which is attributed to wound
infection in two of them and lack of efficacy in others. Other adverse
events were not reported.
Conclusion: This study suggests that VNS is well tolerated and effective
adjuvant therapy in pediatric patients with drug-resistant epilepsy. To
optimize the management of VNS, further studies are needed.
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HIPPOCAMPALDBS: FOLLOW-UPOF 3 PATIENTS
WITHMESIAL TEMPORAL EPILEPSY IN
NEUROCENTRO
A. Lizcano*, N. Sinisterra*, H. Carmona*, J. Cardona*,
J. Marulanda*, A.J. PhD Ortega†
*Neurocentro, Neurology - Epileptology, Pereira, Colombia,
†Universidad de Pamplona, Facultad de Salud, Pamplona,
Colombia
Purpose: Mesial temporal lobe epilepsy (MTLE) is often refractory,
increasing the risk of cognitive and psychosocial dysfunction. Hippocam-
pal deep brain stimulation (Hip-DBS) is proposed in patients with refrac-
toryMTLE in whom a resective surgery is not an option.
Method: Case reports.
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Results: We present the results of 3 patients who underwent to Hip-DBS
for refractory MTLE. The mean follow-up time was 6 months. No cogni-
tive impairment after surgery was observed. Case 1: Female, 20 years
old. Complex partial seizures (CPS) since age 7 months. Median seizure
frequency 1-2/week, catamenial exacerbation. Therapeutic failure of
seven AEDs. Video-EEG: one left mesial temporal seizure onset. Brain-
MRI: left mesial temporal sclerosis (MTS). Neuropsychological testing:
without significant differences between visual and verbal memory. Left
Hip-DBS was implanted, became seizure free with low-voltage stimula-
tion (0.4–0.6 V). Seizure frequency was increased until electrophalo-
graphic status when the stimulation intensity was higher. Case 2:
Female, 50 years old. CPS since age 3 years. Median seizure frequency:
9/month. Uncontrolled after 6 AEDs trials. Video-EEG: four temporal
seizures onset (1 left/3 right). Brain-MRI: right MTS. Neuropsychologi-
cal testing: visual and verbal memory impairment, worse verbal. Bilateral
Hip-DBSwas implanted. The mean monthly seizure frequency decreased
by 67% to 2V.Case 3:Male, 43 years old. CPS since age 24 years, daily
frequency. Uncontrolled after 10 AEDs trials. Video-EEG: 10 temporal
seizures (7 left/3 right). Brain-MRI: bilateral MTS. Neuropsychological
testing: visual and verbal memory impairment, worse visual. Bilateral
Hip-DBS was implanted, the mean seizure frequency reduction was 80%
to 0.4V, with left hippocampal stimulation alone.
Conclusion: Hip-DBS is a safe and effective therapeutic option for
patients with MTLE not candidates to resective surgery. Our patients,
had a mean seizure frequency reduction by 60%. Without observed addi-
tional cognitive deficit. The response has high variability. The stimula-
tion parameters should be evaluated periodically and individually.
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HIGH FREQUENCYCORTICAL FOCAL
STIMULATION IN ABSENCE EPILEPTIC RATS:
TIMINGOF STIMULATIONMATTERS FORACUTE
ANDLONGTERMEFFECTS
A. Lüttjohann*,†, S. van Heukelum†, J. Kelderhuis†,
P. Janssen†, G. van Luijtelaar†
*Institute of Physiology I, Westf€alische Wilhelms University
Münster, Münster, Germany, †Donders Institute for Brain,
Cognition and Behaviour, Radboud University Nijmegen,
Nijmegen, Netherlands
Purpose: Seizure control is one of the ultimate aims of epileptology:
here acute and prolonged effects of 24 h high-frequency stimulation of
the epileptic onset zone of spontaneous, occurring spike and wave dis-
charges (SWD) were investigated in an animal model of absence epi-
lepsy. Closed and open-loop stimulation were compared according to a
yoked control design allowing to investigate the effect of timing, while
controlling for amount and intensity of stimulation.
Method: WAG/Rij rats were implanted with stimulation electrodes in
the deep somatosensory cortex, and recording electrodes in cortex and
thalamus. Closed and open loop stimulation (1sec trains, biphasic
0.4 msec pulses, 130 Hz) were presented for 24 h according to a yoked
control design in a counterbalanced order. The stimulation days were pre-
ceded and followed by 24 h recordings.
Results: Closed-loop stimulation interrupted SWD and duration of SWD
was shortened. Both groups showed a reduction in SWD number during
stimulation days. Closed-loop stimulation also resulted in less SWD dur-
ing the last 8 hours of the post-stimulation day. Open-loop stimulation
sometimes induced low-frequency afterdischarges.
Conclusion: SWD can be aborted by closed-loop stimulation at seizure
onset zone while their number was reduced. It can be regarded as rela-
tively safe neuroplastic technique without habituation or a rebound of
SWD. The reduction of SWD during open-loop stimulation session might
be caused by the afterdischarges. The reduction of SWD on the post-sti-
mulation day demonstrates the critical relevance of timing for the induc-
tion of plasticity: it suggests that absence seizures themselves might be
involved in their reoccurrence.
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SEIZUREONSET ZONE FUNCTIONALCONNECTOME
ASREVEALEDBY SINGLE PULSE ELECTRICAL
STIMULATION IN STEREOENCEPHALOGRAPHIC
STUDIES
M.D. Maliia*, C. Donos†, A. Barborica†,‡, I. Popa*, J. Ciurea§,
L. Craciun*, I. Mindruta*,¶
*Universitary Emergency Hospital Bucharest, Neurology,
Bucharest, Romania, †University of Bucharest, Physics,
Bucharest, Romania, ‡FHC Inc., Bowdoin, ME, USA,
§Bagdasar-Arseni Hospital Bucharest, Neurosurgery,
Bucharest, Romania, ¶University of Medicine and Pharmacy
‘Carol Davila’, Neurology, Bucharest, Romania
Purpose: Focal epilepsy is regarded increasingly as a network disease.
In this conceptual frame, standardized tools that define the functional
connectivity of the seizure onset zone (SOZ) are needed.
Methods: We selected 16 consecutive patients with pharmaco-resistant
epilepsy that were explored in the SEEG method during their presurgical
evaluation. Single pulse electrical stimulations (SPES) (biphasic, 3 ms,
0.25–5 mA) were applied to adjacent contacts while recording responses
from the rest. We calculated the early responses in the 10–110 ms inter-
val and considered only connections between contacts having a RMS
value within the 3 rd quartile of all the responses in an individual patient,
correlated with the stimulation current (Spearman0s rho >0.5, p < 0.05).
Sublobar anatomical structures projecting to SOZ (inbound connections),
as well as SOZ’s projections to other structures (outbound connections)
were systematically assessed. These were classified as either pathologic
(containing at least one contact with interictal epileptiform activity) or
physiologic. We thus defined SOZ’s connectome in each patient, naming
it generically “epileptome”, and listed it’s nodes before and after tailored
resections. Postsurgical outcome was evaluated after >6 months interval
(mean 9) firstly in respect to seizure freedom (10 yes vs. 6 no) and then as
Engel class.
Results: A large range of structures 8–100% (mean 55%, SD = 25%),
sampled for the SEEG exploration, were part of each patient’s epilep-
tome. Postsurgical outcome was highly correlated with the proportion of
pathologic structures in the inbound connections, both pre and post-sur-
gery (62% in seizure free lot vs. 88% in not seizure free lot, MannWhit-
ney-U p = 0.02, Spearmann for Engel score rho=0.654, p = 0.006), on
the same order of magnitude as it was to the ratio of unresected to total
SOZ contacts (p = 0.03).
Conclusions: The balance between pathologic and physiologic struc-
tures projecting to SOZ is associated with post-surgery outcome in our
lot and can be assessed preoperatively.
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VAGUSNERVE STIMULATIONACTIVATES
INHIBITORYNEURONALNETWORK INHUMAN
CEREBRALCORTEX
T. Matsuo*, K. Kawai*, N. Kunii†, K. Ibayashi*, N. Saito†
*NTTMedical Center Tokyo, Neurosurgery, Tokyo, Japan,
†University of Tokyo, Neurosurgery, Tokyo, Japan
Purpose: Vagus nerve stimulation is a surgical treatment for intractable
epilepsy as a palliative therapy for of its less invasiveness and good sei-
zure outcome. More than half patients can get 50% seizure reduction
compared to preoperative seizure frequency. Although vagus nerve stim-
ulation is widely performed for drug resistant epilepsy, little is known
about how the left cervical vagus nerve stimulation affect on the cerebral
cortex. To address this issue, we investigated the cortical activity during
vagus nerve stimulation using electrocorticography.
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Method: Electrocorticography, direct recording of cortical activities,
during vagus nerve stimulation were performed with 6 hemispheres of
4 patients. Eleven electrode sheets containing 20, 40 or 60 grid
arranged contacts were placed on the lateral surface of frontal or tem-
poral lobe on left and/or right hemisphere. Neuronal activities were
recorded through macro electrodes with a sampling rate of 2 kHz,
and recorded signals were analyzed offline. To evaluate the inhibitory
neuronal network, gamma coherence ranging 60 to 120 Hz between
electrodes were calculated and analyzed. The value of gamma coher-
ence was normalized with Z-score in each electrode sheet before
statistics.
Results: Eleven electrode sheets of 420 contacts were implanted.
Among them, 4 electrode sheets, 160 contacts, were placed on the left
side while 7 sheets, 260 contacts, were on the right side. We found ele-
vated gamma coherence in stimulating period compared to inter stimulat-
ing period. Normalized gamma coherence of stimulating period was
significantly higher than inter stimulating period (paired t-test,
p < 104). This phenomena was most observed in right hemisphere
(p < 105).
Conclusion: Our results suggest that increased activity of inhibitory neu-
ronal network elicited by vagus nerve stimulation especially observed in
right hemisphere consequently suppresses seizure occurrence.
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PAINFULHYPERSTIMULATION PHENOMENA
ASSOCIATEDWITHVAGUSNERVE STIMULATOR
MAGNET FIRING: 2 CASE REPORTS IN CHILDREN
WITHREFRACTORYEPILEPSYANDREVIEWOF
LITERATURE
S. Shareef, K. Skjei
University of Louisville, Child Neurology, Louisville, KY, USA
Purpose: Vagal Nerve Stimulation (VNS) is a well-established treat-
ment modality for refractory epilepsy in children and adults. Pain is a rare
complication associated with VNS therapy. When reported, the pain
tends to be localized and persistent. We report two patients with recurrent
episodes of severe pain that occurred during VNS stimulation but inde-
pendent of volitional VNS magnet mode stimulation. These episodes
abated after the VNSmagnet function was disabled.
Method: We report two patients with transient, intolerable painful phe-
nomena associated with spontaneous VNS stimulation. We discuss char-
acteristics of pain phenomena reported in other epilepsy patients with
VNS implants based on a review of the literature.
Results: Our cases were unrelated adolescent males with seizures since
early childhood. Their vagal nerve stimulators had been implanted 14
and 22 months prior to the onset of their pain episodes. Neither had
experienced significant side effects with their VNS previously. Neither
patient had seen significant decreases in seizure frequency or severity
following VNS placement. No recent VNS adjustments had been made
prior to symptom onset. Both patients reported acute onset of repeated
episodes of sudden, brief, paralyzing pain centered around the VNS
device and radiating to the chest and neck. There was no consistent cor-
relation with electronics usage or patient activity at the time of the
attacks. The episodes recurred until the magnet currents were set to zero
microvolts. Reactivation of the magnet setting in one patient caused
recurrence of pain episodes. As of 5 months following VNS magnet
mode deactivation, neither patient had experienced a return of the pain
episodes. In our literature review, we found no reports of VNS patients
with repeated painful episodes that eased with deactivation of the mag-
net settings.
Conclusion: Unintended magnet-mode activations should be investi-
gated as an etiology of transient painful phenomena in epilepsy patients
with VNS.
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THEROLEOFANTERIORNUCLEI OF THE
THALAMUS INCOGNITION. AN INTRACEREBRAL
RECORDING STUDY
K. Štillová*, P. Jurak†, J. Chladek†, J. Chrastina‡, J. Halamek†,
M. Bockova*, S. Goldemundova§, I. Ríha‡, I. Rektor*
*Masaryk University-CEITEC, St. Anne0s Teaching Hospital,
First Department of Neurology, Brno, Czech Republic, †Institute
of Scientific Instruments, Academy of Sciences of the Czech
Republic, Brno, Czech Republic, ‡Masaryk University-CEITEC,
Department of Neurosurgery St. Anne0s Teaching Hospital,
Department of Neurosurgery, Brno, Czech Republic,
§Department of Neurology, St. Anne0s Teaching Hospital,
Medical School of Masaryk University, First Department of
Neurology, Brno, Czech Republic
Purpose: To study the involvement of the anterior nuclei of the thalamus
(ANT) as compared to the involvement of the hippocampus in cognitive
processes of encoding and recognition.
Method: We studied intracerebral recordings in patients with pharma-
coresistent epilepsy who underwent deep brain stimulation (DBS) of the
ANT with depth electrodes implanted bilaterally in the ANT and com-
pared the results with epilepsy surgery candidates with depth electrodes
implanted bilaterally in the hippocampus. We recorded the event-related
potentials (ERPs) elicited by the visual and auditory memory encoding
and recognition tasks.
Results: We observed ERPs elicited by visual and auditory memory
encoding and recognition tasks in the hippocampus. ERPs in the ANT
were recorded by the visual encoding and visual and auditory recognition
tasks. No significant ERPs were recorded during the auditory encoding
task. In the recognition tasks, the ERPs in the ANT preceded the ERPs in
the hippocampus.
Conclusions: Memory disturbance should be considered in patients with
ANT-DBS and in patients with ANT lesions according to the observed
role of the ANT in the memory processes, especially in the memory
recognition.
Others 3
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POST-TRAUMATIC EPILEPSY: A CASE SERIES STUDY
B. Bastan, S. Gunaydin, A. Mutlu, B. Petek Balci, H. Acar,
O. Cokar
Haseki Research and Training Hospital, Istanbul, Turkey
Purpose: Seizures occuring after 1 week of traumatic brain injury (TBI)
and their recurrence are accepted as post-traumatic epilepsy (PTE). The
severity of TBI, age of the patient and genetic factors each have roles in
the onset of PTE.
Method: This study includes 75 epileptic patients with a history of TBI.
Their patient records are retrospectively reviewed and the data about
demographic, clinical, electrophysiologic and neuroimaging features is
gathered.
Results: The mean age of the patients was 25  9.9. Fifty- seven
(76%)out of 75 patients were men. The onset of epilepsy was in the
first year of TBI in 45.3% of patients. Thirty-one patients (41%) were
on polytherapy with antiepileptic drugs. The rate of polytherapy did
not differ between mild-TBI and severe-TBI- groups (43.1% vs 37.5%;
p = 0.84).
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Conclusion: This study shows that nearly half of the PTE-patients were
on polytherapy with antiepileptic drugs. Further research is needed to
delineate drug-resistancy in PTE.
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CLINICAL, NEURORADIOLOGICAL ANDEEG
FINDINGSOFREFLEXEPILEPSIES
G. Gursoy, K. Tutkavul, Y. Cetinkaya, G.A. Yuksel, H. Tireli
Haydarpasa Numune Education and Research Hospital,
Neurology, Istanbul, Turkey
Purpose: Repeating seizures induced by a specific afferent stimuli or
patient activity alone or in combination with spontaneous seizures, and/
or photo paroxysmal response on Electroencephalogram (EEG) is called
reflex epilepsy. We are reviewing clinical, neuroradiological and EEG
findings of reflex epilepsies.
Method: Records of 1395 follow up patients out of 2027 patients who
had been examined at second Epilepsy Outpatient Clinic between July
1995 and January 2015 were analyzed retrospectively.
Results: 69 of 1395 patients had reflex epilepsy and 60 patients had sei-
zures induced by visual stimuli. Considering the somatosensory stimuli;
eating was determined in one, hot water was determined in 3 patients,
both hot water and visual stimuli were determined in another one patient.
The average age of seizure onset was 12.6 years. History of febrile con-
vulsion was present in 27.5% and a family history for epilepsy was pre-
sent in 31 patients. The types of seizures were generalized tonic clonic
seizure in 58, absence in 35 and myoclonia in 30 of them. Neurological
examination was normal in 88.4% and Magnetic Resonance Imaging of
brain or cranial Computed Tomography were normal in 86.9% of them.
EEG revealed generalized epileptiform discharges in 31.8% and focal
epileptiform discharges in 7.2% of the patients who had pathological
EEG findings. Photo paroxysmal response was present in 15 patients
(one of them without clinical photosensitivity). Slow wave paroxysm
was seen at 5 patients and disorganized background activity was seen at 2
patients. Most frequently prescribed drug was Valproate in 38 patients. 7
patients did not need any antiepileptic drug.
Conclusion: In this hospital based study; reflex epilepsy frequency was
4.9% and cranial imaging was mostly found to be normal as in the litera-
ture. Pathological EEG finding were determined at highest rate in hot
water epilepsy.
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ICTALMONOPARESIS: 2 SYMPTOMATIC EPILEPSY
CASES
O. Kamisli*, M. Tecellioglu†
*Inonu University, School of Medicine, Neurology, Malatya,
Turkey, †Private Gozde Hospital, Neurology, Malatya, Turkey
Ictal paresis is a rare manifestation of epileptic seizures. It is sometimes
difficult to differantite from other neurological disorders such as
migraine, transient ischemic attacks and psychogenic paralysis. Video
EEG is usefull to make diagnosis. Here we described 2 patients with ictal
monoparesis whom had a tumour and the other had a head trauma due to
traffic accident. Case 1: 38 year-old woman was admitted to our emer-
gency department with seizures. She had seizures since 2 years. The sei-
zures presented with awereness and left arm monoparesis, the duration is
approximately 2–4 minutes and it repeats once a week. On examination
after the seizure was normal. She had an operation history due to brain
tumour in 1992. She had no family history. She is taking levetiracetam
3000 mg/day and valproate 1000 mg/day. Brain MRI revealed a slight
bilateral frontotemporal subdural effusion and right frontal encephaloma-
lacia. The EEG showed right frontocentral epileptiform activity. Case 2:
34 year-old man admitted to outpatient clinic with seizure history. He
had a traffic accident and had right cerebral hemorragia history 6 months
ago. After the accident his seizures began. The seizure begins with left
monoparesis and evolves to secondary generalised tonic clonic seizures.
The EEG showed right centroparietal epileptiform activity. There was an
encephalomalacia in the right frontal lobe in the brain MRI. He was tak-
ing phenytoin 300 mg/day and levetiracetam 1500 mg/day.
Discussion: Ictal paresis is a rare phenomen of epileptic seizures. There
are two probable pathophysiological hypothesis. If the negative motor
areas located anterior to the primary or supplementary sensorimotor areas
affected it occurs or if the epileptic activities in the sensorimotor areas
activated an inhibitory system it may be occurs. Our both patients had
lesion on the sensorymotor areas so these lesions may be the reason of
ictal paresis.
p0659
DENOVOTOURETTE’S SYNDROME: ACASEREPORT
WITHEPILEPSY
Z. Karaaslan, N. Bebek, B. Baykal, A. G€okyigit, C. Gürses
Istanbul University Istanbul Faculty of Medicine, Neurology,
Istanbul, Turkey
Introduction: Tourette’s syndrome (TS) is a childhood-onset neuropsy-
chiatric disorder characterized by multiple motor and vocal tics with at
least 1 year duration. Age of onset before 21 together with waxing and
waning clinical course of symptoms are typical. Tics are defined as invol-
untary, sudden, non-rhythmic movements and vocalizations. Comorbid
conditions such as obsessive-compulsive disorder (OCD) and attention-
deficit disorder (ADHD) are more common in TS patients than normal
population. Although the underlying pathophysiological mechanism of
TS is unknown, it most likely involves basal ganglia and frontocortical
circuits. Any pathological condition that causes damage on basal ganglia
and its connections may lead to de novo TS presentation. We describe a
case of acquired Tourettism after an arteriovenous malformation (AVM)
operation. Case: A 15 year old man with sudden, brief head-ache and
loss of consciousness, was evaluated for symptomatic epileptic seizures.
He developed tics and behavioural changes 2 years after his AVM opera-
tion. He had secondarily generalized tonic-clonic seizures and well
responded to carbamazepine and lamotrigine treatment. Although he had
no tic disorder prior to surgery, he developed motor and vocal tics. He
complained of memory loss attributed to attention deficiency. On his psy-
chiatric evaluation obsessive-compulsive disorder and psychotic findings
were detected.
Discussion: TS is a rare disease but has an important impact on the
health related quality of life. While the typical definition of the syndrome
posits it as developing with a neuropsychiatric disorder, neuroanatomic
and neurotransmitter changes can also cause TS symptoms as in the case
we described. Better understanding de novo TS will guide furthermore
investigations to unravel the mechanism of TS.
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PARTIAL AND SECONDARYGENERALIZED
SEIZURES INDUCEDBYDECISIONMAKING: ACASE
REPORT
İ.H. Kılıç, B. Uludag, İ. Aydogdu
Ege University Medical Faculty, Neurology Department, İzmir,
Turkey
Introduction: Reflex seizures are defined by the International League
Against Epilepsy (ILAE) as “objectively and consistently demonstrated
to be evoked by a specific afferent stimulus or by activity of the patient”(-
Blume et al., 2001). We want to present a case with seizures evoked by
decision making. Case report: A 52 years old otherwise healthy patient
with no family history, presented at the epilepsy polyclinic at the age of
17 years,with 1 year history of seizures.His seizures start with an anx-
ious feeling, perspiration and are followed by a tonic activity and a
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tingling on the right hand, extending to the right arm and the right side of
his face, causing elevation of the right arm over the head. The patient
keeps conciouss and aware but he sometimes gets a speech arrest. During
some of the seizures he feels like he has to urinate and defecate, but never
looses sphincter control. Visual, auditory or tactil stimuli do not trigger
his seizures. But all of the seizures, except for a small percentage which
are spontaneous and usually occur in the evening, are triggered with ‘de-
cision making’, as he claims. He experienced 2 secondary generalized
seizures in his whole life, one at the age of 17 and the other at the age of
29 (after withdrawal of his treatment). His physical examination is nor-
mal as well as his repeated cranial Magnetic Resonance Imaging
(MRI)’s.His interictal electroencephalogram(EEG)’s showed a left pari-
eto-temporal focus which sometimes extended to the homologue part of
the right hemisphere and occasional diffuse bilaterally synchronous theta
activity.We obtained partial responce to treatment with Levetiracetam
3000 mg/day, Phenytoin 400 mg/day and Phenobarbital 100 mg/day (1–
2 partial seizures/month).
Conclusion: Considering the lack of specific guidance regarding broader
definitions of reflex seizures and reflex epilepsies we want to describe
this rare clinical phenomena we observed.
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SEIZUREASSOCIATEDWITHHEPATITIS AVIRUS
Y.J. Oh, H.I. Kim, W.-J. Kim
Gangnam Severance Hospital, Yonsei University College of
Medicine, Department of Neurology, Seoul, Republic of Korea
Background: Hepatitis A virus (HAV), which causes acute hepatitis, is
transmitted by the fecal-to-oral route. It is known that rarely involves the
CNS. We present two cases of patient who had HAV infection with gen-
eralized seizure. Case 1: A 25-year-old female, with history of fever and
general weakness for 3 days admitted. Body temperature was 38.4°C and
no neurologic deficit was found. In blood tests, leukopenia and elevation
of ALT and AST were found. Serum IgM HAV Ab was detected. On the
4thday, deterioration of consciousness and neck stiffness were found and
generalized seizure followed. CSF pressure was 235mmH2O, but pleocy-
tosis was not present. Generalized delta activity was observed on EEG.
After conservative care, mental status was gradually improved and fol-
low up EEG was interpreted as normal. Case 2: A 34-year-old man was
transferred to neurology department after generalized convulsion a day
ago. 6 days ago, he had mild fever and general weakness. He was alert
and only showed neck stiffness. Serum AST, ALT and total bilirubin
levels were elevated. HAV IgM Ab was detected and other viral markers
were negative. CSF revealed 182mmH2O of opening pressure with WBC
28/mm3. CSF HAV IgM Ab and PCR were positive. EEG revealed dif-
fuse slowing and brain MRI showed normal findings. With conservative
care, he discharged without recurrence of seizure.
Discussion: The etiology of seizure with HAV infection is not well
understood. One possible mechanism is a disturbed detoxification pro-
cess by liver damage. Another is the direct invasion to CNS. In case1,
normal CSF result revealed and the seizure might be from toxic metabo-
lites. But case 2 showed CSF pleocytosis with HAV IgM Ab and PCR,
supporting the viral invasion to CNS. Although some cases were
reported, HAV-associated seizure is a rare disorder and the diagnosis
may be difficult without a clinical suspicion.
Others 4
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MEDIUM-CHAIN TRIGLYCERIDE DIET IMPROVES
SEIZURECONTROL IN EPILEPTIC DOGS
T.H. Law*,†, E. Davies*, P. Yuanlong‡, B. Zanghi‡, E. Want†
*Royal Veterinary College, Hertfordshire, UK, †Imperial
College London, London, UK, ‡Nestle Purina Research, St
Louis, MO, USA
Purpose: Epilepsy is the most common chronic neurological disorder in
dogs as it is in people. Approximately one-third of people and dogs with
epilepsy continue to seizure despite adequate antiepileptic treatment.
There continues to be a need for new treatment strategies to improve the
welfare of epileptic patients.
Method: A 6-month prospective, randomised, double-blinded, placebo
controlled crossover dietary trial was designed to compare a medium
chain triglyceride ketogenic diet (MCTD) to a standardised placebo diet
in chronically treated dogs with idiopathic epilepsy, which had ≥3 sei-
zure(s)/3 months prior enrolment. Dogs were fed either MCTD or pla-
cebo diet for 3 months followed by a subsequent respective switch of
diet for a further 3 months. Seizure frequency, clinical and laboratory
data were collected prospectively and evaluated for 21 dogs completing
the study.
Results: Seizure frequency was reduced when dogs were on MCTD
(2.31/month, 0–9.89/month) in comparison to placebo diet (2.67/month,
0.33–22.92/month, p = 0.0195); 3 dogs achieved seizure freedom, 7
dogs had ≥50% reduction in seizure frequency, 5 had an overall reduc-
tion in seizures and 6 showed no response. Number of days with sei-
zures were also significantly reduced when dogs were on the MCTD
(1.63/month, 0–7.58/month) in comparison to placebo diet (1.69/month,
0.33–13.82/month, p = 0.0216). There were no significant changes in
serum concentrations of glucose (p = 0.9027), phenobarbital
(p = 0.4223), potassium bromide (p = 0.4037) and weight (p = 0.2997)
between groups.
Conclusion: In conclusion the data shown are in accordance with other
studies, showing anti-seizure properties of a MCTD, and provides evi-
dence for the implications of the MCTD as a therapeutic option for treat-
ment in epilepsy.
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EPILEPSY INKOREANTRADITIONALMEDICINE: A
HISTORICALREVIEW
S.-Y. Lee*, H.S. Park†, C. Lin‡, Y.-S. Kang§
*Kangwon National University College of Medicine,
Department of Neurology, Chuncheon, Republic of Korea,
†Seoul National University Hospital, Department of Laboratory
Medicine, Seoul, Republic of Korea, ‡National Central
University, Research Center for Adaptive Data Analysis,
Jhongli, Taiwan, Republic of China, §Won-Kang University
College of Korean Medicine, Department of Medical History,
Iksan, Republic of Korea
Purpose: “Korean Medicine” based on Korean traditional medicine
exists in parallel with “Medicine” based on western modern medicine in
the Korean health care system. People with intractable diseases including
epilepsy often seek traditional medicine.We aimed to understand the per-
spective of Korean medicine on epilepsy by reviewing medical textbooks
of medieval Korea, which might have had a major influence on contem-
porary KoreanMedicine.
Method: We reviewed “Classified Assemblage of Medical Prescriptions
(醫方類聚)” (1445~1477) and “Treasured Mirror of Eastern Medicine
(東醫寶鑑)” (1610) and abstracted their records associated with epi-
lepsy. The Joseon Dynasty supported their publication to create standard
medical textbooks. The “Classified Assemblage of Medical Prescrip-
tions” compiled vast quantities of prescriptions from East Asia that
existed prior to the early 15th century with citations. The “TreasuredMir-
ror of Eastern Medicine” interpreted this information in a more system-
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atic fashion and re-classified the diseases, establishing originality to Kor-
eanMedicine.
Results: Since the 14th century, the concepts of ‘Jeon’ (癲) and ‘Gan’
(癎) approximated the modern concepts of epilepsy or seizure. They
described their differential diagnosis from stroke, psychosis or syn-
cope. The cause of epilepsy was classified as inborn, environmental,
and food related. The pathophysiology was explained on the basis of
obstruction or turbulence of energy flow within the brain, startle
response, or pathological hyperactivity. Attempts were made to clas-
sify seizures based on semiology: ‘Jeon’ (癲) were seizures with psy-
cho-behavioral symptoms and ‘Gan’ (癎) were convulsive seizures.
There was documentation of acute and chronic states, suggesting that
three or more seizures could be considered chronic epilepsy. Medicine,
food, physical therapy, meditation, and acupuncture were all intro-
duced as methods of treatment. Formulation methods for the medica-
tions were described in detail.
Conclusion: Epilepsy was an area of extensive research in medieval
Korea. Appreciating traditional medicine can provide new insight in
developing novel treatment methods for epilepsy.
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DOCIRCADIAN PREFERENCES AND SLEEPQUALITY
DIFFERENTACCORDING TOEPILEPSY
CLASSIFICATION?
S.-I. Lee*, S. Choi†, E.Y. Joo†
*Inam Neuroscience Research Center, Sanbon Hospital,
Wonkwang University School of Medicine, Neurology, Gunpo-
si, Republic of Korea, †SamsungMedical Center,
Sungkyunkwan University School of Medicine, Neurology,
Seoul, Republic of Korea
Purpose: To evaluate the circadian preference and sleep quality in
patients with partial epilepsy (PE) and generalized epilepsy (GE) and to
investigate whether circadian preferences and sleep quality differ accord-
ing to epilepsy classification.
Method: We enrolled the consecutive 170 patients (age 20–49; PE,
n = 127; GE, n = 43) who were diagnosed more than 1 year before and
were taking antiepileptic drugs for more than 6 months. Subjects with
mentally retarded(IQ≤80), serious medical and psychiatric diseases
including depression, and habitual use of hypnotics (≥3 nights/w) for last
4 w, short sleeper (≤5 h/d), and shift worker were excluded. All com-
pleted morningness-eveningness questionnaire (MEQ), Pittsburg sleep
quality index (PSQI), and Epworth sleepiness scale (ESS). Epilepsy his-
tory and seizure frequencies for the last 1 year were obtained from medi-
cal records.
Results: GE was younger (30.3 year) than PE (33.9 year, p = 0.015).
The most common circadian pattern was neither type in both groups
(74.0 and 79.1%), however, the proportion of evening type was signifi-
cantly higher in GE (20.9%, n = 9) than PE (6.3%, n = 8, p < 0.001).
GE reported more sleepy (ESS 7.5) than PE (6.0, p = 0.022). Overall
PSQI scores and each question scores were not different between GE
and PE although more than half in each group were poor sleepers
(PSQI ³ 5). Compared to good sleepers, poor sleepers had more fre-
quent seizures (8.0 vs. 22/y in PE, 1.8 vs. 15.8/y in GE). Poor sleepers
with GE (n = 28) showed the lowest MEQ scores and the highest
ESS.
Conclusion: Younger age of GE may be related to higher frequency of
evening circadian preference than PE. In both group, evening people with
poor sleep quality had more frequent seizures and more sleepy, which
suggests the importance of sleep on seizure control regardless of epilepsy
classification.
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VITAMIND, PARATHORMONEANDCALCIUM
LEVELS IN ADOLESCENTS UNDERANTIEPILEPTIC
DRUGTREATMENT
A. Mutlu, B. Petek Balcı, B. Kul, O. Cokar
Haseki Research and Training Hospital, Neurology, Istanbul,
Turkey
Purpose: In patients with epilepsy side effects can occur due to long
term use of anti-epileptic drugs. In many researches it is shown that due
to use of anti-epileptic drugs vitamin D3 levels drop off. In our research
vitamin D3 levels in adolescent patients with epilepsy has been investi-
gated.
Method: Our research included 30 adolescent patients, 20 of whom are
girls and 30 of whom are boys. The patients were using the same anti-epi-
leptic drug regularly at least for 6 months. They did not have any
endocrinologic or metabolic disorders. They were not taking extra cal-
sium and vitamin D. The patients’ levels of vitamin D3, parathormone
(PTH), and Ca were analysed.
Results: The age interval of the patients was 9–18, and the age average
was 13.9  2.85. The mean values of anti-epileptic drug doses were
between the recommended daily dose intervals. The Ca values of the pai-
ents were found to be 9.7  0.33 mg/dl, that is within normal limits.
PTH has been found to be higher than above normal levels in two patients
(18.45  4.41 ng/ml). The patients’ vitamin D3 level interval was found
to be 11.3–72.75 ng/ml and their vitamin D3 level average was found to
be 34.71  17.4 ng/ml. In 11 patients medium level of vitamin D3 defi-
ciency (18.45  4.41 ng/ml) was found. In 19 patients, 52.63 percent of
whom were girls, optimal vitamin D3 levels were found
(43.79  15.56 ng/ml). The lowest vitamin D3 level was found to be
28.84  14.4 ng/ml in patients who were treated with polytherapy.
Conclusion: Vitamin D3 deficiency is much more significant in the
long-term anti-epileptic drug treatment and in girl patients. This research
has been submitted as a preliminary study showing that it is important to
follow up adolescent patients with epilepsy in whom bone formation is
high.
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SEMIOLOGIC ANDHEMODYNAMIC FEATUREOF
CONVULSIVE SYNCOPE: HEAD-UP TILT TESTWITH
VIDEOMONITORING
D.L. Koo*, D.-W. Seo†, J.S. Kim‡, H. Nam*
*Seoul National University Boramae Hospital, Neurology,
Seoul, Republic of Korea, †Samsung Medical Center,
Sungkyunkwan University School of Medicine, Neurology,
Seoul, Republic of Korea, ‡Samsung Medical Center,
Sungkyunkwan University School of Medicine, Internal
Medicine, Seoul, Republic of Korea
Purpose: Convulsive syncope can be confused with epilepsy. We aimed
to demonstrate the semiologic signs during the syncopal attack and to
characterize eye signs of syncope.
Method: All patients underwent head-up tilting table test (HUT) and
video recording simultaneously, which includes another video setting for
eye observation. We investigated the video of the patients with positive
results and syncope during HUT, especially focusing on the convulsive
features and eye ball deviations. Furthermore, we estimated a certain cor-
relation between these semiologic findings and the hemodynamic
changes including heart rate and blood pressure.
Results: Of 541 patients with HUT, 84 (15.5%) patients experienced
syncope during the test. Among these syncope patients, 49 (58.3%)
patients showed eye opening with eyeball positioning or movements dur-
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ing the syncopal attack. Out of eyeball manifestations, conjugate eyeball
deviation to upward in 35 patients (41.7%) is common position. Twenty
four (28.3%) patients revealed head drop. Forty four (52.4%) patients
showed seizure mimicking movements in their arms or legs, including
myoclonic, tonic, or clonic phase. Interestingly, patients with head drop
and eye opening showed significant decrease of systolic blood pressure
and heart rate during syncopal attack (p = 0.031).
Conclusion: We reported that head drop with eye opening state during
syncope can be the sign of more profound degree of cardiohemodynamic
dysfunction.
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EFFICACYOFKETOGENIC DIETCANBE IMPROVED
WITHHIGHPOLYUNSATURATED FATTYACID
CONTENT
J.K. Nathan
Shushrusha Hospital, Mumbai, India
Purpose: The ketogenic diet (KD) is used to treat persons with uncon-
trolled epilepsy. One proposed mechanism of KD is the elevation of
polyunsaturated fats (PUFA) resulting in increased resistance to seizures
in ketotic brain tissue. However, a high PUFA-enriched KDmay achieve
a better seizure control than a classical KD. Trials to date with high
PUFAKD have shown equivocal results.
Method: This was an open, non-blinded study of 50 patients of age
11 months to 14 years (mean = 7 years) on KD who had inadequate sei-
zure control. They were changed to high PUFA KD. KD consisted of
37.5% PUFAwhile PUFAKD consisted of 73% PUFA.
Results: A total of 17 patients had more than 90% reduction (Of these 13
had 100% reduction) with a responder rate of 46% (23 patients >50%
reduction).
Conclusion: PUFA KD could be tried successfully in those who fail the
KD. The earlier trials were not successful either due to small sample size
or short period pf trial. A randomised control trial comparing KD and
PUFAKDmay help further elucidate this hypothesis.
p0673
DIFFERENT ETIOLOGICAL FACTORSANDCLINICAL
COURSEOPSOCLONUS-MYOCLONUS-ATAXIA
SYNDROME: REPORTONTHREE PEDIATRIC CASES
A. Kacar Bayram*, H. Gumus*, M. Canpolat*, S. Kumandas*,
M.A.Özdemir†, T. Patıroglu†, H. Per*
*Erciyes University Faculty of Medicine, Department of
Pediatrics, Division of Pediatric Neurology, Kayseri, Turkey,
†Erciyes University Faculty of Medicine, Department of
Pediatrics, Division of Pediatric Hematology and Oncology,
Kayseri, Turkey
Purpose: Opsoclonus-myoclonus-ataxia (OMA) syndrome is a rare neu-
rological disorder of acute/subacute onset characterized by multi-direc-
tional chaotic saccadic eye movements, accompanied by myoclonus and
cerebellar ataxia, as well as sleep disturbance, cognitive dysfunction, and
behavioral disruption. OMA syndrome is commonly related to a paraneo-
plastic process, specifically neuroblastic tumors in children. However,
OMA syndrome may occur in association with infectious agents, and
genetic predisposition. The pathophysiology of OMA syndrome is not
well understood. It is postulated dysfunction of the humoral and cell-
mediated immune mechanism.
Method: We describe three children with OMA syndrome, occurring
with different etiological factors and clinical course.
Results: The first patient, a 2-years-old boy, developed a sudden onset of
OMA, and eventually diagnosed with posterior mediastinal ganglioneu-
roma. The second patient, a 2-years-old girl, experienced ataxia and
opsoclonus with a mild degree of myoclonus associated with an adrenal
gland neuroblastoma. The third patient, a 2.5-years-old boy, who pre-
sented with ataxia and myoclonus without opsoclonus. Opsoclonus
occurs after 5 months, and it became clear OMA syndrome. The patient
diagnosed with idiopathic OMA syndrome based on normal laboratory
examinations and imaging results.
Conclusion: We emphasize that three components of OMA syndrome
may not be occur at the same time or one of these can be obscure, there-
fore comprehensive systemic investigations should be made in patients
with suspected OMA syndrome.
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CLINICAL PRESENTATIONOFEPILEPTIC SEIZURES
IN ACHILDWITHDIAGNOSIS OFATRIAL
FIBRILLATION: A PEDIATRIC CASEREPORT
A. Kacar Bayram*,Ö. Pamukcu†, S. Kumandas*, Z. Gündüz‡,
M. Canpolat*, G. KayaÖzcora*, H. Gumus*, A. Baykan†,
H. Per*
*Erciyes University Faculty of Medicine, Department of
Pediatrics, Division of Pediatric Neurology, Kayseri, Turkey,
†Erciyes University Faculty of Medicine, Department of
Pediatrics, Division of Pediatric Cardiology, Kayseri, Turkey,
‡Erciyes University Faculty of Medicine, Department of
Pediatrics, Division of Pediatric Rheumatology, Kayseri, Turkey
Purpose: Many cardiovascular disorders may result blackouts accompa-
nied by abnormal movements attributable to generalized brain hypoxia.
In some cases it may be difficult to distinguish between cardiac and
epileptogenic causes. Misdiagnosis of epilepsy and unnecessary
antiepileptic medication are common in these patients. Although rare in
children atrial fibrillation may cause loss of consciousness. These disor-
der is strong associations with underlying cardiovascular diseases and
male gender.
Method: We describe a previously healthy 13-year-old female patient
who presenting with urinary incontinence and generalized tonic-clonic
convulsions.
Results: The patient diagnosed with atrial fibrillation based on physical
examination and ECG findings.
Conclusion: Cardiovascular disorders should be considered in patients
presenting with loss of consciousness and seizure-like symptoms. We
emphasize that complete physical examination, and ECG recording in
necessary cases are important for correct diagnosis of patients.
Paediatric Epileptology 7
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TREATMENTOF INFANTSWITHEPILEPSY:
COMMONPRACTICEACROSS THEWORLD
J.M. Wilmshurst*, R.J. Burman*, W. Gaillard†, J.H. Cross‡
*Red Cross War Memorial Children’s Hospital; University of
Cape Town, Department of Paediatric Neurology, Cape Town,
South Africa, †George Washington University, Children’s
National Medical Center, Center for Neuroscience, Washington,
WA, USA, ‡University College London, Great Ormond Street
Hospital for Children, Institute of Child Health, London, UK
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Purpose: There is currently a lack of high quality data to guide the
development of treatment recommendations for infants with epilepsy.
The aim of this study was to develop global understanding of the pre-
ferred use of treatment interventions and to identify inter-regional dif-
ferences.
Method: An electronic survey was distributed to chapters of the Interna-
tional League Against Epilepsy (ILAE), the International Child Neurol-
ogy Association (ICNA) and various regional child neurology
associations. Questions were focused on current clinical practice includ-
ing drug and non-drug treatment interventions. Inter-regional compar-
isons were then identified and analysed using the relevant statistical
analysis.
Results: 733 unique responses were captured from 96 different coun-
tries. The survey found that overall most regions have a similar practice
for first line interventions. There were, however, statistically significant
differences identified in North America where more Levetiracetam was
prescribed and in sub-Saharan Africa where there is a large amount of
variability in drug preference. Furthermore, it was also noted that pheno-
barbital was used for generalised and focal seizures in both resource-poor
and resource-equipped regions. For second and third line interventions
the ranges of choices were diverse, often with little correlation across
regions. In terms of alternative therapies, overall previous experience
with vagal nerve stimulation and epilepsy surgery significantly increases
the preferred use of these therapies once seizures have been diagnosed as
medically refractory.
Conclusion: The results from this survey highlight the lack of global
consistency in the management of infants with epilepsy. These findings
further justify the need for more randomized controlled trials within
this population group to guide the development of more useful treat-
ment recommendations. Lastly, the identified differences in global pre-
scribing practices may provide a useful platform for further
investigation into the issues surrounding the management of infants
with epilepsy.
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DEVELOPMENTALOUTCOME INCHILDRENOF
INFANTILE SPASMSWITH FOCALCORTICAL
DYSPLASIA
S. Park, H.-C. Kang, J.S. Lee, H. Kim
Severance Children’s Hospital, Pediatric Neurology, Seoul,
Republic of Korea
Purpose: We investigated developmental and epilepsy outcome in
infantile spasms patients with focal cortical dysplasia, and analyzed clini-
cal factors related to the developmental outcome in these patients, retro-
spectively.
Method: This is a retrospective chart review of 47 children who diag-
nosed with infantile spasms and focal cortical dysplasia. We included the
children treated with diverse modality of treatments, antiepileptic drugs,
ketogenic diet and epileptic surgery at Severance children’s hospital from
January, 2008 to December, 2014. We reviewed patients0 characteristics
and outcomes of treatment, and sorted them into good outcome and poor
outcome groups. With comparing the clinical factors of two groups, we
analyzed predicted factors for better developmental outcomes in these
patient group.
Results: Among 47 children, 12 of them (25.5%) were treated only with
AEDs and 24 children (51.1%) tried on ketogenic diet. Children who
underwent epileptic surgery and pathologically confirmed cortical dys-
plasia were 11(23.4%). Good outcome group (Social quotient >70) were
15 (31.9%) and poor outcome group (Social Quotient <70) were 32
(68.1%). And shorter epilepsy duration (from clinical onset of spasm to
seizure cessation), good initial neurodevelopmental status and unilobar
focal cortical dysplasia distribution were possible predicted factors for
better neurodevelopmental outcomes in this study.
Conclusion: Etiologic diagnosis and providing early and active appro-
priate therapy can lead to shorter epilepsy duration and it can prevent
children from functional declining and may contribute to better develop-
mental outcome.
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THECLINICALANDDEMOGRAPHIC
CHARACTERISTICSOFCHILDRENWITHLATE
FEBRILE SEIZURE
D.S. Kim*, S. Kim†
*Medical Course, School of Medicine, Jeju National University,
Jeju island, Republic of Korea, †Department of Pediatrics,
School of Medicine, Jeju National University, Jeju island,
Republic of Korea
Purpose: The goal of this study was to assess the clinical and demo-
graphic characteristics of children with late febrile seizure on Jeju Island,
South Korea.
Method: We reviewed retrospectively patients whose FS occurred after
5 years of age (defined as late FS) who visited the Jeju National Univer-
sity Hospital between March 2007 and December 2014. We excluded
patients with evidence of intracranial infection.
Results: Eighty-four (53 boys and 31 girls) of a total of 448 patients with
FS were diagnosed with late FS. A family history of FS and epilepsy was
found in 30/83 (35.7%) and 2/83 (2.3%), respectively. Thirty-eight
(45.2%) patients were diagnosed with complex FS. Subsequent non-
febrile seizures were observed in 29/84 (34.5%) patients. Abnormal EEG
findings were observed in 46/78 (58.9%) patients. The 84 patients were
classified into two groups based on the onset of the first FS (before and
after 5 years of age, n = 54 and 30, respectively). Two variables were
significantly more prevalent in the group with the first FS before 5 years
of age: family history of FS and complex FS. Analysis was performed to
compare the patients grouped according to the absence or presence of late
FS (n = 364 and 84, respectively). Three factors were significantly more
prevalent in the group with late FS: neurodevelopmental delay, subse-
quent nonfebrile seizure, and EEG abnormalities.
Conclusion: Patients with late FS had a significantly higher frequency of
EEG abnormalities and subsequent nonfebrile seizures compared with
patients whose last FS developed before 5 years of age. Among patients
with late FS, the group of patients who had their first FS before 5 years of
age had a higher prevalence of family history of FS and complex FS com-
paredwith the group of patients whose first FS occurred after 5 years of age.
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CHILDHOOD-ONSET EPILEPSY IN JAPANESE
PATIENTSWITHDOWN SYNDROME
S. Kimura, H. Toshikawa, T. Kimuzu, T. Ikeda, Y. Mogami,
K. Yanagihara, Y. Suzuki
Osaka Medical Center and Research Institute for Maternal and
Child Health, Pediatric Neurology, Osaka, Japan
Purpose: A retrospective review of patient histories was conducted to
clarify the clinical features of epilepsy in children with Down syndrome.
Method: Based on records in our hospital database entered between
1981 and 2013, we identified 25 patients (14 males) with childhood-onset
(<18 years) epilepsy associated with Down syndrome. The patients were
classified into two groups according to seizure type at onset: epileptic
spasms (ES) and non-ES groups. We compared the clinical manifesta-
tions and outcomes of epilepsy between the groups.
Results: The study included 13 patients in the ES group and 12 in the
non-ES group. Spasms developed at the mean age of 7 months (range
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3–15 months) in the ES group, whereas at 10.5 years (1 month-
17 years) in the non-ES group. Congenital heart diseases were the most
common comorbidity in both groups. There were no significant differ-
ences in clinical features (e.g., gender, gestational week, birth weight)
between the two groups. At the last follow-up, all patients of both groups
had severe mental retardation. All except 2 patients in the ES group could
walk without support. Most (12/13) children in the ES group achieved
seizure control. In contrast, 7/12 patients in the non-ES group had intract-
able seizures.
Conclusion: In our study, patients with epilepsy associated with Down
syndrome classified as ES had more favorable seizure outcomes as com-
pared with those who had non-ES seizures.
p0680
DIFFERENTAMBULANCECALL-OUTRATES
FOLLOWING PROLONGEDACUTECONVULSIVE
SEIZURES BUT SIMILARAVAILABILITYOFRESCUE
MEDICATIONANDTRAINED PERSONNELATHOME
ANDAT SCHOOL INAEUROPEAN SURVEYOF
CHILDRENWITHEPILEPSY
F.J. Kirkham*,†, F. Vigevano‡, B. Wilken§, M. Raspall-
Chaure¶, R. Grebla**, N. Roskell††, T. Kiechle‡‡, L. Lagae§§
*University Hospital Southampton NHS Trust, Department of
Child Health, Southampton, UK, †Institute of Child Health,
University College London, London, UK, ‡Bambino Gesu
Children’s Hospital, Department of Neuroscience, Rome, Italy,
§Klinikum Kassel, Department of Paediatric Neurology, Kassel,
Germany, ¶Vall d’Hebron University Hospital, Department of
Paediatric Neurology, Barcelona, Spain, **Shire, Global Health
Economics and Outcomes Research, Wayne, PA, USA,
††BresMed Health Solutions, Sheffield, UK, ‡‡Shire, Global
Medical Affairs, Zug, Switzerland, §§University Hospitals,
Katholieke Universiteit Leuven, Pediatric Neurology, Leuven,
Belgium
Purpose: To explore rescue medication administration and ambulance
use in children with epilepsy who experience prolonged acute convulsive
seizures (PACS).
Method: Practices in Emergency and Rescue medication For Epilepsy
managed with Community-administered Therapy 3 [PERFECT-3])
enrolled non-institutionalized children (aged 3–16 years) who had been
diagnosed with epilepsy ≥ 12 months previously, had experienced ≥ 1
PACS within the last 12 months, and had currently prescribed rescue
medication(s) for PACS. Patients’ parents/guardians completed web-
based questionnaires.
Results: According to 258 patients’ parents in Germany (n = 87), Italy
(n = 74), Spain (n = 72) and the UK (n = 25), 171/253 (67.6%) had their
most recent PACS at home, 32/253 (12.6%) at kindergarten/nursery/
school and 50/253 (19.8%) elsewhere. Of these, 69.0%, 75.0% and 82.0%
received rescue medication, and an ambulance was called for 19.9%,
56.3% and 14.0%, respectively. Overall, rescue medication was always
carried by 42.4% of children and by an accompanying adult for 44.0%,
with separate supplies often kept at home (84.9%) or school/kindergarten/
nursery (73.3%). Most children’s parents (81.0%), school staff (72.5%) or
relatives (63.6%) were trained to give rescue medication. Most patients’
schools (63.0%) had a documented PACS care process. The majority of
parents (54.3%) were very or extremely confident that their child would
receive rescue medication promptly following PACS at school. Of the
remainder, 48.7% reported that the school protocol was always to call an
ambulance, 28.6% that school staff were not trained to administer and
21.8% that school staff were unwilling to administer rescue medication.
Conclusion: For most but not all surveyed children with epilepsy, their
prescribed PACS rescue medication and people trained in its administra-
tion were available at home and at school. Ambulance utilization follow-
ing PACS was high, especially at school. These findings confirm the
need for improved community training in PACSmanagement.
Study funded by ViroPharma (part of the Shire Group of Companies)
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PSYCHOSOCIAL ISSUESOFADOLESCENTSWITH
EPILEPSY IN JAPAN
Y. Kishimoto*, M. Fujikawa*, K. Kato*,†, Y. Kitazawa*,
Y. Kakisaka*, M. Iwasaki‡, K. Jin*, N. Nakasato*
*Tohoku University Graduate School of Medicine, Epileptology,
Sendai, Japan, †Tohoku University Graduate School of
Medicine, Neurology, Sendai, Japan, ‡Tohoku University
Graduate School of Medicine, Neurosurgery, Sendai, Japan
Purpose: Transitional youths in epilepsy care have gathered attention
worldwide recently, as they face specific psychosocial problems that
need to be incorporated in their treatment. However, only a few studies
investigated these issues in Japan. This study aimed to explore youth’s
multi-dimensional aspects of psychosocial issues in relation to epilepsy.
Method: A mixed-methods study design was utilized to better under-
stand the impact of epilepsy on adolescents and their level of psychoso-
cial adjustment. The study included 11 adolescents with epilepsy (12–
18 years old) and their parents in our epilepsy monitoring unit. Quantita-
tive self-report instruments were first administered to both parties to
assess psychiatric and behavioral issues, and quality of life (QOL). Semi-
structured interviews were then conducted separately. Quantitative data
were analyzed to generate key issues in order to explore more contextual
information from interviews.
Results: Quantitative data indicated youths with psychiatric and behav-
ioral issues tend to perceive a large negative impact from social issues
(i.e., stigma, lack of social support, interpersonal relationship). Three
youths were indicated for possible depression, whose issues extended to
behavioral and social aspects. Of those, 2 youths reported a history of
medication overdose and self-harm episodes, and one was referred for
psychiatric care after the discharge. Semi-structured interviews revealed
36% of the adolescents having experienced stigma, bullying, and friend-
ship issues during secondary school. However, no youths indicated sig-
nificant impact of epilepsy on their QOL. Furthermore, reporting gaps
existed between youths and their parents in terms of emotional issues.
Conclusion: Findings indicated adolescents with epilepsy perceive
environmental issues as significant barriers than their health perception
itself, which subsequently impact their emotional well-beings. Reporting
gaps between adolescents and parents may be suggestive of youths in
transitioning phase into independent adulthood. This provides future
implication to emphasize on psychosocial assessment and educational
intervention for self-management.
p0683
FEATURESOFHOTWATEREPILEPSY INHUNGARY
ANDCOMPARISONSWITHCASES FROMEUROPE
J. Kóbor*, B. Rosdy†, I. Gy€orgy‡, E. Bereg*, D. Sarvari§,
T. Nyari¶
*Univ. Szeged, Fac. Medicine, Dept. Paediatrics, Szeged,
Hungary, †P. Heim Children’s Hospital, Budapest, Hungary,
‡Univ. Debrecen, Fac. Medicine, Dept. Paediatrics, Debrecen,
Hungary, §F. Csolnoky Hospital, Dept. Paediatrics, Veszprém,
Hungary, ¶Univ. Szeged, Fac. Medicine, Dept. Med. Physics and
Informatics, Szeged, Hungary
Purpose: Hot water epilepsy (HWE) is a rare form of reflex epilepsies,
characterized by seizures precipitated by warm bath. Only small series of
patients have been reported outside of India, Turkey and Japan. We
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present 13 cases of HWE and compare their clinical features with HWE
cases published from Europe.
Method: Retrospective chart review. Student0s t-test and chi-square test
were used.
Results: At the time of first seizure the patients age ranged from
1 week to 10 years (11 younger than 14-month). Most commonly
complex partial seizures presented soon after immersion into a normal
temperature bath. 8 patients suffered seizures not related to bath, too.
Interictal EEG revealed focal epileptic discharges in 7. Brain MRI
revealed various abnormalities in 3 children. 7 patients had a family
history of epilepsy. After a mean follow-up period of 9.5 years, 10
patients became seizure free with changes in bath habit and antiepilep-
tic medications. 6 patients suffer comorbid developmental disorder.
We compared our patients with other 38, published from Europe. Age
at onset was lower and developmental disorder was more frequent in
our cohort, however these differences were not significant. Further
comparisons were made after merging our patients with those from
Europe, and grouping them based on the presence or absence of family
history of epilepsy. Non-bathing-related seizures and developmental
disorder were more common in HWE patients with family history of
epilepsy. When groups were formed on the basis of the absence or
presence of developmental disorder, a younger age, non-bathing sei-
zures and the family history of any seizure were found to be more
common in the latter group.
Conclusion: Characteristics of 13 new HWE patients from Hungary are
similar to those in Europe. Further analysis of the merged groups sug-
gests, that some features may outline a subgroup of patients within HWE.
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STUDYABOUT PREVALENCEOF FEBRILE SEIZURE
INCHILDHOODEPILEPSY
A. Kumar
Indira Gandhi Institute of Medical Sciences, Neurology, Patna,
India
Purpose: To determine the prevalence of febrile seizure before the onset
of afebrile seizures in childhood epilepsy.
Method: Children between 1 to 14 years of age with idiopathic,crypto-
genic epilepsy and other rare epilepsy syndromes were included in the
study.Children with acute symptomatic seizures or epilepsy due to identi-
fiable acquired lesion like granulomas etcwere excluded from the final
analysis.Of the 100 cases 49 were localization related, 48 were general-
ized and in 3 cases the syndromes was undetermined.
Results: Seizures provoked by fever had occurred before the onset of
afebrile seizures in 15 of 100 cases studied. 7 of these later developed
generalized epilepsy syndromes 6 developed localization related epi-
lepsy syndromes and in 2 cases it was undetermined.In our study 4%
of the cases had cryptogenic localization related epilepsy.Of these 3%
were semiologically complex partial seizures of temporal lobe origin.
Of the 6 children with absence epilepsy 2 children (33%) had febrile
seizure preceding onset of absence seizures.Of the other idiopathic
generalized epilepsy cases 2 children had a family history of febrile/
afebrile seizures and also prior history of febrile seizures qualifying
the criteria of generalized epilepsy with febrile seizures plus (GEFS+)
syndrome. In one of our cases febrile seizures started at 6 months of
age and had continued till presentation to us at 5 years of age. In the
second patient febrile seizure occurred at 3 years of age and later the
child had two afebrile seizures at 9 and 13 years of age. We had 3
cases of other symptomatic generalized epilepsy (50%) with prior his-
tory of febrile seizures.
Conclusion: Febrile seizures preceded epilepsy in 15% of our patient-
s.Two patients of these had GEFS+ syndrome, a genetic syndrome linked
to the sodium channels. Febrile seizures were also found preceding child-
hood absence epilepsy and cryptogenic localization related epilepsy
especially in children with complex partial seizures.
p0687
ANTI GAD POSITIVEAUTOIMMUNEEPILEPSY IN
CHILDREN: A REPORTOF 3 CASES
R. Kumar, R. Dubey, L. Saini, J. Kaushik, H. Patel,
B. Chakrabarty, S. Gulati
All India Institute of Medical Sciences, Child Neurology
Division, Department of Pediatrics, New Delhi, India
Purpose: To study the clinical profile of anti-GAD positive autoimmune
epilepsy in children.
Method: Case series.
Results: Anti-glutamic acid decarboxylase antibodies act against an
enzyme that catalyzes the conversion of glutamate to GABA. These
antibodies are sometimes associated with epilepsy, often involving tem-
poral lobe. Anti-GAD positive epilepsy in children is rarely reported. In
a pediatric case series by Suleiman J et al., out of 13 cases of suspected
autoimmune epilepsy, only one case of anti-GAD positivity was
reported. We suspected autoimmune epilepsy in 20 children over last
1 year and we found three anti-GAD positive cases. Here, we report
three children with anti-GAD positivity with varied clinical presenta-
tions. First patient is a 4 year girl who presented with single episode of
right focal seizure. MRI brain showed left temporo-occipital gyral swel-
ling. EEG showed left temporal epilepsy. She was anti-GAD positive
and was successfully treated with immunotherapy. MRI changes
reversed over 6 month period. Second patient is an 8 year old girl who
presented with fever followed by aggressive behavior and altered sen-
sorium. Child developed refractory status epilepticus not responding to
high dose barbiturate infusion. MRI brain showed medial temporal lobe
signal changes suggestive of autoimmune encephalitis. Anti-GAD anti-
body was positive. Patient expired in spite of immunotherapy. Third
case is an 8 year old girl, a known case of shunted early onset hydro-
cephalus with intellectual disability, presented with recent onset cogni-
tive decline and behavioral problems for 2 months. MRI brain was
showing shunted hydrocephalus without ooze. Sleep EEG was reveal-
ing continuous spikes and waves during slow-wave sleep. Anti-GAD
antibody was strongly positive. She responded to methyl prednisolone
therapy showing improvement in behavior and cognition and CSWS
pattern resolved in EEG.
Conclusion: These cases highlight the spectrum of anti GAD positive
epilepsy in children and immunotherapy can prove beneficial in such
conditions.
p0690
EFFECTIVENESS ANDTOLERABILITYOF
RUFINAMIDE INKOREANCHILDRENWITH
LENNOX-GASTAUT SYNDROME
S. Kwon, S.K. Hwang, B.H. Kang
Kyungpook National University Children’s Hospital, Daegu,
Republic of Korea
Purpose: Rufinamide is known to be effective for children with Lennox-
Gastaut syndrome (LGS). The aim of this study is to evaluate its efficacy
and tolerability in Korean children with LGS.
Method: This is a single center, open label, retrospective study. The sub-
jects with LGS who had received rufinamide as an adjunctive therapy
were enrolled in this study. Their baseline clinical characteristics, the
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percent change in the seizure frequency per 4 weeks and adverse events
were evaluated.
Results: Thirty two children (20 males and 12 females, aged
11.3  6.6 years) were enrolled in the study. Half of the subjects suf-
fered from symptomatic causes and 72% of them had almost daily head
drops and tonic seizures despite the administration of multiple antiepilep-
tic drugs. After 1 month of rufinamide trial, seizure freedom was
achieved in two patients (6.3%), ≥50% reduction in seizure frequency
was shown in ten (31.3%) and not effective in eight children (25%). After
6 months of rufinamide trial, twenty patients showed a satisfactory
response (seizure free in one, >50% seizure reduction in ten, and <50%
seizure reduction in nine). Adverse events were noted in nine children
(28.1%), which include somnolence, aggressive behavior, drooling, etc.
Conclusion: The study suggests that rufinamide can be considered to be
an efficacious and safe AED for children with intractable epilepsies such
as LGS.
p0691
EVALUATIONOFETIOLOGYAND PROGNOSTIC
FACTORSOFTHEDEVELOPMENTALOUTCOME IN
NEONATAL SEIZURES
B. Lee, J.S. Jung
Pusan Paik Hospital, Inje University College of Medicine,
Busan, Republic of Korea
Purpose: The purpose of this study was to investigate the clinical fea-
tures of neonatal seizures and to identify prognostic factors of neurode-
velopmental outcome in term infants who experienced clinical seizures.
Methods: A retrospective analysis was performed on 153 full term and
preterm infants with seizures from January 2008 to December 2013. Bin-
ary logistic regression analysis was applied to assess risk factors associ-
ated with neurological adverse outcomes using variables that were found
to be significant on univariate analysis.
Results: During the study period, 102 term (66.7%) and 51 preterm
infants (33.3%) were enrolled. The main cause of neonatal seizures was
hypoxic ischemic encephalopathy (24.5%) in term infants and intracra-
nial hemorrhage (74.5%) in preterm infants. The most common type of
seizure was the focal clonic seizure, but the generalized tonic seizure was
more common observed in preterm than in term infants. Totally 39 out of
56 term infants with at least 12 months of neurologic follow-up showed
normal outcomes compared with only one preterm infant with normal
development. Prognostic factors related to adverse neurodevelopmental
outcomes in term infants were perinatal history of fetal distress, etiology
of hypoxic ischemic encephalopathy, a moderately or severely abnormal
EEG, evidence of hypoxic ischemic encephalopathy on brain magnetic
resonance imaging and the need for multiple antiepileptic drugs for sei-
zure control.
Conclusion: Preterm infants showed poor neurodevelopmental out-
comes compared with term infants. The etiology of seizures, treatment
response, neuroimaging and electroencephalographic findings were
important in predicting the developmental outcome in term infants with
seizures.
p0692
SEIZUREOUTCOMEAND
ELECTROENCEPHALOGRAPHIC FEATURE
CHANGESAFTERCORPUS CALLOSOTOMY IN
PATIENTSWITHLENNOX-GASTAUT SYNDROME
D. Lee*, S.Y. Park†, Y.J. Hur‡, H.D. Kim†
*Yonsei University College of Medicine, Epilepsy Research
Institute, Seoul, Republic of Korea, †Yonsei University College
of Medicine, Department of Pediatrics, Seoul, Republic of
Korea, ‡Inje University College of Medicine, Haeundae Paik
Hospital, Pusan, Republic of Korea
Purpose: To evaluate two-year seizure outcome of Corpus Callosotomy
(CC) in children with Lennox-Gastaut syndrome (LGS) and to investi-
gate whether specific electroencephalographic (EEG) features relates to
surgical outcome.
Method: Forty one children (23 boys and 18 girls) with LGS who under-
went CC at Severance Children’s Hospital between 2009 and 2012 were
included in the study. We reviewed EEG before CC and at 3 months,
1 year and 2 years after CC. We rated hemispheric lateralization ratio
(generalization, 6:4, 7:3, 8:2, 9:1, and complete lateralization) of epilepti-
form discharges (EDs). We also categorized severity of EEG into three
(mild, moderate, and severe) based on the background EEG and fre-
quency of EDs.
Results: All patients except five (two 8:2 and three 7:3) showed near
generalized EDs before CC. After 3 months post-CC, twenty-nine
patients (71%) had favorable seizure outcome (Engel class I and II).
Three patients (7%) showed close to normal EEG on both hemispheres.
Twenty patients (49%) showed improved laterality (over 7:3 ratio)
whereas eighteen (44%) showed no lateral improvement. After 2 year
post-CC, seven patients (17%, three had further resection) showed near
complete remission of EDs. Twenty five patients (61%) remained Engel
class I or II. Seven patients underwent subsequent resective surgery after
CC (mean 1.0  0.7 year) and six showed favorable seizure outcome.
While inspecting EEG features, six patients had higher than 7:3 ratio
right before surgery but it did not necessarily predict improved EEG pat-
terns.
Conclusion: This study confirms that CC is an effective surgical treat-
ment in patients with LGS. We also showed that complete remission of
EDs can be achieved by CC only in a small number of patients. When
planning a further resective surgery, background EEG patterns and fre-
quency of EDs as well as the lateralization ratio need to be thoroughly
inspected to achieve favorable outcome.
p0694
COMBINATION TREATMENTWITHACTH
+MAGNESIUM SULFATEVERSUS ACTHMONO
OHTAHARA SYNDROMETHERAPY
T.J. Wang, Z. Wang, B. Zhang, H.W. Lin
First Hospital of Jilin University, Changchun, China
Purpose: This study compared the efficacy and tolerability of ACTH +
magnesium sulfate (MgSO4) versus ACTH monotherapy for the treat-
ment of OS (Ohtahara Syndrome).
Method: This 30-week, randomized, open-label follow-up study
enrolled male and female infants with OS. Patients were randomly
assigned to receive ACTH 20 U/d + MgSO4 0.25 g/kg/d, or ACTH 20
U/d only (control), intravenously for 3 weeks. Efficacy was assessed
over a period of 30 weeks based on seizure Frequency and EEG changes.
Tolerability was assessed by monitoring for adverse events using labora-
tory analysis and clinical evaluation.
Results: 10 OS were enrolled (7 male, 3 female; median age,
1.5 months; 5patients per group). At 12 weeks, 3 patients (60%) who
received ACTH +MgSO4 and 2 patients (40%) in the control group were
seizure free. At 30 weeks, seizurefree rates were 4 (80%) in the ACTH +
MgSO4 group and 3 (60%) in the control group. On EEG, 3 patients
(60%) in the ACTH + MgSO4 group achieved complete recovery (nor-
malized EEG), 1 (10%) attained partial improvement (multifocal spike
wave),and 1 (10%) had no improvement burst suppression. At 4 weeks,
in the control group, 1 patients (10%) achieved complete recovery, 2
(25%) achieved partial improvement, and 3 (60%) had no improvement.
Of the 3 patients who were seizure free at 30 weeks in the ACTH +
MgSO4 group, 4 (80%) had complete recovery (normalized EEG); this
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rate was 3 of 5 (60%) in the control group. In the control group, the differ-
ence before and after treatment was nonsignificant.
Conclusion: In this study in OS, the proportions of patients who were
seizure free from 4 to 30 weeks were significantly greater in the ACTH +
MgSO4 group compared with the ACTHmonotherapy group.
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EPILEPTIC ENCEPHALOPATHIES OFCHILDREN
ABOUT 113 CASES
S.M.L. Dadah*, M. Ndiaye†, J.K. Kafando†, A.G. Diop†,
M.M. Ndiaye†
*University of Nouakchott, Nouakchott, Mauritania, †University
Cheikh Anta Diop, Clinique Neurologique de FANN, Dakar,
Senegal
Introduction: Epilepsy is a public health problem in Senegal and Africa
because of its severity and its social importance. It occurs at any age spar-
ing no sex. It can influence the sexual life and vice versa. The objective
of this work is to study the effects of antiepileptic drugs on the sex lives
of women with epilepsy, the influence of these drugs on pregnancy and
when breastfeeding.
Methods: This prospective study was conducted in the month of March
in the month of August 2011 in the neurological clinic teaching hospital
Fann Dakar Senegal and is directed only at women with epilepsy.
Results: We collected, 120 patients aged 16–64 years with a mean age
of 30.58 years, 45% married, 44.16% were uneducated preponderant All
patients were taking antiepileptic drugs, 89 16% was alone. 55% of our
patients had epilepsy for at least 6 years. 45.83% had generalized epi-
lepsy, 44.17% of partial seizures. In our cohort, 64.16% were under phe-
nobarbital, 69.16% had good adherence. As side effects of drugs 90%
had sexual problems. 75% enjoyed an active sex life, was noted a
decrease in the number of sex per week for the disease [31/
55 = 56.66%]. In addition, 51.17% were using contraception, including
38.7% of oral kind. 64.86% had noticed an increase in seizure frequency
during their pregnancies. Of the 74 women who had contracted a preg-
nancy, 41.89% had premature infants, 16.21% have made abortions.
61.17% had psychosocial life affected.
Discussion and conclusion: People with epilepsy often experience sex-
ual problems that may be caused by epilepsy, antiepileptic and/or reac-
tions of the partner and the other facing the diagnosis of epilepsy.
Keywords: epilepsy, reproductive health, pregnancy, antiepileptic,
Senegal
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PANAYIOTOPOULOS SYNDROME: AREPORTOF 44
CASES
D. Yalcın*, H. Ertaşoğlu Toydemir†
*€Umraniye Training and Research Hospital, Department of
Neurology, Istanbul, Turkey, †Bakırk€oy Dr.Sadi Konuk Training
and Research Hospital, Department of Neurology, Istanbul,
Turkey
Purpose: The purpose of the study was to evaluate the electro-clinical
features of patients with Panayiotopoulos Syndrome (PS) in detail.
Method: An analysis of patients with Panayiotopoulos Syndrome
between 1994 and 2014 was performed.
Results: Forty-four patients were included in the analysis. Twenty-three
of them (52.3%) were female and 21 patients (47.7%) were male. Mean
age was 22.3  4.4 (15–33) currently. Age of seizure onset was
7.2  3.2 (1–12). The number of seizures per patient was 1–3 in 22
patients (50%), 4–10 in 15 patients (34.1%) and >10 in 7 patients
(15.9%). Amongst our patients we defined 36 types of clinical features
some of which were atypical for this syndrome. The most common clini-
cal features were nausea (52.3%), vomiting (47.7%), pallor (47.7%),
deviation of head and eyes (45.5%), generalized seizures (38.6%), ictal
syncope (31.8%) and stomach ache (25.0%). Visual manifestations were
observed in 16 patients (36.4%). The most common negative manifesta-
tion was amaurosis (18.2%) whereas the most common positive manifes-
tation was flashes of colourful lights (15.9%). Autonomic status
epilepticus were detected in 9 patients (20.5%). The timing of the sei-
zures was following awakening (65.9%), during daytime(awake)
(13.6%), both during nocturnal sleep and daytime(11.4%) and during
nocturnal sleep (9.1%). The interictal scalp EEG was abnormal in all
patients. Epileptiform discharges were recorded from right, left or bilat-
eral occipital lobes independently and sometimes they occurred on differ-
ent sides of the same patient. Thirteen patients (29.5%) received
antiepileptic drugs. The antiepileptic drugs used in our series were oxcar-
bazepine (15.9%), carbamazepine (9.1%), valproate (2.3%) and leve-
tiracetam (2.3%).
Conclusion: Although PS is a benign and common syndrome, diagnosis
of this syndrome may be missed due to atypical features or autonomic
features suggesting mainly other non-epileptic conditions. We conclude
that our detailed data might contribute to the awareness of PS.
p0700
A SYSTEMATIC CLINICALAUDITOF THEEPILEPSY
CAREOFCHILDRENANDYOUNGPEOPLEWITH
NEURODISABILITIES ATTENDING SPECIAL
SCHOOLS: PRELIMINARYRESULTS
K. Martin*, A. Shahin†, W.P. Whitehouse†,‡
*Nottingham University Hospitals NHS Trust, Community
Paediatrics, Nottingham, UK, †University of Nottingham,
School of Medicine, Nottingham, UK, ‡Nottingham University
Hospitals NHS Trust, Paediatric Neurology, Nottingham, UK
Purpose: The investigation, diagnosis and management of the epilepsies
is challenging but especially so in children and young people (CYP) with
neurodisabilities due to difficulties in compliance with investigations and
confounding factors such as co-existing non-epileptic movement disor-
ders. The purpose of this clinical audit was to assess the epilepsy care
provided, using an adaptation of the UK Epilepsy 12 national audit.
Method: This was a retrospective case note-based clinical audit. A data
collection sheet was devised to allow collection of anonymised clinical
information from each child’s school health records and electronic hospi-
tal records. 16 performance indicators were devised, based on Epilepsy12
methodology with additional information relevant to CYP with neurodis-
abilities. Inclusion criteria were children attending one of two special
schools for CYP with profound and multiple learning disabilities, on one
or more antiepileptic drug for treatment of epilepsy, resident in the area
for past 5 years. Exclusion criteria were all seizure episodes were febrile,
all seizures were acute symptomatic.
Results: To date 19 patients have been identified and notes reviewed.
95% (18/19) had at least 1 neurodisability diagnosis; 74% (14/19) had 2
or more neurodisability diagnoses. Performance indicators (PIs) that
scored well included seizure classification, written seizure care plan and
input from a paediatrician with expertise in epilepsy (all 100%). PIs high-
lighting areas for improvement were the discussion of risk of dying (0%),
risk of SUDEP (1 patient, 5%) and epilepsy syndrome classification
(26%).
Conclusion: CYP with significant neurodisabilities are at increased risk
of having epilepsies and have other complex needs in addition, making
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appropriate assessment and management a clinical challenge. Our audit
identified areas of high quality practice and areas for improvement in
practice, in particular around documentation of important discussions
such as the risk of death and SUDEP. Further data will be presented in
September.
p0702
FAMILYANDADAPTATIONOUTCOMESOF
CHILDRENWITHEPILEPSY: THEROLEOF SEIZURE
CONTROLANDCONDITION SEVERITY
T. Mendes*, C. Crespo†, A. Joan‡
*University of Coimbra, Coimbra, Portugal, †University of
Lisbon, Lisbon, Portugal, ‡University of Indiana, Indianapolis,
IN, USA
Purpose: To compare children in different seizure control (achieved vs.
non achieved) and severity groups (low vs. moderate/high) with regard to
psychosocial and clinical indicators: family functioning, perceived
stigma, adaptation outcomes (health-related quality of life (HRQOL),
psychopathology), and adherence to treatment.
Method: The participants were 196 children (50.5% males;
M = 12.10 years old) with epilepsy and one of their parents (84.7%
mothers), recruited consecutively in three Portuguese neuropaediatric
units. Inclusion criteria consisted of:
(1) epilepsy diagnosis for at least 9 months;
(2) children aged between 8 and 20 years old
(3) absence of significant developmental delays or other non-neurolo-
gic conditions requiring daily prescriptions.
Most of the children (88.3%) were on medication and had achieved
seizure control (65.8%). Children and parents completed questionnaires
on general and condition management related family functioning, per-
ceptions of stigma, HRQOL and psychopathological symptoms. Neu-
ropaediatricians assessed seizure control status, severity of epilepsy and
adherence to treatment.
Results: No differences were found between the two seizure control
groups. Regarding epilepsy severity, results showed that children within
the moderate/high severity group, reported lower levels of HRQOL,
higher levels of psychopathology and perceived stigma, and showed
worse levels of adherence to treatment, in comparison to children within
the low severity group. Parents in the former group also perceived higher
levels of family functioning difficulties related to epilepsy management
and perceived stigma. No interaction effects between severity and control
were observed.
Conclusion: Epilepsy severity, but not seizure control, significantly
influenced the psychosocial indicators assessed. Results suggest that
within neuropaediatric services, a routine assessment of family factors
and children’s adaptation is warranted, especially among children with
more severe epilepsies. Moreover, interventions designed to promote
positive family interactions, tackle family related difficulties regarding
epilepsy management, discuss stigma related issues alongside emotional
and behavioural problems, may lead to improved family and child adap-
tation outcomes.
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ELECTROCLINICAL PREDICTORSOFOUTCOME IN
WEST SYNDROME& ITS RELATIONSHIP TO
TRACTOGRAPHIC ABNORMALITIES
R. Menon, A. Sundar, J.S. Nair, A. Radhakrishnan, B. Thomas,
S. Thomas
SCTIMST, Trivandrum, India
Purpose: To study tractographic abnormalities in West Syndrome (WS)
in relation to electroclinical characteristics and etiology.
Methods: From the prospectively maintained database of an epilepsy
centre in Kerala, India, children with a diagnosis of WS with a minimum
followup of 1 year were selected. In addition to their electroclinico-radi-
ological data, DTI parameters were statistically compared between con-
trol data published in literature and two etiological groups.
Results: Forty-five children with available DTI sequences were included
in the study (19-cryptogenic; 26- symptomatic). Duration of follow up
varied from 14 months–7 years. The two groups were comparable in age
at the time of DTI study, age at onset, spasm frequency, hypsarrhythmia
pattern, developmental quotient at last followup. Sustained seizure free-
dom was noted in 4 patients (21.1%) in the cryptogenic group and 1 in
symptomatic group (3.8%), evolution into LGS in comparable propor-
tions (p = 0.404). ROI based DTI analysis for 4 mm voxels revealed
mean fractional anisotropy (FA) values to be significantly lower over the
pre-frontal regions in cryptogenic group as opposed to symptomatic
group (0.220  0.025 vs. 0.321  0.072)[p = 0.016] corresponding to
increased mean diffusivity (MD in 106 mm2/s;(1469  206 vs.
1204  940[p = 0.024]. No differences were noted in FA, MD values
over the parietal, temporal, occipital white matter, thalamus, putamen,
posterior limb of internal capsule, upper brain stem, and posterior cere-
bellar hemispheres. Both groups demonstrated reduced FA and increased
MD in comparison to age-matched values from literature (p < 0.001) for
all areas except thalamus and internal capsule. No correlation was found
between age at seizure onset, developmental age and spasm frequency
with these values.
Conclusion: The study quantified impairment of white matter integrity
in the subcortical regions in West syndrome, predominating over the
frontal regions in cryptogenic group. These abnormalities could poten-
tially represent an epiphenomenon of epileptogenesis in West syndrome
and can be used in etiological subgrouping as well.
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DISORDERSOFEARLYLANGUAGEDEVELOPMENT
INDRAVET SYNDROME
D. Chieffo, D. Battaglia, S. Lucibello, M.L. Gambardella,
R. Rubbino, G. Ferrantini, G. Leo, E. Musto, E. Albamonte,
C. Dravet, E. Mercuri, F. Guzzetta
Catholic University, Child Neurology, Rome, Italy
Purpose: Aim of the study is investigating DS patients with specific
assessments of language development in the first years of life, in order to
try to highlight mechanisms underlying language disorders and possibly
to provide new tools to improve their outcome.
Method: Thirteen patients with typical findings of Dravet syndrome,
followed in the Child Neurology Unit of Catholic University in Rome
(Italy) were enrolled in the study. Full clinical observation including
neurological examination and long monitoring EEG were serially per-
formed till a maximum of 7 years of life and detailed epileptic history
was collected in each case. Furthermore, development, cognitive and
language assessments were performed with different tests according to
age (Griffiths: WPPSI: WISC III; First language evaluation, Axia
1995; Language evaluation at pre-school age, Cianchetti and Sannio
Fanciello, 2003).
Results: Beside the cognitive decline a characteristic language impair-
ment was found. With a relative preservation of receptive abilities (com-
prehension) and a strong impairment of productive (phonetic and
phonological) skills.
Conclusion: The defect in sensorimotor integration of verbal processing
together with the well known analogue defect of visual processing shapes
a neuropsychological phenotype in DS patients at the beginning of devel-
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opment, highlighting a possible mechanism underlying cognitive decline
and providing information useful to a targeted treatment strategy.
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FOCALEPILEPSY INCHILDRENWITH PERINATAL
BRAIN INJURY
K.Y. Mukhin, M.B. Mironov, K.S. Borovikov, M.Y. Bobylova
Svt. Luka’s Institute of Child Neurology and Epilepsy, Moscow,
Russian Federation
Purpose: Study of focal epilepsy and the effectiveness of its treatment in
patients with the consequence of perinatal brain injury.
Method: We studied 160 patients with focal epilepsy due to perinatal
brain injury. Inclusion criteria: perinatal brain damage, neurological/cog-
nitive deficits, changes on MRI, originating in the perinatal period, focal
epilepsy, non-progressive neurological deficit due perinatal
encephalopathy. All the patients were divided into two groups: I group –
the focal epilepsy of perinatal etiology (FEPE) without Benign Epilepti-
form Discharge of Childhood (BEDC) on EEG (94 cases), II group – the
FEPEwith BEDC on EEG (66 patients).
Results: We analyzed the effectiveness of antiepileptic therapy. Com-
plete remission of seizures was achieved: in the total group in 55.6%
cases; in I group – 35.1%, in patients with FEPE with BEDC on EEG –
84.8%. Reduction of seizure frequency ≥50% was achieved in 31.9% in
the total group; in I group – 43.6% cases, in II group 13.7%. Effect is
not observed in the total group in 12.5%; in I group – 21.3%, in II group –
1.5%.
Conclusion: We consider that patients with FEPE with BEDC on EEG
represents original epileptic syndrome. It is characterized by the follow-
ing features: 1) The SGTCS, hemiclonic and occipital seizures occur
almost always during falling asleep or upon awakening. Usually they are
not frequent and disappear by puberty spontaneously or by treatment, 2)
BEDC on EEG, 3) structural changes in the brain are diffuse cortical atro-
phy, and not a specific focus. For this form of epilepsy, we suggest using
a new term – Focal Epilepsy with Brain Lesion and Benign Epileptiform
Discharges of Childhood.
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EXPERIENCEMEDICALCORRECTIONOF SPEECH
DISORDERS IN CHILDREN
G.M. Musina, R.V. Magjanov
Bashkir State Medical University, Ufa, Russian Federation
Purpose: Estimate the efficiency of the therapy of children0s speech dis-
orders (CSD) depending on more probable leading disfunction of the
neurotransmitter metabolism.
Method: An open non-comparative study of 72 children from 2 to
6 years old was carried out. Their middle age of the initial research was
38 months, with different CSD: senso/motor alalia, variants of disarthria.
Besides the clinical-neurologic examination, the research of genealogical
anamnesis, logopedic testing, the continual video EEG including a day
sleep. The period of observation was from 2 months to 3 years.
Results: 27 (37.5%) children showed epileptic etiology of CSD [Mukhin
K.U.co-auth, 2011 ], the efficiency of treatment was estimated from 24,
three of them refused from the treatment. Antiepileptic therapy in mono
and duo-therapy, gave positive dynamics of development of speech. Out
of 15 (20.8%) children with CSD and concomitant Attention-Deficit/
Hyperactivity disorder, 11 (73.3%) are successfully treated by noradren-
ergic inhibitor of reuptake by Atomoxetine [Aikardi G. 2013], three
refused from the treatment. 21 (29.2%) with “acetylcholine” CSD were
successfully treated with medicines, that had an influence on metabolism
of acetylcholine directly or indirectly. The psychogenic CSD showed to 2
(2.8%), a positive dynamics was found when treating by Thioridazine.
As it was known, the pathology of neurotransmitter system is on the basis
of anxiety-depressive defects, particularly in serotoninergic [Gurieva
V.A. 1996]. The rest of the children have other reasons of CSD: 6 (8.3%)
have autism and 1- surdomutism. They were excluded from the estima-
tion of efficient therapy. Also in 34 (91.9%) of the 37 surveyed identified
CSD from various relatives.
Conclusion: The therapy of CSD from the point of the most probable
leading neurotransmitter disorders is efficient and has good perspectives
in case of lowering of investment in treatment. But it demands the fol-
low-up detailed research and evidence. When making treatment deci-
sions should take into account heredity.
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PERAMPANEL EFFICACYAND SAFETY IN SEVERE
EPILEPTIC ENCEPHALOPATHIES OFCHILDHOOD
M. Nikanorova*, A. Biro†, M. K€olmel*, G. Kluger†,
K. Olofsson*
*Danish Epilepsy Centre, Children Department, Dianalund,
Denmark, †Epilepsy Center for Children and Adolescents,
Sch€on Klinik, Clinic for Neuropediatrics and
Neurorehabilitation, Vogtareuth, Germany
Rationale: To evaluate the efficacy and tolerability of Perampanel
(PER) in children with severe epileptic encephalopathies.
Methods: Twenty children (mean age: 8.2 years, range: 2–15 years,
male: 10) with severe epileptic encephalopathies (EE) have been prospec-
tively followed for 3–24 months since initiation of adjunctive treatment
with Perampanel (PER). EE were classified as Dravet syndrome (n = 2),
Lennox-Gastaut syndrome (n = 5), EE associated with PCDH19 muta-
tions (n = 5), FIRES (n = 1), EE in non-ketotic hyperglycinemia (n = 1)
and EE without known etiology (n = 6). PER doses varied from 2 to
12 mg/d (mean 5.2 mg/d). Three patients dropped out from the study after
1 month (2 - lack of efficacy, 1 - side effects) and were not included into
final evaluation. The clinical efficacy and tolerability have been assessed
in 17 children during the entire study period and at the end of follow up.
Results: The complete seizure control was achieved in 4/17 patients
(23.5%), lasting 17–21 months. More than 50% reduction of seizures
was observed in 10 patients (58.8%), three children (17.7%) experienced
<50% reduction of seizure frequency. PER efficacy was highest in EE
associated with PCDH19 mutations (3/5 - seizure-free, 2/5 - >50% sei-
zure reduction) and Lennox-Gastaut syndrome (4/5 patients - >50% sei-
zure reduction). As regards seizure types, PER was mostly efficacious
against tonic, focal motor and generalized tonic-clonic seizures, whilst
had minimal or no influence on the frequency of myoclonic, atonic sei-
zures and epileptic spasms. Adverse events (tiredness, aggressiveness,
somnolence, vomiting) were reported in five patients (29.5%), mostly
mild-moderate, with remission spontaneously or with decreasing the
PER dosage. The occurrence of adverse events led to PER withdrawal
only in one patient.
Conclusions: These preliminary data suggest that PER may be a thera-
peutic option in childhood EE. Further studies are needed to determine its
syndrome-specific efficacy.
p0710
FEVER IN THEONSETOF PANAYIOTOPOULOS
SYNDROME: UNDERRECOGNIZED TRIGGER
V. Nogovitsyn*, I. Savkina†, A. Troitsky†, A. Golovteev‡
*European Medical Center, Moscow, Russian Federation,
†Kazaryan Clinic of Epileptology and Neurology, Moscow,
Russian Federation, ‡Burdenko Neurosurgical Institute,
Moscow, Russian Federation
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Purpose: To assess the prevalence of fever-triggered seizure onset of
Panayiotopoulos syndrome, to emphasize the lack of rapid diagnosis in
these cases, and to clarify prognostic role of fever in the onset of PS.
Method: Thirty five patients with PS aged from 2 to 10 years were
included in this retrospective study, divided into two groups: with febrile
onset (FO) and afebrile onset (AO). Age, seizure types, prevalence of sta-
tus epilepticus, history of febrile seizures, precipitating factors were stud-
ied. All patients were followed up for 2–5 years to establish the
remission.
Results: We identified 12 patients with PS whose first seizures were
observed during fever episode (34%). The mean age of onset in this group
was 4.5 years, compared to 6 years in AO group. Seizure semiology was
similar in both groups (mostly versive and autonomic). Status epilepticus
was seen in 58% in FO group and (52%) in AO group. Two children in
FO group and three children in AO group had simple febrile seizures
before the occurrence of PS. Fever was associated with respiratory infec-
tions, urinary tract infections and in one patient seizure was precipitated
by overheating during sunbathing. Correct diagnosis at onset was made
only in three patients in FO group and in 65% in AO group. The most
common false diagnosis were encephalitis and meningitis (nine patients),
gastroenteritis (one patient), migraine (one patient) and intoxication (one
patient). Remissionl was achieved in all children.
Conclusion: Fever triggered seizures in 34% of new-onset seizures in
PS. There is a tendency to earlier age of seizure onset in patients with
fever trigger. Long term prognosis and clinical course were similar in
both groups. Our study showed no link of febrile seizures with prognosis
in Panayiotopoulos syndrome. Misdiagnosis is quite common in cases of
febrile onset seizures in PS.
p0712
MYOCLONIC EPILEPSYOF INFANCY: PHARMACO-
RESPONSIVE BUTWITHRISKOF
NEUROPSYCHOLOGICAL IMPAIRMENT
H.-T. Ong*,†, K.J. Lim†, P.S. Low*,†, S.K. Tay*,†
*Khoo Teck Puat-National University Children’s Medical
Institute, National University Health System, Singapore,
Singapore, †Yong Loo Lin School of Medicine, National
University of Singapore, Paediatrics, Singapore, Singapore
Purpose: Myoclonic epilepsy of infancy (MEI) accounts for <1% of all
epilepsies, with approximately one case in 40 000 children. Although
previously termed “benign”, the risk of adverse neuropsychological out-
comemay be higher followingMEI despite adequate seizure control.
Method: We retrospectively reviewed our patients with MEI, who were
neurodevelopmentally normal at the time of diagnosis. All 11 patients
had the diagnosis confirmed with generalized spike-waves or polyspike-
waves, together with epileptic myoclonic jerks that were recorded on
video-EEG and surface muscle electrodes, in the presence of normal
background for age.
Results: The onset of seizures was between 8 months and 3.5 years.
Two patients had prior history of febrile seizure. Two had family history
of epilepsy. During the EEG recording, photosensitivity was demon-
strated in four patients (36%). Seizure control was achieved in nine
patients with monotherapy using valproic acid at a dose range of 20–
50 mg/kg/day. Two others required the addition of levetiracetam to
achieve seizure control. In eight patients who were successfully weaned
off all medications and remained seizure-free for more than 4 years, two
has attention deficit hyperactivity disorder (inattentive type), one has
dyslexia, and one has central auditory processing deficit.
Conclusion: Although MEI is generally associated with good prognosis,
the neuropsychological and behavioral outcome may be less favourable,
as is suggested by our case series. This may occur despite early treatment
and good seizure control, indicating that other factors play important
roles affecting the neuropsychological outcome.
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THEMEDIATING EFFECTOFDISTRESS IN THE
RELATIONSHIP BETWEEN ILLNESS PERCEPTIONS
ANDQUALITYOF LIFE IN ADOLESCENTSWITH
EPILEPSY
I. Rizou*, A. Soureti†, A. Papavasiliou‡
*General Hospital of Athens ‘G. Gennimatas’, Child Psychiatry
Department, Mental Health Center, Athens, Greece, †Medical
Center of Hellenic Police, Athens, Greece, ‡Pendeli Children’s
Hospital, Child Neurology, Athens, Greece
Purpose: The link between illness perceptions (IP), distress and Quality
of Life (QoL) in adolescents with epilepsy remains inadequately investi-
gated. We aimed to explore the mediating effect of distress in the rela-
tionship between IP and QoL.
Methods: Interviews using the KIDSCREEN-27 Questionnaire, the
Brief Illness Perceptions Questionnaire and the Revised Children0s Anxi-
ety and Depression Scale were conducted in 100 patients (Mage = 13.9,
SD = 2.21.41% girls). A mediation analysis was performed.
Results: Most patients (91%) were well controlled on antiepileptics; 3%
had infrequent seizures; 6% were pharmacoresistant. There was a signifi-
cant negative association between IP and QoL (b = 0.27, P < 0.001)
and a significant negative relationship between distress and QoL
(b = 0.47, P < 0.001). The relationship between IP and distress was
significant (b = 0.39, 95% CI: 0.79; 0.91). Results from bootstrapping
showed a significant mediation effect of distress on QoL (b = 0.08,
CIBCa: 0.25; 0.13). The relationship between IP and QoL remained
significant after including the mediator (b = 0.18, P < 0.05).
Conclusion: Threatening perceptions regarding epilepsy were associ-
ated with worse QoL. When distress was added in this relationship it
acted as a partial mediator. Our findings highlight the importance of
self-reported psychological distress in the relationship between IP and
QoL.
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EFFECTSOF TOPIRAMATEONEPILEPTIFORM
DISCHARGE INHIPPOCAMPAL SLICEOF
IMMATURERAT
S.Y. Park*,†, J.E. Lee*, J.Y. Han†, I.G. Lee*, S.Y. Jung†,
T.H. Um†, J.H. Bin†, Y.H. Kim†
*Seoul St. Mary Hospital, Seoul, Republic of Korea, †Catholic
Medical College, Seoul, Republic of Korea
Purpose: Mechanism of Topiramate is not understood very well and
optimal dose of efficacy in animal models is not determined yet. In order
to elucidate the action mechanism and optimal concentration of TPM, we
observed ictal and interictal discharges from immature-rat-hippocampal-
slices in Mg2+-free, 4-aminopyridine (AP) added artifical-CSF with vari-
ous-TPM-concentration.
Method: We divided rats into 5-groups, control-group (n = 12), 4TPM-
groups; divided by concentration of TPM, 6 (n = 11), 20 (n = 7), 60
(n = 10) and 200 (n = 14) lM. Brains were cut into 400 lm-hippocam-
pal-slices. Slices of control-group were soaked in 200 lM 4-AP added
Mg2+-free, then extracellular recordings were performed in hippocampal
CA1-pyramidal-region. Slices of TPM-groups were soaked in solution
containing 6, 20, 60, 200 lM.
Results: 1) Interictal-discharges were observed in control-group and
6, 20 lM- group but frequency was decreased as concentration of
TPM increases, 90% in 60 lM-group, and 35.7% in 200 lM-group.
Amplitude of TPM-group was much smaller than control-group.
Latency to first interictal-discharge after 4-AP addition was 52.7
second in control-group, but was 290.2 second in 60 lM-group,
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568 second in 200 lM-group. Duration of interictal-discharge was
64.6 second in control-group, but was prolonged to 141 second in
60 lM-group.
2) Ictal-discharges were observed in control-group and 6 lM-group,
but frequency was decreased as concentration of TPM increases, 55.6%
in 60 lM, 28.6% in 200 lM group. Amplitude of TPM-group was much
smaller than control-group. Latency to ictal-discharge after 4-AP addi-
tion was 141 second in control-group, but increased as concentration of
TPM increases, 431.8 second in 60 lM, 627.8 second in 200 lM-group.
Duration of ictal-discharge was 1534.7 second in control-group, but
decreased as concentration of TPM increases, and the-shortest in 60 lM-
group, 155.2 second.
3) Status-epilepticus was seen in 58.3% of control-group and 27.2% of
6 lM-group.
Conclusion: TPM suppresses the frequency, latency, and duration of
epileptiform discharge induced by Mg2+-free, 4-AP added artificial-CSF
in immature-rat-hippocampal-slices, starting from 20 lM-concentration
and reaching maximal effect at over-60 lM. This finding is presumably
due to TPM enhancing of GABA-receptor currents and/or K+ channel
conductance in response to TPM.
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UNIQUEANDRARE SEMIOLOGIES: ICTAL SMILE
ANDGELASTIC SEIZURES
T. Hirfanoglu, Z.Öztürk, A. Serdaroglu, İ. Capraz, E. Bilir,
G. Kurt,Ö. Akdemir,Ö. Kapucu, M. Ucar, Y.Öner
Gazi University, Ankara, Turkey
Purpose: Gelastic seizures are characterized by epileptic laughter and
have most commonly been associated in patients with hypothalamic
hamartomas. Although, different localizations have been reported includ-
ing temporal, frontal and parietal lobes. Ictal smile is an uncommonman-
ifestation which presents a tonic deviation of the mouth or other tonic-
clonic movements and it is localized on temporal, parietal and frontal
regions and lateralized more frequently to right hemisphere. This case
series were performed to analyze the different localizations and lateral-
izations of gelastic and smiling seizures.
Method: We investigated gelastic and smiling seizures from Gazi
University School of Medicine Pediatric Video-EEG Monitoring Unit
between 2011–2014 as retrospectively. Detailed seizure semiology, EEG
and neuroimaging were evaluated.
Results: Ten children (6–15-yer-old) were found having either gelastic
or smiling seizures. 6 of 10 patients had ictal smile, four patients had
gelastic seizures. Among the patients with gelastic seizures, the epileptic
foci were located in the hypothalamus as hamartoma (four patients). In
patients with ictal smile, the localization of the epileptogenic region
revealed FCD in left frontal lobe, dysembryoplastic neuroepithelial
tumor in right orbitofrontal, FCD in left cingulat, FCD in left supra-
marginal gyrus, pachygyria-heterotopia in left hemisphere and one
patient had unknown origin.
Conclusion: Gelastic seizures and ictal smiles are unique and rare semi-
ology. All our patients with gelastic seizures had hypothalamic hamar-
tomas. Ictal smile may originate from frontal lobe, cingulate gyrus and
supramarginal gyrus. Beyond right hemispheric involvement, we found
left hemisphere may also be responsible for ictal smile different from the
current literature. As supported our findings, the differential diagnosis of
gelastic and smiling seizures require detailed electrophysiological, radio-
logical and pathophysiological work up especially in case of non lesional
patients.
p0716
COBALAMINCDEFICIENCYWITH INFANTILE
SPASMANDCUTANEOUS FINDINGS: A UNIQUECASE
Z.Öztürk*, E. Arhan*, K. Aydın*, İ. Okur*, L. Tümer†,
A. Serdaroglu*, T. Hirfanoglu*, Y. Akbaş*, C. Havalı*
*Gazi University, Ankara, Turkey, †Gazi University Faculty of
Medicine, Ankara, Turkey
Introduction: Cobalamin C (cblC) deficiency is a rare disorder of vita-
min B12 metabolism which results from impaired conversion of both its
active forms methylcobalamin and adenosylcobalamin. Early onset cblC
deficiency typically presents in the first year of life with hypotonia,
lethargy, seizures, microcephaly, hydrocephalus, developmental delay
and other multisystem involvement including hematologic, ocular, renal,
hepatic and cardiac sypmtoms. We report a case of a female infant with
cblC deficiency who presented with seizures,developmental delay and
hypopigmented cutaneous lesions.
Case: A 4-month old previously healthy, female infant born to non-con-
sanguineous parents was referred to our pediatric neurology department
with one month history of loss of eye contact and smile. She also had
failure to feeding,slowing of movements and spasms .She was lethargic,
pale and hypotonic. On physical examination,her weight and head cir-
cumference were below the 10th percentile, there were hypopygmented
macules in her chest, arm and abdomen. MRI of the brain showed sig-
nificant cerebral atrophy and delay of myelinization. Urine methyl
malonic acid level was 4923 mmol/mol cr (0), plasma homocystein
109 lmol /l (5–14),significantly elevated and methionine was 9 Umol/
L,(9–29) low. Genetic testing revealed a single copy of a previously
identified pathogenic mutation, c.394 C>T, in the MMACHC gene and
confirmed a diagnosis of a cblC deficiency. After treatment her mental
status improved and seizures were controlled with antiepileptic drug
therapy.
Conclusion: In conclusion, any infant presenting with seizures,
developmental delay and cutaneous findings, disorders of cobalamin
metabolism should be considered in differantial diagnosis and the
role of cblC deficiency should be identified in aetiology of skin
pigmentation.
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PHARMACO-RESISTANT EPILEPSY INCHILDREN
WITHNEONATALHYPOGLYCEMIA
Z.Öztürk, E. Arhan, A. Serdaroglu, K. Aydın, T. Hirfanoglu,
Y. Akbaş
Gazi University Faculty of Medicine, Ankara, Turkey
Purpose: To report on long-term clinical course in patients with symp-
tomatic epilepsy secondary to neonatal hypoglycemia.
Method: We retrospectively reviewed the medical records of patients
with neonatal hypoglycemia who have been followed at Gazi University
Faculty of Medicine Pediatric Neurology Department between 2008–
2014. Patients with perinatal asphyxia were excluded. Thirty three
patients (range 6 months–15 years) with a history of neonatal hypo-
glycemia were included the study.
Results: Epilepsy developed in 24 (%72) patients and 14 of them had
intractable epilepsy. Other neurologic problems included neurodevelop-
mental delay (n:21), autism spectrum disorders (n:3), microcephaly (n:4)
and visual disturbance (n:4).Two patients did not have any neurological
disability during follow-up. Two of 14 patients with intractable seizures
had hyperinsulinism. Their seizures have been controlled after pancreate-
ctomy. Two patients had vagal nerve stimulator and showed a partial
response to treatment.
Conclusion: Our findings demonstrate that neonatal hypoglycemia can
influence neurodevelopmental outcome and epilepsy secondary to
neonatal hypoglycemia is mostly intractable during childhood. They
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show poor response to antiepileptic drug therapy. Therefore, early diag-
nosis and treatment of neonatal hypoglycemia can prevent future neuro-
logical sequelae and may prevent drug resistance.
p0718
CLINICALAND IMAGINGCORRELATESOF EEG
PATTERNS IN PEDIATRIC PATIENTSWITHACUTE
ENCEPHALOPATHY
E. Arhan, Y. Akbaş, A. Serdaroglu, K. Aydın, T. Hirfanoglu,
Z.Öztürk
Gazi University School of Medicine, Ankara, Turkey
Purpose: We aimed to study the relationship between clinical, electro-
physiological and imaging findings of pediatric patients with acute
encephalopathy.
Method: Electroencephalographic reports of children from January
2012 to march 2015 were retrospectively analyzed at Neurophysiology
Laboratory, Department of Pediatric Neurology at Gazi University
Medical Faculty. All electroencephalograms (EEGs) consistent with
encephalopathy between January 2012 and March 2015 were identi-
fied. Clinical and imaging data were collected from charts of patients
with encephalopathy. EEGs were classified according to five prede-
fined patterns: Isolated continuous slowing of background activity
(theta, theta/delta and delta activity) and patterns with slowing back-
ground activity with episodic transients [i.e., triphasic waves (TWs) or
frontal intermittent delta activity (FIRDA)]. Clinical characteristics,
type and frequency of the disorders and neuroimaging data were docu-
mented.
Results: We identified 37 EEGs consistent with encephalopathy pat-
tern from a total of 5125 EEGs. EEGs were performed because of a
history of altered mental status, seizure, headache. Three patients had
encephalopathy due to encephalitis, one due to limbic encephalitis.
One patient has ADEM. One of the patients had recurrent
encephalopathy periods and was diagnosed with H1N1 associated
RANBP2 mutation. Three patients had hepatic encephalopathy. One
patient had a vasculopathy due to varicella infection. Two patients had
head trauma. The theta pattern was present in 18.6% of patients,
27.1% had theta/delta, 10.2% delta, 3.4% TWs, and 3.4% presented
with FIRDA. The most common imaging abnormalities were oedema
(15.3%), white matter changes (66%), brain atrophy (7.5%). Theta was
associated with brain atrophy, theta/delta with infectious and metabolic
disorders, FIRDA with otoimmun encepahlitis, TWs with liver or renal
failure.
Conclusion: In encephalopathic patients, well-defined EEG patterns are
associated with specific pathological conditions, suggesting that mecha-
nistic hypotheses underlie these abnormal EEG patterns and these pat-
terns can be correlated to cerebral imaging findings.
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EXPRESSION PATTERNSOFMICRORNAS -146A, -34A,
-132, -134 AND -184 IN PEDIATRIC EPILEPSY
PATIENTS
İ. Polat*, M. Ayanoglu*, U. Tüfekci†, Ş. Genc†, U. Yiş*, S. Hız
Kurul*
*Dokuz Eylül University, Department of Pediatrics, Division of
Child Neurology, Izmir, Turkey, †Dokuz Eylül University,
Department of Neuroscience, Izmir, Turkey
Purpose: Epilepsy is one of the most common brain disorder in children.
Dysregulation of immunologic and inflammatory systems have been con-
sidered to play role in the pathogenesis of epilepsy. The regulation of
these systems has been shown to be related to microRNAs. MicroRNAs
are small non-coding RNAs which have been known to be an important
controller of post-transcriptional gene expression. The aim of this study
is to investigate the expression patterns of microRNA-34a, -132, -134,
-146a and -184 in peripheral blood mononuclear cells of patients with
drug-resistant and drug-controlled epilepsy.
Method: We enrolled 49 epilepsy patients (25 drug-controlled, 24 drug-
resistant) and 24 healthy control subjects. Quantative analysis of micro-
RNAs were performed using specific stem loop primers followed by real-
time polimerase chain reaction.
Results: Fourty-nine epilepsy patients (mean age 11.00  4.36) and 24
healthy controls. The expression levels of microRNA-34a and -184 were
significantly decreased in epilepsy patients as compared to control sub-
jects (0.79  0.69 vs. 1.07  0.45, p = 0.000; 0.60  0.45 vs.
1.44  1.31, p = 0.000). There was no significant difference between
epilepsy and control groups regarding expression levels of microRNA-
132, -134 and 146a. The patients who were mentally deficient had signifi-
cantly lower microRNA-146a, -132, -184, -134 expression levels
(p = 0.001; p = 0.026; p = 0.004; p = 0.009). The patients with motor
deficiency had significantly lower microRNA-146a expression levels
(p = 0.043).
Conclusion: MicroRNAs are emerging key controllers of gene expres-
sion which may play role in epileptogenesis. There are conflicting reports
about the effects of microRNAs in pediatric epilepsy patients. Alterations
of microRNAs may shed new light on pathogenesis and new treatment
choices in pediatric epilepsy patients.
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EFFECTIVENESS OFMETHYLPREDNISOLONEAND
DIAZEPAMFORCONTINUOUS SPIKEWAVES
DURING SLOWWAVE SLEEP
İ. Polat, M. Ayanoglu, U. Yiş, S. Hız Kurul
Dokuz Eylül University, Department of Pediatrics, Division of
Child Neurology, Izmir, Turkey
Purpose: Epilepsy with continuous spike-waves during slow wave sleep
(CSWS) is an age related condition characterized by heterogeneous sei-
zure types, neuropsychological and behavioral impairment and a typical
EEG pattern that shows “significant activation of epileptiform discharges
by sleep”. We describe a patient with CSWS who had been previously
diagnosed as benign childhood epilepsy with centrotemporal spikes
(BCECTS). She benefited well from combination of steroid and diaze-
pam.
Case report: This 7.5-year-old girl was born at 37 weeks with no peri-
natal problem. Her psychomotor development was appropriate for her
age. She had been previously diagnosed BCECTS when she was 5-years-
old and was treated with levetiracetame and carbamazepine. She had fre-
quent hemiclonic seizures involving right side of the body with jerking of
eye lids, mouth and upper limb during the sleep. EEG revealed left fron-
tocentrotemporal spikes which became more frequent during sleep. We
ended levetiracetame due to side effects; and ended carbamazepine
because of worsening of EEG discharges during sleep. Her seizures
stopped with combination of valproic acid and clobazam. After one sei-
zure-free year, she was admitted with ataxia, right hand weakness and
deterioration of cognitive functions. EEG demonstrated pattern of contin-
uous spike and wave during slow wave sleep. She did not response to
sulthiame treatment and she was started methylprednisolone and high
dose diazepam. After 2 weeks, dramatic improvement in clinical and
EEG findings were observed. Methylpredisolone and diazepam was
tapered at 3th month of the medication and outpatient follow up showed
sustained improvement.
Conclusion: The current case showed that combination of methylpredis-
olone and diazepam is an effective treatment for continuous spike and
wave during slow wave sleep related to BCECTS.
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EXPERIENCE FROMAFIRST SEIZURECLINIC FOR
CHILDREN: ALL THAT SEIZES IS NOT EPILEPSY
A.N. Prasad*,†,‡, E.G. Mazza§, S. Levin*, M. Devries-rizzo§,
R. Hicks§, P. Geurtjens§, C. Campbell*
*Children’s Hospital, London Health Sciences Centre,
Pediatrics and Clinical Neurosciences, London, Canada,
†Western University, Pediatics, London, Canada, ‡Child Health
Research Institute, Pediatrics and Clinical Neurosciences,
London, Canada, §Children’s Hospital, London Health Sciences
Centre, Pediatrics, London, Canada
Purpose: Report on the experience of a first-seizure clinic for children
(Birth to 16 years) based on a triaging system to reduce wait times for a
neurological assessment.
Method: We established and implemented a triaging system with the
aid of a Nurse Case Manager. An early telephone interview with fami-
lies upon receipt of referral by the Nurse. Coordinator enabled the neu-
rologist with information to apply the triaging system on a case-by-
case basis. Objective outcome measures included; wait times for evalu-
ation, investigations, return visits, discharge as well as final diagnoses
established.
Results: A total of 368 referrals received during the period of study.
There were 186 males and 182 female participants. The triaging sys-
tem helped reduce wait times from a mean of 179 days (38–312 days)
in the pre-study period to a mean of 88 days (5–239 days) during the
study. Age ranges of patients (n) included: 1–5 years (85), 6–10 years
(96), 11–15 years (80), 16–20 years (107). Only 159 (43%) patient
referrals to the program were actually diagnosed with epilepsy, 24
(7%) with a single or first epileptic seizure, while 140(38%) patient
referrals were given an alternate diagnosis. Eleven % of referrals
missed or cancelled appointments, 1% could not be given a specific
diagnosis within the time frame of the project. Conditions presenting
as a first seizure in children included; syncope with reflex anoxic sei-
zures (12%) psychogenic non-epileptic seizures (PNES 10%). Anxiety
disorder (3%), breathholding spells (2%), behavioral inattention (3%),
tics (3%), GE reflux (1%), sleep disorders (1%), migraine and
migraine equivalents (2%), while narcolepsy, jitteriness, cyclical vom-
iting, congenital nystagmus, and spasmus nutans made up the remain-
der (n of 1 each).
Conclusion: Over a third of new patient referrals to the First Seizure
Clinic did not to have epilepsy. A search for alternative diagnosis in first
seizure presentations by referring physicians could reduce referral vol-
umes and wait times for patients with epilepsy.
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CLINICALCLASSIFICATIONOF INFANTILE SPASMS
USINGVIDEOEEGFOR INITIALDIAGNOSIS: TO
HAVEHYPSARRYTHMIAWILL BEWORSE
PROGNOSIS?
M.F. Rios Pistoia, M. Avesrastury, B. Comas, N. Espinosa,
W. Silva
Universidad de Buenos Aires, Buenos Aires, Argentina
Purpose: To classify the video EEGs with IS according to the Delphi
West group classification and analyze outcome.
Method: Observational retrospective study that included 33 video-EEGs
of infants with IS, performed between January 2010 and December 2014.
To simplify the analysis, we grouped West with HWIS (hypsarrythmia)
and ISSVwith IS (without Hypsarrythmia).
Results: The median of age was 6.1 months, 18 (%) were female.
According to the classification, we observed: 19 (57.57%) had West, 2
(6.06%) HWIS, 6 (18.18%) ISSV and, 6 (18.18%) IS cluster without
hypsarrythmia. Twenty four patients had symptomatic epilepsy and
seven cryptogenic. EEG findings: 21 (63.6%) presented hypsarrythmia,
27 (81.81%) multifocal paroxysms and 6 (1.81%) unifocal paroxysms.
17 of the 21 (80.95%) patients with hypsarrythmia, had symptomatic
epilepsy. Two patients were lost to follow-up, so we analyzed 31
patients. 8 (25.8%) were preterm. 23 (74.2%) had a normal neurologi-
cal exam before seizures started, but 15 (49.5%) worsened or acquired
developmental delay. One patient died. The median duration of the
spasms was 4 months (IQR 1.5–9), 5.56 months in patients with hyp-
sarrythmia and 3.83 months in patients without hypsarrythmia. When
we analyzed oucome, we observed that; 10/31 developed a refractory
epilepsy. Of this subgroup, 7/10 had symptomatic epilepsy and 5/10
hypsarrythmia. Five of the twelve patients that lost patterns neurode-
velopmental in the moment to diagnosis (=12 patients/5 had not nor-
mal exam previously): 10 had hypsarrythmia and not have exam
before the spasms started.
Conclusion: In our population, we observed a higher prevalence of
patients with hypsarrytmia. We found that hypsarrythmia itself is not a
predictor of refractory epilepsy, as if it would be the symptomatic etiol-
ogy. The duration of infantile spasms would be higher in patients who
associate hypsarritmia.
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LACOSAMIDE POPULATION PHARMACOKINETICS
IN CHILDREN FROM 6MONTHS TO 17 YEARSOFAGE
J. Winkler*, R. Schoemaker*, A. Stockis†
*SGS Exprimo, Mechelen, Belgium, †UCB Pharma, Braine-
l’Alleud, Belgium
Purpose: Lacosamide is approved as monotherapy (USA only) and
adjunctive therapy of partial-onset seizures in adults with epilepsy
(maximum maintenance dose of 400 mg/day). The purpose was to
develop a pediatric population pharmacokinetic model for lacosamide
considering the effects of demographic variables and concomitant
antiepileptic drugs, and perform simulations supporting pediatric dos-
ing adaptations.
Methods: Two studies (SP0847, SP1047) were conducted in children
with epilepsy in which sparse plasma samples were collected for
lacosamide determination. A population pharmacokinetic model was
developed using the nonlinear mixed effects method. The structural
model had a single compartment with first order absorption and elim-
ination. Plasma clearance was modelled using allometric scaling on
body weight with a freely estimated allometric exponent, while vol-
ume of distribution (V) used a fixed theoretical allometric exponent.
Residual error was modelled using additive and proportional error
terms.
Results: Lacosamide plasma concentration-time data (n = 402) were
available from 79 children, with a balanced distribution of 14, 22, 25, and
18 subjects in age groups 6 months to <2 years, 2 to <6 years, 6 to
<12 years, and 12 to <18 years, respectively. Body weights ranged from
6–76 kg. Covariate search did not evidence significant effects for race,
sex, age, renal function or co-administration of valproate on lacosamide
plasma clearance, but an increase by co-administration of carba-
mazepine, phenobarbital and phenytoin was observed. Different pediatric
dosing adaptations were simulated with the aim of reaching the range of
concentrations obtained in adults receiving lacosamide 400 mg/day. This
was achieved with a dosing scheme of 12 mg/kg/day in children weigh-
ing <30 kg, 8 mg/kg/day from 30 to <50 kg, and 400 mg/day in children
weighing ≥50 kg.
Conclusion: A population pharmacokinetic model was developed that
adequately describes the plasma concentration of lacosamide in children.
Weight-based dosing adaptations could be selected to guide subsequent
pediatric development. UCB Pharma-Funded.
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RIGHT SELECTIVEHIPPOCAMPECTOMYAND
PERSISTENTGENITALAROUSALDISORDER
H.O. Dede*, C. Gurses*, E. Ertekin†, N. Bebek*, B. Baykan*,
A. Gokyigit*
*Istanbul University Istanbul Faculty of Medicine, Neurology,
Istanbul, Turkey, †Istanbul University Istanbul Faculty of
Medicine, Psychiatry, Istanbul, Turkey
Introduction: Persistent Genital Arousal Disorder (PGAD) refers to the
experience of persistent sensations of genital arousal that are unpro-
voked, intrusive and unrelieved by one or several orgasms. It is often mis-
taken for hypersexuality since PGAD often results in a high frequency of
sexual behaviour. At present little is known with certainty about the etiol-
ogy of this condition.
Case presentation: We describe a 37 year-old single woman with typi-
cal PGAD symptoms. She had had drug resistant temporal lobe epilepsy
for 17 years until right hippocampectomy because of right mesial tempo-
ral sclerosis. After 6 years from the surgery, she had obsessive compul-
sive neurosis and hypersexuality. These persistent feelings of sexual
excitation were not associated with epileptic (ictal) sexual manifestation.
There was no epileptic abnormality in her EEGs and she had no seizures
after the surgery. She is still on oxcarbazepine 900 mg/day. The patient’s
symptoms resolved briefly after psychotherapy and risperidon 2 mg/day,
paroxetine 30 mg/day treatment.
Conclusions: PGAD can be tremendously distressing, adding signifi-
cant burden onto a woman who may already be suffering from anxiety.
The proposed etiologies of PGAD are plentiful and may involve a
range of psychological, pharmacological, neurological, and vascular
causes. Our aim is to discuss and draw attention to PGAD following
epilepsy surgery. Successful treatment requires a multidisciplinary
approach and consideration of all reversible causes as well as cognitive
therapy.
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EMOTIONALAFFECTIVEDISORDERS IN ELDERLY
PATIENTSWITHPOST-STROKEEPILEPSY
A.K. Druzhinin, V.A. Mikhailov, L.V. Lipatova
St. Petersburg V.M. Bekhterev Psychoneurological Research
Institute, St. Petersburg, Russian Federation
Introduction: Ninety six patients post-stroke sequelae were studied. In
55 patients, the course of disease was complicated by symptomatic epi-
lepsy.
Study objectives: To study the structure of non-psychotic mental disor-
ders in elderly patients with post-stroke epilepsy and to assess the impact
of the disorders on the patients’ quality of life.
Materials and methods: Two patient groups (96 persons) were studied.
Group 1 (55 patients: 31 men 24 women) included patients whose stroke
was complicated by the development of epilepsy; Group 2 (41 patients:
21 men and 20 women) included post-stroke seizure-free patients. The
average age in Group 1 was 63.0  2.0 years; in Group 2:
62.5  2.5 years.
Results: The leading symptoms were depressive and anxiety disorders:
depression was found in 68.96% of the patients with epilepsy and in
21.4% of the seizure-free patients, whereas anxiety disorder was found in
21.4% and 64.3% of the patients, respectively. Average scores in Group
1 and Group 2 on the BDI scale were 34.81  2.73 and 28.57  3.07,
respectively; on the HRDS scale, 21.84  1.50 and 13.79  1.36
(p ≤ 0.01), respectively. The Global Severity Index (GSI) in Group 1 and
Group 2 was 1.21 and 0.70, respectively. Quality of life (QL) indices
were significantly lower in the patients with epilepsy. According to the
QOLIE-31, the overall scores QL in Group 1 was 82.27, which is lower
than the norm (p < 0.001). A comparative analysis of SCL-90-R and
QOLIE-31 constructs has provided us with findings on the impact of psy-
chopathological factors on the QL domains.
Conclusion: The peculiarity of psychopathological syndromes in elderly
patients with post-stroke epilepsy consists in the predominance of depres-
sive disorders over anxiety. The clinical manifestations of psychopatho-
logical symptoms correlate with the indices of QL domains. Emotional
affective disorders play an important role in the formation of the QL of
elderly patients with epilepsy and require additional rehabilitation inter-
ventions.
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NON-EPILEPTIC PSYCHOGENIC SEIZURES IN
EPILEPSY PRACTICE
A. Erdal*, F. Genc*, E. Uygur*, Y. Bicer G€omceli*, G. Kutlu†
*Antalya Research and Training Hospital, Neurology, Antalya,
Turkey, †Mugla SK University School of Medicine, Neurology,
Mugla, Turkey
Purpose: Non-epileptic psychogenic seizure (NEPS) is a condition
which is frequently encountered in epilepsy practice, composes differen-
tial diagnosis and treatment problems. In this study, we searched NEPS
incidence in the patients with epilepsy diagnosis who are directed to our
epilepsy department that is a tertiary healthcare center.
Method: Thousand hundred and fourty patients who were followed in
epilepsy department of neurology clinic in Antalya Training and
Research Hospital between July 2011 and January 2015 were examined
retrospectively. All patients with NEPSwere recruited into the study.
Results: Total 70 patients were examined; 54 of them were female
(77.1%) and 16 of them were male (22.9%). The age average was 35.49;
the youngest one of patients was 18 years old and the eldest one was
74 years old. Average epilepsy terms were 12.38  11.38 years. There
were 24 patients having only NEPS (34.3%) and 46 patients having com-
bination of epilepsy and NEPS (65.7%). While 43 (61.4%) of the patients
used antidepressant, 6 (8.6%) patients did not use any antiepileptic, 35
(50%) patients took antiepileptic monotherapy, 29 patients (41.4%) took
antiepileptic polytherapy. The diagnosis of NEPS was established in 8
(11.4%) patients in clinic, in 32 patients (45.7%) with induction EEG, in
24 patients (34.3%) with history, in 6 patients (8.6%) with video EEG
monitorization. When educational levels were examined, it was noted
that 1 (1.4%) patient took private education and 10 (14.3%) patients grad-
uated from the university.
Conclusion: The most important stage in diagnosis of non-epileptic psy-
chogenic seizures is the formation of clinical suspicion. It should be defi-
nitely taken into account that non-epileptic psychogenic seizures
accompany with actual seizures. NEPS should be definitely kept in mind
in patients who were diagnosed with epilepsy, for whom antiepileptic
treatment was started and refractory epilepsy was considered.
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BEHAVIOURAL FEATURESOF PATIENTSWITH
PSYCHOGENIC NON-EPILEPTIC SEIZURES (PNES)
C. Helmstaedter, J.-A. Witt, V. Vogt, C.E. Elger
University Clinic Bonn, Epileptology, Bonn, Germany
Purpose: This retrospective study in patients with nonepileptic sei-
zures (PNES), with epilepsy (PWE), and both conditions (PNES+PWE)
evaluated whether the groups can be differentiated by use of a German
clinical personality questionnaire (FPZ), which is routinely used in
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epilepsy and which originally had been designed for patients with CNS
pathologies.
Method: Groups of 58 PNES, 207 PWE and 70 PNES+ were selected
and evaluated on the basis of having answered a questionnaire on person-
ality (FPZ) which assesses Neuroticism, Organic psycho syndrome,
Intra/extra-version, and Addiction via 22 sub-scales with 98 questions.
Subgroups had received neuropsychological testing and additional scales
for depression (BDI), anxiety (SAS), and quality of life (German modi-
fied QOLIE-10)
Results: All questionnaires indicated greater behavioural problems in
PNES and PWE+ as compared to PWE. A profile with greater emotional
lability and aspects of an organic psychosyndrome was indicated in
PNES. PNES patients showed a trend of more frequent somatisation,
poorer reward learning, greater impulsivity, and communication prob-
lems when compared to PNES+. Cluster analysis of the FPZ revealed 4
clusters, two being associated more with epilepsy, (Cl1. mild psycho-
syndrome and depression, CL3. emotional stable and non-depressed),
two being associated more with PNES (Cl2. strong neuroticism, psy-
chosyndrome, and depression CL4. neuroticism and not depressed). Cog-
nitive problems were indicated in each group with a non-significant trend
to be poorest in PNES+.
Conclusion: Patients with PNES and PNES+ share common behavioural
features with increased neuroticism and behaviours reminding of a
fronto-medial dysfunction. Cluster analysis identifies clinical subgroups
which may turn out to have a different aetiology or prognosis. A prospec-
tive study taking this as well as seizure semiology into consideration has
been initiated.
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DEPRESSION IN PERSONSWITHEPILEPSY:
RELATEDTO PERCEPTIONOFADVERSE EFFECTS
ANDADHERENCE?
O.J. Henning*, M.A. Mevag†,‡, A. Villagran*,
S.I. Johannessen*,§, C. Johannessen Landmark*,‡,§
*Oslo University Hospital, National Center for Epilepsy,
Sandvika, Norway, †South-East Norway Pharmaceutical Trust,
Oslo, Norway, ‡Oslo and Akershus University College of
Applied Sciences, Oslo, Norway, §Oslo University Hospital,
Dept of Pharmacology, Oslo, Norway
Purpose: Depression has a high impact on quality of life and might
affect factors for a successful treatment with antiepileptic drugs (AEDs)
as adverse effects and adherence. The purpose of this study was to inves-
tigate the correlation between symptoms for depression and patients’ per-
ception of adverse effects and adherence.
Method: Prospective data from an anonymous questionnaire answered
by patients admitted at the National Center for Epilepsy, Norway in 2014
were used. Data regarding symptoms for depression (Beck Depression
Inventory/BDI), current AED medication, perception of adherence and
adverse effects in the Adverse Event Profile (AEP) were collected. For
further analysis patients with a BDI-score >14 were considered to have
relevant symptoms for depression and an AEP score >44 was used as a
cut-off to label patients with a severe adverse effect load. Questions
regarding adherence dealt with intentional and unintentional non-adher-
ence occurring occasionally or often. The project was approved by the
local ethics committee.
Results: Questionnaires from 158/184 patients were analysed. The
patients’ mean age was 36 years (18–78 years). Age at seizure onset
was 21 years (0–78 years). 62% of the patients used AED polytherapy.
30% of the patients scored 15 or higher in the BDI. 37% of patients
reported a severe adverse effect load. 30% of the patients reported to
forget AED, whereas 12% reported to intentionally take AED differ-
ently than prescribed occasionally or often (an additional 40% respec-
tively 10% would do so rarely). We found highly significant
correlations between symptoms for depression and a severe adverse
effect load (p < 0.001), unintentional (p < 0.01) and intentional non-
adherence (p < 0.005).
Conclusion: There is a high prevalence of symptoms for depression in
epilepsy that is highly correlated to perception of adverse effects and
poor adherence. This is important regarding a need for better communi-
cation and understanding to improve the treatment outcome.
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EPILEPSYANDAED INDUCEDDECREASED LIBIDO -
THEUNASKED PSYCHOSOCIALCOMORBIDITY
K.R. Kaufman*, S. Wong†, A. Zimmerman*, K. Sivaraaman†,
C. Anim‡, D. Delatte‡
*Rutgers Robert Wood Johnson Medical School, Psychiatry and
Neurology, New Brunswick, NJ, USA, †Rutgers Robert Wood
Johnson Medical School, Neurology, New Brunswick, NJ, USA,
‡Rutgers Robert Wood Johnson Medical School,
Anesthesiology, New Brunswick, NJ, USA
Purpose: Epilepsy is the 4th leading neurologic condition with a lifetime
prevalence of 3.8%. Quality of life in epilepsy (QOLIE) is inversely
related to both seizure frequency and severity of psychosocial comorbidi-
ties. Treatment gap in epilepsy is defined as percent of all patients with
epilepsy who receive subtherapeutic and/or no antiepileptic drug (AED)
treatment. Since QOLIE also reflects severity of psychosocial comorbidi-
ties, perhaps true treatment gap should include the percent of all patients
with epilepsy who receive subtherapeutic and/or no treatment for psy-
chosocial comorbidities. An important psychosocial comorbidity associ-
ated with epilepsy and AED treatment is decreased libido. This paper
addresses whether “libido” is questioned with/without utilizing federally
mandated electronic medical record (EMR) by epilepsy, pain manage-
ment and psychiatry clinicians.
Method: Quality improvement initiative at an academic medical center
(AMC) was employed.
Results: This AMC utilized a federally mandated EMR in outpatient epi-
lepsy/pai/psychiatry clinics. The EMR Review of Systems (ROS) GU
section included libido only for male patients in these clinics. Clinicians
from each outpatient service were directly questioned regarding use of
EMR (100%), use of EMR ROS-GU section (66.67% pain/25% epilepsy/
20% psychiatry), whether libido was directly asked of all patients (0%
pain/0% epilepsy/20% psychiatry), awareness that epilepsy and AEDs
both can induce decreased libido (33.33% pain/25% epilepsy/20% psy-
chiatry), and whether this survey will increase future review of libido
(100%).
Conclusion: Treatment gap of epilepsy-induced and/or AED-induced
decreased libido in patients with epilepsy/psychiatric/pain disorders may
be related to both lack of education and efficacy of EMR. Education of
clinicians is indicated.
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TOWHATEXTENTDEPRESSIVEMOOD INFLUENCE
ONQUALITYOFLIFE IN PEOPLEWITHDRUG
RESISTANTEPILEPSY. ANARGENTINE STUDY
L. Scévola*,†,‡, M. Fernandez Lima*,‡,§,¶, M. Sarudiansky*,¶,
S. Oddo*,‡,§, S. Kochen*,‡,¶,**, L. D’Alessio*,‡,§,¶
*Ramos Mejía Hospital, Epilepsy Center, Buenos Aires,
Argentina, †Ramos Mejía Hospital, Mental Health Center,
Buenos Aires, Argentina, ‡Neuroscience Epilepsy Hospital El
Cruce, Buenos Aires, Argentina, §E de Robertis Neuroscience
Institute, Buenos Aires, Argentina, ¶CONICET, Buenos Aires,
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Argentina, **E de Robertis Neuroscience Institute, Epilepsy
Research Laboratory, Buenos Aires, Argentina
Purpose: The aim of this study was to determine if the quality of life
(QofL) is differentially affected in patients with drug resistant epilepsy
(DRE) with and without depression, in an epilepsy reference center of
Buenos Aires, Argentina.
Methods: Patients with DREwho were admitted to the monitoring video
EEG unit during the period 2010–2013 underwent a standardized psychi-
atric assessment using (SCID I and BDI). QofL was evaluated using GAF
(Global assessment of functioning) and QlesQ (Quality of life enjoyment
and satisfaction questionnaire).Two groups were compared according to
the presence of current affective disorders (depression) codified in axis I
of DSM IV) and the lack of affective disorders (absence of depression
and/or a psychiatric disorder de according DSM IV). Statistical tests used
were student t test, ANOVA, Chi square test (v2) and Pearson. SPSS for
Windows was used.
Results: Eighty one patients with DRE were included, 40 men (49.4%) y
41 women (50.6%). Forty four patients (54.32%) had depression criteria,
and were compared with 37 (45.67%) patients without depression. No
significant differences in age and sex were found between the groups.
The total score of QofL was significantly lower in depression group
(p0.005). The most affected areas were physical health (p0.039), mood
(p0.01), leisure activities (p0.04), and social activities (p0.041). GAF did
not show significant differences.
Conclusion: Depression is the most frequent psychiatric co morbidity in
epilepsy and this study showed a worst QofL in DRE patients with
depression compared with DRE patients without depression. Therapeutic
approach should be interdisciplinary (neurology, psychiatry, psychology)
in people with DRE and should also address mood to improve QofL.
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THERELEVANCEOFCLINICALRECOGNITIONAND
DIFFERENTIAL SEMIOLOGYTO FACILITATEA
QUICKACCESS TOVIDEO-EEG IN PATIENTSWITH
PSYCHOGENIC NONEPILEPTIC SEIZURES
L. Scévola*,†,‡, N. Lombardi*,‡, N. Alonso*,‡, G. Korman*,
S. Oddo*,‡,§, S. Kochen*,‡,§,¶, L. D’Alessio*,‡,§,¶
*Ramos Mejía Hospital, Epilepsy Center, Buenos Aires,
Argentina, †Ramos Mejía Hospital, Mental Health Center,
Buenos Aires, Argentina, ‡Neuroscience Epilepsy Hospital El
Cruce, Buenos Aires, Argentina, §E de Robertis Neuroscience
Institute, Buenos Aires, Argentina, ¶CONICET, Buenos Aires,
Argentina
Purpose: In this work we compared the seizure semiology in PNES and
in Temporal Lobe Epilepsy TLE patients recorded during VEEG. The
aim was to detect specific clinical signs which will allow the clinician to
suspect the PNES diagnosis, and accelerate the access to VEEG for diag-
nosis confirmation.
Method: VEEG records were reviewed and seizures were analyzed and
classified according to the presence of: aura, lack of responsiveness,
hypermotor, automatisms and motionless. All patients had a psychiatric
evaluation (Structured Clinical Interview for DSM-IV I and II). Results
were compared between PNES and TLE groups. For the statistical analy-
sis student test and chi square were used with SPSS for windows.
Results: Twenty one patients with PNES (age: 35  11 years) and 21
with TLE (age: 34  13 years) were included. Seizure’s duration was of
1.44  0.5 minutes in TLE and of 6.7  8.8 minutes in PNES
(p < 0.05). Absences of Lack of responsiveness and hypermotor seizures
were more frequent in PNES (p < 0.05) and automatisms were more
frequent in TLE (p < 0.05). Age of seizure onset was lower in
TLE (p < 0.05) and females prevailed in PNES group (p < 0.05). The
presence of aura and motionless was similar in both groups. Inside the
psychiatric evaluation the PNES group presented a higher frequency of
depression (p < 0.05) and personality disorders (p < 0.05).
Conclusion: In the present study we found differences that may orientate
the differential diagnosis between PNES and TLE. Even though VEEG is
the gold standard in PNES diagnosis, clinical semiology may help to
speed up the access to VEEG and therefore the differential diagnosis,
which delays the instauration of the correct mental health treatment.
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CALBINDIN DISTRIBUTION INDENTATEGYRUS
LAYERSOF PATIENTSWITHDEPRESSIONAND
RESISTANTTEMPORAL LOBE EPILEPSY
L. D’Alessio, H. Konopka, A. Acu~na, E. Escobar, L. Scévola,
M. Fernandez Lima, E. Seoane, S. Kochen
Neuroscience Institute (IBCN), Epilepsy Center, Ramos Mejía
and El Cruce Hospital, CONICET, Buenos Aires, Argentina
Purpose: The aim of this study was to determine the immunoreactivity
for calbindin (expressed in post-mitotic new generated cells during sinap-
togenesis), in dentate gyrus layers of patients with resistant TLE (tempo-
ral lobe epilepsy) and hippocampal sclerosis (HS) with and without
depressive disorders. Both depression and TLE have been linked to
abnormalities in hippocampal neuroplasticity but pathogenic mecha-
nisms are still unclear.
Method: Patients with HS and TLE were evaluated according clinical,
neurological and psychiatric assessment protocols before surgery. For
psychiatric diagnoses, Structured Clinical Interviews for DSM IV disor-
ders (SCID-I and -II), were determined. After surgery selected hippocam-
pal sections from patients with and without depressive disorders and
archival material from normal post-mortem hippocampus were processed
using immunoperoxidase with antibody anti-calbindin. Reactive area for
calbindin, number of positive cells per field (20X), and MGV (mean gray
value), were measured by computerized image analysis (Image J).
ANOVATest was determined.
Results: Hippocampal sections of eight patients with TLE and depres-
sion (TLE+D), eight patients with TLE without depression, and five
matched postmortem controls were included. Calbindin immunoreactiv-
ity (Calbindin IR) was found in granule cells layers of both controls and
patients. A significant reduction in the total number of calbindin IR cells
per field was found in patients, more intense in TLE +D (p < 0.01). Many
reactive cells in TLE dentate gyrus have larger somas with more staining
intensity reaction: these findings were stronger in TLE +D (p < 0.01).
Conclusion: Calbindin-IR cells in dentate gyrus are reduced in HS as
was previously reported. These alterations were more prominent in
patients with TLE+D comparing to TLE and controls, suggesting a most
important compromise of hippocampal neuroplasticity in these patients.
Deeper studies using double immunostaing should be performed to con-
firm these preliminary findings.
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HOW2TELL -THECOLLABORATIVE DEVELOPMENT
OFANEVIDENCE-BASED RESOURCE FOR SELF-
DISCLOSURE STRATEGIES FOR PEOPLEWITH
EPILEPSY: INTERIMRESULTS
N. Elliott*, S. Pembroke*, M. White†, N. Pender‡, C. Doherty§,
A. Higgins*
Epilepsia, 56(Suppl. 1):3–263, 2015
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*Trinity College Dublin, School of Nursing and Midwifery,
Dublin, Ireland, †Beaumont Hospital, Department of Nursing/
Neurology, Dublin, Ireland, ‡Beaumont Hospital, Department of
Psychology, Dublin, Ireland, §St James’Hospital, Department
of Neurology, Dublin, Ireland
Purpose: To generate evidence-based information about the strategies
that adult people with epilepsy (PWE) use in the process of telling others
about their epilepsy. To design a self-management APP/multimedia
resource based on PWE’s experiential knowledge of self-disclosure that
will support PWE in social, personal and work situations.
Method: Using grounded theory approach, in-depth interviews explored
PWE’s first-hand experiences of self-disclosure (or not) and grounded
theory methods of data analysis were used to identify core strategies. To
account for maximum variation within the sample, adult PWE with dif-
ferent life experiences and situations relating to (a) support group, (b)
family relationship, (c) personal relationship, and (d) work status were
included. Given the many variables and psychosocial issues associated
with epilepsy, demographic details and validated measures including
Coping Inventory of Stressful Situations, QOLIE-10-P and Patient
Health Questionnaire were used to profile participants.
Results: Twenty-nine adults with epilepsy participated. Participants
reported using a range of different strategies: calculating need-to-know;
selecting 1st confidant; using humour; making it “ordinary”; seeding
hints for disclosure; disclosing gradually depending on level of interest;
and, tailoring the message to audience needs. For example, in employ-
ment situations, participants presented information to employers in a
structured, factual format that addressed work performance and safety
management issues. Whereas in social situations, telling friends involved
a more casual approach, and information was presented in a way that was
designed to educate, reassure and also to maintain social relationship.
Conclusion: PWE use multiple and varied strategies in the process of
self-disclosure about their epilepsy to others. These strategies will inform
the development of How2tell multi-media educational resources, includ-
ing an APP, on self-disclosure for practical use in everyday social and life
situations. TheHow2tell study is funded by Epilepsy Ireland/HRB (Grant
No. MRCG/2013/6)
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ETHNICDIFFERENCES IN CULTURALAND
SPIRITUAL PERCEPTIONS ANDCOPING
STRATEGIES IN FAMILIESWITHEPILEPSY
A. Joshi*, E. Stevens†, M. Ramphul*, M. Eisenhut*
*Luton and Dunstable University Hospital NHS Foundation
Trust, Paediatrics, Luton, UK, †Cambridgeshire Community
Services NHS Trust, Luton, UK
Purpose: To determine factors emerging from cultural and spiritual
background of different ethnic groups, which could influence perception
and management of epilepsy in children.
Method: Retrospective questionnaire based survey in families whose
children have epilepsy. Data were collected when families attended epi-
lepsy clinics at Luton & Dunstable University Hospital, United Kingdom
(UK) and when visited by the Epilepsy Specialist Nurse in the commu-
nity. We extracted data on ethnic origin, religion or spiritual belief, con-
cepts of epilepsy, stigmatisation, degree of influence of religion and
cultural beliefs and use of non-medical therapies. We compared Cau-
casian and Asian families. Data were analysed using Fisher0s exact test
and Chi-square test.
Results: A total of 70 families participated in the survey. 28 were of Cau-
casian, 30 of Asian, 6 of African and 6 of mixed ethnic origin. There were
34 Muslims, 29 Christians, 6 Atheists and 1 unspecified. Significantly
more Asian families had the belief that epilepsy was influenced by non-
medical causes like fate or destiny (50%) or spirit related (43%) than
Caucasian families (0%). There was no difference in perception of stig-
matisation between Caucasian and Asian families. Influence on treatment
and management of epilepsy by family, religion or culture was signifi-
cantly more common in Asian compared to Caucasian families
(p < 0.001). Non-medical therapies (use of traditional healers, prayers,
complementary therapies) were used in significantly more Asian com-
pared to Caucasian families (p < 0.001).
Conclusion: Non-medical influences on perception of cause and on
treatment of epilepsy were more common in Asian compared to Cau-
casian families. Since the UK has a diverse population, consisting of a
wide range of spiritual and cultural beliefs, clinicians should strive to
understand all different viewpoints in order to develop a better rapport
with families. This will allow for a more holistic healthcare provision,
and may improve patient outcomes.
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PERCEPTIONOFEPILEPSY IN LUBUMBASHI,
DEMOCRATIC REPUBLICOFCONGO: FINDINGS
FROMPUBLICOPINION POLL
K.J. Kabongo
Lubumbashi University, Neurology, Lubumbashi, the
Democratic Republic of the Congo
Purpose: The purpose of the present study was to investigate the public
opinion on the perception of epilepsy in Lubumbashi, an urban city in the
Democratic Republic of Congo.
Methods: We conducted a cross-sectional study using a household sur-
vey questionnaire specially designed to collect information on people
perception of epilepsy. Community clusters from Lubumbashi were ran-
domly selected for heterogeneity. A total of 885 households were inter-
viewed.
Results: Of the 885 respondents in the survey, 45.5% were female and
54.5% were male. It was reported that the majority of the respondents
have either high school or higher education level (94.70%). All the
respondents believe in God, of which 82.67% were Christians. 28.8% of
the respondents reported that they have heard about epilepsy at school,
whereas 21.8% in mental health centers. Only 49.4% have heard about
epilepsy on public media such radio and television. The majority of the
respondents (61.8%) refused to marry an epileptic person. Less than a
quarter (18.3%) reported to have visualized a seizure. More than half of
the respondents believe that epilepsy is a disease with both mystical and
religious component (73.0%) and only 33.1% of the respondents believe
that epilepsy can be treated by the neurologists.
Conclusion: Findings from this survey suggested that the majority of the
population in Lubumbashi still believe that epilepsy is a mystical-reli-
gious disease, though most of the interviewed had a level of education
higher than secondary school. In this respect, one would expect that the
perception of epilepsy is more scientific than metaphysical. More studies
are needed to better understand the community perception of neurologi-
cal diseases in an African setting.
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HEALTHCARECOSTS AMONGPATIENTSWITH
POST-STROKE SEIZURE
Y.-C. Kuan*, Y.-H. Huang*, C.-H. Bai†
*Taipei Medical University - Shuang Ho Hospital, Department
of Neurology, New Taipei City, Taiwan, Republic of China,
†School of Public Health Taipei Medical University, Taipei,
Taiwan, Republic of China
Purpose: Stroke is commonly considered as one of the major causes of
epilepsy in adults, and accounts for almost half of all cases of epilepsy
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with identifiable etiologies. The incidence of post-stroke epilepsy ranges
from 3% to 67% across various studies in different populations. Our aim
in this study is to determine the burden of post-stroke epilepsy by evaluat-
ing readmissions, and medical expenditure during the first year after
acute stroke under the National Health Insurance (NHI) program in Tai-
wan.
Method: We conducted this nationwide retrospective cohort study by
using claim data about new incidence of stroke obtained from a subset of
the National Health Insurance Research Database (NHIRD), which con-
tains the data of all medical claims from 2002 to 2009 of 1 million ran-
domly sampled NHI enrollees in Taiwan, with a 1-year follow-up
duration. Early-onset post-stroke seizure was defined as onset of seizures
within 14 days of the stroke index date, whereas late-onset post-stroke
seizure was defined as onset of seizures more than 14 days after the
stroke index date. The total amount of the first-year hospitalization medi-
cal expenditure of patient with late-onset post-stroke seizure was
assessed and compared to the expenditures of stroke patients without
post-stroke seizure.
Results: Of 3502 stroke patients, we identified 72 patients with early-
onset post-stroke seizure and 76 patients with late-onset post-stroke sei-
zure. Overall, 2.21 late-onset post-stroke seizure incidence occurred per
100 person-year and a cumulative incidence of 4.23%. The first-year hos-
pitalization medical expenditure was NT$ 631, 344 and NT$ 920 831 for
patients with early-onset post-stroke seizure and patients with late-onset
post-stroke seizure, respectively. This is significantly higher compared to
stroke patients without post-stroke seizure (NT$ 465 655).
Conclusion: Our study suggests that patients with post-stroke seizure
had a significantly higher medical expenditure than without seizure,
especially in late-onset post-stroke seizure.
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AN EXPLORATORY STUDYOFTHE SOCIALWORK
NEEDS ANDOUTCOMEOFADULTSWITHEPILEPSY
J.V. Laarhoven, R.C. Dabekaussen-Spiering, S. Lavrijssen,
M.J.C. van Hattum
Kempenhaeghe, Social Work, Heeze, Netherlands
Purpose: The objective of this study is to explore the social work needs
of adults with epilepsy and the benefits derived from social services (out-
come), to establish whether outcome and needs match.
Method: A structured questionnaire was sent to 100 clients and a focus-
group of social workers was used to interpret the results of the question-
naire. The results were mapped in three categories: supporting and stabi-
lizing guidance (SSG), practical and informational services (PIS) and
chance-oriented and competence-based guidance (CCG).
Results: In total, 48 clients (48%) took part. 76% had SSG needs, 80%
PIS needs and 67%CCG needs.
1. The main SSG needs were: to “stand one’s ground” (81%) and to
share emotions (54%). The outcome was: emotional support (62%) and
being heard (68%).
2. The main PIS needs were: work-related issues (59%) and insight
into statutory provisions (34%). The outcome was: ability to organize
things by themselves (28%), referral to other agencies (26%) and work-
related questions were answered (26%).
3. The main CCG needs were: self-esteem issues (61%) and dealing
with the daily consequences of epilepsy (61%). The outcome was: ability
to set boundaries (42%), learning to deal with daily consequences (30%),
acceptance (24%) and increased self-esteem (24%).
A small group (27%) found the outcome to be unsatisfactory, but the
provision of social services for this group is still ongoing.
The focus-group showed:: 1. There are many work-related issues, but
few opportunities in the current labour market. Solution-oriented services
and management of expectations can be the key to increase the benefits
in this area.
2. Further empowerment of adults with epilepsy is a challenge for the
future.
Conclusion: The outcome of the social services appears to relate to the
needs of adults with epilepsy. On a critical note, outcomes could be
improved, especially on work-related questions and empowerment.
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“I AMNOTMUCHOFAMAN” - A QUALITATIVE
RESEARCH PROJECTWITH FOCUSON SEXUALITY
OFTHEMALEADULT EPILEPSY PATIENT
T. Moos
The Danish Epilepsy Center Filadelfia, Adult Epilepsy Unit,
Dianalund, Denmark
Purpose: The aim of this project was to clarify, analyze and discuss the
experience of sexuality in the male epilepsy patient. In this context sexu-
ality is seen as a multidimensional issue.
Methods: The project is carried out within the framework of a qualita-
tive research interview based on a phemonological and hermeneutical
approach. Literature theories on men, masculinity, and life quality con-
tributed individually to an understanding of the statements of the male
epilepsy patients.
Results: The project shows that sexuality has a big influence on the iden-
tity of the male epilepsy patients and their self awareness and body integ-
rity. The interviews shows that sexuality is experienced as a
multidimensional concept, when dealing with life quality. Themes like
identity and self awareness appear to be closely connected and impossi-
ble to separate.
Conclusion: Sexual problems can generate feelings of inadequateness,
guilt and shame in the men. Those feelings very much affect the experi-
ence of masculinity. It is however in this context also noticeable that the
feeling of being a “real man” is depending on their ability to control their
epilepsy. Furthermore the interviews showed that the relationships can
be challenged by change of roles within the partnership which again can
accumulate a feeling of inferiority in the sexual relation. Finally the pro-
ject highlighted that taboos arises when sexuality as a theme has to be
articulated. The taboo is thus not only from patient and his partner but
also exists in the health professionals such as the nurse and the doctor.
This taboo seems to produce an underestimation of sexual issues in the
epilepsy patients in clinical practice and should be taken further into con-
sideration when dealing with the epilepsy adults patients.
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NON-INTRAVENOUSMIDAZOLAMVERSUS
INTRAVENOUSORRECTALDIAZEPAMFORTHE
TREATMENTOFEARLY STATUS EPILEPTICUS: A
SYSTEMATIC REVIEWWITHMETA-ANALYSIS
F. Brigo*,†, R. Nardone†,‡, F. Tezzon†, E. Trinka‡
*University of Verona, Verona, Italy, †Franz Tappeiner
Hospital, Merano, Italy, ‡Paracelsus Medical University,
Department of Neurology, Christian Doppler Klinik, Salzburg,
Austria
Purpose: To determine if non-intravenous (non-IV) MDZ is as effective
and safe as intravenous or rectal diazepam (DZP) in terminating early sta-
tus epilepticus (SE) in children and adults.
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Method: We searched CENTRAL, ClinicalTrials.gov, and MEDLINE
for randomized controlled trials comparing non-IV MDZ with DZP (by
any route) in patients (all ages) with early SE, defined as seizures lasting
>5 minutes or as seizures at arrival in the emergency department. Fol-
lowing outcomes were assessed: seizure cessation within 15 minutes of
drug administration; serious adverse effects; time interval to drug admin-
istration; time from arrival in the emergency department to seizure cessa-
tion. Outcomes were assessed with random-effects Mantel-Haenszel
meta-analyes to calculate risk ratio (RR) and mean difference (MD) with
95% confidence intervals (95%CIs).
Results: Nineteen studies with 1933 seizures in 1602 patients were
included. 1573 patients were younger than 16 years. For seizure cessa-
tion, non-IV MDZ was as effective as DZP (any route) (RR: 1.03; 95%
CIs: 0.98–1.08). No difference in adverse effects was found between
non-IM MDZ and DZP by any route (RR: 0.87; 95% CIs: 0.50–1.50).
Buccal MDZ was more effective than rectal DZP in terminating SE (RR:
1.78; 95% CIs: 1.11–2.85). Time interval between arrival and seizure
cessation was shorter with non-IV MDZ by any route than with DZP by
any route (MD: -3.67 minutes; 95% CIs: 5.98 to 1.36); a similar
result was found for time from arrival to drug administration (MD: -
3.56 minutes; 95%CIs:5.00 to2.11).
Conclusion: Non-IV MDZ is as effective and safe as intravenous or rec-
tal DZP in terminating early SE in children. Times from arrival in the
emergency department to drug administration and seizure cessation are
shorter with non-IV MDZ than with intravenous or rectal DZP, but this
does not necessarily result in higher seizure control.
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NON-CONVULSIVE STATUS EPILEPTICUS -
THERAPEUTIC APPROACH
H.M. Delgado*, V. Silva†, R. Pinto†, F. Morim†, N. Canas†
*Centro Hospitalar de Lisboa Ocidental, Neurology, Lisboa,
Portugal, †Hospital Beatriz Angelo, Neurology, Loures,
Portugal
Purpose: Non-convulsive status epilepticus (NCSE) is a common disor-
der comprising at least 1/3 of all cases of status epilepticus (SE).
Although including a great diversity of syndromes, these forms of SE
share two important features: the diagnostic difficulty and uncertainty
about the best treatment approach. We evaluate the therapeutic approach
and its effect in NCSE outcome.
Method: All consecutive cases of NCSE according to Beniczky et al.
2013 criteria, seen in an unselected hospital cohort, between January/
2012 and December/2014, were identified and the files reviewed.
Therapeutic approaches were identified retrospectively and related to
outcome.
Results: A total of 42 patients were found, 23 females, mean age
72 years (24–90). The subtypes of NCSE were: complex partial SE in 33
patients, NCSE in coma in 7, simple partial SE in 2 patients. 29 were pro-
voked NCSE. NCSE was treated with one antiepileptic drug (AED) in 10
patients, with two AED in 14 patients, with three in nine patients, with
four in four patients and coma was induced in five patients. NCSE
resolved when a BZD was started in 1/23 patients, PHT in 6/15 patients,
VPA in 9/25, LEV in 20/33, CBZ in 1/1 and propofol/midazolam in 2/5.
10 patients died, three without NCSE resolution. At discharge only 12
patients were treated with >1 AE.
Conclusion: Therapeutic approaches were heterogeneous reflecting the
absence of NCSE treatment guidelines. Despite that, success rate with
AED was high and coma induction was rarely needed. In the majority of
patients ≥2 AED were necessary to treat NCSE, but once treated the
underlying factor and outdated the acute phase, AED discontinuation
does not seem to be related with a high risk of recurrence. In our series
mortality was high but essentially related with the underlying etiology
and medical complications.
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NON-CONVULSIVE STATUS EPILEPTICUS: CLINICAL
PRESENTATIONS ANDEEGPATTERNS
H.M. Delgado*, V. Silva†, R. Pinto†, F. Morim†, N. Canas†
*Centro Hospitalar de Lisboa Ocidental, Neurology, Lisboa,
Portugal, †Hospital Beatriz Angelo, Neurology, Loures,
Portugal
Purpose: Non-convulsive status epilepticus (NCSE) is classically char-
acterized by changes in behavior/awareness caused by continuous or very
frequent epileptiform activity. However, its clinical manifestations can
be very heterogeneous and attributable to a non-epileptic etiology, being
the EEG fundamental for its definitive diagnosis.We describe the clinical
presentation and EEG patterns in a cohort of patients with EEG con-
firmed NCSE.
Method: We identified all consecutive patients admitted to our hospital
(1/2012 to 12/2014) with EEG criteria for NCSE (1 hour video-EEG);
their clinical presentation was retrospectively evaluated.
Results: 38 patients were identified (21 female, mean 73 years-old,
24–90), 13 with known epilepsy. Most presented with behavioral
(58%) or consciousness abnormalities (stupor/coma, 27%); visual
impairment or aphasia were the only clinical manifestation in two
patients. Before EEG confirmation, the diagnosis of NCSE was only
considered in nine patients, in all following an isolated generalized
tonic-clonic seizure; in 59% of the remaining patients, the clinical
changes were attributed to a medical cause (metabolic, infectious) or
acute CNS injury (stroke/trauma). In the initial EEG, the most com-
monly patterns were epileptiform discharges >2.5 Hz (42%) or
≤2.5 Hz (40%), in these with the definitive diagnosis of NCSE made
by registration of electro-clinical seizures (subtle eye versions, myoclo-
nus, 16%), EEG/clinic response to intravenous benzodiazepines (16%)
or by demonstrating ictal dynamic EEG changes (11%). In four
patients, all with initial EEG showing less epileptiform activity and
dominated by slow rhythmic activities, occasionally with recruitment
features, the definitive diagnosis of NCSE was only made in subse-
quent EEG0s (2–4, mean 2.7).
Conclusion: The diagnosis of NCSE should be considered in patients
with behavior/awareness changes, even in those without previous epi-
lepsy or with a medical/neurological condition that could justify the
clinic presentation. Its EEG patterns are variable and dynamic, often
being necessary pharmacological manipulations/ repeated EEG to make
a definitive diagnosis.
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INDICATIONS ANDDIAGNOSTICYIELDOF
EMERGENCYELECTROENCEPHALOGRAPHY
(EEEG) IN AN “ERA”OF ELECTRICAL STATUS
EPILEPTICUS
N.N. Hewage*, M.S.S. Fernando*, K.N.H. Wadige†,
D. Sirisena‡, T.R. Wijerathne†, A.J.B. Thilina†
*Teaching Hospital Anuradhapura, Paediatric Neurology,
Anuradhapura, Sri Lanka, †Teaching Hospital Anuradhapura,
Anuradhapura, Sri Lanka, ‡Teaching Hospital Kurunegala,
Kurunegala, Sri Lanka
Purpose: The electroencephalogram (EEG) is a unique and valuable
measure of the brain’s electrical function. The use of EEG in emergent
conditions have been boosted with the definition of electrical status
epilepticus (ESE), however the precise role and value of EEG in emer-
gent conditions have yet to be clearly defined. Therefore, our objective
was to determine the indications and the yield of EEG in an emergency
setup.
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Method: A descriptive cross sectional study, 20 minutes standard
digital EEGs (10–20 system) were performed. Individual bias was
minimized by independent reporting done by two. Authors retrospec-
tively reviewed the reports of eEEGs performed over a period of
12 months.
Results: A total number of 1028 were performed, out of which 166
(16.1%) through emergent requests, nullified 11 due to inadequate infor-
mation. The mean age of eEEG was 22.0 years, no significant difference
compared to routine-EEG (rEEG), Sex-male 57.8% for eEEG, 48.2% for
rEEG (p < 0.05). The commonest clinical indication for eEEGs was
altered level of consciousness 78(46.9%). None suspected ESE on clini-
cal grounds. The sensitivity of eEEGs for positive yield was 27.1%.
Twenty-one had inter-ictal-epiletiform discharges (14 = focal), 16 had
background slowing (12 = diffuse), only 04 had ESE (diffuse dis-
charges). Moreover, 02 had burst-suppression, 01 spindle-coma and 01
periodic-lateralized-epileptiform-discharge. Majority (68.2%) with
reduced level of consciousness had background slowing; only 01 had
ESE. There was no significant difference between the sensitivity of
eEEG versus rEEG (P > 0.05).
Conclusion: Reduced level of consciousness is the commonest indica-
tion for eEEG, only a minority had ESE. Sensitivity of eEEG for a posi-
tive yield is the same as of routine EEG.
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PANORAMAOFQUANTITATIVE EEG (QEEG)
MONITORING IN ICU: OUR EXPERIENCE IN PSMMC,
RIYADH
M. Kabiraj, N. Biary, M. Zawahmah, S. Khan, W. Khoja, I. Babli
Prince Sultan Military Medical City, Riyadh, Saudi Arabia
Purpose: To understand concepts of quantitative EEG in trend display
and to evaluate the diagnostic accuracy of seizure (Sz) probability,
rhythmic run detection and display (R2D2), color density spectrogram
(FFT), burst-suppression patterns and amplitude-integrated EEG
(aEEG).
Method: The trending study was made by using Cadwell machines (32
channels,sampling frequency of 250 Hz) and Persyst 12 software. A total
of nine comatose patents (4M+5F) age ranged 17–78 years have 160–
4320 minutes recordings. The size of the files for visual analysis ranged
from 800 pages to 21 600 pages at 12 second/page (Mean = 8488
pages). These CEEG records were frequently read by our five readers
independently by visual analysis. The EEG background, electroclinical
seizures and artifacts were identified and discussed for their correction.
All of them were subsequently subjected to Trend analysis at a rate of
1 hour recording/page.
Results: Seven of our nine patients were elderly (74–78 years). All
the electrographic seizures identified by visual analysis were identi-
fied by combined trends (100% sensitivity) with the exception of sei-
zure probability detection trend alone. The small amplitude slowly
evolving Szs are missed by trends and thereby produces high false
positive results. However, using all trends, the distinctive SZ detec-
tion frequency was 76 Szs/hour in one of our young patients with
intractable Sz.
Conclusion: The study showed higher sensitivity in identifying seizures
and focal/generalized slowing, burst-suppression patterns while using the
seizure signature of all the above trend tools than others (Stewart C.P.
et al, 2010). The study also reveals the simplicity and reliability of the
program for analysis. However, the trend data must be checked by open-
ing the raw data for further confirmation and a single trend for seizure
analysis should be avoided. A future study using Persyst 13 with artifact
reduction technique (a step forward in clinical Neurophysiology after
Digital EEG) will continue.
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NON-CONVULSIVE STATUS EPILEPTICUSWITH
UNILATERALEEGCHANGES INANELDERLY
PATIENT
M. Kandemir*, T.G. Ince†, Z.B. Yalciner*
*Bayindir Hospital Icerenkoy, Neurology, Istanbul, Turkey,
†Bayindir Hospital Icerenkoy, Anesthesiology and Reanimation,
Istanbul, Turkey
Purpose: Altered mental status is a very common presentation in the
elderly causing from different etiologies. As they have the same clinical
presentation, it is difficult to diagnose non-convulsive status epilepticus.
It has been determined that about 16% of patients older than 60 years with
confusion of unknown origin have non-convulsive status epilepticus.
Method: We report a 84 years-old patient who diagnosed of non-con-
vulsive status epilepticus with continuous unilateral EEG changes. She
had chronic left middle cerebral artery infarct. After preperation of colo-
noscopy, she had developed confusion and then unconsciousness. The
clinical state of the patient and EEG changes of non-convulsive status
epilepticus was refractory to diazepam. She had been taking levetirac-
etam so we administered her levetiracetam infusion. Because of no
response to antiepileptic drugs, the patient treated with midazolam infu-
sion and her status had been undercontroled. After administration of the
drugs, PLEDs on the left hemisphere had continued for a while.
Conclusion: We present this case because of the non-convulsive status
epilepticus with unilateral EEG changes. We assumed that it’s important
to be careful about any kind of interventional prosedures in an elderly
patient, especially who had brain lesion.
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EARLY INTRODUCTIONOFKETOGENIC DIETMAY
IMPROVETHEOUTCOME IN SEVEREREFRACTORY
STATUS EPILEPTICUS OF FEBRILE INFECTION-
RELATEDEPILEPSY SYNDROME (FIRES)
K.P. Vinayan*, B. Nivedita†, A.G. Roy*, G.A. Thomas*,
S. Mohan*
*Amrita Institute of Medical Sciences, Division of Pediatric
Neurology, Department of Neurology, Cochin, India, †Amrita
Institute of Medical Sciences, Department of Clinical Nutrition,
Cochin, India
Purpose: To evaluate the therapeutic outcome of Ketogenic Diet (KD)
in the intensive care setting in severe refractory status epilepticus of feb-
rile infection-related epilepsy syndrome (FIRES).
Method: This retrospective observational study (2011–2014) included
children who were initiated on KD for refractory status epilepticus of
FIRES. Those with previous history of seizures were excluded. Baseline
characteristics, fever and status epilepticus onset, ketogenic diet initia-
tion, efficacy, and side-effect profile were analyzed.
Results: Fourteen children were initiated on KD for status during this
period. Of these, five were excluded from final analysis due to various
reasons. Of the remaining nine children (M: F = 4: 5), age at presentation
varied from 1 to 15 years (median 7 years). Fever to status interval was
1–9 days (median 4 days). All were on multiple (4–7) AEDs prior to KD
(median 5). Six were on anesthetic infusions at initiation of KD. The
interval from status onset to KD initiation was 5–86 days (median
11 days). Five patients were on 3:1 diet, while the other four were on
4:1diet. Hypoglycemia was noted in three children, necessitating diet
withdrawal in one child. Two other children discontinued the diet due to
other reasons. In the remaining six patients, KD was effective within 0–
4 days (median 1 day) of onset of ketonuria and 1–12 days (median
6 days) after diet initiation. Complete seizure freedom was achieved in
three children; one showed >90% and two showed 50–80% reduction in
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seizure frequency. Of the three children, who discontinued KD, one
became seizure free; other two expired due to persistent seizures and sys-
temic complications. The outcome was relatively better for patients with
early introduction of KD.
Conclusion: Ketogenic diet can be instituted safely and effectively in
the ICU setup for children with FIRES in refractory status epilepticus.
Early introduction of ketogenic diet may have a more favorable outcome.
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ANTENATALCAREAMONGPREGNANTWOMEN
WITHEPILEPSY INADEVELOPINGCOUNTRY: A
RETRO-PROSPECTIVE SURVEY IN CHINA
N. Hao, H. Jiang, M. Wu, D. An, X. Zou, L. Chen, D. Zhou
West China Hospital, Sichuan University, Department of
Neurology, Chengdu, China
Purpose: The aims of this study were to investigate the implementation
of antenatal care among pregnant women with epilepsy (WWE) in China
and to identify its potential correlations with selected sociodemographic
and clinical factors.
Method: A detailed survey was conducted in China using a structured
questionnaire from December 2013 to January 2014. Information on the
awareness and implementation of antenatal care, as well as selected
sociodemographic and clinical characteristics, were collected from 206
pregnant WWE. Descriptive and logistic regression analyses were
applied in this survey.
Results: Among the enrolled subjects, 2.9% suffered ionising radiation
exposure 3 months before pregnancy. And 62.3% exposed to antiepilep-
tic drugs (AEDs), almost half of whom were under polytherapy. Only
30.1% of them knew the exact effects of folic acid, and 73.8% had taken
folic acid at some point during periconception. About 45.1% obtained
continuity of care throughout the antenatal period. Majority of the sub-
jects performed malformation directed ultrasound (88.3%) and Down0s
screening (81.6%). Minority performed chorionic villus sampling (3.9%)
and amniocentesis (5.8%). But still 7.3% of the subjects knew little about
antenatal care. Pregnant WWE with higher education levels, those with a
planned pregnancy, or those who live in urban areas were more likely to
know about and implement antenatal care during pregnancy.
Conclusion: The extent of awareness and implement of antenatal care
among pregnant WWE remains insufficient in China. More efforts are
needed to promote antenatal care for WWE, especially those with low
education levels and those who live in rural areas.
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THE FREQUENCYOF SEIZURES IN PREGNANT
WOMENWITHEPILEPSY
S. Bek*, G. Koc†, G. Genc‡, Z. Gokcil§
*Baskent University, Medical Faculty, Adana Research and
Teaching Center, Adana, Turkey, †Turkish Armed Forces
Rehabilitation Center, Neurology, Ankara, Turkey, ‡Gumussuyu
Military Hospital, Neurology, Istanbul, Turkey, §Gulhane
Medical Faculty (Retired), Neurology, Ankara, Turkey
Purpose: We aimed to investigate seizure frequency in pregnant women
with epilepsy.
Method: We evaluated 175 pregnant women with epilepsy from 1996 to
2015. Total 216 pregnancy were investigated retrospectively and
prospectively. The patients whose pregnancy were terminated and who
have not enough information were excluded. All the patients had taken
folic acid during pregnancy. Seizure frequency 1 year before pregnancy,
first tremester, during pregnancy and after pregnancy were recorded
respectively.
Results: The mean pregnancy age of patients was 27.05  4.66 years.
The etiology of epilepsy in patients was idiopathic (78.7%) or symp-
tomatic (21.3%). Seizures types were primary generalized epilepsy, par-
tial epilepsy or mix type epilepsy and the frequencies were 34.2%, 10.25
and 55.6% respectively. The percentage of patients who were followed
up during pregnacy without therapy, monotherapy or polytherapy were
16.3%, 69.3%, and 14.4% respectively. 216 pregnancies ended with 77
normal delivery, 105 cesarean section, 17 abortus and 17 curettage.
Before pregnancy there was no seizure in 101 (46.8%) and there was at
least one seizure in 115 (53.2%) patients. The pregnancies which were
terminated or ended with abortus or curettage were excluded to inves-
tigete seizure frequency during pregnancy and postpartum stage. The fre-
quency of seizures decreased 25.3%, increased 12.1% and unchanged
62.6% of patients in first tremester. The frequency of seizures decreased
15.4%, increased 24.2% and unchanged 60.4% of patients during preg-
nancy. The frequency of seizures decreased 20.3%, increased 19.8% and
unchanged 59.9% of patients after pregnancy.
Conclusion: In literature most of the investigations revealed that the fre-
quency of seizures is not increased in perinatal period of pregnancy,
either during or after, and our results are consistent with this information.
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THE FREQUENCYOFMALFORMATION IN
PREGNANTWOMENWITHEPILEPSY
S. Bek*, G. Koc†, G. Genc‡, Z. Gokcil§
*Baskent University, Medical Faculty, Adana Research and
Teaching Center, Adana, Turkey, †Turkish Armed Forces
Rehabilitation Center, Neurology, Ankara, Turkey, ‡Gumussuyu
Military Hospital, Neurology, Istanbul, Turkey, §Gulhane
Medical Faculty (Retired), Neurology, Ankara, Turkey
Purpose: We aimed to investigate malformation frequency in pregnant
women with epilepsy (WWE).
Method: We evaluated 175 pregnant WWE from 1996 to 2015. Total
216 pregnancy were investigated retrospectively and prospectively. All
the patients had taken folic acide during pregnancy. Malformation fre-
quency was investigated.
Results: The mean pregnancy age of patients was 27.05  4.66 years.
The etiology of epilepsy in patients was idiopathic (78.7%) or symp-
tomatic (21.3%). Seizures types were primary generalized epilepsy, par-
tial epilepsy or mix type epilepsy and the frequencies were 34.2%, 10.25
and 55.6% respectively. The percentage of patients who were followed
up during pregnacy without therapy, monotherapy or polytherapy were
16.3%, 69.3%, and 14.4% respectively. 216 pregnancy were end with 77
normal delivery, 105 cesarean section, 17 abortus and 17 curettage. 11
babies had congenital malformation. These malformations and the drugs
which mothers used were cleft lip and palate (three babies, valproate
(VPA) 1000 mg/day, phenobarbital 200 mg/day, phenytoin (PHT)
300 mg/day as monothrapy), hypospadias (three babies, VPA 1200 mg/
day, carbamazepine (CBZ) 400 mg/day as monotherapy, and topiramate
(TPM) 200 mg/day, levetiracetam 1500 mg/day, CBZ 800 mg/day as
polytherapy), sacral teratoma (one baby, VPA 500 mg/day and TPM
50 mg/day), renal malformation (one baby, CBZ 400 mg/day), cuta-
neouse hemangioma (one baby, CBZ 1200 mg/day), atrial septal defect
(one baby, PHT 300 mg/day), spina bifida (one baby, VPA 500 mg/day,
lamotrigine (LTG) 200 mg/day, TPM 50 mg/day). Three pregnancies
were terminated due to renal cists (LTG 100 mg/day), meningomyelo-
cele (CBZ 400 mg/day), trizomie 18 (CBZ 400 mg/day) respectively
and one pregnancy was finished with abortus due to omphalocele (CBZ
600 mg/day).
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Conclusion: The seizures and teratogenic effects of AED are risk factors
for pregnancy in WWE. Carbamazepine was found associated with mal-
formations mostly in this study results and our results are consistent and
comparable with literature data.
p0758
ETHICALASPECTSOF EPILEPSY TREATMENT IN
ONEOF THEMOSTVULNERABLEGROUPSOF
PATIENTS -WOMENOF THEREPRODUCTIVEAGE
E.P. Mikhalovska-Karlova
N.A. Semashko National Research Institute of Public Health,
Moscow, Russian Federation
Purpose: Women of the reproductive age who suffer from epilepsy con-
stitute one of the most vulnerable groups of patients. Along with classical
ethical principles, a physician must adhere to the special principle of
bioethics - protection of future generation. Study of physicians’ motiva-
tion to apply ethical principles to woman epilepsy treatment.
Method: Twenty five years of experience of teaching Bioethics to stu-
dents of MoscowMedical Schools, teaching biomedical and professional
ethics to graduate medical students and physicians attending continuous
education courses and certificate courses on Neurology and Epileptol-
ogy; personal experience of participating in expert committees of various
levels. Sociological surveys, self-administered questionnaires, interviews
of 211 epileptologists.
Results: Sixty percent of respondents start treatment after receiving the
patient’s informed consent; 57% of respondents are guided in their prac-
tice by the principle of respecting the patient’s autonomy and dignity; and
53% of the respondents adhere to the partnership and contract model. T
he physicians’ motivation to apply bioethical principles to the treatment
process is very importance. The index of motivation (IM) was calculated
as a ratio of 1:10. The IM of physicians-epileptologists was rather high:
0.8–0.95. In comparison, the IM of medical graduate students was 0.8–
0.9. Over 97% of the respondents among these groups try to follow the
principles of Bioethics in their medical practice and research. At the same
time, 29% of respondents had difficulty identifying the type of model
they use in their work. 70% of epileptologists admitted to a significant
deficit in their knowledge in the field of bioethics and its applications.
Conclusion: Bioethics as it is currently taught in medical schools is
insufficient for an ethically informed treatment process. The bioethics
classes should be moved to the curricula of the upper level students and
included in the system of the continuous medical education.
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EMILIA ROMAGNA STUDYON PREGNANCYAND
EXPOSURETOANTIEPILEPTIC DRUGS (ESPEA): A
POPULATION-BASED STUDY INAN ITALIANREGION
B. Mostacci*, C. Piccinni†, F. Bisulli*,‡, G. Astolfi§,
E. Poluzzi†, G. Accetta*, A. Curti¶, R. D’Alessandro*,
G. Cocchi**, L. Conti†, P. Tinuper*,‡, ESPEA Study Group
*IRCCS Institute of Neurological Sciences of Bologna, Bologna,
Italy, †University of Bologna, Department of Medical and
Surgical Sciences DIMEC, Bologna, Italy, ‡University of
Bologna, Department of Biomedical and Neuromotor Sciences
DIBINEM, Bologna, Italy, §University of Ferrara, Registro
IMER, Dipartimento di Scienze biomediche e chirurgico
specialistiche, Ferrara, Italy, ¶University of Bologna,
Department of Medical and Surgical Sciences DIMEC, Division
of Prenatal Medicine, St. Orsola Malpighi Hospital, Bologna,
Italy, **University of Bologna, Department of Medical and
Surgical Sciences DIMEC, Division of Neonatology, St. Orsola-
Malpighi Hospital, Bologna, Italy
Purpose: To assess the prevalence of Antiepileptic Drug (AED) expo-
sure in pregnant women with or without epilepsy and the comparative
risk of terminations of pregnancy (TOPs) and major congenital malfor-
mations (MCMs) following intrauterine AED exposure in the Emilia
Romagna region (RER), Northern Italy (4 million inhabitants).
Method: Data were obtained from official regional registries: Certificate
of Delivery Assistance, Hospital Discharge Card, reimbursed prescrip-
tion databases and Registry of Congenital Malformations. We identified
all the deliveries, hospitalized abortions and MCMs occurred between
January 2009 and December 2011. The following active substances were
considered: Phenobarbital, Primidone, Phenytoin, Ethosuximide, Clon-
azepam, Carbamazepine, Oxcarbamazepine, Rufinamide, Valproic Acid,
Vigabatrin, Tigabine, Lamotrigine, Felbamate, Topiramate, Gabapentin,
Levetiracetam, Zonisamide, Pregabalin, Lacosamide.
Results: We identified 145243 pregnancies: 111284 deliveries (112845
live births and 279 stillbirths), 16408 spontaneous abortions and 17551
induced terminations of pregnancy (TOP). Six hundred and eleven cases
(0.42% 95% CI: 0.39–0.46) were exposed to AEDs. Twenty-one per cent
of pregnancies ended in TOP in the AED group versus 12% in the non-
exposed (OR: 2.24; CI 1.41–3.56). Three hundred fifty-three babies
(0.31%, 95% CI: 0.28–0.35) were exposed to AEDs during the first tri-
mester. The rate of MCMs was 2.3% in the AED group (2.2% in babies
exposed to monotherapy and 3.1% in babies exposed to polytherapy) ver-
sus 2.0% in the non-exposed.
Conclusion: The prevalence of AED exposure in pregnancy in the RER
was 0.42%. The rate of MCMs in children exposed to a single AED in
utero was almost superimposable to the one of the non-exposed, however
polytherapy carried a slightly increased risk. The rate of TOPs was signif-
icantly higher in the exposed women. Further studies are needed to clar-
ify whether this high rate reflects a higher rate of MCMs detected
prenatally or other more elusive reasons.
Acknowledgements: This project was funded by the Italian Ministry of
Health-Research ProgramRF 2010-2315893.
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VALPROICACID USEDURING PREGNANCY:
OUTCOMES INREALCLINICAL PRACTICE
P.N. Vlasov
Moscow State University of Medicine and Dentistry, Neurology,
Moscow, Russian Federation
Purpose: Recently important data emerged on valproic acid (VA) effects
related to pregnancy outcome and subsequent physical and mental devel-
opment of the child, however according to EURAP data, VA is still the
3rd. most frequently used antiepileptic drugs during pregnancy.
Method: Six clinical situations of pregnancy were examined in focal
epilepsy (FE): (a) VA continued; (b) VA discontinued after stable remis-
sion for the last 2–3 years; (c) VA discontinued, but infrequent focal sei-
zures (FS) observed without secondary generalized tonic-clonic seizures
(SGTCS); (d) VA discontinued, infrequent FS and single SGTCS; (e) VA
discontinued, frequent FS and SGTCS; (f) VA discontinued, FS and
SGTCS increased versus before treatment. Six clinical situations of preg-
nancy were examined in juvenile myoclonic epilepsy (JME): (a) VA
continued; (b) VA discontinued after stable remission verified clinically
and by EEG testing for the last 5 years; (c) VA discontinued, but duration
of remission is 1–3 years only, and previously the patient had generalized
tonic-clonic seizures (GTCS) predicted by increased absences and myo-
clonic seizures (MS); (d) VA discontinued, no GTCS, but infrequent MS
and absences are present; (e) VA discontinued, asynchronicMS, absences
and infrequent GTCS; (f) VA discontinued, all types of seizures increased
versus before treatment. All clinical situations may burden by self-can-
cellation of VA by pregnant women at I-st trimester of pregnancy.
Results and conclusion: Best pregnancy outcomes were observed, when
the following conditions were met:
Epilepsia, 56(Suppl. 1):3–263, 2015
doi: 10.1111/epi.13241
186
Abstracts
(1) VA gradually discontinued 9 months before pregnancy;
(2) continued VA use during the 1st trimester in daily dose not exceed-
ing 800 mg.
However in case of five andmore GTCS during the 1st trimester, preg-
nancy discontinuation was recommended. At the 2nd trimester, the daily
dose of VA was usually increased from 800 mg, or VA was combined
either with levetiracetam (in FE or JME) or pregabalin (only in FE).
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SEIZUREOCCURRENCE, PREGNANCYOUTCOME
AMONGWOMENWITHEPILEPSY; ONEYEAR
PROSPECTIVE STUDY
M.M. Watila*, O. Beida†, S. Kwari‡, N.W. Nyandaiti§,
Y.W. Nyandaiti*
*University of Maiduguri Teaching Hospital, Department of
Medicine, Maiduguri, Nigeria, †Federal Neuropsychiatric
Hospital, Maiduguri, Nigeria, ‡University of Maiduguri
Teaching Hospital, Obstetric and Gynaecology, Maiduguri,
Nigeria, §University of Maiduguri Teaching Hospital, School of
Nursing, Maiduguri, Nigeria
Purpose: To determine the prevalence of epilepsy, seizure frequency
and the outcome of pregnancy amongst a cohort of pregnant women
attending antenatal clinic (ANC) at two tertiary hospitals.
Methods: An observational cohort study conducted at the University of
Maiduguri Teaching Hospital and State Specialist Hospital, Northeast
Nigeria. Pregnant women attending antenatal care were screened for pre-
vious history of active convulsive epilepsy, and recruited consecutively
according to a specified protocol. A standardized questionnaire was
administered to record pregnancy history, nature of epilepsy and treat-
ments received. They were followed-up during the course of the preg-
nancy based on the ANC schedule up to delivery. The outcome of
pregnancies was recorded.
Results: A total of 7 063 pregnant women were screened, from which
103 (1.46%) subjects had at least a past history of seizure. Seventy-eight
(1.10%) had a past history of seizure(s) from eclampsia and 23 (0.33%)
pregnant subjects recruited were identified to have active convulsive epi-
lepsy. The unadjusted prevalence of epilepsy in pregnant women was
found to be 3.33 per 1000 (95% CI: 2.1–4.8). Subjects who had a history
of head injury and encephalitis were more likely to have seizures during
pregnancy. (P = 0.013 and P = 0.041). Those who had recurrent seizures
within the last 6 months before recruitment were more likely to have a
negative pregnancy outcome (P = 0.043).
Conclusion: Our study found a prevalence of active epilepsy of 3.33 per
1 000 among pregnant women, with about one percent having a past his-
tory of seizure from eclampsia.
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CIRCADIANCHANGESOF EPILEPTIFORM
DISCHARGES INGENETICGENERALISED
EPILEPSIES
U. Seneviratne*,†, M. Cook*, W. D’Souza*
*St. Vincent’s Hospital, Neuroscience, Melbourne, Australia,
†Monash Medical Centre, Neuroscience, Melbourne, Australia
Purpose: We sought to study the circadian patterns and sleep-specific
epileptiform abnormalities in genetic generalised epilepsy (GGE).
Methods: The diagnosis of GGE was established according to Interna-
tional League against Epilepsy criteria. All patients had 24-hour ambula-
tory electroencephalograms recorded according to a standard protocol.
The duration of all epileptiform discharges were measured manually
using a software tool and details of all discharges were entered into an
electronic database. The details included time of discharge, state of arou-
sal and duration. Generalised epileptiform discharges lasting ≥2 second
were classified as paroxysms and <2 seconds as fragments. Spikes over-
lapping with K-complexes (epileptiform K-complexes) and sleep spin-
dles (epileptiform spindles) were identified as sleep-specific epileptiform
abnormalities. We plotted a histogram of the frequency of epileptiform
discharges against 24-hour time scale followed by cluster analysis to
study circadian patterns.
Results: Out of 120 patients who participated, 107 had abnormal EEGs
which were analysed. The cohort consisted of 37 (34.6%) males and 70
(65.4%) females with mean age of 28.5  10.7 years (range, 13–58).
Epileptiform K-complexes were more frequent (66.7%) than epilepti-
form spindles (10.5%). Amongst syndromes, epileptiform K-complexes
and spindles were more commonly seen in juvenile myoclonic epilepsy
(71.4%) and juvenile absence epilepsy (70.6%). Generalised fragments
and focal discharges were more frequently seen during non-REM sleep
whilst paroxysms were more in wakefulness. Overall, 67% of epilepti-
form discharges occurred in non-REM sleep, whilst 33% occurred in
wakefulness. The cluster analysis showed four clusters of epileptiform
discharges around 2 am, 7 am, 2.30 pm and 10 pm confirming the
impression from the histogram.
Conclusion: Our study demonstrates epileptiform K-complexes occur in
the majority of GGE indicating the importance of arousal in the genera-
tion of epileptiform discharges. Furthermore, the study shows that epilep-
tiform discharges are more likely to occur at certain times of the day,
probably reflecting circadian rhythms of epileptogenicity.
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DEVELOPMENTANDEVALUATIONOFACLINIC-
BASEDDECISION SUPPORT SYSTEMFOREPILEPSY
SELF-MANAGEMENT IN THEUSA
R. Shegog*, C. Begley†
*University of Texas School of Public Health, Behavioral
Science, Houston, TX, USA, †University of Texas School of
Public Health, Management and Policy Science, Houston, TX,
USA
Purpose: Decision support electronic tools (“e-tools”) to improve self-
management of patients with epilepsy are being developed by member
organizations of the CDC-sponsored Managing Epilepsy Well (MEW)
Network in the USA. This presentation will describe the development
and evaluation of the Management Information & Decision Support Epi-
lepsy Tool (MINDSET).
Method: The stepped Intervention Mapping framework informed
MINDSET development including to create a logic model of the problem
and expected change (Steps 1 & 2), plan and produce MINDSET (Steps 3
& 4), and to implement and evaluate MINDSET (Steps 5 & 6). A 9-
month RCT of MINDSET (Version 3.1) compared to a usual care only
condition was conducted with 42 adult patients at three participating neu-
rology specialty clinics in Houston, Texas to determine impact of MIND-
SET on patient self-management.
Results: MINDSET, mounted on a Windows-based Dell tablet, provides
real-time self-management decision support to patients (>18 years) and
their providers in the context of the clinic visit. Patients input data on sei-
zure, medication, and lifestyle management using embedded validated
surveys including the Epilepsy Self-Management Scale, the Neurological
Disorders Depression Inventory for Epilepsy (NDDIE) Screening Tool,
and the Epilepsy Adverse Events profile. A tailored management action
plan is printed for review by the patient and provider. RCT preliminary
results indicate significant between-group difference for self-efficacy for
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management of lifestyle issues (p < 0.05). Between-group behavioral
impact was not demonstrated. Study challenges included cross-contami-
nation, small sample size, and variable number of patient return visits.
Conclusion: Decision support to assess patient epilepsy self-manage-
ment behavior and provision of a tailored action plan is consistent with
approaches from other chronic diseases. RCT findings suggest MIND-
SET’s potential to impact lifestyle behaviors, often ignored in patient-
provider discussions. However, results indicate modifications to further
engage providers and a more rigorous RCT to overcome study design
challenges.
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EEG, HALLUCINATORY SEIZURES AND
SOCIOCULTURAL IMPLICATIONS IN ANAFRICAN
COUNTRY: SENEGAL
A.D. Sow Sembene*, N.F. Ndoye Sall†, M.S. Diop Sene†,
A.M. Basse Faye†, L.B. Seck†, M.M. Sarr†, K. Toure†,
N.S. Diagne†, M. Ba†, N.M. Gaye†, O. Cssé†, M. Ndiaye†,
A.G. Diop†, M.M. Ndiaye†
*Cheikh Anta Diop University, Medecine, Dakar, Senegal,
†Fann Hospital, Neurology, Dakar, Senegal
Purpose: Hallucinatory seizures are partial seizures with strong subjec-
tive connotation. They are difficultly or awkwardly reported by the
patients and/or their relatives. This study is one part of a research long term
project comprising four sections (electrophysiological, socio-psychiatric,
ORL and ophthalmologic).We try to understand these hallucinatory mani-
festations knowing origin and cultural impregnation of our patients.
Method: Prospective study during 5 months in our Neurophysiological
unit in 2014. It concerns all patients refer for hallucinatory seizures, iso-
lated or associated with others types of seizures. Patients did an interview
with the neurologist and after psychiatry, ORL and ophthalmologist for
eliminating organic troubles can explain hallucinations.
Results: We found 31 patients, including 76.9% old from 20 to 50 years,
and a sex-ratio of 1.38 in favor of the men. Patients had a low level
instruction. 25% had done their first seizure before 5 years old and 39%
after 18 years. Hallucinations manifestations was mainly visual (19
cases) and were isolated or associated especially with convulsive sei-
zures. Auditive hallucinations concerned 14 patients against five cases
gustative and psychosensorial (intrapsychic) hallucinations. EEG were
mainly (17 cases) normal or with focal abnormalities, mainly in pariéto-
temporal seat (90% of abnormal cases).
Conclusion: Hallucinatory seizures have a large share of subjectivity
and critical polymorphism. Their dissociation from a particular psycho-
logical state and cultural influences, make more difficult their interpreta-
tion. And then, sociocultural correlations are very hard because of
variable origin and different interpretations of hallucinations toward eth-
nics. Anatomo-electroclinic correlations are also difficult because they
are in the borders between frontal, parietal, temporal, and occipital lobes.
EEG helps to specify the localization of the discharge and its propaga-
tion. Our study shows in 42% of cases parieto-temporal discharges with
posterior propagation.
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ICTALCHANGES IN PARASYMPATHETIC TONE: CAN
THEY PREDICT POST-ICTALOXYGEN
DESATURATION?
W. Szurhaj*, P. Derambure†, F. Semah*, P. Ryvlin‡, J. De
Jonckheere§
*Lille2 University / Lille Medical Center, Lille, France,
†University of Lille 2, Lille, France, ‡Lausanne University
Medical Center, Department of Clinical Neuroscience,
Lausanne, Switzerland, §INSERMCIC-IT 1403, Lille University
Medical Center, Lille, France
Purpose: To measure changes in parasympathetic tone before, during
and after temporal seizures, and to determine whether changes in high-
frequency heart rate variability are correlated with post-ictal oxygen
desaturation. Seizures with desaturation could be associated with a higher
decrease in parasympathetic tone, which could explain the increased risk
of sudden death in patients with epilepsy.
Methods: Retrospective review of 55 partial seizures, with or without
impairment of consciousness but without secondarily generalization,
including recordings of ECG and oxygen saturation during seizures. We
calculated a high-frequency variability index (HFVI, based on the vari-
ability of RR intervals at high frequencies) as a marker of parasympa-
thetic tone for periods of 20 minutes (centered on seizure onset). We
then compared HFVI values in seizures with and without post-ictal
hypoxemia.
Results: At the onset of seizures, HFI decreased rapidly, reached its min-
imum value at the end of the seizure and then gradually returned to its
pre-ictal value. Changes in parasympathetic tone were more intense and
longer-lasting in older patients with a longer duration of epilepsy. The
HFVI was significantly lower during seizures with hypoxemia, and
remained significantly lower five minutes after the end of the seizure.
The change in the HFVI0s slope over the first 30 seconds of the seizure
was predictive of post-ictal oxygen desaturation.
Conclusion: We show a strong link between the presence of oxygen
desaturation and duration of impairment of ANS during partial seizures.
Seizures with desaturation are associated with a more prolonged distur-
bance of ANS, with a delay in the recovery of parasympathetic basal
tone. This prolonged impairment of parasympathetic tone could predis-
pose to a higher risk of sudden death.
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OPTIMIZINGCAREDELIVERY FORPATIENTSWITH
EPILEPSY: OUTCOMES FROMACANADIAN SINGLE
SEIZURECLINIC
S.A. Rizvi, J.F. Tellez-Zenteno, L. Hernandez-Ronquillo
University of Saskatchewan, Neurology, Saskatoon, Canada
Purpose: To determine if a single seizure clinic (SSC) is superior alter-
native to standard care for people with epilepsy (PWE). Care for PWE is
fragmented and there is a lack of evidence to support specific care deliv-
ery platforms.
Methods: A prospective study of all patients (n = 200) referred to our
SSC for first seizure evaluation. Demographic, clinical, and paraclinicial
variables were analyzed against a historical cohort. Binary logistic
regression analysis was conducted to predict impact of dichotomized
variables on epilepsy. Diagnostic concordance between epilepsy nurses
and epileptologists was assessed.
Results: Mean patient age was 42.1 years. Referral sources were
emergency department physicians and general practitioners. A diagno-
sis was established at first-contact in 80.9% of cases while 16.1% of
patients required a second a visit. 41% of patients (n = 81) were diag-
nosed with epilepsy. The most common non-seizure diagnosis was
syncope (24.5% of cases). Mean wait-time for first assessment was sig-
nificantly reduced by 71% (23.6 SSC vs. 80.1 days standard care).
Mean wait-time for an EEG was 4.0 days (37.1 days standard care).
63 patients were started on anti-epileptic drugs (63.50% starting lamot-
rigine, 7% levetiracetam, 5% phenytoin, and 5% topiramate). In 18%
of cases driving restrictions were initiated by the SSC. An abnormal
EEG was found in 63% of patients diagnosed with epilepsy. Presence
of EEG abnormalities increased the odds of epilepsy diagnosis
(OR=2.00–12.75). Patients stratified as high (OR=4.29) or medium risk
(OR=3.57) for seizure recurrence, had imaging abnormalities
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(OR=2.00), reported being amnestic (OR=3.11), had limb stiffening
(OR=2.52), tongue trauma (OR=6.31), or incontinence (OR=4.62) were
at higher risk for epilepsy. There was only moderate correlation
between SSC epilepsy nurses and physicians (kappa=0.54; p < 0.001).
Physicians were significantly more likely to diagnose epilepsy (likeli-
hood ratio of 32).
Conclusion: The SSC, under supervision of epileptologists, reduces
wait-times, improves patient access, and streamlines care.
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ETIOLOGYOFCONVULSIVE ANDNONCONVULSIVE
SEIZURES IN PATIENTSWITH SEVERE TBI
I. Trifonov*,†, V. Krylov*,†, A. Guekht‡, L. Sumskiy†,
I. Kaimovskii§, A. Talypov†
*Moscow State University of Medicine and Dentistry, Moscow,
Russian Federation, †Scientific Research Institute of Emergency
Care named after N. V. Sklifosovsky, Moscow, Russian
Federation, ‡Moscow City Hospital№8 for Neuropsychiatry,
Moscow, Russian Federation, §Moscow City Hospital№12,
Moscow, Russian Federation
Background: There are insufficient data about incidence of convulsive
and nonconvulsive seizures (Sz), convulsive and nonconvulsive status
epilepticus (SE) in traumatic brain injury (TBI) patients. According to
different studies the incidence of convulsive SE and nonconvulsive SE is
8–48%, convulsive Sz and noncovulsive Sz is 3–10%.
Objective: To evaluate the incidence of convulsive SE and nonconvul-
sive SE, convulsive and nonconvulsion Sz in patients with severe TBI
(GCS 4–8).
Methods: Consecutive 24 cohort with TBI were evaluated by EEGmon-
itoring, MRI, CT and followed for 3 months or until death.
Results: Seizures were detected in 13 (54%) patients, including nine
patients with convulsive Sz, two with nonconvulsive Sz and two with
SE. Convulsive Sz occurred immediately in two cases, within 7 days
in three cases and after 7 days in three cases (12–70 days after TBI)
and one patient had early and late seizures. In patients with subdural
hematomas (SDH), epidural hematomas (EDH), diffuse axonal injury
(DAI) the proportion of patients with Sz and without Sz were almost
equal - about 50%. However, patients with multiple brain injury
(MBI) were prone to seizures (80% with seizures, including two non-
covulsive Sz). Nonconvulsive SE and convulsive SE occurred in two
patients: in one patient - convulsive SE and in one patient -were both
convulsive SE and nonconvulsive SE. The mortality rate in all
patients was 41% (10/24), among 10 died patients, 7 (70%) were with
Sz and SE.
Conclusion: The pilot study demonstrate importance of detection con-
vulsive Sz and nonconvulsive Sz, convulsive and nonconvulsive SE in
patients with TBI and confirms the negative prognostic significance in
patients with Sz.
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CLINICAL PROFILEOF PATIENTSWITH
MALFORMATIONSOFCORTICALDEVELOPMENT
I.F. Uludag, I. Ilgezdi, U. Sener, Y. Zorlu
Izmir Tepecik Educational Research Hospital, Neurology, Izmir,
Turkey
Purpose: Cortical dysplasia of various types, reflecting abnormalities of
brain development, have been closely associated with epileptic activities.
The aim of the study was to elucidate the clinical-radiological profile of
patients with malformations of cortical development.
Method: This observational study was conducted at Izmir Tepecik Edu-
cational and Research Hospital, Department of Neurology, Epilepsy Out-
patient Unit. The diagnosis of “Malformations of cortical development”
was based on clinical-radiological data. Details of clinical symptoms and
treatment were reviewed.
Results: Thirty-six cases (17 women and 19 men) of “Malformations of
cortical development” were identified. The mean age was
34.14  10.9 years. The commonest malformations were focal cortical
dysplasia (26/36), polymicrogyria (4/36) and lissencephaly (3/36). agyr-
ia-pachygyria, schizencephaly, and heterotopias were the other malfor-
mations seen. Developmental delay was seen in 8 (22.2%) patients. All
patients had seizures; being as presenting symptom in majority of
patients. All patients were taking anti-epileptic drugs and none of them
had surgery. Thirteen patients (36.1%) were seizure free and 13 (36.1%)
patients were having <2 seizures per month. Drug resistant epilepsy was
seen in 10 patients (27.8%).
Conclusion: The present study provides data on the pattern of malforma-
tions of cortical development seen in a Epilepsy Outpatient Unit. It
emphasize that in most of the patients with malformations of cortical
development, seizures may be controlled with anti-epileptic drugs.
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MYOCLONUS EPILEPTIC STATEAS ARARE
CLINICALMANIFESTATIONOFRING
CHROMOSOME 20 SYNDROME
E. Valle*, I. Garamendi†, M. Agundez†, I. Maestro*,
I. Yurrebaso*, J.J. Zarranz†, A. Marinas†
*Hospital de Cruces, Clinical Neurophysiology. Epilepsy Unit,
Baracaldo, Spain, †Hospital de Cruces, Neurology. Epilepsy
Unit, Baracaldo, Spain
Purpose: Ring Chromosome 20 has a remarkable association with
refractory epilepsy and frequent nonconvulsive status epilepticus. Con-
tinuous myoclonus has been infrequently reported during the clouding of
consciousness periods. The aim of this study is the electroclinical
description of two patients with Myoclonus epileptic state and Ring
Chromosome 20 syndrome.
Methods: Two women (Patient 1: 60 and Patient 2: 37 years old) with
pharmacoresistant epilepsy were admitted in our hospital. They suffered
from tremor states with impairment of consciousness several times a
week. Both patients had mild cognitive impairment. They underwent
long term Video EEG monitoring. After video EEG findings, karyotyp-
ing was performed.
Results: Daily long periods of rhythmic 4–5 Hz clonic axial movements
with a state of fluctuating consciousness were recorded in both patients.
They lasted up to one hour in patient 1 and until six in patient 2. These
states were precipitated by the drowsiness in patient 1 and they appeared
in patient 2 while she was awake. The response to parenteral diazepam
was better in patient 1. Ictal recording showed bilateral rhythmic slow
activity with changing in frequency and a peack of 4–5 Hz, intermixed
with spikes. This activity had higher amplitude in fronto temporal areas
in patient 1 and in central areas in patient 2. The duration of the muscle
activity was 120 msg and was synchronous in the agonist antagonist mus-
cles. This activity was accentuated by touch and during postural holding.
Karyotyping revealed 46, XX/46, XX r(20) in both patients with mosai-
cism of 15% in Patient 1 and 20% in Patient 2.
Conclusion: Our findings support the existence of continuous rhythmi-
cal myoclonus at 4–5 Hz during the confusional long states in patients
with ring chromosome 20. Recognition of this type of seizure could
contribute towards a better diagnosis of Ring Chromosome 20 syn-
drome.
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CARDIACARRHYTHMIAS DURINGORAFTER
EPILEPTIC SEIZURES
M. van der Lende*,†, R. Surges‡, J.W. Sander*,§, R.D. Thijs*,†
*Stichting Epilepsie Instelling Nederland, Heemstede,
Netherlands, †Leiden University Medical Center, Departement
of Neurology, Leiden, Netherlands, ‡University of Bonn Medical
Center, Department of Epileptology, Bonn, Netherlands, §NIHR
University College London Hospitals Biomedical Research
Centre, Department of Clinical & Experimental Epilepsy,
London, UK
Purpose: Seizure-related cardiac arrhythmias are frequently reported
and have been implicated as potential pathomechanisms of Sudden
Unexpected Death in Epilepsy (SUDEP). We attempted to identify clini-
cal profiles associated with various (post)ictal cardiac arrhythmias.
Method: We conducted a systematic search from the first date available
to July 2013 on the combination of two terms: “cardiac arrhythmias” and
“epilepsy”. Databases searched were PubMed, Embase (OVID version),
Web of Science and COCHRANE Library. We attempted to identify all
case reports and case series.
Results: We identified seven distinct patterns of (post)ictal cardiac
arrhythmias: ictal asystole (103 cases), postictal asystole (13 cases), ictal
bradycardia (25 cases), ictal AV-conduction block (11 cases), postictal
AV-conduction block (two cases), (post)ictal atrial flutter/atrial fibrilla-
tion (14 cases) and postictal ventricular fibrillation (three cases). Ictal
asystole had a mean prevalence of 0.318% (95% confidence interval
0.316–0.320) in people with refractory epilepsy who underwent video-
EEG monitoring. Ictal asystole, bradycardia and AV-conduction block
were self-limiting in all but one case and seen during complex partial sei-
zures. Seizure onset was mostly temporal (91%) without consistent later-
alization. Postictal arrhythmias were mostly found following convulsive
seizures and often associated with (near) SUDEP.
Conclusion: The contrasting clinical profiles of ictal and postictal
arrhythmias suggest different pathomechanisms. Postictal rather than
ictal arrhythmias seem of greater importance to the pathophysiology of
SUDEP.
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VALUEOFVIDEOMONITORING FORNOCTURNAL
SEIZUREDETECTION IN EPILEPSYRESIDENTIAL
CARINGHOMES: AN INTERIMANALYSIS
M. van der Lende*,†, J.W. Sander*,‡, R.D. Thijs*,†
*Stichting Epilepsie Instellingen Nederland, Heemstede,
Netherlands, †Leiden University Medical Center, Departement
of Neurology, Leiden, Netherlands, ‡NIHR University College
London Hospitals Biomedical Research Centre, Department of
Clinical & Experimental Epilepsy, London, UK
Purpose: Following a case of SUDEP at a residential care unit, the Dutch
care inspectorate requested the use of video monitoring (VM) at such unit.
All those residents with a clinical suspicion of unwitnessed nocturnal con-
vulsions are now monitored. We audited whether VM resulted in an
increase in the reporting of seizures needing clinical intervention.
Methods: The unit cares for 340 individuals. Acoustic detection systems
cover all and 37 people also have a bed motion sensor (Epicare, Danish
Care). As a result of the request of the care inspectorate, 46 people with
possible nocturnal seizures are monitored by VM regardless whether a
bed motion sensor had been evaluated. We analyzed the seizure charts
for a two month period. Care providers were asked to report which
device/system alerted them of suspected seizure and to indicate if it lead
to an intervention (repositioning; emergency medication; activation
vagal nerve stimulator).
Results: Four hundred and sixty five seizures in 31 individuals were
reported. Eleven of the 31 had an additional bed motion sensor. The total
number of reported seizures was higher in those with versus those with-
out a bed motion sensor (295 vs. 170). The proportion of seizures that
were reported to be seen only on video footage differed per seizure type:
14/158 tonic clonic seizures; 58/125 tonic seizures; 4/11 complex partial
seizures; 18/103 myoclonic seizures; 0/1 simple partial seizures and 18/
67 “unclassified” seizures. Of 97 seizures requiring intervention, 16 were
reported only to be seen on video. This proportion was lower for people
with (6/64) than for those without (10/33) a bed motion sensor.
Conclusion: VM may increase the identification of nocturnal seizures,
especially in those without other detection devices.
Adult Epileptology 8
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GENITALAUTOMATISMS: RAREOR
UNDERESTIMATED SYMPTOMOF FOCAL
SEIZURES?
H.O. Dede, N. Bebek, L. Baysal, C. Gürses, B. Baykan,
A. G€okyigit
Istanbul University Istanbul Faculty of Medicine, Neurology,
Istanbul, Turkey
Purpose: Genital automatisms (GAs) are rare clinical phenomena during
or after epileptic seizures. They are defined as repeated fondling, grab-
bing, or scratching of the genitals. The anatomic correlates of GAs have
been discussed controversially. The aim of this investigation was to
assess the localizing and lateralizing value of GAs.
Methods: Three hundred and fifty one consecutive patients with intract-
able seizures referred to our University Hospital for presurgical evalua-
tion between 2009 and 2014 were investigated. We evaluated the
incidence of these behaviours, the clinical semiology, the associated
symptoms/signs with the corresponding ictal EEG findings and their
potential role in lateralizing the epileptogenic zone.
Results: Eleven (3.2%) of 351 patients showed GAs. GAs occurred
more often in men than in women (M/F: 8/3). GAs were associated with
unilateral hand automatisms as postictal nosewiping or manuplating
movements in 8 (%72.7) of 11. Seven of eleven patients (63.7%) were
affected by temporal lobe epilepsy and four of them (36.3%) were
affected by frontal lobe epilepsy. Epileptic focus lateralized to the left
hemisphere in seven patients, lateralized to the right hemisphere in three
patients and just a patient had bilateral frontal focus in scalp EEG. The
surface EEG showed ipsilateral seizure pattern in six of 11 seizures (%
54) at the onset of GAs. All patients had amnesia for the performance of
GAs.
Conclusions: GAs appear in the ictal or postictal period with impaired
consciousness. Men exhibit GAs more often than women. GAs do not
localize or lateralize per se. Our results indicate that ictal genital automa-
tisms are slightly more frequent in seizures originating from temporal
lobe and they can be seen in frontal lobe seizures too.
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INVESTIGATIONOFNEURONALAUTO-ANTIBODIES
INMESIAL TEMPORAL LOBE EPILEPSYWITH
HIPPOCAMPAL SCLEROSIS
E.N. Vanli- Yavuz*,†, E. Tuzun‡, C. Ulusoy‡, E. Ekizoglu*,
L. Baysal Kırac*, N. Bebek*, C. Gurses*, A. Gokyigit*,
B. Baykan*
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*Istanbul University, Istanbul Faculty of Medicine, Department
of Neurology, Clinical Neurophysiology Unit, Istanbul, Turkey,
†Koc University Hospital, Department of Neurology, Istanbul,
Turkey, ‡Istanbul University, Research Institute of Experimental
Medicine, Department of Neuroscience, Istanbul, Turkey
Purpose: There is increased awareness of autoimmune factors in the eti-
ology of epilepsy. Our aim is to investigate the antibodies developed
against various neuronal proteins in a large series of mesial temporal lobe
epilepsy with hippocampal sclerosis (MTLE-HS) and to elucidate the rela-
tionships between these neuronal auto-antibodies and clinical findings.
Method: We studied eight different anti-neuronal antibodies by RIA,
ELISA and cell based assays in sera of 111 consecutive adult patients
diagnosed with MTLE-HS according to clinical and MRI criteria. The
clinical and laboratory features of antibody positive patients were investi-
gated with a standard form, after their consent. The patients with dual
pathology and without neuropathological confirmation of HS after the
operation were excluded.
Results: We found antibodies against voltage-gated potassium channel
(VGKC)-complex in five patients, contactin-associated protein2
(CASPR-2) in four, glycine receptor (GLY-R) in one and N-methyl-D-
aspartate receptor (NMDA-R) in one patient with MTLE-HS, making a
total of 9.9% seropositivity in the study group. Their current ages were
40.63 years (11.76) and follow-up periods were 97.18 months
(64.63). Two of them had bilateral HS, other two had status epilepticus
episodes and five patients had febrile seizure history. Except two patients
(diagnosed with SLE and Hashimoto) none of the others had a history of
autoimmune disorders. Four of nine patients with drug-resistant course
were operated ending up with Engel 1–2 in the first year. Two patients
had a history of psychotic attacks; one of them became seizure-free spon-
taneously, indicating a fluctuating course. Glutamic acid decarboxylase
(GAD), leucine rich glioma inactivated 1 (LGI1), a-amino-3-hydroxy-5-
methyl-4-isoxazolepropionic acid receptor (AMPA) and GABA receptor
antibodies were not detected in any patients’ sera.
Conclusion: We showed that 9.9% of MTLE-HS patients harbored vari-
ous anti-neuronal antibodies with heterogeneous clinical characteristics.
These antibodies, mostly against potassium channels should be screened
for enlightening the etiology and immune treatment possibilities.
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A BIOSENSOR FORTRACKING SEIZURES: LINKINGA
WRIST ACCELEROMETER TOANONLINE SEIZURE
DATABASE
M. Velez*, R.S. Fisher*, V. Bartlett†, S. Le*
*Stanford University, Neurology, Epilepsy, Stanford, CA, USA,
†Harvard University, Cambridge, MA, USA
Purpose: Because patient and caregiver reports of seizures are unreli-
able, there is a critical need for improved accuracy and reliability of
tracking seizures. Both clinical management of epilepsy and current anti-
convulsant and epilepsy device trials rely on paper diaries with self-
reported seizure frequency as the primary outcome. This is the first study
addressing the feasibility of detecting and recording convulsive seizures
through a biosensor to an online seizure database.
Method: This prospective trial was conducted in the video EEG (vEEG)
Epilepsy Monitoring Unit. Epilepsy patients wore a wristwatch
accelerometer (SmartWatch, SmartMonitor©) that detected and trans-
mitted events via Wi-Fi to a bedside electronic tablet with an online por-
tal. The watch recorded the date, time, audio, duration, frequency and
amplitude of convulsive events. Events logged by the watch were com-
pared to vEEG to determine device sensitivity and specificity to detect
and record convulsions to an online database.
Results: Twenty-one patients were enrolled, 41 epileptic seizures were
recorded on vEEG: 10 convulsive and 31 non-convulsive. The watch cap-
tured 8/10 convulsive seizures. One patient was not wearing the watch at
the time of convulsion. Of the remaining nine convulsions, watch sensi-
tivity was 88.9% (8/9): one short duration myoclonic seizure was not
detected. Watch audio recordings demonstrated seizure activity in 7/9
(77.8%). The watch recorded 77 false positives and 38 patient-initiated
cancellations (49% specificity). False positives were easily explained on
vEEG as non-epileptic repetitive movements such as teeth brushing.
Patients and caregivers reported 5/41 (12.2% sensitivity) seizures but
zero seizures were recorded on paper logs.
Conclusion: Through a biosensor, automatic detection and recording of
tonic clonic seizures to an online database is feasible and should be
employed in for clinical decision making and future clinical drug and
device trials to improve accuracy of seizure counts and characteristics.
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ANTI-NMDARECEPTORENCEPHALITIS: CLINICAL
CHARACTERISTICS, PREDICTORSOFOUTCOME
ANDTHEKNOWLEDGE-PRACTICEGAP IN
SOUTHWESTCHINA
W.Wang, F.-Y. Hu, Z.-X. Ma, X.-H. Lai, B. Yan, Q. Zhang,
L.-Y. Tian, L. Liu, H.-Y. Zhou, B. Zhao, L. Chen, J. Mu, Q. Chen,
R. Wang, J.-M. Li, D. Zhou
West China Hospital, Sichuan University, Department of
Neurology, Chengdu, China
Purpose: This study aimed to analyze the clinical profiles and outcomes
of patients with anti-NMDAR encephalitis in China.
Method: We reviewed the clinical data of patients who received a defini-
tive diagnosis of anti-NMDAR encephalitis between June 2011 and June
2014. Clinical information was obtained, and we compared the patients
who initially presented with seizure with those who initially presented with
psychiatric symptoms.We also analyzed the predictors of poor outcome.
Results: A total of 51 patients with a definitive diagnosis of anti-
NMDAR encephalitis were included in this study. Four of them were
surgically confirmed to have a neoplasm. Thirty-two patients, among
whom 24 were female, presented with psychiatric disorder as the initial
symptom, whereas 14 patients, only five of whomwere female, presented
with seizure as the initial symptom (p = 0.011). Older patients and those
with an extended hospital stay, memory deficits, decreased conscious-
ness, central hypoventilation, complications, positive CSF results, or ele-
vated creatine kinase levels were more likely to have a poor outcome
(p = 0.041, 0.016, 0.031, 0.019, 0.011 0.027, 0.049, and 0.028, respec-
tively). It typically took three weeks before these patients were admitted
to our hospital and another two weeks before the correct diagnosis was
made. The misdiagnosis rate was 56.86%, and 58.8% of the patients
experienced at least one type of complication.
Conclusion: The treatment of anti-NMDAR encephalitis in China con-
tinues to face many challenges. Increasing the awareness of this disorder
and reducing the interval to diagnosis and the rate of complications are
essential and practical measures to improve the prognosis of afflicted
patients.
p0783
IS TEMPORAL LOBEEPILEPSYA PREDISPOSING
FACTOR FOR SLEEPAPNEA?
F.G. Yildiz*, F.I. Tezer†, S. Saygi†
*Institute of Neurological Sciences and Psychiatry, Hacettepe
University, Ankara, Turkey, †School of Medicine, Hacettepe
University, Department of Neurology, Ankara, Turkey
Purpose: The interaction between epilepsy and sleep is known. It
has been shown that patients with epilepsy have more sleep problems.
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However, there is no recent study that compares the frequency of sleep
disorders in groups with medically refractory Temporal lobe epilepsy
(TLE) and Extratemporal lobe epilepsy (ETLE). The main purpose of
this study was to investigate sleep disorders in two subtypes of epilepsy
by using sleep questionnaire forms.
Method: One hundred and eighty-nine patients from 215 who were mon-
itored for refractory epilepsy were followed by the video EEG monitor-
ing unit, divided into TLE and ETLE groups. The medical outcome
study-sleep scale (MOS-SS), Epworth sleepiness scale (ESS) and sleep
apnea scale of the sleep disorders questionnaire (SA/SDQ) were com-
pleted after admission to the video EEGmonitoring unit. The total scores
in the TLE and ETLE groups were compared.
Results: TLE was diagnosed in 101 (53.4%) (45 female) and ETLE was
diagnosed in 88 (46.6%) (44 female) patients. Comparison of MOS-SS
and Epworth sleepiness scale scores in the two subgroups did not reveal
significant differences. In the TLE group SA/SDQ scores were signifi-
cantly higher compared to the ETLE group.
Conclusion: Temporal lobe epilepsy patients have higher risk of OSA
according to their reported symptoms. Early detection of OSA in epilepsy
patients by using questionnaire forms may decrease the risk of ictal or
postictal respiratory related “Sudden Unexpected Death in Epilepsy”
(SUDEP).
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ASSOCIATION BETWEEN INTERLEUKIN 1 BETA (IL-
1b) GENEVARIATIONANDTEMPORAL LOBE
EPILEPSYWITHHIPPOCAMPAL SCLEROSIS
A. Sariteke*, I.F. Uludag*, B. Ozyilmaz†, Y. Zorlu*
*Izmir Tepecik Educational Research Hospital, Neurology,
Izmir, Turkey, †Izmir Tepecik Educational Research Hospital,
Medical Genetics, Izmir, Turkey
Purpose: We attempted to demonstrate a positive association between a
polymorphism in the promoter region of the IL-1b gene resulting in
enhanced gene transcription and the clinical phenotype of temporal lobe
epilepsy with hippocampal sclerosis (TLE+HS).
Method: We determined the frequency of a single nucleotide polymor-
phism (SNP) that results in a C>T transition 511 base pairs five prime to
the transcription start site of the IL-1b gene in a group of 21 patients with
TLE+HS patients, 21 patients with temporal lobe epilepsy without hip-
pocampal sclerosis (TLE-HS) and 23 healthy volunteers.
Results: The frequency of the -511T allele was 11/21 in TLE-HS, 13/21
in TLE+HS and 12/23 in normal control groups. Chi squared analysis of
genotype and allele distribution showed no significant difference
between patients with TLE+HS, TLE-HS and controls.
Conclusion: The results of the current study fail to document an associa-
tion between the -511/C>T SNP variation and TLE+HS.
Basic Science 6
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HISTOPATHOLOGICALCHARACTERISTICSOF
CORTICAL TUBERS IN PATIENTSWITHTUBEROUS
SCLEROSIS COMPLEX - ACOMPREHENSIVE
SEMI-AUTOMATEDTISSUEANALYSIS
A. Mühlebner*,†, J.G.M. van Scheppingen*, H.M. Hulshof‡,
T. Scholl†,§, A. Iyer*, A.M.W. van den Ouweland¶,
M.D. Nellist¶, F.E. Jansen‡, W.G.M. Spliet**, P. Krsek††,
B. Benova††, J. Zamecnik‡‡, M. Feucht†, J.A. Hainfellner§,
D. Prayer§§, T. Czech¶¶, E. Aronica*,***
*Academic Medical Center, Neuropathology, Amsterdam,
Netherlands, †Medical University Vienna, Pediatrics, Vienna,
Austria, ‡University Medical Center Utrecht, Pediatric
Neurology, Utrecht, Netherlands, §Medical University Vienna,
Institute of Neurology, Vienna, Austria, ¶Erasmus Medical
Center Rotterdam, Clinical Genetics, Roterdam, Netherlands,
**University Medical Center Utrecht, Pathology, Utrecht,
Netherlands, ††Charles University, Motol University Hospital,
Pediatric Neurology, Praque, Czech Republic, ‡‡Charles
University, Motol University Hospital, Pathology andMolecular
Medicine, Praque, Czech Republic, §§Medical University
Vienna, Radiology, Vienna, Austria, ¶¶Medical University
Vienna, Neurosurgery, Vienna, Austria, ***Swammerdam
Institute for Life Sciences, Neuroscience, Amsterdam,
Netherlands
Purpose: Tuberous Sclerosis Complex (TSC) is a rare pediatric genetic
syndrome frequently associated with severe intractable epilepsy. In some
of the patients epilepsy surgery can be conducted as treatment option if
the epileptogenic zone can be located to one lesion. On histopathology
the lesions contain dysmorphic neurons, brightly eosinophilic giant cells
and white matter alterations. The aim of this study was to generate a
lesion classification system based on semi-automated histological quan-
tification and find clinically significant correlations.
Method: We studied 29 cases of TSC with representative cortical tubers
and eight matched samples of perituberal cortex in relation to an age- and
region matched control group (n = 12). The following panel of cellular
features were assessed: mTOR activation, amount of neurons, dysmor-
phic neurons, calcification, gliosis, giant cells, vessels, inflammation,
myelin content and amount of oligodendroglia. An Olympus whole slide
scanning system (BX53) was used to obtain images for further processing
on the ImagePro software package (MediaCybernatics, USA). Field frac-
tioning and smart segmentation was applied to analyze the data. The
thresholds were kept the same throughout the analysis.
Results: With regard to the lesion severity (assessed by presence of cal-
cifications, dysmorphic neurons and giant cells) were strong correlations
with inflammation, neuronal cell loss, reduction in myelin content,
mTOR activation, TSC mutation, age of epilepsy-onset and duration of
active epilepsy.
Conclusion: On basis of the available set of data and the clinical impli-
cations we propose a three-tiered classification system: A: presence of
giant cells ≤10 cell/mm². B: giant cells >10 cell/mm²OR presence of dys-
morphic neurons >5/mm². C: giant cells, dysmorphic neurons and calcifi-
cations. This histopathological classification system provides consistent
objective criteria for a better definition of the clinico-pathological fea-
tures of cortical tuber variants and may represent the basis to further
explore imaging, functional and molecular features, and postsurgical sei-
zure outcome.
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BRIVARACETAMDOES NOTMODULATE THE
MAJOR IONIC CONDUCTANCES IN NEURONS
I. Niespodziany*, E.A. Lukyanetz†, A. Matagne*, H. Klitgaard*,
C. Wolff*
*UCB Pharma, Braine l’Alleud, Belgium, †Bogomoletz Institute
of Physiology, Kiev, Ukraine
Purpose: Brivaracetam (BRV) is a selective, high affinity ligand for
synaptic vesicle protein 2A (SV2A) and recently demonstrated positive
Phase III results as adjunctive treatment for partial-onset (focal) seizures
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in adults with epilepsy. BRV binds SV2A with 10- to 30-fold higher
affinity than levetiracetam (LEV), but its exact mechanism of action is
not known. Electrophysiological investigations were performed to deter-
mine whether BRV modulates the major ionic currents activated in neu-
rons. Previous pharmacological studies of BRV, which explored its
effect on low-voltage activated (LVA) and high-voltage activated (HVA)
Ca2+ currents1 and on fast Na+ voltage-gated currents (INaf)
2, are sum-
marised and supplemented with the results of further investigations per-
formed on voltage-gated K+ (IK) and persistent voltage-gated Na
+ (INaP)
currents.
Method: Voltage-clamp experiments were performed under whole-cell
patch-clamp configuration. LVACa2+ currents, HVACa2+ currents, volt-
age-gated K+ currents and voltage-gated Na+ currents were investigated
in isolated dorsal root ganglia neurons from 1- to 2-month-old rats, in dis-
sociated CA1 hippocampal neurons from 14-day-old rats, in primary cul-
tures of mouse hippocampal neurons (10–21 DIV) and in CA1 neurons
from adult rat hippocampal slices, respectively.
Results: In isolated neurons, BRV (0.1 lM–1 mM) did not affect LVA
and HVA Ca2+ current properties, with respect to maximal amplitude,
voltage-dependence and activation/inactivation kinetics. In primary hip-
pocampal cultured neurons, BRV tested at 1, 10 and 100 lMdid not alter
the amplitude of the non-inactivating outward K+ current. Finally, perfu-
sion of BRV did not modify the amplitudes of INaf (300 lM) and INaP (2–
20 lM) recorded in CA1 neurons.
Conclusion: These results suggest that the molecular mechanism of
BRV does not involve major ionic voltage-dependent conductances in
rodent neurons. UCB supported.
References1. Kostyuk PG et al. Epilepsia 2014;45(suppl 7):141–142,
abstract 1.375. 2. Niespodziany I et al. CNS Neurosci Ther 2014;DOI
10.1111/cns.12347.
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EFFECTOFANTIOXIDANTMNTMPYPON
ELECTROENCEPHALOGRAPHIC ACTIVITYDURING
EXPERIMENTALLY INDUCED STATUS EPILEPTICUS
BY LI-PILOCARPINE, 4-AMINOPYRIDINEORKAINIC
ACID IN IMMATURERAT
J. Otáhal, J. Folbergrova, H. Kubova, P. Jiruska
Institute of Physiology of the Czech Academy of Sciences,
Prague, Czech Republic
Purpose: An oxidative stress has been convincingly shown to be an
important contributor to neuronal and mitochondrial damage observed
after status epilepticus in both adult and immature brain. We have shown
recently that acute treatment with cell-permeant SOD mimetic man-
ganese (III) tetrakis(1-methyl-4-pyridyl)porphyrin (MnTMPYP) protects
brain against excessive production of superoxide during status epilepti-
cus. The purpose of the present study was to assess an effect of the
MnTMPYP on the electrographic epileptiform activity during status
epilepticus induced in immature rat.
Method: To record EEG activity during status epilepticus four epidural
silver wire electrodes were bilaterally implanted above sensorimotor cor-
tex. Reference and ground electrode were placed in the occipital bone
above cerebellum. Status epilepticus was induced after postsurgical
recovery in immature 12-day-old male Wistar rats by substances with a
different mechanism of action, namely 4-aminopyridine (bilateral i.c.v.,
100 nmol/side, n = 8), Li-pilocarpine (i.p., LiCl 127 mg/kg at P11 and
the next day pilocarpine 35 mg/kg, n = 13) or kainic acid (i.p., 6 mg/kg,
n = 8). A water soluble antioxidative agent MnTMPYP was applied
(3 mg/kg i.p.) in two time points, 30 minutes before and 30 minutes after
application of the convulsant. The control group obtained adequate vol-
ume of saline. The EEG was continuously recorded for 120 minutes cov-
ering whole period of the experiment. Number and frequency of spikes
and power spectra were obtained usingMatlab software.
Results: Application of all convulsants consistently led to both
behavioral and electrographic seizure activity. The treatment with
MnTMPYT did not affect latency nor severity of behavioral seizures
induced by all three convulsants. Similarly, spike analysis did not
revealed significant alterations in spike frequency and count after
the treatment.
Conclusion: The present study has shown that protective effect of
MnTMPYP during status epilepticus is likely to its antioxidative action.
The study was supported by grant project no. 15-08565S from Czech
Science Foundation.
p0790
DIFFERENTIAL PROTEOMEANALYSIS DURING
EPILEPTOGENESIS: FOCUSON INFLAMMATION
H. Potschka*, A. Walker*, V. Russmann*, L. von Rüden*,
J. Goc*, K.J. Kleinwort*, C.M. Szober*, C. von Toerne†,
C.A. Deeg*, S.M. Hauck†
*Ludwig-Maximilians-University, Munich, Germany,
†Helmholtz Center Munich, Neuherberg, Germany
Purpose: Excessive inflammatory signaling is considered as a major
contributing factor to epileptogenesis. Differential proteome analysis can
provide comprehensive information about the sequential alterations in
inflammatory signaling cascades during epileptogenesis. Expected data
sets can suggest novel target and biomarker candidate.
Method: Epileptogenesis was triggered by electrical stimulation of the
basolateral amygdala and induction of status epilepticus in Sprague Daw-
ley rats. Hippocampus and parahippocampal cortex tissue has been col-
lected at three different time points reflecting the early post-insult phase,
the latency phase and the chronic phase with spontaneous recurrent sei-
zures. Development of seizures was monitored by a 2 week video-EEG
recording. Samples were subjected to a liquid chromatography tandem
mass spectrometry (LC-MS/MS) proteomics profiling approach based on
label-free quantifications.
Results: Parahippocampal cortex data sets revealed a higher number
of differentially expressed proteins as compared to the hippocampus.
The most pronounced regulation of protein groups linked with immune
and inflammatory responses was observed during the latency phase.
The functional categories comprised proteins associated with leukocyte
transendothelial migration, Toll-like receptor signaling, prostaglandin
synthesis and regulation, heat shock protein regulation, and heat shock
factor interaction. In the early post-insult phase, proteins associated
with signaling of transforming growth factor beta proved to be differ-
entially expressed. In the chronic phase findings from the parahip-
pocampal cortex demonstrated a regulation of proteins associated with
integrin signaling.
Conclusion: In-depth bioinformatic analysis of the proteomic data sets
rendered novel information about the time course of expression regula-
tion of inflammation-associated proteins. Moreover, the findings point to
previously unknown players in the disease-associated inflammatory
interactome, which are co-regulated along with other proteins already
known to be regulated during epileptogenesis. Future studies are neces-
sary validating novel target and biomarker candidates.
p0793
COGNITIVEDEFICITS ANDASTROCYTICMYO-
INOSITOL (MINS) PREDICT EPILEPSY
DEVELOPMENT INARATMODELOF STATUS
EPILEPTICUS
T. Ravizza, R. Pascente, F. Frigerio, M. Rizzi, D. Tolomeo,
M. Filibian, A. Vezzani
Epilepsia, 56(Suppl. 1):3–263, 2015
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IRCCS-Istituto di Ricerche Farmacologiche ‘Mario Negri’,
Milano, Italy
Purpose: We evaluated cognitive deficits and astrocyte activation dur-
ing epileptogenesis to explore whether they represent predictive
biomarkers of epilepsy development and neuropathology.
Method: Animal randomization and blinding procedure for data analy-
sis were applied. Status epilepticus (SE) was induced by lithium+pilo-
carpine in 21 day-old Sprague-Dawley male rats (n = 27) to provoke
epilepsy only in ~60% of rats. Rats were exposed longitudinally to 1H-
MRS (7 Tesla) at day 1, 2, 3, 7, 9, 22 and 75 post-SE, to encompass
epileptogenesis preceding spontaneous seizure onset in this model. We
measured mIns (a metabolite specifically induced in activated astro-
cytes) in the hippocampus, a key epileptogenic area in this model. Rats
were tested in the Morris water-maze at 15 and 65 days post-SE.
Thereafter, all rats were electrode-implanted and EEG recorded for
2 weeks (24/7) at 7 months post-SE to identify animals with or with-
out spontaneous seizures. A post-hoc analysis of learning ability and
mIns level measured during epileptogenesis was done in these two
groups. Age-matched controls (lithium+saline, n = 18) were exposed
to 1H-MRS and behavioral test.
Results: SE severity and duration were similar in all animals, as quanti-
fied behaviorally in MRI-exposed animals and by EEG analysis in a par-
allel cohort of electrode-implanted rats. Our data show: (a) an
irreversible learning deficit at 15 and 65 day-post SE (2-fold longer
latency to reach the platform) only in rats later developing epilepsy; (b)
~40% increase in mIns levels at 7 and 9 days post-SE (p < 0.01 vs. con-
trol); mIns increase persisted up to 75 days only in rats later developing
epilepsy, whereas it returned to control level in non-epileptic rats. Brain
histology will assess if behavioral changes and mIns levels predict the
extent of neurodegeneration in rats.
Conclusion: Our results identify putative biomarkers for predicting epi-
lepsy development in individuals at-risk using approaches readily trans-
latable to the clinic.
p0794
ROLEOFMATRIXMETALLOPROTEINASE-9 (MMP-
9), RHOKINASE (ROCK II) ANDGLYCOGEN
SYNTHASEKINASE-3b (GSK-3b) IN THE PROTECTIVE
EFFECTOFCURCUMIN IN PENTYLENETETRAZOLE
(PTZ)-INDUCEDKINDLING IN RATS
K. Reeta, P. Prabhakar, Y.K. Gupta
All India Institute of Medical Sciences, Pharmacology, New
Delhi, India
Purpose: We have recently demonstrated anti-epileptic effect of cur-
cumin. Matrix metalloproteinase-9 (MMP-9), rho kinase (ROCK II) and
glycogen synthase kinase-3-b (GSK-3b) have been implicated in patho-
genesis of epilepsy. In the present study, the effect of curcumin on the
expression of MMP-9, ROCK II and GSK-3b in pentylenetetrazole
(PTZ)-induced kindling was evaluated.
Method: PTZ (30 mg/kg, i.p.) was administered on alternate days up
to day 43 or until seizure stage 5 on two consecutive trials was
achieved, whichever was earlier. Curcumin, suspended in 0.1% car-
boxymethylcellulose (CMC), was administered daily per orally (p.o).
The animals were randomly divided into five groups (n = 6). Group I
(Normal control) received no active treatment. Group II (vehicle con-
trol) was administered 0.9% saline i.p. and CMC p.o. Group III (PTZ
group) was injected PTZ, i.p on alternate days. Group IV was pre-
treated with curcumin in a dose of 300 mg/kg in addition to alternate
day PTZ. In this group, curcumin was administered 30 minutes before
PTZ administration on the days of PTZ injection. Group V (per se)
was administered curcumin, 300 mg/kg, p.o daily. Western blot analy-
sis was performed to study the expression of MMP-9, ROCK II and
GSK-3b.
Results: Curcumin caused significant increase in development of kin-
dling, latency to myoclonic jerks as well as latency to GTCS and
decrease in number of myoclonic jerks as compared to PTZ group.
PTZ-induced kindling in rats caused significant increase in the
expressions of MMP-9, ROCK II and GSK -3b which were prevented
by curcumin. Curcumin per se did not alter MMP-9, ROCK II and
GSK -3b expressions.
Conclusion: This study demonstrates a possible role of MMP-9, ROCK
II and GSK -3b in the antiepileptic effect of curcumin in PTZ-induced
kindling in rats.
Acknowledgement: The work was supported by Institute Research
Grant to Dr KH Reeta.
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UPSTREAMANDDOWNSTREAMMTORPATHWAY
HYPERACTIVATION IN FOCALCORTICAL
DYSPLASIA TYPE II
L. Rossini*, R. Garbelli*, F. Villani*, T. Granata†, E. Freri†,
L. Tassi‡, G. Tringali§, M. Cossu‡, R. Spreafico*
*IRCCS Foundation Neurological Institute ‘C. Besta’,
Department of Clinical Epileptology and Experimental
Neurophysiology, Milan, Italy, †IRCCS Foundation
Neurological Institute ‘C. Besta’, Pediatric Neuroscience,
Milan, Italy, ‡Niguarda General Hospital, Epilepsy Surgery
Center ‘C. Munari’, Milan, Italy, §IRCCS Foundation
Neurological Institute ‘C. Besta’, Neurosurgery, Milan, Italy
Purpose: FCD II are malformation of cortical development frequently
associated with intractable epilepsy and characterized by cortical dys-
lamination and abnormal cells including dysmorphic neurons (DNs) and
balloons (BCs). The downstream mediators of the mTOR pathway -
important network involved in multiple functions during development
and maturational stages - are abnormally activated in both DNs and BCs,
suggesting a role in the pathogenesis of FCD II, but less is known about
upstream activators. Aim of this work is to clarify the contribution of the
upstream compartment PI3K-Akt to mTOR pathway activation in surgi-
cal specimens presenting FCD II.
Method: We analyzes, in surgical samples from patients with FCD II
(19 cases) and Rasmussen Encephalitis (RE- three cases used as compar-
ison tissue without developmental malformation), the expression pattern
of pS6 (downstream target), pPDK1 and pAkt (upstream targets). We
also perform a cell count and a plotting analysis of BCs and DNs positive
for mTOR markers. Moreover, immunofluorescence experiments were
made combining mTOR markers with GAD, VIM and SMI (to identify
interneurons, BCs and DNs).
Results: In FCD II, DNs and BCs express upstream and downstream tar-
gets. pS6 is detected in almost all abnormal cells, conversely, pPDK1 and
pAkt, distributed in the same spatial areas of pS6, are observed in a less
proportion of DNs (respectively in 41% and 25%) and BCs (respectively
in 87% and 63%). In contrast, in RE cases, the rare DNs are pS6 positive
but pPDK1 and pAkt negative.
Conclusion: In FCD II, the PI3K-Akt compartment is only partially
responsible to the mTOR hyperactivation; therefore, as in acquired epi-
lepsy (RE), additional mechanisms, for example linked to epileptic activ-
ity or inflammatory mechanisms might be involved.
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UPHOLDINGWAG/RIJ RATSAS AMODELOF
EPILEPTOGENESIS: PHARMACOLOGICAL
EFFICACY
E. Russo, R. Citraro, G. De Sarro
University of Catanzaro, Science of Health, Catanzaro, Italy
Purpose: WAG/Rij rats display spontaneous absence-type seizures that
are accompanied by generalized SWDs similar to human absence sei-
zures and represent a validated animal model of absence epilepsy[1].
Recently, WAG/Rij rats have been indicated as a relevant model of
genetically determined epileptogenesis[2]. WAG/Rij rats, as well as
GAERS, are genetically prone to develop spontaneous absence seizures
during their lifespan with only few early immature EEG-SWDs, which
increase in number and duration with ageing also changing their mor-
phology to become fully matured and expressed in all rats only after 2–
3 months of age. In this light, both strains can be considered models of
epileptogenesis where an early intervention can modify the underlying
process and future development of seizures[2, 3].
Method: We have reviewed all scientific articles on antiepileptogenic
treatments inWAG/Rij rats.
Results: The first article demonstrating that an early drug intervention
has antiepileptogenic effects in WAG/Rij rats was published at the end of
2007 by Blumenfeld, et al.[2]. Ethosuximide was demonstrated to sup-
press the development of SWDs. In the same year, we demonstrated that
fetal exposure to ethanol had similar effects [4]. Subsequently,
antiepileptogenic effects were demonstrated for levetiracetam, zon-
isamide, vigabatrin, rapamycin, statins, fluoxetine, duloxetine, clomipra-
mine and etoricoxib while no effects were observed for carbamazepine,
haloperidol, risperidone and quetiapine.
Conclusion: WAG/Rij rats may represent a good opportunity to study
genetically determined epileptogenesis. Molecular studies are needed to
better define the process underlying seizure development in this strain.
Finally, the recent study by Berg et al.[5] supporting that ethosuximide
might have disease-modifying effects in childhood absence epilepsy has
confirmed the data obtained in this model.
[1] Sarkisova & van Luijtelaar. Prog Neuropsychopharmacol Biol
Psychiatry 2011;35:854–76.
[2] Blumenfeld et al. Epilepsia 2008;49:400–9.
[3] Pitkanen & Engel. Neurotherapeutics 2014;11:231–41.
[4] Russo et al. Int J Dev Neurosci 2008;26:739–44.
[5] Berg et al. Epilepsia 2014;55:551–7.
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THE BLOOD-BRAIN BARRIER INTEGRITYAND
EPILEPTOGENESIS INGENETIC ABSENCE
EPILEPSYOFWAG/RIJ RATSWITHCORTICAL
DYSPLASIA
D. Sahin*, C.U. Yilmaz†, N. Orhan‡, C. Gürses§, B. Ahıshalı§,
N. Arıcan§, M. Kucuk§, N. Ateş*, I. Elmas§, M. Kaya¶
*Kocaeli University / Medical Faculty, Kocaeli, Turkey,
†Istanbul University, Institute for Experimental and Medical
Research (DETAE), Istanbul, Turkey, ‡Istanbul University,
Institute of Experimental Medicine, Istanbul, Turkey, §Istanbul
University, Istanbul Faculty of Medicine, Istanbul, Turkey,
¶Istanbul University, Istanbul Faculty of Medicine Department
of Physiology, Istanbul, Turkey
Purpose: Absence epilepsy appears with age in WAG/Rij rats. This
study investigates the effects of cortical dysplasia (CD) on the blood-
brain barrier (BBB) integrity and epileptogenesis in genetic absence epi-
lepsy model ofWAG/Rij rats.
Method: Pregnant WAG/Rij rats with genetic absence epilepsy were
exposed to 145 cGy of gamma-irradiation on embryonic day 17 to induce
CD. In the offsprings of the pregnant animals, EEG was recorded and
horseradish peroxidase (HRP) was used as the BBB tracer.
Results: A massive cortical atrophy indicating cerebral cortex loss was
shown in WAG/Rij rats with CD. There is a significant decrease in the
number and duration of spike-and-wave discharges (SWDs) and an
increase in the frequency of SWDs in WAG/Rij rats with CD when com-
pare to the properties of SWDs in the intact WAG/Rij rats (p < 0.05).
Ultrastructurally, frequent vesicles containing HRP reaction products
were observed in the cytoplasm of capillary endothelial cells in the cere-
bral cortex and thalamus of WAG/Rij rats with CD prominently more in
the intact WAG/Rij group. Tight junctions were ultrastructurally intact in
animals in both groups.
Conclusion: In conclusion, CD could play an important role both in
the formation and duration of SWD and also in the frequency patterns
of this wave in WAG/Rij rats. Our data also demonstrated that the
induction of CD exacerbated BBB disruption that was observed in the
WAG/Rij rats.
p0800
WHITEMATTER PATHOLOGY IN PEDIATRIC
EPILEPSY SURGERY SPECIMEN - AQUANTITATIVE
HISTOLOGICALANALYSIS
T. Scholl*,†, A. Mühlebner†,‡, G. Ricken*, A. Fabing*,†,
T. Czech§, J. Hainfellner*, E. Aronica‡,¶,**, M. Feucht†
*Medical University of Vienna, Institute of Neurology, Vienna,
Austria, †Medical University of Vienna, Department of
Paediatrics and Adolescent Medicine, Vienna, Austria,
‡Academic Medical Center, Department of (Neuro) Pathology,
Amsterdam, Netherlands, §Medical University of Vienna,
Department of Neurosurgery, Vienna, Austria, ¶University of
Amsterdam, Swammerdam Institute for Life Sciences, Centre for
Neuroscience, Amsterdam, Netherlands, **SEIN – Stichting
Epilepsie Instellingen Nederland, Heemstede, Netherlands
Purpose: Focal Cortical Dysplasia (FCD) can be found in 42% of chil-
dren with medically refractory seizures. It is characterized by: disruption
of cortical lamination (Type I), balloon cells and/or dysmorphic neurons
(Type II) or can be associated with other principal lesions (Type III).
Specific histopathological features characterize each subgroup and quite
recently white matter alterations have been identified.
Aim: The aim of this study was to evaluate the degree of white matter
pathology and give insights into underlying causes.
Methods: An immunohistochemical analysis of cortical white matter
sections for oligodendroglial and myelination markers in 80 pediatric
patients ([mean age 11 years], lesional and perilesional regions was
performed in: cortical tubers, focal cortical dysplasia, complex cortical
malformations, mild malformations of cortical development and con-
trols). Stained sections were digitalized in high resolution, followed by
a standardized quantitative image analysis, utilizing a ImageJ based
macro for full automatic processing of whole region specific staining.
Correlations and linear regression models were performed using SPSS
(Version 22.0).
Results: Immunoreactive responses (CD3, CD68) were seen in all
lesions compared to perilesional areas. Evaluation of oligodendroglial
staining (Olig2) identified an increased amount of oligodendroglial cells
in FCD type Ia and IIa compared to perilesional regions and controls. In
contrast, two populations were identified in FCD type IIb, showing either
increase or decrease of Olig2-positive cells. These populations signifi-
Epilepsia, 56(Suppl. 1):3–263, 2015
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cantly correlate with the degree of myelin pathology (MBP, CNPase).
Immunofluorescence double staining identified a slight increase in prolif-
erating oligodendrocytes (Olig2, Ki67) compared to samples with lower
expression.
Conclusion: The myelination pathology in all FCD lesions shows a con-
tinuous spectrum ranging from increase in oligodendroglia up to severe
myelin and oligodendrocyte loss suggesting a regenerative process due to
intractable epilepsy.
p0801
CYCLICGABACONFORMERANDGLYCINEAS
NATURAL ENDOGENAGONISTSOFGABA-
BENZODIAZEPINE-RECEPTORCOMPLEX
G.N. Shilau
Byelorussian Medical Academia of Postgraduate Education,
Minsk, Belarus
Purpose: The aim of the present work is searching for natural endogen
agonists of GABA-benzodiazepine’s receptors and synthesis of new anti-
convulsants (Ac) on the basis of their structural similarity.
Method:
We studied:
1. Molecular geometry and quantum chemistry of the barbiturates and
benzodiazepines pharmacophores, main GABA conformers (linear, cyc-
lic, scoop) and glycine using molecular mechanics approximation with
the use of the MM2 force field;
2. Effect of introventrical injection of GABA and glycine on the cere-
bral neurophysiological activity in rats (EEG analysis);
3. Anticonvulsant activity of different one-valence salts of glycine and
GABA using strychnine, picrotoxin, pentylenetetrazol and maximal elec-
tro seizure models.
4. Activity of the chlorine ionic channels was studied using the patch-
clampmethod on rat gliome cell cultures of C6 line.
Results: 1. Molecular geometry of the derivatives of barbiturates, benzo-
diazepines and glycine reminds that of cyclic GABA-conformer.
2. Introduced in same dosage glycine produces more pronounced and
prolong inhibition of the brain cortex bioelectrical activity as GABA.
3 Using the main convulsive models (pentylenetetrazol and maximal
electro seizure) there was revealed a pronounced anticonvulsant activity
of the glycine Li salt,
4. It is believed that GABA-scoop conformer and glycine open chlo-
rine ionic channels; Li salt of glycine has an ability of passing through
BBB using a channel with strong inside field (11-th Eisenman’s
sequence).
Conclusion: 1. GABA-cyclic conformer and glycine act as natural
endogen agonists of GABA-a-benzodiazepines receptor complex in
CNS, while barbiturates and benzodiazepines act as their artificial ago-
nists.
2. GABA-scoop conformer and glycine act like biotic endogen agonist
GABA-benzodiazepine-receptor complex.
3. Developing new antiseizure drugs incorporating glycine pharma-
cophore in their structure (like Li salt of glycine) might be a promising
direction in antiepileptic neuropharmacology.
p0805
EFFECTOFTHEENDOCANNABINOID RECEPTOR
AGONISTWIN-55 212-2 ON EARLY
ELECTROGRAPHIC CHANGES INA POST-STATUS
MODELOFEPILEPTOGENESIS
E. Suleymanova*, V. Blik*, C.M. van Rijn†, L.V. Vinogradova*
*Institute of Higher Nervous Activity and Neurophysiology RAS,
Moscow, Russian Federation, †Donders Institute for Brain,
Cognition and Behavior, Radboud University, Nijmegen,
Netherlands
Purpose: This study was performed to investigate whether stimulation
of endocannabinoid system early after status epilepticus (SE) could pre-
vent or modify the subsequent epileptogenesis. We studied the effect of
an agonist of endocannabinoid receptors, WIN-55 212-2, on electro-
graphic features during the latent period of post-SE epileptogenesis in
rats.
Method: The study was carried out on the lithium-pilocarpine model of
temporal lobe epilepsy (TLE). Rats were treated with LiCl (127 mg/kg)
24 hour before administration of pilocarpine (25 mg/kg). SE lasted for
90 minutes and was stopped by injection of pentobarbital (25 mg/kg).
WIN-55 212-2 (5 mg/kg) or vehicle (DMSO) was administered 4 hour
after the end of SE. Cortical and hippocampal electrographic activity was
recorded in awake freely moving rats using NeuroLogger (TSE Systems).
Behavior was video-recorded. Data of video-EEG monitoring were ana-
lyzed offline; the first 34 hour after SE and two 30 hour records made
during the period from day 7 to day 12 after SE were included in the anal-
ysis.
Results: During the first 34 hour after SE, recurrent generalized seizures
appeared on EEG. These seizures included both convulsive seizures and
ones without obvious motor manifestations. In the period 7—12 days
after SE, such generalized seizures did not occur; however, short (1–
3 second) 5 Hz cortical spike-and-wave discharges were observed.
These discharges were not associated with motor seizures. Administra-
tion of WIN-55 212-2 significantly reduced the total duration of convul-
sive seizures during the first 34 hour after SE and in addition, suppressed
the following development of cortical 5 Hz discharges.
Conclusion: Administration of the potent agonist of endocannabinoid
receptors WIN-55 212-2 had an anticonvulsive effect during the first
34 hour after SE and suppressed further development of non-convulsive
cortical spike-and-wave discharges during the early latent period of
epileptogenesis. This study was supported by the Russian Foundation for
Basic Research, project no. 14-04-01184.
p0806
VOXEL-BASEDMORPHOMETRY IN THEEPILEPTIC
BABOON
C.A. Szabo*, F.S. Salinas†
*UTHSC at San Antonio, Neurology, San Antonio, TX, USA,
†UTHSC at San Antonio, Research Imaging Institute, San
Antonio, TX, USA
Purpose: There is conflicting data regarding structural imaging and
histopathological findings in people with genetic generalized epilepsies
(GGE). The epileptic baboon represents a natural model for GGE, elec-
troclinically resembling juvenile myoclonic epilepsy. We evaluated
structural MRI differences between epileptic baboons and asymptomatic
controls using voxel-based morphometry (VBM). We intend to correlate
these abnormalities using functional neuroimaging and histopathological
findings.
Methods: Twenty-eight, adult baboons (14 EPI/ 14 CTL; 12  5 years)
underwent standard anatomical (MP-RAGE) MRI scanning on a 3T Sie-
mens TIM Trio (Siemens, Erlangen, Germany); each baboon was sedated
using intravenous ketamine (5–6 mg/kg/hour) and paralyzed with
vecuronium (0.1–0.3 mg/kg) throughout the scan. Data processing and
analysis were performed using FSL’s VBM toolbox, in which each
baboon’s scan underwent
1) brain extraction,
2) tissue segmentation,
3) study-specific gray matter baboon template creation,
4) non-linear image registration to the baboon brain template.
Each baboon’s spatially normalized scan was then used to assess
voxel-wise differences between the EPI and CTL groups.
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Results: Significant (p < 0.05) increases in gray matter volume (GMV)
were noted bilaterally in the anterior medial frontal and occipital, lateral
frontoparietal, as well as cingulate cortices (Figure 1). Significant
decreases in gray matter volume were noted in the thalami, midline cere-
bellum and pontomedullary brainstem.
Conclusions: Similar to human studies of GGE, the epileptic baboons
with GGE demonstrated (GMV) decreases in the thalami, cerebellar
midline and and brainstem suggesting secondary injury due to chronic
epilepsy. Cortical GMV, on the other hand, is increased diffusely, but
sparing the medial frontoparietal and basal temporal cortices.
Increased cortical GMV in human GGE is thought to reflect develop-
mental abnormalities. In summary, this preliminary VBM study indi-
cates suspected developmental and acquired GMV changes in the
epileptic baboon, which need to be confirmed with cerebral
histopathology.
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ALTERATIONOF THEGABA-A RECEPTOR a1
SUBUNIT EXPRESSION IN DIFFERENT TYPESOF
INTERNEURONSOFTHEHUMANEPILEPTIC
HIPPOCAMPUS
K. Toth*,†, M. Drexel‡, L. Er}oss§, J. Vajda§, P. Halasz†,
G. Sperk‡, Z. Magloczky†
*Research Centre for Natural Sciences, Institute of Cognitive
Neuroscience and Psychology, Budapest, Hungary, †Institute of
Experimental Medicine, Hungarian Academy of Sciences,
Budapest, Hungary, ‡Innsbruck Medical University, Innsbruck,
Austria, §National Institute of Clinical Neurosciences,
Budapest, Hungary
GABAergic inhibition is known to play a complex role in the pathome-
chanism of epilepsy. Beside the interneuron loss and fiber reorganiza-
tion, other factors like changes in the subunit composition of certain
transmitter receptors also contribute in the pathological changes affect-
ing the function of the preserved interneurons. In this study we exam-
ined the changes of the expression of GABA-A receptor a1 subunit
(a1) in different functional types of interneurons. Surgically removed
hippocampi of drug-resistant temporal lobe epileptic patients were
examined and compared with control samples. We analyzed the density
and synaptic coverage of the a1-immunopositive interneurons. The
coexpression of a1 and calcium binding proteins - parvalbumin (PV)
and calbindin (CB) - in interneurons was studied using immunofluores-
cent double labeling. In control, a1-positive cells were found through-
out the entire hippocampus with largest densities in the CA1 region
and the hilus. The density decreased in the hilus of patients with hip-
pocampal sclerosis. In the CA1 region an increased density of
immunoreactive cells was found, which may be partially explained by
the tissue shrinkage. The percentage of a1-positive-neurons also
expressing CB is reduced significantly in the sclerotic CA1. In the
hilus, the percentage of a1-positive neurons containing CB increased,
and significantly more CB-positive interneuron showed a1-expression.
In contrast, a decreased amount of PV-positive cells expressed the a1
subunit in the hilus of epileptic patients. Electron microscopic exami-
nation showed that both asymmetric- and symmetric synaptic coverage
of a1-positive dendrites was increased in the sclerotic epileptic sam-
ples, probably reflecting the sprouting of excitatory pathways and inhi-
bitory cells. These data suggest pronounced differences of co-
expression of a1 with interneuron-markers in sclerotic epileptic human
hippocampal tissue, as well as regional differences between the hilus
and CA1 region. Changes in the subunit composition can lead to an
altered response to GABAergic inputs and influence the sensitivity to
certain drugs.
p0809
INFLAMMATORYMEDIATORS INHUMANEPILEPSY:
A SYSTEMATIC REVIEWANDMETA-ANALYSIS
B. Van den Munckhof*, E.E. de Vries*, K.P. Braun*, A. van
Royen-Kerkhof†, W. de Jager‡, F.E. Jansen*
*Brain Center Rudolf Magnus, University Medical Center
Utrecht, Department of Pediatric Neurology, Utrecht,
Netherlands, †University Medical Centre Utrecht, Department
of Pediatric Immunology, Utrecht, Netherlands, ‡University
Medical Center Utrecht, Laboratory of Translational
Immunology, Department of Pediatric Immunology, Utrecht,
Netherlands
Purpose: The mechanisms underlying epileptogenesis and seizures are
incompletely understood. Accumulating evidence suggests a link
between inflammation and epilepsy. The objective of this systematic
review is to provide an overview of studies that investigated the involve-
ment of inflammatory mediators, in human epilepsy.
Methods: A systematic literature search was conducted in MEDLINE,
EMBASE and Cochrane databases. Original studies reporting inflamma-
tory mediator levels in serum, cerebrospinal fluid or brain tissue of
patients with epilepsy were included. Only studies comparing patients to
controls were included in an aggregate meta-analysis.
Results: The search yielded 3.980 articles, of which 66 articles reporting
on 1934 patients were eligible for inclusion. IL-1ra, IL-1b, IL-6, IL-10,
IFN-c and TNF-a were the most extensively investigated proteins and
results concerning their significance are equivocal. Elevated levels for
IL-1ra, IL-1b and IL-6 were reported in several different epilepsy etiolo-
gies and media, while other proteins were specifically increased for one
etiology. In brain tissue IL-22, -25, -27, TGF-b, CCL 2, 3, 4, 5, 19, 22,
CXCL 19, S100-b and COX-2 were reported significantly elevated. In a
meta-analysis combining the results of 27 studies including serum and
CSF data of 664 epilepsy patients, we found a significant difference in
inflammatory protein levels between patients and controls for serum IL-
6, IL-17 and CSF IL-1b and IL-10.
Conclusion: The results of this systematic review confirm that inflam-
matory pathways are involved in epilepsy. The inflammatory response in
epilepsy can be divided in a systemic response and a focal (brain)
response, as reflected by the different inflammatory profiles that we
found. Future studies may further clarify the role of inflammation in epi-
lepsy and may prove the potential of anti-inflammatory treatment.
p0811
SEIZURES, SLEEP-WAKE STATES AND JET LAG:
DOESMELATONERGICANTIDEPRESSANTHELP TO
RESTORE INTERNAL SYNCHRONY?
M.K. Smyk*,†, G. van Luijtelaar†, H. Huysmans‡,
W.H. Drinkenburg‡
*Jagiellonian University in Krakow, Department of
Neurophysiology and Chronobiology, Chair of Animal
Physiology, Institute of Zoology, Krakow, Poland, †Radboud
University Nijmegen, Donders Centre for Cognition, Donders
Institute for Brain, Cognition and Behaviour, Nijmegen,
Netherlands, ‡Janssen Pharmaceutica NV, Department of
Neuroscience, Janssen Research &Development, Beerse,
Belgium
Purpose: Rhythmic occurrence of absence seizures in WAG/Rij rats, a
validated animal model of childhood absence epilepsy, is determined
by the circadian timing system. Stable phase-relationship between sei-
zures and sleep-wake states is maintained in the 12:12 light-dark cycle.
Rapid, unexpected changes in the photoperiod, e.g. caused by long-dis-
tance air travels, result in a loss of the synchrony. Re-synchronization
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was found to be accelerated by melatonin and its agonists. The aims of
the present study were to investigate the re-adaptation of the various
sleep-wake states and absence seizures to an 8 hour phase delay and to
assess the effect of the melatonergic antidepressant agomelatine on the
speed of re-synchronization of the different electroencephalographic
(EEG) states.
Method: Simultaneous EEG and electromyographic (EMG) recordings
were made in adult, male WAG/Rij rats, a strain endowed with hun-
dreds spike-wave discharges (SWDs) daily, to assess the effect of vari-
ous doses of agomelatine on sleep-wake states and absence seizures
(acute study, 3 days) and to investigate the effect of the compound on
the process of re-synchronization after the phase delay (chronic study,
11 days).
Results: Agomelatine showed neither an effect on sleep-wake parame-
ters in the acute study, nor affected SWDs and re-synchronization in the
chronic study. Internal desynchronization between various rhythm was
observed, however, some rhythms remained coupled (active wakefulness
and deep slow-wave sleep, SWDs and light slow-wave sleep). A post-
shift increase in passive wakefulness and a reduction in deep slow-wave
sleep resulted in an aggravation of epileptic activity.
Conclusion: Different speed of re-entrainment and coupling between
various rhythms suggests that SWDs and light slow-wave sleep are con-
trolled by common circadian mechanism distinct from that for active
wakefulness and deep slow-wave sleep. The increase in the number of
seizures after the phase shift may be of significant importance for people
with epilepsy planning transmeridian flight.
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EXPRESSIONOF INFLAMMATIONRELATED
MICRORNASMIR21,MIR146A ANDMIR155 IN
TUBEROUS SCLEROSIS COMPLEXCORTICAL
TUBERSANDTHEIRMODULATION INCULTURED
HUMANASTROCYTES
J. van Scheppingen*, A.M. Iyer*, J.J. Anink*, A. Muehlebner-
Fahrngruber*, F.E. Jansen†, W.G. Spliet‡, E.A. van Vliet*,
E. Aronica*,§,¶
*Academic Medical Center, University of Amsterdam,
Neuropathology, Amsterdam, Netherlands, †University Medical
Center Utrecht, Department of Pediatric Neurology, Utrecht,
Netherlands, ‡University Medical Center Utrecht, Department
of Pathology, Utrecht, Netherlands, §SEIN – Stichting Epilepsie
Instellingen Nederland, Heemstede, Netherlands, ¶Swammerdam
Institute for Life Sciences, Center for Neuroscience, University
of Amsterdam, Amsterdam, Netherlands
Purpose: Tuberous sclerosis complex (TSC) is a genetic disease charac-
terized by cortical tubers, giant cell astrocytomas and sub-ependymal
nodules in the brain. Seventy to 90% of people with TSC have epilepsy,
often unresponsive to anti-epileptic drugs. The innate inflammatory
response is thought to play an important role in TSC pathology. Recent
studies suggest that microRNAs (miRNAs), specifically miR21, miR146
and miR155, may function as crucial regulators of inflammatory path-
ways linked to epileptogenesis. The aim of the present study was to char-
acterize the expression of the inflammation-related miRNAs miR21,
miR146a and miR155 in TSC and control brain tissue and the effect of
their modulation on inflammatory signaling in IL-1b stimulated astrocyte
cultures.
Method: Expression and localization of miR21, miR146a and miR155
was studied in human TSC and control brain tissue using qPCR (n = 20
TSC/13 controls) and in situ hybridization (n = 7 TSC/6 controls)
respectively. Expression of miRNAs and their targets under inflamma-
tory conditions was mimicked by IL-1b-stimulation of human astrocyte
cultures (n = 6). Furthermore, the effect of overexpression or knock-
down of miRNAs on inflammatory signaling by transfection of astrocytes
with miRNAmimics or antisense molecules was examined (n = 4).
Results: Expression of miR21, miR146a and miR155 was increased in
TSC tubers compared to control and perituberal brain tissue. Expression
was localized in dysmorphic neurons, reactive astrocytes and giant cells.
IL-1b stimulation of cultured astrocytes strongly induced intracellular
miR21, miR146a and miR155 expression, as well as miR21 extracellular
release. Preliminary results showed that overexpression of miR155
increases pro-inflammatory signaling, while overexpressing miR146a
tends to dampen inflammatory signaling after IL-1b stimulation.
Conclusion: These data suggest that the studied miRNAs are associated
with TSC and epilepsy. Inflammatory pathways underlying epilepsy
pathology can be regulated in vitro by modulating miRNAs.
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INCREASED EXPRESSIONOFCONSTITUTIVE (b1, b5)
AND IMMUNOPROTEASOME (b1I, b5I) SUBUNITS IN
EPILEPSYASSOCIATEDHUMANFOCALLESIONS
E.A. van Vliet*, D.W.M. Broekaart*, M.R.J. Zuidberg*, J. van
Scheppingen*, J.J. Anink*, W.G.M. Spliet†, P.C. van Rijen‡,
J.C. Baayen§, E. Aronica*,¶,**
*University of Amsterdam, Academic Medical Center, (Neuro)
Pathology, Amsterdam, Netherlands, †University Medical
Center Utrecht, Rudolph Magnus Institute for Neuroscience,
Pathology, Utrecht, Netherlands, ‡University Medical Center
Utrecht, Rudolph Magnus Institute for Neuroscience,
Neurosurgery, Utrecht, Netherlands, §VUUniversity Medical
Center, Neurosurgery, Amsterdam, Netherlands, ¶University of
Amsterdam, Swammerdam Institute for Life Sciences, Center for
Neuroscience, Amsterdam, Netherlands, **Stichting Epilepsie
Instellingen Nederland, Heemstede, Netherlands
Purpose: The proteasome is a multisubunit enzyme complex involved in
protein degradation, which is essential for many cellular processes. Dur-
ing inflammation, the constitutive subunits are replaced by their induci-
ble counterparts, resulting in the formation of the immunoproteasome,
which has been suggested to play a role in epilepsy.
Method: Immunohistochemical analysis of b1, b1i, b5 and b5i subunits
was performed in a cohort of surgical specimens from patients with drug-
resistant epilepsy: hippocampal specimens with hippocampal sclerosis
(HS, n = 20; ILAE type 1) and without (n = 16), cortical specimens of
patients with focal cortical malformations, including Mild Malforma-
tions of Cortical Development (mMCD, n = 6), Focal Cortical Dysplasia
(FCDIIa, n = 5; FCDIIb, n = 6) and cortical tubers from patients with
Tuberous Sclerosis Complex (TSC, n = 6); as well as in autopsy controls
(n = 14).
Results: In temporal lobe epilepsy, b1, b1i, b5 and b5i expression
increased in hippocampal neurons and reactive astrocytes and was most
pronounced in HS. In HS, neuronal b1, b5 and b5i expression was posi-
tively correlated to seizure frequency. Neuronal b1i and b5i expression
was positively correlated to epilepsy duration. In the cortex, expression
in mMCD was not different from controls. In FCD, the expression of b1,
b1i, b5 increased in dysmorphic neurons, balloon cells and reactive astro-
cytes and was most pronounced in FCDIIb. The most prominent changes
were observed in TSC: the expression of all subunits increased in dys-
morphic neurons, giant cells and reactive astrocytes. In TSC, b1 and b5
expression in dysmorphic neurons and b1i in giant cells was correlated to
seizure frequency.
Conclusion: These observations suggest that dysregulation of the pro-
teasome system represents a common pathologic hallmark of human
focal lesions associated with drug-resistant epilepsy. Since the expression
of the (immuno)proteasome is associated with the severity of pathologi-
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cal alterations and epilepsy, this system may represent an interesting
novel target for drug treatment in epilepsy that deserves further investiga-
tion.
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MBD5/MBD5DEPLETIONVIACHRISPR/CAS9 AFFECT
NEURALDEVELOPMENTTHROUGHEPIGENETIC
MODIFICATION INAZEBRAFISHMODEL
Y. Wang*, Y. Pi†, X. Du*, X. Xu*, T. Lu*, X. Zhang*, Y. Wang*
*Children’s Hospital of Fudan University, Shanghai, China,
†Fudan University, Shanghai, China
Purpose: Recent progress support that MBD5 heterozygous deficiency
causes epilepsy in comorbid with ASD and other neurological disorders
with the mechanisms behind are unclear. To further elucidate the mecha-
nistic relevance between MBD5 deficiency with disease etiology, mani-
festation, as well as the role of MBD5 in regulating neural development
in vivo, we created a Zebrafish model with CRISPR/Cas9 that abolishes
the expression of fish homologue gene mbd5 subjected for phenotypic/
molecular characterization.
Method: To create the mbd5-/- fish, we hired the CRISPR/Cas9 system
with sgRNAs targeting at two independentmbd5 genomic sites that com-
pletely abolished the endogenous expression of mbd5. .Transgenic lines
were then subjected for social behavioral, electrophysiological, and
pathological analysis. To investigate how mbd5 deficiency was involved
in disease progress we also compared the profile of gene expression and
DNA methylation between wildtype and mbd5-/- fish, with RNA
sequencing and pyrosequencing.
Results: The mbd5-/- fish manifested dysmorphism particularly in the
head, in together with developmental delay and elevated sensitivity to
PTZ, a chemical compound used for inducing seizure in animal model.
Immunohistochemistry indicated brain malformation, a phenotype
caused probably by down-regulation of genes involved in neural develop-
ment based on the RNA sequencing data. Besides, the genomic loci with
perturbation in DNA methylation also partially overlapped with the dys-
regulated genes in mutant animal.
Conclusion: Knocking-down of fish mbd5 expression created similar
phenotypic characteristics with patient carryingMBD5mutation support-
ing this fish model can be used to investigate the molecular mechanisms
of a type of neural disorders including epilepsy and ASD. Our prelimi-
nary studies suggested a model of mbd5/MBD5 in regulating gene
expression involved in proper neural development probably through
affecting epigenetic modification.
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WAVELET ENTROPYANALYSIS OFDIGITAL EEG
FORCHILDABSENCE EPILEPSY
M. Zhang*, N. Jiang†
*Tianjin Union Medicine Center, Department of Neurology,
Tianjin, China, †Tianjin University, Department of Mechanics,
Tianjin, China
Purpose: The individual-scale and integral wavelet entropy of digital
electroencephalogram (EEG) are employed to investigate the dynamical
complexity mechanism of central nervous system and evaluate the dam-
age of epileptic discharge to the central nervous system function in child
absence epilepsy (CAE).
Method: Comparing the individual-scale and integral wavelet entropy
of ictal and interictal EEG for child absence epilepsy with that of normal
control. A total of 15 patients with CAE and 12 healthy, age- and gender-
matched children were enrolled. EEG signals of 15 CAE patients and 12
normal children were recorded. Epileptic discharge signals during clini-
cal and sub-clinical seizures were collected 10 and 20 times, respectively.
All the digital EEG signals collected from 21 leads were decomposed
into 30 scales components by continuous wavelet transform (CWT). The
individual-scale and integral wavelet entropy of EEG was computed to
measure the dynamical complexity measure of central nervous system
and evaluate the damage of epileptic discharge to the central nervous sys-
tem and its function.
Results: The integral wavelet entropy of EEG for CAE is significantly
lower than that of normal control. The integral wavelet entropy of ictal
EEG is lower than that of interictal EEG for CAE. The individual-scale
wavelet entropies of ictal EEG from 2 to 5 Hz are much higher than that
of normal control. The individual-scale wavelet entropies of ictal EEG
from 0.01 to 1 Hz and from 7 to 100 Hz are much lower than that of nor-
mal control. The individual-scale wavelet entropy of interictal EEG from
5 to 50 Hz is lower than that of normal control.
Conclusion: The individual-scale and integral wavelet entropy of digital
EEG can be considered as a quantitative index for evaluating dynamical
complexity of central nervous system. The epileptic discharge of CAE
can reduce the integral wavelet entropy and damage the central nervous
system function.
Clinical Neurophysiology 4
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PATIENT TOLERABILITYOFCONTINUOUS
CARDIOVASCULARANDRESPIRATORY
PHYSIOLOGICALRECORDINGS INATELEMETRY
UNIT
T. Neves, R. Luz, F. Abreu, R. Elwes, R. Delamont
King’s College Hospital, Clinical Neurophysiology, London, UK
Purpose: Current studies suggest epileptic seizures can be associated
with autonomic changes which are thought to contribute to the risk of
sudden unexpected death in epilepsy (SUDEP). Furthermore, some have
suggested ictal autonomic changes may be a SUDEP marker. We aimed
to assess the tolerability of continuous and simultaneous non-invasive
recordings of multiple autonomic variables in epilepsy patients.
Method: This is a pilot study examining pre-surgical epilepsy patients
in a telemetry unit at King’s College Hospital. Physiological parame-
ters were studied via continuous measurement of heart rate (Medifit
Ltd), blood pressure (Portapres), respiratory effort (Smart BeltTM),
oxygen and carbon dioxide levels (TCM4 series) and electroen-
cephalography (Ambu/Unimed/AD-TECH). At the end of the moni-
toring each patient assessed the tolerability of the devices using a
standardized form.
Results: Fifteen subjects underwent autonomic monitoring for variable
lengths of time, ranging from two hours and forty minutes to forty-five
hours and twenty minutes. The durations varied for different reasons but
the main factor was the patient’s tolerance for the equipment. Each
patient rated each device as comfortable or uncomfortable and whether
they would have the monitoring repeated with that device. The Por-
tapres unit was rated uncomfortable by up to 57% of the participants,
along with the system used to monitor heart rate (36%) and electroen-
cephalography (29%). Only 14% of the subjects did not wish to undergo
continuous monitoring of blood pressure and/or respiration in further
studies.
Conclusion: The Portapres device was the most uncomfortable. The
equipment used for heart rate and electroencephalography monitoring
(both core components of telemetry) were identified as being uncomfort-
able in a substantial number of subjects. If ictal autonomic measures are
to be studied continuously further development in device technology is
required. This is particularly so if parameters recorded including blood
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pressure or baroreflex sensitivity are found to be biomarkers for SUDEP
risk.
p0819
DOES LONG-TERMVIDEO-EEGRECORDING
PREDICT SEIZUREDEVELOPMENTAFTER STROKE
INCRITICALCARE PATIENTS?
H. Onder*, E.M. Arsava*, M.A. Topcuoglu†, N. Dericioglu†
*Hacettepe University, Medical Faculty, Neurology, Ankara,
Turkey, †Hacettepe University, Medical Faculty, Ankara,
Turkey
Purpose: Seizures are not an infrequent complication after stroke.
Although there are numerous publications related to EEG findings in
these patients, few investigators have examined the predictive role of
EEG in the early post-stroke period. In this study, we investigated
whether video-EEG monitoring (VEEGM) results of stroke patients in
our neuro-intensive care unit (NICU) could predict seizure development
and survival.
Method: Fifty patients (23M, 27F; age: 66  14; 37 ischemic, 13 hem-
orrhagic stroke) hospitalized in our NICU between 2009–2014, were
included in the study. Follow-up information regarding development of
seizures and survival was obtained from patient charts and telephone
calls. We tried to determine whether the presence of epileptic discharges
or ictal patterns in EEG correlated with the above measures of outcome.
Results: Twenty nine (58%) patients developed seizures during follow-
up (26  16 months). Of these, 18 (62%) patients had early (£1 week),
and 11 (38%) patients had late (>1 week) seizures. Thirteen patients
(26%) developed recurrent seizures (i.e., epilepsy). The risk of epilepsy
was significantly higher in the late seizure group (p < 0.001). We did not
find a correlation between type of stroke and seizures (p = 0.72). Epilep-
tic discharges were detected in 17 (34%) patients. In two of them dis-
charges were periodic (PED). Non-convulsive status epilepticus (NCSE)
was detected in 3 (6%) patients. Overall, the presence of epileptic dis-
charges did not correlate with seizure development (p = 0.6) or survival
(p = 1), as was the case with NCSE. However both patients with PEDs
developed seizures and died within one year after stroke.
Conclusion: Almost 2/3 of our study cohort developed seizures. In
agreement with the literature, late seizures were a risk factor for epilepsy
development. VEEGM results did not correlate with the occurrence of
seizures or survival. However, more studies with larger patient popula-
tions are needed to better clarify this issue, especially regarding PEDs.
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CYCLIC ALTERNATING PATTERNAND INTERICTAL
EPILEPTIFORMDISCHARGES INCHLIDRENWITH
ABSENCE EPILEPSY
J.S. Ortiz De la Rosa, A.M. Uscategui Daccarett
National University of Colombia, Pediatric Neurology
Department, Bogota D.C., Colombia
Purpose: Cyclic alternating patterns (CAP) represent sleep instability in
the NonREM. Theses patterns are related to learning, neurodevelopmen-
tal processes and epileptiform activity. Controversy about the
microstructure of sleep and the presence of epileptiform generalized
interictal discharges and their implication in clinical aspects of patients
exists. In the setting of patients with childhood absence epilepsy (CAE),
the challenge between how the difficulties found in cognitive processes
are related to epileptic activity and in what extent this is due to external
factors other than the siezure activity per se. This study pretends to
explore the relationship of interictal activity (spike-slow wave) in CAE
and sleep microstructure in term of CAP assessment, as one of the associ-
ated factors to impairment of cognitive processes CAE.
Methods: 24 hour-Polygraphic studies of patients with CAE were per-
formed and assessed their sleep pattern, we analyzed the interictal epilep-
tiform activity and their CAP
Results: patients were between 9 and 12 years, all patients had seizures
during the wake period, one of them had no treatment. 93 interictal
epileptiform activity of spike-slow wave paroxysms. 60 (64.51%) were
during CAP-A1, while seven presented in CAP-B and only two presented
during a NonCAP period. The mean duration of Interictal discharges (ID)
was 4.94 second in CAP-A1, 5.6 second in CAP-A2 and 0.58 second in
the Non-CAP period. ID were more frequent in CAP-A1 than other sleep
stages. The CAP-A1 is an important feature of sleep microstructure have
been close related to learning processes, attention and behavior. This
results suggests that attention, execution and scholar performance of
patients with absence epilepsy might have a multi factorial origin, not
only related to the seizures but to the impairment of sleep architecture,
that is strongly associated to cognitive function, behavior and learning
consolidation.
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CHARACTERISTICSOFALTEREDCORTICAL
EXCITABILITY IN PATIENTSWITHGENERALIZED
OR FOCALEPILEPSY
E.Y. Joo, Y.K. Park, H.-J. Kim, S.B. Hong
Samsung Medical Center, Sungkyunkwan University School of
Medicine, Seoul, Republic of Korea
Purpose: We used transcranial magnetic stimulation (TMS) to investi-
gate the difference of cortical excitability between patients with IGE or
PE and normal controls.
Methods: We consecutively recruited 55 drug-na€ıve patients with epi-
lepsy (IGE 35, PE 25, mean age 28.5 years) and 32 age- and sex-
matched normal subjects. Epileptic focus was lateralized into right
(N = 7) or left hemisphere (N = 8) in PE patients. We measured TMS
parameters including resting motor threshold (RMT), motor evoked
potential (MEP) amplitudes, cortical silent period (CSP), intracortical
inhibition (ICI) and facilitation (ICF) during seizure free more than
24 hours.
Results: In both epilepsy patient and control groups, the CSP was
lengthened approximately linearly with increases of stimulus intensity
in both hemispheres. In IGE patients, interhemispheric differences of
CSP were not found in any stimulus intensity (p > 0.05). However, the
mean CSP was longer in IGE patients compared with normal controls
at all stimulus intensities (p < 0.05). In PE patients, TMS parameters
were compared between 1) ipsilateral hemisphere to epileptic focus
(IH) versus contralateral one (CH), or 2) IH or CH versus normal con-
trols, and 3) IH or CH versus IGE patients. The mean CSP was signifi-
cantly shorter in IH than that in CH at 120% (p = 0.028) and 140% of
RMT (p = 0.003). Mean CSP duration in CH was significantly longer
at the stimulus intensities 120–150% of RMT and that in IH was
longer only at 120% of RMT than that of normal controls (p = 0.005).
Between PE and IGE patients, there were no significant differences of
CSP at any stimulus intensity.
Conclusion: These findings suggest that the CSP may have a lateralizing
value in partial epilepsy by shorter CSP in the epileptic hemisphere. Pro-
longed CSP in epilepsy patients compared to normal subjects may indi-
cate the abnormally increased interictal cortical inhibition.
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DETECTIONOFEPILEPTIC ACTIVITY INABSENCE
OFEEG INTERICTAL EPILEPTIC DISCHARGES
F. Pittau*, M. Genetti†, G. Birot†, M.I. Tomescu†, S. Baldini†,
S. Vulliémoz*, C.M. Michel†, M. Seeck*
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*University Hospitals and Faculty of Medicine of Geneva, EEG
and Epilepsy Unit, Neurology Department, Geneva, Switzerland,
†University of Geneva, Functional Brain Mapping Laboratory,
Department of Fundamental Neurosciences, Geneva,
Switzerland
Purpose: Currently there are not reliable bio-markers of active epilepto-
genicity in the individual patient.
Aim: to assess if the EEGs of epileptic patients without any detectable
spikes contain the voltage epileptic map, specific of the individual
patient.
Methods: Fifteen patients with pharmaco-resistant focal epilepsy were
included. Six minutes of EEG with spikes and six minutes without any
detectable spikes were selected from long-term monitoring recording
during wakeful resting state (EEG 31-channels, ref: FCz). Resting-state
EEG from 48 healthy control subjects were also recorded and corrected
for artifacts. For the EEG of each patient, we calculated the averaged
spike and its voltage map. We fitted the spike map on i) EEG of patient
with visible spikes ii) EEG of the same patient without any visible spike
and iii) EEGs of the 48 controls. The amount of presence of the voltage
epileptic map was characterized using two criteria: mean correlation and
Global Explained Variance (GEV). For these criteria statistical differ-
ences between 1) controls and EEG with spikes, and 2) controls and EEG
without spikes were evaluated using z-scores.
Results: The patient-specific epileptic voltage map was significantly
more represented in the spike-free EEGs of patients than in EEGs of
healthy controls (GEV p = 0.029; mean correlation p = 0.032). This dif-
ference was more accentuated for the patient EEGs containing spikes
(GEV p = 0.001, mean correlation p < 0.001).
Conclusions: Scalp EEGs of patients with pharmaco-resistant epilepsy
contains the epileptic voltage map (index of epileptic activity), even in
absence of any detectable interictal epileptic discharges. This finding
suggests that epileptic voltage map could be a new epileptic bio-marker
(SPUM grant 140332 and 141165).
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SCALPHFOSANDBILATERAL SYNCHRONOUS
SPIKEANDWAVE IN FOCALAND IDIOPATHIC
GENERALIZED EPILEPSY
F. Pizzo*,†, T. Ferrari-Marinho*, M. Amiri*, B. Frauscher*,
F. Dubeau*, J. Gotman*
*Montreal Neurological Institute, McGill University, Montréal,
Canada, †NEUROFARBA Department, Neuroscience Section,
University of Florence, Firenze, Italy
Purpose: Localizing the epileptic focus in patients with secondary bilat-
eral synchrony and differentiation from generalized epilepsy is challeng-
ing. High Frequency Oscillations (HFOs) opened a promising research
area for localizing the epileptogenic zone. We evaluated if scalp HFOs
lateralize the origin of secondary bilateral synchrony, if HFOs are detect-
able in idiopathic generalized epilepsy (IGE) and if their distribution dif-
fers between focal and generalized epilepsy.
Method: We analyzed 30 minutes of 18 scalp EEG recordings (300 Hz
filtered, 1000 Hz sampled) characterized by bilateral synchronous dis-
charges of patients with focal (Focal Group: 11) and generalized (Gener-
alized Group: 7) epilepsy. Spikes and ripples (at least four consecutive
oscillations above 80 Hz) were visually marked.We calculated the ripple
rate (number of ripples co-occurring with spikes over spiking duration)
for each channel, each hemisphere and in anterior and posterior head
regions. The higher ripple rate hemisphere was called prevalent and the
higher ripple rate head region was called predominant. Prevalent/non
prevalent hemisphere and predominant/non predominant head region rip-
ple rates were compared using t test (a<0.05) within group and between
groups.
Results: Ripples co-occurring with spikes occurred in nine patients of
the focal group and in three of the generalized group. Eight of the nine
focal patients had a clinical lateralization, which was always concordant
with the prevalent ripple hemisphere. All three generalized patients
showed a prevalent hemisphere. The ripple rates comparison in preva-
lent/non prevalent hemisphere and predominant/non predominant head
region showed no difference between focal and generalized patients but
significant difference within each group (p < 0.01 and p < 0.05 respec-
tively)
Conclusion: Ripples do not help in the differentiation between focal epi-
lepsy with secondary bilateral synchrony and IGE but, if we suspect a
focal origin, HFOs help the lateralization of the focus. This is the first
report of ripples in IGE.
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COGNITIVE EVOKED POTENTIALS P3 IN PATIENTS
WITH IDIOPATHIC EPILEPSY
S. Juric*,†, R. Susak*,†, M. Candrlic*,†, S. Butkovic - Soldo*,†,
J. Saric†
*Faculty of Medicine, University J.J. Strossmayer of Osijek,
Osijek, Croatia, †University Hospital Osijek, Department of
Neurology, Osijek, Croatia
Purpose: The goal of this four-year prospective study was to investigate
and determine whether there are cognitive changes in patients with idio-
pathic epilepsy (IE) detected with cognitive evoked potential P3 com-
pared to the results obtained in the healthy population of the same age
and sex characteristics. The secondary goal was to determine whether
there is a connection between certain demographic (age, gender) and
clinical (type of epilepsy, duration of disease, frequency of the seizures,
severity of the interictal EEG changes, antiepileptic therapy, duration of
treatment, etc.) characteristics of patients with IE with possible cognitive
changes. We compared the obtained results with the PASAT test and
determine the correlation between these two tests.
Method: The study was conducted on 82 patients with IE in age from
18–65 years, who were treated at least one year and in 82 healthy sub-
jects, that were control group of the appropriate age, sex, education and
other demographic characteristics. P3 were recorded in all study subjects
using sound paradigm. For further analyse we used values of latency of
P1, N1, P2, N2, P3 and P3 amplitude. We have also studied the localiza-
tion of P3. All study subjects underwent PASAT test whose values were
compared with values obtained from P3. Interictal EEG were recorded in
patients with IE, and we analysed data related to the underlying disease:
type of epilepsy, duration of epilepsy, seizure frequency, type of AED
and EEG changes.
Results: Patients with IE have significantly extended latency of N2 and
P3 and also decreasement of P3 amplitude compared with healthy sub-
jects. Changes of cognitive evoked potentials P3 characteristics correlate
with changes of PASAT testing.
Conclusion: On the results of the both tests affect auditory attention, so
we assume that the brain regions, that are activated when performing
these tasks, are equal or at least overlap.
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SLEEPDEPRIVATION EEG FOR INCREASINGEEG
YIELD IN EPILEPTIC PATIENTS
D.S. Seker, S.K. Velioglu, S. Gazioglu
Karadeniz Technical University, Neurology, Trabzon, Turkey
Purpose: First routine EEG is unlikely to detect interictal epileptiform
abnormalities in 30%–50% of patients with epilepsy. Sleep deprivation
(SD) is an important activation method for diagnosis of epilepsy-like
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intermittent photic stimulation and hyperventilation. In this study, we
assess the usefulness of SD-EEG in terms of diagnosis and type of epi-
lepsy.
Method: From among the 896 adult patients undergoing SD-EEG in
2004–2015, we retrospectively and prospectively selected for analysis
only those: (a) with epilepsy or suspected epilepsy; (b) with a normal/
non-specific routine EEG; (c)using or not using antiepileptic drugs at the
time of SD-EEG and routine EEG; (d)with previous MRI; (f)with at least
1 year of follow-up. SD was applied for at least 24 hour, while partial
SD was applied for less than 24 hour. EEGs were reported as being nor-
mal or non-specific and abnormal, with abnormalities defined as the pres-
ence of epileptiform abnormalities, focal or generalized. We analyzed
epileptic interictal abnormalities (IIAs) defined as spike, sharp, spike and
wave discharge complexes.
Results: Two hundred fifty-eight patients fulfilled the inclusion criteria.
SD-EEG revealed IIAs in 34.8% (n = 90) and supported diagnosis of epi-
lepsy in patients with suspected epilepsy. Focal epilepsy was diagnosed
in 68% (n = 61) of subjects and generalized epilepsy in 25% (n = 23),
while no epileptic syndrome could be identified in 7% (n = 6). Of the 61
patients with focal epilepsy, 84% (n = 51) exhibited localized epileptic
interictal abnormalities and 8% (n = 5) patients lateralized IIAs, while
8% (n = 5) exhibited generalized IIAs. Of the 23 patients with general-
ized epilepsy, 13% (n = 3) exhibited generalized, bilateral and asymmet-
ric IIAs and 87% (n = 20) exhibited generalized, bilateral and symmetric
IIAs.
Conclusion: The use of SD-EEG will help clarify diagnosis of epilepsy
and epileptic syndrome in patients with normal/non-specific routine
EEG. We suggest that SD EEG records should include both wakefulness
and sleep in order to identify IIAs.
p0826
TESTING PATIENTS IN THEEPILEPSYMONITORING
UNIT
C. Skaarup, B.M. Karstensen
Filadelfia, Neurofysiologi Department, Dianalund, Denmark
Interacting with the patients during seizures in the Epilepsy Monitoring
Unit (EMU) is essential for evaluation of the semiological signs, for
accurate classification and, for focal seizures for localization of the
symptomatogenic zone. Although many publications addressed the value
of various semiological signs, there are no published standards on the
protocol for testing the patients during seizures in EMUs. Since 2009, the
EMU at the Danish Epilepsy centre has implemented a standardized pro-
tocol for patient testing. The protocol focuses on highlighting cognitive
changes, attention, memory and speech alterations. Our results show that
the protocol is feasible and provides the semiological information neces-
sary for seizure classification and for localization. A standardized patient
testing protocol should be implemented in all EMUs.
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USEFULNESSOF ELECTROENCEPHALOGRAPHY IN
DEMENTIA
S. Smirani, A. Gargouri-Berrechid, I. Kacem, M. Ben Djebara,
F. Laatar, Y. Hizem, R. Gouider
Razi Hospital, Neurology Department/Research Unit
12SP21Razi, Tunis, Tunisia
Purpose: To determine the correlation between the type of dementia, the
cognitive impairment and the electroencephalographic abnormalities and
to evaluate the usefulness of systematic EEG in a dementia.
Methods: A retrospective study including 543 patients with dementia
(276 Alzheimer’s disease, 70 vascular dementias, 91 mixed dementias,
17 Fronto-temporal dementias, 20 Lewy body dementias and 69 other
dementias) followed up in the department of Neurology at Razi Hospital
for a year (2008–2009). An EEG was systematically practiced in all
patients. A patient file was developed, including epidemiological data,
clinical MMSE, radiological, EEG and therapeutic data.
Results: The mean age of onset of cognitive impairment was
60.19 years. 285 patients were female (52.5%). Dementia was moderate
in 49% of cases and severe in 37% of cases. The EEG was normal in
72%. Diffuse slowing of background activity was present in 17% of cases
with mild dementia, 16% of cases with moderate dementia and 35% in
cases of severe dementia. Paroxysmal abnormalities were observed in 59
patients (11%), eight of them presented clinical epilepsy.
Conclusion: In our series, a slowing of background activity was corre-
lated with the severity of dementia. The EEGwas not decisional for diag-
nosis. It remains useful in cases of specific orientation such as
Creutzfeldt-Jakob disease or associated epilepsy.
Clinical Neurophysiology 5
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FUNCTIONALCONNECTIVITY IN JUVENILE
MYOCLONIC EPILEPSY:MEG-BASEDNETWORK
ANDANALYSIS
X. Yao*, W. Tang†, W. Mao*, X. Liu*, Z. Li*, N. Zhang*,
Y. Yang*, Y. Wang*, W. Sun*
*XuanWu Hospital, Capital Medical University, Department of
Neurology, Beijing, China, †Massachusetts General Hospital &
Harvard Medical School, MA 02129, USA, Charlestown, MA,
USA
Purpose: To investigate the functional connectivity between patients
with juvenile myclonic epilepsy (JME) and healthy controls using mag-
netoencephalography (MEG) investigations. We test the hypothesis that
Motor functional connectivity is altered in JME compared to healthy con-
trols.
Method: Seventeen epileptics with JME and fourteen age-matched and
sex-matched healthy controls performed audio-motor tasks during MEG
examination. We selected region of interests including motor area (M1),
sensory area (S1), supplementary motor area (SMA), default mode net-
work (DMN), frontoparietal control network (FPC) and dorsal attention
network (DA). MNE (minimum-norm estimate) software was used to
analyze and map the functional connectivity between patients and
healthy controls.
Results: The coherence values had significantly increased in alpha and
beta band between left M1 and left SMA in patients with JME compared
to controls. Also the coherence values had significantly increased in the
left M1 and S1, in the right M1 and DMN in beta band. There was no sig-
nificant difference amongM1, the FPC and the DA.
Conclusion: Motor functional connectivity is altered in JME compared
to healthy controls. In JME, functional connectivity increased coactiva-
tion in M1 and SMA after perform finger movement compared to con-
trols. There is stronger connectivity in motion and sensory network.
Furthermore, we found impaired the deactivation of the default mode net-
work.
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ELECTRO-CLINICALANALYSIS OF ICTALKISSING
AUTOMATISM
E. Taskiran*, I. Carpraz†, E. Bilir†, A. Bican‡, I. Bora‡,
F. Chassoux§, I. Aydogdu¶, C. Ozkara**
Epilepsia, 56(Suppl. 1):3–263, 2015
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*Istanbul Medipol University, Istanbul, Turkey, †Gazi
University Faculty of Medicine, Ankara, Turkey, ‡Uludag
University, Bursa, Turkey, §Centre Hospitalier Sainte Anne,
Paris, France, ¶Ege University Medical Faculty, Izmir, Turkey,
**Istanbul University Cerrahpasa Faculty of Medicine,
Istanbul, Turkey
Purpose: Ictal kissing automatism (IKA) is a rarely seen ictal phe-
nomenon. We aimed to study electro-clinical characteristics of this com-
plex ictal behaviour.
Method: The clinical and imaging data and video – EEG recordings
(when available) of 23 patients with IKB from five different centers were
reviewed.
Results: Eighteen patients (11 females) were included. The mean age of
the patients were 33.2 years (20–51 years). Seizure onset was 12.8 years
(5–23). Fourty-eight ictal video-EEG obtained from 16 patients were
reviewed. In 24 of them, IKA was observed during the seizure. All of 24
seizures revealed temporal lobe (TL) involvement during the kissing epi-
sode with seizure onset at TL in 12 patients (10 right, 2 left), at occipital
in one patient. MRI showed hippocampal sclerosis in 10 (8 right, 2 left),
parietal cortical developmental malformation and occipital lesion in 2
patients where it was normal in 6 patients. Different types of kissing
(hands, arm, cheek, and blowing kisses) were seen during the ictal
events.
Conclusion: Ictal kissing is a very rare automatism during epileptic sei-
zures. There were only nine patients reported in the literature which four
of them are from our series. In this study EEG and MRI revealed right
side in 12, left side in three patients. Three other patients with negative
MR showed bilateral EEG findings which disabled the delineation of
epileptogenic zone. In conclusion, IK is a complex behavior usually
related to right, nondominant temporal lobe although involvement of the
other side is also possible.
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COMPARISONOFTHEEFFECTOFTRANSCRANIAL
DIRECTCURRENT STIMULATION BETWEEN
FOCALANDGENERALIZEDEPILEPSY
SYNDROMES
P. Tekturk*, E. Tuna Erdogan†, A. Kurt‡, E.N. Vanlı Yavuz§,
E. Kocagoncu¶, S. Aksu**, Z. Kucuk**, Z. Yapıcı††, B. Baykan*,
S. Karamürsel**
*Istanbul University, Istanbul Faculty of Medicine, Department
of Neurology and Clinical Neurophysiology, Istanbul, Turkey,
†Istanbul Bilim University, Faculty of Medicine, Department of
Physiology, Istanbul, Turkey, ‡Istanbul University, Istanbul
Faculty of Medicine, Department of Physiology, Istanbul,
Turkey, §Koc University, Faculty of Medicine, Neurology,
Istanbul, Turkey, ¶University of Cambridge, Centre for Speech,
Language and the Brain, Psychology, Cambridge, UK,
**Istanbul University, Istanbul Faculty of Medicine, Physiology,
Istanbul, Turkey, ††Istanbul University, Istanbul Faculty of
Medicine, Department of Neurology and Clinical
Neurophysiology, Neurology, Istanbul, Turkey
Purpose: Transcranial direct current stimulation (tDCS) is a non-inva-
sive and safe method tried in drug-resistant epilepsies. Our aim was to
compare the effect of t-DCS between Lennox-Gastaut syndrome (LGS)
and temporal lobe epilepsy with hippocampal sclerosis (TLE-HS) which
are two well-known drug-resistant epileptic syndromes differing from
each other by causing generalized versus focal seizures and EEG find-
ings.
Method: Twelve LGS patients (mean age: 15.5; six males) and 14 TLE-
HS patients (mean age 35.5; six males) diagnosed with their typical
clinical, EEG and MRI findings were included after signed consent. All
patients received cathodal stimulation. TLE-HS group were stimulated
over the concordant MRI and EEG foci whereas LGS patients were stim-
ulated over Cz region. Five patients from LGS group and all patients from
TLE-HS group also received sham stimulation (60 seconds stimulation
gradually decreased in 15 seconds). All were followed up by standard
seizure diaries.
Results: Eleven patients (78%) among TLE-HS group had more than
50% decrease in their seizure frequencies by cathodal stimulation
whereas three patients also showed positive sham effect. Among LGS
patients, two patients (16%) had more than 50% decrease in their sei-
zure frequencies by cathodal stimulation. However sham stimulation of
these patients did not show any change in seizure frequency. Interest-
ingly both of the responders with LGS had prominent additional focal
EEG findings when compared to non-responders. No adverse effect has
been reported.
Conclusion: Our small series suggested that cathodal t-DCS may be
used as an additional option in focal epilepsies with significant EEG find-
ings. It may be tried in TLE-HS patients rejecting epilepsy surgery or
even with ineffective surgery results. However t-DCS is not effective
enough in generalized refractory epilepsies such as LGS unless there are
prominent focal EEG abnormalities. More studies are needed with large
series of patients.
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EFFECTOFCATHODALTRANSCRANIAL DIRECT
CURRENT STIMULATION IN PATIENTSWITH
TEMPORAL LOBEEPILEPSY – PRELIMINARY
RESULTS
D. Terney, E. Gardella, P. Meritam, S. Beniczky
Danish Epilepsy Centre, Dianalund, Denmark
Introduction: Temporal lobe epilepsy is a chronic condition character-
ized by recurrent, unprovoked epileptic seizures. Pharmacological treat-
ment may be relatively effective in about 2/3 of the patients; for the other
1/3 surgical resection of the epileptogenic region is usually successful.
Video-EEG monitoring in the epilepsy monitoring unit (EMU) is part of
the presurgical evaluation. Transcranial direct current stimulation (tDCS)
is a non-invasive, safe, painless stimulation technique, offering the possi-
bility to induce prolonged excitability alterations in different cortical
areas. Early animal experiments have revealed that cathodal tDCS
reduces spontaneous firing rates of cortical cells, most likely by hyperpo-
larizing the cell body. TDCS allows diagnostic applications and offer a
potential therapeutic use in neurorehabilitation, chronic pain, focal epi-
lepsy and neuropsychiatric disorders. There is limited evidence on the
efficacy of tDCS in epilepsy.
Objective: To detect the possible therapeutic effect of cathodal tDCS
due to reduction of the epileptiform activity on the EEG/ reduction of the
seizure frequency.
Materials and methods: Patients (age > 18 years) affected from drug
resistant temporal lobe epilepsy, undergoing to EMU recordings, were
recruited (planned 20 patients). Cathodal tDCS was delivered through a
pair of rubber electrodes positioned over the epileptogenic focus. Current
intensity was 1.0 mA; current duration: 20 minutes. For control stimula-
tion we used sham stimulation. The effect of tDCS was measured on
EEG, by quantifying the percentage of the epileptiform discharges by
Brain Electrical Source Analysis program at least 4 hours before and
after stimulation.
Results: Our preliminary data shows that the effect of tDCS is mainly in
reducing propagation of the epileptiform discharges.
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POLYGRAPHIC FEATURES ANDCLINICALCOURSE
IN POST-ANOXICMYOCLONUS (LANCE-ADAMS
SYNDROME)
K.S. Thygesen*, E. Gardella†, G. Rubboli‡
*Danish Epilepsy Centre, Dianalund, Denmark, †University of
Southern Denmark, Odense, Denmark, ‡University of
Copenhagen, Copenhagen, Denmark
Purpose: Post anoxic myoclonus is a severe condition resulting from
coma and myoclonic status caused by prolonged anoxic insult. Poor
prognosis has been associated with occurrence of myoclonic status and
absence of SSEPs (Wijdicks et al., 2006). We describe the polygraphic
features and clinical course in a patient with severe post-anoxic myoclonus.
Method: We investigated clinically and neurophysiologically a 18 years
old girl who developed post-anoxic myoclonus after an episode of severe
brain anoxia for 15 minutes. Prolonged coma and refractory status
epilepticus followed the anoxic insult. Therapeutic hypothermia and
antiepileptic drugs (levetiracetam, phenytoin, sodium thiopental, mida-
zolam, lacosamid) were used. SSEP in the 3rd day were normal.
Results: 1 month post-anoxia, she shifted from vegetative to minimally
conscious state. After 3 months she recovered consciousness completely.
BrainMRI showed ischemic changes in basal ganglia, and mild brain atro-
phy. Seven months post-insult she displayed cognitive dysfunction in sev-
eral domains, severe action myoclonus and myoclonic seizures. After
11 months she had mild cognitive deficits, action myoclonus and myoclo-
nic seizures, treated with clonazepam, zonisamid, levetiracetam, valproic
acid. Polygraphic recordings showed two patterns of myoclonic activities:
(1) massive jerks that occurred with a rostro-caudal muscular recruit-
ment, isolated or in brief rhythmic (12–15 Hz) bursts, associated with
EEG spikes, facilitated by voluntary movement.
(2) myoclonic bursts without EEG correlates, showing an activation
pattern starting from sternocleidomastoideus and spreading upward to
orbicularis oris, masseter and downward to deltoid, consistent with sub-
cortical myoclonus. MEP showed prolonged central conduction time
bilaterally, consistent with a central dysfunction of motor pathways.
Conclusion: Our patient with post-anoxic myoclonus showed a good
outcome in spite of initially prolonged coma and refractory status epilep-
ticus. We provide neurophysiological evidence that action myoclonus
results from a mixture of cortical and subcortical myoclonia, associated
with a central dysfunction of motor pathways.
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THERELATIONBETWEEN INTERICTAL EPILEPTIC
SPIKES ANDRIPPLES IN SURFACE EEG
N.E.C. van Klink*,†, B. Frauscher*, M. Zijlmans†,‡, J. Gotman*
*McGill University, Montreal Neurological Institute, Montreal,
Canada, †University Medical Center Utrecht, Brain Center
Rudolf Magnus, Dept. of Neurology and Neurosurgery, Utrecht,
Netherlands, ‡SEIN – Stichting Epilepsie Instellingen
Nederland, Heemstede, Netherlands
Purpose: Ripples (80–250 Hz) have been shown to be a more specific
biomarker for the epileptogenic zone than epileptic spikes in intracranial
EEG and even in surface EEG. Ripples often co-occur with spikes, but
we do not know whether one evokes the other. We investigated the spa-
tiotemporal relation between spikes and ripples, and the differences
between spikes that do and do not co-occur with ripples.
Method: We marked 50 time points with spikes in bipolar surface EEG
during NREM sleep in patients with focal or multifocal epilepsy. We
marked ripples that occurred within 400 ms of these time points. We cal-
culated several parameters relating spikes and ripples: the duration,
amplitude and slope of spikes, the timing of the start of ripples compared
to spikes and the proportion of overlap.
Results: In total 219 ripples and 5995 individual spikes were marked in
31 patients. Spikes with ripples were on average significantly shorter,
had higher amplitude and higher slope than spikes without ripples,
although there was no clear cut-off. 64% of ripples started before spikes
started. The proportion of ripples before, during the first and second
slopes and after spikes was on average 26%, 37%, 30% and 7%. Spikes
occurred on a median of 13 (5–26) channels per patient, and ripples on 3
(0–14) channels, which were also spike channels.
Conclusion: Ripples precede rather than follow spikes, so ripples are
unlikely to result from spikes. Ripples and spikes seem not one-on-one
couples, but certain states of the brain can accommodate both.
p0836
AUTOMATIC IDENTIFICATIONOFTHE
EPILEPTOGENIC ZONE BASEDONHIGH
FREQUENCYOSCILLATIONS INMEG
F. van Rosmalen*,†, N. van Klink*, M. Zijlmans*,‡,
A. Hillebrand§
*University Medical Center Utrecht, Department of Neurology
and Neurosurgery, Utrecht, Netherlands, †MIRA Institute for
Biomedical Technology and Technical Medicine, Enschede,
Netherlands, ‡SEIN – Stichting Epilepsie Instellingen
Nederland, Heemstede, Netherlands, §VUUniversity Medical
Center, Department of Clinical Neurophysiology and
Magnetoencephalograpy Center, Amsterdam, Netherlands
Purpose: High frequency oscillations (HFOs, >80 Hz) are a biomarker
for the epileptogenic zone (EZ). Our final goal is to automatically local-
ize the HFO region using magnetoencephalography (MEG).
Method: Fifteen minutes of resting state MEG data were selected in 12
patients. We increased the signal to noise ratio in MEG recordings by
computing spatial filters using beamforming, and used this technique to
reconstruct time series (virtual sensors, VS) for a priori defined brain
regions. As a first step we placed VS around the epileptic spikes (affected
region) and in the contralateral hemisphere. We manually marked HFOs
and spikes in MEG in the time domain in these VS. The time points with
HFOs in VS were reviewed in the physical sensors. The next step will be
to use a detector to automatically identify HFOs for all brain regions (a
task which is too time-consuming to do manually) and to generate a 3D
map to reveal regions with HFOs.
Results: We identified 575 HFOs in VS, at 78 points in time, in eight
patients. 513 HFOs were in the affected region. HFOs could not be visu-
ally identified in physical sensors for 61 of the 78 time points that showed
HFOs in VS. These manually marked HFOs will be used to optimize an
automatic detection algorithm.
Conclusion: Beamformer-based VS analysis can help to identify HFOs
that are not discernable in physical MEG sensors. This step eases the
automatic detection of the HFO region. These findings are a preliminary
step towards our goal: to automatically localize the HFO region in
patients with focal epilepsy using MEG. This map can be used to tailor
epilepsy surgery.
Comorbidities 4
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COMORBID DISEASES IN EPILEPSY PATIENTS
H. Ertaşoğlu Toydemir, D. Bozkurt, F. Azman, B. Yurtsever,
H.Örnek, V.A. Yayla
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Bakırk€oy Dr.Sadi Konuk Training and Research Hospital,
Department of Neurology, Istanbul, Turkey
Purpose: Epilepsy is a chronic disorder that may be associated with vari-
ous comorbid diseases. In this study, we aimed to evaluate the comorbid
diseases detected in our patients with epilepsy.
Method: We analyzed 365 patients who were followed up in the epi-
lepsy department between 2011 and 2014 retrospectively. Besides demo-
graphic and clinical findings of the patients, neurological, psychiatric,
systemic and other comorbid diseases were recorded.
Results: Mean age of total 365 patients was 30.9  13.9 (10–83) years
and 182 (49.9%) were female, 183 (50.1%) were male. Age at seizure
onset was between the 1st year of life and 80 years. Mental retardation
was detected in 13.7% of the patients. The most common comorbidities
were psychiatric diseases (21.1%), headache (11.2%), hypertension
(4.7%), thyroid diseases (4.7%), anemia (4.1%), gastrointestinal prob-
lems (3%), coronary artery diseases (2.5%), cerebrovascular accidents
(2.2%), diabetes mellitus (2.2%), hyperlipidemia (1.9%), asthma (1.6%),
genito-urinary diseases (1.4%) and cancer (0.8%). Depression and anxi-
ety disorders were the most common psychiatric comorbidities. Other
psychiatric comorbidities consisted of psychosis, obsessive compulsive
disease, agitation, behavioral problems, autism, panic and conversion
disorders. Amongst headache comorbidity, migraine was more common
than tension-type headache. Smoking in 63 (17.3%) and alcohol con-
sumption in 14 (3.8%) patients were recorded. EEG revealed pathologi-
cal patterns in 247 (67.7%) patients. MR/BT investigations were
abnormal in 40.8% of the patients and the most common pathological
finding was encephalomalacia.
Conclusion: Psychiatric, neurological and other systemic disorders may
be together with epilepsy. Especially psychiatric comorbidities and epi-
lepsy have a bidirectional relationship. Comorbid diseases may con-
tribute to functional disability of epileptic patients and may complicate
epilepsy treatment. The diagnosis and treatment of comorbid diseases is
necessary for the improvement of life qualities of epilepsy patients.
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IMPROVEDMATERNALCAREOF FOSTERWISTAR
MOTHEREARLY IN DEVELOPMENTREDUCES
SEIZUREACTIVITY, ANXIETYANDDEPRESSION-
LIKECOMORBIDITY INADULTWAG/RIJ RATSWITH
GENETIC PREDISPOSITION TOABSENCE EPILEPSY
K. Sarkisova, K. Tanaeva, I. Midzyanovskaya, E. Suleymanova
Institute of Higher Nervous Activity and Neurophysiology RAS,
Moscow, Russian Federation
Purpose: WAG/Rij rats are a valid genetic animal model of absence epi-
lepsy with comorbid depression. Adult WAG/Rij rats at the age of
6–8 months exhibit depression-like behavioral symptoms and seizure
activity characterized by spontaneous generalized spike-wave discharges
(SWDs) in the EEG. We have recently found that WAG/Rij dams in
addition to depression-like behavior display reduced maternal care in
comparison with Wistar controls. We have hypothesized that impaired
early rearing environment in WAG/Rij rats may contribute to the expres-
sion of seizure activity and depression-like comorbidity later in life. To
test this hypothesis, a cross-fostering procedure has been used.
Method: Rat pups of “depressive” WAG/Rij and “normal” Wistar dams
were cross-fostered on postnatal day 2. Control rats remained with their
birth mother. EEG and behavior in the light-dark choice, open field,
elevated plus-maze and forced swimming tests were assessed in the
offspring of “depressive” WAG/Rij and “normal” Wistar rats reared by
their own or foster mothers at the age of 7–8 months.
Results: WAG/Rij rats reared with improved maternal care of “normal”
Wistar dam exhibited less seizure activity (a decreased SWDs number,
duration and index), reduced depression-like behavior in the forced
swimming test and anxiety in the elevated plus-maze in comparison with
age-matched WAG/Rij rats reared under abnormal maternal care of their
own “depressive” dam. Adoption byWAG/Rij dam didn’t exert a signifi-
cant effect on EEG and behavior in the forced swimming test in “normal”
Wistar rats.
Conclusion: Results suggest that an epigenetic factor such as maternal
care early in development reduces epileptogenesis and expression of
depression-like comorbidity in the WAG/Rij rat model of genetic gener-
alized absence epilepsy. We propose that the improvement of early care-
giving environment can be used as disease-modifying treatment to pre-
vent or ameliorate the process of epileptogenesis and behavioral comor-
bidities in people with genetic predisposition to absence epilepsy.
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SLEEPDISORDERS IN PATIENTSWITHEPILEPSY: A
SYSTEMATIC REVIEW
S. Singh, R. Avendano, S. Wiebe, Y. Aghakhani
University of Calgary, Clinical Neurosciences, Calgary, Canada
Introduction: Sleep and epilepsy interact on many levels. The preva-
lence of sleep disorders and their impact on epilepsy has been addressed
by several studies with significant heterogeneity in observations. We
appraised the evidence to assess the relationship between sleep and epi-
lepsy.
Methods: We searched Embase and Medline databases for publications
in English until December 2014, using MeSH headings and keywords
related to “epilepsy,” “seizure,” and various sleep disorders. We included
articles describing original data on adult patients with sleep disorders and
epilepsy. Two reviewers independently reviewed abstracts and selected
articles which fulfilled eligibility criteria. We analyzed data descrip-
tively.
Results: From 2778 citations 19 articles were included. Nine studies
were questionnaire based and six polysomnography (PSG) based. A total
of 2070 patients (38% women, mean age 35.3 years) were included.
Most studies investigated excessive daytime somnolence (EDS; n = 773
patients), insomnia (n = 218) and obstructive sleep apnea (OSA; n =
849) and reported increased prevalence (upto 38.6%) in patients with epi-
lepsy (PWE). However, three studies found no significant difference in
the occurrence of OSA in PWE and controls. Only three (n = 541)
focused on epilepsy diagnosis. Overall, 62.5% patients had focal epi-
lepsy. On PSG assessments, all sleep related parameters were worse in
PWE, including sleep latency, sleep efficiency, total sleep time and EDS.
In four studies (n = 153) looking at the impact of CPAP therapy on sei-
zure control, more than 50% of patients improved in seizure control. One
study concluded that subjective sleep complaints improved after epilepsy
surgery.
Conclusions: There is increased prevalence of sleep disorders including
EDS, insomnia, OSA and RLS in PWE as compared to normal controls,
and treatment of OSA with CPAP therapy improves seizure outcomes.
Successful epilepsy surgery may lead to improvement in subjective sleep
parameters. No studies look at the relationship of the epilepsy syndrome
or localization and the type of sleep disorder.
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LACKOFHEARTRATEVARIABILITY (HRV) DURING
APNEA INDRUGNA€IVE PATIENTSWITHTEMPORAL
LOBEEPILEPSY: AMARKEROF SUDEP?
S. Sinha*, C. Nayak†, A.B. Taly†, K. Thennarasu†
*NIMHANS, Neurology, Bangalore, India, †NIMHANS,
Bangalore, India
Purpose: There is lack of literature about heart rate variability (HRV)
during apnea among patients with temporal lobe epilepsy (TLE). The
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aim was to characterize the heart rate variability (HRV) during the peri-
apneic period in TLE.
Method: Overnight-PSG on 10 patients of drug-na€ıve TLE (M:F = 6:4;
age: 22.8  4.1 years) and 10 TLE on carbamazepine (CBZ) (M:
F = 6:4; age: 20.5  4.3 years) were performed and compared with 10,
age (p = 0.205) and gender (p = 0.271) matched healthy controls (M:
F = 5:5; age: 24.3  5.03 years). EC approval and consent was
obtained. The time/frequency domains and non-linear HRV indices were
analyzed for two minutes before and after apnea/hypopnea termination
and analyzed using paired t-test. Changes in HRV parameters in the peri-
apnea/hypopnea period were compared among three groups using one-
way ANOVA followed by post hoc comparison.
Results: Among controls, there was an increase in SD of RR interval
(SDNN) (p = 0.010), very low frequency (VLF) (p = 0.001) and long
term HRV (SD2) (p = 0.004) parameters, along with a decrease in low
frequency (LF) component (p = 0.011) in the post-apneic period com-
pared to the pre-apneic period. Conversely, in drug na€ıve TLE, all the
HRV parameters, including nonlinear measures were comparable during
the pre and post-apneic period. However, patients on CBZ showed a
decrease in LF (p = 0.010) and increase in high frequency component
(HF) component (p = 0.001) in the post-apneic period compared to the
pre-apneic period. Finally, comparison of HRV changes in the peri-
apnea/hypopnea period among healthy controls, drug na€ıve TLE and on
CBZ TLE showed significant differences in SDNN (p = 0.021), VLF
(p = 0.002), LF (p = 0.017) and SD2 (p = 0.004).
Conclusion: This study, first of its kind, showed a lack of apnea medi-
ated HRV changes in patients with drug na€ıve TLE, suggesting possible
alteration in reflex baroreceptor activation, and was partially reversible
with carbamazepine.
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COMPARISONOFTHEEFFECTIVENESS OF
SERTRALINE, VINPOCETINE AND SEVERAL
CONVENTIONALANTIEPILEPTIC DRUGS TO
INHIBIT THEEPILEPTIFORMEEGACTIVITY
INDUCEDBY 4-AMINOPYRIDINE IN THERAT
M. Sitges*, B.I. Aldana†, R.C. Reed‡
*Instituto de Investigaciones Biomédicas, Universidad Nacional
Autonoma de México, Departamento de Biología Celular y
Fisiología, Mexico City, Mexico, †University of Copenhagen,
Department of Drug Design and Pharmacology, Copenhagen,
Denmark, ‡School of Pharmacy, Husson University, Department
of Pharmacy Practice, Bangor, ME, USA
Background: Depression is a major comorbidity in patients with epi-
lepsy. Previously we found that the anti-depressive, sertraline (a novel
non-FDA-approved agent for seizures), effectively inhibits presynaptic
Na+ channels permeability, and thus, may have anti-seizure potential.
Herein, we compared the epileptiform EEG activity induced by 4-amino-
pyridine (4-AP) for sertraline (0.75 & 2.5 mg/kg), vinpocetine (2.5 mg/
kg), and several conventional antiepileptic drugs (AEDs): CBZ & TOP
(25 mg/kg only), and PHT, LTG, OXC, (latter 3 at 2.5 & 25 mg/kg),
VPA& LEV (100 mg/kg only).
Methods: 59 Wistar rats, avg wgt = 315 + 3 g were used. All animal
experiments were carried out in compliance with the “Guidelines for Ani-
mal Experimentation” and had Institutional approval. The control group
(n = 10) and each of 9 drug/AED groups (n = 3–5 rats), had 4-AP
administered i.p. at a convulsive dose of 2.5 mg/kg. Following 4-AP,
EEG cortical activity (highest peak amplitude value [EEG-hpav], in lV)
was monitored (Nihon-Kohden Neuropack IV Mini (MEB-5304 K) sys-
tem) 9 1 hour. EEG-hpav lV changes at 10, 20 & 30 minute post-base-
line were analysed via ANOVA.
Results: Results show a marked increase in the EEG amplitude (lV)
near 20 minute following 4-AP, reaching maximum at 30 minute in all
rats. Sertraline and vinpocetine (2.5 mg/kg dose) statistically signifi-
cantly prevented this epileptiform EEG activity induced by 4-AP
(p < 0.05). Likewise, PHT, LTG and OXC were ineffective at 2.5 mg/
kg, but were effective at 25 mg/kg; CBZ was effective at 25/mg/kg.
TOP, LEV and VPA all failed to prevent the epileptiform EEG activity
induced by 4-AP.
Conclusions: Sertraline and vinpocetine are effective and potent anti-
seizure drugs in this model, perhaps due to their action on cerebral presy-
naptic ionic channels permeability. Secondly, 4-AP is a powerful experi-
mental tool to investigate the anti-seizure mechanism of action of AEDs.
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ATHEROSCLEROSIS DISEASE RISK IN EPILEPSY
PATIENTS
A. Terzoudi*, G. Tsivgoulis†, L. Stilou*, M. Flamouridou*,
I. Iliopoulos*, K. Vadikolias*, C. Piperidou*
*Democritus University of Thrace, Alexandroupoli, Greece,
†National and Kapodistrian University of Athens, Athens,
Greece
Purpose: Chronic epilepsy has been linked with vascular atherosclerotic
disease. Previous studies have correlated increased common carotid
artery intima-media thickness (CCA-IMT), an index of carotid artery
atherosclerosis, with chronic epilepsy and prolonged anti-epileptic drug
(AED) usage. The aim of our study was to evaluate the association
between increased CCA-IMT and the factors regarding epilepsy and its
treatment.
Method: We included epilepsy inpatients and outpatients who attended
the epilepsy clinic during an 1 year period. Inclusion criteria were a defi-
nite diagnosis of epilepsy of >1 year duration and AED treatment. We
assessed demographic and clinical characteristics regarding epilepsy and
vascular risk factors. Patients’ CCA-IMT was measured using a B-mode
ultrasound examination of both carotid arteries.
Results: We evaluated a total of 116 patients with epilepsy (mean age
34  14 years, 52% men, mean BMI 26  4 kg/m2) treated with
antiepileptic drugs (median number of drugs: 2, interquartile range: 1–3;
median duration of antiepileptic treatment in years: 6, interquartile range
3–13). The mean CCA-IMT in the study population was 0.61 
0.18 mm. Patients receiving more than two AEDs had higher CCA-IMT
values than patients under single or dual antiepileptic treatment (0.69 
0.22 mm vs. 0.59  0.22 mm; p = 0.013). Duration of antiepileptic
treatment correlated positively with mean CCA-IMT (Pearson’s correla-
tion coefficient: 0.257; p = 0.007). The use of >2 AEDs was indepen-
dently associated with greater CCA-IMT values (standardized linear
regression coefficient: 0.250; 95%CI: 0.012–0.182; p = 0.026) in multi-
ple linear regression models adjusting for demographic characterstics
(age, sex, BMI) vascular risk factors (hypertension, diabetes mellitus,
hypercholesterolemia, atrial fibrillation, coronary artery disease, hyperc-
holesterolemia, current smoking) and duration of antiepileptic therapy.
Conclusion: Our study showed increased atherosclerosic disease risk in
epilepsy patients on long-term treatment, in accordance with previous
studies, and in patients taking more than two AEDs. These patients
should be closely monitored and treated for vascular risk factors in order
to prevent vascular disease progression.
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COMPARISONOFTHEEFFECTOFVALPROATEAND
LEVETIRACETAMMONOTHERAPYON SUBJECTIVE
ANDOBJECTIVE SLEEP PARAMETERS IN PERSONS
WITHEPILEPSY
M. Tripathi*, P. Mohan†, A. Goyal†, Y. Gupta†, D. Dash‡,
S. Malviya§, V. Srivastava¶
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*All India Institute of Medical Sciences, Delhi, India, †AIIMS,
Pharmacology, Delhi, India, ‡AIIMS, Neurology, Delhi, India,
§AIIMS, Biostatistics, Center of Excellence Epilepsy, Delhi,
India, ¶AIIMS, Delhi, India
Purpose: Sleep disturbance and its consequences are a comorbidity in
persons with epilepsy (PWE). Almost every antiepileptic drug (AED)
impacts sleep. Valproate (VPA) and levetiracetam (LEV) are two com-
mon agents used in the treatment of generalised epilepsies. The aim of
this study was to document prospectively changes in the subjective and
objective aspects of sleep and its resultant effects in PWE receiving these
two AEDs .
Method: 52 consecutive PWE on monotherapy with VPA and 58 PWE
on LEV were included in this study conducted from 2012–2014. A mini-
mum 12 months of seizure freedom was the entry criteria. Parameters
documented were BMI, metabolic syndrome criteria (IDF), adverse event
profile by LAEP, depression by PHQ-9, physical activity assessed by
IPAQ, sleepiness by ESS, insomnia by ISI. Overnight PSG was done on
the somnomedics system.
Results: Majority of the patients were women (69). Most had JME (94),
age range was 28  6 years. Physical activity was significantly more
impacted in those on VPA so did they have higher BMIs.Sleep architec-
ture changes in REM and stage 3 were significant. Sleep efficiency was
significantly reduced in the LEV versus VPA group (80.33  2.00, vs.
91.98  3.12 respectively; p < 0.01), the number of times of that the
patients awoke was increased in the LEV group (5.20  2.86 vs.
2.65  1.50, p < 0.01). Patients on treatment for more than 1 year had
in the VPA group an AHI of 19  15 versus LEV group who had a AHI
of 7  2 this was significant. Those on VPA higher than 800 mg were
more likely to have higher AHIs.
Conclusion: VPA results in significantly more PWE having snoring,
OSA, hypersomnia, increased BMI, impaired daytime performance.
PWE on LEV were significantly more likely to have insomnia and its
consequences. Informed choice of the possibility of these comorbidities
must be discussed before prescribing these AEDs.
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FACTORSASSOCIATEDWITHHOSPITAL
ADMISSIONAND INJURY IN PEOPLEWITH
EPILEPSY
S. Gur-Ozmen*,†,‡, N. Agrawal†,§, M. Mula†, H.R. Cock†,§,
D. Lozsadi†, T.J. von Oertzen†,¶
*Istanbul University, Institute for Experimental and Medical
Research (DETAE), Department of Neuroscience, Istanbul,
Turkey, †St George’s University of London, Department of
Neurology, London, UK, ‡Igdir General Hospital, Department
of Neurology, Igdir, Turkey, §St. George’s Hospital, Atkinson
Morley Neuroscience Centre, London, UK, ¶Kepler University
Hospital, Wagner-Jauregg Neuroscience Centre, Linz, Austria
Purpose: People with epilepsy (PWE) have an increased risk of acci-
dents and injuries. The cause of injuries have been studied before but the
results are diverse. There is a high frequency of hospital admission due to
various factors. It is important to determine the cause of injuries and hos-
pital admissions since preventing them may increase the quality of life in
PWE, and reduce costs.
Method: Consecutive follow up patients over a 10 month period attend-
ing a London epilepsy clinic were included. All patients completed a self
filling questionnaire including questions about injury and/or hospital
admissions that had occurred since their last appointment, Neurological
Disorders Depression Inventory for Epilepsy (NDDI-E) and adverse
event profile (AEP). Other information including about seizures and
treatment were obtained from clinical records. Multivariate analyses of
the potential predictors of injury or hospital admission were performed
seperately. Descriptives and multivariate regression analysis were per-
formed using SPSS forWindows 17.0.
Results: 448 participants with confirmed diagnosis of epilepsy were
included. Patients with missing data (n = 36) were excluded. Among the
remaining 407 patients (243 female) mean age was 43.09 years (SD:
15.75 year). NDDIE-total (OR: 1.085; 95%CI: 1.032–1.140, p = 0.001)
and presence of seizures (OR: 6.777; 95%CI: 2.641–17.389, p = 0.000)
were independently associated with injury in multivariate model. Injury
(OR: 2.134; 95%CI: 1.194–3.814, p = 0.011) and presence of seizure
(OR: 2.495; 95%CI: 1.301–4.787, p = 0.006) were independently associ-
ated with hospital admission in multivariate model.
Conclusion: Presence of seizures is an important determinant for risk of
injuries and hospital admissions of PWE. Unexpectedly, a significant
association between depression and injuries was also identified.
Although a frequent comorbidity in PwE, and strongly associated with
QoL, depression is often missed. Individuals presenting with injuries
should be a trigger for mood screening, and treatment where appropriate.
Further prospective studies are needed to ascertain whether depression
maybe a determinant for injury or a consequence.
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THEROLEOFLACOSAMIDEASADJUNCTIVE
THERAPY FOR PARTIAL-ONSET SEIZURES
S. Bek*, G. Koc†, G. Genc‡, Z. Gokcil§
*Baskent University, Medical Faculty, Adana Research and
Teaching Center, Adana, Turkey, †Turkish Armed Forces
Rehabilitation Center, Neurology, Ankara, Turkey, ‡Gumussuyu
Military Hospital, Neurology, Istanbul, Turkey, §Gulhane
Medical Faculty (Retired), Neurology, Ankara, Turkey
Purpose: Lacosamide (LCM) is a newly registered antiepileptic drug
with dual mechanisms of action. It has been found effective on uncon-
trolled partial epilepsy for reducing seizure frequency as add-on therapy.
We aimed to investigate retrospective data of our patients on LCM.
Method: We performed a retrospective medical record review of 63
patients with uncontrolled partial epilepsy who received LCM as add-on
therapyfor at least 6 months. Data included demographics, LCM dosing,
concomitant AED therapy and seizure activity.
Results: 32 patients were female and 31 patients were male. The mean
age of patients were 33,7611,17 years. The mean onset of seizures
were 16,2610,72 years. The median of seizure frequency in a month was
5 (1–300). The median number of AED before LCM was 3 (1–5). The
median dose of LCM was 200 mg/day (50–400 mg/day). The mean
duration of onset of LCM was 9.85 (6–39) months. 61.9% of patients had
decreased seizure frequency in 1st month but in 6 months or after
6 months 54% of patients had decreased seizure frequency. The mean
percent reduction in seizure frequency was 35.82  36.23% in 1st month
and 31.25  35.90% in 6 or after 6 months. Three patients had gastroen-
terological side effects, two patients had diplopia, two patients suffered
from blurred vision and two patients had itchy skin. In three patients
LCM treatment was stopped (one patient had side effect and LCM was
ineffective in two).
Conclusion: In literature median percent reduction in seizure frequency
was 18.4% for placebo, 33.3% for LCM 200 mg/day, and 36.8% for
LCM 400 mg/day. These results are consistent with our results. But we
found that the reduction in seizure frequency decreased in some patients
after 1 month. Prospective, randomized, placebo controlled, multicenter
studies which include more patients are necessary to investigate the role
of LCM on add-on therapy in patients with partial seizures.
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EFFECTOFESLICARBAZEPINE ACETATEON
SERUMLIPID PROFILE
J.J. Poza*, J. Ruiz*, M.A. De la Morena†, A. Gabilondo‡,
M. Maneiro*, C. Sistiaga‡, V. Olasagasti*, E. Mondragon*,
M. Arruti§, P. De la Riva*, J.F. Martí-Masso*
*Hospital Universitario Donosti, Neurology, San Sebastian,
Spain, †Hospital Universitario Infanta Cristina, Neurology,
Madrid, Spain, ‡Hospital del Bidasoa, Neurology, Irun, Spain,
§Hospital de Zumarraga, Neurology, Zumarraga, Spain
Purpose: The increase in cholesterol level is a well-known side-effect of
enzyme inducers antiepileptic drugs (EIAEDs) such as carbamazepine
(CBZ). Our objective was to analyze if ESL, a milder inducer agent, mod-
ifies or not serum lipid profile.
Method: Serum lipid profile (total cholesterol, HDL-C, LDL-C and
triglycerides) before and 6 months after the beginning of ESL treatment
were compared.
Results: 45 patients (28 women) were included. Age ranged from 16 to
82 years (mean: 52.82 years). In 14 patients (31.11%) ESL was added to
baseline AED medication; in 27 (60%) one AED was switched to ESL
(12 of them stayed in monotherapy with ESL when the other AED was
withdrawan); in 4 (8.93%) ESL was started as monotherapy. The mean
number of concomitant AED was 0.84 per patient. Dose of ESL ranged
from 400 to 1200 mg/day (mean 897.78 mg/day). In the total group,
serum lipid parameters did not changed significantly after the introduc-
tion of ESL. Only two patients with basal total cholesterol levels under
220 mg/dL experienced an increase of this value over 220 mg/dL at the
end of the follow-up. None of them were concomitantly being treated
with EIADs. Patients switched from CBZ to ESL (n = 8) experienced a
significant decrease of cholesterol levels. No significant change was
observed when oxcarbazepine was switched to ESL. Five patients were
under statin treatment at the beginning of the study. No change in their
serum lipid profile with the addition of ESL was observed
Conclusion: ESL does not seem to modify serum lipid profile. When
CBZ is switched to ESL, a decrease in the cholesterol levels can be
observed.
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EFFICACYAND SAFETYOFOXCARBAZEPINEORAL
SUSPENSION IN PEDIATRIC PATIENTS AGED 2–
5 YEARSWITH PARTIAL SEIZURESAND/OR
GENERALIZED TONIC-CLONIC SEIZURES IN
ROUTINECLINICAL PRACTICE INCHINA
J. Qin*,†, Y. Wang‡, X. Huang§, Y. Zhang¶, F. Fang**,
Y. Chen††, Z. Lin‡‡, Y. Deng§§, F. Yin¶¶, L. Jiang***, Y. Wu†,
X. Hu†††
*Peking University People’s Hospital, Department of
Pediatrics, Beijing, China, †Peking University First Hospital,
Department of Pediatrics, Beijing, China, ‡Children’s Hospital
of Fudan University, Department of Neurology, Shanghai,
China, §Quanzhou Women’s and Children’s Hospital,
Department of Pediatrics, Quanzhou, China, ¶Tianjin
Children’s Hospital, Department of Neurology, Tianjin, China,
**Beijing Children’s Hospital, Department of Neurology,
Beijing, China, ††The First Bethune Hospital of Jilin University,
Department of Pediatric Neurology, Changchun, China, ‡‡The
2nd Affiliated Hospital of Wenzhou Medical University,
Department of Pediatric Neurology, Wenzhou, China, §§Xijing
Hospital, Department of Neurology, Xi’an, China, ¶¶Xiangya
Hospital Central South University, Department of Pediatrics,
Changsha, China, ***Children’s Hospital of Chongqing
Medical University, Department of Neurology, Chongqing,
China, †††Guangdong 999 Brain Hospital, 3rd Department of
Neurology, Guangzhou, China
Purpose: The efficacy of Oxcarbazepine (OXC) for seizure control has
been confirmed by many international studies. However, there are few
reports about treatment with its oral suspension, of young pediatric
patients in real-world clinical practice, especially in China. Our study
aimed to assess efficacy and safety of OXC oral suspension in pediatric
patients aged 2–5 years with partial seizures (PS) and/or generalized
tonic-clonic seizures (GTCS) in real-world clinical practice in China.
Method: This 26 week, single arm, multicenter, observational study
recruited pediatric patients aged 2–5 years. OXC oral suspension was
administered as per physicians’ discretion. Study parameters were cap-
tured at baseline and four follow up visits conducted at 4, 8, 13 and
26 weeks. The efficacy endpoints were to assess the change in fre-
quency of seizures at the end of study compared to baseline. Safety
endpoints mainly included incidence of adverse events (AEs) and sev-
ere adverse events (SAEs). Dosing strategy in clinical practice was
also recorded.
Results: A total of 606 pediatric patients were enrolled and majority of
the subjects (531; 87.6%) completed the study. After 26 weeks of treat-
ment, 93.3% subjects had achieved reduction in seizure frequency ≥50%,
and 81.8% had achieved complete seizure control compared to baseline.
Among different seizure types, OXC was found to be effective in all sub-
jects with simple PS type. Mean initial dose was 192.6 mg/day and mean
maintenance dose was 454.8 mg/day. AEs were observed in 49 (8.1%)
subjects. Only two cases namely rash and hypersensitivity were severe.
Skin and subcutaneous tissue disorders were the most frequently reported
AEs and had 19 (3.14%) occurrences. Only 17 subjects discontinued due
to AEs.
Conclusion: This study, reporting the real-world data, further confirms
the efficacy and good safety profile of OXC oral suspension in Chinese
pediatric patients aged 2–5 years with PS and/or GTCS.
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EFFICACYAND SAFETYOFADJUNCTIVE
BRIVARACETAMFORPARTIAL-ONSET (FOCAL)
SEIZURES: POOLEDRESULTS FROMTHREE FIXED-
DOSE, RANDOMISED, DOUBLE-BLIND, PLACEBO-
CONTROLLED PHASE III STUDIES
P.P. Quarato*, J. Whitesides†, J. D’Souza‡, M.E. Johnson†,
J. Schiemann†
*IRCCS Instituto Neurologico, Pozzilli, Italy, †UCB Pharma,
Raleigh, NC, USA, ‡UCB Pharma, Smyrna, GA, USA
Purpose: To assess the efficacy and safety of adjunctive brivaracetam
(BRV), a selective, high-affinity SV2A ligand, for the treatment of par-
tial-onset (focal) seizures (POS).
Method: Data were pooled from three studies (NCT00490035,
NCT00464269, NCT01261325) of adult patients with POS uncontrolled
by 1–2 antiepileptic drugs (AEDs) receiving BRV 5, 20, 50, 100, or
200 mg/day or placebo. Efficacy population: patients from primary effi-
cacy analyses, not receiving concomitant levetiracetam. Safety popula-
tion: patients taking ≥1 dose study drug, with/without levetiracetam. This
analysis reports data for the proposed dose range 50–200 mg/day, for
which approval is being sought.
Results: Patients (efficacy population; n = 1,160) were 50.6% female;
72.5% white; 24.3%, 38.3% and 37.4% took 0–1, 2–4 and ≥5 previous
AEDs, respectively. Most common concomitant AEDs: carbamazepine
(41.0%), lamotrigine (25.5%) and valproate (22.9%). Baseline median
(IQR) POS frequency/28 days was 8.9 (5.5–17.3), 50 mg/day; 8.9 (5.5–
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20.6), 100 mg/day; 9.3 (5.5–18.8), 200 mg/day and 9.6 (5.5–24.3), pla-
cebo. Across the groups, 90.1%–94.7% completed the studies.Percent
reduction over placebo (95% CI) in baseline-adjusted POS frequency/
28 days was 19.5% (8.0%, 29.6%), 50 mg/day (n = 161); 24.4%
(16.8%, 31.2%), 100 mg/day (n = 332); 24.0% (15.3%, 31.8%),
200 mg/day (n = 249). The ≥50% responder rate was 34.2% (50 mg/
day), 39.5% (100 mg/day), 37.8% (200 mg/day) versus 20.3% (placebo).
Median percent reduction in POS frequency from baseline was 34.7%
(50 mg/day), 37.6% (100 mg/day), 35.6% (200 mg/day) versus 17.2%
(placebo).In the safety population (n = 1,262), 68.0% (BRV, n = 803),
62.1% (placebo, n = 459) reported treatment-emergent adverse events
(TEAEs). Serious TEAEs were reported by 3.0% (BRV), 2.8% (placebo);
three patients on BRV and one on placebo died. TEAEs reported in ≥5%
patients taking BRV were somnolence (15.2% vs. 8.5%), dizziness
(11.2% vs. 7.2%), headache (9.6% vs. 10.2%) and fatigue (8.7% vs.
3.7%) for BRV versus placebo, respectively.
Conclusion: In a pooled analysis of adults with POS, adjunctive BRV
(50–200 mg/day) was effective and generally well-tolerated. UCB-sup-
ported.
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QUANTITATIVE ANALYSIS CONFIRMS THE
POTENTIALOF THE PHOTOSENSITIVITYMODEL TO
PREDICT THECLINICALLY EFFICACIOUSAEDDOSE
D.G. Kasteleijn Nolst-Trenite*,†, R.C. Reed‡
*University of Rome, Sapienza II, Faculty of Medicine &
Psychology, Roma, Italy, †University Medical Center Utrecht,
Medical Genetics, Utrecht, Netherlands, ‡Husson University,
Dept. of Pharmacy Practice, School of Pharmacy, Bangor, ME,
USA
Purpose: The Photosensitivity Model (testing suppression of Photo-Par-
oxysmal EEG Response [PPR]) is a useful tool to qualitatively predict
newly developed anti-epileptic drug (AED) efficacy as proof-of-concept
(PoC) (Kasteleijn-Nolst Trenité DGA, Epilepsy Res 1996; Schmidt B.
Neurotherapeutics 2007). Some researchers (Yuen, Seizure 2014) have
retrospectively attempted to quantitatively compare the doses used in
AED PoC photosensitivity trials with the eventual AED doses used in
clinical epilepsy. The average ratio of AED minimum effective dose
(MED) to clinically effective dose (ED50-100) was 0.95 (95% CI = 0.6–
1.30). Herein, we substantially expand on those initial observations, by
quantitative analysis of PoC AED rank-potency versus rank-dose for epi-
lepsy.
Method: Our retrospective analysis preliminarily includes #10 AEDs in
#10 publications. Dose ranges for efficacy in the treatment of epilepsy
and for suppression of EEG in the photo-sensitivity paradigm were
obtained from literature. Dose-ranges were then ranked by the mean of
the range (If tied, the ranks involved were averaged). Spearman’s rank
correlation coefficient was calculated from a conventional formula
(Myers JL 2003.
Research design & statistical analysis: [2nd edition]. Lawrence Erl-
baum, Editor. pg 508). Separate analyses were performed for those AEDs
studied in Phase 2/3, in double-blind trials, and for all data combined.
Results: We identified the AED dose used in every PoC trial, ranked it,
and compared it with the mg dose used clinically (by rank) for all data
combined; the Spearman rank correlation coefficient (SRCC) = 0.9634;
2-tailed p value <0.01. Similar SRCC values were seen for ranked data
from double-blind trials or Phase 2 trials.
Conclusion: The AED dose utilized in the human Photosensitivity
Model accurately and very strongly predicts the AED dose eventually
used in clinical epilepsy. We confirm Yuen’s quantitative analysis of the
utility of the photosensitivity model to aid dose selection for newly-
developed AEDs in early AED development.
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ANTICONVULSANT EFFECTOFNEURAL
REGENERATION PEPTIDE 2945 ONTHE
PRODUCTIONOFDARKNEURON IN THETHE
HIPPOCAMPUSOF PENTYLENETETRAZOL-
INDUCEDMODEL
A. Sajadian*, S. Steghamat*, F. Karimzadeh*,†,
A. Eshaghabadi*, A. Gorji*,‡,§,¶
*Shefa Neuroscience Research Center, Tehran, Iran, Republic of
Islamic, †School of Advanced Technology of Medical, Tehran
Medical University, Neuroscience, Tehran, Iran, Republic of
Islamic, ‡Westf€alische Wilhelms-Universit€at Münster,
Neurology, Münster, Germany, §Westf€alische Wilhelms-
Universit€at Münster, Physiology, Münster, Germany,
¶Westf€alische Wilhelms-Universit€at Münster, Epilepsy Research
Center, Münster, Germany
Purpose: Neuron regeneration peptides (NRPs) are small synthetic pep-
tides that stimulate neural proliferation, migration, and differentiation
with no apparent toxicity and high target specificity in CNS. The aim of
this study was to investigate the effect of NRP2945 on seizure activity
induced by pentylenetetrazol (PTZ) in rats.
Method: Using behavioural assessment and electrocorticographical
recordings, the effects of different doses of NRP2945 (5–20 lg/kg) were
tested on seizure attacks induced by PTZ injection. In addition, the effect
of NRP2945 was evaluated on the production of dark neurons in the hip-
pocampus of the rat brain.
Results: Intraperitoneal injection of NRP2945 at 20 lg/kg prevented
seizure attacks after PTZ injection. NRP2945 at doses of 5 and 10 lg/kg
significantly decreased the total duration of seizure attacks and reduced
the amplitude, duration and latency of epileptiform burst discharges
induced by PTZ. In addition, the peptide significantly inhibited the pro-
duction of dark neurons in the hippocampus of epileptic rats.
Conclusion: This study indicates that NRP2945 is able to prevent the
seizure attacks and neuronal injuries induced by PTZ.
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PRESCRIBINGAEDS IN A PEDIATRIC NEUROLOGY
CLINIC INMALTA
A.M. Scerri*, D. Soler†, N. Calleja‡, J. Mifsud§
*University of Malta, Department of Clinical Pharmacology and
Therapeutics, Msida, Malta, †Mater Dei Hospital, Department
of Paediatrics, Msida, Malta, ‡Ministry for Health, Health
Information and Research Directorate, Pieta, Malta,
§University of Malta, Clinical Pharmacology and Therapeutics,
Msida, Malta
Purpose: The selection of appropriate antiepileptic drugs (AEDs) in pae-
diatric populatons depends on seizure type, available drugs, possible drug
interactions, and susceptibility to drug toxicity.This study aimed to inves-
tigate the prescribing patterns of AEDs in a population of children pre-
senting to a paediatric epilepsy clinic.
Method: Clinical records were reviewed retrospectively from the 31st
December 2013 to the date of first presentation of each patient to hospital
services for the management of epilepsy.
Results: Following the application of inclusion and exclusion criteria,
the final study population comprised 76 children, ages 0–16 years, 32
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girls and 44 boys, whose mean age at diagnosis was of 4.54 years and
whose main duration of the epilepsy had been of 8.7 years. The most
common type of epilepsy was generalised tonic clonic seizures only
(28.95%), childhood absence epilepsy (19.74%) and BECTS (14.47%).
Valproate was the most commonly prescribed AED overall (40.8%).
Lamotrigine was the most commonly prescribed newer AED (19.7%).
The use of older AEDs exceeded that of newer ones, suggesting clini-
cian confidence with working with time-tested drugs. The most com-
monly prescribed AED combination was valproate with lamotrigine.
48.7% of children were receiving AEDs as monotherapy, similar to
studies from other countries. Around a third of the children (35.5%)
were off AED therapy on the 31st December 2013 since they were in
seizure remission. In 55.3% of cases the first AED started at diagnosis
remained unchanged. AED selection was not affected by gender or
comorbidity.
Conclusion: This study identified prescribing trends in a cohort of chil-
dren with epilepsy in Malta. Results regarding demographic findings and
selection of drug therapy are comparable to findings from studies from
other countries This study may serve as a basis for further pharmacoepi-
demiological and pharmacoeconomic studies which could guide local
drug-related policy.
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BRIVARACETAMANDTOPIRAMATE INTERACTION
STUDY INHEALTHY SUBJECTS
A. Stockis, S. Watanabe
UCB Pharma, Braine l’Alleud, Belgium
Purpose: Brivaracetam is a high-affinity synaptic vesicle protein 2A
ligand that is under review as adjunctive treatment for adults with partial-
onset (focal) epilepsy. The objective of this study was to investigate the
effects of steady-state brivaracetam concentration on topiramate pharma-
cokinetics in healthy subjects.
Method: This was a phase I, single-centre, open-label study. All partici-
pants received brivaracetam 200 mg twice daily on Days 5–17 and sin-
gle-dose topiramate 200 mg on Days 1 and 14. Trough plasma
brivaracetam was measured on Days 7, 10, 13, 14 and 16; plasma topira-
mate was measured pre-dose and up to 96 hours post-dose on Days 1 and
14. Geometric least squares means ratios (Day 14:Day 1) and 90% confi-
dence intervals (CIs) were derived from analysis of variance for topira-
mate maximum plasma concentration (Cmax), area under the plasma
concentration versus time curve to last measurable concentration (AUCt)
and extrapolated to infinity (AUCinf). Time to Cmax (tmax) was analysed
using Wilcoxon’s signed ranks test. Safety assessments included adverse
events, physical examinations, laboratory tests, vital signs and electrocar-
diograms.
Results: All 14 participants [male:female 6:8, mean (SD) age 33 (8)
years, body weight (SD) 70 (9) kg] completed the study. Topiramate
plasma concentration versus time profiles were similar on Days 1 and 14.
Geometric means ratios (90%CI) of topiramate with brivaracetam versus
without brivaracetam were 0.98 (0.93, 1.03) for Cmax, 0.95 (0.89, 1.01)
for AUCt, and 0.94 (0.88, 0.99) for AUCinf. All CIs were within the
acceptance range (0.80, 1.25). Median topiramate tmax was 3 hours with
and without brivaracetam; median difference [Day 14Day 1] (90% CI)
was0.5 (3.5, 0.2). Brivaracetamwas well tolerated.
Conclusion: Brivaracetam 200 mg twice daily did not significantly alter
topiramate pharmacokinetics. UCB supported.
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BRIVARACETAMANDLAMOTRIGINE INTERACTION
STUDY INHEALTHY SUBJECTS
A. Stockis, S. Watanabe, S. McCabe
UCB Pharma, Braine l’Alleud, Belgium
Purpose: Brivaracetam is a selective, high-affinity synaptic vesicle pro-
tein 2A ligand that is under FDA and EMA review as adjunctive treat-
ment for adults with partial-onset (focal) epilepsy. The objective of this
study was to investigate the effects of steady-state brivaracetam on lam-
otrigine pharmacokinetics in healthy subjects.
Method: This was a Phase I, single-centre, open-label study. All partici-
pants received brivaracetam 200 mg twice daily on Days 5–17 and sin-
gle-dose lamotrigine 25 mg on Days 1 and 14. Trough plasma
brivaracetam was measured on Days 7, 10, 13, 14 and 16; plasma lamot-
rigine was measured pre-dose and up to 96 hours post-dose on Days 1
and 14. Geometric least squares means ratios (Day 14:Day 1) and 90%
confidence intervals (CIs) were derived from analysis of variance for
lamotrigine maximum plasma concentration (Cmax), area under the
plasma concentration versus time curve to last measurable concentration
(AUCt) and extrapolated to infinity (AUCinf). Time to Cmax (tmax) was
analysed using Wilcoxon’s signed ranks test. Safety assessments
included adverse events, physical examinations, laboratory tests, vital
signs and electrocardiograms.
Results: Fourteen male participants [mean (SD) age 26 (5) years, body
weight (SD) 73 (8) kg] completed the study; 13 were evaluable for phar-
macokinetic assessments. Lamotrigine plasma concentrations appeared
to be slightly higher when co-administered with brivaracetam. Geometric
means ratios (90% CI) of lamotrigine with brivaracetam versus without
brivaracetam were 1.10 (1.03, 1.17) for Cmax and 1.17 (1.09, 1.25) for
AUCt. Both CIs were within the acceptance range (0.80, 1.25). AUCinf
could not be accurately estimated for some participants as the extrapo-
lated part exceeded 20%. Median lamotrigine tmax was 3 hours with and
without brivaracetam; median difference [Day 14Day 1] (90% CI) was
0.5 (1.75, 0.75). Brivaracetam was well tolerated.
Conclusion: Brivaracetam 200 mg twice daily did not significantly alter
lamotrigine pharmacokinetics. UCB supported.
p0859
BRIVARACETAMANDCARBAMAZEPINE
INTERACTION STUDY INADULT PATIENTSWITH
EPILEPSY
A. Stockis*, M.L. Sargentini-Maier*, M. Brodie†
*UCB Pharma, Braine l’Alleud, Belgium, †Western Infirmary,
Glasgow, UK
Purpose: Brivaracetam is a selective, high-affinity synaptic vesicle pro-
tein 2A ligand that is under review as adjunctive treatment for adults with
partial-onset (focal) epilepsy. The objective of this investigation was to
assess the effects of steady-state brivaracetam on the pharmacokinetics
of carbamazepine (CBZ) in patients with epilepsy, in the presence and
absence of the epoxide hydrolase inhibitor valproate (VPA).
Method: In this Phase I, open-label, dose escalation study, brivaracetam
was administered during successive 1-week periods at dosages of 50,
100, 200 and 100 mg twice daily (bid) to adult patients with epilepsy
chronically treated with ≥600 mg/day CBZ alone (n = 9) or ≥600 mg/
day CBZ and ≥500 mg/day VPA (n = 9). Dosages of CBZ and VPA
must have been stable for at least 3 months. Trough plasma concentra-
tions of brivaracetam, CBZ, CBZ metabolites (CBZ-E, CBZ-diol) and
VPA were determined on Days 1, 8, 15, 22 and 29. Safety assessments
included adverse events, laboratory tests, vital signs and electrocardio-
grams.
Results: Thirteen male and five female patients with median (range)
age of 46 (20–62) years and body weight of 74 (59–124) kg were
enrolled and completed the study. In the presence of CBZ alone, bri-
varacetam dose-dependently increased mean trough levels of CBZ-E
from 1.38 lg/mL at baseline to 2.16 lg/mL (+57%), 2.72 lg/mL
(+98%), 3.02 lg/mL (+120%) and 2.67 lg/mL (+94%) on Day 8
(50 mg bid), Day 15 (100 mg bid), Day 22 (200 mg bid) and Day 29
(100 mg bid), respectively. In the presence of CBZ and VPA, CBZ-E
increased from 1.98 lg/mL at baseline to 2.72 lg/mL (+37%),
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3.53 lg/mL (+78%), 4.43 lg/mL (+124%) and 3.22 lg/mL (+63%),
respectively. There was no trend for changes in CBZ, CBZ-diol or VPA
levels. Brivaracetam levels increased linearly with dose. Brivaracetam
was well tolerated.
Conclusion: These findings are consistent with a dose-dependent and
reversible inhibition of microsomal epoxide hydrolase by brivaracetam.
The effect was similar in presence of valproate. UCB supported.
p0860
RUFINAMIDEAS ADJUNCTIVE TREATMENT FOR
ADULTSWITHLENNOX-GASTAUT SYNDROME:
SUBGROUPANALYSIS FROMAPHASE III TRIAL
P. Striano*, R. McMurray†
*University of Genoa, G. Gaslini Institute, Department of
Neurosciences, Rehabilitation, Ophthalmology, Genetics,
Maternal and Child Health, Genova, Italy, †Eisai Europe Ltd,
Hatfield, UK
Purpose: Rufinamide is a triazole derivative, structurally unrelated to
other antiepileptic drugs, approved for adjunctive treatment of seizures
associated with Lennox–Gastaut syndrome (LGS) in patients aged
≥4 years. LGS often persists into adulthood, or may have late onset in
adulthood. Management of LGS in adulthood is challenging; seizures are
often intractable and most patients have from moderate to severe cogni-
tive impairment. A post-hoc subgroup analysis of data from a Phase III
trial was conducted to investigate efficacy of rufinamide in adults with
LGS.
Method: A randomised, double-blind, placebo-controlled trial was con-
ducted in patients with LGS, aged 4–37 years, with multiple seizures
types (including drop-attack seizures and atypical absence seizures) and
a minimum of 90 seizures during a 28-day baseline period. During a 14-
day titration phase plus 70-day maintenance period, patients received
double-blind treatment with either rufinamide (titrated to approximately
45 mg/kg/day maximum) or placebo. In a post-hoc subgroup analysis,
efficacy in adult patients (≥18 years) was assessed as median percentage
change from baseline in monthly frequency of all seizures and drop-
attack seizures during double-blind treatment.
Results: Adults with LGS were randomised to adjunctive treatment with
rufinamide (n = 21; 15 male, 6 female) or placebo (n = 10; 5 male, 5
female). Mean (standard deviation [SD]; range) age was 25.2 (4.7; 18–
35) and 29.3 (7.1; 18–37) years in the rufinamide and placebo groups,
respectively; mean (SD; range) time since LGS diagnosis was 18.5 (8.9;
0–33) and 25.5 (8.1; 8–34) years. Median change from baseline in seizure
frequency was 31.5% for rufinamide versus +22.1% for placebo
(p = 0.008, Wilcoxon Rank Sum test, unadjusted) for all seizures and
54.9% versus +21.7% (p = 0.002) for drop-attack seizures.
Conclusion: Rufinamide demonstrated favourable efficacy, compared
with placebo, when used as adjunctive treatment for adults with LGS.
Study and abstract supported by Eisai.
p0864
PERAMPANEL IN FOCALEPILEPSY: A FRENCH
COHORT
N.P.L. Tang*, A. Crespel†, P. Gélisse†, P. Coubes†, P. Genton‡
*Ho^pital Gui de Chauliac, Unité d’Epileptologie, Montpellier
Cedex, France, †Ho^pital Gui de Chauliac, Epilepsy Unit,
Montpellier Cedex, France, ‡Centre Saint Paul-Henri Gastaut,
Marseille, France
Purpose: Perampanel (PER) was introduced in France in May, 2014 as
add-on in drug-resistant focal epilepsy (DRFE). All patients newly trea-
ted with PER have been prospectively added to an ad hoc database in two
tertiary epilepsy clinics (Montpellier and Marseille), in order to assess
efficacy (with at least 3 months of follow-up) and tolerability of PER in a
practical setting.
Method: Patients were reviewed at 3 month intervals and were encour-
aged to manifest at shorter intervals in case of problems. We recorded all
personal and epilepsy data, and actively looked for side-effects and all
parameters of clinical efficacy at each contact.
Results: As of February 25, 2015, we have treated 218 DRFE patients
with PER (101 M, 117 F, mean age 42.5 years, range 11–83; mean
duration of epilepsy: 26.6 years, range 1–67). All had DRFE (symp-
tomatic: 137, cryptogenic: 81) with a least one seizure per month (up
to several per day) and were receiving a mean of 3.1 drugs (range 1–
6). 24 patients stopped PER within 2 months because of at least one
intolerable side-effect: seizure aggravation 9, psychiatric side-effects 6,
dizziness/ataxia 3, fatigue/somnolence 2, headache 2, skin rash 2,
abdominal pain 2; 110 were evaluated after at least 3 months: 21
(19.1%) were seizure-free, 14 (12.7%) had ≥90% seizure reduction,
10 ≥ 75% (9.1%), 28 ≥ 50% (25.5%), and 39 (35.5%) no worthwile
improvement; 8 patients stopped PER after 3 to 6 months due to side-
effects (7 with seizure aggravation); 8 patients reported (independently
of seizure control) a noticeable feeling of well-being, which may point
to a positive side-effect.
Conclusion: Although the follow-up is still short at this time, a large
cohort has enabled us to use PER with a major benefit for 40% of patients
with DRFE, an outstanding result in our experience.
p0865
DOANTIEPILEPTIC DRUGSAFFECT LIPID PROFILE?
E.A. Demirel*, N.F. Tascilar†, A. Varol‡, F. Kokturk§
*Bulent Ecevit University, Faculty of Medicine, Neurology,
Zonguldak, Turkey, †Medipol University, Faculty of Medicine,
Neurology, Istanbul, Turkey, ‡Bartın Government Hospital,
Neurology, Bartın, Turkey, §Bulent Ecevit University, Faculty of
Medicine, Biostatistics, Zonguldak, Turkey
Purpose: Several studies have reported that commonly used antiepilep-
tic drugs such as phenytoin, phenobarbital and carbamazepine increase
low density lipoprotein-cholesterol profile, but others couldn’t find any
relationship between antiepileptic drug usage and hyperlipidemia. The
present study was planned to assess and compare serum lipid profile of
epileptic patients on antiepileptic drugs.
Method: 830 patients with epilepsy who admitted to the hospital of
BEU, Faculty of Medicine for the last 8 years were screened retrospec-
tively. Patients with stroke, chronic renal/hepatic failure, hypo- or hyper-
thyroidism, diabetes mellitus and patients on medication which were
known to change the lipid profile were excluded. So 205 patients with
epilepsy who were taking the same antiepileptic drug(s) for at least
3 months were taken into account. Lipid profile (total, HDL-, LDL-
cholesterol, triglyceride, apolioprotein B/apolipoprotein A) on the last
visit were extracted from chart reviews. Age and sex matched 31 healthy
volunteers were taken as the control group.
Results: 126 patients out of 205 were on monotherapy (on pheny-
toin = 16, carbamazepine = 40, oxcarbazepine = 17, valproic
acid = 22, levetiracetam = 25, others = 6). Lipid profile wasn’t statisti-
cally significant different between the patient and control groups. Fur-
thermore there wasn’t any difference between patients on monotherapy
and polytherapy as for the lipid profile.
Conclusion: Although it is suggested that antiepileptics, especially CYP
enzyme inducers is strongly associated with increased levels of choles-
terol, our study didnot confirm this. It could be due to our strict exclusion
criteria, which allowed us to study the solitary effect of antiepileptic
drugs on lipid profile. Because of our subgroups being small, other stud-
ies with larger groups are needed.
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UNEXPLAINED LAMOTRIGINE TOXICITY-
EVIDENCEOFNONLINEARKINETICS IN SELECT
INDIVIDUALS
B. Abou-Khalil, M. Osborn, P. Ramey, K. Lowen
Vanderbilt University, Neurology, Nashville, TN, USA
Purpose: To report acute lamotrigine (LTG) toxicity after minor or no
change in LTG dose.
Method: We searched our database for patients with LTG levels of
≥25 mcg/mL and analyzed medication changes that preceded the ele-
vated serum concentration. We also reviewed clinical correlates of ele-
vated LTG level.
Results: 40 patients had a serum LTG concentration measurement of
≥25 mcg/mL (range 25–40.3). The previous measured concentration was
above 15 mcg/mL in 25 of the patients (mean 16.5), and there was a rela-
tive mean increase of 150%. In 29 patients, the increase in LTG concen-
tration was not preceded by any change in dose and had no explanation.
In two patients, the increase was related to addition of valproate, despite
some concomitant reduction in LTG dose. In the remaining nine patients,
there was a 164% mean increase in LTG concentration in response to a
12%mean increase in dose. Clinical manifestations of toxicity were seen
in 29 patients and included tremor, light-headedness, vertigo, ataxia,
lethargy, confusion, agitation, delirium, nausea and vomiting. 11 patients
had no clinical toxicity.
Conclusion: LTG may follow nonlinear kinetics at elevated concentra-
tions in select individuals, and a large increase in concentration may be
seen with a small change or even no change in dose. Close monitoring of
LTG serum concentration is warranted for symptoms consistent with
LTG toxicity, particularly when the baseline serum concentration has
been above 15 mcg/mL.
p0867
VALPROICACID-INDUCEDHYPERAMMONEMIC
ENCEPHALOPATHY INA PATIENTWITH
CONCOMITTANTUSEOFLEVETIRACETAMAND
ZONISAMIDE
E.A. Dogan*, N. Guzelay*, A. Unal*, E. Gunsoy†, C. Eken†
*Akdeniz University School of Medicine, Neurology
Department, Antalya, Turkey, †Akdeniz University School of
Medicine, Department of Emergency Medicine, Antalya, Turkey
Hyperammonemic encephalopathy is a rare but potentially fatal compli-
cation of valproic acid (VA) treatment. The mechanism by which VA
induces hyperammonemia remains incompletely understood but is likely
to relate to deficiencies in the uric acid cycle. Frequently encountered
symptoms of VA-induced hyperammonemia are lethargy, impaired con-
sciousness, focal neurological signs, increased number of seizures and
rarely coma. A mentally and motor retarded 44-year old female with a
history of generalized tonic clonic seizures since 4 years old was admit-
ted for altered state of consciousness and an increased number of seizures
for 5 days. The patient has been on levetiracetam (1000 mg/day) carba-
mazepine (400 mg/day) and zonisamide (300 mg/day) treatments for
more than a year. Carbamazepine treatment has been gradually tapered
and changed to valproic acid (250 mg/day) a week ago in a local hospital.
On admission, she was unresponsive with reactive pupils and normal
vital signs. Routine blood chemistry including hepatic functions, urine
analysis and computed tomography were normal. Electroencephalogra-
phy was consistent with moderate to severe encephalopathy. VA was
therapeutic at 80 lg/dL; (50–100 lg/dL) whereas serum ammonia level
was elevated at 130 lg/dL (20–50 lg/dL). VA was immediately discon-
tinued and the patient was admitted to the intensive care unit where she
recovered completely. Concomittant use of levetirasetam and/or zon-
isamide might have promoted hyperammonemic encephalopathy. Any
suspected patient even if receiving very low doses of VA with normal
liver functions, should be sought rigorously.
p0868
ZONISAMIDE TREATMENT FORREFRACTORY
IDIOPATHICGENERALIZED EPILEPSY:
PRELIMINARYRESULTSOFANOBSERVATIONAL
STUDY
E.A. Dogan*,†, B.O. Genc†, E. Genc†
*Akdeniz University School of Medicine, Neurology
Department, Antalya, Turkey, †N.E.University, Meram School of
Medicine, Neurology Department, Konya, Turkey
Purpose: The efficacy of zonisamide (ZNS) for the treatment of patients
with refractory idiopathic generalized epilepsy (IGE) was analyzed retro-
spectively.
Method: Fourteen patients with different types of IGEs with at least two
generalized tonic clonic seizures per month were regarded as patients
with refractory IGE. Patients who were treated with ZNS were identified.
Efficacy was assessed at 3 month intervals after ZNS treatment.
Response was defined as a 50% or greater reduction in seizure frequency
according to the patient and caregiver reports.
Results: Mean age was 25.5 years. Mean daily dose was 228.6 mg
(range 100–300 mg/day). Mean follow-up period was 9.8 months
(range: 2–19 months). ZNS was effective for all patients except one
patient, who discontinued ZNS due to a major depressive disorder.
Response was achieved in 11 (78.6%) patients whereas 9 patients
(64.3%) were seizure free. Retention rate was found as 92.9%.
Conclusion: Despite limitations, including the small sample size of
patient population and the short follow-up period, according to the results
of this observational study, ZNS might be regarded as a promising anti-
epileptic drug for patients with refractory IGE.
p0869
LACOSAMIDEASADJUNCTIVE THERAPY INADULT
PATIENTSWITHRESISTANT PARTIAL EPILEPSY
E. Taşkıran, S. Kutluhan
Süleyman Demirel University Faculty of Medicine Department of
Neurology, Isparta, Turkey
Purpose: Lacosamide (LCM) is a novel antiepileptic drug (AED). Its
efficacy as adjunctive therapy for focal seizures is confirmed in adult pla-
cebo controlled trials with >50% reduction in seizure frequency in up to
50% patients. We aimed to investigate efficacy and tolerance of LCM as
adjunct therapy in treatment of adult patients with resistant partial epi-
lepsy (RPE).
Method: The study was performed between May 2013 and January
2015. In the current study, 17 with RPE (age 22–51 years) who had failed
two or more antiepileptic drugs and in whom LCMwas used as an add-on
drug was enrolled. LCM was given a dose of 50 mg for 1 week followed
by 100 mg twice daily for the remaining period. Total dose of LCM as
150 mg was given to twice daily up two patients. Efficacy and tolerabil-
ity evaluation was performed monthly three times at beginning and fol-
low-up visits at three monthly intervals. Electrocardiogram and liver
function tests were also performed before enrollment and at the end of
3 months of LCM therapy.
Results: Seventeen patients with RPE were followed. The mean age was
35.23  10.36 years; 8 patients (50%) were men. Twelve patients were
responded of 50%–90%. One patient left the study because of side
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effects. There was no response to treatment even the dose increased to
the effective levels in three patients. The agranulocytosis appeared in a
case. Three patients had weakness, dizziness and nausea. One of them left
the treatment. In the remaining two patients all symptoms disappeared
spontaneously in the following 2 weeks.
Conclusion: It seems that LCM is a well-tolerated AED with RPE in
adults in 94.1% (16 cases). Frequency and severity of seizures were
reduced in cases of 70.5% (12 cases). LCMmay be useful in treatment of
RPE in adults.
p0870
SAFETYANDTOLERABILITYOF LONG-TERM
TREATMENTWITHADJUNCTIVE BRIVARACETAM
FORPARTIAL-ONSET SEIZURES
M. Toledo*, M.E. Johnson†, J. Whitesides†, J. Schiemann†
*Hospital Universitari Vall d’Hebron, Barcelona, Spain, †UCB
Pharma, Raleigh, NC, USA
Purpose: To assess long-term safety/tolerability of brivaracetam (BRV)
for adjunctive treatment of partial-onset (focal) seizures (POS).
Method: Data were pooled from two Phase II (NCT00175929,
NCT00175825), six Phase III (NCT00490035, NCT00464269,
NCT00504881, NCT01405508, NCT01261325, NCT01653262) and
associated long-term follow-up (LTFU) studies (NCT00175916,
NCT00150800, NCT01728077, NCT01339559). Adults (≥16 years)
with epilepsy received BRV 5–200 mg/day. Treatment-emergent
adverse event (TEAE) monitoring and safety/laboratory assessments
were performed at protocol-specified time points until 17 January 2014.
Results: Of 2388 patients who received BRV (Europe 46.2%; North
America 20.7%; Asia Pacific/other countries 20.0%; Latin America
13.1%), treatment is ongoing in 943 (39.5%), 1293 (54.1%) discontinued
treatment in core or LTFU studies and 152 (6.4%) completed core studies
but had not entered LTFU. At baseline, patients (mean [SD] age 37.0
[12.6] years; 50.3% male) most frequently had POS (97.1%); other sei-
zure types 2.9%. Most common concomitant AEDs (≥20%): carba-
mazepine (42.0%), lamotrigine (27.3%) and valproate (24.2%).
Exposure to BRV was 5558.0 patient-years in total; 1740, 1363, 923, and
569 patients were exposed for ≥6, ≥12, ≥24 and ≥60 months; some
received BRV for >8.5 years. Altogether 84.8% patients reported TEAEs
(55.0% drug-related); 14.1% patients discontinued due to TEAEs. The
most common TEAEs (≥10%) were headache (20.9%), dizziness
(17.3%), somnolence (15.2%), nasopharyngitis (12.7%), fatigue (11.5%)
and convulsion (10.5%). Serious TEAEs (SAEs) were reported in 18.1%
patients (4.4% drug-related), most commonly convulsion (2.5%), status
epilepticus (0.8%); pneumonia, epilepsy, grand mal convulsion, suicidal
ideation and suicidal attempt (0.5% each). There were 34 (1.4%) deaths,
of these five (0.2%) were considered possibly related to study drug. Vital
signs, electrocardiograms and laboratory assessments did not reveal any
clinical concerns.
Conclusion: Pooled long-term safety data show that treatment with
adjunctive BRV for up to 8.5 years was generally well tolerated, with a
low incidence of TEAEs, drug-related TEAEs and SAEs. UCB sup-
ported.
p0871
DAYTIME SLEEPINESS AND SLEEPQUALITY IN
PATIENTS TREATEDWITHPERAMPANEL
M. Toledo*, M. Gonzalez-Cuevas*, A. Molins†, J. Miro‡,
M. Falip‡, A.B. Martinez§, S. Fernandez¶, M. Quintana**,
E. Santamarina**, J. Salas Puig**
*Hospital Universitari Vall d’Hebron, Epilepsy Unit,
Neurology, Barcelona, Spain, †Hospital Universitari Josep
Trueta, Girona, Spain, ‡Hospital Universitari Bellvitge,
Barcelona, Spain, §Hospital Son Espases, Palma de Mallorca,
Spain, ¶Hospital Plato, Barcelona, Spain, **Hospital
Universitari Vall d’Hebron, Barcelona, Spain
Purpose: The purpose of this study was to evaluate the effects of peram-
panel (PER) as adjunctive therapy on daytime somnolence and sleep
quality in adult patients with focal onset epilepsy.
Method: Multicenter prospective study performed during 6 months,
assessing daytime somnolence by means of the Epworth Sleepiness
Scales (ESS) before and 3 months after starting treatment with PER.
Sleep quality by using Pittsburgh Sleep Quality Index (PSQI) was also
recorded when available. Demographic and clinical data were considered
to analyze the results.
Results: Of 67 patients included at baseline visit (Age 43, range 17–
75 years; 60% Female), 49 completed the study evaluation at 3 months
with ESS, and 34 with PSQI.
PER was used as ≥3rd AED in all patients. The average seizure fre-
quency at baseline was 49 per months, which was reduced to 38 at fol-
low-up (p = 0.007). The responders rate (>50%) was 30%, with a
median PER doses of 4 mg (range 2–8 mg). The retention rate at follow-
up was 73%, drug withdrawn was due to lack of efficacy (12%) or side
effects (15%). Most common treatment emergent adverse events were
somnolence (20%) and dizziness (18%). Average baseline ESS (6) score
was within normal limits and PSQI (8) was considered abnormal in the
sample. At follow-up, daytime sleepiness was not impaired by PER treat-
ment (ESS = 6). However, the quality of sleep improved significantly by
two points in the PSQI (p = 0.004). Sleep improvement was independent
from demographic variables, seizure response and PER doses.
Conclusion: PER is an effective and safe antiepileptic drug, which can
improve the sleep quality without impact in the daytime somnolence in
patients with epilepsy.
p0873
VITAMIND SUPPLEMENTATIONCOULDBE
INSUFFICIENT FOROSTEOPOROSIS PREVENTION IN
PERSONSWITHEPILEPSYONANTIEPILEPTIC
DRUGS
I. Villegas-Martinez*, R. Carrasco Torres*, I. de Miguel-
Elizaga†, M.J. Yedra Guzman*, M. Martinez Villanueva†,
D. Tortosa Conesa*, J. Martín Fernandez*
*Hospital Universitario Virgen de la Arrixaca, Neurology,
Murcia, Spain, †Hospital Universitario Virgen de la Arrixaca,
Clinical Analysis, Murcia, Spain
Purpose: Antiepileptic drugs (AED) as carbamazepine (CBZ), pheny-
toin (PHT) and valproic acid (VPA) are strongly related to disturbances
in bone metabolism in persons with epilepsy, and can lead to a premature
osteoporosis. Vitamin D supplementation (VD) has been recommended
but dosage is still not clear. The aim of our study was to determine if VD
administration as performed in everyday clinical practice is related to a
better outcome on densitometry parameters in patients on chronic AEDs.
Method: We conducted a prospective observational study on adult
epileptic outpatients from the Epilepsy Unit of Arrixaca’s Hospital (Mur-
cia, Spain), on stable monotherapy with AEDs, either classical or new
(levetiracetam (LEV), eslicarbazepine (ESL), lacosamide (LCM)), that
were going to start VD (cholecalciferol 400 UI/calcium carbonate
1500 mg). A similar sample of patients not taking VD was collected as
control group. Bone mineral density (BMD) at lumbar level and neck of
left femur was studied by dual energy X-ray absorptiometry at the begin-
ning of the study and after 6 months.
Results: 26 patients on VD and 38 controls were studied. Mean age was
45.27  14.74 years in VD group (16 men, 13 on LEV, 5 on CBZ, 5 on
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VPA and 3 on PHT), and 39  14.20 years in control group (26 men, 17
on LEV, 13 on VPA, 4 on ESL, rest on CBZ, PHT and LCM). Differences
between basal and follow-up lumbar and femoral BMD values were not
significantly different in patient group than in control group
(0.016  0.541 g/cm2 versus 0.004  0.063 g/cm2, and
0.021  0.115 g/cm2 vs. 0.010  0.045 g/cm2, respectively). No dif-
ference was found when adjusted to sex, age, AED and other confound-
ing factors.
Conclusion: VD at low doses could be an insufficient measure to prevent
BMD disturbances in patients on AEDs. Guidelines are needed to estab-
lish an accurate management of bone disease in our patients.
p0875
EPILEPSYOUTCOME INWEST SYNDROMEAT
4 YEARSOF LIFE FOLLOWINGTREATMENTWITH
ACTHORPREDNISOLONEAS FIRST LINE THERAPY:
PRELIMINARY FINDINGS FROMARANDOMIZED
CLINICAL TRIAL
J. Wanigasinghe*, C. Arambepola†, K.A. Jayasundara‡,
Y. Jayasinghe§, E. Muhandirum*
*University of Colombo, Colombo, Sri Lanka, †University of
Colombo, Community Medicine, Colombo, Sri Lanka, ‡Ministry
for Health, Colombo, Sri Lanka, §University of Colombo,
Paediatrics, Colombo, Sri Lanka
Purpose: West syndrome is a devastating epileptic encephalopathy asso-
ciated with significant mortality and morbidity.Majority evolve to differ-
ent epilepsy syndromes in later life. Descriptions on late outcomes are
very limited.
Method: Ninety seven children with previously untreated West Syn-
drome were randomized to receive ACTH (48) and Prednisolone (49)
according to the UKISS protocol. They were prospectively followed at
different time points. This abstract describes epilepsy outcome at 4 years
of life.
Results: There were 43 children completing 4 years by 28.02.2015.
Only 25 presented for the 4 year evaluation; seven died before this date
and eleven did not respond. All the deaths were in ACTH arm, but were
unrelated to epilepsy or drug side effects. Out of 25 reviewed, eighteen
children (72%) were spasm free by their 4th birthday. Nine children were
completely free of any form of seizures (36%). There were 16 experienc-
ing ongoing epilepsy. These epilepsies included epileptic spasms only in
3 (18%), spasms  other seizure type/types in balance thirteen. A clear
evolution into a focal epilepsy occurred in 4 (25%). Multiple seizure
types were noted in 9 (55%) and this included one child with definite
Lennox Gastout syndrome (6%), and another with focal plus reflex (pho-
tic) epilepsy (6%). The likelihood of spasm freedom at 4 years was not
affected by the initial treatment method (p = 0.2). Likelihood of evolving
into other type of epilepsy was also equal (p = 0.56). However, better
seizure control (Engels class 1 or 2) in those with ongoing epilepsy, was
seen in those treated with prednisolone (p = 0.02).
Conclusion: Preliminary findings in this clinical trial on outcome at
4 years indicate that treatment with steroids as first line resulted in sus-
tained spasm freedom in 72%. Irrespective of treatment type, 52%
evolved to different seizure types. Overall epilepsy outcome was better if
initially treated with prednisolone.
p0876
EFFICACYAND SIDEEFFECT PROFILEOF
LACOSAMIDE INREFRACTORY FOCALONSET
EPILEPSY PATIENTS
R.J. Gowda, V. Hegde
University Hospitals of Coventry and Warwickshire, Neurology/
Neurophysiology, Coventry, UK
Purpose: To evaluate efficacy and safety profile of Lacosamide.
Method: 30 adult patients (>18 year) who are on Lacosamide were ret-
rospectively and randomly selected from our electronic database. Each
patient’s epilepsy/AED history and seizure control were reviewed before
and after Lacosamide introduction.
Results: Of 30 patients (mean age 41 years, 53% women, mean epi-
lepsy duration 18 years, 1/3rd Learning disability), 63% had Complex
partial seizures. Commonest epilepsy syndrome was Symptomatic/
Cryptogenic partial epilepsy (43%) followed by Idiopathic partial epi-
lepsy. 40% were on 4 AED, 30% on ≥5AEDs, 20% on 3 AED, 10% on
2 AED. <50% seizure reduction was seen in all patients on ≤2 AED and
84% on ≥3 AED. None reported ≥75% seizure reduction. Following
introduction of Lacosamide (mean treatment duration 25 months; mean
daily dose 345 mg), commonest side effect was dizziness and cognitive/
behaviour change (10% each), ataxia (9%) and increase in seizure fre-
quency (7%). 20% stopped Lacosamide due to adverse events, 7% due
to increase in seizure frequency; all who stopped were on 3 or more
AED. Those who reported side effects did so in first few months of
starting Lacosamide. Lacosamide showed ≥75% reduction in seizure
frequency in 50%, 25% showing 50%–75% reduction; 7% had >2 years
of seizure freedom.
Conclusion: Lacosamide is effective in reducing seizure frequency sig-
nificantly or achieving seizure freedom (7%) in refractory focal onset
epilepsy patients. 7% reported increase in seizure frequency. Signifi-
cant adverse events or increase in seizure frequency are noted espe-
cially in those on 3 or more AEDs before addition of Lacosamide and
early on during Lacosamide treatment. There may be a justification to
introduce Lacosamide as a 2nd add-on AED in focal onset epilepsies,
in order to improve seizure control with less side effect profile for the
patient.
Drug Therapy 11
Tuesday, 8th September 2015
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THEADVERSE EFFECTSOFANTIEPILEPTIC DRUGS
D. Bozkurt*, Y. Karamanlı†, B. Tekin Güveli‡, S. Şenadım‡,
V.A. Yayla*
*Bakırk€oy Dr.Sadi Konuk Training and Research Hospital,
Department of Neurology, Istanbul, Turkey, †İslahiye State
Hospital, Department of Neurology, Gaziantep, Turkey,
‡Bakırk€oy Education and Research Hospital for Psychiatric and
Neurological Diseases, Department of Neurology, Istanbul,
Turkey
Purpose: Epileptic patients should use long-term antiepileptic drugs
(AEDs). Side effects are common with immediate and long-term usage.
We aimed to raise awareness on the side effects of AEDs and to compare
these adverse effects of old and new generation drugs
Method: We evaluated retrospectively the type and frequency of the side
effects of old and new generation AEDs in 189 patients with epilepsy
who were followed up in our clinic.
Results: The age range of 79M:110F patients was 7–82 years
(26.9  13.8). Idiopathic epilepsy was diagnosed in 104 patients
(55%), symptomatic in 57 (30%) and cryptogenic in 28 (15%).
Monotherapy was applied in 129 patients whereas polytherapy in 60
patients. The frequency of side effects was 50% and 46% of them were
in monotherapy. Both in monotherapy and polytherapy, the most fre-
quent AED was valproate (52%). Valproate had the highest frequency
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of side effects; weight gain, tremor, hair loss and drowsiness. Carba-
mazepine was the second common drug (16.1%) with the side effects of
liver enzymes increase, drowsiness and weight gain. Levatiracetam was
the third frequent and the side effects were irritability and dizziness.
The frequency of side effects in the old generation AED’s was 69.9%,
in the new generation 21.5%.
Conclusion: It is important to follow up the frequency and type of side
effects of AEDs as well as the seizure frequency of patients and the side
effects seems to be less frequent in new generation drugs.
p0878
RATIONALEAND STUDYDESIGN FORANOVEL
PHASE 3, RANDOMIZED, DOUBLE-BLIND TRIALOF
ADJUNCTIVE LACOSAMIDE IN PATIENTSWITH
IDIOPATHICGENERALIZED (GENETIC) EPILEPSY
ANDUNCONTROLLED PRIMARYGENERALIZED
TONIC-CLONIC SEIZURES
R. Warnock*, S. Yates*, M. Schmid†, K. Werhahn†, P. Doty*
*UCB Pharma, Raleigh, NC, USA, †UCB Pharma, Monheim am
Rhein, Germany
Purpose: SP0982 is a Phase 3 study designed to evaluate the efficacy
and safety of oral lacosamide as adjunctive therapy for uncontrolled pri-
mary generalized tonic-clonic seizures (PGTCS) in patients (≥4 years)
with idiopathic generalized (genetic) epilepsy (IGE). It will utilize a
novel “time to nth PGTCS” primary endpoint. This differs from tradi-
tional outcomes which assess reduction in seizure frequency and require
a high Baseline PGTCS frequency. Post-hoc analysis of a lamotrigine
trial comprising patients with low PGTCS frequency (French et al.
Epilepsia. 2007; 48[Suppl.6]: 77) demonstrated statistical separation
from placebo for “time to third PGTCS.” Clinical experience in patients
(≥16 years) with focal epilepsy indicates that an effective adjunctive
lacosamide dose would be achieved more rapidly than with lamotrigine,
suggesting that “time to second PGTCS” would be an appropriate pri-
mary endpoint in SP0982.
Methods: This international, double-blind, placebo-controlled study
will randomize up to 250 patients to achieve 125 events, defined as a
patient experiencing ≥2 PGTCS. Patients taking 1–3 AEDs and experi-
encing ≥3 PGTCS during the 16-week Baseline (12-week Historical/4-
week Prospective) will be randomized (1:1; stratified by age and seizure
frequency) to receive placebo or lacosamide (target: up to 12 mg/kg/day
or 400 mg/day). Treatment continues for up to 24 weeks (6-week Titra-
tion Phase and up to 18-week Maintenance Phase), or until the patient
completes ≥6 weeks’ treatment with ≥2 PGTCS. All patients may enter
the open-label extension study (EP0012).
Results: Recruitment planned to begin Q2 2015.
Conclusion: SP0982 will pioneer a “time to second PGTCS” primary
endpoint to evaluate lacosamide efficacy in adult and pediatric patients
with IGE and uncontrolled PGTCS. This design facilitates entry of
patients with a range of seizure frequencies, representative of the broader
IGE patient population, and enables patients experiencing ongoing
PGTCS to complete the trial early, therefore minimizing their exposure
to potentially suboptimal treatment.
Disclosures: UCB Pharma-funded.
p0879
EVIDENCE FORADIFFERENTIAL INTERACTIONOF
BRIVARACETAMANDLEVETIRACETAMWITHTHE
SV2A PROTEIN
M.Wood, D. Urbain, M. Gillard
UCB Pharma, Braine l’Alleud, Belgium
Purpose: The synaptic vesicle protein 2A (SV2A) represents the
molecular site of action for the antiepileptic drugs brivaracetam
(BRV) and levetiracetam (LEV). In animal models of epilepsy, BRV
has a higher potency and more complete seizure suppression than
LEV (Matagne et al, BJP 2008), suggesting different interactions
with the SV2A protein. We recently identified a compound that
modulates the confirmation of the SV2A protein (Daniels et al, BJP
2013). We have therefore investigated the effect of this allosteric
modulator on the binding of [3H]-LEV and [3H]-BRV to the human
SV2A protein.
Method: Saturation binding studies in membranes (25 lg per well) from
HEK 293 cells expressing human SV2A protein (Daniels et al, BJP 2013)
were incubated for 120 minute at 4°C in 0.2 mL buffer. Data were anal-
ysed in GraphPad PRISM and are mean  SD (n = 3).
Results: Both [3H]-LEV and [3H]-BRV bind to single apparent binding
sites. The modulator produced a 2–3 fold increase in affinity, Kd (nM),
for [3H]-LEV (2500  180 to 900  28) and a 2-fold increase in Bmax
(pmoles/mgPr: from 67  3 to 140  3). On [3H]-BRV binding, the
modulator produced a 10-fold increase in affinity, Kd (nM), from
190  3 to 20  2 and a 0.7–0.8 fold increase in Bmax from 130  5 to
170  3.
Conclusion: We have previously suggested that the SV2A allosteric
modulator alters the confirmation of the SV2A protein producing differ-
ential effects on SV2A ligands. The differential modulation of the bind-
ing of [3H]-LEV and [3H]-BRV suggests that their antiepileptic effects
derive from distinct interactions with the SV2A protein. In the absence of
a functional assay or an understanding of the function of the SV2A and
the role of conformational states, the consequence of this differential
interaction remains unknown. This warrants further studies, including
assessing whether these effects are seen in native tissue such as human
cortex. UCB supported.
p0881
EFFECTSOFANTIEPILEPTICS ONBODYWEIGHT
F.M. Yilmaz, Y. Cetinkaya, K. Tutkavul, S. Ozyurt, G. Yuksel,
H. Tireli
Haydarpasa Research and Teaching Hospital, Istanbul, Turkey
Purpose: To point on the effects of antiepileptic medications on body-
weight.
Method: We screened 362 follow up patients in Haydarpasa Research
and Training Hospital Epilepsy Outpatient Clinic.
Results: We had 137 valproate, 95 carbamazepine, 22 phenytoin, 81
levetiracetam and 19 topiramate users. There were 42 patients with vari-
ous weight gain complaints. 38 of them were using valproate, 3 of them
were carbamazepine users and 1 of them were levetiracetam user. 8
patients were presented with weight lose. 2 of them were using levetirac-
etam and 3 of themwere using topiramate.
Conclusion: Weight problems affect continuity and adherence to long
term drug treatments such as epilepsy treatments. Weight gain also has
effects on health conditions and psychology. Weight changes should be
questioned for antiepileptic users to maintain health, stability and medi-
cation adherence.
p0882
ANTIOXIDANT STATUSANDTHEEFFECTOF SINGLE
ORMULTIPLE ANTIEPILEPTIC DRUGUSE TO
OXIDATIVE STRESS IN PATIENTSWITHEPILEPSY
S. Keskin Guler*, B. Aytac†, Z.E. Durak‡, B. Gokce Cokal*,
G. Nalan*, I. Durak§, T. Yoldas*
Epilepsia, 56(Suppl. 1):3–263, 2015
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*Ankara Training and Research Hospital, Department of Adult
Neurology, Ankara, Turkey, †Ministry of Health, General
Directorate of Health Information Systems, Ankara, Turkey,
‡Ordu University Faculty of Medicine, Research Laboratory,
Ordu, Turkey, §Ankara University Faculty of Medicine,
Department of Biochemistry, Ankara, Turkey
Purpose: Oxidative stress has been implicated in various disorders
including epilepsy. The aim of this study was to investigate the antioxi-
dant status of patients with epilepsy using antiepileptic drugs (AEDs)
regularly and to compare themwith healthy subjects.
Method: We investigated the plasma catalase, malondialdehyde
(MDA), glutathione peroxidase (GSH-Px), superoxide dismutase (SOD),
and xanthine oxidase (XO) levels in 58 epilepsy patients using AEDs and
25 healthy controls. Patients were divided into polytherapy (n = 17) or
monotherapy (n = 41) groups and antioxidan status was compared with
the two groups and controls.
Results: Catalase and SOD levels were significantly lower in patients
with epilepsy than the control group (p < 0.01). Malondialdehyde, GSH-
Px and XO levels were significantly higher in patient group (p < 0.01).
High level of GSH-Px is likely to have increased as a compensatory
response to low catalase level and oxidative stress. Increased MDA level
is associated with an increase in lipid peroxidation. Increased XO level is
associated with increased degredation of nucleotids, meanwhile oxida-
tive stress is augmented by high XO and low catalase levels. There was
no statistically significant difference between the monotherapy and poly-
therapy groups in terms of serum catalase, MDA, GSH-Px or SOD levels
while XO level was higher in the monotherapy group (p < 0.01).
Although serum XO level was significantly lower in polytherapy group
thanmonotherapy group (p < 0.01), was significantly higher than control
group (p < 0.01).
Conclusion: Our results showed that antioxidant status was significantly
lower in patients with epilepsy using AEDs than the healthy control
group. Whereas polytherapy has not considerably affected oxidative
stress parameters. Therefore we believe that the oxidative stress caused
by epilepsy itself rather than the antiepileptic drugs. Recommendation of
antioxidant replacement may be helpful for patients with epilepsy.
p0883
THE EFFECTOFLEVETIRACETAMANDCURCUMIN
ONGENEEXPRESSIONOF INFLAMMATIONAND
IMMUNERESPONSE INHIPPOCAMPAL BRAIN
TISSUESOFKAINATE-INDUCED POST-STATUS
EPILEPTICUSWISTARRATS
H.Y. Yow*, M. Makmor-Bakry†
*University Kebangsaan Malaysia, Faculty of Pharmacy, Kuala
Lumpur, Malaysia, †University Kebangsaan Malaysia, Kuala
Lumpur, Malaysia
Purpose: To evaluate the effect of levetiracetam and curcumin on gene
expression of inflammation and immune response in hippocampal brain
tissues of kainate-induced post-status epilepticus (SE) wistar rats.
Method: SE was induced in Female Wistar rats with 10 mg/kg kainic
acid. Only rats achieved stage 4 and 5 limbic seizures were used and trea-
ted intraperitoneally with levetiracetam 100 mg/kg, curcumin 100 mg/
kg and vehicle 50% DMSO respectively, for 1 week. After the treatment,
the rats from each group were decapitated and RNA was extracted from
hippocampus tissues for microarray analysis.
Results: A list of 59 genes related with inflammation and immune
response was differentially expressed based on fold change more than
two in either direction and p value less than 0.05 by ANOVA analysis.
Kainic acid up-regulated the pro-inflammatory cytokines included Il18
and Ifngr1, which played an important role in neuroinflammation. Kainic
acid also up-regulated a class II major histocompatibility complex, Cd74
and complement component, C3. Despite of treatment given, pro-inflam-
matory cytokines was remained up-regulated in the kainate-induced sta-
tus epilepticus rodents (levetiracetam: Il18, Ifngr1, Ccl2, Ccl3, Ccr5,
Cx3cr1; curcumin: Cx3cr1, Cx3 cl1). In addition to pro-inflammatory
cytokines, anti-inflammatory cytokines was also up-regulated by both
levetiracetam (Il10rb, Tgfbr1, Cxcl16) and curcumin (Il10rb, Cxcl16,
Cxcl17), but not by kainic acid treatment. Levetiracetam was potentially
modulating the inflammation process during epileptogenesis via up-regu-
lation of Tgfbr1 as well as up-regulation of Il10rb and Cxcl16. Curcumin
may be potentially exert anti-inflammatory activities via up-regulation of
anti-inflammatory cytokines, such as Il10rb,Cxcl16 andCxcl17.
Conclusion: Both levetiracetam and curcumin may be involved in acti-
vation of anti-inflammatory factors, which was likely to contribute in
counteracting neuroinflammation induced by kainic acid.
p0884
ANTI-EPILEPTIC DRUGS IN EPILEPSYWITH
FEBRILE SEIZURES PLUS: EFFICACYANDTHE
RELATIONSHIPWITH SCN1AMUTATIONS
L. Yu*,†, N. He†, X. Liu†, B. Li†, Y. Shi†, M. Gao†, Y. Yi†,
W. Liao†
*The First Affiliated Hospital of Guangxi Medical University,
Department of Neurology, Guangxi, China, †Institute of
Neurosicence and the Second Affiliated Hospital of Guangzhou
Medical University, Guangzhou, China
Purpose: To explore the proper medical strategies on early stage of epi-
lepsy with febrile seizure plus (EFS+) and their relationship with SCN1A
mutations.
Method: The data of anti-epileptic drugs (AEDs) treatment in 202
patients with EFS+ searching for SCN1A mutations were collected. The
seizure control at different levels were compared in each AED adminis-
trated to patients with EFS+ and further compared between patients with
SCN1Amutations and those without SCN1Amutations.
Results: A total of 9 AEDs used in more than 10 cases were indentified,
including Valproate, Topiramete, Clonazepam, Phenobarbital, Levetirac-
etam, Lamotrigine, Carbamazepine, Oxcarbazepine and Phenytoin. The
three highest prescriptions were Valproate, Topiramete and Clonazepam.
Combined therapy was predominant (166/202, 82.2%). Compared with
other AEDs, the improvement rate was the highest in Valproate (169/
187, 90.4%), Topiramete (111/120, 92.5%) and Clonazepam (69/78,
88.5%), and were lowest in Phenytoin and Lamotrigine (0 and 4/45,
8.9%) (p < 0.01). The improvement rate of Phenobarbital (58.1%, 25/
43)) and Levetiracetam (44.7%, 21/47)) were intermediate, and no statis-
tical difference between them but had difference with others (p < 0.01).
The aggravation rats of Lamotrigine (57.8%, 26/45) and Carbamazepine
(36.7%, 18/49) were the highest, followed by Oxcarbazepine (33.3%, 15/
45) and Phenytoin (26.9%, 7/26). All of them showed statistical differ-
ence compared with others (p < 0.01). The aggravation rate of Lamotrig-
ine in patients with SCN1A mutations (81.3%, 13/16) was significant
higher than those without SCN1A mutations (44.8%, 13/29), and there
was statistical difference between them (x2 = 5.607, p = 0.018); simi-
larly, the aggravation rates of Carbamazepine, Oxcarbazepine and
Phenytoin showed an increase tendency, but no difference compared with
other AEDs.
Conclusion: Valproate, Topiramete and Clonazepam are relatively
proper choices in patients with EFS+ on early stage. Sodium channel
blocking AEDs should be avoided in EFS+, especially in the patients
with SCN1Amutations. The efficacy of Levetiracetam and Phenobarbital
in EFS+ remain uncertain.
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THE EFFECTOFVITAMIN EONTHE SEIZURE
FREQUENCY, EEG FINDINGSANDBIOCHEMICAL
PARAMETERSOFEPILEPTIC PATIENTS TREATING
WITHCARBAMAZEPIN, SODIUMVALPROATEAND
LEVETIRACETAM
M. Zare*, F. Gholami*, J. Mahvary*, M.R. Agha Ghazwyni†,
M.R. Najafi*, A.M. Alavinaeeny†
*Isfahan Medical Science University, Isfahan, Iran, Republic of
Islamic, †Tehran Medical Science University, Isfahan, Iran,
Republic of Islamic
This study aimed to evaluate the effect of vitamin E on increasing the
effects of antiepileptic drugs.
Materials and methods: This double-blind, placebo-controlled clinical
trial have done on 66 patients with epilepsy treated with antiepileptic
drugs referred to Kashani hospital and private clinics in Isfahan. Non-
random simple sampling 33 patients were allocated to intervention and
control groups. The intervention group was given daily supplements of
400 IU vitamin E and the control group gave similar pills of vitamin E
as placebo. Patients were examined monthly about the seizure fre-
quency and EEG and blood biochemical markers at the end of sixth
months. Data were analyzed by SPSS software using chi square test
and T-test.
Results: The mean of total antioxidant in cases before treatment was
6.2  2 and significantly increased to 7.7  2.1 after treatment
(p = 0.001), but in controls was increased of 7.3  1.9 to 7.4  2.1
(p = 0.91). The mean of catalase in cases was 14.3  5.1 and signifi-
cantly increased to 17.5  5.4 after treatment (p < 0.0001), in controls
was 17.5  5.2 and increased to 17.4  6 (p = 0.44). The mean of glu-
tathione in cases after treatment was significantly increased compare to
before treatment (13.6  6.1 to 18.5  8.2, p < 0.0001), in controls
(16.4  5.7 to 16.3  5.4 respectively, p = 0.88). malondialdehyde
decreased but was not statistically significant in case (p = 0.1),but in
control don’t decreased(p = 0.53). The mean number of seizure in cases
after treatment was significantly decreased compare to before
(2.25  0.62 to 1.34  0.83, p < 0.0001), but in controls was similar
(2.36  1.1 to 2.57  1.2, p < 0.0001). Changes in the positive EEG
findings in cases observed more than control group (50% vs. 12.1%
respectively, p = 0.001).
Conclusion: Our results showed that vitamin E in addition to
antiepileptic drugs improved antioxidant parameters and seizure fre-
quency and positive EEG finding in compare to placebo,but no signifi-
cant effect on reduced oxidative stress(respect to malon di aldehid
enzyme).
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IDENTIFYING FOCALRESECTIVE SURGERY
CANDIDATES IN CHILDRENWITHNONLOCALIZING
MRI
L. Wong-Kisiel*, R.J. Witte†, A.L. Kotsenas†, R.E. Watson†,
G.A. Worrell*, E.C. Wirrell*
*Mayo Clinic, Department of Neurology, Rochester, MN, USA,
†Mayo Clinic, Department of Radiology, Rochester, MN, USA
Purpose: Presurgical evaluation in individuals with nonlocalizing (nor-
mal or nonfocal lesional) MRI requires multimodal evaluations due to
lack of an anatomic surgical target. The impact of noninvasive evalua-
tions on surgical candidacy and outcome was assessed in a single institu-
tion, retrospective review of children with medically refractory focal
epilepsy and nonlocalizing MRI.
Method: Children with nonlocalizing MRI undergoing a standardized
presurgical evaluation were identified through the Epilepsy Monitor-
ing Database between 2000 and 2009. Surgical candidacy was based
on multidisciplinary epilepsy surgical conference. Surgical outcome
was defined as favorable (Engel I and II) or unfavorable (Engel III
and IV).
Results: Among a total of 135 children, 41 patients (30%) had a single
focal ictal scalp-EEG onset. Subtraction ictal SPECT co-registered to
MRI (SISCOM) provided additional localization in 43/94 patients
(36%) without focal scalp-EEG. Among 73 patients deemed to be sur-
gical candidates, 42 patients (31%) proceeded to surgery or phase II
intracranial EEG (iEEG) monitoring. Due to nonlocalizing iEEG, 12
of 24 patients undergoing phase II evaluation were not offered surgery.
Surgical candidacy was highly associated with the presence of focal
scalp-EEG (p < 0.0001, OR: 5.6, 95%CI: 2.3–13.3) and concordant
focal EEG and focal SISCOM (p = 0.02, OR: 4.3, 95%CI: 1.2–15.7).
Favorable outcome at last follow-up was achieved in 11/30 patients
(37%) who had resective surgery and more likely with concordant
focal scalp-EEG and focal SISCOM (p = 0.03, OR: 5.3, 95%CI: 1.35–
20.89).
Conclusion: Focal ictal scalp-EEG and concordant focal SISCOM were
the most useful tests for surgical candidacy in children with nonlocalizing
MRI. Favorable surgical outcome was associated with concordant focal
scalp-EEG and focal SISCOM. Favorable outcome was seen 11/30
patients (37%) who ultimately underwent resective surgery and in 6/30
patients (20%) who underwent phase II evaluation, demonstrating the
challenges in evaluating such children with nonlocalizing MRI for resec-
tive surgery.
p0892
AURA0S PREDICTIVE VALUE IN TEMPORAL LOBE
EPILEPSY SURGERY PATIENTS
İ. YıldırımCapraz*, R. Genc Perdecioglu*, E. Bilir*, G. Kurt†,
T. Hirfanoglu‡, O. Akdemir§, A. Serdaroglu‡
*Gazi University Faculty of Medicine, Department of
Neurology, Ankara, Turkey, †Gazi University Faculty of
Medicine, Neurosurgery, Ankara, Turkey, ‡Gazi University
Faculty of Medicine, Pediatric Neurology, Ankara, Turkey,
§Gazi University School of Medicine, Nucleer Medicine,
Ankara, Turkey
Purpose: The aura is an epileptic phenemonen, which is frequently
observed before the attack. It is seen in 90% of the epilepsy patients.
While the aura is a sign of the onset of the focal attack, the symptoms
could localize the epileptogenic zone. In TLE, abdominal, emotional and
psychic aura are the most commonly observed symptoms.
Method: The study included 100 patients with medically refractory TLE
undergoing anterior temporal lobectomy (ATL) between 2010 and 2014
in our center. A multidisciplinary preoperative evaluation was per-
formed. We investigated the association of aura with the postoperative
seizures, descriptive factors and preoperative tests. Postoperative seizure
outcome was evaluated using Engel’s outcome classification.
Results: The abdominal and emotional aura were among the most fre-
quently observed aura in our patients. In this patients group, the most fre-
quently detected histopathological finding was MTS. In patients with
abdominal and emotional aura, the risk factor of febrile convulsion (FK)
was more commonly observed. However, any relationships between aura
and the lateralization could not be found. In TLE patients with a later
onset, the incidence of abdominal and emotional aura and the frequency
of FK history were lower. After surgery only in 11 cases, only the aura
was maintained, and in 2 of them, the type of aura was changed after the
surgery. When the rate of absence seizure were evaluated according to
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Engel classification I, it was detected as 83%, which was considered as
sufficient.
Conclusion: Our findings were clearly suggested that there were a rela-
tionship between FK, MTS and abdominal-emotional aura. However,
there was no effect of having abdominal and emotional aura on the prog-
nosis of surgery. Finally, although the aura could be instructive about the
onset of the seizure, it did not allow to make a prediction about the sei-
zure free after surgery.
p0893
LOCALIZATIONOFCORTICAL LANGUAGEAREA
FOR PATIENTSWITHREFRACTORYEPILEPSY: A
COMPARISIONOFANEWMETHODBASEDONHIGH
GAMMAACTIVITIESWITHELECTRICALCORTICAL
STIMULATION
T. Yu*, Z. Hu†, X. Li†, Y. Li‡
*Capital Medical University, Xuanwu Hospital, Beijing Institute
of Functional Neurosurgery, Beijing, China, †Beijing Normal
University, Beijing, China, ‡Capitial Medical University,
Beijing Institute of Functional Nerurosurgery, Beijing, China
Purpose: To localize the cortical language area based on high gamma
activities recorded from electrocorticogram for patients with refractory
epilepsy and to compare the new method with classic electrical cortical
stimulation (ECS).
Method: Electrocorticographic signals were recorded during an audi-
tory-language task for eight patients with refractory epilepsy who under-
went intracranial recording to localize the epileptogenic zone and
language area. The high gamma activities were analyzed with event-
related synchronization (ERS) and adaptive directed transfer function
(ADTF). The results were compared to that of ECS.
Results: The analysis of ERS based on auditory-language task showed
the activated cortical areas on all patients. The ADTF analysis provided
dynamic information about the connectivity pattern of cortical interac-
tion. Totally, 111 cortical nodal points were identified as the predominant
points in the event-related information outflow according to the ADTF
analysis, and 76 of the points lied in frontal or central area, 35 lied in tem-
poral area. By contrast, 22 cortical points were positive according to ECS
in 7 of the 8 patients (19 in frontal and 3 in temporal area). Additionally,
ECS was terminated for continuous after discharges in 21 points in 5
patients and secondary seizures occurred in 7 of these points. Excluding
the numbers of one patient without electrodes covering temporal area,the
positive numbers of ADTF analysis and ECS were 60 versus 17 in frontal
area and 35 versus 3 in temporal area (p = 0.059). The positive points
were not completely the same between the two methods. The process of
recording electrocorticographic signals is quick and safe.
Conclusion: The method of ADTF analysis based on high gamma activi-
ties may be a useful complement to traditional ECS in the localization of
language area for patients with refractory epilepsy. The combination of
the method of ECS and ADTF analysis may be a better way.
p0894
ANALYSESOF PATIENTSWHOUNDERWENT
INVASIVE ELECTROENCEPHALOGRAPHY
MONITORINGBEFORE EPILEPSY SURGERY
B. Zeydan*, S. Delil*, G. Akdeniz†, C. Ozkara*, M. Uzan‡
*Istanbul University Cerrahpasa Faculty of Medicine,
Department of Neurology, Istanbul, Turkey, †Ankara Yildirim
Beyazit University, Department of Biophysics, Ankara, Turkey,
‡Istanbul University Cerrahpasa Faculty of Medicine,
Department of Neurosurgery, Istanbul, Turkey
Purpose: Accurate delineation of epileptogenic zone is crucial before
epilepsy surgery, however non-invasive presurgical evaluation may not
provide adequate data. Therefore invasive electroencephalography moni-
toring (IEM) is needed in selected patients. In this study, we aimed to
investigate electro-clinical characteristics and long-term outcome of our
case series with IEM.
Method: Patients who were admitted to our Clinical Neurophysiology
Division-Epilepsy Unit and underwent IEM between 2003 and 2014 are
included in this retrospective study.
Results: Sixty patients (32 Males/28 Females) with mean age of
29.7  9.6 (5–50 years) were included. Mean age at seizure onset and
time of IEM were 9.5  8.3 and 24.3  9.4 years, respectively. Cranial
MRIs of 14 patients were normal, while FDG-PET showed hypometabo-
lism. FDG-PET was normal in two patients, while MRI showed lesions
and in four patients both MRI and FDG-PET findings were negative.
Subdural electrodes were implanted in 35, depth electrodes in 14, and
combined electrodes in 6 patients (data not available (N/A): 5 patients).
Apart from non-operated 2 patients, 53 cases underwent lobectomy, one
had hemispherectomy (N/A: 4 patients), and 5 cases were re-operated.
Eight patients had hippocampal sclerosis, 32 had focal cortical dysplasia
(13: type-1, 19: type-2), other etiologies such as polymicrogyria/reactive
gliosis were defined in 12 cases (N/A: 6 patients). Postoperative compli-
cations including focal neurological deficits/hemorrhage, which were
transient observed in nine patients. Antiepileptic drug therapy was dis-
continued postoperatively in 4 patients (7%) and decreased to monother-
apy in 18 patients (31%). Postoperative follow-up was 6.3  2.8 years.
On the last follow-up visit, 30 patients are Engel-I (52%), 12 patients
Engel-II (21%), 12 cases Engel-III (21%), and 4 patients Engel-4 (7%).
Conclusion: Favorable results are still possible in patients, whose
epileptogenic zone cannot be described by non-invasive techniques dur-
ing presurgical evaluation. Majority of our patients, who needed IEM
had FCD or were MRI negative. In carefully selected patients with medi-
cally refractory epilepsy, IEM provides critical information before sur-
gery and increases success rate.
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HIGH FREQUENCYOSCILLATIONS IN THE INTRA-
OPERATIVE ECOGTOGUIDE EPILEPSY SURGERY
(THEHFOTRIAL): A RANDOMIZEDCONTROLLED
CLINICAL TRIAL PROTOCOL
M.A. van ‘t Klooster*, F.S.S. Leijten*, G.J.M. Huiskamp*,
H.E. Ronner†, J. Baayen†, P.C. van Rijen*, K.P. Braun*,
M. Zijlmans*,‡, HFO study group
*University Medical Center Utrecht, Utrecht, Netherlands, †VU
University Medical Center, Amsterdam, Netherlands, ‡SEIN
Stichting Epilepsie Instellingen Nederland, Heemstede,
Netherlands
Purpose: Intra-operative electrocorticography (ioECoG), based on inter-
ictal spikes and spike patterns, is often performed to optimize delineation
of the epileptogenic tissue during epilepsy surgery. High Frequency
Oscillations (HFOs, 80–500 Hz) have been identified as more precise
biomarkers for epileptogenic tissue. Aim of the study is to determine if
ioECoG-tailored surgery using HFOs instead of interictal spikes is feasi-
ble and will lead to equal or better seizure outcome.
Method: A single blinded multi-center randomized controlled trial (“the
HFO trial”), includes children (all ages) and adults with refractory focal
epilepsy who undergo surgery with ioECoG. Surgery is tailored by HFOs
(arm 1) or interictal spikes (arm 2). Primary outcome is post-operative
result after 1 year, dichotomized in seizure freedom (Engel 1a&b) versus
seizure recurrence (Engel 1c-4). Secondary outcome measures are the
volume of resected tissue, neurologic deficits, surgical duration and com-
plications, cognition and quality of life. The study has a non-inferiority
design to test feasibility and at least equal performance in terms of surgi-
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cal outcome. We aim to include 78 patients within 3 years including
1 year follow-up.
Results: Results are expected in 2018.
Conclusion: This trial provides a transition from observational research
towards clinical interventions using HFOs. We address methodological
difficulties in designing this trial. We aim to make a first step in using
HFOs to increase the success rate of tailored epilepsy surgery, while min-
imizing resection volume. This may reduce neurological deficits and
yield a better quality of life. Meanwhile, the identification and quantifica-
tion of HFOs can be automated, resulting in a potential objective surgical
tailoring measure that can be readily implemented.
p0896
HIGH FREQUENCYOSCILLATIONS AND
FUNCTIONALNETWORKCHARACTERISTICS IN THE
INTRA-OPERATIVE ELECTROCORTICOGRAM IN
TEMPORAL LOBEEPILEPSY
W. Zweiphenning*, M. van ‘t Klooster*, E. van Diessen†, N. van
Klink*, G. Huiskamp*, T. Gebbink*, F. Leijten*, P. Gosselaar*,
W. Otte†,‡, K. Braun†, M. Zijlmans*,§
*Brain Center Rudolf Magnus, Dept. of Neurology and
Neurosurgery, UMCUtrecht, Netherlands, †Brain Center
Rudolf Magnus, Dept. of Pediatric Neurology, UMCUtrecht,
Netherlands, ‡Biomedical MR Imaging and Spectroscopy
Group, Image Sciences Institute, UMCUtrecht, Netherlands,
§SEIN – Stichting Epilepsie Instellingen Nederland, Heemstede,
Netherlands
Purpose: High frequency oscillations (HFOs; ripples, 80–250 Hz),
especially fast ripples (FR, 250–500 Hz), are biomarkers for epilepto-
genic tissue. Removal of tissue generating HFOs correlates with good
surgical outcome. Network studies show that patients with focal epilepsy
have pathological highly connected nodes (hubs). Resection of these
hubs is associated with good outcome. We investigated the overlap
between functional network characteristics and HFOs in subdural intra-
operative electrocorticography.
Methods: We studied pre-resection electrocorticography recorded at
2048 Hz in fourteen patients with refractory temporal lobe epilepsy. We
marked FRs, ripples and spikes in 1 minute of these recordings. Connec-
tivity was assessed in four event-free epochs (2 second) within this min-
ute using the phase lag index. Graphs were constructed, and centrality-
measures (eigenvector centrality (ECM), Minimum Spanning Tree-
degree (MST-deg), and MST-betweenness centrality (MST-bc) were
computed for each channel in the theta, gamma, ripple and FR frequency
band. We related percentages of events per channel to centrality-mea-
sures using linear regression.
Results: We found FRs in 8 patients (mean number: 10, range: 2–32),
ripples in twelve patients (mean: 41, range: 1–140), and spikes in 11
patients (mean: 180, range: 13–535). Preliminary analysis showed nega-
tive correlations between the percentages of all events and the ECM in
the gamma band (RFR-ECM: 0.133; Rripples-ECM: 0.141; Rspikes-ECM:
0.159, p < 0.01). The percentage of ripples was negatively correlated
to MSTdeg and MSTbc in the gamma band (Rripples-MSTdeg: 0.135;
Rripples-MSTbc: 0.125, p < 0.01). The percentage of spikes was posi-
tively correlated to MSTdeg and MSTbc in the FR band (Rspikes-MSTdeg:
0.129; Rspikes-MSTbc: 0.131, p < 0.01).
Conclusion: Areas with high HFO and spike rates are functionally iso-
lated, characterized by low centrality-measures, in the gamma band in
subdural temporal lobe recordings. High spike rate areas show high cen-
trality-measures in the FR band. These findings can help improve identi-
fication of the epileptogenic tissue and unravel the pathophysiology of
epileptogenic networks.
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AGENOME-WIDEMETA-ANALYSIS OF AROMATIC
ANTI-EPILEPTIC DRUG INDUCEDMACULOPAPULAR
EXANTHEMA
M.McCormack*, H. Gui†, M. Kwok‡, D. Speed§, C. Depondt¶,
S. Petrovski**, T.J. O’Brien**, E. Heinzen††, D.B. Goldstein††,
S. Cherny†, N. Delanty‡‡, S.M. Sisodiya§§, L. Baum‡,
P. Kwan¶¶, G.L. Cavalleri*, the EpiPGX Consortium, the ILAE
Consortium on Complex Epilepsies
*Royal College of Surgeons in Ireland, Molecular and Cellular
Therapeutics, Dublin, Ireland, †The Univeristy of Hong Kong,
Psychiatry, Hong Kong, Hong Kong, ‡The Chinese University of
Hong Kong, School of Pharmacy, Hong Kong, Hong Kong,
§University College London, Genetics Institute, London, UK,
¶Université Libre de Bruxelles, Ho^pital Erasme, Brussels,
Belgium, **University of Melbourne, Department of Neurology,
Melbourne, Australia, ††Columbia University, Institute for
Genomic Medicine, New York, NY, USA, ‡‡Beaumont Hospital,
Dublin, Ireland, Neurology, Dublin, Ireland, §§University
College London, Institute of Neurology, London, UK,
¶¶University of Melbourne, Royal Melbourne Hospital,
Melbourne, Australia
Purpose: Carbamazepine, lamotrigine and phenytoin are among the
world’s leading anti-epileptic drugs (AEDs) for treating epilepsy. How-
ever, it is estimated that 5%–10% of patients exposed to these aromatic
drugs develop an idiosyncratic cutaneous adverse drug reaction (ADR)
characterized by a generalized maculopapular exanthematous rash
(MPE). The ILAE Consortium on Complex Epilepsies has collected
detailed point-of-care phenotypic and genetic information for epilepsy
patients across Europe, North America, Australia and China and provides
a framework to study ADRs. Alleles in the major histocompatibility
locus,HLA-A*3101 and HLA-B*1502, have powerful diagnostic value in
predicting carbamazepine-hypersensitivity yet these markers do not have
complete prognostic sensitivity and markers for lamotrigine-related
hypersensitivity remain elusive.
Method: We conducted a genome-wide association study of 251 MPE
cases and 858 drug-tolerant controls from epilepsy patient cohorts of
northern European and Han Chinese descent. Cases were stratified
according to the causal aromatic drug; namely carbamazepine, lamotrig-
ine or phenytoin. We imputed genotype data with IMPUTE2 and per-
formed logistic regression of cases versus controls per ancestral cohort,
controlling for within-population differences by principal components
analysis. Common HLA serotypes were imputed using SNP2HLA.
Results from each cohort were then meta-analysed.
Results: There were no significant markers for MPE to all aromatic
drugs. In the drug-specific analyses, we observed some novel loci with
suggestive association warranting further investigation. HLA-A*3101
was the most significant marker for carbamazepine-MPE in Europeans
(p = 1.29 9 108, OR = 5.29 [2.69–10.39]) and following meta-analy-
sis with Han Chinese (p = 0.009, OR = 3.71 [2.04–6.76], I2 = 49).
Conclusion: Identification of secure genetic markers for AED-induced
MPE will result in more personalized prescribing and is expected to
reduce the overall rates of AED discontinuation due to ADRs.
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MODELINGOF FEVER-ASSOCIATED EPILEPSY
SYNDROMES CAUSED BYMUTATIONS IN STX1B IN
ZEBRAFISH
A. Siekierska*, J. Schubert†, M. Langlois‡, P. May‡,
C. Huneau§, F. Becker†, H. Muhle¶, A. Suls**, J.R. Lemke††,
C.G.F. de Kovel‡‡, H. Thiele§§, A. Kecskés*, M. Jacmin‡,
B. Koeleman‡‡, B. Martin§, P.A.M. de Witte*, S. Biskup†, P. De
Jonghe**, I. Helbig¶, R. Balling‡, P. Nürnberg§§,
A.D. Crawford*,‡, Y.G. Weber†, H. Lerche†, C.V. Esguerra*,
EuroEPINOMICS RES Consortium
*KU Leuven, Laboratory for Molecular Biodiscovery, Dept. of
Pharmaceutical and Pharmacological Sciences, Leuven,
Belgium, †University of Tübingen, Tübingen, Germany,
‡University of Luxembourg, Esch-sur-Alzette, Luxembourg,
§INSERM, Rennes, France, ¶University Medical Center
Schleswig-Holstein, Christian Albrechts University, Kiel,
Germany, **VIB DMGUniversity of Antwerp, Antwerp,
Belgium, ††University Hospital Leipzig, Leipzig, Germany,
‡‡University Medical Center Utrecht, Utrecht, Netherlands,
§§University of Cologne, Cologne, Germany
Purpose: Febrile seizures affect 2%–4% of all children and are known to
have a strong genetic component (SCN1A, SCN1B, GABRG2). Lately,
mutations in syntaxin-1B (STX1B) have been identified in several inde-
pendent large pedigrees with febrile seizure and epilepsy (genetic analy-
sis underlying this research can be found in greater detail in Schubert,
Siekierska et al., 2014). In recent years, zebrafish has emerged as a
promising in vivo model for the functional analysis of novel human dis-
ease candidate genes and, more specifically, has been expansively used
as a novel experimental model for epilepsy. To clarify the role of STX1B
in fever-associated epilepsies we established an in vivo zebrafish model
of stx1b knockdown.
Method: Functional consequences of an STX1B defect in vivo were
investigated in a stx1b knockdownmodel using morpholino antisense oli-
gomers in zebrafish. Local field potential recordings were performed to
investigate abnormal brain activity under normal conditions and hyper-
thermia. The specificity of the stx1b antisense phenotype was confirmed
by rescue experiments through CNS-specific Tol2-mediated transgene-
sis.
Results: Video-recording and local field potential analyses of zebrafish
larvae using antisense knockdown of stx1b, revealed seizure-like behav-
ior and epileptiform discharges that were highly sensitive to increased
temperature. The specificity of the knockdown experiment could be pro-
ven by a rescue with wild type STX1B. Moreover, the loss-of-function
character of one of the mutations was demonstrated by its inability to
ameliorate spontaneous epileptiform discharges in stx1b-knockdown lar-
vae.
Conclusion: Our study provides evidence that stx1b knockdown in a
vertebrate in vivo system causes abnormal seizure-like behaviors and
“epileptiform” discharges increasing under hyperthermia.
p0899
STXBP1: CLINICALANDGENETIC DESCRIPTIONOF
39 NEWPATIENTSWITHAN STXBP1MUTATIONAND
REVIEWOFLITERATURE
H. Stamberger*,†, M. Nikanorova‡, M. Willemsen§, R. Fjaer¶,
K. Ramsey**, M. Viri††, K. Sterbova‡‡, M. Wolf§§,
H. Verhelst¶¶, I. Benkel***, M. Fannemel†††, H. Mühle‡‡‡,
G. Casara§§§, R. Van Coster¶¶, M. Angriman§§§,
D. Lederer¶¶¶, P. De Jonghe*,†, P. Striano****,
J. Lemke††††,‡‡‡‡, R.S. Møller‡,§§§§, S. Weckhuysen*,¶¶¶¶
*VIB DMG, Neurogenetics Group, Antwerp, Belgium,
†University Hospital of Antwerp, Antwerp, Belgium, ‡Danish
Epilepsy Centre, Dianalund, Denmark, §Radboud University
Medical Center Nijmegen, Department of Human Genetics,
Nijmegen, Netherlands, ¶Oslo University Hospital, Medical
Genetics, Oslo, Norway, **Translational Genomics Research
Institute, Neurogenomics Division, Phoenix, AZ, USA,
††‘Fatebenefratelli e Oftalmico’Hospital, Pediatric Neurology
Unit and Epilepsy Center, Department of Neuroscience, Milano,
Italy, ‡‡University Hospital Motol, Child Neurology
Department, Prague, Czech Republic, §§University Children’s
Hospital, Department of Pediatric Neurology, Tuebingen,
Germany, ¶¶Ghent University Hospital, Department of
Pediatrics, Division of Pediatric Neurology andMetabolism,
Ghent, Belgium, ***Sana Krankenhaus Gerresheim,
Department of Neuropediatrics, Düsseldorf, Germany, †††Oslo
University Hospital, Department of Medical Genetics, Oslo,
Norway, ‡‡‡University Medical Center Schleswig-Holstein,
Christian Albrechts University, Department of Neuropediatrics,
Kiel, Germany, §§§Central Hospital of Bolzano, Neurology Unit
and Laboratories, Bolzano, Italy, ¶¶¶Institut de Pathologie et de
Génétique, Gosseliers, Belgium, ****University of Genova,
Pediatric Neurology and Neuromuscular Diseases Unit,
Department of Neurosciences, Institute G. Gaslini, Genova,
Italy, †University Hospital Leipzig, Institute of Human
Genetics, Leipzig, Germany, ‡University Children’s
Hospital Inselspital, Division of Human Genetics, Bern,
Switzerland, 19University of Southern Denmark, Institute
for Regional Health Services, Odense, Denmark,
¶¶¶¶Ho^pital de la Pitié-Salpe^triere, Institut du Cerveau et de la
Moelle Epiniere, Paris, France
Purpose: To describe the phenotypical spectrum associated with
STXBP1 encephalopathy (STXBP1-E) through description of a large
cohort of newly diagnosed patients and a review of all STXBP1-E
patients published to date. To look for possible genotype-phenotype cor-
relations.
Method: Newly diagnosed patients with a STXBP1 mutation were
recruited through a European network of collaborating child neurolo-
gists. A PubMed search was performed to retrieve all publications report-
ing STXBP1-E patients.
Results: We describe 39 new patients with STXBP1-E, between the age
10 weeks and 56 years and 31 novel STXBP1 mutations. We further
reviewed available information on 78 reported patients. Two third of all
mutations were whole gene deletions or truncating mutations, 1/3 mis-
sense mutations. The majority of patients have an epileptic encephalopa-
thy with onset in the 1st year of life, with Ohtahara and West syndrome
being the most frequent recognizable syndromes and epileptic spasms the
most frequent seizure type. Five percent of patients have childhood onset
epilepsy with ID, and 6% ID without epilepsy. More than one third of
patients achieved seizure freedom at time of publication. Non-epileptic
motor features were seen in more than half of the patients with dyskine-
sia, tremor and ataxia being the most frequent. All patients had some
degree of ID, mostly severe to profound (88%). One patient out of five
showed autism or autistic traits. Although MRI0s were normal in the
majority of patients, cortical atrophy, delayed myelinisation and thin cor-
pus callosum were recurrent findings. There was no correlation between
mutation type (truncating vs. missense) and presence and severity of epi-
lepsy, or degree of ID.
Conclusion: De novo STXBP1 mutations are one of the most frequent
causes of early onset epileptic encephalopathy and the large majority of
patients are severely disabled. So far no specific genotypes seem to be
predictive of a better outcome.
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ANGIOTENSIN-CONVERTING ENZYMEAND
ANGIOTENSIN II TYPE 1 RECEPTORGENE
POLYMORPHISMS INCHILDRENWITH SUBACUTE
SCLEROSING PANENCEPHALITIS
N. Taşdemir
University of Dicle, Diyarbakir, Turkey
Purpose and method: Subacute sclerosing panencephalitis (SSPE) is a
progressive, debilitating, and fatal brain disorder caused by mutant
measles virus infection. Although both viral and host factors seem to be
involved in SSPE, the exact pathogenesis remains to be determined.
Autoimmune demyelination is characteristic of SSPE. The bood angio-
tensin – converting enzyme (ACE) activity and Angiotensin II (AngII)
levels are associated with the ACE gene polymorphism. Proinflamma-
tory effects of AngII may contribute to the development of SSPE. The
aim of this study was to investigate whether the ACE and Ang II type I
receptor (ATIR) (A1166C) gene polymorphisms were investigated by
polymerase chain reaction (PCR) in 43 patients with SSPE and 100
healthy controls.
Results: The genotype distribution of the SSPE children and Healthy
controls were as follows: DD 58.1% versus 34.0, ID 37.2% versus
48.0%, and II 4.7% versus 18.0, respectively (p = 0.012). Allele frequen-
cies of patients and controls were D 76.7% versus 58.0% and I 23.3% ver-
sus 42.0% respectively (p = 0.004). The frequency of DD genotype and
D allele were significantly higher in SSPE children compared with con-
trols (p < 0.05). ATIR gene polymorphism distribution was found to be
similar in SSPE children and control subjects: AA 55.8% versus 60.7%,
AC 37.2% versus 32.1% and CC 7.0% versus 7.2% respectively
(p > 0.05).
Conclusion: The results of this study suggest that the DD genotype of
ACE I/D poılymorphism may be reletad to SSPE. Due to small size of
this study, further studies with more patients are needed to confirm these
results.
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CHRNA2: THEMISSINGGENETOBETESTED IN
INFANTILE ANDNEONATAL BENIGN SEIZURES?
M. Trivisano*, A. Terracciano†, T. Milano‡, R. Cusmai*,
S. Cappelletti§, N. Pietrafusa¶, E.S. Bertini†, F. Vigevano*,
N. Specchio**
*Bambino Gesu Children’s Hospital, Department of
Neuroscience, Neurology Unit, Rome, Italy, †Bambino Gesu
Children’s Hospital, Department of Neuroscience, Unit of
Molecular Medicine for Neuromuscular and Neurodegenerative
diseases, Rome, Italy, ‡La Sapienza University, Department of
Biochemical Science, Rome, Italy, §Bambino Gesu Children’s
Hospital, Department of Neuroscience, Unit of Clinical
Psychology, Rome, Italy, ¶University of Bari, Department of
Basic Medical Sciences, Neurosciences and Sense Organs, Bari,
Italy, **Bambino Gesu Children’s Hospital, Department of
Neuroscience, Neurology unit, Rome, Italy
Purpose: The actual mutational screening for Neonatal and Infantile
Benign Seizures (BNFS, BFNIS and BFIS) includes KCNQ2, KCNQ3,
SCN2A and PRRT2 genes. BFNS and BFNIS families are mainly linked
to KCNQ2,while PRRT2 represents the major gene for BFIS cases. How-
ever, a causative gene is still lacking in about 10% of families. Differ-
ently, nicotinic acetylcholine receptor genes (CHRNA4, CHRNB2,
CHRNA2) are mainly involved in Autosomal Dominant Nocturnal Fron-
tal Lobe Epilepsy (ADNFLE). Despite extensive studies, CHRNA2 has
been reported only in a single family, and never confirmed in large
cohorts of patients with ADNFLE.
Method: Through a TrueSeq Custom Amplicon (TSCA) sequencing
approach we screened 10 ion channel genes in patients with idiopathic
epilepsies. PRRT2mutations were excluded by Sanger sequencing.
Results: TSCA revealed a heterozygous single-nucleotide substitution
in CHRNA2 gene (c.1126 C>T; p. Arg376Trp) that segregated in a
family with BFIS (Trivisano et al. Epilepsia 2015, in press). Based on
bio-informatics inspection, the change was predicted to be pathogenic.
The investigated family includes parents and their three daughters.
Seizures started between 6 and 24 months of age, they were almost in
cluster and well-controlled. Outcome was good in all subjects. A sec-
ond CHRNA2 gene mutation was found in a 6-month-old girl with
normal psychomotor development, diagnosed as sporadic neonatal
benign seizures. Differently from the CHRNA2 mutation associated
with ADNFLE, our two mutations fall in the cytoplasmic domain.
Bioinformatic structural studies are ongoing to assess to role of cyto-
plasmic mutations in the pathogenesis of neonatal and infantile benign
seizures.
Conclusion: Our genetic findings open new chance in the genetic
diagnosis of infantile and neonatal benign epilepsy. Further studies on
patients negative for KCNQ2, KCNQ3, SCN2A and PRRT2 are needed
to assess the CHRNA2 role in both neonatal and infantile benign sei-
zures.
p0904
INHERITEDKCNQ2DUPLICATION IN 3 PATIENTS
WITHBENIGNNEONATAL SEIZURES
S. Usluer*, D. Turkdogan†, H.S. Caglayan*
*Bogazici University, Molecular Biology and Genetics, Istanbul,
Turkey, †Marmara University, Faculty of Medicine, Department
of Child Neurology, Istanbul, Turkey
Purpose: Benign familial partial epileptic syndromes of the 1st year of
life are classified into three groups based on the age of seizure onset as
neonatal (BFNS) (less than 30 days), neonatal-infantile (BFNE) (1–
4 months) and infantile (after 4 months). The majority of typical BFNS
families are linked to KCNQ2 and of BFNIS to SCN2A. Sporadic forms
of BFNS are also linked to inherited or de novo KCNQ2 mutations. We
aimed to find genetic etiology in 5 patients with sporadic form of early
benign infantile partial seizures with similar clinical and electrophysio-
logical features.
Patients: The seizures characterized by apne, peroral cyanosis, stiffing
of chin and blank stare occur during breast-feeding or spontaneously.
The age of onset is within first 2 week for three patients and 35 and
70 days for the other two, respectively. Ictal EEG showed temporal onset
in one neonate. Interictal abnormalities were in the temporal regions in
all patients.
Method: Candidate gene screening including SCN2A, KCNQ2 and
PRRT2 genes were conducted with Sanger sequencing. Patient samples
were also analyzed by array CGH using a custom array targeting
KCNQ2, KCNQ3, SCN2A, and PRRT2 at exon resolution. KCNQ2
qPCR assay were employed for patient and parental samples to validate
CGH results.
Results: SCN2A, KCNQ2 and PRRT2 genes were negative for point
mutations in all patients. Array CGH analysis showed inherited KCNQ2
gene duplication in three patients with neonatal onset of seizures and the
duplication was validated byKCNQ2 qPCR.
Conclusion: The genetic etiology is highly correlated with the age onset
of seizures but not the clinical and electrophysiological features. Though
majority of reported KCNQ2 mutations are single nucleotide alterations,
there are several deletions and duplications leading to BFNS.
KCNQ2deletions/duplications are also associated with KCNQ2-related
neonatal epileptic encephalopathy with intellectual disability.
Pathogenicity ofKCNQ2 duplication is under further investigation.
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COPYNUMBERVARIANTS IN AHOSPITAL-BASED
COHORTOFCHILDRENWITHEPILEPSY
D.R.M. Vlaskamp*, P.M.C. Callenbach*, P. Rump†, C.M.A. van
Ravenswaaij-Arts†, O.F. Brouwer*
*University of Groningen, University Medical Center
Groningen, Department of Neurology, Groningen, Netherlands,
†University of Groningen, University Medical Center
Groningen, Department of Genetics, Groningen, Netherlands
Purpose: Copy number variants (CVNs), detected with chromosomal
microarray, have been shown to cause or predispose to epilepsy. We
aimed to evaluate the diagnostic yield of microarray in a large cohort of
children with epilepsy and to identify novel genes and regions for epi-
lepsy.
Method: From a single university hospital-based cohort of children
below 18 years who were treated for epilepsy, diagnosed after 2000, we
included all children who had undergone microarray before May 2014.
Oligonucleotide array Comparative Genome Hybridization or Single
Nucleotide Polymorphisms array was performed to report CNVs of at
least 4 consecutive probes on chromosome 1–22 or X. CNVs that were
found in <1% of healthy controls and comprised protein-coding genes
were evaluated for their pathogenicity.
Results: Microarray had been performed in 226 of 1100 (21%) children
with epilepsy. In 66% of them, symptomatic focal epilepsy was diag-
nosed, 60% had intellectual disability (ID), and 48% had facial dysmor-
phisms. In 181 children, 408 CNVs were evaluated for their
pathogenicity. Twenty-seven CNVs that are known to cause or predis-
pose to epilepsy were found in 26 (12%) children. All these children had
developmental or behavioral problems, and two-third had focal epilepsy.
In five children, novel CNVs comprisedNRNX3 (n = 2), SCN4B, MYT1L
andUNC5D as potential candidate genes for epilepsy.
Conclusion: In our cohort, we found a 12% yield of microarray resulting
in CNVs that cause or predispose to epilepsy, which is much higher than
the 5% yield in an American cohort of 805 epilepsy patients (Olsen,
2014). This variability is probably due to the way how children are
selected for microarray, based on their additional features. We identified
novel CNVs with four genes of major interest for further evaluation of
their role in epilepsy.
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THEHEREDITARY FEATURESOFEPILEPSIESWITH
SCN1AMUTATIONS
J. Wang*, H. Xu*, H. Meng*,†, L. Yu*, W. Liao*
*Institute of Neuroscience and The Second Affiliated Hospital of
Guangzhou Medical University; Key Laboratory of
Neurogenetics and Channelopathies of Guangdong Province
and the Ministry of Education of China, Guangzhou, China,
†Department of Neurology, The First Affiliated Hospital of
Jinan University, Guangzhou, China
Purpose: SCN1A mutations have been identified in both familial and
sporadic cases with epilepsy. In the majority of cases, generalized epi-
lepsy with febrile seizures plus (GEFS+) is a familial disorder, whereas
severe myoclonic epilepsy in infancy (SMEI) is mostly sporadic cases,
suggesting that the phenotypes may be associated with hereditary fea-
tures. We want to investigate the hereditary features and identify a possi-
ble genotype-inheritance correlation in epilepsy patients with SCN1A
mutations.
Method: We systematically reviewed all SCN1A mutation-related pub-
lications and established a database that includes 1,248 SCN1A muta-
tions associated with epilepsy (http://www.gzneurosci.com/
scn1adatabase/). A further analysis was preformed to investigate the
hereditary feature of each phenotype and identify a possible genotype-
inheritance correlation.
Results: This study demonstrated a negative correlation between phe-
notype severity of and the frequency of familial cases caused by
SCN1A mutations; familial cases represented 83.7% of mild cases with
GE (generalized epilepsy) and/or FS (febrile seizures), 62.8% of PE
(partial epilepsy) and PEFS+ (partial epilepsy and febrile seizures plus)
cases, 23.3% of epileptic encephalopathy cases, but only 9.8% of SME
cases. Missense mutations frequency was higher in familiar cases,
whereas destructive mutations occurred more frequently in individuals
with severe phenotypes. For different phenotypes, the penetrance of
SCN1A mutations in GE and/or FS, PE&PEFS+ and SME was 91.0%,
94.0% and 92.2%, respectively. While the penetrance of SCN1A muta-
tions for different genotypes of missense, splice-site, truncating and
genomic rearrangements was 91.3%, 88.9%, 100% and 100%, respec-
tively.
Conclusion: The frequency of inherited mutations is related to geno-
type and phenotype in familiar cases. The hereditary features of epilep-
sies with SCN1A mutations differed in each phenotype, and the
penetrance of which didn’t differ among phenotypes or genotypes.
However, incomplete penetrance was associated with missense and
splice-site mutations, but was not associated with truncating mutations
or genomic rearrangements. These results have implications for clinical
genetic conseling.
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GENETIC EVALUATIONOF INTRACTABLE EPILEPSY
PATIENTWITHACUSTOMDESIGNED SCREEN
PANELREVEALEDNEWPATHOLOGICAL
MUTATIONS IN EPILEPSYGENES
Y. Wang, X. Xu, W. Yan, Y. Wang
Children’s Hospital of Fudan University, Shanghai, China
Purpose: Epilepsy of unknown etiology (particularly in children) posts a
major challenge in clinical diagnosis and treatment. However, numerous
disease relevant mutations have been detected through next generation
sequencing, making custom-designed and cost-efficient target sequenc-
ing as a possible solution for clinical diagnosis. To test this feasibility we
have designed a panel containing selected candidate epilepsy genes sub-
jected for sequencing potential pathological mutations in a group of
patients prone to have genetic origin in their disease onset.
Method: A custom-made NimbleGen SeqCap EZ Choice Library
(Roche NimbleGen, Madison, USA) was designed to capture the exons,
splice sites and the immediately adjacent introns of 407 candidate genes
selected with the key words such as epilepsy, seizure, and etc. 75 unre-
lated Chinese individuals (34 females, 41 males) diagnosed as epilepsy
(48 IS, 9 CAE, 4 CFS, 5 EE, 1 FLE, 2 LGS, 1 PSE, 5 EP) from our hospi-
tal and their family members were studied. Data was then processed with
standard analytical protocol to generate a mutation list.
Results: 25 mutations were detected in 12 patients and validated by tra-
ditional Sanger sequencing. Among them, a number of mutations were
detected for the first time for well-known epilepsy genes such as SCN1A
(3), CDKL5, STXBP1, POLG, and TSC2. Besides, we also find mutations
that are predicted to be damage to encoding protein’s proper function in
candidate epilepsy genes.
Conclusion: The data indicated that, custom-designed panel sequencing
is capable of identifying potential pathological genetic mutations in epi-
lepsy patients. Besides, the data also expanded the mutation spectrum of
epilepsy. In long run, it would be worth to test the behavior of the panel
sequencing in large cohort.
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IDENTIFICATIONANDFUNCTIONALANALYSIS OF
MULTIPLE ISOFORMSOFEPILEPSYRELATED
PROTEIN FMRP
F. Wei, Y. Long, Y. Yi, Q. Zhao, W. Liao
Institute of Neuroscience and The Second Affiliated Hospital of
Guangzhou Medical University; Key Laboratory of
Neurogenetics and Channelopathies of Guangdong Province
and the Ministry of Education of China, Guangzhou, China
Purpose: 20% of Fragile X syndrome (FXS) patients suffer seizures dur-
ing lifetime. Fragile X mental retardation protein (FMRP) is a global reg-
ulator of translation in neurons and an important factor in synaptic
plasticity, absence of which results in epileptogenesis. Distinct FMRP
isoforms may have important differences in their expression and func-
tion, lead to various susceptibility of epilepsy.
Method: We identified the transcript isoforms in the brain tissue of FVB
inbred embryonic mice (E18) and adult mice (P28) respectively and com-
pared their frequency of utilization with each other. We constructed plas-
mids of fusion protein coupling V5-tag with isoform proteins, analyzed
the distribution of exogenous mFMRP isoforms in N1E-115, Neuro-2A
and HEK-293 cell lines, observed the affection of these isoforms struc-
ture for distribution, and explored the latent function and regulation
mechanism of mFMRP.
Results: In the whole brain tissues of E18 and P28 mice, there were five
patterns of sequence alternative splicing which formed seven different
mFmr1 transcript isoforms base on GT-AG rule. The mFmr1 transcript
isoforms distributed diversely in different stages of neurodevelopment,
which might lead to diversity of the recognition and binding functions
between FMRP and RNA sequences, suiting the special features in indi-
vidual developmental periods. Individual mFMRP isoform had specific
characters in expression among different types of cell lines whilst all
mFMRP isoforms had diversity in distribution in same cell line as well.
Varying location of V5-tag in the fusion protein (either at N-terminal or
at C-terminal) affected the expression and distribution of related protein
isoforms.
Conclusion: We identified seven mFmr1 transcript isoforms lacking
some important functional elements, in which it was also confirmed the
diversity of distribution and expression, and the isoform six was detected
for the first time. It suggested that the difference of FMRP structure con-
tributed to the difference of its distribution and expression.
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SIMULTANEOUS IMPAIRMENTOFNEURONALAND
METABOLIC FUNCTIONOFGEPHYRIN INA
PATIENTWITHEPILEPTIC ENCEPHALOPATHY
T. Djémié*,†, B. Dejanovic‡, A. Suls*,†, N. Grünewald‡,
D. Craiu§,¶, M. Zemel**, P. Gormley††,‡‡,§§,¶¶,
D. Lal***,†††, C.T. Myers**, H. Mefford**,
A. Palotie††,‡‡,§§,¶¶,‡‡‡,§§§,¶¶¶, I. Helbig****,††††, P. De
Jonghe*,†,‡‡‡‡, G. Schwarz‡,§§§§,¶¶¶¶, S. Weckhuysen*,†,
*****, EuroEPINOMICS Dravet working group
*Neurogenetics Group, VIB-Department of Molecular Genetics,
Antwerp, Belgium, †Laboratory of Neurogenetics, Institute
Born-Bunge, University of Antwerp, Antwerp, Belgium,
‡Institute of Biochemistry, Department of Chemistry, University
of Cologne, Cologne, Germany, §Pediatric Neurology Clinic, Al
Obregia Hospital, Bucharest, Romania, ¶Department of
Neurology, Pediatric Neurology, Psychiatry, Child and
Adolescent Psychiatry, and Neurosurgery, Carol Davila
University of Medicine and Pharmacy, Bucharest, Romania,
**Division of Genetic Medicine, Department of Pediatrics,
University of Washington, Seattle, WA, USA, ††Wellcome Trust
Sanger Institute, Hinxton, UK, ‡‡Psychiatric &
Neurodevelopmental Genetics Unit, Department of Psychiatry,
Massachusetts General Hospital and Harvard Medical School,
Boston, MA, USA, §§Program in Medical and Population
Genetics, The Broad Institute of MIT and Harvard, Cambridge,
MA, USA, ¶¶The Stanley Center for Psychiatric Research, The
Broad Institute of MIT and Harvard, Cambridge, MA, USA,
***Cologne Center for Genomics, Cologne Excellence Cluster
on Cellular Stress Responses in Aging-Associated Diseases,
University of Cologne, Cologne, Germany, †††Department of
Neuropediatrics, University Medical Faculty Giessen and
Marburg, Giessen, Germany, ‡‡‡Institute for Molecular
Medicine Finland (FIMM), University of Helsinki, Heslinki,
Finland, §§§Analytic and Translational Genetics Unit,
Department of Medicine, Massachusetts General Hospital and
Harvard Medical School, Boston, MA, USA, ¶¶¶Department of
Neurology, Massachusetts General Hospital, Boston, MA, USA,
****Department of Neuropediatrics, University Medical Center
Schleswig-Holstein, Christian Albrechts University, Kiel,
Germany, ††††The Children’s Hospital of Philadelphia,
Division of Neurology, Philadelphia, PA, USA, ‡‡‡‡Antwerp
University Hospital, Division of Neurology, Antwerp, Belgium,
§§§§Center for Molecular Medicine Cologne (CMMC),
University of Cologne, Cologne, Germany, ¶¶¶¶Cologne
Excellence Cluster on Cellular Stress Responses in Aging-
Associated Diseases (CECAD), University of Cologne,
Cologne, Germany, *****Inserm U 1127, CNRS UMR
7225, Sorbonne Universités, UPMCUniv Paris 06 UMR S
1127, Institut du Cerveau et de la Moelle Epiniere, ICM,
AP-HP, Ho^pital de la Pitié Salpe^triere, Service de Neu-
rologie, Paris, France
Purpose: Using whole exome sequencing on a cohort of patients with
epileptic encephanolapthies (EE) and their unaffected parents we iden-
tified a de novo heterozygous missense mutation in the gene gephyrin
(GPHN): c.1124G>A, p.Gly375Asp. Gephyrin directly interacts with
and clusters GABAA and glycine receptors and is thereby indispens-
able for normal functioning of inhibitory synapses. Additionally,
gephyrin catalyzes the synthesis of the molybdenum cofactor (Moco)
in peripheral tissue. In this study we further wanted to explore the
functional consequences of this mutation and search for extra muta-
tions in the gene.
Method: We performed various functional assays to characterize the
effect of this novel GPHN mutation and to gain further insights in the
underlying pathomechanisms leading to epilepsy. We also used different
targeted resequencing technologies aiming to identify additional muta-
tions inGPHN.
Results: We showed that the mutation abolishes both functions of
gephyrin without affecting the structure and folding of the protein: (a)
mutant gephyrin exerts a dominant negative effect on gephyrin clustering
and significantly reduces postsynaptic GABA receptor clustering and (b)
the mutant protein is unable to synthesize the molybdenum cofactor
which is vital for the function of molybdo-enzymes.
Genetic screenings ofGPHN in follow-up cohorts of patients with dif-
ferent types of EEs did not lead to the identification of additional muta-
tions.
Conclusion: We present the first patient with an infantile onset EE and a
heterozygous de novo missense mutation in the GPHN gene. This alter-
ation disrupts both functions of the protein. We suggest that the identified
defect at GABAergic synapses is the mechanism underlying the patient’s
severe phenotype. Our findings strengthen previous associations of
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GPHN with epilepsy and other neurodevelopmental disorders and
expand the spectrum to an infantile onset EE.
p0910
THEMEMBRANAL EXPRESSION LEVELAND
FUNCTIONALALTERATIONOF SCN1A TRUNCATION
PROTEINS ARECORRELATEDWITHEPILEPSY
WITH FEBRILE SEIZURES PLUS
H.-Q. Xu*,†, B. Tang*, X.-Q. Cai*, M.-L. Chen*, L. Yu*, Y.-
J. Chen*, W.-P. Liao*
*Institute of Neuroscience and The Second Affiliated Hospital of
Guangzhou Medical University; Key Laboratory of
Neurogenetics and Channelopathies of Guangdong Province
and the Ministry of Education of China, GuangZhou, China,
†Departmet of Neuropsychiatry, Affiliated Zhong Da Hospital of
Southeast University, NanJing, China
Background and purpose: SCN1A mutations have been identified in
patients with epilepsies with antecedent febrile seizures plus, which
mainly comprise Dravet syndrome (DS), partial epilepsy with febrile sei-
zures plus (PEFS+) and generalized epilepsy with febrile seizures plus.
Our recent study has showed that the SCN1A truncation mutations were
not only occurred in DS, but aslo in PEFS+. Therefore, we suspected that
the membranal expression level and functional alteration of SCN1A trun-
cation proteins might correlate with severity of vary phenotypes. We
studied the membranal expression and the electrophysiological function
in six truncated Nav1.1 mutants, which included H1848fsX1861,
R1874fsX1944, R542X and W280X originated from four DS patients,
respectively, and M145fsX148, S662X originated from two PEFS+
patients, respectively.
Methods: We engineered H1848fsX1861, R1874fsX1944, R542X,
W280X, M145fsX148 and S662X in the human NaV1.1 cDNA and stud-
ied their membranal expression level and the electrophysiological func-
tion by transfecting HEK293 cell lines.
Results: We found all of six truncation proteins can expressed on
HEK293 cells membrane and cytoplasm, and the membranal expression
quantity of which obviously decreased compared with wildtype Nav1.1
protein (p < 0.05). The expression quantity on membrane of truncation
protein originated from both PEFS+ patients was less than that from DS
(p < 0.05). According to electrophysiological records, the shorter trunca-
tion proteins which included R542X, W280X, M145fsX148 and S662X,
lead to the loss of function, while the truncation proteins with longer
(H1848fsX1861and R1874fsX1944) lead to partial loss of function.
Conclusions: We concluded the membranal expression level and func-
tional alteration of SCN1A truncation proteins were correlated with epi-
lepsy with febrile seizures plus.
p0912
EXOME SEQUENCE IDENTIFIES ANEWMUTATION
OF PKHD1L1 IN ACHINESE FAMILYWITH
CORTICAL TREMORANDEPILEPSY
P. Yu, G. Zhu, D. Ding, L. Xu, Y. Ge, Z. Hong
Institute of Neuorlogy, Huashan Hospital, Fudan University,
Shanghai, China
Autosomal dominant cortical tremor and epilepsy (ADCTE) is a heredi-
tary myoclonic epilepsy syndrome. The core symptoms of this syndrome
are adult-onset hand tremor with the electrophysiological features of cor-
tical reflex myoclonus (giant sensory evoked potential [g-SEP] and long
latency reflex), myoclonus and/or generalized tonic-clonic seizures and a
rather benign course. In this study, we used whole-exome sequencing to
screen potentially novel causal mutations in a Chinese with ADCTE.
Two cases and one family control were subjected to exome sequencing.
By a. filtering out synonymous mutations that do not affect the function
of the genes, only retaining the mutation that affect the function of the
genes such as non-synonymous mutations and splice site mutations; b.
filtering out common mutations carrying out by normal people in the
public genetic mutation database(dbSNP), the normal individual muta-
tions that have been published, and the mutations carrying out by the con-
trol who subject exome sequencing in the experiment; then making
intersection of the mutation set of the two patients, we reduce the number
of candidate pathogenic mutations. By the candidate pathogenic region
on chromosome 8q23.3–q24.11, we further reduce the number of the can-
didate pathogenic genes. And then using the software that can predict the
affection the mutations can make to the function of the protein, we further
filter to identify the possible mutation/gene of ADCTE. Using PCR
sequencing methods, we validate the mutation identified by exome
sequencing in the family to observe whether the disease phenotype is
caused by the mutation. Using real-time quantitative PCR method, we
test the expression difference of the pathogenic gene between ADCTE
patients and normal controls. In conclusion, we identified a heterozygous
mutation in underlying causal gene PKHD1L1 in this family with
ADCTE.
p0913
FUNCTIONALCORRELATESOF SEVERITY IN
GLUCOSE TRANSPORTER 1 (GLUT1) DEFICIENCY
S.M. Zaman*,†, E. Gazina†, M.A. Phillips†, H. Lerche‡,
Y. Weber‡, S. Berkovic§, I.E. Scheffer§, C.A. Reid†, S. Mullen§,
S. Petrou*,†
*The University of Melbourne, Department of Medicine,
Dentistry and Health Sciences, Parkville, Australia, †Florey
Institute of Neuroscience and Mental Health, Ion Channels and
Diseases, Parkville, Australia, ‡Universit€at Tübingen, Abteilung
Neurologie mit Schwerpunkt Epileptologie, Tübingen, Germany,
§Austin Health, Melbourne Brain Centre, Melbourne, Australia
Purpose: We investigated the function of SLC2A1 variants from patients
with mild and severe forms of epilepsy to develop an understanding of
how combined genetic and functional assessment can be used to reveal
pathophysiological mechanisms and develop precision diagnostics.
SLC2A1 accounts for approximately 1% of genetic generalised epilepsy
patients and encodes the glucose transporter 1 (GLUT1) protein found in
glia and the epithelium of the blood brain barrier. Very severe GLUT1
deficiency disorders, such as De Vivo disease, are associated with com-
plete loss of GLUT1 function. However, the association between muta-
tion severity and phenotype is less clear in the milder epilepsies
harbouring GLUT1mutations.
Method: A Xenopus laevis oocyte glucose uptake assay was employed
to measure the kinetics and affinity of expressed GLUT1 transporter
with a minimum n = 5 for each group.This characterisation was under-
taken in GLUT1 mutations from control cases and patients with two
grades of clinical severity. “Unaffected” is comprised of variants found
in the control population, “mild” is treatment responsive epilepsy and
“severe” is characterised by refractory epilepsy and/or mild intellectual
disability.
Results: A total of 20 variants were analysed with 11 from the mild
cohort, 5 from the severe and the remaining 4 from unaffected cases.
Although there was a spectrum of functional change within each group,
with overlapping Vmax and Km’s of unaffected (Vmax M = 21.35,
SEM = 2.841, Km M = 47.38, SEM = 3.435) with mild (Vmax
M = 14.18, SEM = 2.426, Km M = 41.26, SEM = 7.421) and severe
(Vmax M = 4.417, SEM = 2.484, Km not ascertainable), population
analysis showed an overall correlation of molecular dysfunction with
clinical severity (Unaffected vs. Mild r2 = .826, Unaffected vs. Severe
r2 = .011).
Conclusion: The functional genotype-phenotype correlation found in
GLUT1 testing suggests that a risk model for acquiring GLUT1 disorders
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could be developed by the functional profiling of a patient’s variant. A
better understanding of the relationship between clinical severity and
GLUT1 function will provide a foundation for building our understand-
ing of the neurobiology of GLUT1 disorders critical for diagnosis and tar-
geted therapy.
Neuroimaging 4
Tuesday, 8th September 2015
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USEOF FMRI TODETERMINE LANGUAGEAND
MEMORYLATERALIZATION IN EPILEPSY SURGERY
CANDIDATES
B. Metin*, C. Ozkara†, S. Yagci‡
*Uskudar University, Istanbul, Turkey, †Istanbul University
Cerrahpasa Medical Faculty, Department of Neurology,
Istanbul, Turkey, ‡Istanbul University Cerrahpasa Faculty of
Medicine, Istanbul, Turkey
Purpose: Wada test is the gold standard for language lateralization, how-
ever its routine use is limited due to invasiveness. Functional magnetic
resonance imaging (fMRI) is a non-invasive alternative. However stan-
dard fMRI procedures for lateralization are not established.
Method: We developed standardized language and memory paradigms
activating language comprehension and verbal/non-verbal memory
encoding via scanning healthy individuals. Until now we tested five epi-
lepsy (two left handed) surgery candidates with left temporal lobe epi-
lepsy to determine language and memory lateralization.
Results: Left handed patients had right lateralized language and memory
functions. In all right handed patients we found left language dominance,
however memory was lateralized to left in one patient, to right in the sec-
ond one and lateralization could not be determined due to equal activa-
tion in both temporal lobes in the third patient. fMRI results were also
compared with neropsychological test battery findings.
Conclusion: fMRI is a safe and non-invasive alternative to Wada test
These preliminary findings suggest that it could also be efficient method
for language and memory lateralization.
p0917
CURRENT EUROPEAN PRESURGICALDIAGNOSTIC
PROCEDURES IN EPILEPSY SURGERYCENTERS
B. Mouthaan, M. Rados, G. Huiskamp, P. Van Eijsden,
F. Leijten, K. Braun, on behalf of the E-PILEPSY consortium
Brain Center Rudolf Magnus, Department of (Child)Neurology,
University Medical Center Utrecht, Utrecht, Netherlands
Purpose: In January 2014 the E-PILEPSY project, a European Union
funded project, was launched to improve awareness of, and accessibility
to, epilepsy surgery across different countries in Europe. We compared
the use of presurgical imaging and source localization procedures
between participating centers and with guideline recommendations.
Methods: A survey was distributed through the E-PILEPSY consortium
to collect data regarding the use of MRI, PET, SPECT with correspond-
ing post-processing procedures, and EEG/MEG source localization in
pediatric and adult epilepsy surgery patients.
Preliminary results: Twenty centers were included. Eighteen centers
performed epilepsy surgery both on children and adults, two centers
focused on either adults or children. Of the 20 centers 65% utilized a 3T
MRI scanner, 35% had only access to a 1.5T system. In only 21% of adult
and 26.3% of pediatric centers all guideline recommended MRI
sequences, with correct angulation and resolution, were included in the
MR protocol. These recommendations include 3D T1 GRE (resolution:
=<1 mm), T2 and FLAIR axial and coronal (resolution: =<3 mm). Use
of additional sequences (mostly fMRI and DTI) is reported by 89.5% of
centers. MRI post-processing (e.g. VBM/SPM, image reformatting) is
performed by 65% of centers. PET is performed by 94.8% of adult and
73.7% of pediatric centers, and PET post-processing by 72.2% and
85.7% of those, respectively. SPECT is performed by 90% of centers, of
which 89% perform post-processing. MEG is utilized by 45% of centers.
Only 40% perform EEG source localization.
Discussion: There is much variation in the presurgical diagnostic work
up between epilepsy surgery centers in Europe. A minority follow all
MRI protocol guideline recommendations. These findings could be
explained by differences in healthcare/reimbursement policies, clinical
experience or expert opinion among centers. Harmonization in pre-surgi-
cal diagnostics is needed to improve selection of candidates for epilepsy
surgery across Europe.
p0918
THE EFFECTOFMEDICATIONWITHDRAWALON
EEGRELATED FMRI CONNECTIVITY PATTERNS IN
FOCALEPILEPSY
P. Ossenblok*, K. Hermans†,‡, A. Colon§, P. van Houdt†,
L. Geerts¶, R. Verdaasdonk‡, P. Boon†, J. de Munck‡
*Academic Center of Epileptology, Kempenhaeghe &
Maastricht UMC+, Clin Physics, Heeze, Netherlands,
†Academic Center of Epileptology, Kempenhaeghe &
Maastricht UMC+, R&D, Heeze, Netherlands, ‡VUMedical
Center, Physics andMedical Technology, Amsterdam,
Netherlands, §Academic Center of Epileptology, Kempenhaeghe
&Maastricht UMC+, Neurology, Heeze, Netherlands, ¶Philips,
HealthCare, Best, Netherlands
The effect of anti-epileptic drugs (AEDs) most likely is reflected in func-
tional brain activity recorded with EEG and fMRI. These effects may
cause substantial inter-subject variability in studies where EEG corre-
lated functional MRI (EEG-fMRI) is used to determine the epileptogenic
zone in epilepsy surgery candidates. In the present study the effects on
resting state fMRI measures are quantified due to withdrawal of AEDs.
EEG-fMRI data were obtained of 10 patients in the condition that the
patient was on the maintenance doses of AEDs as prescribed (condition
A) and after withdrawal of AEDs (condition B), at the end of a video-
EEG seizure monitoring session. EEG-fMRI data were analysed using
both the general linear model (GLM) approach and independent compo-
nent analysis. The epileptic independent component (ICE) was identified
by selecting the component with the largest overlap with the EEG-fMRI
correlation pattern (van Houdt et al., Brain Topogr. 2014). A similar pro-
cedure was used to select the well-known resting state networks (RSNs)
(Shirer et al., Cereb Cortex 2012). Next, the difference in resting state
functional connectivity (rsFC) between conditions A and B was quanti-
fied by using a GLM approach applied to the concatenated time series of
the RSNs, including the ICE. EEG-fMRI correlation analysis was suc-
cessful in 30% and 100% of the cases in conditions A and B, respectively.
Spatial patterns of ICEs appeared to be comparable in conditions A and
B, except for one patient for whom it was not possible to identify the ICE
in condition A, while the global rsFC of all selected resting state compo-
nents was significantly increased after withdrawal of AEDs. The results
indicate that both the higher sensitivity of EEG-fMRI and the increased
rsFCmight be related to an increased excitability of the brain what makes
resting state fMRI potentially a new biomarker for investigating AED
effects.
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RAPAMYCIN TREATMENTRESTRAINS
MODIFICATIONOFWHOLE-BRAIN FUNCTIONAL
NETWORKBACKBONETOPOLOGYDURING
TEMPORAL LOBEEPILEPTOGENESIS IN THE
KAINIC ACID RATMODEL
W.M. Otte*,†, E.A. van Vliet‡, J.A. Gorter§, K.P. Braun†,
R.M. Dijkhuizen*
*University Medical Center Utrecht, Image Sciences Institute,
Utrecht, Netherlands, †University Medical Center Utrecht,
Pediatric Neurology, Utrecht, Netherlands, ‡University of
Amsterdam, Department of (Neuro)Pathology, Amsterdam,
Netherlands, §University of Amsterdam/Swammerdam Institute
for Life Sciences, Center for Neuroscience, Amsterdam,
Netherlands
Purpose: Focal epilepsy affects global structural and functional brain
network topology. Whether these topological changes already occur dur-
ing epileptogenesis and might be halted at this early stage is unknown.
Rapamycin, an inhibitor of the mammalian target of rapamycin, is one of
the few drugs known to reduce epileptogenesis. We aimed to determine
whether rapamycin treatment modulates global functional network topo-
logical changes from serial fMRI measurements during epileptogenesis
of focal epilepsy in rats.
Method: Temporal lobe epileptogenesis was induced with the kainic
acid-based status epilepticus model in adult male rats (n = 12; 350–
450 g). The brain0s functional status was longitudinally assessed with
resting-state blood oxygenation level-dependent (BOLD) fMRI at days
7, 1, 4, 8, 21 and 48, in twelve rats with status epilepticus Racine’s
scores class IV–V. Four rats were treated with rapamycin starting 4 hours
after status epilepticus (GroupRAP; 6 mg/kg i.p. daily every 24 (first
week) or 48 hours). Eight rats received saline at similar intervals (Group-
SALINE). Functional connectivity between various brain regions was
calculated from correlation of low-frequency BOLD fluctuations.
Whole-brain network backbones, based on functional connectivity val-
ues, were quantified using minimum-spanning-tree metrics. At day 48,
seizures were quantified using video monitoring.
Results: Backbone hierarchy and leaf number significantly dropped,
while network diameter increased, at day four and eight in the GroupSA-
LINE, but not in GroupRAP, relative to the pre status epilepticus net-
works. Eccentricity increased from day 4–21 in the GroupSALINE.
Reduced eccentricity was found in the GroupRAP at day 48. The median
daily seizure frequencies (interquartile range) were GroupSALINE:
2.7  3.23 and GroupRAP: 0  0.3.
Conclusion: Network topology changes during epileptogenesis in rats.
Rapamycin treatment diminishes these effects and directionality of these
changes. Rapamycin-induced seizure reduction is associated with func-
tional network modulation. Further research should elucidate whether
this is caused by anti-epileptogenesis or seizure-load reduction.
p0920
INFLUENCEOF SEIZURE FREQUENCYON
LONGITUDINALMEMORY PERFORMANCEANDT2
RELAXOMETRY IN PATIENTSWITHMESIAL
TEMPORAL LOBEEPILEPSYANDHIPPOCAMPAL
ATROPHY
D. Pacagnella, T.M. Lopes, M.E. Morita, A.C. Coan,
C.L. Yasuda, F. Cendes
University of Campinas, Department of Neurology, Campinas,
Brazil
Purpose: To evaluate the role of seizure frequency on longitudinal mem-
ory performance and T2 relaxometry in patients with Mesial Temporal
Lobe Epilepsy (MTLE) and Hippocampal Atrophy (HA).
Method: We performed two MRI acquisitions and neuropsychological
assessments in 20 MTLE patients with frequent seizures and 24 MTLE
patients with infrequent seizures. Frequent seizures were considered as,
at least, one dyscognitive seizure per month. Infrequent seizures were
considered as three or less dyscognitive seizures per year and no event
evolving to a bilateral convulsive seizure. All images were acquired in a
3T scanner. We used a control group for T2 relaxometry comparisons.
Neuropsychological assessment included: Wechsler Adult Intelligence
Scale-Revised; Wechsler Memory Scale-Revised and Rey Auditory Ver-
bal Learning Test. We performed statistical analyses in SPSS 21, using
General Linear Model for repeated measures on longitudinal analyses.
Results: There was a significant longitudinal increase in the mean of T2
values on the side of HA in the infrequent seizures group (p = 0.022).
However, in the frequent seizures group, the mean of T2 values was
higher than the infrequent seizures group from the baseline, although
there was not longitudinal difference, probably due to a “floor effect.”
There were no differences related to the contralateral hippocampus.
Comparing the second versus first neuropsychological assessment, the
frequent seizures group had better longitudinal scores in Visual Repro-
duction I (p = 0.047). The mean interval between evaluations was
23.55  8.65 months. Infrequent seizures group showed better longitu-
dinal scores in general memory (p = 0.005), delayed recall (p = 0.035)
and Visual Reproduction I (p = 0.042). The mean interval between eval-
uations was 25.75  8.99 months.
Conclusion: Longitudinal increase of T2 values in infrequent seizures
group suggests progressive hippocampal damage despite the low seizure
frequency and better longitudinal scores on memory performance, sug-
gesting that the frequent seizure group had a decreased ability of familiar-
ity/learning in the second neuropsychological assessment.
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PHOTOSENSITIVITY IN IDIOPATHICGENERALIZED
EPILEPSIES: AN EEG-FMRI STUDY
I. Pappalardo*, A.E. Vaudano†, A. Ruggieri†, S. Meletti†
*IRCCS Foundation Neurological Institute “C. Besta,” Clinical
Epileptology and Experimental Neurophysiology Unit, Milan,
Italy, †University of Modena and Reggio Emilia, Department of
Biomedical Sciences, Metabolic and Neuroscience, Modena,
Italy
Purpose: The presence of reflex traits in idiopathic generalized epilep-
sies (IGEs) is largely known. In this study we identified the hemody-
namic maps of generalized spike-and-wave discharges (GSWDs)
recorded in IGE patients with photosensitivity respect with the one
detected in IGEs without reflex traits. We aim to reveal differences that
might be linked with the presence of photosensitivity and hence improve
the knowledge of its pathogenesis.
Method: 34 IGEs (26 females) who underwent an EEG-functional MRI
(EEG-fMRI) study with the recording of GSWDs were selected. Based
on the electro-clinic data, the population recruited was divided into
Group(1): IGEs with photosensitivity and Group(2): IGEs without photo-
sensitivity. Within each IGEs sub-group, a random effect group analysis
was performed, comparing Group(1) and Group(2) with a two-sample T-
test.
Results: Group(1) included 18 patients, Group(2) 14 cases. Group(1)
random effect analysis showed positive BOLD changes at the thalamus,
basal ganglia, the motor cortex bilaterally and the right temporal-parietal
cortex. At the group level, Group(2) showed a thalamic, left orbito-fron-
tal cortex and bilateral occipital cortex BOLD signal increases. A two-
sample T-test random analysis revealed the involvement of the motor
cortex bilaterally and the right temporal-parietal cortex time-locked with
GSWDs in the reflex traits group compared with the not-reflex group.
Conclusion: Our results showed that the GSWDs recorded in patients
with photosensitivity involve distinctive cortical networks (motor
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cortex). This finding might explain the different clinical features (my-
oclonus) observed in these patients.
p0922
BRAINMORPHOLOGY IN JUVENILEMYOCLONIC
EPILEPSYANDABSENCE SEIZURES
K.M. Park, S.E. Kim
Haeundae Paik Hospital, Inje University College of Medicine,
Busan, Republic of Korea
Purpose: We evaluated the differences in brain morphology among
patients with juvenile myoclonic epilepsy according to the occurrence of
absence seizures.
Method: Twenty-one juvenile myoclonic epilepsy patients with (n = 6)
and without (n = 15) absence seizures were enrolled. We analyzed
whole-brain T1-weightedMRI using FreeSurfer 5.1. Measures of cortical
morphology, such as thickness, surface area, volume, and curvature, and
the volumes of subcortical structures, the cerebellum, and cerebrum were
compared between the groups. Moreover, we quantified correlations
between clinical variables and each measures of abnormal brain mor-
phology.
Results: Compared to normal controls, patients without absence sei-
zures demonstrated thinning of the cortical thickness in the right hemi-
sphere, including the post-central, lingual, orbitofrontal, and lateral
occipital cortex. Compared to normal controls, patients with absence
seizures had more widespread thinning of the cortical thickness,
including the right post-central, lingual, orbitofrontal, and lateral occip-
ital cortexes as well as the right inferior temporal cortex. Additionally,
the volume of cerebellar white matter in patients without absence sei-
zures was significantly smaller than that in normal controls. Patients
with absence seizures had a much smaller cerebellar white matter vol-
ume than normal controls or patients without absence seizures. More-
over, there was significantly positive correlation between age of
seizure onset and the volume of cerebellar white matter in patients with
JME.
Conclusion: We demonstrated that there were significant brain mor-
phology differences in patients with juvenile myoclonic epilepsy accord-
ing to the presence of absence seizures. These findings support the
hypothesis that juvenile myoclonic epilepsy may be a heterogeneous syn-
drome.
Neuroimaging 5
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AUTOMATIC SEGMENTATIONOFDEPTH
ELECTRODES IMPLANTED IN EPILEPTIC PATIENTS:
AMODULARTOOLADAPTABLE TOMULTICENTRIC
PROTOCOLS
F. Pérez-García*, K. Lehongre*, E. Bardinet*, P. Jannin†,
V. Navarro*, D. Hasboun*, S. Fernandez Vidal*
*Institut du Cerveau et de la Moelle épiniere – ICM – CNRS
UMR 7225 – INSERMU 1127 –UPMC-P6 UMR S 1127, PF
STIM, CENIR, Paris, France, †Université de Rennes 1, MediCIS
–UMR LTSI U1099 INSERM, Rennes, France
Purpose: Automating the localization of implanted depth electrodes, as
well as their visualization in three-dimensional (3D) space, can greatly
decrease the amount of resources needed for planning, executing and val-
idating resection in epilepsy surgery. We present an integrated and auto-
mated image processing modular research tool that uses pre-operative
MR and post-operative CT images to accurately detect the position of
each implanted electrode.
Method: First, an initial segmentation of different brain structures is car-
ried out, followed by a CT to MRI rigid registration. Then, electrode con-
tacts are segmented using a watershed transform-based algorithm
followed by different image processing steps allowing for correct feature
classification. Meshes of all segmented structures are generated for visu-
alization with Slicer. An interactive tool may be used in case any mis-
takes in the segmentation process have been found. Finally, the MRI is
normalized to the MNI space to automatically calculate the anatomical
label for each contact and visualize the results on coregistered subject
images.
Results: Data from ten patients (from two centers) have been used. The
method was able to automatically detect all the electrodes in most
patients, allowing an interactive refinement when the automatic approach
was not totally accurate. The whole process takes around 10 minutes for
each patient, in contrast to the multiple hours that an operator would take
to manually localize all the contacts. Software was easily used by opera-
tors without prior image processing experience.
Conclusion: We propose an easy to use, novel research tool for accu-
rately segmenting and visualizing depth electrodes in 3D space on epilep-
tic patients. Although the method is yet to be validated, first results are
promising and feedback from operators is encouraging. A connection
with a tool for electroencephalography monitoring is being developed.
Unlike manual localization procedures, our algorithm achieves excellent
results without time-consuming and difficult judgments from an operator.
p0925
1H-MRS INMESIAL TEMPORAL LOBEEPILEPSY
WITHANDWITHOUTHIPPOCAMPALATROPHY
L.R. Pimentel*,†, R.F. Casseb*,†, R. Barbosa*,†,
M.M.A. Koutsodontis*, G. Castellano†,‡, F. Cendes*,†
*Unicamp/FCM, Campinas, Brazil, †Unicamp/BRAINN,
Campinas, Brazil, ‡Unicamp/IFGW, Campinas, Brazil
Purpose: To investigate changes in proton magnetic resonance spec-
troscopy (1H-MRS) in relation to response to antiepileptic drugs (AED)
and hippocampal atrophy (HA) in patients with mesial temporal lobe epi-
lepsy (mTLE). We analyzed myo-inositol/creatine (Ins/Cr+PCr), N-
acetyl aspartate+N-acetyl-aspartate-glutamate/creatine (NAA+NAAG/
Cr+PCr), and glycerophoscholine/creatine (GPC/Cr+PCr) as markers of
cellular structural and functional alterations.
Method: 1H-MRS were acquired using a PRESS (Point Resolved Spec-
troscopy) sequence with repetition time (TR) = 2000 msec and echo time
(TE) = 35 msec in a 3.0T Philips MRI scanner with a single voxel placed
in the anterior portion of hippocampi. Individuals with unilateral HA or
non-lesional mTLE onMRI were divided according to AED response:
(1) refractory with HA;
(2) refractory non-lesional;
(3) responders with HA,
(4) responders non-lesional, and compared to
(5) healthy controls.
Metabolite were quantified ipsi- and contralateral to the EEG lateral-
ization using LCModel. All patients with HA had concordant EEG later-
alization. Metabolites from controls were defined as the mean values of
right+left hippocampi. We performed statistical analyses with SPSS
(Version 22.0) using MANCOVA co-varying for age with Bonferroni
post hoc comparisons.
Results: We found a relative increase of Ins/Cr+PCr, a marker of astro-
cytes, in groups refractory with HA and refractory non-lesional, in the
ipsilateral hippocampus, when compared to the other groups (p < 0.0001,
p = 0.001 and p = 0.024). Moreover, NAA+NAAG/Cr+PCr, a marker of
neuronal damage, was reduced in group refractory with HA in the ipsilat-
eral hippocampus compared to all other groups (p = 0.028, p = 0.048,
p = 0.041 and p < 0.0001, respectively). In addition, GPC/Cr+PCr, a
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product of choline metabolism, was increased in the group responders
with HA in the contralateral hippocampus compared to group responders
non-lesional, although this finding needs further investigation.
Conclusion: Our findings indicate that 1H-MRS changes in mTLE
appear to be related to the presence of HA rather than the pattern of AED
response.
p0926
MAPPINGANDVOLUMETRYOFHESCHL’S GYRUS
BYVBMAIDS IN PLANNINGTEMPORAL LOBE
RESECTION IN PATIENTSWITH “TLEWITH
AUDITORY AURA”
A. Radhakrishnan*, J.S. James†, A. Sundar†, B. Thomas†,
R. Menon†, G.C. Vilanilam†, M. Abraham†
*RMadhavan Nayar Centre for Comprehensive Epilepsy Care,
Sree Chitra Tirunal Institute for Medical Sciences and
Technology, Neurology, Trivandrum, India, †RMadhavan
Nayar Centre for Comprehensive Epilepsy Care, Sree Chitra
Tirunal Institute for Medical Sciences and Technology,
Trivandrum, India
Purpose: TLEwith auditory aura (TLE-AA) form a specific subgroup of
patients where the ictal onset zone extends to Heschl’s gyrus (HG). After
anterior temporal lobectomy (ATL), TLE-AA patients seldom become
seizure-free. Through VBM of HG, we analyzed the reasons for surgical
failure in them.
Methods: Of 456 consecutive patients operated for TLE from 2000–
2010, we identified TLE-AA patients. Their HG was mapped by VBM
pre-and post-surgically. Automated anatomical labeling using T1 image
“normalized” to customized template was then “segmented” into GM,
WM and CSF using probability maps. “Modulation” and “smoothing”
with a 12-mm isotropic Gausian Kernel was done. The volume of the HG
(cm3) was computed by multiplying and summing voxel-by-voxel vol-
ume. Bivariate followed by multivariate logistic regression model analy-
sis was performed comparing TLE-AA from patients with other auras.
Pre-and-post-surgical VBM of HGwas compared by ANOVA.
Results: Of 456 patients who underwent ATL, 344 (75.4%) had aura; 19
(5.5%) were TLE-AA. 11/19 (57.8%) with TLE-AA had prior encephali-
tis (p = 0.006),10/19 (52.6%) had normal MRI and 8/19 (42.1%) had
normal histopathology (p = 0.000). 10/19 had persistent seizures after
surgery versus 86/325 with other auras (p = 0.01). 7/10 (70%) patients
underwent left ATL (p = 0.01). HG was intact in 9/10 patients (90%)
who had seizures postoperatively. In nine patients without seizures, the
HG was disrupted completely by more than two-third its volume (mean
pre- vs. post-surgery volume, 2.02 cm3 vs. 0.41 cm3, p = 0.001).
Conclusions: Volumetric mapping of HG pre and post-surgically in
patients with TLE-AA confirmed that major disruption or removal of HG
will only make the patient seizure-free. A presurgical VBM-HGmapping
to incorporate it in resection should be attempted by anatomic landmarks
or by neuronavigation.
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WHITEMATTERABNORMALITIES IN PATIENTS
WITHHOTWATEREPILEPSYREVEALED BY
DIFFUSION TENSOR IMAGINGANALYSIS IN A
VOXELWISE APPROACH
K. Raghavendra*, R.D. Bharath†, S. Sinha*, G. Chaitanya*,
R. Panda†, P. Satishchandra*
*National Institute of Mental Health and Neuro Sciences
(NIMHANS), Neurology, Bangalore, India, †National Institute
of Mental Health and Neuro Sciences (NIMHANS),
Neuroimaging & Interventional Radiology, Bagalore, India
Purpose: We investigated changes of White Matter (WM) integrity in
patients with Hot water epilepsy (HWE), and their relationships with epi-
lepsy-specific clinical factors by comparing the fractional anisotropy
(FA) and the mean diffusivity (MD) maps between patients and the con-
trols.
Method: We performed diffusion tensor imaging (DTI) in 100 patients
with HWE and 57 controls matched for age and gender. Between-group,
comparisons of DTI parameters were carried out in a whole-brain voxel-
wise manner using tract-based spatial statistics (TBSS).In addition ROI
based evaluation of both, FA andMDwas correlated with epilepsy-speci-
fic clinical variables.
Results: Compared to controls, patients with HWE had significantly
reduced FA and increased MD in both hemispheres, mainly in the frontal
lobes, cingulum, and forceps major and minor, anterior thalamic radia-
tion, superior longitudinal fasciculus, uncinate fasciculus, cortico-spinal
tract, and inferior fronto-occipital fasciculus. HWE subgroup with family
history had higher FA values in bilateral anterior thalamic radiation, cin-
gulum (hippocampus), forceps major, inferior fronto-occipital fasciculus,
right inferior longitudinal fasciculus, superior longitudinal fasciculus and
uncinate fasciculus. Subgroup with frequent seizures had lower FA val-
ues in left -anterior thalamic radiation,superior longitudinal fasciculus,
cingulum, inferior fronto-occipital fasciculus, uncinate fasciculus and
forceps minor. Drug na€ıve HWE subgroup had lower FA values in bilat-
eral anterior thalamic radiation,corticospinal tract, hippocampal,cingu-
late gyrus, uncinate,inferior fronto-occipital fasciculus, inferior
longitudinal fasciculus, superior longitudinal fasciculus, forceps major
and minor. On ROI based evaluation, MD value of the superior longitudi-
nal fascicle and the splenium of the corpus callous had a positive co-rela-
tion with age at onset of seizure.
Conclusion: Relative to healthy controls, hot water epilepsy subjects
showed aberrations in several major inter-and intra-hemispheric tracts.
Patients with family history of epilepsy had increased connections in the
right hemisphere.The frequency of seizure, the age at onset of seizure
and treatment influenced the DTI parameters.
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RESTING-STATE FUNCTIONALCONNECTIVITY IN
THEBABOONMODELOFGENETICGENERALIZED
EPILEPSY
F.S. Salinas*, C.A. Szabo†
*University of Texas Health Science Center at San Antonio,
Research Imaging Institute, San Antonio, TX, USA, †University
of Texas Health Science Center at San Antonio, Dept. of
Neurology, San Antonio, TX, USA
Purpose: The baboon provides a natural model of genetic generalized
epilepsy (GGE) that closely resembles juvenile myoclonic epilepsy. This
study uses a data-driven approach to determine the intrinsic connectivity
networks of epileptic (EPI) and healthy control (CTL) baboons using
resting-state fMRI and assess any group-wise functional connectivity
(FC) differences.
Method: Twenty baboons, matched for age and weight, were classified
into two groups (10 EPI, 10 CTL) on the basis of scalp EEG findings.
Each animal underwent one MRI session–one 5-minute resting state (rs-
fMRI) and one anatomical MRI. All images were pre-processed using the
most current rs-fMRI techniques. Using independent component analysis
(ICA), we identified 14 unique components (i.e. networks) which were
then used to characterize each network’s functional connectivity. We uti-
lized a data-driven approach to evaluate functional connectivity so that
our results would not be influenced/limited by our seed selection. Each
network mask was then thresholded (|z| > 2.3), then used to assess
group-wise FC differences using cluster analysis.
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Results: Similar to human studies of GGE, the epileptic baboons demon-
strated significant FC decreases in the anterior cingulate and insular cor-
tices as well as FC increases in the network’s associated with the mid-
cingulate and thalamic regions. We also found significant FC increases in
the motor and default mode networks. Additionally, we identified that
the sensitivity (i.e. strength) and specificity (i.e. size) of the two groups’
functional connectivity maps were significantly different in the visual,
motor, thalamic, insular, and default mode networks.
Conclusion: This is the first study (using rs-fMRI) to demonstrate FC
differences between EPI and CTL baboons that resemble the network dif-
ferences observed in human GGE patients. However, this data-driven
approach may be used to assess the effects anti-epileptic drugs on a medi-
cation na€ıve patient population. This approach may also inform the tar-
geting of neurostimulation therapies in GGE patients.
p0930
GRAYMATTERVOLUMEREDUCTIONAND ITS
RELATED FACTORS IN TEMPORAL LOBE EPILEPSY
J.H. Seo, W.S. Hwang, S.B. Hong
Samsung Medical Center, Neurology, Seoul, Republic of Korea
Purpose: This study aimed to estimate the difference in gray matter vol-
ume (GMV) in patients with mesial temporal lobe epilepsy (MTLE)
using a voxel-based morphometry (VBM), and to determine whether
these changes correlate with their clinical features.
Method: VBM analysis of brain magnetic resonance imaging using sta-
tistical parametric mapping software (SPM8) was performed to 60MTLE
patients (30 left-sided and 30 right-sided) and 30 age- and gender-
matched healthy volunteers. We also analyzed the correlations between
GMV changes and clinical features of MTLE patients. We also measured
entire hippocampal volumes in all patients and healthy controls.
Results: No significant differences between right and left MTLE groups
were observed in demographic characteristics except epilepsy durations
and seizure frequencies. Left MTLE patients showed significant GMV
reductions in the hippocampus ipsilateral to the epileptic focus, and bilat-
eral thalami, and putamen contralateral to the epileptic focus. More
extensive GMV reductions were seen in the bilateral hemispheres of the
right MTLE patients, including bilateral hippocampi, thalami, caudate
nuclei, putamens, ipsilateral uncus, insula, inferior temporal gyrus, and
contralateral frontal gyrus. GMV reduction in parahippocampal gyrus
and middle temporal gyrus negatively correlated with seizure onset age
in the right MTLE (uncorrected p < 0.001). In the left MTLE, in contrast,
only positive correlation was observed between presence of febrile sei-
zure and GMV reduction in superior temporal gyrus (uncorrected
p = 0.001). Total hippocampal volume negatively correlated with the
epilepsy duration in the right MTLE group (p = 0.004, r = 0.505).
Conclusion: Our VBM analyses revealed GMV reduction in not only
hippocampi, but also extra-hippocampal regions such as thalamus and
basal ganglia in MTLE patients. Epilepsy duration was related to the total
hippocampal volume.
p0932
ACCURACYOFARTERIAL SPIN-LABELEDMRI
PERFUSION INDETECTING THEEPILEPTOGENIC
ZONE IN PATIENTSWITHDRUG-RESISTANT
NEOCORTICAL EPILEPSY: COMPARISONWITH
ELECTROPHYSIOLOGICALDATA, STRUCTURAL
MRI, SISCOMANDFDG-PET
A. Sierra-Marcos*, X. Setoain†, A. Lopez-Rueda†, J. Aparicio*,
A. Donaire*, M. Carre~no*, N. Bargallo†
*Institute of Neurosciences, Hospital Clinic, Barcelona, Spain,
†Image Diagnosis Center, Hospital Clinic, Barcelona, Spain
Purpose: Locating the epileptogenic zone (EZ) in patients with neocorti-
cal epilepsy presents major challenges. We aimed to assess the accuracy
of arterial spin-labeling (ASL), an emerging noninvasive MRI-perfusion
technique, in locating the EZ in patients with drug-resistant neocortical
epilepsy.
Method: 25 consecutive patients with neocortical epilepsy referred to
our presurgical epilepsy unit underwent a standardized evaluation includ-
ing video-EEG monitoring, structural MRI, subtraction ictal SPECT co-
registered to MRI (SISCOM), and FDG-PET studies. We included an
ASL sequence in the MRI studies. We classified areas of hypoperfusion
or hyperperfusion on ASL into 15 anatomic-functional cortical regions,
comparing these regional CBF maps with the EZ determined by the other
tests, and assessing the strength of concordance with the kappa coeffi-
cient. We used the EZ determined after the overall consensus from the
different non-invasive evaluations (electrophysiological data, structural
MRI, SISCOM and FDG-PET) to calculate the sensitivity, specificity
and accuracy of ASL.
Results: Of the 25 patients (16 (64%) women; mean age, 32.4 [13.8]
years), 18 (72%) had lesions on structural MRI. ASL abnormalities were
seen in 15 (60%) patients (nine hypoperfusion, six hyperperfusion). ASL
had a very good concordance with FDG-PET (k = 0.84), a good concor-
dance with structural MRI (k = 0.76), a moderate concordance with
video-EEGmonitoring (k = 0.53), and a fair concordance with SISCOM
(k = 0.28). ASL had 71.43% sensitivity, 100% specificity, and 76% of
accuracy, when compared with the overall consensus.
Conclusion: ASL might help to determine the location and extent of the
EZ in the presurgical workup of patients with drug-resistant neocortical
epilepsy.
p0933
COMPLEXNEUROVASCULARREACTIVITY IN
PATIENTSWITHPARTIAL EPILEPSY
G. Tekgol Uzuner, N. Uzuner
Eskisehir Osmangazi University, Neurology, Eskisehir, Turkey
Purpose: Complex neurovascular activation by transcranial Doppler
(TCD) is not presented at the moment in patients with partial epilepsy.
The objective of this study is to assess the neurovascular activation to
complex visual stimulation of patients with partial epilepsy during inter
ictal period.
Method: Twenty-four patients with partial epilepsy at least 10 days later
after last epileptic attack and 75 healthy subjects were screened for this
study during the last year in our Neurosonology laboratory. We per-
formed transtemporal TCD recordings from the P2-segments of both pos-
terior cerebral arteries (PCA) simultaneously during complex visual
stimulation. The individual reactivity was defined with a relative increase
of the blood flow velocities as a percentage change of the baseline
values.
Results: Most of the patients have an epileptic focus on the temporal
lobe documented by the EEG. The Doppler data of the epileptic sides and
non-epileptic sides were analysed separately in patients. The complex
visual reactivity was significantly higher at the epileptic side in the
patients (52.5%) from those of the controls (43.6%) (p = 0.034),
although the difference between the non-epileptic side of the patients
(40.1%) and controls (46.0%) was not significant (p = 0.14).
Conclusion: In contrast to the earlier reports of the studies which was
found diminished neurovascular reactivity to simple visual stimulation
using TCD, our study showed the temporal and occipital region perfused
by PCA of the patients with partial epilepsy have hyperactive neurons at
the epileptic side during the inter ictal period when comparing with the
healthy subjects.
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CAN T2/ FLAIR SIGNAL INTENSITYRATIOSOF THE
HIPPOCAMPUSWITHTHATOF IPSILATERAL
INSULAR, CINGULATEAND FRONTALCORTICES
OBVIATE THENEED FORT2 RELAXOMETRY IN
EVALUATING TLE?
B. Thomas*, A. Mohimen*, A. Radhakrishnan†, S.V. Thomas†,
R. Madhavan Nayar Center for Comprehensive Epilepsy Care
*SCTIMST, Imaging Sciences and Interventional Radiology,
Trivandrum, India, †SCTIMST, Neurology, Trivandrum, India
Purpose: To find out, if the signal intensity ratios of the hippocampus
with ipsilateral insular cortex, cingulate gyrus and the frontal cortex have
a positive correlation with elevated T2 relaxometry values in histopatho-
logically proven cases of unilateral hippocampal sclerosis.
Methods: MR Images of 44 consecutive patients with histopathologi-
cally proven unilateral hippocampal sclerosis, who had undergone ATL
after pre surgical work up from Jan 2008, were retrospectively analyzed.
Signal intensity ratios on FLAIR and T2 coronal sequences were deter-
mined for the hippocampus with the respective ipsilateral cingulate
gyrus, insular cortex and frontal cortex. Similar signal intensity ratios
were obtained on the contralateral side (normal) which acted as controls.
These ratios were compared with T2 relaxometry values of the hip-
pocampus on each side at the same level.
Results: Mean hippocampal signal intensity ratios on FLAIR sequences
of the abnormal side with the cingulate, insula and frontal cortex were
1.24, 1.21 and 1.39 respectively. The same on the normal side were 1.07,
1.05 and 1.21. On T2 weighted sequences the signal intensity ratios of the
abnormal side were 1.36, 1.29 and 1.56 and the normal side were 1.1,
1.08 and 1.27. Statistically significant difference was noted on both T2
and FLAIR sequences between the normal and abnormal sides
(p < 0.0001). Mean T2 relaxometry values were 138.4 ms and 110.3 ms
for the abnormal and normal sides respectively. Pearson correlation co-
efficient of 0.46 was noted with the T2 relaxometry values on FLAIR and
0.49 on T2 in the abnormal sides.
Conclusion: The insula and the limbic structures have higher signal
intensity compared to neocortex, due to differences in cortical lamination.
Signal intensity ratios help in diagnosis of hippocampal sclerosis, and
with moderate positive correlation to T2 relaxometry values, may be used
instead of the time intensive relaxometry sequence in evaluating TLE.
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FDG-PET ANDMRI COREGISTRATION INMRI-
SUBSTRATENEGATIVEREFRATORY EPILEPSY
M. Tripathi*, A. Garg†, M. Tripathi‡, C. Bal*, S.P. Chandra§
*All India Institute of Medical Sciences, Nuclear Medicine and
PET, New Delhi, India, †All India Institute of Medical Sciences,
Neuroradiology, New Delhi, India, ‡All India Institute of
Medical Sciences, Neurology, New Delhi, India, §All India
Institute of Medical Sciences, New Delhi, India
Purpose: Utility of F-18 Fluorordeoxyglucose (FDG) Positron Emission
Tomography (PET) and MRI coregistration for detection of the epilepto-
genic zone in MRI-substrate negative (SN) refractory epilepsy (RE).
Methods: 35 patients undergoing pre-surgical evaluation for RE with
non-localizing/ normal MRI were included in the study. The pre-surgical
evaluation in these patients included resting brain FDG-PET and FDG-
PET/MRI fusion in all. Hypometabolism was visually interpreted on
both studies and compared with the presumed epileptogenic zone on
electroclinical studies including vEEG and MEG. The MRI was then
reviewed by the neuroradiologist for lesion definition corresponding to
the area of focal hypometabolism. 15 patients with concordance for local-
ization of epileptogenic zone on electroclinical and fusion PET/MRI fur-
ther underwent surgery and were followed up for 1 year.
Results: Hypometabolism on FDG-PET and PET/MRI coregistration
was identified in 24 (68.5%) patients. Hypometabolism detected by PET/
MRI was located in the same hemisphere as indicated by the electroclini-
cal study in 62% (15/24) of patients and localized to the same focus in
37.5% (9/24) patients. Re-evaluation of MRI in these patients subse-
quently revealed abnormality in 41.6% (10/24) of patients. Surgical out-
come was evaluated at 1 year post-op for the 15 patients undergoing
epilepsy surgery-70% had an Engel 1 outcome, 20% Engel 2 and 10%
Engel 3.
Conclusion: PET/MRI coregistration is a useful non-invasive investiga-
tion that can be included in the pre-operative evaluation of intractable
epilepsy, especially in MRI SN cases. Subsequent surgery in these cases
is associated with good surgical outcomes.
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UTILIZATIONOF FMRI IN PATIENTSWITH
EPILEPSYANDRIGHTHEMISPHERIC DOMINANCE
P. Van Ness*, Z. Yetkin†, M. Agostini‡, G. Uppal*, K. Ding*,
R. Hays*, R. Mccoll†, D. Mendelsohn†
*University of Texas Southwestern Medical Center, Neurology,
Dallas, TX, United States, †University of Texas Southwestern
Medical Center, Radiology, Dallas, TX, United States,
‡University of Texas Southwestern Medical Center, Dallas, TX,
United States
Purpose: fMRI and Wada findings are discordant in 40%–51% in right
sided or bilateral language lateralization. Our aims were: A) To evaluate
the concordance of language lateralization between fMRI andWada tests
in patients with epilepsy and right sided language. B) To compare the dis-
tribution of language activation and contralateral language representation
as detected with fMRI andWada.
Method: Medical charts of patients with intractable epilepsy who under-
went Wada and fMRI to evaluate language dominance were reviewed.
Patients with right hemispheric language dominance as determined with
Wada test were included. Data included demographics, past medical his-
tory, information about Wada and fMRI results, intraoperative cortical
mapping findings and outcomes of surgery.
Results: Eight patients (6 male, 2 female, age range: 21–46 years) had
right hemispheric language dominance as detected withWada and under-
went fMRI. Five patients had right-handedness, two had left-handedness,
and one was ambidextrous. Wada language protocol consisted of naming,
comprehension, reading, and repetition tests. Mutism, aphasia, and para-
phesia with right sided amytal injection was recorded. FMRI protocol to
evaluate language included category fluency and word generation tasks.
Regions of activation in the inferior and middle frontal gyri, temporal
and parietal lobes were included in the evaluation of laterality. Of the six
patients with right hemispheric language lateralization with Wada test,
four showed bilateral frontal activation with right dominance on fMRI
and two showed right sided activation.
Conclusion: The results of fMRI compared to Wada was concordant in
all cases. fMRI results however were not similar to that of Wada, func-
tional maps revealed activation in contralateral language areas that was
undetected with Wada. These regions might represent non-critical areas
or provide more information about language distribution. Concurrent use
of FMRI and Wada in language assessment has potential to enhance sur-
gical planning and prediction of postoperative language changes.
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RELATINGCOGNITIVE ADVERSE EVENTSOF
ANTIEPILEPTIC DRUGS TO FUNCTIONALNETWORK
EFFICIENCY
T.M. van Veenendaal*, D.M. Ijff†, R.H.C. Lazeron†,
W.H. Backes*, P.A.M. Hofman*, M.C.G. Vlooswijk‡, A.J. de
Louw†, A.P. Aldenkamp†, J.F.A. Jansen*
*Maastricht University Medical Center, Departments of
Radiology and Nuclear Medicine, Maastricht, Netherlands,
†Epilepsy Center Kempenhaeghe, Heeze, Netherlands,
‡Maastricht University Medical Center, Department of
Neurology, Maastricht, Netherlands
Purpose: Cognitive adverse events (CAE), such as mental slowing,
often arise when antiepileptic drugs (AEDs) are prescribed to treat
patients with epilepsy. To get more insight in the mechanisms of these
adverse events, the relation between graph theoretical measures derived
from resting state fMRI, AED use, and cognitive function was investi-
gated.
Method: Two groups of patients with epilepsy with a different risk at
developing CAE were included: a “low risk” group (30 patients using
lamotrigine or levetiracetam) and a “high risk” group (17 patients using
topiramate or phenytoin). A Computerized Visual Searching Task was
used to measure mental slowing. The results were compared with norm
scores based on age, sex, and global cognitive performance, resulting in a
dichotomous variable “with” or “without” problems (CAE score). Brain
connectivity was assessed using 3.0T resting state fMRI scans. Linear
regression analysis was applied to test whether graph measures (normal-
ized clustering coefficient and global efficiency) can be associated with
AED use and cognitive functioning, with as covariates risk group, CAE
score, the interaction between risk group and CAE score, age, and epi-
lepsy severity score.
Results: CAE were observed in 43% of the low risk group and in 53% of
the high risk group, hinting at a survivor effect in the high risk group. The
clustering coefficient was lower in patients with than without CAE
(p = 0.03), and also lower in high risk compared with low risk patients
(p = 0.04). No significant associations were found between the global
efficiency and risk group or CAE score. Results were robust over a spar-
sity range of 0.1–0.6.
Conclusion: Both CAE and the use of AEDs with a high risk on CAE
can be associated with decreased brain network efficiency. Further
research is needed to better characterize the relationship between AED
use, network efficiency and cognitive adverse events.
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DISTINCTWHITEMATTER INTEGRITY IN
GLUTAMICACIDDECARBOXYLASE ANDVOLTAGE-
GATED POTASSIUMCHANNEL-COMPLEX
ANTIBODY-ASSOCIATED LIMBIC ENCEPHALITIS
J. Wagner*, J.-C. Schoene-Bake†, J.-A. Witt*, B. Weber*,
C.E. Elger*
*University of Bonn Medical Center, Epileptology, Bonn,
Germany, †Klinikum Braunschweig, Pediatrics, Braunschweig,
Germany
Purpose: Autoantibodies against glutamic acid decarboxylase (GAD)
and the voltage-gated potassium channel (VGKC)-complex are associ-
ated with distinct subforms of limbic encephalitis (LE) regarding clinical
presentation, response to therapy, and outcome. Volume and signal
changes of mesiotemporal structures are well-known characteristics on
MRI. However, studies investigating white matter changes in LE are
lacking. We aimed to assess these changes by means of diffusion tensor
imaging (DTI) in LE associated with GAD antibodies (GAD-LE) and LE
associated with VGKC-complex antibodies (VGKC-LE).
Method: DTI data was obtained in 14 patients with GAD-LE and 16
patients with VGKC-LE and compared with age- and gender-matched
control groups. Voxelwise statistical analysis of fractional anisotropy
(FA) and diffusivity parameters was carried out using tract-based spatial
statistics (TBSS). Results were furthermore compared with those of 15
patients with unilateral histologically confirmed hippocampal sclerosis
(HS).
Results: We found widespread changes of FA and all diffusivity parame-
ters in GAD-LE, whereas no changes were found in VGKC-LE. The
changes observed in GAD-LE were even more extensive compared to the
HS group, although the disease duration was markedly shorter in GAD-
LE. Tract-specific FA analysis revealed the most prominent changes in
the uncinate fasciculus in GAD-LE.
Conclusion: The present study provides further evidence that LE fea-
tures clearly distinct imaging characteristics depending on the associ-
ated antibody by showing widespread white matter changes in GAD-LE
and preserved white matter integrity in VGKC-LE. Furthermore, our
results contribute to a better understanding of the specific pathophysio-
logical properties in these two LE subforms by indicating that GAD-LE
shows widespread affections of gray and white matter across various
regions of the brain, whereas in VGKC-LE, the inflammatory process
seems to be more localized, primarily affecting mesiotemporal gray
matter.
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SOURCE STRENGTHOFHIGH-FREQUENCY
OSCILLATION IS A POTENTIAL IMAGING
BIOMARKEROF SEIZURE SEVERITY INABSENCE
EPILEPSY
X. Wang*, L. Tang*,†, J. Xiang‡, A. Miao*, S. Huang*, H. Ge*,
H. Liu*, D. Wu*, Q. Guan*, T. Wu*, Q. Chen*, L. Yang*, X. Lu*,
Z. Hu*
*Nanjing Brain Hospital, Nanjing, China, †Nanjing Medical
University, Nanjing, China, ‡Cincinnati Children’s Hospital
Medical Center, Cincinnati, OH, United States
Purpose: The discovery of high-frequency oscillations in the brain has
had a profound impact on our understanding of epilepsy. The objective of
this study was to quantify the clinical correlates of interictal and ictal
brain activities from low- to very-high-frequency ranges in childhood
absence epilepsy (CAE).
Methods: Twelve patients with clinically diagnosed drug-na€ıve CAE
were studied with a 275-channel whole head magnetoencephalography
(MEG) system. MEG data were digitized at 6000 Hz and analyzed in
nine frequency bands: delta (1–4 Hz), theta (4–8 Hz), alpha (8–12 Hz),
beta (12–30 Hz), low-gamma (30–55 Hz), high-gamma (65–90 Hz), rip-
ple (90–200 Hz), high-frequency oscillation (HFOs, 200–1000 Hz) and
very-high-frequency oscillations (VHFOs, 1000–2000 Hz). MEG
sources were volumetrically localized with accumulated source imaging.
Results: In comparison with interictal neuromagnetic activities, ictal
neuromagnetic activities had significantly higher odds of occurrence in
the medial prefrontal cortex (MPFC) in bands of 1–4 Hz, 4–8 Hz and
30–45 Hz. This was also seen in the parieto-occipito-temporal junction
(POT) in bands of 1–4 Hz, 4–8 Hz, 8–12 Hz and 12–30 Hz. Ictal activity
in 30–45 Hz, 55–90 Hz and 200–1000 Hz showed a trend of elevation as
compared with interictal activity. There were significant correlations
between the number of daily seizure episodes and source strength of ictal
activity in bands of 4–8 Hz (r = 0.587, p < 0.05), 90–200 Hz
(r = 0.640, p < 0.05) and 200–1000 Hz (r = 0.734, p < 0.01).
Conclusion: The results suggest that neuromagnetic HFOs (200–
1000 Hz) are a potential neuroimaging biomarker of clinical seizure
Epilepsia, 56(Suppl. 1):3–263, 2015
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severity. The magnetic sources support that there are focal cortical areas
responsible for absence seizures.
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MULTI-FREQUENCYNEUROMAGNETIC ANALYSIS
REVEALED THEDEFAULTMODENETWORK
IMPAIRMENT INABSENCE EPILEPSY
X. Wang*, L. Tang*,†, J. Xiang‡, S. Huang*, A. Miao*, H. Ge*,
H. Liu*, D. Wu*, Q. Guan*, T. Wu*, Q. Chen*, L. Yang*, X. Lu*,
Z. Hu*
*Nanjing Brain Hospital, Nanjing, China, †Nanjing Medical
University, Nanjing, China, ‡Cincinnati Children’s Hospital
Medical Center, Cincinnati, OH, United States
Purpose: The default mode network has been shown to be selectively
impaired during epileptic seizures associated with loss of consciousness.
This study aimed to characterize neuromagnetic signatures and clinical
correlates of interictal and ictal brain activities from low- to very-high-
frequency ranges in childhood absence epilepsy (CAE).
Methods: Twelve patients with untreated clinically diagnosed CAE
were studied with a 275-Channel high sampling rate MEG system. Neu-
romagnetic data were systematically analyzed in nine frequency bands:
delta (1–4 Hz), theta (4–8 Hz), alpha (8–12 Hz), beta (12–30 Hz), low-
gamma (30–55), high-gamma (65–90 Hz), ripple (90–200 Hz), high-fre-
quency oscillations (HFOs, 200–1000 Hz) and very-HFOs (VHFOs,
1000–2000 Hz). MEG sources were volumetrically localized with accu-
mulated source imaging.
Results: The peak 2–3 sources were mainly localized in the medial pre-
frontal cortex (MPFC), the precuneus (PC) and the parieto-occipito-tem-
poral junction (POT), which were the well-known nodes of the default
mode network. In comparison with interictal neuromagnetic activities,
ictal neuromagnetic activities had significantly higher odds of occurrence
in the MPFC in bands of 1–4 Hz, 4–8 Hz and 30–45 Hz. This was also
seen in the POT in bands of 1–4 Hz, 4–8 Hz, 8–12 Hz and 12–30 Hz.
Conclusions: CAE has significantly focal aberrant brain activity that
can be noninvasively detected. The interictal and ictal activities in CAE
are spatially concordant in high-frequency ranges(>90 Hz). The nodes of
default mode network was selectively impaired in absence seizures.
HFOs may help to explain phenotypic variability in CAE patients.
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7T EXVIVOMRIOF TYPE II FOCALCORTICAL
DYSPLASIA: DIFFERENTIATION BETWEENLESIONS
AND PERILESIONS BY EVALUATIONOF T2-
WEIGHTED SIGNAL INHOMOGENEITY
I. Zucca*, M. Figini*, G. Milesi†, V. Medici†, L. D’Incerti‡,
L. Tassi§, F. Cardinale§, M. Bramerio§, N. Colombo¶,
G. Didato†, F. Deleo†, G. Tringali**, R. Spreafico†,
R. Garbelli†
*Fondazione IRCCS Istituto Neurologico Carlo Besta, Scientific
Direction, Milano, Italy, †Fondazione IRCCS Istituto
Neurologico Carlo Besta, Clinical Epileptology and
Experimental Neurophysiology Unit, Milano, Italy, ‡Fondazione
IRCCS Istituto Neurologico Carlo Besta, Neuroradiology,
Milano, Italy, §Niguarda General Hospital, Epilepsy Surgery
Center “C. Munari”, Milano, Italy, ¶Niguarda General
Hospital, Neuroradiology, Milano, Italy, **Fondazione IRCCS
Istituto Neurologico Carlo Besta, Neurosurgery III, Milano,
Italy
Purpose: The effectiveness of epilepsy surgery largely depends on the
correct identification and removal of the epileptogenic lesion, but their
presurgical identification on MRI is often difficult, especially for Focal
Cortical Dysplasia (FCD) type IIa. Our purpose is to verify the potential-
ity of ex-vivo high-resolution MRI to improve the detection of type II
FCD.
Method: Surgical specimens from patients with histological diagnosis
of FCD type II (IIa, n = 2 or IIb, n = 4), after fixation (PFA 4%) were
embedded in 6% agarose. A high-resolution T2-weighted sequence was
acquired by a 7T-MRI scanner with the following parameters:
TE = 60 ms, TR = 6.5 s, NA = 24, resolution: 50 9 50 9 700 mm3.
Homogeneity and contrast maps were obtained by texture analysis.
Regions of interest were manually delineated in lesions and perilesions
according to histology. The mean and coefficient of variation (CV) of the
signal, and the mean homogeneity and contrast were computed in each
region.
Results: MRI signal alterations were visible in all the FCD IIb cases and
in one FCD IIa case. The mean signal was significantly reduced in FCD
IIb cortical lesions compared to cortical perilesions, while WM lesions
were generally hyperintense. In IIa cases, only the lesions identified by
visual inspection were hypointense. The CV was significantly increased
in the cortical lesions of all the cases, even in one specimen where no
lesion was identified by visual inspection. The CV was reduced in hyper-
intense WM lesions and slightly increased in WM lesions without signal
hyperintensity. Texture parameters showed no significant difference.
Conclusion: While the mean signal intensity allowed to detect only the
visually identifiable lesions, the CV was altered also in apparently isoin-
tense lesions. These preliminary results, if confirmed by a correlation
study including co-registration between MRI and histology, could be
translated to clinical practice when a sufficient spatial resolution will be
achieved.
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MEMORIES AREMADEOF THIS: DETERMINANTSOF
IMPAIREDAUTOBIOGRAPHICALMEMORY IN
EPILEPSY
G. Rayner*,†, G. Jackson†, S.J. Wilson*,†
*The University of Melbourne, Melbourne School of
Psychological Sciences, Melbourne, Australia, †The Florey
Institute of Neuroscience and Mental Health, Melbourne,
Australia
Purpose: Autobiographic memory catalogues the events experienced by
an individual across the lifespan, forming the basis of self-identity and
psychological wellbeing. Deficits in autobiographic memory are com-
mon in patients with epilepsy, and are also associated with psychiatric
disturbances such as depression. This study investigates the antecedents
of autobiographic memory impairments in epilepsy patients with early
(childhood/adolescence) versus late (adulthood) disease onset. It is
hypothesised that impairments in people with onset during the critical
neurodevelopmental period of childhood/adolescence will be linked to
epilepsy-related factors. In contrast, impairments in those with later onset
will be more strongly related to psychiatric factors, such as depressive
symptoms.
Method: Eighty-five adult patients with focal epilepsy were recruited to
the study between 2010–2014 from the Comprehensive Epilepsy Pro-
gramme at Austin Health, with their performances on cognitive and psy-
chiatric measures compared to that of 72 healthy controls. Predictors of
autobiographic memory impairment were contrasted between patients
with early (n = 43) versus late (n = 42) onset.
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Results: Epilepsy patients performed significantly worse on indices of
both semantic and episodic autobiographic memory and had significantly
higher rates of depressive symptoms and disorder than controls
(p < 0.001). Reduced autobiographic memory in epilepsy patients with
early onset was associated with more frequent seizures, young age at
onset, and reduced working memory. In contrast, late onset patients’ dif-
ficulty in recalling autobiographic information was largely associated
with depression and the presence of a MRI-identified lesion.
Conclusion: This study reveals that autobiographic memory deficits in
patients with epilepsy have differing antecedents depending on the tim-
ing of disease onset. While neurobiological factors strongly underpin
reduced autobiographical recall in early onset epilepsy, psychological
difficulties play a role in the impairments of later onset patients. More
broadly, these findings support the use of subtyping patients according to
distinct clinical characteristics to find individualised predictors of cogni-
tive outcome.
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SOCIALCOGNITION IN EPILEPSY
A. Sanabria, M. Toledo, M. Quintana, M. Allegret,
E. Santamarina, M. Gonzalez, X. Salas-Puig
Hospital Universitari Vall d’Hebron, Epilepsy Unit. Neurology
Departament, Barcelona, Spain
Purpose: we aims to evaluate as social cognition can be impaired in
Frontal lobe epilepsy (FLE) and Generalized Idiophatic epilepsy (IGE).
We evaluate Theory of mind (ToM), as the ability to understand and pre-
dict behaviors, intentions and emotions of others, cognitive flexibility,
the decision-making and its impact on the quality of life.
Methods: this is a case-control study of adults patiens with (FLE) and
(IGE), whith IQ > 85 and without relevant comorbility. Subjects com-
pleted a questionnaire about quality of life (QOLIE-31) and ToM task:
Faux-Pas, Eyes-Test, understanding of false beliefs, Happé stories, Facial
emotion recognition, Iowa-Gambling-Task and Wisconsin-Card-Sort-
ing-Test.
Results: we study 100 subjects (30 FLE, 20 IGE and 50 controls). Aver-
age age:38 (12) [18–65] years old. FLE patiens showed lower perfor-
mance in ToM than IGE and controls. (Faux-Pas, Eyes-test, Wisconsin-
perseverations: p < 0.001; understanding of false beliefs, Happé stories:
p < 0.001; Facial emotion recognition: p = 0.003)
We observed a tendency in the concern about the disease and the social
cognition as factors of bigger negative impact on the quality of life of
FLE as compared with IGE). Women with FLE showed lower perfor-
mance in the emotional state than IGE (p = 0.02) And men concerns
about future seizures and driving were the two limitating factors in FLE
compared to IGE.
Conclusion: FLE patients have higher impairment in ToM and less cog-
nition flexibility the IGE. Concerns about the disease and the social cog-
nition are the most negative impact factors on the quality of life.
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COGNITIVE FUNCTIONING INAICARDI SYNDROME
M. Tuft
Oslo University Hospital, National Centre for Rare Epilepsy-
Related Disorders, Oslo, Norway
Background: Aicardi syndrome is a rare neurodevelopmental disorder.
The main diagnostic features are agenesis of corpus callosum, chorioreti-
nal lacunae, and infantile spasms. The outcome is in general severe, with
poor cognitive development and difficult-to-treat epilepsy.
The disorder is only observed in females and in males with chromo-
some 47, XXY.
Purpose: Cognitive investigation of girls with Aicardi syndrome.
Six females aged 7–27 years with the diagnosis of Aicardi syndrome
were identified in Norway in an epidemiologic study. Five of these were
cognitively investigated.
Method: Wineland-II Adaptive Behavior Scales, Survey interview, Bay-
ley Scales of Infant and Toddler Development, WPSSI-R, Weschler
Intelligence Scale for Children, fourth edition, and some additional tests
were used. The cognitive screening was adjusted to the individual level
of functioning.
Results: Three were diagnosed with F 73 Profound mental retardation,
one with F 71 Moderate mental retardation, and one with F 70 Mild men-
tal retardation (ICD-10). The four with the most severe mental retarda-
tion (F 73 anf F 71) all had epilepsy, and the one with mild mental
retardation (F 70) did not have epilepsy.
The girls with profound mental retardation gave few communicative
responses. They all used wheelchairs and had a gastric feeding tube
because of poor food consumption.
The girl with moderate mental retardation used up to three words her-
self at the age of 6 years and was able to follow simple verbal instruc-
tions.
The girl with mild mental retardation could follow normal conversa-
tions on a simple level at the age of 13 years, although with short sen-
tences and a limited vocabulary. She could also read and write.
Conclusion: The neurocognitive level varied in the group, from pro-
found mental retardaton to mild mental retardation. The girl without epi-
lepsy had a far better neurocognitive level of functioning than the girls
with epilepsy.
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EXECUTIVE FUNCTIONS IN ATTENTION-DEFICIT/
HYPERACTIVITYDISORDER (ADHD): COMPARISON
WITHADHDASSOCIATEDWITHROLANDIC
EPILEPSYORROLANDIC SPIKES
D. Turkdogan*, S. Zaimoglu†
*Marmara University Medical Faculty, Department of Pediatric
Neurology, Istanbul, Turkey, †Marmara University Institute of
Neurological Sciences, Department of Child Pscyhiatry,
Istanbul, Turkey
Purpose: Attention-deficit/hyperactivity disorder (ADHD) is commonly
associated with pediatric epilepsy. Both the high prevalence of epilepti-
form abnormalities in children with ADHD and prevalent ADHD diagno-
sis preceding the first seizure in children with epilepsy suggest a
bidirectional relationship between these two disorders. We aimed to
explore the possible neuropsychological differences between ADHD and
ADHD associated with Benign Rolandic Epilepsy (ADHD-BRE) and
ADHD associated with Rolandic Spikes (ADHD-RS).
Method: Ninety-eight children (25 female), aged between 6 and 12
(mean age: 8.06  1.46) years, diagnosed with ADHD according to the
DSM-IV-TR criteria were recruited. The neuropsychological data of
children diagnosed as ADHD (n = 52) with normal EEG were compared
to children with ADHD-RS (n = 25) and to ADHD-BRE (n = 21). All
subjects were given a neuropsychological test battery includingWechsler
Intelligence Scale For Children-Revised (WISC-R), Wisconsin Card
Sorting Test (WCST), Stroop Task, Visual Span subtests of Wechsler
scales, Category Naming Test, and Phonemic Verbal Fluency Task.
Results: Total, verbal and performance IQ scores of WISC-R were not
statistically different between the groups. Vocabulary (F = 5.10;
p = 0.008) and digit span (F = 10.80; p = 0.000) subtests of WISC-R
and failure to maintain set score (F = 3.45; p = 0.036) of WCST were
different between the groups. ADHD cases had a lower Digit Span score
(meanSD: 8.25  2.03) compared to the children with BRE
(10.65  2.52) and RS (10.33  2.82). Children with ADHD had signif-
icantly higher vocabulary subtest scores compared to the group with
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ADHD-RS (meanSD 11.32  2.27; 9.75  2.33). Failure to maintain
set scores of WCST in ADHD group were higher compared to subjects
with ADHD-BRE (mean1.83  1.55; 0.84  0.96).
Conclusion: We found significantly low digit span score in ADHD
group compared to patients with BRE or RS. Digit span performance in
ADHD was linked to a locus and low digit span performance was sug-
gested to be an endophenotype. ADHD might have a different patho-
genetic process compared to the ADHD associated with BRE or RS.
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THEROLEOF POSITIVE ILLUSIONS IN ADJUSTMENT
TOEPILEPSYANDEXPECTATIONSOF SURGERY
S.J. Wilson*,†,‡, G. Rayner*,‡, J. Lawrence*
*The University of Melbourne, Melbourne School of
Psychological Science, Melbourne, Australia, †Comprehensive
Epilepsy Program, Austin Health, Melbourne, Australia,
‡Florey Institute of Neuroscience and Mental Health,
Melbourne, Australia
Purpose: It is well-established that humans use a complex system of
cognitive biases or “positive illusions” that foster emotional wellbeing
and subjective quality of life. These include an inflated assessment of
one’s abilities and personal control over life events. This study aimed to
examine the role of positive illusions in patient adjustment to epilepsy
and expectations of surgical treatment. We hypothesised that a failure to
generate positive illusions about epilepsy would be associated with
poorer adjustment, reflected by lower mood and HRQOL. This, in turn,
would increase the gap between patient perceptions of their current life
and the life they expect after surgery, leading to inflated expectations of
surgery.
Method: Participants included 90 patients (58% female; mean age =
41 years, SD = 13; mean FSIQ = 101, SD = 13) with drug-resistant
focal epilepsy (76% temporal focus; mean seizure onset = 21.5 years,
range = 1–63) admitted to our Comprehensive Epilepsy Program for sur-
gical characterisation. We purpose-built an interactive computer program
to comprehensively assess the experience of living with epilepsy and
expectations of surgery, and assessed mood and HRQOL using standard-
ised questionnaires.
Results: A hierarchical cluster analysis identified 54% of patients with
positive illusions about their epilepsy, including believing they could
control it and feel proud about it. Patients with no illusions (46%)
reported higher levels of depression (p < 0.01) and anxiety (p < 0.05),
and lower levels of HRQOL (p < 0.05). They also endorsed increased
expectations of post-surgical life relating to personal, social and medical
outcomes (p < 0.05). Patient groups showed no differences on clinical or
socio-demographic variables.
Conclusion: Positive illusions can be disrupted in epilepsy, negatively
impacting a patient’s sense of self and control over life events, lowering
mood and HRQOL. Paradoxically, this can increase expectations of life
after surgery and may heighten the risk of post-operative adjustment dif-
ficulties, highlighting the need to address psychological processes under-
pinning patient adjustment to epilepsy before surgery.
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ALTERED SELF-IDENTITY ANDAUTOBIOGRAPHIC
MEMORY IN EPILEPSY
J. Allebone*, G. Rayner*, B. Siveges*, S.J. Wilson*,†
*University of Melbourne, School of Psychological Sciences,
Melbourne, Australia, †Austin Health, Comprehensive Epilepsy
Program, Melbourne, Australia
Purpose: Research suggests that individuals with chronic epilepsy
display differences in their self-identity. The mechanisms by which self-
identity is altered, however, are not well understood. Neural networks
supporting autobiographic memory retrieval in the mesial temporal (MT)
lobe are thought to be fundamental to self-identity processes. Thus, we
examined differences in self-identity and autobiographic memory in
patients with either MT or non-mesial temporal (NMT) foci with early or
late age of habitual seizure onset.
Method: Participants included 102 adults; 51 healthy individuals and 51
patients with drug-resistant focal seizures (19 MT, 32 NMT). We used
the Ego Identity Process Questionnaire to profile the identity develop-
ment of participants, and examined how this related to memory function
assessed using the Autobiographical Memory Test.
Results: Patients and controls had strikingly different self-identity pro-
files, with early onset MT patients showing the least identity develop-
ment compared to controls and other patient groups. In contrast, late
onset NMT patients showed the highest level of identity development of
the patient groups and closely resembled healthy controls (p < 0.05 for
all comparisons). For all MT patients, poor autobiographic memory
retrieval was correlated with altered self-identity (p < 0.001). No associ-
ations between autobiographic memory and self-identity were evident in
the NMT group.
Conclusion: Self-identity in epilepsy may be modulated by the extent to
which seizure foci impinge upon the autobiographic memory network
and the timing of seizure onset. Early disruption to the autobiographic
memory network may constitute a neurocognitive mechanism by which
self-identity is altered in chronic focal epilepsy.
p0953
ACCELERATED LONG-TERMFORGETTING,
RETROGRADEAUTOBIOGRAPHICALMEMORY
LOSS, ANDDEPRESSEDMOOD INGLUTAMICACID
DECARBOXYLASE ANTIBODY POSITIVE LIMBIC
ENCEPHALITIS
J.-A. Witt, V.L. Vogt, C.E. Elger, C. Helmstaedter
University of Bonn, Department of Epileptology, Bonn, Germany
Purpose: To describe the course of clinical and neuropsychological
symptoms in a patient with previously unrecognized glutamic acid decar-
boxylase (GAD) antibody related limbic encephalitis.
Method: Case report of a 35-year old male patient complaining about
severe anterograde and retrograde memory problems after two break-
downs with confusion of unknown etiology who underwent thorough
diagnostics and treatment at our epilepsy center after various practition-
ers and clinics had suggested different etiologies such as a psychosomatic
condition, burnout, depression or dissociative amnesia.
Results: The patient presented with emotional instability and depressed
mood. Retrograde autobiographical memory loss spanned the preceding
3 years and was characterized by loss of emotional attachment and auto-
noetic consciousness. Anterograde memory functions were compromised
by accelerated long-term forgetting. Standardized neuropsychological
assessment indicated selectively impaired figural memory performance.
Extended diagnostics confirmed accelerated forgetting of previously
learned and retrievable verbal material. Structural MRI revealed bilateral
swelling and hyperintensities of temporomesial structures, more promi-
nent in the left hemisphere. Volumetry confirmed an enlargement of the
left amygdala. Video-EEG registered a left temporal epileptic focus and
a subclinical but no overt seizure. Clinical findings and positive antibody
tests in serum and liquor led to the diagnosis of GAD antibody positive
limbic encephalitis. Monthly steroid pulses over a 6 month-period led to
recovery of subjective memory and to intermediate improvement but
subsequent decline of objective material-specific memory performance.
During the course of immunotherapy the patient reported de novo parox-
ysmal non-responsive states which completely remitted under subse-
quent antiepileptic treatment. At the final visit stepwise vocational
reintegration was successfully in progress.
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Conclusion: Amygdala swelling, retrograde autobiographic memory
loss, accelerated long-term forgetting and emotional instability may serve
as indicators of limbic encephalitis even in the absence of overt epileptic
seizures. Themonitoring of such patients calls for a standardized and con-
certed multilevel diagnostic approach with repeated assessments.
p0954
HEALTHRELATEDQUALITYOFLIFE IN PATIENTS
ADMITTED FORVIDEO-EEGMONITORING
DIAGNOSEDAS EPILEPSYORPSYCHOGENIC NON-
EPILEPTIC SEIZURES
D. Yerdelen*, E. Altintas†
*Baskent University, Faculty of Medicine, Neurology, Adana,
Turkey, †Baskent University, Faculty of Medicine, Psychiatry,
Adana, Turkey
Purpose: We sought to determine the health related quality of life
(HRQL) in patients who are admitted for video/EEGmonitoring and diag-
nosed as epileptic seizures or psychogenic non-epileptic seizures (PNES)
according to information obtained from the histories, physical and neuro-
logical examinations and investigations for differential diagnosis.
Method: Consecutive 125 adult patients admitted for video/EEG moni-
toring and diagnosed as epilepsy (64) or PNES (54) were assessed using
The World Health organization quality of life (WHOQOL)-BREF ques-
tionnaire. Additionally, psychiatric comorbidities were diagnosed using
structured clinical interview for Diagnostic and Statistical Manual of
Mental Disorders, Fourth Edition (DSM-IV). Seven patients were
excluded (3 because of diagnosed as both epilepsy and PNES and 4
because of diagnosed as syncope).
Results: The two groups were similar in terms of age, personal and fam-
ily history, marital status, educational level and vocational features.
Patients with epilepsy and PNES were found to have similar HRQL in
physical, psychological, social and environment domains. However, the
percentage of concomitant psychiatric disease diagnosis was higher in
patients with PNES than patients with epilepsy (68.5%, 18.1%, respec-
tively; p < 0.05).
Conclusion: This study suggests that HRQL is affected in patients with
PNES as in patients with epilepsy, however, the concomitant psychiatric
disease is more frequently encountered in PNES group. We think that a
better understanding of the impact of PNES manifestations and epilepsy
would help to provide appropriate clinical, psychological and social care.
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TLAZOLTEOTL THEAZTECGODDESSOF EPILEPSY
L.D. Ladino*, J.F. Tellez-Zenteno†, L. Hernandez-Ronquillo†
*Hospital Pablo Tobon Uribe, Medellín, Colombia,
†Saskatchewan University, Saskatoon, Canada
Purpose: The historical allure of epilepsy transcends academic circles
and serves as fascinating critique of the state of the times. For centuries
the different medical beliefs in epilepsy trough different cultures have
been an indication of the relationship between the disease and the super-
natural. Our purpose is to present the history of the the Aztec goddess of
epilepsy and describe her depictions over time.
Method: We performed a comprehensive search for articles published
from 1800 to 2015 to identify stories and depictions of Tlazolteotl and
the Aztec medicine.
Results: The Aztecs believed that illnesses like epilepsy were punish-
ments send from angry and temperamental god or goddess. In particu-
lar, epilepsy was considered in the Aztec culture a “sacred disease”
and convulsions were traditionally associated with a deified woman
who have died in childbirth. Tlazolteotl was able to give and cure epi-
lepsy from people, in a similar way as other deities such as Shiva and
Apasma^ra in ancient India and Saint Valentine in Germany. Tlazolteotl
is one of the most endearing and complex goddesses of Mesoamerica.
Her name is derived from the Nahuatl word for garbage, tlazolli, liter-
ally old, dirty, which was used to connote filth. The second part of her
name, teotl, signifies a deity. She was the Goddess of the black fertile
and fecund earth that gains its energy from death, and in turn feeds
life. Associated with purification, expiation, and regeneration, she
embodied fertility and turns all garbage, physical and meta-physical,
into rich life.
Conclusion: Tlazolteotl, the mystic Mexican goddess represents the
supernatural view of the sacred disease inMesoamerica, where the illness
of humanity is always consumed and pardoned by the act of childbirth.
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DESIGNANDVALIDATIONOFA SCALEOFQUALITY
OFLIFE FORCHILDRENANDADOLESCENTSWITH
EPILEPSY IN SPANISH LANGUAGE. ECAVINAE-
LICCE. COLOMBIA
S.M. Ramírez*, A.M. Uscategui*, L.A. Diaz†, C. Medina‡
*Universidad Nacional de Colombia, Neuropediatrics, Bogota,
Colombia, †Universidad Industrial de Santander, Pediatrics,
Bucaramanga, Colombia, ‡Liga Central contra la Epilepsia,
Neuropediatrics, Bogota, Colombia
Purpose: To develop and validate a scale to assess the quality of life of
children of different ages with epilepsy in the Colombian context,
according to different domains that are related to the condition of these
patients.
Method: Multicenter study; three-stage: A systematic search of the liter-
ature, creating scale and validation. Population: 0–17 years diagnosed
with epilepsy who consulted Central League Against Epilepsy LICCE
and Hospital LaMisericordia, Bogota, Colombia; from 2014–2015.
Sample Calculation for intraclass correlation 0.08 and 0.05 type I
error: In total 274 patients, 137 of 0–10 years (divided 0–3 years, 4–
10 years) and 137 of 11–17 years.
Results: Stage 1: A literature search was conducted.
Stage 2: biological, psychological, social and school / work: A scale
with 4 domains was designed. The scale was divided into 2 age groups, a
group of 0–10 years to be answered by parents and another group of 11–
17 years to be answered by the patients. The survey was conducted with
Likert questions.
Stage 3: Using data from surveys of population characteristics were
evaluated. Face validity and content validity, construct validity through
factorial analysis, reliability analysis using Cronbach0s alpha (0.7), intra-
class correlation and stability through test-retest (0.99); finding numbers
that pass validation.
Conclusion: It was designed and validated a scale in Spanish to assess
quality of life in children and adolescents with epilepsy in the Colombian
context to assess patients at the time of consultation and monitoring of
this aspect throughout the intervention.
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EPILEPSYANDBURNS: REVIEWOFTHEBURNT
INTENSIVE CAREUNIT BETWEEN 2012-2014
C. Riffo Allende*, C. Astudillo Diaz†, G. Riffo Allende‡
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*Universidad Catolica de Chile-Liga Chilena Contra la
Epilepsia, Santiago, Chile, †UCI Indisa Chile, Burns, Satiago,
Chile, ‡Psicologo Clinico, Santiago, Chile
Introduction: Epilepsy patients can suffer different injuries, including
skin burns. The causes are various, and depend on the type and frequency
of the seizure, antiepileptic drug and comorbidities.
Objective: To identify the risk factors associated with skin burns in
adults patients with epilepsy.
Methods: Retrospective study done in the burnt intensive care unit
between march 2012 and march 2014. From a total 120 patients, there
were only 6 patients that fulfilled the criteria of epilepsy and skin burns
(5%); 3 of them were male. The average age was 45.8 years old (40–76).
All of them currently treated with antiepileptic drugs: 5 in monotherapy
and 1 in politherapy.
Results: 5/6 of the patients presented generalized seizures when they
suffered the skin burn (83%), in 5 of the cases the accident happened at
their houses and 1 at work. 5/6 (83%) recognized partial adherence to the
antiepileptic treatment, including forgetting the medication and 2 out of 6
(33%) had alcohol consumption before the skin burn happened. 1 female
patient died because of the extent of the skin burns lesions. The average
severity index for these patients was 116 (critic).
Conclusion: There is a relation between epilepsy and skin burns, with a
clear tendency to severe lesions. Physicians should emphasize in selfcare
and adherence to antiepileptic therapy in order to minimize the risks of
skin burns among other accidents.
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LONG-TERMOUTCOMES IN SEIZURECONTROL
ANDQUALITYOF LIFEAMONGPATIENTSWITH
MEDICALLY INTRACTABLE EPILEPSY TREATED
WITHMODIFIEDKETOGENIC DIET THERAPY
(MKDT) - A 12-MONTHRETROSPECTIVE STUDY
K. Roehl*, A. Balabanov†
*Rush University Medical Center, Clinical Nutrition, Chicago,
IL, United States, †Rush University Medical Center, Rush
Epilepsy Center, Chicago, IL, United States
Purpose: Modified ketogenic diet therapy (MKDT) is an effective treat-
ment for intractable epilepsy; however, long-term outcome data remains
limited. The aim of this retrospective study was to report outcomes with
long-term use of MKDT.
Methods: Patients with intractable epilepsy, following MKDT for
≥12 months between December 2012 and February 2015 were included.
Treatment outcomes, measured at baseline, 3, 6, and 12 months, included
self-reported change in:
(1) Seizure frequency (< 50% or ≥50 improvement),
(2) Seizure severity (improved intensity and/or duration),
(3) QOL (improvedmood and/or alertness), and
(4) Compliance (strict or occasional deviation).
Results: Twenty-seven patients were included; 85% were aged
≥18 years (n = 23), 70%were females (n = 19).
MKDT resulted in ≥50% improvement in seizure frequency in 74%
(n = 20), 63% (n = 17), and 56% (n = 15) at 3, 6 and 12 months, respec-
tively. Additionally, improved seizure severity was reported in 75%
(n = 15), 82% (n = 14), and 87% (n = 13) of these patients at each time
point. QOL improvements were reported in 90% (n = 18), 88%
(n = 15), and 87% (n = 13) at each time point.
A total of 26% (n = 7), 37% (n = 10) and 44% (n = 12) reported <
50% seizure frequency improvement at 3, 6, and 12 months, respec-
tively. Interestingly, 57% (n = 4), 70% (n = 7), and 58% (n = 7)
reported improved seizure severity, and 57% (n = 4), 50% (n = 5), and
33% (n = 4) reported QOL improvements at each time point.
Among those with ≥50% improvement in seizure frequency, strict
compliance was reported in 80% (n = 16), 59% (n = 10), and 80%
(n = 12) at 3, 6, and 12 months, respectively.
Conclusion: This study demonstrates the efficacy of long-term MKDT
for seizure control and QOL among both pediatrics and adults with medi-
cally intractable epilepsy. Not surprisingly, strict compliance appears to
result in the most benefit. Tolerability of these diets may account for the
sustained/long-term benefits. Further, objective research is needed to ver-
ify these outcomes.
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THEVALUESOF P300 COGNITIVE POTENTIALS IN
CASESOF IDIOPATHIC AND SYMPTOMATIC FORMS
OFEPILEPSY, TASHKENTMEDICALACADEMY
N. Ruzimova
Tashkent Medical Akademy, Tashkent, Uzbekistan
Purpose: At the modern time the methods of cognitive induced
potentials (CIP) find their vast application in clinical practice, making
possible the objective estimation of the cognitive functions linked
with perception and processing of information, and letting us get
objective data.
The aim of the research: Is to study the peculiarities of cognitive
induced potentials in the patients with symptomatic and idiopathic forms
of epilepsy.
Method: the study was based on the results of examination of 72 patients
with epilepsy, among them 38 with symptomatic epilepsy (SE) and 34
with idiopathic form (IE). The average age of the examined patients was
48.0  25.3 years old. The control group included 10 practically healthy
people of the appropriate age.
Results: The patients with symptomatic and idiopathic epilepsy had
characteristic alterations of P300 values, accompanied by more profound
alterations in the cases of idiopathic form. It is, possibly, linked with
more frequent epileptic attacks, longer term of the disease and, as a result,
longer term of anticonvulsants administration.In the cases of idiopathic
and symptomatic forms we detected absence of inter-hemispheric asym-
metry of P300 wave amplitude, indicating dysfunctional disorders. The
values of P300 latent period were increased in the cases of symptomatic
epilepsy, different from idiopathic one, reflecting the inhibition of cogni-
tive processes.
Conclusion: Thus, the neurophysiological values of cognitive induced
potentials of the patients with epilepsy objectively reflect the status of
the higher cerebral functions and depend on the form of epilepsy.
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INTERELATIONOFCOGNITIVE POTENTIALS AND
NEURO-IMMUNOLOGICAL VALUES IN THE
PATIENTSWITHEPILEPSY. TASHKENTMEDICAL
ACADEMY, UZBEKISTAN
N. Ruzimova
Tashkent Medical Akademy, Tashkent, Uzbekistan
Purpose: Nowadays one of the actual problems in epileptology is the
study of interelation of neuro-immunologic values and disorders in
cognitive sphere in epilepsy cases.The aim of the research: is to study
the Interelation of neuro-immunologic values and cognitive induced
potentials P300 among the patients with idiopathic and symptomatic
epilepsy.
Method: We checked 43 patients with epilepsy aged from 16 to 70 years
old (27 men; 16 women), among them 11 had idiopathic epilepsy and 32
patients with symptomatic focal epilepsy. The control group included 16
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clinically healthy people.The quantitative definition of serum immune
reactivity of antibodies to neuromediators0 receptors was performed with
the help of ELI-N-test solid phase immune enzyme method (Russia).The
study of P300 was performed on four-channel electromyograph “Med-
elec.”
Results: We detected the rise of autoantibodies0 level to neuro-specific
proteins NF-200, GFAP and OBM together with the decrease of S 100
among the patients with symptomatic epilepsy. The rise of autoantibod-
ies0 level to neuro-messengers was characterized by decrease of Chol-R,
Glu-R, Da-R, Ser-R, DNA at the same time homogenous values of
GABA-R and B2GP in the cases of symptomatic epilepsy and opposite
data in the cases of idiopathic epilepsy.On the basis of neuro-physiologic
values of CIP we detected the absence of inter-hemisphere assymmetry
of P300 wave amplitude testifying dysfunctional disorders. The values of
latent P300 period were increased in cases of symptomatic epilepsy, dif-
ferent from idiopathic one, and reflect inhibition of cognitive pro-
cesses.We detected an inverse dependence of the latent period and
amplitude increasing on the presence and explicity of neuro-immunolo-
gic values in the analysis of neuro-immunologic values and P300 intere-
lation.
Conclusion: On the basis of the achieved data we can make a conclusion
about inverse dependence of the degree of latent period and amplitude
increasing on the presence and explicity of neuro-immunologic values.
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IMMUNOLOGICAL PARAMETERS IN EPILEPSY
N. Ruzimova
Tashkent Medical Akademy, Tashkent, Uzbekistan
Purpose: Background. Epilepsymay present as a symptom of many neu-
rological disorders and often an etiological explanation cannot be identi-
fied. There is growing evidence that autoimmune mechanisms might
have a role in some patients.
Objective: To study the levels of autoantibodies (AAB) to brain pro-
teins-antigens (NF-200, GFAP, BMP, and S100b) in blood serum of
patients with idiopathic and symptomatic epilepsies.
Method: We studied 52 patients with epilepsy (main group) at the aver-
age age of 36.2  14.7 years old. The main group was divided into 2
groups: I group–38 patients with idiopathic epilepsy, II group–14 patients
with symptomatic epilepsy. The control group consisted of 16 healthy
subjects. Immunological studies were conducted with ELI-Neuro-test by
immunoenzymatic analysis. The data obtained were processed using
methods of variation statistics
Results: We observed significant elevation of AAB to protein S100b in
epilepsy patients, greater in idiopathic epilepsy, compared to control
(54.3  10.3; 39.4  10 and 5.8  1.3 CU, respectively, p < 0.001).
The levels of AAB to MBP were high in the first group (14.9  4.9 CU,
p < 0.001), while in the second group were low (2.6  4.3 CU), in com-
parison with control (8.0  4.7 CU). The levels of AAB to GFAP were
higher in symptomatic epilepsy (13.9  7.9 CU, p < 0.001). Patients
with idiopathic epilepsy had higher (22.0  6.7 CU) levels of AAB to
NF-200 vs. patients with symptomatic epilepsy (11.4  6.4 CU)
(p < 0.001).
Conclusion: Thus, all groups of epilepsy patients differed from control
group by as individual levels, as degree of deviations of the studied
immunological parameters. Early-initiated immunotherapy may improve
seizure outcome in such patients.
Others 6
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REDUCED FREQUENCYOFBLOODCD8+ T
LYMPHOCYTES EXPRESSING PROINFLAMMATORY
CYTOKINES INMESIAL TEMPORAL LOBEEPILEPSY
PATIENTS
D.V. Rosa*, V.B. Rezende*, B.S. Costa†, M. Schutze*,
F.A. Mudado*, K.C. Torres*, L.C. Martins*, C.A. Moreira-
Filho‡, D.M. Miranda*, M.A. Romano-Silva*
*UFMG, Belo Horizonte, Brazil, †Santa Casa de Misericordia,
Belo Horizonte, Brazil, ‡USP, S~ao Paulo, Brazil
Purpose: To compare the proinflammatory and anti-inflammatory cyto-
kine expression profile of CD4+ and CD8+ T lymphocytes between drug
resistant mesial Temporal Lobe Epilepsy (mTLE) patients and healthy
subjects.
Method: mTLE patients were enrolled at the Neurology Center of Santa
Casa de Misericordia de Belo Horizonte (SCM-BH) and healthy volun-
teers were selected at Universidade Federal de Minas Gerais. Individuals
from both groups accepted to participate in this study and signed an
informed consent. Peripheral blood mononuclear cells (PBMC) were iso-
lated from whole blood using Ficoll/Hypaque followed by flow cytome-
try analysis. Data analysis was perfomed using FlowJo.
Results: Compared to healthy individuals, mTLE patients showed
reduced frequency of CD8+
T lymphocytes expressing IFN-c, TNF-a, IL-17 and IL-4. Moreover,
mTLE patients presented increased frequency of CD4+ T lymphocytes
expressing IL-6 when compared to healthy volunteers.
Conclusion: Epilepsy is the third most common chronic brain disorder.
Mesial temporal lobe epilepsy (mTLE) is a major and severe form of epi-
lepsy and 30% of the mTLE patients do not respond to conventional med-
ications. Our data suggest that mTLE patients have distinct
immunological profiles that are related to disease pathophysiology.
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EPILEPSYCARE IN BANGLADESH: THE
EXPERIENCEOF FIRSTVIDEO-EEGCENTER
A. Salam,M.R. Quddus, M.S. Rahman
Shahid Sheikh Abu Naser Specialized Hospital, Neurology,
Khulna, Bangladesh
Purpose: Video-EEG is a very effective diagnostic tool for differentia-
tion of seizure and pseudo-seizure and to classify various seizure types.
In Bangladesh this investigation has been introduced since February,
2014 in our institute. The objective of this study is to evaluate the find-
ings of the Video-EEGs.
Method: This is a retrospective study. The electro-clinical information
of the patients who had their Video-EEGs performed in our laboratory
were collected and reviewed. All patients from February, 2014 to Octo-
ber, 2014 were included in this study. Clinical diagnosis was made by
taking the history meticulously and doing clinical examination by the
investigator. Video-EEGs were performed for various durations, ranging
from 30 min to 24 hours with a view to capture an event and classify it.
The seizures were classified following the International League Against
Epilepsy classification (ILAE 1989, 1993). The EEG findings were inter-
preted accordingly.
Results: In 09 months total 25 Video-EEGs have been done. The
duration of these V-EEGs were 0.5–24 hour. Age of the patients were
5 month-78 year. Male-female ratio was 12:13. In 14 cases clinical
events could be captured. Various types of EEG pathology were found
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in 20 cases. The final diagnosis is, CPS-T-7, PS with secondary gener-
alization- 4, IGE-2, Symptomatic Gen. Ep.-3, Childhood Absence Epi-
lepsy-2, Juvenile Myoclonic Epilepsy-1, SSPE-1, Status Epilepticus of
Atypical Absence Seizure-1(LGS) and Pseudo-seizure-4. EEG was
positive in 95% cases in our study. In 56% cases it was possible to
capture an event which provided conclusive result of the presenting
complain.
Conclusion: This result demands wide-spread use of Video-EEG in
selected cases by trained experts for the accurate diagnosis and classifica-
tion of epilepsy and to differentiate seizures from pseudo-seizures.
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EPILEPSYCLINICALGUIDELINES: A “HOWTO”
GUIDE
K.M. Sauro*,†, S. Wiebe†, A. de Marinis‡, C. Dunkley§,
J. French¶, M. Kirkpatrick**, E. Perucca††, N. Jette*,†
*University of Calgary, Community Health Sciences, Calgary,
Canada, †University of Calgary, Clinical Neurosciences,
Calgary, Canada, ‡Universidad del Desarrollo, Santiago, Chile,
§Kings Mill Hospital, Pediatrics, Sutton in Ashfield, United
Kingdom, ¶New York University, Neurology - Comprehensive
Epilepsy Center, New York, NY, United States, **Tayside
Children’s Hospital, Dundee, United Kingdom, ††University of
Pavia, Internal Medicine and Therapeutics, Pavia, Italy
Purpose: Clinical practice guidelines (CPGs) contain evidence-based
recommendations to guide clinical care, policy development and improve
quality of care.While CPGs can be a valuable resource, they are not with-
out limitations. There are no universally accepted standards for CPG
development, which can negatively impact their quality. A recent sys-
tematic review of epilepsy guidelines identified considerable variability
in the quality of available guidelines. Although excellent frameworks for
CPG development exist (i.e. AAN, SIGN, NICE) systematic processes
are not uniformly followed internationally and resources to develop
CPGs may be limited in certain settings. An ILAE working group has
been charged with proposing methodology to guide the development of
future epilepsy-specific CPGs.
Method: A comprehensive literature search including grey literature
(1985–2014) was performed to identify CPG development handbooks
and related articles. Guideline handbooks were included if they were: in
English, publicly available, and if CPGs had been developed using the
methodology. A table was developed comparing and contrasting identi-
fied CPG methodologies. The working group0s expert opinion was also
gathered to develop unique CPG methodologies and processes to support
future CPG development for the ILAE.
Results: Five CPG handbooks (North America, Europe, Australia, and
World Health Organization) and additional references were identified
to produce evidence-based and consensus-driven methodology for the
development of epilepsy-specific CPGs. Key components of CPG
development were: Identifying topic and defining scope (including for-
mulating clinical question); establishing working group; reviewing evi-
dence (systematic review and evaluating evidence using GRADE);
formulating recommendations and determining strength of recommen-
dations (using GRADE); peer review; dissemination, implementation,
and auditing; updating and retiring. A practical toolkit and handbook
was developed.
Conclusion: The resulting CPG development toolkit should facilitate
the development of high quality ILAE CPGs for the care of persons with
epilepsy internationally. The resulting CPGs will fill important gaps for
healthcare professionals caring for persons with epilepsy.
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CURRENT STATEOF INTERNATIONAL EPILEPSY
GUIDELINES
K. Sauro*,†, S. Wiebe*, T. Pedley‡, C. Dunkley§, E. Kumlien¶,
S. Moshe**,††, N. Nakasato‡‡, E. Perucca§§, H. Senties¶¶,
S. Thomas***, Y. Wang†††, J. Wilmshurst‡‡‡, N. Jette*,†
*University of Calgary, Clinical Neurosciences, Calgary,
Canada, †University of Calgary, Community Health Sciences,
Calgary, Canada, ‡Columbia University, Neurology, New York,
NY, United States, §Kings Mill Hospital, Pediatrics, Sutton in
Ashfield, United Kingdom, ¶University Hospital, Neurosciences,
Uppsala, Sweden, **Albert Einstein College of Medicine,
Neurology, Bronx, NY, United States, ††Albert Einstein College
of Medicine, Pediatrics, Bronx, NY, United States, ‡‡Tohoku
University School of Medicine, Epileptology, Seiryo-Machi,
Japan, §§University of Pavia, Internal Medicine and
Therapeutics, Pavia, Italy, ¶¶Médica Sur Consultorio,
Neurology, Madero, Mexico, ***Sree Chitra Tirunal Institute for
Medical Sciences and Technology, Department of Neurology,
Trivandrum, India, †††XuanWu Hospital, Neurology, Beijing,
China, ‡‡‡Red Cross War Memorial Children’s Hospital;
University of Cape Town, Paediatrics, Cape Town, South Africa
Purpose: The Epilepsy Guidelines Task Force, composed of 13 interna-
tional members, was commissioned by the International League Against
Epilepsy in 2011. The first aim of the task force was to identify, using
systematic review methodology, existing international epilepsy clinical
care guidelines, to assess the quality of guidelines, and to identify gaps in
topics.
Method: A systematic review of the literature (1985–2014) was per-
formed in six electronic databases
(eg. Medline, Embase) using a broad search strategy developed to
identify published epilepsy guidelines. Six grey literature databases (e.g.
AAN, ILAE) were also searched to minimize publication bias. Two inde-
pendent reviewers screened abstracts, reviewed full text articles and per-
formed the data abstraction. There were no language exclusions. Basic
descriptive statistics were generated.
Results: The search identified 10,925 abstracts, of which 409 articles
were selected for full text review and 63 met our eligibility criteria for a
guideline. Of those included, 54 were English and 9 were in other lan-
guages. Of all guidelines, 29% did not specify the target age groups, 28%
were targeted at adults, and 23% were targeted at children. The included
guidelines were most commonly aimed at guiding clinical practice for
status epilepticus (n = 7), first seizures (n = 6), drug resistant epilepsy
(n = 5), women with epilepsy (n = 4), and febrile seizures (n = 4),
among others. Most of the guidelines were diagnostic (n = 16) or thera-
peutic (n = 35) in nature. The quality of the guidelines on a 1–7 point
scale varied and was moderate overall (median/mean = 5  1.0 (SD)).
Conclusion: In this internationally-led systematic review of epilepsy
clinical care guidelines, significant gaps in topics and issues regarding
quality were identified. The findings provide a valuable resource for
physicians caring for people with epilepsy and will guide the prioritiza-
tion, development and dissemination of future epilepsy-related guide-
lines.
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THERETROSPECTIVE EVALUATIONOFELEVEN
EPILEPTIC PATIENTSWITHADIAGNOSIS OF
TUBEROUS SCLEROSIS COMPLEX
S. Sayin*, N. Bebek†, Ş. Deveci‡, C. Gürses†, B. Baykan†,
A. G€okyigit†
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*Sakarya Yenikent State Hospital, Neurology, Sakarya, Turkey,
†Istanbul University, Istanbul Faculty of Medicine, Department
of Neurology and Clinical Neurophysiology, Neurology,
Istanbul, Turkey, ‡Private Nisa Hospital, Neurology, Istanbul,
Turkey
Aim: Tuberous sclerosis complex (TSC) is an autosomal dominant, neu-
rocutaneous disease, affecting multiple organ systems. Epilepsy is the
most common neurologic manifestation in TSC. The aim of this study is
to evaluate the clinical and laboratory findings of the epileptic patients
with a diagnosis of TSC and to determine the factors which may affect
the prognosis of the disease.
Material and method: Eleven patients with TSC, (7 male and 4 female)
followed up because of epileptic seizures between 1996–2014 at Istanbul
University,Faculty of Medicine, were assessed with their clinical and lab-
oratory datas, retrospectively.
Results: Three of TSC patients were familial and the others were spo-
radic. Neurocognitive impairment was observed in 2 patients and mental
retardation in 3 patients. Seizure onset age ranged between 3,5 months–
51 years. 5 patients had status epilepticus and 1 patient had infantile
spasms. The most common seizure type was focal seizure. 5 patients were
without seizures in the last 2 years and two patients had rare seizures
(once or two times a year). On MRI, except multiple cortical tubers and
subependimal nodules, one patient had giant cell astrocytoma. The most
common cutaneous finding was adenoma sebaseum and was found in 7
patients. Besides cranial and skin findings, eye involvement was detected
in 1 patient and renal involvement in 5 patients. Two of the patients with
renal involvement had the diagnosis of renal cell ca. Interestingly, two
daughters of two index familial patients had also renal cell ca.
Conclusion: In our study, we showed that TSC patients could have a bet-
ter seizure prognosis than expected. These patients need a close follow-
up and care should be taken about possible malignancies, especially,
renal cell ca.
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MISDIAGNOSIS IN JUVENILEMYOCLONIC EPILEPSY
D. Ataklı, B. Tekin Güveli, S. Şenadım, Z. Kurtpınar, G. Gül,
A. Ceyhan
Bakirkoy Research and Training Hospital for Psychiatry,
Neurology, Neurosurgery, Department of Neurology, Istanbul,
Turkey
Purpose: Juvenile myoclonic epilepsy (JME) is a generalized idiopathic
epileptic syndrome a prevalence of 5–l 1% amongst other forms of epi-
lepsy. Despite the certain diagnostic criteria, JME is still misdiagnosed
by physicians and even experienced neurologists 1–4. We investigated
our cases retrospectively to assess the pitfalls in JME diagnosis.
Method: We included 200 patients with JME examined at the epilepsy
outpatient clinic. There were 94 (59 female, 35 male) patients who were
misdiagnosed. All patients had well-documented diagnoses of JME,
based on both clinical and EEG findings. Patients were evaluated demo-
graphic and clinical data; type of seizures and age at onset, precipitating
factors, family history of epilepsy, neurological and mental examination,
initial diagnosis, age at correct diagnosis, duration and causes of delay in
diagnosis, EEG findings, neuroimaging findings, initial treatment.
Results: The mean age and the mean duration of epilepsy of 94 patients
were 26.7  8.46 (12–55) and 10.7  7.28 years (1–35) respectively.
The definite diagnosis was delayed by a mean of 3.0  4 years. The
most common seizure-precipitating factors were sleep deprivation, pho-
tic stimulation, stress, fatigue and menstruation. The typical and pathog-
nomonic epileptic discharges were found in 42.6% of cases. Fifth-teen
patients (16%) had focal EEG abnormality. The most common reasons of
misdiagnosis are:
(1) most of the patients did not complain of myoclonic jerks and these
were revealed only by questioning.
(2) In some cases physicians seemed to be unaware of the syndrome.
(3) Another factor in misdiagnosis may be presence of atypical EEG
findings.
Conclusion: Whereas in our study from 15 years ago the definite diag-
nosis was delayed by 5.9 years, in this study it is determined as 3 years.
This indicates that there is more knowledge and experience about JME.
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ADESCRIPTIVE ANALYSIS OF VISUAL SEIZURES
SYMPTOMATOLOGY IN PATIENTSWITHOCCIPITAL
LOBEEPILEPSY
I. Stavropoulos, M. Nikolopoulou, S. Giannakodimos
General Hospital of Athens “G. Gennimatas”, Athens, Greece
Purpose: To analyse the characteristics of visual seizures (VS) in occipi-
tal lobe epilepsy (OLE) patients, identify the predominant visual phe-
nomena, and differentiate elementary visual hallucinations (E-VH) from
complex visual hallucinations (C-VH).
Method: We retrospectively studied the ictal characteristics (derived
from patients’ and witnesses’ descriptions) of VS in patients with OLE
followed in our epilepsy clinic since 1996. We specifically recorded the
characteristics of visual hallucinations (VH) such as type (E-VH or C-
VH), morphology, coloring, location in the visual field, flashing or move-
ment, and background characteristics. Other ictal symptoms (duration,
progression, symptoms other than visual) and postictal characteristics
have also being explored. SPSS 22 was used for statistical analysis.
Results: There were 76 (36M; 40F) patients with OLE and VS. Their
mean age (range) was 23.0 (11–83) years. Forty-nine patients described
E-VH with stars, spheres or lights. Almost half of them (46.9%) were
multicolored, mainly of white (16.3%), red (6.1%), silver (6.1%) and
blue (6.1%) color. The majority (65.3%) were located unilaterally. The
remaining 27 patients reported either well-described C-VH (vague
shapes or well-organized scenes) or ill-defined VH; in those, when pre-
dominant colors reported, these were most often black or blue. C-VH
were multicolored (68%) and unilateral (63%). Comparatively, flashing
of the illusion was more frequent in E-VH (38.8%) than C-VH (18.5%)
and longer (>2 min) duration in C-VH (22.2%) than E-VH (14.3%). In
overall, VH movement was more frequently horizontal (21.1%); patients
could see through the VH in 36.8%. VS frequently progressed into a gen-
eralized tonic-clonic seizure (GTCS) (38.2%); importantly, 59.2% of
patients could exhibit GTCS without onset of perceptible visual symp-
toms.
Conclusion: Our study showed that although VH in OLE are not always
easily classified into E-VH or C-VH, there are some specific VH charac-
teristics (morphology, type of color, flashing of the illusion and duration)
that could differentiate those groups.
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PEER SUPPORT FOR PERSONSWITHRARE
EPILEPSYANDTHEIR FAMILIES
V. Tarkiainen, P. H€oltt€a, L. Mets€ahonkala
Finnish Epilepsy Association, Helsinki, Finland
Introduction: A disease/disorder is defined rare when it affects less than
5 persons in every 10 000 people. Infantile spasm syndrome, Dravet syn-
drome, Lennox-Gastaut syndrome and Unverricht-Lundborg disease but
also several other epilepsy syndromes are rare, difficult to treat and some-
times life threatening. Rare epilepsies affect not only the patient, but the
entire family and community. It has been recommended by the EU that
each member state should establish a national program for the develop-
ment of care, support and research of rare diseases. There is need for
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comprehensive care, counselling and peer support. Special information
about rare epilepsies, social security, adequate services and disability
benefits are also needed. We present some solutions in organizing peer
support in a country with special challenges: long distances and a small
population.
Case presentation: Finnish Epilepsy Association (FEA) has organized
restorative weekends for people with rare epilepsies (PWrE) and their
families. Furthermore FEA has produced information material about rare
epilepsies. When one meets another one with the same rare disease, it
helps a lot in finding solutions to cope. Even if diagnosis of a rare epi-
lepsy is the same, there may be differences in the treatment options, prog-
nosis and needed support, yet it is important to share experiences.
Internet offers a great opportunity to share experiences even 24/7.
Online peer support groups have emerged spontaneously and with sup-
port by FEA. Previous studies have highlighted the significance of shar-
ing personal experiences about the disease and its effects. Online
discussion groups support empowering.
Conclusion: : One of the current strategic goals of FEA is to support
PWrE and their families and the means are presented in this poster. In
addition, the role of advocacy to improve public services for the PWrE
will be described. Both face-to-face and online peer support have their
role to support each other.
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DEMOGRAPHICDATAOF PATIENTSWHOHAVE
PSYCHOGENIC NON-EPILEPTIC SEIZURES (PNES)
AND ITS RELATIONWITH SEMIOLOGICAL
CHARACTERISTICSOF PNES
I. Tatlidil, H.S. Ture, N. Gurgor Kanat, S. Arici, V. Ucgun,
G. Akhan
Izmir Katip Celebi University Ataturk Research and Training
Hospital, Izmir, Turkey
Purpose: PNES is a type of somatoform disorder consisting of paroxys-
mal episodes resembling epileptic seizures (ES) without concomitant
Electroencephalographic activity. Distinguishing PNES fromES is impor-
tant to avoid overdiagnosis of Epilepsy as well as overtreatment of epilep-
tic patients. Backgrounds of patients such as gender, having family history
of epilepsy, having epileptic background might have effects on semiologi-
cal characteristics of PNES. The aim of the study is to analyze demo-
graphic data of PNES patients in terms of semiological characteristics.
Method: 114 patients (male:female = 44:70) aged 13–67 years, who
were diagnosed as PNES with video monitoring EEG between 2010 and
2014, were included in this retrospective study. Patients were divided
into groups according to their background data; gender, family history of
ES, epilepsy history. Patients were grouped according to common semio-
logical characteristics of non-epileptic seizure which were defined by
epileptologist during video monitoring EEG. Chi-square test was used
statistically.
Results: Age histogram showed two peaks at age 20–23 and 40–43,
which was more prominent in female gender. Age 20–23 was peak age
for male group. 1–5 min was the most frequent seizure duration. There
was no significant relationship between defined semiological characteris-
tics and gender in exception of high concomitance of opisthotonic pos-
ture in male patients (p = 0,017). There was no significant relation with
defined semiological characteristics of seizures in patient with or without
epileptic background and having or not having family history of epilepsy.
Conclusion: Our results did not show significant relationship between
common semiological seizure characteristics, gender, family history of
epilepsy and having epileptic background. Male patient percentage was
high compared to other studies in literature. High frequency of PNES
patients at age 40–43 was also remarkable. Sociocultural characteristics
of the population could cause the differences of demographic background
from the literature.
Others 7
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HAND PILL ROLLINGTREMORANDTEMPORAL
LOBE SEIZURES
C.A. Tassinari*, F. Pinardi†, E. Gardella‡, G. Cantalupo§
*University of Parma, Bologna, Italy, †University of Bologna,
Bologna, Italy, ‡University of Southern Denmark, Dianalund,
Denmark, §University of Verona, Verona, Italy
Purpose: To validate and define the Hand PILL-ROLLING tremor
(HPRT) as a sign occurring in temporal lobe seizures.
Method: From a cohort of patients undergoing video-EEG intensive
monitoring, we selected 45 out of 70 seizures in 15 patients with a video
recording such as to allow a suitable kinematic analysis of a rhythmic
movement of the thumb against the index and medium fingers defined as
HPRT.
Results: HPRT has frequency around 3.5 sec (range 2–4 sec), onset
occurs from 9 to 185 sec after electroclinical seizure onset; duration ran-
ged from 2 to 35 sec with possible interruption and recurrences; topogra-
phy unilateral or bilateral (simultaneous or not).
Conclusion: HPRT is observed as a rare but up to now reliable-albeit
ancillary sign of temporal lobe seizures. Since HPRT can be bilateral, its
value as a lateralizing sign should be discussed in the light of the presence
of different modifiers. The most relevant is the hand tonic contraction
contralateral hemispheric seizures side susceptible to block the HPRT
and modifying either onset or the end, rendering unilateral a putative
bilateral tremor. HPRT related to an epileptic event is a “new entry” in
the multifactorial list of “tremors”.
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SEIZURES-RELATED FELINE BEHAVIORS INMAN:
HISSING, CLAWING, BITING
C.A. Tassinari*, C. Amarales†, S. Pellegrin‡, G. Cantalupo‡,
S. Meletti§
*University of Parma, Bologna, Italy, †Hospital Clinico
Magallanes, Punta Arenas, Chile, ‡University of Verona,
Verona, Italy, §University of Modena and Reggio Emilia,
Modena, Italy
Purpose: Description of an unusual behavior occurring during seizures.
Method: Retrospective retrieval and analysis of EEG video recorded sei-
zures with hissing, clawing and biting.
Results: Hissing can occur as a single or repetitive behavior followed or
not by clawing and biting. Clawing aimed unusual to surrounding person,
with or without effective contact; biting is the relatively most frequent
behavior which can occur either isolated (Tassinari et al. 2005) or associ-
ated with previous hissing and clawing. It has been associated with grab-
bing, with or without successful actual biting.
Conclusion: Feline Behavior (FB), commonly occur in relation to speri-
mentally induced seizures involving the “temporo-limbic seizures”. FB,
defined as a sequence of the triadic hissing-clawing-biting behavioral
sequence is rare occurrence in man. The FB is likely modulated:
a) by the functional activity in the relevant limbic-hypothalamic,
mammillary bodies circuiting;
b) by the interference with either the effective real surrounding and
how this surrounding “professional space” is internally “felt” by the
patient;
c) the evolution in time from the initial events and its effect on various
functional structure responsible for the “execution” of the behaviors.
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FB is consequently a “vanishing” and modulated behaviors, in inten-
sity and duration, requiring careful analysis for its identification. FB is
discussed in an ethological prospective as “a release” of ancient behav-
iors (Tassinari et al. 2005, 2009).
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FROMGESTURE TO SPEECH: ONRECOVERY FROM
SEIZURE INDUCEDAPHASIA, THEMIRROR
NEURONS SYSTEMRE-ENACTS THEMOTOR
SEQUENCESOFLANGUAGEEVOLUTION?
C.A. Tassinari*, F. Pinardi†, G. Rizzolatti*, G. Cantalupo‡
*University of Parma, Parma, Italy, †University of Bologna,
Bologna, Italy, ‡University of Verona, Verona, Italy
Purpose: To describe the pattern of language recovery from aphasic sei-
zures by analysis of video-EEG recordings.
Methods: We reviewed our video-EEG database searching for aphasic
seizures with an adequate testing of language function. We described the
semiological features during the recovery phase.
Results: In most patients we identified a common pattern characterized
by three distinct phases.
(1) an early phase in which oroalimentary “automatisms” are present
and the hands go repeatedly to the head and/or face, then to the mouth/
lips/tongue;
(2) afterward a series of gestures that can be interpreted as morphemes
or sentences (communicative gestures) appear (e.g. the palm of the hand
with open finger is flashed toward the requesting examiner signaling
“stop asking, I understand. . .wait”; or the hands correctly pantomime the
use of the tools that mount is still unable to name);
(3) finally the first phonemes and words are uttered and progressively
speech is back.
Conclusion: The “mirror neurons system” (MNS), by matching observa-
tion and execution in the same motor format and in the same neuronal
network, is considered to be the most important substrate for understand-
ing the others without language mediation. For this reason MNS has been
proposed as the initial communication system, that - from protosign to
protospeech - evolved into speech (Rizzolatti and Airbib, 1998). Accord-
ingly, (Gentilucci and Corballis, 2006) “an evolutionary scenario is sug-
gested in which mouth movements primarily used in eating gradually
assume dominance over hand movements and were eventually accompa-
nied by voicing and movements of the tongue and vocal trait: thus speech
was born”. We suggest that the pattern of language recovery after an
aphasic seizure recapitulate in fewminutes the samemillenary evolution-
ary process.
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HYPERBARICOXYGENTHERAPY INDUCED
POSTERIORREVERSIBLE ENCEPHALOPATHY
SYNDROMEACCOMPANIED BYCHARLES BONNET’S
SYNDROME
A. Topkan, E. Eruyar, A.P. Titiz, Y. Karadag, S. Bilen,
N. Oztekin, F. Ak
Ankara Numune Training and Research Hospital, Neurology,
Ankara, Turkey
Introduction: Posterior reversible encephalopathy syndrome(PRES) is
a rare situation whose diagnosis is based on magnetic resonance images
and clinical symptoms. It can be confused with acute cerebral infarction.
It is characterised by visual disturbances, alterations in conciousness,
headache, nausea and vomitting.
Hypertension, chemotherapeutic agents, preeclampsia are the factors
included in its aetiology. However, to our knowledge no case report of
PRES induced by hyperbaric oxygen therapy has been reported in the lit-
erature.
Case: Fifty-one year old male was admitted to emergency room with the
complaints of nausea, vertigo and temporary unconciousness followed
by bilateral acute blindness. He had the history of being under hyperbaric
oxygen therapy for his chronic wound currently.
Diffusion restriction on cranial MR diffusion images located at bilat-
eral occipitotemporal gyrus, right occipitotemporal lobe’s white matter
and at thalamus was observed.
Two days following his admission to neurology clinic he reported see-
ing abnormal and frightening images which were smaller or bigger than
normal size. He was aware of their unreality. In the fourth day, an episode
of generalized tonic- clonic seizure beginning from the left side was
observed. In following days the seizures continued and antiepileptic
treatment was initiated. By time his epileptic seizures could be managed.
On control cranial MRI in forty fifth day diffusion restriction was found
as resolved and his blindness was almost improved.
Conclusion: Our patient did not have the known risk factors such as
hypertension, chemotherapeutic agent exposure,nephrotic syndrome etc.
for to develop PRES. He was under hyperbaric oxygen therapy. For this
reason we concluded that this therapy could induce PRES and, Charles
Bonnet’s syndrome might accompany to this radiological and clinical
picture.
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THECOMPARISONOFMETABOLIC SIDE EFFECTS
OF TOPIRAMATEANDLEVETIRACETAM IN
PATIENTS UNDERGOINGCRANIOTOMYWITH
PROPOFOL INFUSION
H. Türe*, S. Bilgen*,Ö. Keskin*, N. Uztüre*,Ö. K€oner*,
B. Aktekin†, C. Aykut-Bing€ol†, U. Türe‡
*Yeditepe University School of Medicine, Department of
Anaesthesiology and Reanimation, Istanbul, Turkey, †Yeditepe
University School of Medicine, Department of Neurology,
Istanbul, Turkey, ‡Yeditepe University School of Medicine,
Department of Neurosurgery, Istanbul, Turkey
Background: Antiepileptic agents are commonly used in the perioper-
ative period in neurosurgical patients. Although metabolic side effects
of topiramate are well known, there is no study about the metabolic
side effects of new generation antiepileptic levetiracetam when it is
used for anti-epileptic prophylaxis in patients undergoing craniotomy
with total intravenous anesthesia. Propofol is an short acting agent
oftenly used for total intravenous anesthesia, and propofol infusion is
associated with perioperative metabolic acidosis. Anti-epileptic drugs
with propofol infusion could be have an additional effect. To our
knowledge there were no study to compare the aforementioned two
drugs.
This study was conducted to compare the metabolic side effects of
topiramate and levetiracetam in patients undergoing craniotomy with
propofol infusion.
Materials and methods: After obtaining the written informed consent
of the local ethics committee and the patients decision who underwent
craniotomy, 80 patients of these were using topiramate with a mini-
mum of 1 month (n = 40) (2 9 100) or levetiracetam (n = 40)
(2 9 500) was included in the study. The blood gases, electrolytes,
liver and kidney function tests, coagulation tests and lipid profiles
were conducted in all patients preoperatively. In patients with meta-
bolic acidosis, topiramate therapy was discontinued, and the anti-epi-
leptic therapy was changed. Before induction of anesthesia and during
anesthesia (1, 2, 4 and 6 hours) blood gases and liver, kidney function
tests, lipid profile and coagulation tests were tested at preoperative and
postoperative period. During the surgery all hemodynamic parameters
were recorded at 10 min intervals. Results in the two groups were
compared statistically.
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Results: The demographic characteristics were similar in both groups
(p > 0.05). In the preoperative period, metabolic acidosis was signifi-
cantly higher in topiramate group than levetiracetam group (p < 0.001).
Metabolic acidosis was recorded following propofol and remifentanil
infusion in 24% of patients In topiramate group, and 11% of these
patients required treatment. In the levetiracetam group, there were no
metabolic changes following propofol and remifentanil infusion. In both
groups, there were no differences in terms of lipid profiles and renal func-
tions during the perioperative period (p > 0.05).
Conclusion: It was concluded that the patients undergoing total intra-
venous anesthesia with propofol and remifentanil, antiepileptic prophy-
laxis with levetiracetam should be preferred to topiramate due to less
metabolic side effects.
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CLINICAL, NEURORADIOLOGICAL ANDEEG
FINDINGSOF PATIENTSWITHEPILEPSYAND
MALFORMATIONOFCORTICALDEVELOPMENT
D. Bayram, K. Tutkavul, Y. Cetinkaya, T. Bayram, H. Tireli
Haydarpasa Numune Education and Research Hospital,
Neurology, Istanbul, Turkey
Purpose: The purpose of the study was reviewing clinical, neuroradio-
logical and EEG findings of patients with Epilepsy and Malformation of
Cortical Development (MCD).
Method: Retrospective analysis of medical records of patients of Hay-
darpasa Numune Education And Research Hospital second Epilepsy Out-
patient Clinic.
Results: 2027 patients were examined between July 1995 and January
2015. 17 out of 1395 patients who has been followed, had MCD. 10 of
the patients were male and 7 female. Time of seizure onset was between
30 months and 39 years (mean 12 years).11 patients had focal seizures,
10 had generalized tonic clonic seizures, 1 had absence and 1 had tonic-
atonic seizures. Syndromic classification revealed 12 patients with symp-
tomatic focal epilepsy, 3 with symptomatic generalized epilepsy, 1 with
Dyke-Davidoff syndrome and 1 with juvenile myoclonic epilepsy.Mental
retardation was present in 5, Autism in 2 and Tubero sclerosis in1 of
them.Family history of Epilepsy was present in 8, consanguinity in 5,
head trauma in 2 and difficulty during delivery in 1 patient.Brain Imaging
revealed 7 patients with cortical dysplasia, 4 with heterotopia, 2 with
subependimal heterotopia, 2 with schiezencephaly, 2 with lissencephaly,
1 with agyria, 1 with pachigyria, 1 with macrogyria, and 1 with polymicr-
ogyria.EEG revealed focal epileptiform discharges in 4 patients, high fre-
quency activity in 2, generalized epileptiform discharge in 1 and diffuse
disorganized background activity in 1. The EEGwas normal in 7 patients.
3 of the patients were on monotherapy but 14 of them were on polyther-
apy.
Conclusion: The time of seizure onset was in the second decade in
majority of our patients, against the known onset time in the early child-
hood. EEG revealed high frequency activity in some of our patients and
the polytherapy was necessary in many patients as expected.
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VALIDITYANDRELIABILITYOFTURKISHVERSION
OFTHEEPILEPSY SELFMANAGEMENT SCALE
K. Yeni*, Z. Tulek*, N. Bebek†
*Istanbul University, Florence Nightingale School of Nursing,
Istanbul, Turkey, †Istanbul University Istanbul Faculty of
Medicine, Department of Neurology, Istanbul, Turkey
Purpose: This research has been conducted to determine the validity and
reliability of the Turkish version of the Epilepsy Self Managemet Scale
developed by Dilorio et al. to evaluate self management behaviours of
patients with epilepsy.
Method: This cross-sectional and methodological study has been carried
out among patients attending to an epilepsy outpatient clinic of a univer-
sity hospital between February and October 2014. The sample consisted
of 194 patients with age above 18, able to communicate and having diag-
nosis of definite epilepsy. Patients seizure-free for two years were
excluded from the group. For linguistic validation, an expert panel of
nine academics was formed, and the Turkish form was finalized accord-
ing to their recommendations. The thirty-eight item likert-type scale was
applied to a group of ten persons, following language translation and con-
tent validation processes, and was implemented following necessary
changes. Exploratory and Confirmatory Factor Analysis was performed
for construct validity.
Results: : Twenty items that factor loadings of less than 0.30 were
removed from the scale. It was determined that the eighteen-item scale
consisted of five factors. Item-total score correlation coefficients of the
scale have been determined to be in range of 0.043 and 0.530, and corre-
lation coefficients of sub-scale items and sub-scale total scores to be in
range of 0.335 and 0.914. For internal consistency analysis, Cronbach
alpha reliability coefficient was determined to be 0.607 for the whole
scale and between 0.573 and 0.677 for the sub-scales. The test was
repeated to evaluate the invariance of the scale and its sub-scale with
respect to time and no difference was determined between two imple-
mentations (p > 0.05).
Conclusion: It was determined that Turkish version of the “Epilepsy Self
Management Scale” needs further refinement to be used in studies.
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CLINICALANDELECTROPHYSIOLOGCAL
FEATURES IN EPILEPTIC PATIENTSWITH
PHENILKETONURIA
S. Yildiz Celik, N. Bebek, R.C. Gurses, B. Baykan, A.Z. Gokyigit
Istanbul University Istanbul Faculty of Medicine, Neurology,
Istanbul, Turkey
Purpose: Phenylketonuria (PKU) is the most common form of amino
acid metabolism disorders with autosomal recessive inheritance. During
the early periods of life, brain damage can be prevented by early diagno-
sis and by a phenylalanine restricted diet. Untreated patients showmental
retardation and other cognitive dysfunctions, motor disability and epi-
lepsy. We aimed to present 10 adult epileptic patients with PKU, three of
them having reflex-induced seizures.
Method: 10 adult epileptic patients with PKU were evaluated
retrospectively. The patients’ ages at the onset of syptoms and seizures,
neurological examination findings, neuroimaging findings, electroen-
cephalography and reflex features were evaluated.
Results: The diagnosis of PKU was made between 3.5 months and
12 years. Of those 4 patients had moderate, 5 patients had severe mental-
motor retardation (one patient was bedridden). The intelligence level of 1
patient was at the border. 4 patients’ parents were cousin. All patients had
experienced the first seizure under the age of 15. Focal or generalized sei-
zures were observed. 3 patients had experienced febrile convulsion, 2
patients had myoclonus. 2 patients had developed status epilepticus.
There was slow background activity for all patients (except one). 7
patients showed up generalized epileptic discharges. Of those 2 had
asymmetric generalized discharges whereas one patient experienced gen-
eralized discharges during the hyperventilation. Magnetic resonance
imaging (MRI) revealed white matter lesions in 5 patients. One patient
had hippocampal sclerosis, one patient had hypointensities in basal gan-
glia and corpus callosum. 3 patients had reflex features without evidence
of EEG findings.
Conclusion: To the best of our knowledge, there hasn’t been sufficent
reports regarding clinical and electrophysiological features of adult PKU
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patients. In this study we showed that reflex feature can be observed in
this metabolic disease. Furthermore, focal epileptiform anomalies and
asymmetries can also assosisate in electrophysiological assessment.
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DISCOURSECOMPREHENSIONANDPRODUCTION IN
RUSSIAN SPEAKERSWITHEPILEPSY
A. Yurchenko*, O. Dragoy*, D. Kopachev†, A. Golovteev†,‡
*National Research University Higher School of Economics,
Moscow, Russian Federation, †Burdenko Neurosurgical
Institute, Moscow, Russian Federation, ‡Kazaryan Clinic of
Epileptology and Neurology, Moscow, Russian Federation
Purpose: The goal of our project is to analyze language comprehension
and production in Russian speakers with epilepsy using the Russian
Aphasia Test. In the report we will focus on discourse comprehension
(DC) and production (DP) results.
Method: During the DC subtest patients had to listen a story and answer
yes/no questions relating to information in the story. In the DP subtest
patients were asked to tell two stories based on two presented pictures.
The data of eight patients were analyzed.
Results: Preliminary results show that, firstly, language competence in
patients with epilepsy depends on age of seizure onset and seizure sever-
ity. For example, a patient with late seizure onset and right temporal lobe
epilepsy (TLE) showed high scores in all the subtests; while a patient
with early seizure onset and right parietal lobe epilepsy (PLE) performed
worse on all the tasks. Secondly, location of the epileptic focus is crucial
for performance on language tasks. Discourse of the patient with right
PLE was characterized by decreased syntactic complexity and syntactic
errors, impairment of discourse structure at macro-level. A patient with
right frontal lobe epilepsy (FLE) made errors during DC task and pro-
vided excessive information during DP. A patient with right TLE also
had problems with DC and failed to create logically structured and coher-
ent discourse. Similarly, two out of three patients with left TLE produced
inappropriately structured discourses with syntactically simple sentences
and deficit in cohesion. No such characteristics were observed for a
patient with left FLE.
Conclusion: Language competence in patients with focal epilepsy is
influenced by both seizure history and location of the seizure focus.
According to our preliminary results, language comprehension and pro-
duction at discourse level is often impaired in patients with right hemi-
sphere epilepsy and left TLE and relatively intact in patients with left
FLE.
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ANTIOXIDATIVE ENZYMEPOLYMORPHISMS AND
THERISK FOREPILEPSYAFTER PERINATAL
HYPOXIC-ISCHAEMIC BRAIN INJURY
Z. Rener-Primec*,†, K. Esih*,†, K. Goricar‡, V. Dolzan‡
*Children`s Hospital, University Medical Centre Ljubljana,
Department of Child, Adolescent and Developmental Neurology,
Ljubljana, Slovenia, †University of Ljubljana, Medical Faculty,
Ljubljana, Slovenia, ‡University of Ljubljana, Medical Faculty,
Institute for Biochemistry, Ljubljana, Slovenia
Introduction: Hypoxic-ischemic encephalopathy (HIE), caused by peri-
natal oxygen deprivation to the brain, represents a major cause of neona-
tal seizures. 20–30% of these infants develop epilepsy. Important
etiopathogenetic mechanism in brain tissue damage is associated with
reactive oxidative species (ROS), which may be important also in epilep-
togenesis.
Purpose: To investigate the impact of decreased capacity for defence
against reactive oxidative species (ROS), we analysed selected functional
polymorphisms of genes for antioxidative enzymes - GPX1, MnSOD and
CAT, in patients with epilepsy after perinatal HIE.
Methods: 230 patients with epilepsy and/or hypoxic ischemic
encephalopathy (HIE) and 95 healthy controls were included. Clinical
data were collected frommedical records retrospectively. Real-time PCR
based methods were used to genotype GPx1 rs1050450, SOD2 rs4880 in
CAT rs1001179. Logistic regression was used for statistical analysis.
Results: Polymorphisms for GPx1 rs1050450, SOD2 rs4880 in CAT
rs1001179 in 204 epilepsy patients did not correlate with epilepsy in
comparison to healthy controls. However, among 64 patients with epi-
lepsy after HIE, more patients had at least one polymorphic GPX
rs105045 allele in comparison to healthy controls, but the difference
was not statistically significant (p = 0,127). CAT rs1001179 distribu-
tion among patients with epilepsy and HIE was not significantly differ-
ent than in controls (p = 0,337); SOD2 rs4880 distribution was similar
to controls. Although pharmacoresistant epilepsy was significantly
more frequent among children with epilepsy after HIE (40/62 pts) in
comparison to other etiologies (67/150, p = 0,009), the number of
patients was not sufficient to demonstrate significant difference in
polymorphisms.
Conclusions: Polymorphisms of genes for antioxidative enzymes GPX1
rs1050450, SOD2 rs4880 and CAT rs1001179, associated with decreased
capacity of defence against ROS, do not influence the overall epilepsy
risk, but may have an impact to development of pharmacoresistant epi-
lepsy. Larger numbers of patients are needed for further studies.
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COMPARISONOF POLISH PAEDIATRIC PATIENTS
WITHANDWITHOUTDIAGNOSED POST-STROKE
EPILEPSY
B. Sarecka-Hujar*, I. Kopyta†
*Medical University of Silesia in Katowice, School of Pharmacy
with the Division of Laboratory Medicine in Sosnowiec,
Department of Drug Form Technology, Sosnowiec, Poland,
†Medical University of Silesia in Katowice, School of Medicine
in Katowice, Department of Paediatrics and Developmental Age
Neurology, Katowice, Poland
Purpose: Arterial ischaemic stroke (AIS) occurs in approximately 3
per 100, 000 children per year. Several neurological complications
(e.g. motor impairment, speech impairment, seizures and intellectual
delay) are the consequences of this disease. The prevalence of post-
stroke epilepsy in quite high and has great impact on daily activity of
little patients.
The aim of the present study was to compare Polish paediatric patients
suffering from AIS and post-stroke epilepsy with post-stroke epilepsy-
free patients.
Method: The study population consisted of 68 children (white Polish
Caucasians): 10 patients with post-stroke epilepsy (mean age
3.50  2.55; 4 females and 6 males) and 58 children suffering with AIS
but epilepsy-free (mean age 8.96  5.42; 23 females and 35 males). Data
were analyzed using STATISTICA 10.1 andMedCalc softwares.
Results: Focal cerebral arteriopathy (FCA) was observed in 90% of
patients with post-stroke epilepsy and in 51% epilepsy-free patients
(Relative risk 1.74, 95%CI 1.26–2.40, p < 0.001). In seven of the par-
ticipants post-stroke epilepsy evolved from late remote seizures (occur-
ring between 7 days and 2 years after AIS onset) and three of the
patients had early post-stroke seizures (occurring up to 7 days after
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AIS onset). In 30% of post-stroke cases and in 14% of epilepsy-free
patients heart diseases were observed (Relative risk 2.74, 95%CI 0.69–
6.83, p = 0.183).
Conclusion: FCA is risk factor for post-stroke epilepsy in the Polish
paediatric patients.
Funded: 3PO5E 135 23, KNW-1-062/P/1/0 and KNW-1-065/09.
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NON-LESIONAL PARTIAL EPILEPSYWITH
VESTIBULARDISTURBANCES IN CHILDHOOD
A. Schteinschnaider, G. Vazquez, J. Boccoli, L. Bongiorni,
C. Binetti, M. Gomez, D. Yacovino
FLENI, Neuropediatric Department, Buenos Aires, Argentina
Purpose: We describe a series of children who share electrical and clini-
cal characteristics of focal epilepsy manifesting as prominent vestibular
disturbances, suggesting a temporal-parietal ictal origin.
Method: We retrospectively reviewed a database of patients admitted
from 2012 to 2014 following these criteria: presence of predominant or
exclusive paroxysmal vestibular symptoms, age range between 5–
18 years and normal magnetic resonance imaging (MRI) and magnetic
resonance angiography (MRA) on 3T equipment. Eight patients were
finally selected (4 females and 4 males).
Results: The symptoms began abruptly as rotational vertigo which lasted
several seconds. The complex vestibular symptoms observed were: feel-
ing of floating, turning inside head and walls caving in. The accompany-
ing symptoms were nausea or vomiting, deja-vu and non-pulsatile
tinnitus. The predominant feature on interictal scalp EEGwas abnormali-
ties over the temporal-parietal areas. There was an average 3 month per-
iod until final diagnosis was established. All patients responded well to
antiepileptic medication.
Conclusions: The patients described show similar electroclinical fea-
tures, normal neuroimaging and remain seizure free after treatment. It
should be considered as a form of epilepsy within the group of non-
lesional focal epilepsies of childhood.
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VAGUSNERVE STIMULATION FOR PHARMACO-
RESISTANT EPILEPSY: A LONGTERMSTUDYOF 59
PATIENTS
A. Serdaroglu*, E. Arhan*, G. Kurt†, A. Erdem‡,
T. Hirfanoglu§, İ. Capraz¶, E. Bilir¶
*Gazi University, Pediatric Neurology, Video-EEG
Monitorization Unit, Ankara, Turkey, †Gazi University,
Department of Neurosurgery, Ankara, Turkey, ‡Ankara
University Faculty of Medicine, Department of Neurosurgery,
Ankara, Turkey, §Gazi University, Pediatric Neurology, Video
EEGMonitorization Unit, Ankara, Turkey, ¶Gazi University,
Department of Neurology, Ankara, Turkey
Purpose: Vagus nerve stimulation (VNS) is thought to have a cumula-
tive effect intime on seizure frequency reduction. In this studywe retro-
spectively reviewed our experience with VNS in pediatric patients with
pharmacoresistant epilepsy and described the long-term outcome of the
patients who have been followed at least 5 years after VNS implantation.
Method: Fifty-nine consecutive children, 26 females and 33 males, with
pharmacoresistant epilepsy under the age of 18 years, who were
implanted with a vagus nerve stimulator and had at least five years of
postimplantation follow-up, were included in the study. A vagus nerve
stimulator was implanted in the period January 2000- March 2010. Fol-
low-up ranges from 5 to 15 years (mean 7.1 years). Efficacy was mea-
sured as the percentage change in seizure rate during 1 year and then
after each year follow-up of VNS compared to 3 months baseline before
implantation.
Results: Median age at implantation was 11,5 (range 4–17) and median
duration of epilepsy 8.0 (2–15) years. At 5 years postimplantation,
thirty-five (63.6%) of the 59 patients had a greater than 50% reduction in
seizure frequency. Eighteen patients (30.5%) reported a lesser reduction
(<50%), 7 had less than 25% reduction. Two patients had no apparent
reduction in seizure frequecy. Eleven patients became seizure free within
24–120 months. The results, once obtained, were maintained steadily
over time without any loss of efficacy during the follow-up. Three stimu-
lators were turned off within 1–2 years after implantation, one because
of the absence of clinical benefit; two because of recurrent local infec-
tion. Three patients received a new pulse generator when the battery was
depleted.
Conclusion: Our results demonstrate that adjunctive VNS Therapy in
children with pharmaco-resistant epilepsy is an effective long-term ther-
apy to control a patients’ seizure frequency.
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EVALUATIONOF PATIENTSWITHTUBEROUS
SCLEROSIS COMPLEXADMITTEDTO PEDIATRIC
VIDEO-EEGMONITOINGUNIT
E. Serdaroglu*, B. Konuskan*, B. Bilginer†, K.K. Oguz‡,
B. Anlar*, M. Topcu*, G. Turanli*, D. Yalnizoglu*
*Hacettepe University, Medical Faculty, Pediatric Neurology,
Ankara, Turkey, †Hacettepe University, Medical Faculty,
Neurosurgery, Ankara, Turkey, ‡Hacettepe University, Medical
Faculty, Radiology, Ankara, Turkey
Purpose: Epilepsy prevalence in Tuberous sclerosis complex (TSC) is
very high and seizures are usually intractable. We studied children with
TSC admitted to the video-EEGmonitoring unit (VEMU).
Method: The study included 30 TSC patients admitted to the Hacettepe
University VEMU between 2006–2014.
Results: 49 episodes of VEMU stay of 30 patients were analysed.
Male/female ratio was 15/15. Three patients had a cardiac rhabdomy-
oma, 4 had renal involvement, 2 had subependymal giant cell astrocy-
toma (SEGA), 20 had hypopigmentated macules, 2 had hemiparesis,
and 20 had developmental delay. Main psychiatric comorbidities were
hyperactivity and autism. With respect to epilepsy; age at seizure onset
was between 1st day and 2.5 years, age at the time of admission was
between 15 months and 14.5 years. 15 patients had epilepsy before
TSC diagnosis, 2 developed seizures after the diagnosis, 13 had sei-
zures at the time of diagnosis. 26 patients had daily seizures; 12
patients had a history of infantile spasms, 3 had a history of status
epilepticus. 12 patients had focal seizures, 7 had generalized seizures, 8
had mixed semiology, and 3 had epileptic spasms. EEG was normal for
one patient with focal seizures. Interictal recordings showed slow and
irregular background for age. Interictal findings were focal for 20
patients, multifocal for 5, focal + secondary generalization for 4
patients. Ictal EEG recordings were lateralizing in 3, both lateralizing
and localizing in 16; not lateralizing or localizing in 10. Two patients
underwent corpus callosotomy, 3 resection of tuber, 3 lobectomies (2
temporal, 1 frontal), 1 SEGA excision, and 2 patients had vagal nerve
stimulation therapy (one of them following two resective surgeries).
After invasive treatments 6 patients became seizure free, 3 had
improved conditions, 1 had ongoing seizures.
Conclusion: Epilepsy in TSC is a challenging burden affecting quality
of life. Epilepsy surgery is a promising treatment for selected patients.
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PATHOLOGICAL LAUGHINGANDCRYINGAS
DIFFERENTIAL DIAGNOSIS OFGELASTIC SEIZURES
V.C. Quixabeira, C.P. Bento, L. Sauma, K. Teixeira,
K. Schmutzler, M.M. Guerreiro, M.A. Montenegro
State University of Campinas, Campinas, Brazil
Purpose: Pathological laughing and crying (PLC) is characterized by
involuntary and uncontrollable laughing and/or crying episodes incon-
gruent to the patient0s mood. The theory most accepted proposes that
motor control of emotions is modulated by the cerebellum, which acts as
a “gate control.” Reduction of the inhibitory input results in disinhibition
of the cerebellum, with socially inappropriate emotional expression.
Occasionally those episodes may be mistaken for epileptic seizures. The
objective of this study was to evaluate systematically the occurrence of
PLC in children.
Method: This was a retrospective study conducted at the neuropediatric
clinic of our University Hospital. Inclusion criteria was age up to
18 years-old and episodes of uncontrollable laughing or crying consistent
with PLC. Exclusion criteria were the presence of an underlying mood or
personality disorder that could explain the abnormal emotion expression,
Angelman syndrome and hypothalamic hamartoma.
Results: Sixteen patients met the inclusion criteria, eight boys, eight
girls; ages ranging from three to 18 years-old (mean = 8.5 years-old).
All patients had pathological laughter; and only four had pathological
crying. Neurological examination was abnormal in all patients, and most
of them showed developmental delay and cognitive impairment. In most
patients the main presenting concern was if the laughing was seizure
related. Only three patients needed treatment. Risperidone was highly
effective in all of them, with no side effects.
Conclusion: We conclude that PLC is not rare in childhood and should
be considered more often as a possible diagnosis. When treatment is
needed, risperidone is a safe and effective option providing major
improvement in quality of life.
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VISUALHALLUCINATIONS IN CHILDHOOD
SYNCOPE - NOTONLYEPILEPSY
C. Shaw, J. Pickard, S. Pye, P. Rughan, R. McMillan, M. Ahmed
Queen’s University Hospital, Paediatrics, Essex, United
Kingdom
Purpose: While the end-point of syncope is a loss of consciousness, the
patient usually describes a progression of symptoms in the prodrome to
this, commonly those of visual disturbances such as blurred vision, grey-
ing out or “blackouts”. Visual hallucinations (VH) are a less documented
phenomena in syncope(1) and are more commonly thought of as manifes-
tations of other paroxysmal conditions such as epilepsy and migraine.
We would like to share our experience regarding VH among young
patients with reflex syncope. We also discuss the significance of the find-
ings and consider a common pathophysiology between visual manifesta-
tions in migraine, epilepsy and syncope.
Method: 274 patients (145 females; 129 males) with reflex syncope
were included. Their mean age was 11.7 years. Each patient reported at
least two separate attacks of syncope occurring at least 24 hours apart.
Results: Premonitory visual hallucinations during syncopal attacks were
identified among 36/274 (13%) patients. This consisted of different col-
ours including white, black, yellow, red, pink, green and blue. 19/36
(53%) patients reported flashing zig-zag lights, and the remaining 17/36
(47%) experienced dots and / or stars of different sizes. Such VH lasted
from seconds to less than 5 min with full reversibility. None of the 36
patients are known to have migraine or epilepsy.
Conclusion: Our findings provide further evidence to support the over-
lapping clinical spectrum of paroxysmal disorders such as epilepsy,
migraine and syncope. Syncope shares cerebral hypoperfusion with epi-
lepsy and migraine(2). Therefore it could be hypothesised that there is a
common element to the pathophysiology of all three disorders, specifi-
cally that of hypoxia/hypoperfusion within the occipital lobe, which
could explain the overlapping symptoms seen in our cohort of patients.
References1. Mathias CJ et al. J Neurol 1999; 246:893-8 2. Tugba B
et al. Cardiology in the young 2015; 25: 267-73
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EFFICACYOFMODIFIEDATKINS DIETVERSUS
KETOGENIC DIET INCHILDRENWITH
REFRACTORYEPILEPSYAGED 1 YEARTO 18 YEARS:
A RANDOMIZEDCONTROLLED TRIAL (RCT)
M.K. Singh*, S. Gulati*, A. Aggarwal†, B. Chakrabarty*,
R.M. Pandey‡, M. Tripathi§, M. Kabra†
*All India Institute of Medical Sciences, Child Neurology
Division, Department of Pediatrics, New Delhi, India, †All India
Institute of Medical Sciences, Department of Pediatrics, New
Delhi, India, ‡All India Institute of Medical Sciences,
Department of Biostatistics, New Delhi, India, §All India
Institute of Medical Sciences, Department of Neurology, New
Delhi, India
Purpose: Around one third of patients with epilepsy are drug refractory,
of which only one third are amenable to surgical resection. Dietary ther-
apy in the form of ketogenic diet (KD) and its variants are useful in
intractable epilepsy. Modified Atkins Diet (MAD) is a milder variant of
KD in terms of composition, tolerability and acceptibility. There is no
prospective RCT comparing the efficacy of MAD with ketogenic diet in
intractable epilepsy.
Method: The objective of the current study was to determine the efficacy
of MAD (vs.) KD for seizure control at three months follow up in chil-
dren aged 1–18 years with intractable epilepsy
In this open label RCT, 30 patients received MAD and 30 patients
received KD, with unchanged anti-epileptic drug treatment in both
groups during the entire study period. Lennox Gestaut syndrome was the
most common diagnosis in the study population.
Results: Percentage of seizure reduction at 3 months follow up from
baseline in MAD group was 47.4 (18.8 to 77.8) and in KD group was
61.9(182.9 to 100) (p = 0.348). At third month follow up, in the MAD
group, seven patients and 9 patients in the KD group achieved more than
50% seizure reduction from baseline (p = 0.341). There were no statisti-
cally significant difference in terms of hematological and biochemical
parameters between the two groups. Five patients in the MAD group and
2 in the KD group had minor adverse vents in the form of diarrhoea, vom-
iting and constipation.
Conclusion: Thus MAD as add on to ongoing AED therapy is not infe-
rior to KD in terms of percentage seizure reduction from baseline and
proportion of patients who achieve >50% seizure reduction from baseline
seizure frequency at 3 months follow up. Studies with larger sample size
and longer follow up period should be planned in future.
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EPILEPSYOF INFANCYWITHMIGRATING FOCAL
SEIZURES: CASE REPORT
C.N. Sinisterra*, A. Lizcano†
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*Instituto de Epilepsia y Parkinson del Eje Cafetero, Child
Neurology - Epileptology, Pereira, Colombia, †Instituto de
Epilepsia y Parkinson del Eje Cafetero, Neurology -
Epileptology, Pereira, Colombia
Introduction: Migrating partial seizures of infancy (MPSI) is a rare,
infantile epileptic encephalopathy, first described by Coppola
et al.(1995). This entity is characterized by refractory focal seizures asso-
ciated with autonomic features, arising independently from both hemi-
spheres, post-natally acquired microcephaly and severe developmental
delay.We present the first Colombian case describes withMPSI.
Case presentation: Is a 2 years-old boy who was a full-term healthy
newborn. He presented with hypotonia, somnolence and poor feeding at
three days of age. He developed hypoglycemia and seizures. Blood anal-
ysis showed transitional hyperammonemia and metabolic acidosis, lac-
tic-acid was normal. Extensive metabolic investigations and comparative
genomic hybridization were all normal. At the age of 2 months he started
to have almost continuous migratory focal motor seizures with auto-
nomic features and asymmetric tonic seizures from both sides, refractory
to antiepileptic drugs. He has severe developmental delay and micro-
cephaly. Actually he is receiving treatment with LVT-VGB-PB-LCM.
He was seizure free for a month when LCM was started; actually his sei-
zure frequency is 2–3/day.
EEG/Video-EEG-recording: multi-focal spikes and background slow-
ing. Electro-clinical seizures from the right and left fronto-central and
temporo-parietal areas, with occasional overlapping of consecutive sei-
zures.
Brain-MRI-T2: delayed myelination with hyperintensity of the deep
white matter.
MRS: slight increase of lactate peak in the white matter and the slight
decrease of N-acetyl aspartate peak. Choline and Creatine peaks were
normal.
Conclusions: Migrating partial seizures of infancy is a rare early onset
epileptic encephalopathy with poor prognosis. Although its prevalence is
unknown, approximately 100 cases have been described in the medical
literature. This baby-boy fulfill the diagnostic criteria of this entity, char-
acterized for highly pharmaco-resistant seizures. In our case good
response was observed when LCM was added. The shifting clinical and
EEG pattern of seizures should alert the physician to the possible diagno-
sis of this devastating infantile epileptic encephalopathy.
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VITAMINDDEFICIENCY INCHILDRENWITH
NEWLYDIAGNOSED IDIOPATHIC EPILEPSY
F.M. Sonmez*, A. Donmez†, M. Namuslu‡, M. Canbal§,
E. Orun†
*Turgut Ozal University, Faculty of Medicine, Child Neurology,
Ankara, Turkey, †Turgut Ozal University, Faculty of Medicine,
Pediatrics, Ankara, Turkey, ‡Turgut Ozal University, Faculty of
Medicine, Biochemistry, Ankara, Turkey, §Turgut Ozal
University, Faculty of Medicine, Family Medicine, Ankara,
Turkey
Purpose: Vitamin D is a neurosteroid, and similar to the classical neu-
rosteroid, it may positively modulate brain neuromediators and receptors
via GABA-A receptors. Several studies have shown a link between vita-
min D deficiency and epilepsy
Method: This study includes 60 newly diagnosed idiopathic epilepsy
patients and 101 healthy controls (between the ages of 5 and 16). Each
group was also divided into two subgroups according to seasonal changes
in terms of months of longer (vs.) shorter daylight. We retrospectively
evaluated the levels of calcium, phosphorus, alkaline phosphatase,
parathyroid hormone, and 25-OH vitamin-D3 in the study participants.
Levels below 20 ng/ml were defined as vitamin D deficiency and levels
of 20–30 ng/ml as insufficiency.
Results: There were no significant differences in age, gender distribu-
tion and levels of calcium, phosphorus, alkaline phosphatase and
parathyroid hormone between the groups. The level of 25-OH vita-
min-D3 in the patient group was significantly lower when compared
to the control group (p < 0.05) (14.07  8.12 and 23.38  12.80 ng/
ml, respectively). This difference also held true when evaluation was
made according to seasonal evaluation (12.38  6.53 and
17.64  1.14 in shorter daylight and 18.71  9.87 and 30.82  1.04
in longer daylight
Conclusion: The mechanism and effect of vitamin D deficiency in sei-
zure is still unknown. We think that screening of vitamin D levels is sim-
ple and relatively inexpensive and should be strongly considered in all
children with epilepsy. We also suggest that further studies including a
larger sample of patients are needed to draw a firm conclusion
Note: This study was published in J Child Neurol. 2015 Jan 30. pii:
0883073814566627. [Epub ahead of print]
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MICRODELETIONOFCHROMOSOME 1Q21.3 IN
FRATERNALTWINSWITHMENTALRETARDATION,
MICROCEPHALY, EPILEPSYANDDYSMORPHIC
FEATURES
E. Uctepe*, D. Aktas†, M.A. Kasifoglu‡, F.M. Sonmez§
*Turgut Ozal University, Faculty of Medicine, Medical Genetic,
Ankara, Turkey, †Hacettepe University, Medical Faculty,
Pediatric Genetics, Ankara, Turkey, ‡Turgut Ozal University,
Faculty of Medicine, Pediatric Genetics, Ankara, Turkey,
§Turgut Ozal University, Faculty of Medicine, Dept of Child
Neurology, Ankara, Turkey
Purpose: The development of genomic DNA microarray technology to
detect whole genome copy number variations (microarray-CGH) has
facilitated the discovery of novel chromosomal phenotypes associated
with epilepsy. There is only one study with 1q21.3 microdeletion syn-
drome until now in which deleted region span about 1.4 Mb with approx-
imate genomic location chr1:152,511,593-153,993,103 (NCBI genome
build 36).
Method: We report on twins carrying a 1q21.3 microdeletion and
exhibiting important common features with earlier reported case like
microcephaly and developmental delay together with other clinical signs
which have never been described to date in this microdeletion like epi-
lepsy, hypotonia and hyperlaxity in joint. The karyotype analysis was
performed. And array comparative genomic hybridization was performed
on the patient using an oligonucleotide array.
Results: The karyotype was normal 46, XX for both of the cases.
Array CGH analyses identified a 2.6 Mb deletion on chromosome
1q21.3 (chr1:153514121-156171335 bp) in case 1 and a 1.6 Mb dele-
tion on chromosome 1q21.3 (chr1:154748365-156358923 bp) in case
2.Both of siblings have common findings like microcephaly develop-
mental delay, epilepsy, distal hypotonia. Deleted region includes
DPM3, MUC1, GBA, PKLR, RIT1 and LAMTOR2 genes in both of
sibling. However, they have some different clinical findings and differ-
ent deleted genes from each other. Deleted region in one of our sibling
encompasses this region and 21 genes are common between our cases
and this patient.
Conclusion: To the best of our knowledge, this is the first study that two
siblings have 1q21.3 microdeletion in a family with mental retardation,
developmental delay, seizures, and dysmorphic features. The identifica-
tion of etiology with array-CGH screening is very useful when all labora-
tory and metabolic investigations were normal and the identification of
causative genetic background associated with seizures and their related
phenotypes is useful for genetic counseling, and possibly for manage-
ment of the patients.
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THERELATIONSHIP BETWEEN INTER-ICTAL
SPIKES AND SPINDLES IN THE IDIOPATHIC FOCAL
EPILEPSIES OFCHILDHOOD
S.D.W. Smith*, D. Sakalleriou*,†, M. Koutroumanidis*,†
*Guys and St-Thomas’ NHS Foundation Trust, Clinical
Neurophysiology and the Epilepsies, London, United Kingdom,
†King’s College, Institute of Psychiatry, Epilepsy Research
Group, London, United Kingdom
Purpose: Research has demonstrated that there may be a link between
the generators of spikes and sleep spindles in idiopathic focal epilepsies
of childhood (IFEs) (Beelke et al., 2000, Kellaway, 2000, Nobili et al.,
1999). Therefore, a study exploring the relationship between spikes and
sleep spindles could provide the knowledge to further define these mech-
anisms and add to our understanding of brain function in children with
IFEs.
Method: Sleep EEGs of children with IFE and controls were analysed
visually and by using the hypnospectrogram. Spikes and spindles were
counted from a single channel in non-rapid eye movement sleep (NREM)
stages two and three. In addition, single isolated spikes and spindles were
marked, averaged over time, and morphologically defined. Two relation-
ships were explored, the density of spikes and spindles, and the associa-
tion between their morphology. To validate these findings were also
analysed in context to the child’s age.
Results: The results conclude that there is evidence of a positive correla-
tion between spike and spindle density. In addition, a positive correlative
relationship was found between the morphology of spikes and spindles.
The lack of correlation with age reinforces this affiliation.
Conclusion: These findings suggest that the generation of spikes and
spindles in IFEs have similar mechanisms.
p1007
POLG1-RELATED EPILEPSY: REVIEWOFREPORTED
CLINICAL, NEUROPHYSIOLOGIC ANDGENETIC
FINDINGS
N. Specchio
Department of Neuroscience - Bambino Gesu Children’s
Hospital, Rome, Italy
Purpose: The clinical spectrum associated with POLG1 gene mutations
is wide, ranging from non-syndromic epilepsy or mild isolated neurologi-
cal signs to neurodegenerative disorders. The aim of the present article is
to review clinical, genetic, neurophysiological, neuroimaging, therapeu-
tic approach and outcome of all the reported cases.
Method: The articles for review were identified through a search of
Medline, searching the terms “epilepsy AND POLG”. Sixty-eight arti-
cles, including 281 cases of epilepsy due to POLG1 mutations, were
found. Thirty-four of them were selected for the review, including 164
cases.
Results: This is an underestimated condition as it is rare, not suffi-
ciently documented. Data on its prevalence are lacking. Age at epi-
lepsy onset varies between 0 and 55 years. Two main peaks of age at
onset are found: respectively at 1 year and at 13 years. The most fre-
quent seizure type is myoclonic. The occurrence of Status Epilepticus
was reported in 48.4% of cases. Most of the reported cases presented
developmental delay or psychomotor regression. Epileptiform and slow
abnormalities were most frequently seen over occipital regions. Brain
MRIs revealed increased T2 signal intensities in thalamic regions.
Many patients developed brain atrophy. Genetic analysis revealed a
large number of mutations with a prevalence of A467T, W748S and
G848S mutations. A large number of antiepileptic drugs were used and
in almost all cases. The use of valproate determined liver dysfunctions.
Survival at 5 years was estimated at very low levels, with a better out-
come in late onset cases.
Conclusion: In this review we included cases with both pediatric and
adult epilepsy onset. The analysis of data regarding prognosis showed
that survival is related to age at epilepsy onset. Serum lactate and muscle
biopsy is not diagnostic. The review of the published cases allowed us to
identify and summarize the epileptic phenotype of POLG-related epi-
lepsy.
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PREVALENCEOF FEBRILE SEIZURES ATCHILDREN
IN SIBERIA
M. Stroganova, A. Diuzhakova, G. Martynova, N. Shnayder
Krasnoyarsk State Medical University named after Prof V.F.
Voyno–Yasenetsky, Krasnoyarsk, Russian Federation
Purpose: The study of prevalence of febrile seizures (FS) at childhood
population in the Krasnoyarsk city (Siberia, RF).
Method: The Krasnoyarsk is a city and the administrative center of the
Krasnoyarsk Krai (Russia), located on the Yenisei River. It is the first city
in Siberia. The Krasnoyarsk experiences a continental climate with long
and very cold winters, and short but warm summers.
The retrospective analysis of official medical records of infectious
division of City Children0s Clinical Hospital №1 (Krasnoyarsk) held us
in 2009 to 2012. For the analyzed period in an infectious hospital 578
children with FS and an acute respiratory virus infection (ARVI) are hos-
pitalized.
Results: The prevalence of FS among children aged from newborn to
14 years old was 75-112/100000 childhood population of the Krasno-
yarsk city in 2009-2012. Annually the increase in number of the
entered patients with FS occurred during the winter and spring period
that is bound to lifting of incidence of ARVI and flu. Relation FS
around boys and girls was 57.3% (vs.) 42.7%. We showed a domi-
nance of FS around children from 12 to 36 month old (57.6%). The
greatest number of FS registered in 2010–177 (30.6%), and the lowest
in 2009–130 (22.5%).
Leading place on the frequency of cases of FS among districts of the
Krasnoyarsk city take Soviet’s district (179 pers.) is as the most multioc-
cupied and big on the area the district of the Krasnoyarsk city, and also
Lenin’s district (112 pers.) is as the most adverse in social aspect the
industrial region.
Conclusion: The prevalence of FS in the Krasnoyarsk city exceeds those
in the Russian Federation. The conducted research testifies that develop-
ment and carrying out correcting actions are necessary for decrease in
risk of FS development in the studied nursery of childhood population in
Siberia.
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THE IMPACTOFMOTOR-SENSORYDEVELOPMENT
ANDLEVELOFDISABILITYONQUALITYOFLIFE
ANDMOTHER’S STRESS LEVEL INCHILDRENWITH
EPILEPSY
M. Tanrıverdi*, F. Mutluay Karantay†, S. Güler*, A. İşcan*
*Bezmialem Vakıf University, Istanbul, Turkey, †Istanbul
Medipol University, Istanbul, Turkey
Purpose: Physiotherapy and rehabilitation reviews are important in epi-
lepsy rehabilitation. This study aims to determine the normal motor
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development level in children with epilepsy, explore its impact on the
child’s activity level and quality of life, and exhibit the potential stress
load of the condition on the parents.
Method: Demographical data of children and parents included in the
study were recorded. The children’s sensory-motor development levels
were assessed by The Neurological, Sensory, Motor, Developmental
Assessment (NSMDA) scale, level of disability by Impact of Childhood
Neurologic Disability Scale (ICND), disease impact level by Impact of
Pediatric Epilepsy Scale (IPES) questionnaires, daily living activities
and quality of life by the Turkish version of the Pediatric Outcomes Data
Collection Instrument (PODCI) scale, and stress/depression conditions
by the Parental Stress Scale (PSS).
Results: The study included 82 children, 53 male (64.64%) and 29
female (35.36%) diagnosed with temporal lobe epilepsy. The mean val-
ues of the scales applied on children were 6.45  0.67 for NSMDA;
47.22  30.94 for ICND; 20.93  11.4 for IPES; 51.38  7.80 for
upper extremities, 48.16  8.15 for transfer and basic mobility,
51.15  7.34 for sports and physical function, 48.06  11.92 for pain/
comfort, 55.30  4.41 for happiness, 49.86  8.14 for global function,
which are the subscales of the PODCI scale; 3.95  0.80 for IPES/ICND
QoL; and 40.54  8.71 for PSS, respectively. There was a statistically
significant correlation between the children’s PODCI transfer and basic
mobility subscale and PSS (r = 0.249; p < 0.05).
Conclusion: The results indicate the need for more structured and
detailed assessment of emotional, intellectual, functional and psychoso-
cial etc. impairments as well as motor-sensory impairments in children
with epilepsy. The results suggest that psychosocially supporting both
the parents and children in conjunction with all other rehabilitation treat-
ments from the very early phases could positively impact the quality of
living of both the parents and children.
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THE EVALUATIONOFMOTORDEVELOPMENT
LEVEL INCHILDRENWITHEPILEPSY
M. Tanrıverdi*, F. Mutluay Karantay†, S. Güler*, A. İşcan*
*Bezmialem Vakıf University, Istanbul, Turkey, †Istanbul
Medipol University, Istanbul, Turkey
Purpose: In our study, we aimed to determine physical disability which
include gross and fine motor development levels of children with epi-
lepsy.
Method: The level of sensory-motor development of children who
between 2–6 years had epilepsy diagnosis are evaluated with “The Neu-
rological Sensory Motor Developmental Assessment (NSMDA)” scale.
NSMDA, defined the motor development from birth through the first
6 years of the properties and describe relationship between the system.
Motor performance, identifies abnormal or dysfunctional movement
components at various ages and problem areas.
Results: 53 boys (64.64%) and 29 girls (35.36%) were included in the
total of 82 children in our study. The average applied to children NSMDA
score is 6.45  0.67.
Conclusion: This study found that although the children were in normal
levels for sensory-motor development in the sensory-motor development
assessment performed only in cases with temporal lobe epilepsies
exhibiting no other neurological diseases, the children were observed to
have difficulties and low scores in certain activities in the fine motor, pro-
prioception and tactile sense subscales of the test. This study found that
the fall in bottom scores in the sensory-motor assessment was not
reflected in the overall score and had a ceiling effect in the overall score,
resulting in the requirement of individual assessment of each motor and
sensory skill in such children.
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INVESTIGATIONOFDISEASE IMPACTAND
DISABILITY LEVELS IN CHILDRENWITHEPILEPSY
ANDTHEIR FAMILIES
M. Tanrıverdi*, F. Mutluay Karantay†, S. Güler*, A. Işcan*
*Bezmialem Vakıf University, Istanbul, Turkey, †Istanbul
Medipol University, Istanbul, Turkey
Purpose: In our study we aimed to determine the influences in daily liv-
ing activities and get over disease in children with temporal lobe epilepsy
and their families.
Method: We determined the child0s disability level by “Impact of Child-
hood Neurologic Disability Scale (ICNDS)” and to measure the disease
efficiency by “Impact of Pediatric Epilepsy Scale (IPES)” survey was
performed after obtaining the use permit.
Results: The study included 82 children, 53 male (64.64%) and 29
female (35.36%) diagnosed with temporal lobe epilepsy. The mean val-
ues of the scales applied on children were 47.22  30.94 (min–
max = 11–132) for ICNDS and 20.93  11.4 (min–max = 0–33) for
IPES.
Conclusion: In harmony with the above findings, this study found that
children with temporal lobe epilepsy and their parents were slightly-
mildly impacted from the disease according to IPES and that the chil-
dren’s disability levels were close to the upper limit according to ICNDS.
Also, in addition to the above result, this study found that the children
were weak in their relations with their parents, with poor social interac-
tion, and this finding could be a proof of the negative impact of epilepsy
on the child’s emotional wellbeing.
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THERELATIONSHIP BETWEENNORMALMOTOR
DEVELOPMENTANDDISEASE IMPACT-DISABILITY
LEVEL INCHILDRENWITHEPILEPSY
M. Tanrıverdi*, F. Mutluay Karantay†, S. Güler*, A. İşcan*
*Bezmialem Vakıf University, Istanbul, Turkey, †Istanbul
Medipol University, Istanbul, Turkey
Purpose: In our study, we aimed to determine the impact on the child0s
illness impact-disability levels of epileptic children0s on motor develop-
ment levels.
Method: In our study to determine the child0s motor development levels
0The Neurological SensoryMotor Developmental Assessment (NSMDA)
scale, determine to disease the effects-disability levels0 Impact of Child-
hood Neurological Disability Scale (ICNDS) 0and0 Impact of Pediatric
Epilepsy Scale (IPES) scale was used.
Results: In the study 82 children with temporal lobe epilepsy, 53 men
(64.64%), 29 were female (35.36%) were enrolled. Motor development
levels and assessing NSMDA the score was 6.45  0.67 (min–max = 6–
8), disease impact assessing ICNDS score was 47.22  30.94 (min–
max = 11–132) and IPES score was 20.93  11:41 (min–max = 0–33),
respectively. A significant relationship was found in children between
NSMDA and ICNDS score (r = 0097; p > 0.05) and between IPES
score (r = 0273; p > 0.05).
Conclusion: This study found that although the children were in normal
levels for sensory-motor development in the sensory-motor development
assessment performed only in cases with temporal lobe epilepsies
exhibiting no other neurological diseases, the children were observed to
have difficulties and low scores in certain activities in the fine motor, pro-
prioception and tactile sense subscales of the test. This study found that
children with temporal lobe epilepsy and their parents were slightly-
mildly impacted from the disease according to IPES and that the chil-
dren’s disability levels were close to the upper limit according to ICNDS.
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Children of the assessment to be made in more detail in the motor level is
thought to be effective on disability-effect levels.
p1014
OVERREPRESENTATIONOFAGERELATED
EPILEPTIFORMDISCHARGES INCHILDRENWITH
HEMISPHERIC EPILEPSY SYNDROMES
O. Tarta Arsene*, T. Pieper†, T. Hartlieb†, B. Pascher†,
A. Zsoter†, P. Winkler†, M. Staudt†, M. Kudernatsch†,
H. Holthausen†
*Pediatric Neurology Department, “Al Obregia”Hospital,
Bucharest, Romania, †Neuropediatric Clinic and Clinic for
Rehabilitation, Epilepsy Surgery for Children and Adolescents,
Schoen Clinic, Vogtareuth, Germany
Introduction/aim: Few publications have reported rare combinations of
age related epileptiform discharges (ARED)/ -epilepsies (ARE) with
symptomatic focal epilepsies (1–2). However, in one study dealing with
children with cerebral palsy and epilepsy after perinatal stroke, higher
rates of ARED and AREwere reported(3).
Methods: Data from 131 children who had undergone hemispherec-
tomy/hemispherotomy from 1998–2014 were screened for the presence
of ARED/ARE. Inclusion criteria for ARED: age of patients >18 months
<18 years, typical multi-phasic morphology of spikes, no continuous
irregular slow or cortical scars over the area over which spikes were
recorded from; facultative: activation of spikes during sleep, cessation of
spikes during puberty.
Results: Overall 28/131 (21.4%) (16 males) had ARED at some time at
pre-, peri-, post-surgery investigations: 15/40 (37%) with porencephalic
cysts, 8/70 (11.4%) with developmental lesions (FCD, hemimegalen-
cephaly, polymicrogyria), 5/21 (23%) with miscellaneous lesions. None
of the patients had an ARE. Positive family history for epilepsy was
found in only 2 of the ARED patients.
Conclusion: In accordance with the publication by Wanigasinghe (3),
we found a dramatic overrepresentation of ARED in epileptic children
with congenital hemiplegia after arterial ischaemic stroke/ porencephalic
cysts. The rate of ARED was much lower in the other etiologies but
higher than expected. Recognizing additional ARED in symptomatic
structural focal epilepsies might have an impact on the management of
these patients, e.g. regarding the indication for surgery as well as the
selection of antiepileptic drugs is concerned (risk of an aggravation of the
ARED- component by drugs acting as sodium channel blockers).
As part of this ongoing study, data are searched for variables explain-
ing the high rate of ARED in patients with porencephalic cysts.
References
1. Degen R et al.. Pediatr Neurol. 1999
2.Wehner et al.. Pediatr Neurol. 2011
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ACASEOF SENSORY (TACTILE) EVOKED
IDIOPATHICMYCLONIC SEIZUREOF INFANCY
G. Akdogan*, N. OlgacDündar†, D. Cavuşoglu*, T. İnce*,
F. Baydan*, B. Sarıoglu*
*Izmir Tepecik Educational Research Hospital, Pediatric
Neurology, Izmir, Turkey, †Izmir Katip Celebi University,
Pediatric Neurology, Izmir, Turkey
Reflex seizures are originated with a specific afferent stimulus or the
patient0s self activities. Reflex sezures have a prevalence of 4–7% among
patients with epilepsy
Ten months old female patient was referred to our hospital with
complaints of upward eye movements that lasted a few seconds for ten
to fifteen times a day since 1 month. This seizure could be provoked
by tapping the nose pf the baby. EEG confirmed a generalized epilep-
tiic discharge. Valproik acid 20 mg/kg was started and the patient was
seizure free. The case was diagnosed as sensory (tactile) evoked idio-
pathic myclonic seizure of infancy. Tactile stimuli given during elec-
troencephalogram may help in diagnosing the patients with this
syndrome.
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EARLY PREDICTORSOFCLINICALANDMENTAL
OUTCOME IN TUBEROUS SCLEROSIS COMPLEX: A
PROSPECTIVE STUDY
B. Benova*, B. Petrak*, M. Kyncl†, P. Jezdik‡, A. Maulisova§,
A. Jahodova*, V. Komarek*, P. Krsek*
*Charles University andMotol University Hospital, Department
of Pediatric Neurology, 2nd Faculty of Medicine, Prague, Czech
Republic, †Charles University and Motol University Hospital,
Department of Radiology, 2nd Faculty of Medicine, Prague,
Czech Republic, ‡Czech Technical University, Faculty of
Electrical Engineering, Department of Measurement, Prague,
Czech Republic, §Charles University and Motol University
Hospital, Department of Psychology, 2nd Faculty of Medicine,
Prague, Czech Republic
Purpose: We aimed to identify early predictors of pharmacoresistance,
mental retardation and autistic spectrum disorder (ASD) in pediatric
patients diagnosed with cardiac rhabdomyomas (CR) in pre- and perina-
tal period. Our goal was to demonstrate significance of standardized pro-
tocol for diagnosis and follow-up in patients in high risk of tuberous
sclerosis complex (TSC), development of intractable epilepsy and its
unfavorable consequences.
Method: Clinical, neuropsychological, electrophysiological and neu-
roimaging data in a group of 22 patients with definite clinical diagnosis
of TSC were followed prospectively according to a standardized protocol
for patients with pre/perinatal diagnosis of CR developed in our centre.
EEG exams from period before the onset of epilepsy, at the time of epi-
lepsy onset and at the end of follow-up period were reevaluated using a
specific parametrical protocol. MR studies from period of incomplete
and complete brain myelination were reviewed and searched for lesions
associated with TSC, including defined features of focal cortical dys-
plasia (FCD). Barnard’s exact test and Kruskal-Wallace test of indepen-
dence (at p < 0.05) were used for statistical evaluation of results.
Results: Development of mental retardation was predicted by abnor-
mal neurological exam, early seizure onset, intractability of seizures,
higher total number of AEDs used, abnormal EEG background at the
end of follow-up, and higher number of both tubers and areas with
FCD-like features on MR. Predictors of ASD included abnormal neu-
rological exam, early developmental delay, first-line AED treatment
failure; abnormal background, presence of spikes, and their higher fre-
quency on EEG at the end of follow-up, as well as higher number of
areas with FCD-like features on MR. Intractable epilepsy at the end of
follow-up was predicted by mental retardation; a trend towards
intractability in children with earlier seizure onset and higher number
of tubers was observed.
Conclusion: Early initiation of antiepileptic treatment and prompt sei-
zure control could improve mental outcome and decrease incidence of
pervasive developmental disorders in TSC patients. We regard stan-
dardized protocol for clinical follow-up and treatment essential in man-
agement of patients with pre/perinatal diagnosis of cardiac
rhabdomyomas.
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SYMPTOMATICWEST SYNDROME: THE
ELECTROPHYSIOLOGICALAND STRUCTURAL
FEATURES AND PROGNOSIS
B. Tekin Güveli*, S. Saltık†,Ö. Cokar‡, N. D€ortcan§,
V. Demirbilek¶, A. Dervent¶
*Bakirkoy Research and Training Hospital for Psychiatry,
Neurology, Neurosurgery, Department of Neurology, Istanbul,
Turkey, †Istanbul University Cerrahpasa Faculty of Medicine,
Department of Pediatric Neurology, Istanbul, Turkey, ‡Haseki
Research and Training Hospital, Istanbul, Turkey, §Fatih Sultan
Mehmet Research and Training Hospital, Istanbul, Turkey,
¶Istanbul University Cerrahpasa Medical Faculty, Department
of Neurology, Pediatric Neurology, Istanbul, Turkey
Purpose: Symptomatic etiology has been well recognized as a factor for
severity in the long-term prognosis of WS. Impact of different etiological
or pathophysiological sub-groups however, is not so much questioned.
The aim of this study was to search a relation between the clinical, elec-
trophysiological and structural features in patients with symptomatic WS
(sWS) in regards to the long-term course of the disease.
Method: Data belonging to a total of 99 patients with sWS recruited
since 1991 were included in the study. According to the neuro-develop-
mental and social conditions during the final evaluation, the patients were
placed into two categories: Group I: patients with normal or subnormal
motor and intellectual outcomes with favorable social status; ambulatory
patients receiving special academic and/or physical support to cope with
social needs. Group II: Patients with severe motor and/or mental impair-
ment with solely supervised living or patients who were deceased. The
EEG findings were reviewed and classified. The cMRI findings were
classified as normal, with diffuse cortical and/or subcortical involvement,
or with unilateral cortical and/ or subcortical involvement.
Results: The study population consisted of 61 males and 38 females
with a mean follow-up duration of 8 years. The most common etiolog-
ical causes were perinatal asphyxia and CNS infections. Sixty-three
patients suited to Group I and 36 patients were in Group II. We exam-
ined a total of 764 video EEG recordings, with a duration of minimum
2 hours. Sixty-two patients had consistently symmetrical, 22 patients
asymmetric hypsarrhythmia and four patients unilateral hypsarrhythmia
in the EEGs. Asymmetry of hypsarrhythmia showed no correlation
with long-term course. Preservation of sleep spindles had a direct and
diffuse involvement in the cMRI revealed an inverse correlation with
better prognosis.
Conclusion: Prognostic consequences of sWS may be partly anticipated
by careful examination of the clinical, imaging and EEG data.
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MEAN PLATELETVOLUME, IRON, FOLICACID AND
VITAMINE B12 LEVELS IN FEBRILE CONVULSIONS
R. Deveci, G. Gürbüz, S. Acar, A. €Unalp
Dr. Behcet UZ Children’s Hospital, Child Neurology, Izmir,
Turkey
Purpose: To evaluate mean platelet volume level in patients with simple
and complicated febrile convulsions, and also investigating the relation-
ship between convulsions and iron, vitamin B12 and folic acid levels in
patients diagnosed with anemia.
Method: Total of 83 patients between month 6-age 5 diagnosed with
febrile convulsion(FC) were included in the study, and as control group
92 cases with inflammatory diseases without convulsions were included.
Hemogram results of all patients in study and control groups were evalu-
ated. Serum iron, total iron binding capacity, plasma ferritin, transferrin
saturation, peripheral distribution, folic acid, vitamin B12 andmean plate-
let volume levels were examined in patients with convulsion and anemia
diagnosis.
Results: We enrolled 83 patients in this study; 47 (56.6%) boys, 36
(43.4%) girls. Control group had 36 (39.1%) girls and 56 (60.9%) boys
who had no history of febrile convulsions. 48 (57.8%) of the patients had
simple febrile convulsions(SFC), 35 (34.9) had complicated febrile con-
vulsions (CFC) and 6 (7.3%) had febrile status. 22.8% of the patients had
anemia. There was no significant difference between SFC and CFC but
also FC and control group for iron, TIBC, transferrin saturation, and folic
acid parameters. The mean of level of ferritin in SFC was 30.58 ng/ml,
whereas it was 13.78 in CFC. There was a significant difference between
two groups (p < 0.001). Vitamine B12 level in SFC group was
430.73 pg/ml and 408.75 pg/ml in CFC group. There was a significant
difference between two groups (p < 0.01). There was no significant dif-
ference between SFC, CFC and control group for the level of mean plate-
let volüme.
Conclusion: Ferritin and vitamin B12 levels of CFC group were found
to be significantly lower with regard to SFC group. This result suggested
low ferritin and vitamin B12 levels may be a factor in complicated type
febrile convulsion.
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USEOFACTHATHIGHDOSES FORTHE
MANAGEMENTOFEPILEPTIC ENCEPHALOPATHY
A. Uscategui-Daccarett*,†, C. Medina-Malo†
*Universidad Nacional de Colombia, Pediatrics, Bogota,
Colombia, †Central League Against Epilepsy, Bogota,
Colombia
Purpose: Describe the response in seizure control in patients with
epileptic encephalopathy treated with ACTH at high doses.
Method: We review the charts of patients who were treated with ACTH
between 2005–2014 under the diagnosis of epileptic encephalopathy. We
analyze demographic characteristics, seizure control, adverse reactions
and follow up.
This protocol of ambulatory administration and weekly follow up,
uses a deposit synthetic ACTH with gradual tapering between 12 to
14 months, previously discarding associated pathologies that contraindi-
cate the use of this treatment.
Results: 49 patients with a mean age of 7 years [1.3–23 years]: 12
(14%) with Doose syndrome, 8 with Lennox-Gastaut, 7 West syndrome,
10 with focal symptomatic epilepsy; 44% had symptomatic epilepsy. The
initial dose of ACTH was 3.3 UI/kg/day (0.1–8 UI/kg/day). The
complete time of the protocol was 20.11 months, seizure control 78.9%
(0–100%) (IC 68.8–88.9) and 26.2% of patients accomplished 100%
seizure control.
Neurodevelopment improved about 33%, with a subjective progress
of 70%. 97% presented adverse reactions, 18.4% had severe adverse
reactions which lead to discontinue the protocol. 36.6% of the patients
continued with complete seizure control after treatment.
Conclusion: ACTH can be used as an effective therapeutic strategy in
patients with epileptic encephalopathy with poor response to pharmaco-
logic treatment, achieving an improvement of 78.9% in seizures, neu-
rodevelopment and performance, with bearable and treatable adverse
reactions.
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A PREDICTIONMODELTODIAGNOSECHILDHOOD
EPILEPSYAFTERA POSSIBLE SEIZURE
E. van Diessen, W.M. Otte, F.E. Jansen, K.P. Braun
University Medical Center Utrecht, Utrecht, the Netherlands
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Purpose: The clinical profile of children who suffered from a possible
seizure is heterogeneous and the sensitivity of diagnostic testing is lim-
ited. This hampers early and accurate diagnosis. We developed a model
to reliably predict diagnosis of epilepsy in children after a possible sei-
zure by combining routinely available information at first consultation.
Method: We collected clinical data of 451 children who visited our first
seizure clinic between January 2008 and May 2013. The gold standard
outcome, classified as epilepsy or no epilepsy, was based on the eventual
diagnosis after clinical follow-up. A multivariate logistic regression
model was fitted on data from 70% of randomly selected children. Patient
characteristics (age, gender), clinical characteristics (age of first seizure,
event frequency, developmental status, event description, medical and
family history) and standard electroencephalography report were used as
predictor variables. Model performance was validated with data from the
remaining 30% of children using a receiver operating characteristic
(ROC) curve.
Results: Overall model performance was excellent, with an area under
the ROC curve (AUC) of 0.90 [95% confidence interval (CI) 0.83 to
0.97]. Model performance in a selective sub-population of 177 children
with unclear diagnosis at initial consultation was good with an AUC of
0.76 [CI 0.68 to 0.83].
Conclusion: This model may prove to be a valuable tool in clinical prac-
tice as all predictor variables are routinely available at first consultation.
A web-application is provided to facilitate the diagnostic process for clin-
icians who are confronted with children with paroxysmal events, sus-
pected of suffering from epilepsy.
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TARGETEDRESEQUENCING IN EPILEPTIC
ENCEPHALOPATHIES: DIAGNOSTIC IMPLICATIONS
ANDGENOTYPE-PHENOTYPECORRELATIONS
M.S. Vari*, F. Pinto*, E. Gennaro†, D. Coviello†, F. Zara*,
P. Striano*
*Insitute G. Gaslini, Department of Neuroscience, Genoa, Italy,
†E.O. Ospedali Galliera, Laboratory of Genetics, Genoa, Italy
Purpose: To assess the diagnostic value of NGS target re-sequencing
approach for epileptic encephalopathies.
Method: The diagnostic tool allows the screening of 20 genes which
have been consistently associated with early-onset epileptic
encephalopathy (EE): ALDH7A1, PNP0, ARHGEF9, ARX, SLC25A22,
PLCB1, TBC1D24, PNKP, KCNT1, KCNQ2, SCN2A, SCN8A,
STXBP1, SCN1A, PCDH19, CDKL5, SPTAN1, SLC2A1, ST3GAL3,
GRIN2A). NGS have been performed by Ampliseq/Ion Torrent technol-
ogy of at least 120X. Patients have been classified into 5 phenotypic
classes:
(1) EEs with onset in the first year of life;
(2) infantile spasms/West syndrome
(3) Dravet Syndrome
(4) CSWS/Landau-Kleffner Syndrome
(5) EEs with onset after the first year of life.
Results: Fifty-four patients have been analyzed: class 1, n°26; class 2,
n°10; class 3, n°6; class 4, n°4; class 5, n°8. Pathogenetic effects of vari-
ants have been attributed according to i) segregation analysis (inherited
vs transmitted; putative functional effect (damaging (vs.) benign); state-
of-art genotype-phenotype correlations. We identified a total of 23 unre-
ported variants: - n°13 variants were classified as likely pathogenetic
(24%) on the following genes: STXBP1 (n°2), SCN1A (n°2), SCN2A
(n°2), KCNQ2 N°2), CDKL5 (n°2), KCTN1 (n°1), GRIN2A (n°1),
PNPO (n°1). -n° 6 variants were classified of uncertain significance
(11%): PCDH19 (n°1); SCN1A (n°1), ARHGEF9 (n°1), KCNQ2 (n°1),
SPTAN (n°1), STXBP1 (n°1). - n° 4 variants were classified likely
benign (7%): ARHGEF9 (n°1), TBC1D24 (n°1), SCN1A (n°1), KCNQ2
(n°1).
Conclusion: In about 1/4 of the cases we were able to reach a defi-
nite diagnosis. Detailed clinical information is required to interprete
genetic findings. The diagnostic yield is particularly high within the
group of EEs with onset in the first year of life. SCN1A, SCN2A,
STXBP1 and CDKL5 show multiple mutations, providing a further
confirmation on their pivotal role in the etiology of epileptic
encephalopathy.
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PREVALENCEOFEPILEPSY INCHILDRENWITH
DOWN SYNDROME, TOOHIGHORTOOLOW?
S. Pula, M. McGowan, I. Hajdikoumi, M. Albery
St. George’s Hospital NHS Trust, Child Development Centre,
London, United Kingdom
Background: Down Syndrome (DS) is the most common chromosomal
abnormality and may be associated with a variety of complications
including epilepsy. Several studies indicate that the frequency of epilepsy
in children with DS ranges between 1% and 13%. The prevalence of epi-
lepsy in DS is more than in general population and less than would be
expected when compared with other groups of children with learning dis-
abilities. In DS, a bimodal distribution of epilepsy onset has been
described: the first peak in early childhood and the second increasing
with age.
Objectives: To assess change in the prevalence of epilepsy in children
with DS and evaluate the type of epilepsy in this population.
Methodology: We reviewed retrospectively our cohort of 79 patients
with DS, aged 0 to 19 years of age (median age 8 years), 44 males, 35
females. All were followed in our clinic at least once per year. The clini-
cal diagnoses of DS based on typical somatic features was confirmed by
cytogenetic analysis in all patients of which 60 had trisomy 21, one
translocation and information of the others was limited to “diagnosis con-
firmed”.
Results: In our cohort of 79 patients with DS none of them was diag-
nosed with epilepsy, according to the ILAE criteria.
Conclusion: Epilepsy as a comorbidity in DS has an age dependent
prevalence. In paediatric population we might consider that the preva-
lence of epilepsy is decreasing as secondary lesions due to congenital
heart anomalies, respiratory distress, metabolic disturbances are diag-
nosed and treated promptly due to improved medical care before and
after the birth in this population.
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PERSISTENT EPILEPTIC SPASMSANDTONIC
SEIZURES INOLDERCHILDRENANDYOUNG
ADULTSWITHDRUGRESISTANT EPILEPSY: ARE
THEREANYBIOLOGICALDIFFERENCES?
G. Venkatachalam*,†, M. Brady*, F. Chivers*, A. Jayal‡,
R. Karuvattil†, K.B. Das*,†
*Young Epilepsy National Centre for Young People with
Epilepsy, Lingfield, United Kingdom, †Great Ormond Street
Hospital for Children NHS Trust, London, United Kingdom,
‡Cardiff Metropolitan University, Department of Computing &
Information Systems, Cardiff, United Kingdom
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Purpose: Epileptic spasms are being increasingly recognised in older
children and young adults. We describe the clinical characteristics of
patients with persistent epileptic spasms (occurring beyond 2 years of
age) in comparison to patients with tonic seizures.
Method: Patients with documented spasms or tonic seizures were identi-
fied from the EEG database at a tertiary epilepsy centre in U.K. Consecu-
tive patients who presented with persisting epileptic spasms or tonic
seizures were recruited. Each group (30 patients) was subdivided into
early onset (<2 years) and late onset (>2 years) based on the age at sei-
zure onset. Thirty patients with mixed seizure types were taken as a com-
parator. Aetiology was divided into structural lesions (including HIE &
ABI), genetic and metabolic causes. The response to medication was also
analysed.
Results: The median age was 17 years (range 2 to 27 years) with a male:
female ratio of 1:1.25. The median age of seizure onset was 2 years
(range Day 1–12 years). Structural causes were noted in 62.5% (10/16)
of early onset spasms and 35.7% (5/14) of late onset spasms [p value
0.028; Fisher0s Exact Test, 95% confidence interval]. Genetic aetiology
was also more associated with early onset spasms than late onset spasms,
31.3% (5/16) (vs.) 14.3% (2/14). [p value 0.028; Fisher0s Exact Test,
95% confidence interval]. When the whole group of spasms was consid-
ered, structural aetiologies were higher 50% (15/30) than in the tonic
group 33.3% (10/30), but did not reach statistical significance. Patients in
both the groups were refractory to treatment.
Conclusion: Structural and genetic aetiologies are significantly higher
in patients presenting with early onset spasms. Structural lesions are
overall commoner in the spasms group than in the tonic group indicating
fundamental biologic differences.
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FEBRILE SEIZURES ANDOTHER EPILEPTIC
DISORDERS FREQUENCY INCHILDRENWITH
INFECTIOUS DISEASES
V. Voitenkov*, N. Skripchenko†, A. Klimkin†
*Scientific Research Institute of Children’s Infections,
Functional Diagnostic, Saint Petersburg, Russian Federation,
†Scientific Research Institute of Children’s Infections, Saint
Petersburg, Russian Federation
Purpose: Our purpose was to establish frequency of febrile seizures and
other epileptic disorders in children attending tertiary hospitals with the
symptoms of infectious diseases
Method: 27 029 patients, aged 0.2–16 years, who were admitted in the
tertiary hospitals in 2009–2013 with acute infectious diseases were
enrolled. Those who developed seizures one day before the admission, at
admission and during the in-hospital stay were thorougly investigated
using lab tests, neurological examination and EEG in all patients and
brain ultrasound andMRI if needed.
Results: Among 27.029 patients 676 (2.5%) had epileptic disorders.
Among these 76.3% (n = 516) had febrile seizures. 16.6% (n = 112) had
seizures during the neuroinfection (35 patients with encephalitis and 77
with meningitis); 7.1% (n = 48) had established childhood epilepsy.
Among patients with febrile seizures 81.4% (n = 420) had acute respira-
tory infections and 14.9% (n = 77) had intestinal infectious diseases.
85% of the patients (n = 575) were younger than 3 years old.
Conclusion: Epileptic disorders are relatively rare in children with infec-
tious diseases and occur in all forms in 2.5% of the cases. Mainly these
seizures appear in early childhood (children younger than 3 years).
Majority of these epileptic disorders are febrile seizures (seen in 76.3%
of the cases). Infectious respiratory diseases seems to cause febrile sei-
zures more often than all other causes.
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THE IMPACTOF PROLONGEDACUTECONVULSIVE
SEIZURESONLEARNINGAND SCHOOLING IN A
EUROPEAN SURVEYOFCHILDRENWITHEPILEPSY
B. Wilken*, F.J. Kirkham†,‡, L. Lagae§, M. Raspall-Chaure¶,
R. Grebla**, N. Roskell††, T. Kiechle‡‡, F. Vigevano§§
*Klinikum Kassel, Department of Paediatric Neurology, Kassel,
Germany, †University Hospital Southampton NHS Trust,
Department of Child Health, Southampton, United Kingdom,
‡Institute of Child Health, University College London, London,
United Kingdom, §University Hospitals, Katholieke Universiteit
Leuven, Pediatric Neurology, Leuven, Belgium, ¶Vall d’Hebron
University Hospital, Department of Paediatric Neurology,
Barcelona, Spain, **Shire, Global Health Economics and
Outcomes Research, Wayne, PA, United States, ††BresMed
Health Solutions, Sheffield, United Kingdom, ‡‡Shire, Global
Medical Affairs, Zug, Switzerland, §§Bambino Gesu Children’s
Hospital, Department of Neuroscience, Rome, Italy
Purpose: To survey educational needs and the burden of disease in chil-
dren with epilepsy who experience prolonged acute convulsive seizures
(PACS).
Method: Practices in Emergency and Rescue medication For Epilepsy
managed with Community-administered Therapy 3 (PERFECT-3) was
an international, cross-sectional, observational study. Eligible patients
were non-institutionalized children with epilepsy (aged 3–16 years) who
had experienced ≥1 PACS within the last 12 months and had current pre-
scription(s) for PACS rescue medication. Investigators provided clinical
assessments and patients and their parents/guardians each completed
web-based questionnaires. Parents/guardians acted as proxies for chil-
dren unable to complete questionnaires.
Results: A total of 286 patients were enrolled in Germany (n = 92
[32.2%]), Italy (n = 75 [26.2%]), Spain (n = 77 [26.9%]) and the UK
(n = 42 [14.7%]). Their mean age was 8.9 years (standard deviation
[SD], 3.8) and 54.9% were male. In the 12 months before enrolment,
patients had experienced 1-400 PACS (median, 4; mean, 23.6 [SD,
59.8]); 54.9% experienced 1–5 and 9.8% experienced ≥51. The majority
of patients (52.7%) could not undertake typical day-to-day activities and
most (76.9%) had learning disabilities. Of these, 69.9% had severe or
moderate learning disabilities, and were unsuited to mainstream school/
kindergarten. Only 108/257 parents (42.0%) reported that their child
attended mainstream school. In the patient/proxy survey (n = 251), most
children reported that PACS always, often or sometimes interfered with
school attendance (60.4%) and their activities at school (62.8%), home
(70.0%) and elsewhere (66.4%).
Conclusion: This European study of children with epilepsy who had
experienced ≥1 PACS in the year before enrolment confirmed that chil-
dren with epilepsy often face learning disabilities and need specialist edu-
cation. Most children also had problems with attendance and
participation at school.
Study funded by ViroPharma (part of the Shire Group of Companies).
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NEURONALANTIBODIES IN PAEDIATRIC EPILEPSY:
CLINICAL FEATURES ANDLONG-TERMOUTCOMES
S. Wright*, A.T. Geerts†, C.M. Jol-van Der Zijde‡,
L. Jacobson*, B. Lang*, P. Waters*, M.J.D. Van Tol‡,
H. Stroink§, R.F. Neuteboom†, O.F. Brouwer¶, A. Vincent*
*University of Oxford, Nuffield Department of Clinical
Neurosciences, Oxford, United Kingdom, †Erasmus Medical
Center, Paediatric Neurology, Rotterdam, Netherlands, ‡Leiden
University Medical Center, Department of Paediatrics, Leiden,
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Netherlands, §Canisius-Wilhelmina Hospital, Department of
Neurology, Nijmegen, Netherlands, ¶University Medical Centre
Groningen, University of Groningen, Department of Neurology,
Groningen, Netherlands
Purpose: Neuronal antibodies (Abs) are now widely accepted as causa-
tive in autoimmune encephalitis (AE), and most patients respond well to
immunotherapy. In paediatric epilepsy (PE), the implications of a posi-
tive test are not yet clear. In this study, a historical cohort of PE patients
were tested for neuronal autoantibodies and their outcomes analysed in
relation to antibody status.
Method: Serum from 178 new-onset PE patients recruited between
1988–1992 as part of the Dutch Study of Childhood Epilepsy and 112
healthy age-matched controls were tested for neuronal-Abs to the
NMDAR, AMPAR, VGKC-complex, LGI1, CASPR2, contactin-2 pro-
teins and GAD, using cell-based and radio-immunoprecipitation assays.
The results were correlated with the clinical data collected over 15 years.
Results: 17 PE patients (17/178; 9.5%) were positive (NMDAR-Ab (7),
VGKC-complex-Ab (3), CASPR2-Ab (4), and contactin-2-Ab (3) com-
pared to 3 healthy controls (VGKC-complex (1) and NMDAR (2), 3/112;
2.6%, p = 0.03; Fisher’s exact test). Ab-positive patients had a signifi-
cantly higher rate of pre-existing cognitive impairment (9/17 (vs.) 33/
161; p = 0.0056). 57% (8/14) Ab-positive patients were on AEDs at final
contact compared to 31% (44/143) of Ab-negative patients (p = 0.07,
ns); 3/17 of Ab-positive patients were intractable (21% (vs.) 10% in the
Ab-negative group, p = 0.18, ns). At final follow-up, 65% of Ab-positive
patients had been seizure free for more than 2 years. Six patients, Ab-
negative at epilepsy onset, became Ab-positive within the first year of
disease (NMDAR-Ab (2), CASPR2-Ab (3), contactin-2-Ab (1)).
Conclusion: Neuronal surface Abs were found more commonly in new-
onset PE patients than in controls, and more frequently in patients with
pre-existing neurological problems. Given that the majority of patients
responded well to standard treatments, and some patients developed Abs
after the onset of epilepsy, this study suggests that Abs can arise sec-
ondary to brain damage, and are not necessarily the primary cause of epi-
lepsy without encephalitis.
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EFFICACYOFEVEROLIMUS AGAINST EPILEPSY
WITHTUBEROUS SCLEROSIS
K. Yanagihara, H. Toshikawa, T. Kimizu, S. Kimura, T. Ikeda,
Y. Mogami, Y. Suzuki
Osaka Medical Center and Research Institute for Maternal and
Child Health, Department of Pediatrics, Izumi, Osaka, Japan
Purpose: An investigation of use of everolimus (EL) was conducted in
patients to confirm the efficacy against epilepsy with tuberous sclerosis
(TS).
Method: We investigated changes in epilepsy symptoms and examina-
tions after EL therapy for angiomyolipoma (AML) and subepedymal
giant cell astrocytoma (SEGA) in 1 male and 2 female patients with TS
aged 21, 16, and 13 years, respectively, at the start of EL. All patients
had repeatedly received resection or embolization of AML, and one had
undergone resection for comorbid SEGA. All patients had epilepsy that
had occurred during infancy: partial seizures (PS, n = 3) and epileptic
spasms in series (ESS, n = 2). Before EL, 2 patients had been receiving
multiple anti-epileptic therapies to successfully prevent epileptic seizures
(ES), and 1 had daily PS accompanying secondarily generalized tonic-
clonic convulsions (sGTC) and ESS.
Results: Two patients had no seizure recurrence during EL. In the patient
with daily PS, sGTC disappeared immediately after introducing EL. PS
decreased from daily to weekly basis at two months of EL, and eventually
disappeared after one year. No changes in EEG or cortical tubers
occurred after EL in any patient. AML became smaller or remained
unchanged, requiring no resection or embolism, and the SEGA tumor
size decreased in all cases. All patients experienced rash and stomatitis
during EL, and one required treatment suspension. No serious adverse
events occurred, including interstitial pneumonia, and all patients contin-
ued EL over one year.
Conclusion: EL was quite effective against intractable PS in one TS
case. Although it currently is not,EL should be indicated for treatment of
intractable epilepsy.
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NEXTGENERATION SEQUENCINGANALYSIS IN
NEONATAL / EARLY EPILEPTIC ENCEPHALOPATHY
S. Yilmaz*, H. Onay†, S. Gokben*, G. Serdaroglu*, T. Atik‡,
H. Tekin*, F. Ozkinay‡
*Ege University Medical Faculty, Pediatrics, Division of Child
Neurology, Izmir, Turkey, †Ege University Medical Faculty,
Genetics, Izmir, Turkey, ‡Ege University Medical Faculty,
Pediatrics, Division of Pediatric Genetics, Izmir, Turkey
Purpose: Epileptic encephalopathy (EE) term describes epilepsy syn-
dromes in which seizures and epileptiform electroencephalographic
abnormalities are considered to contribute to progressive cerebral dys-
function. A subset of all the EEs that still await an etiological explana-
tion, particularly those with onset of seizures within the first year of life.
In this study genetic backround of neonatal /early infantile EE was inves-
tigated by next generation sequencing (NGS) analysis.
Method: Thirty cases who had refractory seizures with neonatal or early
infantile onset were prospectively included in this study. Three cases had
history of hospitalization in neonatal unit due to meconium aspiration
syndrome, and four cases also had cyanosis and/or transient respiratory
distress following the labor. All cases had normal metabolic work up
including serum lactic acid, pyruvic acid, aminoacid and carnitine levels,
biotinidase activity and urine organic acids. Their cranial magnetic reso-
nance imaging findings were normal except cerebral atrophy. Their kary-
otype analyses were normal. None of them had antiquitin gene mutation.
Mutations in 16 genes (ARX, CDKL5, CNTNAP2, FOLR1, FOXG1,
GRPR, LAMC3, MBD5,MECP2, PCDH19, PNKP, SCN1A, SCN1B,
SCN2A, STXBP1, KCNQ2) were examined with NGS method in our
cases.
Results: All they were born at term except three cases. Their ages were
between 6 and 204 (62.5  51.6) months. Parental consanguinity was
found in 11 of 30 cases (36%). Their seizures started between 1 and 270
(91.7  80.25) days of life, eleven cases had seizures with neonatal onset
.Infantile spasms are the predominant seizure type in our group consisting
of 16 of 30 cases. All of them were treated at least two anticonvulsant
drugs.Cranial MRI was normal in half of the cases, the reminder had cor-
tical or cerebellar atrophy in different severity.Only one case had T2
hyperintense signal changes in basal ganglia. The results of NGS analysis
were discussed with the literature.
Psychiatry 3
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EPILEPSYAND PSYCHOSIS: PATTERNOF
PSYCHOTICDISORDERS AMONGPERSONSWITH
EPILEPSY IN ILE-IFE
M.A. Komolafe*, K.S. Mosaku†, A.O. Oginni‡
*Obafemi Awolowo University, Neurology, Ile-Ife, Nigeria,
†Obafemi Awolowo University, Mental Health, Ile-Ife, Nigeria,
‡Obafemi Awolowo University, Mental Health, Ile-ife, Nigeria
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Purpose: Psychiatric disorders are common in Persons with Epilepsy
and these may have a negative impact on the course of epilepsy.
Method: A retrospective case review of 7 persons with epilepsy and psy-
chotic disorder presenting over a 2 year period at the Neurology and psy-
chiatric units of Ile-Ife. In each patient the clinical characteristics,
epilepsy variables, use of antiepileptic and antipsychotic drugs were studied.
Results: The prevalence of psychosis among the 150 patients in both
clinics was 4.6%. There were 7 persons with epilepsy presenting with 8
psychotic episodes comprising 5 females and 2 males. The age ranged
between 16 and 40 years with a mean of 28 years. Majority (4) had com-
plex partial seizures and 3 were one of a pair of twins. Most of the epi-
sodes were interictal (5). In two of the patients with post ictal psychosis
the episode was preceded by poor sleep and status epilepticus. All the
patients were on carbamazepine. Only 4 of the episodes were treated with
antipsychotics and the outcome was good with all patients discharged to
the clinic.
Conclusion: Psychotic disorders occurred among persons with complex
partial seizures and was more prevalent in females. Post-ictal psychosis
is commoner than inter-ictal psychosis. Further studies are needed to find
out the predisposing factors to the occurrence of psychotic disorders in
PWE.
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VALIDATION TURKISHVERSIONOFTHE
NEUROLOGICALDISORDERSDEPRESSION
INVENTORY FOREPILEPSY (NDDI-E)
A. Aybar*, G. Kutlu†, E. Karacay*, Y. Gomceli*
*Antalya Research and Training Hospital, Neurology, Antalya,
Turkey, †Mugla SK University School of Medicine, Neurology,
Mugla, Turkey
Purpose: The Neurological Disorders Depression Inventory for Epi-
lepsy (NDDI-E) was developed for the rapid detection of a major depres-
sive episode in people with epilepsy. This study describes the
development, validation, and psychometric properties of the Turkish ver-
sion of the NDDI-E
Method: A consecutive sample of 100 outpatients with epilepsy has
been assessed using the Beck Depression Scale and the NDDI-E.
Results: All patients had no major difficulties in understanding or
answering the questions of the Turkish version. Nearly all of the other
language validations were performed before 2013 mostly with M.I.N.I.
Plus version 5.0.0 which bases on DSM-IV. We used Beck Depression
Scale in validation because of changing DSM criteria. Distribution of
variables was evaluated with Kolmogorov-Smirnov test, concordance
between each test was studied with kappa test and Spearman correlation
was used to find out correlation between tests. Results of our statistical
analysis were sensitivity of 91%, a specificity of 74%, a positive predic-
tive value of 82.5%, and a negative predictive value of 86.5% of new
Turkish version.
Conclusion: Dealing with treatment of epilepsy usually shadows diag-
nosis of psychiatric comorbidites. Depression is the most common psy-
chiatric comorbidity. The validation of Turkish version of this test is
necessary for correct diagnosis of depression in patients with epilepsy.
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INTERICTALDISPHORICDISORDER: IS IT SPECIFIC
FOR PATIENTSWITHEPILEPSY?
M.Milovanovic, M. Jovanovic, R. Djokic
Institute of Mental Health, Department for Epilepsy and Clinical
Neurophysiology, Belgrade, Serbia
Purpose:: (1) to assess prevalence of interictal dysphoric disorder (IDD)
(Blumer 2000) in patients with epilepsy by comparison to patients with
migraine;
(2) to evaluate influence of IDD on quality of life in patients with
epilepsy.
Method: Adult patients (age range 18–65 years) with definite diagnosis
of epilepsy or migraine, of normal intelligence, without any progressive
neurological disease or psychotic disorder were included in the study.
They were assessed with Interictal Dysphoric Disorder Inventory (IDDI)
(Mula M, Trimble MR, 2008). Beck0s Depression Inventory (BDI),
Beck0s Anxiety Inventory (BAI), and QOLIE-31 Inventory (Serbian ver-
sion) were completed by patients themselves.
Results: Study groups consisted of 59 patients with epilepsy (mean age
42.3  14.4; female 57.6%), and 49 patients with migraine (mean age
36.7  12.3; female: 71.3%). Prevalence of IDDI definite diagnosis in
epilepsy group was similar (12%) to migraine group (11%). IDDI affec-
tive scores were significantly higher in migraine than in epilepsy patients
(p = 0.017). IDDI total and partial (labile depressive symptoms, labile
affective symptoms and specific symptoms) scores showed strong corre-
lations among themselves in both groups supporting the validity of the
IDDI as a construct. In epilepsy group, IDDI total score and IDDI partial
affective score displayed a significant positive correlation with BDI and
BAI scores. In migraine group only IDDI total score was highly posi-
tively correlated with BDI and BAI scores. QOLIE-31 total score was
significantly negatively correlated with: IDDI total score (r = 0.355),
IDDI depressive scores (r = 0.276) and IDDI affective scores
(r = 0.415).
Conclusion: IDD represents a homogenous construct that can be diag-
nosed in a relevant proportion of patients, but it is not typical for epilepsy.
In patients with migraine, IDDI affective symptoms are more pronounced
and severe than in patients with epilepsy. IDDI total score, especially
labile depressive symptoms and affective symptoms have significant
influence on quality of life in patients with epilepsy.
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AUTISM SPECTRUMDISORDERASSESSMENT IN
FEMALE EPILEPSYWITHPCDH-19MUTATION:
CLINICALDATA
L. Ouss*, D. Breuillard*,†, D. Leunen*, N. Chemaly*,†,
A. Kaminska†,‡, J.-M. Pinard§, I. Desguerre¶,**,
L. Auclair†,††, R. Nabbout*,†,**
*Centre de Reference Epilepsies Rares et Sclérose Tubéreuse de
Bourneville Department of Pediatric Neurology Necker Enfants
Malades Hospital, APHP, Paris, France, †INSERMU 1129,
Université Paris Descartes, PRES Sorbonne Paris Cité, Ho^pital
Necker Enfants Malades, Paris, France, ‡Unité
d’Electrophysiologie Clinique Ho^pital Necker Enfants
Malades, Paris, France, §Hopital Raymond Poincaré, Garches,
France, ¶Service de Neurologie Pédiatrique, Ho^pital Necker
Enfants Malades, Paris, France, **Université Paris Descartes,
Paris, France, ††Institut de Psychologie, Centre Henri Piéron,
Université Paris Descartes, Boulogne Billancourt, France
Purpose: Epilepsy with PCDH-19 mutation is an X-linked disorder.
Intellectual delay and behavioral disturbances especially autistic features
are reported in affected females. The aim of our study was to study with a
detailed methodology the Autism Spectrum Disorders (ASD) in patients
with epilepsy with PCDH-19 mutation.
Method: We included eight females aged from 5 to 17 years. Clinical
data and history was reviewed. Patients underwent an autism spectrum
disorder battery of tests and questionnaires: the Autism Diagnostic
Observation Scale (ADOS), ECAR-T, Childhood Autism Rating Scale
and Autism Diagnostic Interview-Revised questionnaires and a detailed
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interview with child psychiatrist. They also had an assessment of the cog-
nitive area using standardized tools: Wechsler tools (WISC-IV or
WPPSI-III) or the Psycho-Educative Profile-III (PEP-III).
Results: Age at seizure onset ranged from M4 to M58. 3/8 patients were
seizure free and 5/8 presented annual seizures at last visit. One patient
had no treatment, others had from 2 to 6 antiepileptic drugs. 6/8 patients
presented ASD with 4/8 patients with definite autism and 2/8 with Perva-
sive Developmental Disorder Non Otherwise Specified. Mainly, patients
presented communication and social interaction difficulties while stereo-
typies and restricted interests features are not predominant. Two groups
are emerging: a group of 2 patients with intellectual abilities in the low
average and no ASD presenting later seizure onset, another with mental
retardation and ASD (6/8). The neurodevelopmental profile is not clearly
linked to seizure and treatment on further aspects.
Conclusion: The ASD and MR comorbidity is important in our popula-
tion justifying the importance of behavioral and cognitive evaluations
and follow-up. We address the possible causal role of the mutation of the
protocadherin 19 protein beyond the seizures per se.
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PERCEIVED STRESS IN PEOPLEWITHEPILEPSY
AND ITS PREDICTORS
S.-P. Park
School of Medicine, Kyungpook National University, Neurology,
Daegu, Republic of Korea
Purpose: People with epilepsy (PWE) have been reported to be more
stressful than those without epilepsy. We investigated perceived stress in
PWE and identified its predictors.
Method: This was a case-control study. Eligible subjects who consecu-
tively visited epilepsy clinic underwent several questionnaires including
the Perceived Stress Scale (PSS), the Revised Stigma Scale (RSS), the
Korean version of the Neurological Disorders Depression Inventory for
Epilepsy (K-NDDI-E), the Generalized Anxiety Disorder-7 (GAD-7),
the Epworth Sleepiness Scale (ESS), and short forms from the Patient-
Reported Outcomes Measurement Information System (PROMIS) Sleep
Disturbance (SD) and Sleep-Related Impairment (SRI) item banks.
Results: Mean PSS score of PWE was not higher than that of people
without epilepsy (PWoE). However, that score was significantly higher
in patients with poorly controlled epilepsy (p = 0.038) or uncontrolled
epilepsy (p < 0.001) than PWoE. Univariate analyses revealed associa-
tions between the PSS score and gender, education, job, household
income, driving license, marital state, the number of antiepileptic drug
(AED), seizure control, co-administration of psychiatric drugs, AED
load, the RSS score, the K-NDDI-E score, the GAD-7 score, the ESS
score, and the PROMIS SD and SRI scores. Multivariate analyses indi-
cated that the strongest predictor for the PSS score was the K-NDDI-E
score (b = 0.375, p < 0.001), followed by the GAD-7 score (b = 0.220,
p = 0.003), and the PROMIS SRI (b = 0.161, p = 0.016) and SD
(b = 0.131, p = 0.047).
Conclusions: Perceived stress in PWE is more closely related to psychi-
atric and sleep problems than demographic, socioeconomic, and seizure-
related factors.
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PSYCHOGENICMODULATIONOF FOCALEPILEPTIC
SEIZURES: A NON-DESCRIBED PSYCHOGENIC
PHENOMENON
R. Rocamora*, M. Ley*, A. Merino†, A. Principe*
*Epilepsy Monitoring Unit, Neurology. Hospital del Mar,
Barcelona, Spain, †INAD, Hospital del Mar, Psychiatry,
Barcelona, Spain
Purpose: Psychogenic non-epileptic seizures (PNES) account for up to
30% of referrals for medically refractory epilepsy. PNES appear most
often isolated in the context of a personality disorder. However, between
5% and 40% of patients with PNES has concomitant epilepsy. Fortu-
nately, the largest numbers of PNES are clearly distinguishable from sei-
zures of epileptic origin. Therefore, patients can be divided into three
groups: epileptic seizures only, PNES only and mixed cases. We have
detected a fourth group: patients with post ictal psychogenic modulation
(PIPM) of epileptic seizures in which the psychogenic event occur timely
related to a focal seizure.
Method: We reviewed the files of patients with pharmacoresistant
focal epilepsy who underwent long-term video-EEG monitoring
(VEEGM) between January 2010 and January 2015. Most of them
underwent presurgical evaluation. All clinical files were screened for
psychogenic events during VEEGM. All selected patients were individ-
ually clustered in one of four groups: only seizures, only PNES, mixed
cases and PIPM.
Results: 565 clinical records were screened. Four patients with PIPM
of focal seizures were found. Two were female patients, with a mean
age of 33.2 years (range, 28–47 years). Two presented temporal, one
insular and one occipital lobe epilepsy. Two were left- and two right-
lateralized. Epilepsy surgery was indicated in 3 cases and was per-
formed in two with excellent outcome. Two patients were studied with
SEEG. In all cases psychogenic events occurred immediately after
focal seizures without generalization. The EEG/SEEG during the
events was normalized.
Conclusion: Psychogenic events can appear timely related with true
epileptic events. Possibly, the perception of an epileptic seizure in a small
group of patients can trigger a psychogenic reaction. This causes addi-
tional difficulties in the interpretation of ictal phenomena that could lead
to false localization/ lateralization hypothesis. Its occurrence does not
preclude the indication of epilepsy surgery.
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TREATMENTCHOICES FORATTENTION-DEFICIT/
HYPERACTIVITYDISORDER INCHILDRENWITH
ANDWITHOUT INTERICTAL EPILEPTIFORM
ABNORMALITIES
D. Socanski*, A. Herigstad†, H. Beneventi*, S. Einarsdottir*
*Stavanger University Hospital, Division of Psychiatry,
Department of Child and Adolescent Psychiatry, Stavanger,
Norway, †Stavanger University Hospital, Department of
Clinical Neurophysiology, Stavanger, Norway
Purpose: The purpose of this retrospective study was to investigate
whether interictal epileptiform discharges (IED) recorded at the atten-
tion-deficit/hyperactivity disorder (ADHD) assessment influence
pharmacological treatment choices for ADHD during 12 months fol-
low-up.
Method: Subjects were 517 ADHD children (82.4% male), aged
between 6 and 14 years, who were diagnosed between January 2000 and
December 2005 with one awake EEG at ADHD assessment. IED were
found in 39 cases, 12 of them had previous epilepsy. 39 cases with IED
(IED group) were matched on age and gender with 39 patients without
IED (non-IED group). We measured initial use of MPH, positive
response to MPH after 4–7 weeks, the use of MPH at 12 months, the use
of antiepileptic drugs (AEDs), and the use of dexamphetamine and ato-
moxetine.
Results: Of the 39 patients with IED, 36 (92.3%) cases were treated with
MPH and initial positive response to MPH was achieved in 83.3%. In the
non-IED group, initial positive response was found in 89.2%. There were
no statistically significant differences between the groups with respect to
MPH use during 12 months. The use of dexamphetamine and atomox-
etine were also without differences (2 cases in each group). In contrast,
the use of AED significantly differed in children with and without IED
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(22 (vs.) 0 cases), regardless of excluding cases with epilepsy. The use of
AEDs alone was not sufficient to reduce ADHD symptoms cases with
IED.
Conclusion: The ADHD children with and without IED differed in using
of AEDs regardless of previous history of epilepsy. The use of AEDs
alone was not sufficient to reduce ADHD symptoms. The IED-group and
non-IED group used MPH, dexamphetamine and atomoxetine similarly
during 12 months follow-up.
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EPILEPSYANDDISABILITY
F. Genc*, G. Kutlu†, G. Akca*, A. Erdal*, Y. Bicer G€omceli*
*Antalya Research and Training Hospital, Antalya, Turkey,
†Mugla SK University School of Medicine, Mugla, Turkey
Introduction: Epilepsy is a chronic disease that results in the loss of
labor and disability. Despite appropriate medical and surgical treatments
patients who experience frequent seizures should be protected by
socially. In Turkey by the rules of Social Security Institution patients are
entitled to disability retirement if they have more than three generalized
tonic clonic seizure in a month or more than two complex partial seizure
in a week.
Method: According to decisions at the health board of Antalya Educa-
tion and Research hospital, patients who followed-up by the second stage
hospitals or had no follow-up would be followed-up at least 3 months
with appropriate and adequate treatment than final decision would be
given. In this study we searched retrospectively the patients who applied
retirement because of disability between January 2014 and January 2015.
All of this patients were evaluated by the experienced neurologists. All
demographic characteristics, type of epilepsy, beginning age, frequency
of seizures were saved. Patient were followed-up at least three months or
monitored at video EEG laboratory.
Results: 39 patients (31 male, 8 female) enrolled to the study. The
mean age was 41.8 years, duration of epilepsy was 20.4  12.6 years
(min 6 months- max. 46 years). At last 7 patients were suitable for dis-
ability retirement and 16 were not. 14 patients withdrew applications.
Finally understood that two patients have syncope attacks rather than
epilepsy.
Conclusion: In the follow-up of patients with epilepsy the management
of medical therapy is not enough alone, we must educate the patients
about their social benefits. Patients who have frequent seizures that
obstacle working, should be promoted as social and financial by the
social state. However this issue is open to abuse, people who deserve to
be determine objectively.
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ADAPTATIONTRAININGAS PSYCHOSOCIAL
EMPOWERMENT INTERVENTION IN EPILEPSY
M. Nylén, M. Niskanen
The Finnish Epilepsy Association, Helsinki, Finland
Epilepsy can have far-reaching psychological and social consequences,
which can be more debilitating than the seizures themselves. As a part of
the Best Practice Guidelines of Epilepsy in Finland, the Finnish Epilepsy
Association has since 1974 implemented adaptation training courses for
people with epilepsy and their family members as an interventive mea-
sure to improve coping with epilepsy.
Case presentation: The purpose of adaptation training is to promote
well-being, decision-making and self-management of epilepsy. Thus, the
training potentially enables people with epilepsy and their family mem-
bers to lead as full a life as possible. This is pursued by adopting an
empowerment-based, collaborative approach, targeting the real life chal-
lenges of living with epilepsy.
Adaptation training is implemented as outpatient and inpatient courses
with governmental funding and 350-450 participants yearly. Inpatient
courses take 5–10 days. Outpatient group-training takes several weeks
and consists of weekly meetings.
The provision of basic facts about epilepsy and individual and peer
support are the key components of adaptation training. The peer group
provides a forum for the exchange of personal experiences and creates an
environment of mutual support. Peer support and collaborate learning
help participants develop new skills and boost their confidence and self-
esteem.
Discussion: The functional goal attainment is evaluated with the Goal
Attainment Scaling (GAS) method. GAS includes defining a set of indi-
vidual goals and evaluating the outcome using a unique scale that reflects
concrete activities. Preliminary results from GAS suggest that the out-
comes of adaptation training are more positive than expected. Final
results will be reviewed in the poster presentation.
Feedback from participants indicates that adaptation training has met
their needs and helped them better understand their epilepsy. Further-
more it provides an opportunity for positive peer support. Post-interven-
tion outcome inquiry indicates an overall positive trend in psychosocial
empowerment.
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EPILEPSIES: KNOWLEDGE, SOCIAL
REPRESENTATION, PERCEPTIONS AND STIGMA
AMONGUNDERGRADUATEHEALTH SCIENCES
STUDENTS FROMABRAZILIAN PUBLIC UNIVERSITY
F.O. Rosa*, S.H.S.S. Batista*, A.V. Silva†
*Universidade Federal de S~ao Paulo, Santos, Brazil,
†Universidade de S~ao Paulo, S~ao Paulo, Brazil
Purpose: To investigate the knowledge, social representations, percep-
tions and stigma among students in health sciences (non-medical stu-
dents) of a Brazilian public university.
Method: Students in the first and last year of the courses Physical Educa-
tion, Physiotherapy, Nutrition, Psychology, Social Work and Occupa-
tional Therapy (n = 372) from UNIFESP answered a questionnaire on
epilepsy consisting of 53 items sub-divided into seven groups. The
Stigma Scale of Epilepsy (SSE) was also used to measure the perception
of stigma. Questionnaires and SSE were presented in two versions: one
with the term “person with epilepsy”, another with the term “epileptic”.
Knowledge of epilepsy and SSE were graduated from 0 to 100 to com-
pare groups.
Results: The mean student’s grade showed no significant increase,
comparing the first (53.0  15.3) and last (57.2  15.6) years. There
was no difference in the scores obtained from questionnaires using
the word “epileptic” (55.3  16.2) and “person with epilepsy”
(55.1  14.9). The mean SSE of last-year students (38.6  15.4) was
lower than the mean of first-year students (42.7  15.1), regardless
of the questionnaire presented. Regarding last-year students, 29.23%
reported having contact with the subject. There was low performance
in items on epidemiology (30.2%), etiology (32.37%) and treatments
(39.52%). Regarding the procedure during a seizure, 51.88% did not
try to contain a person and 27.96% would not put something in the
patient’s mouth to avoid suffocation or choking. Almost forty percent
of students do not associate epilepsy to mental illness, 15.32% do not
consider mental disorders as a cause of epilepsy and 43.28% believe
that people with epilepsy often do not have psychiatric disorders.
Less than twenty percent of students feel prepared for professional
practice.
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Conclusion: It will be necessary to identify trends and gaps in knowl-
edge to develop strategies to minimize the lack of information and stigma
on epilepsy to formmore enlightened professionals.
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ARECREATION PROGRAMTODEVELOP PHYSICAL
LITERACY SKILLS IN CHILDRENWITHEPILEPSY
M. Secco*,†, T. Vercillo*, A. Martiniuk‡,§
*Epilepsy Support Centre, London, Canada, †Ontario Brain
Institute, Toronto, Canada, ‡University of Sydney, Faculty of
Medicine, Sydney, Australia, §The George Institute for Global
Health, Senior Research Fellow, Sydney, Australia
Purpose: The majority of parents using the Epilepsy Support Centre
summer camp program described their child with epilepsy as “inactive”
or “reluctant” to participate in gym class or community sports. Literature
suggests that if children with epilepsy withdraw from physical activity
and sports, they turn to more unhealthy choices and become sedentary
and isolated. This could result in the development of further medical con-
ditions such as obesity, Diabetes, Depression and heart disease. There-
fore, an 8 week physical literacy curriculum was implemented into an
existing summer camp. The program was designed based on Active Start
and FUNdamentals physical literacy curriculum from Physical and
Health Education Canada (PHE). The PHE physical literacy curriculum
is evidence based and helps to develop physical coordination, gross
motor skills, posture, balance, and confidence.
Methods: The program was evaluated using parent feedback, daily
observation logs, and standardized skills assessments. The Physical Lit-
eracy Assessment for Youth (PLAY) tool was used to assess children0s
physical literacy skills pre and post camp. This tool has been validated
through Canadian Sport for Life.
Results: Thirteen children aged 4–12 were included in the analyses. Pre-
liminary data analysis reveals that on average, object manipulation with
the upper body improved the most (40.6%), followed by balance
(37.7%), lower body object manipulation (33.3%), locomotor skills
(24.1%), and running abilities (21.8%). The biggest challenges for the
facilitators was modifying the program to meet the needs of the partici-
pants with cognitive and behavioural challenges.
Conclusion: Previous research demonstrates that physical literacy tea-
ches children to have the competence, confidence and motivation to
apply the fundamental movement and sport skills in new situations. Our
study observed on average a 30% improvement in physical skills. We
expanded the program and now offer a 2 hour recreation program on
Saturday mornings year round.
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THEDIFFERENCES IN BEINGDIFFERENT: A
NARRATIVEANALYSIS OF THENATUREOF
EPILEPSY INADULTS AND ITS PROBLEMS
D.A. Snape
University of Liverpool, Public Health, Liverpool, United
Kingdom
Purpose: Epilepsy is not just a medical condition but a social label; suc-
cessful clinical treatment is therefore only one aspect of epilepsy man-
agement. Mismatches between the medical model of “treat the seizures”
and the lay model of “learning to manage a life with epilepsy” not only
negatively impact on patient expectations and concerns, but also on clini-
cians’ knowledge and interpretations of patients’ concerns. This scenario
can potentially negatively impact on the outcomes of clinician-patient
consultations.
Method: The voice of the individual living with epilepsy is at the core
of this qualitative study. Drawing upon research on illness narratives, I
elicited the illness stories of fourteen adults (7 male; 7 female) with
epilepsy to explore how the condition impacts directly or indirectly on
daily living and life trajectories, and to re-present the diverse nature
and meaning of having epilepsy, including its stigma potential. I con-
ducted in-depth interviews with participants attending epilepsy outpa-
tient clinics. Transcripts were subjected to paradigmatic and narrative
analysis in order to examine thematic similarities and differences. Par-
ticipant stories were identified using Mishler’s theoretical model of
“Core Narrative”.
Results: What emerged was a discourse of disruption and difference.
Epilepsy often imposed barriers to daily living and maintaining a positive
sense of self. While the stories told were uniquely individual, collectively
a dominant plot emerged. For those with epilepsy in this study the plot
takes the individual from a beginning of “discovery and diagnosis”,
through the process of “searching for a cause”, “negotiating risk and
uncertainty”, and, “striving for control”.
Conclusion: Attention to patient stories provides insight into how expe-
rience is constructed and evolves over time. Due consideration of such
stories by health professionals can offer direction in which intervention
(s) can occur to ensure the interests and needs of the individual with epi-
lepsy are holistically considered and met.
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PATIENT’S PERCEPTIONS REGARDINGVARIOUS
STAGESOF THEIR EPILEPSYALONGTHE
EPILEPTO-SEQUENCE TIMELINE
S. Tiamkao*,†, A. Talkul Kuster‡, J. Saengsuwan‡,
S. Boonyaleepan§, S. Tiamkao†,¶
*Khon Kaen University, Medicine, Khon Kaen, Thailand,
†Integrated Epilepsy Research Group, Khon Kaen University,
Khon Kaen, Thailand, ‡Faculty of Public Health, Khon Kaen
University, Khon Kaen, Thailand, §Faculty of Nursing, Khon
Kaen University, Khon Kaen, Thailand, ¶Faculty of Medicine,
Khon Kaen University, Department of Pharmacy, Khon Kaen,
Thailand
Purpose: Preventing a seizure by developing methods that could discon-
tinue the initiation of an epilepto-sequence would obviously be beneficial
for an epileptic’s treatment efficacy and quality of life (QOL). This study
aims at describing patient’s perceptions of their epilepsy along the epi-
lepto-sequence timeline in Northeastern Thailand by cross-sectional
design.
Method: A survey was conducted with people with epilepsy in an epi-
lepsy clinic of university hospital,Khon Kaen, Thailand. This research
was based on a cross-sectional design so to evaluate epileptic patients’
knowledge, attitudes and perceptions regarding epilepsy.
Results: Two hundred and three epileptic patients were randomly
recruited. More than half of the patients in our study (55.2%) had an
aura prior to their seizure. Methods such as deep breathing, focusing
on a point and mindfulness were used to try and prevent the seizure.
Seizures were believed to be triggered by having an illness, hunger,
flashing lights and the weather. During seizures, 87.2% of patients
knew who and how a person was assisting them during a seizure.
However, 82.3% could not describe the characteristics of their seizure.
Patients worried about cognitive losses due to seizures, but in general,
patients were happy with their medical treatment even when their sei-
zures had not been eliminated.
Conclusion: Patient’s perceptions related to their epilepsy may be
used to develop individualized regimens to stop a seizure progression
before it develops. In addition, patients may be able to improve their
QOL by more fully understanding how epilepsy affects them person-
ally.
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CHANGINGTHEWAYEPILEPSYCARE IS
DELIVERED - AUDITOFAMULTIDISCIPLINARY
EPILEPSYOUTREACHCLINIC TOAN
INTELLECTUALDISABILITY FACILITY SUPPORTED
BYANELECTRONIC PATIENTRECORD
M.White*, M. Fitzsimons*, J. Banguiran†, J. O Connor†,
A. Ambikapathy†, J. Lane†, N. Delanty*
*Beaumont Hospital, Department of Neurology, Dublin, Ireland,
†Daughters of Charity Disability Support Services, Dublin,
Ireland
Purpose: People with an intellectual disability (ID) referred to hospital-
based specialist epilepsy clinics face lengthy delays from time of referral,
and may experience frustrating delays on the day of clinic leaving them
stressed and uncooperative. The delays experienced reduce the numbers
of people with severe behavioural problems being referred and the fre-
quent unavailability of key nursing staff attending hospital appointments
impacts upon the quality of information available at specialist epilepsy
clinics.
Method: This study audits a multidisciplinary epilepsy outreach clinic
in one ID facility over a 2 year period. This was facilitated by the avail-
ability of an electronic patient record (EPR). Follow up care between
scheduled appointments was provided by the hospital-based epilepsy
nurse telephone service supported by the EPR.
Results: The advanced nurse practitioner in epilepsy attended 14 out-
reach clinics that provided 100 appointments for 40 individual patients
(newly referred and existing patients). The consultant neurologist
reviewed all newly referred patients at 4 clinics. Five newly referred
patients could not have attended hospital-based appointments due to
coexisting psychiatric and behavioural problems. Key nursing personnel
attended all epilepsy outreach clinic appointments providing good qual-
ity clinical information.
Waiting time for first appointments was reduced from 12 months pre-
viously to <3 months.
Delays on the day of appointment never exceeded 35 min. The “did
not attend rate” was 3% compared to 27% at hospital based epilepsy out-
patient clinics.
Preliminary figures show that staff at the ID facility reported that
patients were less stressed being seen in a familiar environment. They
cited improved continuity of care (75%) increased educational opportuni-
ties (82%) and satisfaction with care between appointments (65%) as
additional benefits.
Conclusion: Changing from a hospital-based epilepsy outpatient clinic
to a multidisciplinary epilepsy outreach clinic supported by an EPR
enhances the outpatient encounter for patients and staff from both ser-
vices.
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TIME-DEPENDENT EFFECTSOF LACOSAMIDE,
KETAMINEANDCOMBINATIONKETAMINEAND
DIAZEPAMTREATMENT INARAT LITHIUM-
PILOCARPINEMODELOF STATUS EPILEPTICUS
V.-H. Nguyen*, B.A. Roger†, S. Dergalust*, C.G. Wasterlain†,‡
*VA Greater Los Angeles Healthcare System, Neurology and
Pharmacy, Los Angeles, CA, United States, †VA Greater Los
Angeles Healthcare System, Los Angeles, CA, United States,
‡University of California, Neurology, Los Angeles, CA, United
States
Purpose: Time-dependent development of pharmacoresistance to
GABAergic benzodiazepines has been reported in the rat lithium-pilocar-
pine model of status epilepticus (SE). Our objective in this study was to
evaluate for time-dependent effects of non-GABAergic agents, lacosa-
mide and ketamine, as well as assess whether the addition of ketamine to
diazepam could overcome the time-dependent loss of efficacy seen with
benzodiazepines.
Method: Wistar rats were implanted with electrodes for EEG recording.
After pretreatment with LiCl, SE was induced by intraperitoneal injection
of pilocarpine 60 mg/kg. Lacosamide, ketamine, or ketamine + di-
azepam was administered as either pretreatment (prior to pilocarpine
injection), early treatment (at 2nd stage 3 Racine seizure), and/or late
treatment (20 min after 2nd stage 3 Racine seizure). Controls received
normal saline.
Results: Lacosamide 50 mg/kg suppressed onset of SE if given prior to
pilocarpine but was unable to suppress SE if administered as early or as
late treatment. Ketamine 30 mg/kg did not suppress onset of SE even if
administered as pretreatment. After seizure induction, ketamine 30 mg/
kg did stop SE in only some pretreatment and early treatment animals.
Ketamine at an increased dose of 100 mg/kg was able to consistently stop
SE when administered early in all animals tested. Neither dose of keta-
mine was able to stop SE when administered as late treatment. Early
administration of diazepam + ketamine 30 mg/kg did stop SE in most
animals, but did not stop SE if administered late.
Conclusion: Time-dependent development of pharmacoresistance was
observed with all agents and combination of agents tested. If adminis-
tered early enough, pharmacoresistance may be overcome by increasing
an agent’s dose as evidenced by our results with high doses of ketamine.
However, if administered too late in the time course, neither high doses
nor combination of agents could halt SE, supporting the current thought
that SE should be treated as quickly as possible.
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PEDIATRIC STATUS EPILEPTICUS: EVALUATIONOF
TREATMENTANDPROGNOSIS
N. Olgac Dundar*, E.E. Sınmaz†, D. Cavusoglu‡, A.B. Anıl‡,
N. Sık†, B. Sarioglu†
*Izmir Katip Celebi University, Pediatric Neurology, Izmir,
Turkey, †Izmir Tepecik Training and Research Hospital, Izmir,
Turkey, ‡Izmir Katip Celebi University, Izmir, Turkey
Purpose: Status epilepticus is associated with high rates of morbidity
and mortality, early diagnosis and proper treatment are of critical impor-
tance. In this study, the medical records of one hundred patients between
1 month and 18 years of age were retrospectively revised. The demo-
graphic characteristics, treatment protocol and prognosis of patients were
evaluated. Thus better management of the future patients was aimed.
Method: One hundred patients (35 girls and 65 boys) with a mean age of
60 months (range 1 months–18 years) were evaluated retrospectively.
Statistical analysis was performed using the Statistical Package for Social
Sciences, version 15. Fisher-Exact test and chi-square tests were used to
analyze the data. p < 0.05 was considered statistically significant.
Results: Seizures had stopped with the first line treatment (diazepam
and/or midazolam) in 29% of the patients, with the second line treatment
(phenytoin and/or valproic acid and/or levetiracetam) in 36% of the
patients, with the third line treatment (midazolam infusion or thiopental
infusion) in 35% of the patients.
Conclusion: During the average 36.5 months follow up period while
mortality rate was 10%, morbidity rate was 90%. Mortality was signifi-
cantly much more in the patients with refractory seizure and cerebral
palsy (p < 0.05). Epilepsy, hemiparesis, spastic tetraparesis and mental
retardation developed in seven percent, two percent, two percent and
three percent of the patients, respectively. Development of mental retar-
dation was muchmore higher in the male gender (p < 0.05).
Epilepsia, 56(Suppl. 1):3–263, 2015
doi: 10.1111/epi.13241
258
Abstracts
p1057
COGNITIVE FUNCTIONAFTER STATUS
EPILEPTICUS
K.N. Power, A. Gramstad, N.E. Gilhus, B.A. Engelsen
University of Bergen/Haukeland University Hospital, Dept. of
Neurology, Bergen, Norway
Purpose: Status epilepticus (SE) can be fatal or cause severe sequelae.
Cognitive impairment is a feared consequence, but there is a lack of stud-
ies systematically investigating this.
Our aim was to conduct systematic cognitive evaluation of patients
after SE, with the hypothesis of finding medial temporal lobe dysfunc-
tion.
Method: Patients were tested when considered clinically recovered from
SE. A computerised cognitive test battery (CANTAB) was used. Tests
were: Motor Screening Task (MOT), assessing speed and accuracy;
DelayedMatching to Sample (DMS), assessing forced choice recognition
memory; Paired Associates Learning (PAL), assessing visual memory
and new learning; Stockings of Cambridge (SOC), measuring nonverbal
planning and execution. Patients with mental retardation, life expectancy
<1 year, or progressive neurological illness were excluded. Bootstrap for
one-sample t-test was used for analysis.
Results: 31 patients were included, mean age 54 years, 25 men, 21 with
convulsive and 10 with nonconvulsive SE. Z-scores were compared to
norm data for: MOT Mean Latency 0.38, p = 0.202, DMS Total Cor-
rect 0.71, p = 0.003, DMS Mean Correct Latency 1.12, p = 0.001,
PAL Total Trials Adjusted1.13, p = 0.023, PAL Total Errors Adjusted
1.74, p = 0.008, SOC Mean Initial Thinking time 2 moves 1.03,
p = 0.009, no significant findings for SOC thinking time > 2 moves, for
SOCmean moves or for SOC problems solved in minimummoves.
Conclusion: Patients performed significantly poorer on tests of memory
and early phase problem solving compared to published norms.
In contrast, motor speed and complex executive function was mostly
normal. Our findings support the hypothesis of accentuated temporal lobe
dysfunction after SE. No significant differences between nonconvulsive
and convulsive SE were found.
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LACOSAMIDE (LCM) IV IN STATUS EPILEPTICUS
(SE): SHOULDBE LOADINGDOSEADJUSTED BY
WEIGHT?
E. Santamarina*, M. Gonzalez*, M. Toledo*, M. Jimenez†,
J.L. Becerra†, A. Quílez‡, M. Quintana§, X. Salas-Puig*
*Vall d Hebron University Hospital. Universitat Autonoma de
Barcelona, Epilepsy Unit, Barcelona, Spain, †Hospital Germans
Trias i Pujol, Epilepsy Unit, Barcelona, Spain, ‡Hospital Arnau
de Vilanova, Neurology, Lleida, Spain, §Vall d Hebron
University Hospital. Universitat Autonoma de Barcelona,
Barcelona, Spain
The optimal dosing of LCM for SE is not clearly defined. Some studies
reported a better response with higher doses; however it is unclear if the
loading dose should be adjusted by weight (as other AEDs).
We aimed to evaluate the relationship between loading dose and the
efficacy of LCM in SE.
We performed an analysis of a group of SE patients treated with LCM.
We collected demographics, SE type, etiology, response rate, last AED
used, line of treatment in which LCM was used, total loading dose and
adjusted by weight.
Results: 71 SE were evaluated, 47.9% were non-convulsive. Mean
age:62.4 + /-18. 60.6% were men. Regarding the etiology: 39.4% were
acute symptomatic, 40.8% delayed symptomatic, 4.2% progressive
symptomatic and 14.1% remained as cryptogenic. 66.2%were refractory.
The dose used was < /= 200 mg in 32.4%, 300–400 mg in 64.8% and
>400 mg in 2.8%. The adjusted dose was < 4 mg/kg in 32.4%, 4–6 mg/
kg in 42.3% and >6 mg/kg in 25.4% (median 5 mg/kg). The response
rate was 74.6%, and 53.6% responded within 24 hours. Regarding effi-
cacy, no relationship was observed regarding the dose in mg (p = 0.86)
or adjusted by weight (p = 0.59). The response was similar in all etio-
logic groups, however in the delayed symptomatic, the response was
slightly higher at doses >4 mg/kg, while in the other groups (symp-
tomatic acute, progressive or cryptogenic) a better response was observed
using >6 mg/kg. In any case, the differences were not significant. In
responders, we found a faster response when LCM was used earlier, but
without finding relationship between speed of response and the adjusted
dose (p = 0.32).
Conclusion: In our SE population, with a median dose of 5 mg/kg of
LCM, we achieved a response rate of 74.6%. There is no clear relation-
ship between increased efficacy or faster action and the ranges of used
doses adjusted by weight.
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IMPACTOFNONCONVULSIVE STATUS
EPILEPTICUS’RECOGNITIONONBRAIN TUMOR
PATIENTSMANAGEMENTS
B. Aktekin*, C.A. Bing€ol*, C. Sayman*, O. Eranıl Terim*,
B. Ormeci*, U. Ture†
*Yeditepe, Neurology, Istanbul, Turkey, †Yeditepe,
Neurosurgery, Istanbul, Turkey
Purpose: The prevalence of nonconvulsive status epilepticus (NCSE) in
brain tumor patients is unknown. The semiology of NCSE covers a wide
range of neurological symptoms, which can be confused with several
condition such as tumor progression or edema. Since NCSE has been
associated with significant mortality and morbidity, differential diagno-
sis is essential. This study describes the clinical and EEG characteristics
and outcome in brain tumor patients with NCSE.
Method: All patients admitted to our neurosurgery department from
2009 to 2014 with a diagnosis of brain tumor were cross-referenced with
epilepsy department’s database were included. Relevant information
from the neurological records of the patients with NCSEwas extracted.
Results: 981 brain tumor patients were identified, of which 304 (30.9%)
had an EEG and 12 (1.2%) had NCSE. The majority of seizures were
diagnosed by consulting neurologist although two patients having only
subclinical seizures in which detected by EEG recording. Although, five
of 12 patients, had grade IV glioblastoma, the NCSE emerged with dis-
ease progression, the remaining 7 patients had different pathologies and
occurrence of the NCSE were not related with disease progression. In the
later group, the NCSE resolved in 6 of the 7 patients with improvement in
overall level of function.
Conclusion: On one hand, the NCSE in brain tumor patients may associ-
ated with tumor progression and decreased survival time, but also in other
hand highly treatable in subgroup of patients with significant improve-
ment in quality of life.
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SUPER-REFRACTORY STATUS EPILEPTICUS (SRSE):
CLINICALCHARACTERISTICS, TREATMENT
APPROACHANDPROGNOSIS IN FOURMEDICAL
CENTERSOFBUENOS AIRES
W. Silva*, M. Canabal†, R. Diaz†, B. Comas*, G. Imhoff†,
M. Aberastury*, B. Daniela†, M. Garcia*
*Hospital Italiano de Buenos Aires, Buenos Aires, Argentina,
†Instituto Argentino de Investigaciones Neurologicas, Buenos
Aires, Argentina
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Purpose: Analyze clinical characteristics, treatment approach and short
term prognosis in a group of patients with SRSE.
Method: Descriptive, retrospective study of 9 patients with SRSE in 4
Medical Centers of Buenos Aires from June 2012 to June 2014. We ana-
lyze demographics, previous history of epilepsy, etiology, type of SE,
treatment approach, duration of Intensive Care Unit (UCI) stay, short
term prognosis and mortality.
Results: The median age was 39 years old. Forty four percent of them
had previous history of epilepsy. The etiologies were Anti-NMDA
encephalitis (n = 1), hypoxic-ischemic encephalopathy (n = 1), brain
tumor (n = 1) and unknown cause (n = 5). Forty four percent were con-
vulsive SE, 33% of them evolved to nonconvulsive SE. Twenty two per-
cent were non convulsive from the onset. The antiepileptic drugs more
frequently used were Levetiracetam (89%), Phenytoin (78%), Valproate
sodium (78%) and Phenobarbital (68%).The anesthetic drugs used
included Midazolam (89%), Propofol (67%), Thiopental (67%) and
Ketamine (44%) with more than 2 anesthetic drugs used in 44% of the
patients. Sixty seven percent received non farmacological treatment
which included ketogenic diet (n = 3), immonumodulatory treatment
(Steroids n = 4, IgIVn=3) and resective surgery (n = 1). The stay in ICU
was more than a month long in 67%. Mortality was 22% (n = 2) and the
3 month prognosis was severe disability in 44% (modified Rankin
Scale).
Conclusion: In our case series more than half of SRSE were of unknown
cause and the most frequent onset was as convulsive SE. Levetiracetam
was the AED more frecuently used and Midazolam the anesthetic drug
more indicated. A prolonged stay in ICU was observed in the majority of
patients with a high morbidity and mortality.
Status Epilepticus 4
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USEFULNESSOFKETOGENIC DIET (KD) IN THE
MANAGEMENTOF SUPERREFRACTORY STATUS
EPILEPTICUS (SRSE) IN PEDIATRIC PATIENTS
F. Solari, X. Varela, X. Raimann, F. Castro, P. Reyes, J. Pavlov,
C. Margarit, J. Osorio
Clínica Las Condes, Departamento Pediatría, Santiago, Chile
KD is a therapeutic choice in Refractory Epilepsy (RE). Studies have
demostrated than 16% of patients become seizure free and 32% experi-
ence a seizure reduction greater than 90%, which is a much better
response than any other add on antiepileptic drug in RE. It has been
reported, as well, its utility in the management of SRSE.
Purpose: To analyze the utility of KD in the management of SRSE in
pediatric patients.
Method: Retrospective review of clinical charts in pediatric patients
under control at Clinica Las Condes, in the period January 2007–Decem-
ber 2014, in SRSE patients who underwent through classic KD. Etiology,
age at onset of KD, therapeutic response in the acute management, follow
up and adverse effects.
Results: 7 patients, 4 males, age at onset of epilepsy 10.1 months (me-
dian 3 months). Etiology: Epileptic Encephalopathy 6/7. Age at onset of
KD 36 months (median 23 months), 3/7 still on KD at cut-off (2
deceased and 2 discontinued because of adverse reactions). With KD 6/7
terminated SRSE in 5 days average. At 3 months follow up, 3 remain sei-
zure free, 3 experienced 50–90% seizure reduction, 1 < 50%, neverthless
was abled to wean ventilatory support. Positive ketonuria were achieved
before the third day. (n = 6), betahydroxibutyrate between 48 to 96 horas
1.2 mmol/L. No adverse effects were reported concerning KD in the
treatment of SRSE.
Conclusion: In this group of patients KD was highly effective in the
management of SRSE, notably those associated to MRI negative epilep-
tic encephalopathy.
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USEOF PERAMPANEL (PER) IN TWOCASESOF
SUPER-REFRACTORYHYPOXICMYOCLONIC
STATUS
M. Sueiras*, E. Santamarina†, R.M. Lidon‡, L. Guzman*,
J. Ba~neras‡, M. Gonzalez†, M. Toledo†, X. Salas-Puig†
*Hospital Vall d’Hebron, Department of Neurophysiology,
Barcelona, Spain, †Hospital Vall d’Hebron, Epilepsy Unit,
Barcelona, Spain, ‡Hospital Vall d’Hebron, Cardiac Care Unit.
Department of Cardiology, Barcelona, Spain
Purpose: Proper treatment of hypoxic myoclonic status is not clearly
determined. Induced hypothermia is improving prognosis and a more
aggressive treatment might be beneficial in some patients. Among the
new options of antiepileptic drugs, Perampanel (PER) is a drug with a
novel mechanism and it might be a promising drug for status or as an
anti-myoclonic drug.
Method: We describe the use of PER in two patients with hypoxic
super-refractory myoclonic status.
Description of cases:: Case 1: A 51 year-old patient presented an out-
of-hospital cardiac arrest due to an acute myocardial infarction. The
patient started a clinical and electrical (EEG) myoclonic status at
rewarming phase. Several treatments were used, starting with clon-
azepam, valproate, sedation (midazolam, propofol) and subsequently
barbiturate-induced coma with persistent myoclonic status. Finally we
decided to try PER (dose: 6–8 mg) through a nasogastric tube, showing a
marked improvement of EEG activity and myoclonus decrease. The
patient had a progressive clinical improvement, with a, CPC (Cerebral
Performance Category) scale score of 1.
Case 2: A 66 year-old patient presented an out-of-hospital cardiac
arrest, and started a clinical myoclonic status confirmed by EEG at
rewarming phase. Despite being treated with levetiracetam, valproate
and lacosamide, clinical and EEG status persisted; an increasing sedation
did not subjugate the situation, therefore we decided to test PER.Myoclo-
nus improved as well as neuronal excitability in the EEG recording. The
neurological exploration improved mildly (CPC 3) however, 23 days
after admission the patient developed a cardiogenic shock leading to
death.
Conclusion: These cases might show the usefulness of PER as a thera-
peutic option in super-refractory hypoxic status. This could raise the pos-
sibility of an earlier use even before increasing sedation or inducing
barbiturate coma.
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A PATTERNOFCHANGES INNEUROTRANSMITTER
GENE EXPRESSIONCORRELATEDWITHEEG
STAGESDURINGLITHIUM/PILOCARPINE-INDUCED
EXPERIMENTAL STATUS EPILEPTICUS
D.M. Treiman, D.E. Schooley, S.T. Marsh, L.J. Treiman
Barrow Neurological Institute, Neurology, Phoenix, AZ, USA
Purpose: Status epilepticus (SE) is a dynamic condition in which EEG
patterns and convulsive behavior evolve if seizure activity continues. To
better understand the pathophysiology of SE we studied the expression of
specific genes associated with selected neurotransmitters in rats at
defined EEG stages of SE (Treiman et al., Epilepsy Res 5:49–60, 1990).
Method: Five days after implantation of epidural screw electrodes, SE
was induced in 180 g male Sprague-Dawley rats by injection of LiCl,
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3 mmol/kg IP, followed 20 hours later by pilocarpine, 30 mg/kg SC.
Control rats were given LiCl plus saline and did not develop SE. Experi-
mental rats were sacrificed 5 minutes after onset of SE EEG stage I, III,
V, and V + 4 hours by isoflurane anesthetization and decapitation.
Brains were removed and dissected for hippocampus and cortex samples.
RNA was extracted, pooled, and then amplified by PCR and analyzed
using Qiagen RT2 Profiler PCR Rat GABA & Glutamate arrays. Statisti-
cal significance was set at p < 0.05.
Results: Eighty-four mRNAs were analyzed for each pooled sample.
Adenylate cyclase 7, GABAAR a6, glutamate receptor metabotropic 4,
phosphoglycerate dehydrogenase, proline dehydrogenase, solute carrier
family 1 member 6, and solute carrier family 1 member 7 all exhibited a
similar pattern: reduction in expression compared to controls during EEG
Stage I and III, significant increase in expression at EEG Stage V com-
pared to Stage 3, followed by a substantial decrease in expression 4 hours
after onset of EEG Stage V. This pattern was noted primarily in genes
from hippocampal tissue with only GABAAR a6 from cortical tissue dis-
playing the same pattern.
Conclusion: A subgroup of neurotransmitter receptor/transport-asso-
ciated genes displayed a marked pattern of gene expression changes dur-
ing the progression of experimental SE through specific EEG changes.
The observations from this study may provide further insight into the
underlying pathophysiology of SE.
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POSTICTAL SERUMAMMONIA: A BIOMARKEROF
GENERALIZED TONIC-CLONIC SEIZURE?
U. Uysal*, R. Albadareen*, J. He†, P. Landazuri*,
N. Hammond*
*University of Kansas Medical Center, Neurology, Kansas City,
KS, USA, †University of Kansas Medical Center, Biostatistics,
Kansas City, KS, USA
Purpose: Transient increase in serum ammonia was recently reported in
patients following generalized tonic-clonic seizures (GTCS), without
sufficient evidence to confirm the epileptic nature of the spells. We
wanted to determine if this postictal increase occurs in different types of
convulsions (epileptic vs nonepileptic) as confirmed electrographically
using continuous video EEGmonitoring (cvEEG).
Method: Patients older than 18 years-old admitted to the epilepsy moni-
toring unit were enrolled in this study. Serum ammonia levels were
drawn from patients at baseline, within 60 minutes of the first event of
interest (epileptic vs nonepileptic) and 24 hours after that event or prior
to discharge whichever comes first. Patients were grouped according to
the cvEEG result. Descriptive statistics and appropriate parametric/non-
parametric methods were used to analyze the data. Mean is used for nor-
mally distributed data and median is used for non-normally distributed
data.
Results: To date, a total of 19 patients with generalized convulsions were
enrolled, 11 GTCS and 8 psychogenic nonepileptic spells (PNES). Mean
age was 30.4  12.2 years and 34.8  10.1 years, respectively. Mean
baseline, median after event, median after 24 hour ammonia levels and
median change from baseline were 43.9  9.8 ml/l (median 39.0 ml/l),
83.0 ml/l, 35.0 ml/l and 46 ml/l in GTCS group and 35.0  10.6 ml/l
(median 37.5 ml/l), 37.0 ml/l, 30.5 ml/l and 1.5 ml/l for PNES group,
respectively. The median change in serum ammonia from baseline after
the index event was significantly different between the groups (p-value:
0.0166).
Conclusion: Despite the small number of our patient sample, there
was a statistically significant increase in serum ammonia following
convulsions in GTCS when compared to PNES group. These prelimi-
nary results suggest a possible role for ammonia as a biomarker for
electrographic convulsive seizures. Further studies are required to con-
firm these results and define the time frame within which this test can
be utilized.
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NONCONVULSIVE STATUS EPILEPTICUS IN AN
URBANACADEMIC TERTIARYMEDICALCENTER
U. Uysal*, T. Shireman†
*University of Kansas Medical Center, Neurology, Kansas City,
KS, USA, †University of Kansas Medical Center, Preventive
Medicine and Public Health, Kansas City, KS, USA
Purpose: The aim of this study is to characterize cohort of nonconvul-
sive status epilepticus (NCSE) patients in an urban tertiary academic care
center.
Methods: We performed a comprehensive retrospective review of elec-
tronic medical records and digital EEG or continuous video EEG of
patients admitted and treated between January 1st, 2009 and June 30th,
2014. We included patients who had NCSE according to clinical findings
and EEG criteria by Beniczky et al., and excluded patients with Creutz-
feldt-Jacob disease or anoxic brain injury at presentation. We collected
data on demographics, clinical findings at the onset of NCSE, co-morbid-
ities, history of epilepsy, underlying etiology, presence of coma, neu-
roimaging, duration of NCSE (in days), length of stay (LOS), treatment,
presence of sepsis during the course, outcome and disposition. We used
Status Epilepticus Severity Score (STESS) to grade the severity of
NCSE.
Results: The search revealed 188 patients, 45 of which were included.
Mean age was 56.3  14.9 years, and 44% were male. All patients had
altered mental status (AMS) ranging from confusion to coma and 53%
had subtle motor findings. Subtle status epilepticus was seen in 31% of
the patients with NCSE. Twenty patients (44%) had acute neurologic
pathology. Individual etiologies were epilepsy (40%), infection (13%),
intracranial hemorrhage (11%), encephalitis (11%) and medication effect
(9%). Twenty-two patients (49%) had STESS >1. Benzodiazepines were
first treatment in 62% patients. Intravenous anesthetic drugs were used in
31 (69%) patients. Median length of time to EEG resolution was 1 day
(mean:2.0  2.1 days). Mean LOS was 21.5  18.6 days. In-hospital
mortality rate was 29%.
Conclusion: We characterized a cohort of patients with NCSE and
showed similar findings to previous reports. NCSE has high mortality rate,
and presents commonly with AMS and subtle motor findings. History of
epilepsy and acute neurologic pathology are most common etiologies.
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CLINICAL PROFILEOFBULGARIAN PATIENTSWITH
STATUS EPILEPTICUS
E. Viteva*, O. Chaneva†
*Medical University - Plovdiv, Department of Neurology,
Plovdiv, Bulgaria, †Medical University - Plovdiv, Plovdiv,
Bulgaria
Purpose: Our purpose was to evaluate the clinical characteristics and
outcome of Bulgarian patients diagnosed with status epilepticus (SE).
Method: We performed a prospective study of 95 consecutive patients
aged 18 years and above, who were admitted in a neuro-intensive care
unit and diagnosed with SE over a period of 3 years. Demographics and
clinical data concerning established epilepsy and SE were collected. The
functional outcome assessment was based on the results from Glasgow
Outcome Scale.
Results: The mean age of study participants was 50.32 years. Mental
retardation had been diagnosed in 13.68% of patients. Existing neurologi-
cal abnormalities had been found in 44.21%. Convulsive SE was
observed in 77.89% of participants. SE etiology included: idiopathic
(35.79%), acute symptomatic (8.42%), remote symptomatic (47.37%),
and progressive encephalopathy (8.42%). The most common SE trigger
factors were poor compliance (29.48%) and alcohol (11.58%). In 41.05%
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SE was treated with a combination of antiepileptic drugs. In 25.31% SE
was refractory to 2 antiepileptic drugs and lasted more than 60 minutes.
Regarding SE functional outcome, mortality was 5.26%, 34.73% were
severely or moderately disabled on hospital discharge, 60% recovered
well. SE outcome depended on age (P < 0.001), existing neurological
abnormalities (P < 0.001), mental retardation (P < 0.01), etiology of
epilepsy (P < 0.01,) SE etiology (P < 0.001), SE type (P < 0.05), SE
duration (P < 0.05).
Conclusion: This study makes a detailed clinical profile of patients with
SE and emphasizes the role of some clinical and demographic factors for
SE outcome.
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SIX CASESOFREFRACTORY STATUS EPILEPTICUS
IN TERTIARY INTENSIVE CAREUNITWITH
DIFFERENT ETIOLOGIES
M.F. Yetkin, F.F. Erdogan, S. Ismailogullari
Erciyes University Faculty of Medicine, Neurology Department,
Kayseri, Turkey
Purpose: The aim of this study is to evaluate refractory status epilepticus
on six cases with etiology, seizure type, imaging and treatment options.
Method: Retrospective data from January 2013 to January 2015 were
obtained from records for six refractory status epilepticus patients.
Results: Six patients were followed in two years diagnosed as refractory
status epilecticus. First case was progressive myoclonic epilepsy that first
myoclonic seizure was started at the age of 23, admitted to emergency
department with fever and recurrent seizures. Brain MRI including hip-
pocampal region was normal but EEG revealed seriously unorganized
background activity with frequently occurring spikemultispike waves
prominent in frontal regions. Refractory status epilepticus was treated
with steroid regimen. Second case was admitted with myoclonies on right
shoulder and gradually become more frequent. Myoclonies become gen-
eralized and almost continuous. Patient was diagnosed as MERRF
because of gradually occurring hear loss, myoclonic seizures, MRİ fea-
tures and history of exercise intolerance and poor night vision history.
Third case had refractory complex partial seizures due to limbic
encephalitis. Patient was seizure free after intravenous immune globulin,
steroid and conventional antiepileptic treatment regimen. Fourth case
was diagnosed as tuberous sclerosis when he was 6 month old after his
first seizure with typical MRI features. Seizures were terminated with
successful antiepileptic regimen including rapamycin and vigabatrin.
Fifth cases seizures were started after stroke affecting temporal lobe.
Patient was seizure free with levetiracetam treatment until urinary infec-
tion and secondary sepsis triggered seizures. Sixth case was diagnosed as
idiopathic generalized epilepsy and seizures became intractable because
of patients insufficient treatment adherence.
Conclusion: Refractory status epilepticus is a heterogeneous condition
arising as the final common pathway from multiple causes. Early recog-
nition and initiation of specific treatment for underlying pathology leads
to a better response and may improve outcomes.
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STATUS EPILEPTICUS IN THEELDERLY IN THE
SUPER-AGING SOCIETY: CLINICALANDEEG
FEATURES AND PROGNOSTIC FACTORS
H. Yoshimura*, R. Matsumoto†, J. Ishii*, T. Kono*, T. Hoshi*,
K. Todo*, M. Kawamoto*, K. Ariyoshi‡, A. Ikeda†, N. Kohara*
*Kobe City Medical Center General Hospital, Department of
Neurology, Kobe, Japan, †Kyoto University Graduate School of
Medicine, Department of Epilepsy, Movement Disorders and
Physiology, Kyoto, Japan, ‡Kobe City Medical Center General
Hospital, Emergency Department, Kobe, Japan
Purpose: We aimed to clarify clinical and EEG features, and prognostic
factors of SE in the elderly in the super-aging society.
Method: We retrospectively investigated 107 consecutive patients (43
men and 64 women) 65 years or older with SE, who were hospitalized in
the comprehensive community hospital from July 2011 to October 2014.
SE was defined as either more than 30 minutes of continuous seizure
activity, or intermittent seizures without full recovery of consciousness
between seizures, and considered refractory when a benzodiazepine and
another antiepileptic drug could not discontinue the clinical or EEG sei-
zure activity. Poor outcome was defined as mortality and persistent mor-
bidity at discharge compared to premorbid state, by rating with modified
Rankin Scale (mRS).
Results: Median age was 80 years (range, 66–98). Median premorbid
mRS was 3. 34 patients (31.8%) had been living in nursing homes. Med-
ian duration of hospitalization was 16 days. 34 patients (31.8%) had been
diagnosed as epilepsy syndrome. Etiology was acute symptomatic in 23
(21.3%), remote symptomatic in 66 (61.7%), and cryptogenic in 18
(16.8%). Acute and remote cerebrovascular disease and dementia were
the major cause. Emergent EEG revealed lateralized periodic discharges
(LPDs) in 23 (21.5%), generalized or lateralized rhythmic delta activity
(GRDA or LRDA) in 10 (9.3%), and conventional seizure patterns with-
out LPDs, LRDA or GRDA in 10 (9.3%). 33 patients (30.8%) had refrac-
tory SE (RSE). 41 patients (38.3%) had poor outcome. Univariate
analysis showed that poor outcome was significantly associated with no
past history of epilepsy syndrome (p = 0.003), acute symptomatic etiol-
ogy (p = 0.04), and RSE (p < 0.001). RSE remained significant with
multivariate analysis (p < 0.001).
Conclusion: Among the elderly, SE occurred in already disabled people
and often further exacerbated activities of daily living. Refractoriness to
the initial therapy was common and regarded as significant prognostic
factor.
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PHARMACOLOGICAL CHARACTERIZATIONOFAN
ANTISENSEKNOCKDOWNZEBRAFISHMODELOF
DRAVET SYNDROME: INHIBITIONOFEPILEPTIC
SEIZURES BYTHE SEROTONIN AGONIST
FENFLURAMINE
Y. Zhang*, A. Kecskes*, D. Copmans*, M. Langlois†,
A.D. Crawford†, B. Ceulemans‡, L. Lagae§, P.A.M. de Witte*,
C.V. Esguerra¶
*Department of Pharmaceutical and Pharmacological Sciences,
KU Leuven, Laboratory for Molecular Biodiscovery, Leuven,
Belgium, †Luxembourg Center for Systems Biomedicine,
University of Luxembourg, Esch-Belval, Luxembourg,
‡Neurology-Child Neurology, University Hospital Antwerp &
University of Antwerp, Antwerp, Belgium, §Paediatric
Neurology, University Hospitals Leuven/KU Leuven, Leuven,
Belgium, ¶Biotechnology Centre of Oslo, Chemical
Neuroscience Group, University of Oslo, Oslo, Norway
Purpose: Dravet syndrome (DS) is one of the most pharmacoresistant
and devastating form of childhood epilepsy syndromes. Distinct de novo
mutations in the SCN1A gene are responsible for over 80% of DS cases.
While DS is largely resistant to treatment with existing anti-epileptic
drugs, promising results have been obtained in clinical trials with human
patients treated with the serotonin agonist fenfluramine as an add-on ther-
apeutic. In order to be able to rapidly analyze the potential anti-epileptic
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activity of fenfluramine, we developed a zebrafish model for this disorder
using morpholino antisense oligomers (MOs).
Method: Zebrafish model of DS was generated by MOs targeting sc-
n1Lab, the zebrafish ortholog of SCN1A. Zebrafish larvae with an anti-
sense knockdown of scn1Lab (scn1Lab morphants) were characterized
by automated behavioral tracking and high-resolution video imaging, in
addition to measuring brain activity through local field potential record-
ings. In additional, hyperthermia induced abnormalities was investigated
by heatshock experiment.
Results: Our findings reveal that scn1Labmorphants display hyperactiv-
ity, convulsive seizure-like behavior, loss of posture, repetitive jerking
and a myoclonic seizure-like pattern. The occurrence of spontaneous sei-
zures was confirmed by local field potential recordings of the forebrain.
Furthermore, we show that these larvae are remarkably sensitive to
hyperthermia. Pharmacological evaluation revealed that sodium val-
proate and fenfluramine significantly decreased the hyperactivity and
reduced epileptiform discharges in scn1Labmorphants.
Conclusion: Our findings for this zebrafish model of DS are in accor-
dance with clinical data for human DS patients. To our knowledge, this is
the first study demonstrating effective seizure inhibition of fenfluramine
in an animal model of Dravet syndrome. Moreover, these results provide
a basis for identifying novel analogs with improved activity and signifi-
cantly milder or no side effects for Dravet syndrome children.
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